Citrus Sinensis ID: 013421

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440---
Protein Sequence
MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEGSSLLRTMSC
Secondary Structure (PSIPRED)
cccccccEEcEEEEEEEEccccEEEEEEEEcccccEEEEEEEEcHHHccccHHHHHHHHHHHHHHcccccEEEEEEEEEcccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEEccccccccccccccccccccccccHHHHccccccccccccHHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccHHHHHHcccccccccccccccccccccccEEccccHHHHHHHHHHHHHHcccEEEEEccEEEEEEccccccccEEEEEEEEEEEccEEEEEEEEccccHHHHHHHHHHHHHccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccHHHEEEEEEEEEccccEEEEEEEcccccEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccEEEcccccHccccHHHHHcccccccHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccccEEEHHHHHccHcHcccccccccccccccccccccccccccccccccccccccccccccccHHHEEEcccccccHHHHHccccccEEEEEEEccccHHHHHHHHHHHHHHcccEEEEcccEEEEEEcccccccEEEEEEEEEEEcccEEEEEEEcccccHHHHHHHHHHHcHHHHHEEEccccccHccccccc
Coil and Loop (DISEMBL)
MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHChskgvyhrdlkpenllldsygnlkvsdfglsalpqqgvellhttcgtpnyvapevlsnrgydgsaadvWSCGVILFVLMAgylpfgetdlptLYKKInaaefscpfwfstgatslihkildpnpktririegirkhpwfrknynpvkcseeeevnlddvhavfdDIEDQYVAEqsenkvggpllMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKtrlegvsanktgQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIiwkptegssllrtmsc
Flexible Loop (DISEMBL)
mkkqtrrvakyevgrtigegtfakvrfaqnretgesvaMKVLakstilkhrmvDQIKREIsimkivrhpniVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATslihkildpnpktririegirkhpwfrknynPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRlegvsanktgQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENiiwkptegssllrtmsc
Low Complexity Region (SEG)
MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEGSSLLRTMSC
Disordered region (IsUnstruct)
*********KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKP************
Disordered Region (DISOPRED)
******R**KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE*VNLDDVHAVF*********************MNAFEMITLSQGLNLA************************IL******************************TGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKP************
Disordered Region (DISEMBL)
**********YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEGS********
Disordered Region (DISPRO)
****TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK*********************************GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTE**********
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEGSSLLRTMSC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	443	2.2.26 [Sep-21-2011]
Q9LDI3	446	CBL-interacting serine/th	yes	no	0.997	0.991	0.764	0.0
Q69Q47	453	CBL-interacting protein k	yes	no	0.988	0.966	0.746	0.0
Q9STV4	445	CBL-interacting serine/th	no	no	0.968	0.964	0.693	0.0
Q5JLD8	446	CBL-interacting protein k	no	no	0.966	0.959	0.700	0.0
Q6ZLP5	450	CBL-interacting protein k	no	no	0.950	0.935	0.616	1e-160
Q93VD3	482	CBL-interacting serine/th	no	no	0.952	0.875	0.604	1e-157
Q2V452	441	CBL-interacting serine/th	no	no	0.957	0.961	0.593	1e-155
Q2QY53	438	CBL-interacting protein k	no	no	0.954	0.965	0.604	1e-155
Q84VQ3	439	CBL-interacting serine/th	no	no	0.972	0.981	0.590	1e-154
Q2RAX3	454	CBL-interacting protein k	no	no	0.954	0.931	0.582	1e-150

>sp|Q9LDI3|CIPKO_ARATH CBL-interacting serine/threonine-protein kinase 24 OS=Arabidopsis thaliana GN=CIPK24 PE=1 SV=1

 Score =  725 bits (1871), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/445 (76%), Positives = 393/445 (88%), Gaps = 3/445 (0%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M K+ RRV KYEVGRTIGEGTFAKV+FA+N +TG++VA+K++AKSTILK+RMVDQIKREI
Sbjct: 1   MTKKMRRVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRL+EVLAS +K+YI+LEFVTGGELFD+IVH+GRL E++ R+YFQQL+D
Sbjct: 61  SIMKIVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVD 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCH KGVYHRDLKPENLLLD+ GNLKVSDFGLSALPQ+GVELL TTCGTPNYVAPEV
Sbjct: 121 AVAHCHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVELLRTTCGTPNYVAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           LS +GYDGSAAD+WSCGVILFV++AGYLPF ETDLP LY+KINAAEFSCP WFS     L
Sbjct: 181 LSGQGYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFL 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           IH+ILDPNPKTRI+I+GI+K PWFR NY P++  EEEEVNLDD+ AVFD IE  YVAE  
Sbjct: 241 IHRILDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENV 300

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
           E    GPL+MNAFEMITLSQGLNL+ALFDRRQD+VKRQTRFVSR+    I++NIEAVA S
Sbjct: 301 ERNDEGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANS 360

Query: 361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
           +  K HTRN+KTRLEG+S+ K GQ AVV+E++EVAPSLFMVDVRKAAG+TLEYHKFYK  
Sbjct: 361 MGFKSHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKL 420

Query: 421 CAKLENIIWKPTEG---SSLLRTMS 442
           C+KLENIIW+ TEG   S +LRT++
Sbjct: 421 CSKLENIIWRATEGIPKSEILRTIT 445

Involved in the regulatory pathway for the control of intracellular Na(+) and K(+) homeostasis and salt tolerance. Activates the vacuolar H(+)/Ca(2+) antiporter CAX1 and operates in synergy with CBL4/SOS3 to activate the plasma membrane Na(+)/H(+) antiporter SOS1. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q69Q47|CIPKO_ORYSJ CBL-interacting protein kinase 24 OS=Oryza sativa subsp. japonica GN=CIPK24 PE=1 SV=1

 Score =  703 bits (1814), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/441 (74%), Positives = 383/441 (86%), Gaps = 3/441 (0%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           +RV +YEVGRTIG+GTFAKV+FA + +TG +VAMKVL K TIL HRM+ QIKREISIMKI
Sbjct: 13  KRVGRYEVGRTIGQGTFAKVKFAVDADTGAAVAMKVLDKDTILNHRMLHQIKREISIMKI 72

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           VRHPNIVRL+EVLA +TK+YIILE +TGGELFDKI  QG+L EN+ R+YFQQLIDA+ +C
Sbjct: 73  VRHPNIVRLNEVLAGKTKIYIILELITGGELFDKIARQGKLRENEARKYFQQLIDAINYC 132

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HSKGVYHRDLKPENLLLDS GNLKVSDFGLS L Q+GV LLHTTCGTPNYVAPEVLSN G
Sbjct: 133 HSKGVYHRDLKPENLLLDSRGNLKVSDFGLSTLAQKGVGLLHTTCGTPNYVAPEVLSNNG 192

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           YDGSAADVWSCGVIL+VLMAGYLPF E DLPTLY KI A +FSCP+WFS GATSLIH+IL
Sbjct: 193 YDGSAADVWSCGVILYVLMAGYLPFEEDDLPTLYDKITAGQFSCPYWFSPGATSLIHRIL 252

Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVG 305
           DPNPKTRI IE IR+  WF+K Y  +K  E+E V+LDDV AVFD+IED+YV+EQ  +  G
Sbjct: 253 DPNPKTRITIEQIREDTWFKKTYVAIKRGEDENVDLDDVQAVFDNIEDKYVSEQVTHNDG 312

Query: 306 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 365
           GPL+MNAFEMITLSQGL+L+ALFDR+Q++VKRQTRFVSR+PA+ I++ IE VAE++ LKV
Sbjct: 313 GPLVMNAFEMITLSQGLDLSALFDRQQEFVKRQTRFVSRKPAKTIVATIEVVAETMGLKV 372

Query: 366 HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLE 425
           H++NYK RLEGVS+N+   FAVVL+VFEVAPSLFMVDVRK AGDTLEYH+FYKN C K+E
Sbjct: 373 HSQNYKLRLEGVSSNRMSPFAVVLQVFEVAPSLFMVDVRKVAGDTLEYHRFYKNLCNKME 432

Query: 426 NIIWKPTE---GSSLLRTMSC 443
           +IIW+P E    S+LLRT +C
Sbjct: 433 SIIWRPIEVSAKSALLRTATC 453

Involved in the regulatory pathway for the control of intracellular Na(+) and K(+) homeostasis and salt tolerance. Operates in synergy with CBL4 to activate the plasma membrane Na(+)/H(+) antiporter SOS1. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9STV4|CIPK8_ARATH CBL-interacting serine/threonine-protein kinase 8 OS=Arabidopsis thaliana GN=CIPK8 PE=1 SV=1

 Score =  643 bits (1659), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 298/430 (69%), Positives = 362/430 (84%), Gaps = 1/430 (0%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R+V KYE+GRTIGEGTFAKV+FAQN ETGESVAMK++ +STI+K +MVDQIKREISIMK+
Sbjct: 4   RKVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKL 63

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           VRHP +VRL+EVLASRTK+YIILE++TGGELFDKIV  GRL E++ R+YF QLID V +C
Sbjct: 64  VRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYC 123

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HSKGVYHRDLKPENLLLDS GNLK+SDFGLSALP+QGV +L TTCGTPNYVAPEVLS++G
Sbjct: 124 HSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQGVTILKTTCGTPNYVAPEVLSHKG 183

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           Y+G+ AD+WSCGVIL+VLMAGYLPF E DLPTLY KI+ AEFSCP +F+ GA SLI++IL
Sbjct: 184 YNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLINRIL 243

Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVG 305
           DPNP+TRI I  IRK  WF K+Y PV+  + E VNLDDV+A FDD E+Q  A Q   +  
Sbjct: 244 DPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYA-QDGTRDT 302

Query: 306 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 365
           GPL +NAF++I LSQGLNLA LFDR +D +K QTRF+S +PA V+LS++E V++S+  K 
Sbjct: 303 GPLTLNAFDLIILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQSMGFKT 362

Query: 366 HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLE 425
           H RNYK R+EG+SANKT  F+V+LEVF+VAPS+ MVD++ AAGD  EY KFYK FC+KL+
Sbjct: 363 HIRNYKMRVEGLSANKTSHFSVILEVFKVAPSILMVDIQNAAGDAEEYLKFYKTFCSKLD 422

Query: 426 NIIWKPTEGS 435
           +IIWKP + S
Sbjct: 423 DIIWKPPDAS 432

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5JLD8|CIPK8_ORYSJ CBL-interacting protein kinase 8 OS=Oryza sativa subsp. japonica GN=CIPK8 PE=2 SV=1

 Score =  642 bits (1656), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 302/431 (70%), Positives = 358/431 (83%), Gaps = 3/431 (0%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           RRV KYEVGRTIGEGTFAKV+FAQN E+GESVAMKV+ +S+ILKH+M DQIKREISIMK+
Sbjct: 8   RRVGKYEVGRTIGEGTFAKVKFAQNTESGESVAMKVVDRSSILKHKMADQIKREISIMKL 67

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           VRHPN+VRLHEVLASR K++IILEF+TGGELFDKI+  GRL E D RRYFQQLID V  C
Sbjct: 68  VRHPNVVRLHEVLASRKKIFIILEFITGGELFDKIIRHGRLNEADARRYFQQLIDGVDFC 127

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HSKGVYHRDLKPENLLLDS GNLK+SDFGLSA P QG  LL TTCGTPNYVAPEVLS++G
Sbjct: 128 HSKGVYHRDLKPENLLLDSQGNLKISDFGLSAWPAQGGALLRTTCGTPNYVAPEVLSHKG 187

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           YDG+ AD WSCGVIL+VL+AGYLPF E DL TLY KI +AE+S P WF  GA SLIH+IL
Sbjct: 188 YDGALADTWSCGVILYVLLAGYLPFDEVDLTTLYGKIESAEYSFPAWFPNGAKSLIHRIL 247

Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVG 305
           DPNP  RIRIE IR   WF+KNY P +  E EEVNLDDV+A FDD E+   A+ + +   
Sbjct: 248 DPNPDKRIRIEEIRNDEWFKKNYEPTREIESEEVNLDDVNAAFDDPEED--ADHTLDDEA 305

Query: 306 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 365
           GPL +NAF++I LSQGLNLAALFDRRQDY K Q RF+SR+PA+VI+S++E VA+S+  K 
Sbjct: 306 GPLTLNAFDLIILSQGLNLAALFDRRQDYDKLQNRFLSRKPAKVIMSSMEVVAQSMGYKT 365

Query: 366 HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLE 425
           H RNYK R+EG++ANKT   AV+LE+FEVAPS+FM+++++AAGDT +Y+KF  N+C+KL+
Sbjct: 366 HIRNYKMRVEGLNANKTSHLAVMLEIFEVAPSIFMIELQRAAGDTSDYNKFINNYCSKLD 425

Query: 426 NIIWK-PTEGS 435
           +IIW  P E S
Sbjct: 426 DIIWNFPIEKS 436

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1

 Score =  565 bits (1455), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 265/430 (61%), Positives = 340/430 (79%), Gaps = 9/430 (2%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           RV +YE+GRT+GEGTFAKV+FA+N ++GE+VA+K+L K  +LKH+M+ QIKREIS MK++
Sbjct: 9   RVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKREISTMKLI 68

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           RHPN++R+HEV+AS+TK+YI++E VTGGELFDKI  +GRL E+D R+YFQQLI+AV +CH
Sbjct: 69  RHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQLINAVDYCH 128

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNR 184
           S+GVYHRDLKPENLLLD+ G LKVSDFGLSAL QQ  E  LLHTTCGTPNYVAPEV++N+
Sbjct: 129 SRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYVAPEVINNK 188

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
           GYDG+ AD+WSCGVILFVLMAGYLPF +++L +LYKKI  A+FSCP WFST A  LI KI
Sbjct: 189 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTSAKKLIKKI 248

Query: 245 LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIED--QYVAEQSEN 302
           LDPNP TRI I  +  + WF+K Y P +  E  +VNLDD++++F++  D  Q V E+ E 
Sbjct: 249 LDPNPSTRITIAELINNEWFKKGYQPPRF-ETADVNLDDINSIFNESGDQTQLVVERREE 307

Query: 303 KVGGPLLMNAFEMITLSQGLNLAALFDRR-QDYVKRQTRFVSRQPAQVILSNIEAVAESL 361
           +   P +MNAFE+I+ SQGLNL  LF+++ Q  VKR+TRF SR PA  ILS IEA A  +
Sbjct: 308 R---PSVMNAFELISTSQGLNLGTLFEKQSQGSVKRETRFASRLPANEILSKIEAAAGPM 364

Query: 362 SLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFC 421
              V  RNYK +L+G +  + GQ A+  EVFEV PSL+MV++RK+ GDTLE+HKFY N  
Sbjct: 365 GFNVQKRNYKLKLQGENPGRKGQLAIATEVFEVTPSLYMVELRKSNGDTLEFHKFYHNIS 424

Query: 422 AKLENIIWKP 431
             L++++WKP
Sbjct: 425 NGLKDVMWKP 434

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1

 Score =  553 bits (1426), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 258/427 (60%), Positives = 332/427 (77%), Gaps = 5/427 (1%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           V KYE+GRT+GEGTFAKV+FA+N E G++VA+KV+ K  +LK++M+ QIKREIS MK+++
Sbjct: 28  VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++R+ EV+AS+TK+Y +LEFVTGGELFDKI   GRL E++ R+YFQQLI+AV +CHS
Sbjct: 88  HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRG 185
           +GVYHRDLKPENLLLD+ G LKVSDFGLSALPQQ  E  LLHTTCGTPNYVAPEV++N+G
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           YDG+ AD+WSCGVILFVLMAGYLPF +++L +LYKKI  AEF+CP WFS  A  LI +IL
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRIL 267

Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIED--QYVAEQSENK 303
           DPNP TRI    + ++ WF+K Y   K  E  +V+LDDV A+FDD  +    V E+ E  
Sbjct: 268 DPNPATRITFAEVIENEWFKKGYKAPKF-ENADVSLDDVDAIFDDSGESKNLVVERREEG 326

Query: 304 VGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSL 363
           +  P+ MNAFE+I+ SQGLNL +LF+++   VKR+TRF S+  A  I++ IEA A  +  
Sbjct: 327 LKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGF 386

Query: 364 KVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAK 423
            V T NYK +L G  + + GQ AV  EVF+VAPSL+MV++RK+ GDTLE+HKFYKN    
Sbjct: 387 DVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLTTG 446

Query: 424 LENIIWK 430
           L++I+WK
Sbjct: 447 LKDIVWK 453

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2

 Score =  547 bits (1409), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 255/430 (59%), Positives = 329/430 (76%), Gaps = 6/430 (1%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           RRV KYEVGRTIGEGTFAKV+FA+N ETGE VA+K+L K  +LKH+M +QI+REI+ MK+
Sbjct: 9   RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMKL 68

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           ++HPN+V+L+EV+AS+TK++IILE+VTGGELFDKIV+ GR+ E++ RRYFQQLI AV +C
Sbjct: 69  IKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYC 128

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSN 183
           HS+GVYHRDLKPENLLLDSYGNLK+SDFGLSAL QQ  +  LLHT+CGTPNYVAPEVL++
Sbjct: 129 HSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLND 188

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 243
           RGYDG+ AD+WSCGV+L+VL+AGYLPF +++L  LYKKI++ EF+CP W S GA  LI +
Sbjct: 189 RGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLITR 248

Query: 244 ILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENK 303
           ILDPNP TR+  + + +  WF+K+Y P    E ++ N+DD+ AVF D E+  V E+ E +
Sbjct: 249 ILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKREEQ 308

Query: 304 VGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSL 363
              P  +NAFE+I++S+GLNL  LFD  Q++ KR+TR   R  A  I+  IE  A+ L  
Sbjct: 309 ---PAAINAFEIISMSRGLNLENLFDPEQEF-KRETRITLRGGANEIIEKIEEAAKPLGF 364

Query: 364 KVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAK 423
            V  +NYK RLE V A + G   V  E+F+VAPSL MV V K+ GDTLE+HKFYK     
Sbjct: 365 DVQKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKLSNS 424

Query: 424 LENIIWKPTE 433
           LE ++W   E
Sbjct: 425 LEQVVWTNNE 434

Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2

 Score =  546 bits (1408), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 260/430 (60%), Positives = 333/430 (77%), Gaps = 7/430 (1%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  RRV KYE+GRTIGEGTFAKV+FA++ ETG+ VA+K+L K  +LKH+MV+QIKREIS 
Sbjct: 5   KVKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREIST 64

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           MK+++HPN+VR++EV+ S+TK+YI+LE+VTGGELFD IV+ GR+ E++ RRYFQQLI+AV
Sbjct: 65  MKLIKHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAV 124

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 180
            +CHS+GVYHRDLKPENLLLDSYGNLKVSDFGLSAL QQ  +  LLHTTCGTPNYVAPEV
Sbjct: 125 DYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEV 184

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L ++GYDG+ AD+WSCGVILFVL+AGYLPF +++L TLYKKI+ AEF+ P W S  A  L
Sbjct: 185 LEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRL 244

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           + +ILDPNP TR+ I  I +  WF+K Y   +  E+ +  LDDV+AVF+D E+ +V E+ 
Sbjct: 245 LTRILDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSEEHHVTEKK 304

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
           E     P  +NAFE+I++S GLNL  LFD  Q++ KR+TRF S+ P + I+  IE  A+ 
Sbjct: 305 EE----PEALNAFELISMSAGLNLGNLFDSEQEF-KRETRFTSKCPPKEIVRKIEEAAKP 359

Query: 361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
           L   V  +NYK RLE V A + G   V  E+ +VAPSL MV+VRKA GDTLE+HKFYKN 
Sbjct: 360 LGFDVQKKNYKLRLEKVKAGRKGNLNVATEILQVAPSLHMVEVRKAKGDTLEFHKFYKNL 419

Query: 421 CAKLENIIWK 430
              L++++WK
Sbjct: 420 SRTLKDVVWK 429

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2

 Score =  546 bits (1406), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 258/437 (59%), Positives = 328/437 (75%), Gaps = 6/437 (1%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  RRV KYEVG+T+G+GTFAKVR A N ETGE VA+K+L K  +LKH+M +QI+REI  
Sbjct: 5   KVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICT 64

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           MK++ HPN+VRL+EVLAS+TK+YI+LEF TGGELFDKIVH GRL E + R+YFQQLI+AV
Sbjct: 65  MKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAV 124

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV 180
            +CHS+GVYHRDLKPENLLLD+ GNLKVSDFGLSAL +Q  G  LLHT CGTPNY APEV
Sbjct: 125 DYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEV 184

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L+++GYDG+ AD+WSCGVILFVL+AGYLPF +++L TLYKKI A E+ CP W S GA +L
Sbjct: 185 LNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNL 244

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           I +ILDPNP TRI I  +    WF+KNY P    E+EE NLDDV AVF D E+ +V E+ 
Sbjct: 245 IVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKK 304

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
           E +   P  MNAFE+I++S+ L+L  LF+  + + KR+TRF ++  A  ++  IE  ++ 
Sbjct: 305 EEQ---PTSMNAFELISMSRALDLGNLFEEEEGF-KRETRFAAKGAANDLVQKIEEASKP 360

Query: 361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
           L   +  +NYK RLE V+A + G   V  E+F+V+PSL M++VRK  GDTLE+HKFYK  
Sbjct: 361 LGFDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKL 420

Query: 421 CAKLENIIWKPTEGSSL 437
              L +++WK  E S L
Sbjct: 421 STSLNDVVWKSGESSGL 437

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1

 Score =  533 bits (1372), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 260/446 (58%), Positives = 331/446 (74%), Gaps = 23/446 (5%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  RRV KYE+GRTIGEGTFAKV+FA++ ETG+ VA+K+L K  +LKH+MV+QIKREIS 
Sbjct: 5   KVKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREIST 64

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           MK+++HPN+VR++EV+ S+T +YI+LE+VTGGELFD IV+ GR+ E++ RRYFQQLI+AV
Sbjct: 65  MKLIKHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAV 124

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 180
            +CHS+GVYHRDLKPENLLLDSYGNLKVSDFGLSAL QQ  +  LLHTTCGTPNYVAPEV
Sbjct: 125 DYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEV 184

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L ++GYDG+ AD+WSCGVILFVL+AGYLPF +++L TLYKKI+ AEF+ P W S  A  L
Sbjct: 185 LEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRL 244

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           + +ILDPNP TRI I  I +  WF+K Y   +  E+ +  LDDV AVF+D E+ +V E+ 
Sbjct: 245 LTRILDPNPMTRITIPEILEDEWFKKGYKRPEFDEKYDTTLDDVDAVFNDSEEHHVTEKK 304

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
           E     P  +NAFE+I++S GLNL  LFD  Q++ KR+TRF S+ P + I+  IE  A+ 
Sbjct: 305 EE----PEALNAFELISMSAGLNLGNLFDSEQEF-KRETRFTSKCPPKEIVRKIEEAAKP 359

Query: 361 LSLKVHTRNYKT----------------RLEGVSANKTGQFAVVLEVFEVAPSLFMVDVR 404
           L   V  +NYK                 RLE V A + G   V  E+ +VAPSL MV+VR
Sbjct: 360 LGFDVQKKNYKICSPCLTTICMNIPFKLRLEKVKAGRKGNLNVATEILQVAPSLHMVEVR 419

Query: 405 KAAGDTLEYHKFYKNFCAKLENIIWK 430
           KA GDTLE+HKFYKN    L++++WK
Sbjct: 420 KAKGDTLEFHKFYKNLSRTLKDVVWK 445

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	443
255567051	449	CBL-interacting serine/threonine-protein	1.0	0.986	0.854	0.0
147846506	446	hypothetical protein VITISV_043742 [Viti	1.0	0.993	0.849	0.0
225445529	446	PREDICTED: CBL-interacting serine/threon	1.0	0.993	0.849	0.0
224993594	444	CBL-interacting protein kinase 26 [Popul	0.986	0.984	0.858	0.0
224142617	444	predicted protein [Populus trichocarpa]	0.986	0.984	0.853	0.0
229893775	446	serine/threonine protein kinase [Malus x	0.997	0.991	0.844	0.0
310896475	445	salt overly sensitive protein 2b [Gossyp	0.997	0.993	0.820	0.0
350535735	446	calcineurin B-like interacting protein k	0.997	0.991	0.802	0.0
224087128	431	predicted protein [Populus trichocarpa]	0.968	0.995	0.834	0.0
356563005	446	PREDICTED: CBL-interacting protein kinas	0.975	0.968	0.810	0.0

>gi|255567051|ref|XP_002524508.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223536296|gb|EEF37948.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  805 bits (2079), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 381/446 (85%), Positives = 416/446 (93%), Gaps = 3/446 (0%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MK  +R+V KYEVGRTIGEGTFAKV+FAQN ETGESVAMKV+AKSTILKHRMVDQIKREI
Sbjct: 4   MKSVSRKVGKYEVGRTIGEGTFAKVKFAQNLETGESVAMKVMAKSTILKHRMVDQIKREI 63

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRH NIVRLHEVLASRTK+YIILEFVTGGELFDKIVHQGRL EN+ RRYFQQLID
Sbjct: 64  SIMKIVRHNNIVRLHEVLASRTKIYIILEFVTGGELFDKIVHQGRLSENEARRYFQQLID 123

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCHSKGVYHRDLKPENLLLDS+GNLKVSDFGLSALPQQGV LLHTTCGTPNYVAPEV
Sbjct: 124 AVAHCHSKGVYHRDLKPENLLLDSFGNLKVSDFGLSALPQQGVGLLHTTCGTPNYVAPEV 183

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           + ++GYDG+AADVWSCGVIL+VLMAGYLPF E DLPTLY+KINAAE+S PFWFS GA SL
Sbjct: 184 IGHQGYDGAAADVWSCGVILYVLMAGYLPFDEVDLPTLYRKINAAEYSSPFWFSPGAKSL 243

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           I KILDPNPKTRI+IEGI+KH WFRKNY PVK SEEEEVNLDDVHAVF DIEDQYVAEQ+
Sbjct: 244 IDKILDPNPKTRIKIEGIKKHLWFRKNYMPVKQSEEEEVNLDDVHAVFGDIEDQYVAEQT 303

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
           EN  GGPL+MNAFEMITLSQGLNL+ALFDR+QDY+KRQTRFVSR+PA+ I+S IEAVAES
Sbjct: 304 ENSEGGPLIMNAFEMITLSQGLNLSALFDRQQDYIKRQTRFVSRRPAKDIISTIEAVAES 363

Query: 361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
           +SLKVHTRNYKTRLEG+SANK G FAVVLEVFEVAPSLFMVDVRKA+GDTLEYHKFYK+F
Sbjct: 364 MSLKVHTRNYKTRLEGISANKAGHFAVVLEVFEVAPSLFMVDVRKASGDTLEYHKFYKDF 423

Query: 421 CAKLENIIWKPTEG---SSLLRTMSC 443
           C+KLE+IIW+P +G    +LLR+M+C
Sbjct: 424 CSKLEDIIWRPADGVNACNLLRSMTC 449

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147846506|emb|CAN83760.1| hypothetical protein VITISV_043742 [Vitis vinifera] gi|229609819|gb|ACQ83525.1| CBL-interacting protein kinase 09 [Vitis vinifera]

 Score =  802 bits (2071), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/446 (84%), Positives = 413/446 (92%), Gaps = 3/446 (0%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK TR+V KYEVGRTIGEGTFAKV+FA N ETGESVAMKV+AKSTILKHRMVDQIK+EI
Sbjct: 1   MKKVTRKVGKYEVGRTIGEGTFAKVKFAHNTETGESVAMKVMAKSTILKHRMVDQIKQEI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRLHEVLAS+T +YIILEFVTGGEL+DKIVHQGRL EN+ RRYFQQLID
Sbjct: 61  SIMKIVRHPNIVRLHEVLASQTTIYIILEFVTGGELYDKIVHQGRLSENESRRYFQQLID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AV+HCHSKGVYHRDLKPENLLLDS GNLKVSDFGLSALP+QGV LLHTTCGTPNYVAPEV
Sbjct: 121 AVSHCHSKGVYHRDLKPENLLLDSNGNLKVSDFGLSALPKQGVGLLHTTCGTPNYVAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           LSN+GYDG+AADVWSCGVIL+VLMAGYLPF E DLP+LYKKINAAEFSCPFWFS+G+ S 
Sbjct: 181 LSNQGYDGAAADVWSCGVILYVLMAGYLPFNEIDLPSLYKKINAAEFSCPFWFSSGSKSF 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           + +ILDPNPKTRIRIEGI+  PWFRKNY   KC E+EEVNLDD+HAVFDDIE+ YV+EQS
Sbjct: 241 LCRILDPNPKTRIRIEGIKNDPWFRKNYVSSKCREDEEVNLDDIHAVFDDIEENYVSEQS 300

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
            N   GPL+MNAFEMITLSQGLNL+ALFDRRQDYVKRQTRFVSR+PA+VI+S IEAVAES
Sbjct: 301 GNNDTGPLIMNAFEMITLSQGLNLSALFDRRQDYVKRQTRFVSREPAKVIISTIEAVAES 360

Query: 361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
           ++ KVHTR+YKTRLEG+SANKT QFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF
Sbjct: 361 MNFKVHTRHYKTRLEGISANKTAQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420

Query: 421 CAKLENIIWKPTEG---SSLLRTMSC 443
           CAKLE+IIWKP E    SSLLRTM+C
Sbjct: 421 CAKLEHIIWKPKEAMTNSSLLRTMTC 446

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225445529|ref|XP_002285262.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 24 [Vitis vinifera] gi|297738965|emb|CBI28210.3| unnamed protein product [Vitis vinifera]

 Score =  801 bits (2069), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/446 (84%), Positives = 413/446 (92%), Gaps = 3/446 (0%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK TR+V KYEVGRTIGEGTFAKV+FA N ETGESVAMKV+AKSTILKHRMVDQIK+EI
Sbjct: 1   MKKVTRKVGKYEVGRTIGEGTFAKVKFAHNTETGESVAMKVMAKSTILKHRMVDQIKQEI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRLHEVLAS+T +YIILEFVTGGEL+DKIVHQGRL EN+ RRYFQQLID
Sbjct: 61  SIMKIVRHPNIVRLHEVLASQTTIYIILEFVTGGELYDKIVHQGRLSENESRRYFQQLID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AV+HCHSKGVYHRDLKPENLLLDS GNLKVSDFGLSALP+QGV LLHTTCGTPNYVAPEV
Sbjct: 121 AVSHCHSKGVYHRDLKPENLLLDSNGNLKVSDFGLSALPKQGVGLLHTTCGTPNYVAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           LSN+GYDG+AADVWSCGVIL+VLMAGYLPF E DLP+LYKKINAAEFSCPFWFS+G+ SL
Sbjct: 181 LSNQGYDGAAADVWSCGVILYVLMAGYLPFNEIDLPSLYKKINAAEFSCPFWFSSGSKSL 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           + +ILD NPKTRIRIEGI+  PWFRKNY   KC E+EEVNLDD+HAVFDDIE+ YV+EQS
Sbjct: 241 LCRILDSNPKTRIRIEGIKNDPWFRKNYVSSKCREDEEVNLDDIHAVFDDIEENYVSEQS 300

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
            N   GPL+MNAFEMITLSQGLNL+ALFDRRQDYVKRQTRFVSR+PA+VI+S IEAVAES
Sbjct: 301 GNNDTGPLIMNAFEMITLSQGLNLSALFDRRQDYVKRQTRFVSREPAKVIISTIEAVAES 360

Query: 361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
           ++ KVHTR+YKTRLEG+SANKT QFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF
Sbjct: 361 MNFKVHTRHYKTRLEGISANKTAQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420

Query: 421 CAKLENIIWKPTEG---SSLLRTMSC 443
           CAKLE+IIWKP E    SSLLRTM+C
Sbjct: 421 CAKLEHIIWKPKEAMTNSSLLRTMTC 446

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224993594|gb|ACN76476.1| CBL-interacting protein kinase 26 [Populus euphratica]

 Score =  796 bits (2055), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 375/437 (85%), Positives = 407/437 (93%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK TR+V KYEVGRTIGEGTFAKV+FAQNRETGESVAMK+L+KS ILKHRMVDQIKREI
Sbjct: 2   MKKVTRKVGKYEVGRTIGEGTFAKVKFAQNRETGESVAMKILSKSAILKHRMVDQIKREI 61

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMK+VRHP IVRLHEVLASRTK+YIILEFVTGGELFDKIVHQGRL EN+ RRYFQQLID
Sbjct: 62  SIMKLVRHPYIVRLHEVLASRTKIYIILEFVTGGELFDKIVHQGRLGENESRRYFQQLID 121

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCH KGVYHRDLKPENLLLD++GNLKVSDFGLSALPQ+GV LLHTTCGTPNYVAPEV
Sbjct: 122 AVAHCHCKGVYHRDLKPENLLLDAFGNLKVSDFGLSALPQKGVGLLHTTCGTPNYVAPEV 181

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L N+GYDG+AADVWSCGVILFVLMAGYLPF E DLPTLY+KINAAE+SCPFWFS GA +L
Sbjct: 182 LGNQGYDGAAADVWSCGVILFVLMAGYLPFEEADLPTLYRKINAAEYSCPFWFSPGAKAL 241

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           I KIL+PNP+TRI IEGI+KHPWF+KNY PV   E+EEVNLDDVHAVFDDIEDQYVAEQ 
Sbjct: 242 IDKILNPNPRTRIGIEGIKKHPWFQKNYEPVGHREDEEVNLDDVHAVFDDIEDQYVAEQL 301

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
           EN VGGPL+MNAFEMITLSQGLNL+ALFDRRQDY+KRQTRFVSR+PA+ I+S IEAVA S
Sbjct: 302 ENSVGGPLVMNAFEMITLSQGLNLSALFDRRQDYIKRQTRFVSRKPAEDIISTIEAVAGS 361

Query: 361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
           ++LKVHTRNYKTRLEGVS NK GQFAVVLEV+EVAPSLFMVD RKA+G+TLEYHKFYKNF
Sbjct: 362 MNLKVHTRNYKTRLEGVSENKAGQFAVVLEVYEVAPSLFMVDARKASGETLEYHKFYKNF 421

Query: 421 CAKLENIIWKPTEGSSL 437
           C KLENIIWKP EG+ L
Sbjct: 422 CTKLENIIWKPPEGAKL 438

Source: Populus euphratica

Species: Populus euphratica

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224142617|ref|XP_002324651.1| predicted protein [Populus trichocarpa] gi|116265968|gb|ABJ91232.1| CBL-interacting protein kinase 26 [Populus trichocarpa] gi|222866085|gb|EEF03216.1| predicted protein [Populus trichocarpa]

 Score =  788 bits (2035), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 373/437 (85%), Positives = 405/437 (92%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK TR+V KYEVGRTIGEGTFAKV+FAQNRETGESVAMK+L+KS ILKHRMVDQIKREI
Sbjct: 2   MKKVTRKVGKYEVGRTIGEGTFAKVKFAQNRETGESVAMKILSKSAILKHRMVDQIKREI 61

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMK+VRHP IV LHEVLASRTK+YIILEFVTGGELFDKIVHQ RL EN+ RRYFQQLID
Sbjct: 62  SIMKLVRHPYIVMLHEVLASRTKIYIILEFVTGGELFDKIVHQRRLEENESRRYFQQLID 121

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCH KGVYHRDLKPENLLLD++GNLKVSDFGLSALPQ+GV LLHTTCGTPNYVAPEV
Sbjct: 122 AVAHCHCKGVYHRDLKPENLLLDAFGNLKVSDFGLSALPQKGVGLLHTTCGTPNYVAPEV 181

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L ++GYDG+AADVWSCGVILFVLMAGYLPF ETDLPTLY+KINAAE+SCPFWFS GA +L
Sbjct: 182 LGHQGYDGAAADVWSCGVILFVLMAGYLPFEETDLPTLYRKINAAEYSCPFWFSPGAKAL 241

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           I KIL+PNPKTRI IEGI+KHPWF+KNY PV   E+EEVNLDDVHAVFDDIEDQYVAEQ 
Sbjct: 242 IDKILNPNPKTRIGIEGIKKHPWFQKNYEPVGHREDEEVNLDDVHAVFDDIEDQYVAEQL 301

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
           EN   GPL+MNAFEMITLSQGLNL+ALFDRRQDY+KRQTRFVSR+PA+ I+S IEAVAES
Sbjct: 302 ENSEDGPLVMNAFEMITLSQGLNLSALFDRRQDYIKRQTRFVSRKPAKDIISAIEAVAES 361

Query: 361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
           ++LKVHTRNYKTRLEGVS NK GQFAVVLEV+EVAPSLFMVD RKA+G+TLEYHKFYKNF
Sbjct: 362 MNLKVHTRNYKTRLEGVSENKAGQFAVVLEVYEVAPSLFMVDARKASGETLEYHKFYKNF 421

Query: 421 CAKLENIIWKPTEGSSL 437
           C KLENIIWKP EG+ L
Sbjct: 422 CTKLENIIWKPPEGAKL 438

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|229893775|gb|ACQ90245.1| serine/threonine protein kinase [Malus x domestica]

 Score =  788 bits (2034), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/445 (84%), Positives = 411/445 (92%), Gaps = 3/445 (0%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK++R V KYEVGRTIGEGTFAKV+FA+N ETGESVAMKVLAKSTILKHRMVDQIKREI
Sbjct: 1   MKKKSRNVGKYEVGRTIGEGTFAKVKFARNCETGESVAMKVLAKSTILKHRMVDQIKREI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRL EVLA RTK++IILEFVTGGELFDKIVHQG+L EN+ R+YFQQLID
Sbjct: 61  SIMKIVRHPNIVRLLEVLAGRTKIFIILEFVTGGELFDKIVHQGKLPENESRKYFQQLID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCHSKGVYHRDLKPENLLLD+YGNLKVSDFGLSALP QG  LLHTTCGTPNY+APEV
Sbjct: 121 AVAHCHSKGVYHRDLKPENLLLDAYGNLKVSDFGLSALPLQGDGLLHTTCGTPNYIAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L ++GYDGSAAD+WSCGVILFVLMAGYLPF ET+L TLY+KIN A+FSCPFWFS  A  L
Sbjct: 181 LGDQGYDGSAADIWSCGVILFVLMAGYLPFDETNLSTLYRKINDADFSCPFWFSPEANKL 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           IHKILDPNPKTRIRI+GIRK PWF+KNY P+   E+EEV+LDDV AVF+DIEDQYVAE+S
Sbjct: 241 IHKILDPNPKTRIRIDGIRKDPWFKKNYAPLTYREDEEVSLDDVRAVFEDIEDQYVAERS 300

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
           E K GGPLLMNAFEMITLSQGLNL+ALFDRRQDYV RQTRFVSR+PA VI+SN+EAVAES
Sbjct: 301 EIKDGGPLLMNAFEMITLSQGLNLSALFDRRQDYVNRQTRFVSRKPAHVIISNVEAVAES 360

Query: 361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
           + LKVHTRNYKTRLEG+SAN+TGQFAVVLEV+EVAPSLFMVDVRKAAGDTLEYHKFYKNF
Sbjct: 361 MGLKVHTRNYKTRLEGISANRTGQFAVVLEVYEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420

Query: 421 CAKLENIIWKPTEG---SSLLRTMS 442
           CAKLE IIWKP EG   S+LL+TM+
Sbjct: 421 CAKLEEIIWKPKEGMGHSNLLKTMT 445

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|310896475|gb|ADP37983.1| salt overly sensitive protein 2b [Gossypium hirsutum]

 Score =  770 bits (1987), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/446 (82%), Positives = 407/446 (91%), Gaps = 4/446 (0%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M+K+T  V KYEVGRTIG+GTFAKV+FA+N  +GESVA+KVL K+TILKHRMVDQIKREI
Sbjct: 1   MRKKTATVGKYEVGRTIGQGTFAKVKFARNSVSGESVALKVLPKATILKHRMVDQIKREI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRLHEVLASRTK+YIILEF++GGELFDKIVH GRL EN+CRRYFQQLID
Sbjct: 61  SIMKIVRHPNIVRLHEVLASRTKIYIILEFISGGELFDKIVHCGRLPENECRRYFQQLID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCHSKGVYHRDLKPENLLLDSYG+LKVSDFGLSAL QQGV LLHTTCGTPNYVAPEV
Sbjct: 121 AVAHCHSKGVYHRDLKPENLLLDSYGDLKVSDFGLSALLQQGVGLLHTTCGTPNYVAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L N+GYDG+AAD+WSCGVILF +MAGYLPF E D+PTLYKKI+A +FS PFWFS  A SL
Sbjct: 181 LGNQGYDGAAADIWSCGVILFFIMAGYLPFYEIDIPTLYKKISAGQFSSPFWFSPEANSL 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           I KILDPNPKTRI+IEGI+KHPWF+KNY PVK S EEEVNLDDV AVFDDIEDQYV+EQS
Sbjct: 241 IKKILDPNPKTRIQIEGIKKHPWFKKNYLPVKPS-EEEVNLDDVRAVFDDIEDQYVSEQS 299

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
             K GGPL+MNAFEMITLSQGLNL++LFDR+QDYVKRQTRFVSR+P + I+S++EAVAES
Sbjct: 300 VAKEGGPLMMNAFEMITLSQGLNLSSLFDRQQDYVKRQTRFVSRKPPRDIISSVEAVAES 359

Query: 361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
           + LKVHTRNYKTRLE +SANK G+FAVVLEVFEVAPSLFM DVRKA+GDTLEYHKFYKNF
Sbjct: 360 MGLKVHTRNYKTRLERISANKVGEFAVVLEVFEVAPSLFMADVRKASGDTLEYHKFYKNF 419

Query: 421 CAKLENIIWKPTE---GSSLLRTMSC 443
           C KLENIIWKPTE     S+LR+++C
Sbjct: 420 CTKLENIIWKPTEDVANPSVLRSLTC 445

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350535735|ref|NP_001234210.1| calcineurin B-like interacting protein kinase [Solanum lycopersicum] gi|66765941|emb|CAG30526.1| calcineurin B-like interacting protein kinase [Solanum lycopersicum] gi|149930452|gb|ABR37648.1| putative SOS2-like protein kinase [Solanum lycopersicum]

 Score =  766 bits (1978), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/445 (80%), Positives = 404/445 (90%), Gaps = 3/445 (0%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK  R++ KYEVGRTIGEGTFAKV+FA+N ETGE+VA+KVLAKSTILKHRMV+QIKREI
Sbjct: 1   MKKVKRKLGKYEVGRTIGEGTFAKVKFARNTETGENVAIKVLAKSTILKHRMVEQIKREI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHP IVRLHEVLAS+TK+YI+ EFVTGGELFDKIVH GRL E++ RRYFQ+LID
Sbjct: 61  SIMKIVRHPCIVRLHEVLASQTKIYIVQEFVTGGELFDKIVHLGRLSEDEARRYFQELID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+AHCHSKGVYHRDLKPENLLLD  GNLK+SDFGLSALPQQGVELL+TTCGTPNYVAPEV
Sbjct: 121 AIAHCHSKGVYHRDLKPENLLLDFQGNLKISDFGLSALPQQGVELLYTTCGTPNYVAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L NRGYDG+AADVWSCG+IL+VLMAGYLPF ETDLPTLY KI AAEFSCPFWFS GATSL
Sbjct: 181 LGNRGYDGAAADVWSCGIILYVLMAGYLPFDETDLPTLYTKIKAAEFSCPFWFSPGATSL 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           I KI+DPNP+TRI+I+GI++ PWFRKNY  VK   +E VNLDD+HAVFDDIED +V+E+S
Sbjct: 241 IQKIIDPNPQTRIKIDGIKRDPWFRKNYRAVKAKADEVVNLDDIHAVFDDIEDAFVSEKS 300

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
           E+   GPL+MNAFEMITLSQGLNL+ALFDRRQDYVKRQTRF+SRQPA+V++  IEA AES
Sbjct: 301 EDSESGPLVMNAFEMITLSQGLNLSALFDRRQDYVKRQTRFISRQPAKVVIETIEAAAES 360

Query: 361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
           L LKVHTR+YKTR+EGV+AN+ GQFAVVLEVF+VAPSLFMVDVRKAAGDTLEYHKFYK F
Sbjct: 361 LGLKVHTRDYKTRIEGVTANRAGQFAVVLEVFQVAPSLFMVDVRKAAGDTLEYHKFYKTF 420

Query: 421 CAKLENIIWKPTEGSS---LLRTMS 442
           C K++++IWKP EG S   LLRT +
Sbjct: 421 CTKIDDVIWKPKEGMSNAVLLRTRT 445

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224087128|ref|XP_002308077.1| predicted protein [Populus trichocarpa] gi|116265970|gb|ABJ91233.1| CBL-interacting protein kinase 27 [Populus trichocarpa] gi|222854053|gb|EEE91600.1| predicted protein [Populus trichocarpa]

 Score =  758 bits (1958), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 362/434 (83%), Positives = 393/434 (90%), Gaps = 5/434 (1%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK TR V KYEVGRTIGEG FAKV+FAQNRETGESVAMK+LAKSTILKH+MVDQIKREI
Sbjct: 2   MKKVTRMVGKYEVGRTIGEGNFAKVKFAQNRETGESVAMKILAKSTILKHKMVDQIKREI 61

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRLHEVL+SRTK+YIILEFVTGGELFDKIVHQGRL EN+ RRYFQQLID
Sbjct: 62  SIMKIVRHPNIVRLHEVLSSRTKIYIILEFVTGGELFDKIVHQGRLSENESRRYFQQLID 121

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCH KGVYHRDLKPENLLLD++GNLKVSDFGLSAL Q+GV LLHTTCGTPNYVAPEV
Sbjct: 122 AVAHCHRKGVYHRDLKPENLLLDAFGNLKVSDFGLSALRQKGVGLLHTTCGTPNYVAPEV 181

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L ++GYDG+AADVWSCGVILFVLMAGYLPF E DLPTL +K     +SCPFWFS  A +L
Sbjct: 182 LGHQGYDGAAADVWSCGVILFVLMAGYLPFEEIDLPTLCRK-----YSCPFWFSPVAKAL 236

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           I KILDPNPKTRI IEGI+KHPWFRK+Y PV  SEEEEVNLDDVHAVFDDIED YVAEQ 
Sbjct: 237 IDKILDPNPKTRIGIEGIKKHPWFRKSYEPVGHSEEEEVNLDDVHAVFDDIEDHYVAEQL 296

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
           EN  GGPL+MNAFEMI LSQGLNL+ALFDRRQDYVK+QTRFVS +PA+VI+S  EAVAES
Sbjct: 297 ENSEGGPLVMNAFEMIALSQGLNLSALFDRRQDYVKKQTRFVSHKPAKVIISAFEAVAES 356

Query: 361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
           ++LK HT NYKTRLEG+S NK GQFAVVLEV+EV PSLFMVD RKA+G+TLEYH+FYKNF
Sbjct: 357 MNLKFHTHNYKTRLEGISENKAGQFAVVLEVYEVGPSLFMVDARKASGETLEYHEFYKNF 416

Query: 421 CAKLENIIWKPTEG 434
           CA+LENIIWKP EG
Sbjct: 417 CAQLENIIWKPPEG 430

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356563005|ref|XP_003549757.1| PREDICTED: CBL-interacting protein kinase 24-like isoform 1 [Glycine max]

 Score =  750 bits (1936), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/432 (81%), Positives = 389/432 (90%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK  R++ KYEVGRTIGEGTFAKV+FA+N ETGESVA+KV+AK+TIL+HRMV+QIKREI
Sbjct: 1   MKKVRRKIGKYEVGRTIGEGTFAKVKFARNSETGESVAIKVMAKTTILQHRMVEQIKREI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRLHEVLAS+TK+YIILEFV GGEL+DKIV  G+L EN+ R YFQQLID
Sbjct: 61  SIMKIVRHPNIVRLHEVLASQTKIYIILEFVMGGELYDKIVQLGKLSENESRHYFQQLID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AV HCH KGVYHRDLKPENLLLD+YGNLKVSDFGLSAL +QG +LLHTTCGTPNYVAPEV
Sbjct: 121 AVDHCHRKGVYHRDLKPENLLLDAYGNLKVSDFGLSALTKQGADLLHTTCGTPNYVAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           LSNRGYDG+AADVWSCGVIL+VLMAGYLPF E DLPTLY++INAAEF CPFWFS    S 
Sbjct: 181 LSNRGYDGAAADVWSCGVILYVLMAGYLPFEEADLPTLYRRINAAEFVCPFWFSADTKSF 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           I KILDPNPKTR++IE IRK PWF+KNY PVK  E+E+VNLDDV AVFDDIEDQYV+E+S
Sbjct: 241 IQKILDPNPKTRVKIEEIRKDPWFKKNYFPVKLGEDEQVNLDDVRAVFDDIEDQYVSERS 300

Query: 301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
           E   GGPL+MNAFEMI LSQGLNL+ LFDR QDYVKRQTRFVSR+PA+VI+S+IEAVAES
Sbjct: 301 EITEGGPLIMNAFEMIALSQGLNLSPLFDRHQDYVKRQTRFVSRKPAKVIISSIEAVAES 360

Query: 361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
           + LKVH+RNYK RLEGVSAN+ GQFAVVLEVFEVAPSLFMVDVRKA GDT +YHKFYKNF
Sbjct: 361 MGLKVHSRNYKVRLEGVSANRVGQFAVVLEVFEVAPSLFMVDVRKATGDTFDYHKFYKNF 420

Query: 421 CAKLENIIWKPT 432
           C KL NIIW+P 
Sbjct: 421 CGKLGNIIWRPA 432

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	443
TAIR|locus:2155233	446	SOS2 "SALT OVERLY SENSITIVE 2"	0.997	0.991	0.764	1e-185
TAIR|locus:2135962	445	CIPK8 "CBL-interacting protein	0.968	0.964	0.690	1.5e-163
TAIR|locus:2009812	482	CIPK23 "CBL-interacting protei	0.954	0.877	0.605	8e-140
TAIR|locus:1005716172	439	CIPK26 "calcineurin B-like pro	0.972	0.981	0.590	2.1e-139
TAIR|locus:2059279	451	CIPK3 "CBL-interacting protein	0.957	0.940	0.593	5.6e-139
TAIR|locus:2126749	441	SIP3 "SOS3-interacting protein	0.927	0.931	0.501	8.3e-106
TAIR|locus:2152380	439	CIPK20 "CBL-interacting protei	0.918	0.927	0.471	1.6e-104
TAIR|locus:2179260	488	CIPK25 "CBL-interacting protei	0.945	0.858	0.490	2.5e-104
TAIR|locus:2181047	421	CIPK15 "CBL-interacting protei	0.905	0.952	0.509	1.3e-102
TAIR|locus:2183720	445	CIPK5 "CBL-interacting protein	0.952	0.948	0.482	1.6e-102

TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1801 (639.0 bits), Expect = 1.0e-185, P = 1.0e-185
 Identities = 340/445 (76%), Positives = 393/445 (88%)

Query:     1 MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
             M K+ RRV KYEVGRTIGEGTFAKV+FA+N +TG++VA+K++AKSTILK+RMVDQIKREI
Sbjct:     1 MTKKMRRVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREI 60

Query:    61 SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
             SIMKIVRHPNIVRL+EVLAS +K+YI+LEFVTGGELFD+IVH+GRL E++ R+YFQQL+D
Sbjct:    61 SIMKIVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVD 120

Query:   121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
             AVAHCH KGVYHRDLKPENLLLD+ GNLKVSDFGLSALPQ+GVELL TTCGTPNYVAPEV
Sbjct:   121 AVAHCHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVELLRTTCGTPNYVAPEV 180

Query:   181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
             LS +GYDGSAAD+WSCGVILFV++AGYLPF ETDLP LY+KINAAEFSCP WFS     L
Sbjct:   181 LSGQGYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFL 240

Query:   241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
             IH+ILDPNPKTRI+I+GI+K PWFR NY P++  EEEEVNLDD+ AVFD IE  YVAE  
Sbjct:   241 IHRILDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENV 300

Query:   301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
             E    GPL+MNAFEMITLSQGLNL+ALFDRRQD+VKRQTRFVSR+    I++NIEAVA S
Sbjct:   301 ERNDEGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANS 360

Query:   361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
             +  K HTRN+KTRLEG+S+ K GQ AVV+E++EVAPSLFMVDVRKAAG+TLEYHKFYK  
Sbjct:   361 MGFKSHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKL 420

Query:   421 CAKLENIIWKPTEG---SSLLRTMS 442
             C+KLENIIW+ TEG   S +LRT++
Sbjct:   421 CSKLENIIWRATEGIPKSEILRTIT 445

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0042802 "identical protein binding" evidence=IPI

GO:0009705 "plant-type vacuole membrane" evidence=IDA

GO:0009651 "response to salt stress" evidence=IMP

TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1592 (565.5 bits), Expect = 1.5e-163, P = 1.5e-163
 Identities = 297/430 (69%), Positives = 361/430 (83%)

Query:     6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
             R+V KYE+GRTIGEGTFAKV+FAQN ETGESVAMK++ +STI+K +MVDQIKREISIMK+
Sbjct:     4 RKVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKL 63

Query:    66 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
             VRHP +VRL+EVLASRTK+YIILE++TGGELFDKIV  GRL E++ R+YF QLID V +C
Sbjct:    64 VRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYC 123

Query:   126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
             HSKGVYHRDLKPENLLLDS GNLK+SDFGLSALP+QGV +L TTCGTPNYVAPEVLS++G
Sbjct:   124 HSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQGVTILKTTCGTPNYVAPEVLSHKG 183

Query:   186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
             Y+G+ AD+WSCGVIL+VLMAGYLPF E DLPTLY KI+ AEFSCP +F+ GA SLI++IL
Sbjct:   184 YNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLINRIL 243

Query:   246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVG 305
             DPNP+TRI I  IRK  WF K+Y PV+  + E VNLDDV+A FDD E+Q  A+      G
Sbjct:   244 DPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGTRDTG 303

Query:   306 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 365
              PL +NAF++I LSQGLNLA LFDR +D +K QTRF+S +PA V+LS++E V++S+  K 
Sbjct:   304 -PLTLNAFDLIILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQSMGFKT 362

Query:   366 HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLE 425
             H RNYK R+EG+SANKT  F+V+LEVF+VAPS+ MVD++ AAGD  EY KFYK FC+KL+
Sbjct:   363 HIRNYKMRVEGLSANKTSHFSVILEVFKVAPSILMVDIQNAAGDAEEYLKFYKTFCSKLD 422

Query:   426 NIIWKPTEGS 435
             +IIWKP + S
Sbjct:   423 DIIWKPPDAS 432

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009749 "response to glucose stimulus" evidence=TAS

GO:0010167 "response to nitrate" evidence=IEP;IMP

GO:0048364 "root development" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 1368 (486.6 bits), Expect = 8.0e-140, P = 8.0e-140
 Identities = 259/428 (60%), Positives = 333/428 (77%)

Query:     7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
             RV KYE+GRT+GEGTFAKV+FA+N E G++VA+KV+ K  +LK++M+ QIKREIS MK++
Sbjct:    27 RVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLI 86

Query:    67 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             +HPN++R+ EV+AS+TK+Y +LEFVTGGELFDKI   GRL E++ R+YFQQLI+AV +CH
Sbjct:    87 KHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCH 146

Query:   127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNR 184
             S+GVYHRDLKPENLLLD+ G LKVSDFGLSALPQQ  E  LLHTTCGTPNYVAPEV++N+
Sbjct:   147 SRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNK 206

Query:   185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
             GYDG+ AD+WSCGVILFVLMAGYLPF +++L +LYKKI  AEF+CP WFS  A  LI +I
Sbjct:   207 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRI 266

Query:   245 LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQ--YVAEQSEN 302
             LDPNP TRI    + ++ WF+K Y   K  E  +V+LDDV A+FDD  +    V E+ E 
Sbjct:   267 LDPNPATRITFAEVIENEWFKKGYKAPKF-ENADVSLDDVDAIFDDSGESKNLVVERREE 325

Query:   303 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 362
              +  P+ MNAFE+I+ SQGLNL +LF+++   VKR+TRF S+  A  I++ IEA A  + 
Sbjct:   326 GLKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMG 385

Query:   363 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 422
               V T NYK +L G  + + GQ AV  EVF+VAPSL+MV++RK+ GDTLE+HKFYKN   
Sbjct:   386 FDVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLTT 445

Query:   423 KLENIIWK 430
              L++I+WK
Sbjct:   446 GLKDIVWK 453

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IPI

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0010107 "potassium ion import" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007584 "response to nutrient" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IMP

GO:0010118 "stomatal movement" evidence=RCA;IMP

GO:0009536 "plastid" evidence=IDA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 1364 (485.2 bits), Expect = 2.1e-139, P = 2.1e-139
 Identities = 258/437 (59%), Positives = 328/437 (75%)

Query:     3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
             K  RRV KYEVG+T+G+GTFAKVR A N ETGE VA+K+L K  +LKH+M +QI+REI  
Sbjct:     5 KVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICT 64

Query:    63 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
             MK++ HPN+VRL+EVLAS+TK+YI+LEF TGGELFDKIVH GRL E + R+YFQQLI+AV
Sbjct:    65 MKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAV 124

Query:   123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV 180
              +CHS+GVYHRDLKPENLLLD+ GNLKVSDFGLSAL +Q  G  LLHT CGTPNY APEV
Sbjct:   125 DYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEV 184

Query:   181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
             L+++GYDG+ AD+WSCGVILFVL+AGYLPF +++L TLYKKI A E+ CP W S GA +L
Sbjct:   185 LNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNL 244

Query:   241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
             I +ILDPNP TRI I  +    WF+KNY P    E+EE NLDDV AVF D E+ +V E+ 
Sbjct:   245 IVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKK 304

Query:   301 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 360
             E +   P  MNAFE+I++S+ L+L  LF+  + + KR+TRF ++  A  ++  IE  ++ 
Sbjct:   305 EEQ---PTSMNAFELISMSRALDLGNLFEEEEGF-KRETRFAAKGAANDLVQKIEEASKP 360

Query:   361 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420
             L   +  +NYK RLE V+A + G   V  E+F+V+PSL M++VRK  GDTLE+HKFYK  
Sbjct:   361 LGFDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKL 420

Query:   421 CAKLENIIWKPTEGSSL 437
                L +++WK  E S L
Sbjct:   421 STSLNDVVWKSGESSGL 437

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007165 "signal transduction" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1360 (483.8 bits), Expect = 5.6e-139, P = 5.6e-139
 Identities = 255/430 (59%), Positives = 329/430 (76%)

Query:     6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
             RRV KYEVGRTIGEGTFAKV+FA+N ETGE VA+K+L K  +LKH+M +QI+REI+ MK+
Sbjct:    19 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMKL 78

Query:    66 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
             ++HPN+V+L+EV+AS+TK++IILE+VTGGELFDKIV+ GR+ E++ RRYFQQLI AV +C
Sbjct:    79 IKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYC 138

Query:   126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSN 183
             HS+GVYHRDLKPENLLLDSYGNLK+SDFGLSAL QQ  +  LLHT+CGTPNYVAPEVL++
Sbjct:   139 HSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLND 198

Query:   184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 243
             RGYDG+ AD+WSCGV+L+VL+AGYLPF +++L  LYKKI++ EF+CP W S GA  LI +
Sbjct:   199 RGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLITR 258

Query:   244 ILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENK 303
             ILDPNP TR+  + + +  WF+K+Y P    E ++ N+DD+ AVF D E+  V E+ E +
Sbjct:   259 ILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKREEQ 318

Query:   304 VGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSL 363
                P  +NAFE+I++S+GLNL  LFD  Q++ KR+TR   R  A  I+  IE  A+ L  
Sbjct:   319 ---PAAINAFEIISMSRGLNLENLFDPEQEF-KRETRITLRGGANEIIEKIEEAAKPLGF 374

Query:   364 KVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAK 423
              V  +NYK RLE V A + G   V  E+F+VAPSL MV V K+ GDTLE+HKFYK     
Sbjct:   375 DVQKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKLSNS 434

Query:   424 LENIIWKPTE 433
             LE ++W   E
Sbjct:   435 LEQVVWTNNE 444

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0009735 "response to cytokinin stimulus" evidence=IEP

TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1047 (373.6 bits), Expect = 8.3e-106, P = 8.3e-106
 Identities = 215/429 (50%), Positives = 288/429 (67%)

Query:    10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
             +YE+GR +G GTFAKV  A+N +TG+SVAMKV+ K  ++K  MVDQIKREIS+M++V+HP
Sbjct:    23 RYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMVKHP 82

Query:    70 NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
             NIV LHEV+AS++K+Y  +E V GGELF K+  +GRL E+  R YFQQLI AV  CHS+G
Sbjct:    83 NIVELHEVMASKSKIYFAMELVRGGELFAKVA-KGRLREDVARVYFQQLISAVDFCHSRG 141

Query:   130 VYHRDLKPENLLLDSYGNLKVSDFGLSA----LPQQGVELLHTTCGTPNYVAPEVLSNRG 185
             VYHRDLKPENLLLD  GNLKV+DFGLSA    L Q G  LLHTTCGTP YVAPEV+  +G
Sbjct:   142 VYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDG--LLHTTCGTPAYVAPEVILKKG 199

Query:   186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
             YDG+ AD+WSCGVILFVL+AGYLPF + +L  +Y+KI   +F CP W S+ A  L+ K+L
Sbjct:   200 YDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLL 259

Query:   246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVG 305
             DPNP TRI IE +   PWF+K       S  E V    +    +D++  ++  +S+ +  
Sbjct:   260 DPNPNTRITIEKVMDSPWFKKQATR---SRNEPVAAT-ITTTEEDVD--FLVHKSKEETE 313

Query:   306 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAE-SLSLK 364
                 +NAF +I LS+G +L+ LF+ ++   KR+ RF + +PA  ++S++E  A       
Sbjct:   314 ---TLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAARVGNKFD 370

Query:   365 VHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAK- 423
             V     + R+EG    + G+ AV  E+F VAPS  +V+V+K  GDTLEY+ F        
Sbjct:   371 VRKSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCSTALRPA 430

Query:   424 LENIIWKPT 432
             L++I W  T
Sbjct:   431 LKDIFWTST 439

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0007275 "multicellular organismal development" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0010540 "basipetal auxin transport" evidence=IMP

GO:0042538 "hyperosmotic salinity response" evidence=IDA

GO:0010118 "stomatal movement" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)]

 Score = 1035 (369.4 bits), Expect = 1.6e-104, P = 1.6e-104
 Identities = 201/426 (47%), Positives = 295/426 (69%)

Query:    10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
             KYE+GR +G+GTFAKV  A+N +TGESVA+KV+ K  + K  ++DQIKREIS+M++VRHP
Sbjct:    11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70

Query:    70 NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
             ++V LHEV+AS+TK+Y  +E+V GGELFDK V +G+L EN  R+YFQQLI A+ +CHS+G
Sbjct:    71 HVVFLHEVMASKTKIYFAMEYVKGGELFDK-VSKGKLKENIARKYFQQLIGAIDYCHSRG 129

Query:   130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYD 187
             VYHRDLKPENLLLD  G+LK+SDFGLSAL +   +  LLHTTCGTP YVAPEV+  +GYD
Sbjct:   130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189

Query:   188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
             G+ ADVWSCGV+L+VL+AG+LPF E +L  +Y+KI   EF CP WF      L+ +ILDP
Sbjct:   190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDP 249

Query:   248 NPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGP 307
             NP +RI+IE I ++ WF+K +  ++  +  E +   + ++  D+   +  +        P
Sbjct:   250 NPNSRIKIEKIMENSWFQKGFKKIETPKSPESH--QIDSLISDVHAAFSVK--------P 299

Query:   308 LLMNAFEMIT-LSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS-LKV 365
             +  NAF++I+ LSQG +L+ LF++ +   + +++F +++ A+ I+S  E +A S     +
Sbjct:   300 MSYNAFDLISSLSQGFDLSGLFEKEE---RSESKFTTKKDAKEIVSKFEEIATSSERFNL 356

Query:   366 HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFY-KNFCAKL 424
                +   ++E     + G  A+ +E+FEV  S  MV+ +K+ GDT+EY +F  +     L
Sbjct:   357 TKSDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCDRELRPSL 416

Query:   425 ENIIWK 430
             ++I+WK
Sbjct:   417 KDIVWK 422

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;TAS

GO:0005524 "ATP binding" evidence=IEA

GO:0005829 "cytosol" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IMP

TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 1033 (368.7 bits), Expect = 2.5e-104, P = 2.5e-104
 Identities = 215/438 (49%), Positives = 300/438 (68%)

Query:     2 KKQTRRV--AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
             ++Q  RV  AKYE+GR +G+GTF KV + +   TGESVA+K++ K  + +  M++QIKRE
Sbjct:    32 EQQQLRVLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQIKRE 91

Query:    60 ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
             ISIM++VRHPNIV L EV+A++TK++ I+E+V GGELF KIV +G+L E+  R+YFQQLI
Sbjct:    92 ISIMRLVRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIV-KGKLKEDSARKYFQQLI 150

Query:   120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVA 177
              AV  CHS+GV HRDLKPENLL+D  G+LKVSDFGLSALP+Q ++  LLHT CGTP YVA
Sbjct:   151 SAVDFCHSRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAYVA 210

Query:   178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGA 237
             PEVL  +GYDG+  D+WSCG+IL+VL+AG+LPF + +L  +Y+KI  +EF  P WFS  +
Sbjct:   211 PEVLRKKGYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSPES 270

Query:   238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PV--KCSEEEEVNLDDVHAVFDDIEDQ 294
               LI K+L  +P  RI I  I + PWFRKN N P+  K  E E  N++D           
Sbjct:   271 KRLISKLLVVDPNKRISIPAIMRTPWFRKNINSPIEFKIDELEIQNVEDETPT----TTA 326

Query:   295 YVAEQSENKVGGPLLMNAFEMIT-LSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSN 353
               A  +   V  P   NAFE I+ +S G +L++LF+ ++   K ++ F SR  A  I+  
Sbjct:   327 TTATTTTTPVS-PKFFNAFEFISSMSSGFDLSSLFESKR---KLRSMFTSRWSASEIMGK 382

Query:   354 IEAVAESLSLKV-HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLE 412
             +E + + +++KV  T+++K +L G +  + GQ AV  EVFEVAP + +V++ K+AGDTLE
Sbjct:   383 LEGIGKEMNMKVKRTKDFKVKLFGKTEGRKGQIAVTAEVFEVAPEVAVVELCKSAGDTLE 442

Query:   413 YHKFYKNFCAK-LENIIW 429
             Y++ Y+      LE I+W
Sbjct:   443 YNRLYEEHVRPALEEIVW 460

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0050832 "defense response to fungus" evidence=IEP

TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)]

 Score = 1017 (363.1 bits), Expect = 1.3e-102, P = 1.3e-102
 Identities = 214/420 (50%), Positives = 287/420 (68%)

Query:     2 KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
             KK +  + +YEVG+ +G+GTFAKV  A++ +TG+SVA+KV+ K  ILK  M +QIKREIS
Sbjct:     3 KKGSVLMLRYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKREIS 62

Query:    62 IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
              M+++RHPNIV LHEV+A+++K+Y ++E V GGELF+K V  G+L E+  R+YFQQL+ A
Sbjct:    63 AMRLLRHPNIVELHEVMATKSKIYFVMEHVKGGELFNK-VSTGKLREDVARKYFQQLVRA 121

Query:   122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPE 179
             V  CHS+GV HRDLKPENLLLD +GNLK+SDFGLSAL     +  LLHTTCGTP YVAPE
Sbjct:   122 VDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAPE 181

Query:   180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 239
             V+S  GYDG  ADVWSCGVILFVL+AGYLPF +++L  LYKKI  AE   P W + GA  
Sbjct:   182 VISRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAKR 241

Query:   240 LIHKILDPNPKTRIRIEGIRKHPWFRKNYNP-VKCSEEEEVNLDDVHAVFDDIEDQYVAE 298
             L+ +ILDPNP TR+  E I K  WFRK     VK S EEE  +D       + E    AE
Sbjct:   242 LLKRILDPNPNTRVSTEKIMKSSWFRKGLQEEVKESVEEETEVDA------EAEGNASAE 295

Query:   299 QSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVA 358
             + + +    + +NAFE+I+LS G +L+ LF++ ++  K + RF S + A  I   +  + 
Sbjct:   296 KEKKRC---INLNAFEIISLSTGFDLSGLFEKGEE--KEEMRFTSNREASEITEKLVEIG 350

Query:   359 ESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYK 418
             + L +KV  + ++ R++ +SA  T    V  EVFE+APS  MV ++K+ GDT EY +  K
Sbjct:   351 KDLKMKVRKKEHEWRVK-MSAEAT---VVEAEVFEIAPSYHMVVLKKSGGDTAEYKRVMK 406

GO:0004672 "protein kinase activity" evidence=IEA;ISS;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0009788 "negative regulation of abscisic acid mediated signaling pathway" evidence=IMP

TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1016 (362.7 bits), Expect = 1.6e-102, P = 1.6e-102
 Identities = 210/435 (48%), Positives = 295/435 (67%)

Query:     3 KQTRRV--AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR-MVDQIKRE 59
             ++ RRV   KYE+GR +G+GTFAKV + +    GE VA+KV+ K  ++K   M++QIKRE
Sbjct:     2 EEERRVLFGKYEMGRLLGKGTFAKVYYGKEIIGGECVAIKVINKDQVMKRPGMMEQIKRE 61

Query:    60 ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
             ISIMK+VRHPNIV L EV+A++TK++ ++EFV GGELF KI  +G+L E+  RRYFQQLI
Sbjct:    62 ISIMKLVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKI-SKGKLHEDAARRYFQQLI 120

Query:   120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVA 177
              AV +CHS+GV HRDLKPENLLLD  G+LK+SDFGLSALP+Q ++  LLHT CGTP YVA
Sbjct:   121 SAVDYCHSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVA 180

Query:   178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGA 237
             PEVL  +GYDG+ AD+WSCGV+L+VL+AG LPF + +L  +Y+KI  A+F  P WFS  A
Sbjct:   181 PEVLKKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEA 240

Query:   238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVA 297
               LI K+L  +P  RI I  I + PW RKN+ P    + +E          ++ E+    
Sbjct:   241 RRLISKLLVVDPDRRISIPAIMRTPWLRKNFTPPLAFKIDEPICSQSSKNNEEEEEDGDC 300

Query:   298 EQSENKVGGPLLMNAFEMIT-LSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEA 356
             E     +  P   NAFE I+ +S G +L++LF+ ++   K Q+ F SR  A  ++  IE 
Sbjct:   301 ENQTEPIS-PKFFNAFEFISSMSSGFDLSSLFESKR---KVQSVFTSRSSATEVMEKIET 356

Query:   357 VAESLSLKV-HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHK 415
             V + +++KV  T+++K ++EG +  + G+ ++  EVFEVAP + +V+  K+AGDTLEY +
Sbjct:   357 VTKEMNMKVKRTKDFKVKMEGKTEGRKGRLSMTAEVFEVAPEISVVEFCKSAGDTLEYDR 416

Query:   416 FYKNFCAK-LENIIW 429
              Y+      L +I+W
Sbjct:   417 LYEEEVRPALNDIVW 431

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q5JLD8	CIPK8_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7006	0.9661	0.9596	no	no
Q69Q47	CIPKO_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7460	0.9887	0.9668	yes	no
Q9LDI3	CIPKO_ARATH	2, ., 7, ., 1, 1, ., 1	0.7640	0.9977	0.9910	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	443
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-106
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-91
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-78
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-75
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-70
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-66
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-65
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-62
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-62
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-62
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-61
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-54
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-54
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-53
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-53
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-53
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-51
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-51
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-51
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-50
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-49
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-49
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-49
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-49
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-49
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-48
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-47
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-47
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-47
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-46
cd12195	116	cd12195, CIPK_C, C-terminal regulatory domain of C	2e-45
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-45
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-44
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-44
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-44
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-44
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-44
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-43
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-43
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-43
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-43
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-43
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-43
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-42
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-42
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-42
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-42
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-42
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-42
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-41
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-41
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-40
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-40
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-39
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-39
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-39
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-39
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-39
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-39
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-39
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-38
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-38
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-38
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-38
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-38
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-37
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-37
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-37
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-37
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-37
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-37
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-36
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-36
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-36
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-36
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-36
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-36
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-35
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-35
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-35
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-35
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-35
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-34
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-34
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-34
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-34
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-33
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-33
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-33
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-33
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-33
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-33
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-33
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-33
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-32
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-32
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-32
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-32
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-32
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-31
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-31
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-30
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-30
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-30
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-30
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-30
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-30
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-30
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-30
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-29
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-29
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-29
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-29
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-29
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-29
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-28
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-28
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-28
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-28
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-28
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-28
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-28
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-28
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-28
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-28
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-27
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-27
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-27
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-27
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-27
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-27
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-27
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-27
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-26
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-26
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-26
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-26
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-26
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-26
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-26
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-26
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-25
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-25
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-24
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-24
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-24
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-24
pfam03822	58	pfam03822, NAF, NAF domain	3e-24
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-24
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-24
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-24
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-24
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-23
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-23
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-23
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-23
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-23
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-22
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-22
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-22
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-22
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-22
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-22
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-22
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-22
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-21
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-21
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-21
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-21
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-20
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-20
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-20
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-20
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-20
cd12120	95	cd12120, AMPKA_C_like, C-terminal regulatory domai	3e-20
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-19
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-19
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-18
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-17
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-17
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-17
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-17
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-16
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-16
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-16
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-16
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-14
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-08
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	9e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.003
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  314 bits (806), Expect = e-106
 Identities = 116/258 (44%), Positives = 169/258 (65%), Gaps = 8/258 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YE+   +GEG+F KV  A++++TG+ VA+KV+ K  I K R  ++I REI I+K ++HPN
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPN 58

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IVRL++V     K+Y+++E+  GG+LFD +  +GRL E++ R Y +Q++ A+ + HSKG+
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRDLKPEN+LLD  G++K++DFGL+     G E L T  GTP Y+APEVL  +GY   A
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVLLGKGYGK-A 176

Query: 191 ADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW---FSTGATSLIHKILD 246
            D+WS GVIL+ L+ G  PF G+  L  L+KKI   +   P      S  A  LI K+L 
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236

Query: 247 PNPKTRIRIEGIRKHPWF 264
            +P+ R+  E   +HP+F
Sbjct: 237 KDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  275 bits (706), Expect = 8e-91
 Identities = 101/261 (38%), Positives = 149/261 (57%), Gaps = 8/261 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YE+ R +G G+F  V  A+++ TG+ VA+K+L K +  K +     +REI I++ + HPN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IVRL +    +  +Y+++E+  GG+LFD +   G L E++ ++   Q++  + + HS G+
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRDLKPEN+LLD  G +K++DFGL+    +    L T  GTP Y+APEVL      G  
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-----EFSCPFWFSTG--ATSLIHK 243
            DVWS GVIL+ L+ G  PF   ++    + I        EF  P W S    A  LI K
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 244 ILDPNPKTRIRIEGIRKHPWF 264
            L+ +P  R   E I +HPWF
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  243 bits (624), Expect = 1e-78
 Identities = 99/251 (39%), Positives = 149/251 (59%), Gaps = 4/251 (1%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G+F KV   + ++TG+  AMKVL K  I+K + V+    E +I+  + HP IV+LH 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
              +  K+Y++LE+  GGELF  +  +GR  E   R Y  +++ A+ + HS G+ +RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
           PEN+LLD+ G++K++DFGL+          +T CGTP Y+APEVL  +GY G A D WS 
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSL 179

Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI--- 253
           GV+L+ ++ G  PF   D   +Y+KI       P + S  A  LI  +L  +P  R+   
Sbjct: 180 GVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG 239

Query: 254 RIEGIRKHPWF 264
             E I+ HP+F
Sbjct: 240 GAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  237 bits (607), Expect = 1e-75
 Identities = 92/260 (35%), Positives = 157/260 (60%), Gaps = 9/260 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E  +T+G G+F +V   +++ +G+  A+K+L+K+ I+K + V+ +  E  I++ +RHP 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V L+      + +Y+++E+V GGELF  +   GR  E   R Y  Q++ A+ + HS  +
Sbjct: 63  LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPENLLLDS G +K++DFG +   +      +T CGTP Y+APE++ ++GY G A
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT---YTLCGTPEYLAPEIILSKGY-GKA 178

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D W+ G++++ ++AGY PF + +   +Y+KI   +   P +FS  A  LI  +L  +  
Sbjct: 179 VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLT 238

Query: 251 TRI-----RIEGIRKHPWFR 265
            R+      +  I+ HPWF 
Sbjct: 239 KRLGNLKNGVNDIKNHPWFA 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  220 bits (562), Expect = 6e-70
 Identities = 89/248 (35%), Positives = 138/248 (55%), Gaps = 35/248 (14%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +GEG F  V  A++++TG+ VA+K++         +++++ REI I+K + HPNIV+L+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 77  VLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
           V      +Y+++E+  GG L D +  ++G+L E++  R   Q+++ + + HS G+ HRDL
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 136 KPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           KPEN+LLDS  G +K++DFGLS L      LL T  GTP Y+APEVL  +GY    +D+W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178

Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR 254
           S GVIL+             LP L                     LI K+L  +P+ R  
Sbjct: 179 SLGVILYE------------LPELKD-------------------LIRKMLQKDPEKRPS 207

Query: 255 IEGIRKHP 262
            + I +H 
Sbjct: 208 AKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  212 bits (542), Expect = 3e-66
 Identities = 91/259 (35%), Positives = 141/259 (54%), Gaps = 15/259 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G F +V   + +    + A+K + K  I++    + I  E  I++   HP IV+L+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
               +  +Y+++E+  GGEL+  +  +G   E   R Y   ++ A  + H++G+ +RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
           PENLLLDS G +K+ DFG  A   +  +   T CGTP YVAPE++ N+GYD  + D WS 
Sbjct: 121 PENLLLDSNGYVKLVDFG-FAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWSL 178

Query: 197 GVILFVLMAGYLPFGETDLPTL--YKKINAA----EFSCPFWFSTGATSLIHKILDPNPK 250
           G++L+ L+ G  PFGE D   +  Y  I       EF  P +    A  LI ++L  NP+
Sbjct: 179 GILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAAKDLIKQLLRRNPE 236

Query: 251 TRI-----RIEGIRKHPWF 264
            R+      I+ I+KH WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  211 bits (540), Expect = 1e-65
 Identities = 89/280 (31%), Positives = 149/280 (53%), Gaps = 28/280 (10%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE-ISIMKIVRHP 69
           ++ G+ IGEG+F+ V  A+ +ET +  A+K+L K  ++K + V  +K E   + ++  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
            I++L+        +Y +LE+   GEL   I   G L E   R Y  +++ A+ + HSKG
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFG--------LSALPQQGVELLHTT------------ 169
           + HRDLKPEN+LLD   ++K++DFG         S    +G      +            
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182

Query: 170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFS 228
            GT  YV+PE+L+     G ++D+W+ G I++ ++ G  PF G  +  T ++KI   E+S
Sbjct: 183 VGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQKILKLEYS 240

Query: 229 CPFWFSTGATSLIHKILDPNPKTRIRI----EGIRKHPWF 264
            P  F   A  LI K+L  +P+ R+ +    + ++ HP+F
Sbjct: 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  202 bits (517), Expect = 1e-62
 Identities = 83/256 (32%), Positives = 140/256 (54%), Gaps = 11/256 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKIVR 67
           KYE+ + IG+G+F KV   + +  G+   +K   L+  +  K R  +    E+ I+K + 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KER--EDALNEVKILKKLN 57

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI---VHQGRLL-ENDCRRYFQQLIDAVA 123
           HPNI++ +E    + K+ I++E+  GG+L  KI     +G+   E     +F QL  A+ 
Sbjct: 58  HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           + HS+ + HRD+KP+N+ L S G +K+ DFG+S +    V+L  T  GTP Y++PE+  N
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIH 242
           + Y+   +D+WS G +L+ L     PF   +L  L  KI   ++   P  +S+   +L+ 
Sbjct: 178 KPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236

Query: 243 KILDPNPKTRIRIEGI 258
            +L  +P+ R  I  I
Sbjct: 237 SLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  203 bits (519), Expect = 5e-62
 Identities = 100/264 (37%), Positives = 156/264 (59%), Gaps = 9/264 (3%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +++ +E+G T+G G+F +VR A+++ TGE  A+K L K  ILK + V  + +E SI+  +
Sbjct: 16  KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            HP IV +        +VY +LEFV GGELF  +   GR   +  + Y  +L+ A  + H
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH 135

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           SK + +RDLKPENLLLD+ G++KV+DFG +   ++  +   T CGTP Y+APEV+ ++G+
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFA---KKVPDRTFTLCGTPEYLAPEVIQSKGH 192

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            G A D W+ GV+L+  +AGY PF +     +Y+KI A     P WF   A  L+  +L 
Sbjct: 193 -GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQ 251

Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            +   R+      +  ++ HP+F 
Sbjct: 252 TDHTKRLGTLKGGVADVKNHPYFH 275

Length = 329

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  201 bits (513), Expect = 6e-62
 Identities = 85/261 (32%), Positives = 146/261 (55%), Gaps = 14/261 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           I +G + +V  A+ + TG+  A+KV+ K+ +++   VDQ+  E  I+   + P +V+L+ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
               +  +Y+++E++ GG+L   + + G L E+  R Y  +++ A+ + HS G+ HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELL--------HTTCGTPNYVAPEVLSNRGYDG 188
           P+N+L+DS G+LK++DFGLS +     ++             GTP+Y+APEV+  +G+  
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179

Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--FWFSTGATSLIHKILD 246
              D WS G IL+  + G  PF       +++ I   +   P     S  A  LI K+L 
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239

Query: 247 PNPKTRI---RIEGIRKHPWF 264
           P+P+ R+    IE I+ HP+F
Sbjct: 240 PDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  198 bits (506), Expect = 7e-61
 Identities = 82/262 (31%), Positives = 139/262 (53%), Gaps = 9/262 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++  G  +G G+F  V  A +++TGE +A+K + + +      ++ ++REI I+  ++HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHP 59

Query: 70  NIVRL--HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIVR    E    +  + I LE+V+GG L   +   G+L E   R+Y +Q+++ +A+ HS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRG 185
            G+ HRD+K  N+L+DS G +K++DFG +         E   +  GTP ++APEV+    
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPF--WFSTGATSLIH 242
           Y G AAD+WS G  +  +  G  P+ E  +      KI ++          S  A   + 
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238

Query: 243 KILDPNPKTRIRIEGIRKHPWF 264
           K L  +PK R   + + +HP+ 
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  184 bits (468), Expect = 1e-54
 Identities = 99/258 (38%), Positives = 149/258 (57%), Gaps = 10/258 (3%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + +G+G+F KV   R     + G+  AMKVL K+T LK R   + K E  I+  V HP I
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT-LKVRDRVRTKMERDILAEVNHPFI 60

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           V+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H HS G+ 
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ RG+   +A
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSA 179

Query: 192 DVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT 251
           D WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  +   NP  
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN 239

Query: 252 RI-----RIEGIRKHPWF 264
           R+      +E I++HP+F
Sbjct: 240 RLGAGPDGVEEIKRHPFF 257

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  182 bits (463), Expect = 3e-54
 Identities = 86/271 (31%), Positives = 154/271 (56%), Gaps = 14/271 (5%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
              E  +T+G GTF +V   ++R +    A+KV+A   +++ +    +  E  ++K V H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           P I+RL      +  +Y+++E+V GGELF  + + GR   +    Y  +++ A+ + HSK
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            + +RDLKPEN+LLD  G++K++DFG +   ++  +   T CGTP Y+APEV+ ++G+  
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFA---KKLRDRTWTLCGTPEYLAPEVIQSKGH-N 176

Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            A D W+ G++++ ++ GY PF + +   +Y+KI A +   P      A  LI K+L   
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV-V 235

Query: 249 PKTRIRI-------EGIRKHPWFRK-NYNPV 271
            +TR R+       + ++ H WF+  +++ V
Sbjct: 236 DRTR-RLGNMKNGADDVKNHRWFKSVDWDDV 265

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  181 bits (460), Expect = 2e-53
 Identities = 96/281 (34%), Positives = 155/281 (55%), Gaps = 22/281 (7%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRM-VDQIKREISIMKIVRHPN 70
           + +G+G + KV   R     +TG+  AMKVL K+TI++++      K E +I++ V+HP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV L     +  K+Y+ILE+++GGELF  +  +G  +E+    Y  ++  A+ H H +G+
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD+ G++K++DFGL         + HT CGT  Y+APE+L   G+ G A
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-GKA 180

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D WS G +++ ++ G  PF   +      KI   + + P + +  A  L+ K+L  NP 
Sbjct: 181 VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPS 240

Query: 251 TRI-----RIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHA 286
           +R+         ++ HP+FR             VN DD+ A
Sbjct: 241 SRLGAGPGDAAEVQSHPFFR------------HVNWDDLLA 269

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  183 bits (463), Expect = 2e-53
 Identities = 100/320 (31%), Positives = 154/320 (48%), Gaps = 30/320 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y + R +GEG+F +V  A++R+    VA+KVLAK    K + V++  REI I+  + HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 70  -NIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQQLIDAVAHC 125
            NIV+L++       +Y+++E+V GG L D +     +G L E++      Q++ A+ + 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 126 HSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSAL------PQQGVELLHTTCGTPNYVAP 178
           HSKG+ HRD+KPEN+LLD  G  +K+ DFGL+ L            L  T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 179 EVLS--NRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEF----- 227
           EVL   +  Y  S++D+WS G+ L+ L+ G  PF      +      K I          
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 228 ----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDD 283
               S P   S  A+ L+ K+L  +PK R+       H               + +  DD
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES-DLSDLLKPDD 296

Query: 284 VHAVFDDIEDQYVAEQSENK 303
              +   +     A  S   
Sbjct: 297 SAPLRLSLPPSLEALISSLN 316

Length = 384

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  177 bits (451), Expect = 7e-53
 Identities = 80/260 (30%), Positives = 139/260 (53%), Gaps = 9/260 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ R IG+G F KV   Q R+T +  AMK + K   ++   V  +  E  I++ + HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V L         +Y++++ + GG+L   +  + +  E   + +  +++ A+ + HSKG+
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+KP+N+LLD  G++ ++DF ++        L  +T GTP Y+APEVL  +GY   A
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPEVLCRQGY-SVA 179

Query: 191 ADVWSCGVILFVLMAGYLPF-GETDLPT---LYKKINAAEFSCPFWFSTGATSLIHKILD 246
            D WS GV  +  + G  P+ G +         K+  A       W ST A   I+K+L+
Sbjct: 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW-STEAIDAINKLLE 238

Query: 247 PNPKTRI--RIEGIRKHPWF 264
            +P+ R+   ++ ++ HP+F
Sbjct: 239 RDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  176 bits (447), Expect = 1e-51
 Identities = 91/260 (35%), Positives = 150/260 (57%), Gaps = 13/260 (5%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVR 73
           + +G+G+F KV  A+ + T E  A+KVL K  IL+   V+    E  ++ +  +HP + +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    ++ +++ ++E+V GG+L   I   GR  E   R Y  +++  +   H +G+ +R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DLK +N+LLDS G++K++DFG+    ++G+    TT   CGTP+Y+APE+LS + Y G A
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPA 176

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D W+ GV+L+ ++AG  PF   D   L++ I   E   P W S  A S++   L  NP+
Sbjct: 177 VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPE 236

Query: 251 TRIRI-----EGIRKHPWFR 265
            R+       + I+ HP+FR
Sbjct: 237 KRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  173 bits (441), Expect = 8e-51
 Identities = 89/253 (35%), Positives = 138/253 (54%), Gaps = 4/253 (1%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F KV   + R+T    A+K + K+ I+    V     E +++  V  P IV L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
              S  K+Y++L F+ GGELF  +  +GR   +  R Y  +L+ A+ + H   V +RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
           PEN+LLD  G++ + DFGL  L  +  +  +T CGTP Y+APE+L   GY   A D W+ 
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTL 179

Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           GV+L+ ++ G  PF + ++  +Y+KI       P  F   A  L+  +L  +P  R+   
Sbjct: 180 GVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN 239

Query: 257 G---IRKHPWFRK 266
           G   I+ HP+F +
Sbjct: 240 GAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  172 bits (437), Expect = 9e-51
 Identities = 77/208 (37%), Positives = 121/208 (58%), Gaps = 9/208 (4%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           G  IG GTF KV  A N +TGE +A+K +        + + +I  E+ ++++++HPN+V+
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCHSKGVYH 132
            + V   R KVYI +E+ +GG L + ++  GR+L E+  R Y  QL++ +A+ HS G+ H
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122

Query: 133 RDLKPENLLLDSYGNLKVSDFG----LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
           RD+KP N+ LD  G +K+ DFG    L        E + +  GTP Y+APEV++     G
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 189 --SAADVWSCGVILFVLMAGYLPFGETD 214
              AAD+WS G ++  +  G  P+ E D
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELD 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  173 bits (441), Expect = 2e-50
 Identities = 94/317 (29%), Positives = 159/317 (50%), Gaps = 31/317 (9%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G + +V  A+ ++TGE VA+K + KS + K   V  +  E  I+   +   +V+L  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  +Y+ +E+V GG+    + + G L E+  R Y  ++ +AV   H  G  HRDLK
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
           PEN L+D+ G++K++DFGLS      V   ++  G+P+Y+APEVL  +GYD +  D WS 
Sbjct: 129 PENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKGYDFT-VDYWSL 184

Query: 197 GVILFVLMAGYLPFG-----ETDLPTLY--KKINAAEFSCP-FWFSTGATSLIHKILDPN 248
           G +L+  + G+ PF      ET     Y  + +    +  P F  S  A  LI K+++ +
Sbjct: 185 GCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLIN-D 243

Query: 249 PKTRIR-IEGIRKHPWFRK-NYNPVKCSE----------------EEEVNLDDVHAVFDD 290
           P  R   +E I+ HP+F++ ++N ++  +                ++  N DD+    D 
Sbjct: 244 PSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPELESEIDTGYFDDFENEDDMAKYKDV 303

Query: 291 IEDQYVAEQSENKVGGP 307
            E +  A +       P
Sbjct: 304 HEKKKAAGKGGANGRDP 320

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  169 bits (429), Expect = 1e-49
 Identities = 82/257 (31%), Positives = 136/257 (52%), Gaps = 13/257 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-PNIVRLH 75
           I +G F  V  A+ R TG+  A+KVL KS ++    V  +K E +IM I    P + +L+
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
               S+  +Y+++E++ GG+    I   G L E+  ++Y  +++  V   H +G+ HRD+
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           KPENLL+D  G+LK++DFGLS    +         GTP+Y+APE +   G D   +D WS
Sbjct: 124 KPENLLIDQTGHLKLTDFGLS----RNGLENKKFVGTPDYLAPETILGVG-DDKMSDWWS 178

Query: 196 CGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS----LIHKILDPNPKT 251
            G ++F  + GY PF       ++  I +   + P       +     LI+++L  +P  
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238

Query: 252 RIR---IEGIRKHPWFR 265
           R+     + I+ HP+F+
Sbjct: 239 RLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  171 bits (434), Expect = 1e-49
 Identities = 90/259 (34%), Positives = 138/259 (53%), Gaps = 12/259 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           + IG+G+F KV  A+++  G+  A+KVL K  ILK +    I  E +++ K V+HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  K+Y +L++V GGELF  +  +    E   R Y  ++  A+ + HS  + +R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DLKPEN+LLDS G++ ++DFGL    ++G+E   TT   CGTP Y+APEVL  + YD   
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC---KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RT 176

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D W  G +L+ ++ G  PF   D   +Y  I           S  A  L+  +L  +  
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRT 236

Query: 251 TRI----RIEGIRKHPWFR 265
            R+        I+ H +F 
Sbjct: 237 KRLGAKDDFLEIKNHVFFS 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  171 bits (435), Expect = 2e-49
 Identities = 98/325 (30%), Positives = 156/325 (48%), Gaps = 48/325 (14%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +EV + IG G F +V   ++++TG+  AMKVL KS ++K   +  ++ E  I+     P 
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV+L+        +Y+++E++ GG+L + ++ +    E   R Y  +L+ A+   H  G 
Sbjct: 63  IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA----------LPQQGVELL-------------- 166
            HRD+KP+N+L+D+ G++K++DFGL                   LL              
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 167 -----HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK 220
                ++T GTP+Y+APEVL    Y     D WS GVIL+ ++ G+ PF  +T   T  K
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241

Query: 221 KINAAE-FSCPF--WFSTGATSLIHKILDPNPKTRI-RIEGIRKHPWFRK--------NY 268
            IN  E    P     S  A  LI ++L   P+ R+   E I+ HP+F+           
Sbjct: 242 IINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKGIDWENLRETK 300

Query: 269 NPVKCSEEEEVNLDDVHAVFDDIED 293
            P       E++     + FDD ED
Sbjct: 301 PPFV----PELSSPLDTSNFDDFED 321

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  168 bits (428), Expect = 3e-49
 Identities = 82/265 (30%), Positives = 136/265 (51%), Gaps = 14/265 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            YEV  TIG+G+F  VR  + +  G+ +  K +     +  +   Q+  E++I++ ++HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHP 59

Query: 70  NIVRL--HEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVA 123
           NIVR     +  S   +YI++E+  GG+L   I      +  + E    R   QL+ A+ 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 124 HCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
            CH++      V HRDLKP N+ LD+  N+K+ DFGL+ +         T  GTP Y++P
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP 179

Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-PFWFSTGA 237
           E L++  YD   +D+WS G +++ L A   PF   +   L  KI   +F   P+ +S+  
Sbjct: 180 EQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHP 262
             +I  +L+ +P  R   E + + P
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  166 bits (423), Expect = 9e-49
 Identities = 76/256 (29%), Positives = 128/256 (50%), Gaps = 3/256 (1%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y++G  IG G F  V    N ETG+ VA+K ++   I +  +   I +EI ++K ++HP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL-KSIMQEIDLLKNLKHP 59

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV+    + +   +YIILE+   G L   I   G   E+    Y  Q++  +A+ H +G
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRD+K  N+L    G +K++DFG++       +   +  GTP ++APEV+   G   +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS-T 178

Query: 190 AADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           A+D+WS G  +  L+ G  P+ +   +  L++ +       P   S      + +    +
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD 238

Query: 249 PKTRIRIEGIRKHPWF 264
           P  R   + + KHPW 
Sbjct: 239 PNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  164 bits (418), Expect = 5e-48
 Identities = 86/259 (33%), Positives = 140/259 (54%), Gaps = 11/259 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +E+   IG+G F +V  A+++ TG+ VA+KV+ K    + +  ++I  EI I+K  +HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKK--EKIINEIQILKKCKHP 57

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           NIV+ +     + +++I++EF +GG L D +      L E+      ++L+  + + HS 
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
           G+ HRD+K  N+LL S G +K+ DFGLSA         +T  GTP ++APEV++ + YD 
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDY 176

Query: 189 SAADVWSCGVILFVLMA-GYLPFGE-TDLPTLYK--KINAAEFSCPFWFSTGATSLIHKI 244
             AD+WS G I  + +A G  P+ E   +  L+K           P  +S      + K 
Sbjct: 177 -KADIWSLG-ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKC 234

Query: 245 LDPNPKTRIRIEGIRKHPW 263
           L  NP+ R   E + KHP+
Sbjct: 235 LQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  165 bits (419), Expect = 2e-47
 Identities = 92/258 (35%), Positives = 142/258 (55%), Gaps = 12/258 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           + IG+G+F KV  A+ +  G   A+KVL K TILK +  + I  E +++ K ++HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  K+Y +L++V GGELF  +  +   LE   R Y  ++  A+ + HS  + +R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DLKPEN+LLDS G++ ++DFGL    ++GVE   TT   CGTP Y+APEVL    YD   
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC---KEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RT 176

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D W  G +L+ ++ G  PF   D+  +Y  I       P   +  A  L+  +L  + +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQR 236

Query: 251 TRIRIEG----IRKHPWF 264
            R+  +     I+ H +F
Sbjct: 237 RRLGAKADFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  164 bits (416), Expect = 2e-47
 Identities = 94/272 (34%), Positives = 152/272 (55%), Gaps = 18/272 (6%)

Query: 11  YEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIV 66
           +E+ R +G G + KV   R     + G+  AMKVL K+TI+ K +  +  + E  +++ V
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 67  RH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           R  P +V LH    + TK+++IL++V GGELF  +  +    E++ R Y  +++ A+ H 
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSN 183
           H  G+ +RD+K EN+LLDS G++ ++DFGLS   L ++  E  ++ CGT  Y+APEV+  
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVI-R 179

Query: 184 RGYDG--SAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEFSCPFWFSTGA 237
            G  G   A D WS GV+ F L+ G  PF     +     + ++I  ++   P   S  A
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239

Query: 238 TSLIHKILDPNPKTRIRIEG---IRKHPWFRK 266
              I K+L+ +PK R+   G   I+ HP+F+ 
Sbjct: 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  163 bits (416), Expect = 3e-47
 Identities = 87/311 (27%), Positives = 139/311 (44%), Gaps = 86/311 (27%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLA---------KSTILKHRMVDQIKREIS 61
           YE    +GEGT+  V  A++++TGE VA+K +           + +          REIS
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL----------REIS 50

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGE-----LFDKIVHQGRLLENDCRRYFQ 116
           ++K ++HPNIV+L +V+ +  K+Y++ E+    +       DK    G L  N  +    
Sbjct: 51  LLKELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDK--RPGPLSPNLIKSIMY 105

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-- 174
           QL+  +A+CHS  + HRDLKP+N+L++  G LK++DFGL+              G P   
Sbjct: 106 QLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-----------RAFGIPLRT 154

Query: 175 ---------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK--- 220
                    Y APE+L  ++ Y  +A D+WS G I   ++ G   F G++++  L+K   
Sbjct: 155 YTHEVVTLWYRAPEILLGSKHY-STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213

Query: 221 ----------------KINAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRI 253
                                 F  P +                  L+ K+L  NP  RI
Sbjct: 214 ILGTPTEESWPGVTKLPDYKPTF--PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI 271

Query: 254 RIEGIRKHPWF 264
             +   KHP+F
Sbjct: 272 SAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  161 bits (410), Expect = 4e-46
 Identities = 88/259 (33%), Positives = 138/259 (53%), Gaps = 12/259 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG+  AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS  V +RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSAA 191
           LK ENL+LD  G++K++DFGL    ++G+    T    CGTP Y+APEVL +  Y G A 
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 176

Query: 192 DVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT 251
           D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK 
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 236

Query: 252 RI-----RIEGIRKHPWFR 265
           R+       + I +H +F 
Sbjct: 237 RLGGGPEDAKEIMEHRFFA 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases

 Score =  153 bits (388), Expect = 2e-45
 Identities = 56/117 (47%), Positives = 81/117 (69%), Gaps = 2/117 (1%)

Query: 311 NAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRN- 369
           NAF++I+LS GL+L+ LF+  +D VKR+TRF SR+PA+ I+  +E  A+ L  +V  +  
Sbjct: 1   NAFDLISLSSGLDLSGLFEE-EDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKE 59

Query: 370 YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLEN 426
              +LEG    + G+ AV +EVFEV PSL +V+V+K+AGDTLEYHKF+K+    L  
Sbjct: 60  GGVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116

CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  156 bits (398), Expect = 6e-45
 Identities = 71/263 (26%), Positives = 129/263 (49%), Gaps = 13/263 (4%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           E  + +G+G+   V   +++ TG+  A+K +      + R   Q+ RE+  ++    P +
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK--QLLRELKTLRSCESPYV 61

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GV 130
           V+ +       ++ I+LE++ GG L D +   G++ E       +Q++  + + H+K  +
Sbjct: 62  VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+KP NLL++S G +K++DFG+S + +  ++  +T  GT  Y++PE +        A
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYA 180

Query: 191 ADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFW----FSTGATSLIHK 243
           AD+WS G+ L     G  PF   G+     L + I   +   P      FS      I  
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--DGPPPSLPAEEFSPEFRDFISA 238

Query: 244 ILDPNPKTRIRIEGIRKHPWFRK 266
            L  +PK R     + +HP+ +K
Sbjct: 239 CLQKDPKKRPSAAELLQHPFIKK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  157 bits (398), Expect = 2e-44
 Identities = 83/239 (34%), Positives = 128/239 (53%), Gaps = 1/239 (0%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y G A D W
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179

Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  157 bits (398), Expect = 2e-44
 Identities = 88/258 (34%), Positives = 144/258 (55%), Gaps = 12/258 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           + IG+G+F KV  A+ +  G+  A+KVL K  +L  +    I  E +++ K V+HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  K+Y +L+FV GGELF  +  +    E   R Y  ++  A+ + HS  + +R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DLKPEN+LLDS G++ ++DFGL    ++G+    TT   CGTP Y+APEV+  + YD + 
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT- 176

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D W  G +L+ ++ G  PF   D+  +Y  I           S  A S++ ++L+ + +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQ 236

Query: 251 TRIRIEG----IRKHPWF 264
            R+  +     I++HP+F
Sbjct: 237 RRLGAKEDFLEIQEHPFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  157 bits (400), Expect = 3e-44
 Identities = 89/300 (29%), Positives = 139/300 (46%), Gaps = 47/300 (15%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E  + IG G F +VR  Q ++TG   AMK L KS +L+   V  ++ E  I+    +P 
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V+L+        +Y+I+E++ GG++   ++ +    E + R Y  + I A+   H  G 
Sbjct: 63  VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGL---------------------------SALPQQGV 163
            HRD+KP+NLLLD+ G++K+SDFGL                            + P    
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 164 ELLHT-----------TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
               T           T GTP+Y+APEV    GY     D WS GVI++ ++ GY PF  
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241

Query: 213 TDLPTLYKKI----NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEG---IRKHPWFR 265
            +    Y+KI       +F      S  A  LI ++     + R+   G   I+ HP+F+
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  156 bits (396), Expect = 5e-44
 Identities = 98/310 (31%), Positives = 171/310 (55%), Gaps = 25/310 (8%)

Query: 11  YEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIV 66
           +E+ + +G G + KV   R     +TG+  AMKVL K+ ++ K + V+  + E ++++ V
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 67  RH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           R  P +V LH    +  K+++IL++V+GGE+F  +  +    E++ R Y  ++I A+ H 
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 184
           H  G+ +RD+K EN+LLDS G++ ++DFGLS     +  E  ++ CGT  Y+APE++  +
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT-LYKKINAAEFSCPFWFSTGATSL 240
           G  G A D WS G+++F L+ G  PF   GE +  + + ++I   +   P +    A  L
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDL 241

Query: 241 IHKILDPNPKTRI-----RIEGIRKHPWF----------RKNYNPVKCSEEEEVNLDDVH 285
           +HK+L  +PK R+         I++HP+F          RK   P + S   E+++ +  
Sbjct: 242 LHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFA 301

Query: 286 AVFDDIEDQY 295
             F ++E  Y
Sbjct: 302 EEFTNLEPVY 311

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  156 bits (395), Expect = 6e-44
 Identities = 84/260 (32%), Positives = 140/260 (53%), Gaps = 9/260 (3%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVR 73
           + +G+G+F KV  A+ + T E  A+KVL K  IL+   VD    E  I+ +   HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    ++ +++ ++E+V GG+L  +I    +  E   R Y  ++  A+   H  GV +R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD+ G+ K++DFG+            T CGTP+Y+APE+L    Y G + D 
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSVDW 179

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W+ GV+++ +MAG  PF   +   L++ I   +   P W S  A S++   +  NP  R+
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239

Query: 254 RI-------EGIRKHPWFRK 266
                    + I++HP+F++
Sbjct: 240 GCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  155 bits (392), Expect = 2e-43
 Identities = 82/239 (34%), Positives = 130/239 (54%), Gaps = 1/239 (0%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + +G+  AMK+L K  I+    V     E  ++K  RHP +  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                ++ ++  ++E+V GGELF  +  +    E+  R Y  +++ A+ + HS  + +RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LK ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y G A D W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179

Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   +   P   S  A SL+  +L  +P  R+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  153 bits (388), Expect = 2e-43
 Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 37/287 (12%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVRH 68
           Y+    IGEGT+  V  A+++ TGE VA+K +                 REI ++K + H
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNH 57

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-CRRYFQQLIDAVAHCHS 127
           PNI++L +V   +  +Y++ EF+   +L+  I  + R L     + Y  QL+  +A CHS
Sbjct: 58  PNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            G+ HRDLKPENLL+++ G LK++DFGL+      V        T  Y APE+L      
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 188 GSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYKKINAAEFS 228
            +  D+WS G I   L++    F                        P         +FS
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236

Query: 229 CPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            P              S  A  L+ ++L  +P  RI  E    HP+F
Sbjct: 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  154 bits (390), Expect = 3e-43
 Identities = 88/267 (32%), Positives = 147/267 (55%), Gaps = 17/267 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVR 73
           R IG G++AKV   + ++T    AMKV+ K  +     +D ++ E  + +    HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    + ++++ ++EFV+GG+L   +  Q +L E   R Y  ++  A+   H +G+ +R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD+ G++K++D+G+     +  +   T CGTPNY+APE+L    Y  S  D 
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDW 179

Query: 194 WSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFSTGATSLIHKI 244
           W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S  A+S++   
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239

Query: 245 LDPNPKTRI---RIEG---IRKHPWFR 265
           L+ +PK R+      G   I+ HP+FR
Sbjct: 240 LNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  154 bits (390), Expect = 4e-43
 Identities = 83/267 (31%), Positives = 133/267 (49%), Gaps = 12/267 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++V   +G G F +V+  + + TG+  AMKV+ KS +L    V   + E  I+ I   P 
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I +L      +  +Y+++E+  GG+L   +  ++ +  E+  + Y  +L+ A+   H  G
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSN-RGYD 187
             HRD+KPEN+L+D  G++K++DFG +A L    +       GTP+Y+APEVL+   G  
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 188 GSAADV----WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGATS 239
                V    WS GVI + ++ G  PF E      Y  I   +    F      S+    
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLD 242

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           LI  +L    K R+  EG+  HP+F K
Sbjct: 243 LIQSLL-CGQKERLGYEGLCCHPFFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  153 bits (388), Expect = 5e-43
 Identities = 86/258 (33%), Positives = 139/258 (53%), Gaps = 8/258 (3%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVR 73
           R +G+G+F KV  A+ +E+G   A+KVL K  IL+   V+    E  I+ + R HP + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           L+    +  +++ ++EFV GG+L   I    R  E   R Y  ++  A+   H KG+ +R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD  G+ K++DFG+        +   T CGTP+Y+APE+L    Y G + D 
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W+ GV+L+ ++ G+ PF   +   L++ I   E   P W S  A  ++   +  NP  R+
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239

Query: 254 RI------EGIRKHPWFR 265
                   E I +HP+F+
Sbjct: 240 GSLTLGGEEAILRHPFFK 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  152 bits (385), Expect = 9e-43
 Identities = 89/290 (30%), Positives = 139/290 (47%), Gaps = 40/290 (13%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++   IGEG    V  A++RETGE+VA+K +A    L+  + +Q  REI  ++  +HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA-LRRLEGGIPNQALREIKALQACQHP 59

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSK 128
            +V+L +V    +   +++E++    L + +  + R L E   + Y + L+  VA+ H+ 
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT-TCGTPNYVAPEVL-SNRGY 186
           G+ HRDLKP NLL+ + G LK++DFGL+ L  +    L++    T  Y APE+L   R Y
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178

Query: 187 DGSAADVWSCGVILFVLMAGYLPF--GETD------------------------LPTLYK 220
           D    D+W+ G I   L+ G  P   GE D                        LP  Y 
Sbjct: 179 D-PGVDLWAVGCIFAELLNG-SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP-DYN 235

Query: 221 KINAAEFSCPFW------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
           KI   E             S  A  L+  +L  +P  R+      +HP+F
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  152 bits (386), Expect = 1e-42
 Identities = 84/258 (32%), Positives = 138/258 (53%), Gaps = 10/258 (3%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK---IVRHPNIVR 73
           IG+GTF +V   + ++T    AMKVL+K  I+  + V     E +I+    +   P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           L     + + +Y++ ++++GGELF  +  +GR  E+  + Y  +L+ A+ H H   + +R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-LSNRGYDGSAAD 192
           DLKPEN+LLD+ G++ + DFGLS       +  +T CGT  Y+APEV L  +GY     D
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKHVD 179

Query: 193 VWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF-WFSTGATSLIHKILDPNPKT 251
            WS GV++F +  G+ PF   D   +Y+ I   +   P    S      +  +L+ NP+ 
Sbjct: 180 FWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQH 239

Query: 252 RI----RIEGIRKHPWFR 265
           R+        +++HP+F 
Sbjct: 240 RLGAHRDAVELKEHPFFA 257

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  151 bits (383), Expect = 2e-42
 Identities = 97/300 (32%), Positives = 144/300 (48%), Gaps = 59/300 (19%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD----QIKREISIMKIV 66
           YE    IGEGT+ +V  A+N++TGE VA+K      I      +       REI +++ +
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKL 55

Query: 67  RHPNIVRLHEVLASRTK--VYIILEFV----TGGELFDKIVHQGRLLENDCRRYFQQLID 120
           RHPNIVRL E++ S+ K  +Y++ E++    TG  L D    + +  E+  + Y +QL++
Sbjct: 56  RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLE 111

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG--TPNYVAP 178
            + + HS G+ HRD+K  N+L+++ G LK++DFGL A P         T    T  Y  P
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRPP 170

Query: 179 EVL--SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI----------NAA 225
           E+L  + R Y G   D+WS G IL  L  G   F G T+L  L +KI          N  
Sbjct: 171 ELLLGATR-Y-GPEVDMWSVGCILAELFLGKPIFQGSTELEQL-EKIFELCGSPTDENWP 227

Query: 226 EFSCPFWF---------------------STGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
             S   WF                        A  L+ K+L  +PK RI  +   +H +F
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  151 bits (383), Expect = 3e-42
 Identities = 89/270 (32%), Positives = 149/270 (55%), Gaps = 23/270 (8%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           R IG G++AKV   + ++T    AMKV+ K  +     +D ++ E  +  +   HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H +G+ +R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DLK +N+LLDS G++K++D+G+    ++G+    TT   CGTPNY+APE+L    Y G +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFS 176

Query: 191 ADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFSTGATSLI 241
            D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S  A S++
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236

Query: 242 HKILDPNPKTRI------RIEGIRKHPWFR 265
              L+ +PK R+          I+ HP+FR
Sbjct: 237 KSFLNKDPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  150 bits (381), Expect = 4e-42
 Identities = 92/314 (29%), Positives = 143/314 (45%), Gaps = 66/314 (21%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK----REISIMKI 65
           +YE G+ +GEGT+A V  A+++ETG  VA+K + K    K    D I     REI +++ 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKI-KLGERKEAK-DGINFTALREIKLLQE 58

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTG---GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++HPNI+ L +V   ++ + ++ EF+       + DK +    L   D + Y    +  +
Sbjct: 59  LKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLMTLRGL 115

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-------- 174
            + HS  + HRDLKP NLL+ S G LK++DFGL+            + G+PN        
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-----------RSFGSPNRKMTHQVV 164

Query: 175 ---YVAPEVLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYKKI------- 222
              Y APE+L    + G   D+WS G I   L+    +LP G++D+  L  KI       
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP-GDSDIDQL-GKIFEALGTP 222

Query: 223 ---NAAEFSC-------------PFW--FSTG---ATSLIHKILDPNPKTRIRIEGIRKH 261
              N    +              P    F      A  L+ ++L  NP  RI      +H
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282

Query: 262 PWFRKNYNPVKCSE 275
           P+F  +  P   S+
Sbjct: 283 PYFSNDPAPTPPSQ 296

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  149 bits (378), Expect = 7e-42
 Identities = 91/274 (33%), Positives = 157/274 (57%), Gaps = 20/274 (7%)

Query: 11  YEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIV 66
           +E+ + +G G + KV   R     ++G+  AMKVL K+TI+ K +  +  + E  +++ +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 67  RH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           R  P +V LH    + TK+++IL+++ GGELF  +  + R  E + + Y  +++ A+ H 
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 184
           H  G+ +RD+K EN+LLDS G++ ++DFGLS    +  VE  ++ CGT  Y+AP+++  R
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV--R 179

Query: 185 GYDG---SAADVWSCGVILFVLMAGYLPFG----ETDLPTLYKKINAAEFSCPFWFSTGA 237
           G DG    A D WS GV+++ L+ G  PF     +     + ++I  +E   P   S  A
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239

Query: 238 TSLIHKILDPNPKTRI-----RIEGIRKHPWFRK 266
             +I ++L  +PK R+       + I+KHP+F+K
Sbjct: 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  150 bits (381), Expect = 8e-42
 Identities = 83/260 (31%), Positives = 132/260 (50%), Gaps = 16/260 (6%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVR 73
           +G G F KV  A+ ++TGE  A+K L K  I+    V+ +  E  I +     RHP +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           L     +   V  ++E+  GG+L   I H     E     Y   ++  + + H   + +R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DLK +NLLLD+ G +K++DFGL    ++G+     T   CGTP ++APEVL+   Y   A
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRA 181

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D W  GV+++ ++ G  PF   D   ++  I   E   P + S  A S++ ++L  NP+
Sbjct: 182 VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPE 241

Query: 251 TRI-----RIEGIRKHPWFR 265
            R+       E ++K P+FR
Sbjct: 242 RRLGSGEKDAEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  149 bits (378), Expect = 1e-41
 Identities = 84/254 (33%), Positives = 139/254 (54%), Gaps = 5/254 (1%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVRHPNIV 72
           + +G+G+F KV  A+ + T E  A+K L K  +L+   V+   ++R +  +    HP + 
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLT 59

Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
            L     ++  ++ ++E++ GG+L   I   GR  E   R Y  ++I  +   H KG+ +
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLK +N+LLD  G++K++DFG+      G     T CGTP+Y+APE+L  + Y+ S  D
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNES-VD 178

Query: 193 VWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTR 252
            WS GV+L+ ++ G  PF   D   L+  I       P W S  A   + K+ + +P  R
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238

Query: 253 IRIEG-IRKHPWFR 265
           + ++G IR+HP+FR
Sbjct: 239 LGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  150 bits (379), Expect = 2e-41
 Identities = 86/269 (31%), Positives = 137/269 (50%), Gaps = 10/269 (3%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNR-ETGESVAMKVLAKSTILKHRMVDQIKREI 60
           +K   +   +   RT+G G+F +V  A  + E    VA+K   KS I+K + VD +  E 
Sbjct: 23  RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I+  + HP  V L+      + +Y++LEFV GGE F  +    R   +    Y  Q++ 
Sbjct: 83  KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
              +  S  + +RDLKPENLLLD  G +K++DFG + +        +T CGTP Y+APE+
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT---YTLCGTPEYIAPEI 199

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L N G+ G AAD W+ G+ ++ ++ G  PF   +   +Y+KI       P +       L
Sbjct: 200 LLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258

Query: 241 IHKILDPNPKTRI-----RIEGIRKHPWF 264
           + K+L  +   R        + +++HPWF
Sbjct: 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287

Length = 340

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  147 bits (372), Expect = 1e-40
 Identities = 85/240 (35%), Positives = 130/240 (54%), Gaps = 2/240 (0%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHR 133
                +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K V +R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK ENL+LD  G++K++DFGL     +    + T CGTP Y+APEVL +  Y G A D 
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  145 bits (367), Expect = 1e-40
 Identities = 69/257 (26%), Positives = 122/257 (47%), Gaps = 9/257 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++V + +G+G++  V   +     +  A+K +   ++ +    D +  EI I+  V HPN
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPN 60

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLLEND-CRRYFQQLIDAVAHCH 126
           I+   E      K+ I++E+   G+L   I     + +L+      R F QL+  +   H
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            + + HRDLK  N+LL +   +K+ D G+S + ++   +  T  GTP+Y+APEV   R Y
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPY 178

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKIL 245
               +D+WS G +L+ +     PF    +  L  K+   ++   P  +S    + I  +L
Sbjct: 179 S-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237

Query: 246 DPNPKTRIRIEGIRKHP 262
              PK R   + I   P
Sbjct: 238 QVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  143 bits (363), Expect = 2e-39
 Identities = 81/255 (31%), Positives = 139/255 (54%), Gaps = 7/255 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLH 75
           +G+G+F KV  A+ + T E  A+K+L K  I++   V+    E  ++ +   P  + +LH
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
               +  ++Y ++E+V GG+L   I   G+  E     Y  ++   +   HSKG+ +RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           K +N++LD+ G++K++DFG+      G +   T CGTP+Y+APE+++ + Y G + D W+
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186

Query: 196 CGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI 255
            GV+L+ ++AG  PF   D   L++ I     S P   S  A S+   +L  +P  R+  
Sbjct: 187 FGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246

Query: 256 -----EGIRKHPWFR 265
                  IR+H +FR
Sbjct: 247 GPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  145 bits (366), Expect = 2e-39
 Identities = 95/309 (30%), Positives = 162/309 (52%), Gaps = 17/309 (5%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           ++K   +   Y+V + IG G F +V+  +++ + +  AMK+L+K  ++K         E 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            IM     P +V+L         +Y+++E++ GG+L + ++    + E   + Y  +++ 
Sbjct: 95  DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVL 153

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPE 179
           A+   HS G+ HRD+KP+N+LLD +G+LK++DFG    + + G+    T  GTP+Y++PE
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPE 213

Query: 180 VLSNR---GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFW 232
           VL ++   GY G   D WS GV LF ++ G  PF    L   Y KI    N+  F     
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273

Query: 233 FSTGATSLIHKILDPNPKT--RIRIEGIRKHPWFRK---NYNPVKCSEE---EEVNLDDV 284
            S  A +LI   L        R  +E I++HP+F+    N++ ++ +      E++ D  
Sbjct: 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDID 333

Query: 285 HAVFDDIED 293
            + FDDIED
Sbjct: 334 SSNFDDIED 342

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  143 bits (362), Expect = 3e-39
 Identities = 84/255 (32%), Positives = 134/255 (52%), Gaps = 6/255 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           + IG+G+F KV  A+++   +  A+KVL K  ILK +    I  E +++ K V+HP +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  K+Y +L+++ GGELF  +  +   LE   R Y  ++  A+ + HS  + +R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLKPEN+LLDS G++ ++DFGL     +      T CGTP Y+APEVL  + YD    D 
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W  G +L+ ++ G  PF   +   +Y  I           +  A  L+  +L  +   R+
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239

Query: 254 RIEG----IRKHPWF 264
             +     I+ H +F
Sbjct: 240 GAKDDFMEIKNHIFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  142 bits (359), Expect = 4e-39
 Identities = 86/259 (33%), Positives = 131/259 (50%), Gaps = 17/259 (6%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G+G F KV  AQ++ETG   A K+  +     L+  MV     EI I+   +HPNIV L
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV-----EIDILSECKHPNIVGL 67

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKGVYHR 133
           +E      K++I++EF  GG L   ++   R L     RY  +Q+++A+   HS  V HR
Sbjct: 68  YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-----SNRGYDG 188
           DLK  N+LL   G++K++DFG+SA  +  ++   T  GTP ++APEV+      +  YD 
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD- 186

Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLIHKIL 245
             AD+WS G+ L  L     P  E +   +  KI  +E      P  +S+     +   L
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCL 246

Query: 246 DPNPKTRIRIEGIRKHPWF 264
             +P  R     + KHP+ 
Sbjct: 247 VKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  144 bits (364), Expect = 5e-39
 Identities = 95/307 (30%), Positives = 151/307 (49%), Gaps = 25/307 (8%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +   ++V + IG G F +V+  +++ + +  AMK+L+K  ++K         E  IM   
Sbjct: 41  KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
               IV+LH        +Y+++E++ GG+L + ++    + E   R Y  +++ A+   H
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIH 159

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           S G  HRD+KP+N+LLD  G+LK++DFG    +   G+    T  GTP+Y++PEVL ++G
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 186 YD---GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFSTGAT 238
            D   G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S  A 
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK 279

Query: 239 SLIHKILDPNPKT--RIRIEGIRKHPWF----------RKNYNPVKCSEEEEVNLDDVHA 286
            LI   L        R  ++ I+ HP+F          R+   PV      E++ D   +
Sbjct: 280 DLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVV----PELSSDIDTS 335

Query: 287 VFDDIED 293
            FDDIED
Sbjct: 336 NFDDIED 342

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  141 bits (358), Expect = 7e-39
 Identities = 78/215 (36%), Positives = 115/215 (53%), Gaps = 7/215 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KYEV   +GEG +  V   +N+ TGE VA+K   +S   +        RE+ +++ +RH 
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK-KTALREVKVLRQLRHE 60

Query: 70  NIVRLHEVLASRTKVYIILEFV--TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIV L E    + ++Y++ E+V  T  EL +     G L  +  R Y  QL+ A+A+CHS
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
             + HRD+KPEN+L+   G LK+ DFG + AL  +    L     T  Y APE+L     
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK 220
            G   DVW+ G I+  L+ G   F G++D+  LY 
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  142 bits (358), Expect = 9e-39
 Identities = 86/305 (28%), Positives = 163/305 (53%), Gaps = 6/305 (1%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVR 73
           + +G+G+F KV  A+ + T +  A+K L K  +L    V+    E  ++ +   HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           L+    ++  ++ ++E++ GG+L   I    +        Y  ++I  +   HSKG+ +R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD+ G++K++DFG+      G     T CGTP+Y+APE+L  + Y  ++ D 
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSVDW 179

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           WS GV+L+ ++ G  PF   D   L++ I       P W +  A  ++ K+    P+ R+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL 239

Query: 254 RIEG-IRKHPWFRK-NYNPVKCSEEEEVNLDDVHAVFD--DIEDQYVAEQSENKVGGPLL 309
            ++G IR+HP+FR+ +++ ++  E E      V +  D  + + +++ E+    V   +L
Sbjct: 240 GVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSVTDRML 299

Query: 310 MNAFE 314
           +N+ +
Sbjct: 300 INSMD 304

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  141 bits (356), Expect = 1e-38
 Identities = 91/287 (31%), Positives = 133/287 (46%), Gaps = 49/287 (17%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVL-------AKSTILKHRMVDQIKREISIMKIVRHP 69
           +GEGT+A V   +NR TGE VA+K +         ST +         REIS+MK ++H 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI---------REISLMKELKHE 58

Query: 70  NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIVRLH+V+ +  K+ ++ E++     +  D    +G L  N  + +  QL+  +A CH 
Sbjct: 59  NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-SNRGY 186
             V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+VL  +R Y
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----------------NAAEFSCP 230
             S  D+WS G I+  ++ G   F  T+      KI                   E+   
Sbjct: 179 STS-IDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237

Query: 231 F-------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
           F                     L+H++L  NP+ RI      +HPWF
Sbjct: 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  141 bits (357), Expect = 2e-38
 Identities = 82/265 (30%), Positives = 144/265 (54%), Gaps = 15/265 (5%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           R IG G++AKV   + ++  +  AMKV+ K  +     +D ++ E  +  +   +P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    + +++++++E+V GG+L   +  Q +L E   R Y  ++  A+   H +G+ +R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD+ G++K++D+G+        +   T CGTPNY+APE+L    Y G + D 
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDW 179

Query: 194 WSCGVILFVLMAGYLPFG-ETDLPT------LYKKINAAEFSCPFWFSTGATSLIHKILD 246
           W+ GV++F +MAG  PF   TD P       L++ I       P + S  A+ ++   L+
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239

Query: 247 PNPKTRIRIE------GIRKHPWFR 265
            +PK R+  +       I+ H +FR
Sbjct: 240 KDPKERLGCQPQTGFSDIKSHTFFR 264

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  139 bits (352), Expect = 2e-38
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 9/259 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKIVR 67
           ++  G  +G G+F  V    N + G+  A+K   LA         V Q+++EI+++  ++
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+          +YI LE V GG L   +   G   E   R Y +Q++  + + H 
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC--GTPNYVAPEVLSNRG 185
           +   HRD+K  N+L+D+ G +K++DFG++   +Q VE        G+P ++APEV++ +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEF-SCPFWFSTGATSLIHK 243
             G AAD+WS G  +  +  G  P+ +   +  ++K   + E    P   S  A   I K
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237

Query: 244 ILDPNPKTRIRIEGIRKHP 262
            L  +P  R     + +HP
Sbjct: 238 CLQRDPSLRPTAAELLEHP 256

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  140 bits (354), Expect = 2e-38
 Identities = 81/274 (29%), Positives = 139/274 (50%), Gaps = 18/274 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y+    IGEG   +V  A +R TG+ VA+K +    + K    + I  EI IMK  +HP
Sbjct: 20  LYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNK-ELIINEILIMKDCKHP 75

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           NIV  ++      ++++++E++ GG L D I  +  R+ E       ++++  + + HS+
Sbjct: 76  NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V HRD+K +N+LL   G++K++DFG +A   +     ++  GTP ++APEV+  + Y  
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG- 194

Query: 189 SAADVWSCGVILFVLMAGYLP-FGETDLPTLY----KKINAAEFSCPFWFSTGATSLIHK 243
              D+WS G++   +  G  P   E  L  L+    K I       P  +S      ++K
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI--PPLKNPEKWSPEFKDFLNK 252

Query: 244 ILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
            L  +P+ R   E + +HP+ +K      C +EE
Sbjct: 253 CLVKDPEKRPSAEELLQHPFLKK-----ACPKEE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  139 bits (351), Expect = 3e-38
 Identities = 72/256 (28%), Positives = 137/256 (53%), Gaps = 5/256 (1%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY   + IGEG+F K    +++E G+   +K +  S  +  +  ++ ++E++++  ++HP
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVAHCHS 127
           NIV+  E       +YI++++  GG+L+ KI  Q  +L  E+    +F Q+  A+ H H 
Sbjct: 60  NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + + HRD+K +N+ L   G +K+ DFG++ +    VEL  T  GTP Y++PE+  NR Y+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYN 179

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILD 246
            + +D+W+ G +L+ +      F   ++  L  KI    +      +S    +L+ ++  
Sbjct: 180 -NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238

Query: 247 PNPKTRIRIEGIRKHP 262
            NP+ R  +  I +  
Sbjct: 239 RNPRDRPSVNSILEKN 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 1e-37
 Identities = 70/201 (34%), Positives = 108/201 (53%), Gaps = 21/201 (10%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-REI-SIMKIVRH 68
           Y+V + +G+GTF  V  A+N+ETGE VA+K + K     +   + +  RE+ S+ K+  H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF---YSWEECMNLREVKSLRKLNEH 57

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLL-ENDCRRYFQQLIDAVAHCH 126
           PNIV+L EV     ++Y + E++ G  L+  +   +G+   E+  R    Q++  +AH H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGL-----SALPQQGVELLHTT-CGTPNYVAPEV 180
             G +HRDLKPENLL+     +K++DFGL     S  P       +T    T  Y APE+
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-------YTDYVSTRWYRAPEI 169

Query: 181 LSNRGYDGSAADVWSCGVILF 201
           L       S  D+W+ G I+ 
Sbjct: 170 LLRSTSYSSPVDIWALGCIMA 190

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  137 bits (346), Expect = 2e-37
 Identities = 81/262 (30%), Positives = 133/262 (50%), Gaps = 21/262 (8%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR-----EISIMKI 65
           +++ + IG+G F+ V  A     G  VA+K   K  I +  M+D   R     EI ++K 
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALK---KVQIFE--MMDAKARQDCLKEIDLLKQ 58

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQLIDA 121
           + HPN+++         ++ I+LE    G+L   I H   Q RL+ E    +YF QL  A
Sbjct: 59  LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + H HSK + HRD+KP N+ + + G +K+ D GL           H+  GTP Y++PE +
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF---WFSTG 236
              GY+   +D+WS G +L+ + A   PF   + +L +L KKI   ++  P     +S  
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP-PLPADHYSEE 236

Query: 237 ATSLIHKILDPNPKTRIRIEGI 258
              L+ + ++P+P+ R  I  +
Sbjct: 237 LRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  137 bits (346), Expect = 2e-37
 Identities = 76/259 (29%), Positives = 130/259 (50%), Gaps = 10/259 (3%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH--RMVDQIKREISIMKIVRHPNI 71
           G+ +G+G F +V    + +TG  +A+K +          + V+ ++ EI ++K ++H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           V+ +  L     + I +E++ GG + D++   G L E   R+Y +Q+++ V + HS  + 
Sbjct: 67  VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 132 HRDLKPENLLLDSYGNLKVSDFG----LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           HRD+K  N+L DS GN+K+ DFG    L  +   G  +   T GTP +++PEV+S  GY 
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPEVISGEGY- 184

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFWFSTGATSLIHKIL 245
           G  ADVWS G  +  ++    P+ E +      KI         P   S  A + + +  
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTF 244

Query: 246 DPNPKTRIRIEGIRKHPWF 264
             N K R   E + +H + 
Sbjct: 245 VENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 2e-37
 Identities = 81/218 (37%), Positives = 118/218 (54%), Gaps = 27/218 (12%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------REISIMKIVRHP 69
           IGEGT+  V  A+++ TGE VA+K        K R+  + +       REIS++K + HP
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALK--------KIRLETEDEGVPSTAIREISLLKELNHP 58

Query: 70  NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIVRL +V+ S  K+Y++ EF+     +  D     G L     + Y  QL+  +A+CHS
Sbjct: 59  NIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHS 117

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTT--CGTPNYVAPEVLSNR 184
             V HRDLKP+NLL+D  G LK++DFGL+ A    GV +   T    T  Y APE+L   
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEILLGS 174

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK 220
               +  D+WS G I F  M    P   G++++  L++
Sbjct: 175 RQYSTPVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFR 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  138 bits (349), Expect = 2e-37
 Identities = 78/253 (30%), Positives = 136/253 (53%), Gaps = 3/253 (1%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVR 73
           + +G+G+F KV  A+ +  GE  A+K L K  +L    V+    E  ++ +   +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           L+    ++  ++ ++EF+ GG+L   I  +GR        Y  +++  +   HSKG+ +R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N++LD  G++K++DFG+      G     T CGTP+Y+APE+L    Y  S  D 
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS-VDW 179

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           WS GV+L+ ++ G  PF   D   L++ I       P W +  +  ++ K+ + +P  R+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL 239

Query: 254 RIEG-IRKHPWFR 265
            + G IR HP+F+
Sbjct: 240 GVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  137 bits (347), Expect = 4e-37
 Identities = 79/255 (30%), Positives = 141/255 (55%), Gaps = 7/255 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLH 75
           +G+G+F KV  A+ + T E  A+K+L K  +++   V+    E  ++ +  + P + +LH
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
               +  ++Y ++E+V GG+L  +I   GR  E     Y  ++   +   HSKG+ +RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           K +N++LDS G++K++DFG+            T CGTP+Y+APE+++ + Y G + D W+
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186

Query: 196 CGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI 255
            GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   ++  +P  R+  
Sbjct: 187 FGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246

Query: 256 --EG---IRKHPWFR 265
             EG   I++H +FR
Sbjct: 247 GPEGERDIKEHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  137 bits (347), Expect = 1e-36
 Identities = 92/296 (31%), Positives = 144/296 (48%), Gaps = 44/296 (14%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E  + IG G F +VR  Q ++TG   AMK+L K+ +L+   V  I+ E  I+       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V++      +  +Y+I+EF+ GG++   ++ +  L E   + Y  + + A+   H  G 
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGL---------------------SALPQQGV------ 163
            HRD+KP+NLLLD+ G++K+SDFGL                     S    Q +      
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 164 --------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETD 214
                   +L ++T GTP+Y+APEV    GY+    D WS GVI++ ++ GY PF  ET 
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 215 LPTLYKKINAAE---FSCPFWFSTGATSLIHKILDPNPKTRI---RIEGIRKHPWF 264
             T  K +N  E   F      S  A  LI +    + + RI    +E I+ HP+F
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  136 bits (343), Expect = 1e-36
 Identities = 79/256 (30%), Positives = 140/256 (54%), Gaps = 7/256 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLH 75
           +G+G+F KV  A+ + T E  A+K+L K  +++   V+    E  ++ +  + P + +LH
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
               +  ++Y ++E+V GG+L   I   G+  E     Y  ++   +   H +G+ +RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           K +N++LDS G++K++DFG+            T CGTP+Y+APE+++ + Y G + D W+
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186

Query: 196 CGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI 255
            GV+L+ ++AG  PF   D   L++ I     S P   S  A S+   ++  +P  R+  
Sbjct: 187 YGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246

Query: 256 --EG---IRKHPWFRK 266
             EG   IR+H +FR+
Sbjct: 247 GPEGERDIREHAFFRR 262

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  133 bits (336), Expect = 3e-36
 Identities = 82/248 (33%), Positives = 127/248 (51%), Gaps = 10/248 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKIVR 67
           +Y V R +GEG+F +    Q+  + +  AMK   L KS+      V+  ++E  ++  ++
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS----SAVEDSRKEAVLLAKMK 56

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLL-ENDCRRYFQQLIDAVAHC 125
           HPNIV   E   +   +YI++E+  GG+L  KI  Q G+L  E+   ++F Q+   V H 
Sbjct: 57  HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H K V HRD+K +N+ L   G +K+ DFG + L         T  GTP YV PE+  N  
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKI 244
           Y+ + +D+WS G IL+ L     PF       L  K+    +   P  +S    SLI ++
Sbjct: 177 YN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235

Query: 245 LDPNPKTR 252
              NP++R
Sbjct: 236 FKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  136 bits (343), Expect = 4e-36
 Identities = 93/310 (30%), Positives = 155/310 (50%), Gaps = 17/310 (5%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +   YEV + IG G F +V+  +++ T +  AMK+L+K  ++K         E  IM   
Sbjct: 41  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             P +V+L         +Y+++E++ GG+L + ++    + E   R Y  +++ A+   H
Sbjct: 101 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIH 159

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNR- 184
           S G  HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL ++ 
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 185 --GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFSTGAT 238
             GY G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S  A 
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279

Query: 239 SLIHKILDPNPKT--RIRIEGIRKHPWFR------KNYNPVKCSEEEEVNLDDVHAVFDD 290
           +LI   L        R  +E I++H +F+      +           +++ D   + FDD
Sbjct: 280 NLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDD 339

Query: 291 IEDQYVAEQS 300
           IE+    E++
Sbjct: 340 IEEDKGEEET 349

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  134 bits (339), Expect = 4e-36
 Identities = 81/280 (28%), Positives = 143/280 (51%), Gaps = 30/280 (10%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E  + I  G +  V   +++ET +  AMK + K  ++    + Q+  E  I+    +P 
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V +     ++  + +++E+V GG+    + + G L  +  R YF + + A+ + H+ G+
Sbjct: 63  VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT------------------TCGT 172
            HRDLKP+NLL+ S G++K++DFGLS +   G+  L T                   CGT
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKDTREFLDKQVCGT 179

Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF 231
           P Y+APEV+  +GY G   D W+ G+IL+  + G +PF G+T    L+ ++ + +   P 
Sbjct: 180 PEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIEWPE 237

Query: 232 W---FSTGATSLIHKILDPNPKTRIRIEG---IRKHPWFR 265
                   A  LI ++L  NP  R+   G   +++H +F 
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  135 bits (341), Expect = 9e-36
 Identities = 84/305 (27%), Positives = 133/305 (43%), Gaps = 52/305 (17%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +   +TIG G F +V   +  +T    AMK L K+ +L       +K E  I+    +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V+L+     +  +Y +++++ GG++   ++  G   E+  R Y  +L  A+   H  G 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLS---------------------------------- 156
            HRD+KP+N+L+D  G++K++DFGL                                   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 157 ---------ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY 207
                       Q    L H+  GTPNY+APEVL   GY     D WS GVIL+ ++ G 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQ 241

Query: 208 LPF-GETDLPTLYKKIN-AAEFSCPFW--FSTGATSLIHKILDPNPKTRI---RIEGIRK 260
            PF  +T   T  K IN       P     S  A+ LI + L    + R+     + I+ 
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKA 300

Query: 261 HPWFR 265
           HP+F+
Sbjct: 301 HPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  132 bits (333), Expect = 1e-35
 Identities = 81/260 (31%), Positives = 136/260 (52%), Gaps = 8/260 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+ + IGEG+F K+  A+ +   E   +K +   T +  +  +  K+E+ ++  ++HP
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEI-DLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLEND-CRRYFQQLIDAVAHCHS 127
           NIV          +++I++E+  GG+L  +I  Q G L   D    +F Q+   + H H 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 128 KGVYHRDLKPENLLLDSYGNL-KVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + + HRD+K +N+ L   G + K+ DFG++      +EL +T  GTP Y++PE+  NR Y
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW--FSTGATSLIHKI 244
           + +  D+WS G +L+ L     PF   +L  L  KI    F+ P    FS    SLI ++
Sbjct: 180 N-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLISQL 237

Query: 245 LDPNPKTRIRIEGIRKHPWF 264
              +P+ R  I  I K P+ 
Sbjct: 238 FKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  135 bits (341), Expect = 1e-35
 Identities = 87/305 (28%), Positives = 139/305 (45%), Gaps = 56/305 (18%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG+G F +VR  Q ++TG+  AMK L KS + K   +  +K E  ++     P +V L
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           +        +Y+I+EF+ GG+L   ++      E+  R Y  + + A+   H  G  HRD
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126

Query: 135 LKPENLLLDSYGNLKVSDFGLS------------------------ALPQQGVE------ 164
           +KP+N+L+D  G++K+SDFGLS                           +  V       
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186

Query: 165 -----------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY 207
                            + ++T GTP+Y+APE+   +GY G   D WS G I+F  + G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245

Query: 208 LPFGETDLPTLYKKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEG---IRK 260
            PF   +    Y+KI     +  F      S  A  LI +++  N + R+   G   I+ 
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304

Query: 261 HPWFR 265
           HP+FR
Sbjct: 305 HPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  134 bits (338), Expect = 1e-35
 Identities = 78/247 (31%), Positives = 123/247 (49%), Gaps = 36/247 (14%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E  + IG G F +VR  Q ++TG   AMK+L K+ +L+   V  I+ E  I+       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V++      +  +Y+I+EF+ GG++   ++ +  L E + + Y  + + A+   H  G 
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLS-----------------ALPQQGV---------- 163
            HRD+KP+NLLLDS G++K+SDFGL                  +LP              
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 164 --------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL 215
                   +L  +T GTP+Y+APEV    GY+    D WS GVI++ ++ GY PF     
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 216 PTLYKKI 222
              YKK+
Sbjct: 242 QETYKKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 5e-35
 Identities = 82/288 (28%), Positives = 140/288 (48%), Gaps = 38/288 (13%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+G   +V   + + TG+  A+KVL K  ++K   V ++  E  I+  + HP +  L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           +    + T + +++++  GGELF  +  Q    L E   R Y  +++ A+ + H  G+ +
Sbjct: 67  YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126

Query: 133 RDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGV----------ELLHTT------ 169
           RDLKPEN+LL   G++ +SDF LS           + +           +   T      
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186

Query: 170 ------CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN 223
                  GT  Y+APEV+S  G+ GSA D W+ G++L+ ++ G  PF  ++    +  I 
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245

Query: 224 AAEFSCP--FWFSTGATSLIHKILDPNPKTRI----RIEGIRKHPWFR 265
             E + P     S+ A  LI K+L  +P  R+        I++HP+FR
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  130 bits (329), Expect = 7e-35
 Identities = 78/261 (29%), Positives = 129/261 (49%), Gaps = 13/261 (4%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V   Q + TG+  A K L K  + K +       E  I++ V    IV L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
              ++  + +++  + GG+L   I + G     E     Y  Q+I  + H H + + +RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKPEN+LLD +GN+++SD GL A+  +G + +    GTP Y+APEVL    YD  + D +
Sbjct: 121 LKPENVLLDDHGNVRISDLGL-AVELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVDWF 178

Query: 195 SCGVILFVLMAGYLPFGE----TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
           + G  L+ ++AG  PF +     +   L ++        P  FS  A  L   +L  +P+
Sbjct: 179 ALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238

Query: 251 TRI-----RIEGIRKHPWFRK 266
            R+       + +R+HP F+ 
Sbjct: 239 KRLGCRGGSADEVREHPLFKD 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  130 bits (328), Expect = 1e-34
 Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 62/278 (22%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVR- 67
           Y++   IGEGTF++V  AQ+R+TG+  A+K + K      + ++Q+   REI  ++ +  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56

Query: 68  HPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDAV 122
           HPNI+RL EVL  R   ++ ++ E +    L++ I  +GR   L E   + Y  QL+ ++
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELI--KGRKRPLPEKRVKSYMYQLLKSL 113

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV------ 176
            H H  G++HRD+KPEN+L+     LK++DFG S                P Y       
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFG-SC---------RGIYSKPPYTEYISTR 162

Query: 177 ---APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW 232
              APE L   GY G   D+W+ G + F +++ +  F G  +L  + K            
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK------------ 210

Query: 233 FSTGATSLIHKIL-DPNPKTRIRIEGIRKHPWFRKNYN 269
                   IH +L  P+ +        +       NYN
Sbjct: 211 --------IHDVLGTPDAEV-----LKKFRKSRHMNYN 235

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  128 bits (325), Expect = 2e-34
 Identities = 71/198 (35%), Positives = 106/198 (53%), Gaps = 18/198 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            YE+ + IG GT+  V  A++  TGE VA+KV+    +      + I++EIS++K  RHP
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRHP 60

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL-LEND-----CRRYFQQLIDAVA 123
           NIV        R K++I++E+  GG L D I    R  L        CR   + L    A
Sbjct: 61  NIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGL----A 115

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           + H  G  HRD+K  N+LL   G++K++DFG+SA     +    +  GTP ++APEV + 
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 184 R---GYDGSAADVWSCGV 198
               GYDG   D+W+ G+
Sbjct: 176 ERKGGYDG-KCDIWALGI 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  129 bits (326), Expect = 2e-34
 Identities = 94/296 (31%), Positives = 132/296 (44%), Gaps = 53/296 (17%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------REISI 62
           KYE    IGEGT+  V  A+NRET E VA+K        + R+ D  +       REI +
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREICL 52

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 120
           +K ++H NIVRL++VL S  K+ ++ E+      + FD     G +     + +  QL+ 
Sbjct: 53  LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLK 110

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
            +A CHS  V HRDLKP+NLL++  G LK++DFGL+      V        T  Y  P+V
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 170

Query: 181 L-SNRGYDGSAADVWSCGVILFVLMAGYLPF--------------------------GET 213
           L   + Y  S  D+WS G I   L     P                           G +
Sbjct: 171 LFGAKLYSTS-IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229

Query: 214 DLPT-----LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            LP      +Y    +     P   STG   L+  +L  NP  RI  E   +HP+F
Sbjct: 230 KLPDYKPYPMYPATTSLVNVVPKLNSTG-RDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  128 bits (324), Expect = 4e-34
 Identities = 74/191 (38%), Positives = 108/191 (56%), Gaps = 7/191 (3%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 66

Query: 77  VLASRTKVYIILEFVTGG-ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
           V+ +  K+Y++ EF+    + F        +     + Y  QL+  +A CHS  V HRDL
Sbjct: 67  VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPEVLSNRGYDGSAADV 193
           KP+NLL+++ G +K++DFGL+     GV +   T    T  Y APE+L    Y  +A D+
Sbjct: 127 KPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 184

Query: 194 WSCGVILFVLM 204
           WS G I F  M
Sbjct: 185 WSLGCI-FAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  126 bits (319), Expect = 1e-33
 Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 11/219 (5%)

Query: 12  EVGRTIGEGTFAKVR----FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           E+G+ +GEG F +V           T   VA+K L +         ++   E SIMK + 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA--SEEEREEFLEEASIMKKLS 59

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCH 126
           HPNIVRL  V      +YI+ E++ GG+L D +  H  +L   D  +   Q+   + +  
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
           SK   HRDL   N L+     +K+SDFGLS  + +            P  ++APE L + 
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179

Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 222
            +  S +DVWS GV+L+ +   G  P+       + + +
Sbjct: 180 KFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217

Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  127 bits (320), Expect = 1e-33
 Identities = 80/258 (31%), Positives = 133/258 (51%), Gaps = 10/258 (3%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A ++ TG  VA+K   K  + K +  + +  E+ IM+  +HPNIV ++ 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D IV   R+ E         ++ A++  H++GV HRD+K
Sbjct: 84  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL S G +K+SDFG  A   + V    +  GTP ++APEV+S   Y G+  D+WS 
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWSL 201

Query: 197 GVILFVLMAGYLP-FGETDLPTLYKKINAAE---FSCPFWFSTGATSLIHKILDPNPKTR 252
           G+++  ++ G  P F E  L  + K+I              S    S + ++L  +P  R
Sbjct: 202 GIMVIEMVDGEPPYFNEPPLQAM-KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR 260

Query: 253 IRIEGIRKHPWFRKNYNP 270
                +  HP+  K   P
Sbjct: 261 ATAAELLNHPFLAKAGPP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  128 bits (322), Expect = 3e-33
 Identities = 71/207 (34%), Positives = 116/207 (56%), Gaps = 16/207 (7%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVL---AKSTILKHRMVDQIKREISIMKIVRH 68
           E    IG G    V    +R TG   A+KV+    + T+ +     QI REI I++ V H
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR-----QICREIEILRDVNH 131

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           PN+V+ H++     ++ ++LEF+ GG L    +   + L +  R    Q++  +A+ H +
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRR 187

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS---NRG 185
            + HRD+KP NLL++S  N+K++DFG+S +  Q ++  +++ GT  Y++PE ++   N G
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247

Query: 186 -YDGSAADVWSCGVILFVLMAGYLPFG 211
            YDG A D+WS GV +     G  PFG
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPFG 274

Length = 353

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  125 bits (315), Expect = 4e-33
 Identities = 74/257 (28%), Positives = 122/257 (47%), Gaps = 9/257 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   R +G+G F +    +  E    V  K +  +  L  +       EI I+ +++HPN
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPN 60

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVAHCHSK 128
           I+  +        + I +E+  GG L+DKIV Q   L  E     Y  Q++ AV++ H  
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--TTCGTPNYVAPEVLSNRGY 186
           G+ HRD+K  N+ L   G +K+ DFG+S     G E     T  GTP Y++PE+     Y
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISK--ILGSEYSMAETVVGTPYYMSPELCQGVKY 178

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKIL 245
           +   +D+W+ G +L+ L+     F  T+   L  KI    ++     +S+   SL+H +L
Sbjct: 179 N-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLL 237

Query: 246 DPNPKTRIRIEGIRKHP 262
             +P+ R   + +   P
Sbjct: 238 QQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  125 bits (317), Expect = 5e-33
 Identities = 90/310 (29%), Positives = 139/310 (44%), Gaps = 69/310 (22%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------- 57
           R V +YE    I EGT+  V  A++++TGE VA+K              ++K        
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--------------KLKMEKEKEGF 47

Query: 58  -----REISIMKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKI-VHQGRLLEN 109
                REI+I+  ++HPNIV + EV+      K+Y+++E+V   +L   +   +   L++
Sbjct: 48  PITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS 106

Query: 110 DCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 169
           + +    QL+  VAH H   + HRDLK  NLLL++ G LK+ DFGL+   + G  L   T
Sbjct: 107 EVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYT 164

Query: 170 CG--TPNYVAPEVLSNRGYDGSAADVWSCGVIL--FVLMAGYLPFGETDLPTLYK----- 220
               T  Y APE+L       +A D+WS G I    +      P G++++  L K     
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP-GKSEIDQLNKIFKLL 223

Query: 221 -----KINAAEFSCPFW----------------FSTGATS-----LIHKILDPNPKTRIR 254
                KI       P                  F   + S     L++++L  +P  RI 
Sbjct: 224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283

Query: 255 IEGIRKHPWF 264
            E   KHP+F
Sbjct: 284 AEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  124 bits (314), Expect = 5e-33
 Identities = 76/262 (29%), Positives = 131/262 (50%), Gaps = 17/262 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ----IKREISIMKI 65
           KYE  R +G G F  V   + +   + V +K      I   +M        + E  ++K+
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIK-----QIPVEQMTKDERLAAQNECQVLKL 55

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVA 123
           + HPNI+  +E       + I++E+  GG L + I  +   L  E+    +F Q++ A+ 
Sbjct: 56  LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115

Query: 124 HCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           H H+K + HRDLK +N+LLD +   +K+ DFG+S +     +  +T  GTP Y++PE+  
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-AYTVVGTPCYISPELCE 174

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--WFSTGATSL 240
            + Y+   +D+W+ G +L+ L +    F   +LP L  KI +  F+ P    +S     L
Sbjct: 175 GKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-PISDRYSPDLRQL 232

Query: 241 IHKILDPNPKTRIRIEGIRKHP 262
           I  +L+ +P  R ++  I   P
Sbjct: 233 ILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  125 bits (315), Expect = 5e-33
 Identities = 70/209 (33%), Positives = 112/209 (53%), Gaps = 12/209 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHR-----MVDQIKREISIMKIV 66
           G  IG+GT+ +V  A N  TGE +A+K   L  +   +H      MV  ++ EI  +K +
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            H NIV+      +   + I LE+V GG +   +   GR  E   R + +Q+++ +A+ H
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC--GTPNYVAPEVLSN- 183
           SKG+ HRDLK +NLL+D+ G  K+SDFG+S       +        G+  ++APEV+ + 
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 184 -RGYDGSAADVWSCGVILFVLMAGYLPFG 211
            +GY     D+WS G ++  + AG  P+ 
Sbjct: 186 SQGYSAK-VDIWSLGCVVLEMFAGRRPWS 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  124 bits (313), Expect = 7e-33
 Identities = 71/245 (28%), Positives = 120/245 (48%), Gaps = 5/245 (2%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   IG+G+F  V     +      AMK +  S  +  R  ++   E  ++  +    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSSY 60

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSK 128
           I+R +E    + K+ I++E+   G+L   +  Q    L E+   R+F Q++  +AH HSK
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            + HRD+K  NL LD+Y N+K+ D G++ L        +T  GTP Y++PE+  ++ Y+ 
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN- 179

Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKILDP 247
             +DVW+ GV+L+    G  PF   +   L  KI    F      +S     LI + L  
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239

Query: 248 NPKTR 252
           + + R
Sbjct: 240 DYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  124 bits (313), Expect = 8e-33
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 15/229 (6%)

Query: 14  GRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           G+ +GEG F +V   +      +    VA+K L +    +     +  RE  IM+ + HP
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIE--EFLREARIMRKLDHP 61

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSK 128
           N+V+L  V      +YI++E++ GG+L   +  ++ +L  +D   +  Q+   + +  SK
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYD 187
              HRDL   N L+     +K+SDFGLS                P  ++APE L    + 
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF- 180

Query: 188 GSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAEF-----SCP 230
            S +DVWS GV+L+ +   G  P+       + + +          +CP
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCP 229

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  126 bits (318), Expect = 1e-32
 Identities = 86/323 (26%), Positives = 138/323 (42%), Gaps = 87/323 (26%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVR 67
           +YE+ + IG G +  V  A ++ TG  VA+K ++   +     +D  +I REI +++ +R
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN--VFDDL-IDAKRILREIKLLRHLR 57

Query: 68  HPNIVRLHEVLASRTK-----VYIILEFVTGGELFD----KIVHQGRLLENDCRRYFQ-Q 117
           H NI+ L ++L   +      VYI    VT  EL +    K++   + L +D  +YF  Q
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYI----VT--ELMETDLHKVIKSPQPLTDDHIQYFLYQ 111

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYV 176
           ++  + + HS  V HRDLKP N+L++S  +LK+ DFGL+  +     E    T     YV
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT----EYV 167

Query: 177 ------APEV-LSNRGYDGSAADVWSCGVILFVLMAG----------------------- 206
                 APE+ LS+  Y   A D+WS G I   L+                         
Sbjct: 168 VTRWYRAPELLLSSSRYT-KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226

Query: 207 ---------------YL----PFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
                          YL       +  L  L+   +             A  L+ K+L  
Sbjct: 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPE-----------AIDLLEKMLVF 275

Query: 248 NPKTRIRIEGIRKHPWFRKNYNP 270
           +PK RI  +    HP+  + ++P
Sbjct: 276 DPKKRITADEALAHPYLAQLHDP 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  127 bits (319), Expect = 1e-32
 Identities = 91/305 (29%), Positives = 136/305 (44%), Gaps = 56/305 (18%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +T+G G F +V  A+  +T    AMK L K  +L    V  +K E  I+    +  +VRL
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           +     +  +Y +++++ GG++   ++  G   E+  R Y  +L  AV   H  G  HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126

Query: 135 LKPENLLLDSYGNLKVSDFGL--------------------------------------- 155
           +KP+N+L+D  G++K++DFGL                                       
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186

Query: 156 --------SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY 207
                    A  Q    L H+  GTPNY+APEVL   GY     D WS GVIL+ ++ G 
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245

Query: 208 LPF-GETDLPTLYKKIN-AAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEG---IRK 260
            PF  +T L T  K IN       P     S  A+ LI K+    P+ R+   G   I+ 
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKA 304

Query: 261 HPWFR 265
           HP+F+
Sbjct: 305 HPFFK 309

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  124 bits (313), Expect = 1e-32
 Identities = 85/287 (29%), Positives = 136/287 (47%), Gaps = 48/287 (16%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------REISIMKIVRHP 69
           IGEGT+  V   +N++TG+ VAMK        K R+  + +       REIS++K ++HP
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMK--------KIRLESEEEGVPSTAIREISLLKELQHP 59

Query: 70  NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIV L +VL   +++Y+I EF++    +  D +     +     + Y  Q++  +  CHS
Sbjct: 60  NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + V HRDLKP+NLL+D+ G +K++DFGL+      V +      T  Y APEVL      
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 188 GSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK-----------------KINAAEFS 228
            +  D+WS G I F  MA   P   G++++  L++                  +   + +
Sbjct: 180 STPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238

Query: 229 CPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            P W                  L+ K+L  +P  RI  +    HP+F
Sbjct: 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  122 bits (308), Expect = 3e-32
 Identities = 76/254 (29%), Positives = 131/254 (51%), Gaps = 11/254 (4%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +A + + + IG G F++V  A     G  VA+K +    ++  +      +EI ++K + 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQLIDAVA 123
           HPN+++ +       ++ I+LE    G+L   I H   Q RL+ E    +YF QL  A+ 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           H HS+ V HRD+KP N+ + + G +K+ D GL           H+  GTP Y++PE +  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF---WFSTGAT 238
            GY+   +D+WS G +L+ + A   PF   + +L +L KKI   ++  P     +S    
Sbjct: 181 NGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPSDHYSEELR 238

Query: 239 SLIHKILDPNPKTR 252
            L++  ++P+P+ R
Sbjct: 239 QLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  121 bits (307), Expect = 5e-32
 Identities = 62/203 (30%), Positives = 109/203 (53%), Gaps = 7/203 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +++   +GEG++  V  A ++ETG+ VA+KV+     L+     +I +EISI+K    P 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-----EIIKEISILKQCDSPY 59

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           IV+ +      T ++I++E+   G + D + +    L E +      Q +  + + HS  
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
             HRD+K  N+LL+  G  K++DFG+S      +   +T  GTP ++APEV+   GY+ +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-N 178

Query: 190 AADVWSCGVILFVLMAGYLPFGE 212
            AD+WS G+    +  G  P+ +
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSD 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  122 bits (308), Expect = 7e-32
 Identities = 83/267 (31%), Positives = 136/267 (50%), Gaps = 17/267 (6%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVRH 68
           +E+   +G+G F KV  A+N+ETG   A KV+   +   L+  MV     EI I+    H
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-----EIEILATCNH 68

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHS 127
           P IV+L        K++I++EF  GG +   ++   R L E   +   +Q+++A+ + HS
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-----LS 182
             + HRDLK  N+LL   G++K++DFG+SA   + ++   +  GTP ++APEV     + 
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATS 239
           +  YD   AD+WS G+ L  +     P  E +   +  KI  +E    S P  +S     
Sbjct: 189 DTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD 247

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
            +   LD +P+TR     + +HP+   
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  121 bits (306), Expect = 1e-31
 Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 33/276 (11%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG G  A V  A      E VA+K   L K        VD++++E+  M    H
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT----SVDELRKEVQAMSQCNH 58

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQQLIDAVAHC 125
           PN+V+ +       ++++++ +++GG L D +     +G L E       ++++  + + 
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL----LHTTCGTPNYVAPEVL 181
           HS G  HRD+K  N+LL   G++K++DFG+SA    G +       T  GTP ++APEV+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 182 SN-RGYDGSAADVWSCGVILFVLMAGYLPFG------------ETDLPTLYKKINAAEFS 228
               GYD   AD+WS G+    L  G  P+             + D P+L    +  ++S
Sbjct: 179 EQVHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237

Query: 229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
             F        +I   L  +P  R   E + KH +F
Sbjct: 238 KSF------RKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  120 bits (304), Expect = 2e-31
 Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 16/230 (6%)

Query: 14  GRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           G+ +GEG F +V               VA+K L +    +     +  RE  IM+ + HP
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIE--EFLREARIMRKLDHP 61

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYF-QQLIDAVAHCHS 127
           NIV+L  V      + I++E++ GG+L D +  ++ + L       F  Q+   + +  S
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
           K   HRDL   N L+     +K+SDFGLS                P  ++APE L    +
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 187 DGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAEF-----SCP 230
             S +DVWS GV+L+ +   G  P+       + + +          +CP
Sbjct: 182 -TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCP 230

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  120 bits (304), Expect = 3e-31
 Identities = 73/214 (34%), Positives = 117/214 (54%), Gaps = 6/214 (2%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-REISIMKIVRH 68
           KYE    +GEG++  V   +++ETG+ VA+K   +S     +MV +I  REI ++K +RH
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE--DDKMVKKIAMREIRMLKQLRH 59

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
            N+V L EV   + ++Y++ EFV    L D   +   L E+  R+Y  Q++  +  CHS 
Sbjct: 60  ENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            + HRD+KPEN+L+   G +K+ DFG +       E+      T  Y APE+L      G
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 189 SAADVWSCGVILFVLMAG--YLPFGETDLPTLYK 220
            A D+W+ G ++  ++ G    P G++D+  LY 
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYH 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  118 bits (297), Expect = 1e-30
 Identities = 74/254 (29%), Positives = 129/254 (50%), Gaps = 11/254 (4%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +A +++ + IG G F++V  A      + VA+K +    ++  +      +EI ++K + 
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQLIDAVA 123
           HPN+++  +      ++ I+LE    G+L   I +   Q RL+ E    +YF QL  AV 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           H HS+ V HRD+KP N+ + + G +K+ D GL           H+  GTP Y++PE +  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF---WFSTGAT 238
            GY+   +D+WS G +L+ + A   PF   + +L +L +KI   ++  P     +S    
Sbjct: 181 NGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP-PLPTEHYSEKLR 238

Query: 239 SLIHKILDPNPKTR 252
            L+   + P+P  R
Sbjct: 239 ELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  118 bits (296), Expect = 2e-30
 Identities = 80/267 (29%), Positives = 133/267 (49%), Gaps = 22/267 (8%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMK------VLAKSTILKHRMVDQIKREISIMKIVR 67
           G  IG G+F  V    N  +GE +A+K      V A S   K  M+D + REI+++K ++
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           H NIV+          + I LE+V GG +   + + G   E   R + +Q++  + + H+
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGT--PN------YVA 177
           +G+ HRD+K  N+L+D+ G +K+SDFG+S    + +E   L T      P+      ++A
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGIS----KKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFWFSTG 236
           PEV+    Y    AD+WS G ++  ++ G  PF + T L  ++K    A    P   S+ 
Sbjct: 181 PEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239

Query: 237 ATSLIHKILDPNPKTRIRIEGIRKHPW 263
           A   + K  + +   R     + KHP+
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  120 bits (303), Expect = 2e-30
 Identities = 76/257 (29%), Positives = 115/257 (44%), Gaps = 49/257 (19%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +T+G G F +V  A   +T    AMK L K  +L    V  +K E  I+    +  +V+L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           +     +  +Y +++++ GG++   ++      E   R Y  +L  A+   H  G  HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 135 LKPENLLLDSYGNLKVSDFGL----------------SALPQQGVE-------------- 164
           +KP+N+L+D  G++K++DFGL                S + Q  +E              
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 165 -----------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY 207
                            L H+  GTPNY+APEVL  +GY     D WS GVILF ++ G 
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245

Query: 208 LPF-GETDLPTLYKKIN 223
            PF   T   T  K IN
Sbjct: 246 PPFLAPTPTETQLKVIN 262

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  118 bits (298), Expect = 3e-30
 Identities = 89/312 (28%), Positives = 140/312 (44%), Gaps = 68/312 (21%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------R 58
           R V K+++   IGEGT+ +V  A++++TGE VA+K        K R+ ++ +       R
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALK--------KVRLDNEKEGFPITAIR 55

Query: 59  EISIMKIVRHPNIVRLHEVLASRTKV----------YIILEFVTG---GELFDKIVHQGR 105
           EI I++ + H NIV L E++  +             Y++ E++     G L   +VH   
Sbjct: 56  EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH--- 112

Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
             E+  + + +QL++ + +CH K   HRD+K  N+LL++ G +K++DFGL+ L       
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 166 LHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL--------------------- 203
            +T    T  Y  PE+L      G A DVWSCG IL  L                     
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232

Query: 204 MAGY-----------LPFGETDLPT-LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT 251
           + G            LP+  T  P   Y++    EFS   +  T A  L+  +L  +P  
Sbjct: 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS---FIPTPALDLLDHMLTLDPSK 289

Query: 252 RIRIEGIRKHPW 263
           R   E     PW
Sbjct: 290 RCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 3e-30
 Identities = 76/283 (26%), Positives = 137/283 (48%), Gaps = 44/283 (15%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRH 68
            +E+   IGEGT+ KV  A++++TG+ VA+K++     +     ++IK E +I+ K   H
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSNH 62

Query: 69  PNIVRLHEV------LASRTKVYIILEFVTGG---ELFDKIVHQGRLLENDCRRYF-QQL 118
           PNI   +          +  ++++++E   GG   +L   +  +G+ L+ +   Y  ++ 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +A+ H   V HRD+K +N+LL     +K+ DFG+SA     +   +T  GTP ++AP
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182

Query: 179 EVLS-----NRGYDGSAADVWSCGVILFVLMAGYLPFGE------------TDLPTLYKK 221
           EV++     +  YD + +DVWS G+    L  G  P  +               PTL   
Sbjct: 183 EVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241

Query: 222 IN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW 263
            N + +F+            I + L  N + R  +E + +HP+
Sbjct: 242 ENWSKKFN----------DFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  117 bits (295), Expect = 5e-30
 Identities = 74/276 (26%), Positives = 133/276 (48%), Gaps = 22/276 (7%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM--VDQIKREISIMKIVR 67
            + +   IG+G+F +V  A ++ T + VA+KV+     L+     ++ I++EI  +   R
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID----LEEAEDEIEDIQQEIQFLSQCR 57

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P I + +      +K++II+E+  GG   D ++  G+L E       ++++  + + H 
Sbjct: 58  SPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           +G  HRD+K  N+LL   G++K++DFG+S      +   +T  GTP ++APEV+   GYD
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETD-------LPTLY-KKINAAEFSCPFWFSTGATS 239
              AD+WS G+    L  G  P  +         +P      +   +FS PF        
Sbjct: 177 -EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF------KD 229

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
            +   L+ +PK R   + + KH + +K       + 
Sbjct: 230 FVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTL 265

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 6e-30
 Identities = 70/210 (33%), Positives = 116/210 (55%), Gaps = 10/210 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLA--KSTILKHRMVDQIKREISIMKIVRH 68
           + +G+ +G G F +V    + +TG  +A+K +     +    + V+ ++ EI ++K +RH
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 69  PNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             IV+ +  L      K+ I +E++ GG + D++   G L EN  RRY +Q++  V++ H
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ----QGVELLHTTCGTPNYVAPEVLS 182
           S  + HRD+K  N+L DS GN+K+ DFG S   Q     G  +   T GTP +++PEV+S
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-GTPYWMSPEVIS 182

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
             GY G  ADVWS    +  ++    P+ E
Sbjct: 183 GEGY-GRKADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  116 bits (292), Expect = 8e-30
 Identities = 74/265 (27%), Positives = 131/265 (49%), Gaps = 14/265 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLA---KSTILKHRMVDQIKREISIMKIVRHPN 70
           G+ +G G F+    A++ +TG  +A+K +     ++  +  +V+ +++EI +M  + HP+
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+R+       +   + +E++ GG +   +   G   E     Y +QL+  +++ H   +
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 131 YHRDLKPENLLLDSYGN-LKVSDFGLSA-LPQQGV---ELLHTTCGTPNYVAPEVLSNRG 185
            HRD+K  NLL+DS G  L+++DFG +A L  +G    E      GT  ++APEVL    
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEF-SCPFWFSTGATSL 240
           Y G + DVWS G ++  +     P+        L  ++K  +A    S P   S G   +
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFR 265
             + L+  P+ R     + KHP FR
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  116 bits (293), Expect = 1e-29
 Identities = 90/330 (27%), Positives = 141/330 (42%), Gaps = 87/330 (26%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------- 57
           R V ++E    IGEGT+  V  A++  +GE VA+K        K RM D  +        
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALK--------KVRM-DNERDGIPISSL 54

Query: 58  REISIMKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRY 114
           REI+++  +RHPNIV L EV+  +    +++++E+                LL+N    +
Sbjct: 55  REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE---------QDLASLLDNMPTPF 105

Query: 115 --------FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGV 163
                     QL+  + + H   + HRDLK  NLLL   G LK++DFGL+    LP + +
Sbjct: 106 SESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165

Query: 164 ELLHTTCGTPN-----YVAPEVLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDL- 215
                   TP      Y APE+L       +A D+W+ G IL  L+A    LP G++++ 
Sbjct: 166 --------TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP-GKSEIE 216

Query: 216 -----------------PTLYKKINAAEFSCP----------F-WFSTGATSLIHKILDP 247
                            P         +F+ P          F W S     L++ +L  
Sbjct: 217 QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMY 276

Query: 248 NPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
           +PK R   E   +  +F++   P+ C  E 
Sbjct: 277 DPKKRATAEEALESSYFKE--KPLPCEPEM 304

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  115 bits (290), Expect = 2e-29
 Identities = 83/275 (30%), Positives = 141/275 (51%), Gaps = 20/275 (7%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR---EISIMKIVR 67
           +E+   +G+G F KV  AQN+ETG      VLA + ++  +  ++++    EI I+    
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETG------VLAAAKVIDTKSEEELEDYMVEIDILASCD 60

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCH 126
           HPNIV+L +       ++I++EF  GG +   ++   R L E   R   +Q ++A+ + H
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL----- 181
              + HRDLK  N+L    G++K++DFG+SA   + ++   +  GTP ++APEV+     
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGAT 238
            +R YD   ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+   
Sbjct: 181 KDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVK 272
             + K L+ N   R     + +HP+   N N P++
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIR 274

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  114 bits (287), Expect = 3e-29
 Identities = 78/261 (29%), Positives = 132/261 (50%), Gaps = 9/261 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVR 67
           +Y + + +G+G+F  V   ++++      +KVL +  +  L      Q  +E  ++  + 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI---VHQGRLL-ENDCRRYFQQLIDAVA 123
           HP IV+ H     R    II E+  G +L  K+    H G+ L EN    +F QL+  V 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           + H + + HRDLK +N+ L +   LK+ DFG+S L     +L  T  GTP Y++PE L +
Sbjct: 121 YMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           +GYD S +D+WS G IL+ +      F G+  L  + + +     S P  +S    S++ 
Sbjct: 180 QGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238

Query: 243 KILDPNPKTRIRIEGIRKHPW 263
            +L+ +P  R     I ++P+
Sbjct: 239 SMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  114 bits (288), Expect = 3e-29
 Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 34/271 (12%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVL---AKSTILKHRMVDQIKREISIMKIVRHPNI 71
             +G G    V    +R TG+ +A+K +       I K     QI RE+ I+     P I
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK-----QILRELDILHKCNSPYI 61

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCRRYFQQLIDAVAHCHSK- 128
           V  +    +   + I +E++ GG L DKI    QGR+ E    +    ++  + + H K 
Sbjct: 62  VGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            + HRD+KP N+L++S G +K+ DFG+S   Q    L  T  GT +Y+APE +    Y  
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 189 SAADVWSCGVILFVLMAGYLPFG------ETDLPTLYKKIN-------AAEFSCPFWFST 235
             +D+WS G+ L  L  G  P+       +     L   +N       + +FS  F    
Sbjct: 179 K-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF---- 233

Query: 236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
                ++  L  +P+ R   + + +HP+ +K
Sbjct: 234 --QDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  114 bits (287), Expect = 6e-29
 Identities = 78/262 (29%), Positives = 131/262 (50%), Gaps = 13/262 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I + G     E     Y  +++  +   H +   +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD YG++++SD GL+    +G E +    GT  Y+APEVL+N+ Y   + D
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRY-TLSPD 183

Query: 193 VWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            W  G +++ ++ G  PF     +     + +++   E      FS  A S+   +L  +
Sbjct: 184 YWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKD 243

Query: 249 PKTRI--RIEG---IRKHPWFR 265
           PK R+  + EG   +++HP+FR
Sbjct: 244 PKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  114 bits (288), Expect = 7e-29
 Identities = 80/312 (25%), Positives = 128/312 (41%), Gaps = 68/312 (21%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK----REISIMKIV 66
           YE+   +GEGTF +V  A+  +TG  VA+K      IL H   D       REI I+K +
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKKL 64

Query: 67  RHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDCRRYF 115
           +HPN+V L ++   R          VY++  ++     G L +  V    L E+  + Y 
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKCYM 121

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--------ALPQQGVELLH 167
            QL++ + + H   + HRD+K  N+L+D+ G LK++DFGL+             G     
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 168 TTCG---TPNYVAPE-VLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK- 220
                  T  Y  PE +L  R Y  +A D+W  G +   +      L  G++D+  L+  
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRRPILQ-GKSDIDQLHLI 239

Query: 221 --------KINAAEFS----CPFWFST----------------GATSLIHKILDPNPKTR 252
                   +     +     C    S                     L+ K+L  +P  R
Sbjct: 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKR 299

Query: 253 IRIEGIRKHPWF 264
           +      +HP+F
Sbjct: 300 LTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  114 bits (287), Expect = 8e-29
 Identities = 76/226 (33%), Positives = 118/226 (52%), Gaps = 28/226 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL--------AKSTILKHRMVDQIKREIS 61
           +YE    IGEGT+  V  A++R T E++A+K +          ST +         REIS
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI---------REIS 53

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL-FDKIVHQGRLLENDCR---RYFQQ 117
           ++K ++H NIVRL +V+ S  ++Y++ E++   +L   K +        + R    Y  Q
Sbjct: 54  LLKEMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQ 110

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           ++  +A+CHS  V HRDLKP+NLL+D   N LK++DFGL+      V        T  Y 
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK 220
           APE+L    +  +  D+WS G I F  M    P   G++++  L+K
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFK 215

Length = 294

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  113 bits (283), Expect = 1e-28
 Identities = 67/210 (31%), Positives = 116/210 (55%), Gaps = 10/210 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLA--KSTILKHRMVDQIKREISIMKIVRH 68
           + +G+ +G+G F +V    + +TG  +A+K +     +    + V+ ++ EI ++K + H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 69  PNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             IV+ +  L       + I +E + GG + D++   G L EN  R+Y +Q+++ V++ H
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ----QGVELLHTTCGTPNYVAPEVLS 182
           S  + HRD+K  N+L DS GN+K+ DFG S   Q     G  +   T GTP +++PEV+S
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSPEVIS 182

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
             GY G  AD+WS G  +  ++    P+ E
Sbjct: 183 GEGY-GRKADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 1e-28
 Identities = 74/265 (27%), Positives = 134/265 (50%), Gaps = 19/265 (7%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
           + E+   IG G +  V   ++  TG  VA+K++   T      V  I+RE++++  +R  
Sbjct: 5   RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQS 59

Query: 69  --PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             PNI + +       +++II+E+  GG +   ++  G + E       ++++ A+ + H
Sbjct: 60  QPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIH 118

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
             GV HRD+K  N+L+ + GN+K+ DFG++AL  Q      T  GTP ++APEV++  + 
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP-----FWFSTGATSL 240
           YD + AD+WS G+ ++ +  G  P+ + D    ++ +     S P       +S      
Sbjct: 179 YD-TKADIWSLGITIYEMATGNPPYSDVD---AFRAMMLIPKSKPPRLEDNGYSKLLREF 234

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFR 265
           +   LD  PK R+  E + K  W +
Sbjct: 235 VAACLDEEPKERLSAEELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  112 bits (282), Expect = 1e-28
 Identities = 67/207 (32%), Positives = 116/207 (56%), Gaps = 10/207 (4%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLA--KSTILKHRMVDQIKREISIMKIVRHPNI 71
           G+ +G+G F +V    + +TG  +A K +     +    + V  ++ EI ++K ++H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 72  VRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           V+ +  L  R +  + I +E++ GG + D++   G L E+  R+Y +Q+++ +++ HS  
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQ----QGVELLHTTCGTPNYVAPEVLSNRG 185
           + HRD+K  N+L DS GN+K+ DFG S   Q     G  +   T GTP +++PEV+S  G
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWMSPEVISGEG 185

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGE 212
           Y G  ADVWS G  +  ++    P+ E
Sbjct: 186 Y-GRKADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 2e-28
 Identities = 64/269 (23%), Positives = 107/269 (39%), Gaps = 31/269 (11%)

Query: 15  RTIGEGTFAKVRFA---QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + +GEG F +V              VA+K L +    + R      +E  +MK + HPN+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER--KDFLKEARVMKKLGHPNV 58

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--------QQLID--- 120
           VRL  V      +Y++LE++ GG+L         L ++              + L+    
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDL------LDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112

Query: 121 ----AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TPN- 174
                + +  SK   HRDL   N L+     +K+SDFGLS            T G  P  
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172

Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEF-SCPFW 232
           ++APE L +  +  S +DVWS GV+L+ +   G  P+       + + +        P +
Sbjct: 173 WMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEY 231

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                  L+      +P+ R     + + 
Sbjct: 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  114 bits (286), Expect = 2e-28
 Identities = 81/269 (30%), Positives = 134/269 (49%), Gaps = 17/269 (6%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + + TG+  AMK+L K  +LK       + E  ++       
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + RL E+  R Y  +++ A+   H  G
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFG--LSALPQQGVELLHTTCGTPNYVAPEVL----SN 183
             HRD+KP+N+LLD  G+++++DFG  L  L    V+      GTP+Y++PE+L      
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN-VAVGTPDYISPEILQAMEDG 181

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW---FSTGAT 238
           +G  G   D WS GV ++ ++ G  PF    L   Y KI   +  F  P      S  A 
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAK 241

Query: 239 SLIHKILDPNPKTRIRIEGI---RKHPWF 264
            LI +++   P+TR+   G+   + HP+F
Sbjct: 242 DLIRRLICS-PETRLGRNGLQDFKDHPFF 269

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  113 bits (284), Expect = 2e-28
 Identities = 64/194 (32%), Positives = 114/194 (58%), Gaps = 5/194 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A+ + +G  VA+K++    + K +  + +  E+ IM+  +H N+V +++
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D IV Q RL E       + ++ A+ + HS+GV HRD+K
Sbjct: 86  SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V    +  GTP ++APEV+S   Y G+  D+WS 
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSL 203

Query: 197 GVILFVLMAGYLPF 210
           G+++  ++ G  P+
Sbjct: 204 GIMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  112 bits (282), Expect = 3e-28
 Identities = 81/262 (30%), Positives = 129/262 (49%), Gaps = 14/262 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V   Q R TG+  A K L K  + K +  +    E  I+  V    IV L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCHSKGVYH 132
              ++T + +++  + GG+L   I +         E     Y  Q+I  + H H + + +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD+ GN+++SD GL+   + G        GTP ++APE+L    YD S  D
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS-VD 179

Query: 193 VWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            ++ GV L+ ++A   PF   GE  +   L ++I     + P  FS  + S    +L  +
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239

Query: 249 PKTRI-----RIEGIRKHPWFR 265
           P+ R+       +G+R HP FR
Sbjct: 240 PEKRLGFRDGNCDGLRTHPLFR 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  113 bits (284), Expect = 3e-28
 Identities = 74/267 (27%), Positives = 128/267 (47%), Gaps = 13/267 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + +   +  AMK+L K  +LK       + E  ++    +  
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + RL E+  R Y  +++ A+   H   
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLS----NR 184
             HRD+KP+N+L+D  G+++++DFG    L + G        GTP+Y++PE+L      +
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFW---FSTGATS 239
           G  G   D WS GV ++ ++ G  PF    L   Y KI  +   F  P      S  A  
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKD 242

Query: 240 LIHKILDPNPKT--RIRIEGIRKHPWF 264
           LI +++        +  IE  ++HP+F
Sbjct: 243 LIRRLICSREHRLGQNGIEDFKQHPFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 4e-28
 Identities = 76/265 (28%), Positives = 128/265 (48%), Gaps = 17/265 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I + G     E     Y  ++   +   H + + +
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD YG++++SD GL+    +G E +    GT  Y+APEV+ N  Y   + D
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKNERY-TFSPD 183

Query: 193 VWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSCPFWFSTGATSLIHKILD 246
            W  G +++ ++ G  PF +       +++      +  E+S    FS  A S+  ++L 
Sbjct: 184 WWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK--FSEAARSICRQLLT 241

Query: 247 PNPKTRI-----RIEGIRKHPWFRK 266
            +P  R+       E ++ HP+FR 
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFFRT 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  111 bits (279), Expect = 5e-28
 Identities = 78/262 (29%), Positives = 128/262 (48%), Gaps = 20/262 (7%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGES-VAMK-------VLAKSTILKHRMVDQIKREISI 62
           Y V   +G G F  V   + +  G++ +A+K          K    + + +  I  E++I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 63  MK-IVRHPNIVRLHEVLASRTKVYIILEFVTG---GELFDKIVHQG-RLLENDCRRYFQQ 117
           +K  +RHPNIVR ++      ++YI+++ + G   GE F+ +  +  R  E      F Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 118 LIDAVAHCH-SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           ++ A+ + H  K + HRDL P N++L     + ++DFGL A  +Q    L +  GT  Y 
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL-AKQKQPESKLTSVVGTILYS 180

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF---WF 233
            PE++ N  Y G  ADVW+ G IL+ +     PF  T++ +L  KI  A +  P     +
Sbjct: 181 CPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE-PLPEGMY 238

Query: 234 STGATSLIHKILDPNPKTRIRI 255
           S   T +I   L P+ + R  I
Sbjct: 239 SEDVTDVITSCLTPDAEARPDI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  112 bits (281), Expect = 5e-28
 Identities = 89/298 (29%), Positives = 134/298 (44%), Gaps = 48/298 (16%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
            YE    IGEGT+ KV  A+++ TG+ VA+K   +  + +  +     REIS+++++   
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSES 60

Query: 69  PNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGR-----LLENDCRRYFQQL 118
             IVRL +V     K     +Y++ E++   +L   +   GR     L     + +  QL
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
           +  VAHCH  GV HRDLKP+NLL+D     LK++D GL       V+       T  Y A
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179

Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDL------------------PT 217
           PEVL    +  +  D+WS G I F  M+   P   G+++L                  P 
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCI-FAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238

Query: 218 LYKKINAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
           + K  +  EF  P W            S     L+ K+L  +P  RI  +    HP+F
Sbjct: 239 VSKLRDWHEF--PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  111 bits (278), Expect = 1e-27
 Identities = 63/194 (32%), Positives = 111/194 (57%), Gaps = 5/194 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  + TG+ VA+K   K  + K +  + +  E+ IM+   H N+V ++ 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A+++ H++GV HRD+K
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL S G +K+SDFG  A   + V    +  GTP ++APEV+S   Y G+  D+WS 
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSL 204

Query: 197 GVILFVLMAGYLPF 210
           G+++  ++ G  P+
Sbjct: 205 GIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  110 bits (277), Expect = 1e-27
 Identities = 82/261 (31%), Positives = 130/261 (49%), Gaps = 15/261 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREI--SIMKIVRHPNIVR 73
           IG G F +V   +  +TG+  AMK L K  I +K      +   I  S++     P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           +     +  K+  IL+ + GG+L   +   G   E + R Y  ++I  + H H++ V +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RGYDGSAAD 192
           DLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL     YD S+AD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAYD-SSAD 178

Query: 193 VWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
            +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +L  + 
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 238

Query: 250 KTRIRIEG-----IRKHPWFR 265
             R+   G     +++HP+FR
Sbjct: 239 NRRLGCLGRGAQEVKEHPFFR 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  110 bits (275), Expect = 2e-27
 Identities = 81/266 (30%), Positives = 135/266 (50%), Gaps = 19/266 (7%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I H G     + R  F   ++   +   H + + +
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD +G++++SD GL+    +G + +    GT  Y+APEV+ N  Y  S  D
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFS-PD 183

Query: 193 VWSCGVILFVLMAGYLPFGE-------TDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
            W+ G +L+ ++AG  PF +        ++  L K++   E+S    FS  A SL   +L
Sbjct: 184 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-EEYSEK--FSPDARSLCKMLL 240

Query: 246 DPNPKTRIRIEG-----IRKHPWFRK 266
             +PK R+  +G     +++HP F++
Sbjct: 241 CKDPKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  109 bits (273), Expect = 3e-27
 Identities = 73/253 (28%), Positives = 129/253 (50%), Gaps = 6/253 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G++ +V   ++R  G+   +K L        R     ++E  ++  ++HPNIV  
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 75  HEVLASRT-KVYIILEFVTGGELFDKIVHQ-GRLL-ENDCRRYFQQLIDAVAHCHSKGVY 131
            E        +YI++ F  GG+L+ K+  Q G+LL EN    +F Q+  A+ + H K + 
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           HRDLK +N+ L     +KV D G++ + +   ++  T  GTP Y++PE+ SN+ Y+   +
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYN-YKS 183

Query: 192 DVWSCGVILFVLMAGYLPFGETDLPTL-YKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
           DVW+ G  ++ +      F   D+ +L Y+ I       P  +S     LI  +L   P+
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPE 243

Query: 251 TRIRIEGIRKHPW 263
            R  ++ I + P+
Sbjct: 244 KRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score =  114 bits (288), Expect = 3e-27
 Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 14/234 (5%)

Query: 32  ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL-HEVLASRTKVYIILEF 90
            TG  VA+K+L      +     + +RE ++   + HPNIV L     A    ++ + E+
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 91  VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---N 147
           V G  L + +   G L   +  R   Q++DA+A  H++G+ HRDLKP+N+++   G   +
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 148 LKVSDFGLSAL-------PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVIL 200
            KV DFG+  L           +       GTP Y APE L         +D+++ G+I 
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIF 179

Query: 201 FVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWF-STGATSLIHKILDPNPKTR 252
              + G     G +    LY++++  + S P W        ++ K L+ +P+ R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 4e-27
 Identities = 96/306 (31%), Positives = 145/306 (47%), Gaps = 57/306 (18%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHP 69
           Y+    IGEG +  V  A ++ TG  VA+K   K +  +H+   Q   REI I++  +H 
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIK---KISPFEHQTFCQRTLREIKILRRFKHE 63

Query: 70  NIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVA 123
           NI+ + +++   +      VYI+ E +   +L+  I  Q   L ND  +YF  Q++  + 
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH--LSNDHIQYFLYQILRGLK 120

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTT-----CGTPNYV 176
           + HS  V HRDLKP NLLL++  +LK+ DFGL   A P+      HT        T  Y 
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD----HTGFLTEYVATRWYR 176

Query: 177 APEV-LSNRGYDGSAADVWSCGVILFVLMAG--------Y-----LPFGETDLPT---LY 219
           APE+ L+++GY   A D+WS G IL  +++         Y     L  G    P+   L 
Sbjct: 177 APEIMLNSKGYT-KAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235

Query: 220 KKIN--AAEF--SCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
             I+  A  +  S PF     W          A  L+ K+L  NP  RI +E    HP+ 
Sbjct: 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295

Query: 265 RKNYNP 270
            + ++P
Sbjct: 296 EQYHDP 301

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  110 bits (275), Expect = 6e-27
 Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 13/267 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + + T    AMK+L K  +LK       + E +++       
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + RL E+  R Y  +++ A+   H   
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLS----NR 184
             HRD+KP+N+LLD  G+++++DFG    + Q G        GTP+Y++PE+L       
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFWF---STGATS 239
           G  G   D WS GV ++ ++ G  PF    L   Y KI   E  F  P      S  A  
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKD 242

Query: 240 LIHKILDPNPKT--RIRIEGIRKHPWF 264
           LI +++    +   +  IE  +KH +F
Sbjct: 243 LIQRLICSRERRLGQNGIEDFKKHAFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  109 bits (276), Expect = 8e-27
 Identities = 100/349 (28%), Positives = 151/349 (43%), Gaps = 77/349 (22%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL---------AKSTILKHRMVDQIKREI 60
           KYE+ + +G+G +  V  A +R T E VA+K +         A+ T           REI
Sbjct: 8   KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF----------REI 57

Query: 61  SIMKIVR-HPNIVRLHEVL-ASRTK-VYIILEFVTGGELFDKIVHQGRLLENDCRRY-FQ 116
             ++ +  HPNIV+L  V+ A   K +Y++ E++   E     V +  +LE+  +RY   
Sbjct: 58  MFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM---ETDLHAVIRANILEDVHKRYIMY 114

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL----SALPQ-QGVELLHTTCG 171
           QL+ A+ + HS  V HRDLKP N+LL+S   +K++DFGL    S L +     +L     
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 172 TPNYVAPEVL--SNRGYDGSAADVWSCGVILFVLMAG----------------------- 206
           T  Y APE+L  S R Y     D+WS G IL  ++ G                       
Sbjct: 175 TRWYRAPEILLGSTR-YT-KGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232

Query: 207 --------YLPFGET---DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI 255
                     PF  T    LP+  +K            S  A  L+ K+L  NP  R+  
Sbjct: 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA---SDDALDLLKKLLVFNPNKRLTA 289

Query: 256 EGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKV 304
           E   +HP+  + +NP     +E V    +    DD   +    +  NK+
Sbjct: 290 EEALEHPYVAQFHNP----SDEPVLPYPITIPLDD-NVKLSVAEYRNKL 333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  109 bits (274), Expect = 1e-26
 Identities = 87/314 (27%), Positives = 134/314 (42%), Gaps = 66/314 (21%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMK---------VLAKSTILKHRMVDQIKRE 59
            KY   + IG G +  V  A+N ET E VA+K         + AK T+          RE
Sbjct: 5   TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----------RE 54

Query: 60  ISIMKIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQ----GRLLEND 110
           I +++ + H N++ + +++    +     VYI+ E      L D  +HQ     + L +D
Sbjct: 55  IKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE------LMDTDLHQIIRSSQTLSDD 108

Query: 111 -CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 169
            C+ +  QL+  + + HS  V HRDLKP NLLL++  +LK+ DFGL+    +  + +   
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEY 168

Query: 170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------- 222
             T  Y APE+L N     +A DVWS G I   L+     F   D     K I       
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228

Query: 223 -----------NAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGI 258
                       A  +  S P+             +  A  L+ K+L  +P  RI +E  
Sbjct: 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288

Query: 259 RKHPWFRKNYNPVK 272
             HP+    ++P  
Sbjct: 289 LAHPYLASLHDPSD 302

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  107 bits (269), Expect = 1e-26
 Identities = 72/262 (27%), Positives = 122/262 (46%), Gaps = 14/262 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMK--VLAKSTILK-HRMVDQIKREISIMKIVRHPN 70
           G  +G+G +  V +      G+ +A+K   L  S +L   +  ++++ E+ ++K ++H N
Sbjct: 5   GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV+          + I +EFV GG +   +   G L E    +Y +Q++D VA+ H+  V
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLS------ALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HRD+K  N++L   G +K+ DFG +       L      +L +  GTP ++APEV++  
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGATSLI 241
           GY G  +D+WS G  +F +  G  P    D       I A        P  FS  A   +
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242

Query: 242 HKILDPNPKTRIRIEGIRKHPW 263
              L  +   R     + +H +
Sbjct: 243 TSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  107 bits (268), Expect = 2e-26
 Identities = 72/214 (33%), Positives = 110/214 (51%), Gaps = 8/214 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           K+EV   +GEG +  V   +++ET E VA+K   K +     + +   RE+ +++ ++  
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60

Query: 70  NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIV L E    R K+Y++ E+V     EL ++      +     R Y  QLI A+  CH 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHK 118

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSNRGY 186
             + HRD+KPENLL+     LK+ DFG +    +G    +T    T  Y +PE+L    Y
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 219
            G A D+WS G IL  L  G   F GE+++  L+
Sbjct: 179 -GKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  107 bits (268), Expect = 3e-26
 Identities = 74/262 (28%), Positives = 129/262 (49%), Gaps = 18/262 (6%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  + +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V    +  GTP ++APE++S   Y G   D+WS 
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSL 202

Query: 197 GVILFVLMAGYLP-FGETDLP-------TLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           G+++  ++ G  P F E  L         L  K+       P          + ++L  +
Sbjct: 203 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPS-----LKGFLDRLLVRD 257

Query: 249 PKTRIRIEGIRKHPWFRKNYNP 270
           P  R     + KHP+  K   P
Sbjct: 258 PAQRATAAELLKHPFLAKAGPP 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  106 bits (265), Expect = 4e-26
 Identities = 76/260 (29%), Positives = 122/260 (46%), Gaps = 10/260 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG GT+  V  A+N  TGE  A+KV+    +        +++EI +MK  +H N
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV        R K++I +EF  GG L D     G L E+      ++ +  + + HSKG 
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV--LSNRGYDG 188
            HRD+K  N+LL   G++K++DFG+SA     +    +  GTP ++APEV  +  +G   
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187

Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP-----FWFSTGATSLIHK 243
              D+W+ G+    L     P  +         +  + F  P       +S      +  
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKM 247

Query: 244 ILDPNPKTRIRIEGIRKHPW 263
            L  NPK R   E + +HP+
Sbjct: 248 ALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 4e-26
 Identities = 69/213 (32%), Positives = 99/213 (46%), Gaps = 34/213 (15%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLA---------KSTILKHRMVDQIKREIS 61
           YE    IGEG +  V  A++  TG  VA+K +           ST+          REI+
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL----------REIA 50

Query: 62  IMKIVR---HPNIVRLHEVLA-----SRTKVYIILEFVTG--GELFDKIVHQGRLLENDC 111
           ++K +    HPNIVRL +V          K+ ++ E V         K    G L     
Sbjct: 51  LLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETI 109

Query: 112 RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC- 170
           +   +QL+  V   HS  + HRDLKP+N+L+ S G +K++DFGL+ +     E+  T+  
Sbjct: 110 KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVV 167

Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL 203
            T  Y APEVL    Y  +  D+WS G I   L
Sbjct: 168 VTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  106 bits (267), Expect = 4e-26
 Identities = 70/217 (32%), Positives = 110/217 (50%), Gaps = 12/217 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS----TILKHRMVDQIKREISIMKI 65
           KYE    IGEG++  V   +NRETG+ VA+K   +S     I K  +     REI ++K 
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL-----REIRMLKQ 56

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           ++HPN+V L EV   + K++++ E+     L +   +   + E+  ++   Q + AV  C
Sbjct: 57  LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H     HRD+KPEN+L+   G +K+ DFG + +     +       T  Y APE+L    
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 186 YDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK 220
             G   DVW+ G +   L+ G  P   G++D+  LY 
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYL 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  107 bits (268), Expect = 5e-26
 Identities = 79/316 (25%), Positives = 135/316 (42%), Gaps = 69/316 (21%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK------- 57
              V+KYE    IG+GTF +V  A++++T + VA+K        K  M ++ +       
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK--------KVLMENEKEGFPITAL 59

Query: 58  REISIMKIVRHPNIVRLHEVLAS--------RTKVYIILEFVT---GGELFDKIVHQGRL 106
           REI I+++++H N+V L E+  +        +   Y++ EF      G L +K V   + 
Sbjct: 60  REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KF 116

Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGV 163
             ++ ++  + L++ + + H   + HRD+K  N+L+   G LK++DFGL+   +L +   
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176

Query: 164 ELLHTT-CGTPNYVAPEVLSN-RGYDGSAADVWSCGVIL------FVLMAG--------- 206
              +T    T  Y  PE+L   R Y G   D+W  G I+        +M G         
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDY-GPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL 235

Query: 207 ------------------YLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
                                F + +LP   K+        P+     A  LI K+L  +
Sbjct: 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK-PYVKDPHALDLIDKLLVLD 294

Query: 249 PKTRIRIEGIRKHPWF 264
           P  RI  +    H +F
Sbjct: 295 PAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  105 bits (264), Expect = 6e-26
 Identities = 78/260 (30%), Positives = 128/260 (49%), Gaps = 13/260 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREI--SIMKIVRHPNIVR 73
           IG G F +V   +  +TG+  AMK L K  I +K      +   I  S++     P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           +     +  K+  IL+ + GG+L   +   G   E + R Y  ++I  + H H++ V +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLKP N+LLD +G++++SD GL+    +  +  H + GT  Y+APEVL       S+AD 
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTAYDSSADW 179

Query: 194 WSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
           +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +L  +  
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS 239

Query: 251 TRIRIEG-----IRKHPWFR 265
            R+   G     +++H +F+
Sbjct: 240 KRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 15  RTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +GEG F KV           TGE VA+K L  S   +HR     +REI I++ + H N
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR--SDFEREIEILRTLDHEN 67

Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V        + +I+E++  G L D +  H+ ++       +  Q+   + +  S
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-----YVAPEVLS 182
           +   HRDL   N+L++S   +K+SDFGL+ +  +  +  +     P      + APE L 
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD--YYYVKEPGESPIFWYAPECLR 185

Query: 183 NRGYDGSAADVWSCGVILFVL 203
              +  SA+DVWS GV L+ L
Sbjct: 186 TSKFS-SASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  105 bits (263), Expect = 3e-25
 Identities = 76/302 (25%), Positives = 133/302 (44%), Gaps = 49/302 (16%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKI 65
            +Y+    +G G + +V  A + +TG  VA+K L++   S I   R      RE+ ++K 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR----TYRELRLLKH 70

Query: 66  VRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           + H N++ L +V      L     VY++   + G +L + IV   +L ++  +    Q++
Sbjct: 71  MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQIL 128

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
             + + HS G+ HRDLKP N+ ++    LK+ DFGL+   +   + +     T  Y APE
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPE 185

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA 224
           ++ N  +     D+WS G I+  L+ G   F  +D                  L +KI++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 225 AE---------------FSCPF-WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY 268
                            F   F   +  A  L+ K+L  +P  RI       HP+  + +
Sbjct: 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305

Query: 269 NP 270
           +P
Sbjct: 306 DP 307

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  103 bits (258), Expect = 7e-25
 Identities = 75/261 (28%), Positives = 130/261 (49%), Gaps = 12/261 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA+K +      K  +   I  EI +M+  +HP
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKHP 76

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 135

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV++ + Y 
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY- 192

Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGATSLIHKI 244
           G   D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252

Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           L+ + + R   + + +HP+ +
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  102 bits (257), Expect = 1e-24
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 34/288 (11%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
             +GEG    V   + + TG   A+K +         +   QI RE+ I K  + P IV+
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK---QILRELEINKSCKSPYIVK 63

Query: 74  LHE--VLASRTKVYIILEFVTGGEL---FDKIVHQG-RLLENDCRRYFQQLIDAVAHCHS 127
            +   +  S + + I +E+  GG L   + K+  +G R+ E    +  + ++  +++ HS
Sbjct: 64  YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + + HRD+KP N+LL   G +K+ DFG+S   +    L  T  GT  Y+APE +  + Y 
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSFYMAPERIQGKPYS 181

Query: 188 GSAADVWSCGVILFVLMAGYLPF---GETDLP---TLYKKINAAEF---SCP----FWFS 234
            + +DVWS G+ L  +     PF   GE  L     L   +N         P     W S
Sbjct: 182 IT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW-S 239

Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLD 282
                 I + L+ +P  R     + +HPW       +K   +++VN+ 
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPW-------IKAQMKKKVNMA 280

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  102 bits (257), Expect = 2e-24
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 40/215 (18%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMK---------VLAKSTILKHRMVDQIKRE 59
           ++Y+    IG G +  V  A +  +G+ VA+K          LAK T+          RE
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----------RE 54

Query: 60  ISIMKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           + I++  +H NI+ + ++L  R        VY++++ +   +L   I+H  + L  +  R
Sbjct: 55  LKILRHFKHDNIIAIRDIL--RPPGADFKDVYVVMDLM-ESDL-HHIIHSDQPLTEEHIR 110

Query: 114 YF-QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL------SALPQQGVELL 166
           YF  QL+  + + HS  V HRDLKP NLL++    L++ DFG+      S    +     
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170

Query: 167 HTTCGTPNYVAPEVL-SNRGYDGSAADVWSCGVIL 200
           +    T  Y APE+L S   Y  +A D+WS G I 
Sbjct: 171 YVA--TRWYRAPELLLSLPEYT-TAIDMWSVGCIF 202

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  101 bits (253), Expect = 3e-24
 Identities = 74/261 (28%), Positives = 132/261 (50%), Gaps = 12/261 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA+K +    + K    + I  EI +MK +++P
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNP 76

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   H+  
Sbjct: 77  NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV++ + Y 
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY- 192

Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGATSLIHKI 244
           G   D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252

Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           L+ + + R   + + +HP+ +
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  101 bits (253), Expect = 3e-24
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 3/207 (1%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +GEG++A V    +R  G+ VA+KV++  T  +  +     RE S++K ++H NIV LH+
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
           ++ ++  +  + E++        I H G L   + R +  QL+  +A+ H + + HRDLK
Sbjct: 71  IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLK 130

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
           P+NLL+   G LK++DFGL+       +   +   T  Y  P+VL       SA D+W  
Sbjct: 131 PQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGA 190

Query: 197 GVILFVLMAGYLPF-GETDLPTLYKKI 222
           G I   ++ G   F G +D+    +KI
Sbjct: 191 GCIFIEMLQGQPAFPGVSDVFEQLEKI 217

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|217748 pfam03822, NAF, NAF domain

 Score = 94.5 bits (236), Expect = 3e-24
 Identities = 26/57 (45%), Positives = 41/57 (71%)

Query: 310 MNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVH 366
           +NAF++I+LS GL+L+ LF+  +   K++TRF SR+PA  I+S +E +A+ L  KV 
Sbjct: 1   LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVK 57

Length = 58

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  100 bits (250), Expect = 4e-24
 Identities = 67/194 (34%), Positives = 105/194 (54%), Gaps = 13/194 (6%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ---IKREISIMKIVR 67
           YE+ + +G GT+  V  A+N  TGE  A+K      I+K    D    I++EI ++K  +
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVK------IIKLEPGDDFSLIQQEIFMVKECK 64

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           H NIV       SR K++I +E+  GG L D     G L E       ++ +  +A+ HS
Sbjct: 65  HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS---NR 184
           KG  HRD+K  N+LL   G++K++DFG++A     +    +  GTP ++APEV +   N 
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNG 184

Query: 185 GYDGSAADVWSCGV 198
           GY+    D+W+ G+
Sbjct: 185 GYN-QLCDIWAVGI 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score =   99 bits (249), Expect = 4e-24
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 29/254 (11%)

Query: 20  GTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA 79
           G   KV    +  T ++  +K L KS+        + +  I I   V  PN+V LH+ + 
Sbjct: 4   GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTI-IPHCV--PNMVCLHKYIV 55

Query: 80  SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN 139
           S   V+++L+   GG+L+  I     + E   +R+  +++ A+   H +G+  RDL P N
Sbjct: 56  SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115

Query: 140 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGSAADVWSC 196
           +LLD  G+++++ F       +  E+  +  G      Y APEV      +  A D WS 
Sbjct: 116 ILLDDRGHIQLTYFS------RWSEVEDSCDGEAVENMYCAPEV-GGISEETEACDWWSL 168

Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINA-AEFSCPFWFSTGATSLIHKILDPNPKTRI-- 253
           G ILF L+      G+T +      IN     + P W S  A SL+ ++L  NP  R+  
Sbjct: 169 GAILFELLT-----GKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223

Query: 254 ---RIEGIRKHPWF 264
               +E I+ HP+F
Sbjct: 224 GVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  100 bits (251), Expect = 5e-24
 Identities = 74/261 (28%), Positives = 129/261 (49%), Gaps = 12/261 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA+K +      K  +   I  EI +M+  ++P
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKNP 76

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV++ + Y 
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY- 192

Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGATSLIHKI 244
           G   D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252

Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           L+ +   R   + + +HP+ +
Sbjct: 253 LEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  100 bits (249), Expect = 9e-24
 Identities = 77/264 (29%), Positives = 129/264 (48%), Gaps = 17/264 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I + G    ++ R  F   +L   +     + + +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD  G++++SD GL+    +G E +    GT  Y+APEV++N  Y  S  D
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINNEKYTFS-PD 183

Query: 193 VWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSCPFWFSTGATSLIHKILD 246
            W  G +++ ++ G  PF +       +++      +  E+S    FS  A S+   +L 
Sbjct: 184 WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK--FSEDAKSICRMLLT 241

Query: 247 PNPKTRIRIEG-----IRKHPWFR 265
            NPK R+   G     +++HP F+
Sbjct: 242 KNPKERLGCRGNGAAGVKQHPIFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  103 bits (258), Expect = 2e-23
 Identities = 76/237 (32%), Positives = 124/237 (52%), Gaps = 37/237 (15%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R+ +YEV + IG G F +V   +++ T E    K ++    LK R   Q+  E+++M+ +
Sbjct: 11  RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG-LKEREKSQLVIEVNVMREL 69

Query: 67  RHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLID 120
           +H NIVR  +   ++   K+YI++EF   G+L   I       G++ E+      +QL+ 
Sbjct: 70  KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129

Query: 121 AVAHCHS-------KGVYHRDLKPENLLLDS-----------YGNL------KVSDFGLS 156
           A+A+CH+       + V HRDLKP+N+ L +             NL      K+ DFGLS
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 157 ALPQQGVE-LLHTTCGTPNYVAPEVL--SNRGYDGSAADVWSCGVILFVLMAGYLPF 210
                G+E + H+  GTP Y +PE+L    + YD   +D+W+ G I++ L +G  PF
Sbjct: 190 K--NIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  102 bits (254), Expect = 2e-23
 Identities = 80/257 (31%), Positives = 118/257 (45%), Gaps = 24/257 (9%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIV 66
           V    VGR      F   R       G     KV+AK  +L   R     + E+  +   
Sbjct: 70  VLTTLVGRNPTTAAFVATR-------GSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC 122

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAV 122
            H  IV+  +   S  K+ +I+E+ +GG+L  +I  + +      E +    F Q++ A+
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEV 180
              HS+ + HRDLK  N+ L   G +K+ DFG S      V L    + CGTP Y+APE+
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPEL 242

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFG-----ETDLPTLYKKINAAEFSCPFWFST 235
              + Y    AD+WS GVIL+ L+  + PF      E     LY K +   F CP   S+
Sbjct: 243 WERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP--FPCP--VSS 297

Query: 236 GATSLIHKILDPNPKTR 252
           G  +L+  +L  NP  R
Sbjct: 298 GMKALLDPLLSKNPALR 314

Length = 478

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 98.5 bits (245), Expect = 3e-23
 Identities = 64/196 (32%), Positives = 100/196 (51%), Gaps = 4/196 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V   Q + TG+  A K L K  + K         E  I++ V  P IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQG-RLLE-NDCRRYFQQLIDAVAHCHSKGVYHRD 134
              S+T + +++  + GG+L   I + G R LE      Y  Q+   + H HS  + +RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +KPEN+LLD  GN ++SD GL A+  +  + +    GT  Y+APE+L    Y     D +
Sbjct: 121 MKPENVLLDDQGNCRLSDLGL-AVELKDGKTITQRAGTNGYMAPEILKEEPYSYP-VDWF 178

Query: 195 SCGVILFVLMAGYLPF 210
           + G  ++ ++AG  PF
Sbjct: 179 AMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 97.8 bits (243), Expect = 5e-23
 Identities = 68/254 (26%), Positives = 124/254 (48%), Gaps = 9/254 (3%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++          ++ I++EI+++     P + + + 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G   E       ++++  + + HS+   HRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL   G++K++DFG++          +T  GTP ++APEV+    YD S AD+WS 
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSL 187

Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW---FSTGATSLIHKILDPNPKTRI 253
           G+    L  G  P   +D+  +       + + P     FS      I   L+ +P  R 
Sbjct: 188 GITAIELAKGEPP--NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRP 245

Query: 254 RIEGIRKHPWFRKN 267
             + + KH +  KN
Sbjct: 246 TAKELLKHKFIVKN 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 97.9 bits (243), Expect = 7e-23
 Identities = 73/261 (27%), Positives = 129/261 (49%), Gaps = 12/261 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      K  +   I  EI +M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV++ + Y 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY- 193

Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGATSLIHKI 244
           G   D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253

Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           LD + + R   + + +H + +
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 97.8 bits (243), Expect = 8e-23
 Identities = 76/295 (25%), Positives = 127/295 (43%), Gaps = 51/295 (17%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ------IKREISIMK 64
           YE    +GEG++A V   +++  G+ VA+KV+        R+ ++        RE S++K
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVI--------RLQEEEGTPFTAIREASLLK 58

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAV 122
            ++H NIV LH+++ ++  + ++ E+V     +  DK  H G L   + + +  QL+  +
Sbjct: 59  GLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGL 116

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           ++ H + + HRDLKP+NLL+   G LK++DFGL+               T  Y  P+VL 
Sbjct: 117 SYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF--------------------------GETDLP 216
                 +  D+W  G I   ++ G   F                          G   LP
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236

Query: 217 -------TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
                  TLY   N  +      +   A  L  K+L   PK R+  +    H +F
Sbjct: 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 96.7 bits (241), Expect = 8e-23
 Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 8/203 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + + R +G G F +V +    +    VA+K+L    +LK +     ++E+  +K +RH +
Sbjct: 8   FTLERKLGSGYFGEV-WEGLWKNRVRVAIKILKSDDLLKQQD---FQKEVQALKRLRHKH 63

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQ-QLIDAVAHCHSK 128
           ++ L  V +    VYII E +  G L   +   +G++L          Q+ + +A+   +
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
              HRDL   N+L+      KV+DFGL+ L ++ V L         + APE  S+  +  
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS- 182

Query: 189 SAADVWSCGVILFVLMA-GYLPF 210
           + +DVWS G++L+ +   G +P+
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPY 205

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 14/192 (7%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           ++G TIG+G F  V     R  G+ VA+K L   +            E S+M  +RHPN+
Sbjct: 9   KLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNL 62

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLIDAVAHCHSKG 129
           V+L  V+     +YI+ E++  G L D +  +GR ++    +  F   + + + +   K 
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDG 188
             HRDL   N+L+      KVSDFGL+    QG      +   P  + APE L  + +  
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----QDSGKLPVKWTAPEALREKKFS- 177

Query: 189 SAADVWSCGVIL 200
           + +DVWS G++L
Sbjct: 178 TKSDVWSFGILL 189

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 96.3 bits (239), Expect = 2e-22
 Identities = 58/196 (29%), Positives = 104/196 (53%), Gaps = 4/196 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++          ++ I++EI+++     P + + + 
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL  +G +K++DFG++          +T  GTP ++APEV+    YD S AD+WS 
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSL 187

Query: 197 GVILFVLMAGYLPFGE 212
           G+    L  G  P  E
Sbjct: 188 GITAIELAKGEPPHSE 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 80/294 (27%), Positives = 134/294 (45%), Gaps = 61/294 (20%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVL-------AKSTILKHRMVDQIKREISIMKIVRHP 69
           +GEG++A V   +++ TG+ VA+K +       A  T +         RE S++K ++H 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI---------REASLLKDLKHA 63

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSK 128
           NIV LH+++ ++  + ++ E++   +L   +   G  L  ++ R +  QL+  +A+CH +
Sbjct: 64  NIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGV--ELLHTTCGTPNYVAPEVLSN 183
            V HRDLKP+NLL+   G LK++DFGL+   ++P +    E++     T  Y  P+VL  
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-----TLWYRPPDVLLG 177

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDL-------------------PTLYKKIN 223
                ++ D+W  G I + +  G   F G TD+                   P +     
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237

Query: 224 AAEFSCPFW-------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
              +S PF+                    L  K L   PK RI      KHP+F
Sbjct: 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 96.3 bits (239), Expect = 2e-22
 Identities = 68/252 (26%), Positives = 121/252 (48%), Gaps = 17/252 (6%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T E VA+K++          ++ I++EI+++     P I R + 
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL   G++K++DFG++          +T  GTP ++APEV+    YD   AD+WS 
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADIWSL 187

Query: 197 GVILFVLMAGYLPFGETD-------LPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
           G+    L  G  P  +         +P         ++S PF         +   L+ +P
Sbjct: 188 GITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPF------KEFVEACLNKDP 241

Query: 250 KTRIRIEGIRKH 261
           + R   + + KH
Sbjct: 242 RFRPTAKELLKH 253

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 98.8 bits (246), Expect = 2e-22
 Identities = 74/258 (28%), Positives = 124/258 (48%), Gaps = 17/258 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY + R +G G    V  A+    GE  A+KV+     +     ++ + E+  +      
Sbjct: 33  KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG-MSEADKNRAQAEVCCLLNCDFF 91

Query: 70  NIVRLHEVLASRTK--------VYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQ 117
           +IV+ HE  A +          + ++L++   G+L  +I  + +      E++    F Q
Sbjct: 92  SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNY 175
           ++ AV H HSK + HRD+K  N+LL S G +K+ DFG S +    V  ++  T CGTP Y
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFS 234
           VAPE+   + Y    AD++S GV+L+ L+    PF   ++  +  K  A  +   P   S
Sbjct: 212 VAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSIS 270

Query: 235 TGATSLIHKILDPNPKTR 252
                ++  +L  +PK R
Sbjct: 271 PEMQEIVTALLSSDPKRR 288

Length = 496

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 95.8 bits (238), Expect = 3e-22
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 20/217 (9%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HP 69
           +E+  TIG+GT+ KV    N++ G   A+K+L       H + ++I+ E +I+K +  HP
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI----HDIDEEIEAEYNILKALSDHP 75

Query: 70  NIVRLHEVLASRTKV-----YIILEFVTGGELFDKI---VHQGRLLENDCRRY-FQQLID 120
           N+V+ + +   +        +++LE   GG + D +   + +G  +E     Y   + + 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
            + H H     HRD+K  N+LL + G +K+ DFG+SA         +T+ GTP ++APEV
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195

Query: 181 LS-----NRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
           ++     +  YD +  DVWS G+    L  G  P  +
Sbjct: 196 IACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLAD 231

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 95.6 bits (238), Expect = 4e-22
 Identities = 59/189 (31%), Positives = 99/189 (52%), Gaps = 12/189 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R IG G+F  V FA++  T E VA+K ++ S    +     I +E+  ++ +RHPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 75  HEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
                     ++++E+  G   ++ +  VH+  L E +        +  +A+ HS    H
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERIH 138

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL--SNRG-YDGS 189
           RD+K  N+LL   G +K++DFG ++L    V   ++  GTP ++APEV+   + G YDG 
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASL----VSPANSFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 190 AADVWSCGV 198
             DVWS G+
Sbjct: 195 -VDVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 95.1 bits (236), Expect = 5e-22
 Identities = 69/226 (30%), Positives = 120/226 (53%), Gaps = 21/226 (9%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRHP 69
           +E+  TIG+GT+ KV    N++ G   A+K+L   +     + ++I+ E +I++ +  HP
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHP 79

Query: 70  NIVRLHEVLASRTK-----VYIILEFVTGG---ELFDKIVHQGRLLENDCRRY--FQQLI 119
           N+V+ + +     K     ++++LE   GG   EL   ++  G+ L+     Y  +  L+
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
             + H H+  + HRD+K  N+LL + G +K+ DFG+SA         +T+ GTP ++APE
Sbjct: 140 -GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198

Query: 180 VLS-NRGYDGS---AADVWSCGVILFVLMAGYLPFGETD-LPTLYK 220
           V++  + YD S     DVWS G+    L  G  P  +   + TL+K
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 98.4 bits (245), Expect = 6e-22
 Identities = 45/140 (32%), Positives = 81/140 (57%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           I  G F KV   + +   +  A+KV+ K+ ++   MV Q++ E   + + + P IV L+ 
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
            L S   VY+++E++ GG++   +   G   E    +Y  ++  A+ + H  G+ HRDLK
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131

Query: 137 PENLLLDSYGNLKVSDFGLS 156
           P+N+L+ + G++K++DFGLS
Sbjct: 132 PDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 95.3 bits (237), Expect = 8e-22
 Identities = 71/208 (34%), Positives = 108/208 (51%), Gaps = 27/208 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIV 66
           +Y   + +G G F  V  A+++ TG++VA+K + K   + +L  R      RE+ ++K +
Sbjct: 11  RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY----RELKLLKHL 66

Query: 67  RHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQ-QLIDA 121
           RH NI+ L ++  S    +Y    FVT  EL    +H     R LE    +YF  Q++  
Sbjct: 67  RHENIISLSDIFISPLEDIY----FVT--ELLGTDLHRLLTSRPLEKQFIQYFLYQILRG 120

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPE 179
           + + HS GV HRDLKP N+L++   +LK+ DFGL A  Q        T    T  Y APE
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCDLKICDFGL-ARIQDP----QMTGYVSTRYYRAPE 175

Query: 180 V-LSNRGYDGSAADVWSCGVILFVLMAG 206
           + L+ + YD    D+WS G I   ++ G
Sbjct: 176 IMLTWQKYD-VEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 25/213 (11%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRET--GESVAMK----VLAKSTILKHRMVDQIKREISIMK 64
           YE+ + +G+G +  V  A+N ET   E+VA+K    V +K  + K  +     RE+ +++
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----RELKLLR 56

Query: 65  IVR-HPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQL 118
             R H NI  L+++      +  ++Y+  E +       +I+  G+ L +   + F  Q+
Sbjct: 57  HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQI 114

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL----SALPQQGVELLHTTCGTPN 174
           +  + + HS  V HRDLKP NLL+++   LK+ DFGL    S  P +    +     T  
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 175 YVAPEV-LSNRGYDGSAADVWSCGVILFVLMAG 206
           Y APE+ LS + Y   A DVWS G IL  L+  
Sbjct: 175 YRAPEIMLSFQSYT-KAIDVWSVGCILAELLGR 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 87/336 (25%), Positives = 137/336 (40%), Gaps = 64/336 (19%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMK--VLAKSTILKHRMVDQIKREISIMKIV 66
           ++Y   R +G G+   V  A + +  + VA+K  VL     +KH +     REI I++ +
Sbjct: 5   SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-----REIKIIRRL 59

Query: 67  RHPNIVRLHEVLASRTK--------------VYIILEFVTGGELFDKIVHQGRLLENDCR 112
            H NIV+++EVL                   VYI+ E++        ++ QG L E   R
Sbjct: 60  DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHAR 117

Query: 113 RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQGVE---LLHT 168
            +  QL+  + + HS  V HRDLKP N+ +++    LK+ DFGL+ +          L  
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177

Query: 169 TCGTPNYVAPE-VLSNRGYDGSAADVWSCGVILFVLMAGYLPFG---------------- 211
              T  Y +P  +LS   Y   A D+W+ G I   ++ G   F                 
Sbjct: 178 GLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236

Query: 212 ---ETDLPTLYKKI------NAAEFSCPFW-----FSTGATSLIHKILDPNPKTRIRIEG 257
              E D   L   I      +  E   P        +  A   + +IL  NP  R+  E 
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296

Query: 258 IRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIED 293
              HP+         C  +E V+L   H + D+++D
Sbjct: 297 ALMHPYMS----CYSCPFDEPVSLHPFH-IEDELDD 327

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 57/193 (29%), Positives = 105/193 (54%), Gaps = 8/193 (4%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVRHPNIVRL 74
           +GEGT+A V   +++ T   VA+K +     L+H         RE+S++K ++H NIV L
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKNLKHANIVTL 68

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHR 133
           H+++ +   + ++ E++   +L   + + G L+  ++ + +  QL+  +++CH + + HR
Sbjct: 69  HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLKP+NLL++  G LK++DFGL+       +       T  Y  P+VL       +  D+
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDM 187

Query: 194 WSCGVILFVLMAG 206
           W  G IL+ +  G
Sbjct: 188 WGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 60/214 (28%), Positives = 114/214 (53%), Gaps = 19/214 (8%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRHP 69
           +E+   +G GT+ +V   ++ +TG+  A+KV+     +     ++IK EI+++K    H 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73

Query: 70  NIVRLHEVLASRT------KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYF-QQLIDA 121
           NI   +     ++      ++++++EF   G + D + + +G  L+ D   Y  ++++  
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +AH H+  V HRD+K +N+LL     +K+ DFG+SA   + V   +T  GTP ++APEV+
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 182 S-----NRGYDGSAADVWSCGVILFVLMAGYLPF 210
           +     +  YD   +D+WS G+    +  G  P 
Sbjct: 194 ACDENPDATYD-YRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 93.1 bits (231), Expect = 4e-21
 Identities = 59/198 (29%), Positives = 105/198 (53%), Gaps = 18/198 (9%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVRHPNIVRL 74
           +GEGT+A V   +++ T   VA+K +     L+H         RE+S++K ++H NIV L
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQ-----GRLLE-NDCRRYFQQLIDAVAHCHSK 128
           H+++ +   + ++ E++      DK + Q     G ++  ++ + +  Q++  +A+CH +
Sbjct: 70  HDIVHTDKSLTLVFEYL------DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V HRDLKP+NLL++  G LK++DFGL+       +       T  Y  P+VL       
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183

Query: 189 SAADVWSCGVILFVLMAG 206
           +  D+W  G I F + +G
Sbjct: 184 TQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 73/251 (29%), Positives = 117/251 (46%), Gaps = 25/251 (9%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+GT+  V  A++  T   +A+K +        R V  +  EI++   ++H NIV+   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIP---ERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQ-GRLL--ENDCRRYFQQLIDAVAHCHSKGVYHR 133
             +      I +E V GG L   +  + G L   E     Y +Q+++ + + H   + HR
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132

Query: 134 DLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSA 190
           D+K +N+L+++Y G +K+SDFG S           T  GT  Y+APEV+    RGY G+ 
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAP 191

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW---------FSTGATSLI 241
           AD+WS G  +  +  G  PF E   P       AA F    +          S  A + I
Sbjct: 192 ADIWSLGCTIVEMATGKPPFIELGEP------QAAMFKVGMFKIHPEIPESLSAEAKNFI 245

Query: 242 HKILDPNPKTR 252
            +  +P+P  R
Sbjct: 246 LRCFEPDPDKR 256

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 91.8 bits (228), Expect = 7e-21
 Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 17/272 (6%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           EV   +G+G +  V    +R TG ++AMK +     L     +QI  E+ I+     P I
Sbjct: 4   EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYI 61

Query: 72  VRLHEVLASRTKVYIILEFVTGG---ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           V  +        VY+ +E++  G   +L+   V    + E+  RR    ++  +     +
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 129 -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HRD+KP N+L++  G +K+ DFG+S        L  T  G  +Y+APE + + G +
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAPERIKSGGPN 179

Query: 188 GSA-----ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA----AEFSCPFWFSTGAT 238
            +      +DVWS G+ +  +  G  P+       ++ +++A       + P  +S  A 
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQ 239

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             + K L+  P  R     + +HPW  K  N 
Sbjct: 240 DFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 90.8 bits (225), Expect = 1e-20
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 15/206 (7%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + K  +G  IGEG F  V   Q   TG+ VA+K + K  +     ++    E ++M  + 
Sbjct: 5   LQKLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNI-KCDVTAQAFLE----ETAVMTKLH 57

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--RYFQQLIDAVAHC 125
           H N+VRL  V+     +YI++E ++ G L + +  +GR L +  +  ++   + + + + 
Sbjct: 58  HKNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
            SK + HRDL   N+L+   G  KVSDFGL+ +   GV+    +     + APE L ++ 
Sbjct: 117 ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKLPVKWTAPEALKHKK 173

Query: 186 YDGSAADVWSCGVILF-VLMAGYLPF 210
           +  S +DVWS GV+L+ V   G  P+
Sbjct: 174 FS-SKSDVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 77/317 (24%), Positives = 123/317 (38%), Gaps = 60/317 (18%)

Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-----------REIS 61
            G  +GEGT+ KV  A +  TG+ VA+K +    I      D+             RE+ 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLI 119
           IM  ++H NI+ L +V      + ++++ +     ++ D+ +   RL E+  +    Q++
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI---RLTESQVKCILLQIL 129

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVEL--LHTTCGTPN 174
           + +   H     HRDL P N+ ++S G  K++DFGL+     P     L    T      
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 175 ---------YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----------- 214
                    Y APE+L        A D+WS G I   L+ G   F   +           
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249

Query: 215 --------------LP--TLYKKINAAEFSCPFWF-STGATSLIHKILDPNPKTRIRIEG 257
                         LP  T +      +    F   S  A  L+  +L  NP  RI  + 
Sbjct: 250 LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309

Query: 258 IRKHPWFRKNYNPVKCS 274
             KH +F    +P+ C 
Sbjct: 310 ALKHEYF--KSDPLPCD 324

Length = 335

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 18/198 (9%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVRHPNIVRL 74
           +GEGT+A V   +++ T   VA+K +     L+H         RE+S++K ++H NIV L
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQ-----GRLLE-NDCRRYFQQLIDAVAHCHSK 128
           H+++ +   + ++ E++      DK + Q     G  +  ++ + +  QL+  + +CH +
Sbjct: 70  HDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V HRDLKP+NLL++  G LK++DFGL+       +       T  Y  P++L       
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183

Query: 189 SAADVWSCGVILFVLMAG 206
           +  D+W  G I + +  G
Sbjct: 184 TQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 71/258 (27%), Positives = 118/258 (45%), Gaps = 22/258 (8%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R IG G+F  V FA++  T E VA+K ++ S    +     I +E+  ++ ++HPN +  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                     ++++E+  G       VH+  L E +        +  +A+ HS  + HRD
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV---LSNRGYDGSAA 191
           +K  N+LL   G +K++DFG +++        ++  GTP ++APEV   +    YDG   
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASI----ASPANSFVGTPYWMAPEVILAMDEGQYDGK-V 205

Query: 192 DVWSCGVILFVLMAGYLP-FGETDLPTLYK-------KINAAEFSCPFWFSTGATSLIHK 243
           DVWS G+    L     P F    +  LY         + + E+S   +F     S + K
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD--YFRNFVDSCLQK 263

Query: 244 ILDPNPKTRIRIEGIRKH 261
           I    P+ R   E + KH
Sbjct: 264 I----PQDRPTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 89.4 bits (222), Expect = 3e-20
 Identities = 64/196 (32%), Positives = 94/196 (47%), Gaps = 19/196 (9%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR----EISIMKIVRHPN 70
             IG+G F  V +    +    VA+K   +ST     +   +KR    E  I+K   HPN
Sbjct: 1   EKIGKGNFGDV-YKGVLKGNTEVAVKT-CRST-----LPPDLKRKFLQEAEILKQYDHPN 53

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA---HCHS 127
           IV+L  V   +  +YI++E V GG L   +  +   L    ++  Q  +DA A   +  S
Sbjct: 54  IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLT--VKKLLQMSLDAAAGMEYLES 111

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRG 185
           K   HRDL   N L+     LK+SDFG+S   + G+  +       P  + APE L N G
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL-NYG 170

Query: 186 YDGSAADVWSCGVILF 201
              S +DVWS G++L+
Sbjct: 171 RYTSESDVWSYGILLW 186

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 26/218 (11%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR---EISIMKIV 66
           +Y+  + IG G    V  A +  TG++VA+K L++      + V   KR   E+ +MK+V
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP----FQNVTHAKRAYRELVLMKLV 72

Query: 67  RHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQ--GRLLENDCRRYF-QQ 117
            H NI+ L  V   +        VY+++E      L D  + Q     L+++   Y   Q
Sbjct: 73  NHKNIIGLLNVFTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQ 126

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYV 176
           ++  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y 
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 184

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           APEV+   GY     D+WS G I+  ++ G + F  TD
Sbjct: 185 APEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTD 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 91.0 bits (226), Expect = 3e-20
 Identities = 62/208 (29%), Positives = 110/208 (52%), Gaps = 15/208 (7%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVR 67
           +Y++   IG+G++  V  A +  TGE VA+K +  + + +H + D  +I REI +++++R
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--NDVFEH-VSDATRILREIKLLRLLR 57

Query: 68  HPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           HP+IV +  ++   ++     +Y++ E +   +L   I     L     + +  QL+ A+
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTT-CGTPNYVAPE 179
            + H+  V+HRDLKP+N+L ++   LK+ DFGL+  A       +  T    T  Y APE
Sbjct: 117 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176

Query: 180 VL-SNRGYDGSAADVWSCGVILFVLMAG 206
           +  S       A D+WS G I   ++ G
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains

 Score = 84.5 bits (209), Expect = 3e-20
 Identities = 26/94 (27%), Positives = 34/94 (36%), Gaps = 4/94 (4%)

Query: 335 VKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTR--NYKTRLEGV--SANKTGQFAVVLE 390
            K +    SR     I   I  V E     +  R  N+    + V             +E
Sbjct: 2   KKWELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIE 61

Query: 391 VFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKL 424
           V+EV P LFMVD +K  G T  + K       KL
Sbjct: 62  VYEVGPGLFMVDFKKKTGSTKTFTKLATKIQIKL 95

This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 89.3 bits (221), Expect = 6e-20
 Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 14/201 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-- 67
           +YE    IG G +  V  A++  +G  VA+K +   T      +  + RE++++K +   
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTV-REVALLKRLEAF 59

Query: 68  -HPNIVRLHEVLAS-----RTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLI 119
            HPNIVRL +V A+      TKV ++ E V        DK+   G   E   +   +Q +
Sbjct: 60  DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET-IKDLMRQFL 118

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
             +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    + L      T  Y APE
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-TLWYRAPE 177

Query: 180 VLSNRGYDGSAADVWSCGVIL 200
           VL    Y  +  D+WS G I 
Sbjct: 178 VLLQSTY-ATPVDMWSVGCIF 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 89.7 bits (222), Expect = 7e-20
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 20/217 (9%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G+F  V FA N  T E VA+K ++ S    +     I +E+  ++ ++HPN +    
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                   ++++E+  G       VH+  L E +        +  +A+ HS  + HRD+K
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV---LSNRGYDGSAADV 193
             N+LL   G +K++DFG ++         ++  GTP ++APEV   +    YDG   DV
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPA----NSFVGTPYWMAPEVILAMDEGQYDGK-VDV 203

Query: 194 WSCGVILFVL------------MAGYLPFGETDLPTL 218
           WS G+    L            M+      + D PTL
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL 240

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 88.4 bits (219), Expect = 9e-20
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 16/223 (7%)

Query: 11  YEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++M
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVM 56

Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLIDA 121
           K ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  A
Sbjct: 57  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 180
           + +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE 
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176

Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
           L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+ +
Sbjct: 177 LAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 71/211 (33%), Positives = 101/211 (47%), Gaps = 27/211 (12%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + IG G F +V   R     +    VA+K L   +  K R       E SIM    HPNI
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR--LDFLTEASIMGQFDHPNI 67

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVAH 124
           +RL  V+     V II E++  G L DK      L END +    QL+         + +
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIASGMKY 121

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG--TP-NYVAPEVL 181
                  HRDL   N+L++S    KVSDFGLS    +  E  +TT G   P  + APE +
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR-LEDSEATYTTKGGKIPIRWTAPEAI 180

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
           + R +  SA+DVWS G++++ +M+    +GE
Sbjct: 181 AYRKFT-SASDVWSFGIVMWEVMS----YGE 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 87.1 bits (215), Expect = 2e-19
 Identities = 73/271 (26%), Positives = 132/271 (48%), Gaps = 25/271 (9%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRHP 69
           +E+   +G GT+ +V   ++ +TG+  A+KV+  +   +    ++IK+EI+++K    H 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 63

Query: 70  NIVRLHEVLASRT------KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYF-QQLIDA 121
           NI   +     +       ++++++EF   G + D I + +G  L+ +   Y  ++++  
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           ++H H   V HRD+K +N+LL     +K+ DFG+SA   + V   +T  GTP ++APEV+
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 182 S-----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT----LYKKINAAEFSCPFW 232
           +     +  YD   +D+WS G+    +  G  P  +   P     L  +  A       W
Sbjct: 184 ACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW 241

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPW 263
            S    S I   L  N   R   E + KHP+
Sbjct: 242 -SKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 8/187 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R IG G+F  V FA++    E VA+K ++ S    +     I +E+  ++ +RHPN ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                     ++++E+  G       VH+  L E +        +  +A+ HS  + HRD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV---LSNRGYDGSAA 191
           +K  N+LL   G +K+ DFG +++    +   +   GTP ++APEV   +    YDG   
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQYDGK-V 195

Query: 192 DVWSCGV 198
           DVWS G+
Sbjct: 196 DVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 86.2 bits (213), Expect = 4e-19
 Identities = 64/192 (33%), Positives = 95/192 (49%), Gaps = 14/192 (7%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G F +V   + R     VA+K   ++  L   +  +  +E  I+K   HPNIVRL  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA---HCHSKGVYHR 133
           V   +  +YI++E V GG+    +  +G  L+   +   Q + +A A   +  SK   HR
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLK--VKELIQMVENAAAGMEYLESKHCIHR 118

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN----YVAPEVLSNRGYDGS 189
           DL   N L+     LK+SDFG+S   + GV    +T G       + APE L N G   S
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGV--YASTGGMKQIPVKWTAPEAL-NYGRYSS 175

Query: 190 AADVWSCGVILF 201
            +DVWS G++L+
Sbjct: 176 ESDVWSFGILLW 187

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 86.1 bits (214), Expect = 5e-19
 Identities = 65/258 (25%), Positives = 121/258 (46%), Gaps = 30/258 (11%)

Query: 19  EGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEV 77
           +G F KV   +++ T      K+  +  I K +  + I  E  + ++++ +PN ++L+  
Sbjct: 26  DGKFGKVSVLKHKPT-----QKLFVQKII-KAKNFNAI--EPMVHQLMKDNPNFIKLYYS 77

Query: 78  LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP 137
           + +     +I++++  G+LFD +  +G+L E + ++  +QL++A+   H   + H D+K 
Sbjct: 78  VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137

Query: 138 ENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
           EN+L D     + + D+GL  +   G    +   GT +Y +PE +    YD S  D W+ 
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCKI--IGTPSCYD--GTLDYFSPEKIKGHNYDVS-FDWWAV 192

Query: 197 GVILFVLMAGYLPFGETD---------LPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           GV+ + L+ G  PF E +         L    KK+   +       S  A   +  +L  
Sbjct: 193 GVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV-----SKNANDFVQSMLKY 247

Query: 248 NPKTR-IRIEGIRKHPWF 264
           N   R      I KHP+ 
Sbjct: 248 NINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.9 bits (213), Expect = 6e-19
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 32/202 (15%)

Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +   G+   VA+K L KS  L   M D + +E +IM  + H N++R
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFL-KEAAIMHSLDHENLIR 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           L+ V+ +   + ++ E    G L D  +    G  L +    Y  Q+ + + +  SK   
Sbjct: 61  LYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYV------------AP 178
           HRDL   N+LL S   +K+ DFGL  ALPQ             +YV            AP
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQ----------NEDHYVMEEHLKVPFAWCAP 169

Query: 179 EVLSNRGYDGSAADVWSCGVIL 200
           E L  R +   A+DVW  GV L
Sbjct: 170 ESLRTRTFS-HASDVWMFGVTL 190

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.1 bits (213), Expect = 6e-19
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 23/212 (10%)

Query: 15  RTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + IG G F +V   + +  G+    VA+K L      K R       E SIM    HPNI
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRR--DFLSEASIMGQFDHPNI 67

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI-------DAVAH 124
           + L  V+     V I+ E++  G L         L ++D +    QL+         + +
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVL 181
               G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + APE +
Sbjct: 122 LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 182 SNRGYDGSAADVWSCGVILFVLMA-GYLPFGE 212
           + R +  SA+DVWS G++++ +M+ G  P+ E
Sbjct: 182 AYRKFT-SASDVWSYGIVMWEVMSYGERPYWE 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 81/308 (26%), Positives = 130/308 (42%), Gaps = 48/308 (15%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + IG G    V  A +   G +VA+K L++          +  RE+ ++K V H 
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHK 80

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAHCH 126
           NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H H
Sbjct: 81  NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 140

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   GY
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPYVVTRYYRAPEVILGMGY 199

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSC----------- 229
             +  D+WS G I+  L+ G + F  TD    + K+       +AEF             
Sbjct: 200 KEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVE 258

Query: 230 --------------PFWF-----------STGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
                         P W            ++ A  L+ K+L  +P  RI ++   +HP+ 
Sbjct: 259 NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318

Query: 265 RKNYNPVK 272
              Y+P +
Sbjct: 319 TVWYDPAE 326

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 71/253 (28%), Positives = 117/253 (46%), Gaps = 18/253 (7%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V F    +    VA+K   +   L   +  +   E  I+K   HPNIV+L  
Sbjct: 3   LGKGNFGEV-FKGTLKDKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA---VAHCHSKGVYHR 133
           V   R  +YI++E V GG+    +  +   L+   ++  +  +DA   +A+  SK   HR
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCIHR 117

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN----YVAPEVLSNRGYDGS 189
           DL   N L+     LK+SDFG+S     G+   +++ G       + APE L N G   S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGI---YSSSGLKQIPIKWTAPEAL-NYGRYSS 173

Query: 190 AADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
            +DVWS G++L+   + G  P+ G T+     +       SCP         ++ +  D 
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDY 233

Query: 248 NPKTRIRIEGIRK 260
            P+ R +   ++K
Sbjct: 234 KPENRPKFSELQK 246

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 18/222 (8%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIV 66
           +Y+    +G G +  V  A +    + VA+K L++   S I   R      RE+ ++K +
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY----RELRLLKHM 71

Query: 67  RHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           +H N++ L +V    T      +VY++   +  G   + IV   +L +   +    QL+ 
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLR 129

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
            + + HS G+ HRDLKP N+ ++    L++ DFGL+   +Q  + +     T  Y APE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYRAPEI 186

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
           + N  +     D+WS G I+  L+ G   F   D     K+I
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 82.7 bits (204), Expect = 9e-18
 Identities = 70/230 (30%), Positives = 103/230 (44%), Gaps = 18/230 (7%)

Query: 15  RTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + IG G F +V     +  G     VA+K L      K R       E SIM    H NI
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHHNI 68

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           +RL  V+       II E++  G L DK +  H G           + +   + +     
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNRGY 186
             HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + APE ++ R +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187

Query: 187 DGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN-----AAEFSCP 230
             SA+DVWS G++++ +M+ G  P+ +     + K IN      A   CP
Sbjct: 188 -TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCP 236

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 19/227 (8%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMK 64
            + E  + +G G F  V        GE     VA+KVL + T  K     +I  E  +M 
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA--NKEILDEAYVMA 64

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVA 123
            V HP++VRL  +  S   V +I + +  G L D +  H+  +       +  Q+   ++
Sbjct: 65  SVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVL 181
           +   K + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E +
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
            +R Y    +DVWS GV ++ LM     FG    P  Y+ I A E  
Sbjct: 184 LHRIYT-HKSDVWSYGVTVWELMT----FGA--KP--YEGIPAVEIP 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 83.6 bits (206), Expect = 1e-17
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIV 66
           +Y+    +G G +  V  A + +TG  VA+K L++   S I   R      RE+ ++K +
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHM 73

Query: 67  RHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           +H N++ L +V            VY++   +  G   + IV   +L ++  +    Q++ 
Sbjct: 74  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 131

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
            + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE+
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEI 188

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + N  +     D+WS G I+  L+ G   F  TD
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 38/215 (17%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
            R +G G F +V       T + VA+K L   T+      +   +E  IMK +RH  +V+
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQ 65

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY--FQQLID-------AVAH 124
           L+ V +    +YI+ E+++ G L D        L++   +     QL+D        +A+
Sbjct: 66  LYAVCSEEEPIYIVTEYMSKGSLLD-------FLKSGEGKKLRLPQLVDMAAQIAEGMAY 118

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL-------PQQGVELLHTTCGTP-NYV 176
             S+   HRDL   N+L+      K++DFGL+ L        ++G +        P  + 
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF-------PIKWT 171

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
           APE  +N G     +DVWS G++L  ++  G +P+
Sbjct: 172 APEA-ANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 22/212 (10%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVL---AKSTILKHRMVDQIKREISIMKIVRH 68
           E    +G G    V   ++  TG  +A KV+   AKS++ K     QI RE+ IM   R 
Sbjct: 8   ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK-----QILRELQIMHECRS 62

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHS 127
           P IV  +    +   + + +EF+  G L D+I  + G +      +    +++ + + ++
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121

Query: 128 K-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPEVLS 182
              + HRD+KP N+L++S G +K+ DFG+S       EL++    T  GT  Y++PE + 
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG------ELINSIADTFVGTSTYMSPERIQ 175

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
              Y    +DVWS G+ +  L  G  PF  ++
Sbjct: 176 GGKYT-VKSDVWSLGISIIELALGKFPFAFSN 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 10/205 (4%)

Query: 12  EVGRTIGEGTFAKVRFA--QNRETGE-SVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
            +GR IGEG F  V      + E  + +VA+K     T    R  ++  +E  IM+   H
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQFDH 66

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHS 127
           P+IV+L  V+ +   V+I++E    GEL   + V++  L       Y  QL  A+A+  S
Sbjct: 67  PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           K   HRD+   N+L+ S   +K+ DFGLS  L  +             ++APE ++ R +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 187 DGSAADVWSCGVILF-VLMAGYLPF 210
             SA+DVW  GV ++ +LM G  PF
Sbjct: 186 T-SASDVWMFGVCMWEILMLGVKPF 209

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 18/215 (8%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKI 65
            +Y   + +G G +  V  A +R TG  VA+K L +   S +   R      RE+ ++K 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKH 70

Query: 66  VRHPNIVRLHEVLASRTKV------YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           ++H N++ L +V      +      Y+++ F+  G    K++   +L E+  +    Q++
Sbjct: 71  MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
             + + H+ G+ HRDLKP NL ++    LK+ DFGL+   +Q    +     T  Y APE
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVVTRWYRAPE 185

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           V+ N  +     D+WS G I+  ++ G   F   D
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 77/304 (25%), Positives = 130/304 (42%), Gaps = 49/304 (16%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVRHPNIV 72
           R IG G F  V    +   G+ VA+K +     +   +V   ++ RE+ ++   +H N++
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMPN---VFQNLVSCKRVFRELKMLCFFKHDNVL 62

Query: 73  RLHEVLASR-----TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
              ++L         ++Y++ E +   +L   IV    L  +  + +  Q++  + + HS
Sbjct: 63  SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRG 185
            G+ HRD+KP NLL++S   LK+ DFGL+ +  P +   +      T  Y APE+L    
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEILMGSR 180

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGE----------TDL---PTLYKKINAAE------ 226
           +  SA D+WS G I   L+   + F            TDL   P+L    +A E      
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI 240

Query: 227 ---------FSCPFWFSTGAT----SLIHKILDPNPKTRIRIEGIRKHPWF---RKNYNP 270
                        +  S+ AT     L+ ++L  +P  RI       HP+    R  Y+ 
Sbjct: 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHT 300

Query: 271 VKCS 274
             C 
Sbjct: 301 CMCK 304

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 83.6 bits (206), Expect = 3e-17
 Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 24/233 (10%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKV---------------RFAQNRETGESVAMKVLAKS 45
           +K     +A + V   +  G F K+               R   +   G+    +++AK 
Sbjct: 140 LKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKR 199

Query: 46  TILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII---LEFVTGGELFDKIVH 102
                R   Q++ EI  +  + H NI+++ E+L S    Y+I    +F     ++D+   
Sbjct: 200 VKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD 259

Query: 103 -QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP-- 159
            + R L    R   +QL+ AV + H K + HRD+K EN+ L+  G + + DFG +A+P  
Sbjct: 260 WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFE 318

Query: 160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFG 211
           ++     +   GT    +PE+L+  GY     D+WSCG+IL  +++  + P G
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIG 370

Length = 501

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.1 bits (200), Expect = 3e-17
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)

Query: 15  RTIGEGTFAKVRF----AQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV        N  TGE VA+K L +    ++      K+EI+I+K + H N
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHEN 67

Query: 71  IVRLHEVLASRTK--VYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQQLIDAVAH 124
           IV+     + +    + +I+E+V  G L D +    ++  +LL      + QQ+ + +A+
Sbjct: 68  IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL-----LFAQQICEGMAY 122

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVL 181
            HS+   HRDL   N+LLD+   +K+ DFGL+    +G E         + V   A E L
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 182 SNRGYDGSAADVWSCGVILFVLM 204
               +   A+DVWS GV L+ L+
Sbjct: 183 KENKF-SYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 80.4 bits (198), Expect = 6e-17
 Identities = 75/224 (33%), Positives = 113/224 (50%), Gaps = 18/224 (8%)

Query: 10  KYEVGRTIGEGTFAKVRFAQN-RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR- 67
           +YE    IGEG + KV  A++ +  G  VA+K +   T  +   +  I RE+++++ +  
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLET 60

Query: 68  --HPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
             HPN+VRL +V   SRT    K+ ++ E V        DK+   G   E   +    QL
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET-IKDMMFQL 119

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    +  L +   T  Y AP
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAP 178

Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK 220
           EVL    Y  +  D+WS G I F  M    P   G +D+  L K
Sbjct: 179 EVLLQSSY-ATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGK 220

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 12/224 (5%)

Query: 15  RTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + +G G F  V              VA+K L +  I   +   +  RE S+M  + HP I
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           VRL  V      + +++E    G L   +  +  +  +D +    Q+   +A+  SK   
Sbjct: 59  VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT-P-NYVAPEVLSNRGYDG 188
           HRDL   N+LL +    K+SDFG+S AL         TT G  P  + APE ++   +  
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS- 176

Query: 189 SAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAE-FSCP 230
           S +DVWS GV L+     G  P+GE     +   + + E    P
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVR 73
           +TIG+G F  V     R  G  VA+K +      K+    Q    E S+M  +RH N+V+
Sbjct: 12  QTIGKGEFGDVMLGDYR--GNKVAVKCI------KNDATAQAFLAEASVMTQLRHSNLVQ 63

Query: 74  LHEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLIDAVAHCHSKGV 130
           L  V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + +A+ +  +   
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF 123

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGS 189
            HRDL   N+L+      KVSDFGL+    +       T   P  + APE L  + +  +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALREKKFS-T 178

Query: 190 AADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCP 230
            +DVWS G++L+ + + G +P+    L  +  ++    +   P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 221

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 82.1 bits (203), Expect = 1e-16
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 32/231 (13%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++ R IG+G   +V  A +      VA+K + +       +  +  RE  I   + HP
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGEL--FDKIVHQGRLLENDCR---------RYFQQL 118
            IV ++ + +    VY  + ++ G  L    K V Q   L  +             F ++
Sbjct: 63  GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-------------SALPQQGVEL 165
              + + HSKGV HRDLKP+N+LL  +G + + D+G                + ++ +  
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 166 LHTT-----CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLPF 210
              T      GTP+Y+APE L   G   S + D+++ GVIL+ ++    P+
Sbjct: 183 SSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 67/211 (31%), Positives = 96/211 (45%), Gaps = 28/211 (13%)

Query: 17  IGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           IG G F +V   + +  G+    VA+K L      K R       E SIM    HPNI+ 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDHPNIIH 69

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY-- 131
           L  V+     V II EF+  G L D  + Q     ND +    QL+  +    +   Y  
Sbjct: 70  LEGVVTKSRPVMIITEFMENGAL-DSFLRQ-----NDGQFTVIQLVGMLRGIAAGMKYLS 123

Query: 132 -----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT----CGTP-NYVAPEVL 181
                HRDL   N+L++S    KVSDFGLS   +        T       P  + APE +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
           + R +  SA+DVWS G++++ +M+    +GE
Sbjct: 184 AYRKFT-SASDVWSYGIVMWEVMS----YGE 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 74

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 134

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 192

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 193 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311

Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 312 PYINVWYDPAE 322

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 77/266 (28%), Positives = 130/266 (48%), Gaps = 28/266 (10%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV--RH--PNIV 72
           IG GT  +V   + ++TG  +A+K + ++        ++ KR +  + +V   H  P IV
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-----NKEENKRILMDLDVVLKSHDCPYIV 77

Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           + +    + + V+I +E +      DK++   QG + E+   +    ++ A+ +   K G
Sbjct: 78  KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LLHT-TCGTPNYVAPEVL----SN 183
           V HRD+KP N+LLD+ GN+K+ DFG+S    + V+    T + G   Y+APE +     N
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISG---RLVDSKAKTRSAGCAAYMAPERIDPPDPN 192

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF--WFSTGATS 239
             YD   ADVWS G+ L  L  G  P+   +T+   L K +     S P    FS    S
Sbjct: 193 PKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCS 251

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFR 265
            +   L  + + R +   + +HP+ R
Sbjct: 252 FVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 18/199 (9%)

Query: 17  IGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           +G+G F  V   +       TGE VA+K L  ST     + D  +REI I+K ++H NIV
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRD-FEREIEILKSLQHDNIV 68

Query: 73  RLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           +   V   A R  + +++E++  G L D +  H+ RL       Y  Q+   + +  SK 
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-----YVAPEVLSNR 184
             HRDL   N+L++S   +K+ DFGL+ +  Q  E  +     P      + APE L+  
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE--YYKVREPGESPIFWYAPESLTES 186

Query: 185 GYDGSAADVWSCGVILFVL 203
            +   A+DVWS GV+L+ L
Sbjct: 187 KFS-VASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 6/216 (2%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V H 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHK 83

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAHCH 126
           NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   GY
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGY 202

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
             +  D+WS G I+  ++ G + F  TD    + K+
Sbjct: 203 KEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)

Query: 15  RTIGEGTFAKVRFA-QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           + +G G F +V     N  T   VA+K L   T+     V     E ++MK ++H  +VR
Sbjct: 12  KKLGAGQFGEVWMGYYNNST--KVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVR 65

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           L+ V+     +YII E++  G L D +     G++L      +  Q+ + +A+   K   
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSA 190
           HRDL+  N+L+      K++DFGL+ + +            P  + APE + N G     
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-NFGSFTIK 184

Query: 191 ADVWSCGVILF-VLMAGYLPF 210
           +DVWS G++L+ ++  G +P+
Sbjct: 185 SDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 73/263 (27%), Positives = 119/263 (45%), Gaps = 25/263 (9%)

Query: 11  YEVGRTIGEGTFAKVRFAQ---NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +GR +G+G F  VR AQ      + + VA+K+L K+ I     +++  RE + MK   
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59

Query: 68  HPNIVRLHEV-LASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID- 120
           HPN+++L  V L SR K       +IL F+  G+L   ++   R+ E       Q L+  
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRF 118

Query: 121 ------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP- 173
                  + +  SK   HRDL   N +L+    + V+DFGLS     G +     C +  
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG-DYYRQGCASKL 177

Query: 174 --NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK-INAAEFSC 229
              ++A E L++  Y  + +DVW+ GV ++ +M  G  P+   +   +Y   I       
Sbjct: 178 PVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236

Query: 230 PFWFSTGATSLIHKILDPNPKTR 252
           P         L+ +   P PK R
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 26/208 (12%)

Query: 15  RTIGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           R +G G F +V     N  T   VA+K L   T+           E  IMK +RHP +++
Sbjct: 12  RKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQ 65

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVY- 131
           L+ V      +YI+ E +  G L + +    GR L+        QLID  A   S   Y 
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK------LPQLIDMAAQVASGMAYL 119

Query: 132 ------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE-VLSN 183
                 HRDL   N+L+      KV+DFGL+ + ++ +         P  + APE  L N
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN 179

Query: 184 RGYDGSAADVWSCGVILFVLMA-GYLPF 210
           R    S  DVWS G++L  ++  G +P+
Sbjct: 180 RFSIKS--DVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 78.8 bits (194), Expect = 4e-16
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 33/221 (14%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIV 66
           +Y   + +G G +  V  A ++ TGE VA+K L++   S I   R      RE++++K +
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY----RELTLLKHM 71

Query: 67  RHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLI 119
           +H N++ L +V  S          Y+++ ++       KI+  G  L  D  +Y   Q++
Sbjct: 72  QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIM--GHPLSEDKVQYLVYQML 127

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 176
             + + HS G+ HRDLKP NL ++    LK+ DFGL+          H       YV   
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMTGYVVTR 178

Query: 177 ---APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
              APEV+ N  +     D+WS G I+  ++ G   F   D
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 78.8 bits (194), Expect = 5e-16
 Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 16/208 (7%)

Query: 2   KKQTRRVAK---YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR 58
           K++ R V     Y V +T+  G+  +V  A      + V +K+  K T L   M      
Sbjct: 56  KQKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM------ 109

Query: 59  EISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQ 117
              +++ V HP+++R+ + L S     ++L   +  +L+  +  +   L  +      +Q
Sbjct: 110 ---LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
           +++ + + H++ + HRD+K EN+ ++    + + D G +  P      L    GT    A
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-GLAGTVETNA 224

Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMA 205
           PEVL+   Y+ S AD+WS G++LF ++A
Sbjct: 225 PEVLARDKYN-SKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 9e-16
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 27/210 (12%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
            + +G G F  V   + R     VA+K++ +  + +    D    E  +M  + HPN+V+
Sbjct: 9   LKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQ 63

Query: 74  LHEVLASRTKVYIILEFVTGGELFD------KIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           L+ V   +  ++I+ E++  G L +        +    LL+  C      + +A+ +  S
Sbjct: 64  LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM-C----SDVCEAMEYLES 118

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTP---NYVAPEVLS 182
            G  HRDL   N L+     +KVSDFGL+   L  Q      ++ GT     +  PEV  
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT----SSQGTKFPVKWAPPEVF- 173

Query: 183 NRGYDGSAADVWSCGVILF-VLMAGYLPFG 211
           +     S +DVWS GV+++ V   G +P+ 
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFA--QNRETGESVAMKVLAKSTILKHRMVDQIK-REISIMKIV 66
           KYE+   IG GT+ +V  A  +N + G+  A+K   K    ++  + Q   REI++++ +
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLREL 59

Query: 67  RHPNIVRLHEVLASRT--KVYIILEFVTGGELFD--KIVHQGR------LLENDCRRYFQ 116
           +H N+V L EV        VY++ ++       D  +I+   R      +  +  +    
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLLW 115

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGN----LKVSDFGLSALPQQGVELLHTTCG- 171
           Q+++ V + HS  V HRDLKP N+L+   G     +K+ D GL+ L    ++ L      
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 172 --TPNYVAPEV-LSNRGYDGSAADVWSCGVIL 200
             T  Y APE+ L  R Y   A D+W+ G I 
Sbjct: 176 VVTIWYRAPELLLGARHYT-KAIDIWAIGCIF 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 31/210 (14%)

Query: 15  RTIGEGTFAKVRFAQNRETGE-SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           + +G G F  V++ + R  G+  VA+K++ + ++ +    D+   E  +M  + H  +V+
Sbjct: 10  KELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQ 63

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVAHCH 126
           L+ V   +  +YI+ E+++ G L + +   G+  +        QL++        +A+  
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP------SQLLEMCKDVCEGMAYLE 117

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTP---NYVAPEVL 181
           SK   HRDL   N L+D  G +KVSDFGLS   L  +      ++ G+     +  PEVL
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPEVL 173

Query: 182 SNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
               +  S +DVW+ GV+++ V   G +P+
Sbjct: 174 LYSKFS-SKSDVWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 17/203 (8%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V   + R     VA+K + +  + +   +++ K    +M  + HP +V+L
Sbjct: 10  KELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQL 64

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  +YI+ EF+  G L + +   QG+L ++      Q + + + +       HR
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124

Query: 134 DLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDG 188
           DL   N L+ S G +KVSDFG++   L  +      ++ G      +  PEV +   Y  
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT----SSSGAKFPVKWSPPEVFNFSKYS- 179

Query: 189 SAADVWSCGVILF-VLMAGYLPF 210
           S +DVWS GV+++ V   G +PF
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 6/203 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G    V   Q++ +G  +A K++     +K  + +QI RE+ ++     P IV  + 
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDL 135
              S  ++ I +E + GG L   +    R+ E    +    ++  +A+   K  + HRD+
Sbjct: 71  AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y    +D+WS
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWS 187

Query: 196 CGVILFVLMAGYLPFGETDLPTL 218
            G+ L  L  G  P    D   L
Sbjct: 188 MGLSLVELAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 48/223 (21%)

Query: 10  KYEVGRTIGEGTFAKVR--FAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V    A+    GE    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMK 64

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQ 116
                ++VRL  V+++     +++E +  G+L    +   R    +          ++ Q
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKS-YLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 117 ---QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL---------------SAL 158
              ++ D +A+  +K   HRDL   N ++     +K+ DFG+                 L
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
           P +             ++APE L + G   + +DVWS GV+L+
Sbjct: 184 PVR-------------WMAPESLKD-GVFTTKSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 70/271 (25%), Positives = 114/271 (42%), Gaps = 40/271 (14%)

Query: 16  TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
            +G G    V  A +  T   +A+KV+     ++  +  QI  E+ I+     P I+  +
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDSPYIIGFY 65

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
                  ++ I  EF+ GG L D      ++ E+   R    ++  + +  S  + HRD+
Sbjct: 66  GAFFVENRISICTEFMDGGSL-DVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSNRGYDGSAADVW 194
           KP N+L+++ G +K+ DFG+S    Q V  +  T  GT  Y+APE +S   Y G  +DVW
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVS---TQLVNSIAKTYVGTNAYMAPERISGEQY-GIHSDVW 177

Query: 195 SCGVILFVLMAGYLPFGE-------------------TDLPTLYKKINAAEFSCPFWFST 235
           S G+    L  G  P+ +                    D P L       +FS  F    
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL----PVGQFSEKF---- 229

Query: 236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
                I + +   PK R   E +  HP+  +
Sbjct: 230 --VHFITQCMRKQPKERPAPENLMDHPFIVQ 258

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI-SIMKIVRHPNIVRLH 75
           IG G F  V    ++ +G  +A+K + +ST+ +     ++  ++  +M+    P IV+ +
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQ-KRLLMDLDVVMRSSDCPYIVKFY 69

Query: 76  EVLASRTKVYIILEFV-TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG----- 129
             L      +I +E +    + F K V+     E       ++++  +A    K      
Sbjct: 70  GALFREGDCWICMELMDISLDKFYKYVY-----EVLKSVIPEEILGKIAVATVKALNYLK 124

Query: 130 ----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE-VLSNR 184
               + HRD+KP N+LLD  GN+K+ DFG+S      +         P Y+APE +  + 
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPERIDPSA 183

Query: 185 --GYDGSAADVWSCGVILFVLMAGYLPF 210
             GYD   +DVWS G+ L+ +  G  P+
Sbjct: 184 RDGYD-VRSDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 74.7 bits (183), Expect = 9e-15
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 6/209 (2%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 64

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 181

Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTL 218
            +D+WS G+ L  +  G  P    D   L
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 13/207 (6%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
              ++ + +G G F +V  A  N+ T   VA+K +   ++     V+    E ++MK ++
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSM----SVEAFLAEANVMKTLQ 59

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHC 125
           H  +V+LH V+ ++  +YII EF+  G L D  K     +        +  Q+ + +A  
Sbjct: 60  HDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
             +   HRDL+  N+L+ +    K++DFGL+ + +            P  + APE + N 
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-NF 177

Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
           G     +DVWS G++L  ++  G +P+
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 62/240 (25%), Positives = 109/240 (45%), Gaps = 36/240 (15%)

Query: 10  KYEVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           +  +G+ +GEG F +V  A+     N     +VA+K+L K    +  + D +  E+ +MK
Sbjct: 13  RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVS-EMEMMK 70

Query: 65  IV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFD----------------KIVHQGRLL 107
           ++ +H NI+ L  V      +Y+++E+   G L D                    +  L 
Sbjct: 71  MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 108 ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL- 166
           + D   +  Q+   +    SK   HRDL   N+L+     +K++DFGL+    + +  + 
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA----RDIHHID 186

Query: 167 ----HTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK 220
                T    P  ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 13/200 (6%)

Query: 15  RTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV       +   TGE VA+K L   +   H  +  +K+EI I++ + H N
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 67

Query: 71  IVRLHEVLASR--TKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   +        + +I+EF+  G L + +  ++ ++      +Y  Q+   + +  S
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ--QGVELLHTTCGTPNY-VAPEVLSNR 184
           +   HRDL   N+L++S   +K+ DFGL+   +  +    +     +P +  APE L   
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187

Query: 185 GYDGSAADVWSCGVILFVLM 204
            +   A+DVWS GV L+ L+
Sbjct: 188 KF-YIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 70/227 (30%), Positives = 110/227 (48%), Gaps = 25/227 (11%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y++G  IG G+F  V  A   +T E VA+K + +    K+R       E+ IMK + H N
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-------ELLIMKNLNHIN 120

Query: 71  IVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQ--GRLLEND-------CRRYFQQ 117
           I+ L +   +    + +  I L  V   E   + VH+       N+        + Y  Q
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVM--EFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ 178

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           L  A+A+ HSK + HRDLKP+NLL+D   + LK+ DFG +     G   +   C +  Y 
Sbjct: 179 LCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC-SRFYR 237

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI 222
           APE++       +  D+WS G I+  ++ GY  F G++ +  L + I
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284

Length = 440

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 22/270 (8%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVDQIKREISIMKIVRHP 69
           EV   +G G +  V   ++  TG  +A+K +  +  +  + R++  +  +IS M+ V  P
Sbjct: 4   EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDL--DIS-MRSVDCP 60

Query: 70  NIVRLHEVLASRTKVYIILEFV-TGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCH 126
             V  +  L     V+I +E + T  + F K V      + E+   +    ++ A+ + H
Sbjct: 61  YTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120

Query: 127 SK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPE---- 179
           SK  V HRD+KP N+L++  G +K+ DFG+S      V+ +  T   G   Y+APE    
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINP 177

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAAEFSCPF-WFSTG 236
            L+ +GYD   +DVWS G+ +  L  G  P+    T    L + +       P   FS  
Sbjct: 178 ELNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236

Query: 237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
               ++K L  N K R     + +HP+F  
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 27/216 (12%)

Query: 19  EGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR---EISIMKIVRHPNIVR-L 74
           EGTF ++ +    +       +V  K T+  H    Q+     E  ++  + H NI+  L
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVK-TVKDHASEIQVTLLLQESCLLYGLSHQNILPIL 74

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLID-------AVAHC 125
           H  +      +++  ++  G L    + Q RL E +  +    QQL+         +++ 
Sbjct: 75  HVCIEDGEPPFVLYPYMNWGNL-KLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPN----YVAPE 179
           H +GV H+D+   N ++D    +K++D  LS    P       H      N    ++A E
Sbjct: 134 HKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD----YHCLGDNENRPVKWMALE 189

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 214
            L N+ Y  SA+DVWS GV+L+ LM  G  P+ E D
Sbjct: 190 SLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEID 224

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F +V           VA+K L + ++      +    E ++MK ++HP +VRL
Sbjct: 12  KKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRL 66

Query: 75  HEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           + V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    K   H
Sbjct: 67  YAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIH 125

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAA 191
           RDL+  N+L+      K++DFGL+ L +            P  + APE + N G     +
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKS 184

Query: 192 DVWSCGVILF-VLMAGYLPF 210
           DVWS G++L  ++  G +P+
Sbjct: 185 DVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 73/301 (24%), Positives = 126/301 (41%), Gaps = 72/301 (23%)

Query: 37  VAMKVLAKST--ILKHRMV---------DQIKREISIMKIVRHPNIVRLHEVLASRTKVY 85
           V  KVL + +  I+  +++         +QI RE+ ++     P IV  +    S  ++ 
Sbjct: 16  VVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEIS 75

Query: 86  IILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLD 143
           I +E + GG L D+++ + GR+ EN   +    ++  + +   K  + HRD+KP N+L++
Sbjct: 76  ICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134

Query: 144 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL 203
           S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y    +D+WS G+ L  +
Sbjct: 135 SRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEM 191

Query: 204 MAGYLPFGETDLPTLYKKINAAEFSCPF-------------------------------- 231
             G  P     +P    K   A F  P                                 
Sbjct: 192 AIGRYP-----IPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYI 246

Query: 232 -----------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVN 280
                       FS      + K L  NPK R  ++ + KHP+ ++       +E EEV+
Sbjct: 247 VNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR-------AELEEVD 299

Query: 281 L 281
            
Sbjct: 300 F 300

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 64/239 (26%), Positives = 109/239 (45%), Gaps = 38/239 (15%)

Query: 13  VGRTIGEGTFAKVRFA-------QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           +G+ +GEG F +V  A          +   +VA+K+L K       + D I  E+ +MK+
Sbjct: 16  LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLIS-EMELMKL 73

Query: 66  V-RHPNIVRLHEVLASRTKVYIILEFVTGGEL---------------FDKI-VHQGRLLE 108
           + +H NI+ L  V      +Y+I+E+   G L               FD   V + +L  
Sbjct: 74  IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133

Query: 109 NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT 168
            D      Q+   + +  S+   HRDL   N+L+     +K++DFGL+    +GV  +  
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA----RGVHDIDY 189

Query: 169 TCGTPN------YVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
              T N      ++APE L +R Y    +DVWS G++++ +   G  P+    +  L+K
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 11/212 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IG G F  V      E  + VA+K     TI +  M ++    E  +M  + HP +V+L+
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIK-----TIREGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
            V   R+ + ++ EF+  G L D +  Q G+  +         + + +A+  S  V HRD
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRD 125

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAADV 193
           L   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +DV
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SKSDV 184

Query: 194 WSCGVILF-VLMAGYLPFGETDLPTLYKKINA 224
           WS GV+++ V   G  P+       + + INA
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVVETINA 216

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 29/221 (13%)

Query: 12  EVGRTIGEGTFAKVRFAQNR-ETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVRH 68
            + R +G G F +V     R   G++V ++V  K+        D+     E  IM    H
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLI----DAVA 123
            NIVRL  V   R   +I+LE + GG+L    + + R   E       + L+    D   
Sbjct: 69  QNIVRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 124 HCH---SKGVYHRDLKPENLLLDSYGN---LKVSDFGL-------SALPQQGVELLHTTC 170
            C         HRD+   N LL   G     K++DFG+       S   + G  +L    
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI-- 185

Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
               ++ PE   + G   S  DVWS GV+L+ + + GY+P+
Sbjct: 186 ---KWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 25/207 (12%)

Query: 15  RTIGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           + +G G F +V     N  T   VA+K L   T+     ++    E  IMK +RH  +V+
Sbjct: 12  KKLGNGQFGEVWMGTWNGNT--KVAVKTLKPGTMSPESFLE----EAQIMKKLRHDKLVQ 65

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVY- 131
           L+ V+ S   +YI+ E+++ G L D +   +GR L+         L+D  A   +   Y 
Sbjct: 66  LYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALK------LPNLVDMAAQVAAGMAYI 118

Query: 132 ------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
                 HRDL+  N+L+      K++DFGL+ L +            P  + APE  +  
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA-ALY 177

Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPF 210
           G     +DVWS G++L  L+  G +P+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 34/237 (14%)

Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 77

Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                V + +L
Sbjct: 78  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137

Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 138 SFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197

Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 38/214 (17%)

Query: 17  IGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           +GEG F KV   +      R +  SVA+K L ++   K +   + ++E  +M  ++HPNI
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQEAELMSDLQHPNI 70

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIV----HQGRLLEN---------DCRRYFQ-- 116
           V L  V        ++ E++  G+L + +V    H     E+         DC  +    
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 117 -QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL-------PQQGVELLHT 168
            Q+   + +  S    HRDL   N L+     +K+SDFGLS           Q   LL  
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190

Query: 169 TCGTPNYVAPE-VLSNRGYDGSAADVWSCGVILF 201
                 ++ PE +L  +    S  D+WS GV+L+
Sbjct: 191 -----RWMPPEAILYGKFTTES--DIWSFGVVLW 217

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 21/212 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE G  +G GT+  V  A+ ++  +    K  A   I    +     REI++++ ++HP
Sbjct: 3   EYE-GCKVGRGTYGHVYKAKRKDGKDE---KEYALKQIEGTGISMSACREIALLRELKHP 58

Query: 70  NIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQG--------RLLENDCRRYFQQLI 119
           N++ L +V  S +  KV+++ ++           H+         +L  +  +    Q++
Sbjct: 59  NVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118

Query: 120 DAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSAL---PQQGVELLHTTCGT 172
           D + + H+  V HRDLKP N+L+       G +K++D G + L   P + +  L     T
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
             Y APE+L    +   A D+W+ G I   L+
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 65.3 bits (159), Expect = 7e-12
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 22/208 (10%)

Query: 15  RTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G G F ++     +    RE    VA+  L      K R       E   +    H 
Sbjct: 11  RILGTGRFGELCRGCLKLPSKREL--PVAIHTLRAGCSDKQRR--GFLAEALTLGQFDHS 66

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIVRL  V+     + I+ E+++ G L D  +  H+G+L+          L   + +   
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNR 184
            G  H+ L    +L++S    K+S F    L +   E ++TT    + V   APE +   
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAI-QY 182

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGE 212
            +  SA+DVWS G++++ +M+    +GE
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS----YGE 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 64/230 (27%), Positives = 104/230 (45%), Gaps = 32/230 (13%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-----IMKIVRHPNI 71
           IGEG F +V  A  ++ G    +K+ A   +LK    +   R+ +     + K+  HPNI
Sbjct: 10  IGEGNFGQVIRAMIKKDG----LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--------------CRRYFQQ 117
           + L     +R  +YI +E+   G L D  + + R+LE D               ++  Q 
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLD-FLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 118 LIDAVAHCH---SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP- 173
             D          K   HRDL   N+L+      K++DFGLS    + V +  T    P 
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPV 182

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 222
            ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 183 RWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 25/214 (11%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES--VAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +YE G  +G GT+  V  A+ ++  +    A+K +  + I          REI++++ ++
Sbjct: 3   EYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC-----REIALLRELK 56

Query: 68  HPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQG--------RLLENDCRRYFQQ 117
           HPN++ L +V  S    KV+++ ++           H+         +L     +    Q
Sbjct: 57  HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSAL---PQQGVELLHTTC 170
           ++D + + H+  V HRDLKP N+L+       G +K++D G + L   P + +  L    
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
            T  Y APE+L    +   A D+W+ G I   L+
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 32/230 (13%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-----IMKIVRHPNI 71
           IGEG F +V  A+ ++ G    +++ A    +K        R+ +     + K+  HPNI
Sbjct: 3   IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-----------------CRRY 114
           + L      R  +Y+ +E+   G L D  + + R+LE D                    +
Sbjct: 59  INLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP- 173
              +   + +   K   HRDL   N+L+      K++DFGLS    Q V +  T    P 
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 175

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 222
            ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 176 RWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 74/269 (27%), Positives = 116/269 (43%), Gaps = 26/269 (9%)

Query: 13  VGRTIGEGTFAKVRFAQ--NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +G+T+GEG F  V   Q    ++   VA+K +  +   +  M D +  E   MK   HPN
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHPN 61

Query: 71  IVRLHEVLASRTKV------YIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLI--- 119
           ++RL  V     +        +IL F+  G+L   +++  RL   DC +Y   Q L+   
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS-RL--GDCPQYLPTQMLVKFM 118

Query: 120 ----DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT--P 173
                 + +  SK   HRDL   N +L+   N+ V+DFGLS     G             
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAA-EFSCPF 231
            ++A E L++R Y  + +DVWS GV ++ +   G  P+   +   +Y  +        P 
Sbjct: 179 KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237

Query: 232 WFSTGATSLIHKILDPNPKTRIRIEGIRK 260
               G  SL+      NPK R   E +R 
Sbjct: 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 24/218 (11%)

Query: 13  VGRTIGEGTFAKVRFAQ-NRETGES--VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +G+ +GEG F  V   Q +++ G    VA+K + K  I  +  +++   E + MK   HP
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHP 61

Query: 70  NIVRLHEV---LASRTKV---YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
           N+++L  V    +S  K+    +IL F+  G+L   +++  RL     +   Q L+  + 
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLKFMV 120

Query: 124 -------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP--- 173
                  +  ++   HRDL   N +L     + V+DFGLS     G +            
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPV 179

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
            ++A E L++R Y  S +DVW+ GV ++ +   G  P+
Sbjct: 180 KWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 68/248 (27%), Positives = 109/248 (43%), Gaps = 12/248 (4%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V       T + VA+K L   T+    M +   +E  IMK +RH  +V L+ 
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 77  VLASRTKVYIILEFVTGGELFDKIVH-QGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ S   +YI+ EF+  G L D +    G+ L+         Q+ D +A+       HRD
Sbjct: 69  VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAADV 193
           L+  N+L+      K++DFGL+ L +            P  + APE  +  G     +DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDV 186

Query: 194 WSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT 251
           WS G++L  L+  G +P+ G  +   L +        CP         L+      +P  
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDE 246

Query: 252 RIRIEGIR 259
           R   E I+
Sbjct: 247 RPTFEYIQ 254

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 27/206 (13%)

Query: 17  IGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G+G F +V     N  T   VA+K L   T+     +    +E  +MK +RH  +V+L+
Sbjct: 14  LGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLY 67

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLIDAVAHCHSKGVY-- 131
            V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D  A   S   Y  
Sbjct: 68  AVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119

Query: 132 -----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRG 185
                HRDL+  N+L+      KV+DFGL+ L +            P  + APE  +  G
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA-ALYG 178

Query: 186 YDGSAADVWSCGVILFVLMA-GYLPF 210
                +DVWS G++L  L   G +P+
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 8/157 (5%)

Query: 58  REISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ 117
           REI I+K + H  I+ L      ++ V +++      +LF  +   G L         ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC----GTP 173
           L++A+A+ H +G+ HRD+K EN+ LD   N  + DFG  A  +         C    GT 
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG--AACKLDAHPDTPQCYGWSGTL 251

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
              +PE+L+   Y  +  D+WS G++LF +    +  
Sbjct: 252 ETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 5/158 (3%)

Query: 59  EISIMKIVRHPNIVRLHEVLASRTKVYIIL-EFVTGGELFDKIVHQGRLLENDCRRYFQQ 117
           E  I++ + HP+I++L           +IL  + T  +L+  +  +  +   D     + 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERS 190

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ-GVELLHTTCGTPNYV 176
           ++ A+ + H   + HRD+K EN+ ++  G++ + DFG +  P        +   GT    
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           APE+L+   Y G A D+WS G++LF +   +    E D
Sbjct: 251 APELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKD 287

Length = 391

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 62.1 bits (151), Expect = 9e-11
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 48/270 (17%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGES-----VAMKVLAKSTILKHRMVDQIKREISIM-KI 65
             G+T+G G F KV  A      +S     VA+K+L  +     R  + +  E+ IM  +
Sbjct: 38  SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIMSHL 95

Query: 66  VRHPNIVRLHEVLASRTK---VYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLI 119
             H NIV L   L + T    + +I E+   G+L +  + + R   L   D   +  Q+ 
Sbjct: 96  GNHENIVNL---LGACTIGGPILVITEYCCYGDLLN-FLRRKRESFLTLEDLLSFSYQVA 151

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 176
             +A   SK   HRDL   N+LL     +K+ DFGL+       ++++ +    NYV   
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR------DIMNDS----NYVVKG 201

Query: 177 ---------APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT---LYKKI- 222
                    APE + N  Y    +DVWS G++L+ + + G  P+    +P     YK I 
Sbjct: 202 NARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPY--PGMPVDSKFYKLIK 258

Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTR 252
                + P         ++    D +P  R
Sbjct: 259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKR 288

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 59/238 (24%), Positives = 106/238 (44%), Gaps = 30/238 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 16  KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 73

Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V   +
Sbjct: 74  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133

Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      Q+   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193

Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 63/258 (24%), Positives = 108/258 (41%), Gaps = 27/258 (10%)

Query: 16  TIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVDQI----KREISIMKIVRHPN 70
           T+G G F +V  A+ +   E      VL K+  L+    + +    +RE+ + + + H N
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKA--LQKTKDENLQSEFRRELDMFRKLSHKN 69

Query: 71  IVRLHEVLASRTKVYIILEFVTGGEL--FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           +VRL  +       Y+ILE+   G+L  F +   + +  +        +   A+    + 
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRA-TKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 129 GV--------YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           G+         HRDL   N L+ S   +KVS   LS                P  ++APE
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188

Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGAT 238
            +    +  + +DVWS GV+++ V   G LPF       +  ++ A +   P     G  
Sbjct: 189 AVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP--VPEGCP 245

Query: 239 SLIHKIL----DPNPKTR 252
           S ++K++      NPK R
Sbjct: 246 SRLYKLMTRCWAVNPKDR 263

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)

Query: 15  RTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE     VA+K L ++T  K     +I  E  +M  V +P+
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 70

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 71  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT 189

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 190 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 34/241 (14%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKRE 59
            +  +G+ +GEG F +V  A+         N+    +VA+K+L      K   +  +  E
Sbjct: 12  TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPV--TVAVKMLKDDATDKD--LSDLVSE 67

Query: 60  ISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGEL---------------FDKI-VH 102
           + +MK++ +H NI+ L         +Y+++E+ + G L               FD   + 
Sbjct: 68  MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127

Query: 103 QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG 162
           + +L   D      Q+   + +  S+   HRDL   N+L+     +K++DFGL+      
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187

Query: 163 VELLHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLY 219
                TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246

Query: 220 K 220
           K
Sbjct: 247 K 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 15/218 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE+    VA+KVL ++T  K     +I  E  +M  V  P 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPY 70

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V ++ + +  G L D +  ++ R+   D   +  Q+   +++     
Sbjct: 71  VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ S  ++K++DFGL+ L        H   G  P  ++A E + +R + 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 188 GSAADVWSCGVILFVLMA----GYLPFGETDLPTLYKK 221
              +DVWS GV ++ LM      Y      ++P L +K
Sbjct: 190 -HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 34/226 (15%)

Query: 10  KYEVGRTIGEGTFAKVRFA-----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
              +G+T+GEG F KV  A     + R    +VA+K+L ++          +  E +++K
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR--DLLSEFNLLK 58

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGEL----------------FDKIVHQGRLLE 108
            V HP++++L+   +    + +I+E+   G L                 D   +   L  
Sbjct: 59  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 109 NDCR--------RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LP 159
            D R         +  Q+   + +     + HRDL   N+L+     +K+SDFGLS  + 
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178

Query: 160 QQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
           ++   +  +    P  ++A E L +  Y  + +DVWS GV+L+ ++
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 30/229 (13%)

Query: 17  IGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIV 72
           IGEG F +V  A+ ++ G   ++   ++   ++   HR       E+ ++ K+  HPNI+
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 71

Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND----------CRRYFQQLIDAV 122
            L      R  +Y+ +E+   G L D  + + R+LE D               QQL+   
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 123 A-------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-N 174
           A       +   K   HRDL   N+L+      K++DFGLS    Q V +  T    P  
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 188

Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
           ++A E L+   Y  + +DVWS GV+L+ ++  G  P+       LY+K+
Sbjct: 189 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 27/224 (12%)

Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE+V    A+K+L ++T  K  +  +   E  IM  + HP+
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPH 70

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQQLIDAVAH 124
           +VRL  V  S T + ++ + +  G L D  VH+       +LL N C     Q+   + +
Sbjct: 71  LVRLLGVCLSPT-IQLVTQLMPHGCLLD-YVHEHKDNIGSQLLLNWC----VQIAKGMMY 124

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVL 181
              + + HRDL   N+L+ S  ++K++DFGL+ L  +G E  +   G      ++A E +
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNADGGKMPIKWMALECI 183

Query: 182 SNRGYDGSAADVWSCGVILFVLMA-GYLPFG---ETDLPTLYKK 221
             R +    +DVWS GV ++ LM  G  P+      ++P L +K
Sbjct: 184 HYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 29/88 (32%), Positives = 51/88 (57%), Gaps = 3/88 (3%)

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ--QGVELLHTTCGTP 173
           +QL+ A+ + H +G+ HRD+K EN+L++   ++ + DFG +   +        +   GT 
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILF 201
           +  APEVL+   Y  S  D+WS G+++F
Sbjct: 327 DTNAPEVLAGDPYTPS-VDIWSAGLVIF 353

Length = 461

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 49/242 (20%), Positives = 101/242 (41%), Gaps = 50/242 (20%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL---AKSTILKHRMVDQIKREISIMKIVR 67
             +G+   +     V  A+++ T   VA+K +   + S       +  +++EI   + ++
Sbjct: 4   TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCS----KEDLKLLQQEIITSRQLQ 57

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDC---------RRYFQQL 118
           HPNI+         +++Y++   +  G   D       LL+                + +
Sbjct: 58  HPNILPYVTSFIVDSELYVVSPLMAYGSCED-------LLKTHFPEGLPELAIAFILKDV 110

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--------------LPQQGVE 164
           ++A+ + HSKG  HR +K  ++LL   G + +S    S                P+  V+
Sbjct: 111 LNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170

Query: 165 LLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY-KK 221
            L        +++PEVL    +GY+   +D++S G+    L  G++PF +     +  +K
Sbjct: 171 NL-------PWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEK 222

Query: 222 IN 223
           + 
Sbjct: 223 VR 224

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 52/191 (27%), Positives = 99/191 (51%), Gaps = 10/191 (5%)

Query: 17  IGEGTFAKVR--FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  V+    + +++ ++VA+K+L K+      + D++ RE ++M+ + +P IVR+
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
             +  + + + +++E    G L +K + + + + E +      Q+   + +       HR
Sbjct: 62  IGICEAESWM-LVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119

Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT-P-NYVAPEVLSNRGYDGSA 190
           DL   N+LL +    K+SDFGLS AL          T G  P  + APE ++   +  S 
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS-SK 178

Query: 191 ADVWSCGVILF 201
           +DVWS GV+++
Sbjct: 179 SDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 48/254 (18%)

Query: 15  RTIGEGTFAKVRFAQNRETG-------ESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           R IG+G F +V   Q R  G         VA+K+L +       M    +RE ++M    
Sbjct: 11  RDIGQGAFGRV--FQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFD 66

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQ---- 116
           HPNIV+L  V A    + ++ E++  G+L +       +         +  R+       
Sbjct: 67  HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 117 -----------QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
                      Q+   +A+   +   HRDL   N L+     +K++DFGLS    + +  
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS----RNIYS 182

Query: 166 LHTTCGTPN------YVAPE-VLSNRGYDGSAADVWSCGVILFVLMA-GYLP-FGETDLP 216
                 + N      ++ PE +  NR Y  + +DVW+ GV+L+ + + G  P +G     
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNR-YT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240

Query: 217 TLYKKINAAEFSCP 230
            +Y   +    SCP
Sbjct: 241 VIYYVRDGNVLSCP 254

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 12/222 (5%)

Query: 17  IGEGTFAKVR--FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  V+    + R+    VA+KVL      +  + D++ RE  IM  + +P IVR+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
             V  +   + +++E  +GG L   +   +  +  ++      Q+   + +   K   HR
Sbjct: 61  IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT-P-NYVAPEVLSNRGYDGSA 190
           DL   N+LL +    K+SDFGLS AL          + G  P  + APE ++ R +  S 
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS-SR 178

Query: 191 ADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAE-FSCP 230
           +DVWS G+ ++     G  P+ +   P +   I   +   CP
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCP 220

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 32/215 (14%)

Query: 10  KYEVGRTIGEGTFAKVR--FAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V    A++   GE+   VA+K + +S  L+ R+  +   E S+MK
Sbjct: 7   KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 64

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELF--------DKIVHQGRLLENDCRRYFQ 116
                ++VRL  V++      +++E +  G+L         +   + GR      +   Q
Sbjct: 65  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT-LQEMIQ 123

Query: 117 ---QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELL 166
              ++ D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                   ++APE L + G   +++D+WS GV+L+
Sbjct: 184 PV-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 45/203 (22%), Positives = 79/203 (38%), Gaps = 19/203 (9%)

Query: 17  IGEGTFAKVRFAQNRETGESVA---MKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           IG G F KV        G S A   +K L  S     ++     +E+   + + HPN+++
Sbjct: 3   IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQL--LFLQEVQPYRELNHPNVLQ 59

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ-----LIDAVAHCHSK 128
                       ++LEF   G+L + +     ++    ++   Q     +   +   H  
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
              H DL   N  L +  ++K+ D+GL     P+              ++APE++  RG 
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179

Query: 187 DGSAAD------VWSCGVILFVL 203
           D    D      +WS GV ++ L
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 38/224 (16%)

Query: 15  RTIGEGTFAKVRFAQNRE-----TGES-VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
             +G G F +V      +     +G   VA+K L K    + +   +  +E  +M    H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFD------KIVHQGRLLENDCRRYFQQLIDAV 122
           PNIV+L  V       YII+E + GG+L               LL    +      +D  
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT--LKELLDICLDVA 116

Query: 123 AHCH---SKGVYHRDLKPENLLLDSYGN-----LKVSDFGLSA-------LPQQGVELLH 167
             C         HRDL   N L+   G      +K+ DFGL+          ++G  LL 
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
                  ++APE L + G   + +DVWS GV+++ +L  G  P+
Sbjct: 177 V-----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPY 214

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           R IG+G F  V       +       A+K L + T L+   V+Q  +E  IMK   HPN+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE--VEQFLKEGIIMKDFSHPNV 58

Query: 72  VRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLIDAVAHCH 126
           + L  + L S     ++L ++  G+L + I  +     N    D   +  Q+   + +  
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLA 115

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--------LPQQGVELLHTTCGTP-NYVA 177
           SK   HRDL   N +LD    +KV+DFGL+                  HT    P  ++A
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN-----HTGAKLPVKWMA 170

Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 214
            E L  + +  + +DVWS GV+L+ LM  G  P+ + D
Sbjct: 171 LESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVD 207

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 53.4 bits (128), Expect = 9e-08
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 27/219 (12%)

Query: 17  IGEG--TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           IG G      V  A+ + TGE V ++ +       + MV  ++ E+ + K+  HPNIV  
Sbjct: 6   IGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
                +  +++++  F+  G   D I       + E       Q ++ A+ + H  G  H
Sbjct: 65  RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVH 124

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQ-----QGVELLHTTCGTPNY-------VAPEV 180
           R +K  ++L+   G + +S  GL +        Q + ++H     P Y       ++PEV
Sbjct: 125 RSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHD---FPKYSVKVLPWLSPEV 179

Query: 181 LSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT 217
           L    +GYD + +D++S G+    L  G++PF   D+P 
Sbjct: 180 LQQNLQGYD-AKSDIYSVGITACELANGHVPF--KDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 52/214 (24%), Positives = 100/214 (46%), Gaps = 30/214 (14%)

Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 7   KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 64

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+        ++  Q 
Sbjct: 65  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124

Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 185 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 39/172 (22%), Positives = 65/172 (37%), Gaps = 29/172 (16%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGES----------------VAMKVLAKSTILKHRMVDQ 55
                +GEG F +V   +     +                 VA+KVL       +   D 
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDF 66

Query: 56  IKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL----------FDKIVHQGR 105
           +K E+ I+  +  PNI RL  V      + +I+E++  G+L             +    +
Sbjct: 67  LK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 106 LLENDCRRYF-QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS 156
            L      Y   Q+   + +  S    HRDL   N L+     +K++DFG+S
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 34/213 (15%)

Query: 15  RTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +GEG F KV        +     E VA+K L ++     R     +RE  ++   +H 
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNFQHE 68

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGEL----------FDKIVHQ----GRLLENDCRRYF 115
           NIV+ + V        ++ E++  G+L             +       G L  +   +  
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLHT 168
            Q+   + +  S+   HRDL   N L+     +K+ DFG+S            G  +L  
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188

Query: 169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                 ++ PE +  R +  + +DVWS GV+L+
Sbjct: 189 -----RWMPPESIMYRKFT-TESDVWSFGVVLW 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 15/219 (6%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS----IMKIVRHP 69
            + +G G F  V        G+S+ + V  K   ++ R   Q  +EI+     M  + H 
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIK--TIQDRSGRQTFQEITDHMLAMGSLDHA 69

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
            IVRL  +      + ++ +    G L D +  H+  L       +  Q+   + +    
Sbjct: 70  YIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
            + HR+L   N+LL S   ++++DFG++  L     +  ++   TP  ++A E +    Y
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Query: 187 DGSAADVWSCGVILFVLMA-GYLPFGET---DLPTLYKK 221
               +DVWS GV ++ +M+ G  P+      ++P L +K
Sbjct: 189 T-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 27/210 (12%)

Query: 15  RTIGEGTFAKVRFAQNRETGES-----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +GEG F KV  A+      +     VA+K L   T+   +     +RE  ++  ++H 
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLTNLQHE 67

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFD---------KIVHQGRLLENDCRRYFQQLID 120
           +IV+ + V      + ++ E++  G+L            I+  G+  +        Q++ 
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 121 AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCG 171
             +   S  VY       HRDL   N L+ +   +K+ DFG+S          +   T  
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
              ++ PE +  R +  + +DVWS GVIL+
Sbjct: 188 PIRWMPPESIMYRKFT-TESDVWSFGVILW 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 28/166 (16%)

Query: 17  IGEGTFAKVRFAQ------------NRETGES--VAMKVLAKSTILKHRMVDQIKREISI 62
           +GEG F +V   +                G+   VA+K+L ++ + K    D +K EI I
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RADVTKTARNDFLK-EIKI 70

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG---------ELFDKIVHQGRLLE---ND 110
           M  +++PNI+RL  V  S   + +I E++  G         E+     H   +      +
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS 156
                 Q+   + +  S    HRDL   N L+ ++  +K++DFG+S
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 43/234 (18%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR----EISIMKI 65
           ++++   +GEGTF KV  A +R+  E  A+K++        R V +  R    EI  M+ 
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV--------RNVPKYTRDAKIEIQFMEK 181

Query: 66  VRHPN------IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           VR  +      ++++     + T    I+    G  L D I+  G        R+  Q+I
Sbjct: 182 VRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPF----SHRHLAQII 237

Query: 120 ----DAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL----LHTTC 170
                A+ + H++  + H DLKPEN+L+++  +  V      ALP     +    L   C
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILMET-SDTVVDPVTNRALPPDPCRVRICDLGGCC 296

Query: 171 ----------GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
                      T +Y +PEV+   G+  S  D+WS G I++ L  G L +   D
Sbjct: 297 DERHSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHD 349

Length = 467

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 27/218 (12%)

Query: 17  IGEGTFAKVR----FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           +GE  F K+     +    +  + VA+K L      +     + ++E S+M  + HPNIV
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQW--GEFQQEASLMAELHHPNIV 70

Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVH-----------------QGRLLENDCRRYF 115
            L  V+     V ++ E++  G+L + ++                  +  L   D     
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP- 173
            Q+   + +  S    H+DL   N+L+    ++K+SD GLS  +       +      P 
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
            ++ PE +    +  S +D+WS GV+L+ + + G  P+
Sbjct: 191 RWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)

Query: 15  RTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +GEG F KV  A+       +    VA+K L  ++    +      RE  ++  ++H 
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK---DFHREAELLTNLQHE 67

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-------------RLLENDCRRYFQ 116
           +IV+ + V      + ++ E++  G+L   +   G              L ++      Q
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPN 174
           Q+   + +  S+   HRDL   N L+     +K+ DFG+S          +   T     
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILF 201
           ++ PE +  R +  + +DVWS GV+L+
Sbjct: 188 WMPPESIMYRKFT-TESDVWSLGVVLW 213

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 4/97 (4%)

Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP 230
           GTP+Y+APE+L  + + G A D W+ GV LF  + G  PF +     +++ I   +   P
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Query: 231 FW---FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
                 S  A + I  +L  +P  R  ++ +++HP F
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 24/74 (32%), Positives = 39/74 (52%), Gaps = 10/74 (13%)

Query: 112 RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGV-----EL 165
           +   +Q++ A+   HS G+ HRD+KP+N++     G+ K+ D G +A  + G+     E 
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEF 317

Query: 166 LHTTCGTPNYVAPE 179
           L      P Y APE
Sbjct: 318 LL----DPRYAAPE 327

Length = 566

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 20/203 (9%)

Query: 17  IGEGTFAKVRFAQNRETGESVA---MKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           IG G F KV  ++   T   VA   +K L  +   K +  ++  ++    +I++HPNI++
Sbjct: 3   IGNGWFGKVLLSE-IYTDTGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNILQ 59

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL---IDA-VAHCHSKG 129
                       ++ E+   G+L   +  +     N      Q++   I A V H H   
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             H DL   N  L S   +KV D+G+  S   +  +E     C    ++APE++    + 
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF-HG 178

Query: 188 G-------SAADVWSCGVILFVL 203
           G         ++VW+ GV L+ L
Sbjct: 179 GLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 31/211 (14%)

Query: 16  TIGEGTFAKVRFAQNRETGE-------SVAMKVLAKSTILKHRMVDQIKRE-ISIMKIVR 67
           ++G+GTF K+     RE G+        V +KVL KS    HR   +   E  S+M  + 
Sbjct: 2   SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLS 57

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY--FQQLIDAVAHC 125
           H ++V  + V     +  ++ E+V  G L D  + + + L N   +    +QL  A+   
Sbjct: 58  HKHLVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFL 116

Query: 126 HSKGVYHRDLKPENLLL-----DSYGN---LKVSDFGLS--ALPQQGVELLHTTCGTPNY 175
             KG+ H ++  +N+LL        GN   +K+SD G+S   LP+   E+L      P +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EIL--LERIP-W 170

Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
           V PE + N      AAD WS G  L+ + +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 3/95 (3%)

Query: 89  EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL 148
           EF+  G+     + Q +   N  +   +Q++  +   H  G+ HRD+KPENLL+   G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348

Query: 149 KVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEVL 181
           K+ DFG +     G+    L+     P Y  PE L
Sbjct: 349 KIIDFGAAVDMCTGINFNPLYGML-DPRYSPPEEL 382

Length = 507

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 32/217 (14%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           V K+E    +GEG F KV  A+       +    VA+K L +++          +RE  +
Sbjct: 8   VLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAEL 60

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD---------KIVHQGRLLENDCRR 113
           + +++H +IVR + V      + ++ E++  G+L           KI+  G  +    + 
Sbjct: 61  LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPG-QL 119

Query: 114 YFQQLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVE 164
              Q++   +   S  VY       HRDL   N L+     +K+ DFG+S          
Sbjct: 120 TLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179

Query: 165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
           +   T     ++ PE +  R +  + +D+WS GV+L+
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLW 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 27/218 (12%)

Query: 17  IGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           +GE  F KV           E  ++VA+K L        R  ++ K E  +   ++HPNI
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFKHEAMMRSRLQHPNI 70

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRLLENDCRRYF 115
           V L  V+     + +I  + +  +L + +V                 +  L   D     
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTTCGTP 173
            Q+   +    S  V H+DL   N+L+    N+K+SD GL          +L+  +    
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
            +++PE +   G     +D+WS GV+L+ V   G  P+
Sbjct: 191 RWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 26/133 (19%), Positives = 53/133 (39%), Gaps = 17/133 (12%)

Query: 31  RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIV-RLHEVLASRTKVYIIL 88
               E   +K+         R     +RE++I++++      V ++     S    Y+++
Sbjct: 18  GTKDEDYVLKINPSREKGADR-----EREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72

Query: 89  EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY---HRDLKPENLLLDSY 145
           E++ G  L         + E +     +QL + +A  H   +    H DL P N+L+D  
Sbjct: 73  EWIEGETL-------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125

Query: 146 GNLKVSDFGLSAL 158
             L + D+  +  
Sbjct: 126 KILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 38/131 (29%), Positives = 60/131 (45%), Gaps = 13/131 (9%)

Query: 37  VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL 96
           VA+K+L +    K+   D +K EI IM  ++ PNI+RL  V  +   + +I E++  G+L
Sbjct: 49  VAVKML-REDANKNARNDFLK-EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106

Query: 97  ---FDKIVHQGRLLENDCRRY-FQQLIDAVAHCHSKGVY-------HRDLKPENLLLDSY 145
                +   Q    + D     +  LI       S   Y       HRDL   N L+   
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN 166

Query: 146 GNLKVSDFGLS 156
             +K++DFG+S
Sbjct: 167 YTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 22/197 (11%)

Query: 33  TGESVAMKVLAKSTILKHRMVDQIKREI-SIMKIVRHPNIVRLHEVLASRTKVYIILEFV 91
                 +KV+ K     HR +     E  S+M+ V H +IV L+ V     +  ++ EFV
Sbjct: 27  YSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFV 86

Query: 92  TGGELFDKIVH-QGRLLENDCR-RYFQQLIDAVAHCHSKGVYHRDLKPENLLL-----DS 144
             G L D  +H +  +L    + +  +QL  A+++   K + H ++  +N+LL     D 
Sbjct: 87  EFGPL-DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDG 145

Query: 145 YGN--LKVSDFG--LSALP-QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVI 199
                +K+SD G  ++ L  Q+ VE +        ++APE + +      AAD WS G  
Sbjct: 146 ECGPFIKLSDPGIPITVLSRQECVERI-------PWIAPECVEDSKNLSIAADKWSFGTT 198

Query: 200 LF-VLMAGYLPFGETDL 215
           L+ +   G +P  +  L
Sbjct: 199 LWEICYNGEIPLKDKTL 215

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 22/159 (13%)

Query: 59  EISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 118
           EI+ M  ++HPNIV+L  +  S    Y+I E++ G  L         +L N      +++
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL-------SEVLRNLSWERRRKI 785

Query: 119 IDAVA------HCH-SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 171
              +A      HC  S  V   +L PE +++D        D     L   G+    T C 
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCF 839

Query: 172 TPN-YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP 209
             + YVAPE    +      +D++  G+IL  L+ G  P
Sbjct: 840 ISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 23/87 (26%)

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---------- 176
           S+   HRDL   N+LL     +K+ DFGL+                P+YV          
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDPDYVRKGDARLPLK 240

Query: 177 --APEVLSNRGYDGSAADVWSCGVILF 201
             APE + ++ Y  + +DVWS GV+L+
Sbjct: 241 WMAPESIFDKVYT-TQSDVWSFGVLLW 266

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 34/209 (16%)

Query: 15  RTIGEGTFAKVRFAQNRETGE----------SVAMKVLAKSTILKHRMVDQIKREISIMK 64
             +G+GTF  +     R   +          SV +KVL       HR         S+M 
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS----DHRDSLAFFETASLMS 56

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYF-QQLIDAV 122
            + H ++V+L+ V   R +  ++ E+V  G L D  +H +   +    +    +QL  A+
Sbjct: 57  QLSHKHLVKLYGVCV-RDENIMVEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASAL 114

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGN-------LKVSDFG--LSALPQQGVELLHTTCGTP 173
            +   K + H ++  +N+L+  YG        +K+SD G  ++ L ++           P
Sbjct: 115 HYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIP 169

Query: 174 NYVAPEVLSN-RGYDGSAADVWSCGVILF 201
            ++APE + N +     AAD WS G  L 
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLL 197

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 64/257 (24%), Positives = 105/257 (40%), Gaps = 58/257 (22%)

Query: 17  IGEGTFAKV--------------RFAQNRETGES--VAMKVLAKSTILKHRMVDQIKREI 60
           +GEG F +V              +F  N   G    VA+K+L +    K+   D +K E+
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLK-EV 70

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY------ 114
            I+  ++ PNI+RL  V      + +I E++  G+L   +     L + +          
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH-HLDDKEENGNDAVPPA 129

Query: 115 -------FQQLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSA--- 157
                  +  L+       S   Y       HRDL   N L+     +K++DFG+S    
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 158 ----LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF--VLMAGYLPFG 211
                  QG  +L        ++A E +   G   +A+DVW+ GV L+  +++    P+G
Sbjct: 190 AGDYYRIQGRAVLPI-----RWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPYG 243

Query: 212 E-TDLPTLYKKINAAEF 227
           E TD   +    NA EF
Sbjct: 244 ELTDEQVIE---NAGEF 257

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 35/220 (15%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           E+GR  G      V  A++  TG  V +++       +  +   ++ E+ +    RHPNI
Sbjct: 5   EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61

Query: 72  VRLHEVLASRTKVYIILEFVTGG---ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           +    V  + + +++I  F+  G    L      +G + E          +  + + H  
Sbjct: 62  MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSAL----------------PQQGVELLHTTCGT 172
           G  HR++K  ++L+   G + +S  GLS L                PQ    +L      
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVL------ 172

Query: 173 PNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPF 210
             +++PE+L     GY+   +D++S G+    L  G +PF
Sbjct: 173 -PWLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 25/134 (18%)

Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           L   D   +  Q+   +    SK   HRDL   N+LL     +K+ DFGL+       ++
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR------DI 287

Query: 166 LHTTCGTPNYV------------APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-G 211
           +H +    NYV            APE + +  Y  + +DVWS G++L+ + + G  P+ G
Sbjct: 288 MHDS----NYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPG 342

Query: 212 ETDLPTLYKKINAA 225
                T Y KI + 
Sbjct: 343 MIVDSTFYNKIKSG 356

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 28/87 (32%), Positives = 39/87 (44%), Gaps = 23/87 (26%)

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---------- 176
           S+   HRDL   N+LL     +K+ DFGL+                P+YV          
Sbjct: 197 SRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDPDYVRKGDARLPLK 246

Query: 177 --APEVLSNRGYDGSAADVWSCGVILF 201
             APE + +R Y    +DVWS GV+L+
Sbjct: 247 WMAPETIFDRVYT-IQSDVWSFGVLLW 272

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 23/87 (26%)

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---------- 176
           S+   HRDL   N+LL     +K+ DFGL+                P+YV          
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDPDYVRKGSARLPLK 241

Query: 177 --APEVLSNRGYDGSAADVWSCGVILF 201
             APE + ++ Y  + +DVWS GV+L+
Sbjct: 242 WMAPESIFDKVYT-TQSDVWSFGVLLW 267

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	443
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
PRK10345	210	hypothetical protein; Provisional	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
smart00090	237	RIO RIO-like kinase.	99.85
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.61
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.59
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
KOG1243	690	consensus Protein kinase [General function predict	99.55
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.53
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.52
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.5
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
PF03822	63	NAF: NAF domain; InterPro: IPR004041 The NAF domai	99.42
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.22
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.19
KOG3087	229	consensus Serine/threonine protein kinase [General	99.19
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.06
COG4248	637	Uncharacterized protein with protein kinase and he	99.06
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.02
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.01
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.87
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.72
PRK09902	216	hypothetical protein; Provisional	98.69
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.66
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.65
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.59
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.59
PF01636	239	APH: Phosphotransferase enzyme family This family	98.53
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.49
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.32
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.3
PLN02876	822	acyl-CoA dehydrogenase	98.29
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.1
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.07
PF02149	47	KA1: Kinase associated domain 1; InterPro: IPR0017	98.05
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.03
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.02
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.01
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.84
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.82
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.75
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.75
PRK10593	297	hypothetical protein; Provisional	97.74
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.73
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.7
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.69
PRK05231	319	homoserine kinase; Provisional	97.54
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.47
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.44
KOG2270	520	consensus Serine/threonine protein kinase involved	97.41
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.28
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.12
PLN02236	344	choline kinase	96.99
PLN02756	418	S-methyl-5-thioribose kinase	96.95
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.86
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.74
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.39
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.21
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.05
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.03
PRK12396	409	5-methylribose kinase; Reviewed	95.9
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.89
PTZ00384	383	choline kinase; Provisional	95.73
PRK11768	325	serine/threonine protein kinase; Provisional	95.43
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.04
PRK06148	1013	hypothetical protein; Provisional	94.88
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	94.01

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-64  Score=481.77  Aligned_cols=260  Identities=38%  Similarity=0.696  Sum_probs=234.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchH----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR----MVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ..+.|.+.++||+|+||.|.+|..+.||+.||||++++.......    ....+.+|+++|++|+|||||+++++|+..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            455688899999999999999999999999999999987654422    2344789999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC---CCeEEeeecCcCCC
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALP  159 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~---~~~kL~DFGls~~~  159 (443)
                      ..|+||||++||+|++++..++.+.|+..+.+++||+.|+.|||++||+||||||+|||+..+   -.+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999999999999999999999999999999999999999999999876   67999999999988


Q ss_pred             ccccccccccCCCcccCCCcccccCCC--CCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhhhccCCCC--CC--
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGY--DGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSCP--FW--  232 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~--~~--  232 (443)
                      .. ...+.+.||||.|+|||++.+.++  ++.++||||+|||||.+|+|.+||.+.... .+.++|..+.+.+.  .|  
T Consensus       330 g~-~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  330 GE-GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR  408 (475)
T ss_pred             cc-ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence            74 467889999999999999987764  345889999999999999999999876554 48999999988765  34  


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +|.++++||.+||..||++|||++|+|+||||+..
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            89999999999999999999999999999999854

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-63  Score=491.19  Aligned_cols=265  Identities=55%  Similarity=0.996  Sum_probs=248.6

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch--HHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH--RMVDQIKREISIMKIVR-HPNIVRLHEVLASRT   82 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~   82 (443)
                      ...++|.+++.||+|+||+|++|.+..+|+.||+|++++......  ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            567899999999999999999999999999999998887633211  34577889999999998 999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC-CCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~-~~~kL~DFGls~~~~~  161 (443)
                      .+|+|||||.||+|++++...+++.|..++++|+||++||+|||++||+||||||||||++.+ +++||+|||++.....
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999 9999999999998854


Q ss_pred             ccccccccCCCcccCCCcccccCC-CCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCC-CHHHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF-STGATS  239 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~~~~  239 (443)
                      ....+.+.|||+.|+|||++.+.+ |++.++|||||||+||.|++|..||++.+...++.+|..+.+.+|.++ |+++.+
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~  253 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARS  253 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHH
Confidence            457889999999999999999988 999999999999999999999999999999999999999999999999 999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCccccc-cCCC
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFRK-NYNP  270 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~-~~~~  270 (443)
                      ||.+||.+||.+|+|+.+|+.||||+. +..+
T Consensus       254 Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~~  285 (370)
T KOG0583|consen  254 LIEKMLVPDPSTRITLLEILEHPWFQKENPLP  285 (370)
T ss_pred             HHHHHcCCCcccCCCHHHHhhChhhccCCCCC
Confidence            999999999999999999999999998 4433

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-63  Score=499.47  Aligned_cols=264  Identities=43%  Similarity=0.832  Sum_probs=251.1

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ....+|.|+++++||.|+-|.|.+|++..||+..|||++.+...........+.+||.+|+.+.|||++++|++|+++.+
T Consensus         7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen    7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             ccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            34678999999999999999999999999999999999998754444456779999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +|+|+||++||+||+++..+|+++|.++.++|+||+.|+.|||..+|+||||||||+|||..+++||+|||+|.+...+ 
T Consensus        87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-  165 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-  165 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999876554 


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      .++.+.||+|.|.|||++.+.+|+|.++||||||||||.||+|.+||++.+...++.++..+.|..|..+|+++++||++
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~  245 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR  245 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCHHHHhcCccccccC
Q 013421          244 ILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ||+.||.+|+|.+||++|||+++..
T Consensus       246 ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  246 MLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             HhccCccccccHHHHhhCchhhcCC
Confidence            9999999999999999999998754

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-62  Score=487.34  Aligned_cols=261  Identities=36%  Similarity=0.678  Sum_probs=250.2

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      .+|..++.||+|+|+.||.+++..+|+.||+|++.+..+.+....+.+.+||+|++.|+|||||+++++|++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            45999999999999999999999999999999999988888888899999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      |+|+.++|..++++.+.++|.+++.+++||+.||.|||+++|+|||||..|++|+++.++||+|||||+........-.+
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T  177 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT  177 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence            99999999999999999999999999999999999999999999999999999999999999999999988766566779


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCC
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (443)
                      .||||.|+|||++...++. ..+||||+|||||.||.|++||...+..+.+.+|...++..|..+|.++++||.+||++|
T Consensus       178 lCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~  256 (592)
T KOG0575|consen  178 LCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPN  256 (592)
T ss_pred             ecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCC
Confidence            9999999999999987774 999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCHHHHhcCccccccCCC
Q 013421          249 PKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       249 P~~R~t~~eil~hp~f~~~~~~  270 (443)
                      |.+|||+++||.|+||+..+.|
T Consensus       257 P~~Rpsl~~vL~h~Ff~~g~~p  278 (592)
T KOG0575|consen  257 PSERPSLDEVLDHPFFKSGFTP  278 (592)
T ss_pred             cccCCCHHHHhcCHhhhCCCcC
Confidence            9999999999999999777654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-61  Score=454.18  Aligned_cols=261  Identities=38%  Similarity=0.712  Sum_probs=246.6

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ....++|++++.||+|+||+|++++.++|++.||+|+++|..+......+....|..||..++||+||+++..|++.+++
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            35578999999999999999999999999999999999999988887889999999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+|+||+.||+|+..|++.+.++|..++.|+..|+.||.|||++||+||||||||||||.+|+++|+|||+|+..-....
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999997666556


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC-CCCCHHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP-FWFSTGATSLIHK  243 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-~~~s~~~~~li~~  243 (443)
                      ..++.|||+.|||||++.+.+|+ ..+|+||||+++|+|++|.+||.+.+...++++|..+....+ ..+|.+++++|++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~  259 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKK  259 (357)
T ss_pred             ccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHH
Confidence            67789999999999999999987 999999999999999999999999999999999999985544 4599999999999


Q ss_pred             ccCCCCCCCC----CHHHHhcCccccc
Q 013421          244 ILDPNPKTRI----RIEGIRKHPWFRK  266 (443)
Q Consensus       244 ~L~~dP~~R~----t~~eil~hp~f~~  266 (443)
                      +|..||.+|.    ++.+|.+||||..
T Consensus       260 LL~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  260 LLKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             HhccCHHHhcCCCCChHHhhcCccccc
Confidence            9999999996    6899999999974

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-60  Score=433.57  Aligned_cols=257  Identities=36%  Similarity=0.720  Sum_probs=246.2

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      -.+.+|+++++||.|+||.|.+++++.+|..+|+|++++..+.+...++...+|..+|+.+.||+++++++.+.+.+++|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            56889999999999999999999999999999999999999888888899999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      +||||.+||+|+.++++.++++|..++.|+.||+.||+|||+++|++|||||||||||.+|.+||+|||++......   
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999865432   


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHcc
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  245 (443)
                      ..+.||||.|+|||+++.++|. .++|.|||||++|||++|.+||.+.+...++.+|..+++.+|..+|+++++||+++|
T Consensus       198 T~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL  276 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLL  276 (355)
T ss_pred             EEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHH
Confidence            6789999999999999999986 999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCC-----CHHHHhcCccccc
Q 013421          246 DPNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       246 ~~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      +.|-.+|.     ..++|..||||+.
T Consensus       277 ~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  277 QVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             hhhhHhhhcCcCCCccccccCccccc
Confidence            99999994     6789999999974

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-58  Score=455.39  Aligned_cols=260  Identities=34%  Similarity=0.644  Sum_probs=243.9

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~   84 (443)
                      ....+|.+++.||+|+|++|++|+++.+++.||||+++|..+.++..++-+.+|-.+|.+| .||.|+++|-.|+++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            4677999999999999999999999999999999999999988888888899999999999 899999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+|+||+++|+|.++|.+.+.++|..++.|+.||+.||+|||++|||||||||||||||.+|++||+|||.+..+.....
T Consensus       150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999876643111


Q ss_pred             -----------c--ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC
Q 013421          165 -----------L--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF  231 (443)
Q Consensus       165 -----------~--~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~  231 (443)
                                 .  ..+.+||-.|++||+|... +.++.+|||+||||||+|++|.+||.+.+....+++|..-.+.+|+
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~  308 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE  308 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence                       1  1457899999999999764 4569999999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      .+++.+++||+++|..||++|+|+++|.+||||..
T Consensus       309 ~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  309 GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             CCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            99999999999999999999999999999999975

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-56  Score=427.14  Aligned_cols=262  Identities=37%  Similarity=0.669  Sum_probs=240.9

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ....+++|.+.+.||+|+||.||+|+++.++..||||.|.+... .....+.+..||.+|+.++|||||.++++..+++.
T Consensus         5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen    5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence            35678999999999999999999999999999999999998765 34467889999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC------CCeEEeeecCcC
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY------GNLKVSDFGLSA  157 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~------~~~kL~DFGls~  157 (443)
                      +|+|||||+||+|.++|.+.++++|..++.++.||+.||++||+++|+||||||+||||+..      -.+||+|||+|+
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999865      358999999999


Q ss_pred             CCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC---CCCCCC
Q 013421          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS---CPFWFS  234 (443)
Q Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s  234 (443)
                      ....+ ....+.||||.|||||++....|+ .|+|+||+|+|+|++++|+.||+..+..++...+..+...   .|.+++
T Consensus       164 ~L~~~-~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s  241 (429)
T KOG0595|consen  164 FLQPG-SMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS  241 (429)
T ss_pred             hCCch-hHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence            88754 678899999999999999888887 8999999999999999999999999999998888776543   345688


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      +...+|+...|..+|..|.+..+-..||+...+.
T Consensus       242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             CchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            8899999999999999999999999999987654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.7e-56  Score=440.66  Aligned_cols=260  Identities=36%  Similarity=0.665  Sum_probs=237.2

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ...+++|++++.||+|+||+||+|+.+.||+.+|+|++++......+.++.++.|-.+|...++|+||++|..|++.+++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            45678999999999999999999999999999999999998888878889999999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc---
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ---  161 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~---  161 (443)
                      ||||||++||++..+|.+.+.++|+.+++|+.+++.|++-+|+.|++||||||+|+|||..|++||+|||||+-...   
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999852211   


Q ss_pred             -------------------cc-c------------------------cccccCCCcccCCCcccccCCCCCCccchHHHH
Q 013421          162 -------------------GV-E------------------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCG  197 (443)
Q Consensus       162 -------------------~~-~------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlG  197 (443)
                                         .+ .                        .....+|||.|+|||++.+.+|. ..+|+||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG  375 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLG  375 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHH
Confidence                               00 0                        01234699999999999999985 999999999


Q ss_pred             HHHHHHhhCCCCCCCCChHHHHHHhhhcc--CCCCC--CCCHHHHHHHHHccCCCCCCCCC---HHHHhcCccccc
Q 013421          198 VILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF--WFSTGATSLIHKILDPNPKTRIR---IEGIRKHPWFRK  266 (443)
Q Consensus       198 vil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~f~~  266 (443)
                      ||+||||.|.+||.+.+..+.+++|...+  +.+|.  .++++++|||.+||. ||.+|..   ++||.+||||+.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~  450 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG  450 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence            99999999999999999999999987765  55554  479999999999999 9999995   899999999985

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-56  Score=423.18  Aligned_cols=257  Identities=28%  Similarity=0.464  Sum_probs=233.1

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-KVY   85 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~   85 (443)
                      ..++.+.++.||+|+.|+||+++|+.|++.+|+|++....  +....+++.+|+++++..+||+||.+|+.|.++. .++
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is  154 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS  154 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence            3456778899999999999999999999999999995443  4556789999999999999999999999999998 499


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+||||+||+|.+.+...++++|.....++.++++||.|||. ++|+||||||+|||++..|.+||||||.+......  
T Consensus       155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            999999999999999998999999999999999999999995 99999999999999999999999999999876553  


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC-----ChHHHHHHhhhcc-CCCCCC-CCHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET-----DLPTLYKKINAAE-FSCPFW-FSTGA  237 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~-~s~~~  237 (443)
                      ...+.+||..|||||.+.+..|. .++||||||+.+.|+.+|+.||...     +..++...|..+. +..|.. +|+++
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef  311 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF  311 (364)
T ss_pred             hcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence            67899999999999999998875 8899999999999999999999875     5667777777754 456665 99999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ++||..||++||.+|+|+.|+++|||+++..
T Consensus       312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            9999999999999999999999999998654

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-57  Score=428.62  Aligned_cols=262  Identities=39%  Similarity=0.723  Sum_probs=249.2

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      .-.+|++.++||+|+||+|.+|.....|+.||||.|.++.+.+++..-.+.+||+||..|+||||+.+|++|++.+.+.|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            34589999999999999999999999999999999999999988888899999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      ||||+++|+|+|||...+.++|.+++.+|+||++|+.|||.++++|||||.+|||+|.|+++||+|||++..+... ..+
T Consensus       131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kfL  209 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KFL  209 (668)
T ss_pred             EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-cHH
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999988664 778


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccC
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD  246 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~  246 (443)
                      .+.||+|-|.+||++.+.+|.|+.+|-|||||+||.|..|..||++.+...+.++|..+.+.-|. -+.++..||+.||-
T Consensus       210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwmLm  288 (668)
T KOG0611|consen  210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRWMLM  288 (668)
T ss_pred             HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHHHHh
Confidence            99999999999999999999999999999999999999999999999999999999999887765 47788999999999


Q ss_pred             CCCCCCCCHHHHhcCccccccCCC
Q 013421          247 PNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       247 ~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                      .||.+|.|+++|-.|=|.+=.|+.
T Consensus       289 VNP~RRATieDiAsHWWvNwgy~~  312 (668)
T KOG0611|consen  289 VNPERRATIEDIASHWWVNWGYNM  312 (668)
T ss_pred             cCcccchhHHHHhhhheeeccccc
Confidence            999999999999999998766653

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-56  Score=405.97  Aligned_cols=249  Identities=32%  Similarity=0.571  Sum_probs=227.1

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEE-EE-EeCC
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE-VL-ASRT   82 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~-~~~~   82 (443)
                      ...+.+|++++.||+|+||+||++++..+|..+|.|.++-... +....+.+..|+.+|++|+|||||++++ .+ +++.
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            4556789999999999999999999999999999999985543 4445678899999999999999999998 34 4555


Q ss_pred             EEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--CEeecCCCCcEEEcCCCCeEEeeec
Q 013421           83 KVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHS--KG--VYHRDLKPENLLLDSYGNLKVSDFG  154 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~--~g--i~HrDlkp~NILl~~~~~~kL~DFG  154 (443)
                      .++||||||.+|+|...|++    ...++|..+|+++.||+.||.+||+  ..  |+||||||.||+|+.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            59999999999999999865    3568999999999999999999999  44  9999999999999999999999999


Q ss_pred             CcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC-CC-CC
Q 013421          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CP-FW  232 (443)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~-~~  232 (443)
                      +++.+.......++.+|||+||+||++.+.+|+ .+|||||+||++|||++-++||.+.+..++.++|..++++ +| ..
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~  252 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH  252 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence            999998877788899999999999999999997 9999999999999999999999999999999999999886 66 56


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCH
Q 013421          233 FSTGATSLIHKILDPNPKTRIRI  255 (443)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~  255 (443)
                      +|.++..||..|+.+||..||+.
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCc
Confidence            89999999999999999999986

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-55  Score=393.45  Aligned_cols=261  Identities=39%  Similarity=0.696  Sum_probs=247.3

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ....+++|++++.||+|.||.||+|+.+.++-.||+|++.+..+...+...++.+|++|...|+||||+++|++|.+...
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR   96 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence            46778999999999999999999999999999999999999988777778899999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           84 VYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~--~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      +|+++||+++|+++..+.  ...+++|..++.|+.|++.|+.|||.++|+||||||+|+|++.+|.+||+|||-+.....
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            999999999999999998  567899999999999999999999999999999999999999999999999998876543


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI  241 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li  241 (443)
                        ....+-|||..|.|||...+.+++ ..+|+|++|++.||++.|.+||...+..+.+++|...++.+|..+|.++.|||
T Consensus       177 --~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI  253 (281)
T KOG0580|consen  177 --NKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLI  253 (281)
T ss_pred             --CCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHH
Confidence              445789999999999999999887 99999999999999999999999999999999999999999999999999999


Q ss_pred             HHccCCCCCCCCCHHHHhcCcccccc
Q 013421          242 HKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .+||..+|.+|.+..|++.|||+...
T Consensus       254 ~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  254 SRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHhccCccccccHHHHhhhHHHHhc
Confidence            99999999999999999999998653

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-54  Score=435.73  Aligned_cols=260  Identities=33%  Similarity=0.620  Sum_probs=243.8

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   83 (443)
                      ...+.+|.+++.||+|+||+|++|..+.+++.+|||+++|..+...+.++..+.|-+|+... +||.+++++..|++.++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            34678999999999999999999999999999999999999998888899999999999988 59999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +|+||||+.||++ -.+.+.+.++|..++.|+..++.||.|||++||+|||||.+|||||.+|++||+|||+++..-...
T Consensus       444 l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  444 LFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             EEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence            9999999999994 444555889999999999999999999999999999999999999999999999999998655444


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ....|.||||.|+|||++.+..|. ..+|+|||||+||+||.|+.||.+.+.++++..|...++.+|.|+|.++.+++++
T Consensus       523 ~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~  601 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRR  601 (694)
T ss_pred             CccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHH
Confidence            577899999999999999998885 9999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCH-----HHHhcCccccc
Q 013421          244 ILDPNPKTRIRI-----EGIRKHPWFRK  266 (443)
Q Consensus       244 ~L~~dP~~R~t~-----~eil~hp~f~~  266 (443)
                      +|..||.+|..+     ++|++||||+.
T Consensus       602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  602 LLRKNPEKRLGSGERDAEDIKKHPFFRS  629 (694)
T ss_pred             HhccCcccccCCCCCCchhhhhCCcccc
Confidence            999999999964     88999999975

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-54  Score=418.39  Aligned_cols=264  Identities=35%  Similarity=0.643  Sum_probs=233.6

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchH-----------HHHHHHHHHHHHHhCCCCCcce
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR-----------MVDQIKREISIMKIVRHPNIVR   73 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~HpnIv~   73 (443)
                      ...+++|++++.||+|.||+|.+|++..+++.||||++++.......           ..+.+.+||.+|++|+|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            35678999999999999999999999999999999999875532211           2368999999999999999999


Q ss_pred             EEEEEEeC--CEEEEEEecCCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEE
Q 013421           74 LHEVLASR--TKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV  150 (443)
Q Consensus        74 l~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL  150 (443)
                      ++++..+.  +.+|||+|||+.|.+... -.... +++.+++.|+++++.||+|||.+||+||||||+|+||+.+|++||
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence            99999754  689999999999987443 33344 899999999999999999999999999999999999999999999


Q ss_pred             eeecCcCCCcc-----ccccccccCCCcccCCCccccc---CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHh
Q 013421          151 SDFGLSALPQQ-----GVELLHTTCGTPNYVAPEVLSN---RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  222 (443)
Q Consensus       151 ~DFGls~~~~~-----~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  222 (443)
                      +|||.+..+..     .+..+...+|||.|+|||.+.+   ..+.+.+.||||+||+||.|+.|+.||.+....+++.+|
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI  331 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI  331 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence            99999876622     2334556889999999999977   567789999999999999999999999999999999999


Q ss_pred             hhccCCCCCC--CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          223 NAAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       223 ~~~~~~~~~~--~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                      .+..+.+|..  +.+.+++||.+||.+||.+|+++.+|..|||......
T Consensus       332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            9998888876  7999999999999999999999999999999987643

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8e-56  Score=397.26  Aligned_cols=257  Identities=40%  Similarity=0.755  Sum_probs=235.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      -+.|++.+.||+|+|+.||++.+..||+.+|+|+++...+... ..+.+.+|++|-+.|+||||+++++.+.+....|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4579999999999999999999999999999999998776555 568899999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC---CCCeEEeeecCcCCCccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~---~~~~kL~DFGls~~~~~~~~  164 (443)
                      +|+++|++|+.-|....-++|..+-.+++||++||.|||.+||+|||+||+|+++..   ..-+||+|||++.... +..
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~  167 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGE  167 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Ccc
Confidence            999999999988887777899999999999999999999999999999999999953   3469999999998776 445


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC--C--CCHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--W--FSTGATSL  240 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~s~~~~~l  240 (443)
                      .....+|||.|+|||++...+|. .++|||++|||||-||.|++||.+.+...+++.|..+.+..|+  |  +++++++|
T Consensus       168 ~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L  246 (355)
T KOG0033|consen  168 AWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL  246 (355)
T ss_pred             ccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence            67788999999999999988875 9999999999999999999999999999999999998776654  4  89999999


Q ss_pred             HHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          241 IHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +++||..||++|+|+.|+|+|||+.+.
T Consensus       247 vrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  247 IRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHhccChhhhccHHHHhCCchhcch
Confidence            999999999999999999999999753

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-54  Score=425.94  Aligned_cols=259  Identities=31%  Similarity=0.572  Sum_probs=245.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +++|.+.+.||+|+||.||+|+.+.+.+.||||.++|.... +...+.+.+|++|++.++|||||.+++.|++..++|+|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            57899999999999999999999999999999999987643 34578899999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      +|||.| +|+.++..++.++|+.++.+..|++.||.|||+.+|.|||+||.|||++.+|.+|+||||+++.+..+.....
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            999977 9999999999999999999999999999999999999999999999999999999999999998888777788


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCC
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP  247 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~  247 (443)
                      ...|||.|||||++.+.+|+ ..+|+||+|||+||+++|++||...+..++.+.|.......|...|+.+++|++.+|.+
T Consensus       159 sikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~k  237 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIK  237 (808)
T ss_pred             eccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhc
Confidence            88899999999999988887 99999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHhcCccccccCC
Q 013421          248 NPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       248 dP~~R~t~~eil~hp~f~~~~~  269 (443)
                      ||.+|+|..+++.|||.+....
T Consensus       238 dP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  238 DPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             ChhhcccHHHHhcChHHhhhhh
Confidence            9999999999999999987653

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-54  Score=417.23  Aligned_cols=262  Identities=39%  Similarity=0.686  Sum_probs=244.8

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..-+=|.+.++||+|-|+.|.+|++.-||+.||||++++.+.... ....+.+|++.|+.++|||||++|++......+|
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly   93 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY   93 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence            344569999999999999999999999999999999999876543 3567889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc-CCCCeEEeeecCcCCCcccc
Q 013421           86 IILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~-~~~~~kL~DFGls~~~~~~~  163 (443)
                      +|+|+-++|+|+++|..+ .++.|+.+++||.||+.|+.|||+..++|||||||||.+- .-|-+||+|||++..+..+ 
T Consensus        94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-  172 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-  172 (864)
T ss_pred             EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-
Confidence            999999999999999765 5899999999999999999999999999999999998775 6799999999999988765 


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ..+.+.||+..|.|||++.+..|+.+++||||||||||-|.+|++||...+..+....|+...+..|..+|.++++||..
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~s  252 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQS  252 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHH
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCHHHHhcCccccccCC
Q 013421          244 ILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                      ||+.||++|.+.++|..|+|++..-.
T Consensus       253 MLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  253 MLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHhcCchhhccHHHHhccccccCCCC
Confidence            99999999999999999999987543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.4e-54  Score=396.59  Aligned_cols=257  Identities=27%  Similarity=0.440  Sum_probs=221.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +++|+.+.++|+|+||.||++++++||+.||||.+-... .+....+-..+||++|++|+|||+|.++++|.-...+++|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            468999999999999999999999999999999986443 2233345578999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      +|||+..-|.+.-....+++++.++.|+.|++.|+.|||+++++||||||||||++.+|.+||||||+|+.........+
T Consensus        80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT  159 (396)
T KOG0593|consen   80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT  159 (396)
T ss_pred             eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence            99997755555445557899999999999999999999999999999999999999999999999999998876667888


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh--c-------------------c
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--A-------------------E  226 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~-------------------~  226 (443)
                      .++.|.+|+|||.+.+...+|.++||||+||++.||++|++.|++.+..+..-.|..  +                   .
T Consensus       160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence            999999999999999877778999999999999999999999998765443322211  0                   0


Q ss_pred             CCCC----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          227 FSCP----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       227 ~~~~----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      ++-|          +.++.-+.+|+++||+.||.+|++.++++.||||.
T Consensus       240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence            1111          12577899999999999999999999999999994

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.2e-52  Score=412.54  Aligned_cols=259  Identities=38%  Similarity=0.718  Sum_probs=237.2

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ....+++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   92 (329)
T PTZ00263         13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR   92 (329)
T ss_pred             CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence            34567899999999999999999999999999999999987654444456778999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      .|++|||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... 
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            9999999999999999999889999999999999999999999999999999999999999999999999998755332 


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                        ..+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..+...+|.++++.+.+||.+
T Consensus       172 --~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  248 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG  248 (329)
T ss_pred             --cceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence              2356899999999999887764 8999999999999999999999988888888888888889999999999999999


Q ss_pred             ccCCCCCCCCC-----HHHHhcCccccc
Q 013421          244 ILDPNPKTRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       244 ~L~~dP~~R~t-----~~eil~hp~f~~  266 (443)
                      ||+.||.+|++     +++++.||||+.
T Consensus       249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        249 LLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            99999999997     799999999975

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-53  Score=413.69  Aligned_cols=262  Identities=32%  Similarity=0.508  Sum_probs=229.1

Q ss_pred             cccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 013421            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASR   81 (443)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~   81 (443)
                      +....+.+|.+++.||.|+||.||+|+...+|+.||||.+++....-++ . .-.||+..|++|+ |||||++.+++.+.
T Consensus         4 ~~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~-~nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    4 TQVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-C-MNLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             eehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-H-HHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            3445678999999999999999999999999999999999876544333 2 2358999999998 99999999999888


Q ss_pred             C-EEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           82 T-KVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        82 ~-~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      + .+|+||||| ..+|++.++..+ .+++..++.|+.||++||+|+|.+|+.|||+||||||+..+..+||+|||+|+..
T Consensus        82 ~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   82 DRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             CceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence            7 999999999 569999998754 6899999999999999999999999999999999999999999999999999877


Q ss_pred             ccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh---------------
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA---------------  224 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---------------  224 (443)
                      ... ...+.++.|.+|+|||++...++++.+.|+|++|||++|+.+-++.|++.+..+...+|..               
T Consensus       161 ~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  161 RSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             ccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            654 5678899999999999999999999999999999999999999999999887655554421               


Q ss_pred             ----ccCCCCC-----------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          225 ----AEFSCPF-----------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       225 ----~~~~~~~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                          -.+.+|.           ..++++.++|.+||..||.+||||+++|+||||+...
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                1233332           2688999999999999999999999999999998654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-52  Score=404.35  Aligned_cols=259  Identities=32%  Similarity=0.555  Sum_probs=222.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT--KVY   85 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~   85 (443)
                      ..+|..++.||+|+||.||++.+..+|+..|||.+.....  . ..+.+.+|+.+|++++|||||++++......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--P-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--h-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            3458899999999999999999999999999999987631  1 2678999999999999999999999754444  799


Q ss_pred             EEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-CCCeEEeeecCcCCCcc--
Q 013421           86 IILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQ--  161 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~--  161 (443)
                      ++|||++||+|.+++.+.+ +++|..+++|.+||++||.|||++||+||||||+|||++. +|.+||+|||++.....  
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999987 7999999999999999999999999999999999999999 79999999999886653  


Q ss_pred             -ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCC-CChHHHHHHhhhc--cCCCCCCCCHHH
Q 013421          162 -GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAA--EFSCPFWFSTGA  237 (443)
Q Consensus       162 -~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~--~~~~~~~~s~~~  237 (443)
                       .........||+.|||||++.+....+.++||||+||++.||+||..||.. .......-.+...  .+.+|.++|+++
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence             122344678999999999998633334599999999999999999999987 3433333333322  357888999999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                      ++||.+||..||.+||||+++|.|||.+....
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999999976543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-52  Score=407.88  Aligned_cols=261  Identities=31%  Similarity=0.487  Sum_probs=226.9

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--T   82 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~   82 (443)
                      +.+.+.|+.++.||+|+||+||+|++..+|+.||+|.+..+.. +.+...-..+||.||++|+||||+++.+...+.  .
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence            4556789999999999999999999999999999999987653 344567788999999999999999999998776  7


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      .+|+|+|||+. +|.-++... ..+++.++..|++||+.||+|||++||.|||||.+|||||++|.+||+|||||+++..
T Consensus       192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            89999999965 777777764 4899999999999999999999999999999999999999999999999999997765


Q ss_pred             c-cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--c--------CCCC
Q 013421          162 G-VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--E--------FSCP  230 (443)
Q Consensus       162 ~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~--------~~~~  230 (443)
                      . ...++..+-|++|+|||++.+...++.++|+||+||||.||++|++.|.+.+..+...+|...  .        ...|
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            3 345778889999999999999888889999999999999999999999998877666555211  0        0111


Q ss_pred             -------------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          231 -------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       231 -------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                         ..+++.+.+|+..||..||.+|.||.++|+|+||...
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence                               1268899999999999999999999999999999443

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-51  Score=410.40  Aligned_cols=257  Identities=40%  Similarity=0.735  Sum_probs=236.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l   86 (443)
                      -..|++.+.||+|.||.||.++++.||+.+|+|++.+.........+.+.+|+.+|+++. |||||.++++|++.+.+|+
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            347999999999999999999999999999999999987765556678999999999998 9999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC----CCeEEeeecCcCCCccc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY----GNLKVSDFGLSALPQQG  162 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~----~~~kL~DFGls~~~~~~  162 (443)
                      |||+|.||+|++.|... .++|..+..++.|++.|+.|||+.||+||||||||+|+...    +.+|++|||++..... 
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-  191 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-  191 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence            99999999999999887 59999999999999999999999999999999999999633    5799999999988776 


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCC--CCC--CCHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC--PFW--FSTGAT  238 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~--~s~~~~  238 (443)
                      ....++.|||+.|+|||++...+|. ..+||||+||++|.|++|.+||.+.+......++..+++.+  +.|  +|..++
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ak  270 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAK  270 (382)
T ss_pred             CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHH
Confidence            4678899999999999999877875 99999999999999999999999999888888888887654  445  799999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +||++||..||.+|+|+.++|+|||++..
T Consensus       271 d~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  271 DFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            99999999999999999999999999764

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-51  Score=401.35  Aligned_cols=254  Identities=33%  Similarity=0.625  Sum_probs=232.3

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999998654434344567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||+++|+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++......   ...
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~~  157 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TWT  157 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---ccc
Confidence            99999999999998889999999999999999999999999999999999999999999999999998755332   234


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCC
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (443)
                      .+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++.+.+||++||+.|
T Consensus       158 ~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~d  236 (291)
T cd05612         158 LCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD  236 (291)
T ss_pred             ccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCC
Confidence            6799999999999877764 899999999999999999999999888888888888888888889999999999999999


Q ss_pred             CCCCCC-----HHHHhcCccccc
Q 013421          249 PKTRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       249 P~~R~t-----~~eil~hp~f~~  266 (443)
                      |.+|++     ++++++||||+.
T Consensus       237 p~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         237 RTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             HHHccCCccCCHHHHhcCccccC
Confidence            999995     999999999964

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.8e-51  Score=406.11  Aligned_cols=251  Identities=34%  Similarity=0.596  Sum_probs=228.6

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg   94 (443)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765444445567889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcc
Q 013421           95 ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN  174 (443)
Q Consensus        95 ~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~  174 (443)
                      +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  160 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence            99999998889999999999999999999999999999999999999999999999999998754333334456789999


Q ss_pred             cCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC-
Q 013421          175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-  253 (443)
Q Consensus       175 y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-  253 (443)
                      |+|||++.+..+. .++||||+||++|+|++|..||...+.......+......+|..+++++.+||.+||+.||++|| 
T Consensus       161 y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05571         161 YLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             ccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            9999999877764 89999999999999999999999888888888888888888889999999999999999999999 


Q ss_pred             ----CHHHHhcCccccc
Q 013421          254 ----RIEGIRKHPWFRK  266 (443)
Q Consensus       254 ----t~~eil~hp~f~~  266 (443)
                          ++.++++||||..
T Consensus       240 ~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         240 GGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             CCCCCHHHHHcCCCcCC
Confidence                8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-52  Score=416.27  Aligned_cols=263  Identities=40%  Similarity=0.755  Sum_probs=249.2

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ...++.|.+.++||+|.|++|.+|++..++..||||++++....... ...+.+|+++|+.|+|||||+++.+......+
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            45688999999999999999999999999999999999998765543 44599999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+||||+.+|++++++.+++++.+..++.+|.|+++|++|||+++|+|||||++||||+.+.++||+|||++..+..+ .
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-~  209 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-L  209 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-c
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999988754 6


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHc
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (443)
                      .+.+.||++.|.|||++.+..|+++.+|+||+|++||.|+.|.+||++.+..++......+.+.+|..+|.++.++|+++
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~  289 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKF  289 (596)
T ss_pred             cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHh
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccccccCC
Q 013421          245 LDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                      |.++|.+|+++++|+.|+|....+.
T Consensus       290 lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  290 LVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             hccCccccCCHHHhhhhcccchhhh
Confidence            9999999999999999999876543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.5e-51  Score=405.54  Aligned_cols=259  Identities=32%  Similarity=0.594  Sum_probs=234.3

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCC-cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETG-ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ....+++|++.+.||+|+||.||+|.+..++ ..||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            3455778999999999999999999876654 689999998765544445677889999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      ..|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++......
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH  242 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~  242 (443)
                         ..+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+..+...+|..+++.+.++|+
T Consensus       185 ---~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  260 (340)
T PTZ00426        185 ---TYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMK  260 (340)
T ss_pred             ---cceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence               345689999999999987666 4899999999999999999999999888888888888888889999999999999


Q ss_pred             HccCCCCCCCC-----CHHHHhcCccccc
Q 013421          243 KILDPNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       243 ~~L~~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      +||+.||.+|+     +++++++||||+.
T Consensus       261 ~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        261 KLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             HHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            99999999996     8999999999975

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-50  Score=398.64  Aligned_cols=250  Identities=35%  Similarity=0.632  Sum_probs=227.6

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCCCh
Q 013421           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (443)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L   96 (443)
                      ||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999999999999999875544444567788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcccC
Q 013421           97 FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV  176 (443)
Q Consensus        97 ~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~  176 (443)
                      .+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.............+||+.|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  160 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL  160 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence            99999888999999999999999999999999999999999999999999999999999876443333445678999999


Q ss_pred             CCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC---
Q 013421          177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI---  253 (443)
Q Consensus       177 aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---  253 (443)
                      |||++.+..+. .++||||+||++|+|++|..||.+.+....+..+......+|..+++++.+||.+||..||.+||   
T Consensus       161 aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~  239 (312)
T cd05585         161 APELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN  239 (312)
T ss_pred             CHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCC
Confidence            99999887765 89999999999999999999999988888888888888888889999999999999999999997   


Q ss_pred             CHHHHhcCcccccc
Q 013421          254 RIEGIRKHPWFRKN  267 (443)
Q Consensus       254 t~~eil~hp~f~~~  267 (443)
                      ++.+++.||||...
T Consensus       240 ~~~e~l~hp~~~~~  253 (312)
T cd05585         240 GAQEIKNHPFFSQL  253 (312)
T ss_pred             CHHHHHcCCCcCCC
Confidence            57999999999753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-51  Score=391.76  Aligned_cols=260  Identities=28%  Similarity=0.475  Sum_probs=233.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      -+..|++++.||.|.-|+||+++.+.++..+|+|++++..........++..|-+||+.++||.++.+|..|+++...|+
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            35678999999999999999999999999999999999888777777889999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc---
Q 013421           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ---  161 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~---  161 (443)
                      +||||+||+|....+++  +.+++..+++|+.+++.||+|||..||++||||||||||-++|++-|+||.|+.....   
T Consensus       155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            99999999999888765  4799999999999999999999999999999999999999999999999998632100   


Q ss_pred             ------------------------------c-c----------------------ccccccCCCcccCCCcccccCCCCC
Q 013421          162 ------------------------------G-V----------------------ELLHTTCGTPNYVAPEVLSNRGYDG  188 (443)
Q Consensus       162 ------------------------------~-~----------------------~~~~~~~gt~~y~aPE~l~~~~~~~  188 (443)
                                                    . .                      ......+||-.|+|||++.+.+.. 
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg-  313 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG-  313 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC-
Confidence                                          0 0                      001234699999999999998875 


Q ss_pred             CccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC--CCCHHHHHHHHHccCCCCCCCCC----HHHHhcCc
Q 013421          189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--WFSTGATSLIHKILDPNPKTRIR----IEGIRKHP  262 (443)
Q Consensus       189 ~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~s~~~~~li~~~L~~dP~~R~t----~~eil~hp  262 (443)
                      .++|+|+|||++||||.|..||.+.+..+...+|......+|.  .+|..++|||+++|.+||++|..    +.||.+||
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~Hp  393 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHP  393 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCc
Confidence            9999999999999999999999999999999998888777775  47899999999999999999998    99999999


Q ss_pred             ccccc
Q 013421          263 WFRKN  267 (443)
Q Consensus       263 ~f~~~  267 (443)
                      ||+.-
T Consensus       394 FF~gV  398 (459)
T KOG0610|consen  394 FFEGV  398 (459)
T ss_pred             cccCC
Confidence            99864

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-52  Score=380.19  Aligned_cols=258  Identities=36%  Similarity=0.674  Sum_probs=232.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS   80 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~   80 (443)
                      -...|+-.+.||.|..+.|..+.++.+|..+|+|++......     ..+..+.-.+|+.||+++ .||+|+++.++|++
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            356788899999999999999999999999999999753321     223456677899999999 69999999999999


Q ss_pred             CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      +..+++|+|.|+.|+|+|++.....++|...+++++||+.|+.|||.++|+||||||+|||+|++.++||+|||+++...
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999887


Q ss_pred             cccccccccCCCcccCCCcccccC------CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC--CCCC
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNR------GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS--CPFW  232 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~  232 (443)
                      .+ ..+...||||+|.|||.+...      +| +..+|+|+||||+|.||+|.+||-.....-+.+.|+.+.+.  .|.|
T Consensus       175 ~G-ekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW  252 (411)
T KOG0599|consen  175 PG-EKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW  252 (411)
T ss_pred             Cc-hhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence            65 456788999999999998643      44 47899999999999999999999887777888889888765  5677


Q ss_pred             --CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          233 --FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       233 --~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                        +|..+++||.+||+.||.+|+|+.|.|.||||..
T Consensus       253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence              7999999999999999999999999999999954

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.3e-50  Score=399.10  Aligned_cols=251  Identities=34%  Similarity=0.611  Sum_probs=228.0

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg   94 (443)
                      +.||+|+||.||++.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765544455677889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcc
Q 013421           95 ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN  174 (443)
Q Consensus        95 ~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~  174 (443)
                      +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+.
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~  160 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE  160 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence            99999988888999999999999999999999999999999999999999999999999998754333334456789999


Q ss_pred             cCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC-
Q 013421          175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-  253 (443)
Q Consensus       175 y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-  253 (443)
                      |+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||++||+.||.+|+ 
T Consensus       161 y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (328)
T cd05593         161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG  239 (328)
T ss_pred             ccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence            999999987666 489999999999999999999999888888888887788888889999999999999999999997 


Q ss_pred             ----CHHHHhcCccccc
Q 013421          254 ----RIEGIRKHPWFRK  266 (443)
Q Consensus       254 ----t~~eil~hp~f~~  266 (443)
                          ++.++++||||..
T Consensus       240 ~~~~~~~~il~h~~~~~  256 (328)
T cd05593         240 GGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CCCCCHHHHhcCCCcCC
Confidence                8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.9e-50  Score=402.17  Aligned_cols=257  Identities=33%  Similarity=0.595  Sum_probs=223.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765444445677889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-----
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-----  163 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-----  163 (443)
                      ||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||++.......     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999986532210     


Q ss_pred             ------------------------------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC
Q 013421          164 ------------------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET  213 (443)
Q Consensus       164 ------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  213 (443)
                                                    ....+.+||+.|+|||++.+.+++ .++|||||||++|+|++|..||.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                          012346899999999999887775 8999999999999999999999988


Q ss_pred             ChHHHHHHhhhc--cCCCCC--CCCHHHHHHHHHccCCCCC---CCCCHHHHhcCcccccc
Q 013421          214 DLPTLYKKINAA--EFSCPF--WFSTGATSLIHKILDPNPK---TRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       214 ~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~---~R~t~~eil~hp~f~~~  267 (443)
                      +....+.++...  ...+|+  .+++++++||.+|+. +|.   .||+++||++||||+..
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            887777777653  344454  379999999999875 444   46899999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.3e-50  Score=396.29  Aligned_cols=251  Identities=33%  Similarity=0.597  Sum_probs=227.3

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg   94 (443)
                      +.||+|+||.||++++..+|..||+|++.+...........+.+|+.+++.++||||+++++.+...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765444445667888999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcc
Q 013421           95 ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN  174 (443)
Q Consensus        95 ~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~  174 (443)
                      +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~  160 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence            99999988888999999999999999999999999999999999999999999999999998754333233445689999


Q ss_pred             cCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC-
Q 013421          175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-  253 (443)
Q Consensus       175 y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-  253 (443)
                      |+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||+.||.+|+ 
T Consensus       161 y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05595         161 YLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             cCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCC
Confidence            9999999877664 89999999999999999999999888888888887778888888999999999999999999998 


Q ss_pred             ----CHHHHhcCccccc
Q 013421          254 ----RIEGIRKHPWFRK  266 (443)
Q Consensus       254 ----t~~eil~hp~f~~  266 (443)
                          ++.++++||||..
T Consensus       240 ~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         240 GGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             CCCCCHHHHHcCCCcCC
Confidence                8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.4e-50  Score=395.09  Aligned_cols=256  Identities=31%  Similarity=0.592  Sum_probs=231.0

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP-NIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lv~   88 (443)
                      +|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.+++.++|+ +|+++++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999999876544444567788899999999764 6888999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++............
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT  160 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence            99999999999998889999999999999999999999999999999999999999999999999998654333334456


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCC
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (443)
                      .+||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+.......+......+|..+++++.++|.+||.+|
T Consensus       161 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  239 (324)
T cd05587         161 FCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH  239 (324)
T ss_pred             ecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            7899999999999877764 899999999999999999999999888888888888888888899999999999999999


Q ss_pred             CCCCCCH-----HHHhcCccccc
Q 013421          249 PKTRIRI-----EGIRKHPWFRK  266 (443)
Q Consensus       249 P~~R~t~-----~eil~hp~f~~  266 (443)
                      |.+|+++     +++++||||+.
T Consensus       240 P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         240 PAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             HHHcCCCCCCCHHHHhcCCCcCC
Confidence            9999986     89999999975

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.8e-50  Score=396.16  Aligned_cols=251  Identities=33%  Similarity=0.622  Sum_probs=227.1

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999876544444556778888888876 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            99999999888999999999999999999999999999999999999999999999999999875433333445678999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      .|+|||++.+..+. .++||||+||++|+|++|..||...+.......+.......|.++++++.+||++||+.||.+||
T Consensus       161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  239 (320)
T cd05590         161 DYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL  239 (320)
T ss_pred             cccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence            99999999876664 89999999999999999999999998888888888888888999999999999999999999999


Q ss_pred             CH------HHHhcCccccc
Q 013421          254 RI------EGIRKHPWFRK  266 (443)
Q Consensus       254 t~------~eil~hp~f~~  266 (443)
                      ++      +++++||||+.
T Consensus       240 ~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         240 GSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             CCCCCCCHHHHHcCCCcCC
Confidence            98      99999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.4e-50  Score=367.73  Aligned_cols=259  Identities=32%  Similarity=0.481  Sum_probs=225.8

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      .+|...+.||+|+||.||+|++..||+.||||.+...... +.......+||..|+.++|+||+.++++|...+.+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            5799999999999999999999999999999999876533 233456789999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           89 EFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      ||++. +|...|+... .++..++..|+.+++.||+|||++.|.||||||.|+|++.+|.+||+|||+++.+........
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            99954 8988887654 688999999999999999999999999999999999999999999999999999888766666


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc----------------------
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----------------------  225 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------------  225 (443)
                      ..+-|.+|+|||.+.+...++..+|+||.|||+.||+-|.+-|++.+.-+....|-..                      
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            6789999999999988777789999999999999999999999887765554444211                      


Q ss_pred             cCCCC------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          226 EFSCP------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       226 ~~~~~------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                      .++.|      +..++++.+|+.+||..||.+|+|+.|+++||||+....
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence            01111      125788999999999999999999999999999987443

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.1e-50  Score=394.71  Aligned_cols=251  Identities=33%  Similarity=0.627  Sum_probs=227.7

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..+++.+ +||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999876544444556677899998876 899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.............+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            99999999888999999999999999999999999999999999999999999999999999875443334445678999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      .|+|||++.+..+. .++||||+||++|+|++|+.||...+.......+.......|.++++++.++|.+||+.||++|+
T Consensus       161 ~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~  239 (321)
T cd05591         161 DYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL  239 (321)
T ss_pred             cccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence            99999999877664 89999999999999999999999999888888998888889999999999999999999999999


Q ss_pred             -------CHHHHhcCccccc
Q 013421          254 -------RIEGIRKHPWFRK  266 (443)
Q Consensus       254 -------t~~eil~hp~f~~  266 (443)
                             +++++++||||..
T Consensus       240 ~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         240 GCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             CCCCCCCCHHHHhcCCccCC
Confidence                   9999999999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-51  Score=402.94  Aligned_cols=257  Identities=25%  Similarity=0.475  Sum_probs=229.5

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      .....|.....||+|+.|.||.|....+++.||||.++......   .+.+.+|+.+|+..+|+|||++++.|...+.+|
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            34567999999999999999999999999999999999876443   467899999999999999999999999889999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      +||||++||+|.|.+.. ..++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|.........
T Consensus       347 VVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             EEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            99999999999888876 56999999999999999999999999999999999999999999999999999887665556


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHH-HHHHhhhc--cCCCCCCCCHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT-LYKKINAA--EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~--~~~~~~~~s~~~~~li~  242 (443)
                      ..+-+|||+|||||++....|. ++.||||||+++.||+-|++||-..+.-. ++.-..++  .+..|..+|+++++|+.
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG-~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~  504 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD  504 (550)
T ss_pred             cccccCCCCccchhhhhhcccC-ccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence            7788999999999999988885 99999999999999999999998655443 33333333  45667789999999999


Q ss_pred             HccCCCCCCCCCHHHHhcCcccccc
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +||+.||.+|+++.|+|+||||+..
T Consensus       505 ~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  505 RCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             HHhhcchhcCCCHHHHhcChhhhhc
Confidence            9999999999999999999999543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-50  Score=384.80  Aligned_cols=260  Identities=31%  Similarity=0.494  Sum_probs=225.8

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      .-.+.|++...||.|.-++||+|+...+++.||||+++.+.+...  .+.+.+|+..|+.++||||++++..|..+..+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            345689999999999999999999999999999999999887653  789999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc-c
Q 013421           86 IILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ-G  162 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~-~  162 (443)
                      +||.||.+|++++.+...  .+++|..+..++++++.||.|||++|-+|||||+.||||+.+|.+||+|||.+..... +
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999999999874  4699999999999999999999999999999999999999999999999998754322 2


Q ss_pred             cc--cc-cccCCCcccCCCccccc--CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC------
Q 013421          163 VE--LL-HTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF------  231 (443)
Q Consensus       163 ~~--~~-~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~------  231 (443)
                      .+  .. ++.+|||+|||||++..  .+|+ .|+||||||++..||.+|..||.......+.-.-.++.++.+.      
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK  259 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence            11  11 67799999999999543  3665 9999999999999999999999887665554433334443221      


Q ss_pred             ----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          232 ----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       232 ----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                          .++..++.+|..||+.||.+|||++++|+|+||+...
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence                2688899999999999999999999999999998643

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.5e-49  Score=392.48  Aligned_cols=254  Identities=32%  Similarity=0.560  Sum_probs=226.4

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEE
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM---KIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      |++.+.||+|+||.||+|.+..+++.||||++.+.........+.+.+|+.++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78999999999999999999999999999999876544444456777777765   456799999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |||++|++|...+.. +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS  159 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence            999999999888754 6799999999999999999999999999999999999999999999999999875433333345


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCC
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP  247 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~  247 (443)
                      ..+|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|..+++++.++|.+||+.
T Consensus       160 ~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~  238 (324)
T cd05589         160 TFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRR  238 (324)
T ss_pred             ccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhc
Confidence            6789999999999987666 489999999999999999999999988888888888888888888999999999999999


Q ss_pred             CCCCCC-----CHHHHhcCccccc
Q 013421          248 NPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       248 dP~~R~-----t~~eil~hp~f~~  266 (443)
                      ||.+||     ++.++++||||+.
T Consensus       239 dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         239 NPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             CHhHcCCCCCCCHHHHhhCCCcCC
Confidence            999999     7999999999975

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-49  Score=393.66  Aligned_cols=254  Identities=31%  Similarity=0.599  Sum_probs=225.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998765444445677889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   ....
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~  157 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANS  157 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCC
Confidence            9999999999999888999999999999999999999999999999999999999999999999999875533   3456


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--CCCCC------CCCHHHHHH
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF------WFSTGATSL  240 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~------~~s~~~~~l  240 (443)
                      .+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+....  ...|.      .+++++.+|
T Consensus       158 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l  236 (333)
T cd05600         158 VVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL  236 (333)
T ss_pred             cccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence            6799999999999877665 89999999999999999999999888777666554322  22222      358999999


Q ss_pred             HHHccCCCCCCCCCHHHHhcCccccc
Q 013421          241 IHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      |.+||..+|.+||+++++++||||..
T Consensus       237 i~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         237 ITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             HHHHhhChhhhcCCHHHHHhCcccCC
Confidence            99999999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-49  Score=399.36  Aligned_cols=257  Identities=34%  Similarity=0.634  Sum_probs=224.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      .+|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998765444445567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc----
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE----  164 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~----  164 (443)
                      ||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........    
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            9999999999999888999999999999999999999999999999999999999999999999999864321100    


Q ss_pred             ----------------------------------cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCC
Q 013421          165 ----------------------------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  210 (443)
Q Consensus       165 ----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf  210 (443)
                                                        .....+||+.|+|||++.+.++. .++|||||||++|+|++|..||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence                                              11235799999999999877765 8999999999999999999999


Q ss_pred             CCCChHHHHHHhhhcc--CCCCC--CCCHHHHHHHHHccCCCCCCCCC---HHHHhcCcccccc
Q 013421          211 GETDLPTLYKKINAAE--FSCPF--WFSTGATSLIHKILDPNPKTRIR---IEGIRKHPWFRKN  267 (443)
Q Consensus       211 ~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~f~~~  267 (443)
                      ...+.......+....  +..|.  .+++++.+||++||. +|.+|++   ++++++||||+..
T Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9888777666665432  33333  379999999999997 9999998   9999999999753

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-49  Score=391.59  Aligned_cols=251  Identities=30%  Similarity=0.606  Sum_probs=224.4

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||.||+|.+..+|+.||+|++.+.........+....|..++... +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4799999999999999999999999999875433333455677788888765 899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999875433334455678999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      .|+|||++.+..+. .++||||+||++|+|++|..||...+.......+.......|.+++.++.+||++||+.||++|+
T Consensus       161 ~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~  239 (316)
T cd05620         161 DYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL  239 (316)
T ss_pred             CccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence            99999999877765 89999999999999999999999888888888888888888899999999999999999999999


Q ss_pred             CH-HHHhcCccccc
Q 013421          254 RI-EGIRKHPWFRK  266 (443)
Q Consensus       254 t~-~eil~hp~f~~  266 (443)
                      ++ +++++||||+.
T Consensus       240 ~~~~~~~~h~~f~~  253 (316)
T cd05620         240 GVVGNIRGHPFFKT  253 (316)
T ss_pred             CChHHHHcCCCcCC
Confidence            98 58999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.6e-50  Score=395.19  Aligned_cols=252  Identities=35%  Similarity=0.593  Sum_probs=227.4

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg   94 (443)
                      +.||+|+||.||++.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765444445667788999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           95 ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        95 ~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      +|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++.............+||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            999999888899999999999999999999997 7999999999999999999999999999875433333345668999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      .|+|||++.+..+. .++||||+||++|+|++|..||...+.......+......+|..+++++.+||.+||+.||++|+
T Consensus       161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~  239 (325)
T cd05594         161 EYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL  239 (325)
T ss_pred             ccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhC
Confidence            99999999877664 89999999999999999999999888888888888888888888999999999999999999997


Q ss_pred             -----CHHHHhcCcccccc
Q 013421          254 -----RIEGIRKHPWFRKN  267 (443)
Q Consensus       254 -----t~~eil~hp~f~~~  267 (443)
                           ++.++++||||...
T Consensus       240 ~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         240 GGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             CCCCCCHHHHhcCCCcCCC
Confidence                 89999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.2e-49  Score=384.10  Aligned_cols=255  Identities=29%  Similarity=0.477  Sum_probs=221.2

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      .|++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++.+.+..+++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            48899999999999999999999999999999987654443344567899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        90 y~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |+++|+|.+.+...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVR  159 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Ceec
Confidence            99999998887653  36899999999999999999999999999999999999999999999999998765332 2234


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH----HHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP----TLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ..+||+.|+|||++.+..++ .++||||+||++|+|++|+.||...+..    .....+......++..+++++.+||++
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  238 (285)
T cd05631         160 GRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM  238 (285)
T ss_pred             CCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence            56799999999999877765 8999999999999999999999875432    233334445556677799999999999


Q ss_pred             ccCCCCCCCCC-----HHHHhcCccccc
Q 013421          244 ILDPNPKTRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       244 ~L~~dP~~R~t-----~~eil~hp~f~~  266 (443)
                      ||+.||.+||+     ++++++||||+.
T Consensus       239 ~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         239 LLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             HhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence            99999999997     899999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.5e-49  Score=384.30  Aligned_cols=255  Identities=26%  Similarity=0.442  Sum_probs=215.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      .+++|++.+.||+|+||.||+|.+..++..||+|++.......  ....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            4688999999999999999999999999999999997543221  23567789999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           87 ILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      ||||+++ +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT  159 (288)
T ss_pred             EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence            9999975 8999887654 5789999999999999999999999999999999999999999999999998765443334


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-------------------c
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------E  226 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~  226 (443)
                      .....|++.|+|||++.+....+.++||||+||++|+|++|++||.+.+..+....+...                   .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            456678999999999876544468999999999999999999999877654443322110                   0


Q ss_pred             CCCC-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          227 FSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       227 ~~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      ..+|           +.+++++++||++||+.||.+|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            0111           2368899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.3e-49  Score=391.02  Aligned_cols=256  Identities=30%  Similarity=0.574  Sum_probs=230.9

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      +|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+..|..++..+ +||+|+++++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            589999999999999999999999999999999876544444456677888888877 5899999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999998754333334456


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCC
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (443)
                      .+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+.......+......+|..+++++.+++.+||+.|
T Consensus       161 ~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~  239 (323)
T cd05616         161 FCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH  239 (323)
T ss_pred             CCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccC
Confidence            7899999999999887765 899999999999999999999999888888888888888888899999999999999999


Q ss_pred             CCCCCCH-----HHHhcCccccc
Q 013421          249 PKTRIRI-----EGIRKHPWFRK  266 (443)
Q Consensus       249 P~~R~t~-----~eil~hp~f~~  266 (443)
                      |.+|+++     .++++||||+.
T Consensus       240 p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         240 PGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             HHhcCCCCCCCHHHHhcCCCcCC
Confidence            9999984     89999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-51  Score=380.16  Aligned_cols=262  Identities=32%  Similarity=0.592  Sum_probs=247.0

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ....+++|+.++.||+|.||+|-+++.+.+++.+|||+++++.+...+.+..-..|-++|+..+||.+..+...|+.++.
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR  242 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence            34578899999999999999999999999999999999999988777777778889999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +|+||||+.||+|+-.+.+...++|+.++.|-..|++||.|||+++|++||||.+|+|+|.+|++||+|||++...-...
T Consensus       243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998655555


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ....+.||||.|.|||++....| +.++|+|.+||++|||++|++||...+...++..|...+..+|..+|++++.|+..
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsG  401 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSG  401 (516)
T ss_pred             ceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHH
Confidence            67889999999999999988777 49999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCC-----CHHHHhcCccccc
Q 013421          244 ILDPNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       244 ~L~~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      +|.+||.+|.     .+.||.+|+||..
T Consensus       402 LL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  402 LLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            9999999998     5789999999974

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.5e-49  Score=398.60  Aligned_cols=257  Identities=31%  Similarity=0.522  Sum_probs=221.8

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ..|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            36999999999999999999999999999999998766555556678999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc------
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG------  162 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~------  162 (443)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            99999999999998889999999999999999999999999999999999999999999999999987532100      


Q ss_pred             -----------------------------------------cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHH
Q 013421          163 -----------------------------------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF  201 (443)
Q Consensus       163 -----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~  201 (443)
                                                               .....+.+||+.|+|||++.+..+. .++||||+||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~  239 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILF  239 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHH
Confidence                                                     0011345799999999999877775 8999999999999


Q ss_pred             HHhhCCCCCCCCChHHHHHHhhh--ccCCCCC--CCCHHHHHHHHHcc--CCCCCCCCCHHHHhcCccccc
Q 013421          202 VLMAGYLPFGETDLPTLYKKINA--AEFSCPF--WFSTGATSLIHKIL--DPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       202 ~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~s~~~~~li~~~L--~~dP~~R~t~~eil~hp~f~~  266 (443)
                      +|++|..||...+......++..  .....|.  .+++++.+||.+|+  ..+|..|+++++++.||||+.
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE  310 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence            99999999988776655555432  2334444  47999999999965  455666999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.5e-49  Score=391.78  Aligned_cols=251  Identities=33%  Similarity=0.617  Sum_probs=221.7

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999999876554555567788999999998 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999875333233445678999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC---------hHHHHHHhhhccCCCCCCCCHHHHHHHHHc
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---------LPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (443)
                      .|+|||++.+..++ .++||||+||++|+|++|+.||+...         .....+.+.......|..+++++.++|++|
T Consensus       161 ~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~  239 (329)
T cd05588         161 NYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF  239 (329)
T ss_pred             cccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            99999999877765 89999999999999999999996321         123455566777788889999999999999


Q ss_pred             cCCCCCCCCC------HHHHhcCccccc
Q 013421          245 LDPNPKTRIR------IEGIRKHPWFRK  266 (443)
Q Consensus       245 L~~dP~~R~t------~~eil~hp~f~~  266 (443)
                      |+.||.+|+|      ++++++||||..
T Consensus       240 L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         240 LNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             hccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            9999999997      789999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.1e-49  Score=398.99  Aligned_cols=256  Identities=32%  Similarity=0.560  Sum_probs=222.1

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            36999999999999999999999999999999998765444455678899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc------
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG------  162 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~------  162 (443)
                      ||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999997532100      


Q ss_pred             -----------------------------------------cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHH
Q 013421          163 -----------------------------------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF  201 (443)
Q Consensus       163 -----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~  201 (443)
                                                               .....+.+||+.|+|||++.+.+|+ .++||||+||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~  239 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY  239 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence                                                     0011245799999999999887775 8999999999999


Q ss_pred             HHhhCCCCCCCCChHHHHHHhhhc--cCCCC--CCCCHHHHHHHHHccCCCCCCCCC---HHHHhcCccccc
Q 013421          202 VLMAGYLPFGETDLPTLYKKINAA--EFSCP--FWFSTGATSLIHKILDPNPKTRIR---IEGIRKHPWFRK  266 (443)
Q Consensus       202 ~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~f~~  266 (443)
                      +|++|.+||...+..+...++...  ....|  ..+++++.++|.+|+ .+|.+|++   ++++++||||+.
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  310 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT  310 (382)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence            999999999987766655555432  23333  358999999999987 59999997   999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-49  Score=396.30  Aligned_cols=256  Identities=34%  Similarity=0.644  Sum_probs=227.7

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999998765444445677899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-----
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-----  163 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-----  163 (443)
                      ||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999987654332     


Q ss_pred             ------------------------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHH
Q 013421          164 ------------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  219 (443)
Q Consensus       164 ------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  219 (443)
                                              .......||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                    223456799999999999887664 8999999999999999999999988877777


Q ss_pred             HHhhh--ccCCCCCC--CCHHHHHHHHHccCCCCCCCCC-HHHHhcCccccc
Q 013421          220 KKINA--AEFSCPFW--FSTGATSLIHKILDPNPKTRIR-IEGIRKHPWFRK  266 (443)
Q Consensus       220 ~~i~~--~~~~~~~~--~s~~~~~li~~~L~~dP~~R~t-~~eil~hp~f~~  266 (443)
                      .++..  .....|..  +++++.+||.+||. ||.+|++ ++++++||||+.
T Consensus       240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            76665  34444443  59999999999997 9999999 999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.3e-49  Score=388.76  Aligned_cols=251  Identities=33%  Similarity=0.637  Sum_probs=223.8

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++..+ +||||+++++++...+..|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999876544344455666777777654 899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999875544334455678999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      .|+|||++.+..+. .++||||+||++|+|++|..||.+.+.......+.......|.+++.++.+||.+||+.||.+||
T Consensus       161 ~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~  239 (316)
T cd05592         161 DYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRL  239 (316)
T ss_pred             cccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence            99999999877664 89999999999999999999999988888888888777888889999999999999999999999


Q ss_pred             CH-HHHhcCccccc
Q 013421          254 RI-EGIRKHPWFRK  266 (443)
Q Consensus       254 t~-~eil~hp~f~~  266 (443)
                      ++ .+++.||||..
T Consensus       240 ~~~~~l~~h~~~~~  253 (316)
T cd05592         240 GVDGDIRQHPFFRG  253 (316)
T ss_pred             CChHHHHcCcccCC
Confidence            86 58999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-49  Score=398.40  Aligned_cols=256  Identities=33%  Similarity=0.600  Sum_probs=221.7

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++++.||+|+||.||+|.+..+++.||||++.+......+..+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999997755444445677899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-----
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-----  163 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-----  163 (443)
                      ||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......     
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999986321100     


Q ss_pred             ------------------------------------------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHH
Q 013421          164 ------------------------------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF  201 (443)
Q Consensus       164 ------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~  201 (443)
                                                                ......+||+.|+|||++.+..+. .++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~  239 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF  239 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence                                                      000135799999999999877764 8999999999999


Q ss_pred             HHhhCCCCCCCCChHHHHHHhhhc--cCCCCC--CCCHHHHHHHHHccCCCCCCC---CCHHHHhcCccccc
Q 013421          202 VLMAGYLPFGETDLPTLYKKINAA--EFSCPF--WFSTGATSLIHKILDPNPKTR---IRIEGIRKHPWFRK  266 (443)
Q Consensus       202 ~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~~R---~t~~eil~hp~f~~  266 (443)
                      +|++|.+||...+....+..+...  ...+|.  .+++++.+||.+||. +|.+|   +|+.+++.||||+.
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            999999999887777766666542  334444  479999999999998 67765   59999999999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-50  Score=377.79  Aligned_cols=260  Identities=30%  Similarity=0.449  Sum_probs=221.6

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CCE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-----RTK   83 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~   83 (443)
                      .+|..++.||+|+||.|..|.++.+|+.||||.+.... ...-..+...+|+.+|+.++|+||+.+.+++..     -+.
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            35666799999999999999999999999999986433 344456788899999999999999999999854     467


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc--
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--  161 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~--  161 (443)
                      +|+|+|+| +.+|...|+.+..++++.++.++.||+.||+|+|+.||+||||||+|+|++.+..+||+|||+|+....  
T Consensus       101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            99999999 668999888877799999999999999999999999999999999999999999999999999987653  


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh-----------------
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-----------------  224 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-----------------  224 (443)
                      ....++.++.|.+|+|||++.+...++...||||+|||+.||++|++.|.+.+.....+.|..                 
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence            335567889999999999987666567999999999999999999999988775443333211                 


Q ss_pred             ------ccCCCC--------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          225 ------AEFSCP--------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       225 ------~~~~~~--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                            .....|        +..++.+.+|+.+||..||.+|+|++|+|+|||+..-..|
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence                  111111        2479999999999999999999999999999999876554

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.6e-49  Score=388.87  Aligned_cols=252  Identities=35%  Similarity=0.646  Sum_probs=225.2

Q ss_pred             eeeeeccCceEEEEEEEC---CCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           14 GRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      ++.||+|+||.||++.+.   .+++.||+|++.+..... ......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999864   478899999998654322 2234567899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccccc
Q 013421           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      |++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.............
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999987543333344567


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCC
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP  249 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP  249 (443)
                      +||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+..+....|..+++++.+||.+||+.||
T Consensus       161 ~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  239 (323)
T cd05584         161 CGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP  239 (323)
T ss_pred             CCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence            899999999999876664 8999999999999999999999998888888888888888899999999999999999999


Q ss_pred             CCCC-----CHHHHhcCccccc
Q 013421          250 KTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       250 ~~R~-----t~~eil~hp~f~~  266 (443)
                      ++||     ++++++.||||..
T Consensus       240 ~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         240 SSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             hHcCCCCCCCHHHHhcCCCcCC
Confidence            9999     8999999999975

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.8e-49  Score=389.40  Aligned_cols=251  Identities=35%  Similarity=0.596  Sum_probs=223.0

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-IMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||+||+|.+..+|+.||+|++.+...........+..|.. +++.++||||+++++.+.+.+..|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999999999999999998765433333445555655 56789999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.............+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP  160 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence            99999999888999999999999999999999999999999999999999999999999999875433333445668999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      .|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+.......++.+++++.++|++||+.||.+||
T Consensus       161 ~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~  239 (323)
T cd05575         161 EYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL  239 (323)
T ss_pred             hhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCC
Confidence            99999999877765 89999999999999999999999988888888888877778888999999999999999999999


Q ss_pred             CH----HHHhcCccccc
Q 013421          254 RI----EGIRKHPWFRK  266 (443)
Q Consensus       254 t~----~eil~hp~f~~  266 (443)
                      ++    .+++.||||..
T Consensus       240 ~~~~~~~~il~~~~~~~  256 (323)
T cd05575         240 GAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             CCCCCHHHHHcCCCcCC
Confidence            88    69999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6e-49  Score=384.21  Aligned_cols=258  Identities=27%  Similarity=0.451  Sum_probs=212.2

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.......  ....+.+|+.+++.++||||+++++++.+....|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            3478999999999999999999999999999999997643222  23456789999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           87 ILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      ||||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            999995 5787777654 57899999999999999999999999999999999999999999999999998754433334


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhhh--cc----------------
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINA--AE----------------  226 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~--~~----------------  226 (443)
                      ....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.... .....+..  +.                
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            456778999999999876554568999999999999999999999875332 22211110  00                


Q ss_pred             ---CC--CC---------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          227 ---FS--CP---------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       227 ---~~--~~---------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                         +.  .|         ..+++++.+||.+||+.||++|||+.|+++||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence               00  00         0145788999999999999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.4e-49  Score=387.46  Aligned_cols=256  Identities=30%  Similarity=0.575  Sum_probs=229.4

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      +|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+..|+.+++.+. |++|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4789999999999999999999999999999998765444444567788999998885 577889999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            99999999999998889999999999999999999999999999999999999999999999999998754333233456


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCC
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (443)
                      .+||+.|+|||++.+..++ .++||||+||++|+|++|..||...+.....+.+.......|..+++++.+++.+||+.|
T Consensus       161 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~  239 (323)
T cd05615         161 FCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH  239 (323)
T ss_pred             ccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccC
Confidence            6799999999999877664 899999999999999999999999888888888888888888899999999999999999


Q ss_pred             CCCCCC-----HHHHhcCccccc
Q 013421          249 PKTRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       249 P~~R~t-----~~eil~hp~f~~  266 (443)
                      |.+|++     .+++++||||+.
T Consensus       240 p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         240 PSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             HhhCCCCCCCCHHHHhcCcccCC
Confidence            999997     479999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.9e-49  Score=395.37  Aligned_cols=262  Identities=31%  Similarity=0.547  Sum_probs=227.6

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            34567899999999999999999999999999999999865444444456688999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (443)
                      |+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... 
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999998865 568999999999999999999999999999999999999999999999999987654321 


Q ss_pred             ccccccCCCcccCCCcccccCC---CCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--CCCCC--CCCHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF--WFSTG  236 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~  236 (443)
                      ......+||+.|+|||++.+..   +.+.++|||||||++|+|++|..||...+....+.++....  ..+|.  .+|.+
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ  277 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence            1234568999999999986542   34589999999999999999999999988877777776533  44454  47999


Q ss_pred             HHHHHHHccCCCCCC--CCCHHHHhcCcccccc
Q 013421          237 ATSLIHKILDPNPKT--RIRIEGIRKHPWFRKN  267 (443)
Q Consensus       237 ~~~li~~~L~~dP~~--R~t~~eil~hp~f~~~  267 (443)
                      +.+||++||+.+|.+  |+|++++++||||+..
T Consensus       278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            999999999999998  9999999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.8e-49  Score=387.09  Aligned_cols=252  Identities=31%  Similarity=0.595  Sum_probs=223.7

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||+||+|++..+++.||+|++.+..............|..+++.. +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876433333445667788888764 999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999875433333345668999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      .|+|||++.+..++ .++||||+||++|+|++|..||...+.......+.......|.+++.++.++|.+||+.||.+||
T Consensus       161 ~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~  239 (316)
T cd05619         161 DYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL  239 (316)
T ss_pred             cccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcC
Confidence            99999999877664 89999999999999999999999888888888887777778889999999999999999999999


Q ss_pred             CHH-HHhcCcccccc
Q 013421          254 RIE-GIRKHPWFRKN  267 (443)
Q Consensus       254 t~~-eil~hp~f~~~  267 (443)
                      ++. ++++||||+..
T Consensus       240 ~~~~~l~~h~~~~~~  254 (316)
T cd05619         240 GVKGDIRQHPFFREI  254 (316)
T ss_pred             CChHHHHcCcccCCC
Confidence            996 99999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.1e-49  Score=387.74  Aligned_cols=252  Identities=35%  Similarity=0.666  Sum_probs=227.3

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999876544444566778899999888 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.............+|++
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            99999999888999999999999999999999999999999999999999999999999999865333333344567999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      .|+|||++.+..+. .++||||+||++|+|++|..||...+.......+.......|..++.++.+||++||+.||.+||
T Consensus       161 ~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~  239 (318)
T cd05570         161 DYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL  239 (318)
T ss_pred             cccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcC
Confidence            99999999877765 89999999999999999999999888888888888888888888999999999999999999999


Q ss_pred             CH-----HHHhcCcccccc
Q 013421          254 RI-----EGIRKHPWFRKN  267 (443)
Q Consensus       254 t~-----~eil~hp~f~~~  267 (443)
                      |+     .+++.||||+..
T Consensus       240 s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         240 GCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CCCCCCHHHHhcCCCcCCC
Confidence            99     999999999763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.8e-49  Score=379.74  Aligned_cols=254  Identities=30%  Similarity=0.434  Sum_probs=213.8

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            4799999999999999999999999999999999765432 233567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-cccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-ELLH  167 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~~~~  167 (443)
                      ||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            999988776555555679999999999999999999999999999999999999999999999999987654321 2234


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-------------------cCC
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------EFS  228 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~~  228 (443)
                      ..+|++.|+|||++.+..++ .++||||+||++|+|++|++||...+.......+...                   ...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR  238 (287)
T ss_pred             ccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence            56799999999999877764 8999999999999999999999876543322221110                   000


Q ss_pred             C-------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          229 C-------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       229 ~-------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      .             ...+|+++.+||++||++||++|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            1             11268889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.7e-49  Score=397.53  Aligned_cols=256  Identities=30%  Similarity=0.541  Sum_probs=221.1

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997655433444567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc------
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG------  162 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~------  162 (443)
                      ||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...      
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999997532100      


Q ss_pred             -------------------------------------cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh
Q 013421          163 -------------------------------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA  205 (443)
Q Consensus       163 -------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~  205 (443)
                                                           .......+||+.|+|||++.+..+. .++|||||||++|+|++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~  239 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV  239 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence                                                 0011235799999999999887775 89999999999999999


Q ss_pred             CCCCCCCCChHHHHHHhhhc--cCCCCC--CCCHHHHHHHHHccCCCCCCCC---CHHHHhcCccccc
Q 013421          206 GYLPFGETDLPTLYKKINAA--EFSCPF--WFSTGATSLIHKILDPNPKTRI---RIEGIRKHPWFRK  266 (443)
Q Consensus       206 G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~f~~  266 (443)
                      |..||...+.......+...  ....|.  .+++++.++|.+|+ .+|.+|+   |++++++||||+.
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            99999988766655554432  223333  48999999999977 5999999   9999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.2e-49  Score=387.83  Aligned_cols=251  Identities=33%  Similarity=0.606  Sum_probs=220.8

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++.++ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876555555567788999998877 899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.............+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999875433333345678999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC---------ChHHHHHHhhhccCCCCCCCCHHHHHHHHHc
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---------DLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (443)
                      .|+|||++.+..+. .++|||||||++|+|++|..||...         ......+.+.......|..++..+.+||++|
T Consensus       161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~  239 (329)
T cd05618         161 NYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF  239 (329)
T ss_pred             cccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            99999999877664 8999999999999999999999521         1223445566677788888999999999999


Q ss_pred             cCCCCCCCCC------HHHHhcCccccc
Q 013421          245 LDPNPKTRIR------IEGIRKHPWFRK  266 (443)
Q Consensus       245 L~~dP~~R~t------~~eil~hp~f~~  266 (443)
                      |+.||.+|||      ++++++||||+.
T Consensus       240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         240 LNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             hcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            9999999998      589999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.4e-50  Score=372.30  Aligned_cols=265  Identities=32%  Similarity=0.431  Sum_probs=227.7

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eC
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA--SR   81 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~   81 (443)
                      +.+.++.|+.+.+|++|+||.||+|+++.|++.||+|.++.+. .....--.-.+||.+|.+++|||||.+-++..  +-
T Consensus        71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence            3467889999999999999999999999999999999998765 22233334579999999999999999999875  45


Q ss_pred             CEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      +.+|+|||||+. +|...+..-+ ++...+++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+.
T Consensus       150 d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  150 DKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             ceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            679999999966 8888887755 89999999999999999999999999999999999999999999999999999888


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------------  225 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------  225 (443)
                      .....++..+-|.+|+|||.+.+...++.+.|+||+|||+.||+++++.|.+.+......+|-..               
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            87677778888999999999988877779999999999999999999999998766655554210               


Q ss_pred             ----cCCCC------------CC-CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          226 ----EFSCP------------FW-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       226 ----~~~~~------------~~-~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                          ...++            .. +|....+|+..+|..||.+|.|++|.|+|+||.....|
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence                01111            11 46889999999999999999999999999999875443

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.3e-49  Score=393.68  Aligned_cols=256  Identities=34%  Similarity=0.628  Sum_probs=224.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998655444445677889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-----
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-----  163 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-----  163 (443)
                      ||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.......     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999986432110     


Q ss_pred             ------------------------------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC
Q 013421          164 ------------------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET  213 (443)
Q Consensus       164 ------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  213 (443)
                                                    ....+.+||+.|+|||++.+.+++ .++|||||||++|+|++|..||...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence                                          012245799999999999887775 8999999999999999999999988


Q ss_pred             ChHHHHHHhhhc--cCCCCC--CCCHHHHHHHHHccCCCCCCCC---CHHHHhcCccccc
Q 013421          214 DLPTLYKKINAA--EFSCPF--WFSTGATSLIHKILDPNPKTRI---RIEGIRKHPWFRK  266 (443)
Q Consensus       214 ~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~f~~  266 (443)
                      +....+.++...  ...+|.  .+++++++||.+|+. ||.+|+   +++++++||||+.
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence            877777776542  333444  379999999999875 999998   4899999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.8e-48  Score=385.87  Aligned_cols=257  Identities=33%  Similarity=0.629  Sum_probs=222.6

Q ss_pred             CeEEeeeeeccCceEEEEEEEC---CCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~   84 (443)
                      +|++++.||+|+||.||++++.   .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999864   47899999999765432 223456788999999999 599999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc-c
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-V  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~  163 (443)
                      |+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            999999999999999988888999999999999999999999999999999999999999999999999998764332 2


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC----ChHHHHHHhhhccCCCCCCCCHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET----DLPTLYKKINAAEFSCPFWFSTGATS  239 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~~~~  239 (443)
                      ......+||+.|+|||++.+....+.++|||||||++|+|++|..||...    ........+......+|..+++.+.+
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD  240 (332)
T ss_pred             CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            22345689999999999976654568999999999999999999999643    23344555666667777889999999


Q ss_pred             HHHHccCCCCCCCC-----CHHHHhcCccccc
Q 013421          240 LIHKILDPNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       240 li~~~L~~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      +|.+||+.||++||     +++++++||||+.
T Consensus       241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            99999999999999     8899999999975

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-48  Score=393.41  Aligned_cols=262  Identities=32%  Similarity=0.565  Sum_probs=225.7

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            34457899999999999999999999999999999999875444444456688999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc-c
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-V  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~  163 (443)
                      |+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            999999999999998865 46899999999999999999999999999999999999999999999999998765432 1


Q ss_pred             ccccccCCCcccCCCcccccCC---CCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cCCCCC--CCCHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPF--WFSTG  236 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~  236 (443)
                      ....+.+||+.|+|||++.+.+   +.+.++||||+||++|+|++|..||...+....+.++...  .+.+|.  .++..
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  277 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH  277 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence            2234678999999999987543   3458999999999999999999999988877777777553  344444  46999


Q ss_pred             HHHHHHHccCCCCCC--CCCHHHHhcCcccccc
Q 013421          237 ATSLIHKILDPNPKT--RIRIEGIRKHPWFRKN  267 (443)
Q Consensus       237 ~~~li~~~L~~dP~~--R~t~~eil~hp~f~~~  267 (443)
                      ++++|.+||..+|.+  |+|++++++||||+..
T Consensus       278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            999999999866654  8999999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.1e-48  Score=386.46  Aligned_cols=251  Identities=34%  Similarity=0.596  Sum_probs=222.5

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-IMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||+||+|.+..+|+.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999998764433334455566655 46789999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.............+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP  160 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence            99999999888999999999999999999999999999999999999999999999999999875433333445678999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      .|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.......++..+..+.++|++||..||.+||
T Consensus       161 ~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~  239 (325)
T cd05604         161 EYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRL  239 (325)
T ss_pred             hhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcC
Confidence            99999999887775 89999999999999999999999988888888888777777778999999999999999999999


Q ss_pred             CH----HHHhcCccccc
Q 013421          254 RI----EGIRKHPWFRK  266 (443)
Q Consensus       254 t~----~eil~hp~f~~  266 (443)
                      ++    .+++.||||..
T Consensus       240 ~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         240 GAKEDFLEIQEHPFFES  256 (325)
T ss_pred             CCCCCHHHHhcCCCcCC
Confidence            77    58999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-48  Score=387.04  Aligned_cols=257  Identities=32%  Similarity=0.568  Sum_probs=223.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++.+......+..+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765444445677899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-cc
Q 013421           89 EFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LL  166 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~~  166 (443)
                      ||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            999999999999876 6899999999999999999999999999999999999999999999999999876543222 23


Q ss_pred             cccCCCcccCCCccccc-----CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc----CCCCCCCCHHH
Q 013421          167 HTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE----FSCPFWFSTGA  237 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----~~~~~~~s~~~  237 (443)
                      ...+||+.|+|||++..     ....+.++|||||||++|+|++|..||...+....+.++....    ++....+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            34579999999999863     2233589999999999999999999999887777666664432    22334589999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      .+||++||. ||.+|||++++++||||..
T Consensus       241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         241 LDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             HHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            999999998 9999999999999999975

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-49  Score=388.21  Aligned_cols=250  Identities=33%  Similarity=0.594  Sum_probs=220.8

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      ||+|+||+||+|++..+++.||+|++.+..............|..++..+   +||||+++++++.+.+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999999875544433445556677777665   699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            99999999888999999999999999999999999999999999999999999999999999875444334455678999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC-CCCHHHHHHHHHccCCCCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF-WFSTGATSLIHKILDPNPKTR  252 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~-~~s~~~~~li~~~L~~dP~~R  252 (443)
                      .|+|||++.+....+.++|||||||++|+|++|..||...+..+.+..+..+....|. .+++++.+||++||+.||.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R  240 (330)
T cd05586         161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR  240 (330)
T ss_pred             cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence            9999999876554468999999999999999999999998888888888777776665 479999999999999999999


Q ss_pred             C----CHHHHhcCccccc
Q 013421          253 I----RIEGIRKHPWFRK  266 (443)
Q Consensus       253 ~----t~~eil~hp~f~~  266 (443)
                      |    +++++++||||..
T Consensus       241 ~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         241 LGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             CCCCCCHHHHhcCccccC
Confidence            8    7999999999975

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.3e-48  Score=383.42  Aligned_cols=251  Identities=35%  Similarity=0.609  Sum_probs=222.5

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-IMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||.||+|++..+++.||+|++.+...........+.+|+. +++.++||||+++++++.+.+..|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999998765433333445555654 67889999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      ++|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.............+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP  160 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999875433333445678999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      .|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.......|...+.++.++|.+||+.||.+|+
T Consensus       161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~  239 (321)
T cd05603         161 EYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL  239 (321)
T ss_pred             ccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcC
Confidence            99999999877765 89999999999999999999999988888888888888888888999999999999999999999


Q ss_pred             CH----HHHhcCccccc
Q 013421          254 RI----EGIRKHPWFRK  266 (443)
Q Consensus       254 t~----~eil~hp~f~~  266 (443)
                      ++    .++++||||..
T Consensus       240 ~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         240 GAKADFLEIKNHVFFSP  256 (321)
T ss_pred             CCCCCHHHHhCCCCcCC
Confidence            76    59999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.5e-48  Score=383.33  Aligned_cols=251  Identities=31%  Similarity=0.595  Sum_probs=221.6

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.++.++ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999886655555567788999999888 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999875333333445678999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC-------ChHHHHHHhhhccCCCCCCCCHHHHHHHHHccC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET-------DLPTLYKKINAAEFSCPFWFSTGATSLIHKILD  246 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~  246 (443)
                      .|+|||++.+..++ .++|||||||++|+|++|..||...       ......+.+.......|..++..+.++|.+||+
T Consensus       161 ~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~  239 (327)
T cd05617         161 NYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN  239 (327)
T ss_pred             ccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence            99999999877664 8999999999999999999999532       223445556666677888899999999999999


Q ss_pred             CCCCCCCC------HHHHhcCccccc
Q 013421          247 PNPKTRIR------IEGIRKHPWFRK  266 (443)
Q Consensus       247 ~dP~~R~t------~~eil~hp~f~~  266 (443)
                      .||.+|++      +++++.||||+.
T Consensus       240 ~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         240 KDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             cCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            99999998      579999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-48  Score=384.80  Aligned_cols=251  Identities=38%  Similarity=0.663  Sum_probs=224.3

Q ss_pred             eeeeeccCceEEEEEEE---CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013421           14 GRTIGEGTFAKVRFAQN---RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      ++.||+|+||.||++.+   ..+|+.||+|++.+..... .....+.+|+.++++++||||+++++++.+++..|+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            36899999999999976   3578999999998754322 2345677899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccC
Q 013421           91 VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC  170 (443)
Q Consensus        91 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~  170 (443)
                      +++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  159 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC  159 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence            99999999998888899999999999999999999999999999999999999999999999999876544333445678


Q ss_pred             CCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCC
Q 013421          171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK  250 (443)
Q Consensus       171 gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~  250 (443)
                      |++.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.......|..+++++.+||++||+.||.
T Consensus       160 g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~  238 (318)
T cd05582         160 GTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA  238 (318)
T ss_pred             CChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence            99999999999876664 89999999999999999999999888888888888888888888999999999999999999


Q ss_pred             CCCC-----HHHHhcCccccc
Q 013421          251 TRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       251 ~R~t-----~~eil~hp~f~~  266 (443)
                      +||+     +++++.||||+.
T Consensus       239 ~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         239 NRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             HcCCCCCCCHHHHhCCCCcCC
Confidence            9999     778999999975

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-48  Score=370.68  Aligned_cols=259  Identities=31%  Similarity=0.478  Sum_probs=223.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC----
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRT----   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~----   82 (443)
                      +..|+.+++||+|+||+||+|+++.+|+.||+|.+..+.-. +..-....+|+.+++.|+|+| |+.+++++.+.+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            55688889999999999999999999999999999876532 223455689999999999999 999999998877    


Q ss_pred             --EEEEEEecCCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           83 --KVYIILEFVTGGELFDKIVHQG----RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        83 --~~~lv~Ey~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                        .+|+|+||+ .-+|..++....    .++...++.+++||+.||+|||++||+||||||+|||++++|.+||+|||+|
T Consensus        89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              899999999 558999998755    5788899999999999999999999999999999999999999999999999


Q ss_pred             CCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-----------
Q 013421          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-----------  225 (443)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-----------  225 (443)
                      +....+.......++|.+|+|||++.+...++...||||+|||++||+++++.|++.+..+....|-..           
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            977766667788899999999999998877779999999999999999999999998776555444210           


Q ss_pred             -------cCCCCCC------------CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          226 -------EFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       226 -------~~~~~~~------------~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                             ...++.|            .+++..+++.+||+.+|.+|.|+..++.||||+...
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence                   1122222            245899999999999999999999999999998654

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.5e-48  Score=382.85  Aligned_cols=251  Identities=33%  Similarity=0.590  Sum_probs=220.9

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-IMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||.||+|++..+++.||+|++.+...........+..|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999999999999999998754433333344445544 56888999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  160 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP  160 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence            99999999888899999999999999999999999999999999999999999999999999875433333445678999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      .|+|||++.+..++ .++||||+||++|+|++|.+||...+....+..+.......++.+++.+.++|.+||+.||.+|+
T Consensus       161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~  239 (325)
T cd05602         161 EYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL  239 (325)
T ss_pred             cccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence            99999999877665 89999999999999999999999988888888887777777778999999999999999999999


Q ss_pred             CHH----HHhcCccccc
Q 013421          254 RIE----GIRKHPWFRK  266 (443)
Q Consensus       254 t~~----eil~hp~f~~  266 (443)
                      ++.    ++++|+||..
T Consensus       240 ~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         240 GAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             CCCCCHHHHhcCcccCC
Confidence            876    8999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.2e-48  Score=373.48  Aligned_cols=249  Identities=31%  Similarity=0.516  Sum_probs=215.6

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCCCh
Q 013421           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (443)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L   96 (443)
                      ||+|+||+||++.+..+++.||+|.+.+.........+.+..|+.+++.++||||+++++++...+..|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999999999999999999876544444456778899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCC
Q 013421           97 FDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT  172 (443)
Q Consensus        97 ~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt  172 (443)
                      .+.+..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..............||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            887743    3568999999999999999999999999999999999999999999999999987654433334456799


Q ss_pred             cccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh----HHHHHHhhhccCCCCCCCCHHHHHHHHHccCCC
Q 013421          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL----PTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (443)
Q Consensus       173 ~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (443)
                      +.|+|||++.+..++ .++||||+||++|+|++|+.||...+.    ......+.......|..+++++.+++.+||+.|
T Consensus       161 ~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  239 (280)
T cd05608         161 PGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD  239 (280)
T ss_pred             cCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCC
Confidence            999999999887765 899999999999999999999976542    233334444555667779999999999999999


Q ss_pred             CCCCC-----CHHHHhcCccccc
Q 013421          249 PKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       249 P~~R~-----t~~eil~hp~f~~  266 (443)
                      |++||     +++++++||||+.
T Consensus       240 P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         240 PEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             HHHhcCCCCCCHHHHhcChhhhc
Confidence            99999     8899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-50  Score=387.79  Aligned_cols=256  Identities=28%  Similarity=0.443  Sum_probs=228.8

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ..|+..+.||+|+||.||+|++..+++.||||+++.+....  .++.+.+|+.++..++++||.++|+.+..+..++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            35888899999999999999999999999999999886433  5788999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      |||.||++.+.++....+.|..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+...........+
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            99999999999999777799999999999999999999999999999999999999999999999999876654444589


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCCCCCHHHHHHHHHccCC
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDP  247 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~  247 (443)
                      .+|||.|||||++.+.+|+ .++||||||++.+||++|.+||.....+.....|.+..+ .....+|+.+++|+..||+.
T Consensus       171 fvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k  249 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDK  249 (467)
T ss_pred             ccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhc
Confidence            9999999999999988887 999999999999999999999988776443333333322 22335899999999999999


Q ss_pred             CCCCCCCHHHHhcCcccccc
Q 013421          248 NPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       248 dP~~R~t~~eil~hp~f~~~  267 (443)
                      ||+.||+|.++|+|+|++..
T Consensus       250 ~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  250 NPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             CcccCcCHHHHhhhHHHHhc
Confidence            99999999999999999873

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-49  Score=364.12  Aligned_cols=255  Identities=36%  Similarity=0.657  Sum_probs=223.9

Q ss_pred             ccccccCeEEe-eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-
Q 013421            4 QTRRVAKYEVG-RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS-   80 (443)
Q Consensus         4 ~~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-   80 (443)
                      +....++|.+. +.||-|-.|+|..+.++.||+.+|+|++...        ...++|++++-+. .|||||.++++|++ 
T Consensus        56 ~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs  127 (400)
T KOG0604|consen   56 EYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENS  127 (400)
T ss_pred             cccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence            34567788886 5799999999999999999999999987532        3456889887666 69999999999853 


Q ss_pred             ---CCEEEEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC---CCCeEEee
Q 013421           81 ---RTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSD  152 (443)
Q Consensus        81 ---~~~~~lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~---~~~~kL~D  152 (443)
                         ...+.+|||.++||+||+.|+.++.  ++|.++..+++||..|+.|||+.+|+||||||||+|...   |..+||+|
T Consensus       128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence               4678899999999999999998765  999999999999999999999999999999999999975   45799999


Q ss_pred             ecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC----hHHHHHHhhhccCC
Q 013421          153 FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFS  228 (443)
Q Consensus       153 FGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~  228 (443)
                      ||+++..... ..+.+.|-||+|+|||++....|+ ..+|+||+|||+|.||+|++||....    ...+..+|..+.+.
T Consensus       208 fGFAK~t~~~-~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~  285 (400)
T KOG0604|consen  208 FGFAKETQEP-GDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE  285 (400)
T ss_pred             cccccccCCC-ccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence            9999876543 567899999999999999888876 89999999999999999999997644    35678889988877


Q ss_pred             CC--CC--CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          229 CP--FW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       229 ~~--~~--~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      +|  .|  +|..++++|+++|..+|.+|.|+++++.|||+....
T Consensus       286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            66  45  899999999999999999999999999999997654

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.9e-48  Score=386.60  Aligned_cols=261  Identities=32%  Similarity=0.560  Sum_probs=224.5

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+.+..|
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            34578999999999999999999999999999999997654444444566889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc-cc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-VE  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~~  164 (443)
                      +||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++...... ..
T Consensus       120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            99999999999998865 56899999999999999999999999999999999999999999999999998765432 12


Q ss_pred             cccccCCCcccCCCcccccCC---CCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--CCCC--CCCCHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCP--FWFSTGA  237 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~~  237 (443)
                      ...+.+||+.|+|||++.+..   +.+.++|||||||++|+|++|..||...+....+.++....  ..+|  ..++.++
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  278 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence            234678999999999987543   34589999999999999999999999988877777776532  3344  3589999


Q ss_pred             HHHHHHccCCCCCC--CCCHHHHhcCcccccc
Q 013421          238 TSLIHKILDPNPKT--RIRIEGIRKHPWFRKN  267 (443)
Q Consensus       238 ~~li~~~L~~dP~~--R~t~~eil~hp~f~~~  267 (443)
                      .++|.+||..+|.+  |+++++|++||||+..
T Consensus       279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            99999999855543  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.2e-47  Score=376.17  Aligned_cols=255  Identities=25%  Similarity=0.405  Sum_probs=219.1

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|+||.||++++..++..+|+|++....  .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999997643  233457799999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....  ...
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~  159 (331)
T cd06649          82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMA  159 (331)
T ss_pred             eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc--ccc
Confidence            99999999999999888899999999999999999999986 699999999999999999999999999875533  233


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh----------------------
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA----------------------  224 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~----------------------  224 (443)
                      ...+|++.|+|||++.+..+. .++||||+||++|+|++|+.||...+..++...+..                      
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            456799999999999876664 899999999999999999999977654433221110                      


Q ss_pred             ------------------------c-cCCCC-CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          225 ------------------------A-EFSCP-FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       225 ------------------------~-~~~~~-~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                              . ....+ ..+++++.+||.+||+.||++|||+++|++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                    0 01111 1368899999999999999999999999999999754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-47  Score=377.66  Aligned_cols=257  Identities=26%  Similarity=0.438  Sum_probs=210.1

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----TKV   84 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~   84 (443)
                      +|++.+.||+|+||.||+|++..+|+.||||.+..... .......+.+|+.+++.++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            69999999999999999999999999999999875332 222345688999999999999999999987543     358


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc--
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--  162 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--  162 (443)
                      |+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999994 689999988888999999999999999999999999999999999999999999999999998754321  


Q ss_pred             -cccccccCCCcccCCCcccccC-CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHh---------------hh-
Q 013421          163 -VELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI---------------NA-  224 (443)
Q Consensus       163 -~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i---------------~~-  224 (443)
                       .......+||+.|+|||++.+. ...+.++|||||||++|+|++|++||.+.+.......+               .. 
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence             1123456799999999998652 23358999999999999999999999876543221111               00 


Q ss_pred             ----------ccCCC-----CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          225 ----------AEFSC-----PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       225 ----------~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                                ...+.     -+.+++++.++|.+||+.||++|||++++++||||+.-.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence                      00000     023678899999999999999999999999999997543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-47  Score=369.21  Aligned_cols=255  Identities=29%  Similarity=0.486  Sum_probs=220.1

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      .|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.+++..|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48999999999999999999999999999999976554433334567889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        90 y~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++...... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~  159 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIR  159 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Cccc
Confidence            99999999888654  46899999999999999999999999999999999999999999999999998765432 2234


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHH----HHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL----YKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ..+|++.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....    ...+.......+..+++.+.+||.+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (285)
T cd05605         160 GRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ  238 (285)
T ss_pred             cccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence            56799999999999776654 889999999999999999999987654332    2334444455666789999999999


Q ss_pred             ccCCCCCCCC-----CHHHHhcCccccc
Q 013421          244 ILDPNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       244 ~L~~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      ||+.||.+||     +++++++||||..
T Consensus       239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         239 LLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            9999999999     8999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-47  Score=376.89  Aligned_cols=258  Identities=29%  Similarity=0.548  Sum_probs=219.7

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++++.||+|+||.||++.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998654444444567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-cc
Q 013421           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LL  166 (443)
Q Consensus        89 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~~  166 (443)
                      ||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999999976 45799999999999999999999999999999999999999999999999999865433211 22


Q ss_pred             cccCCCcccCCCccccc----CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--CCCC---CCCCHHH
Q 013421          167 HTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCP---FWFSTGA  237 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~~  237 (443)
                      ...+||+.|+|||++..    ....+.++||||+||++|+|++|+.||...+..+.+..+....  +..|   ..+|+++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            33579999999999863    2334589999999999999999999999887777766664432  3333   2479999


Q ss_pred             HHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 013421          238 TSLIHKILDPNPKT--RIRIEGIRKHPWFRK  266 (443)
Q Consensus       238 ~~li~~~L~~dP~~--R~t~~eil~hp~f~~  266 (443)
                      +++|++||..++.+  |++++++++||||..
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             HHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            99999999764443  889999999999965

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-48  Score=384.96  Aligned_cols=259  Identities=27%  Similarity=0.474  Sum_probs=240.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK-VY   85 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~   85 (443)
                      .+++|+.++.+|+|+||.+++++++..+..+++|.+......... .+...+|+.++++++|||||.+.+.|..++. ++
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            467899999999999999999999999999999999987765543 4578899999999999999999999988887 99


Q ss_pred             EEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           86 IILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |+|+||+||++.+.|....  -++|+.++.|+.|++.||.|||++.|.|||||+.||+++.++.+||+|||+|+......
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999999997654  58999999999999999999999999999999999999999999999999999988876


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIH  242 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~  242 (443)
                      ....+.+|||.|++||++.+.+|. .++|||||||++|||++-+++|.+.+...+..+|.... .+.|..+|.+++.+|+
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~  239 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVK  239 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence            688899999999999999999986 99999999999999999999999999999999998877 6778889999999999


Q ss_pred             HccCCCCCCCCCHHHHhcCcccccc
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .||..+|..||++.++|.+|..+..
T Consensus       240 ~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  240 SMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHhhcCCccCCCHHHHhhChhhhhH
Confidence            9999999999999999999987643

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.9e-47  Score=371.16  Aligned_cols=260  Identities=27%  Similarity=0.430  Sum_probs=216.8

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..+++|++.+.||+|+||.||+|.+..+++.||+|.+.......  ....+.+|+.+++.++||||+++++++.+++..|
T Consensus         3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (309)
T cd07872           3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT   80 (309)
T ss_pred             CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence            45688999999999999999999999999999999997654222  2345678999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           86 IILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      +||||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            99999975 7888876644 578999999999999999999999999999999999999999999999999876544333


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-------------------
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------  225 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------  225 (443)
                      ......+++.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+...                   
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            3445678999999999876554568999999999999999999999876654332222110                   


Q ss_pred             cCCC-----------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          226 EFSC-----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       226 ~~~~-----------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ....           .+.+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            0111           123688999999999999999999999999999998643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-49  Score=413.67  Aligned_cols=260  Identities=33%  Similarity=0.565  Sum_probs=236.8

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|++++.||+|+||.|.+++++.|++.||+|++++-...+......|..|-.+|..-+.+-|++++-.|.++.++|+
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence            45689999999999999999999999999999999988655544456789999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc-cccc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ-GVEL  165 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~-~~~~  165 (443)
                      ||||++||+|...+.+.++++|+.+++|+..|+.||.-+|+.|+|||||||+|||||..|++||+|||.|-.... +.-.
T Consensus       153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE
Confidence            999999999999999988999999999999999999999999999999999999999999999999998876653 4445


Q ss_pred             ccccCCCcccCCCccccc----CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cCCCC--CCCCHHH
Q 013421          166 LHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCP--FWFSTGA  237 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~  237 (443)
                      ....+|||.|++||++..    .+.+|..+|+||+||++|||+.|..||...+..+.|.+|...  .+.+|  ..+|+++
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeea  312 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEA  312 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHH
Confidence            678899999999999853    256689999999999999999999999999999999999876  67778  5589999


Q ss_pred             HHHHHHccCCCCCCCCC---HHHHhcCcccccc
Q 013421          238 TSLIHKILDPNPKTRIR---IEGIRKHPWFRKN  267 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t---~~eil~hp~f~~~  267 (443)
                      ++||++++. +|..|..   +++|..||||.+.
T Consensus       313 kdLI~~ll~-~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  313 KDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             HHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence            999999886 6888988   9999999999763

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-47  Score=376.94  Aligned_cols=248  Identities=27%  Similarity=0.443  Sum_probs=216.8

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcE-EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGES-VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-KVYI   86 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~-vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~l   86 (443)
                      .+..+.+.||+|+||+||+|.++  |.. ||+|++......... .+.+.+|+.+|.+++|||||++++++.+.. .+++
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            34566677999999999999986  555 999999877655444 788999999999999999999999999887 7999


Q ss_pred             EEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CEeecCCCCcEEEcCCC-CeEEeeecCcCCCccc
Q 013421           87 ILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKG-VYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQG  162 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~yLH~~g-i~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~  162 (443)
                      ||||+++|+|.+++..  ...++...+..++.||+.|++|||+++ |+||||||+|||++.++ ++||+|||+++.....
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999999987  578999999999999999999999999 99999999999999998 9999999999876543


Q ss_pred             cccccccCCCcccCCCcccc--cCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHh--hhccCCCCCCCCHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFWFSTGAT  238 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~s~~~~  238 (443)
                      ........||+.|||||++.  ...|+ .++|||||||+||||+||..||.+....+....+  ...++.+|..+++.+.
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~  276 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLS  276 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence            23344478999999999998  44665 9999999999999999999999987765544443  3445667777999999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhc
Q 013421          239 SLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .|+.+||..||.+||++.+|+.
T Consensus       277 ~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  277 SLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHhCCCCCCcCCCHHHHHH
Confidence            9999999999999999999876

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.3e-47  Score=379.36  Aligned_cols=257  Identities=30%  Similarity=0.479  Sum_probs=216.3

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..+++|++++.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.++|+||+++++++...+.+|
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            34678999999999999999999999999999999996543  2334567899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      +||||+++++|.+.    ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus       149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            99999999998643    34577888999999999999999999999999999999999999999999998766543333


Q ss_pred             ccccCCCcccCCCccccc----CCCCCCccchHHHHHHHHHHhhCCCCCCCCChH---HHHHHh-hhccCCCCCCCCHHH
Q 013421          166 LHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---TLYKKI-NAAEFSCPFWFSTGA  237 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i-~~~~~~~~~~~s~~~  237 (443)
                      ....+||..|+|||++..    ..+.+.++|||||||++|+|++|+.||......   .....+ .......+..++.++
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  304 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF  304 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence            456689999999999743    244557899999999999999999999743322   222222 222334556689999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .+||.+||+.||++|||+.|+++||||.+..
T Consensus       305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            9999999999999999999999999998754

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=9.7e-47  Score=373.71  Aligned_cols=258  Identities=28%  Similarity=0.533  Sum_probs=220.5

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||.||++++..+++.+|+|++.+...........+.+|+.++..++|+||+++++.+.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999997654444444566889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc-cccc
Q 013421           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-VELL  166 (443)
Q Consensus        89 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~~~~  166 (443)
                      ||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999999977 467899999999999999999999999999999999999999999999999998654322 1223


Q ss_pred             cccCCCcccCCCccccc----CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--CCCCC---CCCHHH
Q 013421          167 HTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF---WFSTGA  237 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~~  237 (443)
                      ...+||+.|+|||++..    ....+.++|||||||++|+|++|+.||...+..+.+.++....  ...|.   .+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            34679999999999862    2334589999999999999999999999888777777775543  23332   479999


Q ss_pred             HHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 013421          238 TSLIHKILDPNPKT--RIRIEGIRKHPWFRK  266 (443)
Q Consensus       238 ~~li~~~L~~dP~~--R~t~~eil~hp~f~~  266 (443)
                      .+||++||..+|.+  |++++++++||||+.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             HHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            99999999765544  789999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.2e-46  Score=363.69  Aligned_cols=254  Identities=36%  Similarity=0.716  Sum_probs=231.1

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+....|++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998765544455678899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++......   ...
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~  157 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYT  157 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCC
Confidence            99999999999998889999999999999999999999999999999999999999999999999998765443   345


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCC
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (443)
                      .+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+..+....|..+++.+.++|.+||..|
T Consensus       158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  236 (290)
T cd05580         158 LCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD  236 (290)
T ss_pred             CCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCC
Confidence            578999999999877655 4889999999999999999999988887777777777778888889999999999999999


Q ss_pred             CCCCC-----CHHHHhcCccccc
Q 013421          249 PKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       249 P~~R~-----t~~eil~hp~f~~  266 (443)
                      |.+|+     +++++++||||+.
T Consensus       237 p~~R~~~~~~~~~~l~~~~~~~~  259 (290)
T cd05580         237 LTKRLGNLKNGVNDIKNHPWFAG  259 (290)
T ss_pred             HHHccCcccCCHHHHHcCccccc
Confidence            99999     9999999999964

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-46  Score=380.51  Aligned_cols=251  Identities=23%  Similarity=0.328  Sum_probs=208.6

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|++++.||+|+||.||+|.+..+++.||+|....         ..+.+|+.+++.++||||+++++++..+...++
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            44689999999999999999999999999999996432         346789999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc-cccc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ-GVEL  165 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~-~~~~  165 (443)
                      ++|++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus       161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            999994 78999998888899999999999999999999999999999999999999999999999999865432 2223


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC-------hHHHHHHh----------------
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-------LPTLYKKI----------------  222 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-------~~~~~~~i----------------  222 (443)
                      ....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+       .......+                
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             cccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            345689999999999987766 489999999999999999998874321       00111100                


Q ss_pred             ----------hhcc----CCCCC-----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          223 ----------NAAE----FSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       223 ----------~~~~----~~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                                ....    ...|.     .++.++.+||.+||+.||.+|||++|+++||||+...
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                      0000    01111     2467899999999999999999999999999998644

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.4e-47  Score=389.30  Aligned_cols=251  Identities=28%  Similarity=0.378  Sum_probs=205.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR------   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------   81 (443)
                      ..+|++++.||+|+||.||+|.+..+++.||||.+....       ....+|+.+|+.++||||+++++++...      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            357999999999999999999999999999999886532       2234799999999999999999887432      


Q ss_pred             --CEEEEEEecCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC-CeEEeeec
Q 013421           82 --TKVYIILEFVTGGELFDKIV----HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFG  154 (443)
Q Consensus        82 --~~~~lv~Ey~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~-~~kL~DFG  154 (443)
                        ..+++||||+++ +|.+++.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence              257799999975 6766664    346789999999999999999999999999999999999999665 79999999


Q ss_pred             CcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---------
Q 013421          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------  225 (443)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------  225 (443)
                      ++...... ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+......++...         
T Consensus       217 la~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        217 SAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             cchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            99865443 22345678999999999876544468999999999999999999999887654433332110         


Q ss_pred             --------cC------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          226 --------EF------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       226 --------~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                              ..            .+|...|+++.+||.+||+.||.+|||+.|+++||||+.-
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence                    01            1233468899999999999999999999999999999754

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-46  Score=379.15  Aligned_cols=256  Identities=25%  Similarity=0.424  Sum_probs=215.6

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-----KV   84 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~   84 (443)
                      +|++++.||+|+||.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++...+     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            4789999999999999999999999999999986532 22234567889999999999999999999998776     89


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc-c
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-V  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~  163 (443)
                      |+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            99999996 689898888888999999999999999999999999999999999999999999999999998765432 1


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh-------------------
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-------------------  224 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------------  224 (443)
                      .......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..                   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence            2234457899999999998765556899999999999999999999987765443333211                   


Q ss_pred             ----ccC---------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          225 ----AEF---------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       225 ----~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                          ...         ......++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                011         1223358899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.7e-46  Score=371.84  Aligned_cols=258  Identities=29%  Similarity=0.515  Sum_probs=220.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998654333444566889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-cc
Q 013421           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LL  166 (443)
Q Consensus        89 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~~  166 (443)
                      ||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99999999999987 46789999999999999999999999999999999999999999999999999875543211 22


Q ss_pred             cccCCCcccCCCcccccC----CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--CCCCC---CCCHHH
Q 013421          167 HTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF---WFSTGA  237 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~~  237 (443)
                      ...+||+.|+|||++.+.    +..+.++||||+||++|+|++|+.||...+..+.+.++....  ++.|.   .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            346799999999998642    223589999999999999999999999887777777665432  33343   368999


Q ss_pred             HHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 013421          238 TSLIHKILDPNPKT--RIRIEGIRKHPWFRK  266 (443)
Q Consensus       238 ~~li~~~L~~dP~~--R~t~~eil~hp~f~~  266 (443)
                      .++|.+||..++.+  |++++++++||||+.
T Consensus       241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             HHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            99999999876654  579999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.7e-46  Score=362.58  Aligned_cols=252  Identities=30%  Similarity=0.419  Sum_probs=207.1

Q ss_pred             cCeEEeeeeeccCceEEEEEEECC-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceEEEEEE-----
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRE-TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVRLHEVLA-----   79 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-----   79 (443)
                      .+|++.+.||+|+||.||+|++.. ++..||+|.+....... .....+.+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999864 57889999987654322 2234456777777766   6999999999875     


Q ss_pred             eCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421           80 SRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus        80 ~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      ....++++|||++ ++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            3456999999996 5898888653  458999999999999999999999999999999999999999999999999987


Q ss_pred             CCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-CC--------
Q 013421          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FS--------  228 (443)
Q Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~--------  228 (443)
                      ..... .......||+.|+|||++.+..+. .++||||+||++|+|++|.+||.+.+..+...++.... .+        
T Consensus       159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         159 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eccCC-cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            65433 334456799999999999776664 89999999999999999999998877655554443210 00        


Q ss_pred             ------------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          229 ------------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       229 ------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                        ..+.+++.+.+||.+||+.||++|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.1e-46  Score=373.13  Aligned_cols=259  Identities=29%  Similarity=0.470  Sum_probs=211.7

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR----   81 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----   81 (443)
                      ..+++|++.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++...    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            457899999999999999999999999999999999976532 233456778999999999999999999998644    


Q ss_pred             --CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           82 --TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        82 --~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                        ...|+||||+++ +|.+.+.  ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence              357999999965 5666653  45889999999999999999999999999999999999999999999999998754


Q ss_pred             ccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhh----------------
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN----------------  223 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~----------------  223 (443)
                      ... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+.                
T Consensus       174 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         174 CTN-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             ccC-ccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            332 233456789999999999887775 89999999999999999999998765432221110                


Q ss_pred             ------hccCC---------CC-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          224 ------AAEFS---------CP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       224 ------~~~~~---------~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                            .....         ++           ...++++.+||.+||+.||++|||+.|+++||||+..+.+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  324 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP  324 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence                  00000         01           1146789999999999999999999999999999865543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.5e-47  Score=359.06  Aligned_cols=253  Identities=37%  Similarity=0.640  Sum_probs=215.3

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      |++++.||+|+||+||++.+..+++.||+|++......... .....+|+.++++++||||+++++++.+....+++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999887543332 33445699999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccC
Q 013421           91 VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC  170 (443)
Q Consensus        91 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~  170 (443)
                      +++++|.+++...+.+++..+..++.||+.||.+||++||+||||||+||+++.++.++|+|||.+.............+
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999888999999999999999999999999999999999999999999999999999875433334556778


Q ss_pred             CCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH---HHHHHhhhccCCCCC----CCCHHHHHHHHH
Q 013421          171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---TLYKKINAAEFSCPF----WFSTGATSLIHK  243 (443)
Q Consensus       171 gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i~~~~~~~~~----~~s~~~~~li~~  243 (443)
                      +++.|+|||++......+.++||||||+++|+|++|..||...+..   ....+........+.    ..++.+.++|.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK  239 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence            9999999999873344469999999999999999999999987332   222222222211111    124899999999


Q ss_pred             ccCCCCCCCCCHHHHhcCccc
Q 013421          244 ILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f  264 (443)
                      ||+.||++|||+.++++||||
T Consensus       240 ~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  240 MLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HSSSSGGGSTTHHHHHTSGGG
T ss_pred             HccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.3e-46  Score=369.35  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=217.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|+||.||+|.+..++..+|+|++....  .....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            468999999999999999999999999999999987643  233456789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++.....  ...
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~  159 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMA  159 (333)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh--hcc
Confidence            99999999999999888899999999999999999999985 799999999999999999999999999875433  223


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHh------------------------
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------------------------  222 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i------------------------  222 (443)
                      ...+|++.|+|||++.+..+ +.++||||+||++|+|++|..||...........+                        
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             ccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            45679999999999987665 48999999999999999999999765433221110                        


Q ss_pred             --------------------hh-ccCCCC-CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          223 --------------------NA-AEFSCP-FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       223 --------------------~~-~~~~~~-~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                                          .. .....+ ..++.++.+||.+||+.||++|||++|++.||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                                00 001111 13678899999999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-46  Score=353.64  Aligned_cols=255  Identities=29%  Similarity=0.500  Sum_probs=220.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK--HRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      +.|++.+.||+|++|.||.|.+..+++.||+|.+.......  ......+.+|+.++++++||||+++++++.+....|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46999999999999999999999999999999987643222  2234678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc--
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--  164 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--  164 (443)
                      ++||++|++|.+.+...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........  
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999875433211  


Q ss_pred             -cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh--ccCCCCCCCCHHHHHHH
Q 013421          165 -LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPFWFSTGATSLI  241 (443)
Q Consensus       165 -~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~li  241 (443)
                       ......|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||...+......++..  .....|..++..+.++|
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence             1134568899999999987665 4899999999999999999999987665544444332  23456667899999999


Q ss_pred             HHccCCCCCCCCCHHHHhcCccc
Q 013421          242 HKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      .+||..+|.+|||+.++++||||
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         241 RRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5e-46  Score=363.07  Aligned_cols=259  Identities=25%  Similarity=0.435  Sum_probs=217.2

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..+++|++.+.||+|+||.||+|.+..+++.||+|.+.......  ....+.+|+.+++.++||||+++++++.+.+..|
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~   80 (301)
T cd07873           3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   80 (301)
T ss_pred             ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence            46789999999999999999999999999999999987544222  2345678999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           86 IILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      +||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            9999997 5888888654 4689999999999999999999999999999999999999999999999999876544333


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-------------------
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------  225 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------  225 (443)
                      ......+++.|+|||++.+....+.++|||||||++|+|++|++||...+.......+...                   
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            3445567899999999876555568999999999999999999999887654443322110                   


Q ss_pred             cCCCC-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          226 EFSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       226 ~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ....|           ..+++.+.+||.+||+.||.+|||++|+++||||+.-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            01111           2468899999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.2e-47  Score=360.71  Aligned_cols=252  Identities=33%  Similarity=0.506  Sum_probs=211.6

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----TKV   84 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~   84 (443)
                      .|+-.+.+|.|+||.||.|...++++.||||.+-.+.-..       .+|+.+|+.++|||||++.-+|...     -..
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            5888999999999999999999999999999886654332       2799999999999999998887532     145


Q ss_pred             EEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC-CCeEEeeecCcCCC
Q 013421           85 YIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALP  159 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~-~~~kL~DFGls~~~  159 (443)
                      .+||||++. +|.+.+..    +.+++...++-|..||+.||.|||+.||+||||||.|+|+|.+ |.+||||||.|+..
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            689999964 88888874    5789999999999999999999999999999999999999965 99999999999887


Q ss_pred             ccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhh------------hc--
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN------------AA--  225 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~------------~~--  225 (443)
                      ..+.. ..++..|..|+|||.+.+...++.+.||||+|||+.||+-|++.|.+.+.......|.            ..  
T Consensus       177 ~~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  177 VKGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             ccCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence            66533 4677789999999999988777899999999999999999999999877544433221            00  


Q ss_pred             ---cCCCC------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          226 ---EFSCP------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       226 ---~~~~~------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                         +..+|            ...++++.+|+.++|..+|.+|.++.|++.||||..-..+
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence               11111            2268999999999999999999999999999999765443

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.8e-46  Score=360.19  Aligned_cols=255  Identities=29%  Similarity=0.492  Sum_probs=217.1

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.+.........+.+.+|+.+++.++|+||+.+++.+.+.+..|++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            47889999999999999999999999999999987654444445667889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           90 FVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        90 y~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |++|++|.+++...+  .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... ....
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~  159 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIK  159 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-cccc
Confidence            999999999886543  5899999999999999999999999999999999999999999999999998654332 2223


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH----HHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP----TLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ...|++.|+|||++.+..+. .++||||+||++|+|++|..||......    .............+..+++++.+|+.+
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (285)
T cd05630         160 GRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM  238 (285)
T ss_pred             CCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHH
Confidence            45799999999999876664 8999999999999999999999864322    111111222334556689999999999


Q ss_pred             ccCCCCCCCCC-----HHHHhcCccccc
Q 013421          244 ILDPNPKTRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       244 ~L~~dP~~R~t-----~~eil~hp~f~~  266 (443)
                      ||+.||.+|||     ++|+++||||+.
T Consensus       239 ~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         239 LLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             HhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            99999999999     899999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.4e-46  Score=386.76  Aligned_cols=259  Identities=29%  Similarity=0.464  Sum_probs=224.6

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----   82 (443)
                      .-++|++.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..++|+||+++++.+...+    
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            346899999999999999999999999999999999876543 334567889999999999999999988775322    


Q ss_pred             ----EEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeec
Q 013421           83 ----KVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG  154 (443)
Q Consensus        83 ----~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFG  154 (443)
                          .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence                478999999999999988653    468999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCccc--cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCC
Q 013421          155 LSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPF  231 (443)
Q Consensus       155 ls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~  231 (443)
                      ++......  .....+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+......++..+.. +.|.
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  267 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP  267 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence            98765431  2234567899999999999877765 899999999999999999999998887777776655443 4677


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .+++++.+++.+||+.||.+||++.++++|||++..
T Consensus       268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            799999999999999999999999999999998753

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.9e-45  Score=349.71  Aligned_cols=253  Identities=28%  Similarity=0.531  Sum_probs=219.7

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-RTKVYIIL   88 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~   88 (443)
                      +|++.+.||+|++|.||++.+..+++.||+|.+....... ...+.+.+|+.+++.++|||++++++.+.. +...|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            5999999999999999999999999999999997654332 235678899999999999999999998764 45789999


Q ss_pred             ecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           89 EFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      ||+++++|.+++...  ..+++.+++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..........
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            999999999999763  458999999999999999999999999999999999999999999999999987664433444


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCCCCCHHHHHHHHHcc
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L  245 (443)
                      ....|++.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+..+.. ..+..+++++.+++.+||
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  238 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATML  238 (257)
T ss_pred             ccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHh
Confidence            566789999999999876664 889999999999999999999988776666555544433 455668999999999999


Q ss_pred             CCCCCCCCCHHHHhcCccc
Q 013421          246 DPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f  264 (443)
                      ++||.+|||+.++++||||
T Consensus       239 ~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         239 SKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ccCcccCCCHHHHhcCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-45  Score=383.38  Aligned_cols=255  Identities=26%  Similarity=0.454  Sum_probs=222.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCC-CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ...|.+.+.||+|+||.||+|.+..+ ++.||+|.+...   .......+.+|+.+++.++||||+++++++...+..|+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            34599999999999999999998877 788999977543   23344667889999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           87 ILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      ||||++||+|.+++..    ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999999987753    346899999999999999999999999999999999999999999999999999765432


Q ss_pred             c--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCCCCCHHHHH
Q 013421          163 V--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATS  239 (443)
Q Consensus       163 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~  239 (443)
                      .  ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+..+.. +.|..+++++.+
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  301 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA  301 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence            1  234566899999999999876664 899999999999999999999998887777777665544 355678999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      +|.+||..||++||++++++.|||++.
T Consensus       302 li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        302 LLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            999999999999999999999999864

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.8e-46  Score=358.13  Aligned_cols=248  Identities=29%  Similarity=0.474  Sum_probs=208.9

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCCCh
Q 013421           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (443)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L   96 (443)
                      ||+|+||.||++++..+|+.||+|.+.............+..|+.+++.++||||+++++++.++...|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999999999999999999765443333345566799999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcc
Q 013421           97 FDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN  174 (443)
Q Consensus        97 ~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~  174 (443)
                      .+.+....  .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... .......|++.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~  159 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRAGTNG  159 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccCCCCC
Confidence            98886543  5788899999999999999999999999999999999999999999999998765432 22345679999


Q ss_pred             cCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh----HHHHHHhhhccCCCC-CCCCHHHHHHHHHccCCCC
Q 013421          175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL----PTLYKKINAAEFSCP-FWFSTGATSLIHKILDPNP  249 (443)
Q Consensus       175 y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~-~~~s~~~~~li~~~L~~dP  249 (443)
                      |+|||++.+..+ +.++||||+||++|+|++|..||.....    ..............+ ..+++++.+||.+||+.||
T Consensus       160 y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P  238 (277)
T cd05607         160 YMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKP  238 (277)
T ss_pred             ccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCH
Confidence            999999987775 4899999999999999999999976432    233333333333322 3579999999999999999


Q ss_pred             CCCCCH----HHHhcCccccc
Q 013421          250 KTRIRI----EGIRKHPWFRK  266 (443)
Q Consensus       250 ~~R~t~----~eil~hp~f~~  266 (443)
                      .+||++    ++++.||||+.
T Consensus       239 ~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         239 EDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             hhCCCCccchhhhhcChhhcC
Confidence            999999    77889999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=365.11  Aligned_cols=260  Identities=32%  Similarity=0.590  Sum_probs=241.6

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~   84 (443)
                      .+..+|.++..||+|+||+|.+|..+.+.+.+|||+++++.+...+.++--..|-++|... +-|.+++++..|++-+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            4567899999999999999999999999999999999998876665566666788888877 578899999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+||||+.||+|-..|++-+++.|..|..|+..|+-||-+||++||++||||.+|||+|.+|++||+|||++..--.+..
T Consensus       426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999986555556


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHc
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (443)
                      ...+.||||.|+|||++.-++| +..+|+||+||+|||||+|++||++.+..++++.|.....++|..+|.++.++++..
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~  584 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGL  584 (683)
T ss_pred             ceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHH
Confidence            7789999999999999988887 499999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCH-----HHHhcCccccc
Q 013421          245 LDPNPKTRIRI-----EGIRKHPWFRK  266 (443)
Q Consensus       245 L~~dP~~R~t~-----~eil~hp~f~~  266 (443)
                      |.+.|.+|..+     .+|..||||+.
T Consensus       585 ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  585 LTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             hhcCCccccCCCCccccchhhCcchhh
Confidence            99999999865     68999999974

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8e-46  Score=358.64  Aligned_cols=251  Identities=31%  Similarity=0.437  Sum_probs=205.4

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----C
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVRLHEVLAS-----R   81 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~   81 (443)
                      +|++.+.||+|+||.||+|+++.+++.||+|.+....... .....+.+|+.+++.+   +||||+++++++.+     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            5999999999999999999999999999999987643222 1223455677777665   79999999998854     3


Q ss_pred             CEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      ...+++|||+++ +|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            568999999974 888888764  35899999999999999999999999999999999999999999999999998765


Q ss_pred             ccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--------------
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--------------  225 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------  225 (443)
                      ... .......||+.|+|||++.+..+ +.++||||+||++|+|++|.+||...+......++...              
T Consensus       159 ~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         159 SCQ-MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             cCc-ccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            432 22345578999999999987666 48999999999999999999999876655444333210              


Q ss_pred             ----cC---------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          226 ----EF---------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       226 ----~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                          .+         ...+.++..+.++|.+||++||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                00         0112367888999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.6e-46  Score=371.12  Aligned_cols=258  Identities=29%  Similarity=0.448  Sum_probs=212.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----   81 (443)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            46899999999999999999999999999999999976432 223356678999999999999999999987543     


Q ss_pred             -CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        82 -~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                       ...|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence             468999999965 67777653  58889999999999999999999999999999999999999999999999997654


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------------  225 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------  225 (443)
                      .. .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+......++...               
T Consensus       178 ~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         178 TS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             CC-CcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            32 233456799999999999887765 8999999999999999999999887655444333210               


Q ss_pred             -------cCC--------------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          226 -------EFS--------------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       226 -------~~~--------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                             ...                    .....+.++++||.+||+.||.+|||++++++||||...+.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  327 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP  327 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence                   000                    001135678999999999999999999999999999865443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1e-45  Score=369.58  Aligned_cols=259  Identities=28%  Similarity=0.455  Sum_probs=212.0

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR----   81 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----   81 (443)
                      ..+++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            457899999999999999999999999999999999976542 233456778999999999999999999988543    


Q ss_pred             --CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           82 --TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        82 --~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                        ...|++|||+++ +|.+.+..  .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence              357999999965 57666643  5889999999999999999999999999999999999999999999999999765


Q ss_pred             ccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh---------------
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA---------------  224 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---------------  224 (443)
                      ... ......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+..               
T Consensus       170 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         170 GTS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             CCc-cccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            432 233456799999999999887765 899999999999999999999987664333221110               


Q ss_pred             -------cc-----C---------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          225 -------AE-----F---------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       225 -------~~-----~---------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                             ..     .               ..+...+.++.+||.+||+.||++|||++|+++||||+..+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence                   00     0               0111235678999999999999999999999999999865543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-47  Score=352.40  Aligned_cols=254  Identities=30%  Similarity=0.590  Sum_probs=222.5

Q ss_pred             eEE-eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 013421           11 YEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus        11 y~i-~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      |.+ .+.||+|+|+.|--+++..+|..||||++++..   ......+.+|++++..+ .|+||++++++|++++.+|+||
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf  155 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF  155 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence            444 367999999999999999999999999999874   23457899999999999 5999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC---CeEEeeecCcCCCcc----
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQ----  161 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~~~~----  161 (443)
                      |.+.||.|...|..+..++|.++.++.++|+.||.|||.+||+||||||+|||.....   -+|||||.+..-...    
T Consensus       156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            9999999999999999999999999999999999999999999999999999997554   589999998653221    


Q ss_pred             ---ccccccccCCCcccCCCcccc----cCCCCCCccchHHHHHHHHHHhhCCCCCCCCC---------------hHHHH
Q 013421          162 ---GVELLHTTCGTPNYVAPEVLS----NRGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLY  219 (443)
Q Consensus       162 ---~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---------------~~~~~  219 (443)
                         ....+.+.||+..|||||+.-    ...+++.++|.||||||||-||+|++||.+.-               ...++
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence               234567889999999999862    23455699999999999999999999995421               23567


Q ss_pred             HHhhhccCCCCC--C--CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          220 KKINAAEFSCPF--W--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       220 ~~i~~~~~~~~~--~--~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ..|..+.+.+|.  |  +|.++++||..+|..|+.+|.++.++++|||++..
T Consensus       316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence            789999999986  3  89999999999999999999999999999999864

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.3e-45  Score=355.87  Aligned_cols=256  Identities=29%  Similarity=0.493  Sum_probs=220.3

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+.+++..|++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            47889999999999999999999999999999987654444445667889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        90 y~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |+++++|.+.+...  .++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIR  159 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cccc
Confidence            99999999888653  36899999999999999999999999999999999999999999999999988654332 2234


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHH----HHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL----YKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ...|++.|+|||++.+..+. .++|+||+||++|+|++|..||........    ...+......++..+++++.+|+.+
T Consensus       160 ~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM  238 (285)
T ss_pred             CCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence            56799999999999776664 899999999999999999999987654332    2233444445566789999999999


Q ss_pred             ccCCCCCCCCC-----HHHHhcCcccccc
Q 013421          244 ILDPNPKTRIR-----IEGIRKHPWFRKN  267 (443)
Q Consensus       244 ~L~~dP~~R~t-----~~eil~hp~f~~~  267 (443)
                      ||+.||.+||+     +++++.||||+..
T Consensus       239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         239 LLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            99999999999     8899999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.8e-46  Score=369.02  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=211.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----   81 (443)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.+++.++||||+++++++...     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            457899999999999999999999999999999998764322 22345677899999999999999999887533     


Q ss_pred             -CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        82 -~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                       ...|+++|++ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence             4579999998 778877765 4679999999999999999999999999999999999999999999999999987553


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------  226 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------------  226 (443)
                      .   .....+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+....              
T Consensus       170 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         170 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             C---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence            3   23456799999999999775555689999999999999999999998766543333221100              


Q ss_pred             ---------CCCC--------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          227 ---------FSCP--------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       227 ---------~~~~--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                               ...+        ...++.+.+||.+||+.||.+|||+.+++.||||.....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence                     0001        125677899999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.9e-45  Score=381.08  Aligned_cols=253  Identities=24%  Similarity=0.380  Sum_probs=204.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC------CCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH------PNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~   81 (443)
                      .++|++++.||+|+||+||+|.+..+++.||||++....    ........|+.+++.++|      ++++++++++...
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            368999999999999999999999999999999996432    123445667777776654      4588899988754


Q ss_pred             -CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCC-------------
Q 013421           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYG-------------  146 (443)
Q Consensus        82 -~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~-------------  146 (443)
                       ..+|+|||++ |++|.+++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++             
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence             5789999998 78999999888899999999999999999999998 5999999999999998765             


Q ss_pred             ---CeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhh
Q 013421          147 ---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  223 (443)
Q Consensus       147 ---~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  223 (443)
                         .+||+|||++.....   .....+||+.|+|||++.+..|. .++|||||||++|+|++|++||++.+..+....+.
T Consensus       283 ~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        283 DPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             CCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence               499999998764322   23467899999999999887775 89999999999999999999998766543322221


Q ss_pred             hccCCC------------------------C------------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          224 AAEFSC------------------------P------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       224 ~~~~~~------------------------~------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ......                        +                  ..-++.+.+||.+||+.||.+|||++|+|+|
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence            100000                        0                  0014567899999999999999999999999


Q ss_pred             ccccccCC
Q 013421          262 PWFRKNYN  269 (443)
Q Consensus       262 p~f~~~~~  269 (443)
                      |||++.+.
T Consensus       439 p~~~~~~~  446 (467)
T PTZ00284        439 PYVLKYYP  446 (467)
T ss_pred             ccccccCC
Confidence            99987553

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.9e-45  Score=345.87  Aligned_cols=253  Identities=28%  Similarity=0.494  Sum_probs=223.0

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++++.+.+..|++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            589999999999999999999999999999999765433 3345778899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        90 y~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |++|++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            99999999999774  5788999999999999999999999999999999999999999999999999876554433344


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC-CCCCCCHHHHHHHHHccC
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKILD  246 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~  246 (443)
                      ..+|++.|+|||++.+..++ .++|+|||||++++|++|..||...+......++..+..+ .+..++.++.++|.+||+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT  238 (256)
T ss_pred             ccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence            56789999999999877664 8999999999999999999999988876666666555433 344688999999999999


Q ss_pred             CCCCCCCCHHHHhcCccc
Q 013421          247 PNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       247 ~dP~~R~t~~eil~hp~f  264 (443)
                      .+|++||++.++++|||+
T Consensus       239 ~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         239 KDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CCcccCcCHHHHhhCCCC
Confidence            999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.8e-45  Score=354.04  Aligned_cols=253  Identities=31%  Similarity=0.459  Sum_probs=210.4

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||+|++|.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            589999999999999999999999999999998764322 2234668899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           90 FVTGGELFDKIVHQ---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        90 y~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |++ ++|.+++...   ..+++..++.++.||+.||.|||++|++||||||+||+++.+|.+||+|||++..........
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            997 5888887643   468999999999999999999999999999999999999999999999999987654433334


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh------------------ccC-
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA------------------AEF-  227 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------~~~-  227 (443)
                      ....+++.|+|||++.+....+.++|||||||++|+|++|++||.+.+.......+..                  ... 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            4556889999999987655445899999999999999999999987554322111100                  000 


Q ss_pred             ----------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          228 ----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       228 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                .....+++++.++|++||+.||.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                      0112378999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.7e-45  Score=356.64  Aligned_cols=254  Identities=27%  Similarity=0.440  Sum_probs=216.3

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....  ......++.+|+.++++++||||+++++.+.+++..|++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            47999999999999999999999999999999987543  2334567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.....  ....
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~  156 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMAN  156 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc--cccc
Confidence            999999999999988889999999999999999999997 5999999999999999999999999998865432  2234


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc----------------------
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----------------------  225 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------------  225 (443)
                      ..+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+...                      
T Consensus       157 ~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         157 SFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             cCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            5679999999999876655 48999999999999999999999765543332222111                      


Q ss_pred             ---------------cCCCCC-CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          226 ---------------EFSCPF-WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       226 ---------------~~~~~~-~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                     ....|. .+++++.+|+.+||..||++|||+.++++||||...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                           011111 267889999999999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-47  Score=365.06  Aligned_cols=261  Identities=31%  Similarity=0.504  Sum_probs=236.0

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ++.....|+.-+.||+|+||.|+-++-+.||+.+|+|.+++..+....-.....+|-.+|.+++.+.||.+-..|++.+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            45667789999999999999999999999999999999998877666555667899999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           84 VYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      +++||..|+||+|.-+|.+.+  .++|..+++|+.+|+.||++||+++|++|||||+|||||+.|+++|+|+|||.....
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999999998877  899999999999999999999999999999999999999999999999999987765


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC----hHHHHHHhhhccCCCCCCCCHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFSCPFWFSTGA  237 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~  237 (443)
                      + ......+||.+|||||++.+..|+ ...|+|||||++|+|+.|+.||....    ..++-+.+......+|..+|+++
T Consensus       340 g-~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea  417 (591)
T KOG0986|consen  340 G-KPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA  417 (591)
T ss_pred             C-CccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence            4 444566999999999999998875 99999999999999999999996533    34556667777778889999999


Q ss_pred             HHHHHHccCCCCCCCC-----CHHHHhcCccccc
Q 013421          238 TSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      +++.+.+|..||++|.     +++++.+||||+.
T Consensus       418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             HHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            9999999999999998     5679999999986

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.9e-45  Score=347.62  Aligned_cols=254  Identities=28%  Similarity=0.498  Sum_probs=219.2

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccc------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK------HRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      +|.+.+.||+|++|.||+|.+..+++.+|+|.+.......      ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            5889999999999999999999899999999987654322      2234678899999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      .+++|||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999987654211


Q ss_pred             ------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-cCCCCCCCCHH
Q 013421          164 ------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-EFSCPFWFSTG  236 (443)
Q Consensus       164 ------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~  236 (443)
                            .......|++.|+|||.+.+..+. .++|+||+||++|+|++|+.||...+.......+... ....|..++..
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE  239 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence                  111234688999999999876664 8899999999999999999999876654444443332 34556668999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      +.++|++||++||.+||++.++++||||
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         240 AIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-45  Score=357.36  Aligned_cols=258  Identities=31%  Similarity=0.536  Sum_probs=225.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+.+.........+.+.+|+.+++.++||||+++++.+.+....|++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999998776554445677899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc--
Q 013421           89 EFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--  164 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--  164 (443)
                      ||+.|++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998754  5689999999999999999999999999999999999999999999999998764322110  


Q ss_pred             ---------------------------cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHH
Q 013421          165 ---------------------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  217 (443)
Q Consensus       165 ---------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  217 (443)
                                                 ......|+..|+|||++.+..+ +.++||||||+++|+|++|..||.+.+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                       1123468899999999987665 489999999999999999999998887777


Q ss_pred             HHHHhhhccCCCCCC--CCHHHHHHHHHccCCCCCCCCC----HHHHhcCcccccc
Q 013421          218 LYKKINAAEFSCPFW--FSTGATSLIHKILDPNPKTRIR----IEGIRKHPWFRKN  267 (443)
Q Consensus       218 ~~~~i~~~~~~~~~~--~s~~~~~li~~~L~~dP~~R~t----~~eil~hp~f~~~  267 (443)
                      .+..+.......+..  ++..+.++|.+||..||++|||    +++++.||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            666666555555544  6999999999999999999999    9999999999763

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-45  Score=356.69  Aligned_cols=253  Identities=33%  Similarity=0.491  Sum_probs=210.1

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||+|+||.||+|++..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+.+..|+++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            599999999999999999999999999999999764322 2233567789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           90 FVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        90 y~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      |++ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++............
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            996 478887765 467899999999999999999999999999999999999999999999999998765443333445


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCC-CCCChHHHHHHhhhc----------------c---C-
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA----------------E---F-  227 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~----------------~---~-  227 (443)
                      ..+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+.......+...                .   + 
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            668899999999876555568999999999999999988885 444433333322110                0   0 


Q ss_pred             ---------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          228 ---------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       228 ---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                               ...+.+++++.+||.+||+.||.+|||+++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                     0112368899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-45  Score=353.26  Aligned_cols=257  Identities=32%  Similarity=0.471  Sum_probs=221.5

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||.|+||.||++.+..++..+|+|++...   .....+.+.+|+.+++.++||||+++++++.++...|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            45799999999999999999999889999999998654   233456788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR  160 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence            9999999999998764 468999999999999999999999999999999999999999999999999886554433333


Q ss_pred             cccCCCcccCCCcccccC----CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc---CCCCCCCCHHHHH
Q 013421          167 HTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATS  239 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~  239 (443)
                      ....|++.|+|||++...    ...+.++|+||+||++|+|++|.+||...+......++....   +..|..++.++.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND  240 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence            455789999999997532    222468999999999999999999998877666555555443   2345568999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +|.+||+.+|.+||+++++++||||...
T Consensus       241 li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         241 FLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHhccChhhCcCHHHHhcChhhccc
Confidence            9999999999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.6e-45  Score=349.36  Aligned_cols=253  Identities=31%  Similarity=0.587  Sum_probs=224.9

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+.+....|+++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999999999999999987665554567889999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccccc
Q 013421           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      |++|++|.+++....++++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ......
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~  159 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTST  159 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC-cccccc
Confidence            9999999999988778999999999999999999999999999999999999999999999999998765443 233456


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh---HHHHHHhhhccCCCCCCCCHHHHHHHHHccC
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---PTLYKKINAAEFSCPFWFSTGATSLIHKILD  246 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~  246 (443)
                      .|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.   ..............|..++..+.++|.+||.
T Consensus       160 ~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (258)
T cd05578         160 SGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLE  238 (258)
T ss_pred             CCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHcc
Confidence            68899999999977665 4899999999999999999999987663   3333333335566777789999999999999


Q ss_pred             CCCCCCCCH--HHHhcCccc
Q 013421          247 PNPKTRIRI--EGIRKHPWF  264 (443)
Q Consensus       247 ~dP~~R~t~--~eil~hp~f  264 (443)
                      .||.+||++  .|+++||||
T Consensus       239 ~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         239 RDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             CChhHcCCccHHHHhcCCCC
Confidence            999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=8.4e-45  Score=350.71  Aligned_cols=255  Identities=30%  Similarity=0.454  Sum_probs=214.1

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++......|++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            4799999999999999999999999999999998754322 122356789999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||++++.|..++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++............
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            99999888888777778999999999999999999999999999999999999999999999999998766543333345


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---------------c----CCC
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------------E----FSC  229 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------~----~~~  229 (443)
                      ..++..|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...               .    ...
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            568899999999876554458999999999999999999999876543322221110               0    000


Q ss_pred             C------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          230 P------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       230 ~------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      |            ..++..+.+||.+||++||++|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0            1357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.5e-45  Score=350.26  Aligned_cols=252  Identities=31%  Similarity=0.470  Sum_probs=213.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++.+...+..|++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            458999999999999999999999999999999987543   22345678899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999865543323334


Q ss_pred             ccCCCcccCCCcccc---cCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC-----CCCCHHHHH
Q 013421          168 TTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP-----FWFSTGATS  239 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~~~~  239 (443)
                      ...|++.|+|||++.   ...+ +.++|+||+||++|+|++|..||...................+     ..++..+.+
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH  243 (267)
T ss_pred             cccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence            567999999999974   2234 4899999999999999999999976543333222222222221     236788999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCcc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPW  263 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~  263 (443)
                      +|.+||..||++|||++++++|||
T Consensus       244 li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         244 FVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.6e-45  Score=359.46  Aligned_cols=245  Identities=27%  Similarity=0.438  Sum_probs=194.4

Q ss_pred             eeeeeccCceEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 013421           14 GRTIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RTKVYIILE   89 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~E   89 (443)
                      +++||+|+||.||+|++.  .++..||+|.+.....     ...+.+|+.+++.++||||+++++++.+  +..+|++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            478999999999999976  3678999999865432     2346789999999999999999999853  567899999


Q ss_pred             cCCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE----cCCCCeEEeeecCc
Q 013421           90 FVTGGELFDKIVHQ---------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLS  156 (443)
Q Consensus        90 y~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl----~~~~~~kL~DFGls  156 (443)
                      |+. ++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            995 5888877532         258999999999999999999999999999999999999    45678999999999


Q ss_pred             CCCcccc---ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH---------HHHHHhhh
Q 013421          157 ALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---------TLYKKINA  224 (443)
Q Consensus       157 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------~~~~~i~~  224 (443)
                      .......   ......+||+.|+|||++.+....+.++||||+||++|+|++|++||...+..         .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            7654321   22345678999999999977555568999999999999999999999653311         11111100


Q ss_pred             ----------------------------ccCCC----------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          225 ----------------------------AEFSC----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       225 ----------------------------~~~~~----------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                                  .....          ....+.++.+||++||+.||.+|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                        00000          01135678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.5e-45  Score=348.90  Aligned_cols=253  Identities=29%  Similarity=0.417  Sum_probs=213.5

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....   .....+.+|+.+++.++||||+++++++..++..|+|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            4579999999999999999999999999999999975432   2345688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++...........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            99999999999998888899999999999999999999999999999999999999999999999999876543322234


Q ss_pred             ccCCCcccCCCcccccC--CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC-----CCCCHHHHHH
Q 013421          168 TTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP-----FWFSTGATSL  240 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~~~~l  240 (443)
                      ...|++.|+|||.+...  ...+.++|+||+||++|+|++|..||...+.......+....+..+     ..++..+.+|
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF  244 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence            55789999999988432  2224789999999999999999999976543333222222222222     2368899999


Q ss_pred             HHHccCCCCCCCCCHHHHhcCcc
Q 013421          241 IHKILDPNPKTRIRIEGIRKHPW  263 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~  263 (443)
                      |++||..||.+|||+++|++|+|
T Consensus       245 i~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         245 VKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHhhCChhhCcCHHHHhcCCC
Confidence            99999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-47  Score=376.82  Aligned_cols=255  Identities=30%  Similarity=0.467  Sum_probs=227.7

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      +.|+|+..||.|+||+||+|.+++++-.-|.|+|...   ..+..+.+.-||.||..++||+||++++.|...+.+||+.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            4588999999999999999999999988899999754   3556788999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           89 EFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |||.||-....+..- ..+++.+++.+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.+...........
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD  188 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD  188 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence            999999887777654 5789999999999999999999999999999999999999999999999999875544334456


Q ss_pred             ccCCCcccCCCccccc-----CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC---CCCCCCHHHHH
Q 013421          168 TTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS---CPFWFSTGATS  239 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~  239 (443)
                      +..|||+|||||++.+     .+|+ +++||||||++|.+|..+.+|....+.....-+|.+.+++   .|..-|..+.|
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D  267 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD  267 (1187)
T ss_pred             cccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence            7899999999999754     4666 8999999999999999999999999999888888776654   45556889999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      |+.+||..||..||++++|++||||++.
T Consensus       268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  268 FLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            9999999999999999999999999853

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.5e-44  Score=351.07  Aligned_cols=261  Identities=30%  Similarity=0.450  Sum_probs=220.1

Q ss_pred             cccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      +.-..-+.|++++.||.|+||.||+|.+..++..+|+|.+...   .....+.+.+|+.+++.++||||+++++.+..+.
T Consensus         6 ~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (292)
T cd06644           6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG   82 (292)
T ss_pred             cccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence            3344456799999999999999999999999999999998754   2334677889999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..|+||||+++++|...+.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999999999887755 45789999999999999999999999999999999999999999999999998865433


Q ss_pred             ccccccccCCCcccCCCcccccC----CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc---CCCCCCCC
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFS  234 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s  234 (443)
                      .........|++.|+|||++.+.    ...+.++|||||||++|+|++|.+||...+......++....   ...+..++
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS  242 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccC
Confidence            22223455688999999998532    112478999999999999999999998776655555544332   22345578


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      .++.++|.+||..||++||+++++++||||..
T Consensus       243 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  274 (292)
T cd06644         243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSS  274 (292)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            99999999999999999999999999999964

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.8e-44  Score=352.83  Aligned_cols=257  Identities=30%  Similarity=0.579  Sum_probs=222.6

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+..++..|++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999998765434445567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc------
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG------  162 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~------  162 (443)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......      
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999987632110      


Q ss_pred             ---------cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC--
Q 013421          163 ---------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--  231 (443)
Q Consensus       163 ---------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--  231 (443)
                               ........|+..|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......|.  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD  239 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence                     001123457889999999877665 58999999999999999999999887777777766655443332  


Q ss_pred             -CCCHHHHHHHHHccCCCCCCCCC---HHHHhcCccccc
Q 013421          232 -WFSTGATSLIHKILDPNPKTRIR---IEGIRKHPWFRK  266 (443)
Q Consensus       232 -~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~f~~  266 (443)
                       .++.++.++|.+||+.||.+||+   +.++++||||..
T Consensus       240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence             47899999999999999999998   799999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.5e-44  Score=349.02  Aligned_cols=254  Identities=30%  Similarity=0.479  Sum_probs=217.1

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      |++.+.||+|+||.||+|.+..++..+|+|.+....   ....+.+.+|+.+++.++||||+++++++...+..|+++||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            788999999999999999999999999999986543   33456788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccccc
Q 013421           91 VTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        91 ~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      +++++|...+.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.............
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            999999888765 4578999999999999999999999999999999999999999999999999987554332333455


Q ss_pred             CCCcccCCCcccccC----CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc---CCCCCCCCHHHHHHHH
Q 013421          170 CGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLIH  242 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~  242 (443)
                      .|++.|+|||++...    ...+.++||||+||++|+|++|.+||...+.......+....   ...|..++.++.++|.
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK  243 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence            789999999998421    222478999999999999999999998876655555544332   2345568899999999


Q ss_pred             HccCCCCCCCCCHHHHhcCcccccc
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +||+.||.+|||++++++||||+..
T Consensus       244 ~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         244 KCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHccCChhhCcCHHHHhcCCCEecc
Confidence            9999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.8e-44  Score=342.95  Aligned_cols=253  Identities=28%  Similarity=0.579  Sum_probs=221.7

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++.+.+..|+|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            6999999999999999999999999999999997654332 345678999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           90 FVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        90 y~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |+++++|.+.+....  .+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            999999999987643  578999999999999999999999999999999999999999999999999876544333334


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCCCCCHHHHHHHHHccC
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILD  246 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~  246 (443)
                      ...|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..+.. ..+..++.++.++|.+||+
T Consensus       160 ~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  238 (256)
T cd08218         160 TCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK  238 (256)
T ss_pred             hccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhh
Confidence            4568899999999977665 4899999999999999999999988777776666555443 3556689999999999999


Q ss_pred             CCCCCCCCHHHHhcCccc
Q 013421          247 PNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       247 ~dP~~R~t~~eil~hp~f  264 (443)
                      .+|.+||++.++++||||
T Consensus       239 ~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         239 RNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CChhhCcCHHHHhhCcCC
Confidence            999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.9e-44  Score=351.40  Aligned_cols=257  Identities=26%  Similarity=0.431  Sum_probs=219.9

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ....+|++.+.||+|+||.||+|++..++..||+|.+......   ..+.+.+|+.+++.++||||+++++.+......|
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence            4456899999999999999999999999999999999765432   2466889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      +||||++|++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus        94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            99999999999998865 56899999999999999999999999999999999999999999999999998765443333


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh-c--cCCCCCCCCHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-A--EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-~--~~~~~~~~s~~~~~li~  242 (443)
                      .....|++.|+|||.+.+..+ +.++||||+||++|+|++|+.||...+.......+.. .  ....+..+++.+.++|.
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  251 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (296)
T ss_pred             cCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence            345578999999999977655 4899999999999999999999987665332222221 1  22335568899999999


Q ss_pred             HccCCCCCCCCCHHHHhcCcccccc
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +||..||.+|||+.++++||||...
T Consensus       252 ~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         252 RCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHCcCCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-44  Score=345.59  Aligned_cols=248  Identities=36%  Similarity=0.681  Sum_probs=220.6

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCCCh
Q 013421           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (443)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L   96 (443)
                      ||.|+||.||+|.+..+++.+|+|++.+.........+.+.+|+.+++.++||||+++++.+.++...|+++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            69999999999999999999999999876655445567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcccC
Q 013421           97 FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV  176 (443)
Q Consensus        97 ~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~  176 (443)
                      .+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....+|++.|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~  159 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYV  159 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCcc
Confidence            9999888889999999999999999999999999999999999999999999999999987664432 233457899999


Q ss_pred             CCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC--hHHHHHHhh--hccCCCCCCCCHHHHHHHHHccCCCCCCC
Q 013421          177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKIN--AAEFSCPFWFSTGATSLIHKILDPNPKTR  252 (443)
Q Consensus       177 aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R  252 (443)
                      |||.+.+..++ .++|+||+|+++|+|++|..||....  ......++.  ......|...++++.++|.+||..||.+|
T Consensus       160 ~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  238 (262)
T cd05572         160 APEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER  238 (262)
T ss_pred             ChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhC
Confidence            99998776664 89999999999999999999998766  555566655  44566777789999999999999999999


Q ss_pred             CC-----HHHHhcCccccc
Q 013421          253 IR-----IEGIRKHPWFRK  266 (443)
Q Consensus       253 ~t-----~~eil~hp~f~~  266 (443)
                      |+     +.|+++||||+.
T Consensus       239 ~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         239 LGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             cCCcccCHHHHhcChhhhC
Confidence            99     999999999974

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6e-45  Score=351.97  Aligned_cols=255  Identities=29%  Similarity=0.432  Sum_probs=215.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+..... ...+.+.+|+.+++.++||||+++++++.++...|+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            47999999999999999999999899999999987644322 34567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||++++.|..+......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++............
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            99999988887777677999999999999999999999999999999999999999999999999998765444344445


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-------------------cC--
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------EF--  227 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~--  227 (443)
                      ..|+..|+|||++.+....+.++||||+||++|+|++|.+||...+.......+...                   ..  
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            678999999999876555568899999999999999999999765543322221110                   00  


Q ss_pred             ----------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          228 ----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       228 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                ..++.++..+.+|+.+||+.+|.+||++.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                      0123468889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.3e-44  Score=351.04  Aligned_cols=256  Identities=26%  Similarity=0.439  Sum_probs=220.6

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ...+|++.+.||.|++|.||+|.+..+|+.||+|.+.....   ...+.+.+|+.+++.++||||+++++++...+..|+
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   93 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV   93 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence            34579999999999999999999999999999999876432   234678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |+||+++++|.+++.. ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..........
T Consensus        94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  172 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR  172 (296)
T ss_pred             EEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence            9999999999998865 578999999999999999999999999999999999999999999999999987654433333


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---cCCCCCCCCHHHHHHHHH
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~  243 (443)
                      ...+|++.|+|||.+.+..+. .++|||||||++|+|++|..||...+.......+...   ....+..+++.+.++|.+
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  251 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR  251 (296)
T ss_pred             CCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence            455789999999999876654 8999999999999999999999887654433333322   233455689999999999


Q ss_pred             ccCCCCCCCCCHHHHhcCcccccc
Q 013421          244 ILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ||..||.+|||+.+++.||||+..
T Consensus       252 ~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         252 CLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HhhcChhhCCCHHHHhhChHhhhc
Confidence            999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=347.80  Aligned_cols=255  Identities=27%  Similarity=0.452  Sum_probs=222.1

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||.|++|.||+|.+..+++.||+|++.....  ......+.+|+.+++.++||||+++++++.+....|+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            479999999999999999999999999999999976532  223567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||+++++|.+++... ++++..++.++.|++.|+.|||++|++||||+|+||+++.++.++|+|||++............
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            999999999998764 8899999999999999999999999999999999999999999999999998766543333445


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-CCCCCC-CCHHHHHHHHHccC
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFW-FSTGATSLIHKILD  246 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~-~s~~~~~li~~~L~  246 (443)
                      ..|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+.... ...+.. +++++.+++.+||.
T Consensus       158 ~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  236 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN  236 (274)
T ss_pred             ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhh
Confidence            678999999999987665 489999999999999999999998766555544444432 233344 78999999999999


Q ss_pred             CCCCCCCCHHHHhcCcccccc
Q 013421          247 PNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       247 ~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .||++|||++++++||||++.
T Consensus       237 ~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         237 KDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             CChhhCcCHHHHhhChhhcCC
Confidence            999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9.2e-45  Score=360.08  Aligned_cols=250  Identities=22%  Similarity=0.371  Sum_probs=204.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~   81 (443)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++.+ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            358999999999999999999752     346789999987543  223456788999999999 899999999988654


Q ss_pred             -CEEEEEEecCCCCChHHHHHhc---------------------------------------------------------
Q 013421           82 -TKVYIILEFVTGGELFDKIVHQ---------------------------------------------------------  103 (443)
Q Consensus        82 -~~~~lv~Ey~~gg~L~~~i~~~---------------------------------------------------------  103 (443)
                       ..+|++|||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999998753                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc--cccccCCCcccC
Q 013421          104 -----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYV  176 (443)
Q Consensus       104 -----~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~  176 (443)
                           .++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  ......+++.|+
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence                 2367788899999999999999999999999999999999999999999999875432211  122334667899


Q ss_pred             CCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHH-HHHHhhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          177 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT-LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       177 aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      |||++.+..++ .++|||||||++|+|++ |..||.+..... ....+..+ ....|..+++++.+++.+||+.||.+||
T Consensus       244 aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  322 (338)
T cd05102         244 APESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP  322 (338)
T ss_pred             CcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence            99999877664 89999999999999997 999998755433 33333333 3445667899999999999999999999


Q ss_pred             CHHHHhc
Q 013421          254 RIEGIRK  260 (443)
Q Consensus       254 t~~eil~  260 (443)
                      |+.++++
T Consensus       323 s~~el~~  329 (338)
T cd05102         323 TFSALVE  329 (338)
T ss_pred             CHHHHHH
Confidence            9999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.1e-45  Score=369.02  Aligned_cols=251  Identities=31%  Similarity=0.464  Sum_probs=214.5

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-C-----CCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-H-----PNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~~~   81 (443)
                      -.+|++.+.||+|+||+|-+|.+..|++.||||+++...    ....+-..|+.+|..|+ |     -|+|+++++|...
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            348999999999999999999999999999999998654    34567788999999997 4     4899999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC--CCeEEeeecCcC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY--GNLKVSDFGLSA  157 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~--~~~kL~DFGls~  157 (443)
                      +++|||+|.+ +.+|+++++.+.  +++...++.+++||+.||.+||+.||||+|||||||||.+.  ..+||+|||.|+
T Consensus       261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence            9999999999 669999998764  78999999999999999999999999999999999999754  379999999998


Q ss_pred             CCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh-------------
Q 013421          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-------------  224 (443)
Q Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------  224 (443)
                      .....   ..+++-+..|+|||++.+.+|+ .+.||||||||++||++|.+.|++.+..+....|..             
T Consensus       340 ~~~q~---vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  340 FESQR---VYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             ccCCc---ceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            76543   3388999999999999999997 999999999999999999999988876554433310             


Q ss_pred             ---------------------------------------ccCCCCCC-----------CCHHHHHHHHHccCCCCCCCCC
Q 013421          225 ---------------------------------------AEFSCPFW-----------FSTGATSLIHKILDPNPKTRIR  254 (443)
Q Consensus       225 ---------------------------------------~~~~~~~~-----------~s~~~~~li~~~L~~dP~~R~t  254 (443)
                                                             .+...|..           -...+.+||++||+.||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence                                                   00011200           1345789999999999999999


Q ss_pred             HHHHhcCcccccc
Q 013421          255 IEGIRKHPWFRKN  267 (443)
Q Consensus       255 ~~eil~hp~f~~~  267 (443)
                      +.++|+||||...
T Consensus       496 p~qal~Hpfl~~~  508 (586)
T KOG0667|consen  496 PAQALNHPFLTGT  508 (586)
T ss_pred             HHHHhcCcccccc
Confidence            9999999999853

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.3e-44  Score=344.22  Aligned_cols=253  Identities=27%  Similarity=0.458  Sum_probs=216.1

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL---KHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      +|++.+.||.|+||+||+|.+ .+++.+|+|.+......   ..+....+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            588999999999999999987 47889999998754321   22345678999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc-----
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ-----  161 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~-----  161 (443)
                      ++||++|++|.+++.+.+++++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....     
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            999999999999998888899999999999999999999999999999999999999999999999998864321     


Q ss_pred             -ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---cCCCCCCCCHHH
Q 013421          162 -GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGA  237 (443)
Q Consensus       162 -~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~  237 (443)
                       .........|++.|+|||++.+..+. .++|+|||||++|+|++|..||...+.......+...   ....+..++.++
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA  238 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence             11223345689999999999876664 8999999999999999999999876544433333222   234555689999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      .++|++||..+|.+||++.++++||||
T Consensus       239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         239 IDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.5e-44  Score=346.57  Aligned_cols=251  Identities=27%  Similarity=0.411  Sum_probs=210.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe------C
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS------R   81 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~------~   81 (443)
                      +.|++.+.||+|+||.||+|.+..+++.||+|.+.....    ....+.+|+.+++.+ +||||+++++++..      .
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            578999999999999999999999999999999875431    235678999999998 79999999999864      3


Q ss_pred             CEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      ..+|++|||+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            5689999999999999998864  36899999999999999999999999999999999999999999999999998765


Q ss_pred             ccccccccccCCCcccCCCccccc-----CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--CCCCCC
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW  232 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~  232 (443)
                      ...........|++.|+|||++.+     ..+ +.++||||+||++|+|++|..||...........+....  ...+..
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK  240 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence            443333456679999999999853     234 478999999999999999999997665444333332221  112234


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      ++.++.+||.+||..||.+|||+.+++.||||
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            78999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.9e-44  Score=348.55  Aligned_cols=249  Identities=30%  Similarity=0.457  Sum_probs=206.3

Q ss_pred             eeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHH---hCCCCCcceEEEEEEeCCEEEEEEecCC
Q 013421           16 TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK---IVRHPNIVRLHEVLASRTKVYIILEFVT   92 (443)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~---~l~HpnIv~l~~~~~~~~~~~lv~Ey~~   92 (443)
                      .||+|+||.||++.+..+++.+|+|.+.+.............+|..+++   ..+||||+.+++++...+..|+||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999998765433322233444544433   4479999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCC
Q 013421           93 GGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT  172 (443)
Q Consensus        93 gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt  172 (443)
                      +++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......  ......|+
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~  158 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGT  158 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCCC
Confidence            9999999988889999999999999999999999999999999999999999999999999998654332  22345799


Q ss_pred             cccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh---HHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCC
Q 013421          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---PTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP  249 (443)
Q Consensus       173 ~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP  249 (443)
                      +.|+|||.+.+....+.++||||+||++|+|++|..||.....   ..............|..+++++.++|.+||..||
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  238 (279)
T cd05633         159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV  238 (279)
T ss_pred             cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence            9999999986433345899999999999999999999975432   2222222333445667789999999999999999


Q ss_pred             CCCC-----CHHHHhcCccccc
Q 013421          250 KTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       250 ~~R~-----t~~eil~hp~f~~  266 (443)
                      ++|+     |+.++++||||+.
T Consensus       239 ~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         239 SKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             HHhcCCCCCCHHHHHhCccccC
Confidence            9999     6999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.6e-44  Score=343.27  Aligned_cols=254  Identities=28%  Similarity=0.443  Sum_probs=218.3

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++++.||.|+||.||+|....++..+|+|++.......  ....+.+|+.+++.++|+||+++++.+...+..|++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999998899999999997654333  4678999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-
Q 013421           89 EFVTGGELFDKIVHQ---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-  164 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-  164 (443)
                      ||++|++|.+++...   ..+++..++.++.|++.||.|||+.|++||||+|+||++++++.++|+|||++........ 
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999764   4589999999999999999999999999999999999999999999999999875544222 


Q ss_pred             ---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCC-----CCCCH
Q 013421          165 ---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCP-----FWFST  235 (443)
Q Consensus       165 ---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~-----~~~s~  235 (443)
                         .....+|+..|+|||++......+.++|+|||||++|+|++|+.||...+......+...... ..+     ..+++
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK  238 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence               223456899999999987663446899999999999999999999987766555544433322 111     24688


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          236 GATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      .+.+++.+||..||.+|||+.+++.||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-44  Score=340.85  Aligned_cols=251  Identities=32%  Similarity=0.476  Sum_probs=217.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..|++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            579999999999999999999999999999999976532   24578899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           89 EFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      ||+++++|.+++... .++++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++...........
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            999999999998776 7899999999999999999999999999999999999999999999999999876544322334


Q ss_pred             ccCCCcccCCCcccccC---CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC-----CCCCCCHHHHH
Q 013421          168 TTCGTPNYVAPEVLSNR---GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-----CPFWFSTGATS  239 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~---~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~~~~  239 (443)
                      ...|+..|+|||.+.+.   .++ .++|+|||||++|+|++|..||...+.......+....+.     .+..++.++.+
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD  238 (262)
T ss_pred             cccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHH
Confidence            56788999999998765   554 8999999999999999999999877655444444333222     22335788999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCcc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPW  263 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~  263 (443)
                      +|.+||..||..|||+++++.|||
T Consensus       239 li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         239 FIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHcCCChhhCCCHHHHhcCCC
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.7e-44  Score=352.18  Aligned_cols=264  Identities=29%  Similarity=0.418  Sum_probs=217.7

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--T   82 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~   82 (443)
                      ...+++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.++++++|+||+++++++...  +
T Consensus         3 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             cccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            346789999999999999999999999999999999987543222 1223456899999999999999999998754  5


Q ss_pred             EEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            78999999964 78888765 36789999999999999999999999999999999999999999999999999876654


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc----------------
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----------------  225 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------  225 (443)
                      .........+++.|+|||++.+....+.++||||+||++|+|++|.+||...+.......+...                
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence            3333334456888999999876554468999999999999999999999887766555443221                


Q ss_pred             ---cCCCC-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          226 ---EFSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       226 ---~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                         .+..+           .++++++.+||.+||+.||++|||+++++.||||+....+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence               11111           2358899999999999999999999999999999866543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.2e-44  Score=350.42  Aligned_cols=261  Identities=31%  Similarity=0.434  Sum_probs=219.2

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL--KHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+......  .......+..|+.+++.++|+||+++++++.+.+..|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            589999999999999999999999999999999765533  122345677899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||+|+||+++.+|.++|+|||++..........
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 999999998766 79999999999999999999999999999999999999999999999999987665443334


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--------------------
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------------  226 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------------------  226 (443)
                      ....+++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+......++....                    
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            445678899999998655555689999999999999999998887766544433332110                    


Q ss_pred             ---CC-----CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCCC
Q 013421          227 ---FS-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV  271 (443)
Q Consensus       227 ---~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~~  271 (443)
                         ..     .....+..+.++|.+||.+||++|||+.+++.||||++...+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence               00     0122478899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.1e-44  Score=345.83  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=210.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+|+.++++++||||+++++.+...+..+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            36899999999999999999999999999999997653  2234567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....  .....
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~--~~~~~  152 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN--SIAKT  152 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc--ccccC
Confidence            99999988544    4578999999999999999999999999999999999999999999999999875433  22345


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh-------HHHHHHhhhccC-CC-CCCCCHHHHH
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-------PTLYKKINAAEF-SC-PFWFSTGATS  239 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-------~~~~~~i~~~~~-~~-~~~~s~~~~~  239 (443)
                      .+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||.....       ......+..... .. ....++++.+
T Consensus       153 ~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (279)
T cd06619         153 YVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH  231 (279)
T ss_pred             CCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence            689999999999987666 4899999999999999999999965321       122222222211 11 2347889999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +|.+||+.||.+||+++++++||||+..
T Consensus       232 li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         232 FITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            9999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.9e-44  Score=351.71  Aligned_cols=258  Identities=26%  Similarity=0.434  Sum_probs=219.8

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ....+|++++.||+|+||.||+|.+..+++.||+|.+......   ..+.+.+|+.+++.++||||+++++++...+..|
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELW   92 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence            4457899999999999999999999999999999999764422   2466889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      +||||+++++|.+++.. ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus        93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            99999999999998865 56899999999999999999999999999999999999999999999999998765443333


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh-c--cCCCCCCCCHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-A--EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-~--~~~~~~~~s~~~~~li~  242 (443)
                      .....|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+.. +  ....|..++..+.+|+.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN  250 (297)
T ss_pred             cCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence            345678999999999987665 4899999999999999999999977654332222221 1  22244567899999999


Q ss_pred             HccCCCCCCCCCHHHHhcCccccccC
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      +||..||.+||+++++++||||+...
T Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         251 RCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             HHccCChhhCcCHHHHhcCchhcccc
Confidence            99999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-44  Score=357.07  Aligned_cols=252  Identities=22%  Similarity=0.387  Sum_probs=205.9

Q ss_pred             Eeeeeecc--CceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013421           13 VGRTIGEG--TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        13 i~~~LG~G--~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      +++.||+|  +|++||++.++.+|+.||+|.++..... ....+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            56889999  7899999999999999999999765432 33456788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc-cc----
Q 013421           91 VTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ-GV----  163 (443)
Q Consensus        91 ~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~-~~----  163 (443)
                      +++|+|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+..... ..    
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999999653  4589999999999999999999999999999999999999999999999986432211 10    


Q ss_pred             --ccccccCCCcccCCCcccccC--CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC-----------
Q 013421          164 --ELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-----------  228 (443)
Q Consensus       164 --~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----------  228 (443)
                        .......++..|+|||++.+.  ++ +.++||||+||++|+|++|..||..............+..+           
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE  239 (327)
T ss_pred             cccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence              111234577889999998753  34 48999999999999999999999865433322221111100           


Q ss_pred             -----------------------------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          229 -----------------------------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       229 -----------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                                                         ....+++++.+||.+||+.||++|||++++++||||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence                                               11125778999999999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.5e-44  Score=345.58  Aligned_cols=254  Identities=30%  Similarity=0.468  Sum_probs=215.0

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++......|+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            699999999999999999999999999999999775432 2345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-cccc
Q 013421           90 FVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-ELLH  167 (443)
Q Consensus        90 y~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~~~~  167 (443)
                      |+ +++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++....... ....
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            99 99999998653 568999999999999999999999999999999999999999999999999987664432 2344


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-------------------cCC
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------EFS  228 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~~  228 (443)
                      ...|+..|+|||++.+....+.++||||+||++|+|++|.+||...+.......+...                   ...
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT  238 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence            5678999999999876555568999999999999999999999776544433322110                   000


Q ss_pred             -----------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          229 -----------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       229 -----------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                                 ..+..+.++.++|++||+.||.+|||+++++.||||.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                       0123578899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-44  Score=344.64  Aligned_cols=255  Identities=27%  Similarity=0.474  Sum_probs=216.4

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccc---hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK---HRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      +|+..+.||+|+||.||+|.+..+++.||+|++.......   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            5889999999999999999999999999999997543221   2245778999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC-CeEEeeecCcCCCcccc--
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQGV--  163 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~~--  163 (443)
                      |+||++|++|.+++...+++++..+..++.||+.||.|||++|++||||+|+||+++.++ .+||+|||++.......  
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998776 59999999986554321  


Q ss_pred             --ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHh-----hhccCCCCCCCCHH
Q 013421          164 --ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-----NAAEFSCPFWFSTG  236 (443)
Q Consensus       164 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i-----~~~~~~~~~~~s~~  236 (443)
                        .......|+..|+|||++.+..+. .++|+||+|+++|+|++|..||...+.......+     .......|..++++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence              112234688999999999776654 8999999999999999999999765433222222     12234455668999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      +.+++.+||..||.+|||+.++++||||+
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.6e-44  Score=338.70  Aligned_cols=253  Identities=28%  Similarity=0.499  Sum_probs=223.0

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++++.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            6999999999999999999999999999999987654333 345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        90 y~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++...........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999999999775  4689999999999999999999999999999999999999999999999999876544333345


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC-CCCCCCHHHHHHHHHccC
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKILD  246 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~  246 (443)
                      ...|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+..+....+..+.+. .+..++.++.++|.+||.
T Consensus       160 ~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQ  238 (256)
T ss_pred             ccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence            6678999999999877665 48899999999999999999999987777777666555443 345579999999999999


Q ss_pred             CCCCCCCCHHHHhcCccc
Q 013421          247 PNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       247 ~dP~~R~t~~eil~hp~f  264 (443)
                      .+|.+||++.++++|||+
T Consensus       239 ~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         239 QDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             cCcccCCCHHHHhhCcCC
Confidence            999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.9e-44  Score=346.06  Aligned_cols=250  Identities=31%  Similarity=0.468  Sum_probs=210.0

Q ss_pred             eeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHH---HHHHhCCCCCcceEEEEEEeCCEEEEEEecCC
Q 013421           16 TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI---SIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (443)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei---~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~   92 (443)
                      .||+|+||.||+|.+..+++.||+|.+.+..............|.   ..++...||||+++++++.+.+..|+||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999999875443222222233333   34555689999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCC
Q 013421           93 GGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT  172 (443)
Q Consensus        93 gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt  172 (443)
                      |++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......  .....+|+
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~  158 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGT  158 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCCC
Confidence            9999999988888999999999999999999999999999999999999999999999999998754332  23456799


Q ss_pred             cccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC---ChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCC
Q 013421          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP  249 (443)
Q Consensus       173 ~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP  249 (443)
                      ..|+|||++.+....+.++||||+||++|+|++|..||...   ................|..+|+++.+++.+||..||
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p  238 (278)
T cd05606         159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV  238 (278)
T ss_pred             cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence            99999999875433458899999999999999999999876   333444444445566677789999999999999999


Q ss_pred             CCCC-----CHHHHhcCcccccc
Q 013421          250 KTRI-----RIEGIRKHPWFRKN  267 (443)
Q Consensus       250 ~~R~-----t~~eil~hp~f~~~  267 (443)
                      .+||     ++.++++||||+..
T Consensus       239 ~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         239 NRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             HhccCCCCCCHHHHHhCccccCC
Confidence            9999     99999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.7e-44  Score=347.02  Aligned_cols=255  Identities=33%  Similarity=0.635  Sum_probs=228.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++ ||||+++++++.+.+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999998765545555677899999999998 99999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc----
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV----  163 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~----  163 (443)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.+|.++|+|||++.......    
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            9999999999999988899999999999999999999999999999999999999999999999999987554321    


Q ss_pred             ----------------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC
Q 013421          164 ----------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF  227 (443)
Q Consensus       164 ----------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~  227 (443)
                                      .......|+..|+|||++....+ +.++||||+|++++++++|..||...+....++.+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  239 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY  239 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence                            11233457889999999876554 5899999999999999999999998887777777777777


Q ss_pred             CCCCCCCHHHHHHHHHccCCCCCCCCCH----HHHhcCccc
Q 013421          228 SCPFWFSTGATSLIHKILDPNPKTRIRI----EGIRKHPWF  264 (443)
Q Consensus       228 ~~~~~~s~~~~~li~~~L~~dP~~R~t~----~eil~hp~f  264 (443)
                      ..|..+++.+.++|.+||+.||.+|||+    +++++||||
T Consensus       240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            8888899999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.9e-44  Score=339.40  Aligned_cols=253  Identities=32%  Similarity=0.589  Sum_probs=221.7

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA--SRTKVYII   87 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lv   87 (443)
                      +|++.+.||.|+||.||+|.+..++..||+|++...... ....+.+..|+.+++.++||||+++++++.  .....|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            589999999999999999999999999999999765433 334567889999999999999999999775  45678999


Q ss_pred             EecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCEeecCCCCcEEEcCCCCeEEeeecCcCC
Q 013421           88 LEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCH-----SKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH-----~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (443)
                      |||+++++|.+++..    ..++++..++.++.||+.||.|||     +.+++||||+|+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999876    357899999999999999999999     89999999999999999999999999999887


Q ss_pred             CccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCCCCCHHH
Q 013421          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGA  237 (443)
Q Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~  237 (443)
                      ............|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..+.. ..|..++..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL  238 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence            6554333455679999999999977665 4889999999999999999999998877777777666544 3556789999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      .+++.+||+.+|.+|||+.+|++|||+
T Consensus       239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         239 NEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.8e-44  Score=386.76  Aligned_cols=265  Identities=28%  Similarity=0.429  Sum_probs=219.0

Q ss_pred             cccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 013421            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--   80 (443)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--   80 (443)
                      .+...+++|++++.||+|+||+||+|.+..++..||+|++...... ......+..|+.+++.++||||++++++|.+  
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            3567789999999999999999999999999999999999865433 3345778999999999999999999998854  


Q ss_pred             CCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CCEeecCCCCcEEEcC-----
Q 013421           81 RTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSK-------GVYHRDLKPENLLLDS-----  144 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~-------gi~HrDlkp~NILl~~-----  144 (443)
                      ...+||||||+++|+|.++|..    .+.+++..++.++.||+.||.|||+.       +|+||||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            4679999999999999999865    35799999999999999999999995       4999999999999964     


Q ss_pred             ------------CCCeEEeeecCcCCCccccccccccCCCcccCCCcccccC-CCCCCccchHHHHHHHHHHhhCCCCCC
Q 013421          145 ------------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFG  211 (443)
Q Consensus       145 ------------~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~  211 (443)
                                  .+.+||+|||++...... ......+||+.|+|||++.+. ...+.++||||||||||+|++|..||.
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                        235899999998765432 233456799999999998643 233589999999999999999999997


Q ss_pred             CCChH-HHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          212 ETDLP-TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       212 ~~~~~-~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                      ..+.. .+...+...........++++.+||.+||..+|.+||++.++|.|||++....
T Consensus       245 ~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        245 KANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             cCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            65543 33333333322222347899999999999999999999999999999985543

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.8e-44  Score=341.58  Aligned_cols=254  Identities=29%  Similarity=0.489  Sum_probs=214.6

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL--KHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RTKVY   85 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~   85 (443)
                      +|+..+.||+|+||.||+|.+..++..||+|.+......  ..+....+.+|+.+++.++||||+++++++.+  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            689999999999999999999999999999998754322  22345678999999999999999999998865  46789


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc---
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG---  162 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~---  162 (443)
                      +++||+++++|.+++...+.+++...+.++.|++.||+|||++||+||||+|+||+++.++.+||+|||++......   
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS  162 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence            99999999999999988888999999999999999999999999999999999999999999999999998654321   


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh--ccCCCCCCCCHHHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPFWFSTGATSL  240 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~l  240 (443)
                      ........|+..|+|||.+.+..+ +.++||||+||++|+|++|+.||...+.......+..  .....|..+++.+.++
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (266)
T cd06651         163 GTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF  241 (266)
T ss_pred             CCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence            112233568899999999977665 4899999999999999999999987655444433322  2344566789999999


Q ss_pred             HHHccCCCCCCCCCHHHHhcCcccc
Q 013421          241 IHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      | +||..+|++||+++|+++||||+
T Consensus       242 i-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         242 L-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             H-HHhcCChhhCcCHHHHhcCcccc
Confidence            9 56778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.6e-44  Score=340.14  Aligned_cols=255  Identities=29%  Similarity=0.497  Sum_probs=215.2

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RTKV   84 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~   84 (443)
                      .+|++.+.||+|+||.||.|.+..+|..||+|.+.....  ......+.+.+|+.+++.++||||+++++++.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            579999999999999999999999999999999864322  122345778999999999999999999998865  3578


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc--
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--  162 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--  162 (443)
                      |++|||+++++|.+++.....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......  
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            899999999999999988788999999999999999999999999999999999999999999999999998754321  


Q ss_pred             -cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cCCCCCCCCHHHHH
Q 013421          163 -VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFWFSTGATS  239 (443)
Q Consensus       163 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~  239 (443)
                       ........|+..|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+...  ....|..++..+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence             112334568999999999977665 48999999999999999999999876544443333322  23345567889999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      +|.+|+. +|++||+++++++|||+.
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            9999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.1e-43  Score=344.66  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=214.1

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC--
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR--   81 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--   81 (443)
                      ....++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++++ +|||++++++++...  
T Consensus        18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            345678999999999999999999999999999999986532    1235678899999999 899999999998643  


Q ss_pred             ---CEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeec
Q 013421           82 ---TKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG  154 (443)
Q Consensus        82 ---~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFG  154 (443)
                         +..|+||||++|++|.+++..    ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg  173 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG  173 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence               468999999999999998753    3578999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCccccccccccCCCcccCCCcccccCCC----CCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc---C
Q 013421          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGY----DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---F  227 (443)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~----~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~  227 (443)
                      ++.............+|+..|+|||++.....    .+.++||||+||++|+|++|++||...+.......+....   .
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  253 (291)
T cd06639         174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL  253 (291)
T ss_pred             cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence            98765433222344578999999999854321    2589999999999999999999998766544444443332   2


Q ss_pred             CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          228 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       228 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      ..+...+..+.+||.+||+.||.+||++.+|++||||+
T Consensus       254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            23445678899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-44  Score=346.02  Aligned_cols=255  Identities=29%  Similarity=0.471  Sum_probs=208.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      .+++|++.+.||+|++|.||+|.++.+++.||+|.+.......  ....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            4688999999999999999999999899999999987643221  12346689999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           87 ILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      ||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.........
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            9999975 899988764 46899999999999999999999999999999999999999999999999998654332222


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC-hHHHHHHhhhc-------------------
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYKKINAA-------------------  225 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~-------------------  225 (443)
                      .....+++.|+|||++.+....+.++||||+||++|+|++|..||...+ ..+....+...                   
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence            3344578899999998764444589999999999999999999997655 22221111100                   


Q ss_pred             cCCC-----------CCCCC--HHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          226 EFSC-----------PFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       226 ~~~~-----------~~~~s--~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      ....           ...++  .++.++|.+||+.||.+|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000           01234  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.1e-44  Score=346.09  Aligned_cols=248  Identities=31%  Similarity=0.512  Sum_probs=213.0

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCCCh
Q 013421           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (443)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L   96 (443)
                      ||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999999999999999999875443333445667899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcc
Q 013421           97 FDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN  174 (443)
Q Consensus        97 ~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~  174 (443)
                      .+++....  .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... .......|+..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~  159 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPG  159 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCC
Confidence            99998766  7899999999999999999999999999999999999999999999999988755432 22344568889


Q ss_pred             cCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh----HHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCC
Q 013421          175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL----PTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK  250 (443)
Q Consensus       175 y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~  250 (443)
                      |+|||++.+..+ +.++||||+||++|+|++|+.||...+.    ......+.......+..+++.+.++|.+||+.||.
T Consensus       160 y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  238 (277)
T cd05577         160 YMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE  238 (277)
T ss_pred             cCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChh
Confidence            999999877665 4899999999999999999999977543    23333334444556667899999999999999999


Q ss_pred             CCC-----CHHHHhcCccccc
Q 013421          251 TRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       251 ~R~-----t~~eil~hp~f~~  266 (443)
                      +||     ++.+++.||||..
T Consensus       239 ~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         239 KRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             HccCCCcccHHHHHhChhhhc
Confidence            999     8888999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.6e-44  Score=346.40  Aligned_cols=253  Identities=32%  Similarity=0.470  Sum_probs=211.2

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++++.||.|++|.||+|.+..+|+.||||.+...... ......+.+|+.++++++||||+++++++.+.+..|++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            489999999999999999999999999999998754422 2233568899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           90 FVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        90 y~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |+. ++|.+++..  ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++...........
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            996 588888865  35689999999999999999999999999999999999999999999999999876544333344


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh-cc-----------------CCC
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-AE-----------------FSC  229 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-~~-----------------~~~  229 (443)
                      ...+++.|+|||++.+....+.++|||||||++|+|++|..||...+......++.. ..                 ..+
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            556789999999987655556889999999999999999999987654332222110 00                 001


Q ss_pred             -----------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          230 -----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       230 -----------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                 .+.+++++.++|.+||+.||.+|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                       12368899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-44  Score=363.45  Aligned_cols=250  Identities=23%  Similarity=0.356  Sum_probs=206.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE--TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      -.+|++++.||+|+||.||++....  ++..||+|.+....        ...+|+.+++.++||||+++++++......|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            3479999999999999999997643  56789999886432        3457999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc--
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--  163 (443)
                      ++||++. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            9999995 6899999777889999999999999999999999999999999999999999999999999987554321  


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH---HHHHHhhh----------------
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---TLYKKINA----------------  224 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i~~----------------  224 (443)
                      ......+||+.|+|||++....|. .++||||+||++|+|++|..||.+....   .....+..                
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             ccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            122356799999999999877775 8999999999999999999999664321   11111100                


Q ss_pred             -------------ccCCCCC-----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          225 -------------AEFSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       225 -------------~~~~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                   ..+..|.     .++.++.++|.+||..||.+|||+.+++.||||++.
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                         0011111     246788999999999999999999999999999764

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.7e-44  Score=346.73  Aligned_cols=240  Identities=16%  Similarity=0.213  Sum_probs=209.7

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEec
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS----RTKVYIILEF   90 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv~Ey   90 (443)
                      ..||+|++|.||+|..  +|+.||+|.+.+.........+.+.+|+.+|++++||||+++++++.+    ...++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999987  689999999987654444456788999999999999999999999876    4578999999


Q ss_pred             CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccccc
Q 013421           91 VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        91 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      ++||+|.+++...+.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......   ....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~  180 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFKN  180 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---cccc
Confidence            99999999999888899999999999999999999984 9999999999999999999999999998754332   2345


Q ss_pred             CCCcccCCCccccc--CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh--ccCCCCCCCCHHHHHHHHHcc
Q 013421          170 CGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       170 ~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~li~~~L  245 (443)
                      .|++.|+|||++.+  ..+ +.++|||||||++|+|++|..||...+..+.+..+..  ..++.|..+++++.+++.+||
T Consensus       181 ~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl  259 (283)
T PHA02988        181 VNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT  259 (283)
T ss_pred             cCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence            78999999999975  344 5899999999999999999999998887777776643  345566678999999999999


Q ss_pred             CCCCCCCCCHHHHhc
Q 013421          246 DPNPKTRIRIEGIRK  260 (443)
Q Consensus       246 ~~dP~~R~t~~eil~  260 (443)
                      +.||++|||++++++
T Consensus       260 ~~dp~~Rps~~ell~  274 (283)
T PHA02988        260 SHDSIKRPNIKEILY  274 (283)
T ss_pred             cCCcccCcCHHHHHH
Confidence            999999999999986

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-43  Score=337.87  Aligned_cols=254  Identities=32%  Similarity=0.576  Sum_probs=217.7

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++|+||+++++...+.+..++++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            699999999999999999999989999999999876533 3456889999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc----
Q 013421           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL----  165 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~----  165 (443)
                      |+++++|.+++.....+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.........    
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            9999999999988778999999999999999999999999999999999999999999999999998765442221    


Q ss_pred             ccccCCCcccCCCcccccCC--CCCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhh-hccCCCCCCC--CHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKIN-AAEFSCPFWF--STGATS  239 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~-~~~~~~~~~~--s~~~~~  239 (443)
                      .....|++.|+|||++.+..  ..+.++||||+|+++|+|++|+.||...+.. .....+. ......|.+.  ++.+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence            22456889999999987654  1358999999999999999999999765322 2222222 2234455554  899999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCccc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      +|.+||+.+|.+|||+++++.|||+
T Consensus       240 li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         240 FLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.7e-44  Score=346.88  Aligned_cols=256  Identities=26%  Similarity=0.432  Sum_probs=217.3

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++++.||+|+||.||+|.+..++..||+|.+....  .......+.+|+.++++++||||+++++.+...+..|++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            47999999999999999999999999999999986542  2333567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           89 EFVTGGELFDKIVHQ---GRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      ||++|++|..++...   ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....  .
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--S  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC--C
Confidence            999999998888763   378999999999999999999997 5999999999999999999999999999865433  2


Q ss_pred             cccccCCCcccCCCcccccCCC-----CCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHH---hhh-ccCCCCCCCCH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGY-----DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK---INA-AEFSCPFWFST  235 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~---i~~-~~~~~~~~~s~  235 (443)
                      ......|++.|+|||++.+...     .+.++||||+||++|+|++|..||...+.......   +.. .....|..+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd06622         157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD  236 (286)
T ss_pred             ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence            3345678899999999854332     25789999999999999999999977554443332   222 23445666899


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ++.++|.+||+.+|.+||++++++.||||....
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            999999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-44  Score=345.28  Aligned_cols=255  Identities=32%  Similarity=0.493  Sum_probs=216.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|+.+++.++|+||+++++++.+.+..|++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            479999999999999999999999999999999876432 2234577899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-ccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LLH  167 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~~~  167 (443)
                      ||++++.+.........+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++........ ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            9999877776666667799999999999999999999999999999999999999999999999999876654332 344


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---------------------c
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------------------E  226 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------------~  226 (443)
                      ...|++.|+|||++.+....+.++||||+|+++|+|++|.+||...+.......+...                     .
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            5678899999999987634468999999999999999999999876544332221110                     0


Q ss_pred             -----------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          227 -----------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       227 -----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                 ..++..+++++.+||++||..+|++|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                       01233458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.5e-44  Score=339.81  Aligned_cols=250  Identities=28%  Similarity=0.472  Sum_probs=216.8

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||.||+|.+..++..+|+|.+....     ..+.+.+|+.+++.++||||+++++.+.+....|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            57999999999999999999999889999999986542     1578899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        89 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      ||+++++|.+++.. ...+++..+..++.|++.|+.|||+.|++||||+|+||+++.++.++|+|||++...........
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            99999999999975 45789999999999999999999999999999999999999999999999999876654333334


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh---ccCCCCCCCCHHHHHHHHHc
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA---AEFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---~~~~~~~~~s~~~~~li~~~  244 (443)
                      ...|+..|+|||++.+..++ .++||||+|+++|+|++|..||...+.......+..   .....+..++.++.++|.+|
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC  236 (256)
T ss_pred             cccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence            45688999999999877664 899999999999999999999987655443332222   12233445788999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccc
Q 013421          245 LDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f  264 (443)
                      |+.||++|||+.+++.||||
T Consensus       237 l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         237 LVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1e-43  Score=337.76  Aligned_cols=249  Identities=31%  Similarity=0.548  Sum_probs=218.1

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+.....  ....+.+.+|+.+++.++||||+++++.+.+.+..|++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            58999999999999999999999999999999875432  2345778899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        90 y~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |+++++|.+++...  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            99999999988653  3579999999999999999999999999999999999999999999999999876544333334


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCCCCCHHHHHHHHHccC
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILD  246 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~  246 (443)
                      ...|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. +.|..++..+.++|.+||+
T Consensus       159 ~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK  237 (255)
T ss_pred             cccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHh
Confidence            5678999999999977665 4899999999999999999999998877766666655543 3556689999999999999


Q ss_pred             CCCCCCCCHHHHhcC
Q 013421          247 PNPKTRIRIEGIRKH  261 (443)
Q Consensus       247 ~dP~~R~t~~eil~h  261 (443)
                      .||.+|||+.+++.-
T Consensus       238 ~~P~~Rp~~~~il~~  252 (255)
T cd08219         238 RNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCCCHHHHhhc
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-43  Score=337.34  Aligned_cols=254  Identities=28%  Similarity=0.473  Sum_probs=219.3

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +|+..+.||+|+||+||+|.+..+++.|++|.+.....  ...+..+.+.+|+.+++.++||||+++++++.+....|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            58888999999999999999998999999999876432  1233457789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      +||+++++|.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAK  159 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-ccc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999987654432 234


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh--ccCCCCCCCCHHHHHHHHHcc
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~li~~~L  245 (443)
                      ...|++.|+|||.+......+.++|+||+||++|+|++|..||...........+..  .....|..+++.+.+++.+||
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  239 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL  239 (258)
T ss_pred             ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence            566899999999987655235899999999999999999999987664444333332  233456678999999999999


Q ss_pred             CCCCCCCCCHHHHhcCccc
Q 013421          246 DPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f  264 (443)
                      +.+|.+||++.+++.|||+
T Consensus       240 ~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         240 QRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             hcCcccCcCHHHHhcCCCC
Confidence            9999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-44  Score=341.16  Aligned_cols=254  Identities=28%  Similarity=0.436  Sum_probs=213.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC---
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT---   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~---   82 (443)
                      ..++|++.+.||+|++|.||+|.+..+++.+++|++.....    ..+.+.+|+.+++++ +||||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            45799999999999999999999998999999999876432    346788999999999 7999999999996544   


Q ss_pred             ---EEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecC
Q 013421           83 ---KVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (443)
Q Consensus        83 ---~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (443)
                         ..|++|||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence               58999999999999998865    35789999999999999999999999999999999999999999999999999


Q ss_pred             cCCCccccccccccCCCcccCCCcccccCC----CCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc---CC
Q 013421          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRG----YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FS  228 (443)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~  228 (443)
                      +..............|++.|+|||++....    ..+.++|||||||++|+|++|..||...+.......+....   ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  239 (275)
T cd06608         160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK  239 (275)
T ss_pred             ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCC
Confidence            875544333344567899999999875422    22478999999999999999999998665444444443332   22


Q ss_pred             CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      .+..++.++.+||.+||..||++|||++++++|||+
T Consensus       240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            233367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.8e-43  Score=335.57  Aligned_cols=252  Identities=29%  Similarity=0.502  Sum_probs=219.6

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            5999999999999999999999999999999998765433 346788999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC-CeEEeeecCcCCCccccccc
Q 013421           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        90 y~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~~~~~  166 (443)
                      |+++++|.+++...  ..+++..+..++.|++.|++|||++|++||||+|+||+++.++ .+||+|||++...... ...
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-~~~  158 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKA  158 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC-ccc
Confidence            99999999999764  3589999999999999999999999999999999999998654 5899999998765443 222


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHHHHcc
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L  245 (443)
                      ....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.... .+.+..+++++.+++.+||
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  237 (256)
T cd08220         159 YTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSML  237 (256)
T ss_pred             cccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHc
Confidence            34568999999999977655 489999999999999999999998877766666654443 3456668999999999999


Q ss_pred             CCCCCCCCCHHHHhcCccc
Q 013421          246 DPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f  264 (443)
                      ..||.+|||++++++||||
T Consensus       238 ~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         238 NLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             cCChhhCCCHHHHhhCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-44  Score=358.24  Aligned_cols=246  Identities=25%  Similarity=0.414  Sum_probs=200.2

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      .+|++++.||+|+||.||+|.+..+++.||+|+..+..         ...|+.+++.++||||+++++++......|+||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            46999999999999999999999999999999754332         246899999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        89 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      ||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus       137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~  214 (357)
T PHA03209        137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFL  214 (357)
T ss_pred             EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-cccc
Confidence            9995 588888765 457899999999999999999999999999999999999999999999999998754332 2234


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCC-CCCCCCChH----------HHHHHhhhcc---CCCC---
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY-LPFGETDLP----------TLYKKINAAE---FSCP---  230 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~-~Pf~~~~~~----------~~~~~i~~~~---~~~~---  230 (443)
                      ...||+.|+|||++.+..+. .++||||+||++|+|+++. .+|......          .+...+....   ..+|   
T Consensus       215 ~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  293 (357)
T PHA03209        215 GLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP  293 (357)
T ss_pred             cccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence            56799999999999877764 8999999999999999854 444432110          1111111000   0001   


Q ss_pred             ---------------------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          231 ---------------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       231 ---------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                                                 ..++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                       125677888999999999999999999999999974

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.1e-44  Score=347.27  Aligned_cols=256  Identities=32%  Similarity=0.459  Sum_probs=214.8

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--TKV   84 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~   84 (443)
                      .+++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.++++++||||+++++++...  +..
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            467899999999999999999999999999999999765432 22334677899999999999999999998877  899


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |++|||+++ +|.+.+.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999999974 8988887644 58999999999999999999999999999999999999999999999999987665543


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc------------------
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA------------------  225 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------  225 (443)
                      .......+++.|+|||.+.+....+.++||||+|+++|+|++|.+||...+......++...                  
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            33445668899999999876554568999999999999999999999876655443332110                  


Q ss_pred             -------------cCCCCCC-CCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          226 -------------EFSCPFW-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       226 -------------~~~~~~~-~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                   ...++.. +++.+.++|++||+.||++|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                         0112222 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-43  Score=340.18  Aligned_cols=255  Identities=30%  Similarity=0.472  Sum_probs=214.5

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccc-------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK-------HRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      +|.+.+.||+|+||.||+|.+..+|+.+|+|.+.......       ....+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            6899999999999999999999899999999986432111       113457889999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998754331


Q ss_pred             --cccccccCCCcccCCCcccccCC-CCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cCCCCC----CC
Q 013421          163 --VELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPF----WF  233 (443)
Q Consensus       163 --~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~----~~  233 (443)
                        ........|+..|+|||++.... ..+.++|+||||+++|++++|..||...+.......+...  ....+.    .+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence              11233456889999999987654 2358999999999999999999999765544333332222  222222    36


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      +.++.++|.+||.++|.+|||++++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-43  Score=344.49  Aligned_cols=255  Identities=31%  Similarity=0.442  Sum_probs=209.3

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE----
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTK----   83 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~----   83 (443)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.+. ||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            4799999999999999999999999999999998764322 223456788999999995 6999999999877665    


Q ss_pred             -EEEEEecCCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-CCCeEEeeecCc
Q 013421           84 -VYIILEFVTGGELFDKIVHQ-----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLS  156 (443)
Q Consensus        84 -~~lv~Ey~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls  156 (443)
                       .|++|||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||++
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999986 788888653     35799999999999999999999999999999999999998 899999999998


Q ss_pred             CCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc----------
Q 013421          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE----------  226 (443)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------  226 (443)
                      ..............+++.|+|||++.+....+.++||||+|+++|+|++|..||.+.+......++....          
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            7554333333445678899999988654444589999999999999999999998766544433321100          


Q ss_pred             ---------C-C--------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          227 ---------F-S--------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       227 ---------~-~--------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                               + .        ..+.+++++.+||.+||.+||.+|||+++++.||||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                     0 0        0023788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.1e-44  Score=339.80  Aligned_cols=249  Identities=34%  Similarity=0.635  Sum_probs=220.8

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCCCh
Q 013421           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (443)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L   96 (443)
                      ||.|+||.||++.+..+|+.+|+|++...........+.+.+|+.++++++||||+++++.+......|+++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999999999876554445567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc--------cccc
Q 013421           97 FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--------LLHT  168 (443)
Q Consensus        97 ~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--------~~~~  168 (443)
                      .+++.+.+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........        ....
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            99998878899999999999999999999999999999999999999999999999999875433211        2234


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCC--CHHHHHHHHHccC
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF--STGATSLIHKILD  246 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--s~~~~~li~~~L~  246 (443)
                      ..+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..+....|...  ++.+.+++.+||+
T Consensus       161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  239 (265)
T cd05579         161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV  239 (265)
T ss_pred             cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence            568889999999877664 4899999999999999999999998888777777776666666554  9999999999999


Q ss_pred             CCCCCCCCH---HHHhcCccccc
Q 013421          247 PNPKTRIRI---EGIRKHPWFRK  266 (443)
Q Consensus       247 ~dP~~R~t~---~eil~hp~f~~  266 (443)
                      .+|.+|||+   .++++||||++
T Consensus       240 ~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         240 PDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             CCHhhcCCCccHHHHhcCccccC
Confidence            999999999   99999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-44  Score=342.09  Aligned_cols=256  Identities=28%  Similarity=0.487  Sum_probs=218.6

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR---HPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l   86 (443)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.....  ....+.+.+|+.+++.++   |||++++++++.+....|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            58889999999999999999999999999999876432  224567889999999996   9999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      +|||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..........
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            9999999999998866 588999999999999999999999999999999999999999999999999987665443334


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCC-CCCHHHHHHHHHc
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPF-WFSTGATSLIHKI  244 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~-~~s~~~~~li~~~  244 (443)
                      ....|+..|+|||.+.+....+.++|+||+||++|+|++|..||...+.......+..... ..+. .++.++.+++.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC  238 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHH
Confidence            4557999999999987654446899999999999999999999987665544433333222 2222 2788999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccccccC
Q 013421          245 LDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      |+.||++||++.+++.||||+...
T Consensus       239 l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         239 LDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             cCCCcccCcCHHHHhhChHhhccc
Confidence            999999999999999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-43  Score=342.11  Aligned_cols=252  Identities=33%  Similarity=0.518  Sum_probs=212.5

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||.|++|.||+|.+..+|+.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            589999999999999999999999999999999765422  224567789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           90 FVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        90 y~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |+++ +|.+++...+   .+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++..........
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence            9975 8888886543   58999999999999999999999999999999999999999999999999987554433333


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc------------------cCC
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA------------------EFS  228 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~~~  228 (443)
                      ....+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...                  ...
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            45568899999999876555568999999999999999999999887655444432211                  000


Q ss_pred             -----------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          229 -----------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       229 -----------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                 ..+.+++.+.++|.+||+.||.+||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                       112357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.2e-43  Score=342.59  Aligned_cols=253  Identities=26%  Similarity=0.408  Sum_probs=210.7

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEE------
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLA------   79 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~------   79 (443)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+..|+.+++.+ +||||+++++++.      
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            4578999999999999999999999999999999986542    2345688899999998 7999999999984      


Q ss_pred             eCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421           80 SRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus        80 ~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      .....|++|||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence            356899999999999999998763  458889999999999999999999999999999999999999999999999987


Q ss_pred             CCccccccccccCCCcccCCCccccc-----CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-C-CC
Q 013421          158 LPQQGVELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-S-CP  230 (443)
Q Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~-~~  230 (443)
                      .............|++.|+|||++..     ..+ +.++|+|||||++|+|++|..||...........+..... . .+
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  248 (282)
T cd06636         170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS  248 (282)
T ss_pred             hhhccccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence            55433233445678999999999853     234 4789999999999999999999976554333332222211 1 12


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      ..++.++.+||.+||+.||.+|||+.+|++||||
T Consensus       249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            2478999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.3e-43  Score=342.36  Aligned_cols=254  Identities=30%  Similarity=0.454  Sum_probs=206.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|+||.||+|.+..+|..||+|++.......  ....+.+|+.+++.++|+||+++++++.+....|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            468999999999999999999999999999999987654222  234567899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..........
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            99995 677776654 3567888999999999999999999999999999999999999999999999987544333333


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhhh-cc------------------
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINA-AE------------------  226 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~-~~------------------  226 (443)
                      ....+++.|+|||++.+....+.++||||+||++|+|++|..||...+.. +....+.. ..                  
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            45568999999999876443457899999999999999999999765432 11111100 00                  


Q ss_pred             --C--CCC---------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          227 --F--SCP---------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       227 --~--~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                        .  ..+         ...++++.+++.+||..||++|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence              0  000         0125688999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.6e-43  Score=341.02  Aligned_cols=249  Identities=33%  Similarity=0.533  Sum_probs=206.2

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEE
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASR--TKVYII   87 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lv   87 (443)
                      |++.+.||+|+||.||+|.+..+++.||+|.+.+......  .....+|+.+++++. ||||+++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            7889999999999999999999999999999876432221  223457888998885 99999999999887  899999


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||++ ++|.+.+... ..+++..++.++.|++.||.|||+.|++||||+|+||+++. +.+||+|||++...... ...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~-~~~  155 (282)
T cd07831          79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK-PPY  155 (282)
T ss_pred             EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC-CCc
Confidence            99997 5788888764 57899999999999999999999999999999999999999 99999999998765432 222


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh------------------ccCC
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA------------------AEFS  228 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------~~~~  228 (443)
                      ....+++.|+|||++....+.+.++||||+||++|+|++|.+||.+.+..+....+..                  ..+.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07831         156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN  235 (282)
T ss_pred             CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccccc
Confidence            3456889999999876655566899999999999999999999987765443333221                  0111


Q ss_pred             CC-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          229 CP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       229 ~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      +|           ..++.++.++|.+||++||++|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            11           2368899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=359.20  Aligned_cols=247  Identities=34%  Similarity=0.654  Sum_probs=222.6

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg   94 (443)
                      +.||+|.||+||-|+++.+|+.||||+|++..+...+ ..++++|+.||+.+.||.||.+...|++.+.+++|||.+.| 
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            7899999999999999999999999999998876654 48899999999999999999999999999999999999955 


Q ss_pred             ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC---CeEEeeecCcCCCcccccccccc
Q 013421           95 ELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        95 ~L~~~i~~--~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      +..+.|..  .++++|..-++++.||+.||.|||-++|+|+||||||||+....   ++||||||++++.... ....+.
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsV  726 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSV  726 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhhh
Confidence            66666643  57899999999999999999999999999999999999997543   7999999999988764 445678


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC--C--CCHHHHHHHHHcc
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--W--FSTGATSLIHKIL  245 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~s~~~~~li~~~L  245 (443)
                      +|||.|.|||++.+++|. ..-|+||.|||+|.-|+|..||.+.  ++...+|.+..+.+|+  |  +|+++.+||..+|
T Consensus       727 VGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LL  803 (888)
T KOG4236|consen  727 VGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLL  803 (888)
T ss_pred             cCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence            999999999999999997 8899999999999999999999754  4566678888777764  4  8999999999999


Q ss_pred             CCCCCCCCCHHHHhcCcccccc
Q 013421          246 DPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +..-.+|.|++..+.|||++..
T Consensus       804 qVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  804 QVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHhcchHhhccchhhhcc
Confidence            9999999999999999999864

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=337.43  Aligned_cols=247  Identities=33%  Similarity=0.619  Sum_probs=210.5

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+..|..++ ...+||||+++++++.+.+..|+++||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999999999999999999765433333334445555544 455899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      ++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....    .....|++
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~  157 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTP  157 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCc
Confidence            99999998888899999999999999999999999999999999999999999999999998875433    23456889


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCHHHHHHHHHccCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGATSLIHKILDPNP  249 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L~~dP  249 (443)
                      .|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+.......+    ..+++++.++|.+||+.||
T Consensus       158 ~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  236 (260)
T cd05611         158 DYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP  236 (260)
T ss_pred             CccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCH
Confidence            9999999977664 5899999999999999999999988877777666655443322    3478999999999999999


Q ss_pred             CCCCC---HHHHhcCccccc
Q 013421          250 KTRIR---IEGIRKHPWFRK  266 (443)
Q Consensus       250 ~~R~t---~~eil~hp~f~~  266 (443)
                      ++||+   ++|++.||||++
T Consensus       237 ~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         237 AKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             HHccCCCcHHHHHcChHhhc
Confidence            99994   579999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-43  Score=342.29  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=218.8

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      +.|+..+.||.|+||.||.|.+..++..||+|++.....  ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            568889999999999999999999999999999876532  234578899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||++|++|.+++.. +++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++............
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            99999999998865 67899999999999999999999999999999999999999999999999998665443222334


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHHccCC
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDP  247 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~  247 (443)
                      ..++..|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+... ....+..++..+.+++.+||+.
T Consensus       161 ~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK  239 (277)
T ss_pred             ccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHccc
Confidence            568889999999876655 48999999999999999999999876655444443322 2233345788999999999999


Q ss_pred             CCCCCCCHHHHhcCcccccc
Q 013421          248 NPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       248 dP~~R~t~~eil~hp~f~~~  267 (443)
                      +|++||+++++++||||...
T Consensus       240 ~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         240 DPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             CcccCcCHHHHHhChHhhhc
Confidence            99999999999999999654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.3e-44  Score=347.74  Aligned_cols=257  Identities=26%  Similarity=0.464  Sum_probs=218.6

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      +.|.....||+|+||.||++.+..++..||||.+....   ....+.+.+|+.+++.++||||+++++.+...+..|++|
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            44666788999999999999999999999999986533   234567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++............
T Consensus        99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            99999999988754 57899999999999999999999999999999999999999999999999998755433333345


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---cCCCCCCCCHHHHHHHHHcc
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~~L  245 (443)
                      ..|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+...   .......++..+.+++.+||
T Consensus       178 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  256 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML  256 (292)
T ss_pred             eecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence            6789999999999776664 8999999999999999999999877665544444322   12222347889999999999


Q ss_pred             CCCCCCCCCHHHHhcCccccccCCC
Q 013421          246 DPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                      ..||.+|||++++++||||+....|
T Consensus       257 ~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         257 VREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             cCChhHCcCHHHHhhChhhhccCCc
Confidence            9999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9.8e-44  Score=348.96  Aligned_cols=245  Identities=26%  Similarity=0.440  Sum_probs=192.9

Q ss_pred             eeeeeccCceEEEEEEECC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEe
Q 013421           14 GRTIGEGTFAKVRFAQNRE--TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA--SRTKVYIILE   89 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lv~E   89 (443)
                      +.+||+|+||.||+|.+..  ++..||+|.+.....     ...+.+|+.+++.++||||+++++++.  .+...|++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            3689999999999999754  568899999865431     235678999999999999999999884  4568899999


Q ss_pred             cCCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE----cCCCCeEEeeecCc
Q 013421           90 FVTGGELFDKIVHQ---------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLS  156 (443)
Q Consensus        90 y~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl----~~~~~~kL~DFGls  156 (443)
                      |+. ++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            986 4787777521         247899999999999999999999999999999999999    56679999999999


Q ss_pred             CCCcccc---ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH---------HHHHH---
Q 013421          157 ALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---------TLYKK---  221 (443)
Q Consensus       157 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------~~~~~---  221 (443)
                      .......   .......||+.|+|||++.+....+.++||||+||++|+|++|.+||......         .....   
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            7654321   12345578999999999876555568999999999999999999999653311         00000   


Q ss_pred             ------------hh-------------hccC----------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          222 ------------IN-------------AAEF----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       222 ------------i~-------------~~~~----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                  +.             ....          ......+..+.+||.+||+.||.+|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                        00             0000          0011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.4e-44  Score=340.72  Aligned_cols=253  Identities=26%  Similarity=0.445  Sum_probs=217.2

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+.....  ......+.+|+.+++.++||||+++++.+...+..|+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            468899999999999999999999999999999977542  234577889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           89 EFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      ||+++++|.+++... ..+++..+..++.|++.|+.|||+ .|++||||||+||+++.++.++|+|||.+.......  .
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~  156 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--A  156 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH--h
Confidence            999999999999876 788999999999999999999999 999999999999999999999999999986553321  1


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC-----hHHHHHHhhhc-cCCCCCC-CCHHHHH
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----LPTLYKKINAA-EFSCPFW-FSTGATS  239 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-----~~~~~~~i~~~-~~~~~~~-~s~~~~~  239 (443)
                      ....|+..|+|||.+.+..+. .++||||+|+++|+|++|..||...+     .....+.+... ....+.. +++++.+
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06605         157 KTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD  235 (265)
T ss_pred             hcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence            226788999999999877664 89999999999999999999997642     22333333222 2333333 7899999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      +|.+||..||.+|||+.+++.||||+.
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-43  Score=364.05  Aligned_cols=248  Identities=20%  Similarity=0.304  Sum_probs=204.1

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|....         ..+.+|+.++++++||||+++++++...+..+++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            3479999999999999999999999999999995321         2356899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc--c
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--E  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--~  164 (443)
                      ||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  .
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            99995 6888888664 469999999999999999999999999999999999999999999999999987654321  1


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC--------ChHHHHHHhhhccC---------
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET--------DLPTLYKKINAAEF---------  227 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~--------~~~~~~~~i~~~~~---------  227 (443)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|..|+...        ....+.+.+.....         
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            22345799999999999887765 8999999999999999987654321        11222222222111         


Q ss_pred             --------------------CCCC-----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          228 --------------------SCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       228 --------------------~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                                          ..+.     .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                1111     24678999999999999999999999999999974

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.6e-43  Score=337.79  Aligned_cols=250  Identities=20%  Similarity=0.292  Sum_probs=211.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEEC---CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ..+|++.+.||+|+||.||+|.+.   ..+..||+|.+.....  ......+.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            357999999999999999999765   3467899999876532  23346788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |+||||+++|+|.+++... +.+++..++.++.||+.||+|||++|++||||||+||+++.++.++++|||.+.......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999998764 578999999999999999999999999999999999999999999999999876543221


Q ss_pred             c-cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHH
Q 013421          164 E-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL  240 (443)
Q Consensus       164 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l  240 (443)
                      . ......++..|+|||++.+..+. .++||||+||++|++++ |..||...+.......+..+ ..+.|..++..+.++
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL  240 (266)
T ss_pred             hhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence            1 11123356789999999776664 89999999999999775 99999988777766666544 345566789999999


Q ss_pred             HHHccCCCCCCCCCHHHHhc
Q 013421          241 IHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~  260 (443)
                      +.+||+.+|.+|||+++|++
T Consensus       241 i~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         241 MLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-46  Score=362.74  Aligned_cols=259  Identities=34%  Similarity=0.594  Sum_probs=242.0

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..+.+.+++.+||-|+||.|-++........+|+|++++..+.+....+.+..|-.||..++.|.||++|..|.+...+|
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            45677888999999999999999876655569999999998888878889999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      ++||-|-||+|+..+...+.+++..+++|+..+++|++|||++||++|||||||+++|.+|-+||.|||+++....+ ..
T Consensus       497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-~K  575 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-RK  575 (732)
T ss_pred             hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-Cc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999987765 45


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cCCCCCCCCHHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~  243 (443)
                      ..+.||||.|+|||++.+++.+ .++|+||||+++||||+|.+||.+.+....|+.|.++  ...+|..++..+.+||++
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK  654 (732)
T ss_pred             eeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence            6799999999999999999997 9999999999999999999999999999999998876  467888899999999999


Q ss_pred             ccCCCCCCCCC-----HHHHhcCccccc
Q 013421          244 ILDPNPKTRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       244 ~L~~dP~~R~t-----~~eil~hp~f~~  266 (443)
                      +...+|.+|..     +.+|.+|.||..
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            99999999985     899999999964

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.6e-43  Score=336.10  Aligned_cols=253  Identities=28%  Similarity=0.521  Sum_probs=215.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++.+.+..|++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            47899999999999999999999999999999998765444455567788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           88 LEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +||+++++|.+++..    ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999988853    3458899999999999999999999999999999999999999999999999987665433


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh--HHHHHHhhhccCC-CC-CCCCHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL--PTLYKKINAAEFS-CP-FWFSTGATS  239 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~~~~~~-~~-~~~s~~~~~  239 (443)
                      .......|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||.....  ......+....++ .+ ..++..+.+
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE  239 (267)
T ss_pred             HHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence            334456789999999999776664 889999999999999999999965432  3444444433322 22 247889999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcC
Q 013421          240 LIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ++.+||..+|++||++.++++.
T Consensus       240 li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         240 LVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHCCCCcccCcCHHHHHHH
Confidence            9999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.3e-43  Score=335.05  Aligned_cols=253  Identities=30%  Similarity=0.581  Sum_probs=218.3

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||+|+||.||++.+..+|..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+.+....|+++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            5899999999999999999999999999999997754322 234678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC-eEEeeecCcCCCccccccc
Q 013421           90 FVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        90 y~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~-~kL~DFGls~~~~~~~~~~  166 (443)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.|++|+||||+||++++++. +||+|||.+..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999999997644  4789999999999999999999999999999999999998864 6999999987665433333


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCCCCCHHHHHHHHHcc
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L  245 (443)
                      ....|++.|+|||++.+..+. .++|+||+|+++++|++|..||...+.......+..... ..++.++.++.++|.+||
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  238 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF  238 (257)
T ss_pred             cccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence            445689999999998766654 899999999999999999999988776665555444332 344557899999999999


Q ss_pred             CCCCCCCCCHHHHhcCccc
Q 013421          246 DPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f  264 (443)
                      ..+|++|||+.++++||||
T Consensus       239 ~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         239 KVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ccChhhCcCHHHHhhCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.6e-43  Score=340.73  Aligned_cols=254  Identities=27%  Similarity=0.433  Sum_probs=210.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEE-----e
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLA-----S   80 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~-----~   80 (443)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+ +||||+++++++.     .
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            4568999999999999999999999999999999876432    1235678899999999 7999999999873     4


Q ss_pred             CCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           81 RTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                      .+..|++|||++|++|.+++..    ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            5679999999999999988753    356889999999999999999999999999999999999999999999999998


Q ss_pred             CCCccccccccccCCCcccCCCcccccC----CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---cCCC
Q 013421          157 ALPQQGVELLHTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSC  229 (443)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~  229 (443)
                      ..............|++.|+|||++...    ...+.++||||+||++|+|++|..||...+......++...   ....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ  251 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccC
Confidence            7554332233455799999999998532    11247899999999999999999999876554433333222   1223


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       230 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      |..++..+.++|.+||+.||.+|||+.++++||||
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            44568899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3e-43  Score=343.83  Aligned_cols=258  Identities=25%  Similarity=0.398  Sum_probs=207.9

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT--   82 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--   82 (443)
                      ...+++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.++++++||||+++++++....  
T Consensus         8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   86 (310)
T cd07865           8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATP   86 (310)
T ss_pred             cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence            345788999999999999999999999999999999987543222 22345668999999999999999999986543  


Q ss_pred             ------EEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecC
Q 013421           83 ------KVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (443)
Q Consensus        83 ------~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (443)
                            ..|+||||+. ++|.+.+.... .+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence                  4699999996 47887776543 789999999999999999999999999999999999999999999999999


Q ss_pred             cCCCcccc----ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-----
Q 013421          156 SALPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-----  226 (443)
Q Consensus       156 s~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-----  226 (443)
                      +.......    .......++..|+|||.+.+....+.++||||+|+++|+|++|..||...+.......+....     
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            87554321    122345678899999998665444589999999999999999999998766543322221100     


Q ss_pred             --------------CCC-------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          227 --------------FSC-------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       227 --------------~~~-------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                    ...             +...++.+.+||.+||..||.+|||++++++||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                          000             11136778899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.5e-43  Score=351.12  Aligned_cols=260  Identities=30%  Similarity=0.478  Sum_probs=212.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----   81 (443)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            46789999999999999999999999999999999875432 233446677899999999999999999988543     


Q ss_pred             -CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        82 -~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                       ...|+||||+. ++|.+.+...  +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence             35799999995 5888877653  8999999999999999999999999999999999999999999999999987654


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------------  225 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------  225 (443)
                      .. .......|++.|+|||.+.+..+. .++|||||||++|+|++|..||...+....+.++...               
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         170 TS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CC-CCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence            32 223455689999999999887765 8999999999999999999999876643333222110               


Q ss_pred             -------cCC--------------C-------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCCCC
Q 013421          226 -------EFS--------------C-------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK  272 (443)
Q Consensus       226 -------~~~--------------~-------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~~~  272 (443)
                             ...              .       +...++.+.++|.+||+.||++|||+.|++.||||+.-+.+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~  322 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE  322 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence                   000              0       1123567899999999999999999999999999986655433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.8e-43  Score=341.31  Aligned_cols=252  Identities=23%  Similarity=0.378  Sum_probs=215.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCC-----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETG-----ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      .+++|++.+.||+|+||.||+|.+...+     ..||+|.+....  .......+.+|+.+++.++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            3568999999999999999999876554     689999986543  233456789999999999999999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY  145 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~  145 (443)
                      ...|++|||+++++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||+++++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            9999999999999999999764                457888999999999999999999999999999999999999


Q ss_pred             CCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHh
Q 013421          146 GNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI  222 (443)
Q Consensus       146 ~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i  222 (443)
                      +.+||+|||++.......  .......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999987543221  223345678899999998776664 89999999999999998 99999988877777776


Q ss_pred             hhcc-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          223 NAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       223 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .... ...|..+++++.+|+.+||+.||.+||++.+|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            5543 34566789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.2e-43  Score=341.79  Aligned_cols=257  Identities=30%  Similarity=0.443  Sum_probs=212.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +++|++.+.||+|++|.||+|.+..+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            47899999999999999999999999999999998664322 22346688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-CCCeEEeeecCcCCCccccc
Q 013421           88 LEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~~~~  164 (443)
                      |||++ ++|.+.+.....  +++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++........
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            99995 578888765443  578889999999999999999999999999999999985 45799999999876544333


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-------------------
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------  225 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------  225 (443)
                      ......|++.|+|||++.+....+.++||||+||++|+|++|.+||...+......++...                   
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence            3345568899999999866544458999999999999999999999876554443332110                   


Q ss_pred             ----cCC------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          226 ----EFS------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       226 ----~~~------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                          .+.      ..+.+++++.+++.+||+.||.+||++.+++.||||..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~  289 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD  289 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence                000      12346888999999999999999999999999999975

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.8e-43  Score=338.58  Aligned_cols=255  Identities=25%  Similarity=0.416  Sum_probs=219.4

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      -|++.+.||+|+||.||+|.+..++..||+|++.....  ......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            47888999999999999999998999999999865432  2245678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccccc
Q 013421           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      |+++++|.+++.. ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++.............
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            9999999988865 578999999999999999999999999999999999999999999999999986554432223345


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHHccCCC
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPN  248 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~d  248 (443)
                      .|+..|+|||.+.+...+ .++|+||+||++|+|++|..||...+.......+... ....+..++.++.++|.+||+.+
T Consensus       162 ~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  240 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE  240 (277)
T ss_pred             cCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence            688999999998765554 8899999999999999999999876655555544433 23345568999999999999999


Q ss_pred             CCCCCCHHHHhcCccccccC
Q 013421          249 PKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       249 P~~R~t~~eil~hp~f~~~~  268 (443)
                      |.+||++.++++||||.+..
T Consensus       241 p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         241 PSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             hhhCcCHHHHHhCHHHhhhh
Confidence            99999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-43  Score=341.33  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=217.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ..+|++++.||+|+||+||++.+..+|+.||+|++....  .....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            468999999999999999999999999999999987543  233457889999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++......  ..
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~  159 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IA  159 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--cc
Confidence            9999999999999887889999999999999999999997 69999999999999999999999999998654322  22


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-----------HHHHHhhhc-cCCCCCC-C
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-----------TLYKKINAA-EFSCPFW-F  233 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-----------~~~~~i~~~-~~~~~~~-~  233 (443)
                      ...+|+..|+|||++.+..+ +.++||||+||++|+|++|..||......           .....+... ....+.. +
T Consensus       160 ~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF  238 (284)
T ss_pred             CccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence            34579999999999876655 48999999999999999999999864431           222222222 2222222 7


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      +.++.+||.+||++||.+|||++|+++||||....
T Consensus       239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            88999999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-43  Score=330.03  Aligned_cols=253  Identities=30%  Similarity=0.511  Sum_probs=223.2

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|++++++++|||++++++++.+....|++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            589999999999999999999999999999999876533 2356789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccccc
Q 013421           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      |+++++|.+++...+.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.............
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            99999999999988899999999999999999999999999999999999999999999999999998765544434556


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHh-hhccCCCCCCCCHHHHHHHHHccCCC
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIHKILDPN  248 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i-~~~~~~~~~~~s~~~~~li~~~L~~d  248 (443)
                      .|+..|+|||.+.+..+ +.++||||+|+++|+|++|..||...+......+. .......+..++..+.+++.+||..+
T Consensus       160 ~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  238 (254)
T cd06627         160 VGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD  238 (254)
T ss_pred             ccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence            78999999999876664 58999999999999999999999876644333333 33444566678999999999999999


Q ss_pred             CCCCCCHHHHhcCccc
Q 013421          249 PKTRIRIEGIRKHPWF  264 (443)
Q Consensus       249 P~~R~t~~eil~hp~f  264 (443)
                      |++|||+.+++.||||
T Consensus       239 p~~R~~~~~~l~~~~~  254 (254)
T cd06627         239 PNLRPTAKQLLKHPWI  254 (254)
T ss_pred             hhhCcCHHHHhcCCCC
Confidence            9999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5e-43  Score=333.85  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=222.7

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      .+|++.+.||+|++|.||+|.+..+++.||+|++......  .....+.+|+..++.++||||+++++++......|++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            3689999999999999999999999999999998765422  34577899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      ||+++++|.+++.....+++.....++.|++.|+.|||+ .|++||||+|+||+++.++.++|+|||++...........
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            999999999999888889999999999999999999999 9999999999999999999999999999876654433334


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC---ChHHHHHHhhhc-cCCCCCC-CCHHHHHHHH
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---DLPTLYKKINAA-EFSCPFW-FSTGATSLIH  242 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~-~~~~~~~-~s~~~~~li~  242 (443)
                      ...|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...   ...+....+... ....+.. ++..+.++|.
T Consensus       159 ~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  237 (264)
T cd06623         159 TFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS  237 (264)
T ss_pred             ceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence            5678899999999877654 58999999999999999999999776   344444444432 3344445 7899999999


Q ss_pred             HccCCCCCCCCCHHHHhcCccccc
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      +||.++|++|||+.++++||||+.
T Consensus       238 ~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         238 ACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHccCChhhCCCHHHHHhCHHHHh
Confidence            999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-43  Score=332.90  Aligned_cols=247  Identities=40%  Similarity=0.725  Sum_probs=223.9

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCCCh
Q 013421           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (443)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L   96 (443)
                      ||.|+||.||++.+..+++.+|+|++.+.........+.+..|+.+++.++||||+++++.+.++...|++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999989999999999887655555667899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcccC
Q 013421           97 FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV  176 (443)
Q Consensus        97 ~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~  176 (443)
                      .+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............|+..|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL  160 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence            99999888899999999999999999999999999999999999999999999999999876554333345567899999


Q ss_pred             CCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCCCH-
Q 013421          177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI-  255 (443)
Q Consensus       177 aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-  255 (443)
                      |||...+... +.++|+||||+++|+|++|..||...+.......+....++.|..++..+.++|++||..||.+||++ 
T Consensus       161 ~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~  239 (250)
T cd05123         161 APEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG  239 (250)
T ss_pred             ChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence            9999876554 48899999999999999999999888777777777777788888899999999999999999999999 


Q ss_pred             --HHHhcCccc
Q 013421          256 --EGIRKHPWF  264 (443)
Q Consensus       256 --~eil~hp~f  264 (443)
                        +++++||||
T Consensus       240 ~~~~l~~~~~f  250 (250)
T cd05123         240 GAEEIKAHPFF  250 (250)
T ss_pred             cHHHHHhCCCC
Confidence              999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-43  Score=339.58  Aligned_cols=252  Identities=33%  Similarity=0.462  Sum_probs=211.1

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      |++.+.||.|++|.||+|.+..+|..||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            67889999999999999999999999999999765432 22335677899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           91 VTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        91 ~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ++ ++|.+++....  .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++............
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            95 68999987765  6899999999999999999999999999999999999999999999999998755433333344


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-----------------------
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-----------------------  225 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-----------------------  225 (443)
                      ..+++.|+|||++.+....+.++||||+|+++|+|++|.+||...+......++...                       
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP  238 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence            567889999998866544458899999999999999999999876653332222110                       


Q ss_pred             c------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          226 E------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       226 ~------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      .      ......++..+.++|.+||++||.+|||+++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            0      01123467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.6e-43  Score=338.24  Aligned_cols=254  Identities=28%  Similarity=0.474  Sum_probs=218.2

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      .|.-.+.||+|++|.||++.+..+++.+|+|.++...   ....+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            4566689999999999999999899999999986533   2234568899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccccc
Q 013421           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      |++|++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.............
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            9999999999887 779999999999999999999999999999999999999999999999999876544332233445


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC---CCCCCCHHHHHHHHHccC
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS---CPFWFSTGATSLIHKILD  246 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~li~~~L~  246 (443)
                      .|++.|+|||.+.+..+. .++||||+||++|+|++|..||...+.......+......   .+..++..+.+++.+||+
T Consensus       176 ~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (285)
T cd06648         176 VGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLV  254 (285)
T ss_pred             cCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence            689999999999776654 8999999999999999999999887766555555544222   223378999999999999


Q ss_pred             CCCCCCCCHHHHhcCccccccC
Q 013421          247 PNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       247 ~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .+|++|||+.++++||||++..
T Consensus       255 ~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         255 RDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             cChhhCcCHHHHccCcccccCC
Confidence            9999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.2e-43  Score=334.66  Aligned_cols=248  Identities=28%  Similarity=0.440  Sum_probs=208.8

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      ...||+|+||.||+|.+..++..||+|.+....   .+..+.+.+|+.+++.++|+||+++++++...+..|+++||+++
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   89 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG   89 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence            468999999999999999999999999887543   23456789999999999999999999999999999999999999


Q ss_pred             CChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-CCCeEEeeecCcCCCcccccccccc
Q 013421           94 GELFDKIVHQ-GRL--LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        94 g~L~~~i~~~-~~l--~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      ++|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.............
T Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  169 (268)
T cd06624          90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF  169 (268)
T ss_pred             CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccC
Confidence            9999999864 455  78889999999999999999999999999999999986 6799999999987654333333445


Q ss_pred             CCCcccCCCcccccCC-CCCCccchHHHHHHHHHHhhCCCCCCCCChHH--HHHH-hhhccCCCCCCCCHHHHHHHHHcc
Q 013421          170 CGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPT--LYKK-INAAEFSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~--~~~~-i~~~~~~~~~~~s~~~~~li~~~L  245 (443)
                      .|++.|+|||++.+.. ..+.++|+||+|+++|+|++|..||.......  .... ........|..+++++.+++.+||
T Consensus       170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  249 (268)
T cd06624         170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCF  249 (268)
T ss_pred             CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHc
Confidence            6899999999986533 23589999999999999999999997644322  1111 223334566778999999999999


Q ss_pred             CCCCCCCCCHHHHhcCccc
Q 013421          246 DPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f  264 (443)
                      +.+|.+|||+.+++.||||
T Consensus       250 ~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         250 EPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             CCCchhCCCHHHHHhCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.8e-43  Score=356.09  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=206.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~   81 (443)
                      .++|++++.||+|+||.||+|++..+     +..||+|++.....  ....+.+.+|+.+++.+ +||||+++++.+...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            44799999999999999999986443     45899999976542  22356788999999999 899999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhc----------------------------------------------------------
Q 013421           82 TKVYIILEFVTGGELFDKIVHQ----------------------------------------------------------  103 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~----------------------------------------------------------  103 (443)
                      ...|+||||+++|+|.+++...                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            9999999999999999998642                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc--ccccc
Q 013421          104 ------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTT  169 (443)
Q Consensus       104 ------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~~~~~  169 (443)
                                  .++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  ...+.
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                        2467888999999999999999999999999999999999999999999999875433211  11223


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc--cCCCCCCCCHHHHHHHHHccC
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA--EFSCPFWFSTGATSLIHKILD  246 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~  246 (443)
                      .+++.|+|||++.+..+. .++||||+||++|+|++ |..||...............  ....|..+++++.++|.+||+
T Consensus       275 ~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  353 (374)
T cd05106         275 RLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN  353 (374)
T ss_pred             CCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence            356679999999776664 89999999999999997 99999875544333332222  345566789999999999999


Q ss_pred             CCCCCCCCHHHHhc
Q 013421          247 PNPKTRIRIEGIRK  260 (443)
Q Consensus       247 ~dP~~R~t~~eil~  260 (443)
                      .||.+|||++++++
T Consensus       354 ~dp~~RPs~~~l~~  367 (374)
T cd05106         354 LEPTERPTFSQISQ  367 (374)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.2e-43  Score=342.30  Aligned_cols=250  Identities=21%  Similarity=0.309  Sum_probs=204.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC----------------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE----------------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI   71 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI   71 (443)
                      -++|++.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.+++.++||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence            4689999999999999999998642                34479999987643  23345678999999999999999


Q ss_pred             ceEEEEEEeCCEEEEEEecCCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEe
Q 013421           72 VRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-------------------RLLENDCRRYFQQLIDAVAHCHSKGVYH  132 (443)
Q Consensus        72 v~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-------------------~l~e~~~~~~~~qll~aL~yLH~~gi~H  132 (443)
                      +++++++.+.+..|++|||+++|+|.+++....                   .+++..+..++.||+.||.|||+.||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999999999999999999999999986532                   3567788999999999999999999999


Q ss_pred             ecCCCCcEEEcCCCCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh--CCC
Q 013421          133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA--GYL  208 (443)
Q Consensus       133 rDlkp~NILl~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~--G~~  208 (443)
                      |||||+|||++.++.+||+|||++.......  .......++..|+|||++.+..+ +.++|||||||++|+|++  +..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999987543321  12234456788999999877665 489999999999999986  678


Q ss_pred             CCCCCChHHHHHHhhh--------ccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          209 PFGETDLPTLYKKINA--------AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       209 Pf~~~~~~~~~~~i~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ||...+.......+..        .....|+.+++.+.+|+.+||+.||.+|||+++|.+
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            8887665554433211        112335567899999999999999999999999843

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7.7e-44  Score=343.22  Aligned_cols=254  Identities=26%  Similarity=0.427  Sum_probs=216.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      +.|+..+.||+|+||.||+|.+..++..||+|.+.....  ....+.+.+|+.+++.++||||+++++.+..++..|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            457788999999999999999999999999999875432  234567899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||+++++|.+++.. +.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence            99999999998864 67899999999999999999999999999999999999999999999999998765443222334


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHHHHccCC
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDP  247 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~  247 (443)
                      ..|+..|+|||++.+..+. .++|+||+||++|+|++|..||...........+.... ...+..++.++.++|.+||+.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK  239 (277)
T ss_pred             ccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccC
Confidence            5688999999999876654 89999999999999999999997655444443333322 223345788999999999999


Q ss_pred             CCCCCCCHHHHhcCccccc
Q 013421          248 NPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       248 dP~~R~t~~eil~hp~f~~  266 (443)
                      +|.+|||+.++++||||..
T Consensus       240 ~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         240 DPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             CcccCcCHHHHHHhHHHHH
Confidence            9999999999999999965

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.4e-43  Score=337.27  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=207.3

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .+|++.+.||+|+||.||+|++..+|+.||+|.+.......  ....+..|+.+ ++.++||||+++++++..++..|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            47999999999999999999999999999999997654322  23445556665 6677999999999999999999999


Q ss_pred             EecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           88 LEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      |||++ |+|.+++..    ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99996 577776653    34689999999999999999999997 9999999999999999999999999998765332


Q ss_pred             cccccccCCCcccCCCccccc----CCCCCCccchHHHHHHHHHHhhCCCCCCCCCh--HHHHHHhhhccCCCC-CCCCH
Q 013421          163 VELLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDL--PTLYKKINAAEFSCP-FWFST  235 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~~~~~~~~-~~~s~  235 (443)
                       .......|+..|+|||++.+    .++ +.++|+||+||++|+|++|..||.....  ......+.......| ..+|.
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd06617         158 -VAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSP  235 (283)
T ss_pred             -cccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCH
Confidence             12233568899999998854    223 4789999999999999999999975322  222222333333333 24789


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ++.++|.+||..+|.+|||+++++.||||++..
T Consensus       236 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         236 EFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.4e-43  Score=336.85  Aligned_cols=247  Identities=24%  Similarity=0.459  Sum_probs=205.7

Q ss_pred             cccCeEEeeee--eccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013421            7 RVAKYEVGRTI--GEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (443)
Q Consensus         7 ~~~~y~i~~~L--G~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   83 (443)
                      ..++|++.+.+  |+|+||.||++.++.++..+|+|++.......        .|+.....+ +||||+++++.+...+.
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            34577887776  99999999999999999999999987643221        122222222 79999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC-CeEEeeecCcCCCccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQG  162 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~  162 (443)
                      .|+||||+++++|.+++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            999999999999999998878999999999999999999999999999999999999999988 9999999988755332


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHH----HHHhhhccCCCCCCCCHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL----YKKINAAEFSCPFWFSTGAT  238 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~  238 (443)
                          ....|++.|+|||++.+..+. .++|+||+||++|+|++|..||........    ...........+..+|+.+.
T Consensus       164 ----~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T PHA03390        164 ----SCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAN  238 (267)
T ss_pred             ----ccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHH
Confidence                234689999999999877764 899999999999999999999976543221    11112333445556899999


Q ss_pred             HHHHHccCCCCCCCCC-HHHHhcCccccc
Q 013421          239 SLIHKILDPNPKTRIR-IEGIRKHPWFRK  266 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t-~~eil~hp~f~~  266 (443)
                      +||.+||++||.+||+ ++++++||||++
T Consensus       239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        239 DFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            9999999999999996 699999999963

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-42  Score=328.81  Aligned_cols=253  Identities=32%  Similarity=0.576  Sum_probs=223.4

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||.|+||.||++.+..+++.||+|++...... .+....+.+|+++++.++|||++++++.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            589999999999999999999999999999999765432 2345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           90 FVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        90 y~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      |+++++|.+.+...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            99999999999764    67899999999999999999999999999999999999999999999999998766554334


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHHHHc
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~  244 (443)
                      ....+|++.|+|||.+.+..+. .++|+||+|+++++|++|..||...+............ ...|..++..+.+++.+|
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL  238 (258)
T ss_pred             ecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            4556789999999998776654 88999999999999999999998887766666554443 344556899999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccc
Q 013421          245 LDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f  264 (443)
                      |..+|++|||+.++++||||
T Consensus       239 l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         239 LQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             cCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=344.88  Aligned_cols=252  Identities=25%  Similarity=0.445  Sum_probs=220.3

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      |.++.+||+|+||.||+|+++++|..+|||.+..+.     ....+.+||.+|++++.|++|++|+.|-....+|+||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            778999999999999999999999999999886543     467788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccccc
Q 013421           91 VTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        91 ~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      |..|+..+.++. +.+++|+++..+++.-+.||+|||...-+|||||..|||++.+|+.||+|||.+..........++.
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV  189 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV  189 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence            999999999975 4689999999999999999999999999999999999999999999999999987655444455788


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc---CCCCCCCCHHHHHHHHHccC
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLIHKILD  246 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~~L~  246 (443)
                      .|||.|||||++..-+|+ .++||||||++..||.-|++||.+-......-.|-...   +.-|..-|.++-+|+++||.
T Consensus       190 IGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi  268 (502)
T KOG0574|consen  190 IGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI  268 (502)
T ss_pred             ccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence            999999999999999997 89999999999999999999997655433222222211   12233358889999999999


Q ss_pred             CCCCCCCCHHHHhcCccccccC
Q 013421          247 PNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       247 ~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ++|++|.|+-++++|||+++..
T Consensus       269 K~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  269 KKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             CCHHHHHHHHHHhhhhhhcCCC
Confidence            9999999999999999998654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-44  Score=352.11  Aligned_cols=241  Identities=27%  Similarity=0.455  Sum_probs=211.4

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      +.+++.||+|-||+||.|.+. ....||+|.+.......    +.+.+|+.+|++|+|+|||++++++..+..+||||||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~  282 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY  282 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence            455789999999999999985 34579999997654332    5677999999999999999999999998899999999


Q ss_pred             CCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           91 VTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        91 ~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ++.|+|.+++..  ...+...+...++.||++|++||+++++|||||-..|||++++..+||+||||++....+  ....
T Consensus       283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~--~Y~~  360 (468)
T KOG0197|consen  283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD--EYTA  360 (468)
T ss_pred             cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC--ceee
Confidence            999999999987  456888999999999999999999999999999999999999999999999999944332  2222


Q ss_pred             cCC---CcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHH
Q 013421          169 TCG---TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       169 ~~g---t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~  243 (443)
                      ..|   ..-|.|||.+....+. .+||||||||+|+||+| |+.||++.+..+..+.+..+ +.+.|..+|+++.+++..
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~  439 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKS  439 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Confidence            222   2359999999877765 99999999999999998 99999999999999988776 688999999999999999


Q ss_pred             ccCCCCCCCCCHHHHh
Q 013421          244 ILDPNPKTRIRIEGIR  259 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil  259 (443)
                      |+..+|++|||++.+.
T Consensus       440 CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  440 CWHEDPEDRPTFETLR  455 (468)
T ss_pred             HhhCCcccCCCHHHHH
Confidence            9999999999999654

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-42  Score=340.21  Aligned_cols=257  Identities=25%  Similarity=0.378  Sum_probs=215.6

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+........+....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            34569999999999999999999999999999999876544444455678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           87 ILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      |+||+. |++.+.+.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++......   
T Consensus        93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607          93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence            999996 567676654 457899999999999999999999999999999999999999999999999988654332   


Q ss_pred             ccccCCCcccCCCccccc--CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-CCC-CCCCCHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSC-PFWFSTGATSLI  241 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~-~~~~s~~~~~li  241 (443)
                       ....|++.|+|||++.+  ....+.++||||+|+++|+|++|..||...+.......+.... ... +...+..+.++|
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  247 (307)
T cd06607         169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV  247 (307)
T ss_pred             -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence             34568889999998742  2333589999999999999999999998776655444443322 222 223678999999


Q ss_pred             HHccCCCCCCCCCHHHHhcCccccccC
Q 013421          242 HKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .+||..||.+||++.+++.||||....
T Consensus       248 ~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         248 DSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHhcCChhhCcCHHHHhcChhhcccC
Confidence            999999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.1e-43  Score=340.93  Aligned_cols=259  Identities=26%  Similarity=0.441  Sum_probs=218.9

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +...++|++.+.||+|+||.||++.+..++..||+|.+....   ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence            344678999999999999999999998899999999986532   22346788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+|+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999999999998865 4688999999999999999999999999999999999999999999999998875544333


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh-c--cCCCCCCCCHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-A--EFSCPFWFSTGATSLI  241 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-~--~~~~~~~~s~~~~~li  241 (443)
                      ......|++.|+|||.+.+..+ +.++|+||+||++|++++|..||...+.......+.. .  .+..+..++..+.++|
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  249 (293)
T ss_pred             ccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence            3344578999999999877665 4899999999999999999999987654333222221 1  1222334688999999


Q ss_pred             HHccCCCCCCCCCHHHHhcCccccccC
Q 013421          242 HKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .+||..+|.+||++++++.||||+...
T Consensus       250 ~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         250 NRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-43  Score=347.15  Aligned_cols=258  Identities=29%  Similarity=0.442  Sum_probs=209.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----T   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~   82 (443)
                      -++|++.+.||+|+||.||+|.+..+|+.||+|.+....  .......+.+|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            468999999999999999999999999999999986422  223456678899999999999999999887543     3


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      ..|+++||+. ++|.+.+.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            5899999996 478777744 67999999999999999999999999999999999999999999999999998754332


Q ss_pred             c---ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh---------------
Q 013421          163 V---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA---------------  224 (443)
Q Consensus       163 ~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---------------  224 (443)
                      .   ......+|++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..               
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            1   1223457899999999876544446899999999999999999999977654322211100               


Q ss_pred             ---------cc--CC-----CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          225 ---------AE--FS-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       225 ---------~~--~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                               ..  ..     ..+.+++++.++|.+||+.||.+|||+.++++||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                     00  00     01235788999999999999999999999999999986654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-44  Score=334.54  Aligned_cols=261  Identities=31%  Similarity=0.580  Sum_probs=239.1

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   83 (443)
                      ...+.+|++++.||+|+|++|.+++++.|.+.+|+|+++++-+.+.+.++.+..|-.+..+- +||.+|-++..|+++..
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr  325 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR  325 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence            34577999999999999999999999999999999999999888888888888898888766 79999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +++|.||.+||+|--.++++.+++|+.++.|...|+.||.|||++||++||||.+|+|+|..|++||+|+|+++.--.+.
T Consensus       326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            99999999999999889999999999999999999999999999999999999999999999999999999998665556


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCC--------CChHHHHHHhhhccCCCCCCCCH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE--------TDLPTLYKKINAAEFSCPFWFST  235 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~--------~~~~~~~~~i~~~~~~~~~~~s~  235 (443)
                      ...++.||||.|.|||++.+..| +..+|+|+|||+++||++|+.||+-        .+..-+++-|......+|..+|-
T Consensus       406 d~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsv  484 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSV  484 (593)
T ss_pred             cccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeeh
Confidence            77889999999999999999887 5999999999999999999999953        22334677788888999999999


Q ss_pred             HHHHHHHHccCCCCCCCC------CHHHHhcCccccc
Q 013421          236 GATSLIHKILDPNPKTRI------RIEGIRKHPWFRK  266 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~------t~~eil~hp~f~~  266 (443)
                      .+..+++..|++||.+|.      .+.++..||||+.
T Consensus       485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            999999999999999997      4689999999974

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2e-42  Score=327.45  Aligned_cols=253  Identities=32%  Similarity=0.538  Sum_probs=220.5

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--TKVYII   87 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv   87 (443)
                      +|++.+.||+|++|.||+|.+..++..|++|++...... ....+.+.+|+.++++++||||+++++.+.+.  ...+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            588999999999999999999999999999999776532 34567899999999999999999999999988  899999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc--c
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--L  165 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~  165 (443)
                      +||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999876655322  1


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC-hHHHHHHhh--hccCCCCCCCCHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYKKIN--AAEFSCPFWFSTGATSLIH  242 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~--~~~~~~~~~~s~~~~~li~  242 (443)
                      .....++..|+|||.+....+ +.++||||+|+++|+|++|..||...+ .......+.  ......|..++..+.++|.
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  238 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR  238 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence            345678999999999876654 589999999999999999999998765 223333333  2334456667999999999


Q ss_pred             HccCCCCCCCCCHHHHhcCccc
Q 013421          243 KILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      +||..||.+||++.++++||||
T Consensus       239 ~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         239 KCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=330.14  Aligned_cols=254  Identities=31%  Similarity=0.501  Sum_probs=216.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--TKV   84 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~   84 (443)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+.....  ...+....+.+|+.++++++||||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            479999999999999999999999999999999864321  1233457889999999999999999999998654  568


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc--
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--  162 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--  162 (443)
                      ++++||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            999999999999999988788999999999999999999999999999999999999999999999999998754321  


Q ss_pred             -cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cCCCCCCCCHHHHH
Q 013421          163 -VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFWFSTGATS  239 (443)
Q Consensus       163 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~  239 (443)
                       ........|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||..........++...  ....|..+++.+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  240 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD  240 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence             112234568999999999987665 48999999999999999999999876554444443322  34467778999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCccc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      +|.+||+ +|.+||++.+++.|||.
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhcCCCC
Confidence            9999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-43  Score=342.74  Aligned_cols=254  Identities=28%  Similarity=0.436  Sum_probs=206.0

Q ss_pred             CeEEeeeeeccCceEEEEEEECC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRE--TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--TKVY   85 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~   85 (443)
                      +|++.+.||+|+||.||+|.+..  ++..||+|.+...........+.+.+|+.+++.++||||+++++++.+.  ..+|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  8999999999875422233346678899999999999999999999888  8899


Q ss_pred             EEEecCCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC----CCCeEEeeecCc
Q 013421           86 IILEFVTGGELFDKIVHQ-----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS----YGNLKVSDFGLS  156 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~----~~~~kL~DFGls  156 (443)
                      +||||+++ +|.+.+...     ..+++..++.++.|++.||.|||++||+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999965 677766432     36899999999999999999999999999999999999999    899999999998


Q ss_pred             CCCccccc---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHH---------HHHHh--
Q 013421          157 ALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT---------LYKKI--  222 (443)
Q Consensus       157 ~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~---------~~~~i--  222 (443)
                      ........   .....++++.|+|||++.+....+.++|||||||++|+|++|++||...+...         ....+  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            76543221   23345788999999988765444589999999999999999999997544221         00000  


Q ss_pred             ------------------------hhccCCCC-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          223 ------------------------NAAEFSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       223 ------------------------~~~~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                              ......++           ...+.++.++|.+||+.||++|||+++++.||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence                                    00001111           1457789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.1e-43  Score=353.58  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=206.3

Q ss_pred             cCeEEeeeeeccCceEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~   82 (443)
                      ++|++++.||+|+||.||+|.+     ..++..||+|++.....  ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            4799999999999999999974     34677899999865432  22346788999999999 8999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcC----------------------------------------------------------
Q 013421           83 KVYIILEFVTGGELFDKIVHQG----------------------------------------------------------  104 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~----------------------------------------------------------  104 (443)
                      ..|+||||+++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999986532                                                          


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc--c
Q 013421          105 -----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--L  165 (443)
Q Consensus       105 -----------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~  165 (443)
                                       .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence                             367788899999999999999999999999999999999999999999999875543211  1


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChH-HHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP-TLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      .....++..|+|||++.+..+. .++|||||||++|+|++ |..||...... ...+.+..+ ....|...+.++.+||.
T Consensus       273 ~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  351 (375)
T cd05104         273 KGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK  351 (375)
T ss_pred             cCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHH
Confidence            1223356679999999876664 89999999999999997 99999875543 333333333 23345567899999999


Q ss_pred             HccCCCCCCCCCHHHHhcC
Q 013421          243 KILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~h  261 (443)
                      +||+.||++|||+.+|++.
T Consensus       352 ~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         352 SCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHccCChhHCcCHHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4e-43  Score=342.41  Aligned_cols=256  Identities=27%  Similarity=0.476  Sum_probs=218.1

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ..|+....||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++...+..|+++
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            346667789999999999999998999999999875432   22456889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      ||+++++|.+.+.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++............
T Consensus        98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659          98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            99999999887754 67899999999999999999999999999999999999999999999999998755443233345


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc---CCCCCCCCHHHHHHHHHcc
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~~L  245 (443)
                      .+|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+....   ...+..++..+.++|.+||
T Consensus       177 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l  255 (297)
T cd06659         177 LVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML  255 (297)
T ss_pred             eecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence            679999999999977665 489999999999999999999998776555555443322   2223457889999999999


Q ss_pred             CCCCCCCCCHHHHhcCccccccCC
Q 013421          246 DPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                      +.+|.+||+++++++||||.+...
T Consensus       256 ~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         256 TREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             cCCcccCcCHHHHhhChhhccCCC
Confidence            999999999999999999986553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.3e-43  Score=347.62  Aligned_cols=259  Identities=30%  Similarity=0.436  Sum_probs=214.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----T   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~   82 (443)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            35799999999999999999999999999999998764322 22345677899999999999999999987644     3


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      ..|+++||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            5899999995 689999988889999999999999999999999999999999999999999999999999998765443


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh------------------
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA------------------  224 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------  224 (443)
                      ........|+..|+|||.+.+....+.++||||+||++|+|++|.+||.+.+.......+..                  
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence            33345567899999999986544456899999999999999999999987654322221110                  


Q ss_pred             -------c---cC---CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          225 -------A---EF---SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       225 -------~---~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                             .   ..   ...+.+++++.++|++||+.||++|||++++++||||....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence                   0   00   01234789999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.9e-43  Score=334.17  Aligned_cols=252  Identities=29%  Similarity=0.532  Sum_probs=214.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +++|++.+.||+|+||.||+|++..+++.+|+|.+.............+.+|+.+++.++||||+++++++.+++..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            46899999999999999999999999999999988765444444557788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           88 LEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999999998864    3468999999999999999999999999999999999999999999999999987665443


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh--HHHHHHhhhccCC-C-CCCCCHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL--PTLYKKINAAEFS-C-PFWFSTGATS  239 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~~~~~~-~-~~~~s~~~~~  239 (443)
                      ......+|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||.....  ......+....++ . +..+++.+.+
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ  239 (267)
T ss_pred             cccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence            344556799999999999776664 889999999999999999999975433  2333444433322 2 2347899999


Q ss_pred             HHHHccCCCCCCCCCHHHHhc
Q 013421          240 LIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~  260 (443)
                      +|.+||+.||.+|||+.+|++
T Consensus       240 li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         240 LVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHhcCCCcccCCCHHHHHH
Confidence            999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.6e-42  Score=329.75  Aligned_cols=251  Identities=29%  Similarity=0.545  Sum_probs=214.6

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.++++++|+||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999999999999987654444444678899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           89 EFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        89 Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            99999999998864    24589999999999999999999999999999999999999999999999999876544333


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC--hHHHHHHhhhccC-CCCC-CCCHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINAAEF-SCPF-WFSTGATSL  240 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~-~~~~-~~s~~~~~l  240 (443)
                      ......|++.|+|||.+.+..+. .++|+||+||++|+|++|..||....  .......+..+.. +.|. .++..+.++
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL  240 (267)
T ss_pred             ccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHH
Confidence            34456789999999999876664 89999999999999999999996543  2334444433322 2333 578899999


Q ss_pred             HHHccCCCCCCCCCHHHHhc
Q 013421          241 IHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~  260 (443)
                      |.+||..+|++|||+.+|++
T Consensus       241 i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         241 VSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-44  Score=358.75  Aligned_cols=244  Identities=34%  Similarity=0.621  Sum_probs=216.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~   85 (443)
                      ....|++...+|.|+|+.|..+.+..+++.+++|++.+...       +..+|+.++... +||||+++++++.+....|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence            46789999999999999999999999999999999987632       234677666665 7999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE-cCCCCeEEeeecCcCCCccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL-DSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl-~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      +|||++.|+.+.+.+.....+. .++..|+.||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.+......  
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999999999999998866555 7888899999999999999999999999999999 58899999999998765443  


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                       +.+.|-|..|+|||++...+|+ +++||||||++||+||+|+.||...... ++...+..+.++  .++|.++++||++
T Consensus       470 -~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~  545 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQ  545 (612)
T ss_pred             -hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHH
Confidence             5677889999999999988886 9999999999999999999999875444 666667666555  7899999999999


Q ss_pred             ccCCCCCCCCCHHHHhcCccc
Q 013421          244 ILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f  264 (443)
                      ||+.||.+|+++.+++.||||
T Consensus       546 LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  546 LLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             hccCChhhCcChhhhccCcch
Confidence            999999999999999999999

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-44  Score=306.83  Aligned_cols=257  Identities=35%  Similarity=0.523  Sum_probs=221.3

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      .+|.-.++||+|+||+||+|+++++++.||+|.+..+.. ++.......+||.+++.++|.|||+++++..++..+-+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            457778899999999999999999999999999987653 2334467789999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        89 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |||. .+|..+... ++.++.+.++.++.|++.||.+||++++.|||+||.|+||+.+|.+|++|||+++.+.-+..-.+
T Consensus        81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence            9995 477777755 57899999999999999999999999999999999999999999999999999998877666666


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHh-hCCCCCCCCChHHHHHHhhhc-------cC------------
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM-AGYLPFGETDLPTLYKKINAA-------EF------------  227 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~-------~~------------  227 (443)
                      ..+-|.+|++|.++.+...++...|+||.|||+.|+. +|++.|++.+......+|-..       .+            
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            7778999999999998887779999999999999998 599999998877766655211       10            


Q ss_pred             -CCC---------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          228 -SCP---------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       228 -~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                       .+|         +.++..-++|++++|.-+|.+|+++++.++||||...
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence             011         1145567899999999999999999999999999754

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.2e-42  Score=344.56  Aligned_cols=264  Identities=27%  Similarity=0.368  Sum_probs=216.4

Q ss_pred             ccccCeEE-eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchH-----------HHHHHHHHHHHHHhCCCCCcce
Q 013421            6 RRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR-----------MVDQIKREISIMKIVRHPNIVR   73 (443)
Q Consensus         6 ~~~~~y~i-~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~HpnIv~   73 (443)
                      ..-++|.. .+.||+|+||.||+|.+..+++.||+|++.........           ....+.+|+.+++.++||||++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            34567875 46799999999999999999999999998764322210           0124778999999999999999


Q ss_pred             EEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeee
Q 013421           74 LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDF  153 (443)
Q Consensus        74 l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DF  153 (443)
                      +++++...+..|++|||++ |+|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+||
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence            9999999999999999996 589999988888999999999999999999999999999999999999999999999999


Q ss_pred             cCcCCCcc--------------ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHH
Q 013421          154 GLSALPQQ--------------GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  219 (443)
Q Consensus       154 Gls~~~~~--------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  219 (443)
                      |++.....              .........+++.|+|||.+.+....+.++|||||||++|+|++|.+||...+.....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  243 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL  243 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99875541              1112234457889999999876555568999999999999999999999877655444


Q ss_pred             HHhhhcc-------C---------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          220 KKINAAE-------F---------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       220 ~~i~~~~-------~---------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                      ..+....       +                     ......+.++.++|.+||+.+|++|||+++++.||||+....+
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence            3322100       0                     0012357889999999999999999999999999999876544

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-42  Score=340.12  Aligned_cols=252  Identities=23%  Similarity=0.335  Sum_probs=209.6

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcE--EEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGES--VAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~   82 (443)
                      ..+++|++.+.||+|+||.||+|.+..++..  +|+|.+...  ........+.+|+.++.++ +||||+++++++...+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            3567899999999999999999999877764  466665432  2333456788999999999 8999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC
Q 013421           83 KVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG  146 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~  146 (443)
                      ..|++|||+++++|.+++...+                .+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            9999999999999999997543                478899999999999999999999999999999999999999


Q ss_pred             CeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc
Q 013421          147 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA  225 (443)
Q Consensus       147 ~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~  225 (443)
                      .+||+|||++...... .......++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+...
T Consensus       162 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  239 (303)
T cd05088         162 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  239 (303)
T ss_pred             cEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence            9999999998643221 11112234567999999876655 489999999999999998 99999887776666665443


Q ss_pred             -cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          226 -EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       226 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                       ....+..+++++.+||.+||+.+|++||++++++.+
T Consensus       240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             233455578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1e-42  Score=335.33  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=213.5

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      .++|.+.+.||+|+||.||+|.+..     ++..||+|.+.....  .+..+.+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            4679999999999999999998753     467899999876432  224578899999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCe
Q 013421           83 KVYIILEFVTGGELFDKIVHQG--------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL  148 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~--------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~  148 (443)
                      ..|++|||+++++|.+++...+              .+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence            9999999999999999997643              47888999999999999999999999999999999999999999


Q ss_pred             EEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc
Q 013421          149 KVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA  225 (443)
Q Consensus       149 kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~  225 (443)
                      ||+|||++.......  .......+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG  240 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            999999986542211  112344467889999999877664 89999999999999998 99999887777777777665


Q ss_pred             cCC-CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          226 EFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       226 ~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ... .+..++..+.+++.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            543 34568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.5e-42  Score=334.87  Aligned_cols=258  Identities=33%  Similarity=0.606  Sum_probs=218.4

Q ss_pred             CeEEeeeeeccCceEEEEEEEC---CCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~   84 (443)
                      .|++.+.||.|+||.||+|.+.   .+|..||+|++...... .....+.+.+|+.+++.+ +||||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999875   47899999999764322 222346678999999999 699999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (443)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999987654321 


Q ss_pred             ccccccCCCcccCCCcccccC-CCCCCccchHHHHHHHHHHhhCCCCCCCCC----hHHHHHHhhhccCCCCCCCCHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFSCPFWFSTGAT  238 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~~  238 (443)
                      ......+|+..|+|||.+.+. ...+.++||||+|+++|+|++|..||...+    .......+.....+.|..+++.+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK  240 (290)
T ss_pred             cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence            223356789999999998643 233578999999999999999999997432    233444455555666777899999


Q ss_pred             HHHHHccCCCCCCCC-----CHHHHhcCcccccc
Q 013421          239 SLIHKILDPNPKTRI-----RIEGIRKHPWFRKN  267 (443)
Q Consensus       239 ~li~~~L~~dP~~R~-----t~~eil~hp~f~~~  267 (443)
                      +++.+||+.||.+||     ++++++.||||+..
T Consensus       241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            999999999999997     89999999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-43  Score=350.14  Aligned_cols=256  Identities=26%  Similarity=0.427  Sum_probs=208.8

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ..|++++.||.|+.++||++...+ ...||+|.+.... .+...+..+.+||..|.+| .|.+||++++|-..++.+|+|
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            369999999999999999998754 4556666554433 3455778899999999999 599999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCC-HHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc--c
Q 013421           88 LEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--E  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~-e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--~  164 (443)
                      |||- ..+|..++....... ....+.|..|++.|+.++|+.||+|.||||.|+|+-. |.+||+|||+|.......  -
T Consensus       439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI  516 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSI  516 (677)
T ss_pred             eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccce
Confidence            9986 568999888766544 3688999999999999999999999999999999976 999999999998765532  2


Q ss_pred             cccccCCCcccCCCcccccCCCC----------CCccchHHHHHHHHHHhhCCCCCCCCC-hHHHHHHhhhccC--CCCC
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYD----------GSAADVWSCGVILFVLMAGYLPFGETD-LPTLYKKINAAEF--SCPF  231 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~----------~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~--~~~~  231 (443)
                      ...+.|||+.||+||.+....+.          +.++||||||||||+|+.|++||..-. ...-...|.....  .+|.
T Consensus       517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~  596 (677)
T KOG0596|consen  517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPD  596 (677)
T ss_pred             eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccC
Confidence            34578999999999998654433          578999999999999999999997532 3333444554433  4454


Q ss_pred             CCCHH-HHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          232 WFSTG-ATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       232 ~~s~~-~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .-+.. +.++++.||..||++|||+.++|+|||++...
T Consensus       597 ~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  597 IPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             CCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence            43333 99999999999999999999999999998643

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-44  Score=359.75  Aligned_cols=250  Identities=30%  Similarity=0.473  Sum_probs=219.9

Q ss_pred             eeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCCC
Q 013421           16 TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGE   95 (443)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~   95 (443)
                      .||+|+||+||-|++..|...+|||-+....   .+...-+..||.+++.|+|.|||++.+.+..++.+-|+||-++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            5999999999999999999999999986543   3346779999999999999999999999999999999999999999


Q ss_pred             hHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc-CCCCeEEeeecCcCCCccccccccccCC
Q 013421           96 LFDKIVHQ-GRL--LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG  171 (443)
Q Consensus        96 L~~~i~~~-~~l--~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~-~~~~~kL~DFGls~~~~~~~~~~~~~~g  171 (443)
                      |.+.++.. |++  +|..+-.|.+||++||.|||.+.|+|||||-+|||++ -.|.+||+|||-++....-+....+..|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            99999876 677  7889999999999999999999999999999999997 5799999999998877665566778889


Q ss_pred             CcccCCCcccccC-CCCCCccchHHHHHHHHHHhhCCCCCCCCChH--HHHHH-hhhccCCCCCCCCHHHHHHHHHccCC
Q 013421          172 TPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDLP--TLYKK-INAAEFSCPFWFSTGATSLIHKILDP  247 (443)
Q Consensus       172 t~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--~~~~~-i~~~~~~~~~~~s~~~~~li~~~L~~  247 (443)
                      |..|||||++-.. .-+|.++|||||||++.||.||++||.....+  .+++- +.+..+++|..+|.+++.||.+|+.+
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep  818 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP  818 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence            9999999998532 22369999999999999999999999765433  23332 44556788888999999999999999


Q ss_pred             CCCCCCCHHHHhcCccccccC
Q 013421          248 NPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       248 dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ||..||++.++|.+||++.+.
T Consensus       819 d~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  819 DPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             CcccCccHHHhccCcccccCC
Confidence            999999999999999998763

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.5e-43  Score=346.48  Aligned_cols=260  Identities=26%  Similarity=0.420  Sum_probs=213.7

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA----SRTKV   84 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~~~   84 (443)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            689999999999999999999999999999999876432 2234567788999999999999999998875    34578


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (443)
                      |+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....... 
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            99999995 6899999877889999999999999999999999999999999999999999999999999986543211 


Q ss_pred             ---ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh----------------
Q 013421          164 ---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA----------------  224 (443)
Q Consensus       164 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~----------------  224 (443)
                         ......+|+..|+|||.+.+....+.++||||+||++|+|++|+.||.+.+.......+..                
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence               1223457899999999986644456899999999999999999999987654332221110                


Q ss_pred             --------cc--CCC-----CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          225 --------AE--FSC-----PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       225 --------~~--~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                              ..  ...     .+..++++.++|++||+.+|.+|||+++++.||||.....+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~  303 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP  303 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence                    00  001     12368899999999999999999999999999999865433

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.4e-42  Score=329.20  Aligned_cols=248  Identities=26%  Similarity=0.377  Sum_probs=213.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++...+..+++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence            457999999999999999999999999999999986542    2346688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           88 LEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999999998754  35889999999999999999999999999999999999999999999999998765442111


Q ss_pred             -ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          166 -LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       166 -~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                       .....+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....|..+++++.++|.
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  239 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR  239 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence             1122345679999998776664 88999999999999998 99999988777776666543 45566678999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||+.||++|||+.++++
T Consensus       240 ~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         240 ACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHccCCcccCCCHHHHHH
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.2e-43  Score=344.33  Aligned_cols=258  Identities=29%  Similarity=0.416  Sum_probs=218.4

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-----KV   84 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~   84 (443)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            69999999999999999999999999999999876432 2334567889999999999999999999987765     79


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (443)
                      |++|||++ ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999997 5899999887889999999999999999999999999999999999999999999999999987655432 


Q ss_pred             --ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC--------------
Q 013421          164 --ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF--------------  227 (443)
Q Consensus       164 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--------------  227 (443)
                        .......+++.|+|||++.+....+.++|+||+|+++|+|++|.+||...+..+....+.....              
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence              2234556899999999998773446899999999999999999999988776555444322100              


Q ss_pred             -----------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          228 -----------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       228 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                                       ...+.+++++.++|.+||+.||.+|||+++++.||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                             011236888999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-42  Score=327.51  Aligned_cols=244  Identities=25%  Similarity=0.391  Sum_probs=214.5

Q ss_pred             eeeeccCceEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecC
Q 013421           15 RTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFV   91 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~   91 (443)
                      +.||+|+||.||+|.+...   +..||+|++.......  ..+.+.+|+..++.++|+||+++++++.+....+++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4699999999999999866   8899999997654322  4678899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           92 TGGELFDKIVHQ---------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        92 ~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      ++++|.+++...         ..+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         78999999999999999999999999999999999999999999999999998766543


Q ss_pred             c--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHH
Q 013421          163 V--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGAT  238 (443)
Q Consensus       163 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  238 (443)
                      .  .......+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+..+ ....|..+|+++.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY  237 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence            2  22345567889999999877655 489999999999999999 69999988877777776643 4456777899999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcC
Q 013421          239 SLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +++.+||..||++|||+++++++
T Consensus       238 ~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         238 ELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-42  Score=342.28  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=212.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----   82 (443)
                      ..++|++++.||+|+||.||+|.+..++..||+|.+.+.. ........+.+|+.+++.++||||+++++++....    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            4568999999999999999999999999999999986543 22333456889999999999999999999987543    


Q ss_pred             --EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           83 --KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        83 --~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                        .+++||||+ |++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence              468999999 7788877764 679999999999999999999999999999999999999999999999999987553


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-------------  227 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------------  227 (443)
                      ..   .....+++.|+|||.+.+....+.++|+||+||++|+|++|..||...+.......+.....             
T Consensus       170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         170 SE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             cC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence            32   23456789999999987644456899999999999999999999987665433333221100             


Q ss_pred             ------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          228 ------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       228 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                                        .....+++.+.++|.+||..||++|||+.+++.||||+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                              011347888999999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-42  Score=344.92  Aligned_cols=258  Identities=26%  Similarity=0.406  Sum_probs=214.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE---
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK---   83 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---   83 (443)
                      .-++|++.+.||+|++|.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++...+.   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            456899999999999999999999999999999998754322 2234667889999999999999999988765544   


Q ss_pred             ---EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           84 ---VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        84 ---~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                         .|+|+||+ +++|.+++.. .++++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence               89999999 6799888875 679999999999999999999999999999999999999999999999999987654


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-------------  227 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------------  227 (443)
                      ..   .....+++.|+|||.+.+....+.++||||+||++|+|++|+.||...+.......+.....             
T Consensus       170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             cc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            32   34557889999999986544456899999999999999999999987665544443322100             


Q ss_pred             ------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          228 ------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       228 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                                        .....+++.+.++|.+||+.||.+|||+.+|++||||+....+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                              0012358899999999999999999999999999999875443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.1e-42  Score=331.51  Aligned_cols=255  Identities=27%  Similarity=0.421  Sum_probs=210.6

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RTKVYI   86 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l   86 (443)
                      ++|+..+.||.|++|.||++.+..+++.+|+|.+.....  ......+.+|+++++.++||||+++++++.+  .+.+|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            479999999999999999999999999999999876532  2345778999999999999999999998854  447899


Q ss_pred             EEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           87 ILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      ||||++|++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999887653    346899999999999999999999999999999999999999999999999998654332


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC-----hHHHHHHhhhcc-CCCC------
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----LPTLYKKINAAE-FSCP------  230 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-----~~~~~~~i~~~~-~~~~------  230 (443)
                        ......++..|+|||.+.+..++ .++|||||||++|+|++|..||....     ..+....+.... ...+      
T Consensus       159 --~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd06621         159 --LAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG  235 (287)
T ss_pred             --ccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence              12244678899999999776665 89999999999999999999998652     223333332211 1111      


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ...++.+.++|.+||..||.+|||+.|+++||||++..
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence            12467899999999999999999999999999996543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4e-42  Score=327.27  Aligned_cols=247  Identities=23%  Similarity=0.384  Sum_probs=210.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|+||.||++... ++..+|+|.+......    .+.+.+|+.+++.++||||+++++++.+.+..|++
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            357999999999999999999875 4567999988654322    35688899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc-
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL-  165 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~-  165 (443)
                      |||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999999998753 56899999999999999999999999999999999999999999999999998754332111 


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHK  243 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~  243 (443)
                      .....++..|+|||++.+..+. .++||||+|+++|+|++ |+.||...+..+....+..+. ...|...+.++.+++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS  236 (256)
T ss_pred             cCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence            1222355689999999776664 89999999999999999 999999888777777766543 33455678899999999


Q ss_pred             ccCCCCCCCCCHHHHhc
Q 013421          244 ILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~  260 (443)
                      ||+.||.+|||++++++
T Consensus       237 c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         237 CWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HccCCcccCcCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.9e-42  Score=338.25  Aligned_cols=259  Identities=26%  Similarity=0.400  Sum_probs=208.4

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS---   80 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---   80 (443)
                      +...+++|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+   
T Consensus         3 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (311)
T cd07866           3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPD   81 (311)
T ss_pred             CCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence            4455899999999999999999999999999999999987654222 123456789999999999999999988743   


Q ss_pred             -----CCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeec
Q 013421           81 -----RTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG  154 (443)
Q Consensus        81 -----~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFG  154 (443)
                           ...+|+++||+.+ +|...+.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||
T Consensus        82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence                 3357999999965 67666654 3579999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCccccc-----------cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhh
Q 013421          155 LSALPQQGVE-----------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  223 (443)
Q Consensus       155 ls~~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  223 (443)
                      ++........           ......|++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+.......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9875433211           11233578889999988665444689999999999999999999998777655444332


Q ss_pred             hcc-----------------------CCCC-------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          224 AAE-----------------------FSCP-------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       224 ~~~-----------------------~~~~-------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      ...                       ...+       ..+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            110                       0000       1245778899999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.7e-42  Score=332.94  Aligned_cols=256  Identities=23%  Similarity=0.297  Sum_probs=212.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      -++|++.+.||+|+||.||+|.++.     .+..||+|.+.....  ......+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            4689999999999999999997652     345899998865432  223345788999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEee
Q 013421           83 KVYIILEFVTGGELFDKIVHQG----------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (443)
                      ..|++|||+++|+|.+++...+          ..+...+..++.||+.||.|||++||+||||||+||+++.++.++|+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence            9999999999999999997532          245677889999999999999999999999999999999999999999


Q ss_pred             ecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCC
Q 013421          153 FGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFS  228 (443)
Q Consensus       153 FGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~  228 (443)
                      ||++........  ......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD  241 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            999875433211  1123345678999999877665 489999999999999998 89999887777766655444 334


Q ss_pred             CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc------Cccccc
Q 013421          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK------HPWFRK  266 (443)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~------hp~f~~  266 (443)
                      .+...++.+.+++.+||+.||++|||+.++++      ||||+.
T Consensus       242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            55667899999999999999999999999987      898864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.3e-42  Score=343.75  Aligned_cols=255  Identities=28%  Similarity=0.394  Sum_probs=207.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR------   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------   81 (443)
                      -++|++.+.||.|+||.||+|.+..+|..||+|.+.....   ...+.+.+|+.+++.++||||+++++++...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            4789999999999999999999999999999999876542   2356788999999999999999999876543      


Q ss_pred             --------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-CCCeEEee
Q 013421           82 --------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSD  152 (443)
Q Consensus        82 --------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-~~~~kL~D  152 (443)
                              ...|++|||++ ++|.+.+.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                    36899999996 588887754 57999999999999999999999999999999999999984 56789999


Q ss_pred             ecCcCCCccc---cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc----
Q 013421          153 FGLSALPQQG---VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----  225 (443)
Q Consensus       153 FGls~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----  225 (443)
                      ||++......   ........|+..|+|||.+.+....+.++|||||||++|+|++|..||...+.......+...    
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9998754321   112233468889999998765444568999999999999999999999876543333222110    


Q ss_pred             ---------------------cC-----CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          226 ---------------------EF-----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       226 ---------------------~~-----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                           ..     ...+.++.++.+||.+||+.||.+|||+++++.||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                                 00     0112478899999999999999999999999999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.2e-42  Score=332.66  Aligned_cols=248  Identities=23%  Similarity=0.352  Sum_probs=211.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      .+|.+.+.||+|+||+||++.+.     .++..+|+|.+....   ......+.+|+.+++.++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            46999999999999999999853     345678999886532   3345678999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEE
Q 013421           84 VYIILEFVTGGELFDKIVHQG-------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV  150 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~-------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL  150 (443)
                      .|++|||+++++|.+++...+             .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence            999999999999999997543             4899999999999999999999999999999999999999999999


Q ss_pred             eeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhccC
Q 013421          151 SDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEF  227 (443)
Q Consensus       151 ~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~  227 (443)
                      +|||++.......  .......+++.|+|||++.+..+. .++|||||||++|+|++ |.+||...+.......+..+..
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~  240 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV  240 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence            9999987543321  112234457789999999776554 89999999999999998 9999988877777777766543


Q ss_pred             -CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          228 -SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       228 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                       ..+..+++++.+|+.+||++||.+|||+.+++.
T Consensus       241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             445568999999999999999999999999855

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-45  Score=387.96  Aligned_cols=256  Identities=33%  Similarity=0.535  Sum_probs=226.4

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|.-+.+||.|.||+||.|.+.++|+..|+|-+...... ......+.+|..++..++|||+|++|++-...+..||.||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            577788999999999999999999999999999766544 4456789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc----ccc
Q 013421           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG----VEL  165 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~----~~~  165 (443)
                      ||+||+|.+.++..+..+|...+.|..|++.|+.|||+.||+||||||+||+|+.+|.+|++|||.|......    .+.
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            9999999999999888889999999999999999999999999999999999999999999999988654432    234


Q ss_pred             ccccCCCcccCCCcccccCCC--CCCccchHHHHHHHHHHhhCCCCCCCCC--hHHHHHHhhhccCCCCCCCCHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGY--DGSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINAAEFSCPFWFSTGATSLI  241 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~--~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~s~~~~~li  241 (443)
                      +....|||.|||||++.+..-  .+-++||||||||+.||.||+.||...+  +.-+|.--....+++|..+|++.++||
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence            567789999999999976432  2468999999999999999999997644  344555555567788999999999999


Q ss_pred             HHccCCCCCCCCCHHHHhcCccccc
Q 013421          242 HKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      .+||+.||++|.++.||+.|.|-+.
T Consensus      1475 e~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             HHHHhcCchhhhHHHHHHHhhcccc
Confidence            9999999999999999999998653

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.2e-42  Score=332.11  Aligned_cols=252  Identities=22%  Similarity=0.350  Sum_probs=211.7

Q ss_pred             cccCeEEeeeeeccCceEEEEEEEC----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNR----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      .+.+|++.+.||+|+||+||+|.+.    .++..+|+|.+....  ..+....+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            4578999999999999999999853    456789999987533  2334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY  145 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-----------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~  145 (443)
                      ..|++|||+++++|.+++...                 ..+++..+..++.|++.||+|||++|++||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            999999999999999998532                 246788899999999999999999999999999999999999


Q ss_pred             CCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHh
Q 013421          146 GNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI  222 (443)
Q Consensus       146 ~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i  222 (443)
                      +.+||+|||++.......  .......++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999987543321  12234446778999999976665 489999999999999998 99999887665555555


Q ss_pred             hhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          223 NAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       223 ~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ... ..+.+..+++.+.+++.+||+.||.+||++.+|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            433 345566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.8e-42  Score=326.46  Aligned_cols=243  Identities=27%  Similarity=0.455  Sum_probs=204.1

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg   94 (443)
                      +.||+|+||.||+|++..+++.+|+|.+....  ..+....+.+|+.+++.++||||+++++++......|+||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            46999999999999999999999999886432  2334567899999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc--cccCC
Q 013421           95 ELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL--HTTCG  171 (443)
Q Consensus        95 ~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~--~~~~g  171 (443)
                      +|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........  ....+
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            9999997654 68999999999999999999999999999999999999999999999999987543221110  11123


Q ss_pred             CcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhh-ccCCCCCCCCHHHHHHHHHccCCCC
Q 013421          172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-AEFSCPFWFSTGATSLIHKILDPNP  249 (443)
Q Consensus       172 t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~s~~~~~li~~~L~~dP  249 (443)
                      +..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+.. .....+..++..+.+++.+||+.||
T Consensus       159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  237 (252)
T cd05084         159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP  237 (252)
T ss_pred             ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence            456999999877665 488999999999999997 9999987665555444433 2445566689999999999999999


Q ss_pred             CCCCCHHHHhc
Q 013421          250 KTRIRIEGIRK  260 (443)
Q Consensus       250 ~~R~t~~eil~  260 (443)
                      ++|||++++++
T Consensus       238 ~~Rps~~~~~~  248 (252)
T cd05084         238 GQRPSFSTVHQ  248 (252)
T ss_pred             hhCcCHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4e-42  Score=332.83  Aligned_cols=256  Identities=29%  Similarity=0.469  Sum_probs=220.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      .-..|++.+.||+|++|.||+|.+..++..||+|++.....    ..+.+.+|+.+++.++|+||+++++.+...+..|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            45569999999999999999999998899999999976432    35678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           87 ILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      ++||++|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus        93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence            999999999999998876 8999999999999999999999999999999999999999999999999988655433233


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC---CCCCCCCHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGATSLIH  242 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~  242 (443)
                      .....|++.|+|||++.+..++ .++|+||+||++|+|++|..||...+.......+.....   ..+..++.++.++|.
T Consensus       173 ~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  251 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN  251 (286)
T ss_pred             hccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence            3445688899999998876664 899999999999999999999987665544444333221   222337899999999


Q ss_pred             HccCCCCCCCCCHHHHhcCcccccc
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +||+.+|.+|||+.+++.||||++.
T Consensus       252 ~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         252 KCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HHhccChhhCcCHHHHhhChHhhcc
Confidence            9999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-42  Score=327.71  Aligned_cols=251  Identities=24%  Similarity=0.356  Sum_probs=213.5

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      .++|++.+.||+|+||.||+|.+..+   ...||+|.+....  .......+.+|+.+++.++||||+++++.+...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            35799999999999999999998654   4589999987543  233456788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |++|||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999999764 478999999999999999999999999999999999999999999999999998764322


Q ss_pred             ccc--cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHH
Q 013421          164 ELL--HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATS  239 (443)
Q Consensus       164 ~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~  239 (443)
                      ...  ....+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...........+... ..+.+...++.+.+
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  239 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ  239 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            211  223356789999999876664 89999999999999998 99999887776666666544 34555668999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcC
Q 013421          240 LIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ++.+||+.+|++||++++++++
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-44  Score=320.08  Aligned_cols=250  Identities=26%  Similarity=0.416  Sum_probs=206.8

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----eCCE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA-----SRTK   83 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~   83 (443)
                      .||++.+.||+|+|+.||++++..++..||+|.+....   .+..+...+|++..++++|||+++++++..     ....
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            58999999999999999999999999999999986654   445688899999999999999999987753     3345


Q ss_pred             EEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--CEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421           84 VYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~yLH~~g--i~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      .|++++|...|+|.+.|...    ..++|.++..|+.+|++||++||+..  ++||||||.|||+++.+.++|.|||.++
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999999753    36899999999999999999999998  9999999999999999999999999887


Q ss_pred             CCccccc---------cccccCCCcccCCCcccccCCCC--CCccchHHHHHHHHHHhhCCCCCCCCCh--HHHHHHhhh
Q 013421          158 LPQQGVE---------LLHTTCGTPNYVAPEVLSNRGYD--GSAADVWSCGVILFVLMAGYLPFGETDL--PTLYKKINA  224 (443)
Q Consensus       158 ~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~--~~~~DIwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~~  224 (443)
                      ...-.-.         .......|..|+|||.+.-+.+.  ++++|||||||+||+|+.|..||+..-.  ..+.-.+.+
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n  257 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN  257 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence            5432100         11223468999999998655433  6899999999999999999999963211  111222445


Q ss_pred             ccCCCCC--CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          225 AEFSCPF--WFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       225 ~~~~~~~--~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +.+++|.  .+|..+.++|+.||++||.+||++.+++.+
T Consensus       258 ~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  258 AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            5555554  389999999999999999999999999874

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=9.1e-42  Score=321.66  Aligned_cols=249  Identities=33%  Similarity=0.540  Sum_probs=215.0

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||+|++|.||++.+..+++.+++|++.....   .....+.+|+.+++.++||||+++++++......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            58999999999999999999998999999999976543   345788999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           90 FVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        90 y~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+........ ...
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~  156 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNT  156 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccc
Confidence            99999999999876 5889999999999999999999999999999999999999999999999999876654322 345


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-cCC--CCCCCCHHHHHHHHHcc
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-EFS--CPFWFSTGATSLIHKIL  245 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~--~~~~~s~~~~~li~~~L  245 (443)
                      ..|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+........... ...  .+..++..+.++|.+||
T Consensus       157 ~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  235 (253)
T cd05122         157 MVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL  235 (253)
T ss_pred             eecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHc
Confidence            678899999999876654 58999999999999999999999876544333332222 112  22234899999999999


Q ss_pred             CCCCCCCCCHHHHhcCcc
Q 013421          246 DPNPKTRIRIEGIRKHPW  263 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~  263 (443)
                      +.||++|||+.++++|||
T Consensus       236 ~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         236 QKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             cCChhhCCCHHHHhcCCC
Confidence            999999999999999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-42  Score=331.62  Aligned_cols=252  Identities=32%  Similarity=0.489  Sum_probs=211.1

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEE
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--TKVYIIL   88 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~   88 (443)
                      |++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++.+.  +..|+|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            789999999999999999999999999999998764 2233346688999999999999999999999888  8999999


Q ss_pred             ecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-ccc
Q 013421           89 EFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-ELL  166 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~~~  166 (443)
                      ||+++ +|.+.+... ..+++..++.++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++....... ...
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            99975 888888765 578999999999999999999999999999999999999999999999999987654432 123


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--------------------
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------------  226 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------------------  226 (443)
                      ....++..|+|||.+.+....+.++||||+|+++|+|++|+.||...+.......+....                    
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            345678899999987665445689999999999999999999998776554443332110                    


Q ss_pred             ---CC--------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          227 ---FS--------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       227 ---~~--------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                         ..        +...+++.+.++|++||..||.+||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence               00        001138899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.9e-42  Score=336.00  Aligned_cols=258  Identities=29%  Similarity=0.481  Sum_probs=211.8

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT--   82 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--   82 (443)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+..  
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            45678999999999999999999999999999999999765322 222356778999999999999999999987654  


Q ss_pred             --------EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeee
Q 013421           83 --------KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDF  153 (443)
Q Consensus        83 --------~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DF  153 (443)
                              .+|+++||+++ ++.+.+... ..+++..++.++.|++.||.|||+.||+||||||+||++++++.+||+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence                    89999999976 677776653 47899999999999999999999999999999999999999999999999


Q ss_pred             cCcCCCcccc-ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cC---
Q 013421          154 GLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EF---  227 (443)
Q Consensus       154 Gls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~---  227 (443)
                      |++....... .......++..|+|||.+.+....+.++||||+||++|+|++|++||...+.......+...  ..   
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            9987654432 22233456788999998865544468999999999999999999999876655444333221  00   


Q ss_pred             -------------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          228 -------------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       228 -------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                               .....+++.+.++|.+||..||.+|||+++++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                     0011368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-42  Score=330.09  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=214.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      .-.+|++++.||.|+||.||+|.+.. +..+|+|++.....   .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            34679999999999999999999987 88999999876532   234578899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      +|||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999999763  4688999999999999999999999999999999999999999999999999876543322


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      ......++..|+|||++.+..+. .++||||||+++|+|++ |..||...+..+....+... ..+.+..+++.+.+++.
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML  238 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHH
Confidence            22344466789999998776654 89999999999999998 89999887766666665543 44556678999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||+.||.+|||+.+|++
T Consensus       239 ~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         239 ECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHcCCCchhCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.9e-42  Score=338.16  Aligned_cols=251  Identities=21%  Similarity=0.322  Sum_probs=210.5

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcE----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ...+|++.+.||+|+||.||+|.+..+++.    ||+|++....  .....+.+.+|+.+++.++||||+++++++... 
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            346799999999999999999998766654    8999986432  233456788999999999999999999998764 


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..++++||+++|+|.+++... ..+++.....++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            577999999999999999874 4688999999999999999999999999999999999999999999999999986544


Q ss_pred             cccc--ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHH
Q 013421          162 GVEL--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGA  237 (443)
Q Consensus       162 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~  237 (443)
                      ....  .....++..|+|||++.+..++ .++|||||||++|+|++ |..||.+....+....+... ..+.|..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  240 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            2221  1223346789999999877665 89999999999999997 99999887766555444333 345567789999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+++.+||..||.+|||+.+++.+
T Consensus       241 ~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         241 YMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.1e-42  Score=368.86  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=207.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            57999999999999999999999999999999999765444444567789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           88 LEFVTGGELFDKIVHQ-----------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-----------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                      |||++||+|.+++...           ...+...+..++.||+.||+|||++||+||||||+||+++.+|.+||+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999988642           23455677899999999999999999999999999999999999999999998


Q ss_pred             CCCcccc------------------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHH
Q 013421          157 ALPQQGV------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  218 (443)
Q Consensus       157 ~~~~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  218 (443)
                      .......                  ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            7552110                  01123479999999999987766 4899999999999999999999987554332


Q ss_pred             HHHh-hhcc--CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          219 YKKI-NAAE--FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       219 ~~~i-~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .... ....  ......+++.+.+++.+||..||++|++..+.+.
T Consensus       240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2211 1111  1111247899999999999999999987655444

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-43  Score=363.16  Aligned_cols=244  Identities=33%  Similarity=0.512  Sum_probs=206.9

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEE-EE---eC---
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEV-LA---SR---   81 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-~~---~~---   81 (443)
                      ++++.+.|.+|+|+.||+|++...|..||+|.+-..   ++...+.+.+||++|+.|+ |+|||.+++. ..   .+   
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            577889999999999999999988899999988654   5667889999999999996 9999999993 21   11   


Q ss_pred             CEEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--CEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421           82 TKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~yLH~~g--i~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      -.++|.||||.||.|.|++..  ..+|+|.++.+||.|+++||.+||..+  |||||||-|||||+.+|++||||||.++
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            247899999999999999974  357999999999999999999999997  9999999999999999999999999886


Q ss_pred             CCccccc---------cccccCCCcccCCCccc---ccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc
Q 013421          158 LPQQGVE---------LLHTTCGTPNYVAPEVL---SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA  225 (443)
Q Consensus       158 ~~~~~~~---------~~~~~~gt~~y~aPE~l---~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~  225 (443)
                      ..-....         ..-....|+.|+|||++   .+.+. ++|+|||+|||+||-||....||+....    -.|..+
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng  269 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNG  269 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEec
Confidence            4322111         01123479999999987   34444 5999999999999999999999987632    247788


Q ss_pred             cCCCCC--CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          226 EFSCPF--WFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       226 ~~~~~~--~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .|.+|+  .+|..+.+||+.||++||.+||++-+++.+
T Consensus       270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            888887  489999999999999999999999998764

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.7e-42  Score=334.87  Aligned_cols=254  Identities=27%  Similarity=0.475  Sum_probs=214.6

Q ss_pred             EEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecC
Q 013421           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFV   91 (443)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~   91 (443)
                      +-...||+|+||.||++.+..+++.||+|.+....   ......+.+|+.+++.++||||+++++.+...+..|++|||+
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            33467999999999999999999999999885432   234567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCC
Q 013421           92 TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG  171 (443)
Q Consensus        92 ~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~g  171 (443)
                      ++++|.+++.. +.+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++..............|
T Consensus       100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  178 (292)
T cd06657         100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG  178 (292)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence            99999887654 67899999999999999999999999999999999999999999999999987654433222344568


Q ss_pred             CcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---cCCCCCCCCHHHHHHHHHccCCC
Q 013421          172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATSLIHKILDPN  248 (443)
Q Consensus       172 t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~~L~~d  248 (443)
                      ++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+...   .......+++.+.+++.+||+.|
T Consensus       179 ~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  257 (292)
T cd06657         179 TPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD  257 (292)
T ss_pred             CccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence            999999999876555 48999999999999999999999876655444443322   12223347899999999999999


Q ss_pred             CCCCCCHHHHhcCccccccCCC
Q 013421          249 PKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       249 P~~R~t~~eil~hp~f~~~~~~  270 (443)
                      |.+||++.+++.||||.+...|
T Consensus       258 P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         258 PAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             cccCcCHHHHhcChHHhccCCC
Confidence            9999999999999999887754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-42  Score=362.67  Aligned_cols=261  Identities=27%  Similarity=0.414  Sum_probs=197.8

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCC-CcEEEEEE--------------eecccccchHHHHHHHHHHHHHHhCCCC
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRET-GESVAMKV--------------LAKSTILKHRMVDQIKREISIMKIVRHP   69 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vAiK~--------------i~~~~~~~~~~~~~~~~Ei~il~~l~Hp   69 (443)
                      ....++|++++.||+|+||+||++..+.. +...+.|.              +.+...........+.+|+.+|+.++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            34567899999999999999999876542 22223221              1111111223446688999999999999


Q ss_pred             CcceEEEEEEeCCEEEEEEecCCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC
Q 013421           70 NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS  144 (443)
Q Consensus        70 nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~  144 (443)
                      ||+++++++.+.+..|+++|++ +++|++++...     .......++.++.||+.||.|||++||+||||||+|||++.
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence            9999999999999999999999 45787777542     23446778899999999999999999999999999999999


Q ss_pred             CCCeEEeeecCcCCCcccc-ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCC-CCCCCC--h-HHHH
Q 013421          145 YGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL-PFGETD--L-PTLY  219 (443)
Q Consensus       145 ~~~~kL~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~-Pf~~~~--~-~~~~  219 (443)
                      +|.+||+|||++....... ......+||+.|+|||++.+..+. .++|||||||++|+|++|.. ||....  . ..+.
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            9999999999997654422 223356799999999999887775 89999999999999999875 454322  1 1111


Q ss_pred             HHhh---------------------hccC-----CCC-----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          220 KKIN---------------------AAEF-----SCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       220 ~~i~---------------------~~~~-----~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ..+.                     ...+     ..+     ..++.++.++|.+||+.||.+|||+.|++.||||...
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            1111                     0000     000     1246678889999999999999999999999999753

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.3e-42  Score=324.76  Aligned_cols=251  Identities=27%  Similarity=0.489  Sum_probs=220.3

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            5899999999999999999999999999999997654332 335667889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           90 FVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        90 y~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      |+++++|.+++.+    ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++......  .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~  157 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--M  157 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--C
Confidence            9999999998866    356899999999999999999999999999999999999999999999999998766543  3


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCCCCCHHHHHHHHHc
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKI  244 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~  244 (443)
                      .....|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+....+ ..+..++.++.+++.+|
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSM  236 (256)
T ss_pred             cccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHH
Confidence            3456789999999999876664 899999999999999999999998887766666655443 34456889999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccc
Q 013421          245 LDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f  264 (443)
                      |..+|.+|||+.++++||++
T Consensus       237 l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         237 LQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             cCCCcccCCCHHHHhcCCCC
Confidence            99999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.3e-42  Score=329.89  Aligned_cols=251  Identities=21%  Similarity=0.263  Sum_probs=209.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      -++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.++||||+++++++.+..
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            4579999999999999999998642     35689999986533  2223456889999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEee
Q 013421           83 KVYIILEFVTGGELFDKIVHQG----------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (443)
                      ..++||||+++++|.+++....          .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence            9999999999999999987532          246778889999999999999999999999999999999999999999


Q ss_pred             ecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CC
Q 013421          153 FGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FS  228 (443)
Q Consensus       153 FGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~  228 (443)
                      ||++........  ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... ..
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD  241 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            999875433211  1123356778999999977665 489999999999999998 799998877766666554443 34


Q ss_pred             CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+..+++.+.+++.+||+.||++|||+.+++++
T Consensus       242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            566688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.8e-42  Score=325.64  Aligned_cols=242  Identities=22%  Similarity=0.349  Sum_probs=205.4

Q ss_pred             eeeccCceEEEEEEE--CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           16 TIGEGTFAKVRFAQN--RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        16 ~LG~G~~g~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      .||+|+||.||+|.+  ..++..+|+|++.... ......+.+.+|+.+++.++||||+++++++.. +..+++|||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            689999999999965  4567899999987543 233456778999999999999999999998754 567899999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc---ccccC
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL---LHTTC  170 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~---~~~~~  170 (443)
                      ++|.+++.....+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++.........   .....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            999999988888999999999999999999999999999999999999999999999999998765443221   12233


Q ss_pred             CCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHHHHccCCC
Q 013421          171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPN  248 (443)
Q Consensus       171 gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~d  248 (443)
                      +++.|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+..+. .+.|..+++++.++|.+||++|
T Consensus       160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~  238 (257)
T cd05116         160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG  238 (257)
T ss_pred             CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence            4678999999876555 489999999999999998 999998877766666666543 4567779999999999999999


Q ss_pred             CCCCCCHHHHhc
Q 013421          249 PKTRIRIEGIRK  260 (443)
Q Consensus       249 P~~R~t~~eil~  260 (443)
                      |.+||++++|..
T Consensus       239 p~~Rp~~~~i~~  250 (257)
T cd05116         239 VDERPGFAVVEL  250 (257)
T ss_pred             chhCcCHHHHHH
Confidence            999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2e-41  Score=332.89  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=213.2

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      +.|...+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|||++++++++.+....|++|
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            34777789999999999999999999999999998765444445567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        89 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      ||+. |++.+.+.. ..++++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.....    ..
T Consensus       101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~  175 (313)
T cd06633         101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----AN  175 (313)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CC
Confidence            9996 577777765 45789999999999999999999999999999999999999999999999998864322    23


Q ss_pred             ccCCCcccCCCccccc--CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC--CCCCCCHHHHHHHHH
Q 013421          168 TTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS--CPFWFSTGATSLIHK  243 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~~  243 (443)
                      ...|+..|+|||++..  .+..+.++|||||||++|+|++|..||...+......++.....+  ....++..+.+|+.+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  255 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY  255 (313)
T ss_pred             CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence            5578999999999842  233357899999999999999999999877655444444333221  122367889999999


Q ss_pred             ccCCCCCCCCCHHHHhcCcccccc
Q 013421          244 ILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ||+.+|.+||++.+++.||||+..
T Consensus       256 ~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         256 CLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HccCChhhCcCHHHHhcCcccCCC
Confidence            999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.8e-42  Score=329.82  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=210.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            3679999999999999999999977     77899999886543  2233466889999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC---CeEEee
Q 013421           83 KVYIILEFVTGGELFDKIVHQG-------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSD  152 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~---~~kL~D  152 (443)
                      ..|++|||++|++|.+++...+       .+++..+..++.||+.||+|||++|++||||||+||+++.++   .+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            9999999999999999997653       478899999999999999999999999999999999998765   599999


Q ss_pred             ecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhh-ccCC
Q 013421          153 FGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-AEFS  228 (443)
Q Consensus       153 FGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~  228 (443)
                      ||++........  ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+.. ....
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD  241 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            999876532111  1112234567999999977666 489999999999999997 9999998776666655543 3445


Q ss_pred             CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .|..++..+.+++.+||+.||++|||+.++++|
T Consensus       242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            566789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-42  Score=326.69  Aligned_cols=248  Identities=23%  Similarity=0.391  Sum_probs=209.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|++.+....    .+.+.+|+.+++.++||||+++++++...+..|++
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            356899999999999999999886 5678999998654322    24577899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc-
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL-  165 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~-  165 (443)
                      |||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... 
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999999999764 46899999999999999999999999999999999999999999999999998754332111 


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~  243 (443)
                      .....++..|+|||.+.+..+. .++||||||+++|+|++ |..||...+..+....+... ....|...++++.+++.+
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS  236 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence            1112234579999999876664 89999999999999998 89999887766666665544 345566689999999999


Q ss_pred             ccCCCCCCCCCHHHHhcC
Q 013421          244 ILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~h  261 (443)
                      ||..+|++|||+.++++.
T Consensus       237 cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         237 CWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HhcCChhhCcCHHHHHHH
Confidence            999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-43  Score=350.54  Aligned_cols=257  Identities=31%  Similarity=0.550  Sum_probs=222.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      -+-|..++.||-|+||+|.++...+|...||+|.+.+..+...+.+..++.|-.||..-+.+-||++|-.|.+++.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            34578889999999999999999999999999999998887777788899999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc-------
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ-------  160 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~-------  160 (443)
                      |+|++||++-.++.+.+-+.|+.+++|+..|..|+++.|..|+|||||||+|||||.+|++||+|||||+-+.       
T Consensus       708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999986321       


Q ss_pred             --ccc---------------------------------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh
Q 013421          161 --QGV---------------------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA  205 (443)
Q Consensus       161 --~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~  205 (443)
                        .++                                 -+.+..+||+.|+|||++...+|. ..+|+||.|||||+|+.
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhh
Confidence              000                                 011344699999999999998986 99999999999999999


Q ss_pred             CCCCCCCCChHHHHHHhh----hccCCCCCCCCHHHHHHHHHccCCCCCCCC---CHHHHhcCccccc
Q 013421          206 GYLPFGETDLPTLYKKIN----AAEFSCPFWFSTGATSLIHKILDPNPKTRI---RIEGIRKHPWFRK  266 (443)
Q Consensus       206 G~~Pf~~~~~~~~~~~i~----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~f~~  266 (443)
                      |++||-..+..+...++.    ...++....+|+++.++|.++.. +++.|.   .++++..||||+.
T Consensus       867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence            999998766544333322    22344445689999999999764 688887   4678999999975

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=327.43  Aligned_cols=250  Identities=21%  Similarity=0.279  Sum_probs=211.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+....  .......+.+|+.+++.++||||+++++++....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            46899999999999999999988643     3789999986543  2223456889999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEee
Q 013421           83 KVYIILEFVTGGELFDKIVHQG----------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (443)
                      ..|++|||+++|+|.+++....          .+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence            9999999999999999986532          367788999999999999999999999999999999999999999999


Q ss_pred             ecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCC
Q 013421          153 FGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFS  228 (443)
Q Consensus       153 FGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~  228 (443)
                      ||++.......  .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.....+.+... ...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD  241 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence            99987543321  12234557789999999876665 489999999999999998 99999887777766665543 345


Q ss_pred             CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .|..++.++.++|.+||+.+|++|||+.+++.
T Consensus       242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            66678999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.9e-41  Score=333.62  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=214.8

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      .|+..+.||+|+||.||+|.+..++..+|+|.+........+....+.+|+.+++.++|||++++++++.+.+..|+|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            48889999999999999999999999999999986544444556788999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           90 FVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        90 y~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      |+.| +|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.....    ...
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~~~  180 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----ANS  180 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----ccc
Confidence            9975 77777654 45789999999999999999999999999999999999999999999999998865433    234


Q ss_pred             cCCCcccCCCccccc--CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC-C-CCCCCHHHHHHHHHc
Q 013421          169 TCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-C-PFWFSTGATSLIHKI  244 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~-~~~~s~~~~~li~~~  244 (443)
                      ..|++.|+|||.+..  .+..+.++|+||+||++|+|++|..||...+.......+...... . +..+++.+.+++.+|
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  260 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC  260 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence            568999999999742  233458999999999999999999999877665555555443322 2 234788999999999


Q ss_pred             cCCCCCCCCCHHHHhcCcccccc
Q 013421          245 LDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      |+.+|.+||++.++++|||+...
T Consensus       261 l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         261 LQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ccCCcccCcCHHHHHhChhhhcc
Confidence            99999999999999999999654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-41  Score=331.44  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=208.3

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCc--EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~   85 (443)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.+....  .....+.+.+|+.+++++ +||||+++++++.+.+..|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            689999999999999999999887765  46888776322  223356788999999999 7999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeE
Q 013421           86 IILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLK  149 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~k  149 (443)
                      +++||+++++|.+++....                .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999996532                478889999999999999999999999999999999999999999


Q ss_pred             EeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cC
Q 013421          150 VSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EF  227 (443)
Q Consensus       150 L~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~  227 (443)
                      |+|||++........ ......+..|+|||++.+..+. .++|||||||++|+|++ |..||...+......++... ..
T Consensus       160 l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~  237 (297)
T cd05089         160 IADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM  237 (297)
T ss_pred             ECCcCCCccccceec-cCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Confidence            999999864322111 1112234579999999776664 89999999999999997 99999888777776666543 33


Q ss_pred             CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          228 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       228 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ..|..+++++.+||.+||..+|.+|||++++++.
T Consensus       238 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4556689999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-41  Score=339.50  Aligned_cols=257  Identities=26%  Similarity=0.405  Sum_probs=210.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR------   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------   81 (443)
                      -++|++.+.||+|+||.||+|.+..+++.||+|++.+.... ....+.+.+|+.++++++||||+++++++...      
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            47899999999999999999999999999999999764322 22345678899999999999999999988543      


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ...|++++++ |++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            3578888887 7889877754 5799999999999999999999999999999999999999999999999999875432


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc---------------
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---------------  226 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------  226 (443)
                         ......|++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+....               
T Consensus       173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (345)
T cd07877         173 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  249 (345)
T ss_pred             ---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence               23445789999999998664444589999999999999999999997765443332221100               


Q ss_pred             --------CCCC--------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          227 --------FSCP--------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       227 --------~~~~--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                              ...|        ...++++.++|.+||+.||.+|||+.+++.||||++...+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence                    0000        1257889999999999999999999999999999875543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.2e-42  Score=331.24  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=212.1

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~   81 (443)
                      .++|++.+.||+|+||.||++.+...     ...+|+|.+.....  .+....+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            35799999999999999999987643     36899999876432  23456788999999999 899999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC
Q 013421           82 TKVYIILEFVTGGELFDKIVH----------------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY  145 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~----------------~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~  145 (443)
                      +..|++|||+++|+|.+++..                .+.+++..+..++.|++.||.|||+.||+||||||+||+++.+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED  168 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence            999999999999999999864                2457889999999999999999999999999999999999999


Q ss_pred             CCeEEeeecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHh
Q 013421          146 GNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI  222 (443)
Q Consensus       146 ~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i  222 (443)
                      +.+||+|||++........  ......++..|+|||++.+..++ .++||||+||++|+|++ |..||...+..+....+
T Consensus       169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  247 (293)
T cd05053         169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL  247 (293)
T ss_pred             CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            9999999999876543211  11223355679999998776664 89999999999999997 99999988777777666


Q ss_pred             hhcc-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          223 NAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       223 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .... ...|...+.++.+|+.+||..||++|||+.+++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         248 KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            5443 34566789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-42  Score=330.28  Aligned_cols=252  Identities=34%  Similarity=0.500  Sum_probs=212.2

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      |++.+.||+|++|.||+|.+..+++.+|+|.+...... ......+.+|+.++++++||||+++++++.+.+..|+++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            67889999999999999999999999999998765432 23456788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccccc
Q 013421           91 VTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        91 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      +++ +|.+.+... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+.............
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            975 888887663 588999999999999999999999999999999999999999999999999987665433233445


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-------------------cCCC-
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------EFSC-  229 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~~~-  229 (443)
                      .++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+...++...                   ...+ 
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence            68889999999877634468999999999999999999999877655443332111                   0000 


Q ss_pred             ----------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          230 ----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       230 ----------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                ...++.++.++|.+||++||.+||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                      12367889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.5e-41  Score=364.99  Aligned_cols=151  Identities=30%  Similarity=0.572  Sum_probs=141.7

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      .+++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++...+.+|+
T Consensus         2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence            36899999999999999999999999999999999987665555566789999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      ||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.1e-41  Score=324.65  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=209.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++++.||+|+||.||+|.+.. +..+|+|.+......    .+.+.+|+.+++.++||||+++++++.+....|++
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            4679999999999999999998754 456999988754321    35688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-c
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-L  165 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~  165 (443)
                      |||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++........ .
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999999764 4689999999999999999999999999999999999999999999999998875433211 1


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHK  243 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~  243 (443)
                      .....++..|+|||.+.+..+. .++|||||||++|+|++ |..||...+.......+..+. ...+...+..+.+++.+
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS  236 (256)
T ss_pred             cCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            1122345679999999766654 89999999999999998 999998877766666665543 33455578999999999


Q ss_pred             ccCCCCCCCCCHHHHhcC
Q 013421          244 ILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~h  261 (443)
                      ||+.||.+|||+.+|+.+
T Consensus       237 cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         237 CWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HcCCCcccCCCHHHHHHh
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.8e-42  Score=332.40  Aligned_cols=254  Identities=21%  Similarity=0.325  Sum_probs=206.1

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ++|+..+.||+|+||.||++.+..+++.+|+|.+......  .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            4677889999999999999999999999999998765432  34567889999999996 99999999999999999999


Q ss_pred             EecCCCCChHH---HHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           88 LEFVTGGELFD---KIV--HQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        88 ~Ey~~gg~L~~---~i~--~~~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      |||+.+ ++.+   .+.  ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            999864 4433   332  236799999999999999999999975 999999999999999999999999999865433


Q ss_pred             ccccccccCCCcccCCCcccccC--CCCCCccchHHHHHHHHHHhhCCCCCCCCCh-HHHHHHhhhcc-CCC----CCCC
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAE-FSC----PFWF  233 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~-~~~----~~~~  233 (443)
                      . .......|++.|+|||++.+.  ...+.++||||+||++|+|++|..||...+. .+....+.... ...    +..+
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd06616         161 S-IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF  239 (288)
T ss_pred             C-CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence            2 222344689999999999765  2345899999999999999999999976542 12222222221 111    1237


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      +.++.+||.+||+.||++|||+++|+.||||+.
T Consensus       240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            899999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=326.24  Aligned_cols=249  Identities=23%  Similarity=0.339  Sum_probs=208.0

Q ss_pred             eEEeeeeeccCceEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE----
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK----   83 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----   83 (443)
                      |++++.||+|+||.||.|....+   +..||+|.+...... ....+.+.+|+..++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            67899999999999999987653   478999998764432 3345778999999999999999999998765443    


Q ss_pred             --EEEEEecCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecC
Q 013421           84 --VYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (443)
Q Consensus        84 --~~lv~Ey~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (443)
                        .++++||+++|+|..++...      ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999999888542      3589999999999999999999999999999999999999999999999999


Q ss_pred             cCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCC
Q 013421          156 SALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPF  231 (443)
Q Consensus       156 s~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~  231 (443)
                      +........  ......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ....|.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE  238 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            875543211  1122345678999999876655 489999999999999999 99999887776666665543 445667


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+++++.+++.+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         239 DCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.1e-42  Score=339.81  Aligned_cols=260  Identities=30%  Similarity=0.406  Sum_probs=212.7

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC--
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR--   81 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--   81 (443)
                      ....++|++.+.||+|+||.||+|.+..+|+.+|+|.+.+.... ......+.+|+.+++++ +||||+++++++...  
T Consensus         3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            34567899999999999999999999989999999988654322 22345677899999999 999999999998643  


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ...|+||||++ ++|.+++... .+++...+.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++.....
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            46899999997 5898888765 788999999999999999999999999999999999999999999999999875543


Q ss_pred             cc-----ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-----------
Q 013421          162 GV-----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-----------  225 (443)
Q Consensus       162 ~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-----------  225 (443)
                      ..     .......|++.|+|||++.+....+.++||||||+++|+|++|+.||.+........++...           
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            21     22334568999999998866555568999999999999999999999876544332222111           


Q ss_pred             ----------------cC----CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          226 ----------------EF----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       226 ----------------~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                      ..    ...+.++.++.++|.+||+.||++|||+.++++||||+.-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                            00    0112268899999999999999999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-42  Score=329.74  Aligned_cols=252  Identities=33%  Similarity=0.503  Sum_probs=213.2

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      |++.+.||+|.+|.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....|+|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            678899999999999999999999999999998754 2223346678899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccccc
Q 013421           91 VTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        91 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      ++ ++|.+++... ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++.............
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            97 5899999876 589999999999999999999999999999999999999999999999999987665443334455


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc------------------cCCCC-
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA------------------EFSCP-  230 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~~~~~-  230 (443)
                      .++..|+|||.+.+....+.++|+||+||++|+|++|.+||...+......++...                  ....+ 
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            67888999999876644568999999999999999999999887655443332210                  00011 


Q ss_pred             ----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          231 ----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       231 ----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                                +.++..+.++|++||..||++||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                      1247889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-41  Score=324.16  Aligned_cols=248  Identities=21%  Similarity=0.375  Sum_probs=209.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|+++++||+|+||.||+|.+. ++..||+|.+.....    ..+.+.+|+.+++.++||||+++++.+.+.+..|+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            3568999999999999999999875 567799998765332    24678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      +|||+++++|.+++...  ..+++.....++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999999999753  4678889999999999999999999999999999999999999999999999976543211


Q ss_pred             -cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHH
Q 013421          165 -LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (443)
Q Consensus       165 -~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (443)
                       ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ..+.+..++.++.+++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM  237 (261)
T ss_pred             eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence             1123345678999999876655 489999999999999998 99999887766666555443 3334455789999999


Q ss_pred             HHccCCCCCCCCCHHHHhc
Q 013421          242 HKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (443)
                      .+||..+|++|||++++.+
T Consensus       238 ~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         238 KTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-41  Score=326.02  Aligned_cols=249  Identities=27%  Similarity=0.380  Sum_probs=206.5

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------CC
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------RT   82 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~   82 (443)
                      |.+++.||+|+||.||+|.+..++.  .+|+|.+..... .....+.+.+|+.+++.++||||+++++++..      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            4578999999999999999887775  689998876432 33346778899999999999999999997642      23


Q ss_pred             EEEEEEecCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                      ..+++|||+++|+|.+++...      ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            578999999999999887432      34789999999999999999999999999999999999999999999999998


Q ss_pred             CCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CCCCCC
Q 013421          157 ALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFW  232 (443)
Q Consensus       157 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~  232 (443)
                      ........  ......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+..+. ...+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD  238 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            76543211  1123346778999999987665 489999999999999999 899998877766666665543 345566


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          233 FSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ++..+.++|.+||+.||.+|||+++|+++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            88999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.6e-41  Score=332.45  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=210.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLA   79 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~   79 (443)
                      .++|.+++.||+|+||.||+|.+..       +...+|+|.+....  .......+.+|+.+++.+ +||||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            4789999999999999999998643       23579999997643  223356788899999999 7999999999999


Q ss_pred             eCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc
Q 013421           80 SRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD  143 (443)
Q Consensus        80 ~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~  143 (443)
                      ..+..|+||||+++|+|.+++....                .++...+..++.|++.||+|||++|++||||||+||+++
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  174 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence            9999999999999999999997642                478889999999999999999999999999999999999


Q ss_pred             CCCCeEEeeecCcCCCccccccc--cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHH
Q 013421          144 SYGNLKVSDFGLSALPQQGVELL--HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK  220 (443)
Q Consensus       144 ~~~~~kL~DFGls~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~  220 (443)
                      .++.+||+|||++..........  ....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+...
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            99999999999987554321111  12234568999999977665 489999999999999998 999998877777666


Q ss_pred             Hhhhcc-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          221 KINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       221 ~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+.... ...|..++.++.++|.+||..+|.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         254 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            665543 35566789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=348.55  Aligned_cols=253  Identities=25%  Similarity=0.387  Sum_probs=216.4

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      |.-++.||.|+||.||.|++..+.+.||||.+....-...+.-..+..|+..|+.++|||+|.+.++|.-+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            56678899999999999999999999999999876544444456789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccccc
Q 013421           91 VTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        91 ~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      |- |+-.|.+.- ..++.|.++..+..+.+.||.|||+.+.+|||||..|||+++.|.|||+|||.+.+...    .++.
T Consensus       108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----AnsF  182 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----ANSF  182 (948)
T ss_pred             Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc----hhcc
Confidence            95 466666653 46899999999999999999999999999999999999999999999999999876643    4678


Q ss_pred             CCCcccCCCcccc--cCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCC-CCCHHHHHHHHHcc
Q 013421          170 CGTPNYVAPEVLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPF-WFSTGATSLIHKIL  245 (443)
Q Consensus       170 ~gt~~y~aPE~l~--~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~-~~s~~~~~li~~~L  245 (443)
                      +|||+|||||++.  ..+.++-++||||||++..+|.-.++|+-..+.....-.|..++. ..+. .-|..+++|+..||
T Consensus       183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CL  262 (948)
T KOG0577|consen  183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL  262 (948)
T ss_pred             cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHH
Confidence            9999999999985  233334799999999999999999999888776655555544432 2222 24788999999999


Q ss_pred             CCCCCCCCCHHHHhcCccccccC
Q 013421          246 DPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ++-|..|||.+++++|+|....-
T Consensus       263 qKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  263 QKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             hhCcccCCcHHHHhhcchhccCC
Confidence            99999999999999999997654

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-41  Score=322.69  Aligned_cols=247  Identities=22%  Similarity=0.357  Sum_probs=209.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|++|.||+|.+. ++..||+|.+.....    ..+.+.+|+.++++++||||+++++++...+..|++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            457999999999999999999975 457899999876432    235688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           88 LEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      |||+++++|.+++....  .+++.....++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            99999999999997654  6899999999999999999999999999999999999999999999999998765432111


Q ss_pred             -ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          166 -LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       166 -~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                       .....++..|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+... ..+.+...+..+.+++.
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML  238 (261)
T ss_pred             ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence             111223457999999877665 489999999999999999 99999887776666665443 34455668999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||+.+|.+||++.++++
T Consensus       239 ~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         239 DCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHhhcCcccCCCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8e-42  Score=339.34  Aligned_cols=250  Identities=22%  Similarity=0.384  Sum_probs=204.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-C
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS-R   81 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-~   81 (443)
                      ++|++.+.||+|+||.||+|.+..     +++.||+|++....  .....+.+.+|+.+++++ +||||+++++++.. .
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            489999999999999999997543     45789999987543  222346788899999999 89999999998764 4


Q ss_pred             CEEEEEEecCCCCChHHHHHhc----------------------------------------------------------
Q 013421           82 TKVYIILEFVTGGELFDKIVHQ----------------------------------------------------------  103 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~----------------------------------------------------------  103 (443)
                      ..++++|||+++++|.+++...                                                          
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            6789999999999999988642                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc--cccccCCCcccCCC
Q 013421          104 ---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAP  178 (443)
Q Consensus       104 ---~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aP  178 (443)
                         .++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........  ......++..|+||
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence               2578889999999999999999999999999999999999999999999999876533211  12234456789999


Q ss_pred             cccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHH-HHHHhhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCH
Q 013421          179 EVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT-LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRI  255 (443)
Q Consensus       179 E~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~  255 (443)
                      |++.+..+. .++||||+||++|+|++ |..||.+....+ ....+..+ ....|...++++.+++.+||+.+|.+||++
T Consensus       245 E~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~  323 (337)
T cd05054         245 ESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF  323 (337)
T ss_pred             HHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence            999887775 89999999999999998 999997754333 33333332 234455678999999999999999999999


Q ss_pred             HHHhcC
Q 013421          256 EGIRKH  261 (443)
Q Consensus       256 ~eil~h  261 (443)
                      +++++|
T Consensus       324 ~ell~~  329 (337)
T cd05054         324 SELVEI  329 (337)
T ss_pred             HHHHHH
Confidence            999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.7e-41  Score=329.60  Aligned_cols=251  Identities=20%  Similarity=0.259  Sum_probs=210.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCC----------------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETG----------------ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN   70 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~----------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn   70 (443)
                      ..++|++++.||+|+||.||+|.+..++                ..||+|.+.....  ....+.+.+|+.+++.++|||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence            3568999999999999999999876544                5689999876542  234678899999999999999


Q ss_pred             cceEEEEEEeCCEEEEEEecCCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCc
Q 013421           71 IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-----------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN  139 (443)
Q Consensus        71 Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~N  139 (443)
                      |+++++++..+...+++|||+++++|.+++....           .+++..++.++.|++.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999997765           68999999999999999999999999999999999


Q ss_pred             EEEcCCCCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh--CCCCCCCCCh
Q 013421          140 LLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA--GYLPFGETDL  215 (443)
Q Consensus       140 ILl~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~--G~~Pf~~~~~  215 (443)
                      |+++.++.++|+|||++.......  .......+++.|+|||++.+..+ +.++|||||||++|+|++  |..||...+.
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            999999999999999987543321  12234456788999999876555 489999999999999997  7889987666


Q ss_pred             HHHHHHhhhc--------cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          216 PTLYKKINAA--------EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       216 ~~~~~~i~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ..........        ....+..++.++.+++.+||+.||.+|||+.+|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            5555443321        12334557899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-41  Score=321.93  Aligned_cols=242  Identities=26%  Similarity=0.372  Sum_probs=205.3

Q ss_pred             eeeeccCceEEEEEEECCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecC
Q 013421           15 RTIGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFV   91 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~   91 (443)
                      +.||+|+||.||+|....++   ..+|+|.+......  ...+.+.+|+.+++.++||||+++++++.. +..+++|||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence            47999999999999876554   78999999866543  345678899999999999999999998764 5689999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc---c
Q 013421           92 TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH---T  168 (443)
Q Consensus        92 ~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~---~  168 (443)
                      ++++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........   .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            9999999998888899999999999999999999999999999999999999999999999999876544322211   1


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHHHHccC
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILD  246 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~  246 (443)
                      ..++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+..+....+.... ...|..+++.+.++|.+||.
T Consensus       158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  236 (257)
T cd05060         158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK  236 (257)
T ss_pred             ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence            123467999999977665 489999999999999998 999998877766666665443 45666789999999999999


Q ss_pred             CCCCCCCCHHHHhc
Q 013421          247 PNPKTRIRIEGIRK  260 (443)
Q Consensus       247 ~dP~~R~t~~eil~  260 (443)
                      +||++|||+.++++
T Consensus       237 ~~p~~Rp~~~~l~~  250 (257)
T cd05060         237 YRPEDRPTFSELES  250 (257)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999876

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.5e-42  Score=329.82  Aligned_cols=251  Identities=23%  Similarity=0.359  Sum_probs=212.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      +.+|++.+.||+|+||.||+|.+..+     +..||+|++....  .....+.+.+|+.+++.++||||+++++++.+..
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            56789999999999999999987543     5789999997543  2334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC
Q 013421           83 KVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG  146 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~  146 (443)
                      ..++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+||++++++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence            999999999999999998532                3478888999999999999999999999999999999999999


Q ss_pred             CeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhh
Q 013421          147 NLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN  223 (443)
Q Consensus       147 ~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~  223 (443)
                      .+||+|||++.......  .......+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+..+....+.
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999999987543321  12234456789999999876665 489999999999999998 899998887777777766


Q ss_pred             hcc-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          224 AAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       224 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ... .+.|..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            554 34566789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.5e-41  Score=328.34  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=211.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      ..++|.+.+.||+|+||.||+|.+..     ++..+++|.+....   ....+.+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            35679999999999999999998543     45678999886543   22346788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY  145 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~  145 (443)
                      +..++||||+++++|.+++...+                .+++..++.++.||+.||+|||++||+||||||+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999997543                37889999999999999999999999999999999999999


Q ss_pred             CCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHh
Q 013421          146 GNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI  222 (443)
Q Consensus       146 ~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i  222 (443)
                      +.++|+|||++.......  .......|++.|+|||.+.+..+. .++|||||||++|+|++ |..||...+.......+
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999987543321  122345578899999998876654 88999999999999998 99999887777766666


Q ss_pred             hhccCC-CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          223 NAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       223 ~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ..+... .+...+..+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            555443 34557899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2e-41  Score=328.16  Aligned_cols=258  Identities=34%  Similarity=0.600  Sum_probs=216.6

Q ss_pred             CeEEeeeeeccCceEEEEEEEC---CCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~   84 (443)
                      +|++.+.||+|+||.||++.+.   .+++.||+|++.+.... .....+.+.+|+.+++++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4899999999999999999864   46789999999764432 223346688999999999 699999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+||||+++++|.+++.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            99999999999999998878899999999999999999999999999999999999999999999999999876443211


Q ss_pred             -cccccCCCcccCCCcccccCC-CCCCccchHHHHHHHHHHhhCCCCCCCCC----hHHHHHHhhhccCCCCCCCCHHHH
Q 013421          165 -LLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFSCPFWFSTGAT  238 (443)
Q Consensus       165 -~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~~  238 (443)
                       .....+|++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||...+    .......+.....+.|..+++++.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  240 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR  240 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence             223456899999999986543 23589999999999999999999996432    233344455556667777899999


Q ss_pred             HHHHHccCCCCCCCCC---HHHHhcCcccccc
Q 013421          239 SLIHKILDPNPKTRIR---IEGIRKHPWFRKN  267 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t---~~eil~hp~f~~~  267 (443)
                      ++|.+||+.||++|||   +.++++||||+.-
T Consensus       241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             HHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            9999999999999998   5678999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.7e-41  Score=323.71  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=210.1

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      .++|++.+.||+|+||.||+|.+..++.   .+|+|.+.....  ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            3679999999999999999999865543   799999865432  23456789999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |++|||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999999765 468999999999999999999999999999999999999999999999999987654422


Q ss_pred             ccc---cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHH
Q 013421          164 ELL---HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGAT  238 (443)
Q Consensus       164 ~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  238 (443)
                      ...   ....++..|+|||.+.+..+ +.++|+|||||++|++++ |..||...+..+....+... ..+.+..+++.+.
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH  239 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence            111   11223567999999987665 489999999999999886 99999887766666655543 3344455789999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhc
Q 013421          239 SLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +++.+||+.+|.+||++.++++
T Consensus       240 ~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         240 QLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHcccCchhCCCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.6e-42  Score=337.23  Aligned_cols=253  Identities=18%  Similarity=0.288  Sum_probs=203.3

Q ss_pred             eeeecc--CceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCC
Q 013421           15 RTIGEG--TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (443)
Q Consensus        15 ~~LG~G--~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~   92 (443)
                      ..||.|  +||+||+|.+..+|+.||+|++...... .+..+.+.+|+.+++.++||||+++++++...+..|+++||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            456666  9999999999999999999998765433 2345789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc------
Q 013421           93 GGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE------  164 (443)
Q Consensus        93 gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~------  164 (443)
                      +++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++++||+.+........      
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            99999998764  3589999999999999999999999999999999999999999999999985432211100      


Q ss_pred             -cccccCCCcccCCCcccccCC-CCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC---------------
Q 013421          165 -LLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---------------  227 (443)
Q Consensus       165 -~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------------  227 (443)
                       ......++..|+|||++.+.. ..+.++||||+||++|+|++|.+||.................               
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR  242 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence             011223566799999986532 235899999999999999999999987654333322211100               


Q ss_pred             --------------------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          228 --------------------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       228 --------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                                                      +.+..+++.+.+||++||+.||.+|||++++++||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                            01122567899999999999999999999999999997654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=326.16  Aligned_cols=250  Identities=31%  Similarity=0.440  Sum_probs=206.6

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCE----
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVRLHEVLASRTK----   83 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~----   83 (443)
                      |++.+.||+|+||.||+|++..+++.||+|.+..... .......+.+|+.+++.+   +||||+++++++.+.+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            7899999999999999999998999999999975443 222334566788877766   59999999999988776    


Q ss_pred             -EEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           84 -VYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        84 -~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                       .|++|||+++ +|.+++....  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             9999999975 7988887643  58999999999999999999999999999999999999999999999999987654


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-C------C-----
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-F------S-----  228 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~------~-----  228 (443)
                      .. .......+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||...+..+...++.... .      +     
T Consensus       159 ~~-~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         159 FE-MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             CC-cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            33 22234458889999999987665 489999999999999999999998877665554442210 0      0     


Q ss_pred             ----C-----------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          229 ----C-----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       229 ----~-----------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                          +           .+.+++.+.++|.+||+.||++||++++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                0           01246788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.4e-41  Score=323.55  Aligned_cols=246  Identities=24%  Similarity=0.365  Sum_probs=206.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|+||.||+|.+..+ ..||+|.+......    .+.+.+|+.+++.++||||+++++++.. ...|++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv   78 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   78 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence            46799999999999999999988655 45999998764321    2568899999999999999999998754 568999


Q ss_pred             EecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-
Q 013421           88 LEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-  164 (443)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999999999763  3578999999999999999999999999999999999999999999999999875543221 


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      ......++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.........+... ..+.+..++..+.+++.
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  237 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC  237 (262)
T ss_pred             cccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence            1223446778999999876666 489999999999999999 89999887766666655443 34445568999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||++||.+|||+.++++
T Consensus       238 ~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         238 QCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHccCCcccCCCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.4e-41  Score=325.12  Aligned_cols=249  Identities=22%  Similarity=0.330  Sum_probs=209.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ..+|++.+.||+|+||.||+|.+..+++    .||+|++....  .......+.+|+.+++.++||||+++++++.. ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence            4679999999999999999999877776    48999986543  23345678899999999999999999999875 45


Q ss_pred             EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           84 VYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      .++++||+++|+|.+.+... +.+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||++......
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            78999999999999999764 56899999999999999999999999999999999999999999999999998765432


Q ss_pred             ccc--ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHH
Q 013421          163 VEL--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGAT  238 (443)
Q Consensus       163 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  238 (443)
                      ...  .....+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+... ..+.+..++.++.
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY  241 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence            221  1223356789999999777665 89999999999999998 99999877666555555443 3345566899999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhc
Q 013421          239 SLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +++.+||..||++||++.+++.
T Consensus       242 ~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         242 MIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-41  Score=320.34  Aligned_cols=244  Identities=26%  Similarity=0.468  Sum_probs=211.1

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ...+|++.+.||.|+||.||+|...  |+.||+|.+.....    ..+.+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            3568999999999999999999874  78999999976532    35678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           87 ILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      +|||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-  156 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-  156 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence            999999999999998765  68999999999999999999999999999999999999999999999999987653321 


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                        ....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+... ....|..+++++.++|.
T Consensus       157 --~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMK  233 (256)
T ss_pred             --ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHH
Confidence              13345667999999876555 489999999999999997 99999888776666555443 33456668999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||..+|++|||+++++.
T Consensus       234 ~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         234 DCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHhccChhhCcCHHHHHH
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1e-41  Score=325.06  Aligned_cols=253  Identities=29%  Similarity=0.507  Sum_probs=213.5

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL--KHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +|.+.+.||+|+||.||++.+..++..+++|++......  .......+..|+.+++.++||||+++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            699999999999999999999888777777776543321  112234567899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           88 LEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +||+++++|.+.+..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988853    356899999999999999999999999999999999999975 679999999987654443


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIH  242 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~  242 (443)
                      .......|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+..+. ...+..++.++.++|.
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ  238 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence            444456689999999998776665 78999999999999999999998776665555554433 3445568899999999


Q ss_pred             HccCCCCCCCCCHHHHhcCccc
Q 013421          243 KILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      +||..||++||++.++++||||
T Consensus       239 ~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         239 SMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-41  Score=336.37  Aligned_cols=254  Identities=26%  Similarity=0.407  Sum_probs=207.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR------   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------   81 (443)
                      ..+|.+.+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            4689999999999999999999999999999999876432 222345678999999999999999999998654      


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..+|+++||+.. +|....  ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus        93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            357999999964 666554  24689999999999999999999999999999999999999999999999999875432


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc----------------
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----------------  225 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------  225 (443)
                         ......|++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+...                
T Consensus       170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence               2234568899999999876444458999999999999999999999877654433322110                


Q ss_pred             -------cCCC--------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          226 -------EFSC--------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       226 -------~~~~--------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                             ....        .+..++++.+||.+||+.||.+||++++++.||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                   0000        123678899999999999999999999999999997653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3e-41  Score=330.82  Aligned_cols=255  Identities=25%  Similarity=0.371  Sum_probs=213.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ...|+..+.||+|+||.||+|++..+++.+|+|.+.............+.+|+.+++.++|||++++++++......|+|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            34588889999999999999999999999999998765443444556788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||+. |++.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......    
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----  168 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----  168 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence            99996 577777654 456899999999999999999999999999999999999999999999999988654332    


Q ss_pred             cccCCCcccCCCccccc--CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC--CCCCCCHHHHHHHH
Q 013421          167 HTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS--CPFWFSTGATSLIH  242 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~  242 (443)
                      ....|++.|+|||.+.+  .+..+.++|||||||++|+|++|..||...+.......+.....+  .+..++..+.+||.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  248 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD  248 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHH
Confidence            34568899999999742  222357899999999999999999999776554443333333222  22347889999999


Q ss_pred             HccCCCCCCCCCHHHHhcCcccccc
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +||..+|.+||++++++.|||+...
T Consensus       249 ~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         249 SCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHhhCCcccCCCHHHHhhCcccccc
Confidence            9999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5e-41  Score=332.70  Aligned_cols=256  Identities=28%  Similarity=0.387  Sum_probs=207.0

Q ss_pred             CeEEeeeeeccCceEEEEEEECCC--CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CC
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRET--GESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS----RT   82 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~   82 (443)
                      +|++.+.||+|+||.||++.+..+  +..||+|.+..... .......+.+|+.+++++ +||||+++++....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999888  89999999875332 222345678899999999 59999999987532    35


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      ..|+++||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            6889999985 689999988888999999999999999999999999999999999999999999999999998754331


Q ss_pred             c----ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh--------------
Q 013421          163 V----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--------------  224 (443)
Q Consensus       163 ~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------  224 (443)
                      .    .......|++.|+|||++.+....+.++||||+||++|+|++|.+||...+.......+..              
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            1    1223457899999999876543335899999999999999999999987653322221110              


Q ss_pred             -c----------c---CC---CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          225 -A----------E---FS---CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       225 -~----------~---~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                       .          .   ..   ..+..+..+.+++.+||+.||.+|||+.+++.||||+.-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence             0          0   00   112257899999999999999999999999999999743

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-41  Score=343.13  Aligned_cols=250  Identities=25%  Similarity=0.369  Sum_probs=205.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~   81 (443)
                      .++|++++.||+|+||.||+|.+...     +..||+|++....  .....+.+.+|+.+++++. ||||+++++++.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            45788999999999999999987433     3479999996543  2334567899999999996 99999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhc----------------------------------------------------------
Q 013421           82 TKVYIILEFVTGGELFDKIVHQ----------------------------------------------------------  103 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~----------------------------------------------------------  103 (443)
                      +..|+|||||++|+|.+++...                                                          
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            9999999999999999988642                                                          


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC
Q 013421          104 --------------------------------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY  145 (443)
Q Consensus       104 --------------------------------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~  145 (443)
                                                            ..+++..+..++.|++.||.|||+.||+||||||+|||++.+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~  273 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence                                                  236777888999999999999999999999999999999999


Q ss_pred             CCeEEeeecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChH-HHHHH
Q 013421          146 GNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP-TLYKK  221 (443)
Q Consensus       146 ~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~  221 (443)
                      +.+||+|||++........  ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...... .....
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~  352 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK  352 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence            9999999999875433211  1223456788999999977666 489999999999999997 99999875433 33333


Q ss_pred             hhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          222 INAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       222 i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +..+ ....+..++.++.+++.+||+.||++|||+.++.+
T Consensus       353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            3333 34455668999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-41  Score=322.40  Aligned_cols=246  Identities=23%  Similarity=0.372  Sum_probs=206.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|.+......    .+.+.+|+.+++.++||||+++++++. ....|++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV   78 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence            468999999999999999999875 5667999998765432    246889999999999999999999885 4568999


Q ss_pred             EecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-
Q 013421           88 LEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-  164 (443)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            9999999999998753  3589999999999999999999999999999999999999999999999999876543211 


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      ......++..|+|||.+.+..+ +.++||||||+++|+|++ |.+||.+.+.......+... ..+.+...+..+.+|+.
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML  237 (260)
T ss_pred             cccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence            1122335567999999876555 489999999999999999 99999887766666665443 44556678999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||.+||++|||++++..
T Consensus       238 ~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         238 QCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHcccCcccCcCHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=326.17  Aligned_cols=250  Identities=32%  Similarity=0.478  Sum_probs=208.1

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      |++.+.||+|++|+||+|....+++.||||.+.......  ......+|+..+++++ ||||+++++++.+++..|+|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            788999999999999999999999999999987653221  1234457899999998 9999999999999999999999


Q ss_pred             cCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           90 FVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        90 y~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |+ +|+|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-~~~~  156 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-PPYT  156 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-CCcC
Confidence            99 889999887764  7899999999999999999999999999999999999999999999999998765432 2234


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-------------------cCC
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------EFS  228 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~~  228 (443)
                      ...|+..|+|||++.+....+.++|+||||+++++|++|++||...+......++...                   ...
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR  236 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence            4568899999998865444458999999999999999999999876654433322110                   000


Q ss_pred             C-----------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          229 C-----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       229 ~-----------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      .           .+..++++.++|++||+.||.+|||++|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0           11236889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.8e-41  Score=321.25  Aligned_cols=246  Identities=24%  Similarity=0.395  Sum_probs=207.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      -++|++++.||+|+||.||+|... +++.||+|.+......    .+.+.+|+.+++.++||||+++++++. .+..|++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            457999999999999999999865 5788999998764432    356889999999999999999999874 4568999


Q ss_pred             EecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-
Q 013421           88 LEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-  164 (443)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999999998753  3688999999999999999999999999999999999999999999999999876542211 


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      ......++..|+|||++....+ +.++||||+|+++|+|++ |.+||.+.+.......+... ..+.+...+.++.+++.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMR  237 (260)
T ss_pred             cccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            1223345678999999876655 489999999999999998 99999887776666655443 33455668899999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||..+|++|||+++++.
T Consensus       238 ~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         238 LCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHccCChhhCCCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.1e-41  Score=329.38  Aligned_cols=250  Identities=23%  Similarity=0.385  Sum_probs=209.3

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLA   79 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~   79 (443)
                      .++|.+++.||+|+||.||+|.+..       ....+|+|.+....  .......+.+|+.+++.+ +||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            4689999999999999999998632       34579999987543  223456788999999999 6999999999999


Q ss_pred             eCCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc
Q 013421           80 SRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD  143 (443)
Q Consensus        80 ~~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~  143 (443)
                      +.+..|++|||+++|+|.+++...                ..++...+..++.||+.||.|||++|++||||||+||+++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence            999999999999999999999753                2478888999999999999999999999999999999999


Q ss_pred             CCCCeEEeeecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHH
Q 013421          144 SYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK  220 (443)
Q Consensus       144 ~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~  220 (443)
                      .++.+||+|||++........  ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+......
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  247 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK  247 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999976543211  1122334568999999977665 489999999999999999 999998877777666


Q ss_pred             Hhhhcc-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          221 KINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       221 ~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .+.... ...+..++.++.+++.+||..||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            665543 3456668899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.7e-41  Score=327.87  Aligned_cols=253  Identities=23%  Similarity=0.386  Sum_probs=212.2

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEEC-------CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNR-------ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEV   77 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~   77 (443)
                      ....+|++.+.||+|+||.||+|+..       ..+..||+|.+....  .......+.+|+.+++.+ +||||++++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            34568999999999999999999753       234579999987542  223456789999999999 89999999999


Q ss_pred             EEeCCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEE
Q 013421           78 LASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL  141 (443)
Q Consensus        78 ~~~~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NIL  141 (443)
                      +......|++|||+++|+|.+++...                ..++...+..++.||+.||.|||++|++||||||+||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  169 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL  169 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence            99999999999999999999999764                24677788999999999999999999999999999999


Q ss_pred             EcCCCCeEEeeecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHH
Q 013421          142 LDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  218 (443)
Q Consensus       142 l~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  218 (443)
                      ++.++.+||+|||++........  ......+++.|+|||++.+..++ .++||||||+++|+|++ |..||...+....
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            99999999999999876543211  12234466789999999776664 88999999999999998 8999998887777


Q ss_pred             HHHhhhcc-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          219 YKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       219 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ...+.... ...+..++.++.++|.+||.++|.+|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            77765443 34456689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.4e-41  Score=330.75  Aligned_cols=258  Identities=27%  Similarity=0.451  Sum_probs=210.6

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-RTKVY   85 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~   85 (443)
                      .-++|++.+.||.|+||.||+|.+..+++.||+|.+.+.... ....+.+.+|+.+++.++||||+++++++.. ....|
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            346899999999999999999999999999999998764322 2234678899999999999999999999865 56789


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      +++||+ +++|.+.+.. .++++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....   .
T Consensus        87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~  161 (328)
T cd07856          87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---Q  161 (328)
T ss_pred             EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---C
Confidence            999999 5688777654 5788999999999999999999999999999999999999999999999999875432   2


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh---------------------
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA---------------------  224 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---------------------  224 (443)
                      .....+++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+..                     
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            23456788999999986634445899999999999999999999977654222111100                     


Q ss_pred             ---c--cCCCC-----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          225 ---A--EFSCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       225 ---~--~~~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                         .  ....|     +.+++++.++|++||+.+|++|||+++++.||||.....+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence               0  00111     2468899999999999999999999999999999765443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.2e-41  Score=327.74  Aligned_cols=250  Identities=25%  Similarity=0.371  Sum_probs=207.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~   81 (443)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|.+....  .....+.+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            45799999999999999999975     3345689999987543  223456789999999999 799999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      +..|++|||+++|+|.+++....  .+++.+...++.|++.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999999999997643  3899999999999999999999999999999999999999999999999998755


Q ss_pred             ccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHH-hhhc-cCCCCCCCC
Q 013421          160 QQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK-INAA-EFSCPFWFS  234 (443)
Q Consensus       160 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~-i~~~-~~~~~~~~s  234 (443)
                      .....  ......+++.|+|||.+.+..+. .++||||+||++|+|++ |..||..........+ +..+ ....+...+
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAP  270 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCC
Confidence            43211  11223467789999998776654 89999999999999998 9999987665443333 3222 233455689


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          235 TGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +++.+++.+||+++|++|||+.++++
T Consensus       271 ~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         271 AEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.9e-41  Score=324.51  Aligned_cols=248  Identities=22%  Similarity=0.351  Sum_probs=209.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      .+|.+.+.||+|+||.||++...     .++..+|+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            46889999999999999999743     346689999876432   3345689999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCe
Q 013421           84 VYIILEFVTGGELFDKIVHQG---------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL  148 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~---------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~  148 (443)
                      .|++|||+++++|.+++....               .+++..+..++.||+.|++|||++|++||||||+|||+++++.+
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence            999999999999999997643               47889999999999999999999999999999999999999999


Q ss_pred             EEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc
Q 013421          149 KVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA  225 (443)
Q Consensus       149 kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~  225 (443)
                      ||+|||++.......  .......+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...+.......+..+
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG  240 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence            999999986443211  112233457889999999877664 89999999999999998 99999877766666555443


Q ss_pred             -cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          226 -EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       226 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                       ....|..+++.+.++|.+||+.||.+||++++|+.
T Consensus       241 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         241 RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             34456678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.7e-41  Score=319.91  Aligned_cols=243  Identities=25%  Similarity=0.438  Sum_probs=206.7

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVL-ASRTKVY   85 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~   85 (443)
                      .+.+|++.+.||+|+||.||++...  |..+|+|.+....     ..+.+.+|+.++++++|+|++++++++ ..++..|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            3568999999999999999999764  7889999886432     245688999999999999999999875 4567899


Q ss_pred             EEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           86 IILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      ++|||+++++|.+++....  .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...... 
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-  155 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  155 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence            9999999999999997654  4789999999999999999999999999999999999999999999999998754332 


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (443)
                        .....++..|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ....+..+++.+.+++
T Consensus       156 --~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  232 (256)
T cd05082         156 --QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM  232 (256)
T ss_pred             --CCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence              1233456789999998776664 89999999999999997 99999888777766666544 3344566899999999


Q ss_pred             HHccCCCCCCCCCHHHHhc
Q 013421          242 HKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (443)
                      .+||..+|++|||+.++++
T Consensus       233 ~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         233 KQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-41  Score=325.18  Aligned_cols=246  Identities=30%  Similarity=0.494  Sum_probs=204.6

Q ss_pred             EEeeeeeccCceEEEEEEEC----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421           12 EVGRTIGEGTFAKVRFAQNR----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .+.+.||.|+||.||+|...    ..+..|+||++...  ...+..+.+.+|+..+++++||||+++++++...+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence            56789999999999999987    34678999999543  2333468899999999999999999999999988889999


Q ss_pred             EecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc--cc
Q 013421           88 LEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GV  163 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~--~~  163 (443)
                      +||+++|+|.+++...  ..+++.....++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++.....  ..
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999886  6899999999999999999999999999999999999999999999999999876522  11


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (443)
                      .......+...|+|||.+.+..+ +.++||||||+++|||++ |+.||...+......++..+ ....|..++..+.++|
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence            22334457788999999977665 489999999999999999 78999988877777776544 3455667899999999


Q ss_pred             HHccCCCCCCCCCHHHHhc
Q 013421          242 HKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (443)
                      .+||..||.+|||+.+|++
T Consensus       239 ~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  239 QQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHT-SSGGGS--HHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHh
Confidence            9999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8e-43  Score=322.96  Aligned_cols=261  Identities=29%  Similarity=0.427  Sum_probs=209.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-RT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~   82 (443)
                      +..|++++.||+|+||.||+|..+.++.    .+|||.+..+.-.. .......+|+.+++.++|||++.+..++.+ +.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            4579999999999999999997666543    78999987653211 233456799999999999999999999876 88


Q ss_pred             EEEEEEecCCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC----CCeEEeee
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY----GNLKVSDF  153 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~----~~~kL~DF  153 (443)
                      .+++++||++. +|++.|.-+     ..++...++.++.||+.|+.|||++-|+||||||.|||+..+    |.+||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999999966 788888643     358889999999999999999999999999999999999877    89999999


Q ss_pred             cCcCCCcccccc---ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh---------HHHHHH
Q 013421          154 GLSALPQQGVEL---LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------PTLYKK  221 (443)
Q Consensus       154 Gls~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---------~~~~~~  221 (443)
                      |+++.+...-..   ....+-|.+|+|||.+.+...++++.|+|+.|||+.||++-++.|.+...         .....+
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            999988764332   23445688999999999988888999999999999999999988865321         011111


Q ss_pred             hhhc---------------------------cC----CCCCC------CCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          222 INAA---------------------------EF----SCPFW------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       222 i~~~---------------------------~~----~~~~~------~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      |..-                           .+    +.+.|      -++.+.+|+.+||+.||.+|+|++++++|+||
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            1100                           00    01111      25669999999999999999999999999999


Q ss_pred             cccCCC
Q 013421          265 RKNYNP  270 (443)
Q Consensus       265 ~~~~~~  270 (443)
                      .....|
T Consensus       341 ~~d~lp  346 (438)
T KOG0666|consen  341 TEDPLP  346 (438)
T ss_pred             ccCCCC
Confidence            987544

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.4e-41  Score=325.15  Aligned_cols=248  Identities=24%  Similarity=0.347  Sum_probs=207.8

Q ss_pred             CeEEeeeeeccCceEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+.....  ......+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            58899999999999999998753     235789998865432  22356788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcE
Q 013421           85 YIILEFVTGGELFDKIVHQ------------------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL  140 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NI  140 (443)
                      |+++||+.+++|.+++...                        ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999988642                        2477888999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeeecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHH
Q 013421          141 LLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  217 (443)
Q Consensus       141 Ll~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  217 (443)
                      |+++++.+||+|||++........  ......++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+.....
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999875433211  12234567789999998766654 89999999999999998 999998877766


Q ss_pred             HHHHhhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          218 LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       218 ~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ....+... ....|..++.++.+++.+||++||.+||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            66555432 34456678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=343.16  Aligned_cols=235  Identities=24%  Similarity=0.412  Sum_probs=208.5

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      ++-||+|+.|.||+|+..  ++.||||.++.          .-..+|+-|++|+|||||.+.++|.....+|||||||..
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ  196 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence            567999999999999875  78999997642          123578899999999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCc
Q 013421           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (443)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (443)
                      |.|...++....++......|..+|+.|+.|||.+.|+|||||.-||||+.+..+||+|||-+...... ...-..+||.
T Consensus       197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTV  275 (904)
T KOG4721|consen  197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTV  275 (904)
T ss_pred             ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhH
Confidence            999999999999999999999999999999999999999999999999999999999999988765443 3344678999


Q ss_pred             ccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cCCCCCCCCHHHHHHHHHccCCCCCC
Q 013421          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFWFSTGATSLIHKILDPNPKT  251 (443)
Q Consensus       174 ~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~  251 (443)
                      .|||||++.+.+.. +|+|||||||||||||||..||.+.+...++.-+..+  .++.|..++..++=||++||+-.|.+
T Consensus       276 aWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRN  354 (904)
T KOG4721|consen  276 AWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRN  354 (904)
T ss_pred             hhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCC
Confidence            99999999988765 9999999999999999999999887766655544333  45667789999999999999999999


Q ss_pred             CCCHHHHhcCc
Q 013421          252 RIRIEGIRKHP  262 (443)
Q Consensus       252 R~t~~eil~hp  262 (443)
                      ||++.+|+.|=
T Consensus       355 RPSFrqil~Hl  365 (904)
T KOG4721|consen  355 RPSFRQILLHL  365 (904)
T ss_pred             CccHHHHHHHH
Confidence            99999999993

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.6e-41  Score=320.10  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=210.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +++|++.+.||+|+||.||+|.+..+++   .||+|.+....  .......+..|+.+++.++||||+++++++.+....
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            4679999999999999999999887665   69999987543  233457799999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +++|||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999998764 568999999999999999999999999999999999999999999999999986543321


Q ss_pred             c--cccccC---CCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHH
Q 013421          164 E--LLHTTC---GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTG  236 (443)
Q Consensus       164 ~--~~~~~~---gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~  236 (443)
                      .  ......   ++..|+|||.+.+..++ .++||||+||++|+|++ |..||...+.......+... ..+.+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA  239 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence            1  111111   24579999999876664 89999999999999886 99999887776666665433 33445567899


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhc
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +.+++.+||..+|.+||++++|+.
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         240 LHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.3e-41  Score=319.10  Aligned_cols=229  Identities=29%  Similarity=0.463  Sum_probs=194.9

Q ss_pred             cCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCCChHHH
Q 013421           20 GTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDK   99 (443)
Q Consensus        20 G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~   99 (443)
                      |.+|+||++++..+++.||+|.+.+..        ...+|...+....||||+++++++.+.+..|++|||++||+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            899999999999999999999997643        122345555566799999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcccCCCc
Q 013421          100 IVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE  179 (443)
Q Consensus       100 i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE  179 (443)
                      +.....+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||.+......   .....++..|+|||
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE  152 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPE  152 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCc
Confidence            988888999999999999999999999999999999999999999999999999987654332   23445678899999


Q ss_pred             ccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCCCH----
Q 013421          180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI----  255 (443)
Q Consensus       180 ~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----  255 (443)
                      .+....+ +.++|+||+|+++|+|++|..||.......    ........|.++++.+.++|.+||+.||++||++    
T Consensus       153 ~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~  227 (237)
T cd05576         153 VGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAG  227 (237)
T ss_pred             ccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccc
Confidence            9876665 489999999999999999999886432110    0112345678899999999999999999999986    


Q ss_pred             -HHHhcCccc
Q 013421          256 -EGIRKHPWF  264 (443)
Q Consensus       256 -~eil~hp~f  264 (443)
                       +++++||||
T Consensus       228 ~~~~~~h~~~  237 (237)
T cd05576         228 VEDIKSHPFF  237 (237)
T ss_pred             hHHHHcCCCC
Confidence             999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9e-41  Score=318.85  Aligned_cols=246  Identities=25%  Similarity=0.384  Sum_probs=205.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|++|.||+|.+..+ ..+|+|.+.....    ..+.+.+|+.+++.++|||++++++++.. +..|++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV   78 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEE
Confidence            46799999999999999999988654 4699998865432    23567889999999999999999998854 568999


Q ss_pred             EecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-
Q 013421           88 LEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-  164 (443)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            99999999999997643  478899999999999999999999999999999999999999999999999876543211 


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      ......++..|+|||.+.+..+ +.++||||+|+++|+|++ |..||.+.........+... ..+.+..++..+.++++
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK  237 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence            1123345678999999876555 489999999999999999 99999887766666665443 34455668999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||.+||.+||+++++++
T Consensus       238 ~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         238 LCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHccCCcccCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-41  Score=325.97  Aligned_cols=250  Identities=21%  Similarity=0.304  Sum_probs=204.5

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCC--------------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcce
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETG--------------ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR   73 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~--------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~   73 (443)
                      ..+|++.+.||+|+||.||++.+..++              ..||+|.+....  .....+.+.+|+++++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            358999999999999999999875432              358999987643  2334567899999999999999999


Q ss_pred             EEEEEEeCCEEEEEEecCCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEE
Q 013421           74 LHEVLASRTKVYIILEFVTGGELFDKIVHQG------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL  141 (443)
Q Consensus        74 l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NIL  141 (443)
                      +++++...+..|+||||+++++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999986532            3678888999999999999999999999999999999


Q ss_pred             EcCCCCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh--CCCCCCCCChHH
Q 013421          142 LDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA--GYLPFGETDLPT  217 (443)
Q Consensus       142 l~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~--G~~Pf~~~~~~~  217 (443)
                      ++.++.+||+|||++.......  .......+++.|+|||++.+..+ +.++|||||||++|+|++  |..||...+...
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            9999999999999987543321  11223345678999999877665 589999999999999988  778988766555


Q ss_pred             HHHHhhh--------ccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          218 LYKKINA--------AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       218 ~~~~i~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ....+..        .....+..+++.+.+|+.+||+.||.+|||+++|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            4433211        112234557899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=7.9e-41  Score=325.61  Aligned_cols=259  Identities=26%  Similarity=0.395  Sum_probs=208.8

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   83 (443)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|.+.+....  .....+.+|+.++... .||||+++++++.+...
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            34567899999999999999999999989999999999765322  2235566677777666 59999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           84 VYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      .|++|||+. ++|.+.+.. .+.+++..+..++.|++.|+.|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            999999985 467666655 4578999999999999999999997 5999999999999999999999999999875533


Q ss_pred             ccccccccCCCcccCCCcccccCC---CCCCccchHHHHHHHHHHhhCCCCCCCCCh-HHHHHHhhhcc-CCCC--CCCC
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAE-FSCP--FWFS  234 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~-~~~~--~~~s  234 (443)
                      . .......|++.|+|||.+.+..   ..+.++||||||+++|+|++|+.||..... .+....+.... ...+  ..++
T Consensus       168 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (296)
T cd06618         168 S-KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS  246 (296)
T ss_pred             C-CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCC
Confidence            2 1223345788999999986543   234789999999999999999999976332 23333333222 2222  2368


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .++.+||.+||..||.+||++++++.||||+..
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            899999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1e-40  Score=322.23  Aligned_cols=250  Identities=19%  Similarity=0.300  Sum_probs=206.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ..++|++++.||+|+||.||+|.+..+++    .+++|.+....  .......+..|+..++.++||||+++++++.. .
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            34689999999999999999999987776    46777765322  22334677888999999999999999998754 5


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..++++||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            578999999999999999764 5789999999999999999999999999999999999999999999999999875433


Q ss_pred             cc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHH
Q 013421          162 GV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGA  237 (443)
Q Consensus       162 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~  237 (443)
                      ..  .......|+..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.........+..+. .+.+...+.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence            21  122344567789999999776664 89999999999999998 999998877665555555443 33445578899


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .+++.+|+..||.+|||+.++++
T Consensus       241 ~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         241 YMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-42  Score=313.74  Aligned_cols=255  Identities=26%  Similarity=0.422  Sum_probs=211.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l   86 (443)
                      +++.+.+..||+|+-|.|++++.+.+|...|||.+.+..  +.+..+.+...++++... +.|+||+.+++|..+..+++
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I  168 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI  168 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence            345667788999999999999999999999999998765  344567888888887766 48999999999999999999


Q ss_pred             EEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           87 ILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      .||.|.. .+..++.+ .++++|..+-.+...++.||.||..+ ||+|||+||+|||+|+.|++||||||++...... .
T Consensus       169 cMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-k  246 (391)
T KOG0983|consen  169 CMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-K  246 (391)
T ss_pred             HHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc-c
Confidence            9999843 23333322 46799999999999999999999865 8999999999999999999999999999765443 3


Q ss_pred             cccccCCCcccCCCcccccC---CCCCCccchHHHHHHHHHHhhCCCCCCCCCh-HHHHHHhhhccCCC-CC--CCCHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNR---GYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAEFSC-PF--WFSTGA  237 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~---~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~-~~--~~s~~~  237 (443)
                      ..+...|.+.|||||.+.-.   .|+ -.+||||||+.++||.||+.||.+.+. -+...++.+.+++. |.  .+|+.+
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F  325 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDF  325 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence            34456799999999998533   454 789999999999999999999988543 45666666655432 22  389999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .+|+..||.+|+.+||...++|+|||+...
T Consensus       326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             HHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            999999999999999999999999999754

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1e-40  Score=318.43  Aligned_cols=241  Identities=24%  Similarity=0.375  Sum_probs=201.5

Q ss_pred             eeeccCceEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           16 TIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        16 ~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            4899999999999775  445679999987543  23345678999999999999999999998864 578999999999


Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc---cccc
Q 013421           94 GELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL---LHTT  169 (443)
Q Consensus        94 g~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~---~~~~  169 (443)
                      ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.........   ....
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999999875 457899999999999999999999999999999999999999999999999998755432221   1122


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHHccCC
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDP  247 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~  247 (443)
                      .+++.|+|||.+....+ +.++|||||||++|+|++ |..||...........+..+ ....|...++++.++|.+||..
T Consensus       159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            23578999999876665 489999999999999996 99999887776666655543 3556677899999999999999


Q ss_pred             CCCCCCCHHHHhc
Q 013421          248 NPKTRIRIEGIRK  260 (443)
Q Consensus       248 dP~~R~t~~eil~  260 (443)
                      ||++||++.+|.+
T Consensus       238 ~~~~Rp~~~~i~~  250 (257)
T cd05115         238 KWEDRPNFAKVEE  250 (257)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.6e-41  Score=321.28  Aligned_cols=251  Identities=24%  Similarity=0.357  Sum_probs=211.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      .++|++.+.||+|+||.||+|+.+.     +.+.+|+|.+....  .....+.+.+|+.++++++||||+++++++.+.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            3679999999999999999999754     34679999886543  2224567899999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeee
Q 013421           83 KVYIILEFVTGGELFDKIVHQG---------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDF  153 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~---------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DF  153 (443)
                      ..|++|||+++|+|.+++....         .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++++||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999998765         6899999999999999999999999999999999999999999999999


Q ss_pred             cCcCCCccc-cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhccC--CC
Q 013421          154 GLSALPQQG-VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEF--SC  229 (443)
Q Consensus       154 Gls~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~  229 (443)
                      |++...... ........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+.....  ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV  240 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence            988643221 112234456778999999876655 488999999999999998 8999987766666666654443  33


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       230 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +..++..+.+++.+||+.||.+|||+.+++.+
T Consensus       241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            45688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.5e-41  Score=324.20  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=210.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ..+|++.+.||+|+||.||+|.+..     ++..||+|++....  .......+.+|+.+++.++||||+++++++.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            4679999999999999999998743     67899999987543  2334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcE
Q 013421           83 KVYIILEFVTGGELFDKIVHQG----------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL  140 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~----------------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NI  140 (443)
                      ..|++|||+++|+|.+++....                      .+++..+..++.||+.||.|||++|++||||||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            9999999999999999997432                      367888899999999999999999999999999999


Q ss_pred             EEcCCCCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHH
Q 013421          141 LLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  217 (443)
Q Consensus       141 Ll~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  217 (443)
                      +++.++.++|+|||++.......  .......+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+..+
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999986543211  112233456779999998776664 89999999999999997 889998877777


Q ss_pred             HHHHhhhccC-CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          218 LYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       218 ~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ....+..+.. +.|..++.++.++|.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            6666655543 446678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=317.63  Aligned_cols=248  Identities=23%  Similarity=0.370  Sum_probs=210.6

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|++.+.||+|+||.||+|.+. ++..+|+|.+......    .+.+.+|+.+++.++||||+++++++.+....++
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            3568999999999999999999975 4578999998764422    3568899999999999999999999999899999


Q ss_pred             EEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-
Q 013421           87 ILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (443)
                      +|||+++++|.+++....  .+++..+..++.|++.|+.|||++|++|+||||+||+++.++.+||+|||++....... 
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999999999997643  68999999999999999999999999999999999999999999999999987654311 


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (443)
                      .......++..|+|||.+.+..+ +.++||||+|+++|+|++ |+.||.+.+.......+... ..+.|...+.++.+++
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM  237 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            11112234568999999976655 489999999999999998 99999887776666666543 3455666789999999


Q ss_pred             HHccCCCCCCCCCHHHHhc
Q 013421          242 HKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (443)
                      .+||..+|.+||+++++++
T Consensus       238 ~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         238 LQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHcccCcccCCCHHHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.2e-41  Score=334.22  Aligned_cols=251  Identities=23%  Similarity=0.383  Sum_probs=204.1

Q ss_pred             ccCeEEeeeeeccCceEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS-   80 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-   80 (443)
                      -++|++.+.||+|+||.||+|.+     ..+++.||||++.....  ......+.+|+.++.++ +||||+++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            35899999999999999999984     34678999999975432  22356788999999999 68999999998754 


Q ss_pred             CCEEEEEEecCCCCChHHHHHhcC--------------------------------------------------------
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQG--------------------------------------------------------  104 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~~--------------------------------------------------------  104 (443)
                      ....+++|||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            456899999999999999986531                                                        


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc--cccccCC
Q 013421          105 -----------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCG  171 (443)
Q Consensus       105 -----------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~~~~~~g  171 (443)
                                 .++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........  ......+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                       356777889999999999999999999999999999999999999999999876433211  1122345


Q ss_pred             CcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHH-HHHHhhh-ccCCCCCCCCHHHHHHHHHccCCC
Q 013421          172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT-LYKKINA-AEFSCPFWFSTGATSLIHKILDPN  248 (443)
Q Consensus       172 t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~-~~~~~~~~~s~~~~~li~~~L~~d  248 (443)
                      ++.|+|||++.+..+. .++||||||+++|+|++ |..||....... ....+.. .....|.+.++++.+++.+||+.|
T Consensus       244 ~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~  322 (343)
T cd05103         244 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  322 (343)
T ss_pred             CcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence            6789999998776664 89999999999999997 999998754332 2222322 234556678999999999999999


Q ss_pred             CCCCCCHHHHhcC
Q 013421          249 PKTRIRIEGIRKH  261 (443)
Q Consensus       249 P~~R~t~~eil~h  261 (443)
                      |.+|||+.+|++|
T Consensus       323 p~~Rps~~eil~~  335 (343)
T cd05103         323 PSQRPTFSELVEH  335 (343)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.6e-41  Score=329.75  Aligned_cols=246  Identities=21%  Similarity=0.368  Sum_probs=197.6

Q ss_pred             CceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCCChHHHH
Q 013421           21 TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI  100 (443)
Q Consensus        21 ~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i  100 (443)
                      ++|.||.+++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|++|||+++++|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            445566666777899999999987532 2335678999999999999999999999999999999999999999999999


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-------ccccccCC
Q 013421          101 VHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-------ELLHTTCG  171 (443)
Q Consensus       101 ~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-------~~~~~~~g  171 (443)
                      ...  ..+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||.+.......       .......+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence            763  468999999999999999999999999999999999999999999999999875432211       12234457


Q ss_pred             CcccCCCcccccC--CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHH-HHhhhc-----------------------
Q 013421          172 TPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY-KKINAA-----------------------  225 (443)
Q Consensus       172 t~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~-~~i~~~-----------------------  225 (443)
                      +..|+|||++.+.  ++ +.++|+||+||++|+|++|..||......... .++...                       
T Consensus       171 ~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
T cd08216         171 NLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS  249 (314)
T ss_pred             cccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence            8889999998653  34 48899999999999999999999865433222 121100                       


Q ss_pred             ----------cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          226 ----------EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       226 ----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                                ....+..++.++.+|+.+||..||++|||++++++||||+.-.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                      0001112457889999999999999999999999999997543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.5e-40  Score=315.36  Aligned_cols=247  Identities=26%  Similarity=0.394  Sum_probs=211.2

Q ss_pred             eEEeeeeeccCceEEEEEEECCCC----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETG----ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      +++.+.||.|+||.||++.+..++    ..||+|.+.....  ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            357889999999999999998766    8999999965532  2245788999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           87 ILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      +|||+++++|.+++.....  +++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999976554  99999999999999999999999999999999999999999999999999876544311


Q ss_pred             ccc-ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHH
Q 013421          165 LLH-TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLI  241 (443)
Q Consensus       165 ~~~-~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li  241 (443)
                      ... ...+++.|+|||.+.+..+ +.++||||+|+++|+|++ |.+||...+.......+.... ...+..++.++.+++
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM  237 (258)
T ss_pred             cccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence            111 2236789999999865555 589999999999999998 899998877777766665443 345566899999999


Q ss_pred             HHccCCCCCCCCCHHHHhc
Q 013421          242 HKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (443)
                      .+||..||++|||+.++++
T Consensus       238 ~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      238 LQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHCcCChhhCcCHHHHHh
Confidence            9999999999999999886

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-41  Score=321.97  Aligned_cols=239  Identities=25%  Similarity=0.292  Sum_probs=198.3

Q ss_pred             eeeeccCceEEEEEEECCCCcE-------EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421           15 RTIGEGTFAKVRFAQNRETGES-------VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~-------vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +.||+|+||.||+|.+..++..       +|+|.+....   ....+.+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            4699999999999998765544       8888876432   23456788899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC--------eEEeeecCcCC
Q 013421           88 LEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN--------LKVSDFGLSAL  158 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~--------~kL~DFGls~~  158 (443)
                      |||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.        ++++|||++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997654 5899999999999999999999999999999999999987765        69999998865


Q ss_pred             CccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhC-CCCCCCCChHHHHHHhhhccCCCCCCCCHHH
Q 013421          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAAEFSCPFWFSTGA  237 (443)
Q Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~  237 (443)
                      ...    .....+++.|+|||++.+....+.++||||+||++|+|++| ..||...+..... .........|...+.++
T Consensus       158 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  232 (258)
T cd05078         158 VLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWTEL  232 (258)
T ss_pred             cCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcHHH
Confidence            432    23456888999999997655445899999999999999998 5666655443332 23334556666678999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .++|.+||+.||++|||+++|++.
T Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         233 ANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHhccChhhCCCHHHHHHh
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.8e-40  Score=317.85  Aligned_cols=249  Identities=26%  Similarity=0.373  Sum_probs=209.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      .+|+..+.||+|+||.||+|.+..++.   .+|+|.+....  .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            478999999999999999999876655   79999886543  2233567889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           86 IILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      ++|||+++++|.+++... +.+++..+..++.|++.|+.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            999999999999998764 5789999999999999999999999999999999999999999999999999875543211


Q ss_pred             cc-c--ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHH
Q 013421          165 LL-H--TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATS  239 (443)
Q Consensus       165 ~~-~--~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~  239 (443)
                      .. .  ....++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ..+.+..+++++.+
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  241 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQ  241 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence            11 1  1223457999999977666 489999999999999997 99999887766666666543 23334457899999


Q ss_pred             HHHHccCCCCCCCCCHHHHhc
Q 013421          240 LIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~  260 (443)
                      ++.+||+.+|++||++.++++
T Consensus       242 li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         242 LMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=319.55  Aligned_cols=249  Identities=24%  Similarity=0.339  Sum_probs=212.1

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      .++|++.+.||+|+||.||+|.+..+|+    .+|+|.+.....  ......+.+|+.+++.++||||+++++++.. ..
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            4689999999999999999999877665    589998876542  3345678899999999999999999999887 78


Q ss_pred             EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           84 VYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      .+++|||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999999999774 46899999999999999999999999999999999999999999999999998765432


Q ss_pred             cccc--cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHH
Q 013421          163 VELL--HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGAT  238 (443)
Q Consensus       163 ~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  238 (443)
                      ....  ....++..|+|||.+....+. .++||||+||++|++++ |..||......+....+..+ ..+.|...+.++.
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY  241 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence            2211  122235689999998766654 89999999999999998 99999988877777666554 3455667889999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhc
Q 013421          239 SLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +++.+||..||..|||+.++++
T Consensus       242 ~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         242 MVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.2e-42  Score=364.21  Aligned_cols=254  Identities=27%  Similarity=0.467  Sum_probs=208.8

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----   81 (443)
                      -..+|+.++.||+|+||.||+++++-+|..||||.|....  .......+.+|+..+.+|+|||||++|..|.+.     
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            4567888999999999999999999999999999998765  344567899999999999999999998654110     


Q ss_pred             --------------------------------------------------------------------------------
Q 013421           82 --------------------------------------------------------------------------------   81 (443)
Q Consensus        82 --------------------------------------------------------------------------------   81 (443)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CEEEEEEecCCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHH
Q 013421           82 ----------------------------------TKVYIILEFVTGGELFDKIVHQGRL-LENDCRRYFQQLIDAVAHCH  126 (443)
Q Consensus        82 ----------------------------------~~~~lv~Ey~~gg~L~~~i~~~~~l-~e~~~~~~~~qll~aL~yLH  126 (443)
                                                        ..+||-||||+...|.+++.++... ....+|++|+||+.||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                              0479999999988887777765544 47889999999999999999


Q ss_pred             hCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc------------------cccccccccCCCcccCCCcccccCC--C
Q 013421          127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ------------------QGVELLHTTCGTPNYVAPEVLSNRG--Y  186 (443)
Q Consensus       127 ~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~------------------~~~~~~~~~~gt~~y~aPE~l~~~~--~  186 (443)
                      ++||+||||||.||++|+++.|||+|||+++...                  .+....+..+||--|+|||++.+..  .
T Consensus       715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence            9999999999999999999999999999998611                  0112346678999999999997766  3


Q ss_pred             CCCccchHHHHHHHHHHhhCCCCCCCC-ChHHHHHHhhhccCCCCCC----CCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          187 DGSAADVWSCGVILFVLMAGYLPFGET-DLPTLYKKINAAEFSCPFW----FSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       187 ~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ++.|+|+||||||||||+   .||+-. .......++..+.++.|..    --+...++|+.||+.||++||||.|+|++
T Consensus       795 Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             ccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence            359999999999999999   456532 2234455666666666622    13456789999999999999999999999


Q ss_pred             cccc
Q 013421          262 PWFR  265 (443)
Q Consensus       262 p~f~  265 (443)
                      .||.
T Consensus       872 ~llp  875 (1351)
T KOG1035|consen  872 ELLP  875 (1351)
T ss_pred             cCCC
Confidence            9996

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=319.39  Aligned_cols=242  Identities=24%  Similarity=0.359  Sum_probs=201.2

Q ss_pred             eeeeccCceEEEEEEECCCCc--EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecC
Q 013421           15 RTIGEGTFAKVRFAQNRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFV   91 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~   91 (443)
                      +.||+|+||.||+|.+..++.  .+|+|.+....  .....+.+.+|+.+++++ +||||+++++++...+..|++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            468999999999999988776  46888776432  223456788999999999 8999999999999999999999999


Q ss_pred             CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecC
Q 013421           92 TGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (443)
Q Consensus        92 ~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (443)
                      ++|+|.+++....                .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999999997543                478889999999999999999999999999999999999999999999999


Q ss_pred             cCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCC
Q 013421          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWF  233 (443)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~  233 (443)
                      +...... ........+..|+|||++....+ +.++|||||||++|+|++ |..||...+.......+... ....+..+
T Consensus       159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (270)
T cd05047         159 SRGQEVY-VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC  236 (270)
T ss_pred             ccccchh-hhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcC
Confidence            8533221 11112234567999999876665 489999999999999997 99999887777666665443 23445557


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +.++.+++.+|+..||.+|||+++++.
T Consensus       237 ~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         237 DDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.4e-40  Score=323.85  Aligned_cols=249  Identities=21%  Similarity=0.323  Sum_probs=203.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECC----------------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcc
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRE----------------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV   72 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv   72 (443)
                      ++|++.+.||+|+||.||++.+..                ++..+|+|++....  .......+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            479999999999999999986432                34578999987543  233456789999999999999999


Q ss_pred             eEEEEEEeCCEEEEEEecCCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEE
Q 013421           73 RLHEVLASRTKVYIILEFVTGGELFDKIVHQG-----------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL  141 (443)
Q Consensus        73 ~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NIL  141 (443)
                      ++++++...+..|++|||+++++|.+++....           .+++..+..++.|++.||+|||++|++||||||+|||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999999999999987643           3567789999999999999999999999999999999


Q ss_pred             EcCCCCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh--CCCCCCCCChHH
Q 013421          142 LDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA--GYLPFGETDLPT  217 (443)
Q Consensus       142 l~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~--G~~Pf~~~~~~~  217 (443)
                      ++.++.++|+|||++.......  .......+++.|+|||+..+..+ +.++|||||||++|+|++  |..||...+..+
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            9999999999999987543321  11223345678999998876655 489999999999999998  789997766544


Q ss_pred             HHHHhh--------hccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          218 LYKKIN--------AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       218 ~~~~i~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ......        ....+.+..+++.+.+|+.+||+.||.+|||+.+|.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            433221        1123345567899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.6e-40  Score=313.25  Aligned_cols=242  Identities=26%  Similarity=0.441  Sum_probs=203.3

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg   94 (443)
                      +.||+|+||.||+|... ++..+|+|.+....  .......+.+|+.+++.++||||+++++++...+..+++|||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            46899999999999865 68899999987543  2233456889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-cccccCCC
Q 013421           95 ELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LLHTTCGT  172 (443)
Q Consensus        95 ~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~~~~~~gt  172 (443)
                      +|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ ......++
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            999998754 4678999999999999999999999999999999999999999999999999865432211 11122345


Q ss_pred             cccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHHccCCCCC
Q 013421          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPK  250 (443)
Q Consensus       173 ~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~  250 (443)
                      +.|+|||++.+..+ +.++||||+|+++|++++ |..||...+.......+... ....+..++..+.+++.+||..+|+
T Consensus       158 ~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  236 (250)
T cd05085         158 IKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE  236 (250)
T ss_pred             ccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence            67999999976555 489999999999999998 99999887766655555443 3455667899999999999999999


Q ss_pred             CCCCHHHHhc
Q 013421          251 TRIRIEGIRK  260 (443)
Q Consensus       251 ~R~t~~eil~  260 (443)
                      +||++.++++
T Consensus       237 ~Rp~~~~l~~  246 (250)
T cd05085         237 NRPKFSELQK  246 (250)
T ss_pred             cCCCHHHHHH
Confidence            9999999876

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-40  Score=315.95  Aligned_cols=242  Identities=26%  Similarity=0.439  Sum_probs=205.8

Q ss_pred             eeeeccCceEEEEEEECC-CCc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecC
Q 013421           15 RTIGEGTFAKVRFAQNRE-TGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFV   91 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~   91 (443)
                      +.||+|++|.||+|.+.. ++.  .||+|.+......  ...+.+.+|+.++++++||||+++++++.+ ...+++|||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999999865 333  6999999876543  456789999999999999999999999988 8999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc---cc
Q 013421           92 TGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---LL  166 (443)
Q Consensus        92 ~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~---~~  166 (443)
                      ++++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........   ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999998754  689999999999999999999999999999999999999999999999999876544211   11


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc--cCCCCCCCCHHHHHHHHH
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA--EFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~  243 (443)
                      ....++..|+|||.+.+..+. .++|||||||++|+|++ |..||...+..+....+...  ....+..++..+.+++.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ  236 (257)
T ss_pred             cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence            234577889999998776664 88999999999999998 99999887777666655432  233445578999999999


Q ss_pred             ccCCCCCCCCCHHHHhc
Q 013421          244 ILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~  260 (443)
                      ||..+|++|||+.++++
T Consensus       237 ~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         237 CWAHNPADRPTFAALRE  253 (257)
T ss_pred             HCCCCcccCCCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.2e-42  Score=343.83  Aligned_cols=250  Identities=24%  Similarity=0.468  Sum_probs=219.5

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--EEEEEec
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK--VYIILEF   90 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~lv~Ey   90 (443)
                      ...||+|+|-+||+|.|..+|-.||.-.+....+ ...+..+.+..|+.+|+.|+|||||++|++|.+..+  +.+|+|+
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            3679999999999999999999998766554443 344556889999999999999999999999987665  8899999


Q ss_pred             CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCEeecCCCCcEEEcC-CCCeEEeeecCcCCCcccccccc
Q 013421           91 VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK--GVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        91 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~--gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      +.+|+|+.|..+.++++...++.|++||+.||.|||++  .|+|||||.+||+|+. .|.+||+|+|||+.....  ...
T Consensus       125 ~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--~ak  202 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--HAK  202 (632)
T ss_pred             ccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc--ccc
Confidence            99999999999999999999999999999999999998  4999999999999985 599999999999987653  234


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCC-CChHHHHHHhhhccCCC--CCCCCHHHHHHHHHc
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSC--PFWFSTGATSLIHKI  244 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~--~~~~s~~~~~li~~~  244 (443)
                      ..+|||.|||||++- ..|+ +.+||||||+.+.||.|+..||.. .+..++|+++..+..+.  ...-++++++||.+|
T Consensus       203 svIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekC  280 (632)
T KOG0584|consen  203 SVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKC  280 (632)
T ss_pred             eeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHH
Confidence            478999999999986 5776 999999999999999999999976 66778999988775442  223489999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccccccC
Q 013421          245 LDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      |.. .+.|+|+.|+|.||||....
T Consensus       281 l~~-~~~R~sa~eLL~d~Ff~~d~  303 (632)
T KOG0584|consen  281 LAT-KSERLSAKELLKDPFFDEDG  303 (632)
T ss_pred             hcC-chhccCHHHHhhChhhcccc
Confidence            999 99999999999999998763

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.1e-40  Score=315.03  Aligned_cols=248  Identities=25%  Similarity=0.379  Sum_probs=209.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|.+......    ...+.+|+.+++.++||||+++++++......|++
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            357999999999999999999885 4678999998754432    24678899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-c
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-L  165 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~  165 (443)
                      |||+++++|.+++... +.+++..++.++.|++.|+.|||+.|++||||||+||+++.++.+||+|||++........ .
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999998764 4689999999999999999999999999999999999999999999999998865433211 1


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~  243 (443)
                      .....++..|+|||.+.+..+. .++||||||+++|+|++ |..||...+.......+..+ ....|...+..+.+|+.+
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH  236 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence            1222345689999999776654 89999999999999998 99999887777777666554 333355578999999999


Q ss_pred             ccCCCCCCCCCHHHHhcC
Q 013421          244 ILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~h  261 (443)
                      ||+.+|++|||+.+++++
T Consensus       237 ~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         237 CWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HcccChhhCCCHHHHHHh
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-40  Score=328.79  Aligned_cols=250  Identities=23%  Similarity=0.396  Sum_probs=209.5

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCC-------CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRET-------GESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS   80 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~   80 (443)
                      .+|++++.||+|+||.||+|++...       +..||+|.+....  .....+.+.+|+.+++++ +||||+++++++..
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            4799999999999999999986432       2368999887542  233457789999999999 89999999999999


Q ss_pred             CCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS  144 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~  144 (443)
                      .+..|+++||+++|+|.+++....                .++...+..++.|++.||.|||++|++||||||+||+++.
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~  169 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence            999999999999999999997532                3677888899999999999999999999999999999999


Q ss_pred             CCCeEEeeecCcCCCcccccc--ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 013421          145 YGNLKVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK  221 (443)
Q Consensus       145 ~~~~kL~DFGls~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~  221 (443)
                      ++.+||+|||++.........  .....++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  248 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  248 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999999998755432111  1223345679999999876665 88999999999999998 8999998887777776


Q ss_pred             hhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          222 INAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       222 i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +... ....+..++.++.+++.+||+.+|.+|||+.+++.+
T Consensus       249 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            6554 334556688999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-40  Score=319.38  Aligned_cols=248  Identities=28%  Similarity=0.395  Sum_probs=200.4

Q ss_pred             cCe-EEeeeeeccCceEEEEEE----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 013421            9 AKY-EVGRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--R   81 (443)
Q Consensus         9 ~~y-~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~   81 (443)
                      ++| ++.+.||+|+||+||++.    ...++..||+|++.....  ......+.+|+.+++.++||||+++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            466 999999999999998865    335688999999876432  2234678899999999999999999998764  3


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ...|++|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            468999999999999999876 5699999999999999999999999999999999999999999999999999876543


Q ss_pred             ccc---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH--HH-------------HHHhh
Q 013421          162 GVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP--TL-------------YKKIN  223 (443)
Q Consensus       162 ~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--~~-------------~~~i~  223 (443)
                      ...   ......++..|+|||.+.+..+ +.++||||||+++|+|++|..||......  ..             ...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            221   1223345677999999876655 48999999999999999999998653311  00             00011


Q ss_pred             -hccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          224 -AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       224 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                       ....+.|..++.++.+++.+||++||++|||+++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             1122345567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-40  Score=337.26  Aligned_cols=251  Identities=25%  Similarity=0.362  Sum_probs=206.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~   81 (443)
                      .++|.+++.||+|+||.||+|++.     .++..||+|++.....  ....+.+.+|+.+|.++. ||||+++++++...
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            456888999999999999999864     3456899999976432  223457889999999997 99999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcC---------------------------------------------------------
Q 013421           82 TKVYIILEFVTGGELFDKIVHQG---------------------------------------------------------  104 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~---------------------------------------------------------  104 (443)
                      +..|+||||+++|+|.+++...+                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999999996532                                                         


Q ss_pred             -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc
Q 013421          105 -----------------------------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD  143 (443)
Q Consensus       105 -----------------------------------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~  143 (443)
                                                               .++......++.||+.||.|||+.|++||||||+|||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC  273 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence                                                     245667788999999999999999999999999999999


Q ss_pred             CCCCeEEeeecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHH-
Q 013421          144 SYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY-  219 (443)
Q Consensus       144 ~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~-  219 (443)
                      .++.+||+|||++........  ......|++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......+.. 
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~  352 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY  352 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence            999999999999875433211  1223457889999999977665 489999999999999998 89999875544433 


Q ss_pred             HHhhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          220 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       220 ~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ..+..+ ....|..++.++.+|+.+||.++|.+||++++|+..
T Consensus       353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            333333 345666789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.9e-40  Score=316.01  Aligned_cols=250  Identities=28%  Similarity=0.379  Sum_probs=208.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ..+|.+.+.||+|+||.||+|.+...   ...||+|......  .....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            45799999999999999999987654   3478999886543  23345678999999999999999999998875 457


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            89999999999999997644 58999999999999999999999999999999999999999999999999987544321


Q ss_pred             c-cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHH
Q 013421          164 E-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL  240 (443)
Q Consensus       164 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l  240 (443)
                      . ......+++.|+|||.+....+. .++|||||||++|+|++ |..||...+..+....+..+ ..+.|..+++++.++
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL  240 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence            1 11122345689999998766654 89999999999999986 99999887766666665544 345667789999999


Q ss_pred             HHHccCCCCCCCCCHHHHhcC
Q 013421          241 IHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~h  261 (443)
                      |.+|+..+|.+|||+.+++..
T Consensus       241 i~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         241 MTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=312.51  Aligned_cols=242  Identities=26%  Similarity=0.399  Sum_probs=205.3

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg   94 (443)
                      +.||+|+||.||+|.+.. ++.||+|.+......  .....+.+|+.+++.++||||+++++++.+....|++|||++|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            479999999999999977 999999998765432  34567899999999999999999999999999999999999999


Q ss_pred             ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc--cccCC
Q 013421           95 ELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL--HTTCG  171 (443)
Q Consensus        95 ~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~--~~~~g  171 (443)
                      +|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..........  ....+
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999999764 468899999999999999999999999999999999999999999999999987554211111  12234


Q ss_pred             CcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHHccCCCC
Q 013421          172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNP  249 (443)
Q Consensus       172 t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP  249 (443)
                      +..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|..++..+.+++.+||..+|
T Consensus       158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  236 (251)
T cd05041         158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP  236 (251)
T ss_pred             eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence            567999999876655 589999999999999998 89999887766655555443 344566689999999999999999


Q ss_pred             CCCCCHHHHhc
Q 013421          250 KTRIRIEGIRK  260 (443)
Q Consensus       250 ~~R~t~~eil~  260 (443)
                      .+|||++++++
T Consensus       237 ~~Rp~~~ell~  247 (251)
T cd05041         237 ENRPSFSEIYN  247 (251)
T ss_pred             hhCcCHHHHHH
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-40  Score=316.02  Aligned_cols=239  Identities=22%  Similarity=0.245  Sum_probs=195.0

Q ss_pred             eeeeccCceEEEEEEECCC------------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421           15 RTIGEGTFAKVRFAQNRET------------GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~------------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      +.||+|+||.||+|.....            ...+|+|++....   ......+.+|+.+++.++||||+++++++..+.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            4689999999999985322            2358889876542   234467888999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC-------eEEeeec
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN-------LKVSDFG  154 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~-------~kL~DFG  154 (443)
                      ..+++|||+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998888754 56899999999999999999999999999999999999987664       8999999


Q ss_pred             CcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHh-hCCCCCCCCChHHHHHHhhhccCCCCCCC
Q 013421          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM-AGYLPFGETDLPTLYKKINAAEFSCPFWF  233 (443)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  233 (443)
                      ++.....    .....|+..|+|||.+.+....+.++||||+||++|+|+ .|..||......+... ............
T Consensus       158 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~  232 (262)
T cd05077         158 IPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTPS  232 (262)
T ss_pred             CCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCCCC
Confidence            8865432    234568889999999875444568999999999999998 5899998765444322 233333333345


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ++++.+||.+||+.||.+||++.+|+++
T Consensus       233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         233 CKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            7889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.3e-40  Score=319.20  Aligned_cols=248  Identities=25%  Similarity=0.385  Sum_probs=201.7

Q ss_pred             eEEeeeeeccCceEEEEEEE----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 013421           11 YEVGRTIGEGTFAKVRFAQN----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--TKV   84 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~   84 (443)
                      |++++.||+|+||.||+|..    ..++..||+|.+....  .......+.+|+.+++.++||||+++++++.+.  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            68899999999999999974    4578899999986543  233456789999999999999999999998765  678


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +++|||++|++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence            99999999999999997643 58999999999999999999999999999999999999999999999999987654322


Q ss_pred             c---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh---------------HHHHHHhhh-
Q 013421          164 E---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA-  224 (443)
Q Consensus       164 ~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---------------~~~~~~i~~-  224 (443)
                      .   ......|+..|+|||++.+..+. .++||||+||++|+|+++..|+.....               ......+.. 
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG  242 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence            1   12345577789999998776654 899999999999999998776532211               111111111 


Q ss_pred             ccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          225 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       225 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ...+.+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            1233455689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6e-40  Score=316.44  Aligned_cols=251  Identities=21%  Similarity=0.284  Sum_probs=209.5

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECC----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-C
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRE----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-R   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~   81 (443)
                      .-++|++.+.||+|+||.||+|.+..    ++..|++|.+....  .....+.+.+|+.+++.++||||+++++++.. +
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            34689999999999999999999876    35789999886432  33346778999999999999999999998765 5


Q ss_pred             CEEEEEEecCCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeee
Q 013421           82 TKVYIILEFVTGGELFDKIVHQ--------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDF  153 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~--------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DF  153 (443)
                      ...++++||+++++|.+++...        ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            7789999999999999998653        35889999999999999999999999999999999999999999999999


Q ss_pred             cCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCC
Q 013421          154 GLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSC  229 (443)
Q Consensus       154 Gls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~  229 (443)
                      |+++.......  ......++..|+|||++.+..+ +.++|||||||++|++++ |.+||...+..+....+... .+..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ  240 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence            99875433211  1122345678999999977665 489999999999999998 99999887766666555443 2344


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       230 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +..+++++.+++.+||..||++|||+.++++
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         241 PINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            5567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9.3e-40  Score=311.85  Aligned_cols=247  Identities=22%  Similarity=0.405  Sum_probs=206.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|++.+.||+|+||.||+|.+. .+..+|+|.+....    ...+.+.+|+.+++.++|+||+++++++.+ ...|+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            3578999999999999999999865 45679999886532    234678899999999999999999999887 77899


Q ss_pred             EEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      +|||+++++|.+++...  ..++...+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            99999999999999763  3578888999999999999999999999999999999999999999999999875543211


Q ss_pred             -cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHH
Q 013421          165 -LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (443)
Q Consensus       165 -~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (443)
                       ......++..|+|||++....+ +.++|+|||||++|++++ |..||...+.......+... ..+.+...+.++.+++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  236 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM  236 (260)
T ss_pred             ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence             1122335677999999976555 489999999999999998 99999887776666655443 2334556889999999


Q ss_pred             HHccCCCCCCCCCHHHHhc
Q 013421          242 HKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (443)
                      .+||++||++||++.+++.
T Consensus       237 ~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         237 MRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHcccCcccCcCHHHHHH
Confidence            9999999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.2e-40  Score=317.36  Aligned_cols=238  Identities=24%  Similarity=0.278  Sum_probs=194.0

Q ss_pred             eeeccCceEEEEEEECCC------------------------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc
Q 013421           16 TIGEGTFAKVRFAQNRET------------------------GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI   71 (443)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~------------------------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI   71 (443)
                      .||+|+||.||+|....+                        ...||+|++....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            599999999999975321                        2358899886542   2234568889999999999999


Q ss_pred             ceEEEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC----
Q 013421           72 VRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG----  146 (443)
Q Consensus        72 v~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~----  146 (443)
                      +++++++.+....|+||||+++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++..+    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999988865 46789999999999999999999999999999999999998654    


Q ss_pred             ---CeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHh-hCCCCCCCCChHHHHHHh
Q 013421          147 ---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM-AGYLPFGETDLPTLYKKI  222 (443)
Q Consensus       147 ---~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i  222 (443)
                         .+|++|||++......    ....++..|+|||.+.+....+.++|||||||++|+|+ +|..||...+....... 
T Consensus       159 ~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-  233 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-  233 (274)
T ss_pred             ccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-
Confidence               3899999987543221    23457889999999876444468999999999999995 69999987655443332 


Q ss_pred             hhccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       223 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .......|...++.+.++|.+||+.+|++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            223334455567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7e-40  Score=311.43  Aligned_cols=242  Identities=27%  Similarity=0.462  Sum_probs=204.5

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      .+++|++.+.||+|+||.||++..  +++.||+|.+....     ..+.+.+|+.+++.++||||+++++++..+ ..|+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            357899999999999999999864  68889999986532     235688999999999999999999998764 4799


Q ss_pred             EEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           87 ILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      +|||+++++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......  
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            999999999999997654  5789999999999999999999999999999999999999999999999988654321  


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~  242 (443)
                       ......+..|+|||.+.+..+ +.++|+||+||++|+|++ |.+||...+.......+..+. ...+..+++.+.+++.
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  231 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMT  231 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHH
Confidence             122334567999999876665 489999999999999997 999999887776666655442 3334557899999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||+.+|.+||++++++.
T Consensus       232 ~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         232 SCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.7e-40  Score=316.29  Aligned_cols=248  Identities=26%  Similarity=0.397  Sum_probs=200.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEE----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCC
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQN----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA--SRT   82 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~   82 (443)
                      .+|++.+.||+|+||.||.+..    ..++..||+|.+....   ....+.+.+|+.+++.++||||+++++++.  +..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            4799999999999999999973    4578899999986542   334567899999999999999999999864  345


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      .+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            789999999999999999764 4689999999999999999999999999999999999999999999999999886543


Q ss_pred             cccc---ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHH----------------HHHHh
Q 013421          162 GVEL---LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT----------------LYKKI  222 (443)
Q Consensus       162 ~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~----------------~~~~i  222 (443)
                      ....   .....++..|+|||++.+..+ +.++||||+||++|+|++|..|+.......                +...+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            2211   112223456999999977665 489999999999999999987765432111                11111


Q ss_pred             hh-ccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          223 NA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       223 ~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .. ..++.+..++.++.+||.+||..+|++|||+.+|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            11 123444568899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9e-40  Score=319.49  Aligned_cols=251  Identities=22%  Similarity=0.326  Sum_probs=207.5

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ..++|++.+.||+|+||.||+|.+..+|.    .+|+|.+.....  ......+.+|+.+++.++||||+++++++... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            34678999999999999999999887776    468888865432  22345688999999999999999999998754 


Q ss_pred             EEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            4679999999999999987654 689999999999999999999999999999999999999999999999999976543


Q ss_pred             ccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHH
Q 013421          162 GVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGA  237 (443)
Q Consensus       162 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~  237 (443)
                      ...  ......++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.........+..+ .++.+...+..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence            222  12234457789999998776654 89999999999999997 99999876655544444333 344455678999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+++.+|+..+|.+||+++++++.
T Consensus       241 ~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=333.16  Aligned_cols=249  Identities=26%  Similarity=0.394  Sum_probs=214.4

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCc---E-EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGE---S-VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~---~-vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      +-.+.+.||+|+||.||+|..+..+.   . ||+|...............+.+|.++|+.++|||||++||+......+|
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            44556899999999999998765422   3 8999987644445566788999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           86 IILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      +|||+|+||+|.+++...+ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||++...... .
T Consensus       238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~-~  316 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY-V  316 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce-e
Confidence            9999999999999999877 4999999999999999999999999999999999999999999999999998765421 1


Q ss_pred             cccccC-CCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc--CCCCCCCCHHHHHH
Q 013421          165 LLHTTC-GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE--FSCPFWFSTGATSL  240 (443)
Q Consensus       165 ~~~~~~-gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~l  240 (443)
                      .....+ -...|+|||.+....| +.++||||+||++||+++ |..||.+.+..+...++....  .+.|...+.++..+
T Consensus       317 ~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~  395 (474)
T KOG0194|consen  317 MKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV  395 (474)
T ss_pred             eccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence            111122 3457999999987755 599999999999999998 899999999999999885443  45566688999999


Q ss_pred             HHHccCCCCCCCCCHHHHhc
Q 013421          241 IHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~  260 (443)
                      +.+|+..||+.|||+.++.+
T Consensus       396 ~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  396 MKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHhccCChhhccCHHHHHH
Confidence            99999999999999999876

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.5e-39  Score=310.31  Aligned_cols=244  Identities=25%  Similarity=0.326  Sum_probs=197.8

Q ss_pred             eeeeccCceEEEEEEECC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEec
Q 013421           15 RTIGEGTFAKVRFAQNRE---TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA-SRTKVYIILEF   90 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lv~Ey   90 (443)
                      +.||+|+||.||+|.+..   .+..+|+|.+....  .....+.+.+|+.+++.++||||+++++++. .++..+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999998754   34579999875432  2334577889999999999999999999765 45668999999


Q ss_pred             CCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc----cc
Q 013421           91 VTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV----EL  165 (443)
Q Consensus        91 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~----~~  165 (443)
                      +.+++|.+++... ...++.....++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.......    ..
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999999764 346777888999999999999999999999999999999999999999999987543211    11


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHK  243 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~  243 (443)
                      .....+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+..+. ...+..+++.+.+++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  237 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS  237 (262)
T ss_pred             cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence            123345678999999877665 489999999999999999 577787766666555554443 34455678999999999


Q ss_pred             ccCCCCCCCCCHHHHhcC
Q 013421          244 ILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~h  261 (443)
                      ||.++|++||++.++++.
T Consensus       238 cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         238 CWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HcCCChhhCCCHHHHHHH
Confidence            999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.3e-40  Score=313.59  Aligned_cols=243  Identities=23%  Similarity=0.359  Sum_probs=202.5

Q ss_pred             eeeeccCceEEEEEEECCCC------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421           15 RTIGEGTFAKVRFAQNRETG------ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      +.||+|+||.||+|.+....      ..+|+|.+.+...  ......+.+|+.+++.++||||+++++++......|++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            46899999999999886543      6899998865431  223567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC-----CeEEeeecCc
Q 013421           89 EFVTGGELFDKIVHQ-------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-----NLKVSDFGLS  156 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~-------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~-----~~kL~DFGls  156 (443)
                      ||+++++|.+++...       ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999999752       3477889999999999999999999999999999999999877     8999999998


Q ss_pred             CCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCC
Q 013421          157 ALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFW  232 (443)
Q Consensus       157 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~  232 (443)
                      .......  .......++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... .+..+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN  237 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence            6543221  11223345778999999977665 589999999999999998 99999887766666555433 4455667


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          233 FSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +|+.+.++|.+||.++|.+||+++++++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         238 CPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            8999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.8e-39  Score=311.03  Aligned_cols=250  Identities=29%  Similarity=0.506  Sum_probs=210.2

Q ss_pred             CeEEeeeeeccCceEEEEEEECC-CCcEEEEEEeecccc-------cchHHHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRE-TGESVAMKVLAKSTI-------LKHRMVDQIKREISIMKI-VRHPNIVRLHEVLAS   80 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~   80 (443)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+.....       ........+.+|+.++.. ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 688999998864321       222344567788888865 799999999999999


Q ss_pred             CCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCeEEeeecC
Q 013421           81 RTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (443)
                      ++..|++|||++|++|.+++..    ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999988743    3468999999999999999999996 7899999999999999999999999999


Q ss_pred             cCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC-CCC-CC
Q 013421          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPF-WF  233 (443)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~-~~  233 (443)
                      +....... ......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+...... .+. .+
T Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd08528         161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY  238 (269)
T ss_pred             eeeccccc-ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence            87654432 3445678999999999987655 58999999999999999999999887776666665544432 222 57


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ++++.++|.+||+.||++||++.|+..+
T Consensus       239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         239 SEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            8999999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.6e-39  Score=311.54  Aligned_cols=243  Identities=19%  Similarity=0.278  Sum_probs=192.4

Q ss_pred             eeeeccCceEEEEEEECC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCC
Q 013421           15 RTIGEGTFAKVRFAQNRE--TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~   92 (443)
                      +.||+|+||+||+|....  ....+|+|.+....  .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            469999999999996533  34578888775433  23345678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc--c
Q 013421           93 GGELFDKIVHQG-----RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--L  165 (443)
Q Consensus        93 gg~L~~~i~~~~-----~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~  165 (443)
                      +|+|.+++....     ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999997643     246778899999999999999999999999999999999999999999999865332211  1


Q ss_pred             ccccCCCcccCCCcccccC------CCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHH-hhhccCC-----CCCC
Q 013421          166 LHTTCGTPNYVAPEVLSNR------GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK-INAAEFS-----CPFW  232 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~------~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~-i~~~~~~-----~~~~  232 (443)
                      .....+++.|+|||++...      ...+.++||||+||++|+|++ |..||........... +......     .+..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            2233466789999997532      223579999999999999998 8899987665544433 3333222     2334


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          233 FSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +++...+++..|+ .||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            7888899999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.1e-39  Score=310.90  Aligned_cols=243  Identities=20%  Similarity=0.259  Sum_probs=193.5

Q ss_pred             eeeeccCceEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCC
Q 013421           15 RTIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~   92 (443)
                      +.||+|+||.||+|...  .++..+|+|.+.....  ......+.+|+.+++.++||||+++++++.+....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            46899999999999864  3556899998866542  2234578889999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc--c
Q 013421           93 GGELFDKIVHQG-----RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--L  165 (443)
Q Consensus        93 gg~L~~~i~~~~-----~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~  165 (443)
                      +|+|.+++....     ..++..+..++.|++.|+.|||++|++||||||+||+++.++++||+|||++........  .
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999997532     356677889999999999999999999999999999999999999999999865433211  1


Q ss_pred             ccccCCCcccCCCcccccCC------CCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHH-hhhccCC--CC---CC
Q 013421          166 LHTTCGTPNYVAPEVLSNRG------YDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK-INAAEFS--CP---FW  232 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~------~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~-i~~~~~~--~~---~~  232 (443)
                      .....|++.|+|||++.+..      ..+.++||||+|+++|+|++ |..||...+..+.... +......  .|   ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            22345788899999986432      12579999999999999996 9999987665544332 2222221  12   23


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          233 FSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .++.+.+++.+|+ .+|.+|||+++|+.
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            6788999999998 68999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-39  Score=310.09  Aligned_cols=236  Identities=22%  Similarity=0.259  Sum_probs=194.1

Q ss_pred             eeeeccCceEEEEEEECCCC----------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421           15 RTIGEGTFAKVRFAQNRETG----------ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~----------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +.||+|+||.||+|.+..++          ..+++|++.....    ....+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46999999999999998776          3578887654331    14678899999999999999999999887 778


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC-------CeEEeeecCc
Q 013421           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-------NLKVSDFGLS  156 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~-------~~kL~DFGls  156 (443)
                      ++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998766 789999999999999999999999999999999999999887       7999999998


Q ss_pred             CCCccccccccccCCCcccCCCcccccC-CCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhccCCCCCCCC
Q 013421          157 ALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSCPFWFS  234 (443)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s  234 (443)
                      .....    .....++..|+|||++.+. ...+.++|||||||++|+|++ |..||...+.......... ....+...+
T Consensus       156 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~  230 (259)
T cd05037         156 ITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLPMPDC  230 (259)
T ss_pred             ccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCCCCCc
Confidence            75433    2234577889999998765 244589999999999999999 6888877654333333222 222222234


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          235 TGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ..+.++|.+||..+|.+|||+.++++
T Consensus       231 ~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         231 AELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             hHHHHHHHHHhccChhhCCCHHHHHH
Confidence            88999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-41  Score=334.10  Aligned_cols=248  Identities=22%  Similarity=0.344  Sum_probs=210.5

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .+...++.+||+|.||+||+|.+-   -.||||+++......+ ..+.|++|+.++++-+|.||+-+.+++..+.. .||
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII  465 (678)
T ss_pred             HHHhhccceeccccccceeecccc---cceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence            455678899999999999999985   3599999988775544 68899999999999999999999999998887 999


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc--ccc
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVE  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~--~~~  164 (443)
                      +.+|+|.+|+.++.-. .++.....+.|++|+++|+.|||.++|+|||||..||++++++.|||+|||+++....  +..
T Consensus       466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence            9999999999998643 4788889999999999999999999999999999999999999999999999875432  334


Q ss_pred             cccccCCCcccCCCcccccC--CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC-----CCCCCCHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-----CPFWFSTGA  237 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~~  237 (443)
                      .+...-|...|||||++...  ..++..+||||+||++|||++|.+||...+.++....+..+...     .-...+.++
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~m  625 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAM  625 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHH
Confidence            45677789999999998643  22358999999999999999999999976666655555444222     122357799


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ++|+..|+..+|++||.+.+||.
T Consensus       626 k~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  626 KRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHhcCcccCccHHHHHH
Confidence            99999999999999999999887

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.1e-39  Score=311.02  Aligned_cols=249  Identities=26%  Similarity=0.401  Sum_probs=205.2

Q ss_pred             eEEeeeeeccCceEEEEEEECC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRE---TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-----   82 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----   82 (443)
                      |++.+.||+|+||.||+|....   ++..||||++..+... ....+.+.+|+.+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            6788999999999999998643   5789999999765432 334677889999999999999999999875432     


Q ss_pred             -EEEEEEecCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecC
Q 013421           83 -KVYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (443)
Q Consensus        83 -~~~lv~Ey~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (443)
                       ..++++||+++|+|.+++...      ..+++.....++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             347899999999998887532      2478899999999999999999999999999999999999999999999999


Q ss_pred             cCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCC
Q 013421          156 SALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPF  231 (443)
Q Consensus       156 s~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~  231 (443)
                      +........  ......+++.|++||.+.+..+. .++|||||||++|+|++ |.+||...+.......+... ....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP  238 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            876543211  12233456789999998776664 89999999999999999 99999887776666655443 345556


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ..++.+.+++.+||+.+|++|||+.+++++
T Consensus       239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.4e-39  Score=312.08  Aligned_cols=249  Identities=25%  Similarity=0.372  Sum_probs=204.5

Q ss_pred             cCeEEeeeeeccCceEEEEEEECC----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRE----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RT   82 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~   82 (443)
                      .+|++.+.||+|+||.||+|....    ++..+|+|++......  ...+.+.+|+.+++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            568899999999999999998643    4789999999765432  345789999999999999999999999877  66


Q ss_pred             EEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..+++|||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            8999999999999999997654 689999999999999999999999999999999999999999999999999876653


Q ss_pred             cccc---ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHH---------------HHHHhh
Q 013421          162 GVEL---LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT---------------LYKKIN  223 (443)
Q Consensus       162 ~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~---------------~~~~i~  223 (443)
                      ....   .....++..|+|||.+.+..+ +.++||||+|+++|+|++|..||.......               ....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            2121   112334567999999876655 489999999999999999999986543211               112222


Q ss_pred             h-ccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          224 A-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       224 ~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      . ...+.+..++.++.+++.+||+++|.+|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2 223445567889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-38  Score=310.91  Aligned_cols=249  Identities=14%  Similarity=0.128  Sum_probs=190.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCC---CcEEEEEEeecccccchHH--------HHHHHHHHHHHHhCCCCCcceEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRM--------VDQIKREISIMKIVRHPNIVRLHEV   77 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~HpnIv~l~~~   77 (443)
                      ++|++.+.||+|+||.||+|.+..+   +..+|+|+...........        ......+...+..++|+||+++++.
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5899999999999999999998877   6778888654332111000        0112233445567789999999987


Q ss_pred             EEeCC----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeee
Q 013421           78 LASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDF  153 (443)
Q Consensus        78 ~~~~~----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DF  153 (443)
                      .....    ..++++|++. .++.+.+......++..+..++.|++.||.|||++||+||||||+|||++.++.++|+||
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF  170 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY  170 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence            65443    4578888874 466666666556788899999999999999999999999999999999999999999999


Q ss_pred             cCcCCCcccc-------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh-HH--------
Q 013421          154 GLSALPQQGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PT--------  217 (443)
Q Consensus       154 Gls~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~--------  217 (443)
                      |+++......       .......||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+. ..        
T Consensus       171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~  249 (294)
T PHA02882        171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD  249 (294)
T ss_pred             CCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence            9987553211       11233469999999999987776 4999999999999999999999987632 21        


Q ss_pred             HHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          218 LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       218 ~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ....+..+.... +..++.+.++++.|+..+|.+||++++|++
T Consensus       250 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        250 FIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            223333333333 346889999999999999999999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=316.84  Aligned_cols=252  Identities=29%  Similarity=0.474  Sum_probs=205.9

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--C----CcceEEEEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH--P----NIVRLHEVLA   79 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~~~~~   79 (443)
                      ..-++|.++.++|+|+||+|-.+.+..++..||+|+++.-.    ...+..+-|++++.++.+  |    -+|++.++|+
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            34678999999999999999999999999999999986422    233556779999999942  3    3788888999


Q ss_pred             eCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-------------
Q 013421           80 SRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-------------  144 (443)
Q Consensus        80 ~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-------------  144 (443)
                      -.+++|||+|.+ |.++++++..++  +++-..++.+.+||+.+++|||+.+++|.||||||||+.+             
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence            999999999998 779999998865  6889999999999999999999999999999999999932             


Q ss_pred             -------CCCeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHH
Q 013421          145 -------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  217 (443)
Q Consensus       145 -------~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  217 (443)
                             +..++++|||.++.....   -++.+.|..|+|||++.+-++. .++||||+||||+||.+|...|+..+..+
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcHH
Confidence                   235899999998865543   2567789999999999999986 99999999999999999999998765333


Q ss_pred             ---HHHHhhh------------------ccCCCCCC----------------------C---CHHHHHHHHHccCCCCCC
Q 013421          218 ---LYKKINA------------------AEFSCPFW----------------------F---STGATSLIHKILDPNPKT  251 (443)
Q Consensus       218 ---~~~~i~~------------------~~~~~~~~----------------------~---s~~~~~li~~~L~~dP~~  251 (443)
                         +.+.|..                  +.+..|..                      .   -.++.+||++||..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence               2222211                  01111100                      0   124789999999999999


Q ss_pred             CCCHHHHhcCccccc
Q 013421          252 RIRIEGIRKHPWFRK  266 (443)
Q Consensus       252 R~t~~eil~hp~f~~  266 (443)
                      |+|+.|+|.||||+.
T Consensus       397 RiTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  397 RITLREALSHPFFAR  411 (415)
T ss_pred             cccHHHHhcCHHhhc
Confidence            999999999999975

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.6e-38  Score=304.89  Aligned_cols=243  Identities=19%  Similarity=0.295  Sum_probs=192.4

Q ss_pred             eeeeccCceEEEEEEECCC--CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCC
Q 013421           15 RTIGEGTFAKVRFAQNRET--GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~   92 (443)
                      +.||+|+||+||++....+  ...+++|.+....  .....+.+.+|+.+++.++||||+++++.+.+....|++|||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            3699999999999975433  2356677665433  22345778999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc--ccc
Q 013421           93 GGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELL  166 (443)
Q Consensus        93 gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--~~~  166 (443)
                      +|+|.+++...    ...++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+|||++.......  ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999999764    235667788999999999999999999999999999999999999999999875432211  122


Q ss_pred             cccCCCcccCCCcccccCC------CCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-c-----CCCCCCC
Q 013421          167 HTTCGTPNYVAPEVLSNRG------YDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-E-----FSCPFWF  233 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~------~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~-----~~~~~~~  233 (443)
                      ...+|++.|+|||++....      ..+.++|||||||++|+|++ |..||...+..+.+..+... .     ...+..+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            3567889999999985321      12478999999999999996 67899876665555543322 1     2233347


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ++.+.+++..|+ .+|.+||++++|++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            889999999999 67999999999865

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=319.48  Aligned_cols=247  Identities=28%  Similarity=0.370  Sum_probs=196.2

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-KVYII   87 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lv   87 (443)
                      ++|.-.+.||+|+||.||+|...+ |..||||.+.......   ..++.+|+.++.+++|||+|+++++|.+.+ ..+||
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            456667899999999999999864 4899999876654321   345999999999999999999999999988 59999


Q ss_pred             EecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---CEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           88 LEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKG---VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~g---i~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      +||++.|+|.+++....  .+++....+|+.+++.||+|||...   |+||||||+|||||++.+.||+|||++......
T Consensus       151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence            99999999999998765  8899999999999999999999853   999999999999999999999999999655431


Q ss_pred             ccccccc-CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC------hHHHHH-Hhhhcc------CC
Q 013421          163 VELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD------LPTLYK-KINAAE------FS  228 (443)
Q Consensus       163 ~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~------~~~~~~-~i~~~~------~~  228 (443)
                      .....+. .||.+|+|||++... ..+.++|||||||+|.||++|+.|.+...      ...... .+..+.      ..
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~  309 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR  309 (361)
T ss_pred             ccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence            1222222 899999999999763 34589999999999999999998887532      111111 122211      11


Q ss_pred             CC-CCCC--HH---HHHHHHHccCCCCCCCCCHHHHhc
Q 013421          229 CP-FWFS--TG---ATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       229 ~~-~~~s--~~---~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .. ...+  .+   +..+..+|++.+|.+||++.++.+
T Consensus       310 l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  310 LKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             ccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            11 1123  12   456889999999999999999744

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-39  Score=337.92  Aligned_cols=251  Identities=26%  Similarity=0.393  Sum_probs=215.7

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      ...+-...+.||+|+||+||+|+...     ....||||.++...  +.++..+|++|++++..++|||||++++++..+
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            34456778999999999999998642     34689999997654  344678999999999999999999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQG--------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN  147 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~--------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~  147 (443)
                      +.+|+|+|||..|||.+++....              +++..+...++.||+.|+.||-++.++||||-..|.||.++-.
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence            99999999999999999997532              2778889999999999999999999999999999999999999


Q ss_pred             eEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhh
Q 013421          148 LKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA  224 (443)
Q Consensus       148 ~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~  224 (443)
                      |||+|||+++..-..+  +......-...|||||.+....|. .+|||||+||+|+|+++ |..||.+.+.++....+..
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            9999999997543211  111112234589999999887775 99999999999999997 9999999999999998877


Q ss_pred             cc-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          225 AE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       225 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ++ +++|..+|+++.+|+..|++.+|++||++.||-.
T Consensus       721 g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  721 GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            65 6788999999999999999999999999999743

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-40  Score=316.72  Aligned_cols=261  Identities=27%  Similarity=0.419  Sum_probs=219.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchH----HHHHHHHHHHHHHhCCCCCcceEEEEEE-eC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR----MVDQIKREISIMKIVRHPNIVRLHEVLA-SR   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~   81 (443)
                      .-++|-++..||+|+|+.||+|.+....+.||+|+-...+...++    ..+...+|.+|.+.|+||.||++|++|. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            346799999999999999999999988999999998765543322    3355779999999999999999999996 66


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCEeecCCCCcEEEc---CCCCeEEeeecCc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK--GVYHRDLKPENLLLD---SYGNLKVSDFGLS  156 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~--gi~HrDlkp~NILl~---~~~~~kL~DFGls  156 (443)
                      +.+|-|+|||+|.+|.-++..+.-++|.+++.|+.||+.||.||...  .|+|-||||.|||+-   ..|.+||+|||++
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            77999999999999999999999999999999999999999999976  599999999999995   4588999999999


Q ss_pred             CCCccc-------cccccccCCCcccCCCccccc---CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHH-H--HHh-
Q 013421          157 ALPQQG-------VELLHTTCGTPNYVAPEVLSN---RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL-Y--KKI-  222 (443)
Q Consensus       157 ~~~~~~-------~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~-~--~~i-  222 (443)
                      .++...       ..+.....||.+|.+||.+.-   .+..+.++||||.|||+|..+.|+.||+.....+. .  ..| 
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            987642       234566789999999998742   34456899999999999999999999987543322 1  122 


Q ss_pred             hhccCCCC--CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          223 NAAEFSCP--FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       223 ~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ...+..+|  +.+|+++++||++||+.--..|+...++-.||+|...
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            33344454  5699999999999999999999999999999999753

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=6.5e-40  Score=292.16  Aligned_cols=250  Identities=28%  Similarity=0.495  Sum_probs=207.0

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC--E
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRT--K   83 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~   83 (443)
                      ..++|++.+++|+|.|++||.|++..+++.++||+++.-      ..+.+++|+.||+.|. ||||++++++..+..  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            467899999999999999999999999999999998643      2467999999999996 999999999987654  4


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-CCCeEEeeecCcCCCccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~~  162 (443)
                      ..+|+||.++.+.....   ..++.-.++.|+.||+.||.|||++||+|||+||.|++||. ...++|+|+|++.+...+
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            67999999887655443   56888999999999999999999999999999999999995 467999999999887664


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCC-CChHHHHHHh-------------hhc---
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKI-------------NAA---  225 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i-------------~~~---  225 (443)
                       ...+..+.+..|-.||.+..-..+...-|+|||||+|..|+..+.||-. .+.....-+|             .+-   
T Consensus       187 -~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  187 -KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             -ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence             4456778899999999998777667999999999999999999999843 2222211111             111   


Q ss_pred             ----------cCCCCCC-----------CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          226 ----------EFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       226 ----------~~~~~~~-----------~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                                ..+...|           .++++.+|+.++|..|..+|+|+.|++.||||..
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence                      1111111           5799999999999999999999999999999964

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-41  Score=303.70  Aligned_cols=262  Identities=26%  Similarity=0.415  Sum_probs=213.0

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE------
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA------   79 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~------   79 (443)
                      ...+.|+-..++|+|.||+||+|+.+.+|+.||+|++-.+. .+...-....+|+.+|..|+|+|++.+++++.      
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            34567888899999999999999999999999998764322 12223345678999999999999999988773      


Q ss_pred             --eCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           80 --SRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        80 --~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                        +...+|+|+.+|+. +|+-.+.+. .+++..++.+++++++.||.|+|+..|+|||+||+|+||+.+|.+||+|||++
T Consensus        93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence              23459999999965 788888765 68999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccc----ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh--ccC---
Q 013421          157 ALPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEF---  227 (443)
Q Consensus       157 ~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~---  227 (443)
                      +.+....    .-.+..+-|.+|++||.+.+...++++.|||..|||+.+|.++.+.+.+.+.......|..  +..   
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            7654421    1234556699999999999887778999999999999999999999987765544333311  000   


Q ss_pred             -----------------CC-------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          228 -----------------SC-------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       228 -----------------~~-------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                                       +.             |..-++++.+|+.+||..||.+|+++++++.|.||.+...
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~  323 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM  323 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence                             01             1113668999999999999999999999999999987643

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.5e-38  Score=334.46  Aligned_cols=255  Identities=18%  Similarity=0.266  Sum_probs=180.6

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCC----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEE----
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRET----GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEV----   77 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~----   77 (443)
                      ...++|++.+.||+|+||.||+|.+..+    +..||+|.+.....     .+....+  .++...+.++..+...    
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            3567999999999999999999999988    89999998764321     1111111  1122222222222211    


Q ss_pred             --EEeCCEEEEEEecCCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCEeecC
Q 013421           78 --LASRTKVYIILEFVTGGELFDKIVHQGR--------------------LLENDCRRYFQQLIDAVAHCHSKGVYHRDL  135 (443)
Q Consensus        78 --~~~~~~~~lv~Ey~~gg~L~~~i~~~~~--------------------l~e~~~~~~~~qll~aL~yLH~~gi~HrDl  135 (443)
                        .......++|+||+.+++|.+++.....                    ..+..+..++.||+.||.|||++||+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              2456789999999999999998875321                    123446789999999999999999999999


Q ss_pred             CCCcEEEcC-CCCeEEeeecCcCCCccc-cccccccCCCcccCCCcccccCCCC---------------------CCccc
Q 013421          136 KPENLLLDS-YGNLKVSDFGLSALPQQG-VELLHTTCGTPNYVAPEVLSNRGYD---------------------GSAAD  192 (443)
Q Consensus       136 kp~NILl~~-~~~~kL~DFGls~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~---------------------~~~~D  192 (443)
                      ||+|||++. ++.+||+|||++...... .......+|++.|+|||.+....+.                     +.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999985 689999999999755432 2234567899999999976432211                     24569


Q ss_pred             hHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC---------------------CCCCCCHHHHHHHHHccCCCCCC
Q 013421          193 VWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS---------------------CPFWFSTGATSLIHKILDPNPKT  251 (443)
Q Consensus       193 IwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~~~s~~~~~li~~~L~~dP~~  251 (443)
                      |||+||+||+|+++..|++.. .......+......                     .....+....+||.+||+.||.+
T Consensus       362 VwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k  440 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ  440 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence            999999999999987775432 11222222111111                     00112334568999999999999


Q ss_pred             CCCHHHHhcCccccccC
Q 013421          252 RIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       252 R~t~~eil~hp~f~~~~  268 (443)
                      |||+.++|+||||+...
T Consensus       441 R~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        441 RISAKAALAHPYFDREG  457 (566)
T ss_pred             CCCHHHHhCCcCcCCCC
Confidence            99999999999998643

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=340.14  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=213.6

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCC-Cc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRET-GE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~-~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ..-++.+.||+|+||.||.|..... |.    .||||.+.+.  .+.+....+.+|..+|+.++|||||++++++-+...
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            3567889999999999999987653 32    3788877654  456678899999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           84 VYIILEFVTGGELFDKIVHQ-------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~-------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                      .+|++|||+||+|..+|++.       ..++..+...++.|++.|++||++++++||||-..|+||+....+||+|||+|
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence            99999999999999999876       24788899999999999999999999999999999999999999999999999


Q ss_pred             CCCccccccccccCCC--cccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHH-HhhhccCCCCCC
Q 013421          157 ALPQQGVELLHTTCGT--PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK-KINAAEFSCPFW  232 (443)
Q Consensus       157 ~~~~~~~~~~~~~~gt--~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~-~i~~~~~~~~~~  232 (443)
                      +.....+-......+.  ..|||||.+....+ +.++|||||||+|||+++ |..||++.+..+... ....+++..|..
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~  928 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY  928 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence            8332211111111122  46999999987666 599999999999999998 999999988777666 556678899999


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          233 FSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ++..+.+++.+|++.+|++||++..|++
T Consensus       929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  929 CPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CChHHHHHHHHHccCChhhCccHHHHHh
Confidence            9999999999999999999999999988

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=329.27  Aligned_cols=242  Identities=31%  Similarity=0.530  Sum_probs=198.8

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT------   82 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------   82 (443)
                      +-|..-+.||+|+||.||+++++.+|+.||||.+++.....  ..+..-+|+++|++|+|||||+++++-++..      
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            45777899999999999999999999999999998765433  3577889999999999999999999865443      


Q ss_pred             EEEEEEecCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc--CCC--CeEEeeecC
Q 013421           83 KVYIILEFVTGGELFDKIVHQ---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD--SYG--NLKVSDFGL  155 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~--~~~--~~kL~DFGl  155 (443)
                      .-.+|||||+||+|+..+.+.   .+++|.+...++..+..|+.|||.+||+||||||.||++-  .+|  ..||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            567999999999999999754   4799999999999999999999999999999999999994  234  479999999


Q ss_pred             cCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-----HHHHHhh-------
Q 013421          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-----TLYKKIN-------  223 (443)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-----~~~~~i~-------  223 (443)
                      |+..+.+ ....+.+||+.|.+||++....+++..+|.||+||++|+..||..||-.....     .++..+.       
T Consensus       171 Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  171 ARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             cccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            9877665 47788899999999999986566679999999999999999999999542211     2222111       


Q ss_pred             -------------hccCCCCCCCCHHH----HHHHHHccCCCCCCCC
Q 013421          224 -------------AAEFSCPFWFSTGA----TSLIHKILDPNPKTRI  253 (443)
Q Consensus       224 -------------~~~~~~~~~~s~~~----~~li~~~L~~dP~~R~  253 (443)
                                   ...+++|..+++.+    ...+..+|..+|.+|.
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                         11234444455543    4578888999999998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.7e-37  Score=290.26  Aligned_cols=240  Identities=46%  Similarity=0.783  Sum_probs=208.7

Q ss_pred             CceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCCChHHHH
Q 013421           21 TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI  100 (443)
Q Consensus        21 ~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i  100 (443)
                      +||.||+|.+..+|+.+|+|++........  .+.+.+|+..+++++|+||+++++.+......++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999998999999999976543221  578899999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcccCCCcc
Q 013421          101 VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV  180 (443)
Q Consensus       101 ~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~  180 (443)
                      .....++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||.+....... ......|+..|+|||.
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~  157 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEV  157 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHH
Confidence            887678999999999999999999999999999999999999999999999999987655432 3445678899999999


Q ss_pred             cccCCCCCCccchHHHHHHHHHHhhCCCCCCC-CChHHHHHHhhhccCCCCCC---CCHHHHHHHHHccCCCCCCCCCHH
Q 013421          181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW---FSTGATSLIHKILDPNPKTRIRIE  256 (443)
Q Consensus       181 l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~---~s~~~~~li~~~L~~dP~~R~t~~  256 (443)
                      +....++ .++||||+|+++++|++|..||.. .+.......+..........   ++.++.+++.+||..+|++||++.
T Consensus       158 ~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~  236 (244)
T smart00220      158 LLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAE  236 (244)
T ss_pred             HccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHH
Confidence            9766664 799999999999999999999987 55555555555444443322   889999999999999999999999


Q ss_pred             HHhcCccc
Q 013421          257 GIRKHPWF  264 (443)
Q Consensus       257 eil~hp~f  264 (443)
                      ++++||||
T Consensus       237 ~~~~~~~~  244 (244)
T smart00220      237 EALQHPFF  244 (244)
T ss_pred             HHhhCCCC
Confidence            99999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=321.28  Aligned_cols=255  Identities=27%  Similarity=0.438  Sum_probs=219.5

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEE-----eC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLA-----SR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~-----~~   81 (443)
                      -+.|+|.+++|.|.+|+||++.++.+++..|+|+.+...-    ..+.+..|.++++.+ .|||++.+|+++.     .+
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            3569999999999999999999999999999999887542    236678899999988 6999999999984     46


Q ss_pred             CEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      +.+|||||||.||+.-|+++..  .++.|+.+..+++.++.|+.+||...++|||||-.|||++.+|.+||+|||.+...
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            7899999999999999998764  57889999999999999999999999999999999999999999999999999877


Q ss_pred             ccccccccccCCCcccCCCcccccC-----CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC---CCCC
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNR-----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPF  231 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~  231 (443)
                      ........+.+|||.|||||++...     .| +..+|+||||++..||-.|.+|+-+.......-+|..+..   .-|.
T Consensus       174 dsT~grRnT~iGtP~WMAPEViac~e~~d~ty-d~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~  252 (953)
T KOG0587|consen  174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATY-DYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPK  252 (953)
T ss_pred             ecccccccCcCCCcccccceeeecccCCCCCc-ccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchh
Confidence            7666667889999999999999653     34 3789999999999999999999988776554444433321   1223


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .-+.++.+||..||.+|-.+||+..++++|||++..
T Consensus       253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             hHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            347889999999999999999999999999999743

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=295.27  Aligned_cols=249  Identities=26%  Similarity=0.432  Sum_probs=202.7

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEEEecCC
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~   92 (443)
                      +..||.|+||+|++..++.+|+..|||.|.....  +....++..|.+. ++.-+.||||++|+..-.++..|+.||+|+
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd  146 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD  146 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence            5679999999999999999999999999987654  3345778888875 555689999999999999999999999994


Q ss_pred             CCChHH---HH--HhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           93 GGELFD---KI--VHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        93 gg~L~~---~i--~~~~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      - +|..   ++  ..+..++|...-.+.-..+.||.||... .|+|||+||+|||+|..|.+||||||++...... -.-
T Consensus       147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-iAk  224 (361)
T KOG1006|consen  147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-IAK  224 (361)
T ss_pred             h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH-HHh
Confidence            3 3321   11  2346799999999999999999999865 8999999999999999999999999998654432 122


Q ss_pred             cccCCCcccCCCcccccC--CCCCCccchHHHHHHHHHHhhCCCCCCCCCh-HHHHHHhhhccCCC---CC---CCCHHH
Q 013421          167 HTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAEFSC---PF---WFSTGA  237 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~---~~---~~s~~~  237 (443)
                      +...|..+|||||.+...  +|+ -+||+||||++|||+.||..|+...+. .+....+..+.++.   +.   .+|..+
T Consensus       225 T~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~  303 (361)
T KOG1006|consen  225 TVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSM  303 (361)
T ss_pred             hhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHH
Confidence            345689999999998543  465 899999999999999999999987543 23333444454432   22   379999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ..+|..||.+|-+.||...+++++||++..
T Consensus       304 ~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  304 VRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             HHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            999999999999999999999999999754

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=313.07  Aligned_cols=262  Identities=18%  Similarity=0.271  Sum_probs=190.5

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEEC----------------CCCcEEEEEEeecccccchH-----------HHHHHHH
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNR----------------ETGESVAMKVLAKSTILKHR-----------MVDQIKR   58 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~----------------~~~~~vAiK~i~~~~~~~~~-----------~~~~~~~   58 (443)
                      ...++|++.++||+|+||.||+|...                ..++.||||.+........+           ..+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            45679999999999999999999752                24567999998653211100           0122335


Q ss_pred             HHHHHHhCCCCCc-----ceEEEEEEe--------CCEEEEEEecCCCCChHHHHHhcC---------------------
Q 013421           59 EISIMKIVRHPNI-----VRLHEVLAS--------RTKVYIILEFVTGGELFDKIVHQG---------------------  104 (443)
Q Consensus        59 Ei~il~~l~HpnI-----v~l~~~~~~--------~~~~~lv~Ey~~gg~L~~~i~~~~---------------------  104 (443)
                      |+..+.+++|.++     +++++++..        ....|+||||+++++|.+++....                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777776654     566666542        356899999999999999886421                     


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-cccccCCCcccCCCcc
Q 013421          105 ---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEV  180 (443)
Q Consensus       105 ---~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~  180 (443)
                         .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........ ......+|+.|+|||+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence               234567889999999999999999999999999999999999999999999865433211 1112335889999999


Q ss_pred             cccCC--------------------CC-CCccchHHHHHHHHHHhhCCC-CCCCCCh-----------HHHHHHhhhccC
Q 013421          181 LSNRG--------------------YD-GSAADVWSCGVILFVLMAGYL-PFGETDL-----------PTLYKKINAAEF  227 (443)
Q Consensus       181 l~~~~--------------------~~-~~~~DIwSlGvil~~ll~G~~-Pf~~~~~-----------~~~~~~i~~~~~  227 (443)
                      +....                    |. ..+.||||+||++|+|++|.+ ||.....           ...++.+....+
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            85432                    11 124799999999999999986 7754211           111222223333


Q ss_pred             CCC--CCCCHHHHHHHHHccCCCC---CCCCCHHHHhcCcccccc
Q 013421          228 SCP--FWFSTGATSLIHKILDPNP---KTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       228 ~~~--~~~s~~~~~li~~~L~~dP---~~R~t~~eil~hp~f~~~  267 (443)
                      .++  ...++.+++|+.+||..+|   .+|+|++|+|+||||...
T Consensus       462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            343  3479999999999999866   689999999999999643

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=311.86  Aligned_cols=207  Identities=31%  Similarity=0.575  Sum_probs=189.3

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHH-----HHHHHHHHHHhCC---CCCcceEE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD-----QIKREISIMKIVR---HPNIVRLH   75 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~-----~~~~Ei~il~~l~---HpnIv~l~   75 (443)
                      ....+.+|..++.||+|+||+|++|+++.+...|+||.|.|+++.....++     .+-.||.||..|+   |+||++++
T Consensus       556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL  635 (772)
T KOG1152|consen  556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL  635 (772)
T ss_pred             eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence            346678899999999999999999999999999999999998765544332     3678999999997   99999999


Q ss_pred             EEEEeCCEEEEEEecC-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeec
Q 013421           76 EVLASRTKVYIILEFV-TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG  154 (443)
Q Consensus        76 ~~~~~~~~~~lv~Ey~-~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFG  154 (443)
                      ++|++++.+||+||-- +|.+||++|..+..++|.++..+|+|++.|+++||++||+|||||-||+.++.+|-+||+|||
T Consensus       636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             heeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence            9999999999999965 678999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCC
Q 013421          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  212 (443)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  212 (443)
                      .+.....  +.....+||..|.|||++.+..|-|.+-|||++|++||.+.....||..
T Consensus       716 saa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9876654  4567889999999999999999999999999999999999999999853

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-38  Score=290.95  Aligned_cols=252  Identities=30%  Similarity=0.473  Sum_probs=208.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------   80 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------   80 (443)
                      ...+|.-++.+|.|+- .|-.|-+...+++||+|.+..+. ......+...+|..++..++|+||++++.+|.-      
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            3457888899999999 77788888899999999987763 334445778899999999999999999999853      


Q ss_pred             CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      ....|+||||+ ..+|.+.+.  -.++-+.+..++.|++.|++|||+.||+||||||+||++..++.+||.|||++....
T Consensus        93 ~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   93 FQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             HHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence            34689999999 557877776  456778899999999999999999999999999999999999999999999998665


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------------  225 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------  225 (443)
                      .. -.++.++.|..|.|||++.+.+|. +.+||||+|||+.||++|...|.+.+.-..+.++-..               
T Consensus       170 ~~-~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~  247 (369)
T KOG0665|consen  170 TD-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT  247 (369)
T ss_pred             cc-cccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence            43 356778899999999999998864 9999999999999999999999887644443332100               


Q ss_pred             ---------c---CC----CCCC-----------CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          226 ---------E---FS----CPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       226 ---------~---~~----~~~~-----------~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                               +   ++    +|.+           -+..+++|+.+||..||++|.+++++|+||||+
T Consensus       248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                     0   11    1111           245689999999999999999999999999997

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5e-37  Score=305.88  Aligned_cols=244  Identities=28%  Similarity=0.444  Sum_probs=208.4

Q ss_pred             EEeeeeeccCceEEEEEEECCC--C--cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421           12 EVGRTIGEGTFAKVRFAQNRET--G--ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~--~--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .+.+.||+|-||.||.|....-  |  -.||||.-+.+..  .+..+.|..|..+|+.++|||||++++++.+ ...|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv  468 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV  468 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence            3467899999999999986532  3  3688898876543  3346889999999999999999999999976 568999


Q ss_pred             EecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      ||+++-|+|..+++.+. .++......|+.||+.||.|||+...+||||-..|||+.....+||+|||+++..... ...
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~-~yY  547 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD-AYY  547 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc-chh
Confidence            99999999999998754 7888999999999999999999999999999999999999999999999999977654 233


Q ss_pred             cccCCCc--ccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          167 HTTCGTP--NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       167 ~~~~gt~--~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      +...|..  -|||||.+.-..+ +.++|||.|||.+||++. |..||.+....+....+.++ +++.|+.+++.+..|+.
T Consensus       548 kaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslms  626 (974)
T KOG4257|consen  548 KASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMS  626 (974)
T ss_pred             hccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHH
Confidence            3334443  5999999976666 489999999999999985 99999998777777777665 68999999999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +|+..+|.+||++.+|..
T Consensus       627 kcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  627 KCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHhccCcccCCcHHHHHH
Confidence            999999999999877543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.7e-37  Score=302.46  Aligned_cols=251  Identities=26%  Similarity=0.426  Sum_probs=209.5

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC------CCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR------HPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~   81 (443)
                      =++|.+....|+|-||+|..|.+..-|+.||||+|..+.+    +.+.=..|+++|++|+      --|+++++..|...
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            4589999999999999999999999999999999987543    4455678999999996      35899999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC-CCeEEeeecCcC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSA  157 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~-~~~kL~DFGls~  157 (443)
                      +++|||+|-+ ..+|.+.+...|   ++....++.|++||+.||..|...||+|.||||.|||+++. ..+||||||.|.
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence            9999999988 568999988754   68889999999999999999999999999999999999865 468999999887


Q ss_pred             CCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC------
Q 013421          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF------  231 (443)
Q Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~------  231 (443)
                      .....  ..+-+.-+..|.|||++.+.+|+ ...|+||.||.||||.||+..|++.+...+.+..+...-.+|.      
T Consensus       586 ~~~en--eitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  586 FASEN--EITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             ccccc--cccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            65442  23344456689999999999998 9999999999999999999999998766665433221111110      


Q ss_pred             -----------------------------------------------CC-------CHHHHHHHHHccCCCCCCCCCHHH
Q 013421          232 -----------------------------------------------WF-------STGATSLIHKILDPNPKTRIRIEG  257 (443)
Q Consensus       232 -----------------------------------------------~~-------s~~~~~li~~~L~~dP~~R~t~~e  257 (443)
                                                                     .+       -..+++||.+||..||++|+|+.+
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence                                                           01       124789999999999999999999


Q ss_pred             HhcCccccc
Q 013421          258 IRKHPWFRK  266 (443)
Q Consensus       258 il~hp~f~~  266 (443)
                      +|+||||+.
T Consensus       743 AL~HpFi~~  751 (752)
T KOG0670|consen  743 ALKHPFITE  751 (752)
T ss_pred             HhcCCcccC
Confidence            999999974

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=284.02  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=211.8

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-----KV   84 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~   84 (443)
                      +.+--+.||.|+||.||.+.+..+|+.||+|.+..- +.+--..+.+.+|+.+|..++|.|++...++..-..     .+
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            445568899999999999999999999999987542 223334577899999999999999999998876443     47


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc-c
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-V  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~  163 (443)
                      |+++|++ ..+|...|.....++.+.+.-++.||+.||+|||+.||.||||||.|+|++.|..+||||||+++..+.. .
T Consensus       133 YV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  133 YVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            8899999 5589888888899999999999999999999999999999999999999999999999999999877653 2


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHh---------------------
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI---------------------  222 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i---------------------  222 (443)
                      ..++..+-|.+|+|||++.+...++.+.||||.|||+.||+..+..|...+..+..+.|                     
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence            34556677889999999998877789999999999999999999999876654433332                     


Q ss_pred             --hhccCCCCC-----------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          223 --NAAEFSCPF-----------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       223 --~~~~~~~~~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                        ..+....|.           .-..+...++.++|.+||.+|++.++.+.|++....
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence              111111121           234568899999999999999999999999998653

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=301.98  Aligned_cols=254  Identities=27%  Similarity=0.426  Sum_probs=219.1

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCC-Cc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRET-GE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~-~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ++..+.+.||+|+||.|+.|.+... |+  .||||.+.......  ....|.+|+.+|.+|+|||+|++|++..+ ..+.
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            3456678999999999999998753 43  68999998766443  56889999999999999999999999988 7788


Q ss_pred             EEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           86 IILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +|+|+++.|+|.+.+..  ...+.......|+.||+.|+.||.+++.+||||-..|+||-....+||+||||.+-....+
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999999987  3467888999999999999999999999999999999999999999999999998776654


Q ss_pred             ccccc---cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHH
Q 013421          164 ELLHT---TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGAT  238 (443)
Q Consensus       164 ~~~~~---~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  238 (443)
                      +.+..   .--...|+|||.+....+. .++|+|++||++|||++ |+.||.+....++.++|..+ +++.|..+|.++.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY  345 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY  345 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence            43311   1123469999999887775 99999999999999998 89999999999998888754 5778888999999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          239 SLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      ++++.||..+|.+|||+..|...-+.+.
T Consensus       346 ~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  346 QIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             HHHHHhccCCccccccHHHHHHhHHHHh
Confidence            9999999999999999999986655543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=305.91  Aligned_cols=250  Identities=26%  Similarity=0.404  Sum_probs=220.2

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      +.-.|.+.||.|.||+|++|+.+..|+   .||||.++...  .+.....|..|..||-+++||||+++.++......+.
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence            345778999999999999999987664   79999997655  3345578999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           86 IILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      ||+|||++|.|..+++.+ +.++..+...+++.|+.|++||-+.|++||||-..|||++.+-..|++|||+++....+..
T Consensus       707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            999999999999999764 6899999999999999999999999999999999999999999999999999998766443


Q ss_pred             ccc-ccCCC--cccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHH
Q 013421          165 LLH-TTCGT--PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATS  239 (443)
Q Consensus       165 ~~~-~~~gt--~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~  239 (443)
                      ... +.-|-  ..|.|||.+....+. .+|||||+||+|+|.++ |..||-+.+..+..+.|..+ +++.|..++..+..
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~q  865 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQ  865 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHH
Confidence            333 33332  479999999887775 89999999999999876 99999999999999888765 67777889999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcC
Q 013421          240 LIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~h  261 (443)
                      |+..|+++|-..||++.+|+.+
T Consensus       866 LMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  866 LMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHhhcCCCHHHHHHH
Confidence            9999999999999999998874

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=293.47  Aligned_cols=244  Identities=26%  Similarity=0.415  Sum_probs=214.1

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +.....+||.|.||.||.|.++.-.-.||||.++.+..    .++.|..|..+|+.++|||+|+++++|.-+..+|||+|
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            34556889999999999999999888999999876542    35789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           90 FVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        90 y~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      ||..|+|.+|+....  .++.-....++.||.+|++||..++++||||-..|.|+.++..+|++||||++++..+.  .+
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT--YT  421 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT--YT  421 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc--ee
Confidence            999999999998754  46667778889999999999999999999999999999999999999999999876542  22


Q ss_pred             ccCC---CcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          168 TTCG---TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       168 ~~~g---t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      ...|   ..-|.|||-+.-..+. .++|||+|||+|||+.| |..||++-+..+.|..+.++ +...|..+++.+..|++
T Consensus       422 AHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMr  500 (1157)
T KOG4278|consen  422 AHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMR  500 (1157)
T ss_pred             cccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHH
Confidence            3333   3459999999766664 89999999999999997 99999999999999887665 56778889999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      .||+.+|..||++.||-+
T Consensus       501 aCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  501 ACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHhcCCcccCccHHHHHH
Confidence            999999999999999754

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=292.59  Aligned_cols=247  Identities=23%  Similarity=0.320  Sum_probs=207.3

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      ...++++||+|-||.|++++-. .+..||+|.++......  ....+.+||++|.+|+||||+.++++|..++.+++|+|
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            4577899999999999999864 47899999998765433  45789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc--c
Q 013421           90 FVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--L  165 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~  165 (443)
                      |++.|+|.+++..+..  .......+++.||++|++||.+.+++||||.|.|+|+|.++++||+|||+++..-.++.  .
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            9999999999988743  34456678999999999999999999999999999999999999999999985433211  1


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHh--hCCCCCCCCChHHHHHHhhh--------ccCCCCCCCCH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM--AGYLPFGETDLPTLYKKINA--------AEFSCPFWFST  235 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll--~G~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~s~  235 (443)
                      -...+-...|||||.+....+. .++|+|++|+++||++  +.+.||...+.++..++...        .-++.|.-++.
T Consensus       696 qgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~  774 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ  774 (807)
T ss_pred             ecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence            1122345689999998776664 8999999999999975  58899988777766554321        12456777899


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          236 GATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .+.+++-+|+..+-++||+++++..
T Consensus       775 ~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  775 GLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHHHHHHhchhhhcCCCHHHHHH
Confidence            9999999999999999999999865

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-35  Score=284.45  Aligned_cols=130  Identities=28%  Similarity=0.454  Sum_probs=115.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----C---CCcceEEEEEE-
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-----H---PNIVRLHEVLA-   79 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~~~~~-   79 (443)
                      ++|.+.++||-|-|++||+|.+..+.+.||+|+++....    ..+....||.+|++++     |   .+||++++.|. 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            689999999999999999999999999999999976432    3466778999999883     3   47999999995 


Q ss_pred             ---eCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEc
Q 013421           80 ---SRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLD  143 (443)
Q Consensus        80 ---~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~  143 (443)
                         +..++|+|+|++ |.+|+.+|...  ++++...++.|++|++.||.|||.. ||+|.||||||||+.
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence               567899999999 88999999765  5799999999999999999999975 999999999999993

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.8e-35  Score=328.63  Aligned_cols=237  Identities=20%  Similarity=0.254  Sum_probs=187.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ..|...+.||+|+||.||+|++..++..||+|.+......       ...|+..+++++|||||++++++.+.+..|+||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            3456667899999999999999989999999988643311       124688999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH---SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH---~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      ||+++|+|.+++.   .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++..++. ||.......    
T Consensus       763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence            9999999999995   3889999999999999999999   6799999999999999998888775 665433221    


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh-----HHHHHHhhh-c------cCCC----
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-----PTLYKKINA-A------EFSC----  229 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-----~~~~~~i~~-~------~~~~----  229 (443)
                      .....||+.|+|||++.+..+. .++||||+||++|||++|+.||+....     ....+.... .      +...    
T Consensus       835 ~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (968)
T PLN00113        835 DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV  913 (968)
T ss_pred             CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence            1234688999999999877765 899999999999999999999964211     111111000 0      0000    


Q ss_pred             --CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          230 --PFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       230 --~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                        +.....++.+++.+|++.||++|||+.|+++.
T Consensus       914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence              00112356789999999999999999999874

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-36  Score=306.55  Aligned_cols=240  Identities=31%  Similarity=0.469  Sum_probs=193.0

Q ss_pred             eeeeeccCceE-EEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecC
Q 013421           14 GRTIGEGTFAK-VRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFV   91 (443)
Q Consensus        14 ~~~LG~G~~g~-V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~   91 (443)
                      .+.+|.|+.|+ ||+|..  .|+.||||.+-.+      ..+...+||..|+.- +|||||++|+.-.+....||..|.|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             HHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            46789999986 688886  4789999977433      345678999999988 6999999999999999999999999


Q ss_pred             CCCChHHHHHhcCC---C-CHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC---CC--CeEEeeecCcCCCccc
Q 013421           92 TGGELFDKIVHQGR---L-LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YG--NLKVSDFGLSALPQQG  162 (443)
Q Consensus        92 ~gg~L~~~i~~~~~---l-~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~---~~--~~kL~DFGls~~~~~~  162 (443)
                       ..+|.++++..+.   . .....+..+.|++.||++||+.+|+||||||.||||+.   ++  .++|+|||+|+....+
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence             5699999987521   1 11446789999999999999999999999999999975   34  6899999999876653


Q ss_pred             cc---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhC-CCCCCCCChHHHHHHhhhccCCCC---CCCCH
Q 013421          163 VE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAAEFSCP---FWFST  235 (443)
Q Consensus       163 ~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~~---~~~s~  235 (443)
                      ..   ...+..||-+|+|||++..... ..++||||+|||+|+.++| .+||++.-.  ...+|..+.+..-   +.-..
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~~~~d~  741 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLEPLPDC  741 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeeccCchH
Confidence            22   2456779999999999977554 4799999999999999985 999986432  2234555544321   11222


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      ++.+||.+||+++|..||+|.++|.||+|=
T Consensus       742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  742 EAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence            899999999999999999999999999994

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=304.21  Aligned_cols=258  Identities=29%  Similarity=0.446  Sum_probs=223.9

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..-.+|+++.++|+|+||.||+|+++.+++..|+|+++.+.-.   ...-+.+||-+++..+|||||.+++.+.-.+.+|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence            3456899999999999999999999999999999999886533   3567889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      +.||||.||+|.+.-.-.++++|.++....+..+.|++|||+.|-+|||||-.|||+++.|.+|++|||.+......-..
T Consensus        89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            99999999999998887899999999999999999999999999999999999999999999999999998766554344


Q ss_pred             ccccCCCcccCCCcccc---cCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC-----CCCHHH
Q 013421          166 LHTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF-----WFSTGA  237 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~-----~~s~~~  237 (443)
                      .....|||+|||||+-.   ..+|. ..+|||++|+...|+---++|-...........+.+..+..|.     .-++.+
T Consensus       169 rksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f  247 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF  247 (829)
T ss_pred             hhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence            56778999999999853   34554 9999999999999998888887665555555555555555443     247888


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      -+|++.+|..+|++|||++-+|+|||....
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            999999999999999999999999998643

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.2e-34  Score=279.05  Aligned_cols=252  Identities=30%  Similarity=0.456  Sum_probs=201.7

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRE---TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~   81 (443)
                      .....|.++++||+|+|+.||+|.+..   .++.||+|.+....     ....+..|++.|..+ .+.||+++.+.+..+
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            345578999999999999999999887   78899999887543     235688999999999 599999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc-CCCCeEEeeecCcCCCc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~-~~~~~kL~DFGls~~~~  160 (443)
                      +...+|+||.+..+..++...   ++...++.|++.++.||.++|.+||+||||||+|+|.+ ..+.-.|+|||++...+
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            999999999999888777744   67889999999999999999999999999999999998 45789999999986110


Q ss_pred             c-------cc-------c------------------------------cccccCCCcccCCCcccccCCCCCCccchHHH
Q 013421          161 Q-------GV-------E------------------------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC  196 (443)
Q Consensus       161 ~-------~~-------~------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSl  196 (443)
                      .       ..       .                              ......||++|+|||++..-+-.++++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            0       00       0                              00123499999999999887777899999999


Q ss_pred             HHHHHHHhhCCCCCCCCCh-----HH---------HHH------H---------------------h-----hhccC---
Q 013421          197 GVILFVLMAGYLPFGETDL-----PT---------LYK------K---------------------I-----NAAEF---  227 (443)
Q Consensus       197 Gvil~~ll~G~~Pf~~~~~-----~~---------~~~------~---------------------i-----~~~~~---  227 (443)
                      |||+..++++..||-....     .+         +.+      +                     +     ...+.   
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            9999999999999843221     00         000      0                     0     00000   


Q ss_pred             CCC---CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          228 SCP---FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       228 ~~~---~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      ...   ..++..+.+|+.+||..||.+|+|++++|+||||.
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence            000   11466899999999999999999999999999997

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-32  Score=292.93  Aligned_cols=246  Identities=25%  Similarity=0.405  Sum_probs=208.0

Q ss_pred             EEeeeeeccCceEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013421           12 EVGRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (443)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   83 (443)
                      .+.+.||+|+||+|++|....       ....||||........  ...+.+..|+.+|+.+ .||||+.+.+.+...+.
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            466799999999999997431       1457999998766543  4568899999999999 69999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC
Q 013421           84 VYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN  147 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~  147 (443)
                      +++|+||+..|+|.+++...+                .++..+...+..||+.|++||++.+++||||-..|||+..+..
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~  456 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV  456 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence            999999999999999998765                3788899999999999999999999999999999999999999


Q ss_pred             eEEeeecCcCCCccccccc-cccCCCcc--cCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCC-hHHHHHHh
Q 013421          148 LKVSDFGLSALPQQGVELL-HTTCGTPN--YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD-LPTLYKKI  222 (443)
Q Consensus       148 ~kL~DFGls~~~~~~~~~~-~~~~gt~~--y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~-~~~~~~~i  222 (443)
                      +||+|||+++......... ....|+.+  |||||.+....| +.++||||+||+|||+++ |..||.+-. ..++++.+
T Consensus       457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l  535 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFL  535 (609)
T ss_pred             EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHH
Confidence            9999999998544322221 22333344  999999988555 499999999999999998 999998844 55666666


Q ss_pred             hhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          223 NAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       223 ~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ..+ +...|..+++++.++++.|++.+|.+||++.++..
T Consensus       536 ~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  536 KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            665 45788889999999999999999999999999876

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-34  Score=249.53  Aligned_cols=197  Identities=24%  Similarity=0.430  Sum_probs=165.2

Q ss_pred             EEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEec
Q 013421           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      .-+..||+|++|.|-+.++..+|...|+|.+...-  ..+..+++.+|+++..+. .+|.+|.+|+.+.....+++.||.
T Consensus        49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            34678999999999999999999999999997643  234567888899986655 799999999999999999999999


Q ss_pred             CCCCChHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           91 VTGGELFD----KIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        91 ~~gg~L~~----~i~~~~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      |.. +|..    .+...+.++|...-+++..++.||.|||++ .++|||+||+|||++.+|++|+||||++......- .
T Consensus       127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi-A  204 (282)
T KOG0984|consen  127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI-A  204 (282)
T ss_pred             hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh-H
Confidence            943 4432    334456899999999999999999999987 89999999999999999999999999987665421 1


Q ss_pred             ccccCCCcccCCCcccc----cCCCCCCccchHHHHHHHHHHhhCCCCCCCC
Q 013421          166 LHTTCGTPNYVAPEVLS----NRGYDGSAADVWSCGVILFVLMAGYLPFGET  213 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  213 (443)
                      .+...|...|+|||.+.    +.+|+ -++||||||+.++||.+++.||+..
T Consensus       205 kt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  205 KTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             HHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhcccccccc
Confidence            12356889999999974    33665 8999999999999999999999764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=3.4e-32  Score=247.77  Aligned_cols=213  Identities=41%  Similarity=0.749  Sum_probs=188.4

Q ss_pred             eeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCCCh
Q 013421           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (443)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L   96 (443)
                      ||+|++|.||++....+++.+++|++.......  ..+.+.+|+..++.++|++|+++++++......++++||++|++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999997654321  346789999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-CCCeEEeeecCcCCCccccccccccCCCcc
Q 013421           97 FDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPN  174 (443)
Q Consensus        97 ~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~~~~~~~~~~gt~~  174 (443)
                      .+++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+..............+...
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            9999875 57899999999999999999999999999999999999999 899999999998766543222344568889


Q ss_pred             cCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCCC
Q 013421          175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR  254 (443)
Q Consensus       175 y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t  254 (443)
                      |++||.+......+.++|+||+|+++++|                               ..+.+++.+|++.||++||+
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~  207 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPS  207 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcC
Confidence            99999987652445899999999999999                               66789999999999999999


Q ss_pred             HHHHhcCc
Q 013421          255 IEGIRKHP  262 (443)
Q Consensus       255 ~~eil~hp  262 (443)
                      ++++++|+
T Consensus       208 ~~~l~~~~  215 (215)
T cd00180         208 AKEILEHL  215 (215)
T ss_pred             HHHHhhCC
Confidence            99999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-31  Score=247.88  Aligned_cols=217  Identities=42%  Similarity=0.710  Sum_probs=186.3

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      |++.+.||+|++|.||++.+..+++.+|+|.+......  ...+.+.+|+..++.++|+|++++++.+......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            67889999999999999999988999999999875433  2467889999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-ccccc
Q 013421           91 VTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-ELLHT  168 (443)
Q Consensus        91 ~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~~~~~  168 (443)
                      +++++|.+++..... +++.....++.|++.++.+||+.|++|+||+|.||+++.++.++|+|||++....... .....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            999999999988766 8999999999999999999999999999999999999999999999999887654431 12345


Q ss_pred             cCCCcccCCCccc-ccCCCCCCccchHHHHHHHHHHhhCCCCCCC--CChHHHHHHhhhccCCCC
Q 013421          169 TCGTPNYVAPEVL-SNRGYDGSAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAAEFSCP  230 (443)
Q Consensus       169 ~~gt~~y~aPE~l-~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~--~~~~~~~~~i~~~~~~~~  230 (443)
                      ..++..|++||.+ ....+. .++|+||||+++++|++|+.||..  .+...+.+.+..+.....
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLW  222 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccc
Confidence            5688899999998 444444 699999999999999999999977  334466777776654433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-33  Score=283.05  Aligned_cols=245  Identities=24%  Similarity=0.353  Sum_probs=212.1

Q ss_pred             EEeeeeeccCceEEEEEEECCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421           12 EVGRTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +..+.||+|+||+||+|.+-..|+    +||||++......+  ....+.+|.-+|.+++|||++++++++.... +-||
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~--~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK--ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch--hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            345789999999999999865554    78999987765433  4578999999999999999999999997655 8899


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      ++|+++|.|.|+++.+ ..+-......|..||++|+.|||.++++||||-..|||+..-.++|++|||++..........
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            9999999999999765 478888999999999999999999999999999999999999999999999999877655555


Q ss_pred             cccCC--CcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       167 ~~~~g--t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      +...|  .+.|+|=|.+....|. .++||||+||++||++| |..|+++....++-..+..+ +++.|+..+-++..++.
T Consensus       856 ~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv  934 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV  934 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence            54444  3458999998877775 99999999999999997 99999998887777766554 58889999999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||..|+..||+++++-.
T Consensus       935 kCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  935 KCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHhccCcccCccHHHHHH
Confidence            999999999999988654

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-32  Score=263.54  Aligned_cols=243  Identities=25%  Similarity=0.438  Sum_probs=192.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHH--hCCCCCcceEEEEEEeC----C
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK--IVRHPNIVRLHEVLASR----T   82 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~--~l~HpnIv~l~~~~~~~----~   82 (443)
                      .+..+.+.||+|-||+||+|.++  |+.||||++...      ..+...+|.+|.+  .|+|+||+.+++.-..+    .
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             heeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            45788999999999999999986  899999999643      2356677777765  56999999999765322    4


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----C---CCEeecCCCCcEEEcCCCCeEEeeec
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-----K---GVYHRDLKPENLLLDSYGNLKVSDFG  154 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-----~---gi~HrDlkp~NILl~~~~~~kL~DFG  154 (443)
                      ++|||++|.+.|+|+|++.+ ..++.+.+.+++..++.||++||.     +   .|+|||||..|||+..+|..-|+|+|
T Consensus       283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            69999999999999999988 789999999999999999999995     2   49999999999999999999999999


Q ss_pred             CcCCCccc----cccccccCCCcccCCCcccccCC----CCC-CccchHHHHHHHHHHhhC----------CCCCCC---
Q 013421          155 LSALPQQG----VELLHTTCGTPNYVAPEVLSNRG----YDG-SAADVWSCGVILFVLMAG----------YLPFGE---  212 (443)
Q Consensus       155 ls~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~----~~~-~~~DIwSlGvil~~ll~G----------~~Pf~~---  212 (443)
                      ||-.....    +-..+..+||..|||||++...-    +.+ ..+||||||.|++|++..          ++||.+   
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            99765543    22456789999999999985421    111 469999999999998742          688854   


Q ss_pred             --CChHHHHHHh--hhccCCCCC-CCCHH----HHHHHHHccCCCCCCCCCHHHHhc
Q 013421          213 --TDLPTLYKKI--NAAEFSCPF-WFSTG----ATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       213 --~~~~~~~~~i--~~~~~~~~~-~~s~~----~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                        ++.+++.+-+  .+.++++|. |-|.+    +..+++.|+..||.-|.|+--|.+
T Consensus       442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence              4445555443  344455554 44443    346899999999999999877654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=4.7e-32  Score=263.95  Aligned_cols=241  Identities=24%  Similarity=0.349  Sum_probs=189.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC---
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI--VRHPNIVRLHEVLASRT---   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~---   82 (443)
                      +...++.+.+|+|.||.||+|...  ++.||||++...      ..+.+..|-+|.+.  ++|+||+++++.-.-.+   
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            345677889999999999999874  699999998643      34667777777665  58999999998865444   


Q ss_pred             -EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCCEeecCCCCcEEEcCCCCeEEee
Q 013421           83 -KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS---------KGVYHRDLKPENLLLDSYGNLKVSD  152 (443)
Q Consensus        83 -~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~---------~gi~HrDlkp~NILl~~~~~~kL~D  152 (443)
                       .++||+||.+.|+|.+++.. ..++.....+++..++.||+|||+         .+|+|||||..|||+.++++..|+|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence             89999999999999999987 578999999999999999999996         3599999999999999999999999


Q ss_pred             ecCcCCCcc--ccccccccCCCcccCCCcccccCCCC-----CCccchHHHHHHHHHHhhCC------------CCCC--
Q 013421          153 FGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGYD-----GSAADVWSCGVILFVLMAGY------------LPFG--  211 (443)
Q Consensus       153 FGls~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~-----~~~~DIwSlGvil~~ll~G~------------~Pf~--  211 (443)
                      ||+|..+..  ..+.....+||..|||||++.+.--.     -...||||+|.||+||++..            +||.  
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            999977654  33445668999999999998653211     13689999999999998753            3332  


Q ss_pred             ---CCChHHHHHHh--hhccCCCCC-C----CCHHHHHHHHHccCCCCCCCCCHHH
Q 013421          212 ---ETDLPTLYKKI--NAAEFSCPF-W----FSTGATSLIHKILDPNPKTRIRIEG  257 (443)
Q Consensus       212 ---~~~~~~~~~~i--~~~~~~~~~-~----~s~~~~~li~~~L~~dP~~R~t~~e  257 (443)
                         .++.+++....  .+.++.+|. |    --..+.+.+..|++.||+-|.|+.=
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC  495 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence               12333333322  334444543 2    2455789999999999999999853

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=250.73  Aligned_cols=254  Identities=26%  Similarity=0.432  Sum_probs=197.8

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEE-EEeCCE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEV-LASRTK   83 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~-~~~~~~   83 (443)
                      ...+.|.|.+.||+|-||++.+++++.++..+++|.+.++..    ..+.+.+|..---.| .|.||+.-|++ |++.+.
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            345679999999999999999999999999999999987653    346677887765555 58999998876 677788


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC--CCCeEEeeecCcCCCcc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~--~~~~kL~DFGls~~~~~  161 (443)
                      +.+++||++-|+|..-+.. .++-|....+++.|+++|+.|+|+++++|||||.+||||-.  .-.+||||||+++..+.
T Consensus        97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            8999999999999988876 56889999999999999999999999999999999999943  33799999998764432


Q ss_pred             ccccccccCCCcccCCCcccccC---CC-CCCccchHHHHHHHHHHhhCCCCCCCCChH----HHHHHhhhc-cCCCCC-
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNR---GY-DGSAADVWSCGVILFVLMAGYLPFGETDLP----TLYKKINAA-EFSCPF-  231 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~---~~-~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~-~~~~~~-  231 (443)
                      -   ....--+..|.|||++...   .+ ..+.+|||.||+|+|.+|+|.+||......    ..+.++... ....|. 
T Consensus       176 t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~  252 (378)
T KOG1345|consen  176 T---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK  252 (378)
T ss_pred             e---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence            1   1222235679999986422   22 146799999999999999999999753321    122223222 223343 


Q ss_pred             --CCCHHHHHHHHHccCCCCCCC---CCHHHHhcCcccccc
Q 013421          232 --WFSTGATSLIHKILDPNPKTR---IRIEGIRKHPWFRKN  267 (443)
Q Consensus       232 --~~s~~~~~li~~~L~~dP~~R---~t~~eil~hp~f~~~  267 (443)
                        .+|+.+..+.++-|.++|++|   -++.......|....
T Consensus       253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence              279999999999999999999   556666667776543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.4e-32  Score=288.79  Aligned_cols=259  Identities=29%  Similarity=0.486  Sum_probs=209.7

Q ss_pred             cCe-EEeeeeeccCceEEEEEEECCCCcEEEEEEeec---ccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            9 AKY-EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         9 ~~y-~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ..| ...+.+|.|++|.|+.+......+.++.|....   ...........+..|+.+-..+.|||++.....+.+....
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            345 456789999999999998887777777776542   1112222333478888899999999998877776666666


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (443)
                      +-.||||++ +|+..+...+.++..++..++.||+.||+|+|+.||.|||+||+|++++.+|.+||+|||.+..+..+. 
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            666999999 999999998899999999999999999999999999999999999999999999999999998776532 


Q ss_pred             ---ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHH--HHhhhc-------cCCCCC
Q 013421          164 ---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY--KKINAA-------EFSCPF  231 (443)
Q Consensus       164 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~--~~i~~~-------~~~~~~  231 (443)
                         ......+|+.+|+|||++.+..|+....||||+|+|++.|.+|+.||..+...+..  ..-...       ....-.
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence               34567889999999999999999999999999999999999999999765443221  111111       111112


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .++.+.+.+|.+||++||.+|+|+++|++.+||+...
T Consensus       556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            2688899999999999999999999999999998654

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=2.8e-31  Score=291.63  Aligned_cols=199  Identities=17%  Similarity=0.223  Sum_probs=146.6

Q ss_pred             hCCC-CCcceEEEEE-------EeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecC
Q 013421           65 IVRH-PNIVRLHEVL-------ASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL  135 (443)
Q Consensus        65 ~l~H-pnIv~l~~~~-------~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDl  135 (443)
                      .++| +||.++++.+       .....++.++||+ +++|++++... ..+++.++..++.||+.||.|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            4455 5777777766       2334677888987 66999999753 46999999999999999999999999999999


Q ss_pred             CCCcEEEcCCC-------------------CeEEeeecCcCCCcccc----------------ccccccCCCcccCCCcc
Q 013421          136 KPENLLLDSYG-------------------NLKVSDFGLSALPQQGV----------------ELLHTTCGTPNYVAPEV  180 (443)
Q Consensus       136 kp~NILl~~~~-------------------~~kL~DFGls~~~~~~~----------------~~~~~~~gt~~y~aPE~  180 (443)
                      ||+||||+..|                   .+|++|||+++......                ......+||+.|+|||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            99999996544                   45555556554211000                00112468999999999


Q ss_pred             cccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC-CCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 013421          181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIR  259 (443)
Q Consensus       181 l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~eil  259 (443)
                      +.+..| +.++|||||||+||||++|.+|+.....  ....+.....+ .+....+...+++.+||++||.+||++.|++
T Consensus       187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil  263 (793)
T PLN00181        187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL  263 (793)
T ss_pred             hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence            988777 4999999999999999999998764321  11122111111 1111356678999999999999999999999


Q ss_pred             cCcccccc
Q 013421          260 KHPWFRKN  267 (443)
Q Consensus       260 ~hp~f~~~  267 (443)
                      +||||...
T Consensus       264 ~h~~~~~~  271 (793)
T PLN00181        264 QSEFINEP  271 (793)
T ss_pred             hchhhhhh
Confidence            99999763

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=2e-27  Score=229.56  Aligned_cols=254  Identities=37%  Similarity=0.601  Sum_probs=213.6

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEe
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP-NIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lv~E   89 (443)
                      |++.+.||.|+||.||.+.+.   ..+++|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            789999999999999999987   88999999887655544567899999999999988 79999999988888999999


Q ss_pred             cCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC-CeEEeeecCcCCCccccc-
Q 013421           90 FVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQGVE-  164 (443)
Q Consensus        90 y~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~~~-  164 (443)
                      |+.++++.+.+....   .+++.....++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+........ 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999997777764   799999999999999999999999999999999999999988 799999999875544221 


Q ss_pred             -----cccccCCCcccCCCcccccC--CCCCCccchHHHHHHHHHHhhCCCCCCCCCh----HHHHHHhhhccCC-CCCC
Q 013421          165 -----LLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDL----PTLYKKINAAEFS-CPFW  232 (443)
Q Consensus       165 -----~~~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~-~~~~  232 (443)
                           .....+||..|+|||.+.+.  .+.....|+||+|++++++++|..||.....    ......+.....+ ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 34677899999999999874  4556899999999999999999999887663    4455555444433 2222


Q ss_pred             CC--------HHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          233 FS--------TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       233 ~s--------~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ..        ..+.+++.+++..+|..|.+..+...++|....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            22        478999999999999999999999998776543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=3.9e-29  Score=224.40  Aligned_cols=158  Identities=22%  Similarity=0.238  Sum_probs=128.6

Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCC
Q 013421           94 GELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT  172 (443)
Q Consensus        94 g~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt  172 (443)
                      |+|.+++... .++++..++.++.|++.||.|||+++      ||+|||++.++.+|+  ||++......     ...||
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence            6899999874 46999999999999999999999999      999999999999999  9988765432     23689


Q ss_pred             cccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh-HHHHHHhhhccCC-------CCCCCCH--HHHHHHH
Q 013421          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAEFS-------CPFWFST--GATSLIH  242 (443)
Q Consensus       173 ~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~-------~~~~~s~--~~~~li~  242 (443)
                      +.|+|||++.+..|+ .++||||+||++|+|++|..||..... ......+......       .+..++.  ++.++|.
T Consensus        68 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  146 (176)
T smart00750       68 PYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR  146 (176)
T ss_pred             ccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence            999999999887775 899999999999999999999976543 2223332221111       1122344  6999999


Q ss_pred             HccCCCCCCCCCHHHHhcCcccc
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      +||..||.+|||+.++++|+|+.
T Consensus       147 ~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      147 VCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHhcccccccCHHHHHHHHHHH
Confidence            99999999999999999999975

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=2e-28  Score=233.36  Aligned_cols=249  Identities=23%  Similarity=0.313  Sum_probs=203.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCC-----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCC
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETG-----ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA-SRT   82 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~   82 (443)
                      .++++...+-+|+||.||.|++++..     +.|-+|.+....  .+-....+..|--.+..+.|||+..+.++.. +..
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            46778888999999999999876532     345566554433  2223567888988999999999999999874 556


Q ss_pred             EEEEEEecCCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeec
Q 013421           83 KVYIILEFVTGGELFDKIVH--------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG  154 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~--------~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFG  154 (443)
                      .-++++.+..-|+|..++..        .+.++..+...++.|+..|++|||++||+|.||-..|.+||+.-++||+|=.
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa  441 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA  441 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence            77888899988999999872        1346777788899999999999999999999999999999999999999999


Q ss_pred             CcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCC
Q 013421          155 LSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCP  230 (443)
Q Consensus       155 ls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~  230 (443)
                      +++..-..+  .+.........||+||.+.+..|. .++|+|||||+||||++ |+.|+.+-+..++...+..+ +...|
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP  520 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP  520 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence            987532211  111122234579999999988886 99999999999999998 99999999998888887765 57788


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          231 FWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .++++++..++.-||..+|++||+++|+..
T Consensus       521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  521 FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            899999999999999999999999999764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.5e-30  Score=258.99  Aligned_cols=240  Identities=37%  Similarity=0.617  Sum_probs=211.0

Q ss_pred             eeeccCceEEEEEEE---CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEecC
Q 013421           16 TIGEGTFAKVRFAQN---RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYIILEFV   91 (443)
Q Consensus        16 ~LG~G~~g~V~~a~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~   91 (443)
                      ++|+|+||+|++++.   .+.|..+|+|+..+......... .-..|..++..++ ||.+++++..++.+...|+++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            479999999998753   34678899999987665433222 4456777888886 999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCC
Q 013421           92 TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG  171 (443)
Q Consensus        92 ~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~g  171 (443)
                      .||+|+..+.....+++.....+...++.|++++|+.||+|||+|++||+++.+|++++.|||+++..-...    ..||
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----~~cg  155 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----IACG  155 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----hccc
Confidence            999999999998899999999999999999999999999999999999999999999999999998654432    2299


Q ss_pred             CcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCC
Q 013421          172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT  251 (443)
Q Consensus       172 t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~  251 (443)
                      |..|||||++.  +.. ..+|.||+|+++|+|++|..||..    +....|....+..|..++..+++++..++..+|.+
T Consensus       156 t~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~n  228 (612)
T KOG0603|consen  156 TYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPEN  228 (612)
T ss_pred             chhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHH
Confidence            99999999997  444 889999999999999999999987    67778888899999999999999999999999999


Q ss_pred             CCCH-----HHHhcCcccccc
Q 013421          252 RIRI-----EGIRKHPWFRKN  267 (443)
Q Consensus       252 R~t~-----~eil~hp~f~~~  267 (443)
                      |...     .+|++|+||+..
T Consensus       229 rLg~~~~~~~eik~h~f~~~i  249 (612)
T KOG0603|consen  229 RLGAGPDGVDEIKQHEFFQSI  249 (612)
T ss_pred             HhccCcchhHHHhccchheee
Confidence            9854     799999999753

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=2.5e-27  Score=234.81  Aligned_cols=169  Identities=23%  Similarity=0.244  Sum_probs=134.1

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECC-CCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCCcce-EEEEEEe
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRE-TGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVRHPNIVR-LHEVLAS   80 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~   80 (443)
                      +...++|++.+.||+|+||+||+|++.. +++.+|||++.....  ......+.+.+|+.+|+.++|+||+. +++.   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            4567789999999999999999999876 678889998753311  12334567999999999999999985 5442   


Q ss_pred             CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecC-CCCcEEEcCCCCeEEeeecCcCCC
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL-KPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDl-kp~NILl~~~~~~kL~DFGls~~~  159 (443)
                       +..|+||||++|++|.. +..   ..   ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||++...
T Consensus        91 -~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             -CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence             45899999999999963 211   11   1468899999999999999999999 999999999999999999999865


Q ss_pred             cccc--------ccccccCCCcccCCCcccccC
Q 013421          160 QQGV--------ELLHTTCGTPNYVAPEVLSNR  184 (443)
Q Consensus       160 ~~~~--------~~~~~~~gt~~y~aPE~l~~~  184 (443)
                      ....        ......+|++.|+|||.+...
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            4421        112456789999999998643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=5.1e-25  Score=217.41  Aligned_cols=247  Identities=23%  Similarity=0.309  Sum_probs=192.7

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCC-cEEEEEEeecccccchHHHHHHHHHHHHHHhCCC----CCcceEEEEE-EeCCE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETG-ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH----PNIVRLHEVL-ASRTK   83 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-~~~~~   83 (443)
                      +|.+.+.||+|+||.||.+.+..++ ..+|+|+.........   ..+..|+.++..+..    +++..+++.. .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999988765 6789998776432221   267889999998873    6999999999 58888


Q ss_pred             EEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC-----CCeEEeeecCc
Q 013421           84 VYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-----GNLKVSDFGLS  156 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~-----~~~kL~DFGls  156 (443)
                      -|+||+.+ |.+|.+.....  +.++...+.+++.|++.+|+++|+.|++||||||+|+++...     ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999998 88999977544  579999999999999999999999999999999999999865     46999999999


Q ss_pred             CCCc--cccc-------c-ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHh---h
Q 013421          157 ALPQ--QGVE-------L-LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI---N  223 (443)
Q Consensus       157 ~~~~--~~~~-------~-~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i---~  223 (443)
                      +...  ....       . .....||..|+++.+..+... +.+.|+||++-++.+++.|.+||..........+.   .
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            8322  1111       1 223459999999999877665 59999999999999999999999775532222222   1


Q ss_pred             hccCC--CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          224 AAEFS--CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       224 ~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .....  .....+.++..+...+-..+...+|....+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            11111  223345677777777777888889988776654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=2.8e-26  Score=241.88  Aligned_cols=218  Identities=31%  Similarity=0.578  Sum_probs=176.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      -.+|..++++..|+||.||+++|+.+.+.+|+ .++++...        .+.  ++..-..|.+|               
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li--------lRn--ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI--------LRN--ILTFAGNPFVV---------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhh-cccccchh--------hhc--cccccCCccee---------------
Confidence            45799999999999999999999999999999 45544321        111  33333444444               


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc-----
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-----  162 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-----  162 (443)
                            |+-...+...++++.+.        +.+++|+|+.||+|||+||+|++|+.-|++|++|||++......     
T Consensus       136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence                  55666666667777655        78999999999999999999999999999999999987532110     


Q ss_pred             ----------cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCC
Q 013421          163 ----------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW  232 (443)
Q Consensus       163 ----------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  232 (443)
                                .-.....||||.|+|||++..++| |.++|+|++|+|+|+.+.|..||.+.+.++++..........|..
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~  280 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE  280 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence                      001235599999999999998888 599999999999999999999999999999998877666655543


Q ss_pred             ---CCHHHHHHHHHccCCCCCCCC---CHHHHhcCccccc
Q 013421          233 ---FSTGATSLIHKILDPNPKTRI---RIEGIRKHPWFRK  266 (443)
Q Consensus       233 ---~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~f~~  266 (443)
                         ++++++++|.++|+.+|..|.   .+-++.+|+||+.
T Consensus       281 dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~  320 (1205)
T KOG0606|consen  281 DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL  320 (1205)
T ss_pred             CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence               789999999999999999997   5678999999974

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1.2e-26  Score=244.15  Aligned_cols=258  Identities=33%  Similarity=0.569  Sum_probs=218.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE-TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~   85 (443)
                      ...|.+.+.||+|+|+.|-++.... +...+|.|.+.... ......+.+..|..+.+.+. |+|++++++...+.+..+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            5679999999999999999887744 44567777776554 23445677888999999997 999999999999999999


Q ss_pred             EEEecCCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCEeecCCCCcEEEcCCC-CeEEeeecCcCCCcc
Q 013421           86 IILEFVTGGELFDKI-VHQG-RLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQ  161 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i-~~~~-~l~e~~~~~~~~qll~aL~yLH-~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~  161 (443)
                      ++++|..|+++++.+ .... ..+...+.+++.|+..++.|+| ..++.|||+||+|.+++..+ .++++|||+++.+..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999999999 6655 7888999999999999999999 99999999999999999999 999999999987655


Q ss_pred             ---ccccccccCC-CcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHH-HHHhhh--ccCCCCC--C
Q 013421          162 ---GVELLHTTCG-TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL-YKKINA--AEFSCPF--W  232 (443)
Q Consensus       162 ---~~~~~~~~~g-t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~-~~~i~~--~~~~~~~--~  232 (443)
                         ........|| ++.|+|||...+..|.++..|+||+|+++..+++|..||........ +..+..  ..+...+  .
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence               2345677889 99999999999888999999999999999999999999987654321 111211  1212233  3


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      ++..+.+++.+++..+|..|.+.+++..+||+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccc
Confidence            8999999999999999999999999999999987

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=2.7e-24  Score=193.75  Aligned_cols=244  Identities=20%  Similarity=0.292  Sum_probs=194.1

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-PNIVRLHEVLASRTKV   84 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~   84 (443)
                      ...++|.++++||+|+||.+|+|....+|+.||||+-....-     ..++..|..+.+.|++ ..|..+.-+..+...-
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            456899999999999999999999999999999998655431     2467789999999975 7788888888888999


Q ss_pred             EEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC---CCCeEEeeecCcCCCc
Q 013421           85 YIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQ  160 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~---~~~~kL~DFGls~~~~  160 (443)
                      .+||++. |-+|.+...- ...++...+.-++-|++.-++|+|.++++||||||+|+|..-   ...+.|+|||+|..+.
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999998 7788777643 357899999999999999999999999999999999999963   4579999999998654


Q ss_pred             ccc-------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC---hHHHHHHhhhccCCCC
Q 013421          161 QGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---LPTLYKKINAAEFSCP  230 (443)
Q Consensus       161 ~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~  230 (443)
                      ...       .....-.||..|.+--...+... +..-|+=|+|.+|.++.-|.+||.+-.   ..+.+.+|.....+.|
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            321       12234458999988666554333 467899999999999999999998744   3455667776666555


Q ss_pred             C-----CCCHHHHHHHHHccCCCCCCCCCHH
Q 013421          231 F-----WFSTGATSLIHKILDPNPKTRIRIE  256 (443)
Q Consensus       231 ~-----~~s~~~~~li~~~L~~dP~~R~t~~  256 (443)
                      .     .+|.++.-.+.-|-..--.+-|...
T Consensus       245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            3     3788888888888766655666543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=1.3e-24  Score=201.13  Aligned_cols=173  Identities=16%  Similarity=0.210  Sum_probs=135.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHH------HHHHHHHHHhCCCCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ------IKREISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------~~~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      -++|++.+.||.|+||.||++..  ++..+|+|++.......+.....      +.+|+..+.+++||+|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            46899999999999999999655  46689999997665444444344      68999999999999999999886643


Q ss_pred             --------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeee
Q 013421           82 --------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDF  153 (443)
Q Consensus        82 --------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DF  153 (443)
                              +..+++|||++|.+|.+..    .+++    ....+++.++..||+.|++|||+||+||+++.+| ++|+||
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence                    3588999999999997763    2333    2456999999999999999999999999999988 999999


Q ss_pred             cCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHh
Q 013421          154 GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  204 (443)
Q Consensus       154 Gls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  204 (443)
                      |...........            ..++....|. .++||||||+++..+.
T Consensus       179 g~~~~~~e~~a~------------d~~vler~y~-~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKAK------------DRIDLERHYG-IKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhhH------------HHHHHHhHhc-ccccccceeEeehHHH
Confidence            987654321110            1134455676 7999999999877543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=1.5e-24  Score=197.50  Aligned_cols=143  Identities=22%  Similarity=0.269  Sum_probs=114.5

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchH-----------------------HHHHHHHHHHHHHhCCCCC
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR-----------------------MVDQIKREISIMKIVRHPN   70 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~Hpn   70 (443)
                      ...||+|+||.||+|.+. +|+.||+|++.........                       ......+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999765321110                       0123456999999998888


Q ss_pred             cceEEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCEeecCCCCcEEEcCCCCeE
Q 013421           71 IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC-HSKGVYHRDLKPENLLLDSYGNLK  149 (443)
Q Consensus        71 Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yL-H~~gi~HrDlkp~NILl~~~~~~k  149 (443)
                      +.....+....  .++||||++|+++.......+++++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            75544433222  389999999988776655567899999999999999999999 799999999999999998 48899


Q ss_pred             EeeecCcCCCc
Q 013421          150 VSDFGLSALPQ  160 (443)
Q Consensus       150 L~DFGls~~~~  160 (443)
                      |+|||++....
T Consensus       158 LiDFG~a~~~~  168 (190)
T cd05147         158 IIDVSQSVEHD  168 (190)
T ss_pred             EEEccccccCC
Confidence            99999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=1.8e-23  Score=190.64  Aligned_cols=145  Identities=19%  Similarity=0.283  Sum_probs=116.9

Q ss_pred             EeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch----------------------H-HHHHHHHHHHHHHhCCCC
Q 013421           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH----------------------R-MVDQIKREISIMKIVRHP   69 (443)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~----------------------~-~~~~~~~Ei~il~~l~Hp   69 (443)
                      +.+.||+|++|+||+|.+. +|+.||||+++.......                      . ......+|+..+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 899999999986531100                      0 022346899999999999


Q ss_pred             CcceEEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCe
Q 013421           70 NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNL  148 (443)
Q Consensus        70 nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~  148 (443)
                      ++.....+....  .|+||||++|+++........++++..+..++.|++.++.++|+ .||+||||||+||+++ ++.+
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            886555544333  48999999988665544445778899999999999999999999 9999999999999999 7999


Q ss_pred             EEeeecCcCCCcc
Q 013421          149 KVSDFGLSALPQQ  161 (443)
Q Consensus       149 kL~DFGls~~~~~  161 (443)
                      +|+|||++.....
T Consensus       157 ~liDFG~a~~~~~  169 (190)
T cd05145         157 YIIDVSQAVELDH  169 (190)
T ss_pred             EEEEcccceecCC
Confidence            9999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=8.7e-24  Score=201.42  Aligned_cols=235  Identities=28%  Similarity=0.371  Sum_probs=153.5

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC----------CCCcceEEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR----------HPNIVRLHEVLA   79 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~----------HpnIv~l~~~~~   79 (443)
                      ....++.||.|+++.||.+.+.+||+.+|+|++...........+++++|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4566789999999999999999999999999987766444456777877775555532          223333333332


Q ss_pred             e------------CC-----EEEEEEecCCCCChHHHHH---hcCCC---CHHHH-HHHHHHHHHHHHHHHhCCCEeecC
Q 013421           80 S------------RT-----KVYIILEFVTGGELFDKIV---HQGRL---LENDC-RRYFQQLIDAVAHCHSKGVYHRDL  135 (443)
Q Consensus        80 ~------------~~-----~~~lv~Ey~~gg~L~~~i~---~~~~l---~e~~~-~~~~~qll~aL~yLH~~gi~HrDl  135 (443)
                      -            .+     +.+++|+-+ .++|.+.+.   .....   ....+ ..+..|++..+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            1            11     236777777 567766653   22222   12233 344589999999999999999999


Q ss_pred             CCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcccCCCcccccCC-------CCCCccchHHHHHHHHHHhhCCC
Q 013421          136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG-------YDGSAADVWSCGVILFVLMAGYL  208 (443)
Q Consensus       136 kp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~~~~~~DIwSlGvil~~ll~G~~  208 (443)
                      +|+|++++.+|.++|+||+.....+..   ......+..|.+||......       ..+.+.|.|+||+++|.|.||..
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            999999999999999999866544332   11133457899999874421       12478999999999999999999


Q ss_pred             CCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCC
Q 013421          209 PFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTR  252 (443)
Q Consensus       209 Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  252 (443)
                      ||+..........    .+.....++..++.||+.+|++||.+|
T Consensus       249 Pf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9986543221110    233223789999999999999999988

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=6.5e-23  Score=192.52  Aligned_cols=239  Identities=21%  Similarity=0.301  Sum_probs=187.6

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      .|+++++||+|+||..+.|.+.-++++||||.=....     ...++..|.+..+.|. .++|...|-+..+.-+-.+|+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            6999999999999999999999999999999754432     3467899999999995 699999999988888889999


Q ss_pred             ecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC-----CCeEEeeecCcCCCccc
Q 013421           89 EFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-----GNLKVSDFGLSALPQQG  162 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~-----~~~kL~DFGls~~~~~~  162 (443)
                      |++ |-+|.|+..-- .+++...+..++.|++.-++|+|++..|+|||||+|+||..-     ..+.++|||+++.+...
T Consensus       104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence            998 77888877654 479999999999999999999999999999999999999743     35899999999876543


Q ss_pred             cc-------cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCC---CChHHHHHHhhhccCCCC--
Q 013421          163 VE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCP--  230 (443)
Q Consensus       163 ~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~~--  230 (443)
                      ..       .-..-.||..||+---..+... +..-|+=|||-++++.|-|.+||.+   .+..+-+++|....-.-|  
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~  261 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE  261 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence            22       1234469999999777666554 3788999999999999999999987   445566777755443332  


Q ss_pred             ---CCCCHHHHHHHHHccCCCCCCCCCH
Q 013421          231 ---FWFSTGATSLIHKILDPNPKTRIRI  255 (443)
Q Consensus       231 ---~~~s~~~~~li~~~L~~dP~~R~t~  255 (443)
                         ..++.++..-++-.-..+-.+-|..
T Consensus       262 ~Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  262 VLCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             HHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence               2245555444444433343444443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=2.3e-24  Score=227.69  Aligned_cols=245  Identities=24%  Similarity=0.375  Sum_probs=183.9

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKST-ILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      +|...+-||++-|=+|.+|++.+ |. |+||++-+.. ...-+...+..+|++ .+.++|||.+.+.-+...+...|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            68889999999999999999864 44 9999986654 222223344445555 66779999999998888888899999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCC--Cccccc--
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVE--  164 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~--~~~~~~--  164 (443)
                      +|... +|+|.+....-+...+-+.|+.||+.||.-||..||+|||||.|||||+.-+.+.|+||..-+-  ...++.  
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            99954 8999998877788888999999999999999999999999999999999999999999975421  111111  


Q ss_pred             ---cccccCCCcccCCCcccccCC----------CCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhccCC--
Q 013421          165 ---LLHTTCGTPNYVAPEVLSNRG----------YDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFS--  228 (443)
Q Consensus       165 ---~~~~~~gt~~y~aPE~l~~~~----------~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~--  228 (443)
                         ...+...-.+|.|||.+....          .-.++.||||+||+++||++ |++||.-.   ++...-..+...  
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~aYr~~~~~~~e  256 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLAYRSGNADDPE  256 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHhHhccCccCHH
Confidence               112333445899999875422          12468899999999999997 89999421   221111111000  


Q ss_pred             --CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          229 --CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       229 --~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                        ...--+..++.+|..|++.||++|.++++.|+.
T Consensus       257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  257 QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence              000114578999999999999999999999985

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.3e-23  Score=198.45  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=174.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCC-----------------------------------cEEEEEEeecccccc--
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETG-----------------------------------ESVAMKVLAKSTILK--   49 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~-----------------------------------~~vAiK~i~~~~~~~--   49 (443)
                      ++++|+|++.||+|..+.||.|.....|                                   =+.|||.+-.-...+  
T Consensus       155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~  234 (598)
T KOG4158|consen  155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD  234 (598)
T ss_pred             chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence            5678999999999999999998754311                                   134667654322221  


Q ss_pred             hHHHHHHHHHHH------HH--------H-------hC-CCCCcceEEEEEEe---------------------------
Q 013421           50 HRMVDQIKREIS------IM--------K-------IV-RHPNIVRLHEVLAS---------------------------   80 (443)
Q Consensus        50 ~~~~~~~~~Ei~------il--------~-------~l-~HpnIv~l~~~~~~---------------------------   80 (443)
                      ....+.+-+|..      .+        +       .| +|||||++..+|.+                           
T Consensus       235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~  314 (598)
T KOG4158|consen  235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE  314 (598)
T ss_pred             HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence            112233333321      11        1       12 59999999877632                           


Q ss_pred             CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc--CCC--CeEEeeecCc
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD--SYG--NLKVSDFGLS  156 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~--~~~--~~kL~DFGls  156 (443)
                      +..+|+||... ..+|..++-. ...+....+-++.|+++|+.|||++||+|||+|.+|||+.  +++  .+.++|||.+
T Consensus       315 ~~tlylvMkrY-~~tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc  392 (598)
T KOG4158|consen  315 PKTLYLVMKRY-RQTLREYLWT-RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC  392 (598)
T ss_pred             CceEEEehhcc-hhhHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence            33689999877 4578888866 4567778888999999999999999999999999999994  333  5899999976


Q ss_pred             CCCcc-cc-----ccccccCCCcccCCCcccccCCC-----CCCccchHHHHHHHHHHhhCCCCCCCCChHHHH-HHhh-
Q 013421          157 ALPQQ-GV-----ELLHTTCGTPNYVAPEVLSNRGY-----DGSAADVWSCGVILFVLMAGYLPFGETDLPTLY-KKIN-  223 (443)
Q Consensus       157 ~~~~~-~~-----~~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~-~~i~-  223 (443)
                      --... +-     ......-|.-.-||||+....+-     +-.++|.|++|.+.||++....||.......+. +... 
T Consensus       393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe  472 (598)
T KOG4158|consen  393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE  472 (598)
T ss_pred             eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence            43222 10     11123347778999999754321     126899999999999999999999874433221 1122 


Q ss_pred             hccCCCCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 013421          224 AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE  256 (443)
Q Consensus       224 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  256 (443)
                      ..-+..|..+++.+++++..+|+.||++|++..
T Consensus       473 ~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  473 SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             hhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            233456778999999999999999999999864

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=9.6e-22  Score=178.62  Aligned_cols=190  Identities=16%  Similarity=0.184  Sum_probs=141.3

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHH-HHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM-VDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~-~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ..+...|++|+||+|+++..  .+..++.+.+.......... ...+.+|+++|++|. |++|++++++    +..|++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            34668899999999997765  57778877766544322211 225789999999995 5889999886    4579999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecC-CCCcEEEcCCCCeEEeeecCcCCCcccccc--
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL-KPENLLLDSYGNLKVSDFGLSALPQQGVEL--  165 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDl-kp~NILl~~~~~~kL~DFGls~~~~~~~~~--  165 (443)
                      ||+.|.+|...+..      . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||++.........  
T Consensus        78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99999998654321      1 2357889999999999999999999 799999999999999999999855432211  


Q ss_pred             -----------ccccCCCcccCCCcccccCC-CCCCccchHHHHHHHHHHhhCCCCCCCC
Q 013421          166 -----------LHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGET  213 (443)
Q Consensus       166 -----------~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~  213 (443)
                                 ......++.|++|+.-.--. ..-...+.++.|.-+|.++|+..|+-+.
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                       11223677888887542221 1124578889999999999999887543

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=2.7e-21  Score=178.20  Aligned_cols=134  Identities=19%  Similarity=0.202  Sum_probs=108.6

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---EEE
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-----RHPNIVRLHEVLASRT---KVY   85 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~~~   85 (443)
                      .+.||+|+||.||.  ++.++.. +||++......   ..+.+.+|+.+++.+     +||||++++++++++.   .++
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            46899999999995  7777666 69998764322   346789999999999     5799999999998874   434


Q ss_pred             -EEEec--CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCEeecCCCCcEEEcCC----CCeEEeeecCc
Q 013421           86 -IILEF--VTGGELFDKIVHQGRLLENDCRRYFQQLIDAV-AHCHSKGVYHRDLKPENLLLDSY----GNLKVSDFGLS  156 (443)
Q Consensus        86 -lv~Ey--~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL-~yLH~~gi~HrDlkp~NILl~~~----~~~kL~DFGls  156 (443)
                       +|+||  +.+++|.+++.+ +.+++.  ..++.|++.++ +|||+++|+||||||+|||++.+    +.++|+||+.+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence             78999  558999999976 456666  35678888777 99999999999999999999743    47999995543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.1e-22  Score=184.38  Aligned_cols=245  Identities=20%  Similarity=0.318  Sum_probs=197.8

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +..++...++.+|.+...|+.|+|++.  |..++.|+++...+.. +....+..|.-.|+-+.||||+.+++.+.+..++
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnl  262 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNL  262 (448)
T ss_pred             CcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence            344556667788999999999999985  5567778887654432 3346788899999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--CEeecCCCCcEEEcCCCCeEEe--eecCcCC
Q 013421           85 YIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVS--DFGLSAL  158 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~yLH~~g--i~HrDlkp~NILl~~~~~~kL~--DFGls~~  158 (443)
                      .++..|++-|+|++.+.....  ++..++.+++.+++.|++|||+..  |----|....+++|++-+.+|+  |--++- 
T Consensus       263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-  341 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-  341 (448)
T ss_pred             eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-
Confidence            999999999999999977543  577889999999999999999974  3334788999999998776664  322221 


Q ss_pred             CccccccccccCCCcccCCCcccccCCCC--CCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHh--hhccCCCCCCCC
Q 013421          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYD--GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFWFS  234 (443)
Q Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~--~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~s  234 (443)
                       +.     ....-+|.|++||.++.++.+  -.++|+|||+++++||.|...||.+.+..+.-.++  ...+..+|+.+|
T Consensus       342 -qe-----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis  415 (448)
T KOG0195|consen  342 -QE-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGIS  415 (448)
T ss_pred             -ec-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCcc
Confidence             11     122347899999999877654  35799999999999999999999988877766554  445678999999


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHh
Q 013421          235 TGATSLIHKILDPNPKTRIRIEGIR  259 (443)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil  259 (443)
                      +..-.|+.-|++.||.+||.++.|.
T Consensus       416 ~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  416 RHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHHHHhcCCCCcCCCcceeh
Confidence            9999999999999999999988754

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=3.8e-21  Score=181.13  Aligned_cols=146  Identities=17%  Similarity=0.223  Sum_probs=116.8

Q ss_pred             CeEEeeeeeccCceEEEEEE-ECCCCcEEEEEEeecccccc---------------------hHHHHHHHHHHHHHHhCC
Q 013421           10 KYEVGRTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILK---------------------HRMVDQIKREISIMKIVR   67 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~-~~~~~~~vAiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~   67 (443)
                      -|++.+.||+|++|.||+|. +..+|+.||+|++.......                     ......+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999999 66789999999997643110                     001234678999999997


Q ss_pred             CC--CcceEEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CEeecCCCCcEEEcC
Q 013421           68 HP--NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG-VYHRDLKPENLLLDS  144 (443)
Q Consensus        68 Hp--nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~g-i~HrDlkp~NILl~~  144 (443)
                      +.  .+.++++.    ...|+||||++|++|...........+..+..++.|++.++.+||+.| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            53  34444442    235899999999888776555556677778899999999999999999 99999999999999 


Q ss_pred             CCCeEEeeecCcCCCc
Q 013421          145 YGNLKVSDFGLSALPQ  160 (443)
Q Consensus       145 ~~~~kL~DFGls~~~~  160 (443)
                      ++.++|+|||.+....
T Consensus       184 ~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCCEEEEEChhhhccC
Confidence            8899999999876443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=3.5e-22  Score=198.59  Aligned_cols=175  Identities=25%  Similarity=0.383  Sum_probs=136.8

Q ss_pred             EEEEEEecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           83 KVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      .+||.|++|...+|.++|.+..   ..+......++.|+..|++|   +|.+|||+||.||+...++.+||.|||+.+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            4789999999999999997644   34567788999999999999   99999999999999999999999999998765


Q ss_pred             cccc------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhccCCCCCC
Q 013421          160 QQGV------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSCPFW  232 (443)
Q Consensus       160 ~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  232 (443)
                      ....      ...+...||+.||+||.+.+..|. .++||||||+||+||+. =..+|..   ......+..+.++...+
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~  482 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFL  482 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHh
Confidence            5432      134566899999999999988885 99999999999999997 2333221   11222233343332222


Q ss_pred             C-CHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          233 F-STGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       233 ~-s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      . -|+-..|+.+||.+.|.+||++.+.-.|+|.
T Consensus       483 ~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  483 QDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            2 3455689999999999999988887777775

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=3.3e-19  Score=164.84  Aligned_cols=137  Identities=23%  Similarity=0.333  Sum_probs=115.8

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH-----RMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      +.||+|++|.||+|.+  .|..+++|+.........     .....+.+|+.++..+.|++|.....++.+.+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            6799999999999987  677899998654332211     122457889999999999999888877777788999999


Q ss_pred             cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCC
Q 013421           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (443)
                      |++|++|.+.+.....    ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998865332    7889999999999999999999999999999999 78999999998765

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=3.5e-20  Score=199.51  Aligned_cols=193  Identities=23%  Similarity=0.330  Sum_probs=157.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR---HPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~   84 (443)
                      -..|.|-+.||+|+||+||.|.+.. |+.||+|+=.......--...      .++.+|+   -+.|+.+...+.-.+.-
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHHHHccCCcc
Confidence            3479999999999999999999876 999999986654432211122      2334444   35566666666667778


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-------CCCeEEeeecCcC
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-------YGNLKVSDFGLSA  157 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-------~~~~kL~DFGls~  157 (443)
                      ++|+||.+-|+|.+++...+.+++.....+..|++..|+.||..||||+||||+|+||..       +--++|+|||.+.
T Consensus       770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            899999999999999998889999999999999999999999999999999999999942       3359999999885


Q ss_pred             CCcc--ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCC
Q 013421          158 LPQQ--GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL  208 (443)
Q Consensus       158 ~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~  208 (443)
                      -+.-  ........++|-.+-.+|+..++++. ..+|.|.++-+++.||+|+.
T Consensus       850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHH
Confidence            4322  11345677889999999999998886 99999999999999999974

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=4.3e-19  Score=162.80  Aligned_cols=140  Identities=19%  Similarity=0.310  Sum_probs=110.8

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch-------------------HHHHHHHHHHHHHHhCCCCC-
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH-------------------RMVDQIKREISIMKIVRHPN-   70 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~Hpn-   70 (443)
                      |.+.+.||+|+||.||++.+. +|+.||||++........                   .......+|+.++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888999999999999999875 799999999875431000                   01123678999999998874 


Q ss_pred             -cceEEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeE
Q 013421           71 -IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLK  149 (443)
Q Consensus        71 -Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~k  149 (443)
                       ++..++    ....+++|||++|++|......      .....++.+++.++.++|+.||+||||||+||++++++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             444443    2445899999999988654321      35678889999999999999999999999999999999999


Q ss_pred             EeeecCcCCCcc
Q 013421          150 VSDFGLSALPQQ  161 (443)
Q Consensus       150 L~DFGls~~~~~  161 (443)
                      |+|||++.....
T Consensus       166 liDfg~~~~~~~  177 (198)
T cd05144         166 IIDWPQMVSTDH  177 (198)
T ss_pred             EEECCccccCCC
Confidence            999999865544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=9.2e-19  Score=160.46  Aligned_cols=134  Identities=19%  Similarity=0.275  Sum_probs=109.0

Q ss_pred             eeeccCceEEEEEEECCCCcEEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013421           16 TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH-----RMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      .||+|+||.||+|..  +|..+++|+.........     ...+.+.+|+.+++.++|+++....-++...+..+++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  578899998654322111     1235678999999999988766655555666778999999


Q ss_pred             CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           91 VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        91 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      ++|++|.+.+.....       .++.|++.+|.+||+.|++|||++|+||+++ ++.++++|||++...
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999988755321       7899999999999999999999999999999 799999999987653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=6.1e-19  Score=178.46  Aligned_cols=198  Identities=23%  Similarity=0.338  Sum_probs=157.1

Q ss_pred             HHhCCCCCcceEEEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC-EeecCCCCcE
Q 013421           63 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGV-YHRDLKPENL  140 (443)
Q Consensus        63 l~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi-~HrDlkp~NI  140 (443)
                      |+.+.|.|+.++++.+.+....++|.+||+.|+|.|.+.. ...++.--...++++|+.|+.|+|+..| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4678999999999999999999999999999999999987 3467777788889999999999998876 9999999999


Q ss_pred             EEcCCCCeEEeeecCcCCCcc--ccccccccCCCcccCCCcccccCCC------CCCccchHHHHHHHHHHhhCCCCCCC
Q 013421          141 LLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGY------DGSAADVWSCGVILFVLMAGYLPFGE  212 (443)
Q Consensus       141 Ll~~~~~~kL~DFGls~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~------~~~~~DIwSlGvil~~ll~G~~Pf~~  212 (443)
                      ++|....+||+|||+......  .........-..-|.|||.+.....      .+.++||||+|++++|+++...||+.
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999876532  1111122223456999999976422      24679999999999999999999976


Q ss_pred             CCh----HHHHHHhhh-ccCCCCC------CCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          213 TDL----PTLYKKINA-AEFSCPF------WFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       213 ~~~----~~~~~~i~~-~~~~~~~------~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ...    .+....+.. +...+-+      .+.+++..++++|+..+|.+||+++++..
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            322    234444444 3222222      24557899999999999999999998765

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=4e-18  Score=179.48  Aligned_cols=139  Identities=18%  Similarity=0.272  Sum_probs=112.2

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      .|...+.||+|+||.||++.+..  ..+++|+.......     .....+.+.+|+.+++.++|++++....+..+....
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34567899999999999998754  33444443221111     111235688999999999999999888777777788


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      ++||||++|++|.+++.        ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||++...
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999999998875        356789999999999999999999999999999 6789999999998753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=2.9e-18  Score=155.49  Aligned_cols=141  Identities=23%  Similarity=0.356  Sum_probs=102.4

Q ss_pred             EeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHH---------------------HHHHHHHHHhCCCC--
Q 013421           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ---------------------IKREISIMKIVRHP--   69 (443)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~---------------------~~~Ei~il~~l~Hp--   69 (443)
                      +.+.||+|+||+||+|.+. +++.||||++.............                     ...|...+..+.+.  
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999986 89999999987643221111111                     14567777777544  


Q ss_pred             CcceEEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCe
Q 013421           70 NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNL  148 (443)
Q Consensus        70 nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~  148 (443)
                      .+.+.++.    ...+++|||++|+.+........... ..++.++.+++.++.++|+ .||+||||||+||+++ ++.+
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            35555543    23589999999854432111111111 6788999999999999999 9999999999999999 8999


Q ss_pred             EEeeecCcCCCc
Q 013421          149 KVSDFGLSALPQ  160 (443)
Q Consensus       149 kL~DFGls~~~~  160 (443)
                      +|+|||.+....
T Consensus       154 ~liDfg~a~~~~  165 (187)
T cd05119         154 YIIDVPQAVEID  165 (187)
T ss_pred             EEEECccccccc
Confidence            999999986443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.72  E-value=1.5e-18  Score=183.99  Aligned_cols=261  Identities=27%  Similarity=0.449  Sum_probs=212.6

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ...+.+.+.+-+-+|+++.++.+.-..+|...++|+..+.........+.+..+-.++-...+|.++...-.+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            35677888999999999999999888888778888765443222222344444444444455676666655566778899


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc-----
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ-----  160 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~-----  160 (443)
                      ++++|..|++|...+...+..+++.++.++..+..+++|||+..+.|||++|.|++...+|+.+++|||......     
T Consensus       881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            999999999999999998989999999999999999999999999999999999999999999999998321100     


Q ss_pred             ----------------cc--c--------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC
Q 013421          161 ----------------QG--V--------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD  214 (443)
Q Consensus       161 ----------------~~--~--------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~  214 (443)
                                      ..  .        ..-....||+.|.+||.+.+... +..+|+|+.|+++++.++|.+||....
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence                            00  0        01233468999999999988765 589999999999999999999999999


Q ss_pred             hHHHHHHhhhccCCCCC---CCCHHHHHHHHHccCCCCCCCCCHH---HHhcCcccccc
Q 013421          215 LPTLYKKINAAEFSCPF---WFSTGATSLIHKILDPNPKTRIRIE---GIRKHPWFRKN  267 (443)
Q Consensus       215 ~~~~~~~i~~~~~~~~~---~~s~~~~~li~~~L~~dP~~R~t~~---eil~hp~f~~~  267 (443)
                      ....++.+.+...+.|.   ..+.++.+++.++|..+|.+|..+.   +...||||+..
T Consensus      1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence            99999999888777664   3799999999999999999999987   99999999864

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.4e-16  Score=150.41  Aligned_cols=137  Identities=23%  Similarity=0.338  Sum_probs=104.2

Q ss_pred             eeee-ccCceEEEEEEECCCCcEEEEEEeecccc----c------chHHHHHHHHHHHHHHhCCCCCc--ceEEEEEEeC
Q 013421           15 RTIG-EGTFAKVRFAQNRETGESVAMKVLAKSTI----L------KHRMVDQIKREISIMKIVRHPNI--VRLHEVLASR   81 (443)
Q Consensus        15 ~~LG-~G~~g~V~~a~~~~~~~~vAiK~i~~~~~----~------~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~   81 (443)
                      ..|| .|+.|+||.+...  +..+++|.+.....    .      .......+.+|+.++..|+|++|  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 7777888877653  77899998864321    0      11123567899999999998875  6677664332


Q ss_pred             -CE---EEEEEecCCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           82 -TK---VYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        82 -~~---~~lv~Ey~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                       ..   .++||||++| .+|.+++.. ..+++..    +.||+.+|.+||+.||+||||||+|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence             22   3599999997 688887754 4566543    578999999999999999999999999999999999999987


Q ss_pred             CC
Q 013421          157 AL  158 (443)
Q Consensus       157 ~~  158 (443)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            64

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=2.5e-16  Score=136.15  Aligned_cols=133  Identities=20%  Similarity=0.300  Sum_probs=113.4

Q ss_pred             EeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEec
Q 013421           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH--PNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      +++.||+|.++.||++....  ..+++|.+.....     ...+.+|+..++.++|  .++++++.+....+..|++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            46789999999999999753  7899999865432     3568899999999976  5899999998888899999999


Q ss_pred             CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           91 VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK---GVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        91 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~---gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      ++|+.+...       +......++.+++.++.++|..   +++|+|++|+||+++..+.++++|||.+...
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            998877543       5566778899999999999985   7999999999999999899999999987643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=4.1e-16  Score=158.12  Aligned_cols=251  Identities=21%  Similarity=0.224  Sum_probs=191.4

Q ss_pred             CeEEeeeeec--cCceEEEEEEE--CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013421           10 KYEVGRTIGE--GTFAKVRFAQN--RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (443)
Q Consensus        10 ~y~i~~~LG~--G~~g~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~   84 (443)
                      .+-+.+.+|.  |.+|.||.+..  ..++..+|+|.-+....... ....=.+|+.-.+.+ .|+|.++.+..++..+..
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~-~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL-DSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc-ccccccchhhcccccCccccccccCcccccCCcc
Confidence            3556788999  99999999998  88999999997443322111 112234566666666 599999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCCEeecCCCCcEEEcCC-CCeEEeeecCcCC
Q 013421           85 YIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID----AVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSAL  158 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~----aL~yLH~~gi~HrDlkp~NILl~~~-~~~kL~DFGls~~  158 (443)
                      |+-+|+| +.+|..+...... +++..++.++.+...    ||.++|+.+++|-|+||.||++..+ ...+++|||+...
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~  272 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK  272 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence            9999999 5778777766555 889999999999999    9999999999999999999999998 8899999999876


Q ss_pred             Ccccccc-----ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC---ChHHHHHHhhhccCCCC
Q 013421          159 PQQGVEL-----LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---DLPTLYKKINAAEFSCP  230 (443)
Q Consensus       159 ~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~  230 (443)
                      ...+.-.     ....-|...|++||...+  ..+...||+|+|.++.+-.+|..++...   .+.+..+..  -...+-
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--ip~e~~  348 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--IPLEFC  348 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--Cchhhh
Confidence            6543211     122257788999999864  3458999999999999888876655332   222111111  011112


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      ...+.++...+..|++.+|..|++++.++.|+++..
T Consensus       349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            235777788999999999999999999999999863

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.59  E-value=1.4e-15  Score=157.75  Aligned_cols=148  Identities=21%  Similarity=0.404  Sum_probs=104.1

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc--------------------------c-h----HHHH
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL--------------------------K-H----RMVD   54 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--------------------------~-~----~~~~   54 (443)
                      ..+..|+. +.||+|++|+||.|+.+.+|+.||||+.......                          + .    +..+
T Consensus       117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~  195 (537)
T PRK04750        117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK  195 (537)
T ss_pred             HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence            34566777 8999999999999999888999999999754200                          0 0    1122


Q ss_pred             H------HHHHHHHHHhCC----CCCcceEEEEEEe-CCEEEEEEecCCCCChHHH--HHhcC----CCCHHHHHHHHHH
Q 013421           55 Q------IKREISIMKIVR----HPNIVRLHEVLAS-RTKVYIILEFVTGGELFDK--IVHQG----RLLENDCRRYFQQ  117 (443)
Q Consensus        55 ~------~~~Ei~il~~l~----HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~--i~~~~----~l~e~~~~~~~~q  117 (443)
                      .      +.+|...+.++.    +.+.+.+-.++.+ .+..++||||++|+.+.+.  +...+    .+.+..+..++.|
T Consensus       196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence            2      334444444442    4444444444432 4567899999999999764  33333    2455556666777


Q ss_pred             HHHHHHHHHhCCCEeecCCCCcEEEcCCC----CeEEeeecCcCCCcc
Q 013421          118 LIDAVAHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQ  161 (443)
Q Consensus       118 ll~aL~yLH~~gi~HrDlkp~NILl~~~~----~~kL~DFGls~~~~~  161 (443)
                      ++       ..|++|+|+||.||+++.+|    .++++|||++.....
T Consensus       276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            65       58999999999999999888    999999999876544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=3.5e-14  Score=145.33  Aligned_cols=143  Identities=22%  Similarity=0.318  Sum_probs=98.2

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccc---------------------------hH----HHH------HHH
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK---------------------------HR----MVD------QIK   57 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~---------------------------~~----~~~------~~~   57 (443)
                      +.||+|++|+||+|+.. +|+.||||+........                           ..    ...      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            67999999999999975 78999999986432000                           00    001      244


Q ss_pred             HHHHHHHhCC----CCCcceEEEEE-EeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 013421           58 REISIMKIVR----HPNIVRLHEVL-ASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLID-AVAHCHSKGV  130 (443)
Q Consensus        58 ~Ei~il~~l~----HpnIv~l~~~~-~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~-aL~yLH~~gi  130 (443)
                      +|...+.++.    |.+-+.+-.++ ...+..++||||++|++|.+..... ...   ....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            5566555552    32222322222 2334578999999999998876432 122   23345555555 4678899999


Q ss_pred             EeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421          131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus       131 ~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      +|+|+||.||+++.+|.++++|||++.....
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999876543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.55  E-value=1.3e-13  Score=141.32  Aligned_cols=238  Identities=17%  Similarity=0.224  Sum_probs=162.3

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      .+.-.|.+ ...+-++.+....|..+.++.+|.|.+.+...-   .....+.+-+.-|+.++||||+++++.++..+.+|
T Consensus        10 ~~~fpY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~y   85 (690)
T KOG1243|consen   10 SSQFPYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLY   85 (690)
T ss_pred             cccCCccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceE
Confidence            34445666 333333333332455667889999998876542   34567888899999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH-~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      +|+|.+.  .|-.++.+.+   ......-+.||+.||.||| +.+++|++|.-..|+++..|..||++|.++........
T Consensus        86 lvTErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~  160 (690)
T KOG1243|consen   86 LVTERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA  160 (690)
T ss_pred             EEeeccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc
Confidence            9999884  4455665533   6677778899999999998 56899999999999999999999999998764433221


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHc
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (443)
                      ......---.|..|+.+....   -..|.|-|||++++++.|.  +....           +...+..++.....+..+-
T Consensus       161 ~~~~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~--~~~~~-----------~~~~~~~ipk~~~~~~~k~  224 (690)
T KOG1243|consen  161 PAKSLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGS--LLTKT-----------DLSNTGKIPKALIELYCKK  224 (690)
T ss_pred             ccccchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcc--cCcch-----------hhhccCccchhHHHHHHHH
Confidence            111222222466777653221   3579999999999999993  32221           1122223344444455444


Q ss_pred             cCCCCCCCCCH-----HHHhcCccccccC
Q 013421          245 LDPNPKTRIRI-----EGIRKHPWFRKNY  268 (443)
Q Consensus       245 L~~dP~~R~t~-----~eil~hp~f~~~~  268 (443)
                      +--.+..||..     +-.+-|+||++.+
T Consensus       225 ~~~~~~~r~n~~~~~~~~~~~~gff~n~f  253 (690)
T KOG1243|consen  225 LGATELKRPNKLRFILECRLLGGFFRNDF  253 (690)
T ss_pred             hccccccccchhhHHHHHHhccccccchH
Confidence            44555666653     2335589988764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=2e-14  Score=135.70  Aligned_cols=203  Identities=16%  Similarity=0.264  Sum_probs=145.9

Q ss_pred             HHHHHHHhCCCCCcceEEEEEEeC-----CEEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC
Q 013421           58 REISIMKIVRHPNIVRLHEVLASR-----TKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSK  128 (443)
Q Consensus        58 ~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~yLH~~  128 (443)
                      .-...+-++.|.||++++.++.+.     ....++.||++.|++..++++.    ..+......+|+.||+.||.|||+.
T Consensus       116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            334556677899999999998643     4588999999999999999763    4578889999999999999999997


Q ss_pred             --CCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc----ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHH
Q 013421          129 --GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ----GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFV  202 (443)
Q Consensus       129 --gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~  202 (443)
                        -|+|+++...-|++..+|-+|+.--........    .........|-++|.|||.=..... ..++|||++|.-..+
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALE  274 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHH
Confidence              499999999999999999999853322211111    0011122346788999997544333 368999999999999


Q ss_pred             HhhCCCC-CCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          203 LMAGYLP-FGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       203 ll~G~~P-f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      |..|..- -...+.......+.+.-+...   .+.-++++.+||+..|..||++.+++.||-.
T Consensus       275 mailEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpll  334 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLL  334 (458)
T ss_pred             HHHheeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCcee
Confidence            9888643 222222222222322222111   1223678999999999999999999999975

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=9.5e-15  Score=148.29  Aligned_cols=253  Identities=22%  Similarity=0.179  Sum_probs=193.1

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEEC-CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNR-ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   83 (443)
                      ...++|..+..||.|.|+.|+....+ .++..|++|...+........+.. ..|+-+...+ .|.|++.++..|.....
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccccc
Confidence            45678999999999999999987655 678899999887655444332222 3566666666 69999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC-CCeEEeeecCcCCCccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQG  162 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~-~~~kL~DFGls~~~~~~  162 (443)
                      .|+-.|||+++++...+.-...+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..+++|||..+.....
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence            99999999999887777666678899999999999999999999999999999999999886 78899999988642221


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCC-CCCCChHHHHHHhhhccCCCCCCCCHHHHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLYKKINAAEFSCPFWFSTGATSLI  241 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P-f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li  241 (443)
                      ..  ...-++..|-.+|++........++|++|||.-+.+..+|..- +...    ....+..+..+..+..+.++..+.
T Consensus       421 ~~--~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~~q~~~  494 (524)
T KOG0601|consen  421 SG--VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQLQVLL  494 (524)
T ss_pred             cc--cccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHhhhhhh
Confidence            11  1111223342345554444446899999999999999988633 2222    223355565666666668889999


Q ss_pred             HHccCCCCCCCCCHHHHhcCcccc
Q 013421          242 HKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      +.++.+++..|+.+.++..|+-|.
T Consensus       495 kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  495 KVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhcCCccccchhhhhhcccchhh
Confidence            999999999999999999988664

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.50  E-value=3.6e-13  Score=122.28  Aligned_cols=143  Identities=17%  Similarity=0.228  Sum_probs=105.6

Q ss_pred             eeeeeccCceEEEEEEECC------CCcEEEEEEeecccc-------------------cchHHHHHH----HHHHHHHH
Q 013421           14 GRTIGEGTFAKVRFAQNRE------TGESVAMKVLAKSTI-------------------LKHRMVDQI----KREISIMK   64 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~------~~~~vAiK~i~~~~~-------------------~~~~~~~~~----~~Ei~il~   64 (443)
                      ...||.|.-+.||.|....      .+..+|+|+......                   .+......+    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998654      357999999753210                   001112233    48999999


Q ss_pred             hCCC--CCcceEEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCEeecCCCCcEE
Q 013421           65 IVRH--PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC-HSKGVYHRDLKPENLL  141 (443)
Q Consensus        65 ~l~H--pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yL-H~~gi~HrDlkp~NIL  141 (443)
                      ++..  -++.+++++    ..-++||||+.++.+......+..+++..+..++.|++.++..| |+.|++||||+|.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            9953  567777765    45679999997755533333334566677788899999999999 8999999999999999


Q ss_pred             EcCCCCeEEeeecCcCCCcc
Q 013421          142 LDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus       142 l~~~~~~kL~DFGls~~~~~  161 (443)
                      ++ +|.+.|+|||.+.....
T Consensus       158 ~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EE-CCcEEEEECCCceeCCC
Confidence            97 47899999998765443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=4.5e-13  Score=119.19  Aligned_cols=127  Identities=20%  Similarity=0.272  Sum_probs=96.8

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEecCC
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYIILEFVT   92 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey~~   92 (443)
                      ++.|+.|.++.||++...  +..|++|+......    ....+.+|+.+++.+.+.++ .+++....  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            467899999999999864  77899998765431    12345789999998865554 45555433  33579999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-----EeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421           93 GGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV-----YHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus        93 gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi-----~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      |.++.+.        ......++.+++.+|..||+.++     +|+|++|+||+++ ++.++++|||.+.
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9877543        11223467899999999999985     9999999999999 6789999999865

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs)

Probab=99.42  E-value=3.8e-13  Score=97.29  Aligned_cols=61  Identities=41%  Similarity=0.795  Sum_probs=49.0

Q ss_pred             CcccchhhhhccCCCCCCcccCccccc-cccceeeEEeCCCHHHHHHHHHHHHHHcCcEEEe
Q 013421          307 PLLMNAFEMITLSQGLNLAALFDRRQD-YVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHT  367 (443)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~  367 (443)
                      |..+|||++|++|+++||++||+..++ .+++.+||+|+.|++.|+++||++++.+|+.|++
T Consensus         2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K   63 (63)
T PF03822_consen    2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK   63 (63)
T ss_dssp             -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred             CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence            667999999999999999999987554 3578999999999999999999999999999875

Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=7.6e-11  Score=104.09  Aligned_cols=136  Identities=19%  Similarity=0.275  Sum_probs=100.6

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHH-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM-----VDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      ..+++|+-+.+|.+...  |.++++|.=.+.....++.     .+.-.+|..++..+.--.|...+=+..+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            35789999999998663  4456666532222222221     2345689999998876666555555566777789999


Q ss_pred             cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      |.+|..|.+.+...       ...++..+=.-+.-||..||+|+||.++||++... .+.++||||+....
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s~  142 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSD  142 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccccc
Confidence            99999998888765       24566777777889999999999999999999874 49999999987543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=4.7e-11  Score=110.61  Aligned_cols=140  Identities=19%  Similarity=0.321  Sum_probs=106.8

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CEEEEEEe
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH--PNIVRLHEVLASR---TKVYIILE   89 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~lv~E   89 (443)
                      +.||.|..+.||++...+ |+.+++|+.......  .....+.+|..+++.+.+  .++.+++.+....   +..+++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            678999999999998743 688999998654321  123567899999999975  4467777776654   36789999


Q ss_pred             cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 013421           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS------------------------------------------  127 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~------------------------------------------  127 (443)
                      |++|.++.+.+.. ..+++.....++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888765432 356667777777777777777773                                          


Q ss_pred             --------------CCCEeecCCCCcEEEcC--CCCeEEeeecCcCC
Q 013421          128 --------------KGVYHRDLKPENLLLDS--YGNLKVSDFGLSAL  158 (443)
Q Consensus       128 --------------~gi~HrDlkp~NILl~~--~~~~kL~DFGls~~  158 (443)
                                    ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          24699999999999998  56789999997764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.22  E-value=3.4e-10  Score=113.33  Aligned_cols=211  Identities=18%  Similarity=0.246  Sum_probs=158.7

Q ss_pred             ceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCEEEEEEecCCC-CCh
Q 013421           22 FAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA----SRTKVYIILEFVTG-GEL   96 (443)
Q Consensus        22 ~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~~~~lv~Ey~~g-g~L   96 (443)
                      -.+.|++....+|..|++|.++-......   .....-+++++++.|+|+|++.+++.    .+..+++|++|.++ ++|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            46789999999999999999965443322   22345578899999999999999986    34578999999875 677


Q ss_pred             HHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           97 FDKIVH---------------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        97 ~~~i~~---------------~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      .++--.               ..+.+|...|.|+.||..||.++|+.|.+-+-|.|.+||++.+.+++|+..|...+...
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            765532               23468899999999999999999999999999999999999988999988887665544


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh-HHH-HHHhhhccCCCCCCCCHHHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTL-YKKINAAEFSCPFWFSTGATS  239 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~-~~~i~~~~~~~~~~~s~~~~~  239 (443)
                      +.            .  |-+.+.    .+-|.=-||.+++.|.+|..--...+. ... .+.|.       ..+|.++++
T Consensus       446 d~------------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-------~~yS~D~rn  500 (655)
T KOG3741|consen  446 DP------------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-------TTYSTDLRN  500 (655)
T ss_pred             CC------------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-------hhhhHHHHH
Confidence            31            0  112211    567888999999999999643211221 111 12222       236899999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcC
Q 013421          240 LIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +|.-+...++.. -++.+++.|
T Consensus       501 ~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  501 VVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHhcCccc-ccHHHHHHH
Confidence            999999999887 788888876

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=9.1e-12  Score=128.50  Aligned_cols=152  Identities=22%  Similarity=0.355  Sum_probs=114.8

Q ss_pred             HHHHHHHHHHHhC-CCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc---------cccccCCCcccCCCcccccCC
Q 013421          116 QQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---------LLHTTCGTPNYVAPEVLSNRG  185 (443)
Q Consensus       116 ~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~  185 (443)
                      .+...|+.|+|+. +++|++|.|++|.++.+|..||+.|+++.....+..         ......-...|.|||++.+ .
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~  184 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T  184 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence            3444899999976 899999999999999999999999998754333111         1111223557999999987 4


Q ss_pred             CCCCccchHHHHHHHHHHh-hCCCCCCCCChHHHHHH----hhhccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          186 YDGSAADVWSCGVILFVLM-AGYLPFGETDLPTLYKK----INAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       186 ~~~~~~DIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ..+.++|+||+||++|.+. .|+..+...+....+..    ...+.+..+..+++++++=+.++|..++..||++.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence            4568999999999999999 56666655433222211    122234455678999999999999999999999999999


Q ss_pred             CccccccC
Q 013421          261 HPWFRKNY  268 (443)
Q Consensus       261 hp~f~~~~  268 (443)
                      -|||....
T Consensus       265 ~~ff~D~~  272 (700)
T KOG2137|consen  265 IPFFSDPG  272 (700)
T ss_pred             ccccCCch
Confidence            99998653

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.19  E-value=3.6e-10  Score=99.50  Aligned_cols=145  Identities=22%  Similarity=0.271  Sum_probs=108.9

Q ss_pred             EeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchH-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR-----MVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .+..+-+|+-+.|+.+..  .|+...||.=.......+.     .....++|++++.++.--.|.-..-++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            568899999999999876  5888888753222221111     224578899999998766776666667777777899


Q ss_pred             EecCCC-CChHHHHHhcC-CCCHHHH-HHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC---CeEEeeecCcCCC
Q 013421           88 LEFVTG-GELFDKIVHQG-RLLENDC-RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALP  159 (443)
Q Consensus        88 ~Ey~~g-g~L~~~i~~~~-~l~e~~~-~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~~  159 (443)
                      |||.+| .++.+++.... .-.++.. ..++++|-+.+.-||..+|+|+||..+||++..+|   ++.++|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999987 46777776543 2333333 78889999999999999999999999999997655   3589999998654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.06  E-value=4.7e-09  Score=100.46  Aligned_cols=136  Identities=17%  Similarity=0.060  Sum_probs=95.7

Q ss_pred             cCceEEEEEEECCCCcEEEEEEeecccccc---h-----HHHHHHHHHHHHHHhCCCCCc--ceEEEEEEe-----CCEE
Q 013421           20 GTFAKVRFAQNRETGESVAMKVLAKSTILK---H-----RMVDQIKREISIMKIVRHPNI--VRLHEVLAS-----RTKV   84 (443)
Q Consensus        20 G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~---~-----~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~-----~~~~   84 (443)
                      .....|.....  .|+.|.||.........   .     .-.....+|...+..|..-+|  +.++.+.+.     ....
T Consensus        33 ~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s  110 (268)
T PRK15123         33 LEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTS  110 (268)
T ss_pred             CCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcccee
Confidence            33344555543  57789999764322110   0     001136789998888843333  344444432     2357


Q ss_pred             EEEEecCCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-------CCCeEEeeec
Q 013421           85 YIILEFVTGG-ELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-------YGNLKVSDFG  154 (443)
Q Consensus        85 ~lv~Ey~~gg-~L~~~i~~--~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-------~~~~kL~DFG  154 (443)
                      ++|||++++. +|.+++..  ....++.....++.++...+.-||+.||+|+|++|.|||++.       ++.+.|+||+
T Consensus       111 ~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        111 FIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             EEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            8999999886 78888754  345667788899999999999999999999999999999975       4679999999


Q ss_pred             CcC
Q 013421          155 LSA  157 (443)
Q Consensus       155 ls~  157 (443)
                      .+.
T Consensus       191 r~~  193 (268)
T PRK15123        191 RAQ  193 (268)
T ss_pred             ccc
Confidence            775

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.06  E-value=4.3e-09  Score=103.20  Aligned_cols=237  Identities=16%  Similarity=0.208  Sum_probs=154.0

Q ss_pred             EEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEE------EEe-CCE
Q 013421           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEV------LAS-RTK   83 (443)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~------~~~-~~~   83 (443)
                      ..++.||+|+-+.+|-.-.  -+. .+.|++++......   .   +-+..|... .||-+-.=+.+      ..+ ...
T Consensus        14 ~~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecch--hhc-hhheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            3467899999999996532  222 35588887653221   1   123333333 45543321111      012 223


Q ss_pred             EEEEEecCCCCChHHHHHh----c---CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           84 VYIILEFVTGGELFDKIVH----Q---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~----~---~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                      +.+.|..++|..--..+.+    .   .....+-..+..+.|+.+...||..|..-+|++++|+|+++++.+.|.|-..-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            7899999887643222221    1   12456778889999999999999999999999999999999999999886533


Q ss_pred             CCCccccccccccCCCcccCCCcccccCCC----CCCccchHHHHHHHHHHhhC-CCCCCCCC----hH-HHHHHhhhcc
Q 013421          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGY----DGSAADVWSCGVILFVLMAG-YLPFGETD----LP-TLYKKINAAE  226 (443)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~----~~~~~DIwSlGvil~~ll~G-~~Pf~~~~----~~-~~~~~i~~~~  226 (443)
                      .+.. ........+|.+.|.+||.-.-..+    .+...|.|.||+++|++|.| ++||.+-.    .. .....|..+.
T Consensus       165 qi~~-ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         165 QINA-NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eecc-CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            3322 2345567789999999997542211    13679999999999999986 99996421    01 1111222222


Q ss_pred             C-----------CCC---CC--CCHHHHHHHHHccCC--CCCCCCCHHHH
Q 013421          227 F-----------SCP---FW--FSTGATSLIHKILDP--NPKTRIRIEGI  258 (443)
Q Consensus       227 ~-----------~~~---~~--~s~~~~~li~~~L~~--dP~~R~t~~ei  258 (443)
                      +           +.|   +|  +++++..|..+|+..  +|.-|||++..
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW  293 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW  293 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence            1           111   22  789999999999976  46789998653

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.02  E-value=2e-09  Score=97.45  Aligned_cols=128  Identities=20%  Similarity=0.336  Sum_probs=84.1

Q ss_pred             EEEEEEECCCCcEEEEEEeecccc-----------------------cchHHHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 013421           24 KVRFAQNRETGESVAMKVLAKSTI-----------------------LKHRMVDQIKREISIMKIVRHP--NIVRLHEVL   78 (443)
Q Consensus        24 ~V~~a~~~~~~~~vAiK~i~~~~~-----------------------~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~   78 (443)
                      .||.|... .|+.+|+|+......                       ...-......+|.+.|.++..-  ++.+++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48999874 578999999753210                       0011234578999999999765  567777553


Q ss_pred             EeCCEEEEEEecCC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCCEeecCCCCcEEEcCCCCeEEeeecC
Q 013421           79 ASRTKVYIILEFVT--GGELFDKIVHQGRLLENDCRRYFQQLIDAVAH-CHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (443)
Q Consensus        79 ~~~~~~~lv~Ey~~--gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~y-LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (443)
                          .-+|||||++  |..+.. +.. ..++.+....++.+++..+.. +|+.||+|+||.+.||+++++ .+.++|||.
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~-~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKD-VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHH-CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ----CCEEEEEecCCCccchhh-HHh-ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence                2369999998  544433 333 222245677788888886665 579999999999999999986 999999998


Q ss_pred             cCCC
Q 013421          156 SALP  159 (443)
Q Consensus       156 s~~~  159 (443)
                      +...
T Consensus       153 av~~  156 (188)
T PF01163_consen  153 AVDS  156 (188)
T ss_dssp             EEET
T ss_pred             ceec
Confidence            7543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.01  E-value=3.4e-09  Score=99.08  Aligned_cols=138  Identities=20%  Similarity=0.304  Sum_probs=105.8

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc-----------------c--hHHHHHHHHHHHHHHhCCCC--
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----------------K--HRMVDQIKREISIMKIVRHP--   69 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----------------~--~~~~~~~~~Ei~il~~l~Hp--   69 (443)
                      +.++..||-|.-|.||.|.+. .|.++|||.-......                 +  .-.....++|..+|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            457789999999999999986 6899999985321100                 0  00124467899999999654  


Q ss_pred             CcceEEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeE
Q 013421           70 NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLK  149 (443)
Q Consensus        70 nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~k  149 (443)
                      .+.+.+++    +.-.+||||++|-.|...     +++.+.+..++..|+.-+.-+-..||+|+|+++-||+++++|.+.
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            77777765    566799999999877542     234566677777777777777799999999999999999999999


Q ss_pred             EeeecCcCC
Q 013421          150 VSDFGLSAL  158 (443)
Q Consensus       150 L~DFGls~~  158 (443)
                      ++||-.+..
T Consensus       243 vIDwPQ~v~  251 (304)
T COG0478         243 VIDWPQAVP  251 (304)
T ss_pred             EEeCccccc
Confidence            999975543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=4.2e-08  Score=90.51  Aligned_cols=105  Identities=25%  Similarity=0.367  Sum_probs=84.5

Q ss_pred             HHHHHHHHHHHhCCC--CCcceEEEEEEeC----CEEEEEEecCCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 013421           54 DQIKREISIMKIVRH--PNIVRLHEVLASR----TKVYIILEFVTGG-ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH  126 (443)
Q Consensus        54 ~~~~~Ei~il~~l~H--pnIv~l~~~~~~~----~~~~lv~Ey~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH  126 (443)
                      ....+|...+..|..  -..++.+.+....    ...++|+|+++|. +|.+++......+......++.++...+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            457788888887753  3345555555442    2468999999884 78888887555777888999999999999999


Q ss_pred             hCCCEeecCCCCcEEEcCCC---CeEEeeecCcCC
Q 013421          127 SKGVYHRDLKPENLLLDSYG---NLKVSDFGLSAL  158 (443)
Q Consensus       127 ~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~  158 (443)
                      ..||+|+|++|.|||++.++   .+.++||+.+..
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999999887   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.72  E-value=1.6e-07  Score=86.22  Aligned_cols=138  Identities=17%  Similarity=0.261  Sum_probs=91.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHH------HHHHHHHHHhCCC---CCcceEEEEE-
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ------IKREISIMKIVRH---PNIVRLHEVL-   78 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------~~~Ei~il~~l~H---pnIv~l~~~~-   78 (443)
                      ++|.+.+.+-......|.+..-  +|..+++|.........++....      ..+++..+.+++.   .....++-+. 
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            5688888888888777776653  57889999876544222222221      2344444444432   2333333222 


Q ss_pred             ----EeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeec
Q 013421           79 ----ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG  154 (443)
Q Consensus        79 ----~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFG  154 (443)
                          .-....+++|||++|..|.+...    +++    .+...+.+++.-+|+.|+.|+|.+|.|+++++ +.++++||+
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID~~  179 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIIDTQ  179 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEECc
Confidence                22244568999999988866432    233    24466778899999999999999999999986 459999998


Q ss_pred             CcC
Q 013421          155 LSA  157 (443)
Q Consensus       155 ls~  157 (443)
                      ...
T Consensus       180 ~k~  182 (229)
T PF06176_consen  180 GKR  182 (229)
T ss_pred             ccc
Confidence            653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.69  E-value=2.9e-07  Score=84.17  Aligned_cols=138  Identities=12%  Similarity=0.113  Sum_probs=99.0

Q ss_pred             eccCceEEEEEEECCCCcEEEEEEeecccccc---hHHHHHHHHHHHHHHhCCCC--CcceEEEEE--Ee--CCEEEEEE
Q 013421           18 GEGTFAKVRFAQNRETGESVAMKVLAKSTILK---HRMVDQIKREISIMKIVRHP--NIVRLHEVL--AS--RTKVYIIL   88 (443)
Q Consensus        18 G~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~--~~--~~~~~lv~   88 (443)
                      |+|+.|.|+.....  |..+-+|.-.......   ..-...+.+|+..+..|..-  .+.++...-  ..  .-.-+||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            56899999987653  4468888754211110   11236788999999988532  244444211  11  22467999


Q ss_pred             ecCCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC--eEEeeecCcC
Q 013421           89 EFVTG-GELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN--LKVSDFGLSA  157 (443)
Q Consensus        89 Ey~~g-g~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~--~kL~DFGls~  157 (443)
                      |-+.| -+|.+++...  .+.++.....++.++...+.-||+.|+.|+|+.|.||+++.+|.  ++++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97754 5787777653  35577888899999999999999999999999999999987777  9999997554

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.66  E-value=4.3e-07  Score=84.32  Aligned_cols=141  Identities=18%  Similarity=0.235  Sum_probs=101.2

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchH---------------------HHHHHHHHHHHHHhCC--CCC
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---------------------MVDQIKREISIMKIVR--HPN   70 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~---------------------~~~~~~~Ei~il~~l~--Hpn   70 (443)
                      ...|+.|.-+.||+|.. .++..+|+|++......-..                     ......+|+..|+++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34677888889999976 46889999998643321111                     1123567888898884  556


Q ss_pred             cceEEEEEEeCCEEEEEEecCCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCe
Q 013421           71 IVRLHEVLASRTKVYIILEFVTGGEL-FDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNL  148 (443)
Q Consensus        71 Iv~l~~~~~~~~~~~lv~Ey~~gg~L-~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~  148 (443)
                      +.+.+.+..    -.+||||+..... .-.+. ..++..+++..+..+++..+.-|-. .|++|+||+.-|||+. +|.+
T Consensus       132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCCceeecC----CeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            677777653    3589999954311 11111 2334444789999999999998877 8999999999999999 7999


Q ss_pred             EEeeecCcCCCcc
Q 013421          149 KVSDFGLSALPQQ  161 (443)
Q Consensus       149 kL~DFGls~~~~~  161 (443)
                      .++|||-+....+
T Consensus       206 ~iID~~QaV~~~h  218 (268)
T COG1718         206 YIIDVSQAVTIDH  218 (268)
T ss_pred             EEEECccccccCC
Confidence            9999998765543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.65  E-value=2.5e-09  Score=109.59  Aligned_cols=239  Identities=20%  Similarity=0.200  Sum_probs=165.4

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEe
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lv~E   89 (443)
                      |....-+++|+++++++.+...+...+ .+.+...        ....-++++|.+++||| .+..++-++.++..++.++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            556677899999999998876555544 5655432        34556899999999999 7777777788889999999


Q ss_pred             cCCCC-ChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           90 FVTGG-ELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        90 y~~gg-~L~~~i-~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      ++.++ +-.... ...-.+.+-+.....+.-+.+++++|+.--+|||    ||+..+ +..|..||+......... ...
T Consensus       315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~  388 (829)
T KOG0576|consen  315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPR  388 (829)
T ss_pred             hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccc
Confidence            99887 221111 1111233334445566777899999998878998    777665 788999999776544332 345


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC------CCCCHHHHHHH
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP------FWFSTGATSLI  241 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~------~~~s~~~~~li  241 (443)
                      +..+++.++|||+.....++ ...|.||+|+--.++--|.+|-..+-.  ....+.. ....|      .|-+..-.++.
T Consensus       389 t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~-~p~s~~L~~~~aw~~~~~~~~~  464 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGN-GPNSPMLTDKSAWSPVFHRDFP  464 (829)
T ss_pred             cCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCC-CCCccccchhhhcCcccccCCc
Confidence            77899999999999888876 789999999877777777777533110  0000000 00011      11111223577


Q ss_pred             HHccCCCCCCCCCHHHHhcCccccccC
Q 013421          242 HKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ..|+..-|..|+....++.|.+|....
T Consensus       465 ~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  465 APCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             ccccCCCCCCCcchhhHHHHHHhccCc
Confidence            889999999999999999999987543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.59  E-value=5.2e-07  Score=98.54  Aligned_cols=203  Identities=19%  Similarity=0.203  Sum_probs=146.3

Q ss_pred             HHHHHHHHHHhCCCCCcceEEEEEEeCCE----EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 013421           55 QIKREISIMKIVRHPNIVRLHEVLASRTK----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV  130 (443)
Q Consensus        55 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi  130 (443)
                      ...-|+..+..+.|+|++.++.+-.....    ..+..|+|++.++...+..-+..+.+..+.+..+++.|+.|+|+...
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            34456666778899999999988754333    33455899999999999999999999999999999999999999976


Q ss_pred             EeecCCCC---cEEEcCCCCeEEe--eecCcCCCccccccccccCCCcccCCCcccccCCCC-CCccchHHHHHHHHHHh
Q 013421          131 YHRDLKPE---NLLLDSYGNLKVS--DFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD-GSAADVWSCGVILFVLM  204 (443)
Q Consensus       131 ~HrDlkp~---NILl~~~~~~kL~--DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~~DIwSlGvil~~ll  204 (443)
                      .|.-+...   +-..+..+.+.++  ||+.+...... .......-+..+.|||......+. +...|+|++|..+..+.
T Consensus       308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~-~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN-EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             ceeEEecccccccccCccceeecchhhhcccccCCCc-ccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence            66665555   4444566677776  88877655443 222333445678888888665554 22369999999999999


Q ss_pred             hCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          205 AGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       205 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .|..+-....   ....+..      ........+.+.+|+..++++|+++.+++.|||.+..
T Consensus       387 ~~~~i~~~~~---~~~~~l~------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  387 QGEDISEKSA---VPVSLLD------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             hcCccccccc---chhhhhc------cccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence            8875432111   1111111      1112267889999999999999999999999998643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.59  E-value=8.6e-07  Score=82.99  Aligned_cols=133  Identities=16%  Similarity=0.143  Sum_probs=84.7

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceEEEEEEeCCEEEEEEecCC
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLHEVLASRTKVYIILEFVT   92 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lv~Ey~~   92 (443)
                      ..+|+|..+.||+.    .+..+++|......     ....+.+|.++++.+..-  .+.+.+.+..+.+..+++||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            56899999999973    24567889876432     124578999999998643  35778888888888899999999


Q ss_pred             CCC-hH--------------HHHHh------cC---CCCHHH-HHHHHHHH----------HH-HHHHHHh----CCCEe
Q 013421           93 GGE-LF--------------DKIVH------QG---RLLEND-CRRYFQQL----------ID-AVAHCHS----KGVYH  132 (443)
Q Consensus        93 gg~-L~--------------~~i~~------~~---~l~e~~-~~~~~~ql----------l~-aL~yLH~----~gi~H  132 (443)
                      |.+ +.              ..+..      .-   ..+... ...+..++          .. ...+|.+    ..++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            863 11              11110      00   111100 11111111          11 1122221    24789


Q ss_pred             ecCCCCcEEEcCCCCeEEeeecCcC
Q 013421          133 RDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus       133 rDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      +|+.|.||++++++ +.++||+.+.
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcC
Confidence            99999999999888 9999999765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.53  E-value=1.5e-06  Score=80.68  Aligned_cols=137  Identities=18%  Similarity=0.309  Sum_probs=83.1

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceEEEEE---EeCCEEEEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLHEVL---ASRTKVYIIL   88 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~---~~~~~~~lv~   88 (443)
                      ++.|+.|..+.||++....  ..+++|.....     .....+.+|..+++.+...  .+.+++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            4789999999999998764  58999987543     2456788999999888533  356666644   3344689999


Q ss_pred             ecCCCCChHH----------------HHH---hc----CCCCHHHH--H----HH---------------HHHHHH-HHH
Q 013421           89 EFVTGGELFD----------------KIV---HQ----GRLLENDC--R----RY---------------FQQLID-AVA  123 (443)
Q Consensus        89 Ey~~gg~L~~----------------~i~---~~----~~l~e~~~--~----~~---------------~~qll~-aL~  123 (443)
                      ++++|..+..                .+.   ..    .+......  .    ..               ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987766                111   11    01111000  0    00               111222 233


Q ss_pred             HHHh-------CCCEeecCCCCcEEEc-CCCCeEEeeecCcC
Q 013421          124 HCHS-------KGVYHRDLKPENLLLD-SYGNLKVSDFGLSA  157 (443)
Q Consensus       124 yLH~-------~gi~HrDlkp~NILl~-~~~~~kL~DFGls~  157 (443)
                      .+++       .+++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            3332       3599999999999999 66777899998653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.49  E-value=5.7e-07  Score=93.28  Aligned_cols=138  Identities=23%  Similarity=0.363  Sum_probs=92.7

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeeccc---------------------------ccchHH----HH------HHH
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKST---------------------------ILKHRM----VD------QIK   57 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~---------------------------~~~~~~----~~------~~~   57 (443)
                      ..|+.++-|+||.|+.. +|+.||||+....-                           ..-.+.    .+      .+.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67899999999999986 49999999964321                           000111    11      134


Q ss_pred             HHHHHHHhCC-----CCCcceEEEEEEeCCEEEEEEecCCCCChHHHH--HhcCCCCHHH-----HHHHHHHHHHHHHHH
Q 013421           58 REISIMKIVR-----HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLEND-----CRRYFQQLIDAVAHC  125 (443)
Q Consensus        58 ~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i--~~~~~l~e~~-----~~~~~~qll~aL~yL  125 (443)
                      +|...+.+++     .|++.-..=+++-.+.-.++|||++|-.+.+..  .. .+.+...     +..++.|+       
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~-------  281 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQL-------  281 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHH-------
Confidence            5555555552     344333333344456678999999998887774  33 4455222     22333333       


Q ss_pred             HhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421          126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus       126 H~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      =..|+.|.|.+|.||+++.+|.+.+.|||+......
T Consensus       282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            348999999999999999999999999999876544

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.32  E-value=1.5e-08  Score=112.17  Aligned_cols=257  Identities=15%  Similarity=0.079  Sum_probs=178.6

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeec---ccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA--   79 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--   79 (443)
                      .+.+..|++.-.+|.|.+++-..-+.+..  -+.+|+...   +...+ ...+.+..|..-++...|+++...+.-..  
T Consensus      1225 ~s~~e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~Lse-Plkemll~e~de~~~~~h~~~~~~p~rI~ps 1301 (2724)
T KOG1826|consen 1225 FSAMEHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSE-PLKEMLLSERDELREAKHYLTEVDPLRIPPS 1301 (2724)
T ss_pred             HHHhhhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhh-HHHHhhhhhhhhhhhhhceeeecccccCCCC
Confidence            34566677766777777665433332222  234444322   22111 12344556666667778999888776553  


Q ss_pred             eCCEEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---C--CEeecCCCCcEEEcCCCCeEE
Q 013421           80 SRTKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSK---G--VYHRDLKPENLLLDSYGNLKV  150 (443)
Q Consensus        80 ~~~~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~yLH~~---g--i~HrDlkp~NILl~~~~~~kL  150 (443)
                      +....|..++|+.+|.+++.|.+.    ..+.+.-+....++.+.+..-+|+.   |  .+|+++|+-|.+|..+-++|+
T Consensus      1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~ 1381 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKL 1381 (2724)
T ss_pred             CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccc
Confidence            345578999999999999999653    3455555666666768888888875   2  789999999999999999999


Q ss_pred             eeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-CCC
Q 013421          151 SDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSC  229 (443)
Q Consensus       151 ~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~  229 (443)
                      +++|+.++............+++.|++|++...-.+. .++|||+.|+-+|.+..|..||-......+...+.+.. .+.
T Consensus      1382 gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sI 1460 (2724)
T KOG1826|consen 1382 GKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSI 1460 (2724)
T ss_pred             cccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccc
Confidence            9999998555544555677789999999988766664 56999999999999999998885444333333343332 344


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       230 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      +...|.++-.....+|-..-..||.-..++.-|.|.
T Consensus      1461 e~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1461 EKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             cccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            444566666666667777778899988888877764

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.30  E-value=7.9e-06  Score=77.20  Aligned_cols=135  Identities=13%  Similarity=0.126  Sum_probs=83.8

Q ss_pred             eeeccCc-eEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEecCCC
Q 013421           16 TIGEGTF-AKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYIILEFVTG   93 (443)
Q Consensus        16 ~LG~G~~-g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~g   93 (443)
                      .|-.|.. +.||+....  +..+.+|+.....      ...+.+|+.+++.+. +--+.+++.+....+..++|||+++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            3445555 888988653  4678889875432      234678999988883 45567788887777778999999998


Q ss_pred             CChHHHHH----------------h--cC-----CCCHH------HHHHHHH----------------HHHHHHHHHH--
Q 013421           94 GELFDKIV----------------H--QG-----RLLEN------DCRRYFQ----------------QLIDAVAHCH--  126 (443)
Q Consensus        94 g~L~~~i~----------------~--~~-----~l~e~------~~~~~~~----------------qll~aL~yLH--  126 (443)
                      ..+.....                .  ..     ++...      .....+.                .+...+..|-  
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            77653310                0  00     01100      0000000                0111122221  


Q ss_pred             -----hCCCEeecCCCCcEEEcCCCCeEEeeecCcCC
Q 013421          127 -----SKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (443)
Q Consensus       127 -----~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (443)
                           ...++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence                 23489999999999999977788999987653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.29  E-value=1.2e-05  Score=89.37  Aligned_cols=80  Identities=13%  Similarity=0.306  Sum_probs=57.9

Q ss_pred             eeeeeccCceEEEEEEECCCC--cEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRETG--ESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNI--VRLHEVLASR---TKVY   85 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnI--v~l~~~~~~~---~~~~   85 (443)
                      ++.++.|.++.+|+......+  ..+++|+........  ....+.+|+.+|+.+. |+++  .+++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            577899999999998765432  467788765433221  1346889999999995 6665  7777777654   4678


Q ss_pred             EEEecCCCCC
Q 013421           86 IILEFVTGGE   95 (443)
Q Consensus        86 lv~Ey~~gg~   95 (443)
                      +||||++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999998864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.10  E-value=1.7e-05  Score=82.26  Aligned_cols=141  Identities=21%  Similarity=0.298  Sum_probs=87.5

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccc----------------------------cchHHHHH------HHHHH
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI----------------------------LKHRMVDQ------IKREI   60 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~----------------------------~~~~~~~~------~~~Ei   60 (443)
                      +.||.-+.|+||+|+.+. |+.||||+-+..--                            .-.+..+.      +.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            679999999999999875 99999999543210                            00111222      23344


Q ss_pred             HHHHh----CCCCC------cceEEEEEEeCCEEEEEEecCCCCChHH--HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 013421           61 SIMKI----VRHPN------IVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSK  128 (443)
Q Consensus        61 ~il~~----l~Hpn------Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~--~i~~~~~l~e~~~~~~~~qll~aL~yLH~~  128 (443)
                      +...+    +.|-+      |.++|-  .-.....|+|||++|..+.|  .|.+ .+++...+...+.+..  ++-+=..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~--~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAY--LEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHH--HHHHHhc
Confidence            43333    34555      333332  23345779999999986654  4444 3444443322222221  1122357


Q ss_pred             CCEeecCCCCcEEEcC----CCCeEEeeecCcCCCcc
Q 013421          129 GVYHRDLKPENLLLDS----YGNLKVSDFGLSALPQQ  161 (443)
Q Consensus       129 gi~HrDlkp~NILl~~----~~~~kL~DFGls~~~~~  161 (443)
                      |++|+|-+|.||++..    ++.+.+-|||+......
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            8999999999999984    56899999999876544

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.07  E-value=0.0001  Score=67.39  Aligned_cols=130  Identities=19%  Similarity=0.237  Sum_probs=92.8

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccc-------------cchHHHHHHHHHHHHHHhCC------CCCcceEE
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-------------LKHRMVDQIKREISIMKIVR------HPNIVRLH   75 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------HpnIv~l~   75 (443)
                      ..||+|+.-.||.  |+. ....+||++.....             ......++..+|+.-...+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            5689999999994  443 45578999877650             01112455667777666665      88999999


Q ss_pred             EEEEeCCEEEEEEecCCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC---
Q 013421           76 EVLASRTKVYIILEFVTG------GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---  146 (443)
Q Consensus        76 ~~~~~~~~~~lv~Ey~~g------g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~---  146 (443)
                      ++.+++.-..+|+|.+.+      -+|.+++.+ +.+++ ..   ...+-.-..||-+.+|+.+|++|.||++..++   
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            999999999999998632      257777754 45665 33   33444456688999999999999999996432   


Q ss_pred             -CeEEee
Q 013421          147 -NLKVSD  152 (443)
Q Consensus       147 -~~kL~D  152 (443)
                       .+.|+|
T Consensus       159 ~~lvlID  165 (199)
T PF10707_consen  159 FRLVLID  165 (199)
T ss_pred             eEEEEEe
Confidence             466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.05  E-value=1.5e-05  Score=54.64  Aligned_cols=44  Identities=20%  Similarity=0.422  Sum_probs=38.4

Q ss_pred             CccEEEEEEEEEEc-CceEEEEEEecCCCchHHHHHHHHHHHhcc
Q 013421          382 TGQFAVVLEVFEVA-PSLFMVDVRKAAGDTLEYHKFYKNFCAKLE  425 (443)
Q Consensus       382 ~~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~~~~~~~~l~  425 (443)
                      +..+.|.+||+++. ++++.|+|+|.+||.+.|+++|.+|...|+
T Consensus         2 ~~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~   46 (47)
T PF02149_consen    2 KEVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELR   46 (47)
T ss_dssp             CC-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT
T ss_pred             CcceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHcc
Confidence            34688999999998 899999999999999999999999988774

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.03  E-value=9.2e-05  Score=67.35  Aligned_cols=128  Identities=23%  Similarity=0.301  Sum_probs=90.8

Q ss_pred             cCeEEeeeeeccCc-eEEEEEEECCCCcEEEEEEeec---c-------cccch--------HHHHHHHHHHHHHHhCC--
Q 013421            9 AKYEVGRTIGEGTF-AKVRFAQNRETGESVAMKVLAK---S-------TILKH--------RMVDQIKREISIMKIVR--   67 (443)
Q Consensus         9 ~~y~i~~~LG~G~~-g~V~~a~~~~~~~~vAiK~i~~---~-------~~~~~--------~~~~~~~~Ei~il~~l~--   67 (443)
                      .+++.++.||.|+- |.||+++.  .|+.||+|++..   .       .....        .....+..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67899999999999 99999986  578999999321   0       00000        12345778888776664  


Q ss_pred             -CCCc--ceEEEEEEeC------------------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 013421           68 -HPNI--VRLHEVLASR------------------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH  126 (443)
Q Consensus        68 -HpnI--v~l~~~~~~~------------------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH  126 (443)
                       +.++  ++.+++..-.                  ....||-||++...         .++.    .-+.++.+-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence             5566  8999887311                  12467888776643         2222    33456777788999


Q ss_pred             hCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421          127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus       127 ~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                      ..||+-+|+++.|..     .-||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999986     3489999854

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.02  E-value=4.5e-05  Score=71.72  Aligned_cols=73  Identities=7%  Similarity=0.096  Sum_probs=46.1

Q ss_pred             eeeeeccCce-EEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CEEEE
Q 013421           14 GRTIGEGTFA-KVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP---NIVRLHEVLASR---TKVYI   86 (443)
Q Consensus        14 ~~~LG~G~~g-~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~---~~~~l   86 (443)
                      ++.++.|+.. .||..     +..+++|+.....     ....+.+|..+++.+...   .+.++++.....   ...|+
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            3567766666 58865     2347778654321     235788999999888532   345555543332   24588


Q ss_pred             EEecCCCCCh
Q 013421           87 ILEFVTGGEL   96 (443)
Q Consensus        87 v~Ey~~gg~L   96 (443)
                      +|++++|.++
T Consensus        72 l~~~i~G~~l   81 (235)
T cd05155          72 VYRWLEGETA   81 (235)
T ss_pred             EEEeecCCCC
Confidence            9999998765

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.01  E-value=5.1e-05  Score=67.07  Aligned_cols=129  Identities=19%  Similarity=0.312  Sum_probs=91.8

Q ss_pred             EeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEecC
Q 013421           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV-RLHEVLASRTKVYIILEFV   91 (443)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lv~Ey~   91 (443)
                      ..+.||+|.+|.||++.+.  |..+|+|+=..+.     ....+..|.++|..++-.++- ++|.+-.+    ++.|||+
T Consensus        26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i   94 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI   94 (201)
T ss_pred             hhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence            3567999999999999885  6689999765443     246789999999999876664 45554332    3459999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCC-CCcEEEcCCCCeEEeeecCcCCC
Q 013421           92 TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK-PENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        92 ~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlk-p~NILl~~~~~~kL~DFGls~~~  159 (443)
                      .|-.|.+.....   +    +.-+..++++---|-..||-|+.|. |...+|-.++.+.|+||.-++..
T Consensus        95 ~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          95 DGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             cCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            997775544321   1    2233445555556777899999997 66666666679999999988743

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.84  E-value=0.00027  Score=66.23  Aligned_cols=75  Identities=24%  Similarity=0.352  Sum_probs=49.2

Q ss_pred             eeeeeccCceEEEEEEECC-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEecC
Q 013421           14 GRTIGEGTFAKVRFAQNRE-TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRTKVYIILEFV   91 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lv~Ey~   91 (443)
                      ++.|..|-...+|+..... .++.|++|+.......    .-...+|+.+++.+...+ .++++....  +  .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence            4678889999999987543 3578899977543211    122357888888885433 444544332  2  3799999


Q ss_pred             CCCCh
Q 013421           92 TGGEL   96 (443)
Q Consensus        92 ~gg~L   96 (443)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.82  E-value=0.00053  Score=69.30  Aligned_cols=80  Identities=19%  Similarity=0.208  Sum_probs=54.8

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccc--cc--hHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LK--HRMVDQIKREISIMKIVR---HPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--~~--~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l   86 (443)
                      .+.||.|.+..||++.+...++.++||.-.....  ..  .-..+....|.+.|+.+.   ..++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4689999999999999865446899997431110  00  112456677888888763   3467777776  4455789


Q ss_pred             EEecCCCCC
Q 013421           87 ILEFVTGGE   95 (443)
Q Consensus        87 v~Ey~~gg~   95 (443)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.75  E-value=0.00012  Score=69.68  Aligned_cols=134  Identities=16%  Similarity=0.203  Sum_probs=78.5

Q ss_pred             eeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEecCCCC
Q 013421           16 TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYIILEFVTGG   94 (443)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey~~gg   94 (443)
                      .+..|-.+.+|+..  .+++.+++|+.......   ..-...+|..+++.+....+ .+++....    -++||||++|.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence            46678888999886  35678889976543211   10124678889988864333 34444332    36899999986


Q ss_pred             ChHH----------HH----Hh--cC-----CCC-HHHHHHHHHHHH---------HHHHHHHh--------CCCEeecC
Q 013421           95 ELFD----------KI----VH--QG-----RLL-ENDCRRYFQQLI---------DAVAHCHS--------KGVYHRDL  135 (443)
Q Consensus        95 ~L~~----------~i----~~--~~-----~l~-e~~~~~~~~qll---------~aL~yLH~--------~gi~HrDl  135 (443)
                      .+..          .+    .+  ..     +++ ......+..++.         ..+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            5431          11    10  01     111 122223332221         11222221        25899999


Q ss_pred             CCCcEEEcCCCCeEEeeecCcCCC
Q 013421          136 KPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus       136 kp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      .|.||++++++ +.++||..+..-
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCcC
Confidence            99999999877 789999987643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.75  E-value=0.00025  Score=68.97  Aligned_cols=136  Identities=19%  Similarity=0.200  Sum_probs=83.3

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceEEE------EEEeCCEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLHE------VLASRTKVY   85 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~------~~~~~~~~~   85 (443)
                      .+.+..|....+|+....  +..+++|+....      ..+.+..|+.++..+.+.  .+.+++.      +....+..+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            567888888999988643  446889987541      124567788888887432  2445443      223456678


Q ss_pred             EEEecCCCCChHH----H---H-------Hh-cCCCC--------HHHHH------------HHHHHHHHHHHHHHh---
Q 013421           86 IILEFVTGGELFD----K---I-------VH-QGRLL--------ENDCR------------RYFQQLIDAVAHCHS---  127 (443)
Q Consensus        86 lv~Ey~~gg~L~~----~---i-------~~-~~~l~--------e~~~~------------~~~~qll~aL~yLH~---  127 (443)
                      +++++++|..+..    .   +       .. ...+.        .....            .....+..++.++.+   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999999866421    0   0       00 00000        00000            011112334444443   


Q ss_pred             ----CCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421          128 ----KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus       128 ----~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                          .+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                479999999999999987777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=97.74  E-value=0.00058  Score=66.65  Aligned_cols=77  Identities=13%  Similarity=0.105  Sum_probs=55.0

Q ss_pred             EeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCEEEE
Q 013421           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH---PNIVRLHEVLAS---RTKVYI   86 (443)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~---~~~~~l   86 (443)
                      -.+.||.|..+.||...... + .+.+|..+ ...    ....+..|...|+.|..   -.+.++++++..   .+..++
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~-~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQ-G-NPMPLMAR-SFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             eeeecCCccceeEEEEEcCC-C-CEEEEEec-ccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            35679999999999986432 3 46667643 210    12468899999998853   467888887754   366899


Q ss_pred             EEecCCCCCh
Q 013421           87 ILEFVTGGEL   96 (443)
Q Consensus        87 v~Ey~~gg~L   96 (443)
                      |||+++|+++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.73  E-value=0.00057  Score=66.94  Aligned_cols=138  Identities=17%  Similarity=0.184  Sum_probs=81.4

Q ss_pred             EeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceEEEE------EEeCCEE
Q 013421           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLHEV------LASRTKV   84 (443)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~------~~~~~~~   84 (443)
                      .++.++.|....+|+... .+| .+++|+.....  .   .+.+..|+.++..|...  .+.+++..      ....+..
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~   98 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP   98 (307)
T ss_pred             eccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence            356788888889998864 334 57889875421  1   23455677777777422  24444432      1234667


Q ss_pred             EEEEecCCCCChH----H-------HH---Hh-cCCC--------CHHHHH---------------HHHHHHHHHHHHHH
Q 013421           85 YIILEFVTGGELF----D-------KI---VH-QGRL--------LENDCR---------------RYFQQLIDAVAHCH  126 (443)
Q Consensus        85 ~lv~Ey~~gg~L~----~-------~i---~~-~~~l--------~e~~~~---------------~~~~qll~aL~yLH  126 (443)
                      ++++||++|..+.    +       .+   .. ...+        ......               .....+...++++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            8999999885431    0       11   00 0011        000000               00112333455554


Q ss_pred             h-------CCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421          127 S-------KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus       127 ~-------~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      .       .+++|+|+++.||+++.++...|+||+.+.
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            2       689999999999999988877899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.70  E-value=4.7e-05  Score=73.35  Aligned_cols=136  Identities=17%  Similarity=0.243  Sum_probs=98.7

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccc-----------------hHH--HHHHHHHHHHHHhCC-C-
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK-----------------HRM--VDQIKREISIMKIVR-H-   68 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-----------------~~~--~~~~~~Ei~il~~l~-H-   68 (443)
                      -|.+++.||-|.-+.||.+.+. .|.+.++|+-......-                 .-.  .-...+|...|+.|. | 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            3678899999999999999885 58889999754322110                 000  112457888888884 3 


Q ss_pred             CCcceEEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCe
Q 013421           69 PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL  148 (443)
Q Consensus        69 pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~  148 (443)
                      --+.+.+++    +.-++|||++.|..|...-.      ...+..+...++.-+.-|-.+|++|+|..--||++++++.+
T Consensus       172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence            335555543    56789999999887754321      22345666777777888999999999999999999999999


Q ss_pred             EEeeecCc
Q 013421          149 KVSDFGLS  156 (443)
Q Consensus       149 kL~DFGls  156 (443)
                      +++||--+
T Consensus       242 ~vIDFPQm  249 (465)
T KOG2268|consen  242 VVIDFPQM  249 (465)
T ss_pred             EEeechHh
Confidence            99999644

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.69  E-value=0.00018  Score=65.30  Aligned_cols=99  Identities=16%  Similarity=0.259  Sum_probs=79.1

Q ss_pred             HHHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEecCCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 013421           57 KREISIMKIVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDK---IVHQGRLLENDCRRYFQQLIDAVAHCHS---KG  129 (443)
Q Consensus        57 ~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~---i~~~~~l~e~~~~~~~~qll~aL~yLH~---~g  129 (443)
                      ..|.-+++.+++ +++++++|++..    +++.||...+++...   +..--..++.....++.+++..+++++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888999976 699999999833    568899987766421   1122345788999999999999999997   34


Q ss_pred             CEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421          130 VYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus       130 i~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      +.-.|++|+|+-++++|++|++|.......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888899999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK05231 homoserine kinase; Provisional

Probab=97.54  E-value=0.0023  Score=62.92  Aligned_cols=136  Identities=15%  Similarity=0.174  Sum_probs=75.2

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceEEE------EEEeCCEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLHE------VLASRTKVY   85 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~------~~~~~~~~~   85 (443)
                      .+.++.|....+|..... +| .+++|++..  . .   .+.+..|+.+++.|...  .+.+++.      +....+..+
T Consensus        27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~--~-~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~   98 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER--L-T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA   98 (319)
T ss_pred             cchhccccccceEEEEeC-CC-cEEEEEecc--C-C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence            355778888899988753 33 688998752  1 1   13344556666665321  2334332      123356789


Q ss_pred             EEEecCCCCChH-----------HHHH---h-cCCC--------C--H--HHHHH-----------HHHHHH-HHHHHHH
Q 013421           86 IILEFVTGGELF-----------DKIV---H-QGRL--------L--E--NDCRR-----------YFQQLI-DAVAHCH  126 (443)
Q Consensus        86 lv~Ey~~gg~L~-----------~~i~---~-~~~l--------~--e--~~~~~-----------~~~qll-~aL~yLH  126 (443)
                      +++||++|..+.           ..+.   . ...+        .  .  .....           .+.+.+ ..++.+.
T Consensus        99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  178 (319)
T PRK05231         99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA  178 (319)
T ss_pred             EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence            999999987431           1111   0 0000        0  0  00000           111111 1122222


Q ss_pred             -------hCCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421          127 -------SKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus       127 -------~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                             ..|++|+|+.|.||+++.+...-|+||+.+.
T Consensus       179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                   2489999999999999966556899999765

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.47  E-value=0.0005  Score=70.08  Aligned_cols=162  Identities=20%  Similarity=0.206  Sum_probs=106.2

Q ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEe
Q 013421           54 DQIKREISIMKIVRHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH  132 (443)
Q Consensus        54 ~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~H  132 (443)
                      .++.-....++.+.|+|...++++... .....+|||++ +.+|.+...... +-.....                  +|
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~~   86 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------AH   86 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------cc
Confidence            456667888999999999999998864 34578899999 668888876643 2111110                  22


Q ss_pred             ecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCC
Q 013421          133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  212 (443)
Q Consensus       133 rDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  212 (443)
                      |- -+-|       .++.+| .+++.                |  |-      ..++++||||+|.++.++..|...|..
T Consensus        87 ~~-~~~~-------~~~~td-~~~t~----------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   87 GV-LHLN-------IIYITD-HFLTK----------------Y--PS------PIGPKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             cc-ceeh-------hhhccc-ccccc----------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence            21 1112       223333 11110                0  11      112599999999999999999888776


Q ss_pred             CChHHHHHHhhhccCCCC------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          213 TDLPTLYKKINAAEFSCP------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       213 ~~~~~~~~~i~~~~~~~~------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ....+....+.+-.....            -.++.....+..+|+-..|..||...++++|+-|...+
T Consensus       134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~  201 (725)
T KOG1093|consen  134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY  201 (725)
T ss_pred             HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence            555554444433221111            11466778899999999999999999999999997654

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.44  E-value=0.0015  Score=63.68  Aligned_cols=76  Identities=18%  Similarity=0.187  Sum_probs=49.8

Q ss_pred             eeeeeccCceEEEEEEECC------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRE------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRTKVYI   86 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~l   86 (443)
                      ++.|..|-...+|+.....      +++.+++|+......    ......+|..+++.+.... ..+++.++..    .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence            4667788888999987543      257899999755321    1234568888888885333 3455555432    35


Q ss_pred             EEecCCCCChH
Q 013421           87 ILEFVTGGELF   97 (443)
Q Consensus        87 v~Ey~~gg~L~   97 (443)
                      |+||++|..+.
T Consensus        75 v~e~i~G~~l~   85 (302)
T cd05156          75 IEEFIPSRTLT   85 (302)
T ss_pred             hhheeCCCcCC
Confidence            89999887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.41  E-value=0.0018  Score=63.62  Aligned_cols=145  Identities=21%  Similarity=0.296  Sum_probs=99.5

Q ss_pred             EeeeeeccCceEEEEEEECCCCcEEEEEEeecccc----------------------cchHHHH-HHHHHHHHHHhCCCC
Q 013421           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI----------------------LKHRMVD-QIKREISIMKIVRHP   69 (443)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~----------------------~~~~~~~-~~~~Ei~il~~l~Hp   69 (443)
                      |-..|..|.-+.||.|... +|+.+|||+++..-.                      ....+++ ....|++.|++++..
T Consensus       148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3456888999999999764 678899999753210                      1111222 246788899998765


Q ss_pred             CcceEEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCEeecCCCCcEEEcCCCCe
Q 013421           70 NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLLLDSYGNL  148 (443)
Q Consensus        70 nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH-~~gi~HrDlkp~NILl~~~~~~  148 (443)
                      .|.-.--+..  ..-.|||+++.+.....-...+..++...+..+.+|++.-+.-|- ..+.+|.||.--|+|+.+ |.+
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~l  303 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKL  303 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEE
Confidence            5443222221  123589999954322222223456888889999999998888774 569999999999999976 999


Q ss_pred             EEeeecCcCCCcc
Q 013421          149 KVSDFGLSALPQQ  161 (443)
Q Consensus       149 kL~DFGls~~~~~  161 (443)
                      .++|-+-+.....
T Consensus       304 yiIDVSQSVE~DH  316 (520)
T KOG2270|consen  304 YIIDVSQSVEHDH  316 (520)
T ss_pred             EEEEccccccCCC
Confidence            9999987754433

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.28  E-value=0.0028  Score=61.97  Aligned_cols=142  Identities=19%  Similarity=0.241  Sum_probs=87.0

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCC--EEEE
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH--PNIVRLHEVLASRT--KVYI   86 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~--~~~l   86 (443)
                      ..+++....|....+|.....  ++.+++. ... ............+|..+++.+.-  .-+...++.+.++.  ..|.
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            344555555555566666554  7888888 332 11222345677889999998854  23344455554444  6699


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHH-HHHHHHHHHHHh--------------------------------------
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHS--------------------------------------  127 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~-~qll~aL~yLH~--------------------------------------  127 (443)
                      ||+|++|..+.+...     +.....++. ..+...|.-||+                                      
T Consensus       103 v~~~veGe~~~~~~~-----~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~  177 (321)
T COG3173         103 VMEWVEGEVVWSALP-----PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI  177 (321)
T ss_pred             EEEEecceeccCcCC-----cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence            999998853322111     011111111 234444444443                                      


Q ss_pred             --------------------CCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421          128 --------------------KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus       128 --------------------~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                                          ..++|+|+.+.||+++.++-+=+.||+++..-+.
T Consensus       178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                                2589999999999999988899999999876544

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.12  E-value=0.0054  Score=59.19  Aligned_cols=31  Identities=23%  Similarity=0.379  Sum_probs=25.7

Q ss_pred             CCEeecCCCCcEEEcCCCC-eEEeeecCcCCC
Q 013421          129 GVYHRDLKPENLLLDSYGN-LKVSDFGLSALP  159 (443)
Q Consensus       129 gi~HrDlkp~NILl~~~~~-~kL~DFGls~~~  159 (443)
                      .++|+|++|.||++++++. .-|+||+.+..-
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997565 469999987643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=96.99  E-value=0.0062  Score=60.71  Aligned_cols=136  Identities=16%  Similarity=0.226  Sum_probs=80.2

Q ss_pred             eeeeeccCceEEEEEEECC----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRE----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYIIL   88 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~   88 (443)
                      ++.|..|-...+|++....    +++.|++|+.....   ...++ -.+|..+++.+..-++ .++++.+...    .|.
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~  112 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE  112 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence            4566668889999986432    34689999876542   11222 2678888888854433 4556655332    578


Q ss_pred             ecCCCCChHHH----------H----Hh--cCC------C-CHHHHHHHHHHH-----------------HHHHHHH---
Q 013421           89 EFVTGGELFDK----------I----VH--QGR------L-LENDCRRYFQQL-----------------IDAVAHC---  125 (443)
Q Consensus        89 Ey~~gg~L~~~----------i----~~--~~~------l-~e~~~~~~~~ql-----------------l~aL~yL---  125 (443)
                      ||++|.++...          +    .+  ...      . ..+.+..++.++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99877665311          1    00  001      1 122233333222                 1111112   


Q ss_pred             -H----hCCCEeecCCCCcEEEcC-CCCeEEeeecCcC
Q 013421          126 -H----SKGVYHRDLKPENLLLDS-YGNLKVSDFGLSA  157 (443)
Q Consensus       126 -H----~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~  157 (443)
                       .    ...++|+|+++.|||+++ ++.+.++||..+.
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence             1    235899999999999986 4789999998765

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.95  E-value=0.011  Score=59.92  Aligned_cols=77  Identities=9%  Similarity=0.060  Sum_probs=50.6

Q ss_pred             EeeeeeccCceEEEEEEECCCCcEEEEEEeecccccc-h---HHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEE
Q 013421           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK-H---RMVDQIKREISIMKIVR---HPNIVRLHEVLASRTKVY   85 (443)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-~---~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~   85 (443)
                      -.+.||.|....||+..+.  +..++||.-....... .   -....-..|...|+.+.   ..++.+++.+..+  ..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence            3578999999999998863  4568899754211100 0   02334445666666653   3578888888774  456


Q ss_pred             EEEecCCC
Q 013421           86 IILEFVTG   93 (443)
Q Consensus        86 lv~Ey~~g   93 (443)
                      ++|||+++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            78999977

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.86  E-value=0.014  Score=58.12  Aligned_cols=77  Identities=14%  Similarity=0.147  Sum_probs=48.0

Q ss_pred             eeeccCceEEEEEEECCCCcEEEEEEeecccc--c-c-hHHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEEE
Q 013421           16 TIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--L-K-HRMVDQIKREISIMKIVR--HP-NIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--~-~-~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~lv~   88 (443)
                      .+|.|...-||++.+..+++.|+||.-.....  . . .-..++..-|...|+...  -| +++++|.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            57999999999999865446899996421110  0 0 112344557777777663  24 45555544  344556999


Q ss_pred             ecCCCC
Q 013421           89 EFVTGG   94 (443)
Q Consensus        89 Ey~~gg   94 (443)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.74  E-value=0.047  Score=53.26  Aligned_cols=29  Identities=31%  Similarity=0.560  Sum_probs=25.4

Q ss_pred             CCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421          128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus       128 ~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57999999999999988 778999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.39  E-value=0.035  Score=54.98  Aligned_cols=136  Identities=24%  Similarity=0.322  Sum_probs=78.6

Q ss_pred             eeeeeccCceEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEe
Q 013421           14 GRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYIILE   89 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~E   89 (443)
                      ++.|..|-...+|+......   +..|++|+......   . .-.-.+|..+++.+..-++ .+++.++. ..   +|.+
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~   90 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---Y-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS   90 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---e-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence            35566688888998865432   34789998765321   1 1123578888888865444 45565553 22   5889


Q ss_pred             cCCCCChHH----------HHH------hcCC------C-CHHHHHHHHHHH----------------------HHHHHH
Q 013421           90 FVTGGELFD----------KIV------HQGR------L-LENDCRRYFQQL----------------------IDAVAH  124 (443)
Q Consensus        90 y~~gg~L~~----------~i~------~~~~------l-~e~~~~~~~~ql----------------------l~aL~y  124 (443)
                      |++|..|..          .+.      +...      . ....+..++.++                      ..-+..
T Consensus        91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  170 (330)
T PLN02421         91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE  170 (330)
T ss_pred             hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence            987765421          111      0111      1 122233333322                      111222


Q ss_pred             H----HhCC----CEeecCCCCcEEEcC-CCCeEEeeecCcC
Q 013421          125 C----HSKG----VYHRDLKPENLLLDS-YGNLKVSDFGLSA  157 (443)
Q Consensus       125 L----H~~g----i~HrDlkp~NILl~~-~~~~kL~DFGls~  157 (443)
                      +    .+.+    .+|+|+.|.|||+++ ++.++++||..|.
T Consensus       171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            1    1222    799999999999975 5789999998764

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.21  E-value=0.096  Score=51.29  Aligned_cols=29  Identities=17%  Similarity=0.172  Sum_probs=26.9

Q ss_pred             CCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421          129 GVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus       129 gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      +++|+|+.+.|+|+++++.+-++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999998765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.05  E-value=0.035  Score=53.87  Aligned_cols=75  Identities=17%  Similarity=0.195  Sum_probs=47.9

Q ss_pred             EEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEE
Q 013421           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR---HPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      +-.+.+|.|..+.+|...  .+++.+.+|+-....      ...+..|..-|+.|.   --.+++.+.+....+.-|++|
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            345679999999999877  567889999876321      245678888888873   445778888887777779999


Q ss_pred             ecCCCC
Q 013421           89 EFVTGG   94 (443)
Q Consensus        89 Ey~~gg   94 (443)
                      ||++.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            998766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.03  E-value=0.023  Score=56.88  Aligned_cols=61  Identities=15%  Similarity=0.207  Sum_probs=42.0

Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCEeecCCCCcEEEcC
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC-HSKGVYHRDLKPENLLLDS  144 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yL-H~~gi~HrDlkp~NILl~~  144 (443)
                      ...++-+|..|..+..++.. ...+|+....+..--..|+--+ --.+.+|.|++|.||++--
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            34566678888888887765 3445555555555555554433 3458999999999999954

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.90  E-value=0.051  Score=54.82  Aligned_cols=78  Identities=14%  Similarity=0.223  Sum_probs=50.4

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccc---hHHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK---HRMVDQIKREISIMKIVR--HP-NIVRLHEVLASRTKVYII   87 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~lv   87 (443)
                      .+.||.|.-.-||++.+...++.|+||.-..--...   .-..++..-|...|+...  -| +++++|.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            578999999999999985445679998632111000   112355667888887763  34 46666654  34455689


Q ss_pred             EecCCC
Q 013421           88 LEFVTG   93 (443)
Q Consensus        88 ~Ey~~g   93 (443)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998864

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.89  E-value=0.029  Score=55.35  Aligned_cols=86  Identities=24%  Similarity=0.290  Sum_probs=61.4

Q ss_pred             CCCcceEEEEE-EeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCC
Q 013421           68 HPNIVRLHEVL-ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSY  145 (443)
Q Consensus        68 HpnIv~l~~~~-~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~  145 (443)
                      -++..+.+-+- .+....|++|++- |+.+. .+.   .-..+++..++.+.+..+.-+... ..-|||+...||||+ +
T Consensus       284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~  357 (488)
T COG5072         284 SVFLETLKVVSLDETLYLYLHFKDH-GTPIS-IIK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E  357 (488)
T ss_pred             chhhhcceEEecCCceEEEEEEecC-Cceee-eee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence            34444444443 3445677888876 44442 222   234677888888888888777765 689999999999999 8


Q ss_pred             CCeEEeeecCcCCC
Q 013421          146 GNLKVSDFGLSALP  159 (443)
Q Consensus       146 ~~~kL~DFGls~~~  159 (443)
                      |++-|+||-+++..
T Consensus       358 GnvtLIDfklsRl~  371 (488)
T COG5072         358 GNVTLIDFKLSRLS  371 (488)
T ss_pred             CceEEEEeeeeecc
Confidence            99999999998844

>PTZ00384 choline kinase; Provisional

Probab=95.73  E-value=0.092  Score=53.09  Aligned_cols=75  Identities=17%  Similarity=0.250  Sum_probs=45.7

Q ss_pred             eeeeeccCceEEEEEEECCC-CcE-----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRET-GES-----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYI   86 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~-~~~-----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~l   86 (443)
                      ++.|..|-...+|++..... +..     |.+++.....    +..-.-.+|+.+++.+...++ .++++.+..    ++
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~----~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~  126 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN----SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT  126 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC----ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence            45676799999999875433 222     4444322111    111123578999999965544 556666643    58


Q ss_pred             EEecCCCCCh
Q 013421           87 ILEFVTGGEL   96 (443)
Q Consensus        87 v~Ey~~gg~L   96 (443)
                      +.||++|..|
T Consensus       127 l~efIeGr~l  136 (383)
T PTZ00384        127 IQEWVEGNTM  136 (383)
T ss_pred             EEEEeccccC
Confidence            9999988765

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.43  E-value=0.58  Score=46.24  Aligned_cols=71  Identities=14%  Similarity=0.056  Sum_probs=42.6

Q ss_pred             cCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceEE---E--EEEeCCEEEEEEecCC
Q 013421           20 GTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLH---E--VLASRTKVYIILEFVT   92 (443)
Q Consensus        20 G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~---~--~~~~~~~~~lv~Ey~~   92 (443)
                      +.-..||.... .+|..+++|+......    ....+..|+..+..|...  .++...   +  +...++..+.++++++
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~  110 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG  110 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence            34567888765 3567799998764332    235567788877766321  122211   1  2233567888999998


Q ss_pred             CCC
Q 013421           93 GGE   95 (443)
Q Consensus        93 gg~   95 (443)
                      |..
T Consensus       111 G~~  113 (325)
T PRK11768        111 GRA  113 (325)
T ss_pred             CCC
Confidence            764

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.04  E-value=0.095  Score=48.42  Aligned_cols=85  Identities=22%  Similarity=0.319  Sum_probs=57.6

Q ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--CCCE
Q 013421           54 DQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS--KGVY  131 (443)
Q Consensus        54 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~--~gi~  131 (443)
                      ..+..+.+++.++.  .|+++..  .+.-.+.+++|+|-....         .+.    .++.-=+.+|.-.|+  .+.+
T Consensus       103 ~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i---------~~~----N~i~agi~~L~~fH~~~~~~l  165 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI---------NFS----NFITAGIKDLMDFHSENQHCL  165 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc---------chh----HHHHHhHHHHHHhhccCCCee
Confidence            34577788887764  4666663  244567899999943211         000    111112456777884  3799


Q ss_pred             eecCCCCcEEEcCCCCeEEeeecC
Q 013421          132 HRDLKPENLLLDSYGNLKVSDFGL  155 (443)
Q Consensus       132 HrDlkp~NILl~~~~~~kL~DFGl  155 (443)
                      |||-.|+||+-|..|.+||.|-+.
T Consensus       166 HGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  166 HGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             cCCCChhheeecCCCCEEecChhh
Confidence            999999999999999999999873

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=94.88  E-value=0.23  Score=56.72  Aligned_cols=31  Identities=29%  Similarity=0.440  Sum_probs=26.3

Q ss_pred             CCCEeecCCCCcEEEcCCC--CeE-EeeecCcCC
Q 013421          128 KGVYHRDLKPENLLLDSYG--NLK-VSDFGLSAL  158 (443)
Q Consensus       128 ~gi~HrDlkp~NILl~~~~--~~k-L~DFGls~~  158 (443)
                      .+++|+|+.+.|||++.++  .+. |+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999775  565 999997754

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=94.01  E-value=0.35  Score=46.77  Aligned_cols=74  Identities=14%  Similarity=0.114  Sum_probs=43.4

Q ss_pred             eccCceEEEEEEECC----CC----cEEEEEEeecccccch--HHHHHHHHHHHHHHhCC-------------CCCcceE
Q 013421           18 GEGTFAKVRFAQNRE----TG----ESVAMKVLAKSTILKH--RMVDQIKREISIMKIVR-------------HPNIVRL   74 (443)
Q Consensus        18 G~G~~g~V~~a~~~~----~~----~~vAiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~-------------HpnIv~l   74 (443)
                      |.|-.|.+|++.-..    ++    ..+.||..........  .....+.+|+...+.+-             .....++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            677788888876522    22    3678888763222111  12355777877665441             1234566


Q ss_pred             EEEEEeCCEEEEEEecC
Q 013421           75 HEVLASRTKVYIILEFV   91 (443)
Q Consensus        75 ~~~~~~~~~~~lv~Ey~   91 (443)
                      +....+.....||||-+
T Consensus        82 ~~~~~~~~~~~lvlEDL   98 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDL   98 (294)
T ss_pred             EEeccCCCceeeehhhh
Confidence            66655555788999865

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	443
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-69
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-69
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-68
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-67
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-67
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-67
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-67
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-67
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-64
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-58
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-58
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-58
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-58
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-58
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-58
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-57
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-57
2ehb_D	143	The Structure Of The C-Terminal Domain Of The Prote		3e-57
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-56
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-55
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-52
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-51
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-51
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-51
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-51
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-51
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-51
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-51
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-51
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-50
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-50
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-50
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-49
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-49
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-49
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-48
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-48
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-48
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-48
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-48
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-48
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-48
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-48
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-48
3soa_A	444	Full-Length Human Camkii Length = 444		3e-48
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-48
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-48
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-48
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-48
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-48
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-48
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-48
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-48
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-48
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-48
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-48
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-48
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-48
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-47
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-47
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-47
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-47
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-47
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-47
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-47
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-47
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-47
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-47
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-47
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-47
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-47
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-47
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-47
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-47
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-47
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-47
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-47
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-47
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-47
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-47
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-47
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-47
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-47
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-47
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-46
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-46
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-46
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-46
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-46
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-46
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-46
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-46
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-46
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-45
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-45
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-45
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-45
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-45
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-45
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-45
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-44
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-44
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-44
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-44
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-44
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-44
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-44
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-44
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-44
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-44
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-44
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-44
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-44
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-42
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-42
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-42
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-42
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-42
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-42
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-42
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-42
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-42
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-42
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-42
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-42
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-42
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-41
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-41
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-41
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-41
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-41
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-41
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-41
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-41
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-41
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-41
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-41
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-41
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-41
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-41
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-41
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-41
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-41
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-41
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-41
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-41
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-41
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-41
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-41
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-41
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-41
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-41
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-41
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-41
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-41
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-41
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-40
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-40
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-40
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-40
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-40
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-40
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-40
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-40
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-40
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-40
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-40
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-40
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-40
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-40
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-40
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-40
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-40
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-40
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-40
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-40
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-40
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-40
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-40
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-40
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-40
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-40
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-40
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-40
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-40
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-40
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-40
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-40
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-40
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-40
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-40
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-40
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-40
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-40
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-40
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-40
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-40
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-40
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-39
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-39
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-39
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-39
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-39
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-39
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-38
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-38
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-38
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-38
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-38
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-38
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-38
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-38
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-38
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-38
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-38
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-38
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-37
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-37
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-37
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-37
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-37
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-37
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-37
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-37
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-37
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-37
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-37
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-37
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-37
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-37
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-37
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-37
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-37
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-36
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-36
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-35
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-35
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-35
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-35
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-35
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-35
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-35
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-35
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-35
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-35
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-34
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-34
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-34
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-34
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-34
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-34
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-34
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-34
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-34
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-34
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-34
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-34
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-34
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-34
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-34
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-34
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-34
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-34
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-34
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-34
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-34
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-34
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-34
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-34
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-33
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-33
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-33
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-33
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-33
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-32
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-32
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-32
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-31
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-31
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-31
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-31
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-31
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-31
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-30
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-30
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		8e-30
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-29
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-29
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-28
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-28
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-28
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-28
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-28
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-28
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-28
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-28
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-28
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-28
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-28
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-28
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-28
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-28
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-28
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-28
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-28
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-28
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-27
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-27
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-27
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-27
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-27
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-27
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-27
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-27
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-27
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-27
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-27
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-27
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-27
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-27
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-27
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-27
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-27
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-27
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-27
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-27
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-27
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-27
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-27
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-27
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-27
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-27
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-27
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-27
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-27
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-27
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-27
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-27
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-26
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-26
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-26
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-26
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-26
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-26
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-26
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-26
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-26
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-25
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-25
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-25
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-25
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-25
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-25
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-25
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-25
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-25
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-25
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-25
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-25
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-24
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-24
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-24
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-24
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-24
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-24
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-24
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-24
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-24
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-24
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-24
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-24
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-24
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-24
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-24
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-24
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-24
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-24
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-24
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-24
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-24
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-24
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-24
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-24
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-24
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-24
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-23
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-23
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-23
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-23
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-23
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-23
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-23
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-23
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-23
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-23
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-23
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-23
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-23
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-23
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-23
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-23
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-23
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-23
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-23
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-23
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-23
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-22
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-22
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-22
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-22
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-22
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-22
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-22
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-22
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-22
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-21
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-21
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-21
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-21
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-21
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-21
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-20
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-20
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-20
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-20
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-20
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-20
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-20
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-20
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-20
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-20
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-19
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-19
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-19
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-19
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-19
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-19
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-19
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-19
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-19
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-19
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-18
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-18
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-18
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-18
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-18
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-18
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-18
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-18
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-18
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-18
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-18
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-18
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-18
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-18
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-18
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-18
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-18
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-18
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-18
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-18
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-18
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-18
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-18
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-18
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-18
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-18
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-18
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-18
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-18
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-18
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-18
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-18
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-18
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-18
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-18
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-18
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-18
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-18
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-18
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-18
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-18
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-18
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-18
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-18
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-18
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-18
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-18
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-18
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-18
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-17
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-17
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-17
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-17
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-17
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-17
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-17
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-17
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-17
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-17
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-17
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-17
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-17
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-17
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-17
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-17
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-17
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-17
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-17
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-17
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-17
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-17
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-17
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-17
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-17
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-17
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-17
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-17
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-17
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-17
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-17
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-17
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-16
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-16
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-16
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-16
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-16
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-16
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-16
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-16
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-16
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-16
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-16
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-16
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-16
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-16
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-16
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-16
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-16
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-16
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-16
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-16
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-16
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-16
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-16
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-16
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-16
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-16
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-16
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-16
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-16
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-16
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-16
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-16
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-16
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-16
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-16
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-16
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-16
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-16
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-16
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-16
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-16
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-16
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-16
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-16
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-16
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-16
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-16
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-16
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-16
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-16
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-16
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-16
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-16
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-16
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-16
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-16
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-16
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-16
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-16
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-16
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-16
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-16
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-16
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-16
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-16
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-16
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-16
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-16
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-15
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-15
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-15
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-15
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-15
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-15
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-15
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-15
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-15
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		7e-15
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-15
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-14
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-14
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-14
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-14
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-14
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-14
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-14
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-14
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-14
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-14
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-14
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-13
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-13
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-13
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		9e-13
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-12
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-12
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-12
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-12
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-12
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-12
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-11
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-11
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-11
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-11
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-11
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-11
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-11
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-11
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-11
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-11
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-11
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-11
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-11
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-11
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-11
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-11
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-11
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-11
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		6e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-11
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		6e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-11
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-10
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-10
3gni_B	389	Structure Of Strad And Mo25 Length = 389		6e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-10
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		9e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-08
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-08
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-08
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-08
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-08
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-08
2zfd_B	123	The Crystal Structure Of Plant Specific Calcium Bin		4e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-08
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		5e-08
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		5e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-08

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  258 bits (659), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 118/261 (45%), Positives = 178/261 (68%), Gaps = 1/261 (0%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++  Y +G T+G GTF KV+  +++ TG  VA+K+L +  I    +V +IKREI  +K+ 
Sbjct: 9   KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           RHP+I++L++V+++ T  ++++E+V+GGELFD I   GR+ E + RR FQQ++ AV +CH
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
              V HRDLKPEN+LLD++ N K++DFGLS +   G E L T+CG+PNY APEV+S R Y
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLY 187
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            G   D+WSCGVIL+ L+ G LPF +  +PTL+KKI    F  P + +    +L+  +L 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQ 247
Query: 247 PNPKTRIRIEGIRKHPWFRKN 267
            +P  R  I+ IR+H WF+++
Sbjct: 248 VDPLKRATIKDIREHEWFKQD 268

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  258 bits (659), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 122/305 (40%), Positives = 196/305 (64%), Gaps = 15/305 (4%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M    R +  Y +  T+GEG+F KV+ A + +T + VA+K +++  + K  M  +++REI
Sbjct: 1   MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           S +K++RHP+I++L++V+ + T + +++E+  GGELFD IV + R+ E++ RR+FQQ+I 
Sbjct: 61  SYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC 119
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+ +CH   + HRDLKPENLLLD   N+K++DFGLS +   G   L T+CG+PNY APEV
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEV 178
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           ++ + Y G   DVWSCG++L+V++ G LPF +  +P L+KK+N+  +  P + S GA SL
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSL 238
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 300
           I +++  +P  RI I+ IR+ PWF              VNL D     ++++  Y   + 
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWFN-------------VNLPDYLRPMEEVQGSYADSRI 285
Query: 301 ENKVG 305
            +K+G
Sbjct: 286 VSKLG 290

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  256 bits (653), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 117/261 (44%), Positives = 177/261 (67%), Gaps = 1/261 (0%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++  Y +G T+G GTF KV+  +++ TG  VA+K+L +  I    +V +IKREI  +K+ 
Sbjct: 9   KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           RHP+I++L++V+++ T  ++++E+V+GGELFD I   GR+ E + RR FQQ++ AV +CH
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
              V HRDLKPEN+LLD++ N K++DFGLS +   G E L  +CG+PNY APEV+S R Y
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRDSCGSPNYAAPEVISGRLY 187
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            G   D+WSCGVIL+ L+ G LPF +  +PTL+KKI    F  P + +    +L+  +L 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQ 247
Query: 247 PNPKTRIRIEGIRKHPWFRKN 267
            +P  R  I+ IR+H WF+++
Sbjct: 248 VDPLKRATIKDIREHEWFKQD 268

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  253 bits (646), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 114/258 (44%), Positives = 177/258 (68%), Gaps = 2/258 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y++ +T+GEG+F KV+ A +  TG+ VA+K++ K  + K  M  +I+REIS ++++R
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HP+I++L++V+ S+ ++ +++E+  G ELFD IV + ++ E + RR+FQQ+I AV +CH 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HRDLKPENLLLD + N+K++DFGLS +   G   L T+CG+PNY APEV+S + Y 
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYA 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWSCGVIL+V++   LPF +  +P L+K I+   ++ P + S GA  LI ++L  
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 250
Query: 248 NPKTRIRIEGIRKHPWFR 265
           NP  RI I  I +  WF+
Sbjct: 251 NPLNRISIHEIMQDDWFK 268

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  253 bits (645), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 114/258 (44%), Positives = 177/258 (68%), Gaps = 2/258 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y++ +T+GEG+F KV+ A +  TG+ VA+K++ K  + K  M  +I+REIS ++++R
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HP+I++L++V+ S+ ++ +++E+  G ELFD IV + ++ E + RR+FQQ+I AV +CH 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 130
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HRDLKPENLLLD + N+K++DFGLS +   G   L T+CG+PNY APEV+S + Y 
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYA 189
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWSCGVIL+V++   LPF +  +P L+K I+   ++ P + S GA  LI ++L  
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 249
Query: 248 NPKTRIRIEGIRKHPWFR 265
           NP  RI I  I +  WF+
Sbjct: 250 NPLNRISIHEIMQDDWFK 267

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  252 bits (644), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 114/258 (44%), Positives = 177/258 (68%), Gaps = 2/258 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y++ +T+GEG+F KV+ A +  TG+ VA+K++ K  + K  M  +I+REIS ++++R
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HP+I++L++V+ S+ ++ +++E+  G ELFD IV + ++ E + RR+FQQ+I AV +CH 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HRDLKPENLLLD + N+K++DFGLS +   G   L T+CG+PNY APEV+S + Y 
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYA 180
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWSCGVIL+V++   LPF +  +P L+K I+   ++ P + S GA  LI ++L  
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 240
Query: 248 NPKTRIRIEGIRKHPWFR 265
           NP  RI I  I +  WF+
Sbjct: 241 NPLNRISIHEIMQDDWFK 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  252 bits (644), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 114/258 (44%), Positives = 177/258 (68%), Gaps = 2/258 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y++ +T+GEG+F KV+ A +  TG+ VA+K++ K  + K  M  +I+REIS ++++R
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HP+I++L++V+ S+ ++ +++E+  G ELFD IV + ++ E + RR+FQQ+I AV +CH 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 125
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HRDLKPENLLLD + N+K++DFGLS +   G   L T+CG+PNY APEV+S + Y 
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYA 184
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWSCGVIL+V++   LPF +  +P L+K I+   ++ P + S GA  LI ++L  
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 244
Query: 248 NPKTRIRIEGIRKHPWFR 265
           NP  RI I  I +  WF+
Sbjct: 245 NPLNRISIHEIMQDDWFK 262

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  251 bits (641), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 115/261 (44%), Positives = 175/261 (67%), Gaps = 1/261 (0%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++  Y +G T+G GTF KV+  ++  TG  VA+K+L +  I    +V +I+REI  +K+ 
Sbjct: 14  KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF 73
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           RHP+I++L++V+++ + +++++E+V+GGELFD I   GRL E + RR FQQ++  V +CH
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
              V HRDLKPEN+LLD++ N K++DFGLS +   G E L  +CG+PNY APEV+S R Y
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRXSCGSPNYAAPEVISGRLY 192
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            G   D+WS GVIL+ L+ G LPF +  +PTL+KKI    F  P + +    SL+  +L 
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQ 252
Query: 247 PNPKTRIRIEGIRKHPWFRKN 267
            +P  R  I+ IR+H WF+++
Sbjct: 253 VDPMKRATIKDIREHEWFKQD 273

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  223 bits (569), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 114/278 (41%), Positives = 174/278 (62%), Gaps = 4/278 (1%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG  VA+K++ K T L    + ++ RE+ IMKI+ 
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILN 69
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+I+E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+   + YD
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDTFCGSPPYAAPELFQGKKYD 188
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ + L  
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 248
Query: 248 NPKTRIRIEGIRKHPWFRKNY--NPVKCSEEEEVNLDD 283
           NP  R  +E I K  W    +  + +K   E E+++ D
Sbjct: 249 NPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISD 286

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  223 bits (568), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 109/257 (42%), Positives = 165/257 (64%), Gaps = 2/257 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA+K++ K T L    + ++ RE+ IMK++ 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLN 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+   + YD
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYD 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 248 NPKTRIRIEGIRKHPWF 264
           NP  R  +E I K  W 
Sbjct: 251 NPSKRGTLEQIMKDRWM 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  223 bits (568), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 109/257 (42%), Positives = 165/257 (64%), Gaps = 2/257 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA+K++ K T L    + ++ RE+ IMK++ 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLN 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+   + YD
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYD 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 248 NPKTRIRIEGIRKHPWF 264
           NP  R  +E I K  W 
Sbjct: 251 NPSKRGTLEQIMKDRWM 267

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  222 bits (565), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 108/257 (42%), Positives = 165/257 (64%), Gaps = 2/257 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA++++ K T L    + ++ RE+ IMK++ 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDK-TQLNSSSLQKLFREVRIMKVLN 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+   + YD
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYD 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 248 NPKTRIRIEGIRKHPWF 264
           NP  R  +E I K  W 
Sbjct: 251 NPSKRGTLEQIMKDRWM 267

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  221 bits (562), Expect = 7e-58,   Method: Compositional matrix adjust.
 Identities = 113/278 (40%), Positives = 172/278 (61%), Gaps = 4/278 (1%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG  VA+K++ K T L    + ++ RE+ IMKI+ 
Sbjct: 14  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILN 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+I+E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L   CG P Y APE+   + YD
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAAPELFQGKKYD 191
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ + L  
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 251
Query: 248 NPKTRIRIEGIRKHPWFRKNY--NPVKCSEEEEVNLDD 283
           NP  R  +E I K  W    +  + +K   E E+++ D
Sbjct: 252 NPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISD 289

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  221 bits (562), Expect = 9e-58,   Method: Compositional matrix adjust.
 Identities = 108/257 (42%), Positives = 163/257 (63%), Gaps = 2/257 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA+K++ K T L    + ++ RE+ IMK++ 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLN 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L   CG P Y APE+   + YD
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDAFCGAPPYAAPELFQGKKYD 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 248 NPKTRIRIEGIRKHPWF 264
           NP  R  +E I K  W 
Sbjct: 251 NPSKRGTLEQIMKDRWM 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  219 bits (559), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 107/257 (41%), Positives = 164/257 (63%), Gaps = 2/257 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA++++ K T L    + ++ RE+ IMK++ 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDK-TQLNSSSLQKLFREVRIMKVLN 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L   CG+P Y APE+   + YD
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDEFCGSPPYAAPELFQGKKYD 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 248 NPKTRIRIEGIRKHPWF 264
           NP  R  +E I K  W 
Sbjct: 251 NPSKRGTLEQIMKDRWM 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  219 bits (559), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 108/256 (42%), Positives = 164/256 (64%), Gaps = 2/256 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA+K++ K T L    + ++ RE+ IMK++ 
Sbjct: 6   IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLN 64
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  G + E + R  F+Q++ AV +CH 
Sbjct: 65  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+   + YD
Sbjct: 125 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYD 183
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 243
Query: 248 NPKTRIRIEGIRKHPW 263
           NP  R  +E I K  W
Sbjct: 244 NPSKRGTLEQIMKDRW 259

>pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143

Iteration: 1
 Score =  219 bits (557), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 103/140 (73%), Positives = 122/140 (87%), Gaps = 3/140 (2%)
Query: 306 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 365
           GPL+MNAFEMITLSQGLNL+ALFDRRQD+VKRQTRFVSR+    I++NIEAVA S+  K 
Sbjct: 3   GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKS 62
Query: 366 HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLE 425
           HTRN+KTRLEG+S+ K GQ AVV+E++EVAPSLFMVDVRKAAG+TLEYHKFYK  C+KLE
Sbjct: 63  HTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLE 122
Query: 426 NIIWKPTEG---SSLLRTMS 442
           NIIW+ TEG   S +LRT++
Sbjct: 123 NIIWRATEGIPKSEILRTIT 142

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  215 bits (547), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 107/256 (41%), Positives = 160/256 (62%), Gaps = 2/256 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA+K++ K T L    + ++ RE+ I K++ 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIXKVLN 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y++ E+ +GGE+FD +V  GR  E + R  F+Q++ AV +CH 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L   CG P Y APE+   + YD
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK-LDAFCGAPPYAAPELFQGKKYD 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLKKFLIL 250
Query: 248 NPKTRIRIEGIRKHPW 263
           NP  R  +E I K  W
Sbjct: 251 NPSKRGTLEQIXKDRW 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  213 bits (542), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 114/272 (41%), Positives = 170/272 (62%), Gaps = 8/272 (2%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG  VA+K++ K T L    + ++ RE+ IMKI+ 
Sbjct: 14  IGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDK-TQLNPTSLQKLFREVRIMKILN 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD   N+K++DFG S     G + L T CG+P Y APE+   + YD
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK-LDTFCGSPPYAAPELFQGKKYD 191
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K+L  
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKLLVL 251
Query: 248 NPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
           NP  R  +E I K  W    +      EEEE+
Sbjct: 252 NPIKRGSLEQIMKDRWMNVGH------EEEEL 277

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  201 bits (511), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 160/270 (59%), Gaps = 21/270 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+ + IG G F   R  +++++ E VA+K + +      ++ + +KREI   + +RHP
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIDENVKREIINHRSLRHP 74
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++CH+  
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 134
Query: 130 VYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPEVLSN 183
           V HRDLK EN LLD      LK+ DFG S        +LH    +T GTP Y+APEVL  
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLK 189
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--FSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   S   
Sbjct: 190 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC 249
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI +I   +P  RI I  IR H WF KN
Sbjct: 250 RHLISRIFVADPAKRISIPEIRNHEWFLKN 279

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 159/270 (58%), Gaps = 21/270 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+ + IG G F   R  +++++ E VA+K + +      ++   +KREI   + +RHP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIAANVKREIINHRSLRHP 75
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++CH+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 130 VYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPEVLSN 183
           V HRDLK EN LLD      LK+ DFG S        +LH    +T GTP Y+APEVL  
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLK 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--FSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   S   
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC 250
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI +I   +P  RI I  IR H WF KN
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 2   KKQTRRVAK-YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           KKQ   + K +E   T+G G F++V  A+ + TG+  A+K + K  +        I+ EI
Sbjct: 14  KKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKE--SSIENEI 71
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           ++++ ++H NIV L ++  S   +Y++++ V+GGELFD+IV +G   E D     +Q++D
Sbjct: 72  AVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD 131
Query: 121 AVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
           AV + H  G+ HRDLKPENLL    D    + +SDFGLS +  +G +++ T CGTP YVA
Sbjct: 132 AVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG-DVMSTACGTPGYVA 190
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
           PEVL+ + Y   A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   
Sbjct: 191 PEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDI 249
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPW 263
           S  A   I  +++ +P  R   E   +HPW
Sbjct: 250 SDSAKDFIRNLMEKDPNKRYTCEQAARHPW 279

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  198 bits (504), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 158/270 (58%), Gaps = 21/270 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + IG G F   R  +++ T E VA+K + +   +     + ++REI   + +RHP
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHP 76
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVR  EV+ + T + II+E+ +GGEL+++I + GR  E++ R +FQQL+  V++CHS  
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 130 VYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPEVLSN 183
           + HRDLK EN LLD      LK+ DFG S        +LH    +T GTP Y+APEVL  
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLR 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCP--FWFSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  Y+K    I + ++S P     S   
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC 251
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI +I   +P TRI I  I+ H WF KN
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWFLKN 281

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  198 bits (504), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 155/260 (59%), Gaps = 11/260 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y+    +G G F++V  A+++ T + VA+K +AK  +        ++ EI+++  ++HPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + H  G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 131 YHRDLKPENLL---LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPENLL   LD    + +SDFGLS +   G  +L T CGTP YVAPEVL+ + Y 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY- 195
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHK 243
             A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   S  A   I  
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 255
Query: 244 ILDPNPKTRIRIEGIRKHPW 263
           +++ +P+ R   E   +HPW
Sbjct: 256 LMEKDPEKRFTCEQALQHPW 275

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  198 bits (504), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 155/260 (59%), Gaps = 11/260 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y+    +G G F++V  A+++ T + VA+K +AK  +        ++ EI+++  ++HPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + H  G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 131 YHRDLKPENLL---LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPENLL   LD    + +SDFGLS +   G  +L T CGTP YVAPEVL+ + Y 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY- 195
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHK 243
             A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   S  A   I  
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 255
Query: 244 ILDPNPKTRIRIEGIRKHPW 263
           +++ +P+ R   E   +HPW
Sbjct: 256 LMEKDPEKRFTCEQALQHPW 275

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  198 bits (503), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 103/261 (39%), Positives = 155/261 (59%), Gaps = 11/261 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y+    +G G F++V  A+++ T + VA+K +AK  +        ++ EI+++  ++HPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + H  G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 131 YHRDLKPENLL---LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPENLL   LD    + +SDFGLS +   G  +L T CGTP YVAPEVL+ + Y 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY- 195
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHK 243
             A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   S  A   I  
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 255
Query: 244 ILDPNPKTRIRIEGIRKHPWF 264
           +++ +P+ R   E   +HPW 
Sbjct: 256 LMEKDPEKRFTCEQALQHPWI 276

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  197 bits (502), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 155/260 (59%), Gaps = 11/260 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y+    +G G F++V  A+++ T + VA+K +AK  +        ++ EI+++  ++HPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHPN 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + H  G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 131 YHRDLKPENLL---LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPENLL   LD    + +SDFGLS +   G  +L T CGTP YVAPEVL+ + Y 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY- 195
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHK 243
             A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   S  A   I  
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 255
Query: 244 ILDPNPKTRIRIEGIRKHPW 263
           +++ +P+ R   E   +HPW
Sbjct: 256 LMEKDPEKRFTCEQALQHPW 275

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  197 bits (501), Expect = 9e-51,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 159/270 (58%), Gaps = 21/270 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+ + IG G F   R  +++++ E VA+K + +      ++ + +KREI   + +RHP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIDENVKREIINHRSLRHP 75
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++CH+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 130 VYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLHT----TCGTPNYVAPEVLSN 183
           V HRDLK EN LLD      LK+  FG S        +LH+    T GTP Y+APEVL  
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKDTVGTPAYIAPEVLLK 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--FSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   S   
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC 250
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI +I   +P  RI I  IR H WF KN
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  197 bits (501), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 159/270 (58%), Gaps = 21/270 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+ + IG G F   R  +++++ E VA+K + +      ++ + +KREI   + +RHP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIDENVKREIINHRSLRHP 75
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++CH+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 130 VYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPEVLSN 183
           V HRDLK EN LLD      LK+  FG S        +LH    +T GTP Y+APEVL  
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLK 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--FSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   S   
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC 250
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI +I   +P  RI I  IR H WF KN
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 107/270 (39%), Positives = 158/270 (58%), Gaps = 21/270 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+ + IG G F   R  ++++  E VA+K + +      ++ + +KREI   + +RHP
Sbjct: 20  RYELVKDIGAGNFGVARLMRDKQANELVAVKYIERG----EKIDENVKREIINHRSLRHP 75
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++ H+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ 135
Query: 130 VYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPEVLSN 183
           V HRDLK EN LLD      LK++DFG S        +LH    +  GTP Y+APEVL  
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSK-----ASVLHSQPKSAVGTPAYIAPEVLLK 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--FSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   S   
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC 250
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI +I   +P  RI I  IR H WF KN
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 101/258 (39%), Positives = 147/258 (56%), Gaps = 13/258 (5%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G F++V   + R TG+  A+K + KS   +      ++ EI+++K ++H NIV L +
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKHENIVTLED 73
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
           +  S T  Y++++ V+GGELFD+I+ +G   E D     QQ++ AV + H  G+ HRDLK
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK 133
Query: 137 PENLLL---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           PENLL    +    + ++DFGLS + Q G+  + T CGTP YVAPEVL+ + Y   A D 
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPEVLAQKPY-SKAVDC 190
Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHKILDPNP 249
           WS GVI ++L+ GY PF E     L++KI     EF  PFW   S  A   I  +L+ +P
Sbjct: 191 WSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDP 250
Query: 250 KTRIRIEGIRKHPWFRKN 267
             R   E    HPW   N
Sbjct: 251 NERYTCEKALSHPWIDGN 268

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 100/280 (35%), Positives = 159/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   GE++ ++    +  E     Y  +L +A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA 125
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMI 183
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 184 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  191 bits (485), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 103/262 (39%), Positives = 152/262 (58%), Gaps = 9/262 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++   +G+G F+ VR      TG+  A K++  +  L  R   +++RE  I ++++HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKII-NTKKLSARDHQKLEREARICRLLKHP 63
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVRLH+ ++     Y++ + VTGGELF+ IV +    E D     QQ++++V HCH  G
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 130 VYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL S      +K++DFGL+   Q   +      GTP Y++PEVL    Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIH 242
            G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  A  LI+
Sbjct: 184 -GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 243 KILDPNPKTRIRIEGIRKHPWF 264
           K+L  NP  RI      KHPW 
Sbjct: 243 KMLTINPAKRITASEALKHPWI 264

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  191 bits (485), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 106/276 (38%), Positives = 153/276 (55%), Gaps = 9/276 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y++   +G+G F+ VR       G+  A K++  +  L  R   +++RE  I ++++HPN
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKII-NTKKLSARDHQKLEREARICRLLKHPN 82
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IVRLH+ ++     Y+I + VTGGELF+ IV +    E D     QQ+++AV HCH  GV
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 131 YHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPENLLL S      +K++DFGL+   +   +      GTP Y++PEVL    Y 
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY- 201
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHK 243
           G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  A  LI+K
Sbjct: 202 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 261
Query: 244 ILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
           +L  NP  RI      KHPW         C   +E 
Sbjct: 262 MLTINPSKRITAAEALKHPWISHRSTVASCMHRQET 297

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 103/262 (39%), Positives = 152/262 (58%), Gaps = 9/262 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++   +G+G F+ VR      TG+  A K++  +  L  R   +++RE  I ++++HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKII-NTKKLSARDHQKLEREARICRLLKHP 63
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVRLH+ ++     Y++ + VTGGELF+ IV +    E D     QQ++++V HCH  G
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 130 VYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL S      +K++DFGL+   Q   +      GTP Y++PEVL    Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIH 242
            G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  A  LI+
Sbjct: 184 -GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 243 KILDPNPKTRIRIEGIRKHPWF 264
           K+L  NP  RI      KHPW 
Sbjct: 243 KMLTINPAKRITASEALKHPWI 264

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMI 183
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 184 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 105/271 (38%), Positives = 155/271 (57%), Gaps = 10/271 (3%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M   T+    Y+V   +G+G F+ VR   ++ TG   A K++  +  L  R   +++RE 
Sbjct: 21  MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREA 79
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I + ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
           ++A+CHS G+ HR+LKPENLLL S      +K++DFGL A+     E  H   GTP Y++
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSEAWHGFAGTPGYLS 198
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
           PEVL    Y     D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   
Sbjct: 199 PEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 257
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
           +  A SLI  +L  NPK RI  +   K PW 
Sbjct: 258 TPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 18  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 77
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 78  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 138 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMI 195
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 196 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 254
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 255 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 294

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMI 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 182 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 280

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--DTLCGTLDYLPPEMI 179
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 180 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  190 bits (482), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 157/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE +
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEXI 183
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 184 EGRXHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 243 SRLLKHNPSQRPXLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 146
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 147 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMI 204
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 205 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 263
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 264 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 303

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 104/261 (39%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++   IG+G F+ VR      TG   A K++  +  L  R   +++RE  I ++++H 
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKII-NTKKLSARDHQKLEREARICRLLKHS 63
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVRLH+ ++     Y++ + VTGGELF+ IV +    E D     QQ+++AV HCH  G
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 123
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           V HRDLKPENLLL S      +K++DFGL+   Q   +      GTP Y++PEVL    Y
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIH 242
            G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  A +LI+
Sbjct: 184 -GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 242
Query: 243 KILDPNPKTRIRIEGIRKHPW 263
           ++L  NP  RI      KHPW
Sbjct: 243 QMLTINPAKRITAHEALKHPW 263

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  189 bits (480), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 106/282 (37%), Positives = 155/282 (54%), Gaps = 9/282 (3%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           TR   +Y++   +G+G F+ VR       G+  A  ++  +  L  R   +++RE  I +
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMII-NTKKLSARDHQKLEREARICR 65
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           +++HPNIVRLH+ ++     Y+I + VTGGELF+ IV +    E D     QQ+++AV H
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 125 CHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CH  GV HR+LKPENLLL S      +K++DFGL+   +   +      GTP Y++PEVL
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGA 237
               Y G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  A
Sbjct: 186 RKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
             LI+K+L  NP  RI      KHPW         C   +E 
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQET 286

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 100/282 (35%), Positives = 161/282 (57%), Gaps = 8/282 (2%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 179
           +++CHSK V HRD+KPENLLL S G LK++DFG S  A   +  +L    CGT +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPPE 177
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 239
           ++  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  
Sbjct: 178 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
           LI ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 160/281 (56%), Gaps = 6/281 (2%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 146
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEV 180
           +++CHSK V HRD+KPENLLL S G LK++DFG S   P    + L   CGT +Y+ PE+
Sbjct: 147 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL---CGTLDYLPPEM 203
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  L
Sbjct: 204 IEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 262
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
           I ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 263 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 303

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  188 bits (478), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 159/281 (56%), Gaps = 6/281 (2%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEV 180
           +++CHSK V HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE+
Sbjct: 123 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---CGTLDYLPPEM 179
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  L
Sbjct: 180 IEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 238
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
           I ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 239 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 279

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  188 bits (478), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 154/271 (56%), Gaps = 4/271 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R +D   
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHD-EK 186
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 251 TRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            R  +  + +HPW   N + P  C  +E  +
Sbjct: 247 QRPMLREVLEHPWITANSSKPSNCQNKESAS 277

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  188 bits (478), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 98/280 (35%), Positives = 158/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK+++FG S           T CGT +Y+ PE++
Sbjct: 123 LSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT--TLCGTLDYLPPEMI 180
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 181 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 239
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 240 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 279

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  188 bits (478), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 100/282 (35%), Positives = 161/282 (57%), Gaps = 8/282 (2%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 179
           +++CHSK V HRD+KPENLLL S G LK++DFG S  A   +  +L    CGT +Y+ PE
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPPE 181
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 239
           ++  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  
Sbjct: 182 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
           LI ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  188 bits (477), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 160/279 (57%), Gaps = 8/279 (2%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 179
           +++CHSK V HRD+KPENLLL S G LK++DFG S  A   +  +L    CGT +Y+ PE
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPPE 176
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 239
           ++  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  
Sbjct: 177 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEE 277
           LI ++L  NP  R  +  + +HPW   N + P  C  +E
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  188 bits (477), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 99/273 (36%), Positives = 157/273 (57%), Gaps = 8/273 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRD+KPENLLL S G LK++DFG S  A   +  EL    CGT +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTEL----CGTLDYLPPEMIEGRMHD- 184
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
              D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  N
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 249 PKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
           P  R  +  + +HPW   N + P  C  +E  +
Sbjct: 245 PSQRPMLREVLEHPWITANSSKPSNCQNKESAS 277

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  188 bits (477), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 104/266 (39%), Positives = 154/266 (57%), Gaps = 10/266 (3%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           T+    Y+V   +G+G F+ VR   ++ TG   A K++  +  L  R   +++RE  I +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICR 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++A+
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CHS G+ HR+LKPENLLL S      +K++DFGL A+     E  H   GTP Y++PEVL
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGA 237
               Y     D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   +  A
Sbjct: 180 KKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPW 263
            SLI  +L  NPK RI  +   K PW
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPW 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  187 bits (476), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 154/267 (57%), Gaps = 10/267 (3%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           T+    Y+V   +G+G F+ VR   ++ TG   A K++  +  L  R   +++RE  I +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICR 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++A+
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CHS G+ HR+LKPENLLL S      +K++DFGL A+     E  H   GTP Y++PEVL
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGA 237
               Y     D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   +  A
Sbjct: 180 KKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWF 264
            SLI  +L  NPK RI  +   K PW 
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  187 bits (476), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 154/267 (57%), Gaps = 10/267 (3%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           T+    Y+V   +G+G F+ VR   ++ TG   A K++  +  L  R   +++RE  I +
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICR 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++A+
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CHS G+ HR+LKPENLLL S      +K++DFGL A+     E  H   GTP Y++PEVL
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVL 178
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGA 237
               Y     D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   +  A
Sbjct: 179 KKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 237
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWF 264
            SLI  +L  NPK RI  +   K PW 
Sbjct: 238 KSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  187 bits (476), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 159/281 (56%), Gaps = 6/281 (2%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   GE++ ++    +  E     Y  +L +A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA 125
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEV 180
           +++CHSK V HRD+KPENLLL S G LK++DFG S   P      L    GT +Y+ PE+
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---XGTLDYLPPEM 182
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  L
Sbjct: 183 IEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
           I ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  187 bits (476), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 101/280 (36%), Positives = 161/280 (57%), Gaps = 9/280 (3%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MK+Q   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+
Sbjct: 1   MKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAP 178
           A+++CHSK V HRD+KPENLLL S G LK++DFG S  A   +  +L    CGT +Y+ P
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPP 175
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGAT 238
           E++  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA 
Sbjct: 176 EMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEE 277
            LI ++L  NP  R  +  + +HPW   N + P  C  +E
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 96/266 (36%), Positives = 152/266 (57%), Gaps = 3/266 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMI 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 182 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKN 267
            ++L  NP  R  +  + +HPW   N
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 155/272 (56%), Gaps = 6/272 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R +D  
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL---CGTLDYLPPEMIEGRMHD-E 188
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 248
Query: 250 KTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
             R  +  + +HPW   N + P  C  +E  +
Sbjct: 249 SQRPMLREVLEHPWITANSSKPSNCQNKESAS 280

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  186 bits (471), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 153/267 (57%), Gaps = 5/267 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEV 180
           +++CHSK V HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE+
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---CGTLDYLPPEM 180
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  L
Sbjct: 181 IEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKN 267
           I ++L  NP  R  +  + +HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  185 bits (470), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 94/257 (36%), Positives = 148/257 (57%), Gaps = 3/257 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 128
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R +D   
Sbjct: 129 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHD-EK 185
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP 
Sbjct: 186 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 245
Query: 251 TRIRIEGIRKHPWFRKN 267
            R  +  + +HPW   N
Sbjct: 246 QRPMLREVLEHPWITAN 262

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  185 bits (470), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 94/257 (36%), Positives = 148/257 (57%), Gaps = 3/257 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 133
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R +D   
Sbjct: 134 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHD-EK 190
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP 
Sbjct: 191 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 250
Query: 251 TRIRIEGIRKHPWFRKN 267
            R  +  + +HPW   N
Sbjct: 251 QRPMLREVLEHPWITAN 267

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 95/266 (35%), Positives = 152/266 (57%), Gaps = 3/266 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK+++FG S           T CGT +Y+ PE++
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT--TLCGTLDYLPPEMI 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 182 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKN 267
            ++L  NP  R  +  + +HPW   N
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  185 bits (469), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  185 bits (469), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  185 bits (469), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  184 bits (468), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  184 bits (468), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  184 bits (468), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  184 bits (468), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEIXINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  184 bits (468), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  184 bits (468), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 152/265 (57%), Gaps = 3/265 (1%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+   +  +++GR +G+G F  V  A+ R++   +A+KVL K+ + K  +  Q++RE+ I
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
              +RHPNI+RL+      T+VY+ILE+   G ++ ++    R  E     Y  +L +A+
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           ++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++ 
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIE 183
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
            R +D    D+WS GV+ +  + G  PF        Y++I+  EF+ P + + GA  LI 
Sbjct: 184 GRMHD-EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLIS 242
Query: 243 KILDPNPKTRIRIEGIRKHPWFRKN 267
           ++L  N   R+ +  + +HPW + N
Sbjct: 243 RLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  184 bits (468), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 58
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 59  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNK 265

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  184 bits (468), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 97/277 (35%), Positives = 156/277 (56%), Gaps = 3/277 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T  GT +Y+ PE++
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT--TLSGTLDYLPPEMI 179
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 180 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEE 278
            ++L  NP  R  +  + +HPW   N +    S+ +E
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNSQNKE 275

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  184 bits (468), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 94/257 (36%), Positives = 147/257 (57%), Gaps = 3/257 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ ++    +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 126
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R +D   
Sbjct: 127 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHD-EK 183
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP 
Sbjct: 184 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 243
Query: 251 TRIRIEGIRKHPWFRKN 267
            R  +  + +HPW   N
Sbjct: 244 QRPMLREVLEHPWITAN 260

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 152/265 (57%), Gaps = 3/265 (1%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+   +  +++GR +G+G F  V  A+ R++   +A+KVL K+ + K  +  Q++RE+ I
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
              +RHPNI+RL+      T+VY+ILE+   G ++ ++    R  E     Y  +L +A+
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           ++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++ 
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR--DTLCGTLDYLPPEMIE 183
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
            R +D    D+WS GV+ +  + G  PF        Y++I+  EF+ P + + GA  LI 
Sbjct: 184 GRMHD-EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLIS 242
Query: 243 KILDPNPKTRIRIEGIRKHPWFRKN 267
           ++L  N   R+ +  + +HPW + N
Sbjct: 243 RLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  184 bits (467), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  184 bits (467), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 150/267 (56%), Gaps = 3/267 (1%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M K+   +  +++GR +G+G F  V  A+ ++    +A+KVL KS + K  +  Q++REI
Sbjct: 7   MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 66
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I   +RHPNI+R++     R ++Y++LEF   GEL+ ++   GR  E     + ++L D
Sbjct: 67  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD 126
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+ +CH + V HRD+KPENLL+   G LK++DFG S             CGT +Y+ PE+
Sbjct: 127 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRXMCGTLDYLPPEM 184
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  + +D    D+W  GV+ +  + G  PF        +++I   +   P + S G+  L
Sbjct: 185 IEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 243
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKN 267
           I K+L  +P  R+ ++G+ +HPW + N
Sbjct: 244 ISKLLRYHPPQRLPLKGVMEHPWVKAN 270

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 149/258 (57%), Gaps = 5/258 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R +D  
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL---CGTLDYLPPEMIEGRMHD-E 185
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 245
Query: 250 KTRIRIEGIRKHPWFRKN 267
             R  +  + +HPW   N
Sbjct: 246 SQRPMLREVLEHPWITAN 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 149/258 (57%), Gaps = 5/258 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R +D  
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---CGTLDYLPPEMIEGRMHD-E 185
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 245
Query: 250 KTRIRIEGIRKHPWFRKN 267
             R  +  + +HPW   N
Sbjct: 246 SQRPMLREVLEHPWITAN 263

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 149/258 (57%), Gaps = 5/258 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R +D  
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXL---CGTLDYLPPEMIEGRMHD-E 185
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 245
Query: 250 KTRIRIEGIRKHPWFRKN 267
             R  +  + +HPW   N
Sbjct: 246 SQRPMLREVLEHPWITAN 263

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  183 bits (465), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 148/258 (57%), Gaps = 5/258 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ + +   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKV 129
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R +D  
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL---CGTLDYLPPEMIEGRMHD-E 185
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRLLKHNP 245
Query: 250 KTRIRIEGIRKHPWFRKN 267
             R  +  + +HPW   N
Sbjct: 246 SQRPMLREVLEHPWITAN 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  183 bits (465), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 150/258 (58%), Gaps = 5/258 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KPENLLL S G LK++DFG S   P    + L   CGT +Y+ PE++  R +D  
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL---CGTLDYLPPEMIEGRMHD-E 188
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 248
Query: 250 KTRIRIEGIRKHPWFRKN 267
             R  +  + +HPW   N
Sbjct: 249 SQRPMLREVLEHPWITAN 266

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG   +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 103/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I  
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINA 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  181 bits (458), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 100/270 (37%), Positives = 152/270 (56%), Gaps = 9/270 (3%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M   TR    Y++   +G+G F+ VR    +   +  A K++  +  L  R   +++RE 
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKII-NTKKLSARDHQKLEREA 81
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I ++++HPNIVRLH+ ++     Y++ + VTGGELF+ IV +    E D      Q+++
Sbjct: 82  RICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILE 141
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
           +V H H   + HRDLKPENLLL S      +K++DFGL+   Q   +      GTP Y++
Sbjct: 142 SVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLS 201
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
           PEVL    Y G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   
Sbjct: 202 PEVLRKDPY-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTV 260
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPW 263
           +  A +LI+++L  NP  RI  +   KHPW
Sbjct: 261 TPEAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  181 bits (458), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 106/264 (40%), Positives = 151/264 (57%), Gaps = 13/264 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y +  TIG G++ +V+ A  + T    A K + K  +     VD+ K+EI IMK + HPN
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPN 84
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+E     T +Y+++E  TGGELF+++VH+    E+D  R  + ++ AVA+CH   V
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 144
Query: 131 YHRDLKPENLLL--DSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPEN L   DS  + LK+ DFGL+A  + G +++ T  GTP YV+P+VL   G  
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLE--GLY 201
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--WF--STGATSLIHK 243
           G   D WS GV+++VL+ GY PF       +  KI    F+ P   W   S  A SLI +
Sbjct: 202 GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 261
Query: 244 ILDPNPKTRIRIEGIRKHPWFRKN 267
           +L  +PK RI      +H WF K 
Sbjct: 262 LLTKSPKQRITSLQALEHEWFEKQ 285

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 103/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 103/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEIXINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 106/264 (40%), Positives = 151/264 (57%), Gaps = 13/264 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y +  TIG G++ +V+ A  + T    A K + K  +     VD+ K+EI IMK + HPN
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPN 67
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+E     T +Y+++E  TGGELF+++VH+    E+D  R  + ++ AVA+CH   V
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 131 YHRDLKPENLLL--DSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPEN L   DS  + LK+ DFGL+A  + G +++ T  GTP YV+P+VL   G  
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLE--GLY 184
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--FWF--STGATSLIHK 243
           G   D WS GV+++VL+ GY PF       +  KI    F+ P   W   S  A SLI +
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244
Query: 244 ILDPNPKTRIRIEGIRKHPWFRKN 267
           +L  +PK RI      +H WF K 
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEKQ 268

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 149/267 (55%), Gaps = 3/267 (1%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M K+   +  +++ R +G+G F  V  A+ ++    +A+KVL KS + K  +  Q++REI
Sbjct: 6   MPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I   +RHPNI+R++     R ++Y++LEF   GEL+ ++   GR  E     + ++L D
Sbjct: 66  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD 125
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+ +CH + V HRD+KPENLL+   G LK++DFG S             CGT +Y+ PE+
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRXMCGTLDYLPPEM 183
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  + +D    D+W  GV+ +  + G  PF        +++I   +   P + S G+  L
Sbjct: 184 IEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKN 267
           I K+L  +P  R+ ++G+ +HPW + N
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKAN 269

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 103/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 103/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEIXINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 103/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 152/264 (57%), Gaps = 11/264 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +   +G+G+F +V   ++R T +  A+KV+ K++  K++    I RE+ ++K + HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHP 81
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   + + H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 130 VYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPEN+LL+S     ++K+ DFGLS   QQ  + +    GT  Y+APEVL  RG 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVL--RGT 198
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
                DVWS GVIL++L++G  PF   +   + K++   +  F  P W   S  A  LI 
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 243 KILDPNPKTRIRIEGIRKHPWFRK 266
           K+L  +P  RI      +HPW +K
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 110/297 (37%), Positives = 162/297 (54%), Gaps = 22/297 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+K+++K    I   R  D    ++ EI I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 71  KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 188
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W   S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWF-----RKNYNPVKCSEEEEVNLDDVHA 286
             A  L+ K+L  +PK R   E   +HPW      ++ +  +   E E   L  V A
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 110/297 (37%), Positives = 162/297 (54%), Gaps = 22/297 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+K+++K    I   R  D    ++ EI I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 71  KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 188
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W   S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWF-----RKNYNPVKCSEEEEVNLDDVHA 286
             A  L+ K+L  +PK R   E   +HPW      ++ +  +   E E   L  V A
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 105/271 (38%), Positives = 154/271 (56%), Gaps = 17/271 (6%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+K+++K    I   R  D    ++ EI I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 71  KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 188
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W   S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
             A  L+ K+L  +PK R   E   +HPW +
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 105/271 (38%), Positives = 154/271 (56%), Gaps = 17/271 (6%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+K+++K    I   R  D    ++ EI I+K
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 70  KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 128
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 129 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 187
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W   S
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 247
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
             A  L+ K+L  +PK R   E   +HPW +
Sbjct: 248 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 110/297 (37%), Positives = 162/297 (54%), Gaps = 22/297 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+K+++K    I   R  D    ++ EI I+K
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 77  KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 135
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 136 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 194
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W   S
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 254
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWF-----RKNYNPVKCSEEEEVNLDDVHA 286
             A  L+ K+L  +PK R   E   +HPW      ++ +  +   E E   L  V A
Sbjct: 255 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 311

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 153/263 (58%), Gaps = 19/263 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ--IKREISIMKIVRH 68
           +EV   +G G  + V   + + T +  A+KVL K+       VD+  ++ EI ++  + H
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-------VDKKIVRTEIGVLLRLSH 107
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           PNI++L E+  + T++ ++LE VTGGELFD+IV +G   E D     +Q+++AVA+ H  
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 129 GVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           G+ HRDLKPENLL  +      LK++DFGLS + +  V L+ T CGTP Y APE+L    
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-LMKTVCGTPGYCAPEILRGCA 226
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAE--FSCPFW--FSTGATSL 240
           Y G   D+WS G+I ++L+ G+ PF  E     ++++I   E  F  P+W   S  A  L
Sbjct: 227 Y-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDL 285
Query: 241 IHKILDPNPKTRIRIEGIRKHPW 263
           + K++  +PK R+      +HPW
Sbjct: 286 VRKLIVLDPKKRLTTFQALQHPW 308

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 156/265 (58%), Gaps = 11/265 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  +++ RT+G G+F +V   ++R  G   AMKVL K  +++ + V+    E  ++ IV 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HP I+R+        ++++I++++ GGELF  +    R      + Y  ++  A+ + HS
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           K + +RDLKPEN+LLD  G++K++DFG +  +P    ++ +  CGTP+Y+APEV+S + Y
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYXLCGTPDYIAPEVVSTKPY 180
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
           + S  D WS G++++ ++AGY PF +++    Y+KI  AE   P +F+     L+ +++ 
Sbjct: 181 NKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 239
Query: 247 PNPKTRI-----RIEGIRKHPWFRK 266
            +   R+       E ++ HPWF++
Sbjct: 240 RDLSQRLGNLQNGTEDVKNHPWFKE 264

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 152/264 (57%), Gaps = 11/264 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +   +G+G+F +V   ++R T +  A+KV+ K++  K++    I RE+ ++K + HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHP 81
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   + + H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPEN+LL+S     ++K+ DFGLS   QQ  + +    GT  Y+APEVL  RG 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVL--RGT 198
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
                DVWS GVIL++L++G  PF   +   + K++   +  F  P W   S  A  LI 
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 243 KILDPNPKTRIRIEGIRKHPWFRK 266
           K+L  +P  RI      +HPW +K
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 152/264 (57%), Gaps = 11/264 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +   +G+G+F +V   ++R T +  A+KV+ K++  K++    I RE+ ++K + HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHP 81
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   + + H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPEN+LL+S     ++K+ DFGLS   QQ  + +    GT  Y+APEVL  RG 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVL--RGT 198
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
                DVWS GVIL++L++G  PF   +   + K++   +  F  P W   S  A  LI 
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 243 KILDPNPKTRIRIEGIRKHPWFRK 266
           K+L  +P  RI      +HPW +K
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 155/271 (57%), Gaps = 17/271 (6%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+++++K    I   R  D    ++ EI I+K
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 209
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 210 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 268
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 269 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 327
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSC--PFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +++     W   S
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 387
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
             A  L+ K+L  +PK R   E   +HPW +
Sbjct: 388 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ 418

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  174 bits (441), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 87/262 (33%), Positives = 148/262 (56%), Gaps = 2/262 (0%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++  ++VG  +G+G+FA V  A++  TG  VA+K++ K  + K  MV +++ E+ I   +
Sbjct: 9   KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHC 125
           +HP+I+ L+        VY++LE    GE+   + ++ +   EN+ R +  Q+I  + + 
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HS G+ HRDL   NLLL    N+K++DFGL+   +   E  +T CGTPNY++PE+ + R 
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI-ATRS 187
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
             G  +DVWS G + + L+ G  PF    +     K+  A++  P + S  A  LIH++L
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLL 247
Query: 246 DPNPKTRIRIEGIRKHPWFRKN 267
             NP  R+ +  +  HP+  +N
Sbjct: 248 RRNPADRLSLSSVLDHPFMSRN 269

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  174 bits (441), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 155/271 (57%), Gaps = 17/271 (6%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+++++K    I   R  D    ++ EI I+K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 313
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSC--PFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +++     W   S
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
             A  L+ K+L  +PK R   E   +HPW +
Sbjct: 374 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/265 (37%), Positives = 153/265 (57%), Gaps = 12/265 (4%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMK 64
           +++E+ + +G+G+F KV F   + +G       AMKVL K+T LK R   + K E  I+ 
Sbjct: 24  SQFELLKVLGQGSFGKV-FLVKKISGSDARQLYAMKVLKKAT-LKVRDRVRTKMERDILV 81
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            V HP IV+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ R
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
           G+  S AD WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  +
Sbjct: 202 GHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRML 260
Query: 245 LDPNPKTRI-----RIEGIRKHPWF 264
              NP  R+      +E I++H +F
Sbjct: 261 FKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/265 (37%), Positives = 153/265 (57%), Gaps = 12/265 (4%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMK 64
           +++E+ + +G+G+F KV F   + +G       AMKVL K+T LK R   + K E  I+ 
Sbjct: 25  SQFELLKVLGQGSFGKV-FLVKKISGSDARQLYAMKVLKKAT-LKVRDRVRTKMERDILV 82
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            V HP IV+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H
Sbjct: 83  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 142
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ R
Sbjct: 143 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 202
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
           G+  S AD WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  +
Sbjct: 203 GHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRML 261
Query: 245 LDPNPKTRI-----RIEGIRKHPWF 264
              NP  R+      +E I++H +F
Sbjct: 262 FKRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 100/265 (37%), Positives = 153/265 (57%), Gaps = 12/265 (4%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMK 64
           +++E+ + +G+G+F KV F   + +G       AMKVL K+T LK R   + K E  I+ 
Sbjct: 24  SQFELLKVLGQGSFGKV-FLVKKISGSDARQLYAMKVLKKAT-LKVRDRVRTKMERDILV 81
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            V HP IV+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ R
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
           G+  S AD WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  +
Sbjct: 202 GHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRML 260
Query: 245 LDPNPKTRI-----RIEGIRKHPWF 264
              NP  R+      +E I++H +F
Sbjct: 261 FKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 146/264 (55%), Gaps = 10/264 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + +G G + +V   +++ TG   A+K++ KS++        +  E++++K + HP
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 64
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L+E    +   Y+++E   GGELFD+I+ + +  E D     +Q++    + H   
Sbjct: 65  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN 124
Query: 130 VYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S      +K+ DFGLSA  + G + +    GT  Y+APEVL  + Y
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK-MKERLGTAYYIAPEVLRKK-Y 182
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC--PFW--FSTGATSLIH 242
           D    DVWSCGVIL++L+ GY PFG      + K++   +FS   P W   S  A  L+ 
Sbjct: 183 D-EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVK 241
Query: 243 KILDPNPKTRIRIEGIRKHPWFRK 266
            +L   P  RI  E    HPW  K
Sbjct: 242 LMLTYEPSKRISAEEALNHPWIVK 265

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 157/267 (58%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKREISIMKIVR 67
           YE+G  +G G FA VR  + + TG+  A K + K  +   R     ++I+RE++I++ +R
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNI+ LH++  ++T V +ILE V+GGELFD +  +  L E++  ++ +Q++D V + HS
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           K + H DLKPEN++L         +K+ DFG++   + G E      GTP +VAPE+++ 
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNY 206
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTG--AT 238
               G  AD+WS GVI ++L++G  PF GET   TL   I+A   +F   ++ +T   A 
Sbjct: 207 EPL-GLEADMWSIGVITYILLSGASPFLGETKQETL-TNISAVNYDFDEEYFSNTSELAK 264
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I    +H W +
Sbjct: 265 DFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 93/263 (35%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  R +G+G+F +V   +++ TG+  A+KV++K  + +    + + RE+ ++K + HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  + + H   
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S     N+++ DFGLS    +  + +    GT  Y+APEVL    Y
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYIAPEVLHGT-Y 204
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
           D    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S  A  LI 
Sbjct: 205 D-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263
Query: 243 KILDPNPKTRIRIEGIRKHPWFR 265
           K+L   P  RI       H W +
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQ 286

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 146/264 (55%), Gaps = 10/264 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + +G G + +V   +++ TG   A+K++ KS++        +  E++++K + HP
Sbjct: 22  RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 81
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L+E    +   Y+++E   GGELFD+I+ + +  E D     +Q++    + H   
Sbjct: 82  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN 141
Query: 130 VYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S      +K+ DFGLSA  + G + +    GT  Y+APEVL  + Y
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK-MKERLGTAYYIAPEVLRKK-Y 199
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC--PFW--FSTGATSLIH 242
           D    DVWSCGVIL++L+ GY PFG      + K++   +FS   P W   S  A  L+ 
Sbjct: 200 D-EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVK 258
Query: 243 KILDPNPKTRIRIEGIRKHPWFRK 266
            +L   P  RI  E    HPW  K
Sbjct: 259 LMLTYEPSKRISAEEALNHPWIVK 282

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 93/263 (35%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  R +G+G+F +V   +++ TG+  A+KV++K  + +    + + RE+ ++K + HP
Sbjct: 50  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  + + H   
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S     N+++ DFGLS    +  + +    GT  Y+APEVL    Y
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYIAPEVLHGT-Y 227
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
           D    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S  A  LI 
Sbjct: 228 D-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 286
Query: 243 KILDPNPKTRIRIEGIRKHPWFR 265
           K+L   P  RI       H W +
Sbjct: 287 KMLTYVPSMRISARDALDHEWIQ 309

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 93/263 (35%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  R +G+G+F +V   +++ TG+  A+KV++K  + +    + + RE+ ++K + HP
Sbjct: 51  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  + + H   
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S     N+++ DFGLS    +  + +    GT  Y+APEVL    Y
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYIAPEVLHGT-Y 228
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
           D    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S  A  LI 
Sbjct: 229 D-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 287
Query: 243 KILDPNPKTRIRIEGIRKHPWFR 265
           K+L   P  RI       H W +
Sbjct: 288 KMLTYVPSMRISARDALDHEWIQ 310

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 157/267 (58%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKREISIMKIVR 67
           YE+G  +G G FA VR  + + TG+  A K + K  +   R     ++I+RE++I++ +R
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNI+ LH++  ++T V +ILE V+GGELFD +  +  L E++  ++ +Q++D V + HS
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           K + H DLKPEN++L         +K+ DFG++   + G E      GTP +VAPE+++ 
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNY 192
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTG--AT 238
               G  AD+WS GVI ++L++G  PF GET   TL   I+A   +F   ++ +T   A 
Sbjct: 193 EPL-GLEADMWSIGVITYILLSGASPFLGETKQETL-TNISAVNYDFDEEYFSNTSELAK 250
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I    +H W +
Sbjct: 251 DFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 95/260 (36%), Positives = 142/260 (54%), Gaps = 3/260 (1%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  +E+GR +G+G F  V  A+ +++   VA+KVL KS I K  +  Q++REI I   + 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNI+RL+     R ++Y+ILE+   GEL+ ++       E       ++L DA+ +CH 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K V HRD+KPENLLL   G LK++DFG S           T CGT +Y+ PE++  R ++
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWSV--HAPSLRRKTMCGTLDYLPPEMIEGRMHN 199
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
               D+W  GV+ + L+ G  PF        Y++I   +   P    TGA  LI K+L  
Sbjct: 200 -EKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRH 258
Query: 248 NPKTRIRIEGIRKHPWFRKN 267
           NP  R+ +  +  HPW R N
Sbjct: 259 NPSERLPLAQVSAHPWVRAN 278

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 151/264 (57%), Gaps = 10/264 (3%)
Query: 9   AKYEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           + +E+ + +G+G+F KV   R     ++G   AMKVL K+T LK R   + K E  I+  
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKAT-LKVRDRVRTKMERDILAD 86
Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           V HP +V+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L   + H 
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ +G
Sbjct: 147 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQG 206
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           +  S AD WS GV++F ++ G LPF   D       I  A+   P + ST A SL+  + 
Sbjct: 207 HSHS-ADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRALF 265
Query: 246 DPNPKTRI-----RIEGIRKHPWF 264
             NP  R+       E I++H ++
Sbjct: 266 KRNPANRLGSGPDGAEEIKRHVFY 289

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  167 bits (424), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 157/267 (58%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKREISIMKIVR 67
           YE+G  +G G FA VR  + + TG+  A K + K  +   R     ++I+RE++I++ +R
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNI+ LH++  ++T V +ILE V+GGELFD +  +  L E++  ++ +Q++D V + HS
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           K + H DLKPEN++L         +K+ DFG++   + G E      GTP +VAPE+++ 
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNY 185
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTG--AT 238
               G  AD+WS GVI ++L++G  PF GET   TL   I+A   +F   ++ +T   A 
Sbjct: 186 EPL-GLEADMWSIGVITYILLSGASPFLGETKQETL-TNISAVNYDFDEEYFSNTSELAK 243
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I    +H W +
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 157/274 (57%), Gaps = 16/274 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y+  + +G G + +V   +++ T    A+K++ K+++       ++  E++++K++ HPN
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLDHPN 97
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I++L++    +   Y+++E   GGELFD+I+H+ +  E D     +Q++  V + H   +
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157
Query: 131 YHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPENLLL+S      +K+ DFGLSA+ +   + +    GT  Y+APEVL  + YD
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERLGTAYYIAPEVLRKK-YD 215
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIHK 243
               DVWS GVILF+L+AGY PFG      + +K+   +  F  P W   S GA  LI +
Sbjct: 216 -EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274
Query: 244 ILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
           +L  + + RI  +   +HPW ++      CS++E
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKE-----MCSKKE 303

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 93/263 (35%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  R +G+G+F +V   +++ TG+  A+KV++K  + +    + + RE+ ++K + HP
Sbjct: 33  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  + + H   
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S     N+++ DFGLS    +  + +    GT  Y+APEVL    Y
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYIAPEVLHGT-Y 210
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
           D    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S  A  LI 
Sbjct: 211 D-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 269
Query: 243 KILDPNPKTRIRIEGIRKHPWFR 265
           K+L   P  RI       H W +
Sbjct: 270 KMLTYVPSMRISARDALDHEWIQ 292

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/273 (38%), Positives = 155/273 (56%), Gaps = 15/273 (5%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V HPNI+ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVAHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW 232
           VAPE++ N    G  AD+WS GVI ++L++G  PF G+T   TL   I A   +F   F+
Sbjct: 185 VAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANITAVSYDFDEEFF 242
Query: 233 FSTG--ATSLIHKILDPNPKTRIRIEGIRKHPW 263
             T   A   I K+L    + R+ I+   +HPW
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 95/266 (35%), Positives = 151/266 (56%), Gaps = 22/266 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVR 73
           + +GEG+F+  R   ++++ ++ A+K+++K      RM    ++EI+ +K+   HPNIV+
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LHEV   +   ++++E + GGELF++I  +    E +     ++L+ AV+H H  GV HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 134 DLKPENLLL-DSYGNL--KVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
           DLKPENLL  D   NL  K+ DFG + L     + L T C T +Y APE+L+  GYD S 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDES- 189
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLP-------TLYKKINAAEFS--CPFW--FSTGATS 239
            D+WS GVIL+ +++G +PF   D          + KKI   +FS     W   S  A  
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD 249
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFR 265
           LI  +L  +P  R+++ G+R + W +
Sbjct: 250 LIQGLLTVDPNKRLKMSGLRYNEWLQ 275

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +TIG G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 87
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 147
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 204
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 205 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 263
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 145/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  RT+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
            + V  P +V+L       + +Y++LE+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  QQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 87
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 147
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 204
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 205 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 263
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +       T CGTP Y+APE++ 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGAT---WTLCGTPEYLAPEIIL 232
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 233 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 291
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 292 NLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  165 bits (417), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 56  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 232
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 233 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 291
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 292 NLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  165 bits (417), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 93/263 (35%), Positives = 144/263 (54%), Gaps = 10/263 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  R +G+G+F +V   +++ TG+  A+KV++K  + +    + + RE+ ++K + HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI +L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  + + H   
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S     N+++ DFGLS    +  +      GT  Y+APEVL    Y
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKXKDKIGTAYYIAPEVLHGT-Y 204
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
           D    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S  A  LI 
Sbjct: 205 D-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263
Query: 243 KILDPNPKTRIRIEGIRKHPWFR 265
           K L   P  RI       H W +
Sbjct: 264 KXLTYVPSXRISARDALDHEWIQ 286

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +       T CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  164 bits (416), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 149/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF   +   +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  164 bits (416), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 21  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 80
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 81  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 140
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +       T CGTP Y+APE++ 
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEYLAPEIIL 197
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 198 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 256
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 257 NLLQVDLTKRFGNLKDGVNDIKNHKWF 283

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 30  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 89
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 90  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 149
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 150 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 206
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 207 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 265
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 266 NLLQVDLTKRFGNLKNGVNDIKNHKWF 292

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I  H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIXNHKWF 298

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 175
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 232
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 233 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 291
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 292 NLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 22  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 81
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 141
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 142 EYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 198
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 199 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 257
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 258 NLLQVDLTKRFGNLKNGVNDIKNHKWF 284

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 145/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFGL+   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +TIG G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E++ GG++F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLPNGVNDIKNHKWF 297

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +TIG G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E++ GG++F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE++ N
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIV-N 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 145/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIII 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 191 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 248
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 191 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 248
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE++ N
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPAFVAPEIV-N 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G ++V+DFGL+   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 144/267 (53%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P + +L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 154/272 (56%), Gaps = 13/272 (4%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVAHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-EFSCPFWF 233
           VAPE+++     G  AD+WS GVI ++L++G  PF G+T   TL    + + +F   F+ 
Sbjct: 185 VAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 234 STG--ATSLIHKILDPNPKTRIRIEGIRKHPW 263
            T   A   I K+L    + R+ I+   +HPW
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 100/272 (36%), Positives = 154/272 (56%), Gaps = 13/272 (4%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVAHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-EFSCPFWF 233
           VAPE++ N    G  AD+WS GVI ++L++G  PF G+T   TL    + + +F   F+ 
Sbjct: 185 VAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 234 STG--ATSLIHKILDPNPKTRIRIEGIRKHPW 263
            T   A   I K+L    + R+ I+   +HPW
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 145/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 154/272 (56%), Gaps = 13/272 (4%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVAHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-EFSCPFWF 233
           VAPE+++     G  AD+WS GVI ++L++G  PF G+T   TL    + + +F   F+ 
Sbjct: 185 VAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 234 STG--ATSLIHKILDPNPKTRIRIEGIRKHPW 263
            T   A   I K+L    + R+ I+   +HPW
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 154/273 (56%), Gaps = 15/273 (5%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVAHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW 232
           VAPE+++     G  AD+WS GVI ++L++G  PF G+T   TL   I A   +F   F+
Sbjct: 185 VAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANITAVSYDFDEEFF 242
Query: 233 FSTG--ATSLIHKILDPNPKTRIRIEGIRKHPW 263
             T   A   I K+L    + R+ I+   +HPW
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPN-----PKTRIRIEGIRKHPWF 264
            +L  +        +  +  I+ H WF
Sbjct: 271 NLLQVDLTKAFGNLKNGVNDIKNHKWF 297

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 154/273 (56%), Gaps = 15/273 (5%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVAHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW 232
           VAPE+++     G  AD+WS GVI ++L++G  PF G+T   TL   I A   +F   F+
Sbjct: 185 VAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANITAVSYDFDEEFF 242
Query: 233 FSTG--ATSLIHKILDPNPKTRIRIEGIRKHPW 263
             T   A   I K+L    + R+ I+   +HPW
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 144/267 (53%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P + +L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+AP ++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPAIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  161 bits (408), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 144/267 (53%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P + +L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP  +APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEALAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L    GTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---AGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L    GTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---XGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 94/293 (32%), Positives = 151/293 (51%), Gaps = 20/293 (6%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD------- 54
           KK+ +    Y   R +G G + +V   + +      A+KV+ KS   K R  D       
Sbjct: 29  KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEK 88
Query: 55  ---QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDC 111
              +I  EIS++K + HPNI++L +V   +   Y++ EF  GGELF++I+++ +  E D 
Sbjct: 89  FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA 148
Query: 112 RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD---SYGNLKVSDFGLSALPQQGVELLHT 168
               +Q++  + + H   + HRD+KPEN+LL+   S  N+K+ DFGLS+   +  + L  
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRD 207
Query: 169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
             GT  Y+APEVL  +       DVWSCGVI+++L+ GY PFG  +   + KK+   ++ 
Sbjct: 208 RLGTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265
Query: 229 CPF--W--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
             F  W   S  A  LI  +L  +   R   E      W +K  N +  S+++
Sbjct: 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 150/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +I E V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 142/266 (53%), Gaps = 8/266 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  +E  R +G+G+F KV  A+ +ETG+  A+KVL K  IL+   V+    E  I+ + R
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 68  -HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            HP + +L     +  +++ ++EFV GG+L   I    R  E   R Y  ++I A+   H
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            KG+ +RDLK +N+LLD  G+ K++DFG+            T CGTP+Y+APE+L    Y
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            G A D W+ GV+L+ ++ G+ PF   +   L++ I   E   P W    AT ++   + 
Sbjct: 202 -GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMT 260
Query: 247 PNPKTRIRI------EGIRKHPWFRK 266
            NP  R+          I +HP+F++
Sbjct: 261 KNPTMRLGSLTQGGEHAILRHPFFKE 286

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 96/272 (35%), Positives = 151/272 (55%), Gaps = 21/272 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL--AKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG+G F+ VR   NRETG+  A+K++  AK T       + +KRE SI  +++H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAH 124
           P+IV L E  +S   +Y++ EF+ G +L  +IV +        E     Y +Q+++A+ +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CH   + HRD+KPEN+LL S  N   +K+ DFG++    +   +     GTP+++APEV+
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK-------KINAAEFSCPFWFS 234
               Y G   DVW CGVILF+L++G LPF  T    L++       K+N  ++S     S
Sbjct: 206 KREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS---HIS 260
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
             A  L+ ++L  +P  RI +     HPW ++
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 149/264 (56%), Gaps = 10/264 (3%)
Query: 11  YEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKH-RMVDQIKREISIMKIV 66
           +E+ R +G+G + KV   R      TG+  AMKVL K+ I+++ +     K E +I++ V
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           +HP IV L     +  K+Y+ILE+++GGELF ++  +G  +E+    Y  ++  A+ H H
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            KG+ +RDLKPEN++L+  G++K++DFGL         + HT CGT  Y+APE+L   G+
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
           +  A D WS G +++ ++ G  PF   +      KI   + + P + +  A  L+ K+L 
Sbjct: 199 N-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLK 257
Query: 247 PNPKTRIRIEG-----IRKHPWFR 265
            N  +R+         ++ HP+FR
Sbjct: 258 RNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 83/239 (34%), Positives = 128/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 74  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 133
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y G A D W
Sbjct: 134 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 192
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 193 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 251

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 83/239 (34%), Positives = 128/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 92/273 (33%), Positives = 150/273 (54%), Gaps = 18/273 (6%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL-AKSTILKHRMVDQIK----REISIMK 64
           KY+    IG G  + VR   +R TG   A+K++   +  L    +++++    RE  I++
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 65  -IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
            +  HP+I+ L +   S + ++++ + +  GELFD +  +  L E + R   + L++AV+
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-- 181
             H+  + HRDLKPEN+LLD    +++SDFG S   + G E L   CGTP Y+APE+L  
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKC 273
Query: 182 ----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFWFST 235
               ++ GY G   D+W+CGVILF L+AG  PF       + + I     +FS P W   
Sbjct: 274 SMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332
Query: 236 GAT--SLIHKILDPNPKTRIRIEGIRKHPWFRK 266
            +T   LI ++L  +P+ R+  E   +HP+F +
Sbjct: 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 83/239 (34%), Positives = 128/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 93/286 (32%), Positives = 151/286 (52%), Gaps = 30/286 (10%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR--------------- 51
           ++ +Y +   IG+G++  V+ A N       AMKVL+K  +++                 
Sbjct: 11  QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 52  --------MVDQIKREISIMKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV 101
                    ++Q+ +EI+I+K + HPN+V+L EVL   +   +Y++ E V  G + + + 
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VP 129
Query: 102 HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ 161
               L E+  R YFQ LI  + + H + + HRD+KP NLL+   G++K++DFG+S   + 
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 162 GVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY 219
              LL  T GTP ++APE LS   + + G A DVW+ GV L+  + G  PF +  +  L+
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249
Query: 220 KKI--NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW 263
            KI   A EF      +     LI ++LD NP++RI +  I+ HPW
Sbjct: 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 148/264 (56%), Gaps = 10/264 (3%)
Query: 11  YEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKH-RMVDQIKREISIMKIV 66
           +E+ R +G+G + KV   R      TG+  AMKVL K+ I+++ +     K E +I++ V
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           +HP IV L     +  K+Y+ILE+++GGELF ++  +G  +E+    Y  ++  A+ H H
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            KG+ +RDLKPEN++L+  G++K++DFGL         + H  CGT  Y+APE+L   G+
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGH 198
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
           +  A D WS G +++ ++ G  PF   +      KI   + + P + +  A  L+ K+L 
Sbjct: 199 N-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLK 257
Query: 247 PNPKTRIRIEG-----IRKHPWFR 265
            N  +R+         ++ HP+FR
Sbjct: 258 RNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 127/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          +   CGTP Y+APEVL +  Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 127/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 76  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 135
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          +   CGTP Y+APEVL +  Y G A D W
Sbjct: 136 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVDWW 194
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 195 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 253

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 127/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          +   CGTP Y+APEVL +  Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 127/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          +   CGTP Y+APEVL +  Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 101/347 (29%), Positives = 179/347 (51%), Gaps = 39/347 (11%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIV 66
           +  +++ R IG G++AKV   + ++T    AM+V+ K  +     +D ++ E  +  +  
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            +G+ +RDLK +N+LLDS G++K++D+G+     +  +   T CGTPNY+APE+L    Y
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 187 DGSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFSTGA 237
            G + D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S  A
Sbjct: 231 -GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 289
Query: 238 TSLIHKILDPNPKTRI------RIEGIRKHPWFRK-NYN---------PVKCSEEEEVNL 281
            S++   L+ +PK R+          I+ HP+FR  +++         P K +   E  L
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGL 349
Query: 282 DDVHAVFDD-------IEDQYVAEQSENKVGG-----PLLMNAFEMI 316
           D+  + F +        +D  V +  +++  G     PLLM+A E +
Sbjct: 350 DNFDSQFTNEPVQLXPDDDDIVRKIDQSEFEGFEYINPLLMSAEECV 396

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 147/265 (55%), Gaps = 18/265 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV   IG G+++  +   ++ T    A+K++ KS   K    ++I  EI +++  +HPN
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS---KRDPTEEI--EI-LLRYGQHPN 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+ L +V      VY++ E + GGEL DKI+ Q    E +       +   V + H++GV
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 131 YHRDLKPENLL-LDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            HRDLKP N+L +D  GN   +++ DFG +   +    LL T C T N+VAPEVL  +GY
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 187 DGSAADVWSCGVILFVLMAGYLPF--GETDLP-TLYKKINAAEFSCP--FWFSTGATS-- 239
           D +A D+WS GV+L+ ++ GY PF  G  D P  +  +I + +FS    +W S   T+  
Sbjct: 198 D-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKD 256
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWF 264
           L+ K+L  +P  R+    + +HPW 
Sbjct: 257 LVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 141/267 (52%), Gaps = 1/267 (0%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R + +Y  GR +G+G FAK     + +T E  A KV+ KS +LK    +++  EI+I K 
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           + +P++V  H        VY++LE      L +    +  + E + R + +Q I  V + 
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H+  V HRDLK  NL L+   ++K+ DFGL+   +   E   T CGTPNY+APEVL  +G
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           +     D+WS G IL+ L+ G  PF  + L   Y +I   E+S P   +  A++LI ++L
Sbjct: 219 H-SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 277
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVK 272
             +P  R  +  +    +F   Y P++
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAPMR 304

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 104/350 (29%), Positives = 182/350 (52%), Gaps = 45/350 (12%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIV 66
           +  +++ R IG G++AKV   + ++T    AMKV+ K  +     +D ++ E  +  +  
Sbjct: 19  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSN 183
            +G+ +RDLK +N+LLDS G++K++D+G+    ++G+    TT   CGTPNY+APE+L  
Sbjct: 139 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSXFCGTPNYIAPEILRG 195
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFS 234
             Y G + D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S
Sbjct: 196 EDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMS 254
Query: 235 TGATSLIHKILDPNPKTRI------RIEGIRKHPWFRK-NYN---------PVKCSEEEE 278
             A S++   L+ +PK R+          I+ HP+FR  +++         P K +   E
Sbjct: 255 VKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGE 314
Query: 279 VNLDDVHAVFDD-------IEDQYVAEQSENKVGG-----PLLMNAFEMI 316
             LD+  + F +        +D  V +  +++  G     PLLM+A E +
Sbjct: 315 FGLDNFDSQFTNERVQLXPDDDDIVRKIDQSEFEGFEYINPLLMSAEECV 364

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/245 (34%), Positives = 132/245 (53%), Gaps = 2/245 (0%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++E  + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP
Sbjct: 152 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 211
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-K 128
            +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K
Sbjct: 212 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 271
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V +RDLK ENL+LD  G++K++DFGL     +    + T CGTP Y+APEVL +  Y G
Sbjct: 272 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-G 330
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L  +
Sbjct: 331 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKD 390
Query: 249 PKTRI 253
           PK R+
Sbjct: 391 PKQRL 395

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 104/350 (29%), Positives = 182/350 (52%), Gaps = 45/350 (12%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIV 66
           +  +++ R IG G++AKV   + ++T    AMKV+ K  +     +D ++ E  +  +  
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSN 183
            +G+ +RDLK +N+LLDS G++K++D+G+    ++G+    TT   CGTPNY+APE+L  
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSXFCGTPNYIAPEILRG 180
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFS 234
             Y G + D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S
Sbjct: 181 EDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 239
Query: 235 TGATSLIHKILDPNPKTRI------RIEGIRKHPWFRK-NYN---------PVKCSEEEE 278
             A S++   L+ +PK R+          I+ HP+FR  +++         P K +   E
Sbjct: 240 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGE 299
Query: 279 VNLDDVHAVFDD-------IEDQYVAEQSENKVGG-----PLLMNAFEMI 316
             LD+  + F +        +D  V +  +++  G     PLLM+A E +
Sbjct: 300 FGLDNFDSQFTNEPVQLXPDDDDIVRKIDQSEFEGFEYINPLLMSAEESV 349

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 147/264 (55%), Gaps = 18/264 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y V  TIG G++++ +   ++ T    A+KV+ KS   K    ++I  EI +++  +HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKS---KRDPSEEI--EI-LLRYGQHPN 82
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+ L +V      VY++ E + GGEL DKI+ Q    E +       +   V + HS+GV
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 131 YHRDLKPENLL-LDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            HRDLKP N+L +D  GN   L++ DFG +   +    LL T C T N+VAPEVL  +GY
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGY 202
Query: 187 DGSAADVWSCGVILFVLMAGYLPF--GETDLP-TLYKKINAAEF--SCPFW--FSTGATS 239
           D    D+WS G++L+ ++AGY PF  G +D P  +  +I + +F  S   W   S  A  
Sbjct: 203 D-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKD 261
Query: 240 LIHKILDPNPKTRIRIEGIRKHPW 263
           L+ K+L  +P  R+  + + +HPW
Sbjct: 262 LVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 85/245 (34%), Positives = 132/245 (53%), Gaps = 2/245 (0%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++E  + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-K 128
            +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V +RDLK ENL+LD  G++K++DFGL     +    + T CGTP Y+APEVL +  Y G
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-G 327
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L  +
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKD 387
Query: 249 PKTRI 253
           PK R+
Sbjct: 388 PKQRL 392

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 147/264 (55%), Gaps = 18/264 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y V  TIG G++++ +   ++ T    A+KV+ KS   K    ++I  EI +++  +HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKS---KRDPSEEI--EI-LLRYGQHPN 82
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+ L +V      VY++ E + GGEL DKI+ Q    E +       +   V + HS+GV
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 131 YHRDLKPENLL-LDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            HRDLKP N+L +D  GN   L++ DFG +   +    LL T C T N+VAPEVL  +GY
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGY 202
Query: 187 DGSAADVWSCGVILFVLMAGYLPF--GETDLP-TLYKKINAAEF--SCPFW--FSTGATS 239
           D    D+WS G++L+ ++AGY PF  G +D P  +  +I + +F  S   W   S  A  
Sbjct: 203 D-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKD 261
Query: 240 LIHKILDPNPKTRIRIEGIRKHPW 263
           L+ K+L  +P  R+  + + +HPW
Sbjct: 262 LVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 89/277 (32%), Positives = 153/277 (55%), Gaps = 23/277 (8%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIV 66
           +  +++ R IG G++AKV   + ++T    AMKV+ K  +     +D ++ E  +  +  
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSN 183
            +G+ +RDLK +N+LLDS G++K++D+G+    ++G+    TT   CGTPNY+APE+L  
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSXFCGTPNYIAPEILRG 184
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFS 234
             Y G + D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S
Sbjct: 185 EDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243
Query: 235 TGATSLIHKILDPNPKTRI------RIEGIRKHPWFR 265
             A S++   L+ +PK R+          I+ HP+FR
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 1/267 (0%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R + +Y  GR +G+G FAK     + +T E  A KV+ KS +LK    +++  EI+I K 
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           + +P++V  H        VY++LE      L +    +  + E + R + +Q I  V + 
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H+  V HRDLK  NL L+   ++K+ DFGL+   +   E     CGTPNY+APEVL  +G
Sbjct: 143 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           +     D+WS G IL+ L+ G  PF  + L   Y +I   E+S P   +  A++LI ++L
Sbjct: 203 H-SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 261
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVK 272
             +P  R  +  +    +F   Y P++
Sbjct: 262 HADPTLRPSVAELLTDEFFTSGYAPMR 288

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 1/267 (0%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R + +Y  GR +G+G FAK     + +T E  A KV+ KS +LK    +++  EI+I K 
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           + +P++V  H        VY++LE      L +    +  + E + R + +Q I  V + 
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H+  V HRDLK  NL L+   ++K+ DFGL+   +   E     CGTPNY+APEVL  +G
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           +     D+WS G IL+ L+ G  PF  + L   Y +I   E+S P   +  A++LI ++L
Sbjct: 219 H-SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 277
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVK 272
             +P  R  +  +    +F   Y P++
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAPMR 304

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 1/267 (0%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R + +Y  GR +G+G FAK     + +T E  A KV+ KS +LK    +++  EI+I K 
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           + +P++V  H        VY++LE      L +    +  + E + R + +Q I  V + 
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H+  V HRDLK  NL L+   ++K+ DFGL+   +   E     CGTPNY+APEVL  +G
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           +     D+WS G IL+ L+ G  PF  + L   Y +I   E+S P   +  A++LI ++L
Sbjct: 219 H-SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 277
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVK 272
             +P  R  +  +    +F   Y P++
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAPMR 304

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 144/265 (54%), Gaps = 18/265 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV   IG G+++  +   ++ T    A+K++ KS   K    ++I  EI +++  +HPN
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKS---KRDPTEEI--EI-LLRYGQHPN 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+ L +V      VY++ E   GGEL DKI+ Q    E +       +   V + H++GV
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 131 YHRDLKPENLL-LDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            HRDLKP N+L +D  GN   +++ DFG +   +    LL T C T N+VAPEVL  +GY
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGY 197
Query: 187 DGSAADVWSCGVILFVLMAGYLPF--GETDLP-TLYKKINAAEFSCP--FWFSTGATS-- 239
           D +A D+WS GV+L+  + GY PF  G  D P  +  +I + +FS    +W S   T+  
Sbjct: 198 D-AACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKD 256
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWF 264
           L+ K L  +P  R+    + +HPW 
Sbjct: 257 LVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  151 bits (382), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 84/245 (34%), Positives = 131/245 (53%), Gaps = 2/245 (0%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++E  + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP
Sbjct: 9   EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 68
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-K 128
            +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K
Sbjct: 69  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 128
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V +RDLK ENL+LD  G++K++DFGL     +    +   CGTP Y+APEVL +  Y G
Sbjct: 129 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY-G 187
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L  +
Sbjct: 188 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKD 247
Query: 249 PKTRI 253
           PK R+
Sbjct: 248 PKQRL 252

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  151 bits (382), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 84/245 (34%), Positives = 131/245 (53%), Gaps = 2/245 (0%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++E  + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP
Sbjct: 10  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 69
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-K 128
            +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K
Sbjct: 70  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 129
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V +RDLK ENL+LD  G++K++DFGL     +    +   CGTP Y+APEVL +  Y G
Sbjct: 130 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY-G 188
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L  +
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKD 248
Query: 249 PKTRI 253
           PK R+
Sbjct: 249 PKQRL 253

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 84/245 (34%), Positives = 131/245 (53%), Gaps = 2/245 (0%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++E  + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 70
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-K 128
            +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K
Sbjct: 71  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 130
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V +RDLK ENL+LD  G++K++DFGL     +    +   CGTP Y+APEVL +  Y G
Sbjct: 131 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY-G 189
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L  +
Sbjct: 190 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKD 249
Query: 249 PKTRI 253
           PK R+
Sbjct: 250 PKQRL 254

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 148/272 (54%), Gaps = 21/272 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL--AKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG+G F+ VR   NRETG+  A+K++  AK T       + +KRE SI  +++H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAH 124
           P+IV L E  +S   +Y++ EF+ G +L  +IV +        E     Y +Q+++A+ +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CH   + HRD+KP  +LL S  N   +K+  FG++    +   +     GTP+++APEV+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK-------KINAAEFSCPFWFS 234
               Y G   DVW CGVILF+L++G LPF  T    L++       K+N  ++S     S
Sbjct: 206 KREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS---HIS 260
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
             A  L+ ++L  +P  RI +     HPW ++
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 148/272 (54%), Gaps = 21/272 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL--AKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG+G F+ VR   NRETG+  A+K++  AK T       + +KRE SI  +++H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAH 124
           P+IV L E  +S   +Y++ EF+ G +L  +IV +        E     Y +Q+++A+ +
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CH   + HRD+KP  +LL S  N   +K+  FG++    +   +     GTP+++APEV+
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK-------KINAAEFSCPFWFS 234
               Y G   DVW CGVILF+L++G LPF  T    L++       K+N  ++S     S
Sbjct: 208 KREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS---HIS 262
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
             A  L+ ++L  +P  RI +     HPW ++
Sbjct: 263 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 87/256 (33%), Positives = 131/256 (51%), Gaps = 1/256 (0%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G FAK     + +T E  A K++ KS +LK    +++  EISI + + H ++V  H 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  V+++LE      L +    +  L E + R Y +Q++    + H   V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             NL L+    +K+ DFGL+   +   E   T CGTPNY+APEVLS +G+     DVWS 
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH-SFEVDVWSI 203
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  +P  R  I 
Sbjct: 204 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 263
Query: 257 GIRKHPWFRKNYNPVK 272
            +    +F   Y P +
Sbjct: 264 ELLNDEFFTSGYIPAR 279

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 87/256 (33%), Positives = 131/256 (51%), Gaps = 1/256 (0%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G FAK     + +T E  A K++ KS +LK    +++  EISI + + H ++V  H 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  V+++LE      L +    +  L E + R Y +Q++    + H   V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             NL L+    +K+ DFGL+   +   E   T CGTPNY+APEVLS +G+     DVWS 
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH-SFEVDVWSI 203
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  +P  R  I 
Sbjct: 204 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 263
Query: 257 GIRKHPWFRKNYNPVK 272
            +    +F   Y P +
Sbjct: 264 ELLNDEFFTSGYIPAR 279

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 87/256 (33%), Positives = 131/256 (51%), Gaps = 1/256 (0%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G FAK     + +T E  A K++ KS +LK    +++  EISI + + H ++V  H 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  V+++LE      L +    +  L E + R Y +Q++    + H   V HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             NL L+    +K+ DFGL+   +   E   T CGTPNY+APEVLS +G+     DVWS 
Sbjct: 149 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH-SFEVDVWSI 207
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  +P  R  I 
Sbjct: 208 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 267
Query: 257 GIRKHPWFRKNYNPVK 272
            +    +F   Y P +
Sbjct: 268 ELLNDEFFTSGYIPAR 283

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 130/256 (50%), Gaps = 1/256 (0%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G FAK     + +T E  A K++ KS +LK    +++  EISI + + H ++V  H 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  V+++LE      L +    +  L E + R Y +Q++    + H   V HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS +G+     DVWS 
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSI 201
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  +P  R  I 
Sbjct: 202 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 261
Query: 257 GIRKHPWFRKNYNPVK 272
            +    +F   Y P +
Sbjct: 262 ELLNDEFFTSGYIPAR 277

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 130/256 (50%), Gaps = 1/256 (0%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G FAK     + +T E  A K++ KS +LK    +++  EISI + + H ++V  H 
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  V+++LE      L +    +  L E + R Y +Q++    + H   V HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS +G+     DVWS 
Sbjct: 167 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSI 225
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  +P  R  I 
Sbjct: 226 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 285
Query: 257 GIRKHPWFRKNYNPVK 272
            +    +F   Y P +
Sbjct: 286 ELLNDEFFTSGYIPAR 301

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  145 bits (366), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 87/313 (27%), Positives = 162/313 (51%), Gaps = 6/313 (1%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++  +E+ + +G+G+F KV  A+ ++T +  A+K L K  +L    V+    E  ++ + 
Sbjct: 16  KIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 75
Query: 67  -RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
             HP +  +     ++  ++ ++E++ GG+L   I    +   +    Y  ++I  +   
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 135
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HSKG+ +RDLK +N+LLD  G++K++DFG+      G    +  CGTP+Y+APE+L  + 
Sbjct: 136 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK 195
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           Y+ S  D WS GV+L+ ++ G  PF   D   L+  I       P W    A  L+ K+ 
Sbjct: 196 YNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 254
Query: 246 DPNPKTRIRIEG-IRKHPWFRK-NYNPVKCSEEEEVNLDDVHAVFD--DIEDQYVAEQSE 301
              P+ R+ + G IR+HP FR+ N+  ++  E +      V + FD  + + +++ E+  
Sbjct: 255 VREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPR 314
Query: 302 NKVGGPLLMNAFE 314
                  L+N+ +
Sbjct: 315 LXFADRALINSMD 327

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 130/256 (50%), Gaps = 1/256 (0%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G FAK     + +T E  A K++ KS +LK    +++  EISI + + H ++V  H 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  V+++LE      L +    +  L E + R Y +Q++    + H   V HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS +G+     DVWS 
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSI 227
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  +P  R  I 
Sbjct: 228 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 287
Query: 257 GIRKHPWFRKNYNPVK 272
            +    +F   Y P +
Sbjct: 288 ELLNDEFFTSGYIPAR 303

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 9/269 (3%)
Query: 4   QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           + +R   ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62
Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
             + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ 
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVL 181
           + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 182
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           + +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+
Sbjct: 183 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241
Query: 242 HKILDPNPKTRI---RIEG---IRKHPWF 264
            K+L  +   R+    +EG   ++ HP+F
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 9/269 (3%)
Query: 4   QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           + +R   ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M
Sbjct: 2   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 61
Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
             + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ 
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 121
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVL 181
           + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L
Sbjct: 122 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           + +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+
Sbjct: 182 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 240
Query: 242 HKILDPNPKTRI---RIEG---IRKHPWF 264
            K+L  +   R+    +EG   ++ HP+F
Sbjct: 241 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 269

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 9/269 (3%)
Query: 4   QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           + +R   ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M
Sbjct: 4   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 63
Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
             + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ 
Sbjct: 64  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 123
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVL 181
           + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L
Sbjct: 124 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 183
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           + +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+
Sbjct: 184 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 242
Query: 242 HKILDPNPKTRI---RIEG---IRKHPWF 264
            K+L  +   R+    +EG   ++ HP+F
Sbjct: 243 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 271

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 9/269 (3%)
Query: 4   QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           + +R   ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M
Sbjct: 5   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 64
Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
             + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ 
Sbjct: 65  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 124
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVL 181
           + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L
Sbjct: 125 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 184
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           + +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+
Sbjct: 185 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 243
Query: 242 HKILDPNPKTRI---RIEG---IRKHPWF 264
            K+L  +   R+    +EG   ++ HP+F
Sbjct: 244 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 272

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 94/296 (31%), Positives = 163/296 (55%), Gaps = 30/296 (10%)
Query: 8   VAKYEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTIL-KHRMVDQIKREISIM 63
           +  +E+ + +G G + KV   R     +TG+  AMKVL K+TI+ K +  +  + E  ++
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 64  KIVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           + +R  P +V LH    + TK+++IL+++ GGELF  +  + R  E++ + Y  +++ A+
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVL 181
            H H  G+ +RD+K EN+LLDS G++ ++DFGLS        E  +  CGT  Y+AP+++
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 182 --SNRGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT-LYKKINAAEFSCPFWFST 235
              + G+D  A D WS GV+++ L+ G  PF   GE +    + ++I  +E   P   S 
Sbjct: 233 RGGDSGHD-KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 291
Query: 236 GATSLIHKILDPNPKTRI-----RIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHA 286
            A  LI ++L  +PK R+       + I++H +F+K            +N DD+ A
Sbjct: 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK------------INWDDLAA 335

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 141/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      ++  GT  YV+PE+L+ +    
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-AC 209
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 269
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 270 ATKRLGCEEMEGYGPLKAHPFF 291

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 209
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 269
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 270 ATKRLGCEEMEGYGPLKAHPFF 291

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 141/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      ++  GT  YV+PE+L+ +    
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 214
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 215 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 273
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 274 ATKRLGCEEMEGYGPLKAHPFF 295

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 156
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 157 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 216
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 217 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLVLD 275
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 276 ATKRLGCEEMEGYGPLKAHPFF 297

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACK 211
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 135
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 136 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 194
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 195 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 254
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 255 ATKRLGCEEMEGYGPLKAHPFF 276

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 139/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXK 213
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   ++ KI   E+  P  F   A  L+ K+L  +
Sbjct: 214 S-SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 273 ATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 211
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 211
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 214 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 273 ATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 214 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 273 ATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 161/313 (51%), Gaps = 6/313 (1%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++  + + + +G+G+F KV  A+ ++T +  A+K L K  +L    V+    E  ++ + 
Sbjct: 15  KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 67  -RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
             HP +  +     ++  ++ ++E++ GG+L   I    +   +    Y  ++I  +   
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HSKG+ +RDLK +N+LLD  G++K++DFG+      G    +  CGTP+Y+APE+L  + 
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK 194
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           Y+ S  D WS GV+L+ ++ G  PF   D   L+  I       P W    A  L+ K+ 
Sbjct: 195 YNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 253
Query: 246 DPNPKTRIRIEG-IRKHPWFRK-NYNPVKCSEEEEVNLDDVHAVFD--DIEDQYVAEQSE 301
              P+ R+ + G IR+HP FR+ N+  ++  E +      V + FD  + + +++ E+  
Sbjct: 254 VREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPR 313
Query: 302 NKVGGPLLMNAFE 314
                  L+N+ +
Sbjct: 314 LSFADRALINSMD 326

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 214 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 273 ATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 214
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 215 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 273
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 274 ATKRLGCEEMEGYGPLKAHPFF 295

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 158
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 159 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 218
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 219 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 277
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 278 ATKRLGCEEMEGYGPLKAHPFF 299

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 142/278 (51%), Gaps = 24/278 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM-VDQIKREISIMKIVRHP 69
           Y++   +G G F  V     R TG + A    AK  +  H    + +++EI  M ++RHP
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFA----AKFVMTPHESDKETVRKEIQTMSVLRHP 108
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSK 128
            +V LH+      ++ +I EF++GGELF+K+  +  ++ E++   Y +Q+   + H H  
Sbjct: 109 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 129 GVYHRDLKPENLLLDS--YGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNR 184
              H DLKPEN++  +     LK+ DFGL+A   P+Q V++   T GT  + APEV   +
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGK 225
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK------KINAAEFSCPFWFSTGA 237
              G   D+WS GV+ ++L++G  PF GE D  TL         ++ + FS     S   
Sbjct: 226 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG---ISEDG 281
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              I K+L  +P TR+ I    +HPW      P + S+
Sbjct: 282 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 319

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 139/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   ++ KI   E+  P  F   A  L+ K+L  +
Sbjct: 214 S-SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 273 ATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 122/217 (56%), Gaps = 2/217 (0%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KI 65
           + + +   + IG+G+F KV  A+++      A+KVL K  ILK +    I  E +++ K 
Sbjct: 36  KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 95
Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           V+HP +V LH    +  K+Y +L+++ GGELF  +  +   LE   R Y  ++  A+ + 
Sbjct: 96  VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYL 155
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HS  + +RDLKPEN+LLDS G++ ++DFGL     +      T CGTP Y+APEVL  + 
Sbjct: 156 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
           YD +  D W  G +L+ ++ G  PF   +   +Y  I
Sbjct: 216 YDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 142/278 (51%), Gaps = 24/278 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM-VDQIKREISIMKIVRHP 69
           Y++   +G G F  V     R TG + A    AK  +  H    + +++EI  M ++RHP
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFA----AKFVMTPHESDKETVRKEIQTMSVLRHP 214
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSK 128
            +V LH+      ++ +I EF++GGELF+K+  +  ++ E++   Y +Q+   + H H  
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 129 GVYHRDLKPENLLLDS--YGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNR 184
              H DLKPEN++  +     LK+ DFGL+A   P+Q V++   T GT  + APEV   +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGK 331
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK------KINAAEFSCPFWFSTGA 237
              G   D+WS GV+ ++L++G  PF GE D  TL         ++ + FS     S   
Sbjct: 332 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG---ISEDG 387
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              I K+L  +P TR+ I    +HPW      P + S+
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 425

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 139/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+    A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 211
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFF 292

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  141 bits (355), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 143/273 (52%), Gaps = 19/273 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL------AKSTILKHRMVDQIKREISIM- 63
           YE    +G G  + VR   ++ T +  A+K++      + S      + +   +E+ I+ 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
           K+  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-- 181
             H   + HRDLKPEN+LLD   N+K++DFG S     G E L + CGTP+Y+APE++  
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLRSVCGTPSYLAPEIIEC 197
Query: 182 ----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
               ++ GY G   D+WS GVI++ L+AG  PF       + + I +   +F  P W  +
Sbjct: 198 SMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 256
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
           S     L+ + L   P+ R   E    HP+F++
Sbjct: 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  141 bits (355), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 159/304 (52%), Gaps = 17/304 (5%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +   Y+V + IG G F +V+  +++ + +  AMK+L+K  ++K         E  IM   
Sbjct: 73  KAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 132
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             P +V+L         +Y+++E++ GG+L + ++    + E   + Y  +++ A+   H
Sbjct: 133 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIH 191
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR- 184
           S G+ HRD+KP+N+LLD +G+LK++DFG    + + G+    T  GTP+Y++PEVL ++ 
Sbjct: 192 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 185 --GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFSTGAT 238
             GY G   D WS GV LF ++ G  PF    L   Y KI    N+  F      S  A 
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAK 311
Query: 239 SLIHKILDPNPK--TRIRIEGIRKHPWFRK---NYNPVKCSEE---EEVNLDDVHAVFDD 290
           +LI   L        R  +E I++HP+F+    N++ ++ +      E++ D   + FDD
Sbjct: 312 NLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDD 371
Query: 291 IEDQ 294
           IED 
Sbjct: 372 IEDD 375

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   G L   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      ++  GT  YV+PE+L+ +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASK 213
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 214 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 273 ATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 142/273 (52%), Gaps = 19/273 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL------AKSTILKHRMVDQIKREISIM- 63
           YE    +G G  + VR   ++ T +  A+K++      + S      + +   +E+ I+ 
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
           K+  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ + 
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 125
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-- 181
             H   + HRDLKPEN+LLD   N+K++DFG S     G E L   CGTP+Y+APE++  
Sbjct: 126 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIEC 184
Query: 182 ----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
               ++ GY G   D+WS GVI++ L+AG  PF       + + I +   +F  P W  +
Sbjct: 185 SMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 243
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
           S     L+ + L   P+ R   E    HP+F++
Sbjct: 244 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 142/273 (52%), Gaps = 19/273 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL------AKSTILKHRMVDQIKREISIM- 63
           YE    +G G  + VR   ++ T +  A+K++      + S      + +   +E+ I+ 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
           K+  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-- 181
             H   + HRDLKPEN+LLD   N+K++DFG S     G E L   CGTP+Y+APE++  
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIEC 197
Query: 182 ----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
               ++ GY G   D+WS GVI++ L+AG  PF       + + I +   +F  P W  +
Sbjct: 198 SMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 256
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
           S     L+ + L   P+ R   E    HP+F++
Sbjct: 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 150/276 (54%), Gaps = 9/276 (3%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD-QIKREISIM 63
            + + KY +G  +GEG++ KV+   + ET    A+K+L K  + +    +  +K+EI ++
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 64  KIVRHPNIVRLHEVLAS--RTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLI 119
           + +RH N+++L +VL +  + K+Y+++E+   G  E+ D +  + R        YF QLI
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLI 119
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVA 177
           D + + HS+G+ H+D+KP NLLL + G LK+S  G++    P    +   T+ G+P +  
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 178 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTG 236
           PE+ +    + G   D+WS GV L+ +  G  PF   ++  L++ I    ++ P      
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPP 239
Query: 237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
            + L+  +L+  P  R  I  IR+H WFRK + P +
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE 275

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 139/257 (54%), Gaps = 7/257 (2%)
Query: 16  TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRL 74
            +G+G+F KV  A  + T E  A+K+L K  +++   V+    E  ++ ++ + P + +L
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           H    +  ++Y ++E+V GG+L   I   G+  E     Y  ++   +   H +G+ +RD
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRD 145
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LK +N++LDS G++K++DFG+              CGTP+Y+APE+++ + Y G + D W
Sbjct: 146 LKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPY-GKSVDWW 204
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR 254
           + GV+L+ ++AG  PF   D   L++ I     S P   S  A S+   ++  +P  R+ 
Sbjct: 205 AYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPAKRLG 264
Query: 255 I--EG---IRKHPWFRK 266
              EG   +R+H +FR+
Sbjct: 265 CGPEGERDVREHAFFRR 281

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 141/271 (52%), Gaps = 11/271 (4%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +   YEV + IG G F +V+  +++ T +  AMK+L+K  ++K         E  IM   
Sbjct: 72  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 131
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             P +V+L         +Y+++E++ GG+L + ++    + E   R Y  +++ A+   H
Sbjct: 132 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIH 190
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNR- 184
           S G  HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL ++ 
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 185 --GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFSTGAT 238
             GY G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S  A 
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 310
Query: 239 SLIHKILDPNPK--TRIRIEGIRKHPWFRKN 267
           +LI   L        R  +E I++H +F+ +
Sbjct: 311 NLICAFLTDREVRLGRNGVEEIKRHLFFKND 341

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 141/271 (52%), Gaps = 11/271 (4%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +   YEV + IG G F +V+  +++ T +  AMK+L+K  ++K         E  IM   
Sbjct: 72  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 131
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             P +V+L         +Y+++E++ GG+L + ++    + E   R Y  +++ A+   H
Sbjct: 132 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIH 190
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNR- 184
           S G  HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL ++ 
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 185 --GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFSTGAT 238
             GY G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S  A 
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 310
Query: 239 SLIHKILDPNPK--TRIRIEGIRKHPWFRKN 267
           +LI   L        R  +E I++H +F+ +
Sbjct: 311 NLICAFLTDREVRLGRNGVEEIKRHLFFKND 341

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 141/271 (52%), Gaps = 11/271 (4%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +   YEV + IG G F +V+  +++ T +  AMK+L+K  ++K         E  IM   
Sbjct: 67  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             P +V+L         +Y+++E++ GG+L + ++    + E   R Y  +++ A+   H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNR- 184
           S G  HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL ++ 
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 185 --GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFSTGAT 238
             GY G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S  A 
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305
Query: 239 SLIHKILDPNPK--TRIRIEGIRKHPWFRKN 267
           +LI   L        R  +E I++H +F+ +
Sbjct: 306 NLICAFLTDREVRLGRNGVEEIKRHLFFKND 336

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 86/264 (32%), Positives = 136/264 (51%), Gaps = 19/264 (7%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G G F  V   + R +G    +K + K        ++QI+ EI ++K + HPNI+++
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGR---LLENDCRRYFQQLIDAVAHCHSKGV 130
            EV      +YI++E   GGEL ++IV  Q R   L E       +Q+++A+A+ HS+ V
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV 145
Query: 131 YHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            H+DLKPEN+L      +  +K+ DFGL+ L +   E      GT  Y+APEV       
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKRDV-- 202
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTL-----YKKINAAEFSCPFWFSTGATSLIH 242
               D+WS GV+++ L+ G LPF  T L  +     YK+ N A    P   +  A  L+ 
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP--LTPQAVDLLK 260
Query: 243 KILDPNPKTRIRIEGIRKHPWFRK 266
           ++L  +P+ R     +  H WF++
Sbjct: 261 QMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 138/256 (53%), Gaps = 7/256 (2%)
Query: 16  TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRL 74
            +G+G+F KV  ++ + T E  A+K+L K  +++   V+    E  ++ +  + P + +L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           H    +  ++Y ++E+V GG+L   I   GR  E     Y  ++   +    SKG+ +RD
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 146
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LK +N++LDS G++K++DFG+              CGTP+Y+APE+++ + Y G + D W
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY-GKSVDWW 205
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR 254
           + GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   ++  +P  R+ 
Sbjct: 206 AFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLG 265
Query: 255 I--EG---IRKHPWFR 265
              EG   I++H +FR
Sbjct: 266 CGPEGERDIKEHAFFR 281

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 139/277 (50%), Gaps = 18/277 (6%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           KQ      Y++   +G G F  V     + TG     K +     L    V   K EISI
Sbjct: 45  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV---KNEISI 101
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDA 121
           M  + HP ++ LH+    + ++ +ILEF++GGELFD+I  +  ++ E +   Y +Q  + 
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161
Query: 122 VAHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           + H H   + H D+KPEN++ ++    ++K+ DFGL A      E++  T  T  + APE
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL-ATKLNPDEIVKVTTATAEFAAPE 220
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK------KINAAEFSCPFW 232
           ++ +R   G   D+W+ GV+ +VL++G  PF GE DL TL        + +   FS    
Sbjct: 221 IV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS--- 276
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 269
            S  A   I  +L   P+ R+ +    +HPW + +++
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 139/266 (52%), Gaps = 20/266 (7%)
Query: 11  YEVGRT--IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           Y V +T  +G G F +V   +   TG  +A K++ K+  +K +  +++K EIS+M  + H
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKII-KTRGMKDK--EEVKNEISVMNQLDH 145
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHS 127
            N+++L++   S+  + +++E+V GGELFD+I+ +   L E D   + +Q+ + + H H 
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 128 KGVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
             + H DLKPEN+L        +K+ DFGL A   +  E L    GTP ++APEV+ N  
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGL-ARRYKPREKLKVNFGTPEFLAPEVV-NYD 263
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK------KINAAEFSCPFWFSTGAT 238
           +     D+WS GVI ++L++G  PF G+ D  TL         +   EF      S  A 
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD---ISEEAK 320
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWF 264
             I K+L      RI      KHPW 
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWL 346

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 138/255 (54%), Gaps = 7/255 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLH 75
           +G+G+F KV  ++ + T E  A+K+L K  +++   V+    E  ++ +  + P + +LH
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
               +  ++Y ++E+V GG+L   I   GR  E     Y  ++   +    SKG+ +RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           K +N++LDS G++K++DFG+              CGTP+Y+APE+++ + Y G + D W+
Sbjct: 469 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY-GKSVDWWA 527
Query: 196 CGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI 255
            GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   ++  +P  R+  
Sbjct: 528 FGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 587
Query: 256 --EG---IRKHPWFR 265
             EG   I++H +FR
Sbjct: 588 GPEGERDIKEHAFFR 602

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 133/252 (52%), Gaps = 5/252 (1%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY   + IGEG+F K    ++ E G    +K +  S  +  +  ++ +RE++++  ++HP
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHP 83
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVAHCHS 127
           NIV+  E       +YI++++  GG+LF +I  Q  +L  E+    +F Q+  A+ H H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + + HRD+K +N+ L   G +++ DFG++ +    VEL     GTP Y++PE+  N+ Y+
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILD 246
            + +D+W+ G +L+ L      F    +  L  KI +  F      +S    SL+ ++  
Sbjct: 204 -NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFK 262
Query: 247 PNPKTRIRIEGI 258
            NP+ R  +  I
Sbjct: 263 RNPRDRPSVNSI 274

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 141/269 (52%), Gaps = 23/269 (8%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKIVRH- 68
             + +G G FA VR   ++ TG+  A K L K    + R  D   +I  EI+++++ +  
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKK----RRRGQDCRAEILHEIAVLELAKSC 88
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCH 126
           P ++ LHEV  + +++ +ILE+  GGE+F   + +    + END  R  +Q+++ V + H
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 127 SKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
              + H DLKP+N+LL S    G++K+ DFG+S       E L    GTP Y+APE+L+ 
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEILN- 206
Query: 184 RGYD--GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPFWFSTG--A 237
             YD   +A D+W+ G+I ++L+    PF   D    Y  I+    ++S   + S    A
Sbjct: 207 --YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA 264
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
           T  I  +L  NP+ R   E    H W ++
Sbjct: 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 137/260 (52%), Gaps = 9/260 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ R IG+G+F KV   Q  +T +  AMK + K   ++   V  + +E+ IM+ + HP 
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V L         ++++++ + GG+L   +       E   + +  +L+ A+ +  ++ +
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR---GYD 187
            HRD+KP+N+LLD +G++ ++DF ++A+  +  ++  T  GT  Y+APE+ S+R   GY 
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT-TMAGTKPYMAPEMFSSRKGAGY- 194
Query: 188 GSAADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
             A D WS GV  + L+ G  P+     T    +         + P  +S    SL+ K+
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKL 254
Query: 245 LDPNPKTRI-RIEGIRKHPW 263
           L+PNP  R  ++  ++  P+
Sbjct: 255 LEPNPDQRFSQLSDVQNFPY 274

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  128 bits (321), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 138/267 (51%), Gaps = 19/267 (7%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGE-SVAMKVLAKSTILKHR-MVDQIKREISIMKIV 66
           A+Y +G  +G+G F  V FA +R T    VA+KV+ ++ +L    + D +   + +  + 
Sbjct: 31  AEYRLGPLLGKGGFGTV-FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 67  R------HPNIVRLHEVLASRTKVYIILE-FVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +      HP ++RL +   ++    ++LE  +   +LFD I  +G L E   R +F Q++
Sbjct: 90  KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 120 DAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
            A+ HCHS+GV HRD+K EN+L+D   G  K+ DFG  AL     E      GT  Y  P
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDFDGTRVYSPP 207
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGAT 238
           E +S   Y    A VWS G++L+ ++ G +PF E D     ++I  AE   P   S    
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPF-ERD-----QEILEAELHFPAHVSPDCC 261
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFR 265
           +LI + L P P +R  +E I   PW +
Sbjct: 262 ALIRRCLAPKPSSRPSLEEILLDPWMQ 288

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 139/274 (50%), Gaps = 13/274 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD-----QIKREISIMK 64
           KY     +G G F  V  A ++E  + V +K + K  +L+   ++     ++  EI+I+ 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 65  IVRHPNIVRLHEVLASRTKVYIILE-FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
            V H NI+++ ++  ++    +++E   +G +LF  I    RL E      F+QL+ AV 
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           +   K + HRD+K EN+++     +K+ DFG +A  ++G +L +T CGT  Y APEVL  
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMG 203
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 243
             Y G   ++WS GV L+ L+    PF E     L + + AA    P+  S    SL+  
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPFCE-----LEETVEAA-IHPPYLVSKELMSLVSG 257
Query: 244 ILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
           +L P P+ R  +E +   PW  +  N    + EE
Sbjct: 258 LLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEE 291

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 91/273 (33%), Positives = 132/273 (48%), Gaps = 28/273 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHPNI 71
             + +G G   KV    N+ T E  A+K+L            + +RE+ +  +  + P+I
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHI 117
Query: 72  VRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHC 125
           VR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+ + 
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 126 HSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPEVL 
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLG 236
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW--FS 234
              YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W   S
Sbjct: 237 PEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                LI  +L   P  R+ I     HPW  ++
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 91/273 (33%), Positives = 132/273 (48%), Gaps = 28/273 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHPNI 71
             + +G G   KV    N+ T E  A+K+L            + +RE+ +  +  + P+I
Sbjct: 72  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHI 123
Query: 72  VRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHC 125
           VR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+ + 
Sbjct: 124 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 183
Query: 126 HSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPEVL 
Sbjct: 184 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLG 242
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW--FS 234
              YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W   S
Sbjct: 243 PEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 301
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                LI  +L   P  R+ I     HPW  ++
Sbjct: 302 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 334

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 16  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVE 67
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 68  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 127
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 128 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 186
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 187 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 245
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 246 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 289

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 15  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVE 66
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 67  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 126
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 127 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 185
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 186 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 244
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 245 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 288

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 62
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 181
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 182 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 240
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 241 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 284

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/315 (29%), Positives = 146/315 (46%), Gaps = 63/315 (20%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVR 67
           KY +   IG+G++  VR A   +T    A+K++ K+ I  +  + V++IK E+ +MK + 
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI--------------------------- 100
           HPNI RL+EV      + +++E   GG L DK+                           
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 101 -----------------VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD 143
                            V + +L+ N  R    Q+  A+ + H++G+ HRD+KPEN L  
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMR----QIFSALHYLHNQGICHRDIKPENFLFS 202
Query: 144 SYGN--LKVSDFGLS----ALPQQGVELLHTTCGTPNYVAPEVL--SNRGYDGSAADVWS 195
           +  +  +K+ DFGLS     L       + T  GTP +VAPEVL  +N  Y G   D WS
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWS 261
Query: 196 CGVILFVLMAGYLPF-GETDLPTLYKKINAAE-FSCPFW--FSTGATSLIHKILDPNPKT 251
            GV+L +L+ G +PF G  D  T+ + +N    F  P +   S  A  L+  +L+ N   
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321
Query: 252 RIRIEGIRKHPWFRK 266
           R       +HPW  +
Sbjct: 322 RFDAMRALQHPWISQ 336

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 17  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVE 68
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 69  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 128
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 129 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 187
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 188 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 246
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 247 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 290

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 91/273 (33%), Positives = 132/273 (48%), Gaps = 28/273 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHPNI 71
             + +G G   KV    N+ T E  A+K+L            + +RE+ +  +  + P+I
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHI 73
Query: 72  VRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHC 125
           VR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+ + 
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 126 HSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPEVL 
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLG 192
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW--FS 234
              YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W   S
Sbjct: 193 PEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 251
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                LI  +L   P  R+ I     HPW  ++
Sbjct: 252 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 284

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 10  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVE 61
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 62  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 121
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 122 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 180
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 181 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 239
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 240 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 283

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVE 60
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 61  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 120
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 121 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 179
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 180 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 238
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 239 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 282

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 25  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVE 76
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 77  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 136
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 137 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 195
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 196 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 254
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 255 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 298

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 134/268 (50%), Gaps = 14/268 (5%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R   YEV  TIG G++ + +  + +  G+ +  K L   ++ +      +  E+++++ +
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 62
Query: 67  RHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLID 120
           +HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 121 AVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +         T  GTP Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFS 234
           ++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P+ +S
Sbjct: 183 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHP 262
                +I ++L+     R  +E I ++P
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENP 269

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 131/254 (51%), Gaps = 11/254 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +A + + + IG G F++V  A     G  VA+K +    ++  +      +EI ++K + 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQLIDAVA 123
           HPN+++ +       ++ I+LE    G+L   I H   Q RL+ E    +YF QL  A+ 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           H HS+ V HRD+KP N+ + + G +K+ D GL           H+  GTP Y++PE +  
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF---WFSTGAT 238
            GY+   +D+WS G +L+ + A   PF   + +L +L KKI   ++  P     +S    
Sbjct: 211 NGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPSDHYSEELR 268
Query: 239 SLIHKILDPNPKTR 252
            L++  ++P+P+ R
Sbjct: 269 QLVNMCINPDPEKR 282

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 93/284 (32%), Positives = 137/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 60
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 61  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 120
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L   C 
Sbjct: 121 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTEPCY 179
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 180 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 238
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 239 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 282

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G   KV    +R TG+  A+K+L  S   +  +    +           P+IV +
Sbjct: 16  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGG-------PHIVCI 68
Query: 75  HEVLAS----RTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSK 128
            +V  +    +  + II+E + GGELF +I  +G     E +     + +  A+   HS 
Sbjct: 69  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 128
Query: 129 GVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
            + HRD+KPENLL  S      LK++DFG +    Q    L T C TP YVAPEVL    
Sbjct: 129 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPEVLGPEK 186
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAE--FSCPFW--FSTGA 237
           YD S  D+WS GVI+++L+ G+ PF    G+   P + ++I   +  F  P W   S  A
Sbjct: 187 YDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 245
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI  +L  +P  R+ I     HPW  ++
Sbjct: 246 KQLIRLLLKTDPTERLTITQFMNHPWINQS 275

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 133/268 (49%), Gaps = 14/268 (5%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R   YEV  TIG G++ + +  + +  G+ +  K L   ++ +      +  E+++++ +
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 62
Query: 67  RHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLID 120
           +HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 121 AVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +            GTP Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 182
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFS 234
           ++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P+ +S
Sbjct: 183 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHP 262
                +I ++L+     R  +E I ++P
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENP 269

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G   KV    +R TG+  A+K+L  S   +  +    +           P+IV +
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGG-------PHIVCI 87
Query: 75  HEVLAS----RTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSK 128
            +V  +    +  + II+E + GGELF +I  +G     E +     + +  A+   HS 
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 129 GVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
            + HRD+KPENLL  S      LK++DFG +    Q    L T C TP YVAPEVL    
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPEVLGPEK 205
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAE--FSCPFW--FSTGA 237
           YD S  D+WS GVI+++L+ G+ PF    G+   P + ++I   +  F  P W   S  A
Sbjct: 206 YDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 264
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI  +L  +P  R+ I     HPW  ++
Sbjct: 265 KQLIRLLLKTDPTERLTITQFMNHPWINQS 294

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 14/268 (5%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R   YEV  TIG G++ + +  + +  G+ +  K L   ++ +      +  E+++++ +
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 62
Query: 67  RHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLID 120
           +HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 121 AVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +     +      GTP Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYY 182
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFS 234
           ++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P+ +S
Sbjct: 183 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHP 262
                +I ++L+     R  +E I ++P
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENP 269

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 90/286 (31%), Positives = 139/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 70
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF++    +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 71  VIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKPENLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 130 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 190 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 249
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 250 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 90/286 (31%), Positives = 139/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 72
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF++    +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 73  VIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKPENLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 132 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 251
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 252 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 139/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 71
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF++    +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 72  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 131 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 191 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 250
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 251 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 90/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKPENLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 139/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 72
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF++    +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 73  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 251
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 252 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 70
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKPENLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 130 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 190 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 249
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 250 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 71
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKPENLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 131 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 191 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 250
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 251 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 76
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 135
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 136 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIW 195
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 196 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 255
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 256 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 301

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 68
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 68
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 70
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 130 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 190 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 249
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 250 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 73/216 (33%), Positives = 115/216 (53%), Gaps = 4/216 (1%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-REISIMK 64
           + + KYE    +GEG++  V   +N++TG  VA+K   +S     +MV +I  REI ++K
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLK 79
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            +RH N+V L EV   + + Y++ EFV    L D  +    L     ++Y  Q+I+ +  
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           CHS  + HRD+KPEN+L+   G +K+ DFG +       E+      T  Y APE+L   
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD 199
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 219
              G A DVW+ G ++  +  G   F G++D+  LY
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY 235

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 72
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 251
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 252 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 71
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 131 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 191 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 250
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 251 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 70
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 130 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 190 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 249
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 250 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 70
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 130 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 190 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 249
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 250 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 73
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 132
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 133 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 192
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 193 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 252
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 253 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 298

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 71
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 131 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 191 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 250
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 251 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 137/272 (50%), Gaps = 14/272 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   +G+G F KV  AQN+ET    A KV+   +      ++    EI I+    HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPN 95
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKG 129
           IV+L +       ++I++EF  GG +   ++   R L E+  +   +Q +DA+ + H   
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-----SNR 184
           + HRDLK  N+L    G++K++DFG+SA   + ++   +  GTP ++APEV+      +R
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLI 241
            YD   ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+     +
Sbjct: 216 PYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVK 272
            K L+ N   R     + +HP+   + N P++
Sbjct: 275 KKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 306

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 68
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 68
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 72
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 251
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 252 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 137/272 (50%), Gaps = 14/272 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   +G+G F KV  AQN+ET    A KV+   +      ++    EI I+    HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPN 95
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKG 129
           IV+L +       ++I++EF  GG +   ++   R L E+  +   +Q +DA+ + H   
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-----SNR 184
           + HRDLK  N+L    G++K++DFG+SA   + ++   +  GTP ++APEV+      +R
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLI 241
            YD   ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+     +
Sbjct: 216 PYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVK 272
            K L+ N   R     + +HP+   + N P++
Sbjct: 275 KKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 306

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 73
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 132
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 133 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 192
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 193 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 252
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 253 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 298

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 76
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 135
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 136 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 195
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 196 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 255
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 256 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 301

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 137/286 (47%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 72
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+        D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 251
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 252 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 136/272 (50%), Gaps = 14/272 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   +G+G F KV  AQN+ET    A KV+   +      ++    EI I+    HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPN 95
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKG 129
           IV+L +       ++I++EF  GG +   ++   R L E+  +   +Q +DA+ + H   
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-----SNR 184
           + HRDLK  N+L    G++K++DFG+SA   + ++      GTP ++APEV+      +R
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLI 241
            YD   ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+     +
Sbjct: 216 PYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVK 272
            K L+ N   R     + +HP+   + N P++
Sbjct: 275 KKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 306

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  ++ CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLSFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 91/273 (33%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHPNI 71
             + +G G   KV    N+ T E  A+K L            + +RE+ +  +  + P+I
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKXLQD--------CPKARREVELHWRASQCPHI 117
Query: 72  VRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHC 125
           VR+ +V     A R  + I+ E + GGELF +I  +G     E +     + + +A+ + 
Sbjct: 118 VRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYL 177
Query: 126 HSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPEVL 
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLG 236
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW--FS 234
              YD S  D WS GVI ++L+ GY PF    G    P    +I     EF  P W   S
Sbjct: 237 PEKYDKS-CDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVS 295
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                LI  +L   P  R  I     HPW  ++
Sbjct: 296 EEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQS 328

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 137/286 (47%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 72
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ E V     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 73  VIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 251
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 252 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 87/280 (31%), Positives = 136/280 (48%), Gaps = 33/280 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
                        SL+ ++L  +P  RI  +    HP+F+
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 137/286 (47%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+  +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 137/286 (47%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+  +   T  +      I REIS++K + HPNIV+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 68
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 136/286 (47%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 68
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ E V        D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 69  VIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 134/294 (45%), Gaps = 45/294 (15%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G GT+A V    N+ TG  VA+K +   +  +        REIS+MK ++H NIVRL++
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 77  VLASRTKVYIILEFVTGG--ELFDK--IVHQGRLLENDCRRYFQ-QLIDAVAHCHSKGVY 131
           V+ +  K+ ++ EF+     +  D   + +  R LE +  +YFQ QL+  +A CH   + 
Sbjct: 71  VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKIL 130
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           HRDLKP+NLL++  G LK+ DFGL+      V    +   T  Y AP+VL       ++ 
Sbjct: 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI 190
Query: 192 DVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFSCPFWFST------------ 235
           D+WSCG IL  ++ G   F  T+    L  ++  +     S   W S             
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES--LWPSVTKLPKYNPNIQQ 248
Query: 236 --------------------GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 269
                                    +H +L  NP  R+  +    HPWF + Y+
Sbjct: 249 RPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 134/297 (45%), Gaps = 51/297 (17%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------REI 60
           + KYE    IGEGT+  V  A+NRET E VA+K        + R+ D  +       REI
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREI 52
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
            ++K ++H NIVRLH+VL S  K+ ++ EF      + FD     G L     + +  QL
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQL 110
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +  CHS+ V HRDLKP+NLL++  G LK++DFGL+      V        T  Y  P
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLYKKI--------------- 222
           +VL       ++ D+WS G I   L     P F   D+    K+I               
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 223 -NAAEFSCPFWFSTGATSLIH--------------KILDPNPKTRIRIEGIRKHPWF 264
               ++  P+      TSL++               +L  NP  RI  E   +HP+F
Sbjct: 231 TKLPDYK-PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 141/302 (46%), Gaps = 24/302 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREI--SIMKIVR 67
           + V R IG G F +V   +  +TG+  AMK L K  I +K      +   I  S++    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + V +RDLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL      
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 188 GSAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
            S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 428
Query: 245 LDPNPKTRIRIEG-----IRKHPWFR---------KNYNPVKCSEEEEVNLDDVHAV--F 288
           L  +   R+   G     +++ P+FR         + Y P       EVN  D   +  F
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSF 488
Query: 289 DD 290
           D+
Sbjct: 489 DE 490

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 141/302 (46%), Gaps = 24/302 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREI--SIMKIVR 67
           + V R IG G F +V   +  +TG+  AMK L K  I +K      +   I  S++    
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H+
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 309
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + V +RDLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL      
Sbjct: 310 RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAY 367
Query: 188 GSAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
            S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +
Sbjct: 368 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 427
Query: 245 LDPNPKTRIRIEG-----IRKHPWFR---------KNYNPVKCSEEEEVNLDDVHAV--F 288
           L  +   R+   G     +++ P+FR         + Y P       EVN  D   +  F
Sbjct: 428 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSF 487
Query: 289 DD 290
           D+
Sbjct: 488 DE 489

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 29/275 (10%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + +   +  AMK+L K  +LK       + E  ++       
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + RL E   R Y  +++ A+   H   
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL----SNR 184
             HRD+KP+N+L+D  G+++++DFG    L + G        GTP+Y++PE+L      +
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIHK 243
           G  G   D WS GV ++ ++ G  PF    L   Y KI N  E    F F T  T     
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE---RFQFPTQVTD---- 308
Query: 244 ILDPNPKTRIR--------------IEGIRKHPWF 264
            +  N K  IR              IE  +KHP+F
Sbjct: 309 -VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 141/302 (46%), Gaps = 24/302 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREI--SIMKIVR 67
           + V R IG G F +V   +  +TG+  AMK L K  I +K      +   I  S++    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + V +RDLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL      
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 188 GSAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
            S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 428
Query: 245 LDPNPKTRIRIEG-----IRKHPWFR---------KNYNPVKCSEEEEVNLDDVHAV--F 288
           L  +   R+   G     +++ P+FR         + Y P       EVN  D   +  F
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSF 488
Query: 289 DD 290
           D+
Sbjct: 489 DE 490

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 141/302 (46%), Gaps = 24/302 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREI--SIMKIVR 67
           + V R IG G F +V   +  +TG+  AMK L K  I +K      +   I  S++    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + V +RDLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL      
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 188 GSAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
            S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 428
Query: 245 LDPNPKTRIRIEG-----IRKHPWFR---------KNYNPVKCSEEEEVNLDDVHAV--F 288
           L  +   R+   G     +++ P+FR         + Y P       EVN  D   +  F
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSF 488
Query: 289 DD 290
           D+
Sbjct: 489 DE 490

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 137/284 (48%), Gaps = 39/284 (13%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI-SIMKIVRHPNIVRLH 75
           +GEG +AKV+ A + + G+  A+K++ K          ++ RE+ ++ +   + NI+ L 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQA---GHSRSRVFREVETLYQCQGNKNILELI 77
Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
           E     T+ Y++ E + GG +   I  Q    E +  R  + +  A+   H+KG+ HRDL
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDL 137
Query: 136 KPENLLLDS---YGNLKVSDFGL--------SALPQQGVELLHTTCGTPNYVAPEVL--- 181
           KPEN+L +S      +K+ DF L        S  P    EL  T CG+  Y+APEV+   
Sbjct: 138 KPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELT-TPCGSAEYMAPEVVEVF 196
Query: 182 -SNRGYDGSAADVWSCGVILFVLMAGYLPF------------GE---TDLPTLYKKINAA 225
                +     D+WS GV+L+++++GY PF            GE        L++ I   
Sbjct: 197 TDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 256
Query: 226 EFSCP--FW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
           ++  P   W   S+ A  LI K+L  + K R+    + +HPW +
Sbjct: 257 KYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 135/297 (45%), Gaps = 51/297 (17%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------REI 60
           + KYE    IGEGT+  V  A+NRET E VA+K        + R+ D  +       REI
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREI 52
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
            ++K ++H NIVRLH+VL S  K+ ++ EF      + FD     G L     + +  QL
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQL 110
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +  CHS+ V HRDLKP+NLL++  G LK+++FGL+      V        T  Y  P
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLM-AGYLPFGETDLPTLYKKI--------------- 222
           +VL       ++ D+WS G I   L  AG   F   D+    K+I               
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 223 -NAAEFSCPFWFSTGATSLIH--------------KILDPNPKTRIRIEGIRKHPWF 264
               ++  P+      TSL++               +L  NP  RI  E   +HP+F
Sbjct: 231 TKLPDYK-PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 135/262 (51%), Gaps = 13/262 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   +G+G F KV  A+N+ETG   A KV+   +  +  + D I  EI I+    HP 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYI-VEIEILATCDHPY 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKG 129
           IV+L        K++I++EF  GG +   ++   R L E   +   +Q+++A+   HSK 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-----LSNR 184
           + HRDLK  N+L+   G+++++DFG+SA   + ++   +  GTP ++APEV     + + 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLI 241
            YD   AD+WS G+ L  +     P  E +   +  KI  ++      P  +S      +
Sbjct: 198 PYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256
Query: 242 HKILDPNPKTRIRIEGIRKHPW 263
              LD NP+TR     + +HP+
Sbjct: 257 KIALDKNPETRPSAAQLLEHPF 278

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 135/262 (51%), Gaps = 13/262 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   +G+G F KV  A+N+ETG   A KV+   +  +  + D I  EI I+    HP 
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYI-VEIEILATCDHPY 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKG 129
           IV+L        K++I++EF  GG +   ++   R L E   +   +Q+++A+   HSK 
Sbjct: 70  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 129
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-----LSNR 184
           + HRDLK  N+L+   G+++++DFG+SA   + ++   +  GTP ++APEV     + + 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLI 241
            YD   AD+WS G+ L  +     P  E +   +  KI  ++      P  +S      +
Sbjct: 190 PYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 248
Query: 242 HKILDPNPKTRIRIEGIRKHPW 263
              LD NP+TR     + +HP+
Sbjct: 249 KIALDKNPETRPSAAQLLEHPF 270

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 134/257 (52%), Gaps = 8/257 (3%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A+ + +G  VA+K++    + K +  + +  E+ IM+  +H N+V +++
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D IV Q RL E       + ++ A+A+ H++GV HRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APEV+S   Y  +  D+WS 
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLY-ATEVDIWSL 227
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATSLIHKILDPNPKTRI 253
           G+++  ++ G  P+         K++  +   +       S      + ++L  +P+ R 
Sbjct: 228 GIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA 287
Query: 254 RIEGIRKHPWFRKNYNP 270
             + +  HP+  +   P
Sbjct: 288 TAQELLDHPFLLQTGLP 304

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 110/194 (56%), Gaps = 5/194 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  + TG+ VA+K   K  + K +  + +  E+ IM+   H N+V ++ 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A+++ H++GV HRD+K
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL S G +K+SDFG  A   + V       GTP ++APEV+S   Y G+  D+WS 
Sbjct: 169 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPY-GTEVDIWSL 227
Query: 197 GVILFVLMAGYLPF 210
           G+++  ++ G  P+
Sbjct: 228 GIMVIEMIDGEPPY 241

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 137/277 (49%), Gaps = 28/277 (10%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           + KQ   V  ++V   +GEG++  V  A ++ETG+ VA+K +   + L+     +I +EI
Sbjct: 23  LTKQPEEV--FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIKEI 75
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLI 119
           SIM+    P++V+ +      T ++I++E+   G + D I +    L E++     Q  +
Sbjct: 76  SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL 135
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
             + + H     HRD+K  N+LL++ G+ K++DFG++      +   +   GTP ++APE
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPE 195
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-----------TDLPTLYKKINAAEFS 228
           V+   GY+   AD+WS G+    +  G  P+ +           T+ P  ++K       
Sbjct: 196 VIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK------- 247
Query: 229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
            P  +S   T  + + L  +P+ R     + +HP+ R
Sbjct: 248 -PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 135/282 (47%), Gaps = 15/282 (5%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIK 57
           MK++    ++Y+VG  +G G F  V           VA+K + K  I     +    ++ 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 58  REISIMKIVRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRY 114
            E+ ++K V      ++RL +         +ILE      +LFD I  +G L E   R +
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 120
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
           F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT 
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 178
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF 233
            Y  PE +    Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----V 232
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
           S+    LI   L   P  R   E I+ HPW +    P + +E
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 274

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 135/282 (47%), Gaps = 15/282 (5%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIK 57
           MK++    ++Y+VG  +G G F  V           VA+K + K  I     +    ++ 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 58  REISIMKIVRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRY 114
            E+ ++K V      ++RL +         +ILE      +LFD I  +G L E   R +
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 120
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
           F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT 
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 178
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF 233
            Y  PE +    Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----V 232
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
           S+    LI   L   P  R   E I+ HPW +    P + +E
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 274

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 135/282 (47%), Gaps = 15/282 (5%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIK 57
           MK++    ++Y+VG  +G G F  V           VA+K + K  I     +    ++ 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 58  REISIMKIVRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRY 114
            E+ ++K V      ++RL +         +ILE      +LFD I  +G L E   R +
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 120
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
           F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT 
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 178
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF 233
            Y  PE +    Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----V 232
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
           S+    LI   L   P  R   E I+ HPW +    P + +E
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 274

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 132/273 (48%), Gaps = 21/273 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQI--KREISIMKIVR 67
           KY +   +G G F  V    +R    S     +AK   +K +  DQ+  K+EISI+ I R
Sbjct: 6   KYMIAEDLGRGEFGIV----HRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIAR 59
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCH 126
           H NI+ LHE   S  ++ +I EF++G ++F++I      L E +   Y  Q+ +A+   H
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 127 SKGVYHRDLKPENLLLDS--YGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLS 182
           S  + H D++PEN++  +     +K+ +FG +    P     LL T    P Y APEV  
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPEV-H 175
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGAT 238
                 +A D+WS G +++VL++G  PF       + + I  AE++         S  A 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
             + ++L    K+R+      +HPW ++    V
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 127/270 (47%), Gaps = 17/270 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F++V   + ++TG+  AMK++ K  +LK   V   + E  ++       
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKG 129
           I +LH        +Y+++E+  GG+L   +   G R+     R Y  +++ A+   H  G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLS------ 182
             HRD+KP+N+LLD  G+++++DFG    L   G        GTP+Y++PE+L       
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPF---WFSTGA 237
             G  G   D W+ GV  + +  G  PF        Y KI       S P         A
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302
Query: 238 TSLIHKILDPNPKTRIRIEG---IRKHPWF 264
              I ++L P P+TR+   G    R HP+F
Sbjct: 303 RDFIQRLLCP-PETRLGRGGAGDFRTHPFF 331

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 132/274 (48%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE +    +LFD I  +G L E   R +F Q+++AV
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 185
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 239
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 240 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 273

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 132/285 (46%), Gaps = 31/285 (10%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YE+   IG G  A V+ A      E VA+K +          +D++ +EI  M    HPN
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPN 74
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH--------QGRLLENDCRRYFQQLIDAV 122
           IV  +     + +++++++ ++GG + D I H         G L E+      +++++ +
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH-----TTCGTPNYVA 177
            + H  G  HRD+K  N+LL   G+++++DFG+SA    G ++       T  GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 178 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPFG------------ETDLPTLYKKINA 224
           PEV+   RGYD   AD+WS G+    L  G  P+             + D P+L   +  
Sbjct: 195 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 253
Query: 225 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 269
            E      +      +I   L  +P+ R     + +H +F+K  N
Sbjct: 254 KEMLKK--YGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 134/282 (47%), Gaps = 15/282 (5%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIK 57
           MK++    ++Y+VG  +G G F  V           VA+K + K  I     +    ++ 
Sbjct: 23  MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 58  REISIMKIVRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRY 114
            E+ ++K V      ++RL +         +ILE      +LFD I  +G L E   R +
Sbjct: 83  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 142
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
           F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT 
Sbjct: 143 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 200
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF 233
            Y  PE +    Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       
Sbjct: 201 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----V 254
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
           S     LI   L   P  R   E I+ HPW +    P + +E
Sbjct: 255 SXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 296

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 235
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S+    LI
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSSECQHLI 235
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 185
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 239
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 240 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 273

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 126
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 127 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 184
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 238
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 239 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 272

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 124 RHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S     LI
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSXECQHLI 235
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 83  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 142
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 143 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 200
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 254
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 255 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 288

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 156
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S+    LI
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSSECQHLI 268
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 155
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 213
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S+    LI
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSSECQHLI 267
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 143
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 255
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 256 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 289

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 155
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 213
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S+    LI
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSSECQHLI 267
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 156
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S+    LI
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSSECQHLI 268
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 111 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 170
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 228
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 282
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 283 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 316

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 155
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 213
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 267
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 220
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 274
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 275 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 139/295 (47%), Gaps = 37/295 (12%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + KY+    +GEGT+  V  A++ + G  VA+K + +       +     REIS++K + 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRI-RLDAEDEGIPSTAIREISLLKELH 77
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHC 125
           HPNIV L +V+ S   + ++ EF+       K++ + +  L ++  + Y  QL+  VAHC
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H   + HRDLKP+NLL++S G LK++DFGL+      V        T  Y AP+VL    
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-GETD---LPTLYKKI---NAAEF----SCPFW-- 232
              ++ D+WS G I   ++ G   F G TD   LP ++  +   N  E+      P W  
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 233 -----------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
                            F      L+  +L  +P  RI       HP+F K+ +P
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF-KDLDP 309

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 139/295 (47%), Gaps = 37/295 (12%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + KY+    +GEGT+  V  A++ + G  VA+K + +       +     REIS++K + 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRI-RLDAEDEGIPSTAIREISLLKELH 77
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHC 125
           HPNIV L +V+ S   + ++ EF+       K++ + +  L ++  + Y  QL+  VAHC
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H   + HRDLKP+NLL++S G LK++DFGL+      V        T  Y AP+VL    
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-GETD---LPTLYKKI---NAAEF----SCPFW-- 232
              ++ D+WS G I   ++ G   F G TD   LP ++  +   N  E+      P W  
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 233 -----------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
                            F      L+  +L  +P  RI       HP+F K+ +P
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF-KDLDP 309

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  R +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 143
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APE++S   Y G   D+WS 
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWSL 202
Query: 197 GVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           G+++  ++ G  P F E           +LP   K ++          S      + ++L
Sbjct: 203 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV--------SPSLKGFLDRLL 254
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNP 270
             +P  R     + KHP+  K   P
Sbjct: 255 VRDPAQRATAAELLKHPFLAKAGPP 279

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 125/267 (46%), Gaps = 13/267 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + + T    AMK+L K  +LK       + E  ++       
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 151
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + +L E+  R Y  +++ A+   H   
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL----SNR 184
             HRD+KP+N+LLD  G+++++DFG    +   G        GTP+Y++PE+L       
Sbjct: 212 YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 271
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW---FSTGATS 239
           G  G   D WS GV ++ ++ G  PF    L   Y KI   E  F  P      S  A  
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 331
Query: 240 LIHKILDPNPK--TRIRIEGIRKHPWF 264
           LI +++    +   +  IE  +KH +F
Sbjct: 332 LIQRLICSRERRLGQNGIEDFKKHAFF 358

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  R +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 152
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APE++S   Y G   D+WS 
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWSL 211
Query: 197 GVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           G+++  ++ G  P F E           +LP   K ++          S      + ++L
Sbjct: 212 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV--------SPSLKGFLDRLL 263
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNP 270
             +P  R     + KHP+  K   P
Sbjct: 264 VRDPAQRATAAELLKHPFLAKAGPP 288

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 131/282 (46%), Gaps = 31/282 (10%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YE+   IG G  A V+ A      E VA+K +          +D++ +EI  M    HPN
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH--------QGRLLENDCRRYFQQLIDAV 122
           IV  +     + +++++++ ++GG + D I H         G L E+      +++++ +
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH-----TTCGTPNYVA 177
            + H  G  HRD+K  N+LL   G+++++DFG+SA    G ++       T  GTP ++A
Sbjct: 130 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 189
Query: 178 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPFG------------ETDLPTLYKKINA 224
           PEV+   RGYD   AD+WS G+    L  G  P+             + D P+L   +  
Sbjct: 190 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 248
Query: 225 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
            E      +      +I   L  +P+ R     + +H +F+K
Sbjct: 249 KEMLKK--YGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 125/267 (46%), Gaps = 13/267 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + + T    AMK+L K  +LK       + E  ++       
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 135
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + +L E+  R Y  +++ A+   H   
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL----SNR 184
             HRD+KP+N+LLD  G+++++DFG    +   G        GTP+Y++PE+L       
Sbjct: 196 YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 255
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW---FSTGATS 239
           G  G   D WS GV ++ ++ G  PF    L   Y KI   E  F  P      S  A  
Sbjct: 256 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 315
Query: 240 LIHKILDPNPK--TRIRIEGIRKHPWF 264
           LI +++    +   +  IE  +KH +F
Sbjct: 316 LIQRLICSRERRLGQNGIEDFKKHAFF 342

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  R +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 147
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APE++S   Y G   D+WS 
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWSL 206
Query: 197 GVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           G+++  ++ G  P F E           +LP   K ++          S      + ++L
Sbjct: 207 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV--------SPSLKGFLDRLL 258
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNP 270
             +P  R     + KHP+  K   P
Sbjct: 259 VRDPAQRATAAELLKHPFLAKAGPP 283

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  R +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 154
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APE++S   Y G   D+WS 
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWSL 213
Query: 197 GVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           G+++  ++ G  P F E           +LP   K ++          S      + ++L
Sbjct: 214 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV--------SPSLKGFLDRLL 265
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNP 270
             +P  R     + KHP+  K   P
Sbjct: 266 VRDPAQRATAAELLKHPFLAKAGPP 290

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 155
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 213
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S     LI
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSXECQHLI 267
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 156
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S     LI
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSXECQHLI 268
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 143
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S     LI
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSXECQHLI 255
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 256 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 289

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 156
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S     LI
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSXECQHLI 268
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 83  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 142
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 143 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 200
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S     LI
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSXECQHLI 254
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 255 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 288

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 111 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 170
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 228
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S     LI
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSXECQHLI 282
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 283 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 316

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 56  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 115
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 116 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 175
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 176 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 233
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S     LI
Sbjct: 234 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSXECQHLI 287
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 288 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 321

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 143
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S     LI
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSXECQHLI 255
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 256 RWCLALRPXDRPTFEEIQNHPWMQDVLLPQETAE 289

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  R +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APE++S   Y G   D+WS 
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWSL 256
Query: 197 GVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           G+++  ++ G  P F E           +LP   K ++          S      + ++L
Sbjct: 257 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV--------SPSLKGFLDRLL 308
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNP 270
             +P  R     + KHP+  K   P
Sbjct: 309 VRDPAQRATAAELLKHPFLAKAGPP 333

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  R +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 215
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 274
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APE++S   Y G   D+WS 
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWSL 333
Query: 197 GVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           G+++  ++ G  P F E           +LP   K ++          S      + ++L
Sbjct: 334 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK--------VSPSLKGFLDRLL 385
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNP 270
             +P  R     + KHP+  K   P
Sbjct: 386 VRDPAQRATAAELLKHPFLAKAGPP 410

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 114/215 (53%), Gaps = 6/215 (2%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-REISIMKIV 66
           + KYE    IGEG++  V   +NR+TG+ VA+K   +S      ++ +I  REI ++K +
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQL 59
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           +HPN+V L EV   + +++++ E+     L +   +Q  + E+  +    Q + AV  CH
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
                HRD+KPEN+L+  +  +K+ DFG + L     +       T  Y +PE+L     
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 187 DGSAADVWSCGVILFVLMAGYLPF--GETDLPTLY 219
            G   DVW+ G +   L++G +P   G++D+  LY
Sbjct: 180 YGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLY 213

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 135/286 (47%), Gaps = 41/286 (14%)
Query: 16  TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVRL 74
            +GEG  A+V+   N  T +  A+K++ K       +  ++ RE+ ++ +   H N++ L
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
            E      + Y++ E + GG +   I  +    E +     Q +  A+   H+KG+ HRD
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 135 LKPENLLLD---SYGNLKVSDFGLSA--------LPQQGVELLHTTCGTPNYVAPEVLSN 183
           LKPEN+L +       +K+ DFGL +         P    ELL T CG+  Y+APEV+  
Sbjct: 137 LKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELL-TPCGSAEYMAPEVVEA 195
Query: 184 RGYDGSA----ADVWSCGVILFVLMAGYLPF------------GETDLPT----LYKKIN 223
              + S      D+WS GVIL++L++GY PF            GE   P     L++ I 
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA-CPACQNMLFESIQ 254
Query: 224 AAEFSCP--FW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
             ++  P   W   S  A  LI K+L  + K R+    + +HPW +
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 137/293 (46%), Gaps = 39/293 (13%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + KY     IGEGT+  V  AQN   GE+ A+K + +       +     REISI+K ++
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELK 58
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           H NIV+L++V+ ++ ++ ++ E +     +L D  V +G L     + +  QL++ +A+C
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H + V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+VL    
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------------GETDLP---- 216
              +  D+WS G I   ++ G   F                           T+LP    
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 217 --TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             T+Y+ +    F            L+ K+L  +P  RI  +   +H +F++N
Sbjct: 237 NFTVYEPLPWESFLKG--LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 119/262 (45%), Gaps = 22/262 (8%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           +   IG G+F  V  A+    G  VA+K+L +      R V++  RE++IMK +RHPNIV
Sbjct: 41  IKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNIV 97
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA-----HCHS 127
                +     + I+ E+++ G L+  +   G   + D RR      D        H  +
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HRDLK  NLL+D    +KV DFGLS L            GTP ++APEVL +   +
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
              +DV+S GVIL+ L     P+G          +N A+      F      +   +   
Sbjct: 218 -EKSDVYSFGVILWELATLQQPWG---------NLNPAQVVAAVGFKCKRLEIPRNL--- 264
Query: 248 NPKTRIRIEGI-RKHPWFRKNY 268
           NP+    IEG     PW R ++
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSF 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 137/293 (46%), Gaps = 39/293 (13%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + KY     IGEGT+  V  AQN   GE+ A+K + +       +     REISI+K ++
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELK 58
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           H NIV+L++V+ ++ ++ ++ E +     +L D  V +G L     + +  QL++ +A+C
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H + V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+VL    
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------------GETDLP---- 216
              +  D+WS G I   ++ G   F                           T+LP    
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 217 --TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             T+Y+ +    F            L+ K+L  +P  RI  +   +H +F++N
Sbjct: 237 NFTVYEPLPWESFLKG--LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 137/293 (46%), Gaps = 39/293 (13%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + KY     IGEGT+  V  AQN   GE+ A+K + +       +     REISI+K ++
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELK 58
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           H NIV+L++V+ ++ ++ ++ E +     +L D  V +G L     + +  QL++ +A+C
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H + V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+VL    
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------------GETDLP---- 216
              +  D+WS G I   ++ G   F                           T+LP    
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 217 --TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             T+Y+ +    F            L+ K+L  +P  RI  +   +H +F++N
Sbjct: 237 NFTVYEPLPWESFLKG--LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 129/261 (49%), Gaps = 12/261 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      K  +   I  EI +M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV++ + Y 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY- 193
Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGATSLIHKI 244
           G   D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           LD + + R   + + +H + +
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 120/262 (45%), Gaps = 22/262 (8%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           +   IG G+F  V  A+    G  VA+K+L +      R V++  RE++IMK +RHPNIV
Sbjct: 41  IKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNIV 97
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA-----HCHS 127
                +     + I+ E+++ G L+  +   G   + D RR      D        H  +
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HR+LK  NLL+D    +KV DFGLS L         +  GTP ++APEVL +   +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
              +DV+S GVIL+ L     P+G          +N A+      F      +   +   
Sbjct: 218 -EKSDVYSFGVILWELATLQQPWG---------NLNPAQVVAAVGFKCKRLEIPRNL--- 264
Query: 248 NPKTRIRIEGI-RKHPWFRKNY 268
           NP+    IEG     PW R ++
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSF 286

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 108/215 (50%), Gaps = 3/215 (1%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++   +G G  + V  A++      VA+K +      K   + + +RE+     + H 
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV + +V       Y+++E++ G  L + I   G L  +    +  Q++D + H H   
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
           + HRD+KP+N+L+DS   LK+ DFG++ AL +  +   +   GT  Y +PE       D 
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD- 190
Query: 189 SAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI 222
              D++S G++L+ ++ G  PF GET +    K I
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI 225

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 134/286 (46%), Gaps = 41/286 (14%)
Query: 16  TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVRL 74
            +GEG  A+V+   N  T +  A+K++ K       +  ++ RE+ ++ +   H N++ L
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
            E      + Y++ E + GG +   I  +    E +     Q +  A+   H+KG+ HRD
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 135 LKPENLLLD---SYGNLKVSDFGLSA--------LPQQGVELLHTTCGTPNYVAPEVLSN 183
           LKPEN+L +       +K+ DF L +         P    ELL T CG+  Y+APEV+  
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL-TPCGSAEYMAPEVVEA 195
Query: 184 RGYDGSA----ADVWSCGVILFVLMAGYLPF------------GETDLPT----LYKKIN 223
              + S      D+WS GVIL++L++GY PF            GE   P     L++ I 
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA-CPACQNMLFESIQ 254
Query: 224 AAEFSCP--FW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
             ++  P   W   S  A  LI K+L  + K R+    + +HPW +
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 14/264 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G G F +V   Q + TG+  A K L K  + K +       E  I+  V    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCHSKGV 130
                ++T + +++  + GG++   I +         E     Y  Q++  + H H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    YD S 
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS- 369
Query: 191 ADVWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            D ++ GV L+ ++A   PF   GE  +   L +++     + P  FS  +      +L 
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429
Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            +P+ R+       +G+R HP FR
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 14/264 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G G F +V   Q + TG+  A K L K  + K +       E  I+  V    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCHSKGV 130
                ++T + +++  + GG++   I +         E     Y  Q++  + H H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    YD S 
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS- 369
Query: 191 ADVWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            D ++ GV L+ ++A   PF   GE  +   L +++     + P  FS  +      +L 
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429
Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            +P+ R+       +G+R HP FR
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 14/264 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G G F +V   Q + TG+  A K L K  + K +       E  I+  V    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCHSKGV 130
                ++T + +++  + GG++   I +         E     Y  Q++  + H H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    YD S 
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS- 369
Query: 191 ADVWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            D ++ GV L+ ++A   PF   GE  +   L +++     + P  FS  +      +L 
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429
Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            +P+ R+       +G+R HP FR
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 14/264 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G G F +V   Q + TG+  A K L K  + K +       E  I+  V    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCHSKGV 130
                ++T + +++  + GG++   I +         E     Y  Q++  + H H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    YD S 
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS- 369
Query: 191 ADVWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            D ++ GV L+ ++A   PF   GE  +   L +++     + P  FS  +      +L 
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429
Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            +P+ R+       +G+R HP FR
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 135/266 (50%), Gaps = 19/266 (7%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I H G+    + R  F   ++   +   H + + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD +G++++SD GL+    +G + +    GT  Y+APEV+ N  Y  S  D
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFS-PD 367
Query: 193 VWSCGVILFVLMAGYLPFGE-------TDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
            W+ G +L+ ++AG  PF +        ++  L K++   E+S    FS  A SL  ++L
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYS--ERFSPQARSLCSQLL 424
Query: 246 DPNPKTRIRIEG-----IRKHPWFRK 266
             +P  R+   G     +++HP F+K
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 135/266 (50%), Gaps = 19/266 (7%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I H G+    + R  F   ++   +   H + + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD +G++++SD GL+    +G + +    GT  Y+APEV+ N  Y  S  D
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFS-PD 367
Query: 193 VWSCGVILFVLMAGYLPFGE-------TDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
            W+ G +L+ ++AG  PF +        ++  L K++   E+S    FS  A SL  ++L
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYS--ERFSPQARSLCSQLL 424
Query: 246 DPNPKTRIRIEG-----IRKHPWFRK 266
             +P  R+   G     +++HP F+K
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 128/261 (49%), Gaps = 12/261 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      K  +   I  EI +M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q         GTP ++APEV++ + Y 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVTRKAY- 193
Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGATSLIHKI 244
           G   D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           LD + + R   + + +H + +
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 112/213 (52%), Gaps = 10/213 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      K  +   I  EI +M+  ++P
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 78
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HR++K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV++ + Y 
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY- 194
Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 219
           G   D+WS G++   ++ G  P+  E  L  LY
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 227

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 111/213 (52%), Gaps = 10/213 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      K  +   I  EI +M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q         GTP ++APEV++ + Y 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAY- 193
Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 219
           G   D+WS G++   ++ G  P+  E  L  LY
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 111/213 (52%), Gaps = 10/213 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      K  +   I  EI +M+  ++P
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 78
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q         GTP ++APEV++ + Y 
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAY- 194
Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 219
           G   D+WS G++   ++ G  P+  E  L  LY
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 227

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 4/196 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++            Q  +EI+++     P + + + 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 72
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL  +G +K++DFG++          +T  GTP ++APEV+    YD S AD+WS 
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSL 190
Query: 197 GVILFVLMAGYLPFGE 212
           G+    L  G  P  E
Sbjct: 191 GITAIELARGEPPHSE 206

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 108/226 (47%), Gaps = 30/226 (13%)
Query: 51  RMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND 110
           R++D  +R  S + I+  P  V+                     +LFD I  +G L E  
Sbjct: 120 RLLDWFERPDSFVLILERPEPVQ---------------------DLFDFITERGALQEEL 158
Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTT 169
            R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V      
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDF 216
Query: 170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC 229
            GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E D   +  ++   +   
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-- 273
Query: 230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
               S+    LI   L   P  R   E I+ HPW +    P + +E
Sbjct: 274 ---VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 316

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 4/196 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++            Q  +EI+++     P + + + 
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 92
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 151
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL  +G +K++DFG++          +T  GTP ++APEV+    YD S AD+WS 
Sbjct: 152 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSL 210
Query: 197 GVILFVLMAGYLPFGE 212
           G+    L  G  P  E
Sbjct: 211 GITAIELARGEPPHSE 226

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 4/196 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++            Q  +EI+++     P + + + 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 72
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL  +G +K++DFG++          +   GTP ++APEV+    YD S AD+WS 
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-SKADIWSL 190
Query: 197 GVILFVLMAGYLPFGE 212
           G+    L  G  P  E
Sbjct: 191 GITAIELARGEPPHSE 206

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 4/196 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++            Q  +EI+++     P + + + 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 87
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL  +G +K++DFG++          +   GTP ++APEV+    YD S AD+WS 
Sbjct: 147 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-SKADIWSL 205
Query: 197 GVILFVLMAGYLPFGE 212
           G+    L  G  P  E
Sbjct: 206 GITAIELARGEPPHSE 221

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 128/284 (45%), Gaps = 50/284 (17%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 62
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG +               
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------- 167
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
                  +  +   YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 168 -------KETTGEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 22/271 (8%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV +++   + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLS 182
           H  G+ HRD+KP N+L+ +   +KV DFG++ A+   G  +  T    GT  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQAR 192
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFSTG 236
               D + +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S  
Sbjct: 193 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLSAD 249
Query: 237 ATSLIHKILDPNPKTR------IRIEGIRKH 261
             +++ K L  NP+ R      +R + +R H
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 136/305 (44%), Gaps = 47/305 (15%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R  + +E    +G+G F +V  A+N       A+K +  +       +  I  E+ ++  
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLAS 58
Query: 66  VRHPNIVRLHEVLASR-------------TKVYIILEFVTGGELFDKIVHQGRLLE--ND 110
           + H  +VR +     R             + ++I +E+   G L+D ++H   L +  ++
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRDE 117
Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--- 167
             R F+Q+++A+++ HS+G+ HRDLKP N+ +D   N+K+ DFGL+    + +++L    
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 168 -----------TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDL 215
                      +  GT  YVA EVL   G+     D++S G+I F ++    PF    + 
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMER 234
Query: 216 PTLYKKINAAEFSCPFWFSTGATSLIHKI----LDPNPKTRIRIEGIRKHPWFRKNYNPV 271
             + KK+ +     P  F      +  KI    +D +P  R     +    W      PV
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL-----PV 289
Query: 272 KCSEE 276
           K  +E
Sbjct: 290 KHQDE 294

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 125/271 (46%), Gaps = 22/271 (8%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV +++   + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLS 182
           H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFSTG 236
               D + +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S  
Sbjct: 193 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLSAD 249
Query: 237 ATSLIHKILDPNPKTR------IRIEGIRKH 261
             +++ K L  NP+ R      +R + +R H
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 114/235 (48%), Gaps = 39/235 (16%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR--MVDQIKR----EI 60
           R  +YE    +GEG FA V  A+++ T + VA+K +     L HR    D I R    EI
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK----LGHRSEAKDGINRTALREI 63
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQL 118
            +++ + HPNI+ L +    ++ + ++ +F+      + I+    L+   +  + Y    
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN---- 174
           +  + + H   + HRDLKP NLLLD  G LK++DFGL+            + G+PN    
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-----------KSFGSPNRAYX 170
Query: 175 -------YVAPEVLSNRGYDGSAADVWSCGVIL--FVLMAGYLPFGETDLPTLYK 220
                  Y APE+L      G   D+W+ G IL   +L   +LP G++DL  L +
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLTR 224

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 22/271 (8%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV +++   + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLS 182
           H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFSTG 236
               D   +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S  
Sbjct: 193 GDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLSAD 249
Query: 237 ATSLIHKILDPNPKTR------IRIEGIRKH 261
             +++ K L  NP+ R      +R + +R H
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 4/193 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T E VA+K++            Q  +EI+++     P I R   
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYITRYFG 84
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL   G++K++DFG++          +   GTP ++APEV+    YD   AD+WS 
Sbjct: 144 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-FKADIWSL 202
Query: 197 GVILFVLMAGYLP 209
           G+    L  G  P
Sbjct: 203 GITAIELAKGEPP 215

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 125/271 (46%), Gaps = 22/271 (8%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 30  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 89
Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV +++   + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 90  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 149
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLS 182
           H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE   
Sbjct: 150 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 209
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFSTG 236
               D + +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S  
Sbjct: 210 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLSAD 266
Query: 237 ATSLIHKILDPNPKTR------IRIEGIRKH 261
             +++ K L  NP+ R      +R + +R H
Sbjct: 267 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 297

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 120/245 (48%), Gaps = 13/245 (5%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+GT+  V   ++      +A+K + +      R    +  EI++ K ++H NIV+   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQ-GRLLEND--CRRYFQQLIDAVAHCHSKGVYHR 133
             +    + I +E V GG L   +  + G L +N+     Y +Q+++ + + H   + HR
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 134 DLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSA 190
           D+K +N+L+++Y G LK+SDFG S           T  GT  Y+APE++    RGY G A
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKA 205
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLP--TLYK-KINAAEFSCPFWFSTGATSLIHKILDP 247
           AD+WS G  +  +  G  PF E   P   ++K  +       P   S  A + I K  +P
Sbjct: 206 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEP 265
Query: 248 NPKTR 252
           +P  R
Sbjct: 266 DPDKR 270

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 120/245 (48%), Gaps = 13/245 (5%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+GT+  V   ++      +A+K + +      R    +  EI++ K ++H NIV+   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLG 72
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQ-GRLLEND--CRRYFQQLIDAVAHCHSKGVYHR 133
             +    + I +E V GG L   +  + G L +N+     Y +Q+++ + + H   + HR
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 132
Query: 134 DLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSA 190
           D+K +N+L+++Y G LK+SDFG S           T  GT  Y+APE++    RGY G A
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKA 191
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLP--TLYK-KINAAEFSCPFWFSTGATSLIHKILDP 247
           AD+WS G  +  +  G  PF E   P   ++K  +       P   S  A + I K  +P
Sbjct: 192 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEP 251
Query: 248 NPKTR 252
           +P  R
Sbjct: 252 DPDKR 256

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 123/271 (45%), Gaps = 22/271 (8%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV ++    + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 73  AIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLS 182
           H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFSTG 236
               D   +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S  
Sbjct: 193 GDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLSAD 249
Query: 237 ATSLIHKILDPNPKTR------IRIEGIRKH 261
             +++ K L  NP+ R      +R + +R H
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/334 (25%), Positives = 143/334 (42%), Gaps = 48/334 (14%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+  TIG G +  V  A+ R TG+ VA+K +  +  +      +  RE+ I+K  +H 
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN-AKRTLRELKILKHFKHD 113
Query: 70  NIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAV 122
           NI+ + ++L           VY++L+ +       +I+H  + L  +  RYF  QL+  +
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRGL 171
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS----ALPQQGVELLHTTCGTPNYVAP 178
            + HS  V HRDLKP NLL++    LK+ DFG++      P +    +     T  Y AP
Sbjct: 172 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG---------------ETDLPTLYKKIN 223
           E++ +      A D+WS G I   ++A    F                 T  P + + + 
Sbjct: 232 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291
Query: 224 AAEFSC---------PFWFST-------GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           A              P  + T        A SL+ ++L   P  RI      +HP+  K 
Sbjct: 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351
Query: 268 YNP---VKCSEEEEVNLDDVHAVFDDIEDQYVAE 298
           ++P     C+   +   D      + I++  VAE
Sbjct: 352 HDPDDEPDCAPPFDFAFDREALTRERIKEAIVAE 385

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 22/271 (8%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV +++   + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLS 182
           H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFSTG 236
               D + +DV+S G +L+ ++ G  PF G++     Y+ +   E   P        S  
Sbjct: 193 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVR--EDPIPPSARHEGLSAD 249
Query: 237 ATSLIHKILDPNPKTR------IRIEGIRKH 261
             +++ K L  NP+ R      +R + +R H
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/334 (25%), Positives = 143/334 (42%), Gaps = 48/334 (14%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+  TIG G +  V  A+ R TG+ VA+K +  +  +      +  RE+ I+K  +H 
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN-AKRTLRELKILKHFKHD 114
Query: 70  NIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAV 122
           NI+ + ++L           VY++L+ +       +I+H  + L  +  RYF  QL+  +
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRGL 172
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS----ALPQQGVELLHTTCGTPNYVAP 178
            + HS  V HRDLKP NLL++    LK+ DFG++      P +    +     T  Y AP
Sbjct: 173 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG---------------ETDLPTLYKKIN 223
           E++ +      A D+WS G I   ++A    F                 T  P + + + 
Sbjct: 233 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 292
Query: 224 AAEFSC---------PFWFST-------GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           A              P  + T        A SL+ ++L   P  RI      +HP+  K 
Sbjct: 293 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 352
Query: 268 YNP---VKCSEEEEVNLDDVHAVFDDIEDQYVAE 298
           ++P     C+   +   D      + I++  VAE
Sbjct: 353 HDPDDEPDCAPPFDFAFDREALTRERIKEAIVAE 386

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 50/287 (17%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVRHPNIVRL 74
           +GEGT+A V   +++ T   VA+K +     L+H         RE+S++K ++H NIV L
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQ-----GRLLE-NDCRRYFQQLIDAVAHCHSK 128
           H+++ +   + ++ E++      DK + Q     G ++  ++ + +  QL+  +A+CH +
Sbjct: 66  HDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V HRDLKP+NLL++  G LK++DFGL+       +       T  Y  P++L       
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179
Query: 189 SAADVWSCGVILFVLMAGYLPF-------------------GETDLPTL-----YKKINA 224
           +  D+W  G I + +  G   F                    E   P +     +K  N 
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239
Query: 225 AEF-------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            ++         P   S GA  L+ K+L    + RI  E   KHP+F
Sbjct: 240 PKYRAEALLSHAPRLDSDGA-DLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 135/305 (44%), Gaps = 47/305 (15%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R  + +E    +G+G F +V  A+N       A+K +  +       +  I  E+ ++  
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLAS 58
Query: 66  VRHPNIVRLHEVLASR-------------TKVYIILEFVTGGELFDKIVHQGRLLE--ND 110
           + H  +VR +     R             + ++I +E+     L+D ++H   L +  ++
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYD-LIHSENLNQQRDE 117
Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--- 167
             R F+Q+++A+++ HS+G+ HRDLKP N+ +D   N+K+ DFGL+    + +++L    
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 168 -----------TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDL 215
                      +  GT  YVA EVL   G+     D++S G+I F ++    PF    + 
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMER 234
Query: 216 PTLYKKINAAEFSCPFWFSTGATSLIHKI----LDPNPKTRIRIEGIRKHPWFRKNYNPV 271
             + KK+ +     P  F      +  KI    +D +P  R     +    W      PV
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL-----PV 289
Query: 272 KCSEE 276
           K  +E
Sbjct: 290 KHQDE 294

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/308 (23%), Positives = 132/308 (42%), Gaps = 50/308 (16%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR--------- 51
           +K++ + +  Y + RT+ +G F K+   +  +  +  A+K   KS + K R         
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 52  -----MVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL 106
                  D  K E+ I+  +++   +    ++ +  +VYII E++    +  K      +
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSIL-KFDEYFFV 139
Query: 107 LENDCRRYF---------QQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLS 156
           L+ +   +          + ++++ ++ H+ K + HRD+KP N+L+D  G +K+SDFG S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 157 ALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFG-ETD 214
                  + +  + GT  ++ PE  SN   Y+G+  D+WS G+ L+V+    +PF  +  
Sbjct: 200 EYMVD--KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257
Query: 215 LPTLYKKINAAEFSCPF-------------------WFSTGATSLIHKILDPNPKTRIRI 255
           L  L+  I       P                    + S      +   L  NP  RI  
Sbjct: 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317
Query: 256 EGIRKHPW 263
           E   KH W
Sbjct: 318 EDALKHEW 325

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           T+    +E+   +G G F  V    +++TGE VA+K   +    K+R  ++   EI IMK
Sbjct: 11  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMK 68
Query: 65  IVRHPNIVRLHEV------LASRTKVYIILEFVTGGEL---FDKIVHQGRLLENDCRRYF 115
            + HPN+V   EV      LA      + +E+  GG+L    ++  +   L E   R   
Sbjct: 69  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 128
Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL---KVSDFGLSALPQQGVELLHTTCGT 172
             +  A+ + H   + HRDLKPEN++L         K+ D G +    QG EL     GT
Sbjct: 129 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGT 187
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
             Y+APE+L  + Y     D WS G + F  + G+ PF
Sbjct: 188 LQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           T+    +E+   +G G F  V    +++TGE VA+K   +    K+R  ++   EI IMK
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMK 67
Query: 65  IVRHPNIVRLHEV------LASRTKVYIILEFVTGGEL---FDKIVHQGRLLENDCRRYF 115
            + HPN+V   EV      LA      + +E+  GG+L    ++  +   L E   R   
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL---KVSDFGLSALPQQGVELLHTTCGT 172
             +  A+ + H   + HRDLKPEN++L         K+ D G +    QG EL     GT
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGT 186
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
             Y+APE+L  + Y     D WS G + F  + G+ PF
Sbjct: 187 LQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPF 223

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 120/254 (47%), Gaps = 9/254 (3%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++            Q  +EI+++       + + + 
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSSYVTKYYG 88
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                +K++II+E++ GG   D ++  G   E       ++++  + + HS+   HRD+K
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL   G++K++DFG++          +T  GTP ++APEV+    YD S AD+WS 
Sbjct: 148 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSL 206
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW---FSTGATSLIHKILDPNPKTRI 253
           G+    L  G  P   +D+  +       + + P     F+      I   L+ +P  R 
Sbjct: 207 GITAIELAKGEPP--NSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRP 264
Query: 254 RIEGIRKHPWFRKN 267
             + + KH +  KN
Sbjct: 265 TAKELLKHKFIVKN 278

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 84/319 (26%), Positives = 138/319 (43%), Gaps = 53/319 (16%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           + +++   +GEG +  V  A ++ TGE VA+K +      K     +  REI I+K  +H
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKH 68
Query: 69  PNIVRLHEV-----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
            NI+ +  +       +  +VYII E +       +++    L ++  + +  Q + AV 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV----ELLHTTCGTPNYV--- 176
             H   V HRDLKP NLL++S  +LKV DFGL+ +  +      E      G   YV   
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 177 ---APEVLSNRGYDGSAADVWSCGVIL------------------FVLMAGYL--PFGET 213
              APEV+        A DVWSCG IL                   +L+ G +  P  + 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 214 DLPTLYKKINAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRK 260
           DL  + +   A E+  S P +            +     L+ ++L  +P  RI  +   +
Sbjct: 247 DLRCI-ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 261 HPWFRKNYNPVKCSEEEEV 279
           HP+ +  ++P    E E +
Sbjct: 306 HPYLQTYHDPNDEPEGEPI 324

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/319 (26%), Positives = 137/319 (42%), Gaps = 53/319 (16%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           + +++   +GEG +  V  A ++ TGE VA+K +      K     +  REI I+K  +H
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKH 68
Query: 69  PNIVRLHEV-----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
            NI+ +  +       +  +VYII E +       +++    L ++  + +  Q + AV 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL----------PQQGVELLHTTCGTP 173
             H   V HRDLKP NLL++S  +LKV DFGL+ +          P      +     T 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVIL------------------FVLMAGYL--PFGET 213
            Y APEV+        A DVWSCG IL                   +L+ G +  P  + 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 214 DLPTLYKKINAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRK 260
           DL  + +   A E+  S P +            +     L+ ++L  +P  RI  +   +
Sbjct: 247 DLRCI-ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 261 HPWFRKNYNPVKCSEEEEV 279
           HP+ +  ++P    E E +
Sbjct: 306 HPYLQTYHDPNDEPEGEPI 324

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 134/277 (48%), Gaps = 25/277 (9%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRHP 69
           +E+   +G GT+ +V   ++ +TG+  A+KV+  +   +    ++IK+EI+++K    H 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 81
Query: 70  NIVRLHEVLASRT------KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYF-QQLIDA 121
           NI   +     +       ++++++EF   G + D I + +G  L+ +   Y  ++++  
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           ++H H   V HRD+K +N+LL     +K+ DFG+SA   + V   +T  GTP ++APEV+
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 182 S-----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT----LYKKINAAEFSCPFW 232
           +     +  YD   +D+WS G+    +  G  P  +   P     L  +  A       W
Sbjct: 202 ACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW 259
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 269
            S    S I   L  N   R   E + KHP+ R   N
Sbjct: 260 -SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 149/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T      I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 91/322 (28%), Positives = 141/322 (43%), Gaps = 54/322 (16%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRH 68
           +Y   + IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIK---KISPFEHQTYCQRTLREIQILLRFRH 100
Query: 69  PNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAV 122
            N++ + ++L + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  +
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMET-DLYKLLKSQQ--LSNDHICYFLYQILRGL 157
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPE 179
            + HS  V HRDLKP NLL+++  +LK+ DFGL+  A P+      L     T  Y APE
Sbjct: 158 KYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 180 VLSN-RGYDGSAADVWSCGVILFVLMAGYLPF---------------------------- 210
           ++ N +GY  S  D+WS G IL  +++    F                            
Sbjct: 218 IMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 276
Query: 211 ---GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                  L +L  K   A         + A  L+ ++L  NP  RI +E    HP+  + 
Sbjct: 277 NMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQY 336
Query: 268 YNPVKCSEEEE-----VNLDDV 284
           Y+P      EE     + LDD+
Sbjct: 337 YDPTDEPVAEEPFTFAMELDDL 358

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 93
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 153 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 211
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 212 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 260
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 261 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 320
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 321 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 362

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 108
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 226
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 275
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 336 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 377

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 86
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 146 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 204
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 253
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 254 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 313
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 314 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 355

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 75
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 135 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 193
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 242
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 243 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 302
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 303 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 344

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 63
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII+EF+T G L D +    R   N     +   Q+  
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 183
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 184 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 224

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 82
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 142 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 200
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 249
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 250 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 309
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 310 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 351

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 86
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 146 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 204
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 253
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 254 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 313
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 314 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 355

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VY++   + G +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 108 DIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 164
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 165 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 225 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 283
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 284 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 339

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 78
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 138 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 196
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 197 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 245
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 246 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 305
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 306 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 347

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/319 (26%), Positives = 137/319 (42%), Gaps = 53/319 (16%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           + +++   +GEG +  V  A ++ TGE VA+K +      K     +  REI I+K  +H
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKH 68
Query: 69  PNIVRLHEV-----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
            NI+ +  +       +  +VYII E +       +++    L ++  + +  Q + AV 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG----------TP 173
             H   V HRDLKP NLL++S  +LKV DFGL+ +  +         G          T 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVIL------------------FVLMAGYL--PFGET 213
            Y APEV+        A DVWSCG IL                   +L+ G +  P  + 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 214 DLPTLYKKINAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRK 260
           DL  + +   A E+  S P +            +     L+ ++L  +P  RI  +   +
Sbjct: 247 DLRCI-ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 261 HPWFRKNYNPVKCSEEEEV 279
           HP+ +  ++P    E E +
Sbjct: 306 HPYLQTYHDPNDEPEGEPI 324

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 16/231 (6%)
Query: 1   MKKQTRRVAKYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV 53
           M   +    K+E+ RT       +G G + +V     ++   +VA+K L + T+     V
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EV 58
Query: 54  DQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           ++  +E ++MK ++HPN+V+L  V       YII+EF+T G L D +    R   N    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 114 YFQ--QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 171
            +   Q+  A+ +   K   HRDL   N L+     +KV+DFGLS L        H    
Sbjct: 119 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 172 TP-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            P  + APE L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 179 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 102
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 161
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 162 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 220
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 269
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 270 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 329
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 330 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 371

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 87
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 147 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 205
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 254
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 255 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 314
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 315 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 356

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 130/308 (42%), Gaps = 48/308 (15%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + IG G    V  A +   G +VA+K L++          +  RE+ ++K V H 
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHK 83
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAHCH 126
           NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 143
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   GY
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPYVVTRYYRAPEVILGMGY 202
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSC----------- 229
             +  D+WS G I+  L+ G + F  TD    + K+       +AEF             
Sbjct: 203 -AANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 261
Query: 230 --------------PFWF-----------STGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
                         P W            ++ A  L+ K+L  +P  RI ++   +HP+ 
Sbjct: 262 NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321
Query: 265 RKNYNPVK 272
              Y+P +
Sbjct: 322 TVWYDPAE 329

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 110
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 111 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 169
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 170 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 228
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 277
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 278 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 337
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 338 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 379

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 108
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 226
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 275
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 336 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 377

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 79
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 139 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 197
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 246
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 247 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 306
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 307 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 348

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 112
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 113 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 172 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 230
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 279
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 280 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 339
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 340 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 381

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 146
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 147 VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 186 YDGSAADVWSCGVILFVLMAG--------YLP--------FGETDLPTLYKKINAAE--- 226
           Y  S  D+WS G IL  +++         YL          G      L   IN      
Sbjct: 207 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNY 265
Query: 227 -FSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 266 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDP 321

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 150/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 153
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 154 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 213 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 271
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 320
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 321 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 380
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 381 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 422

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 130/308 (42%), Gaps = 48/308 (15%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + IG G    V  A +   G +VA+K L++          +  RE+ ++K V H 
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHK 81
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAHCH 126
           NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H H
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 141
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   GY
Sbjct: 142 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNF-MMTPYVVTRYYRAPEVILGMGY 200
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSC----------- 229
             +  D+WS G I+  L+ G + F  TD    + K+       +AEF             
Sbjct: 201 KEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 259
Query: 230 --------------PFWF-----------STGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
                         P W            ++ A  L+ K+L  +P  RI ++   +HP+ 
Sbjct: 260 NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319
Query: 265 RKNYNPVK 272
              Y+P +
Sbjct: 320 TVWYDPAE 327

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 149/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T      I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK+V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVN 81
Query: 68  HPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQL 118
           H NI+ L  V   +        VYI++E      L D  + Q   +E D  R      Q+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVME------LMDANLSQVIQMELDHERMSYLLYQM 135
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVA 177
           +  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y A
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           PEV+   GY  +  D+WS GVI+  ++ G + F  TD
Sbjct: 194 PEVILGMGYKEN-VDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 16/231 (6%)
Query: 1   MKKQTRRVAKYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV 53
           M   +    K+E+ RT       +G G + +V     ++   +VA+K L + T+     V
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EV 58
Query: 54  DQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           ++  +E ++MK ++HPN+V+L  V       YII EF+T G L D +    R   N    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 114 YFQ--QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 171
            +   Q+  A+ +   K   HRDL   N L+     +KV+DFGLS L        H    
Sbjct: 119 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAK 178
Query: 172 TP-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            P  + APE L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 179 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 9/209 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R IG G+F  V FA++    E VA+K ++ S    +     I +E+  ++ +RHPN ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                     ++++E+  G       VH+  L E +        +  +A+ HS  + HRD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV---LSNRGYDGSAA 191
           +K  N+LL   G +K+ DFG +++    +   +   GTP ++APEV   +    YDG   
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQYDGK-V 195
Query: 192 DVWSCGVILFVLMAGYLP-FGETDLPTLY 219
           DVWS G+    L     P F    +  LY
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALY 224

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 9/209 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R IG G+F  V FA++    E VA+K ++ S    +     I +E+  ++ +RHPN ++ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                     ++++E+  G       VH+  L E +        +  +A+ HS  + HRD
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV---LSNRGYDGSAA 191
           +K  N+LL   G +K+ DFG +++    +   +   GTP ++APEV   +    YDG   
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQYDGK-V 234
Query: 192 DVWSCGVILFVLMAGYLP-FGETDLPTLY 219
           DVWS G+    L     P F    +  LY
Sbjct: 235 DVWSLGITCIELAERKPPLFNMNAMSALY 263

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 100/345 (28%), Positives = 149/345 (43%), Gaps = 50/345 (14%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    +  VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 328
            H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 148
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 135/281 (48%), Gaps = 33/281 (11%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K   +R   Y   + IG G+F  V  A+  E+ E VA+K + +    K+R       E+ 
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR-------ELQ 84
Query: 62  IMKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEND----C 111
           IM+IV+HPN+V L     S    + +V++  +LE+V    ++    H  +L +       
Sbjct: 85  IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLI 143
Query: 112 RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTC 170
           + Y  QL+ ++A+ HS G+ HRD+KP+NLLLD   G LK+ DFG + +   G   +   C
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC 203
Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSC 229
               Y APE++       +  D+WS G ++  LM G   F GE+ +  L + I       
Sbjct: 204 SR-YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV----- 257
Query: 230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
                T +   I K ++PN     +   IR HP F K + P
Sbjct: 258 ---LGTPSREQI-KTMNPN-YMEHKFPQIRPHP-FSKVFRP 292

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 16/231 (6%)
Query: 1   MKKQTRRVAKYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV 53
           M   +    K+E+ RT       +G G + +V     ++   +VA+K L + T+     V
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EV 58
Query: 54  DQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           ++  +E ++MK ++HPN+V+L  V       YII EF+T G L D +    R   N    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 114 YFQ--QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 171
            +   Q+  A+ +   K   HRDL   N L+     +KV+DFGLS L        H    
Sbjct: 119 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 172 TP-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            P  + APE L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 179 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 186 YDGSAADVWSCGVILFVLMAG--------YLP--------FGETDLPTLYKKINAAE--- 226
           Y  S  D+WS G IL  +++         YL          G      L   IN      
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNY 263
Query: 227 -FSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 186 YDGSAADVWSCGVILFVLMAG--------YLP--------FGETDLPTLYKKINAAE--- 226
           Y  S  D+WS G IL  +++         YL          G      L   IN      
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNY 263
Query: 227 -FSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK+V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVN 81
Query: 68  HPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQL 118
           H NI+ L  V   +        VYI++E      L D  + Q   +E D  R      Q+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVME------LMDANLSQVIQMELDHERMSYLLYQM 135
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVA 177
           +  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y A
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           PEV+   GY  +  D+WS GVI+  ++ G + F  TD
Sbjct: 194 PEVILGMGYKEN-VDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 148
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 149
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 209
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 210 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 269 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 324

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 16/231 (6%)
Query: 1   MKKQTRRVAKYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV 53
           M   +    K+E+ RT       +G G + +V     ++   +VA+K L + T+     V
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EV 58
Query: 54  DQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           ++  +E ++MK ++HPN+V+L  V       YII EF+T G L D +    R   N    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 114 YFQ--QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 171
            +   Q+  A+ +   K   HRDL   N L+     +KV+DFGLS L        H    
Sbjct: 119 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 172 TP-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            P  + APE L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 179 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 132/305 (43%), Gaps = 47/305 (15%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R  + +E    +G+G F +V  A+N       A+K +  +       +  I  E+ ++  
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVXLLAS 58
Query: 66  VRHPNIVRLHEVLASR-------------TKVYIILEFVTGGELFDKIVHQGRLLE--ND 110
           + H  +VR +     R             + ++I  E+     L+D ++H   L +  ++
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYD-LIHSENLNQQRDE 117
Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--- 167
             R F+Q+++A+++ HS+G+ HR+LKP N+ +D   N+K+ DFGL+    + +++L    
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 168 -----------TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDL 215
                      +  GT  YVA EVL   G+     D +S G+I F  +    PF    + 
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXER 234
Query: 216 PTLYKKINAAEFSCPFWFSTGATSLIHKI----LDPNPKTRIRIEGIRKHPWFRKNYNPV 271
             + KK+ +     P  F      +  KI    +D +P  R     +    W      PV
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL-----PV 289
Query: 272 KCSEE 276
           K  +E
Sbjct: 290 KHQDE 294

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 20  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 75
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 135
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 136 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 195
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 196 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 236

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 135/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 142
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 186 YDGSAADVWSCGVILFVLMAG--------YLP--------FGETDLPTLYKKINAAE--- 226
           Y  S  D+WS G IL  +++         YL          G  +   L   IN      
Sbjct: 203 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNY 261
Query: 227 -FSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 262 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 317

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 66
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 126
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 187 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 64
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 185 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 146
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 207 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 265
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 266 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDP 321

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 64
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 185 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 148
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 149
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 209
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 210 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 269 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 324

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 93
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 150
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 151 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 210
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 211 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 269
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 270 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 325

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 84
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 141
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 142 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 201
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 202 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 260
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 261 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 316

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 148
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 142
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 203 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 261
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 262 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 317

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 89
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 146
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 207 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 265
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 266 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 321

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 95
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 152
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 212
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 213 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 271
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 272 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 327

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           G  +G+G F +     +RETGE + MK L +      R      +E+ +M+ + HPN+++
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR---TFLKEVKVMRCLEHPNVLK 71
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKGVYH 132
              VL    ++  I E++ GG L   I           R  F + +   +A+ HS  + H
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIH 131
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSAL------PQQGVELL--------HTTCGTPNYVAP 178
           RDL   N L+    N+ V+DFGL+ L        +G+  L        +T  G P ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 179 EVLSNRGYDGSAADVWSCGVIL 200
           E+++ R YD    DV+S G++L
Sbjct: 192 EMINGRSYD-EKVDVFSFGIVL 212

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKCQH--LSNDHICYFLYQILRGLKYIHSAN 148
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 164
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 165 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 225 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 283
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 284 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 339

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII+EF+T G L D +    R   +     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII+EF+T G L D +    R   +     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA++   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIR---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 148
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK+V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVN 81
Query: 68  HPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQL 118
           H NI+ L  V   +        VYI++E      L D  + Q   +E D  R      Q+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVME------LMDANLSQVIQMELDHERMSYLLYQM 135
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVA 177
           +  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y A
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           PEV+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 194 PEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-P 69
           Y++ R +G G +++V  A N    E V +K      ILK    ++IKREI I++ +R  P
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKNKIKREIKILENLRGGP 92
Query: 70  NIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           NI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +CH
Sbjct: 93  NIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYCH 148
Query: 127 SKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           S G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L +  
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDYQ 207
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
               + D+WS G +L  ++    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 16/231 (6%)
Query: 1   MKKQTRRVAKYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV 53
           M   +    K+E+ RT       +G G + +V     ++   +VA+K L + T+     V
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EV 58
Query: 54  DQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           ++  +E ++MK ++HPN+V+L  V       YII EF+T G L D +    R   +    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 118
Query: 114 YFQ--QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 171
            +   Q+  A+ +   K   HRDL   N L+     +KV+DFGLS L        H    
Sbjct: 119 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 172 TP-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            P  + APE L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 179 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK+V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVN 81
Query: 68  HPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQL 118
           H NI+ L  V   +        VYI++E      L D  + Q   +E D  R      Q+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVME------LMDANLSQVIQMELDHERMSYLLYQM 135
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVA 177
           +  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           PEV+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 194 PEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 18/233 (7%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           ++ R IG G F +V   + +  G+   +VA+K L      K R       E SIM    H
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRR--DFLCEASIMGQFDH 103
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCH 126
           PN+V L  V+     V I++EF+  G L D  +  H G+          + +   + +  
Sbjct: 104 PNVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLA 162
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSN 183
             G  HRDL   N+L++S    KVSDFGLS + +   E ++TT G      + APE +  
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 184 RGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN-----AAEFSCP 230
           R +  SA+DVWS G++++ +M+ G  P+ +     + K I       A   CP
Sbjct: 223 RKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCP 274

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/321 (24%), Positives = 134/321 (41%), Gaps = 48/321 (14%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           A Y   + +G G +  V  A +  TG  VA+K L +          +  RE+ ++K +RH
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRH 83
Query: 69  PNIVRL------HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
            N++ L       E L   T  Y+++ F+  G    K++   +L E+  +    Q++  +
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + H+ G+ HRDLKP NL ++    LK+ DFGL+   +Q    +     T  Y APEV+ 
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMXGXVVTRWYRAPEVIL 198
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF--------- 233
           N        D+WS G I+  ++ G   F  +D     K+I     + P  F         
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258
Query: 234 ----------------------STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                                 S  A +L+ K+L  + + R+       HP+F   ++  
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD-- 316
Query: 272 KCSEEEEVNLDDVHAVFDDIE 292
               E+E  +      FDD++
Sbjct: 317 ---TEDEPQVQKYDDSFDDVD 334

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 16/216 (7%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVRHPNIV 72
           R +G G +  V  A +    + VA+K L++   +++  R   +  RE+ ++K ++H N++
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR---RTYRELRLLKHLKHENVI 90
Query: 73  RLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            L +V    T      +VY++   +  G   + IV    L +   +    QL+  + + H
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+ ++    L++ DFGL+   +Q  E +     T  Y APE++ N  +
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLA---RQADEEMTGYVATRWYRAPEIMLNWMH 205
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
                D+WS G I+  L+ G   F  +D     K+I
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 241

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 253 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 308
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 368
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HR+L   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 369 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 428
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 429 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 469

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/197 (33%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           +G  IG G F +V   + R     VA+K   ++  L   +  +  +E  I+K   HPNIV
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIV 175
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA---HCHSKG 129
           RL  V   +  +YI++E V GG+    +  +G  L    +   Q + DA A   +  SK 
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR--VKTLLQMVGDAAAGMEYLESKC 233
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG----TP-NYVAPEVLSNR 184
             HRDL   N L+     LK+SDFG+S     GV   +   G     P  + APE L N 
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEAL-NY 289
Query: 185 GYDGSAADVWSCGVILF 201
           G   S +DVWS G++L+
Sbjct: 290 GRYSSESDVWSFGILLW 306

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 75
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQILRG 133
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 190
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G F +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 5   KWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 60
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   D   +Y+
Sbjct: 181 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 60
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII+EF+T G L D +    R   +     +   Q+  
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   D   +Y+
Sbjct: 181 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 80  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SH 197
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 198 ASDTWMFGVTLW 209

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 86  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTF-SH 203
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 204 ASDTWMFGVTLW 215

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 99
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMXGXVATRWYRAPEIM 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTF-SH 193
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 194 ASDTWMFGVTLW 205

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 86  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SH 203
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 204 ASDTWMFGVTLW 215

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SH 193
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 194 ASDTWMFGVTLW 205

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQL 118
           H NI+ L  V   +        VYI++E      L D  + Q   +E D  R      Q+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVME------LMDANLSQVIQMELDHERMSYLLYQM 135
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVA 177
           +  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           PEV+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 194 PEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SH 193
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 194 ASDTWMFGVTLW 205

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 93/194 (47%), Gaps = 10/194 (5%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           +G  IG G F +V   + R     VA+K   ++  L   +  +  +E  I+K   HPNIV
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIV 175
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA---HCHSKG 129
           RL  V   +  +YI++E V GG+    +  +G  L    +   Q + DA A   +  SK 
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR--VKTLLQMVGDAAAGMEYLESKC 233
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC-GTP-NYVAPEVLSNRGYD 187
             HRDL   N L+     LK+SDFG+S     GV          P  + APE L N G  
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEAL-NYGRY 292
Query: 188 GSAADVWSCGVILF 201
            S +DVWS G++L+
Sbjct: 293 SSESDVWSFGILLW 306

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 80  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SH 197
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 198 ASDTWMFGVTLW 209

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 128/312 (41%), Gaps = 50/312 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 258
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 262 PWFRKNYNPVKC 273
           P+    Y+P + 
Sbjct: 319 PYINVWYDPAEV 330

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 16/216 (7%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVRHPNIV 72
           R +G G +  V  A +    + VA+K L++   +++  R   +  RE+ ++K ++H N++
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR---RTYRELRLLKHLKHENVI 90
Query: 73  RLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            L +V    T      +VY++   +  G   + IV    L +   +    QL+  + + H
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+ ++    L++ DFGL+   +Q  E +     T  Y APE++ N  +
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLA---RQADEEMTGYVATRWYRAPEIMLNWMH 205
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
                D+WS G I+  L+ G   F  +D     K+I
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 241

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 63
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L              P  + APE
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 183
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 184 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 224

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRAPEIM 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL    +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLC---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRAPEIM 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRAPEIM 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 128/312 (41%), Gaps = 50/312 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 258
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 262 PWFRKNYNPVKC 273
           P+    Y+P + 
Sbjct: 319 PYINVWYDPAEV 330

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMAGFVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L+K   +I+  +   +  RE+ ++K ++
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAK---RTYRELRLLKHMK 91
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 206
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 64
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L              P  + APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 184
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 185 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 81
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 196
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMAGFVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    IG G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 84
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 199
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 117/257 (45%), Gaps = 18/257 (7%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G++ +V   +++E G   A+K              ++    S  K+ +HP  VRL +
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
                  +Y+  E + G  L       G  L E     Y +  + A+AH HS+G+ H D+
Sbjct: 125 AWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDV 183
Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT-----PNYVAPEVLSNRGYDGSA 190
           KP N+ L   G  K+ DFGL       VEL     G      P Y+APE+L  +G  G+A
Sbjct: 184 KPANIFLGPRGRCKLGDFGLL------VELGTAGAGEVQEGDPRYMAPELL--QGSYGTA 235
Query: 191 ADVWSCGV-ILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
           ADV+S G+ IL V     LP G      L +     EF+     S+   S++  +L+P+P
Sbjct: 236 ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTA--GLSSELRSVLVMMLEPDP 293
Query: 250 KTRIRIEGIRKHPWFRK 266
           K R   E +   P  R+
Sbjct: 294 KLRATAEALLALPVLRQ 310

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 75
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 190
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 85
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 200
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 75
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMAGFVATRWYRAPEIM 190
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 99
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 128/312 (41%), Gaps = 50/312 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 74
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKH 134
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 193 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
Query: 262 PWFRKNYNPVKC 273
           P+    Y+P + 
Sbjct: 312 PYINVWYDPAEV 323

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 89
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 90  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 147
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 148 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 204
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 237

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 98
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 213
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/317 (25%), Positives = 129/317 (40%), Gaps = 50/317 (15%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 258
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 262 PWFRKNYNPVKCSEEEE 278
           P+    Y+P      +E
Sbjct: 319 PYINVWYDPAXXXXXDE 335

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 85
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 200
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGXVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 16/216 (7%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVRHPNIV 72
           R +G G +  V  A +    + VA+K L++   +++  R   +  RE+ ++K ++H N++
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR---RTYRELRLLKHLKHENVI 82
Query: 73  RLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            L +V    T      +VY++   +  G   + IV    L +   +    QL+  + + H
Sbjct: 83  GLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+ ++    L++ DFGL+   +Q  E +     T  Y APE++ N  +
Sbjct: 141 SAGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADEEMTGYVATRWYRAPEIMLNWMH 197
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
                D+WS G I+  L+ G   F  +D     K+I
Sbjct: 198 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 233

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 8/211 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 269
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HR+L   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 390 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 430

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 84
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 199
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 90
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 205
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 77
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 136
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 137 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 197 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 247

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 75
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+EF+  G L + +  H+ R+      +Y  Q+   + +  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 196 KF-SVASDVWSFGVVLYELFT 215

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLIDAVA 123
            HP+IV+L  V+ +   V+II+E  T GEL  +   Q R    D      Y  QL  A+A
Sbjct: 69  DHPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQLSTALA 125
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLS 182
           +  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++
Sbjct: 126 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESIN 185
Query: 183 NRGYDGSAADVWSCGVILF-VLMAGYLPF 210
            R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 186 FRRFT-SASDVWMFGVCMWEILMHGVKPF 213

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 81
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 196
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 84
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 199
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 102
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMXGYVATRWYRAPEIM 217
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 78
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 79  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 136
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 137 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 193
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 37  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 94
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 153
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 154 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 213
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 214 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 264

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 90
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 205
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 77
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 78  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 135
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 136 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 192
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 81
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 196
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 85
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 200
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 75
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 190
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 8/211 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 91
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 206
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 91
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 206
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 81
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 196
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 47  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 104
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 163
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 164 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 223
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 224 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 274

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 76
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 191
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 76
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 191
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 98
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 213
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 84
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 199
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 99
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 102
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 217
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 33/215 (15%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVDQIKREISIMKIV 66
           V+KYE    IG+GTF +V  A++R+TG+ VA+K VL ++   K        REI I++++
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLL 74
Query: 67  RHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDCRRYF 115
           +H N+V L E+  ++          +Y++ +F      G L + +V   +   ++ +R  
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVM 131
Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN- 174
           Q L++ + + H   + HRD+K  N+L+   G LK++DFGL+    +   L   +   PN 
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA----RAFSLAKNS--QPNR 185
Query: 175 ---------YVAPEVLSNRGYDGSAADVWSCGVIL 200
                    Y  PE+L      G   D+W  G I+
Sbjct: 186 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 128/272 (47%), Gaps = 19/272 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P IV  + 
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 90
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDL 135
              S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  + HRD+
Sbjct: 91  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 150
Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y    +D+WS
Sbjct: 151 KPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWS 207
Query: 196 CGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFWFSTGATSL-----IHKILDPNP 249
            G+ L  +  G  P G  +    +++ ++      P    +G  SL     ++K L  NP
Sbjct: 208 MGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 267
Query: 250 KTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
             R  ++ +  H + ++       S+ EEV+ 
Sbjct: 268 AERADLKQLMVHAFIKR-------SDAEEVDF 292

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 8/211 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 8/211 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 8/211 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 82
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 142
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 200
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 201 MGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 230

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 33/215 (15%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVDQIKREISIMKIV 66
           V+KYE    IG+GTF +V  A++R+TG+ VA+K VL ++   K        REI I++++
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLL 73
Query: 67  RHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDCRRYF 115
           +H N+V L E+  ++          +Y++ +F      G L + +V   +   ++ +R  
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVM 130
Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN- 174
           Q L++ + + H   + HRD+K  N+L+   G LK++DFGL+    +   L   +   PN 
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA----RAFSLAKNS--QPNR 184
Query: 175 ---------YVAPEVLSNRGYDGSAADVWSCGVIL 200
                    Y  PE+L      G   D+W  G I+
Sbjct: 185 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 219

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 85
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 200
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 72
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN---YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+ +  Q  E         +   + APE L+  
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 193 KF-SVASDVWSFGVVLYELFT 212

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 124/275 (45%), Gaps = 36/275 (13%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRH 68
           +  V R + EG FA V  AQ+  +G   A+K L  +   K+R + Q   E+  MK +  H
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMKKLSGH 85
Query: 69  PNIVRL--------HEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
           PNIV+          E    + +  ++ E   G   E   K+  +G L  +   + F Q 
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 119 IDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFG------------LSALPQQGVE 164
             AV H H +   + HRDLK ENLLL + G +K+ DFG             SA  +  VE
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 165 LLHTTCGTPNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
              T   TP Y  PE+  L +    G   D+W+ G IL++L     PF   D   L  +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGAKL--RI 261
Query: 223 NAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRI 255
              ++S P   +  T   SLI  +L  NP+ R+ I
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSI 296

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 33/215 (15%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVDQIKREISIMKIV 66
           V+KYE    IG+GTF +V  A++R+TG+ VA+K VL ++   K        REI I++++
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLL 74
Query: 67  RHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDCRRYF 115
           +H N+V L E+  ++          +Y++ +F      G L + +V   +   ++ +R  
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVM 131
Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN- 174
           Q L++ + + H   + HRD+K  N+L+   G LK++DFGL+    +   L   +   PN 
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA----RAFSLAKNS--QPNR 185
Query: 175 ---------YVAPEVLSNRGYDGSAADVWSCGVIL 200
                    Y  PE+L      G   D+W  G I+
Sbjct: 186 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 33/215 (15%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVDQIKREISIMKIV 66
           V+KYE    IG+GTF +V  A++R+TG+ VA+K VL ++   K        REI I++++
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLL 74
Query: 67  RHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDCRRYF 115
           +H N+V L E+  ++          +Y++ +F      G L + +V   +   ++ +R  
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVM 131
Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN- 174
           Q L++ + + H   + HRD+K  N+L+   G LK++DFGL+    +   L   +   PN 
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA----RAFSLAKNS--QPNR 185
Query: 175 ---------YVAPEVLSNRGYDGSAADVWSCGVIL 200
                    Y  PE+L      G   D+W  G I+
Sbjct: 186 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 69  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 127
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 188 RFT-SASDVWMFGVCMWEILMHGVKPF 213

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 60
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPE 180
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   D   +Y+
Sbjct: 181 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  + + ++G  +A+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 108
Query: 68  HPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V    T       VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 109 HENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 166
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 167 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 223
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTD 256

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 82
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 142
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 200
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 201 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 259
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 260 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 319
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 320 PYINVWYDPAE 330

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 110/239 (46%), Gaps = 50/239 (20%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISI 62
           RR+ K      +GEGT+ +V  A +  T E+VA+K +     L+H    +     RE+S+
Sbjct: 37  RRITK------LGEGTYGEVYKAIDTVTNETVAIKRIR----LEHEEEGVPGTAIREVSL 86
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ------ 116
           +K ++H NI+ L  V+    ++++I E+                 END ++Y        
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYA----------------ENDLKKYMDKNPDVS 130
Query: 117 ---------QLIDAVAHCHSKGVYHRDLKPENLLLDSYGN-----LKVSDFGLSALPQQG 162
                    QLI+ V  CHS+   HRDLKP+NLLL          LK+ DFGL+      
Sbjct: 131 MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190
Query: 163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
           +        T  Y  PE+L    +  ++ D+WS   I   +LM   L  G++++  L+K
Sbjct: 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 448
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLIDAVA 123
            HP+IV+L  V+ +   V+II+E  T GEL  +   Q R    D      Y  QL  A+A
Sbjct: 449 DHPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLS 182
           +  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 183 NRGYDGSAADVWSCGVILF-VLMAGYLPF 210
            R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 566 FRRFT-SASDVWMFGVCMWEILMHGVKPF 593

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 258
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 319 PYINVWYDPAE 329

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/227 (33%), Positives = 113/227 (49%), Gaps = 18/227 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQN-RETGESVAMKVLAKSTILKHRMVDQIKREISIMK---I 65
           +YE    IGEG + KV  A++ +  G  VA+K +   T  +   +  I RE+++++    
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLET 70
Query: 66  VRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
             HPN+VRL +V   SRT    K+ ++ E V        DK+   G   E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    + L      T  Y AP
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAP 188
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKIN 223
           EVL    Y  +  D+WS G I F  M    P   G +D+  L K ++
Sbjct: 189 EVLLQSSY-ATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILD 233

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 80
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 140
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 141 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 198
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 199 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 257
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 258 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 317
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 318 PYINVWYDPAE 328

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 119
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 237
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 238 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 357 PYINVWYDPAE 367

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 258
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 319 PYINVWYDPAE 329

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 82
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 142
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 200
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 201 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 259
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 260 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 319
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 320 PYINVWYDPAE 330

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 119
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 237
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 238 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 357 PYINVWYDPAE 367

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 75
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 135
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 193
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 194 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 252
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 253 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 312
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 313 PYINVWYDPAE 323

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 74
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 134
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 193 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 312 PYINVWYDPAE 322

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 75
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 135
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 193
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 194 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 252
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 253 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 312
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 313 PYINVWYDPAE 323

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 70
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 191 KF-SVASDVWSFGVVLYELFT 210

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 111/227 (48%), Gaps = 18/227 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQN-RETGESVAMKVLAKSTILKHRMVDQIKREISIMK---I 65
           +YE    IGEG + KV  A++ +  G  VA+K +   T  +   +  I RE+++++    
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLET 70
Query: 66  VRHPNIVRLHEVLA-----SRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
             HPN+VRL +V         TK+ ++ E V        DK+   G   E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    + L      T  Y AP
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAP 188
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKIN 223
           EVL    Y  +  D+WS G I F  M    P   G +D+  L K ++
Sbjct: 189 EVLLQSSY-ATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILD 233

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 71
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 192 KF-SVASDVWSFGVVLYELFT 211

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 69  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 127
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 188 RFT-SASDVWMFGVCMWEILMHGVKPF 213

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 13  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 70
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 71  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 129
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 130 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 189
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 190 RFT-SASDVWMFGVCMWEILMHGVKPF 215

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 39  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 96
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 97  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 155
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 156 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 215
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 216 RFT-SASDVWMFGVCMWEILMHGVKPF 241

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 73
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 74  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 193 RFT-SASDVWMFGVCMWEILMHGVKPF 218

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 65
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 66  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 185 RFT-SASDVWMFGVCMWEILMHGVKPF 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 103
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 224 KF-SVASDVWSFGVVLYELFT 243

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGL+ + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/227 (33%), Positives = 113/227 (49%), Gaps = 18/227 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQN-RETGESVAMKVLAKSTILKHRMVDQIKREISIMK---I 65
           +YE    IGEG + KV  A++ +  G  VA+K +   T  +   +  I RE+++++    
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLET 70
Query: 66  VRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
             HPN+VRL +V   SRT    K+ ++ E V        DK+   G   E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    + L      T  Y AP
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAP 188
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKIN 223
           EVL    Y  +  D+WS G I F  M    P   G +D+  L K ++
Sbjct: 189 EVLLQSSY-ATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILD 233

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E +  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 79
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 200 KF-SVASDVWSFGVVLYELFT 219

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 14  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 71
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 72  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 130
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 131 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 190
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 191 RFT-SASDVWMFGVCMWEILMHGVKPF 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 72
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 193 KF-SVASDVWSFGVVLYELFT 212

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ D+GL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 77
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 198 KF-SVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 78
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 199 KF-SVASDVWSFGVVLYELFT 218

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 75
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H  R+      +Y  Q+   + +  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 196 KF-SVASDVWSFGVVLYELFT 215

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/322 (24%), Positives = 140/322 (43%), Gaps = 66/322 (20%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           ++  + + +++V R  G+GTF  V+  + + TG SVA+K + +    ++R + QI ++++
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLA 74
Query: 62  IMKIVRHPNIVRLHE---VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ-- 116
           ++    HPNIV+L      L  R +  I L  V   E     +H+       CR Y++  
Sbjct: 75  VL---HHPNIVQLQSYFYTLGERDRRDIYLNVVM--EYVPDTLHRC------CRNYYRRQ 123
Query: 117 -------------QLIDAVA--HCHSKGVYHRDLKPENLLL-DSYGNLKVSDFGLSALPQ 160
                        QLI ++   H  S  V HRD+KP N+L+ ++ G LK+ DFG +    
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 219
                +   C    Y APE++    +  +A D+WS G I   +M G   F G+     L+
Sbjct: 184 PSEPNVAYICSR-YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 220 --------------KKINAAEFSCPFWFSTG-----------------ATSLIHKILDPN 248
                         +K+N +      + S G                 A  L+  +L   
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302
Query: 249 PKTRIRIEGIRKHPWFRKNYNP 270
           P+ R++      HP+F + ++P
Sbjct: 303 PEERMKPYEALCHPYFDELHDP 324

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 75
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 196 KF-SVASDVWSFGVVLYELFT 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 76
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 197 KF-SVASDVWSFGVVLYELFT 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 72
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 193 KF-SVASDVWSFGVVLYELFT 212

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLIDAVA 123
            HP+IV+L  V+ +   V+II+E  T GEL  +   Q R    D      Y  QL  A+A
Sbjct: 69  DHPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQLSTALA 125
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLS 182
           +  SK   HRD+   N+L+ +   +K+ DFGLS   +       +    P  ++APE ++
Sbjct: 126 YLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 183 NRGYDGSAADVWSCGVILF-VLMAGYLPF 210
            R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 186 FRRFT-SASDVWMFGVCMWEILMHGVKPF 213

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 448
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLIDAVA 123
            HP+IV+L  V+ +   V+II+E  T GEL  +   Q R    D      Y  QL  A+A
Sbjct: 449 DHPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLS 182
           +  SK   HRD+   N+L+ +   +K+ DFGLS   +       +    P  ++APE ++
Sbjct: 506 YLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 183 NRGYDGSAADVWSCGVILF-VLMAGYLPF 210
            R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 566 FRRFT-SASDVWMFGVCMWEILMHGVKPF 593

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 104/227 (45%), Gaps = 7/227 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 83
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 143
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   
Sbjct: 144 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV-TRYYRAPEVILGM 202
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYKKINAAEFSCP 230
           GY  +  D+WS G I+  ++ G + F  TD +    K I      CP
Sbjct: 203 GYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 248

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 90
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 211 KF-SVASDVWSFGVVLYELFT 230

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 77
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E +  G L D  +  H  +          + +   + +   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 136
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 137 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 197 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 247

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 105/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGL  + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 90
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 211 KF-SVASDVWSFGVVLYELFT 230

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E +  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 11/211 (5%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMK 64
            ++  + + IG G   +V + + R  G+    VA+K L      + R       E SIM 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR--DFLSEASIMG 105
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVA 123
              HPNI+RL  V+       I+ E++  G L   +  H G+          + +   + 
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEV 180
           +    G  HRDL   N+L+DS    KVSDFGLS + +   +  +TT G      + APE 
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           ++ R +  SA+DVWS GV+++ VL  G  P+
Sbjct: 226 IAFRTFS-SASDVWSFGVVMWEVLAYGERPY 255

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 16/225 (7%)
Query: 6   RRVAKYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR 58
           + + K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +
Sbjct: 22  QSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM----EVEEFLK 77
Query: 59  EISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ-- 116
           E ++MK ++HPN+V+L  V       YI+ E++  G L D +    R         +   
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMAT 137
Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NY 175
           Q+  A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  +
Sbjct: 138 QISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKW 197
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLY 219
            APE L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y
Sbjct: 198 TAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 241

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 91/347 (26%), Positives = 144/347 (41%), Gaps = 81/347 (23%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRH 68
           KYE+ + +G+G +  V  + +R TGE VA+K +  +         +  REI I+ ++  H
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGH 68
Query: 69  PNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHC 125
            NIV L  VL +     VY++ +++   E     V +  +LE   ++Y   QLI  + + 
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-----------ALPQQGVE---------- 164
           HS G+ HRD+KP N+LL++  ++KV+DFGLS            +P    E          
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG------------------ 206
           +L     T  Y APE+L          D+WS G IL  ++ G                  
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 207 -------------YLPFGETDLPTLYKKINAAEFSCPFWFSTG----------------A 237
                          PF +T + +L +K+   + +    F+                  A
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDV 284
             L+ K+L  NP  RI      KHP+    +NP      EE N D +
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFVSIFHNP-----NEEPNCDHI 347

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 81/322 (25%), Positives = 131/322 (40%), Gaps = 50/322 (15%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 258
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 262 PWFRKNYNPVKCSEEEEVNLDD 283
           P+    Y      +E E  +++
Sbjct: 319 PYINVWYXXXXXXDEREHTIEE 340

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DF L+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 125/274 (45%), Gaps = 27/274 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P IV  + 
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 74
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDL 135
              S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  + HRD+
Sbjct: 75  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 134
Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           KP N+L++S G +K+ DFG+S   Q   E+ +   GT +Y++PE L    Y    +D+WS
Sbjct: 135 KPSNILVNSRGEIKLCDFGVSG--QLIDEMANEFVGTRSYMSPERLQGTHYS-VQSDIWS 191
Query: 196 CGVILFVLMAGYLPFGETDLPTLYK--------KINAAEFSCPFWFSTGATSLIHKILDP 247
            G+ L  +  G  P     +  L          K+ +A FS  F         ++K L  
Sbjct: 192 MGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEF------QDFVNKCLIK 245
Query: 248 NPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
           NP  R  ++ +  H + ++       S+ EEV+ 
Sbjct: 246 NPAERADLKQLMVHAFIKR-------SDAEEVDF 272

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 6/199 (3%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G    V   Q+R +G  +A K++     +K  + +QI RE+ ++     P IV  + 
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 81
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDL 135
              S  ++ I +E + GG L   +    R+ E    +    ++  +A+   K  + HRD+
Sbjct: 82  AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 141
Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y+APE L    Y    +D+WS
Sbjct: 142 KPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMAPERLQGTHYS-VQSDIWS 198
Query: 196 CGVILFVLMAGYLPFGETD 214
            G+ L  L  G  P    D
Sbjct: 199 MGLSLVELAVGRYPIPPPD 217

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK---I 65
           ++YE    IG G +  V  A++  +G  VA+K +      +   +  + RE+++++    
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTV-REVALLRRLEA 62
Query: 66  VRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
             HPN+VRL +V A SRT    KV ++ E V        DK    G L     +   +Q 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQF 121
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    + L      T  Y AP
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-TLWYRAP 180
Query: 179 EVLSNRGYDGSAADVWSCGVIL 200
           EVL    Y  +  D+WS G I 
Sbjct: 181 EVLLQSTY-ATPVDMWSVGCIF 201

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+  FGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 11/211 (5%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMK 64
            ++  + + IG G   +V + + R  G+    VA+K L      + R       E SIM 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR--DFLSEASIMG 105
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVA 123
              HPNI+RL  V+       I+ E++  G L   +  H G+          + +   + 
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEV 180
           +    G  HRDL   N+L+DS    KVSDFGLS + +   +   TT G      + APE 
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEA 225
Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           ++ R +  SA+DVWS GV+++ VL  G  P+
Sbjct: 226 IAFRTFS-SASDVWSFGVVMWEVLAYGERPY 255

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 129/284 (45%), Gaps = 25/284 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 182
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLP-------TLYKKINAAEFSCPFWFSTGATSL-- 240
            +D+WS G+ L  +  G  P    D          +++ ++      P    +G  SL  
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 242
Query: 241 ---IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
              ++K L  NP  R  ++ +  H + ++       S+ EEV+ 
Sbjct: 243 QDFVNKCLIKNPAERADLKQLMVHAFIKR-------SDAEEVDF 279

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 15  RTIGEGTFAKVRF----AQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV        N  TGE VA+K L      +HR     K+EI I++ + H +
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHEH 94
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           I++       A    + +++E+V  G L D +      L      + QQ+ + +A+ H++
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ-LLLFAQQICEGMAYLHAQ 153
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNY-VAPEVLSNRG 185
              HRDL   N+LLD+   +K+ DFGL+    +G E   +     +P +  APE L    
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYK 213
Query: 186 YDGSAADVWSCGVILFVLM 204
           +   A+DVWS GV L+ L+
Sbjct: 214 FY-YASDVWSFGVTLYELL 231

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + R IG G F +V   + +  G+    VA+K L      K R       E SIM    HP
Sbjct: 26  IERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 83
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AV 122
           NI+ L  V+     V I+ E++  G L         L +ND +    QL+         +
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSL------DTFLKKNDGQFTVIQLVGMLRGISAGM 137
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPE 179
            +    G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + APE
Sbjct: 138 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 197
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGE 212
            ++ R +  SA+DVWS G++++ V+  G  P+ E
Sbjct: 198 AIAFRKFT-SASDVWSYGIVMWEVVSYGERPYWE 230

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 108/239 (45%), Gaps = 28/239 (11%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           ++ + IG G F +V   + +  G+    VA+K L      K R       E SIM    H
Sbjct: 32  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDH 89
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           PNI+ L  V+     V II E++  G L         L +ND R    QL+  +    S 
Sbjct: 90  PNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGSG 143
Query: 129 GVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAP 178
             Y       HRDL   N+L++S    KVSDFG+S + +   E  +TT G      + AP
Sbjct: 144 MKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 203
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCPF 231
           E ++ R +  SA+DVWS G++++ +M+ G  P+ +     + K I           CP 
Sbjct: 204 EAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPI 261

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 73
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-----YVAPEVLS 182
           K   HR+L   N+L+++   +K+ DFGL+ +  Q  E  +     P      + APE L+
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKE--YYKVKEPGESPIFWYAPESLT 191
Query: 183 NRGYDGSAADVWSCGVILFVLMA 205
              +   A+DVWS GV+L+ L  
Sbjct: 192 ESKF-SVASDVWSFGVVLYELFT 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 108/239 (45%), Gaps = 28/239 (11%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           ++ + IG G F +V   + +  G+    VA+K L      K R       E SIM    H
Sbjct: 11  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDH 68
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           PNI+ L  V+     V II E++  G L         L +ND R    QL+  +    S 
Sbjct: 69  PNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGSG 122
Query: 129 GVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAP 178
             Y       HRDL   N+L++S    KVSDFG+S + +   E  +TT G      + AP
Sbjct: 123 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCPF 231
           E ++ R +  SA+DVWS G++++ +M+ G  P+ +     + K I           CP 
Sbjct: 183 EAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPI 240

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ D GL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 108/239 (45%), Gaps = 28/239 (11%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           ++ + IG G F +V   + +  G+    VA+K L      K R       E SIM    H
Sbjct: 17  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDH 74
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           PNI+ L  V+     V II E++  G L         L +ND R    QL+  +    S 
Sbjct: 75  PNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGSG 128
Query: 129 GVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAP 178
             Y       HRDL   N+L++S    KVSDFG+S + +   E  +TT G      + AP
Sbjct: 129 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 188
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCPF 231
           E ++ R +  SA+DVWS G++++ +M+ G  P+ +     + K I           CP 
Sbjct: 189 EAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPI 246

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK---I 65
           ++YE    IG G +  V  A++  +G  VA+K +      +   +  + RE+++++    
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTV-REVALLRRLEA 62
Query: 66  VRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
             HPN+VRL +V A SRT    KV ++ E V        DK    G L     +   +Q 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQF 121
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    + L      T  Y AP
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV-TLWYRAP 180
Query: 179 EVLSNRGYDGSAADVWSCGVIL 200
           EVL    Y  +  D+WS G I 
Sbjct: 181 EVLLQSTY-ATPVDMWSVGCIF 201

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ D GL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ D GL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMK-- 64
           ++YE    IG G +  V  A++  +G  VA+K +             I   RE+++++  
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 65  -IVRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQ 116
               HPN+VRL +V A SRT    KV ++ E V        DK    G L     +   +
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMR 127
Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           Q +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    + L      T  Y 
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-TLWYR 186
Query: 177 APEVLSNRGYDGSAADVWSCGVIL 200
           APEVL    Y  +  D+WS G I 
Sbjct: 187 APEVLLQSTY-ATPVDMWSVGCIF 209

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 6/218 (2%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMEPEVVTRYYRAPEVILGM 200
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
           GY  +  D+WS G I+  ++   + F   D    + K+
Sbjct: 201 GYKEN-VDIWSVGCIMGEMVCHKILFPGRDYIDQWNKV 237

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 20/225 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +TIG+G F  V     R  G  VA+K +      +  +      E S+M  +RH N+V+L
Sbjct: 27  QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQL 79
Query: 75  HEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLIDAVAHCHSKGVY 131
             V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + +A+ +       
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           HRDL   N+L+      KVSDFGL+   ++      T      + APE L  + +  + +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS-TKS 195
Query: 192 DVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-----AEFSCP 230
           DVWS G++L+ + + G +P+    L  +  ++       A   CP
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 240

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK---I 65
           ++YE    IG G +  V  A++  +G  VA+K +      +   +  + RE+++++    
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTV-REVALLRRLEA 62
Query: 66  VRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
             HPN+VRL +V A SRT    KV ++ E V        DK    G L     +   +Q 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQF 121
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    +  L     T  Y AP
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LDPVVVTLWYRAP 180
Query: 179 EVLSNRGYDGSAADVWSCGVIL 200
           EVL    Y  +  D+WS G I 
Sbjct: 181 EVLLQSTY-ATPVDMWSVGCIF 201

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F +V       + + VA+K L   T+     V     E ++MK ++H  +VRL
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRL 73
Query: 75  HEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           + V+     +YII E++  G L D  K    G++L      +  Q+ + +A+   K   H
Sbjct: 74  YAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 133
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAA 191
           RDL+  N+L+      K++DFGL+ + +            P  + APE + N G     +
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-NFGCFTIKS 192
Query: 192 DVWSCGVILF-VLMAGYLPF 210
           DVWS G++L+ ++  G +P+
Sbjct: 193 DVWSFGILLYEIVTYGKIPY 212

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 20/225 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +TIG+G F  V     R  G  VA+K +      +  +      E S+M  +RH N+V+L
Sbjct: 12  QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQL 64
Query: 75  HEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLIDAVAHCHSKGVY 131
             V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + +A+ +       
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 124
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           HRDL   N+L+      KVSDFGL+   ++      T      + APE L  + +  + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS-TKS 180
Query: 192 DVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-----AEFSCP 230
           DVWS G++L+ + + G +P+    L  +  ++       A   CP
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 225

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F +V       + + VA+K L   T+     V     E ++MK ++H  +VRL
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRL 72
Query: 75  HEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           + V+     +YII EF+  G L D  K    G++L      +  Q+ + +A+   K   H
Sbjct: 73  YAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 132
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAA 191
           RDL+  N+L+      K++DFGL+ + +            P  + APE + N G     +
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-NFGCFTIKS 191
Query: 192 DVWSCGVILF-VLMAGYLPF 210
           +VWS G++L+ ++  G +P+
Sbjct: 192 NVWSFGILLYEIVTYGKIPY 211

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 20/225 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +TIG+G F  V     R  G  VA+K +      +  +      E S+M  +RH N+V+L
Sbjct: 199 QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQL 251
Query: 75  HEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLIDAVAHCHSKGVY 131
             V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + +A+ +       
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           HRDL   N+L+      KVSDFGL+   ++      T      + APE L  + +  + +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS-TKS 367
Query: 192 DVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-----AEFSCP 230
           DVWS G++L+ + + G +P+    L  +  ++       A   CP
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 412

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 107/236 (45%), Gaps = 29/236 (12%)
Query: 15  RTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + IG G F +V     + +       VA+K L      K R VD +  E  IM    H N
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLG-EAGIMGQFSHHN 107
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVA 123
           I+RL  V++    + II E++  G L DK      L E D      QL+         + 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGAL-DKF-----LREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEV 180
           +  +    HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + APE 
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 181 LSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN-----AAEFSCP 230
           +S R +  SA+DVWS G++++ +M  G  P+ E     + K IN          CP
Sbjct: 222 ISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 276

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 6/218 (2%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMEPEVVTRYYRAPEVILGM 200
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
           GY  +  D+WS G I+  ++   + F   D    + K+
Sbjct: 201 GYKEN-VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 237

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 8/219 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 75
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 76  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 135
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 193
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
            GY  +  D+WS G I+  ++   + F   D    + K+
Sbjct: 194 MGYKEN-VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 231

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 120/258 (46%), Gaps = 20/258 (7%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIVR 67
           A+  +   IG G F KV  A     G+ VA+K           + ++ +++E  +  +++
Sbjct: 7   AELTLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNI+ L  V      + +++EF  GG L ++++   R+  +    +  Q+   + + H 
Sbjct: 65  HPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 128 KG---VYHRDLKPENLLL--------DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           +    + HRDLK  N+L+         S   LK++DFGL+    +  ++  +  G   ++
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAYAWM 181
Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-KINAAEFSCPFWFS 234
           APEV+    +    +DVWS GV+L+ L+ G +PF G   L   Y   +N      P    
Sbjct: 182 APEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 240
Query: 235 TGATSLIHKILDPNPKTR 252
                L+    +P+P +R
Sbjct: 241 EPFAKLMEDCWNPDPHSR 258

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 8/219 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 86
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 87  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 146
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 147 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 204
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
            GY  +  D+WS G I+  ++   + F   D    + K+
Sbjct: 205 MGYKEN-VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 242

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +TIG+G F  V     R  G  VA+K +      +  +      E S+M  +RH N+V+L
Sbjct: 18  QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQL 70
Query: 75  HEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLIDAVAHCHSKGVY 131
             V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + +A+ +       
Sbjct: 71  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 130
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           HRDL   N+L+      KVSDFGL+   ++      T      + APE L    +  + +
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREAAFS-TKS 186
Query: 192 DVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-----AEFSCP 230
           DVWS G++L+ + + G +P+    L  +  ++       A   CP
Sbjct: 187 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 231

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           EV   +G G F  V  A+ R   + VA+K +   +  K  +V     E+  +  V HPNI
Sbjct: 12  EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIV-----ELRQLSRVNHPNI 64
Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE----NDCRRYFQQLIDAVAHCHS 127
           V+L+   A    V +++E+  GG L++ ++H    L          +  Q    VA+ HS
Sbjct: 65  VKLYG--ACLNPVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 121
Query: 128 ---KGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
              K + HRDLKP NLLL + G  LK+ DFG +   Q     +    G+  ++APEV   
Sbjct: 122 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEG 178
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
             Y     DV+S G+IL+ ++    PF E   P  
Sbjct: 179 SNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF 212

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 30  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 87
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 88  DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 146 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMS 204
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           EV   +G G F  V  A+ R   + VA+K +   +  K  +V     E+  +  V HPNI
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIV-----ELRQLSRVNHPNI 63
Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE----NDCRRYFQQLIDAVAHCHS 127
           V+L+   A    V +++E+  GG L++ ++H    L          +  Q    VA+ HS
Sbjct: 64  VKLYG--ACLNPVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 128 ---KGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
              K + HRDLKP NLLL + G  LK+ DFG +   Q     +    G+  ++APEV   
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEG 177
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
             Y     DV+S G+IL+ ++    PF E   P  
Sbjct: 178 SNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF 211

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YEV + IG+G+F +V  A + +  + VA+K++        R   Q   EI I++ +R  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQ 153
Query: 70  ------NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDA 121
                 N++ + E    R  + +  E ++    EL  K   QG  L    R++   ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL-VRKFAHSILQC 212
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           +   H   + H DLKPEN+LL   G   +KV DFG S    Q V   +T   +  Y APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTXIQSRFYRAPE 269
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGY 207
           V+    Y G   D+WS G IL  L+ GY
Sbjct: 270 VILGARY-GMPIDMWSLGCILAELLTGY 296

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YEV + IG+G+F +V  A + +  + VA+K++        R   Q   EI I++ +R  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQ 153
Query: 70  ------NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDA 121
                 N++ + E    R  + +  E ++    EL  K   QG  L    R++   ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL-VRKFAHSILQC 212
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           +   H   + H DLKPEN+LL   G   +KV DFG S    Q V   +T   +  Y APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTXIQSRFYRAPE 269
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGY 207
           V+    Y G   D+WS G IL  L+ GY
Sbjct: 270 VILGARY-GMPIDMWSLGCILAELLTGY 296

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 6/205 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 127
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 188 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 244
Query: 190 AADVWSCGVILFVLMAGYLPFGETD 214
            +D+WS G+ L  +  G  P    D
Sbjct: 245 QSDIWSMGLSLVEMAVGRYPIPPPD 269

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G G +  V  A ++ +GE VA+K L++   S I   R      RE+ ++K ++H N++ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHENVIG 87
Query: 74  LHEVLASRTKV------YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           L +V    + +      Y+++ F+       KI+   +  E   +    Q++  + + HS
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQMLKGLKYIHS 144
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            GV HRDLKP NL ++    LK+ DFGL+   +     +     T  Y APEV+ +  + 
Sbjct: 145 AGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILSWMHY 201
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETD 214
               D+WS G I+  ++ G   F   D
Sbjct: 202 NQTVDIWSVGCIMAEMLTGKTLFKGKD 228

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 15  RTIGEGTFAKVRF----AQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV        N  TGE VA+K L      +HR     K+EI I++ + H +
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR--SGWKQEIDILRTLYHEH 77
Query: 71  IVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           I++       + +  + +++E+V  G L D +      L      + QQ+ + +A+ HS+
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQ-LLLFAQQICEGMAYLHSQ 136
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTP-NYVAPEVLSNRG 185
              HR+L   N+LLD+   +K+ DFGL+    +G E   +     +P  + APE L    
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 186 YDGSAADVWSCGVILFVLMA 205
           +   A+DVWS GV L+ L+ 
Sbjct: 197 F-YYASDVWSFGVTLYELLT 215

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 30  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 87
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 88  DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 146 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 6/205 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 209
Query: 190 AADVWSCGVILFVLMAGYLPFGETD 214
            +D+WS G+ L  +  G  P    D
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPD 234

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G G +  V  A ++ +GE VA+K L++   S I   R      RE+ ++K ++H N++ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHENVIG 105
Query: 74  LHEVLASRTKV------YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           L +V    + +      Y+++ F+       KI+      E   +    Q++  + + HS
Sbjct: 106 LLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLKYIHS 162
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            GV HRDLKP NL ++    LK+ DFGL+   +     +     T  Y APEV+ +  + 
Sbjct: 163 AGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILSWMHY 219
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETD 214
               D+WS G I+  ++ G   F   D
Sbjct: 220 NQTVDIWSVGCIMAEMLTGKTLFKGKD 246

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 58  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 115
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 6/199 (3%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P IV  + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDL 135
              S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  + HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y    +D+WS
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWS 188
Query: 196 CGVILFVLMAGYLPFGETD 214
            G+ L  +  G  P    D
Sbjct: 189 MGLSLVEMAVGRYPIPPPD 207

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 6/205 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 182
Query: 190 AADVWSCGVILFVLMAGYLPFGETD 214
            +D+WS G+ L  +  G  P    D
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 6/205 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 182
Query: 190 AADVWSCGVILFVLMAGYLPFGETD 214
            +D+WS G+ L  +  G  P    D
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 6/205 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 182
Query: 190 AADVWSCGVILFVLMAGYLPFGETD 214
            +D+WS G+ L  +  G  P    D
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 11  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 68
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 69  DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 284

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 14  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 71
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 72  DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 129
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 130 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 188
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 189 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 248
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 249 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 287

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 10  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 67
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 68  DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 125
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 126 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 184
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 185 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 244
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 245 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 283

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 58  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 115
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 21/223 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL-- 74
           +G+G  A V   ++++TG+  A+KV    + L  R VD   RE  ++K + H NIV+L  
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 75  -HEVLASRTKVYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDAVAHCHSKGV 130
             E   +R KV +I+EF   G L+  +        L E++     + ++  + H    G+
Sbjct: 75  IEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 131 YHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL----- 181
            HR++KP N++     D     K++DFG +A   +  E   +  GT  Y+ P++      
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFG-AARELEDDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 182 --SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
              ++   G+  D+WS GV  +    G LPF   + P   K++
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 15  RTIGEGTFAKVRF----AQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV        N  TGE VA+K L      +HR     K+EI I++ + H +
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR--SGWKQEIDILRTLYHEH 77
Query: 71  IVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           I++       + +  + +++E+V  G L D +      L      + QQ+ + +A+ H++
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQ-LLLFAQQICEGMAYLHAQ 136
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTP-NYVAPEVLSNRG 185
              HR+L   N+LLD+   +K+ DFGL+    +G E   +     +P  + APE L    
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 186 YDGSAADVWSCGVILFVLMA 205
           +   A+DVWS GV L+ L+ 
Sbjct: 197 F-YYASDVWSFGVTLYELLT 215

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 112/256 (43%), Gaps = 51/256 (19%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY +G+T+G G+F  V    + E+G+  A+K + +    K+R       E+ IMK++ H 
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-------ELDIMKVLDHV 60
Query: 70  NIVRL--------------------HEVLASRTK------------------VYIILEFV 91
           NI++L                    H  L  +                    + +I+E+V
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 92  --TGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN- 147
             T  ++    +  GR +  N    Y  QL  AV   HS G+ HRD+KP+NLL++S  N 
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 148 LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY 207
           LK+ DFG +         +   C    Y APE++        + D+WS G +   L+ G 
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAXICSR-FYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 208 LPF-GETDLPTLYKKI 222
             F GET +  L + I
Sbjct: 240 PLFSGETSIDQLVRII 255

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 111/239 (46%), Gaps = 21/239 (8%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M  Q+     + +   +G+G  A V   ++++TG+  A+KV    + L  R VD   RE 
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREF 58
Query: 61  SIMKIVRHPNIVRL---HEVLASRTKVYIILEFVTGGELFDKIVHQGR---LLENDCRRY 114
            ++K + H NIV+L    E   +R KV +I+EF   G L+  +        L E++    
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTC 170
            + ++  + H    G+ HR++KP N++     D     K++DFG +A   +  E      
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG-AARELEDDEQFVXLY 176
Query: 171 GTPNYVAPEVL-------SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
           GT  Y+ P++         ++   G+  D+WS GV  +    G LPF   + P   K++
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 108/209 (51%), Gaps = 22/209 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 16  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVAHC 125
            L    +++ ++ I+ ++  G  L+        L  ++ +   ++LID        + + 
Sbjct: 72  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 124
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSN 183
           H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV+  
Sbjct: 125 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 184 RGYDGSA--ADVWSCGVILFVLMAGYLPF 210
           +  +  +  +DV++ G++L+ LM G LP+
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 35/222 (15%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMK--VLAKSTILKHRMVDQIKREISIMKIV 66
           ++Y   + +G G    V  A + +  + VA+K  VL     +KH +     REI I++ +
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-----REIKIIRRL 65
Query: 67  RHPNIVRLHEVLASR--------------TKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
            H NIV++ E+L                   VYI+ E++        ++ QG LLE   R
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEEHAR 123
Query: 113 RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSAL-----PQQGVELL 166
            +  QL+  + + HS  V HRDLKP NL +++    LK+ DFGL+ +       +G    
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG---- 179
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
           H + G  T  Y +P +L +      A D+W+ G I   ++ G
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YEV + IG+G F +V  A + +  + VA+K++        R   Q   EI I++ +R  
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQ 153
Query: 70  ------NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDA 121
                 N++ + E    R  + +  E ++    EL  K   QG  L    R++   ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL-VRKFAHSILQC 212
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           +   H   + H DLKPEN+LL   G   +KV DFG S    Q V   +    +  Y APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YXXIQSRFYRAPE 269
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGY 207
           V+    Y G   D+WS G IL  L+ GY
Sbjct: 270 VILGARY-GMPIDMWSLGCILAELLTGY 296

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 132/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 58  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHS 115
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  G  NY+ PE    +S
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G+F +V   ++++TG   A+K        K R+      E+     +  P IV L+ 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVK--------KVRLEVFRAEELMACAGLTSPRIVPLYG 133
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
            +     V I +E + GG L   +  QG L E+    Y  Q ++ + + HS+ + H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 137 PENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLSNRGYDGSA 190
            +N+LL S G+   + DFG +   Q    G +LL      GT  ++APEV+  R  D + 
Sbjct: 194 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCD-AK 252
Query: 191 ADVWSCGVILFVLMAGYLPF 210
            DVWS   ++  ++ G  P+
Sbjct: 253 VDVWSSCCMMLHMLNGCHPW 272

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 122/274 (44%), Gaps = 25/274 (9%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R  K+++   IG G+F  V    + ET   VA   L    + K     + K E   +K +
Sbjct: 26  RFLKFDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEXLKGL 82
Query: 67  RHPNIVRLHEVLASRTK----VYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQQL 118
           +HPNIVR ++   S  K    + ++ E  T G L   +    V + ++L + CR+  + L
Sbjct: 83  QHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGL 142
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
                H  +  + HRDLK +N+ +    G++K+ D GL+ L +          GTP + A
Sbjct: 143 --QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFXA 198
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET-DLPTLYKKINAAEFSCPFWFSTG 236
           PE    + YD S  DV++ G           P+ E  +   +Y+++ +     P  F   
Sbjct: 199 PEXYEEK-YDES-VDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSG--VKPASFDKV 254
Query: 237 ATSLIHKILD----PNPKTRIRIEGIRKHPWFRK 266
           A   + +I++     N   R  I+ +  H +F++
Sbjct: 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 28  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVAHC 125
            L    +++ ++ I+ ++  G  L+        L  ++ +   ++LID        + + 
Sbjct: 84  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSN 183
           H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+  ++APEV+  
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 184 RGYDGSA--ADVWSCGVILFVLMAGYLPF 210
           +  +  +  +DV++ G++L+ LM G LP+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G+F +V   ++++TG   A+K        K R+      E+     +  P IV L+ 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVK--------KVRLEVFRAEELMACAGLTSPRIVPLYG 152
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
            +     V I +E + GG L   +  QG L E+    Y  Q ++ + + HS+ + H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 137 PENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLSNRGYDGSA 190
            +N+LL S G+   + DFG +   Q    G  LL      GT  ++APEV+  R  D + 
Sbjct: 213 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCD-AK 271
Query: 191 ADVWSCGVILFVLMAGYLPF 210
            DVWS   ++  ++ G  P+
Sbjct: 272 VDVWSSCCMMLHMLNGCHPW 291

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 117/259 (45%), Gaps = 14/259 (5%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G +  V   ++  +G+ +A+K +  +   + +    +  +IS M+ V  P  V  + 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS-MRTVDCPFTVTFYG 73
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCR-RYFQQLIDAVAHCHSK-GVYH 132
            L     V+I +E +     + + +++ +G+ +  D   +    ++ A+ H HSK  V H
Sbjct: 74  ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 133
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE----VLSNRGYDG 188
           RD+KP N+L+++ G +K+ DFG+S      V       G   Y+APE     L+ +GY  
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGISGYLVDDVA-KDIDAGCKPYMAPERINPELNQKGY-S 191
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLP--TLYKKINAAEFSCPF-WFSTGATSLIHKIL 245
             +D+WS G+ +  L     P+     P   L + +       P   FS        + L
Sbjct: 192 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCL 251
Query: 246 DPNPKTRIRIEGIRKHPWF 264
             N K R     + +HP+F
Sbjct: 252 KKNSKERPTYPELMQHPFF 270

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 14  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 70  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 121
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 122 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 120/261 (45%), Gaps = 15/261 (5%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G GT  +V   + R+TG  +A+K + +S   +      +  ++ ++K    P IV+   
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV-VLKSHDCPYIVQCFG 91
Query: 77  VLASRTKVYIILEFV-TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRD 134
              + T V+I +E + T  E   K + QG + E    +    ++ A+ +   K GV HRD
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 150
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-----SNRGYDGS 189
           +KP N+LLD  G +K+ DFG+S       +    + G   Y+APE +     +   YD  
Sbjct: 151 VKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYD-I 208
Query: 190 AADVWSCGVILFVLMAGYLPFG--ETDLPTLYKKINAAEFSCP--FWFSTGATSLIHKIL 245
            ADVWS G+ L  L  G  P+   +TD   L K +       P    FS    S +   L
Sbjct: 209 RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCL 268
Query: 246 DPNPKTRIRIEGIRKHPWFRK 266
             + + R +   + +H + ++
Sbjct: 269 TKDHRKRPKYNKLLEHSFIKR 289

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 17  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 73  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 124
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 12  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 68  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 117/259 (45%), Gaps = 14/259 (5%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G +  V   ++  +G+ +A+K +  +   + +    +  +IS M+ V  P  V  + 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS-MRTVDCPFTVTFYG 117
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDC-RRYFQQLIDAVAHCHSK-GVYH 132
            L     V+I +E +     + + +++ +G+ +  D   +    ++ A+ H HSK  V H
Sbjct: 118 ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 177
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE----VLSNRGYDG 188
           RD+KP N+L+++ G +K+ DFG+S      V       G   Y+APE     L+ +GY  
Sbjct: 178 RDVKPSNVLINALGQVKMCDFGISGYLVDSVAKT-IDAGCKPYMAPERINPELNQKGY-S 235
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLP--TLYKKINAAEFSCPF-WFSTGATSLIHKIL 245
             +D+WS G+ +  L     P+     P   L + +       P   FS        + L
Sbjct: 236 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCL 295
Query: 246 DPNPKTRIRIEGIRKHPWF 264
             N K R     + +HP+F
Sbjct: 296 KKNSKERPTYPELMQHPFF 314

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 17  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 73  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 124
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/242 (30%), Positives = 105/242 (43%), Gaps = 42/242 (17%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMK 64
           ++  ++ + IG G F +V     +  G+    VA+K L      K R       E SIM 
Sbjct: 32  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMG 89
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
              HPN++ L  V+   T V II EF+  G L D  + Q     ND +    QL+  +  
Sbjct: 90  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQ-----NDGQFTVIQLVGMLRG 143
Query: 125 CHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY-- 175
             +   Y       HRDL   N+L++S    KVSDFGLS         L      P Y  
Sbjct: 144 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS-------RFLEDDTSDPTYTS 196
Query: 176 ----------VAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA 224
                      APE +  R +  SA+DVWS G++++ +M+ G  P+ +    T    INA
Sbjct: 197 ALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINA 252
Query: 225 AE 226
            E
Sbjct: 253 IE 254

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 40  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 96  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 147
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           + ++      +DV++ G++L+ LM G LP+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 39  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 95  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 146
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 147 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 240

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G +  V    ++ +G+ +A+K + +ST+ +      +     +M+    P IV+ + 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 77  VLASRTKVYIILEFVTGGELFDKI------VHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
            L      +I +E ++    FDK       V    + E    +     + A+ H      
Sbjct: 89  ALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPEVL----SN 183
           + HRD+KP N+LLD  GN+K+ DFG+S    Q V+ +  T   G   Y+APE +    S 
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF 210
           +GYD   +DVWS G+ L+ L  G  P+
Sbjct: 204 QGYD-VRSDVWSLGITLYELATGRFPY 229

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMK 64
           V+  ++   IG G F +V   + +  G+    VA+K L      + R   +   E SIM 
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR--EFLSEASIMG 70
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
              HPNI+RL  V+ +   V I+ EF+  G L         L  ND +    QL+  +  
Sbjct: 71  QFEHPNIIRLEGVVTNSMPVMILTEFMENGAL------DSFLRLNDGQFTVIQLVGMLRG 124
Query: 125 CHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTC---GTP 173
             S   Y       HRDL   N+L++S    KVSDFGLS  L +   +  +T+      P
Sbjct: 125 IASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIP 184
Query: 174 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
             + APE ++ R +  SA+D WS G++++ +M+    FGE
Sbjct: 185 IRWTAPEAIAFRKFT-SASDAWSYGIVMWEVMS----FGE 219

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 15  RTIGEGTFAKVRF----AQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV        N  TGE VA+K L +    + R     +REI I++ + H +
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR--SGWQREIEILRTLYHEH 71
Query: 71  IVRLHEVLASRTK--VYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQQLIDAVAH 124
           IV+       + +  V +++E+V  G L D +    V   +LL      + QQ+ + +A+
Sbjct: 72  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-----LFAQQICEGMAY 126
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTP-NYVAPEVL 181
            H++   HR L   N+LLD+   +K+ DFGL+    +G E   +     +P  + APE L
Sbjct: 127 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 182 SNRGYDGSAADVWSCGVILFVLMA 205
               +   A+DVWS GV L+ L+ 
Sbjct: 187 KECKFY-YASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 15  RTIGEGTFAKVRF----AQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV        N  TGE VA+K L +    + R     +REI I++ + H +
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR--SGWQREIEILRTLYHEH 72
Query: 71  IVRLHEVLASRTK--VYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQQLIDAVAH 124
           IV+       + +  V +++E+V  G L D +    V   +LL      + QQ+ + +A+
Sbjct: 73  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-----LFAQQICEGMAY 127
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTP-NYVAPEVL 181
            H++   HR L   N+LLD+   +K+ DFGL+    +G E   +     +P  + APE L
Sbjct: 128 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 182 SNRGYDGSAADVWSCGVILFVLMA 205
               +   A+DVWS GV L+ L+ 
Sbjct: 188 KECKFY-YASDVWSFGVTLYELLT 210

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMK 64
           V+  ++   IG G F +V   + +  G+    VA+K L      + R   +   E SIM 
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR--EFLSEASIMG 72
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
              HPNI+RL  V+ +   V I+ EF+  G L         L  ND +    QL+  +  
Sbjct: 73  QFEHPNIIRLEGVVTNSMPVMILTEFMENGAL------DSFLRLNDGQFTVIQLVGMLRG 126
Query: 125 CHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQG----VELLHTTCGTP 173
             S   Y       HRDL   N+L++S    KVSDFGLS   ++      E        P
Sbjct: 127 IASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIP 186
Query: 174 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
             + APE ++ R +  SA+D WS G++++ +M+    FGE
Sbjct: 187 IRWTAPEAIAFRKFT-SASDAWSYGIVMWEVMS----FGE 221

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V+  + +   + VA+K++ + ++ +    D+  +E   M  + HP +V+ 
Sbjct: 14  KELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKF 68
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V +    +YI+ E+++ G L + +   G+ LE +        + + +A   S    HR
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 134 DLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDG 188
           DL   N L+D    +KVSDFG++   L  Q V    ++ GT     + APEV     Y  
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV----SSVGTKFPVKWSAPEVFHYFKY-S 183
Query: 189 SAADVWSCGVILF-VLMAGYLPF 210
           S +DVW+ G++++ V   G +P+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPY 206

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 22/209 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 28  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVAHC 125
            L    ++  ++ I+ ++  G  L+        L  ++ +   ++LID        + + 
Sbjct: 84  -LFMGYSTAPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSN 183
           H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+  ++APEV+  
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 184 RGYDGSA--ADVWSCGVILFVLMAGYLPF 210
           +  +  +  +DV++ G++L+ LM G LP+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 27/220 (12%)
Query: 15  RTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           + +G G F +V  A  N+ T   VA+K +   ++     V+    E ++MK ++H  +V+
Sbjct: 21  KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVK 74
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--CRRYFQQLID-------AVAH 124
           LH V+ ++  +YII EF+  G L D        L++D   ++   +LID        +A 
Sbjct: 75  LHAVV-TKEPIYIITEFMAKGSLLD-------FLKSDEGSKQPLPKLIDFSAQIAEGMAF 126
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSN 183
              +   HRDL+  N+L+ +    K++DFGL+ + +            P  + APE + N
Sbjct: 127 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-N 185
Query: 184 RGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
            G     +DVWS G++L  ++  G +P+     P + + +
Sbjct: 186 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 225

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ---IKREISIMKIVRHPNIVR 73
           +G+G F  V   +    G++    V  K   L+H   DQ    +REI I+K +    IV+
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 74  LHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
              V     R ++ +++E++  G L D +  H+ RL  +    Y  Q+   + +  S+  
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 132
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LP-QQGVELLHTTCGTP-NYVAPEVLSNRGYD 187
            HRDL   N+L++S  ++K++DFGL+  LP  +   ++     +P  + APE LS+  + 
Sbjct: 133 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF- 191
Query: 188 GSAADVWSCGVILFVLM 204
              +DVWS GV+L+ L 
Sbjct: 192 SRQSDVWSFGVVLYELF 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 12  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    ++  ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 68  -LFMGYSTAPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 123/279 (44%), Gaps = 41/279 (14%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV--DQIKREISIM 63
           R +  +E  + +G G F  V  A+N+    + A+K +     L +R +  +++ RE+  +
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR----LPNRELAREKVMREVKAL 57
Query: 64  KIVRHPNIVRL----------HEVLASRTKVY--IILEFVTGGELFDKIVHQGRLLEND- 110
             + HP IVR            ++  S  KVY  I ++      L D +  +  + E + 
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 111 --CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELL- 166
             C   F Q+ +AV   HSKG+ HRDLKP N+       +KV DFGL +A+ Q   E   
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 167 ---------HT-TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP 216
                    HT   GT  Y++PE +    Y     D++S G+ILF L+    PF  T + 
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELL---YPFS-TQME 232
Query: 217 TLYKKINAAEFSCPFWFSTGATS---LIHKILDPNPKTR 252
            +    +      P  F+        ++  +L P+P  R
Sbjct: 233 RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMER 271

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 32  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 88  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 139
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+  ++APEV  
Sbjct: 140 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 233

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 100/199 (50%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +   +++ K    +M  + H  +V+L
Sbjct: 30  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAK----VMMNLSHEKLVQL 84
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS       E        P  +  PEVL    +  S +D
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKF-SSKSD 203
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 204 IWAFGVLMWEIYSLGKMPY 222

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 12  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 68  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+  ++APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 40  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 96  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 147
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+  ++APEV  
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           + ++      +DV++ G++L+ LM G LP+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/341 (24%), Positives = 141/341 (41%), Gaps = 70/341 (20%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---------QIKRE 59
           + Y V R I  G++  V    + E G  VA+K +  +T+   R V+         ++ RE
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVF-NTVSDGRTVNILSDSFLCKRVLRE 79
Query: 60  ISIMKIVRHPNIVRLHEVLA-----SRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-R 113
           I ++    HPNI+ L ++       +  K+Y++ E +       +++H  R++ +    +
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQ 137
Query: 114 YFQQLIDAVAHC-HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT 172
           YF   I    H  H  GV HRDL P N+LL    ++ + DF L+          H     
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 173 PNYVAPE-VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN-------- 223
             Y APE V+  +G+     D+WS G ++  +      F  +   T Y ++N        
Sbjct: 198 -WYRAPELVMQFKGF-TKLVDMWSAGCVMAEMFNRKALFRGS---TFYNQLNKIVEVVGT 252
Query: 224 -----AAEFSCP----------------FWFSTGATS------LIHKILDPNPKTRIRIE 256
                   FS P                 W +   T+      LI K+L+ NP+ RI  E
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312
Query: 257 GIRKHPWFRKNYNPVKCSE---------EEEVNLDDVHAVF 288
              +HP+F   ++P+  +E         E   ++ D+H +F
Sbjct: 313 QALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIF 353

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/341 (24%), Positives = 141/341 (41%), Gaps = 70/341 (20%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---------QIKRE 59
           + Y V R I  G++  V    + E G  VA+K +  +T+   R V+         ++ RE
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVF-NTVSDGRTVNILSDSFLCKRVLRE 79
Query: 60  ISIMKIVRHPNIVRLHEVLA-----SRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-R 113
           I ++    HPNI+ L ++       +  K+Y++ E +       +++H  R++ +    +
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQ 137
Query: 114 YFQQLIDAVAHC-HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT 172
           YF   I    H  H  GV HRDL P N+LL    ++ + DF L+          H     
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 173 PNYVAPE-VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN-------- 223
             Y APE V+  +G+     D+WS G ++  +      F  +   T Y ++N        
Sbjct: 198 -WYRAPELVMQFKGF-TKLVDMWSAGCVMAEMFNRKALFRGS---TFYNQLNKIVEVVGT 252
Query: 224 -----AAEFSCP----------------FWFSTGATS------LIHKILDPNPKTRIRIE 256
                   FS P                 W +   T+      LI K+L+ NP+ RI  E
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312
Query: 257 GIRKHPWFRKNYNPVKCSE---------EEEVNLDDVHAVF 288
              +HP+F   ++P+  +E         E   ++ D+H +F
Sbjct: 313 QALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIF 353

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 15  RTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           + +G G F +V  A  N+ T   VA+K +   ++     V+    E ++MK ++H  +V+
Sbjct: 194 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVK 247
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--CRRYFQQLID-------AVAH 124
           LH V+ ++  +YII EF+  G L D        L++D   ++   +LID        +A 
Sbjct: 248 LHAVV-TKEPIYIITEFMAKGSLLD-------FLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSN 183
              +   HRDL+  N+L+ +    K++DFGL+ + +            P  + APE + N
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-N 358
Query: 184 RGYDGSAADVWSCGVILF-VLMAGYLPF 210
            G     +DVWS G++L  ++  G +P+
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 15  RTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV       +   TGE VA+K L   +   H  +  +K+EI I++ + H N
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 84
Query: 71  IVRLHEVLASR--TKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   +        + +I+EF+  G L + +  ++ ++      +Y  Q+   + +  S
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN---YVAPEVLSNR 184
           +   HRDL   N+L++S   +K+ DFGL+   +   E         +   + APE L   
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 204
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV L  L+ 
Sbjct: 205 KF-YIASDVWSFGVTLHELLT 224

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 58  REISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL--LENDCRRY 114
           RE+ +++    HPN++R       R   YI +E         + V Q     L  +    
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA--TLQEYVEQKDFAHLGLEPITL 123
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLK--VSDFGLS---ALPQQGVELL 166
            QQ    +AH HS  + HRDLKP N+L+   +++G +K  +SDFGL    A+ +      
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 167 HTTCGTPNYVAPEVLSNRGYDGS--AADVWSCGVIL-FVLMAGYLPFGETDLPTLYKKIN 223
               GT  ++APE+LS    +      D++S G +  +V+  G  PFG+    +L ++ N
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK----SLQRQAN 239
Query: 224 AAEFSCPF-------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
               +C              A  LI K++  +P+ R   + + KHP+F
Sbjct: 240 ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 15  RTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV       +   TGE VA+K L   +   H  +  +K+EI I++ + H N
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 72
Query: 71  IVRLHEVLASR--TKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   +        + +I+EF+  G L + +  ++ ++      +Y  Q+   + +  S
Sbjct: 73  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN---YVAPEVLSNR 184
           +   HRDL   N+L++S   +K+ DFGL+   +   E         +   + APE L   
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV L  L+ 
Sbjct: 193 KF-YIASDVWSFGVTLHELLT 212

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ---IKREISIMKIVRHPNIVR 73
           +G+G F  V   +    G++    V  K   L+H   DQ    +REI I+K +    IV+
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 74  LHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
              V     R  + +++E++  G L D +  H+ RL  +    Y  Q+   + +  S+  
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 135
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LP-QQGVELLHTTCGTP-NYVAPEVLSNRGYD 187
            HRDL   N+L++S  ++K++DFGL+  LP  +   ++     +P  + APE LS+  + 
Sbjct: 136 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF- 194
Query: 188 GSAADVWSCGVILFVLM 204
              +DVWS GV+L+ L 
Sbjct: 195 SRQSDVWSFGVVLYELF 211

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ---IKREISIMKIVRHPNIVR 73
           +G+G F  V   +    G++    V  K   L+H   DQ    +REI I+K +    IV+
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 74  LHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
              V     R  + +++E++  G L D +  H+ RL  +    Y  Q+   + +  S+  
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 136
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LP-QQGVELLHTTCGTP-NYVAPEVLSNRGYD 187
            HRDL   N+L++S  ++K++DFGL+  LP  +   ++     +P  + APE LS+  + 
Sbjct: 137 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 196
Query: 188 GSAADVWSCGVILFVLM 204
              +DVWS GV+L+ L 
Sbjct: 197 -RQSDVWSFGVVLYELF 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ---IKREISIMKIVRHPNIVR 73
           +G+G F  V   +    G++    V  K   L+H   DQ    +REI I+K +    IV+
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 74  LHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
              V     R  + +++E++  G L D +  H+ RL  +    Y  Q+   + +  S+  
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LP-QQGVELLHTTCGTP-NYVAPEVLSNRGYD 187
            HRDL   N+L++S  ++K++DFGL+  LP  +   ++     +P  + APE LS+  + 
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 208
Query: 188 GSAADVWSCGVILFVLM 204
              +DVWS GV+L+ L 
Sbjct: 209 -RQSDVWSFGVVLYELF 224

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 133/282 (47%), Gaps = 36/282 (12%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G F KV     R+ G  VA+K   + T    + +++ + EI  +   RHP++V L  
Sbjct: 47  IGHGVFGKVYKGVLRD-GAKVALK---RRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA------HCHSKGV 130
               R ++ +I +++  G L   +   G  L      + Q+L   +       + H++ +
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC-----GTPNYVAPEVLSNRG 185
            HRD+K  N+LLD     K++DFG+S   ++G EL  T       GT  Y+ PE    +G
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGIS---KKGTELGQTHLXXVVKGTLGYIDPEYFI-KG 216
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
                +DV+S GV+LF ++       ++ LP   + +N AE++      +     + +I+
Sbjct: 217 RLTEKSDVYSFGVVLFEVLCARSAIVQS-LPR--EMVNLAEWAV----ESHNNGQLEQIV 269
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKC---SEEEEVNLDDV 284
           DPN   +IR E +RK          VKC   S E+  ++ DV
Sbjct: 270 DPNLADKIRPESLRKF-----GDTAVKCLALSSEDRPSMGDV 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 133/282 (47%), Gaps = 36/282 (12%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G F KV     R+ G  VA+K   + T    + +++ + EI  +   RHP++V L  
Sbjct: 47  IGHGVFGKVYKGVLRD-GAKVALK---RRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA------HCHSKGV 130
               R ++ +I +++  G L   +   G  L      + Q+L   +       + H++ +
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC-----GTPNYVAPEVLSNRG 185
            HRD+K  N+LLD     K++DFG+S   ++G EL  T       GT  Y+ PE    +G
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGIS---KKGTELDQTHLXXVVKGTLGYIDPEYFI-KG 216
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
                +DV+S GV+LF ++       ++ LP   + +N AE++      +     + +I+
Sbjct: 217 RLTEKSDVYSFGVVLFEVLCARSAIVQS-LPR--EMVNLAEWAV----ESHNNGQLEQIV 269
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKC---SEEEEVNLDDV 284
           DPN   +IR E +RK          VKC   S E+  ++ DV
Sbjct: 270 DPNLADKIRPESLRKF-----GDTAVKCLALSSEDRPSMGDV 306

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK---REISIMKIV 66
           + E+G  IG+G F +V     R  GE VA++++     ++    DQ+K   RE+   +  
Sbjct: 34  QLEIGELIGKGRFGQV--YHGRWHGE-VAIRLID----IERDNEDQLKAFKREVMAYRQT 86
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHC 125
           RH N+V       S   + II     G  L+  +     +L+ N  R+  Q+++  + + 
Sbjct: 87  RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGL---SALPQQG--VELLHTTCGTPNYVAPEV 180
           H+KG+ H+DLK +N+  D+ G + ++DFGL   S + Q G   + L    G   ++APE+
Sbjct: 147 HAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 181 LSNRGYD--------GSAADVWSCGVILFVLMAGYLPF 210
           +     D           +DV++ G I + L A   PF
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 10/211 (4%)
Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKST-ILKHRMVDQIKREISIMKIVRHPNIV 72
           G  +GEG F  V       T  +VA+K LA    I    +  Q  +EI +M   +H N+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCR-RYFQQLIDAVAHCHSKG 129
            L    +    + ++  ++  G L D++  +     L    R +  Q   + +   H   
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPEVLSNRGYD 187
             HRD+K  N+LLD     K+SDFGL+   ++  + +  +   GT  Y+APE L  RG  
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL--RGEI 211
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
              +D++S GV+L  ++ G     E   P L
Sbjct: 212 TPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 34/229 (14%)
Query: 2   KKQTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM 52
           K QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     
Sbjct: 168 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAF 226
Query: 53  VDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
           +    +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  
Sbjct: 227 L----QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETG 274
Query: 113 RYFQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV 163
           +Y +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +   
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
Query: 164 ELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                    P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 335 YTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 34/229 (14%)
Query: 2   KKQTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM 52
           K QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     
Sbjct: 168 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAF 226
Query: 53  VDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
           +    +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  
Sbjct: 227 L----QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETG 274
Query: 113 RYFQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV 163
           +Y +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +   
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
Query: 164 ELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                    P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 335 YTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 34/229 (14%)
Query: 2   KKQTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM 52
           K QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     
Sbjct: 251 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAF 309
Query: 53  VDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
           +    +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  
Sbjct: 310 L----QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETG 357
Query: 113 RYFQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV 163
           +Y +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +   
Sbjct: 358 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
Query: 164 ELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                    P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 418 YTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 465

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI++E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 104/242 (42%), Gaps = 42/242 (17%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMK 64
           ++  ++ + IG G F +V     +  G+    VA+K L      K R       E SIM 
Sbjct: 6   ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMG 63
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
              HPN++ L  V+   T V II EF+  G L D  + Q     ND +    QL+  +  
Sbjct: 64  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQ-----NDGQFTVIQLVGMLRG 117
Query: 125 CHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY-- 175
             +   Y       HR L   N+L++S    KVSDFGLS         L      P Y  
Sbjct: 118 IAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLS-------RFLEDDTSDPTYTS 170
Query: 176 ----------VAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA 224
                      APE +  R +  SA+DVWS G++++ +M+ G  P+ +    T    INA
Sbjct: 171 ALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINA 226
Query: 225 AE 226
            E
Sbjct: 227 IE 228

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 10/211 (4%)
Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKST-ILKHRMVDQIKREISIMKIVRHPNIV 72
           G  +GEG F  V       T  +VA+K LA    I    +  Q  +EI +M   +H N+V
Sbjct: 30  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 87
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCR-RYFQQLIDAVAHCHSKG 129
            L    +    + ++  ++  G L D++  +     L    R +  Q   + +   H   
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 147
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYD 187
             HRD+K  N+LLD     K+SDFGL+   ++  +  +     GT  Y+APE L  RG  
Sbjct: 148 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL--RGEI 205
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
              +D++S GV+L  ++ G     E   P L
Sbjct: 206 TPKSDIYSFGVVLLEIITGLPAVDEHREPQL 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 10/211 (4%)
Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKST-ILKHRMVDQIKREISIMKIVRHPNIV 72
           G  +GEG F  V       T  +VA+K LA    I    +  Q  +EI +M   +H N+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCR-RYFQQLIDAVAHCHSKG 129
            L    +    + ++  ++  G L D++  +     L    R +  Q   + +   H   
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYD 187
             HRD+K  N+LLD     K+SDFGL+   ++  +  +     GT  Y+APE L  RG  
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL--RGEI 211
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
              +D++S GV+L  ++ G     E   P L
Sbjct: 212 TPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 27  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 80
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 81  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 198
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 199 VWSFGILLTEIVTHGRIPY 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 29  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 82
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 83  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 141
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 200
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 201 VWSFGILLTEIVTHGRIPY 219

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVD---QIKREISIMKIVR 67
           E  + IG+G F  V   +  +    VA+K ++   +  +  M++   + +RE+ IM  + 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-RYFQQLIDAVAHCH 126
           HPNIV+L+ ++ +  +  +++EFV  G+L+ +++ +   ++   + R    +   + +  
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 127 SKG--VYHRDLKPENLLLDSYGN-----LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++   + HRDL+  N+ L S         KV+DFGLS   QQ V  +    G   ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS---QQSVHSVSGLLGNFQWMAPE 196
Query: 180 VLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
            +      Y    AD +S  +IL+ ++ G  PF E
Sbjct: 197 TIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE 230

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI++E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 23  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 76
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 77  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 135
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 194
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 195 VWSFGILLTEIVTHGRIPY 213

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 22  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 75
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 76  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 134
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 193
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 194 VWSFGILLTEIVTHGRIPY 212

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 30  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 83
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 84  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 142
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 201
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 202 VWSFGILLTEIVTHGRIPY 220

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 21  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 74
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 192
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 193 VWSFGILLTEIVTHGRIPY 211

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 123/271 (45%), Gaps = 25/271 (9%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++ +GR +G+G F  VR AQ ++   S   VA+K+L K+ I+    +++  RE + MK  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF 82
Query: 67  RHPNIVRLHEV-LASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            HP++ +L  V L SR K       +IL F+  G+L   ++   R+ EN      Q L+ 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFNLPLQTLVR 141
Query: 121 -------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
                   + +  S+   HRDL   N +L     + V+DFGLS     G +     C + 
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG-DYYRQGCASK 200
Query: 174 ---NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK-INAAEFS 228
               ++A E L++  Y    +DVW+ GV ++ +M  G  P+   +   +Y   I      
Sbjct: 201 LPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259
Query: 229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIR 259
            P         L+++    +PK R     +R
Sbjct: 260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLR 290

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 21  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 74
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 192
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 193 VWSFGILLTEIVTHGRIPY 211

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +   +++ K    +M  + H  +V+L
Sbjct: 14  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAK----VMMNLSHEKLVQL 68
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 69  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 128
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS                P  +  PEVL    +  S +D
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSD 187
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 188 IWAFGVLMWEIYSLGKMPY 206

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 34/229 (14%)
Query: 2   KKQTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM 52
           K QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     
Sbjct: 168 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAF 226
Query: 53  VDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
           +    +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  
Sbjct: 227 L----QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVGEYMSKGSLLD-------FLKGETG 274
Query: 113 RYFQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV 163
           +Y +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +   
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
Query: 164 ELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                    P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 335 YTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +    D+   E  +M  + H  +V+L
Sbjct: 10  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 64
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 124
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS                P  +  PEVL    +  S +D
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSD 183
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 184 IWAFGVLMWEIYSLGKMPY 202

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKIRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y++ R +G G +++V  A N    E VA+K+L      K       +    +  +   PN
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKK-----IKREIKILENLRGGPN 93
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           I+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +CHS
Sbjct: 94  IITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYCHS 149
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            G+ HRD+KP N+L+D  +  L++ D+GL+     G E  +    +  +  PE+L +   
Sbjct: 150 MGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDYQM 208
Query: 187 DGSAADVWSCGVILFVLMAGYLPF 210
              + D+WS G +L  ++    PF
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +   +++ K    +M  + H  +V+L
Sbjct: 30  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAK----VMMNLSHEKLVQL 84
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS                P  +  PEVL    +  S +D
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSD 203
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 204 IWAFGVLMWEIYSLGKMPY 222

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 26  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 79
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 80  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 138
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSD 197
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 198 VWSFGILLTEIVTHGRIPY 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +    D+   E  +M  + H  +V+L
Sbjct: 21  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 75
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 76  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 135
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS                P  +  PEVL    +  S +D
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSD 194
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 195 IWAFGVLMWEIYSLGKMPY 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 27  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 80
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 81  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSD 198
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 199 VWSFGILLTEIVTHGRIPY 217

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 35/207 (16%)
Query: 15  RTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           + +G G F +V  A  N+ T   VA+K +   ++     V+    E ++MK ++H  +V+
Sbjct: 188 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVK 241
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--CRRYFQQLID-------AVAH 124
           LH V+ ++  +YII EF+  G L D        L++D   ++   +LID        +A 
Sbjct: 242 LHAVV-TKEPIYIITEFMAKGSLLD-------FLKSDEGSKQPLPKLIDFSAQIAEGMAF 293
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
              +   HRDL+  N+L+ +    K++DFGL+ +   G +          + APE + N 
Sbjct: 294 IEQRNYIHRDLRAANILVSASLVCKIADFGLARV---GAKF------PIKWTAPEAI-NF 343
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
           G     +DVWS G++L  ++  G +P+
Sbjct: 344 GSFTIKSDVWSFGILLMEIVTYGRIPY 370

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +    D+   E  +M  + H  +V+L
Sbjct: 15  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 69
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS                P  +  PEVL    +  S +D
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSD 188
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 189 IWAFGVLMWEIYSLGKMPY 207

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 31  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 84
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 85  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 143
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSD 202
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 203 VWSFGILLTEIVTHGRIPY 221

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G+F  V   + +  G+ VA+K+L K            + E+++++  RH NI+ L  
Sbjct: 44  IGSGSFGTV--YKGKWHGD-VAVKIL-KVVDPTPEQFQAFRNEVAVLRKTRHVNIL-LFM 98
Query: 77  VLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
              ++  + I+ ++  G  L+  + V + +          +Q    + + H+K + HRD+
Sbjct: 99  GYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDM 158
Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGYDGSA--- 190
           K  N+ L     +K+ DFGL+ +  +  G + +    G+  ++APEV+  R  D +    
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI--RMQDNNPFSF 216
Query: 191 -ADVWSCGVILFVLMAGYLPFGETD 214
            +DV+S G++L+ LM G LP+   +
Sbjct: 217 QSDVYSYGIVLYELMTGELPYSHIN 241

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 21  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 74
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSD 192
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 193 VWSFGILLTEIVTHGRIPY 211

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G+F +V   ++++TG   A+K        K R+      E+     +  P IV L+ 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYG 117
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
            +     V I +E + GG L   I   G L E+    Y  Q ++ + + H++ + H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 137 PENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLSNRGYDGSA 190
            +N+LL S G+   + DFG +   Q    G  LL      GT  ++APEV+  +  D + 
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AK 236
Query: 191 ADVWSCGVILFVLMAGYLPF 210
            D+WS   ++  ++ G  P+
Sbjct: 237 VDIWSSCCMMLHMLNGCHPW 256

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVRHPNIV 72
           + +GEG F+ V   +    G   A+K      IL H   D  + +RE  + ++  HPNI+
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALK-----RILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 73  RLHEVL----ASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQLIDAVAH 124
           RL         ++ + +++L F   G L+++I     +G  L E+        +   +  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFG------------LSALPQQGVELLHTTCGT 172
            H+KG  HRDLKP N+LL   G   + D G              AL  Q  +     C T
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ--DWAAQRC-T 206
Query: 173 PNYVAPEVLSNRGYD--GSAADVWSCGVILFVLMAGYLPF 210
            +Y APE+ S + +       DVWS G +L+ +M G  P+
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +    D+   E  +M  + H  +V+L
Sbjct: 15  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 69
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS                P  +  PEVL    +  S +D
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKF-SSKSD 188
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 189 IWAFGVLMWEIYSLGKMPY 207

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI++E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVMEYMSKGCLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G+F +V   ++++TG   A+K        K R+      E+     +  P IV L+ 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYG 133
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
            +     V I +E + GG L   I   G L E+    Y  Q ++ + + H++ + H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 137 PENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLSNRGYDGSA 190
            +N+LL S G+   + DFG +   Q    G  LL      GT  ++APEV+  +  D + 
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AK 252
Query: 191 ADVWSCGVILFVLMAGYLPF 210
            D+WS   ++  ++ G  P+
Sbjct: 253 VDIWSSCCMMLHMLNGCHPW 272

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 16  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 69
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 70  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 128
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSD 187
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 188 VWSFGILLTEIVTHGRIPY 206

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 40/236 (16%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREI 60
           K  +    YE+   IG G++  V  A ++   ++VA+K   K   +   ++D  +I REI
Sbjct: 22  KNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIK---KVNRMFEDLIDCKRILREI 78
Query: 61  SIMKIVRHPNIVRLHEV-----LASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRR 113
           +I+  ++   I+RLH++     L    ++YI+LE       +LF   +    L E   + 
Sbjct: 79  TILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIF---LTEQHVKT 135
Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL-------- 165
               L+      H  G+ HRDLKP N LL+   ++K+ DFGL+       ++        
Sbjct: 136 ILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEE 195
Query: 166 -----------------LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
                            L +   T  Y APE++  +    ++ D+WS G I   L+
Sbjct: 196 KEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVCEYMSKGSLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 6/175 (3%)
Query: 40  KVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD- 98
           KV  KS        D    E ++MK ++H  +VRL+ V+ ++  +YII E++  G L D 
Sbjct: 39  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDF 97
Query: 99  -KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA 157
            K     +L  N       Q+ + +A    +   HRDL+  N+L+    + K++DFGL+ 
Sbjct: 98  LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 158 LPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           L +            P  + APE + N G     +DVWS G++L  ++  G +P+
Sbjct: 158 LIEDAEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G+F +V   ++++TG   A+K        K R+      E+     +  P IV L+ 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYG 131
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
            +     V I +E + GG L   I   G L E+    Y  Q ++ + + H++ + H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 137 PENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLSNRGYDGSA 190
            +N+LL S G+   + DFG +   Q    G  LL      GT  ++APEV+  +  D + 
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AK 250
Query: 191 ADVWSCGVILFVLMAGYLPF 210
            D+WS   ++  ++ G  P+
Sbjct: 251 VDIWSSCCMMLHMLNGCHPW 270

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V       T   VA+K L   T+     +    +E  +MK +RH  +V+L+ 
Sbjct: 19  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 73
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLIDAVAHCHSKGVY--- 131
           V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D  A   S   Y   
Sbjct: 74  VV-SEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIASGMAYVER 125
Query: 132 ----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
               HRDL+  N+L+      KV+DFGL+ L +            P  + APE  +  G 
Sbjct: 126 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA-ALYGR 184
Query: 187 DGSAADVWSCGVILFVLMA-GYLPF 210
               +DVWS G++L  L   G +P+
Sbjct: 185 FTIKSDVWSFGILLTELTTKGRVPY 209

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  ++  PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLMGGPN 87
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 143
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 203 YDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 31/208 (14%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G F +V  A++R  G++  +K +  +        ++ +RE+  +  + H NIV  + 
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNG 71
Query: 77  VL-------------ASRTK---VYIILEFVTGGELFDKIVHQGRLLEND---CRRYFQQ 117
                          +SR+K   ++I +EF   G L ++ + + R  + D       F+Q
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTL-EQWIEKRRGEKLDKVLALELFEQ 130
Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYV 176
           +   V + HSK + +RDLKP N+ L     +K+ DFGL ++L   G      + GT  Y+
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRX--RSKGTLRYM 188
Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLM 204
           +PE +S++ Y G   D+++ G+IL  L+
Sbjct: 189 SPEQISSQDY-GKEVDLYALGLILAELL 215

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 34/227 (14%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 1   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 58
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E++  G L D        L+ +  +Y
Sbjct: 59  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLD-------FLKGETGKY 107
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 108 LRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWT 167
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                  P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 168 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V       T   VA+K L   T+     +    +E  +MK +RH  +V+L+ 
Sbjct: 17  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 71
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLIDAVAHCHSKGVY--- 131
           V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D  A   S   Y   
Sbjct: 72  VV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVER 123
Query: 132 ----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
               HRDL+  N+L+      KV+DFGL+ L +            P  + APE  +  G 
Sbjct: 124 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA-ALYGR 182
Query: 187 DGSAADVWSCGVILFVLMA-GYLPF 210
               +DVWS G++L  L   G +P+
Sbjct: 183 FTIKSDVWSFGILLTELTTKGRVPY 207

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V       T   VA+K L   T+     +    +E  +MK +RH  +V+L+ 
Sbjct: 15  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 69
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLIDAVAHCHSKGVY--- 131
           V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D  A   S   Y   
Sbjct: 70  VV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVER 121
Query: 132 ----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
               HRDL+  N+L+      KV+DFGL+ L +            P  + APE  +  G 
Sbjct: 122 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA-ALYGR 180
Query: 187 DGSAADVWSCGVILFVLMA-GYLPF 210
               +DVWS G++L  L   G +P+
Sbjct: 181 FTIKSDVWSFGILLTELTTKGRVPY 205

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 2   KKQTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM 52
           K QT+ +AK  +E+ R        +G+G F +V       T   VA+K L    +     
Sbjct: 169 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGNMSPEAF 227
Query: 53  VDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
           +    +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  
Sbjct: 228 L----QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMG 275
Query: 113 RYFQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV 163
           +Y +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL  L +   
Sbjct: 276 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNE 335
Query: 164 ELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                    P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 336 YTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 383

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 87
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXK 207
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 34/227 (14%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 1   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 58
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E++  G L D        L+ +  +Y
Sbjct: 59  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLD-------FLKGETGKY 107
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 108 LRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 167
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                  P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 168 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 34  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 88
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 89  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 144
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 145 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 203
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 204 YDYS-LDMWSLGCMFAGMIFRKEPF 227

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 34  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLXGGPN 88
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 89  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 144
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 145 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 203
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 204 YDYS-LDMWSLGCMFAGMIFRKEPF 227

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLA-KSTILKHRMVD---QIKREISIMKIVR 67
           E  + IG+G F  V   +  +    VA+K L    +  +  M++   + +RE+ IM  + 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-RYFQQLIDAVAHCH 126
           HPNIV+L+ ++ +  +  +++EFV  G+L+ +++ +   ++   + R    +   + +  
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 127 SKG--VYHRDLKPENLLLDSYGN-----LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++   + HRDL+  N+ L S         KV+DFG S   QQ V  +    G   ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS---QQSVHSVSGLLGNFQWMAPE 196
Query: 180 VLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
            +      Y    AD +S  +IL+ ++ G  PF E
Sbjct: 197 TIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE 230

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 87
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 143
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 203 YDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 34/227 (14%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL   N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                  P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 35  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 89
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 90  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 145
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 146 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 204
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 205 YDYS-LDMWSLGCMFAGMIFRKEPF 228

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 87
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 143
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 203 YDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLXGGPN 87
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 143
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 203 YDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLXGGPN 87
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 143
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 203 YDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 118/287 (41%), Gaps = 58/287 (20%)
Query: 9   AKYEVGRTIGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           A+YE+  T+GEG F KV     ++  G  VA+K++        R  +  + EI +++ + 
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 68  --HPN----IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL--LENDCRRYFQQLI 119
              PN     V++ E       + I+ E + G   +D I   G L    +  R+   Q+ 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 120 DAVAHCHSKGVYHRDLKPENLLL------DSYG-------------NLKVSDFGLSALPQ 160
            +V   HS  + H DLKPEN+L       ++Y              ++KV DFG +    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK 220
              E   T   T +Y APEV+   G+     DVWS G IL     G+  F   D      
Sbjct: 189 ---EHHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHD------ 238
Query: 221 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                        S    +++ +IL P PK    I+  RK  +F  +
Sbjct: 239 -------------SKEHLAMMERILGPLPKH--MIQKTRKRKYFHHD 270

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLXGGPN 87
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 143
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 203 YDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 42/231 (18%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVR 67
           +YE+   IG G++  V  A ++     VA+K + +   +   ++D  +I REI+I+  + 
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRLN 110
Query: 68  HPNIVRLHEVLASRT-----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 120
           H ++V++ +++  +      ++Y++LE       +LF   V+   L E   +     L+ 
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVY---LTELHIKTLLYNLLV 167
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQG--------------- 162
            V + HS G+ HRDLKP N L++   ++KV DFGL+     P+ G               
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 163 VELLHTT---------CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
           V   HT            T  Y APE++  +     A DVWS G I   L+
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 107/215 (49%), Gaps = 20/215 (9%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVD---QIKREISIMKIVR 67
           E  + IG+G F  V   +  +    VA+K ++   +  +  M++   + +RE+ IM  + 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-RYFQQLIDAVAHCH 126
           HPNIV+L+ ++ +  +  +++EFV  G+L+ +++ +   ++   + R    +   + +  
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 127 SKG--VYHRDLKPENLLLDSYGN-----LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++   + HRDL+  N+ L S         KV+DF LS   QQ V  +    G   ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS---QQSVHSVSGLLGNFQWMAPE 196
Query: 180 VLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
            +      Y    AD +S  +IL+ ++ G  PF E
Sbjct: 197 TIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE 230

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 76
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 137 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 196
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 197 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 252

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 54  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLXGGPN 108
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 109 IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 164
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 165 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 223
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 224 YDYS-LDMWSLGCMFAGMIFRKEPF 247

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 87
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 87
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGCLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 80
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 141 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 200
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 201 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 256

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 72
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 79
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 140 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 199
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 200 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 255

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 17  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 70
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 71  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 129
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           +L+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSD 188
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 189 VWSFGILLTEIVTHGRIPY 207

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 87
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 108/238 (45%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            +TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KNTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 128
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 23  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 80
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 81  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 140
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 141 MTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYY 200
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 201 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 257

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG G F  V         + VA+K + + ++ +    D    E  +M  + HP +V+L
Sbjct: 33  QEIGSGQFGLVHLGYWLNK-DKVAIKTIKEGSMSE----DDFIEEAEVMMKLSHPKLVQL 87
Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  + ++ EF+  G L D +   +G             + + +A+     V HR
Sbjct: 88  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 147
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +D
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSD 206
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS GV+++ V   G +P+
Sbjct: 207 VWSFGVLMWEVFSEGKIPY 225

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 25  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 82
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 83  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 142
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 143 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 202
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 203 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 259

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 90  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 145
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 204
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 28  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 85
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 86  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 145
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 146 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 205
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 206 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 262

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 91  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 146
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 205
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 10/211 (4%)
Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKST-ILKHRMVDQIKREISIMKIVRHPNIV 72
           G   GEG F  V       T  +VA+K LA    I    +  Q  +EI +    +H N+V
Sbjct: 27  GNKXGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLV 84
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCR-RYFQQLIDAVAHCHSKG 129
            L    +    + ++  +   G L D++  +     L    R +  Q   + +   H   
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENH 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPEVLSNRGYD 187
             HRD+K  N+LLD     K+SDFGL+   ++  + +  +   GT  Y APE L  RG  
Sbjct: 145 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL--RGEI 202
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
              +D++S GV+L  ++ G     E   P L
Sbjct: 203 TPKSDIYSFGVVLLEIITGLPAVDEHREPQL 233

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 91  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 146
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 205
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 82  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 139
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V       T   VA+K L   T+     +    +E  +MK +RH  +V+L+ 
Sbjct: 16  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 70
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLIDAVAHCHSKGVY--- 131
           V+ S   + I+ E+++ G L D        L+ +  +Y +  QL+D  A   S   Y   
Sbjct: 71  VV-SEEPIXIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIASGMAYVER 122
Query: 132 ----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
               HRDL+  N+L+      KV+DFGL+ L +            P  + APE  +  G 
Sbjct: 123 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEA-ALYGR 181
Query: 187 DGSAADVWSCGVILFVLMA-GYLPF 210
               +DVWS G++L  L   G +P+
Sbjct: 182 FTIKSDVWSFGILLTELTTKGRVPY 206

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG G F  V         + VA+K + +  + +   ++    E  +M  + HP +V+L
Sbjct: 13  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQL 67
Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  + ++ EF+  G L D +   +G             + + +A+     V HR
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHR 127
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +D
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSD 186
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS GV+++ V   G +P+
Sbjct: 187 VWSFGVLMWEVFSEGKIPY 205

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 109/238 (45%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L K    +  + D +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEEDLSDLVS-EMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 97  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 152
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 153 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 211
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 212 QMYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 58  REISIMKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQG--------RLL 107
           REI++++ ++HPN++ L +V  S    KV+++ ++           H+         +L 
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 108 ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSAL---PQ 160
               +    Q++D + + H+  V HRDLKP N+L+       G +K++D G + L   P 
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
           + +  L     T  Y APE+L    +   A D+W+ G I   L+  
Sbjct: 187 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 12/222 (5%)
Query: 17  IGEGTFAKVR--FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  VR    + R+    VA+KVL + T  +    +++ RE  IM  + +P IVRL
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHR 133
             V  +   + +++E   GG L   +V +   +  ++      Q+   + +   K   HR
Sbjct: 76  IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP--NYVAPEVLSNRGYDGSA 190
           DL   N+LL +    K+SDFGLS AL          + G     + APE ++ R +  S 
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 193
Query: 191 ADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAE-FSCP 230
           +DVWS GV ++  L  G  P+ +   P +   I   +   CP
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 235

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 110/259 (42%), Gaps = 14/259 (5%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G +  V   ++  +G+  A+K +  +   + +       +IS  + V  P  V  + 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDIS-XRTVDCPFTVTFYG 100
Query: 77  VLASRTKVYIILEF--VTGGELFDKIVHQGRLLENDC-RRYFQQLIDAVAHCHSK-GVYH 132
            L     V+I  E    +  + + +++ +G+ +  D   +    ++ A+ H HSK  V H
Sbjct: 101 ALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 160
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE----VLSNRGYDG 188
           RD+KP N+L+++ G +K  DFG+S      V       G   Y APE     L+ +GY  
Sbjct: 161 RDVKPSNVLINALGQVKXCDFGISGYLVDDVA-KDIDAGCKPYXAPERINPELNQKGY-S 218
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLP--TLYKKINAAEFSCPF-WFSTGATSLIHKIL 245
             +D+WS G+    L     P+     P   L + +       P   FS        + L
Sbjct: 219 VKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCL 278
Query: 246 DPNPKTRIRIEGIRKHPWF 264
             N K R     + +HP+F
Sbjct: 279 KKNSKERPTYPELXQHPFF 297

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG G F  V         + VA+K + +  + +   ++    E  +M  + HP +V+L
Sbjct: 16  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQL 70
Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  + ++ EF+  G L D +   +G             + + +A+     V HR
Sbjct: 71  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 130
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +D
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSD 189
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS GV+++ V   G +P+
Sbjct: 190 VWSFGVLMWEVFSEGKIPY 208

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG G F  V         + VA+K + +  + +   ++    E  +M  + HP +V+L
Sbjct: 11  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQL 65
Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  + ++ EF+  G L D +   +G             + + +A+     V HR
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +D
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSD 184
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS GV+++ V   G +P+
Sbjct: 185 VWSFGVLMWEVFSEGKIPY 203

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     ++++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 77/146 (52%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K + Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLRQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG G F  V         + VA+K + +  + +   ++    E  +M  + HP +V+L
Sbjct: 13  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQL 67
Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  + ++ EF+  G L D +   +G             + + +A+     V HR
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 127
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +D
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSD 186
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS GV+++ V   G +P+
Sbjct: 187 VWSFGVLMWEVFSEGKIPY 205

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 41/233 (17%)
Query: 11  YEVGRTIGEGTFAKVRFAQNR-ETG--ESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +++   IGEGTF+ V  A  + + G  E +A+K L  ++   H +  +I  E+  + +  
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPI--RIAAELQCLTVAG 77
Query: 68  -HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
              N++ +         V I + ++      D +     L   + R Y   L  A+   H
Sbjct: 78  GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIH 134
Query: 127 SKGVYHRDLKPENLLLDS-YGNLKVSDFGLS-ALPQQGVELLH----------------T 168
             G+ HRD+KP N L +       + DFGL+       +ELL                 +
Sbjct: 135 QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCS 194
Query: 169 TC-----------GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
            C           GTP + APEVL+      +A D+WS GVI   L++G  PF
Sbjct: 195 ICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 44/221 (19%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G F +V  A++R  G++  ++ +  +        ++ +RE+  +  + H NIV  + 
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNN-------EKAEREVKALAKLDHVNIVHYNG 72
Query: 77  VL--------------------------ASRTK---VYIILEFVTGGELFDKIVHQGRLL 107
                                       +SR+K   ++I +EF   G L ++ + + R  
Sbjct: 73  CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL-EQWIEKRRGE 131
Query: 108 END---CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGV 163
           + D       F+Q+   V + HSK + HRDLKP N+ L     +K+ DFGL ++L   G 
Sbjct: 132 KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 191
Query: 164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
                + GT  Y++PE +S++ Y G   D+++ G+IL  L+
Sbjct: 192 RT--RSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELL 229

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 117/287 (40%), Gaps = 58/287 (20%)
Query: 9   AKYEVGRTIGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           A+YE+  T+GEG F KV     ++  G  VA+K++        R  +  + EI +++ + 
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 68  --HPN----IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL--LENDCRRYFQQLI 119
              PN     V++ E       + I+ E + G   +D I   G L    +  R+   Q+ 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 120 DAVAHCHSKGVYHRDLKPENLLL------DSYG-------------NLKVSDFGLSALPQ 160
            +V   HS  + H DLKPEN+L       ++Y              ++KV DFG +    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK 220
           +      T     +Y APEV+   G+     DVWS G IL     G+  F   D      
Sbjct: 189 EHHS---TLVXXRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHD------ 238
Query: 221 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                        S    +++ +IL P PK    I+  RK  +F  +
Sbjct: 239 -------------SKEHLAMMERILGPLPKH--MIQKTRKRKYFHHD 270

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 13  VGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + R +GEG F +V    +  ++    +VA+K   K   L ++  ++   E  IMK + HP
Sbjct: 12  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 69
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR--------YFQQLIDA 121
           +IV+L  ++      +II+E    GEL       G  LE +           Y  Q+  A
Sbjct: 70  HIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLYSLQICKA 121
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 180
           +A+  S    HRD+   N+L+ S   +K+ DFGLS   +       +    P  +++PE 
Sbjct: 122 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 181
Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           ++ R +  +A+DVW   V ++ +L  G  PF
Sbjct: 182 INFRRF-TTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 13  VGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + R +GEG F +V    +  ++    +VA+K   K   L ++  ++   E  IMK + HP
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 73
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR--------YFQQLIDA 121
           +IV+L  ++      +II+E    GEL       G  LE +           Y  Q+  A
Sbjct: 74  HIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 180
           +A+  S    HRD+   N+L+ S   +K+ DFGLS   +       +    P  +++PE 
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 185
Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           ++ R +  +A+DVW   V ++ +L  G  PF
Sbjct: 186 INFRRF-TTASDVWMFAVCMWEILSFGKQPF 215

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG G F  V         + VA+K + +  + +   ++    E  +M  + HP +V+L
Sbjct: 14  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQL 68
Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  + ++ EF+  G L D +   +G             + + +A+     V HR
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSD 187
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS GV+++ V   G +P+
Sbjct: 188 VWSFGVLMWEVFSEGKIPY 206

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 13  VGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + R +GEG F +V    +  ++    +VA+K   K   L ++  ++   E  IMK + HP
Sbjct: 28  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 85
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR--------YFQQLIDA 121
           +IV+L  ++      +II+E    GEL       G  LE +           Y  Q+  A
Sbjct: 86  HIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLYSLQICKA 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 180
           +A+  S    HRD+   N+L+ S   +K+ DFGLS   +       +    P  +++PE 
Sbjct: 138 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 197
Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           ++ R +  +A+DVW   V ++ +L  G  PF
Sbjct: 198 INFRRF-TTASDVWMFAVCMWEILSFGKQPF 227

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           +K   + + +YE+   IG+G+F +V  A +R   E VA+K++      K   ++Q + E+
Sbjct: 46  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEV 101
Query: 61  SIMKIVRHPN------IVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCR 112
            +++++   +      IV L      R  + ++ E ++    +L      +G  L N  R
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSL-NLTR 160
Query: 113 RYFQQLIDAVAHCHSK--GVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGVELLHT 168
           ++ QQ+  A+    +    + H DLKPEN+LL       +K+ DFG S    Q  + ++ 
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQRIYQ 217
Query: 169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
              +  Y +PEVL    YD  A D+WS G IL  +  G
Sbjct: 218 XIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTG 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 106/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+ + + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           +K   + + +YE+   IG+G+F +V  A +R   E VA+K++      K   ++Q + E+
Sbjct: 27  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEV 82
Query: 61  SIMKIVRHPN------IVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCR 112
            +++++   +      IV L      R  + ++ E ++    +L      +G  L N  R
Sbjct: 83  RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSL-NLTR 141
Query: 113 RYFQQLIDAVAHCHSK--GVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGVELLHT 168
           ++ QQ+  A+    +    + H DLKPEN+LL       +K+ DFG S    Q  + ++ 
Sbjct: 142 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQRIYQ 198
Query: 169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
              +  Y +PEVL    YD  A D+WS G IL  +  G
Sbjct: 199 XIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTG 235

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           +K   + + +YE+   IG+G+F +V  A +R   E VA+K++      K   ++Q + E+
Sbjct: 46  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEV 101
Query: 61  SIMKIVRHPN------IVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCR 112
            +++++   +      IV L      R  + ++ E ++    +L      +G  L N  R
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSL-NLTR 160
Query: 113 RYFQQLIDAVAHCHSK--GVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGVELLHT 168
           ++ QQ+  A+    +    + H DLKPEN+LL       +K+ DFG S    Q  + ++ 
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSC---QLGQRIYQ 217
Query: 169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
              +  Y +PEVL    YD  A D+WS G IL  +  G
Sbjct: 218 XIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTG 254

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 24/227 (10%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F +V +         VA+K L   T+     ++    E  IMK ++H  +V+L
Sbjct: 15  KRLGNGQFGEV-WMGTWNGNTKVAIKTLKPGTMSPESFLE----EAQIMKKLKHDKLVQL 69
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVY-- 131
           + V+ S   +YI+ E++  G L D +   +GR L+         L+D  A   +   Y  
Sbjct: 70  YAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALK------LPNLVDMAAQVAAGMAYIE 122
Query: 132 -----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRG 185
                HRDL+  N+L+ +    K++DFGL+ L +            P  + APE  +  G
Sbjct: 123 RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEA-ALYG 181
Query: 186 YDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCP 230
                +DVWS G++L  L+  G +P+ G  +   L +        CP
Sbjct: 182 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP 228

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 106/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+ + + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVRH 68
           Y +   IG G++  V  A ++ T ++VA+K   K   +   ++D  +I REI+I+  ++ 
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIK---KVNRMFEDLIDCKRILREITILNRLKS 84
Query: 69  PNIVRLHEV-----LASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDA 121
             I+RL+++     L    ++YI+LE       +LF   +    L E   +     L+  
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF---LTEEHIKTILYNLLLG 141
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL---------------- 165
               H  G+ HRDLKP N LL+   ++KV DFGL+       +                 
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 166 ------LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
                 L +   T  Y APE++  +     + D+WS G I   L+
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 35/230 (15%)
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQQLI 119
           HPN++R +    +   +YI LE          +V    + + + +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYG-----------NLK--VSDFGLSALPQQGVEL- 165
             VAH HS  + HRDLKP+N+L+ +             NL+  +SDFGL      G    
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 166 ---LHTTCGTPNYVAPEVL--SNRGYDGSAADVWSCG-VILFVLMAGYLPFGET---DLP 216
              L+   GT  + APE+L  S +     + D++S G V  ++L  G  PFG+    +  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 217 TLYKKINAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            +    +  E  C    S    AT LI +++D +P  R     + +HP F
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 35/230 (15%)
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQQLI 119
           HPN++R +    +   +YI LE          +V    + + + +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYG-----------NLK--VSDFGLSALPQQGVEL- 165
             VAH HS  + HRDLKP+N+L+ +             NL+  +SDFGL      G    
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 166 ---LHTTCGTPNYVAPEVL--SNRGYDGSAADVWSCG-VILFVLMAGYLPFGET---DLP 216
              L+   GT  + APE+L  S +     + D++S G V  ++L  G  PFG+    +  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 217 TLYKKINAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            +    +  E  C    S    AT LI +++D +P  R     + +HP F
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 89/352 (25%), Positives = 138/352 (39%), Gaps = 83/352 (23%)
Query: 10  KYEVGRTIGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           +YE+  T+GEGTF +V +   +R  G  VA+K++      K    +  + EI++++ +  
Sbjct: 34  RYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYK----EAARLEINVLEKINE 89
Query: 69  PN------IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE--NDCRRYFQQLID 120
            +       V++ +       + I  E + G   FD +     L    +  R    QL  
Sbjct: 90  KDPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQLCQ 148
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYG-----NL--------------KVSDFGLSALPQQ 161
           AV   H   + H DLKPEN+L  +       NL              +V DFG +     
Sbjct: 149 AVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDH- 207
Query: 162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK 221
             E   T   T +Y APEV+   G+     DVWS G I+F    G+         TL++ 
Sbjct: 208 --EHHSTIVSTRHYRAPEVILELGW-SQPCDVWSIGCIIFEYYVGF---------TLFQT 255
Query: 222 INAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF----------------- 264
            +  E            +++ +IL P P   IR    RK  +F                 
Sbjct: 256 HDNRE----------HLAMMERILGPIPSRMIR--KTRKQKYFYRGRLDWDENTSAGRYV 303
Query: 265 RKNYNPVK---CSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAF 313
           R+N  P++    SE EE      H +FD IE     E ++    G  L + F
Sbjct: 304 RENCKPLRRYLTSEAEE-----HHQLFDLIESMLEYEPAKRLTLGEALQHPF 350

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 12/222 (5%)
Query: 17  IGEGTFAKVRFA--QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  VR    + R+    VA+KVL + T  +    +++ RE  IM  + +P IVRL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHR 133
             V  +   + +++E   GG L   +V +   +  ++      Q+   + +   K   HR
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT-P-NYVAPEVLSNRGYDGSA 190
           +L   N+LL +    K+SDFGLS AL          + G  P  + APE ++ R +  S 
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 519
Query: 191 ADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAE-FSCP 230
           +DVWS GV ++  L  G  P+ +   P +   I   +   CP
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 561

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 39/237 (16%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--- 57
            K +  + A+Y + R +G G F+ V  A++      VAMK++    +      D+IK   
Sbjct: 11  FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70
Query: 58  --------REIS-----IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGE----LFDKI 100
                   +E S     I+K++ H N    H+       V++++ F   GE    L  K 
Sbjct: 71  RVNDADNTKEDSMGANHILKLLDHFN----HK---GPNGVHVVMVFEVLGENLLALIKKY 123
Query: 101 VHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLL---DSYGNL---KVSDF 153
            H+G  L    ++  +QL+  + + H + G+ H D+KPEN+L+   DS  NL   K++D 
Sbjct: 124 EHRGIPLIY-VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
Query: 154 GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           G +       E    +  T  Y +PEVL    + G  AD+WS   ++F L+ G   F
Sbjct: 183 GNACWYD---EHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLF 235

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV----R 67
           + G+T+G G F KV  A     G+  A+  +A   +      D+ +  +S +KI+    +
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--------------CRR 113
           H NIV L         V +I E+   G+L + +  + R+LE D                 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT 172
           +  Q+   +A   SK   HRD+   N+LL +    K+ DFGL+  +      ++      
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 173 P-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           P  ++APE + +  Y    +DVWS G++L+ +   G  P+
Sbjct: 229 PVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY 267

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV----R 67
           + G+T+G G F KV  A     G+  A+  +A   +      D+ +  +S +KI+    +
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--------------CRR 113
           H NIV L         V +I E+   G+L + +  + R+LE D                 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT 172
           +  Q+   +A   SK   HRD+   N+LL +    K+ DFGL+  +      ++      
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 173 P-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           P  ++APE + +  Y    +DVWS G++L+ +   G  P+
Sbjct: 229 PVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY 267

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 39/237 (16%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--- 57
            K +  + A+Y + R +G G F+ V  A++      VAMK++    +      D+IK   
Sbjct: 11  FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70
Query: 58  --------REIS-----IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGE----LFDKI 100
                   +E S     I+K++ H N    H+       V++++ F   GE    L  K 
Sbjct: 71  RVNDADNTKEDSMGANHILKLLDHFN----HK---GPNGVHVVMVFEVLGENLLALIKKY 123
Query: 101 VHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLL---DSYGNL---KVSDF 153
            H+G  L    ++  +QL+  + + H + G+ H D+KPEN+L+   DS  NL   K++D 
Sbjct: 124 EHRGIPLIY-VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
Query: 154 GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           G +       E    +  T  Y +PEVL    + G  AD+WS   ++F L+ G   F
Sbjct: 183 GNACWYD---EHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLF 235

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 15/218 (6%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE+V    A+KVL ++T  K     +I  E  +M  V  P 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPY 80
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V ++ + +  G L D +  ++GRL   D   +  Q+   +++     
Sbjct: 81  VSRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVR 139
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ S  ++K++DFGL+ L        H   G  P  ++A E +  R + 
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT 199
Query: 188 GSAADVWSCGVILFVLMA-GYLPFG---ETDLPTLYKK 221
              +DVWS GV ++ LM  G  P+      ++P L +K
Sbjct: 200 -HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 236

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 17  IGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIV 72
           IGEG F +V  A+ ++ G   ++   ++   ++   HR       E+ ++ K+  HPNI+
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 89
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND----------CRRYFQQLIDAV 122
            L      R  +Y+ +E+   G L D  + + R+LE D               QQL+   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 123 A-------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-N 174
           A       +   K   HRDL   N+L+      K++DFGLS    Q V +  T    P  
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 206
Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 222
           ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 207 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 34/238 (14%)
Query: 11  YEVGRTIGEG--TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG+G      V  A+ + TGE V ++ +       + MV  ++ E+ + K+  H
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNH 85
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCH 126
           PNIV       +  +++++  F+  G   D I       + E       Q ++ A+ + H
Sbjct: 86  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 127 SKGVYHRDLKPENLLLDSYG---------NLKVSDFG-----LSALPQQGVELLHTTCGT 172
             G  HR +K  ++L+   G         NL +   G     +   P+  V++L      
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL------ 199
Query: 173 PNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT---LYKKINAA 225
             +++PEVL    +GYD + +D++S G+    L  G++PF   D+P    L +K+N  
Sbjct: 200 -PWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPF--KDMPATQMLLEKLNGT 253

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 69/157 (43%), Gaps = 20/157 (12%)
Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTT 169
           C   F Q+ +AV   HSKG+ HRDLKP N+       +KV DFGL +A+ Q   E    T
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 170 -----------CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
                       GT  Y++PE +    Y     D++S G+ILF L+  +     T +  +
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSF----STQMERV 280
Query: 219 YKKINAAEFSCPFWFSTGATS---LIHKILDPNPKTR 252
               +      P  F+        ++  +L P+P  R
Sbjct: 281 RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 34/238 (14%)
Query: 11  YEVGRTIGEG--TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG+G      V  A+ + TGE V ++ +       + MV  ++ E+ + K+  H
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNH 69
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCH 126
           PNIV       +  +++++  F+  G   D I       + E       Q ++ A+ + H
Sbjct: 70  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 129
Query: 127 SKGVYHRDLKPENLLLDSYG---------NLKVSDFG-----LSALPQQGVELLHTTCGT 172
             G  HR +K  ++L+   G         NL +   G     +   P+  V++L      
Sbjct: 130 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL------ 183
Query: 173 PNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT---LYKKINAA 225
             +++PEVL    +GYD + +D++S G+    L  G++PF   D+P    L +K+N  
Sbjct: 184 -PWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPF--KDMPATQMLLEKLNGT 237

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 17  IGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIV 72
           IGEG F +V  A+ ++ G   ++   ++   ++   HR       E+ ++ K+  HPNI+
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 79
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND----------CRRYFQQLIDAV 122
            L      R  +Y+ +E+   G L D  + + R+LE D               QQL+   
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 123 A-------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-N 174
           A       +   K   HRDL   N+L+      K++DFGLS    Q V +  T    P  
Sbjct: 139 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 196
Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 222
           ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 197 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 244

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 70  NIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           NI++L + +    S+T   ++ E++   +   K ++Q  L + D R Y  +L+ A+ +CH
Sbjct: 94  NIIKLIDTVKDPVSKTPA-LVFEYINNTDF--KQLYQ-ILTDFDIRFYMYELLKALDYCH 149
Query: 127 SKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           SKG+ HRD+KP N+++D     L++ D+GL+       E  +    +  +  PE+L +  
Sbjct: 150 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE-YNVRVASRYFKGPELLVDYQ 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
               + D+WS G +L  ++    PF
Sbjct: 209 MYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 70  NIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           NI++L + +    S+T   ++ E++   +   K ++Q  L + D R Y  +L+ A+ +CH
Sbjct: 99  NIIKLIDTVKDPVSKTPA-LVFEYINNTDF--KQLYQ-ILTDFDIRFYMYELLKALDYCH 154
Query: 127 SKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           SKG+ HRD+KP N+++D     L++ D+GL+       E  +    +  +  PE+L +  
Sbjct: 155 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE-YNVRVASRYFKGPELLVDYQ 213
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
               + D+WS G +L  ++    PF
Sbjct: 214 MYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 80
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL------SALPQQGVELLHTTCGTP 173
           D +A+ ++K   HRDL   N ++     +K+ DFG+      +A  ++G + L       
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV---- 196
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILF 201
            ++APE L + G   +++D+WS GV+L+
Sbjct: 197 RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 11/216 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK--HRMVDQIKREISIMKIVRHPNIV 72
           + +G G F  V        GES+ + V  K    K   +    +   +  +  + H +IV
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           RL   L   + + ++ +++  G L D +  H+G L       +  Q+   + +    G+ 
Sbjct: 97  RLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 155
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGS 189
           HR+L   N+LL S   ++V+DFG++  LP    +LL++   TP  ++A E +    Y   
Sbjct: 156 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT-H 214
Query: 190 AADVWSCGVILFVLMA-GYLPFGE---TDLPTLYKK 221
            +DVWS GV ++ LM  G  P+      ++P L +K
Sbjct: 215 QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 250

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 27/252 (10%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
            +YEV   I  G    +  A +R   G  V +K L  S   + + +   +R+   +  V 
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF--LAEVV 137
Query: 68  HPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           HP+IV++   +    +      YI++E+V GG+   +   Q +L   +   Y  +++ A+
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKRSKGQ-KLPVAEAIAYLLEILPAL 195
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           ++ HS G+ + DLKPEN++L +   LK+ D G  +     +       GTP + APE++ 
Sbjct: 196 SYLHSIGLVYNDLKPENIML-TEEQLKLIDLGAVSR----INSFGYLYGTPGFQAPEIV- 249
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK-INAAEFSCPFWFSTGATS-L 240
            R     A D+++ G  L  L          DLPT   + ++      P   +  +   L
Sbjct: 250 -RTGPTVATDIYTVGRTLAALT--------LDLPTRNGRYVDGLPEDDPVLKTYDSYGRL 300
Query: 241 IHKILDPNPKTR 252
           + + +DP+P+ R
Sbjct: 301 LRRAIDPDPRQR 312

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 11/216 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK--HRMVDQIKREISIMKIVRHPNIV 72
           + +G G F  V        GES+ + V  K    K   +    +   +  +  + H +IV
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           RL   L   + + ++ +++  G L D +  H+G L       +  Q+   + +    G+ 
Sbjct: 79  RLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGS 189
           HR+L   N+LL S   ++V+DFG++  LP    +LL++   TP  ++A E +    Y   
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT-H 196
Query: 190 AADVWSCGVILFVLMA-GYLPFGE---TDLPTLYKK 221
            +DVWS GV ++ LM  G  P+      ++P L +K
Sbjct: 197 QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 80
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLHTTCGT 172
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 196
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILF 201
             ++APE L + G   +++D+WS GV+L+
Sbjct: 197 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 77
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLHTTCGT 172
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 138 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 193
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILF 201
             ++APE L + G   +++D+WS GV+L+
Sbjct: 194 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 220

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV----R 67
           + G+T+G G F KV  A     G+  A+  +A   +      D+ +  +S +KI+    +
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELF---------DKIVHQGRLLE-NDCRRYFQQ 117
           H NIV L         V +I E+   G+L          D     GR LE  D   +  Q
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NY 175
           +   +A   SK   HRD+   N+LL +    K+ DFGL+  +      ++      P  +
Sbjct: 169 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
           +APE + +  Y    +DVWS G++L+ + + G  P+
Sbjct: 229 MAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY 263

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 18/216 (8%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV----R 67
           + G+T+G G F KV  A     G+  A+  +A   +      D+ +  +S +KI+    +
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 100
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ---------GRLLE-NDCRRYFQQ 117
           H NIV L         V +I E+   G+L + +  +         GR LE  D   +  Q
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NY 175
           +   +A   SK   HRD+   N+LL +    K+ DFGL+  +      ++      P  +
Sbjct: 161 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           +APE + +  Y    +DVWS G++L+ +   G  P+
Sbjct: 221 MAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY 255

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 80
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLHTTCGT 172
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 196
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILF 201
             ++APE L + G   +++D+WS GV+L+
Sbjct: 197 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 2   KKQTRRVAKYEVGRT--IGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQ 55
           + Q R + + E+ R   +G G F  V        GE+V    A+K+L ++T  K  +  +
Sbjct: 6   QAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--E 63
Query: 56  IKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ------GRLLEN 109
              E  IM  + HP++VRL  V  S T + ++ + +  G L +  VH+       +LL N
Sbjct: 64  FMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLE-YVHEHKDNIGSQLLLN 121
Query: 110 DCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 169
            C     Q+   + +   + + HRDL   N+L+ S  ++K++DFGL+ L  +G E  +  
Sbjct: 122 WC----VQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNA 176
Query: 170 CGTP---NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA 205
            G      ++A E +  R +    +DVWS GV ++ LM 
Sbjct: 177 DGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMT 214

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 17  IGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIV 72
           IGEG F +V  A+ ++ G   ++   ++   ++   HR       E+ ++ K+  HPNI+
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 86
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND----------CRRYFQQLIDAV 122
            L      R  +Y+ +E+   G L D  + + R+LE D               QQL+   
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 123 A-------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-N 174
           A       +   K   HR+L   N+L+      K++DFGLS    Q V +  T    P  
Sbjct: 146 ADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 203
Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 222
           ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 204 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 251

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 79
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLHTTCGT 172
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 140 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 195
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILF 201
             ++APE L + G   +++D+WS GV+L+
Sbjct: 196 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 222

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 2   KKQTRRVAKYEVGRT--IGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQ 55
           + Q R + + E+ R   +G G F  V        GE+V    A+K+L ++T  K  +  +
Sbjct: 29  QAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--E 86
Query: 56  IKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ------GRLLEN 109
              E  IM  + HP++VRL  V  S T + ++ + +  G L +  VH+       +LL N
Sbjct: 87  FMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLE-YVHEHKDNIGSQLLLN 144
Query: 110 DCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 169
            C     Q+   + +   + + HRDL   N+L+ S  ++K++DFGL+ L  +G E  +  
Sbjct: 145 WC----VQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNA 199
Query: 170 CGTP---NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA 205
            G      ++A E +  R +    +DVWS GV ++ LM 
Sbjct: 200 DGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMT 237

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 80
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLHTTCGT 172
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 196
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILF 201
             ++APE L + G   +++D+WS GV+L+
Sbjct: 197 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 39/234 (16%)
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQQLI 119
           HPN++R +    +   +YI LE          +V    + + + +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYG-----------NLK--VSDFGLSALPQQGVEL- 165
             VAH HS  + HRDLKP+N+L+ +             NL+  +SDFGL      G    
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 166 ---LHTTCGTPNYVAPEVLSNRGYDGS------AADVWSCG-VILFVLMAGYLPFGET-- 213
              L+   GT  + APE+L       +      + D++S G V  ++L  G  PFG+   
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 214 -DLPTLYKKINAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            +   +    +  E  C    S    AT LI +++D +P  R     + +HP F
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 39/234 (16%)
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQQLI 119
           HPN++R +    +   +YI LE          +V    + + + +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYG-----------NLK--VSDFGLSALPQQGVELL 166
             VAH HS  + HRDLKP+N+L+ +             NL+  +SDFGL      G    
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 167 HTT----CGTPNYVAPEVLSNRGYDGS------AADVWSCG-VILFVLMAGYLPFGET-- 213
            T      GT  + APE+L       +      + D++S G V  ++L  G  PFG+   
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 214 -DLPTLYKKINAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            +   +    +  E  C    S    AT LI +++D +P  R     + +HP F
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 79
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 80  VCRLLGICLTST-VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 198
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 199 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 230

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL---KHRMVDQIKREISIMKIVRHP 69
           +G+ +GEG F  V    N +  +  ++KV  K+  L     R +++   E + MK   HP
Sbjct: 38  LGKILGEGEFGSV-MEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 70  NIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID---- 120
           N++RL  V    +     K  +IL F+  G+L   +++  RL         Q L+     
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMVD 155
Query: 121 ---AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP--NY 175
               + +  ++   HRDL   N +L     + V+DFGLS     G              +
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           +A E L++R Y  S +DVW+ GV ++ +   G  P+
Sbjct: 216 IAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPY 250

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV--RHPNIVR- 73
           +G+G + +V   +    GE+VA+K+ +       R      RE  +   V  RH NI+  
Sbjct: 16  VGKGRYGEV--WRGSWQGENVAVKIFSS------RDEKSWFRETELYNTVMLRHENILGF 67
Query: 74  LHEVLASR---TKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLIDAVAHCH--- 126
           +   + SR   T++++I  +   G L+D +  Q   L+   C R    +   +AH H   
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 127 -----SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HTTCGTPNYVA 177
                   + HRDLK +N+L+   G   ++D GL+ +  Q    L    +   GT  Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 178 PEVLSNR----GYDG-SAADVWSCGVILF 201
           PEVL        +D     D+W+ G++L+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLW 214

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV--RHPNIVR- 73
           +G+G + +V   +    GE+VA+K+ +       R      RE  +   V  RH NI+  
Sbjct: 16  VGKGRYGEV--WRGSWQGENVAVKIFSS------RDEKSWFRETELYNTVMLRHENILGF 67
Query: 74  LHEVLASR---TKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLIDAVAHCH--- 126
           +   + SR   T++++I  +   G L+D +  Q   L+   C R    +   +AH H   
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 127 -----SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HTTCGTPNYVA 177
                   + HRDLK +N+L+   G   ++D GL+ +  Q    L    +   GT  Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 178 PEVLSNR----GYDG-SAADVWSCGVILF 201
           PEVL        +D     D+W+ G++L+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLW 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 81
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 82  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 201 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 232

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 79
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 80  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 198
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 199 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 230

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 78
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 79  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 198 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV--RHPNIVR- 73
           +G+G + +V   +    GE+VA+K+ +       R      RE  +   V  RH NI+  
Sbjct: 45  VGKGRYGEV--WRGSWQGENVAVKIFSS------RDEKSWFRETELYNTVMLRHENILGF 96
Query: 74  LHEVLASR---TKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLIDAVAHCH--- 126
           +   + SR   T++++I  +   G L+D +  Q   L+   C R    +   +AH H   
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 127 -----SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HTTCGTPNYVA 177
                   + HRDLK +N+L+   G   ++D GL+ +  Q    L    +   GT  Y+A
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 178 PEVLSNR----GYDG-SAADVWSCGVILF 201
           PEVL        +D     D+W+ G++L+
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLW 243

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 80
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 81  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 200 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 231

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE     VA+K L ++T  K     +I  E  +M  V +P+
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 82
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 83  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 201
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 202 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 233

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 81
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLHTTCGT 172
           D +A+ ++K   HR+L   N ++     +K+ DFG++          + G  LL      
Sbjct: 142 DGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 197
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILF 201
             ++APE L + G   +++D+WS GV+L+
Sbjct: 198 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 224

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 78
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 79  VCRLLGICLTST-VQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 198 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 80
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLHTTCGT 172
           D +A+ ++K   HR+L   N ++     +K+ DFG++          + G  LL      
Sbjct: 141 DGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 196
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILF 201
             ++APE L + G   +++D+WS GV+L+
Sbjct: 197 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 75
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+ + + +   + 
Sbjct: 76  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRR 134
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 135 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 194
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 195 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 226

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 2/190 (1%)
Query: 37  VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL 96
           VA+K+ +++         + +RE      ++ P++V +H+      ++Y+    + G +L
Sbjct: 62  VALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDL 121
Query: 97  FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL- 155
              +  QG L         +Q+  A+   H+ G  HRD+KPEN+L+ +     + DFG+ 
Sbjct: 122 AAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA 181
Query: 156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL 215
           SA   + +  L  T GT  Y APE  S   +    AD+++   +L+  + G  P+    L
Sbjct: 182 SATTDEKLTQLGNTVGTLYYXAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQL 240
Query: 216 PTLYKKINAA 225
                 IN A
Sbjct: 241 SVXGAHINQA 250

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 103/244 (42%), Gaps = 38/244 (15%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY +GR IG G+F  +    N  +GE VA+K+    T  KH    Q+  E    K+++  
Sbjct: 10  KYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKT--KH---PQLHIESKFYKMMQGG 64
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ---------QLID 120
             +   +   +     +++  + G  L D        L N C R F          Q+I 
Sbjct: 65  VGIPSIKWCGAEGDYNVMVMELLGPSLED--------LFNFCSRKFSLKTVLLLADQMIS 116
Query: 121 AVAHCHSKGVYHRDLKPENLL--LDSYGNL-KVSDFGLSALPQQGVELLH-------TTC 170
            + + HSK   HRD+KP+N L  L   GNL  + DFGL+   +      H          
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 171 GTPNYVAPEVLSNRGYDGSAA-DVWSCGVILFVLMAGYLPFGETDLPT---LYKKINAAE 226
           GT  Y +  + ++ G + S   D+ S G +L     G LP+      T    Y++I+  +
Sbjct: 177 GTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234
Query: 227 FSCP 230
            S P
Sbjct: 235 MSTP 238

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 103
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 104 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 162
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 163 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 222
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 223 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 254

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 88
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 89  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 147
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 148 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 207
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 208 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 239

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 72
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 73  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 192 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 223

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 85
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 86  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 205 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 236

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 78
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 79  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 198 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 80
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 81  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 200 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 231

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 81
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 82  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 201 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 232

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 84
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 85  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 143
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 144 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 203
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 204 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 235

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 81
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 82  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 201 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 232

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 78
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 79  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 198 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 81
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 82  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 201 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 232

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  +
Sbjct: 157 DLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFT-T 215
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 216 KSDVWSFGVLLWELMTRGAPPYPDVN 241

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 159 DLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 217
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 218 KSDVWSFGVLLWELMTRGAPPYPDVN 243

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 13  VGRTIGEGTFAKVRFA-----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +G+T+GEG F KV  A     + R    +VA+K+L K       + D +  E +++K V 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLS-EFNVLKQVN 84
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELF-----DKIVHQGRLLE-------------- 108
           HP++++L+   +    + +I+E+   G L       + V  G L                
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 109 -----NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQG 162
                 D   +  Q+   + +     + HRDL   N+L+     +K+SDFGLS  + ++ 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 163 VELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILF 201
             +  +    P  ++A E L +  Y  + +DVWS GV+L+
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 43/231 (18%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI- 71
           V R +G+GTF +V   Q+ +  +  A+KV+        +     K E  I+K +++ +I 
Sbjct: 39  VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDIN 94
Query: 72  ----VRLHEVLASRTKVYIILEFVTGGELFDKIV---HQGRLLENDCRRYFQQLIDAVAH 124
               V+ H        + +I E + G  L++ I    + G  +E D + Y  +++ A+ +
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE-DIKLYCIEILKALNY 152
Query: 125 CHSKGVYHRDLKPENLLLDS-------------------------YGNLKVSDFGLSALP 159
                + H DLKPEN+LLD                             +K+ DFG +   
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212
Query: 160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
               +   +   T  Y APEV+ N G+D S +D+WS G +L  L  G L F
Sbjct: 213 S---DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLF 259

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 14/203 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G F KV +      G  VA+K L +       +  Q + E+ ++ +  H N++RL  
Sbjct: 46  LGRGGFGKV-YKGRLADGTLVAVKRLKEERXQGGEL--QFQTEVEMISMAVHRNLLRLRG 102
Query: 77  VLASRTKVYIILEFVTGGE----LFDKIVHQGRLLENDCRRYFQQLIDAVA----HCHSK 128
              + T+  ++  ++  G     L ++   Q  L     +R        +A    HC  K
Sbjct: 103 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 162
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ-QGVELLHTTCGTPNYVAPEVLSNRGYD 187
            + HRD+K  N+LLD      V DFGL+ L   +   +     GT  ++APE LS  G  
Sbjct: 163 -IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLST-GKS 220
Query: 188 GSAADVWSCGVILFVLMAGYLPF 210
               DV+  GV+L  L+ G   F
Sbjct: 221 SEKTDVFGYGVMLLELITGQRAF 243

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 216
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 216
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 275
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 276 KSDVWSFGVLLWELMTRGAPPYPDVN 301

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 159 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 217
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 218 KSDVWSFGVLLWELMTRGAPPYPDVN 243

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 155
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 156 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 214
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 215 KSDVWSFGVLLWELMTRGAPPYPDVN 240

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 216
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  +
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-T 216
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 162
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 163 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 221
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 222 KSDVWSFGVLLWELMTRGAPPYPDVN 247

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 9/207 (4%)
Query: 16  TIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
            IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 75  HEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYH 132
             + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   H
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 148
Query: 133 RDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDG 188
           RDL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  
Sbjct: 149 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT- 207
Query: 189 SAADVWSCGVILFVLMA-GYLPFGETD 214
           + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 208 TKSDVWSFGVLLWELMTRGAPPYPDVN 234

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 9/207 (4%)
Query: 16  TIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
            IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 75  HEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYH 132
             + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   H
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 154
Query: 133 RDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDG 188
           RDL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  
Sbjct: 155 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT- 213
Query: 189 SAADVWSCGVILFVLMA-GYLPFGETD 214
           + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 214 TKSDVWSFGVLLWELMTRGAPPYPDVN 240

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 51/236 (21%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES-VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           +YE+   +GEGTF KV    +   G+S VA+K++    + K+R  +  + EI+++K ++ 
Sbjct: 20  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYR--EAARLEINVLKKIKE 75
Query: 69  PN------IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY-------- 114
            +       V + +       + I  E + G   F+       L EN+ + Y        
Sbjct: 76  KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE------FLKENNFQPYPLPHVRHM 128
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLL-----------------DSYGN--LKVSDFGL 155
             QL  A+   H   + H DLKPEN+L                   S  N  ++V+DFG 
Sbjct: 129 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 156 SALPQQGVELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           +    +     HTT   T +Y  PEV+   G+     DVWS G ILF    G+  F
Sbjct: 189 ATFDHEH----HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLF 239

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  +
Sbjct: 157 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-T 215
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 216 KSDVWSFGVLLWELMTRGAPPYPDVN 241

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 51/236 (21%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES-VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           +YE+   +GEGTF KV    +   G+S VA+K++    + K+R  +  + EI+++K ++ 
Sbjct: 29  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYR--EAARLEINVLKKIKE 84
Query: 69  PN------IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY-------- 114
            +       V + +       + I  E + G   F+       L EN+ + Y        
Sbjct: 85  KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE------FLKENNFQPYPLPHVRHM 137
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLL-----------------DSYGN--LKVSDFGL 155
             QL  A+   H   + H DLKPEN+L                   S  N  ++V+DFG 
Sbjct: 138 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 197
Query: 156 SALPQQGVELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           +    +     HTT   T +Y  PEV+   G+     DVWS G ILF    G+  F
Sbjct: 198 ATFDHEH----HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLF 248

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 51/236 (21%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES-VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           +YE+   +GEGTF KV    +   G+S VA+K++    + K+R  +  + EI+++K ++ 
Sbjct: 52  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYR--EAARLEINVLKKIKE 107
Query: 69  PN------IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY-------- 114
            +       V + +       + I  E + G   F+       L EN+ + Y        
Sbjct: 108 KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE------FLKENNFQPYPLPHVRHM 160
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLL-----------------DSYGN--LKVSDFGL 155
             QL  A+   H   + H DLKPEN+L                   S  N  ++V+DFG 
Sbjct: 161 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 220
Query: 156 SALPQQGVELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           +    +     HTT   T +Y  PEV+   G+     DVWS G ILF    G+  F
Sbjct: 221 ATFDHEH----HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLF 271

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 9/207 (4%)
Query: 16  TIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
            IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 75  HEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYH 132
             + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   H
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 153
Query: 133 RDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDG 188
           RDL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  
Sbjct: 154 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT- 212
Query: 189 SAADVWSCGVILFVLMA-GYLPFGETD 214
           + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVN 239

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 9/207 (4%)
Query: 16  TIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
            IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 75  HEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYH 132
             + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   H
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 151
Query: 133 RDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDG 188
           RDL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  
Sbjct: 152 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT- 210
Query: 189 SAADVWSCGVILFVLMA-GYLPFGETD 214
           + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 211 TKSDVWSFGVLLWELMTRGAPPYPDVN 237

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 13  VGRTIGEGTFAKVRFA-----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +G+T+GEG F KV  A     + R    +VA+K+L K       + D +  E +++K V 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLS-EFNVLKQVN 84
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELF-----DKIVHQGRLLE-------------- 108
           HP++++L+   +    + +I+E+   G L       + V  G L                
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 109 -----NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQG 162
                 D   +  Q+   + +     + HRDL   N+L+     +K+SDFGLS  + ++ 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 163 VELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILF 201
             +  +    P  ++A E L +  Y  + +DVWS GV+L+
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   HR
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 176
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  +
Sbjct: 177 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-T 235
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 236 KSDVWSFGVLLWELMTRGAPPYPDVN 261

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   HR
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 175
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  +
Sbjct: 176 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-T 234
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 235 KSDVWSFGVLLWELMTRGAPPYPDVN 260

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  +
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-T 216
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 11  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 68
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 69  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 128
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 129 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 188
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 189 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 216

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 20  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 77
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 78  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 137
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 138 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 197
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 198 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 225

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 13  VGRTIGEGTFAKVRFA-----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +G+T+GEG F KV  A     + R    +VA+K+L K       + D +  E +++K V 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLS-EFNVLKQVN 84
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELF-----DKIVHQGRLLE-------------- 108
           HP++++L+   +    + +I+E+   G L       + V  G L                
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 109 -----NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV 163
                 D   +  Q+   + +     + HRDL   N+L+     +K+SDFGLS    +  
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 164 ELLHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
             +  + G     ++A E L +  Y  + +DVWS GV+L+
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +  G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 85
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 86  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 205 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 236

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 80
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 81  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFG + L     +  H   G  P  ++A E + +R Y 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 200 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 231

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 82
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 83  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFG + L     +  H   G  P  ++A E + +R Y 
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 201
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 202 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 233

>pdb|2ZFD|B Chain B, The Crystal Structure Of Plant Specific Calcium Binding Protein Atcbl2 In Complex With The Regulatory Domain Of Atcipk14 Length = 123

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 306 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 365
           G   MNAF++I+ S G NL+ LF   + Y  R  RFVS   A+ ++  +E +  + +L V
Sbjct: 2   GARRMNAFDIISGSPGFNLSGLFGDARKY-DRVERFVSAWTAERVVERLEEIVSAENLTV 60
Query: 366 HTR-NYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRK 405
             +  +  ++EG    + G FA+V+E+ ++   L M++VRK
Sbjct: 61  AKKETWGMKIEG----QKGNFAMVVEINQLTDELVMIEVRK 97

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 80
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 81  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFG + L     +  H   G  P  ++A E + +R Y 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 200 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 231

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 17  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 74
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 75  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 134
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 135 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 195 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 222

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 6   RRVAK-YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           R +AK  ++ + IG+G + +V   + R  GE VA+KV   +         +I + +    
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTV---- 86
Query: 65  IVRHPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           ++RH NI+           S T++Y+I ++   G L+D +     L      +     + 
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVS 145
Query: 121 AVAHCHSK--------GVYHRDLKPENLLLDSYGNLKVSDFGLSA---LPQQGVEL-LHT 168
            + H H++         + HRDLK +N+L+   G   ++D GL+         V++  +T
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 169 TCGTPNYVAPEVLS---NRGYDGS--AADVWSCGVILF 201
             GT  Y+ PEVL    NR +  S   AD++S G+IL+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKV----LAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V + V    L ++T  K     +I  E  +M  V +P+
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKAN--KEILDEAYVMASVDNPH 112
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 113 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 171
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 172 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 231
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 232 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 263

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 13  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 70
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 71  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 130
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 131 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 191 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 218

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 19  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 76
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 77  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 136
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 137 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 197 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 224

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 102/244 (41%), Gaps = 38/244 (15%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +GR IG G+F  +    +   GE VA+K+    T  KH    Q+  E  I K+++  
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KH---PQLHIESKIYKMMQGG 64
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ---------QLID 120
             +       +     +++  + G  L D        L N C R F          Q+I 
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELLGPSLED--------LFNFCSRKFSLKTVLLLADQMIS 116
Query: 121 AVAHCHSKGVYHRDLKPENLL--LDSYGNL-KVSDFGLSALPQQGVELLH-------TTC 170
            + + HSK   HRD+KP+N L  L   GNL  + DFGL+   +      H          
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 171 GTPNYVAPEVLSNRGYDGSAA-DVWSCGVILFVLMAGYLPFGETDLPT---LYKKINAAE 226
           GT  Y +  + ++ G + S   D+ S G +L     G LP+      T    Y++I+  +
Sbjct: 177 GTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234
Query: 227 FSCP 230
            S P
Sbjct: 235 MSTP 238

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 102/244 (41%), Gaps = 38/244 (15%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +GR IG G+F  +    +   GE VA+K+    T  KH    Q+  E  I K+++  
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KH---PQLHIESKIYKMMQGG 62
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ---------QLID 120
             +       +     +++  + G  L D        L N C R F          Q+I 
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLED--------LFNFCSRKFSLKTVLLLADQMIS 114
Query: 121 AVAHCHSKGVYHRDLKPENLL--LDSYGNL-KVSDFGLSALPQQGVELLH-------TTC 170
            + + HSK   HRD+KP+N L  L   GNL  + DFGL+   +      H          
Sbjct: 115 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 171 GTPNYVAPEVLSNRGYDGSAA-DVWSCGVILFVLMAGYLPFGETDLPT---LYKKINAAE 226
           GT  Y +  + ++ G + S   D+ S G +L     G LP+      T    Y++I+  +
Sbjct: 175 GTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232
Query: 227 FSCP 230
            S P
Sbjct: 233 MSTP 236

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 26  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 83
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 84  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 143
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 204 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 231

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 19  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 76
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 77  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 136
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 137 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 197 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 224

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 24/222 (10%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV----R 67
           + G+T+G G F KV  A     G+  A+  +A   +      D+ +  +S +KI+    +
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRLLENDC 111
           H NIV L         V +I E+   G+L + +                  + +L   D 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 112 RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC 170
             +  Q+   +A   SK   HRD+   N+LL +    K+ DFGL+  +      ++    
Sbjct: 169 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 228
Query: 171 GTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
             P  ++APE + +  Y    +DVWS G++L+ + + G  P+
Sbjct: 229 RLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY 269
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	443
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	0.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-171
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-169
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-167
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-167
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-166
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-165
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-165
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-165
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-165
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-163
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-159
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-157
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-156
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-154
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-150
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-145
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-144
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-141
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-112
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-110
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-109
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-108
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-107
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-106
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-106
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-106
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-105
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-105
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-105
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-104
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-103
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-103
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-102
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-101
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-101
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-101
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-100
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-99
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-99
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-99
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-99
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-99
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-98
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-97
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-96
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-96
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-96
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-94
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-93
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-92
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-92
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-92
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-88
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-87
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-85
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-83
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-83
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-83
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-82
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-82
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-81
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-80
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-79
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-77
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-77
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-77
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-77
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-76
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-75
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-74
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-73
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-73
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-73
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-73
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-72
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-72
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-72
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-71
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-71
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-71
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-71
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-71
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-71
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-70
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-69
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-68
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-67
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-66
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-66
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-58
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-55
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-54
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-54
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-53
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-53
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-53
2ehb_D	143	CBL-interacting serine/threonine-protein kinase 2;	2e-52
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-51
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-50
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-50
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-49
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-49
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-49
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-49
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-49
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-48
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-47
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-46
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-46
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-45
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-44
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-44
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-44
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-43
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-42
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-41
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-41
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-41
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-41
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-40
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-40
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-40
2zfd_B	123	Putative uncharacterized protein T20L15_90; calciu	7e-40
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-39
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-38
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-38
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-38
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-38
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-37
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-37
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-37
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-37
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-37
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-37
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-37
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-37
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-36
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-36
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-36
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-35
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-35
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-35
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-35
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-35
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-34
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-34
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-34
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-33
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-33
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-33
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-32
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-31
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-29
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-29
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-28
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-28
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-27
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-27
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-26
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-25
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-25
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-25
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-24
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-23
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-23
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-22
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-20
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-19
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-17
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-17
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-17
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	3e-05
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	7e-05

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  519 bits (1339), Expect = 0.0
 Identities = 140/469 (29%), Positives = 232/469 (49%), Gaps = 59/469 (12%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
                ++  Y +G T+G GTF KV+  ++  TG  VA+K+L +  I    +V +I+REI 
Sbjct: 9   HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
            +K+ RHP+I++L++V+++ + +++++E+V+GGELFD I   GRL E + RR FQQ++  
Sbjct: 69  NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           V +CH   V HRDLKPEN+LLD++ N K++DFGLS +   G E L T+CG+PNY APEV+
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVI 187

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           S R Y G   D+WS GVIL+ L+ G LPF +  +PTL+KKI    F  P + +    SL+
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLL 247

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVN--------LDDVHAVFDDIED 293
             +L  +P  R  I+ IR+H WF+++       E+   +        L +V   F+  E+
Sbjct: 248 KHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEE 307

Query: 294 QYVAEQSENKVGGPLLMNAFEMI------------------------------------- 316
           + V     N+     L  A+ +I                                     
Sbjct: 308 E-VLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERV 366

Query: 317 --------TLSQGLNLAALFDRRQDYVKRQTRFV---SRQPAQVILSNIEAVAESLSLKV 365
                        L+       +   V++    +   S+     I++ +    + L  + 
Sbjct: 367 PFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEW 426

Query: 366 HTRN-YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEY 413
              N Y  R+   +   +    + L++++V    +++D R    + LE 
Sbjct: 427 KVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  479 bits (1234), Expect = e-171
 Identities = 119/274 (43%), Positives = 179/274 (65%), Gaps = 1/274 (0%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
                ++  Y +G T+G GTF KV+  +++ TG  VA+K+L +  I    +V +IKREI 
Sbjct: 4   HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
            +K+ RHP+I++L++V+++ T  ++++E+V+GGELFD I   GR+ E + RR FQQ++ A
Sbjct: 64  NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           V +CH   V HRDLKPEN+LLD++ N K++DFGLS +   G E L T+CG+PNY APEV+
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVI 182

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           S R Y G   D+WSCGVIL+ L+ G LPF +  +PTL+KKI    F  P + +    +L+
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
             +L  +P  R  I+ IR+H WF+++       E
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE 276

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  472 bits (1218), Expect = e-167
 Identities = 121/293 (41%), Positives = 193/293 (65%), Gaps = 3/293 (1%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M    R +  Y +  T+GEG+F KV+ A + +T + VA+K +++  + K  M  +++REI
Sbjct: 1   MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           S +K++RHP+I++L++V+ + T + +++E+  GGELFD IV + R+ E++ RR+FQQ+I 
Sbjct: 61  SYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC 119

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+ +CH   + HRDLKPENLLLD   N+K++DFGLS +   G   L T+CG+PNY APEV
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEV 178

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           ++ + Y G   DVWSCG++L+V++ G LPF +  +P L+KK+N+  +  P + S GA SL
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSL 238

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNY-NPVKCSEEEEVNLDDVHAVFDDIE 292
           I +++  +P  RI I+ IR+ PWF  N  + ++  EE + +  D   V    E
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGE 291

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  468 bits (1208), Expect = e-167
 Identities = 101/269 (37%), Positives = 151/269 (56%), Gaps = 7/269 (2%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
              V  +++ +T+GEG + +V+ A NR T E+VA+K++     +     + IK+EI I K
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINK 60

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+   +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKNY 268
           L+HKIL  NP  RI I  I+K  W+ K  
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  468 bits (1206), Expect = e-166
 Identities = 90/268 (33%), Positives = 135/268 (50%), Gaps = 1/268 (0%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
            R   +Y  GR +G+G FAK     + +T E  A K++ KS +LK    +++  EISI +
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + H ++V  H        V+++LE      L +    +  L E + R Y +Q++    +
Sbjct: 71  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            H   V HRDLK  NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS +
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
           G+     DVWS G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+
Sbjct: 191 GHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 249

Query: 245 LDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
           L  +P  R  I  +    +F   Y P +
Sbjct: 250 LQTDPTARPTINELLNDEFFTSGYIPAR 277

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  467 bits (1205), Expect = e-165
 Identities = 103/292 (35%), Positives = 156/292 (53%), Gaps = 8/292 (2%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
              V  +++ +T+GEG + +V+ A NR T E+VA+K++     +     + IK+EI I K
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINK 60

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+   +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKNYNP-VKCSEEEEVNLDDVHAVFDD 290
           L+HKIL  NP  RI I  I+K  W+ K      K        + +  + F  
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSK 292

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  467 bits (1205), Expect = e-165
 Identities = 90/270 (33%), Positives = 135/270 (50%), Gaps = 1/270 (0%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
              R   +Y  GR +G+G FAK     + +T E  A K++ KS +LK    +++  EISI
Sbjct: 35  VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 94

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
            + + H ++V  H        V+++LE      L +    +  L E + R Y +Q++   
Sbjct: 95  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 154

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + H   V HRDLK  NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
            +G+     DVWS G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI 
Sbjct: 215 KKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
           K+L  +P  R  I  +    +F   Y P +
Sbjct: 274 KMLQTDPTARPTINELLNDEFFTSGYIPAR 303

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  468 bits (1207), Expect = e-165
 Identities = 113/347 (32%), Positives = 171/347 (49%), Gaps = 19/347 (5%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
               +Y+  + IG G F   R  +++ T E VA+K + +       + + ++REI   + 
Sbjct: 17  HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRS 72

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           +RHPNIVR  EV+ + T + II+E+ +GGEL+++I + GR  E++ R +FQQL+  V++C
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132

Query: 126 HSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           HS  + HRDLK EN LLD      LK+ DFG S           +T GTP Y+APEVL  
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLR 191

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCP--FWFSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  Y+K    I + ++S P     S   
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC 251

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP-VKCSEEEEVNLDDVHAVFDDIEDQYV 296
             LI +I   +P TRI I  I+ H WF KN    +           +       ++    
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQ 311

Query: 297 AEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVS 343
                     P + N      ++  L+L    D      + +    S
Sbjct: 312 IISEATI---PAVRNRCLDDFMTDNLDLDDDMDDFDS--ESEIDIDS 353

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  465 bits (1200), Expect = e-165
 Identities = 88/305 (28%), Positives = 155/305 (50%), Gaps = 14/305 (4%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD-QIKREISIMK 64
           + + KY +G  +GEG++ KV+   + ET    A+K+L K  + +    +  +K+EI +++
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61

Query: 65  IVRHPNIVRLHEVL--ASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 120
            +RH N+++L +VL    + K+Y+++E+   G  E+ D +    R        YF QLID
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAP 178
            + + HS+G+ H+D+KP NLLL + G LK+S  G++         +   T+ G+P +  P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 179 EVLSN-RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGA 237
           E+ +    + G   D+WS GV L+ +  G  PF   ++  L++ I    ++ P       
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVH-----AVFDDIE 292
           + L+  +L+  P  R  I  IR+H WFRK + P +       + D         V   +E
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLE 300

Query: 293 DQYVA 297
           D + A
Sbjct: 301 DLHGA 305

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  460 bits (1185), Expect = e-163
 Identities = 87/271 (32%), Positives = 150/271 (55%), Gaps = 2/271 (0%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
            ++  ++VG  +G+G+FA V  A++  TG  VA+K++ K  + K  MV +++ E+ I   
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAH 124
           ++HP+I+ L+        VY++LE    GE+   + ++ +   EN+ R +  Q+I  + +
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ HRDL   NLLL    N+K++DFGL+   +   E  +T CGTPNY++PE+ +  
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
            + G  +DVWS G + + L+ G  PF    +     K+  A++  P + S  A  LIH++
Sbjct: 188 AH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246

Query: 245 LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
           L  NP  R+ +  +  HP+  +N +     E
Sbjct: 247 LRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  450 bits (1159), Expect = e-159
 Identities = 91/272 (33%), Positives = 152/272 (55%), Gaps = 3/272 (1%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M K+   +  +++GR +G+G F  V  A+ ++    +A+KVL KS + K  +  Q++REI
Sbjct: 6   MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I   +RHPNI+R++     R ++Y++LEF   GEL+ ++   GR  E     + ++L D
Sbjct: 66  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD 125

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+ +CH + V HRD+KPENLL+   G LK++DFG S           T CGT +Y+ PE+
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEM 183

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  + +D    D+W  GV+ +  + G  PF        +++I   +   P + S G+  L
Sbjct: 184 IEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
           I K+L  +P  R+ ++G+ +HPW + N   V 
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  443 bits (1143), Expect = e-157
 Identities = 98/280 (35%), Positives = 157/280 (56%), Gaps = 4/280 (1%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S             CGT +Y+ PE++
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMI 179

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 180 EGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  442 bits (1140), Expect = e-156
 Identities = 91/294 (30%), Positives = 151/294 (51%), Gaps = 30/294 (10%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---------- 51
                ++ +Y +   IG+G++  V+ A N       AMKVL+K  +++            
Sbjct: 6   SGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRG 65

Query: 52  -------------MVDQIKREISIMKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGEL 96
                         ++Q+ +EI+I+K + HPN+V+L EVL   +   +Y++ E V  G +
Sbjct: 66  TRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV 125

Query: 97  FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS 156
            + +     L E+  R YFQ LI  + + H + + HRD+KP NLL+   G++K++DFG+S
Sbjct: 126 ME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 157 ALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
              +    LL  T GTP ++APE LS   + + G A DVW+ GV L+  + G  PF +  
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

Query: 215 LPTLYKKINAAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
           +  L+ KI +     P     +     LI ++LD NP++RI +  I+ HPW  +
Sbjct: 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  438 bits (1129), Expect = e-154
 Identities = 112/291 (38%), Positives = 169/291 (58%), Gaps = 2/291 (0%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
              +   +  Y + +TIG+G FAKV+ A++  TG  VA+K++ K+ +     + ++ RE+
Sbjct: 7   CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREV 65

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            IMKI+ HPNIV+L EV+ +   +Y+I+E+ +GGE+FD +V  GR+ E + R  F+Q++ 
Sbjct: 66  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AV +CH K + HRDLK ENLLLD+  N+K++DFG S     G   L   CG P Y APE+
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPEL 184

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
              + YDG   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDI 291
           + + L  NP  R  +E I K  W    +   +     E  LD       DI
Sbjct: 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDI 295

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  429 bits (1104), Expect = e-150
 Identities = 84/308 (27%), Positives = 146/308 (47%), Gaps = 13/308 (4%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD-----QIK 57
            +     KY     +G G F  V  A ++E  + V +K + K  +L+   ++     ++ 
Sbjct: 18  CEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77

Query: 58  REISIMKIVRHPNIVRLHEVLASRTKVYIILEF-VTGGELFDKIVHQGRLLENDCRRYFQ 116
            EI+I+  V H NI+++ ++  ++    +++E   +G +LF  I    RL E      F+
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           QL+ AV +   K + HRD+K EN+++     +K+ DFG +A  ++G +L +T CGT  Y 
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYC 196

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTG 236
           APEVL    Y G   ++WS GV L+ L+    PF E       ++   A    P+  S  
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKE 250

Query: 237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYV 296
             SL+  +L P P+ R  +E +   PW  +  N    + EE   ++   +         +
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEM 310

Query: 297 AEQSENKV 304
             +S + V
Sbjct: 311 GNRSLSDV 318

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  416 bits (1071), Expect = e-145
 Identities = 85/286 (29%), Positives = 135/286 (47%), Gaps = 17/286 (5%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ---IKR 58
           K +    A+Y +G  +G+G F  V           VA+KV+ ++ +L    +        
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83

Query: 59  EISIMKIVR----HPNIVRLHEVLASRTKVYIILEF-VTGGELFDKIVHQGRLLENDCRR 113
           E++++  V     HP ++RL +   ++    ++LE  +   +LFD I  +G L E   R 
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143

Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGT 172
           +F Q++ A+ HCHS+GV HRD+K EN+L+D   G  K+ DFG  AL            GT
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGT 201

Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW 232
             Y  PE +S   Y    A VWS G++L+ ++ G +PF         ++I  AE   P  
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPAH 255

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEE 278
            S    +LI + L P P +R  +E I   PW +     V  +  + 
Sbjct: 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKG 301

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  412 bits (1061), Expect = e-144
 Identities = 85/289 (29%), Positives = 133/289 (46%), Gaps = 15/289 (5%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKR 58
           K++    ++Y+VG  +G G F  V           VA+K + K  I     +    ++  
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95

Query: 59  EISIMKIVRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYF 115
           E+ ++K V      ++RL +         +ILE      +LFD I  +G L E   R +F
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPN 174
            Q+++AV HCH+ GV HRD+K EN+L+D   G LK+ DFG  AL +    +     GT  
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRV 213

Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFS 234
           Y  PE +    Y G +A VWS G++L+ ++ G +PF         ++I   +       S
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVS 267

Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDD 283
           +    LI   L   P  R   E I+ HPW +    P + +E    +L  
Sbjct: 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  406 bits (1044), Expect = e-141
 Identities = 71/323 (21%), Positives = 130/323 (40%), Gaps = 48/323 (14%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR--------- 51
           +K++ + +  Y + RT+ +G F K+      +  +  A+K   KS + K R         
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDK 80

Query: 52  -----MVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL 106
                  D  K E+ I+  +++   +    ++ +  +VYII E++    +     +   L
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140

Query: 107 L--------ENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSA 157
                        +   + ++++ ++ H+ K + HRD+KP N+L+D  G +K+SDFG S 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200

Query: 158 LPQQGVELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPF-GETDL 215
                   +  + GT  ++ PE  SN   Y+G+  D+WS G+ L+V+    +PF  +  L
Sbjct: 201 YMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258

Query: 216 PTLYKKINAAEFSCPF-------------------WFSTGATSLIHKILDPNPKTRIRIE 256
             L+  I       P                    + S      +   L  NP  RI  E
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318

Query: 257 GIRKHPWFRKNYNPVKCSEEEEV 279
              KH W             +E+
Sbjct: 319 DALKHEWLADTNIEDLREFSKEL 341

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  332 bits (854), Expect = e-112
 Identities = 100/273 (36%), Positives = 149/273 (54%), Gaps = 17/273 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+K+++K         +      ++ EI I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 71  KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129

Query: 125 CHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL 188

Query: 182 SNRGYD--GSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWF--S 234
            + G      A D WS GVILF+ ++GY PF       +L  +I +    F    W   S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248

Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             A  L+ K+L  +PK R   E   +HPW +  
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  326 bits (838), Expect = e-110
 Identities = 67/295 (22%), Positives = 128/295 (43%), Gaps = 38/295 (12%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R  + +E    +G+G F +V  A+N       A+K +  +       +  I  E+ ++  
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLAS 58

Query: 66  VRHPNIVRLHEV-------------LASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDC 111
           + H  +VR +               +  ++ ++I +E+   G L+D I  +      ++ 
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 112 RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-------- 163
            R F+Q+++A+++ HS+G+ HRDLKP N+ +D   N+K+ DFGL+    + +        
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 164 ------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT 217
                 + L +  GT  YVA EVL   G+     D++S G+I F ++  Y      +   
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVN 236

Query: 218 LYKKINAAEFSCPFWF----STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY 268
           + KK+ +     P  F          +I  ++D +P  R     +    W    +
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  323 bits (831), Expect = e-109
 Identities = 102/265 (38%), Positives = 150/265 (56%), Gaps = 10/265 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y+V   +G+G F+ VR   ++ TG   A K++     L  R   +++RE  I + ++HP
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 65

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++A+CHS G
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125

Query: 130 VYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HR+LKPENLLL S      +K++DFGL+       E  H   GTP Y++PEVL    Y
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPY 184

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIH 242
                D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   +  A SLI 
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKN 267
            +L  NPK RI  +   K PW    
Sbjct: 244 SMLTVNPKKRITADQALKVPWICNR 268

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  320 bits (822), Expect = e-108
 Identities = 105/267 (39%), Positives = 149/267 (55%), Gaps = 15/267 (5%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
             Y +  TIG G++ +V+ A  + T    A K + K  +     VD+ K+EI IMK + H
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           PNI+RL+E     T +Y+++E  TGGELF+++VH+    E+D  R  + ++ AVA+CH  
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 129 GVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
            V HRDLKPEN L  +      LK+ DFGL+A  + G +++ T  GTP YV+P+VL    
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVL-EGL 183

Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATSL 240
           Y G   D WS GV+++VL+ GY PF   TD   +  KI      F    W   S  A SL
Sbjct: 184 Y-GPECDEWSAGVMMYVLLCGYPPFSAPTD-SEVMLKIREGTFTFPEKDWLNVSPQAESL 241

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKN 267
           I ++L  +PK RI      +H WF K 
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQ 268

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  323 bits (831), Expect = e-107
 Identities = 100/274 (36%), Positives = 150/274 (54%), Gaps = 19/274 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+++++K         +      ++ EI I+K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 125 CHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL 313

Query: 182 SN---RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWF-- 233
            +    GY   A D WS GVILF+ ++GY PF       +L  +I +    F    W   
Sbjct: 314 VSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372

Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           S  A  L+ K+L  +PK R   E   +HPW +  
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  318 bits (818), Expect = e-106
 Identities = 103/288 (35%), Positives = 154/288 (53%), Gaps = 13/288 (4%)

Query: 1   MKKQTRRV-AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
           M   + +    Y+V   +G+G F+ VR   ++ TG   A K++     L  R   +++RE
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLERE 78

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
             I + ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ++
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL 138

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           +++A+CHS G+ HR+LKPENLLL S      +K++DFGL+       E  H   GTP Y+
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYL 197

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW- 232
           +PEVL    Y     D+W+CGVIL++L+ GY PF  E     LY +I A   ++  P W 
Sbjct: 198 SPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWD 255

Query: 233 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
             +  A SLI  +L  NPK RI  +   K PW             ++ 
Sbjct: 256 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDT 303

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  315 bits (809), Expect = e-106
 Identities = 83/276 (30%), Positives = 140/276 (50%), Gaps = 21/276 (7%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD------QIKREISIM 63
            YE    +G G  + VR   ++ T +  A+K++  +        +         +E+ I+
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77

Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           + V  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ +
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL- 181
              H   + HRDLKPEN+LLD   N+K++DFG S     G E L   CGTP+Y+APE++ 
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIE 196

Query: 182 -----SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW- 232
                ++ GY G   D+WS GVI++ L+AG  PF        + + I +   +F  P W 
Sbjct: 197 CSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQ-MLMLRMIMSGNYQFGSPEWD 254

Query: 233 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
            +S     L+ + L   P+ R   E    HP+F++ 
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  317 bits (814), Expect = e-106
 Identities = 91/275 (33%), Positives = 147/275 (53%), Gaps = 20/275 (7%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-----LKHRMVDQIKREISIM 63
            KY+    IG G  + VR   +R TG   A+K++  +           + +  +RE  I+
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 64  K-IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           + +  HP+I+ L +   S + ++++ + +  GELFD +  +  L E + R   + L++AV
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL- 181
           +  H+  + HRDLKPEN+LLD    +++SDFG S   + G E L   CGTP Y+APE+L 
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILK 272

Query: 182 -----SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW- 232
                ++ GY G   D+W+CGVILF L+AG  PF        + + I     +FS P W 
Sbjct: 273 CSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQ-ILMLRMIMEGQYQFSSPEWD 330

Query: 233 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
             S+    LI ++L  +P+ R+  E   +HP+F +
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  314 bits (806), Expect = e-105
 Identities = 102/277 (36%), Positives = 151/277 (54%), Gaps = 13/277 (4%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T     +     +G G F++V   + R TG+  A+K + KS   +      ++ EI++
Sbjct: 3   QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAV 59

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           +K ++H NIV L ++  S T  Y++++ V+GGELFD+I+ +G   E D     QQ++ AV
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119

Query: 123 AHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
            + H  G+ HRDLKPENLL  +      + ++DFGLS + Q G+  + T CGTP YVAPE
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPE 177

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FST 235
           VL+ + Y   A D WS GVI ++L+ GY PF E     L++KI     EF  PFW   S 
Sbjct: 178 VLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236

Query: 236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
            A   I  +L+ +P  R   E    HPW   N    +
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHR 273

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  312 bits (801), Expect = e-105
 Identities = 81/268 (30%), Positives = 135/268 (50%), Gaps = 17/268 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +   R +G G F  V   + R +G    +K + K        ++QI+ EI ++K + HP
Sbjct: 23  LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHP 80

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHC 125
           NI+++ EV      +YI++E   GGEL ++IV        L E       +Q+++A+A+ 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 126 HSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           HS+ V H+DLKPEN+L      +  +K+ DFGL+ L +   E      GT  Y+APEV  
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVF- 198

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAE--FSCPFWF-STGAT 238
            R       D+WS GV+++ L+ G LPF G +    + +K    E  ++      +  A 
Sbjct: 199 KRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSL-EEVQQKATYKEPNYAVECRPLTPQAV 256

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRK 266
            L+ ++L  +P+ R     +  H WF++
Sbjct: 257 DLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  312 bits (801), Expect = e-105
 Identities = 98/266 (36%), Positives = 151/266 (56%), Gaps = 13/266 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +   +G+G+F +V   ++R T +  A+KV+ K++  K++    I RE+ ++K + HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   + + H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 130 VYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPEN+LL+S     ++K+ DFGLS   QQ    +    GT  Y+APEVL    Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVL-RGTY 199

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATSLI 241
                DVWS GVIL++L++G  PF G+ +   + K++      F  P W   S  A  LI
Sbjct: 200 -DEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKYAFDLPQWRTISDDAKDLI 257

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKN 267
            K+L  +P  RI      +HPW +K 
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQKY 283

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  315 bits (808), Expect = e-104
 Identities = 104/277 (37%), Positives = 152/277 (54%), Gaps = 9/277 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++   +G+G F+ VR       G+  A  ++     L  R   +++RE  I ++++HP
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK-LSARDHQKLEREARICRLLKHP 70

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVRLH+ ++     Y+I + VTGGELF+ IV +    E D     QQ+++AV HCH  G
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 130 VYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           V HR+LKPENLLL S      +K++DFGL+   +   +      GTP Y++PEVL    Y
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIH 242
            G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  A  LI+
Sbjct: 191 -GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
           K+L  NP  RI      KHPW         C   +E 
Sbjct: 250 KMLTINPSKRITAAEALKHPWISHRSTVASCMHRQET 286

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  308 bits (790), Expect = e-103
 Identities = 64/317 (20%), Positives = 117/317 (36%), Gaps = 48/317 (15%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M  Q+     + +   +G+G  A V   ++++TG+  A+KV    + L+   VD   RE 
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREF 58

Query: 61  SIMKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR---LLENDCRRYF 115
            ++K + H NIV+L  +    T     +I+EF   G L+  +        L E++     
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCG 171
           + ++  + H    G+ HR++KP N++     D     K++DFG +   +   E   +  G
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYG 177

Query: 172 TPNYVAPEVLSNRGYD-------GSAADVWSCGVILFVLMAGYLPF-----GETDLPTLY 219
           T  Y+ P++              G+  D+WS GV  +    G LPF        +   +Y
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

Query: 220 KKINAA------------------EFSCPFW------FSTGATSLIHKILDPNPKTRIRI 255
           K I                         P             T ++  IL+ + +     
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 256 EGIRKHPWFRKNYNPVK 272
           +          +     
Sbjct: 298 DQFFAETSDILHRGNSH 314

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  307 bits (789), Expect = e-103
 Identities = 68/280 (24%), Positives = 126/280 (45%), Gaps = 21/280 (7%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y + + IG G  +KV    N E  +  A+K +       ++ +D  + EI+ +  ++  
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 86

Query: 70  N--IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +  I+RL++   +   +Y+++E     +L   +  +  +   + + Y++ +++AV   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRG 185
            G+ H DLKP N L+   G LK+ DFG++   Q      +  +  GT NY+ PE + +  
Sbjct: 146 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 186 YD----------GSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINA-AEFSCPFW 232
                          +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
                  ++   L  +PK RI I  +  HP+ +   +PV 
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  307 bits (788), Expect = e-102
 Identities = 94/266 (35%), Positives = 147/266 (55%), Gaps = 15/266 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +EV   +G G  + V   + + T +  A+KV     + K      ++ EI ++  + HP
Sbjct: 54  FFEVESELGRGATSIVYRCKQKGTQKPYALKV-----LKKTVDKKIVRTEIGVLLRLSHP 108

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L E+  + T++ ++LE VTGGELFD+IV +G   E D     +Q+++AVA+ H  G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168

Query: 130 VYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLL  +      LK++DFGLS + +    L+ T CGTP Y APE+L    Y
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAY 227

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATSLI 241
            G   D+WS G+I ++L+ G+ PF  E     ++++I      F  P+W   S  A  L+
Sbjct: 228 -GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKN 267
            K++  +PK R+      +HPW    
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPWVTGK 312

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  306 bits (785), Expect = e-101
 Identities = 89/271 (32%), Positives = 144/271 (53%), Gaps = 15/271 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ--IKREISIMKIVR 67
            YE+   IG+G F+ VR   NRETG+  A+K++  +       +    +KRE SI  +++
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL----ENDCRRYFQQLIDAVA 123
           HP+IV L E  +S   +Y++ EF+ G +L  +IV +        E     Y +Q+++A+ 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 124 HCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           +CH   + HRD+KP  +LL S  N   +K+  FG++    +   +     GTP+++APEV
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTG 236
           +    Y G   DVW CGVILF+L++G LPF  T    L++ I     + +   W   S  
Sbjct: 205 VKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISES 262

Query: 237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           A  L+ ++L  +P  RI +     HPW ++ 
Sbjct: 263 AKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  303 bits (778), Expect = e-101
 Identities = 94/270 (34%), Positives = 153/270 (56%), Gaps = 15/270 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKREISIMKIV 66
            YE+G  +G G FA VR  + + TG+  A K + K  +   R     ++I+RE++I++ +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           RHPNI+ LH++  ++T V +ILE V+GGELFD +  +  L E++  ++ +Q++D V + H
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125

Query: 127 SKGVYHRDLKPENLLLDSY----GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           SK + H DLKPEN++L         +K+ DFG++   + G        GTP +VAPE+++
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIVN 184

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGA 237
                G  AD+WS GVI ++L++G  PF GET        I+A   +F   ++   S  A
Sbjct: 185 YEPL-GLEADMWSIGVITYILLSGASPFLGETK-QETLTNISAVNYDFDEEYFSNTSELA 242

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
              I ++L  +PK R+ I    +H W +  
Sbjct: 243 KDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  315 bits (808), Expect = e-101
 Identities = 73/310 (23%), Positives = 121/310 (39%), Gaps = 19/310 (6%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
              T+    +E+   +G G F  V    +++TGE VA+K   +   L  +  ++   EI 
Sbjct: 7   SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQ 64

Query: 62  IMKIVRHPNIVRLHEVLASRTKV------YIILEFVTGGELFDKIVHQGR---LLENDCR 112
           IMK + HPN+V   EV     K+       + +E+  GG+L   +        L E   R
Sbjct: 65  IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124

Query: 113 RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTT 169
                +  A+ + H   + HRDLKPEN++L         K+ D G +    QG EL    
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEF 183

Query: 170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFS 228
            GT  Y+APE+L  + Y     D WS G + F  + G+ PF         + K+      
Sbjct: 184 VGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242

Query: 229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK--NYNPVKCSEEEEVNLDDVHA 286
               +     ++    + P P     I   +   W +    ++  +   + +        
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302

Query: 287 VFDDIEDQYV 296
             D I    +
Sbjct: 303 ALDSILSLKL 312

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  300 bits (770), Expect = e-100
 Identities = 94/270 (34%), Positives = 147/270 (54%), Gaps = 15/270 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKREISIMKIV 66
            Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           +HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131

Query: 127 SKGVYHRDLKPENLLLDSY----GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           S  + H DLKPEN++L         +K+ DFGL+     G        GTP +VAPE+++
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVN 190

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGA 237
                G  AD+WS GVI ++L++G  PF G+T   T    ++A   EF   ++   S  A
Sbjct: 191 YEPL-GLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSAVNYEFEDEYFSNTSALA 248

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
              I ++L  +PK R+ I+   +HPW +  
Sbjct: 249 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  299 bits (768), Expect = 2e-99
 Identities = 95/282 (33%), Positives = 149/282 (52%), Gaps = 15/282 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKREISIMKIV 66
            Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE+SI++ V
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++D V + H
Sbjct: 73  LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 127 SKGVYHRDLKPENLLLDS----YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           +K + H DLKPEN++L        ++K+ DFGL+   + G        GTP +VAPE+++
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVN 191

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGA 237
                G  AD+WS GVI ++L++G  PF G+T        I +   +F   F+   S  A
Sbjct: 192 YEPL-GLEADMWSIGVITYILLSGASPFLGDTK-QETLANITSVSYDFDEEFFSHTSELA 249

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
              I K+L    + R+ I+   +HPW     N       E V
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV 291

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  305 bits (782), Expect = 2e-99
 Identities = 97/278 (34%), Positives = 152/278 (54%), Gaps = 11/278 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +   +G+G+F +V   ++R T +  A+KV+ K++  K++    I RE+ ++K + HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   + + H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 130 VYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPEN+LL+S     ++K+ DFGLS   QQ    +    GT  Y+APEVL    Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVL-RGTY 199

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
                DVWS GVIL++L++G  PF   +   + K++   +  F  P W   S  A  LI 
Sbjct: 200 -DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVN 280
           K+L  +P  RI      +HPW +K  +      +    
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSL 296

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  299 bits (768), Expect = 5e-99
 Identities = 99/289 (34%), Positives = 152/289 (52%), Gaps = 15/289 (5%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V HPNI+ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDS----YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN++L        ++K+ DFGL+   + G        GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEF 184

Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW 232
           VAPE+++     G  AD+WS GVI ++L++G  PF G+T        I A   +F   F+
Sbjct: 185 VAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTK-QETLANITAVSYDFDEEFF 242

Query: 233 --FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
              S  A   I K+L    + R+ I+   +HPW             E V
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESV 291

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  298 bits (766), Expect = 6e-99
 Identities = 72/312 (23%), Positives = 133/312 (42%), Gaps = 27/312 (8%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y + + IG G  +KV    N E  +  A+K +       ++ +D  + EI+ +  ++  
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 67

Query: 70  N--IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +  I+RL++   +   +Y+++E     +L   +  +  +   + + Y++ +++AV   H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRG 185
            G+ H DLKP N L+   G LK+ DFG++   Q      +  +  GT NY+ PE + +  
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 186 YD----------GSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINA-AEFSCPFW 232
                          +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE 292
                  ++   L  +PK RI I  +  HP+ +   +PV    +              + 
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM------KYVL 299

Query: 293 DQYVAEQSENKV 304
            Q V   S N +
Sbjct: 300 GQLVGLNSPNSI 311

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  303 bits (777), Expect = 9e-99
 Identities = 93/275 (33%), Positives = 150/275 (54%), Gaps = 11/275 (4%)

Query: 1   MKKQTRRVAK-YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
           ++  T   +  Y+  R +G+G+F +V   +++ TG+  A+KV++K  + +    + + RE
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           + ++K + HPNI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
             + + H   + HRDLKPENLLL+S     N+++ DFGLS   +   + +    GT  Y+
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYI 195

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW-- 232
           APEVL +  Y     DVWS GVIL++L++G  PF   +   + KK+   +  F  P W  
Sbjct: 196 APEVL-HGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
            S  A  LI K+L   P  RI       H W +  
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  297 bits (763), Expect = 2e-98
 Identities = 87/281 (30%), Positives = 141/281 (50%), Gaps = 23/281 (8%)

Query: 1   MKKQTRRV-AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
           + + + +    YEV   IG G+++  +   ++ T    A+K++ K         D    E
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRD-PTEE 65

Query: 60  ISIM-KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 118
           I I+ +  +HPNI+ L +V      VY++ E + GGEL DKI+ Q    E +       +
Sbjct: 66  IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI 125

Query: 119 IDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCGTPN 174
              V + H++GV HRDLKP N+L      +  ++++ DFG +   +    LL T C T N
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185

Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFS 228
           +VAPEVL  +GYD +A D+WS GV+L+ ++ GY PF     +T    +  +I +     S
Sbjct: 186 FVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTP-EEILARIGSGKFSLS 243

Query: 229 CPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             +W   S  A  L+ K+L  +P  R+    + +HPW    
Sbjct: 244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  295 bits (757), Expect = 1e-97
 Identities = 85/316 (26%), Positives = 135/316 (42%), Gaps = 53/316 (16%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ--IKREISIMKIV 66
            KY +   IG+G++  VR A   +T    A+K++ K+ I +    D   IK E+ +MK +
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL------------------- 107
            HPNI RL+EV      + +++E   GG L DK+                          
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 108 ---------------------ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG 146
                                E       +Q+  A+ + H++G+ HRD+KPEN L  +  
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 147 N--LKVSDFGLS----ALPQQGVELLHTTCGTPNYVAPEVLSNRGYD-GSAADVWSCGVI 199
           +  +K+ DFGLS     L       + T  GTP +VAPEVL+      G   D WS GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 200 LFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIHKILDPNPKTRIRI 255
           L +L+ G +PF   +      ++   +  F  P +   S  A  L+  +L+ N   R   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325

Query: 256 EGIRKHPWFRKNYNPV 271
               +HPW  +  + +
Sbjct: 326 MRALQHPWISQFSDKI 341

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  300 bits (770), Expect = 1e-97
 Identities = 89/275 (32%), Positives = 156/275 (56%), Gaps = 12/275 (4%)

Query: 1   MKKQTRRVAK-YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
           +  +   +++ Y+  + +G G + +V   +++ T    A+K++ K++ +      ++  E
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEE 86

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           ++++K++ HPNI++L++    +   Y+++E   GGELFD+I+H+ +  E D     +Q++
Sbjct: 87  VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVL 146

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
             V + H   + HRDLKPENLLL+S      +K+ DFGLSA+ +   + +    GT  Y+
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYI 205

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW-- 232
           APEVL  + Y     DVWS GVILF+L+AGY PFG      + +K+   +  F  P W  
Sbjct: 206 APEVL-RKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN 263

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
            S GA  LI ++L  + + RI  +   +HPW ++ 
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  297 bits (761), Expect = 2e-97
 Identities = 71/312 (22%), Positives = 131/312 (41%), Gaps = 27/312 (8%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y + + IG G  +KV    N E  +  A+K +       ++ +D  + EI+ +  ++  
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 114

Query: 70  N--IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +  I+RL++   +   +Y+++E     +L   +  +  +   + + Y++ +++AV   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRG 185
            G+ H DLKP N L+   G LK+ DFG++   Q      +  +  G  NY+ PE + +  
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 186 YD----------GSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINA-AEFSCPFW 232
                          +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE 292
                  ++   L  +PK RI I  +  HP+ +   +PV                   + 
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV------NQMAKGTTEEMKYVL 346

Query: 293 DQYVAEQSENKV 304
            Q V   S N +
Sbjct: 347 GQLVGLNSPNSI 358

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  296 bits (760), Expect = 2e-97
 Identities = 64/317 (20%), Positives = 118/317 (37%), Gaps = 48/317 (15%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M  Q+     + +   +G+G  A V   ++++TG+  A+KV    + L+   VD   RE 
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREF 58

Query: 61  SIMKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR---LLENDCRRYF 115
            ++K + H NIV+L  +    T     +I+EF   G L+  +        L E++     
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCG 171
           + ++  + H    G+ HR++KP N++     D     K++DFG +   +   E   +  G
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYG 177

Query: 172 TPNYVAPEVLSNRGYD-------GSAADVWSCGVILFVLMAGYLPF-----GETDLPTLY 219
           T  Y+ P++              G+  D+WS GV  +    G LPF        +   +Y
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

Query: 220 KKINAA------------------EFSCPFW------FSTGATSLIHKILDPNPKTRIRI 255
           K I                         P             T ++  IL+ + +     
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 256 EGIRKHPWFRKNYNPVK 272
           +          +   + 
Sbjct: 298 DQFFAETSDILHRMVIH 314

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  294 bits (754), Expect = 2e-97
 Identities = 94/315 (29%), Positives = 159/315 (50%), Gaps = 26/315 (8%)

Query: 10  KYEVG---RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
            Y++    + +GEG+F+  R   ++++ ++ A+K+++K      RM    ++EI+ +K+ 
Sbjct: 9   HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLC 62

Query: 67  R-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
             HPNIV+LHEV   +   ++++E + GGELF++I  +    E +     ++L+ AV+H 
Sbjct: 63  EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 126 HSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           H  GV HRDLKPENLL         +K+ DFG + L     + L T C T +Y APE+L+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN 182

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETD------LPTLYKKINAA--EFSCPFW- 232
             GYD  + D+WS GVIL+ +++G +PF              + KKI      F    W 
Sbjct: 183 QNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241

Query: 233 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN-YNPVKCSEEEEVNLDDVHAVFDD 290
             S  A  LI  +L  +P  R+++ G+R + W +             ++      AV   
Sbjct: 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTC 301

Query: 291 IEDQYVAEQSENKVG 305
           ++  + A     + G
Sbjct: 302 VKATFHAFNKYKREG 316

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  291 bits (748), Expect = 2e-96
 Identities = 74/270 (27%), Positives = 130/270 (48%), Gaps = 15/270 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY +   +G G F  V       + ++   K +      K      +K+EISI+ I RH 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCHSK 128
           NI+ LHE   S  ++ +I EF++G ++F++I      L E +   Y  Q+ +A+   HS 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 129 GVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            + H D++PEN++  +  +  +K+ +FG +   + G +        P Y APEV  +   
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVV 180

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATSLI 241
             +A D+WS G +++VL++G  PF  ET+   + + I  A   F    +   S  A   +
Sbjct: 181 -STATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
            ++L    K+R+      +HPW ++    V
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIERV 268

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  297 bits (762), Expect = 3e-96
 Identities = 92/294 (31%), Positives = 151/294 (51%), Gaps = 21/294 (7%)

Query: 2   KKQTRRV-AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM-------- 52
           +K+  ++   Y   R +G G + +V   + +      A+KV+ KS   K R         
Sbjct: 28  RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIE 87

Query: 53  --VDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND 110
              ++I  EIS++K + HPNI++L +V   +   Y++ EF  GGELF++I+++ +  E D
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147

Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLH 167
                +Q++  + + H   + HRD+KPEN+LL++     N+K+ DFGLS+   +    L 
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLR 206

Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE- 226
              GT  Y+APEVL  + Y     DVWSCGVI+++L+ GY PFG  +   + KK+   + 
Sbjct: 207 DRLGTAYYIAPEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264

Query: 227 -FSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
            F    W   S  A  LI  +L  +   R   E      W +K  N +  S+++
Sbjct: 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  290 bits (744), Expect = 8e-96
 Identities = 84/285 (29%), Positives = 140/285 (49%), Gaps = 16/285 (5%)

Query: 10  KYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
            Y +  + +G G FA VR   ++ TG+  A K L K          +I  EI+++++ + 
Sbjct: 29  FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKS 87

Query: 69  -PNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 125
            P ++ LHEV  + +++ +ILE+  GGE+F   +      + END  R  +Q+++ V + 
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 126 HSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           H   + H DLKP+N+LL      G++K+ DFG+S         L    GTP Y+APE+L+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILN 206

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGA 237
                 +A D+W+ G+I ++L+    PF GE +    Y  I+    ++S   +   S  A
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDN-QETYLNISQVNVDYSEETFSSVSQLA 264

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLD 282
           T  I  +L  NP+ R   E    H W ++         EE  +  
Sbjct: 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSS 309

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  290 bits (743), Expect = 8e-95
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 14/266 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y++   +G G F  V     + TG     K +     L    V   K EISIM  + HP
Sbjct: 52  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV---KNEISIMNQLHHP 108

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCHSK 128
            ++ LH+    + ++ +ILEF++GGELFD+I  +   + E +   Y +Q  + + H H  
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168

Query: 129 GVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            + H D+KPEN++ ++     +K+ DFGL+       E++  T  T  + APE++     
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPV 227

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATSLI 241
            G   D+W+ GV+ +VL++G  PF GE D     + +     EF    +   S  A   I
Sbjct: 228 -GFYTDMWAIGVLGYVLLSGLSPFAGEDD-LETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKN 267
             +L   P+ R+ +    +HPW + +
Sbjct: 286 KNLLQKEPRKRLTVHDALEHPWLKGD 311

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  287 bits (737), Expect = 3e-94
 Identities = 83/268 (30%), Positives = 136/268 (50%), Gaps = 16/268 (5%)

Query: 10  KYEVGRT--IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
            Y V +T  +G G F +V   +   TG  +A K++        +  +++K EIS+M  + 
Sbjct: 88  FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLD 144

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCH 126
           H N+++L++   S+  + +++E+V GGELFD+I+ +   L E D   + +Q+ + + H H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204

Query: 127 SKGVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
              + H DLKPEN+L  +     +K+ DFGL+   +   E L    GTP ++APEV+ N 
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVV-NY 262

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATS 239
            +     D+WS GVI ++L++G  PF G+ D       I A   +     +   S  A  
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWDLEDEEFQDISEEAKE 321

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKN 267
            I K+L      RI      KHPW   +
Sbjct: 322 FISKLLIKEKSWRISASEALKHPWLSDH 349

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  291 bits (746), Expect = 5e-93
 Identities = 81/280 (28%), Positives = 134/280 (47%), Gaps = 14/280 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y++   +G G F  V     R TG + A K +           + +++EI  M ++RHP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHP 214

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSK 128
            +V LH+      ++ +I EF++GGELF+K+  +  ++ E++   Y +Q+   + H H  
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274

Query: 129 GVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
              H DLKPEN++  +     LK+ DFGL+A      + +  T GT  + APEV   +  
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPV 333

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATSLI 241
            G   D+WS GV+ ++L++G  PF GE D  T  + + +         +   S      I
Sbjct: 334 -GYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDWNMDDSAFSGISEDGKDFI 391

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
            K+L  +P TR+ I    +HPW      P + S+      
Sbjct: 392 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRY 431

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  281 bits (721), Expect = 2e-92
 Identities = 88/277 (31%), Positives = 134/277 (48%), Gaps = 30/277 (10%)

Query: 10  KYEVGR-TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVR 67
            Y++ +  +G G   KV    +R TG+  A+K+L  S         + ++E+    +   
Sbjct: 29  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASG 80

Query: 68  HPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDA 121
            P+IV + +V       +  + II+E + GGELF +I  +G     E +     + +  A
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +   HS  + HRD+KPENLL  S      LK++DFG +    Q    L T C TP YVAP
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAP 198

Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDL---PTLYKKINAA--EFSCPFW 232
           EVL    YD  + D+WS GVI+++L+ G+ PF   T     P + ++I      F  P W
Sbjct: 199 EVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257

Query: 233 --FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
              S  A  LI  +L  +P  R+ I     HPW  ++
Sbjct: 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  282 bits (724), Expect = 7e-92
 Identities = 91/286 (31%), Positives = 136/286 (47%), Gaps = 29/286 (10%)

Query: 1   MKKQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
             K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE
Sbjct: 53  QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARRE 104

Query: 60  ISIMK-IVRHPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCR 112
           + +     + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +  
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164

Query: 113 RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTT 169
              + + +A+ + HS  + HRD+KPENLL  S      LK++DFG +         L T 
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTP 223

Query: 170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPT---LYKKINAA 225
           C TP YVAPEVL    YD  + D+WS GVI+++L+ GY PF     L     +  +I   
Sbjct: 224 CYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282

Query: 226 --EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  279 bits (716), Expect = 8e-92
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 40/294 (13%)

Query: 10  KYEVGR-TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR- 67
            Y++    +GEG  A+V+   N  T +  A+K++ K       +  ++ RE+ ++   + 
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQG 69

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           H N++ L E      + Y++ E + GG +   I  +    E +     Q +  A+   H+
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129

Query: 128 KGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQG-------VELLHTTCGTPNYVA 177
           KG+ HRDLKPEN+L +       +K+ DF L +  +            L T CG+  Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 178 PEVL-----SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPT-------------- 217
           PEV+         YD    D+WS GVIL++L++GY PF G                    
Sbjct: 190 PEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248

Query: 218 LYKKINAA--EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           L++ I     EF    W   S  A  LI K+L  + K R+    + +HPW +  
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  269 bits (691), Expect = 4e-88
 Identities = 81/273 (29%), Positives = 141/273 (51%), Gaps = 9/273 (3%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           + + +R   ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  
Sbjct: 23  QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           +M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 179
           + + H KG+ HRDLKPEN+LL+   +++++DFG +    P+      ++  GT  YV+PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 239
           +L+ +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  
Sbjct: 203 LLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261

Query: 240 LIHKILDPNPKTRI------RIEGIRKHPWFRK 266
           L+ K+L  +   R+          ++ HP+F  
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  270 bits (691), Expect = 2e-87
 Identities = 44/305 (14%), Positives = 96/305 (31%), Gaps = 51/305 (16%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
             R      G  +G+        A ++ETGES  + V   +       + Q+K E+  ++
Sbjct: 69  GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 128

Query: 65  IVR-------------------------HPNIVRLHEVLASRTKVYIILEF--------V 91
           ++R                            ++R+         +     +         
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188

Query: 92  TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVS 151
            G  L         L+ +   +   Q+I  +A  H  G+ H  L+P +++LD  G + ++
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 248

Query: 152 DFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG----------YDGSAADVWSCGVILF 201
            F               +  +  +  PE+ + R               + D W+ G++++
Sbjct: 249 GFEHLVRDGA----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304

Query: 202 VLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH 261
            +    LP  +       + I    F           +L+   L    + R+      + 
Sbjct: 305 WIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360

Query: 262 PWFRK 266
           P + +
Sbjct: 361 PEYEQ 365

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  261 bits (670), Expect = 2e-85
 Identities = 80/275 (29%), Positives = 137/275 (49%), Gaps = 14/275 (5%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R   YEV  TIG G++ + +  + +  G+ +  K L   + +       +  E+++++ +
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLREL 62

Query: 67  RHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLID 120
           +HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 121 AVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +         T  GTP Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-PFWFS 234
           ++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P+ +S
Sbjct: 183 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241

Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 269
                +I ++L+     R  +E I ++P   ++++
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  259 bits (663), Expect = 2e-83
 Identities = 74/261 (28%), Positives = 136/261 (52%), Gaps = 5/261 (1%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY   + IGEG+F K    ++ E G    +K +  S  +  +  ++ +RE++++  ++HP
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHP 83

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLL-ENDCRRYFQQLIDAVAHCHS 127
           NIV+  E       +YI++++  GG+LF +I   +G L  E+    +F Q+  A+ H H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + + HRD+K +N+ L   G +++ DFG++ +    VEL     GTP Y++PE+  N+ Y+
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-PFWFSTGATSLIHKILD 246
            + +D+W+ G +L+ L      F    +  L  KI +  F      +S    SL+ ++  
Sbjct: 204 -NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFK 262

Query: 247 PNPKTRIRIEGIRKHPWFRKN 267
            NP+ R  +  I +  +  K 
Sbjct: 263 RNPRDRPSVNSILEKGFIAKR 283

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  261 bits (668), Expect = 4e-83
 Identities = 68/295 (23%), Positives = 112/295 (37%), Gaps = 45/295 (15%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRH 68
                + +G G+   V F      G  VA+K +           D    EI ++ +   H
Sbjct: 16  LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDH 68

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-------RLLENDCRRYFQQLIDA 121
           PN++R +    +   +YI LE      L D +  +           E +     +Q+   
Sbjct: 69  PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 122 VAHCHSKGVYHRDLKPENLLLDS-------------YGNLKVSDFGLSALPQQGVE---- 164
           VAH HS  + HRDLKP+N+L+ +                + +SDFGL      G      
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 165 LLHTTCGTPNYVAPEVLSNRGYD------GSAADVWSCGVILFVLM-AGYLPFG---ETD 214
            L+   GT  + APE+L              + D++S G + + ++  G  PFG     +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247

Query: 215 LPTLYKKINAAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
              +    +  E  C         AT LI +++D +P  R     + +HP F   
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  257 bits (658), Expect = 5e-83
 Identities = 62/285 (21%), Positives = 110/285 (38%), Gaps = 25/285 (8%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y   + +GEG F+ V   +    G   A+K +      + +  ++ +RE  + ++  HP
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHP 86

Query: 70  NIVRLHEVLASRT----KVYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQQLIDA 121
           NI+RL            + +++L F   G L+++I         L E+        +   
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ---------QGVELLHTTCGT 172
           +   H+KG  HRDLKP N+LL   G   + D G                 ++       T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 173 PNYVAPEVLSNRGYD--GSAADVWSCGVILFVLMAGYLPFGETDLPT-LYKKINAAEFSC 229
            +Y APE+ S + +       DVWS G +L+ +M G  P+                + S 
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266

Query: 230 PFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
           P     S+    L++ ++  +P  R  I  +       +   P +
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  255 bits (655), Expect = 2e-82
 Identities = 84/260 (32%), Positives = 153/260 (58%), Gaps = 9/260 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +++ RT+G G+F +V   ++R  G   AMKVL K  +++ + V+    E  ++ IV HP 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+R+        ++++I++++ GGELF  +    R      + Y  ++  A+ + HSK +
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  G++K++DFG +   +   ++ +T CGTP+Y+APEV+S + Y   +
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAPEVVSTKPY-NKS 183

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D WS G++++ ++AGY PF +++    Y+KI  AE   P +F+     L+ +++  +  
Sbjct: 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLS 243

Query: 251 TRI-----RIEGIRKHPWFR 265
            R+       E ++ HPWF+
Sbjct: 244 QRLGNLQNGTEDVKNHPWFK 263

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  256 bits (656), Expect = 3e-82
 Identities = 83/269 (30%), Positives = 147/269 (54%), Gaps = 9/269 (3%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
            + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
             + HS  + +RDLKPENLL+D  G ++V+DFG +   ++      T CGTP  +APE++
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEII 210

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
            ++GY   A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+
Sbjct: 211 LSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269

Query: 242 HKILDPNPKTRI-----RIEGIRKHPWFR 265
             +L  +   R       +  I+ H WF 
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  252 bits (645), Expect = 7e-81
 Identities = 79/283 (27%), Positives = 121/283 (42%), Gaps = 36/283 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-H 68
           +  V R + EG FA V  AQ+  +G   A+K L  +   +      I +E+  MK +  H
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGH 85

Query: 69  PNIVRLH-------EVLASRTKVYIILEFVTGGELFDKIV---HQGRLLENDCRRYFQQL 118
           PNIV+         E   +    +++L  +  G+L + +     +G L  +   + F Q 
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 119 IDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG------------VE 164
             AV H H +   + HRDLK ENLLL + G +K+ DFG +                  VE
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 165 LLHTTCGTPNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
              T   TP Y  PE+  L +    G   D+W+ G IL++L     PF +        +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK----LRI 261

Query: 223 NAAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPW 263
              ++S P      T   SLI  +L  NP+ R+ I  +     
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  249 bits (639), Expect = 2e-80
 Identities = 81/285 (28%), Positives = 126/285 (44%), Gaps = 50/285 (17%)

Query: 2   KKQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
            K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+
Sbjct: 10  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREV 61

Query: 61  SIM-KIVRHPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRR 113
            +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +   
Sbjct: 62  ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 121

Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTC 170
             + + +A+ + HS  + HRD+KPENLL  S      LK++DFG                
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------- 166

Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPT---LYKKINAA- 225
                 A E      YD  + D+WS GVI+++L+ GY PF     L     +  +I    
Sbjct: 167 ------AKETT-GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218

Query: 226 -EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
            EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  252 bits (644), Expect = 2e-79
 Identities = 63/275 (22%), Positives = 106/275 (38%), Gaps = 26/275 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRH 68
            +     +G G    + +         VA+K +               RE+ +++    H
Sbjct: 25  SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPE------CFSFADREVQLLRESDEH 77

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           PN++R       R   YI +E      L + +       L  +     QQ    +AH HS
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 128 KGVYHRDLKPENLLLDSYGN-----LKVSDFGLS---ALPQQGVELLHTTCGTPNYVAPE 179
             + HRDLKP N+L+            +SDFGL    A+ +          GT  ++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 180 VLS---NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSCPFWF-- 233
           +LS            D++S G + + +++ G  PFG++        + A    C      
Sbjct: 197 MLSEDCKENPT-YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255

Query: 234 -STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
               A  LI K++  +P+ R   + + KHP+F   
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  244 bits (625), Expect = 2e-77
 Identities = 41/304 (13%), Positives = 88/304 (28%), Gaps = 45/304 (14%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           ++   K ++   +  G  + V   ++ E  E  A+KV           ++++        
Sbjct: 58  SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAA 117

Query: 65  IVRHPNIVRLHEVL--------------------------ASRTKVYIILEFVTG----- 93
            +   +     +                             +     +++   +      
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL 177

Query: 94  GELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD 152
               D +                 QLI   A+  SKG+ H    P+NL +   G L + D
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGD 237

Query: 153 FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD-GSAADVWSCGVILFVLMAGYLPFG 211
                           +     Y   E L+        A + W  G+ ++ +   +LPFG
Sbjct: 238 VSALWKVG---TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294

Query: 212 ETD--LPTLYKKINAAE-------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP 262
                +   +K+ +          F           +LI + L+ + + R+      + P
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354

Query: 263 WFRK 266
            F +
Sbjct: 355 EFLQ 358

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  242 bits (620), Expect = 2e-77
 Identities = 71/276 (25%), Positives = 128/276 (46%), Gaps = 9/276 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            + + + IG G F++V  A     G  VA+K +    ++  +      +EI ++K + HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHC 125
           N+++ +       ++ I+LE    G+L   I H  +    + E    +YF QL  A+ H 
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HS+ V HRD+KP N+ + + G +K+ D GL           H+  GTP Y++PE +   G
Sbjct: 153 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 212

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFG--ETDLPTLYKKINAAEFSC--PFWFSTGATSLI 241
           Y+   +D+WS G +L+ + A   PF   + +L +L KKI   ++       +S     L+
Sbjct: 213 YN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 271

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
           +  ++P+P+ R  +  +                   
Sbjct: 272 NMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  243 bits (623), Expect = 6e-77
 Identities = 72/258 (27%), Positives = 133/258 (51%), Gaps = 9/258 (3%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R IG+G+F KV   Q  +T +  AMK + K   ++   V  + +E+ IM+ + HP +V L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                    ++++++ + GG+L   +       E   + +  +L+ A+ +  ++ + HRD
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR---GYDGSAA 191
           +KP+N+LLD +G++ ++DF ++A+  +    + T  GT  Y+APE+ S+R   GY   A 
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGY-SFAV 198

Query: 192 DVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           D WS GV  + L+ G  P+     T    +         + P  +S    SL+ K+L+PN
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPN 258

Query: 249 PKTRI-RIEGIRKHPWFR 265
           P  R  ++  ++  P+  
Sbjct: 259 PDQRFSQLSDVQNFPYMN 276

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  239 bits (613), Expect = 8e-77
 Identities = 63/281 (22%), Positives = 114/281 (40%), Gaps = 31/281 (11%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
            R    ++    IG G F +V  A++R  G++  +K +  +        ++ +RE+  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALA 59

Query: 65  IVRHPNIVRLHE----------------VLASRTKVYIILEFVTGGELFDKIVHQ--GRL 106
            + H NIV  +                   +    ++I +EF   G L   I  +   +L
Sbjct: 60  KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119

Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
            +      F+Q+   V + HSK + +RDLKP N+ L     +K+ DFGL    +      
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKR 178

Query: 167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE 226
             + GT  Y++PE +S++ Y     D+++ G+IL  L+       ET     +  +    
Sbjct: 179 TRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGI 235

Query: 227 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                 F     +L+ K+L   P+ R     I +     K 
Sbjct: 236 I--SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  240 bits (615), Expect = 1e-76
 Identities = 70/267 (26%), Positives = 114/267 (42%), Gaps = 8/267 (2%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           + ++     ++    +G G++ +V   +++E G   A+K              ++    S
Sbjct: 50  RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGS 109

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLID 120
             K+ +HP  VRL +       +Y+  E   G  L       G  L E     Y +  + 
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+AH HS+G+ H D+KP N+ L   G  K+ DFGL               G P Y+APE+
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPEL 227

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGY-LPFGETDLPTLYKKINAAEFSCPFWFSTGATS 239
           L    Y  +AADV+S G+ +  +     LP G      L +     EF      S+   S
Sbjct: 228 LQG-SYG-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRS 283

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           ++  +L+P+PK R   E +   P  R+
Sbjct: 284 VLVMMLEPDPKLRATAEALLALPVLRQ 310

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  236 bits (603), Expect = 5e-75
 Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 33/295 (11%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R +  +E  + +G G F  V  A+N+    + A+K +        R   ++ RE+  +  
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAK 59

Query: 66  VRHPNIVRLHEV------------LASRTKVYIILEFVTGGELFDKIVHQGRLL---END 110
           + HP IVR                 + +  +YI ++      L D +  +  +     + 
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL------------ 158
           C   F Q+ +AV   HSKG+ HRDLKP N+       +KV DFGL               
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
           P           GT  Y++PE +    Y     D++S G+ILF L+  Y    + +    
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELL--YPFSTQMERVRT 236

Query: 219 YKKINAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
              +   +F             ++  +L P+P  R     I ++  F     P K
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  235 bits (603), Expect = 1e-74
 Identities = 88/261 (33%), Positives = 143/261 (54%), Gaps = 10/261 (3%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIVRHPN 70
           R +G+G + KV   R      TG+  AMKVL K+ I+   +     K E +I++ V+HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV L     +  K+Y+ILE+++GGELF ++  +G  +E+    Y  ++  A+ H H KG+
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN++L+  G++K++DFGL         + HT CGT  Y+APE+L   G+   A
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRA 201

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D WS G +++ ++ G  PF   +      KI   + + P + +  A  L+ K+L  N  
Sbjct: 202 VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAA 261

Query: 251 TRI-----RIEGIRKHPWFRK 266
           +R+         ++ HP+FR 
Sbjct: 262 SRLGAGPGDAGEVQAHPFFRH 282

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  233 bits (597), Expect = 1e-73
 Identities = 85/256 (33%), Positives = 134/256 (52%), Gaps = 6/256 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 189

Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI- 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+ 
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 249

Query: 254 ----RIEGIRKHPWFR 265
                 + + +H +F 
Sbjct: 250 GGPSDAKEVMEHRFFL 265

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  234 bits (598), Expect = 2e-73
 Identities = 83/256 (32%), Positives = 131/256 (51%), Gaps = 6/256 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           + IG+G+F KV  A+++      A+KVL K  ILK +    I  E +++ K V+HP +V 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  K+Y +L+++ GGELF  +  +   LE   R Y  ++  A+ + HS  + +R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLKPEN+LLDS G++ ++DFGL     +      T CGTP Y+APEVL  + Y     D 
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDW 222

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W  G +L+ ++ G  PF   +   +Y  I           +  A  L+  +L  +   R+
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 282

Query: 254 ----RIEGIRKHPWFR 265
                   I+ H +F 
Sbjct: 283 GAKDDFMEIKSHVFFS 298

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  235 bits (601), Expect = 2e-73
 Identities = 86/266 (32%), Positives = 140/266 (52%), Gaps = 13/266 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV + IG G F +V+  +++ T +  AMK+L+K  ++K         E  IM     P 
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V+L         +Y+++E++ GG+L   ++    + E   R Y  +++ A+   HS G 
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 189

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYD-- 187
            HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL ++G D  
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249

Query: 188 -GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGATSLIH 242
            G   D WS GV L+ ++ G  PF    L   Y KI   + S  F      S  A +LI 
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309

Query: 243 KILDPNPKTRIRIEG---IRKHPWFR 265
             L  + + R+   G   I++H +F+
Sbjct: 310 AFLT-DREVRLGRNGVEEIKRHLFFK 334

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  232 bits (593), Expect = 3e-73
 Identities = 94/260 (36%), Positives = 145/260 (55%), Gaps = 10/260 (3%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + +G+G+F KV   +     +  +  AMKVL K+T+     V   K E  I+  V HP I
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVNHPFI 88

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           V+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H HS G+ 
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ RG+   +A
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSA 207

Query: 192 DVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT 251
           D WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  +   NP  
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPAN 267

Query: 252 RI-----RIEGIRKHPWFRK 266
           R+      +E I++H +F  
Sbjct: 268 RLGAGPDGVEEIKRHSFFST 287

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  230 bits (589), Expect = 2e-72
 Identities = 78/253 (30%), Positives = 133/253 (52%), Gaps = 3/253 (1%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           + +G+G+F KV  A+ ++T +  A+K L K  +L    V+    E  ++     HP +  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           +     ++  ++ ++E++ GG+L   I    +   +    Y  ++I  +   HSKG+ +R
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD  G++K++DFG+      G    +T CGTP+Y+APE+L  + Y   + D 
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDW 201

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           WS GV+L+ ++ G  PF   D   L+  I       P W    A  L+ K+    P+ R+
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRL 261

Query: 254 RIEG-IRKHPWFR 265
            + G IR+HP FR
Sbjct: 262 GVRGDIRQHPLFR 274

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  230 bits (588), Expect = 4e-72
 Identities = 87/258 (33%), Positives = 136/258 (52%), Gaps = 8/258 (3%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           R +G+G+F KV  A+ +ETG+  A+KVL K  IL+   V+    E  I+     HP + +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           L     +  +++ ++EFV GG+L   I    R  E   R Y  ++I A+   H KG+ +R
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD  G+ K++DFG+            T CGTP+Y+APE+L    Y G A D 
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAVDW 207

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W+ GV+L+ ++ G+ PF   +   L++ I   E   P W    AT ++   +  NP  R+
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRL 267

Query: 254 ------RIEGIRKHPWFR 265
                     I +HP+F+
Sbjct: 268 GSLTQGGEHAILRHPFFK 285

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  229 bits (586), Expect = 8e-72
 Identities = 75/257 (29%), Positives = 136/257 (52%), Gaps = 7/257 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
             +G+G+F KV  ++ + T E  A+K+L K  +++   V+    E  ++    + P + +
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  ++Y ++E+V GG+L   I   GR  E     Y  ++   +    SKG+ +R
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N++LDS G++K++DFG+            T CGTP+Y+APE+++ + Y G + D 
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 204

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W+ GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   ++  +P  R+
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 264

Query: 254 -----RIEGIRKHPWFR 265
                    I++H +FR
Sbjct: 265 GCGPEGERDIKEHAFFR 281

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  228 bits (583), Expect = 1e-71
 Identities = 84/267 (31%), Positives = 142/267 (53%), Gaps = 17/267 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           R IG G++AKV   + ++T    AMKV+ K  +     +D ++ E  +  +   HP +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H +G+ +R
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLDS G++K++D+G+     +  +   T CGTPNY+APE+L    Y G + D 
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 193

Query: 194 WSCGVILFVLMAGYLPFGETDLPT---------LYKKINAAEFSCPFWFSTGATSLIHKI 244
           W+ GV++F +MAG  PF                L++ I   +   P   S  A S++   
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 253

Query: 245 LDPNPKTRI------RIEGIRKHPWFR 265
           L+ +PK R+          I+ HP+FR
Sbjct: 254 LNKDPKERLGCHPQTGFADIQGHPFFR 280

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  231 bits (590), Expect = 2e-71
 Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 17/270 (6%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + +   +  AMK+L K  +LK       + E  ++       
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + RL E   R Y  +++ A+   H   
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVL-----SN 183
             HRD+KP+N+L+D  G+++++DFG    L + G        GTP+Y++PE+L       
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF-----WFSTGAT 238
             Y G   D WS GV ++ ++ G  PF    L   Y KI   +    F       S  A 
Sbjct: 256 GRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314

Query: 239 SLIHKILDPNPKTRIRIEG---IRKHPWFR 265
            LI +++      R+   G    +KHP+F 
Sbjct: 315 DLIRRLICSREH-RLGQNGIEDFKKHPFFS 343

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  230 bits (587), Expect = 2e-71
 Identities = 48/300 (16%), Positives = 98/300 (32%), Gaps = 42/300 (14%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
             R      G  +G+        A ++ETGES  + V   +       + Q+K E+  ++
Sbjct: 74  GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133

Query: 65  ----------------------IVRHPNIVRLHEVLASRTKVYIILEFVT---------- 92
                                 +V+ P   ++  V      ++++  F            
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193

Query: 93  -GGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVS 151
            G  L         L+ +   +   Q+I  +A  H  G+ H  L+P +++LD  G + ++
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253

Query: 152 DFGLSALPQQ-GVELLHTTCGTPNYVAPEVLSNRGYDGS----AADVWSCGVILFVLMAG 206
            F          V  +      P   A  +L    +  +    A D W+ G+ ++ +   
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313

Query: 207 YLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
            LP  +       + I    F           +L+   L    + R+      + P + +
Sbjct: 314 DLPNTDDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  228 bits (583), Expect = 2e-71
 Identities = 42/287 (14%), Positives = 97/287 (33%), Gaps = 36/287 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
              V   +GEG FA+V  A        +  +   +KV   +   +  +     + +  +K
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI---GTQLMERLK 122

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-----LLENDCRRYFQQLI 119
                  ++ +     +    ++ E  + G L + I          + +     +  +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 120 DAVAHCHSKGVYHRDLKPENLLL-----------DSYGNLKVSDFGLSA--LPQQGVELL 166
             +   H   + H D+KP+N +L           D    L + D G S          + 
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAA 225
              C T  +   E+LSN+ ++    D +     ++ ++ G Y+           + +   
Sbjct: 243 TAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301

Query: 226 EFSCPFWFSTGATSLIHKILDPNPKTRI-RIEGIRK--HPWFRKNYN 269
                 W         H +L+      +  ++ +R+     F+++Y 
Sbjct: 302 LPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  230 bits (587), Expect = 7e-71
 Identities = 87/257 (33%), Positives = 135/257 (52%), Gaps = 7/257 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHR 133
                +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K V +R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK ENL+LD  G++K++DFGL     +    + T CGTP Y+APEVL +  Y G A D 
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 332

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L  +PK R+
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 392

Query: 254 -----RIEGIRKHPWFR 265
                  + I +H +F 
Sbjct: 393 GGGSEDAKEIMQHRFFA 409

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  228 bits (582), Expect = 8e-71
 Identities = 83/267 (31%), Positives = 142/267 (53%), Gaps = 17/267 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           R IG G++AKV   + ++T    AM+V+ K  +     +D ++ E  +  +   HP +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H +G+ +R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLDS G++K++D+G+     +  +   T CGTPNY+APE+L    Y G + D 
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 236

Query: 194 WSCGVILFVLMAGYLPFGET---------DLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
           W+ GV++F +MAG  PF                L++ I   +   P   S  A S++   
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 296

Query: 245 LDPNPKTRI------RIEGIRKHPWFR 265
           L+ +PK R+          I+ HP+FR
Sbjct: 297 LNKDPKERLGCHPQTGFADIQGHPFFR 323

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  227 bits (580), Expect = 2e-70
 Identities = 76/271 (28%), Positives = 125/271 (46%), Gaps = 17/271 (6%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F++V   + ++TG+  AMK++ K  +LK   V   + E  ++       
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKG 129
           I +LH        +Y+++E+  GG+L   +   G R+     R Y  +++ A+   H  G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYD- 187
             HRD+KP+N+LLD  G+++++DFG    L   G        GTP+Y++PE+L   G   
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242

Query: 188 -----GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF-----WFSTGA 237
                G   D W+ GV  + +  G  PF        Y KI   +               A
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302

Query: 238 TSLIHKILDPNPKTRIRIEG---IRKHPWFR 265
              I ++L   P+TR+   G    R HP+F 
Sbjct: 303 RDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  221 bits (566), Expect = 7e-69
 Identities = 86/270 (31%), Positives = 151/270 (55%), Gaps = 20/270 (7%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTIL-KHRMVDQIKREISIM-KIVRHP 69
           + +G G + KV   R     +TG+  AMKVL K+TI+ K +  +  + E  ++  I + P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
            +V LH    + TK+++IL+++ GGELF  +  + R  E++ + Y  +++ A+ H H  G
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEVL--SNRG 185
           + +RD+K EN+LLDS G++ ++DFGLS   +  +  E  +  CGT  Y+AP+++   + G
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSG 238

Query: 186 YDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           +   A D WS GV+++ L+ G  PF     +     + ++I  +E   P   S  A  LI
Sbjct: 239 H-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 297

Query: 242 HKILDPNPKTRI-----RIEGIRKHPWFRK 266
            ++L  +PK R+       + I++H +F+K
Sbjct: 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  227 bits (581), Expect = 6e-68
 Identities = 75/257 (29%), Positives = 137/257 (53%), Gaps = 7/257 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVR 73
             +G+G+F KV  ++ + T E  A+K+L K  +++   V+    E  ++ +  + P + +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  ++Y ++E+V GG+L   I   GR  E     Y  ++   +    SKG+ +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N++LDS G++K++DFG+            T CGTP+Y+APE+++ + Y G + D 
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 525

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W+ GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   ++  +P  R+
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 585

Query: 254 -----RIEGIRKHPWFR 265
                    I++H +FR
Sbjct: 586 GCGPEGERDIKEHAFFR 602

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  223 bits (569), Expect = 3e-67
 Identities = 73/264 (27%), Positives = 124/264 (46%), Gaps = 14/264 (5%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G G F +V   Q + TG+  A K L K  + K +       E  I+  V    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGV 130
                ++T + +++  + GG++   I +         E     Y  Q++  + H H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    Y   +
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFS 369

Query: 191 ADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            D ++ GV L+ ++A   PF     + +   L +++     + P  FS  +      +L 
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429

Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            +P+ R+       +G+R HP FR
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPLFR 453

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  223 bits (569), Expect = 4e-66
 Identities = 80/264 (30%), Positives = 127/264 (48%), Gaps = 15/264 (5%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNI 71
           R IG G F +V   +  +TG+  AMK L K  I   +       E  ++ +V     P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           V +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H++ V 
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS-NRGYDGSA 190
           +RDLKP N+LLD +G++++SD GL+    +     H + GT  Y+APEVL     Y  S+
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAY-DSS 371

Query: 191 ADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           AD +S G +LF L+ G+ PF      D   + +         P  FS    SL+  +L  
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 431

Query: 248 NPKTRIR-----IEGIRKHPWFRK 266
           +   R+       + +++ P+FR 
Sbjct: 432 DVNRRLGCLGRGAQEVKESPFFRS 455

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  220 bits (561), Expect = 8e-66
 Identities = 74/262 (28%), Positives = 126/262 (48%), Gaps = 13/262 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I H G+    E     Y  ++   +   H + + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD +G++++SD GL+    +G + +    GT  Y+APEV+ N  Y   + D
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERY-TFSPD 367

Query: 193 VWSCGVILFVLMAGYLPFGETDLPT----LYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            W+ G +L+ ++AG  PF +         + + +          FS  A SL  ++L  +
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427

Query: 249 PKTRI-----RIEGIRKHPWFR 265
           P  R+         +++HP F+
Sbjct: 428 PAERLGCRGGSAREVKEHPLFK 449

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  192 bits (490), Expect = 2e-58
 Identities = 54/288 (18%), Positives = 98/288 (34%), Gaps = 33/288 (11%)

Query: 4   QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           ++R   ++     IG G F  V     R  G   A+K   K         + ++   +  
Sbjct: 6   KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA 65

Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL----ENDCRRYFQQLI 119
            + +H ++VR     A    + I  E+  GG L D I    R++    E + +    Q+ 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNL-------------------KVSDFGLSALPQ 160
             + + HS  + H D+KP N+ +                         K+ D G      
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-- 183

Query: 161 QGVELLHTTCGTPNYVAPEVLS-NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY 219
             +       G   ++A EVL  N  +    AD+++  + +             D    +
Sbjct: 184 --ISSPQVEEGDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGAEPLPRNGD---QW 237

Query: 220 KKINAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
            +I        P   S   T L+  ++ P+P+ R     + KH     
Sbjct: 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  185 bits (471), Expect = 4e-55
 Identities = 67/328 (20%), Positives = 110/328 (33%), Gaps = 74/328 (22%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAM-------------------KVLAK------ 44
            +E  + +G G F  V  A+N+    + A+                   K LAK      
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 45  ------------------------------STILKHRMVDQIKREISIMKIVRHPNIVRL 74
                                           +     +D    +I  M      N V  
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND---CRRYFQQLIDAVAHCHSKGVY 131
            +  + +  +YI ++      L D +  +  L + +   C   F Q+ +AV   HSKG+ 
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSAL------------PQQGVELLHTTCGTPNYVAPE 179
           HRDLKP N+       +KV DFGL               P           GT  Y++PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW-FSTGAT 238
            +    Y     D++S G+ILF L+  Y    + +   +   +   +F   F        
Sbjct: 247 QIHGNNYS-HKVDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKFPLLFTQKYPQEH 303

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRK 266
            ++  +L P+P  R     I ++  F  
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  182 bits (463), Expect = 7e-54
 Identities = 81/321 (25%), Positives = 129/321 (40%), Gaps = 70/321 (21%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL--------AKSTILKHRMVDQIK 57
           + + KYE    +GEG++  V   +N++TG  VA+K           K   +         
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM--------- 72

Query: 58  REISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYF 115
           REI ++K +RH N+V L EV   + + Y++ EFV     +  +       L     ++Y 
Sbjct: 73  REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYL 130

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN 174
            Q+I+ +  CHS  + HRD+KPEN+L+   G +K+ DFG +  L   G            
Sbjct: 131 FQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD------- 183

Query: 175 YV------APEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--KI- 222
            V      APE+L  +  Y G A DVW+ G ++  +  G    P G++D+  LY      
Sbjct: 184 EVATRWYRAPELLVGDVKY-GKAVDVWAIGCLVTEMFMGEPLFP-GDSDIDQLYHIMMCL 241

Query: 223 ---------------NAAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRI 255
                            A    P               S     L  K L  +P  R   
Sbjct: 242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC 301

Query: 256 EGIRKHPWFRKNYNPVKCSEE 276
             +  H +F+ +    + S+E
Sbjct: 302 AELLHHDFFQMDGFAERFSQE 322

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  180 bits (459), Expect = 8e-54
 Identities = 69/264 (26%), Positives = 120/264 (45%), Gaps = 15/264 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
              +G+GT+  V   ++      +A+K +        R    +  EI++ K ++H NIV+
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLKHKNIVQ 83

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGV 130
                +    + I +E V GG L   +  +    +  E     Y +Q+++ + + H   +
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143

Query: 131 YHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL--SNRGYD 187
            HRD+K +N+L+++Y G LK+SDFG S           T  GT  Y+APE++    RGY 
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY- 202

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPT--LYKKINAAEFSCPF--WFSTGATSLIHK 243
           G AAD+WS G  +  +  G  PF E   P   ++ K+   +         S  A + I K
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEIPESMSAEAKAFILK 261

Query: 244 ILDPNPKTRIRIEGIRKHPWFRKN 267
             +P+P  R     +    + + +
Sbjct: 262 CFEPDPDKRACANDLLVDEFLKVS 285

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  181 bits (460), Expect = 2e-53
 Identities = 59/265 (22%), Positives = 107/265 (40%), Gaps = 18/265 (6%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           V        +G G+F +V   ++++TG   A+K +        R+      E+     + 
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--------RLEVFRVEELVACAGLS 108

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P IV L+  +     V I +E + GG L   I   G L E+    Y  Q ++ + + H+
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168

Query: 128 KGVYHRDLKPENLLLDSYGNL-KVSDFGLSA-----LPQQGVELLHTTCGTPNYVAPEVL 181
           + + H D+K +N+LL S G+   + DFG +         + +       GT  ++APEV+
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYK--KINAAEFSCPFWFSTGAT 238
             +  D +  D+WS   ++  ++ G  P+ +    P   K           P   +    
Sbjct: 229 MGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPW 263
             I + L   P  R     +R+   
Sbjct: 288 QAIQEGLRKEPVHRASAMELRRKVG 312

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  180 bits (458), Expect = 2e-53
 Identities = 80/317 (25%), Positives = 131/317 (41%), Gaps = 70/317 (22%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL--------AKSTILKHRMVDQIKREIS 61
           KYE    IGEG++  V   +NR+TG+ VA+K           K   L         REI 
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL---------REIR 54

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLI 119
           ++K ++HPN+V L EV   + +++++ E+         D+  +Q  + E+  +    Q +
Sbjct: 55  MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTL 112

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYV-- 176
            AV  CH     HRD+KPEN+L+  +  +K+ DFG +  L        +      + V  
Sbjct: 113 QAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL---TGPSDYYD----DEVAT 165

Query: 177 ----APEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--KI----- 222
               +PE+L  +  Y G   DVW+ G +   L++G    P G++D+  LY   K      
Sbjct: 166 RWYRSPELLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWP-GKSDVDQLYLIRKTLGDLI 223

Query: 223 -----------NAAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIR 259
                        +    P               S  A  L+   L  +P  R+  E + 
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283

Query: 260 KHPWFRKNYNPVKCSEE 276
            HP+F         ++E
Sbjct: 284 HHPYFENIREIEDLAKE 300

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  180 bits (458), Expect = 5e-53
 Identities = 79/314 (25%), Positives = 126/314 (40%), Gaps = 76/314 (24%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK------- 57
             R  +YE    +GEG FA V  A+++ T + VA+K        K ++  + +       
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK--------KIKLGHRSEAKDGINR 57

Query: 58  ---REISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCR 112
              REI +++ + HPNI+ L +    ++ + ++ +F+      +     +   L  +  +
Sbjct: 58  TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIK 115

Query: 113 RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT 172
            Y    +  + + H   + HRDLKP NLLLD  G LK++DFGL+            + G+
Sbjct: 116 AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-----------KSFGS 164

Query: 173 PN-----------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDL--- 215
           PN           Y APE+L   R Y G   D+W+ G IL  L+    +LP G++DL   
Sbjct: 165 PNRAYTHQVVTRWYRAPELLFGARMY-GVGVDMWAVGCILAELLLRVPFLP-GDSDLDQL 222

Query: 216 ---------PT--------------LYKKINAAEFSCPF-WFSTGATSLIHKILDPNPKT 251
                    PT               +K          F         LI  +   NP  
Sbjct: 223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCA 282

Query: 252 RIRIEGIRKHPWFR 265
           RI      K  +F 
Sbjct: 283 RITATQALKMKYFS 296

>2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143

 Score =  171 bits (435), Expect = 2e-52
 Identities = 103/141 (73%), Positives = 122/141 (86%), Gaps = 3/141 (2%)

Query: 305 GGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLK 364
            GPL+MNAFEMITLSQGLNL+ALFDRRQD+VKRQTRFVSR+    I++NIEAVA S+  K
Sbjct: 2   EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61

Query: 365 VHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKL 424
            HTRN+KTRLEG+S+ K GQ AVV+E++EVAPSLFMVDVRKAAG+TLEYHKFYK  C+KL
Sbjct: 62  SHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKL 121

Query: 425 ENIIWKPTEG---SSLLRTMS 442
           ENIIW+ TEG   S +LRT++
Sbjct: 122 ENIIWRATEGIPKSEILRTIT 142

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  175 bits (445), Expect = 1e-51
 Identities = 91/307 (29%), Positives = 132/307 (42%), Gaps = 69/307 (22%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--------RE 59
           + KYE    IGEGT+  V  A+NRET E VA+K        + R+ D           RE
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRL-DDDDEGVPSSALRE 51

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQ 117
           I ++K ++H NIVRLH+VL S  K+ ++ EF      + FD     G L     + +  Q
Sbjct: 52  ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQ 109

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVELLHTTCGTPN 174
           L+  +  CHS+ V HRDLKP+NLL++  G LK+++FGL+    +P +        C +  
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--------CYSAE 161

Query: 175 -----YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDL----------- 215
                Y  P+VL   + Y  ++ D+WS G I   L     P   G               
Sbjct: 162 VVTLWYRPPDVLFGAKLY-STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220

Query: 216 -PT-----------LYKKINAAEFSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGI 258
            PT            YK       +          +     L+  +L  NP  RI  E  
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

Query: 259 RKHPWFR 265
            +HP+F 
Sbjct: 281 LQHPYFS 287

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  171 bits (435), Expect = 5e-50
 Identities = 86/314 (27%), Positives = 136/314 (43%), Gaps = 80/314 (25%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------- 57
             + KY+    +GEGT+  V  A++   G  VA+K        + R+ D           
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALK--------RIRL-DAEDEGIPSTAI 67

Query: 58  REISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYF 115
           REIS++K + HPNIV L +V+ S   + ++ EF+     ++ D+  ++  L ++  + Y 
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYL 125

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN- 174
            QL+  VAHCH   + HRDLKP+NLL++S G LK++DFGL+              G P  
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA-----------RAFGIPVR 174

Query: 175 ----------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYKK 221
                     Y AP+VL  ++ Y  ++ D+WS G I   ++ G    P G TD   L  K
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKY-STSVDIWSIGCIFAEMITGKPLFP-GVTDDDQLP-K 231

Query: 222 I-------------------NAAEFSCPFW-----------FSTGATSLIHKILDPNPKT 251
           I                      + +   +           F      L+  +L  +P  
Sbjct: 232 IFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK 291

Query: 252 RIRIEGIRKHPWFR 265
           RI       HP+F+
Sbjct: 292 RISARDAMNHPYFK 305

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  170 bits (434), Expect = 1e-49
 Identities = 72/321 (22%), Positives = 127/321 (39%), Gaps = 79/321 (24%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--- 57
                  + +Y     +GEGT+ +V  A +  T E+VA+K        + R+ +  +   
Sbjct: 26  AAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK--------RIRL-EHEEEGV 76

Query: 58  -----REISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
                RE+S++K ++H NI+ L  V+    ++++I E+    +L   +     +     +
Sbjct: 77  PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK 135

Query: 113 RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-----GNLKVSDFGLSALPQQGVELLH 167
            +  QLI+ V  CHS+   HRDLKP+NLLL          LK+ DFGL+           
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA----------- 184

Query: 168 TTCGTPN-----------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGET 213
              G P            Y  PE+L  +R Y  ++ D+WS   I   ++      P G++
Sbjct: 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHY-STSVDIWSIACIWAEMLMKTPLFP-GDS 242

Query: 214 DLPTLYK-----------------------------KINAAEFSCPFWFSTGATSLIHKI 244
           ++  L+K                             +    +             L+  +
Sbjct: 243 EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAM 302

Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           L+ +P  RI  +   +HP+F 
Sbjct: 303 LEMDPVKRISAKNALEHPYFS 323

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  169 bits (431), Expect = 3e-49
 Identities = 83/317 (26%), Positives = 128/317 (40%), Gaps = 79/317 (24%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL-------AKSTILKHRMVDQIKRE 59
             ++++    +G GT+A V    N+ TG  VA+K +         ST +         RE
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI---------RE 53

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG-----ELFDKIVHQGRLLENDCRRY 114
           IS+MK ++H NIVRL++V+ +  K+ ++ EF+        +          L  N  + +
Sbjct: 54  ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113

Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN 174
             QL+  +A CH   + HRDLKP+NLL++  G LK+ DFGL+              G P 
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA-----------RAFGIPV 162

Query: 175 -----------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLP----------- 209
                      Y AP+VL  +R Y  ++ D+WSCG IL  ++ G    P           
Sbjct: 163 NTFSSEVVTLWYRAPDVLMGSRTY-STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

Query: 210 F------------GETDLP------TLYKKINAAEF---SCPFWFSTGATSLIHKILDPN 248
           F              T LP            +  +                 +H +L  N
Sbjct: 222 FDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281

Query: 249 PKTRIRIEGIRKHPWFR 265
           P  R+  +    HPWF 
Sbjct: 282 PDMRLSAKQALHHPWFA 298

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  168 bits (428), Expect = 3e-49
 Identities = 60/263 (22%), Positives = 116/263 (44%), Gaps = 15/263 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
              IG G+F  V    + ET   VA   L    + K     + K E  ++K ++HPNIVR
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVR 89

Query: 74  LH----EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
            +      +  +  + ++ E +T G L   +     +     R + +Q++  +   H++ 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 130 --VYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
             + HRDLK +N+ +    G++K+ D GL+ L +          GTP ++APE+     Y
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KY 206

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAE--FSCPFWFSTGATSLIHK 243
           D  + DV++ G+ +  +     P+ E  +   +Y+++ +     S           +I  
Sbjct: 207 D-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265

Query: 244 ILDPNPKTRIRIEGIRKHPWFRK 266
            +  N   R  I+ +  H +F++
Sbjct: 266 CIRQNKDERYSIKDLLNHAFFQE 288

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  168 bits (428), Expect = 3e-49
 Identities = 83/306 (27%), Positives = 138/306 (45%), Gaps = 69/306 (22%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--------RE 59
           + KY     IGEGT+  V  AQN   GE+ A+K        K R+ ++          RE
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALK--------KIRL-EKEDEGIPSTTIRE 50

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQ 117
           ISI+K ++H NIV+L++V+ ++ ++ ++ E +     +L D    +G L     + +  Q
Sbjct: 51  ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQ 108

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVELLHTTCGTPN 174
           L++ +A+CH + V HRDLKP+NLL++  G LK++DFGL+    +P +          T  
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--------KYTHE 160

Query: 175 -----YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLP-----------F----- 210
                Y AP+VL  ++ Y  +  D+WS G I   ++ G    P           F     
Sbjct: 161 IVTLWYRAPDVLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219

Query: 211 -------GETDLP---TLYKKINAAEFSCPF-WFSTGATSLIHKILDPNPKTRIRIEGIR 259
                    T+LP     +       +             L+ K+L  +P  RI  +   
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

Query: 260 KHPWFR 265
           +H +F+
Sbjct: 280 EHAYFK 285

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  168 bits (429), Expect = 6e-49
 Identities = 73/310 (23%), Positives = 129/310 (41%), Gaps = 76/310 (24%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL-------AKSTILKHRMVDQIKREI 60
           +  Y     +GEGT+A V   +++ T   VA+K +       A  T +         RE+
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI---------REV 51

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQL 118
           S++K ++H NIV LH+++ +   + ++ E++     +  D       +  ++ + +  QL
Sbjct: 52  SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQL 109

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN---- 174
           +  +A+CH + V HRDLKP+NLL++  G LK++DFGL+                P     
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA-----------RAKSIPTKTYD 158

Query: 175 -------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--KI 222
                  Y  P++L  +  Y  +  D+W  G I + +  G    P G T    L+   +I
Sbjct: 159 NEVVTLWYRPPDILLGSTDY-STQIDMWGVGCIFYEMATGRPLFP-GSTVEEQLHFIFRI 216

Query: 223 ----------------NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRI 255
                               ++ P +             +    L+ K+L    + RI  
Sbjct: 217 LGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA 276

Query: 256 EGIRKHPWFR 265
           E   KHP+F 
Sbjct: 277 EDAMKHPFFL 286

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  167 bits (425), Expect = 4e-48
 Identities = 80/319 (25%), Positives = 133/319 (41%), Gaps = 75/319 (23%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------- 57
             V+KYE    IG+GTF +V  A++R+TG+ VA+K        K  M +  K        
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--------KVLM-ENEKEGFPITAL 64

Query: 58  REISIMKIVRHPNIVRLHEVLASR--------TKVYIILEFV----TGGELFDKIVHQGR 105
           REI I+++++H N+V L E+  ++          +Y++ +F      G  L        +
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSN--VLVK 120

Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQG 162
              ++ +R  Q L++ + + H   + HRD+K  N+L+   G LK++DFGL+   +L +  
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180

Query: 163 VELLHTTC-GTPNYVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDL--- 215
               +T    T  Y  PE+L   R Y G   D+W  G I+  +      +  G T+    
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQ-GNTEQHQL 238

Query: 216 ---------PT-----------LYKKIN---------AAEFSCPFWFSTGATSLIHKILD 246
                     T           LY+K+                 +     A  LI K+L 
Sbjct: 239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK-AYVRDPYALDLIDKLLV 297

Query: 247 PNPKTRIRIEGIRKHPWFR 265
            +P  RI  +    H +F 
Sbjct: 298 LDPAQRIDSDDALNHDFFW 316

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  163 bits (416), Expect = 2e-47
 Identities = 73/323 (22%), Positives = 115/323 (35%), Gaps = 86/323 (26%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------- 57
              ++YE    IG G +  V  A++  +G  VA+K          R+             
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK--------SVRV-PNGGGGGGGLPI 56

Query: 58  ---REISIMK---IVRHPNIVRLHEVLASR-----TKVYIILEFVTG--GELFDKIVHQG 104
              RE+++++      HPN+VRL +V A+       KV ++ E V        DK    G
Sbjct: 57  STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG 116

Query: 105 RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE 164
            L     +   +Q +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+        
Sbjct: 117 -LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA-------- 167

Query: 165 LLHTTCGTPN----------YVAPEVLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGE 212
                               Y APEVL    Y  +  D+WS G I   +         G 
Sbjct: 168 ---RIYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFC-GN 222

Query: 213 TDLPTLYK-----------------KINAAEFSCPFW-----------FSTGATSLIHKI 244
           ++   L K                  +    F  P                    L+ ++
Sbjct: 223 SEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF--PPRGPRPVQSVVPEMEESGAQLLLEM 280

Query: 245 LDPNPKTRIRIEGIRKHPWFRKN 267
           L  NP  RI      +H +  K+
Sbjct: 281 LTFNPHKRISAFRALQHSYLHKD 303

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  161 bits (410), Expect = 2e-46
 Identities = 69/207 (33%), Positives = 102/207 (49%), Gaps = 11/207 (5%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +   IG G+F  V  A+    G  VA+K+L          V++  RE++IMK +RHPNI
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH--GSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNI 96

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA------HC 125
           V     +     + I+ E+++ G L+  +   G   + D RR      D VA      H 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD-VAKGMNYLHN 155

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
            +  + HR+LK  NLL+D    +KV DFGLS L         +  GTP ++APEVL +  
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP 215

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGE 212
            +   +DV+S GVIL+ L     P+G 
Sbjct: 216 SN-EKSDVYSFGVILWELATLQQPWGN 241

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  160 bits (406), Expect = 7e-46
 Identities = 72/257 (28%), Positives = 108/257 (42%), Gaps = 35/257 (13%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           EV   +G G F  V  A+ R   + VA+K +   +  K         E+  +  V HPNI
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERK-----AFIVELRQLSRVNHPNI 63

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID---AVAHCHS- 127
           V+L    A    V +++E+  GG L++ +     L            +     VA+ HS 
Sbjct: 64  VKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 128 --KGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
             K + HRDLKP NLLL + G  LK+ DFG +   Q     +    G+  ++APEV    
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGS 178

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---------SCPFWFST 235
            Y     DV+S G+IL+ ++    PF E   P    +I  A           + P     
Sbjct: 179 NYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTRPPLIKNLPKPIE- 234

Query: 236 GATSLIHKILDPNPKTR 252
              SL+ +    +P  R
Sbjct: 235 ---SLMTRCWSKDPSQR 248

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  159 bits (405), Expect = 2e-45
 Identities = 79/310 (25%), Positives = 123/310 (39%), Gaps = 66/310 (21%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQN-RETGESVAMKVLAKSTILKHRMVDQIK------- 57
           R   +YE    IGEG + KV  A++ +  G  VA+K        + R+    +       
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK--------RVRV-QTGEEGMPLST 58

Query: 58  -REISIMK---IVRHPNIVRLHEVLASR-----TKVYIILEFVTG--GELFDKIVHQGRL 106
            RE+++++      HPN+VRL +V         TK+ ++ E V        DK+  +  +
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGV 117

Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
                +    QL+  +   HS  V HRDLKP+N+L+ S G +K++DFGL+       ++ 
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMA 175

Query: 167 HTTC-GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--- 220
            T+   T  Y APEVL    Y  +  D+WS G I   +         G +D+  L K   
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLGKILD 233

Query: 221 --------------KINAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRI 255
                          +    F                       L+ K L  NP  RI  
Sbjct: 234 VIGLPGEEDWPRDVALPRQAF--HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 291

Query: 256 EGIRKHPWFR 265
                HP+F+
Sbjct: 292 YSALSHPYFQ 301

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  157 bits (398), Expect = 1e-44
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 31/220 (14%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
             G  +G+G F +     +RETGE + MK L +             +E+ +M+ + HPN+
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNV 69

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVAH 124
           ++   VL    ++  I E++ GG L   I              + Q +         +A+
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP------WSQRVSFAKDIASGMAY 123

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--------------TTC 170
            HS  + HRDL   N L+    N+ V+DFGL+ L                       T  
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           G P ++APE+++ R YD    DV+S G++L  ++      
Sbjct: 184 GNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNAD 222

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  159 bits (403), Expect = 3e-44
 Identities = 83/301 (27%), Positives = 130/301 (43%), Gaps = 49/301 (16%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y   + IG G+F  V  A+  ++GE VA+K   K  +L+ +      RE+ IM+ + H 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---K--VLQDKR--FKNRELQIMRKLDHC 107

Query: 70  NIVRLHEVLASRT------KVYIILEFV--TGGELFDKIVHQGRLLEND-CRRYFQQLID 120
           NIVRL     S         + ++L++V  T   +        + L     + Y  QL  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C +  Y APE
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-SRYYRAPE 226

Query: 180 V-LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI--------------- 222
           +      Y  S+ DVWS G +L  L+ G   F G++ +  L + I               
Sbjct: 227 LIFGATDYT-SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285

Query: 223 -NAAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 269
            N  EF  P                  A +L  ++L+  P  R+       H +F +  +
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345

Query: 270 P 270
           P
Sbjct: 346 P 346

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  155 bits (394), Expect = 3e-44
 Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 27/275 (9%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +     IG+G+F +V    +  T + VA+K++          ++ I++EI+++     P 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 81

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           + + +      TK++II+E++ GG   D ++  G L E       ++++  + + HS+  
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+K  N+LL  +G +K++DFG++          +T  GTP ++APEV+    YD S 
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SK 199

Query: 191 ADVWSCGVILFVLMAGYLPFGET------------DLPTLYKKINAAEFSCPFWFSTGAT 238
           AD+WS G+    L  G  P  E             + PTL        +S P        
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN-----YSKPL------K 248

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 273
             +   L+  P  R   + + KH +  +N      
Sbjct: 249 EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  154 bits (392), Expect = 4e-44
 Identities = 66/266 (24%), Positives = 108/266 (40%), Gaps = 38/266 (14%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVL----AKSTILKHRMVDQIKREISIMKIVR 67
           E  + IG+G F  V   +  +    VA+K L    ++          + +RE+ IM  + 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA---- 123
           HPNIV+L           +++EFV  G+L+ +++ +   +        + ++D       
Sbjct: 82  HPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLDIALGIEY 137

Query: 124 -HCHSKGVYHRDLKPENLLLDSYG-----NLKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
               +  + HRDL+  N+ L S         KV+DFGLS   QQ V  +    G   ++A
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS---QQSVHSVSGLLGNFQWMA 194

Query: 178 PEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-------- 227
           PE +      Y    AD +S  +IL+ ++ G  PF E       K IN            
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIREEGLRPTIP 252

Query: 228 -SCPFWFSTGATSLIHKILDPNPKTR 252
             CP        ++I      +PK R
Sbjct: 253 EDCPPRLR----NVIELCWSGDPKKR 274

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  151 bits (383), Expect = 7e-43
 Identities = 42/211 (19%), Positives = 84/211 (39%), Gaps = 20/211 (9%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
                + E    ++   + +  G  + +KVL K      R       E   ++I  HPN+
Sbjct: 13  NFLTKLNENHSGELWKGRWQ--GNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 72  VRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA------ 123
           + +     S       +I  ++  G L++ ++H+G     D  +  +  +D +A      
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAVKFALD-MARGMAFL 127

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           H     +    L   ++++D     ++S   +    Q            P +VAPE L  
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVAPEALQK 182

Query: 184 RGYDGS--AADVWSCGVILFVLMAGYLPFGE 212
           +  D +  +AD+WS  V+L+ L+   +PF +
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  152 bits (387), Expect = 3e-42
 Identities = 84/295 (28%), Positives = 128/295 (43%), Gaps = 50/295 (16%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y   + IG G+F  V  A+  E+ E VA+K   K  +L+ +      RE+ IM+IV+HP
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDE-VAIK---K--VLQDK--RFKNRELQIMRIVKHP 92

Query: 70  NIVRLHEVLASRT------KVYIILEFV--TGGELFDKIVHQGRLLEND-CRRYFQQLID 120
           N+V L     S         + ++LE+V  T            + +     + Y  QL+ 
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD   G LK+ DFG + +   G   +   C +  Y APE
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC-SRYYRAPE 211

Query: 180 V-LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI--------------- 222
           +      Y  +  D+WS G ++  LM G   F GE+ +  L + I               
Sbjct: 212 LIFGATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270

Query: 223 -NAAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            N  E   P                  A  LI ++L+  P  R+       HP+F
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  149 bits (377), Expect = 2e-41
 Identities = 70/260 (26%), Positives = 136/260 (52%), Gaps = 8/260 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
             +    IGEG+   V  A+ + +G  VA+K++    + K +  + +  E+ IM+  +H 
Sbjct: 46  LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHF 102

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           N+V +++      ++++++EF+ GG L D IV Q RL E       + ++ A+A+ H++G
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRD+K +++LL   G +K+SDFG  A   + V    +  GTP ++APEV+S   Y  +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA-T 220

Query: 190 AADVWSCGVILFVLMAGYLP-FGETDLPTLYK--KINAAEFSCPFWFSTGATSLIHKILD 246
             D+WS G+++  ++ G  P F ++ +  + +       +       S      + ++L 
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280

Query: 247 PNPKTRIRIEGIRKHPWFRK 266
            +P+ R   + +  HP+  +
Sbjct: 281 RDPQERATAQELLDHPFLLQ 300

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  147 bits (373), Expect = 3e-41
 Identities = 68/260 (26%), Positives = 125/260 (48%), Gaps = 8/260 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +    + +    + I  EI +M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNP 77

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRD+K +N+LL   G++K++DFG  A          T  GTP ++APEV++ + Y   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 190 AADVWSCGVILFVLMAGYLP-FGETDLPTLYK--KINAAEFSCPFWFSTGATSLIHKILD 246
             D+WS G++   ++ G  P   E  L  LY        E   P   S      +++ L+
Sbjct: 197 -VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255

Query: 247 PNPKTRIRIEGIRKHPWFRK 266
            + + R   + + +H + + 
Sbjct: 256 MDVEKRGSAKELLQHQFLKI 275

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  149 bits (377), Expect = 3e-41
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 6/243 (2%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++      K  + +QI RE+ ++     P 
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPY 92

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG- 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 209

Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
            +D+WS G+ L  +  G  P    D   L                    +    +     
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269

Query: 250 KTR 252
            +R
Sbjct: 270 DSR 272

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  147 bits (372), Expect = 5e-41
 Identities = 78/266 (29%), Positives = 133/266 (50%), Gaps = 13/266 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +E+   +G+G F KV  A+N+ETG   A KV+   +  +   ++    EI I+    HP
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHP 76

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSK 128
            IV+L        K++I++EF  GG +   ++   R L     +   +Q+++A+   HSK
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-----LSN 183
            + HRDLK  N+L+   G+++++DFG+SA   + ++   +  GTP ++APEV     + +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYK--KINAAEFSCPFWFSTGATSL 240
             YD   AD+WS G+ L  +     P  E + +  L K  K +      P  +S      
Sbjct: 197 TPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRK 266
           +   LD NP+TR     + +HP+   
Sbjct: 256 LKIALDKNPETRPSAAQLLEHPFVSS 281

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  147 bits (374), Expect = 5e-41
 Identities = 76/299 (25%), Positives = 128/299 (42%), Gaps = 56/299 (18%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-H 68
            Y++ R +G G +++V  A N    E V +K      ILK     +IKREI I++ +R  
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRGG 90

Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   +  E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 91  PNIITLADIVKDPVSRTPALVF-EHVNNTDF--KQLYQ-TLTDYDIRFYMYEILKALDYC 146

Query: 126 HSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-SN 183
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E       +  +  PE+L   
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV-RVASRYFKGPELLVDY 205

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF--------------------GETDLPTLYKKIN 223
           + YD  + D+WS G +L  ++    PF                       D    Y    
Sbjct: 206 QMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264

Query: 224 AAEF--SCPFW----------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
              F                        S  A   + K+L  + ++R+      +HP+F
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  147 bits (372), Expect = 7e-41
 Identities = 54/261 (20%), Positives = 104/261 (39%), Gaps = 29/261 (11%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           E+G  IG+G F +V   +       VA++++          +   KRE+   +  RH N+
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGE---VAIRLI-DIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKGV 130
           V       S   + II     G  L+  +     +L+ +  R   Q+++  + + H+KG+
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLS-----ALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
            H+DLK +N+  D+ G + ++DFGL          +  + L    G   ++APE++    
Sbjct: 152 LHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 186 YDGS--------AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA------AEFSCPF 231
            D           +DV++ G I + L A   PF       +  ++        ++     
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270

Query: 232 WFSTGATSLIHKILDPNPKTR 252
             S     ++        + R
Sbjct: 271 EIS----DILLFCWAFEQEER 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  145 bits (368), Expect = 1e-40
 Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 10/204 (4%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            VG+ IG G+F  V   +       VA+K+L   T    + +   K E+ +++  RH NI
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGD---VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKGV 130
           +      ++  ++ I+ ++  G  L+  +       E        +Q    + + H+K +
Sbjct: 83  LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPEVLSNRGYD- 187
            HRDLK  N+ L     +K+ DFGL+    +           G+  ++APEV+  +  + 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 188 -GSAADVWSCGVILFVLMAGYLPF 210
               +DV++ G++L+ LM G LP+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPY 225

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  145 bits (369), Expect = 2e-40
 Identities = 71/262 (27%), Positives = 131/262 (50%), Gaps = 12/262 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            ++V   +GEG++  V  A ++ETG+ VA+K +     ++   + +I +EISIM+    P
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESD-LQEIIKEISIMQQCDSP 84

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           ++V+ +      T ++I++E+   G + D I +    L E++     Q  +  + + H  
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
              HRD+K  N+LL++ G+ K++DFG++      +   +T  GTP ++APEV+   GY+ 
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204

Query: 189 SAADVWSCGVILFVLMAGYLP--FGETDLPTLYK--KINAAEFSCPFWFSTGATSLIHKI 244
             AD+WS G I  + MA   P       +  ++         F  P  +S   T  + + 
Sbjct: 205 V-ADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC 262

Query: 245 LDPNPKTRIRIEGIRKHPWFRK 266
           L  +P+ R     + +HP+ R 
Sbjct: 263 LVKSPEQRATATQLLQHPFVRS 284

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  145 bits (369), Expect = 2e-40
 Identities = 77/311 (24%), Positives = 129/311 (41%), Gaps = 35/311 (11%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHP 69
            E    +G GT  +V   + R+TG  +A+K + +S         +I  ++ + +K    P
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHDCP 84

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK- 128
            IV+      + T V+I +E +       K   QG + E    +    ++ A+ +   K 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH-----TTCGTPNYVAPEVL-- 181
           GV HRD+KP N+LLD  G +K+ DFG+S        L+       + G   Y+APE +  
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG------RLVDDKAKDRSAGCAAYMAPERIDP 198

Query: 182 ---SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKI---NAAEFSCPFWFS 234
              +   YD   ADVWS G+ L  L  G  P+        +  K+             FS
Sbjct: 199 PDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257

Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQ 294
               S +   L  + + R +   + +H + ++        E  EV   DV + F D+  +
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR-------YETLEV---DVASWFKDVMAK 307

Query: 295 YVAEQSENKVG 305
             + +S    G
Sbjct: 308 TESPRSGPSSG 318

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  143 bits (363), Expect = 5e-40
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 24/216 (11%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREISIMKIVRHPN 70
            +   IG G F KV  A     G+ VA+K           + ++ +++E  +  +++HPN
Sbjct: 10  TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA---VAHCHS 127
           I+ L  V      + +++EF  GG L   ++   R+            +     + + H 
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRI---PPDILVNWAVQIARGMNYLHD 123

Query: 128 KGVY---HRDLKPENLLLDSYG--------NLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           + +    HRDLK  N+L+             LK++DFGL+    +  ++  +  G   ++
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAYAWM 181

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
           APEV+    +    +DVWS GV+L+ L+ G +PF  
Sbjct: 182 APEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRG 216

>2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123

 Score =  138 bits (348), Expect = 7e-40
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 7/127 (5%)

Query: 306 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 365
           G   MNAF++I+ S G NL+ LF   +    R  RFVS   A+ ++  +E +  + +L V
Sbjct: 2   GARRMNAFDIISGSPGFNLSGLFGDARK-YDRVERFVSAWTAERVVERLEEIVSAENLTV 60

Query: 366 HTR-NYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKN-FCAK 423
             +  +  ++EG      G FA+V+E+ ++   L M++VRK           + +     
Sbjct: 61  AKKETWGMKIEGQK----GNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPF 116

Query: 424 LENIIWK 430
              ++ +
Sbjct: 117 FVELVHE 123

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  140 bits (355), Expect = 1e-38
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 3/215 (1%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y++   +G G  + V  A++      VA+K +      K   + + +RE+     + H N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV + +V       Y+++E++ G  L + I   G L  +    +  Q++D + H H   +
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KP+N+L+DS   LK+ DFG++ AL +  +   +   GT  Y +PE  +       
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAKGEATDE 191

Query: 190 AADVWSCGVILFVLMAGYLPF-GETDLPTLYKKIN 223
             D++S G++L+ ++ G  PF GET +    K I 
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ 226

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  140 bits (354), Expect = 2e-38
 Identities = 76/284 (26%), Positives = 127/284 (44%), Gaps = 35/284 (12%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG G  A V+ A      E VA+K   L K        +D++ +EI  M    H
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT----SMDELLKEIQAMSQCHH 72

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV------ 122
           PNIV  +     + +++++++ ++GG + D I H     E+      +  I  +      
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 123 --AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL-----HTTCGTPNY 175
              + H  G  HRD+K  N+LL   G+++++DFG+SA    G ++       T  GTP +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 176 VAPEVLS-NRGYDGSAADVWSCGVILFVLMAGYLPFGET------------DLPTLYKKI 222
           +APEV+   RGYD   AD+WS G+    L  G  P+ +             D P+L  + 
Sbjct: 193 MAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL--ET 249

Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
              +      +      +I   L  +P+ R     + +H +F+K
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  141 bits (357), Expect = 3e-38
 Identities = 83/333 (24%), Positives = 129/333 (38%), Gaps = 81/333 (24%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY +G+T+G G+F  V    + E+G+  A+K   K             RE+ IMK++ H 
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALK---KVLQDPRY----KNRELDIMKVLDHV 60

Query: 70  NIVRLHEVLASRTK--------------------------------------VYIILEFV 91
           NI++L +   +                                         + +I+E+V
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 92  --TGGELFDKIVHQGRLLEND-CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GN 147
             T  ++    +  GR +  +    Y  QL  AV   HS G+ HRD+KP+NLL++S    
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180

Query: 148 LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-LSNRGYDGSAADVWSCGVILFVLMAG 206
           LK+ DFG +         +   C +  Y APE+ L    Y   + D+WS G +   L+ G
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLWSIGCVFGELILG 238

Query: 207 YLPF-GETDL------------PTL--YKKIN--AAEFSCPFW----FS--------TGA 237
              F GET +            PT     ++N    E   P      +         + A
Sbjct: 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             L+ +IL   P  RI       HP+F    N 
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPFFDHLRNS 331

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  140 bits (355), Expect = 4e-38
 Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 8/192 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +   R IG G+F  V FA++    E VA+K ++ S    +     I +E+  ++ +RHP
Sbjct: 55  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           N ++           ++++E+  G       VH+  L E +        +  +A+ HS  
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR---GY 186
           + HRD+K  N+LL   G +K+ DFG +++        ++  GTP ++APEV+       Y
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQY 230

Query: 187 DGSAADVWSCGV 198
           DG   DVWS G+
Sbjct: 231 DGK-VDVWSLGI 241

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  138 bits (350), Expect = 1e-37
 Identities = 71/303 (23%), Positives = 124/303 (40%), Gaps = 55/303 (18%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHP 69
            +    IG G +  V    ++ +G+ +A+K +   + +  +   Q+  ++ + M+    P
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV------HQGRLLENDCRRYFQQLIDAVA 123
            IV+ +  L      +I +E ++    FDK            + E    +     + A+ 
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 124 HCHSKG-VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT-----TCGTPNYVA 177
           H      + HRD+KP N+LLD  GN+K+ DFG+S       +L+ +       G   Y+A
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG------QLVDSIAKTRDAGCRPYMA 193

Query: 178 PEVL----SNRGYDGSAADVWSCGVILFVLMAGYLPFGET-------------DLPTLYK 220
           PE +    S +GYD   +DVWS G+ L+ L  G  P+ +              D P L  
Sbjct: 194 PERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL-S 251

Query: 221 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVN 280
                EFS  F       + ++  L  +   R + + + KHP+           EE  V 
Sbjct: 252 NSEEREFSPSF------INFVNLCLTKDESKRPKYKELLKHPFILM-------YEERAVE 298

Query: 281 LDD 283
           +  
Sbjct: 299 VAC 301

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  140 bits (355), Expect = 1e-37
 Identities = 67/334 (20%), Positives = 120/334 (35%), Gaps = 78/334 (23%)

Query: 2   KKQTRRVAKYEV-GRTIGEGTFAKVRFAQNRE--TGESVAMKVLAKSTILKHRMVDQIKR 58
            ++ R    +E  G  +G GT+  V  A+ ++    +  A+K +  + I          R
Sbjct: 13  SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACR 67

Query: 59  EISIMKIVRHPNIVRLHEVLASRT--KVYIILEFV--------TGGELFDKIVHQGRLLE 108
           EI++++ ++HPN++ L +V  S    KV+++ ++                      +L  
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127

Query: 109 NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN----LKVSDFGLSALPQQGVE 164
              +    Q++D + + H+  V HRDLKP N+L+   G     +K++D G + L      
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL--FNSP 185

Query: 165 LLHTTCGTPN-----YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG------------ 206
           L       P      Y APE+L   R Y   A D+W+ G I   L+              
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244

Query: 207 -----------------------------YLPFGETDLPTLYKKINAAEFSCPF------ 231
                                         +P   T +    +          +      
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304

Query: 232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
              + A  L+ K+L  +P  RI  E   + P+F 
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  138 bits (351), Expect = 2e-37
 Identities = 89/339 (26%), Positives = 139/339 (41%), Gaps = 69/339 (20%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRH 68
            +++   +GEG +  V  A ++ TGE VA+K   K       +      REI I+K  +H
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFKH 68

Query: 69  PNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQ---GRLLENDCRRYFQ-QLI 119
            NI+ +  +    +      VYII E      L    +H+    ++L +D  +YF  Q +
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQE------LMQTDLHRVISTQMLSDDHIQYFIYQTL 122

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NY 175
            AV   H   V HRDLKP NLL++S  +LKV DFGL+  + +   +    T        +
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 176 V------APEV-LSNRGYDGSAADVWSCGVILFVLMAG--------YL------------ 208
           V      APEV L++  Y   A DVWSCG IL  L           Y             
Sbjct: 183 VATRWYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 209 PFGETDLPTLYKKINAAEF--SCPFW----FST-------GATSLIHKILDPNPKTRIRI 255
           P  + DL  +     A E+  S P +                  L+ ++L  +P  RI  
Sbjct: 242 PHSDNDLRCIESP-RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300

Query: 256 EGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQ 294
           +   +HP+ +  ++P     +E        + F+    +
Sbjct: 301 KEALEHPYLQTYHDP----NDEPEGEPIPPSFFEFDHYK 335

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  136 bits (346), Expect = 3e-37
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 11/214 (5%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL----AKSTILKHRMVDQIKREIS 61
            +   Y + R +G G    V  A++      VA+K++    +   + + RM    +RE  
Sbjct: 31  TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRM----QREAR 86

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
               ++ P++V +H+      ++Y+ +  + G +L   +  QG L         +Q+  A
Sbjct: 87  TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYVAPEV 180
           +   H+ G  HRD+KPEN+L+ +     + DFG+ SA   + +  L  T GT  Y+APE 
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GET 213
            S        AD+++   +L+  + G  P+ G+ 
Sbjct: 207 FSESHATY-RADIYALTCVLYECLTGSPPYQGDQ 239

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  137 bits (347), Expect = 4e-37
 Identities = 73/289 (25%), Positives = 132/289 (45%), Gaps = 35/289 (12%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRHP 69
           +E+   +G GT+ +V   ++ +TG+  A+KV+     +     ++IK+EI+++K    H 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 81

Query: 70  NIVRLHE------VLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDA 121
           NI   +             ++++++EF   G + D  K      L E       ++++  
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           ++H H   V HRD+K +N+LL     +K+ DFG+SA   + V   +T  GTP ++APEV+
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 182 -----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT--LYK-------KINAAEF 227
                 +  YD   +D+WS G+    +  G  P  +   P   L+        ++ + ++
Sbjct: 202 ACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW 259

Query: 228 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEE 276
           S  F       S I   L  N   R   E + KHP+ R   N  +   +
Sbjct: 260 SKKF------QSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQ 302

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  138 bits (349), Expect = 5e-37
 Identities = 46/204 (22%), Positives = 91/204 (44%), Gaps = 19/204 (9%)

Query: 10  KYEVGRTIGEG--TFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKI 65
            YE+   IG+G      V  A+ + TGE V ++   L   +   + MV  ++ E+ + K+
Sbjct: 26  CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS---NEMVTFLQGELHVSKL 82

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVA 123
             HPNIV       +  +++++  F+  G   D         + E       Q ++ A+ 
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQG------VELLHTTCGTPNYV 176
           + H  G  HR +K  ++L+   G + +S    +  +   G       +    +     ++
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 177 APEVL--SNRGYDGSAADVWSCGV 198
           +PEVL  + +GYD + +D++S G+
Sbjct: 203 SPEVLQQNLQGYD-AKSDIYSVGI 225

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  137 bits (348), Expect = 5e-37
 Identities = 83/342 (24%), Positives = 142/342 (41%), Gaps = 65/342 (19%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI---V 66
           +++V R  G+GTF  V+  + + TG SVA+K   K  +++        RE+ IM+    +
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---K--VIQDPRFR--NRELQIMQDLAVL 76

Query: 67  RHPNIVRLHEVLASRTK-------VYIILEFV--TGGELFDKIVHQGRLLENDCRRYFQ- 116
            HPNIV+L     +  +       + +++E+V  T          +         + F  
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136

Query: 117 QLIDAVA--HCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
           QLI ++   H  S  V HRD+KP N+L++ + G LK+ DFG +         +   C + 
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC-SR 195

Query: 174 NYVAPEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDL------------PTL- 218
            Y APE+   N+ Y  +A D+WS G I   +M G   F G+               P+  
Sbjct: 196 YYRAPELIFGNQHYT-TAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254

Query: 219 -YKKINA--AEFSCPFW--------FSTG-------ATSLIHKILDPNPKTRIRIEGIRK 260
             +K+N    +              FS         A  L+  +L   P+ R++      
Sbjct: 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314

Query: 261 HPWFRKNYNPVKCSEEEEVNLDDVHAV---FDDIEDQYVAEQ 299
           HP+F + ++P      +  N  D+      F   E + ++E 
Sbjct: 315 HPYFDELHDP----ATKLPNNKDLPEDLFRFLPNEIEVMSEA 352

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  136 bits (344), Expect = 7e-37
 Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 9/221 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 71  IVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           IV +++       +    YI++E+V G  L D +  +G +              A+   H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLSN 183
             G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE  + 
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QAR 192

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKIN 223
                + +DV+S G +L+ ++ G  PF G++ +   Y+ + 
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  135 bits (341), Expect = 1e-36
 Identities = 65/290 (22%), Positives = 118/290 (40%), Gaps = 37/290 (12%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHP 69
            E    +G G +  V   ++  +G+ +A+K +  +  +  +   ++  ++ I M+ V  P
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV-----HQGRLLENDCRRYFQQLIDAVAH 124
             V  +  L     V+I +E +      DK           + E+   +    ++ A+ H
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 125 CHSKG-VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL-----HTTCGTPNYVAP 178
            HSK  V HRD+KP N+L+++ G +K+ DFG+S        L+         G   Y+AP
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG------YLVDDVAKDIDAGCKPYMAP 178

Query: 179 EVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLP--TLYKKINAAEFSCP-F 231
           E ++      GY    +D+WS G+ +  L     P+     P   L + +       P  
Sbjct: 179 ERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237

Query: 232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
            FS        + L  N K R     + +HP+F          E +  ++
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL-------HESKGTDV 280

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  138 bits (348), Expect = 2e-36
 Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 56/234 (23%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMK---------VLAKSTILKHRMVDQIKREI 60
           +YE+   IG G++  V  A ++     VA+K         +  K  +          REI
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----------REI 103

Query: 61  SIMKIVRHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF 115
           +I+  + H ++V++ +++  +      ++Y++LE     +   K+      L     +  
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHIKTL 161

Query: 116 Q-QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVELLHTTCG 171
              L+  V + HS G+ HRDLKP N L++   ++KV DFGL+     P+ G   L  +  
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221

Query: 172 TPN------------------YV------APEV-LSNRGYDGSAADVWSCGVIL 200
             +                  +V      APE+ L    Y   A DVWS G I 
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIF 274

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  135 bits (343), Expect = 3e-36
 Identities = 85/336 (25%), Positives = 138/336 (41%), Gaps = 65/336 (19%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKI 65
            +Y+  + IG G    V  A +     +VA+K L++   +     R      RE+ +MK 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMKC 80

Query: 66  VRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ-QL 118
           V H NI+ L  V   +        VYI++E +    L  +++     L+++   Y   Q+
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQME--LDHERMSYLLYQM 136

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  + H HS G+ HRDLKP N+++ S   LK+ DFGL A       ++     T  Y AP
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAP 195

Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----------LPT----LYKKIN 223
           EV+   GY     D+WS G I+  ++ G + F  TD           L T      KK+ 
Sbjct: 196 EVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254

Query: 224 --AAEF--SCPFW-----------------------FSTGATSLIHKILDPNPKTRIRIE 256
                +  + P +                        ++ A  L+ K+L  +   RI ++
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314

Query: 257 GIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE 292
              +HP+    Y+P   SE E           D+ E
Sbjct: 315 EALQHPYINVWYDP---SEAEAPPPKIPDKQLDERE 347

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  136 bits (344), Expect = 1e-35
 Identities = 84/341 (24%), Positives = 137/341 (40%), Gaps = 77/341 (22%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIV 66
           +Y+  + IG G    V  A +     +VA+K L++   +     R      RE+ +MK V
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMKCV 118

Query: 67  RHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ-QLI 119
            H NI+ L  V   +        VY+++E +    L  +++     L+++   Y   Q++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQME--LDHERMSYLLYQML 174

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 176
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+        +      TP YV   
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TP-YVVTR 227

Query: 177 ---APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----------LPT----L 218
              APEV+   GY     D+WS G I+  ++   + F   D           L T     
Sbjct: 228 YYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286

Query: 219 YKKIN--AAEF--SCPFW----FST-------------------GATSLIHKILDPNPKT 251
            KK+      +  + P +    F                      A  L+ K+L  +P  
Sbjct: 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346

Query: 252 RIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE 292
           RI ++   +HP+    Y+P   +E E           D+ E
Sbjct: 347 RISVDDALQHPYINVWYDP---AEVEAPPPQIYDKQLDERE 384

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  132 bits (334), Expect = 1e-35
 Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 28/224 (12%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +   +G+G + +V     +  GE+VA+K+ +     +       + E+    ++RH NI
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSS----RDEKSWFRETELYNTVMLRHENI 64

Query: 72  VRL----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +           S T++++I  +   G L+D  +    L    C R    +   +AH H 
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 128 K--------GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HTTCGTPNY 175
           +         + HRDLK +N+L+   G   ++D GL+ +  Q    L    +   GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 176 VAPEVLSNRGYDGSA-----ADVWSCGVILFVLMAGYLPFGETD 214
           +APEVL               D+W+ G++L+ +    +  G  +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  132 bits (333), Expect = 3e-35
 Identities = 73/315 (23%), Positives = 119/315 (37%), Gaps = 65/315 (20%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLA-KSTILKHRMVDQIKREISIMKIVRH 68
           +Y   + +G G    V  A + +  + VA+K +           +    REI I++ + H
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----REIKIIRRLDH 67

Query: 69  PNIVRLHEVLASRTK--------------VYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
            NIV++ E+L                   VYI+ E++   +L   ++ QG LLE   R +
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLEEHARLF 125

Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLS-ALPQQGVELLHTTCGT 172
             QL+  + + HS  V HRDLKP NL +++    LK+ DFGL+  +        H +   
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS--- 182

Query: 173 PNYV------APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPF--------------- 210
              +      +P + LS   Y   A D+W+ G I   ++ G   F               
Sbjct: 183 -EGLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240

Query: 211 ----GETDLPTLYKKINAAEFSCPFW----FST-------GATSLIHKILDPNPKTRIRI 255
                E D   L   I     +         +         A   + +IL  +P  R+  
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300

Query: 256 EGIRKHPWFRKNYNP 270
           E    HP+      P
Sbjct: 301 EEALSHPYMSIYSFP 315

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  132 bits (333), Expect = 7e-35
 Identities = 76/310 (24%), Positives = 128/310 (41%), Gaps = 65/310 (20%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKI 65
           A Y   + +G G +  V  A +  TG  VA+K L +   S +   R      RE+ ++K 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKH 80

Query: 66  VRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ-QL 118
           +RH N++ L +V             Y+++ F+ G +L   + H+   L  D  ++   Q+
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQM 137

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV-- 176
           +  + + H+ G+ HRDLKP NL ++    LK+ DFGL+    +  +   T      YV  
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMT-----GYVVT 188

Query: 177 ----APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--------- 222
               APEV L+   Y     D+WS G I+  ++ G   F  +D     K+I         
Sbjct: 189 RWYRAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247

Query: 223 ---------NAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRK 260
                     A  +    P              S  A +L+ K+L  + + R+       
Sbjct: 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307

Query: 261 HPWFRKNYNP 270
           HP+F   ++ 
Sbjct: 308 HPYFESLHDT 317

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  131 bits (332), Expect = 9e-35
 Identities = 87/313 (27%), Positives = 137/313 (43%), Gaps = 67/313 (21%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVR 67
            +Y     IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   R
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFR 83

Query: 68  HPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQ---GRLLENDCRRYFQ-QL 118
           H NI+ +++++ + T      VYI+ +      L +  +++    + L ND   YF  Q+
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQD------LMETDLYKLLKTQHLSNDHICYFLYQI 137

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTTCGTPNYV 176
           +  + + HS  V HRDLKP NLLL++  +LK+ DFGL   A P        T      YV
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYV 192

Query: 177 ------APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPF------------------- 210
                 APE+ L+++GY   + D+WS G IL  +++    F                   
Sbjct: 193 ATRWYRAPEIMLNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251

Query: 211 GETDLPTLYKKINAAEF--SCPFW----FST-------GATSLIHKILDPNPKTRIRIEG 257
            + DL  +     A  +  S P      ++         A  L+ K+L  NP  RI +E 
Sbjct: 252 SQEDLNCIINL-KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310

Query: 258 IRKHPWFRKNYNP 270
              HP+  + Y+P
Sbjct: 311 ALAHPYLEQYYDP 323

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  131 bits (332), Expect = 1e-34
 Identities = 77/309 (24%), Positives = 128/309 (41%), Gaps = 65/309 (21%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIV 66
           +Y+    +G G +  V  A + +TG  VA+K L++   S I   R      RE+ ++K +
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHM 85

Query: 67  RHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ-QLI 119
           +H N++ L +V            VY++   + G +L + +  Q   L +D  ++   Q++
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQIL 142

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 176
             + + HS  + HRDLKP NL ++    LK+ DFGL+          HT      YV   
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---------HTADEMTGYVATR 193

Query: 177 ---APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI---------- 222
              APE+ L+   Y+    D+WS G I+  L+ G   F  TD     K I          
Sbjct: 194 WYRAPEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252

Query: 223 --------NAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                   +A  +  S                +  A  L+ K+L  +   RI       H
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312

Query: 262 PWFRKNYNP 270
            +F + ++P
Sbjct: 313 AYFAQYHDP 321

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  130 bits (330), Expect = 1e-34
 Identities = 78/309 (25%), Positives = 127/309 (41%), Gaps = 64/309 (20%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKI 65
             Y     +G G +  V  A ++ +GE VA+K L++   S I   R      RE+ ++K 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKH 79

Query: 66  VRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           ++H N++ L +V    +        Y+++ F+   +L  KI+   +  E   +    Q++
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGL-KFSEEKIQYLVYQML 136

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 176
             + + HS GV HRDLKP NL ++    LK+ DFGL+    +  +   T      YV   
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMT-----GYVVTR 187

Query: 177 ---APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI---------- 222
              APEV LS   Y+    D+WS G I+  ++ G   F   D      +I          
Sbjct: 188 WYRAPEVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246

Query: 223 --------NAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                    A  +  S P              S  A  L+ K+L+ +   R+       H
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306

Query: 262 PWFRKNYNP 270
           P+F    +P
Sbjct: 307 PFFEPFRDP 315

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  129 bits (325), Expect = 5e-34
 Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 28/224 (12%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           ++ + IG+G + +V   + R  GE VA+KV   +           + EI    ++RH NI
Sbjct: 40  QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENI 93

Query: 72  VRL----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +       +   S T++Y+I ++   G L+D  +    L      +     +  + H H+
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 128 K--------GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HTTCGTPNY 175
           +         + HRDLK +N+L+   G   ++D GL+         +    +T  GT  Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 176 VAPEVLSNRGYDGS-----AADVWSCGVILFVLMAGYLPFGETD 214
           + PEVL              AD++S G+IL+ +    +  G  +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  133 bits (335), Expect = 9e-34
 Identities = 55/215 (25%), Positives = 85/215 (39%), Gaps = 19/215 (8%)

Query: 11  YEVGRTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           YEV   I  G    +  A      G  V +K L  S             E   +  V HP
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHP 139

Query: 70  NIVRLHEV-----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           +IV++               YI++E+V G  L        +L   +   Y  +++ A+++
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSY 197

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYVAPEVLSN 183
            HS G+ + DLKPEN++L     LK+ D G  S +   G        GTP + APE++  
Sbjct: 198 LHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINSFG-----YLYGTPGFQAPEIV-- 249

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
           R     A D+++ G  L  L           +  L
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL 284

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  127 bits (322), Expect = 2e-33
 Identities = 73/337 (21%), Positives = 126/337 (37%), Gaps = 68/337 (20%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMK-------VLAKSTILKHRMVDQ-IKREIS 61
            Y V R I  G++  V    +   G  VA+K             IL    + + + REI 
Sbjct: 23  PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81

Query: 62  IMKIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 116
           ++    HPNI+ L ++     +     +Y++ E +   +L   I  Q  ++     +YF 
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM 140

Query: 117 -QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
             ++  +   H  GV HRDL P N+LL    ++ + DF L+                 +Y
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-------THY 193

Query: 176 V------APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----------LPT 217
           V      APE+ +  +G+     D+WS G ++  +      F  +            + T
Sbjct: 194 VTHRWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252

Query: 218 ----LYKKI---NAAEF---SCPFW-----------FSTGATSLIHKILDPNPKTRIRIE 256
                       +A ++   S                   A  LI K+L+ NP+ RI  E
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312

Query: 257 GIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIED 293
              +HP+F   ++P    +  E   +  H  FD+   
Sbjct: 313 QALRHPYFESLFDP---LDLTEGLSERFH--FDESVT 344

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  129 bits (325), Expect = 2e-33
 Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 51/235 (21%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMK---------VLAKSTILKHRMVDQIKREI 60
            Y +   IG G++  V  A ++ T ++VA+K         +  K  +          REI
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL----------REI 76

Query: 61  SIMKIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYF 115
           +I+  ++   I+RL++++          +YI+LE     +L  K+      L  +  +  
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDL-KKLFKTPIFLTEEHIKTI 134

Query: 116 Q-QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------------ALPQQ 161
              L+      H  G+ HRDLKP N LL+   ++KV DFGL+              L + 
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 162 GVELLHTTCGTP---NYV------APEV-LSNRGYDGSAADVWSCGVILFVLMAG 206
                H         ++V      APE+ L    Y   + D+WS G I   L+  
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNM 248

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  126 bits (318), Expect = 6e-33
 Identities = 47/210 (22%), Positives = 93/210 (44%), Gaps = 28/210 (13%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +  +IG+G F +V   + R  GE VA+K+ +             + EI    ++RH NI
Sbjct: 45  VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI 98

Query: 72  VRL----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +      ++   + T+++++ ++   G LFD  +++  +      +        +AH H 
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 128 K--------GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HTTCGTPNY 175
           +         + HRDLK +N+L+   G   ++D GL+       + +    +   GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 176 VAPEVLSNRGYDGS-----AADVWSCGVIL 200
           +APEVL +            AD+++ G++ 
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVF 247

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  127 bits (320), Expect = 7e-33
 Identities = 82/347 (23%), Positives = 128/347 (36%), Gaps = 102/347 (29%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMK---------VLAKSTILKHRMVDQIKRE 59
            KYE+ + +G+G +  V  + +R TGE VA+K           A+ T           RE
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----------RE 58

Query: 60  ISIMKIVR-HPNIVRLHEVLA--SRTKVYIILEFVTGGELFDKIVHQ---GRLLENDCRR 113
           I I+  +  H NIV L  VL   +   VY++ +        +  +H      +LE   ++
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFD------YMETDLHAVIRANILEPVHKQ 112

Query: 114 YFQ-QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT 172
           Y   QLI  + + HS G+ HRD+KP N+LL++  ++KV+DFGLS        + +    +
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 173 PN---------------YV------APEV-LSNRGYDGSAADVWSCGVILFVLMAG---- 206
            N               YV      APE+ L +  Y     D+WS G IL  ++ G    
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIF 231

Query: 207 ----------------------------------YL---------PFGETDLPTLYKKIN 223
                                              +                     K  
Sbjct: 232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL 291

Query: 224 AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             + +     +  A  L+ K+L  NP  RI      KHP+    +NP
Sbjct: 292 LLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP 338

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  122 bits (309), Expect = 7e-32
 Identities = 47/224 (20%), Positives = 86/224 (38%), Gaps = 27/224 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
             ++      G F  V  AQ     E VA+K+         +   Q + E+  +  ++H 
Sbjct: 25  PLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHE 78

Query: 70  NIVRL----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           NI++         +    +++I  F   G L D  +    +  N+     + +   +A+ 
Sbjct: 79  NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD-FLKANVVSWNELCHIAETMARGLAYL 137

Query: 126 HSKGVY----------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTP 173
           H               HRD+K +N+LL +     ++DFGL+   + G     T    GT 
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197

Query: 174 NYVAPEVLSNRGYDGS----AADVWSCGVILFVLMAGYLPFGET 213
            Y+APEVL              D+++ G++L+ L +        
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  120 bits (302), Expect = 3e-31
 Identities = 30/207 (14%), Positives = 63/207 (30%), Gaps = 30/207 (14%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y +    G     +   A +      VA+  +    +L   ++ +       +  +  P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           + R+ +V+ +R    ++ E++ GG L +  V           R  Q L  A    H  GV
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
                 P  + +   G++ ++                        +              
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA--------NPQ 182

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPT 217
            D+   G  L+ L+    P  E  + +
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRS 209

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  117 bits (294), Expect = 2e-29
 Identities = 62/327 (18%), Positives = 122/327 (37%), Gaps = 79/327 (24%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-- 67
           +Y + R +G G F+ V  A++      VAMK++ +         +  + EI +++ V   
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RG---DKVYTEAAEDEIKLLQRVNDA 75

Query: 68  ---------HPNIVRLHE--VLASRTKVYIILEF-VTGGELFD--KIVHQGRLLENDCRR 113
                      +I++L +         V++++ F V G  L    K      +     ++
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135

Query: 114 YFQQLIDAVAHCHSK-GVYHRDLKPENLLLD------SYGNLKVSDFGLSALPQQGVELL 166
             +QL+  + + H + G+ H D+KPEN+L++      +   +K++D G +       E  
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHY 192

Query: 167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----- 221
             +  T  Y +PEVL    +    AD+WS   ++F L+ G   F   +  +  K      
Sbjct: 193 TNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251

Query: 222 -------------INAAEFSCPFWFSTGAT------------------------------ 238
                        +   +++  F+ S G                                
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFR 265
             +  +L  +P+ R    G+  HPW +
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLK 338

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  116 bits (293), Expect = 3e-29
 Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 15/207 (7%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +G  IG G F +V   + R     VA+K   ++     +   +  +E  I+K   HPNI
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNI 174

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKGV 130
           VRL  V   +  +YI++E V GG+    +  +G  L               + +  SK  
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG------TPNYVAPEVLSNR 184
            HRDL   N L+     LK+SDFG+S     GV              T    APE L+  
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYG 290

Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            Y  S +DVWS G++L+     G  P+
Sbjct: 291 RYS-SESDVWSFGILLWETFSLGASPY 316

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  114 bits (287), Expect = 1e-28
 Identities = 45/219 (20%), Positives = 76/219 (34%), Gaps = 39/219 (17%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI--VRHP 69
           ++   IG G +  V           VA+K      +           E +I ++  + H 
Sbjct: 16  KLLELIGRGRYGAVYKGSLD--ERPVAVK------VFSFANRQNFINEKNIYRVPLMEHD 67

Query: 70  NIVRL-----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           NI R            R +  +++E+   G L    +           R    +   +A+
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVTRGLAY 126

Query: 125 CHS---------KGVYHRDLKPENLLLDSYGNLKVSDFGLS--------ALPQQGVELLH 167
            H+           + HRDL   N+L+ + G   +SDFGLS          P +      
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186

Query: 168 TTCGTPNYVAPEVLSNR------GYDGSAADVWSCGVIL 200
           +  GT  Y+APEVL                D+++ G+I 
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  114 bits (288), Expect = 3e-28
 Identities = 70/281 (24%), Positives = 115/281 (40%), Gaps = 43/281 (15%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
           +YEV + IG+G+F +V  A + +  + VA+K++      + R   Q   EI I++ +R  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQ 153

Query: 69  -----PNIVRLHEVLASRTKVYIILEFVTGGELFD---KIVHQGRLLENDCRRYFQQLID 120
                 N++ + E    R  + +  E +    L++   K   QG  L    R++   ++ 
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSL-PLVRKFAHSILQ 211

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
            +   H   + H DLKPEN+LL   G   +KV DFG S    Q V   +T   +  Y AP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTYIQSRFYRAP 268

Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGA 237
           EV+    Y     D+WS G IL  L+ GY    GE +   L                   
Sbjct: 269 EVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQL------------------- 308

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEE 278
            + + ++L    +  +     R   +      P  C+    
Sbjct: 309 -ACMIELLGMPSQKLLD-ASKRAKNFVSSKGYPRYCTVTTL 347

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  112 bits (282), Expect = 9e-28
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 11/206 (5%)

Query: 13  VGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   + +   +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           NI+RL  V+     V I+ E++  G L   +  H  +          + +   + +    
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNRG 185
           G  HRDL   N+L++S    KVSDFGL  + +   E  +TT G    +   +PE ++ R 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226

Query: 186 YDGSAADVWSCGVILF-VLMAGYLPF 210
           +  SA+DVWS G++L+ V+  G  P+
Sbjct: 227 FT-SASDVWSYGIVLWEVMSYGERPY 251

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  111 bits (280), Expect = 9e-28
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 11/207 (5%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
            + + IG G   +V + + R  G+    VA+K L      + R       E SIM    H
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDH 109

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHS 127
           PNI+RL  V+       I+ E++  G L   +  H G+          + +   + +   
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNR 184
            G  HRDL   N+L+DS    KVSDFGLS + +   +  +TT G    +   APE ++ R
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229

Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVWS GV+++ VL  G  P+
Sbjct: 230 TFS-SASDVWSFGVVMWEVLAYGERPY 255

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  113 bits (284), Expect = 2e-27
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 19/220 (8%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +   +G G + +V     ++   +VA+K L + T+     V++  +E ++MK ++HPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNL 278

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQQLIDAVAH 124
           V+L  V       YII EF+T G L D       + V    LL         Q+  A+ +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEY 333

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-YVAPEVLSN 183
              K   HR+L   N L+     +KV+DFGLS L        H     P  + APE L+ 
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393

Query: 184 RGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             +    +DVW+ GV+L+ +   G  P+   DL  +Y+ +
Sbjct: 394 NKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  110 bits (276), Expect = 2e-27
 Identities = 48/218 (22%), Positives = 93/218 (42%), Gaps = 9/218 (4%)

Query: 13  VGRTIGEGTFAKVRFA--QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
             + +G G F  V+    Q ++  ++VA+K+L K+      + D++  E ++M+ + +P 
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IVR+  +        +++E    G L   +     + + +      Q+   + +      
Sbjct: 80  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT--P-NYVAPEVLSNRGYD 187
            HRDL   N+LL +    K+SDFGLS   +              P  + APE ++   + 
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198

Query: 188 GSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA 224
            S +DVWS GV+++     G  P+       +   +  
Sbjct: 199 -SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  110 bits (278), Expect = 2e-27
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 12/207 (5%)

Query: 13  VGRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
             + IG G F +V     + +       VA+K L      K R       E  IM    H
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSH 105

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHS 127
            NI+RL  V++    + II E++  G L   +    G           + +   + +  +
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNR 184
               HRDL   N+L++S    KVSDFGLS + +   E  +TT G    +   APE +S R
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225

Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVWS G++++ V+  G  P+
Sbjct: 226 KFT-SASDVWSFGIVMWEVMTYGERPY 251

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  109 bits (275), Expect = 2e-27
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 10/205 (4%)

Query: 14  GRTIGEGTFAKVRFAQ-NRETGES--VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
              +G+G+F  VR  + +  +G++  VA+K L    + +   +D   RE++ M  + H N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           ++RL+ V      + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK 
Sbjct: 83  LIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNRGY 186
             HRDL   NLLL +   +K+ DFGL     Q  +               APE L  R +
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201

Query: 187 DGSAADVWSCGVILF-VLMAGYLPF 210
              A+D W  GV L+ +   G  P+
Sbjct: 202 S-HASDTWMFGVTLWEMFTYGQEPW 225

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  109 bits (274), Expect = 4e-27
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 13/197 (6%)

Query: 14  GRTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            R +GEG F KV       +   TGE VA+K L   +   H     +K+EI I++ + H 
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHE 83

Query: 70  NIVRLHEV--LASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCH 126
           NIV+   +        + +I+EF+  G L + +  ++ ++      +Y  Q+   + +  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSN 183
           S+   HRDL   N+L++S   +K+ DFGL+   +   E         + V   APE L  
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203

Query: 184 RGYDGSAADVWSCGVIL 200
             +   A+DVWS GV L
Sbjct: 204 SKFY-IASDVWSFGVTL 219

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  107 bits (269), Expect = 2e-26
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 20/200 (10%)

Query: 14  GRTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIK---REISIMKIV 66
            + +G+G F  V           TGE VA+K L      +H   + ++   REI I+K +
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL------QHSTEEHLRDFEREIEILKSL 68

Query: 67  RHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVA 123
           +H NIV+   V  S  +  + +I+E++  G L D +  H+ R+      +Y  Q+   + 
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEV 180
           +  +K   HRDL   N+L+++   +K+ DFGL+ +  Q  E         + +   APE 
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188

Query: 181 LSNRGYDGSAADVWSCGVIL 200
           L+   +   A+DVWS GV+L
Sbjct: 189 LTESKFS-VASDVWSFGVVL 207

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  107 bits (268), Expect = 4e-26
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 20/200 (10%)

Query: 14  GRTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIK---REISIMKIV 66
            + +G+G F  V           TGE VA+K L      +H   + ++   REI I+K +
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL------QHSTEEHLRDFEREIEILKSL 99

Query: 67  RHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVA 123
           +H NIV+   V  S  +  + +I+E++  G L D +  H+ R+      +Y  Q+   + 
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEV 180
           +  +K   HRDL   N+L+++   +K+ DFGL+ +  Q  E         + +   APE 
Sbjct: 160 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219

Query: 181 LSNRGYDGSAADVWSCGVIL 200
           L+   +   A+DVWS GV+L
Sbjct: 220 LTESKFS-VASDVWSFGVVL 238

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  106 bits (266), Expect = 4e-26
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 9/215 (4%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +   +G G + +V     ++   +VA+K L + T+     V++  +E ++MK ++HPN+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNL 71

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           V+L  V       YII EF+T G L D  +  ++  +          Q+  A+ +   K 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDG 188
             HRDL   N L+     +KV+DFGLS L        H     P  + APE L+   +  
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS- 190

Query: 189 SAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             +DVW+ GV+L+ +   G  P+   DL  +Y+ +
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  106 bits (267), Expect = 5e-26
 Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 12/217 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            + +G G F  V        GE     VA+K L ++T  K     +I  E  +M  V +P
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNP 77

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           ++ RL  +    + V +I + +  G L D +  H+  +       +  Q+   + +   +
Sbjct: 78  HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGY 186
            + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 187 DGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
               +DVWS GV ++ ++  G  P+       +   +
Sbjct: 197 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  107 bits (269), Expect = 6e-26
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 21/213 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+   IG+G+F +V  A +R   E VA+K++ K+   K   ++Q + E+ +++++   
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN---KKAFLNQAQIEVRLLELMNKH 110

Query: 70  ------NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDA 121
                  IV L      R  + ++ E +    L+D + +     +  N  R++ QQ+  A
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 122 VAHCHSK--GVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
           +    +    + H DLKPEN+LL +     +K+ DFG S+      + ++    +  Y +
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLG--QRIYQYIQSRFYRS 226

Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           PEVL    YD  A D+WS G IL  +  G   F
Sbjct: 227 PEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLF 258

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  105 bits (264), Expect = 1e-25
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 20/200 (10%)

Query: 14  GRTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIK---REISIMKIV 66
              +G+G F  V           TG  VA+K L      +H   DQ +   REI I+K +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL------QHSGPDQQRDFQREIQILKAL 81

Query: 67  RHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVA 123
               IV+   V     +  + +++E++  G L D +  H+ RL  +    Y  Q+   + 
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEV 180
           +  S+   HRDL   N+L++S  ++K++DFGL+ L     +         + +   APE 
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201

Query: 181 LSNRGYDGSAADVWSCGVIL 200
           LS+  +    +DVWS GV+L
Sbjct: 202 LSDNIFS-RQSDVWSFGVVL 220

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  105 bits (263), Expect = 1e-25
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 13/196 (6%)

Query: 14  GRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            R +GEG F KV        N  TGE VA+K L      +HR     K+EI I++ + H 
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHE 93

Query: 70  NIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +I++            + +++E+V  G L D  + +  +       + QQ+ + +A+ H+
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRD-YLPRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNR 184
           +   HRDL   N+LLD+   +K+ DFGL+    +G E         + V   APE L   
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212

Query: 185 GYDGSAADVWSCGVIL 200
            +   A+DVWS GV L
Sbjct: 213 KFY-YASDVWSFGVTL 227

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  104 bits (262), Expect = 1e-25
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 11/215 (5%)

Query: 17  IGEGTFAKVRFAQ-NRETGE-SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  VR         +  VA+KVL + T       +++ RE  IM  + +P IVRL
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 75

Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
             V      + +++E   GG L   +   +  +  ++      Q+   + +   K   HR
Sbjct: 76  IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT--P-NYVAPEVLSNRGYDGSA 190
           DL   N+LL +    K+SDFGLS                  P  + APE ++ R +  S 
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 193

Query: 191 ADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA 224
           +DVWS GV ++  L  G  P+ +   P +   I  
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  103 bits (259), Expect = 3e-25
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 35/225 (15%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           ++ +TIG+G F  V     R  G  VA+K +                E S+M  +RH N+
Sbjct: 24  KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNL 76

Query: 72  VRLHEV-LASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQQLIDAVA 123
           V+L  V +  +  +YI+ E++  G L D        ++    LL+     +   + +A+ 
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK-----FSLDVCEAME 131

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT--PNYV---AP 178
           +       HRDL   N+L+      KVSDFGL+       E   T      P  V   AP
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLP--VKWTAP 183

Query: 179 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
           E L  + +  + +DVWS G++L+ +   G +P+    L  +  ++
Sbjct: 184 EALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  106 bits (266), Expect = 3e-25
 Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 21/220 (9%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +   +G+G F +V       T   VA+K L   T+     +    +E  +MK +RH  +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKL 241

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQQLIDAVAH 124
           V+L+ V  S   +YI+ E+++ G L D       K +   +L++        Q+   +A+
Sbjct: 242 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 295

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSN 183
                  HRDL+  N+L+      KV+DFGL+ L +            P  + APE    
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 355

Query: 184 RGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             +    +DVWS G++L  +   G +P+       +  ++
Sbjct: 356 GRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  106 bits (267), Expect = 3e-25
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 23/221 (10%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +   +G+G F +V       T   VA+K L   T+     +    +E  +MK +RH  +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKL 324

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLID-------AVA 123
           V+L+ V  S   +YI+ E+++ G L D +    G+ L         QL+D        +A
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR------LPQLVDMAAQIASGMA 377

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLS 182
           +       HRDL+  N+L+      KV+DFGL+ L +            P  + APE   
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 437

Query: 183 NRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
              +    +DVWS G++L  +   G +P+       +  ++
Sbjct: 438 YGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  103 bits (260), Expect = 5e-25
 Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 12/217 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            + +G G F  V        GE     VA+K L ++T  K     +I  E  +M  V +P
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNP 77

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           ++ RL  +    + V +I + +  G L D +  H+  +       +  Q+   + +   +
Sbjct: 78  HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGY 186
            + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 187 DGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
               +DVWS GV ++ ++  G  P+       +   +
Sbjct: 197 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  104 bits (261), Expect = 5e-25
 Identities = 69/333 (20%), Positives = 120/333 (36%), Gaps = 87/333 (26%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
            + V R +G+GTF +V   Q+ +  +  A+KV+ ++     +     K E  I+K +++ 
Sbjct: 36  AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RN---IKKYTRSAKIEADILKKIQND 91

Query: 69  ----PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAV 122
                NIV+ H        + +I E   G  L++ I           D + Y  +++ A+
Sbjct: 92  DINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150

Query: 123 AHCHSKGVYHRDLKPENLLLDSYG-------------------------NLKVSDFGLSA 157
            +     + H DLKPEN+LLD                             +K+ DFG  A
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-CA 209

Query: 158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLP 216
             +   +   +   T  Y APEV+ N G+D  ++D+WS G +L  L  G L F     + 
Sbjct: 210 TFKS--DYHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEHME 266

Query: 217 TL-----------YKKINAAEFSCPFWF-------------STGATS------------- 239
            L              +  A  +    +             ++   S             
Sbjct: 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326

Query: 240 --------LIHKILDPNPKTRIRIEGIRKHPWF 264
                    ++ IL  +P  R     + KH + 
Sbjct: 327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  103 bits (259), Expect = 6e-25
 Identities = 52/217 (23%), Positives = 99/217 (45%), Gaps = 12/217 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            + +G G F  V        GES    V +KV+   +  +      +   +  +  + H 
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF--QAVTDHMLAIGSLDHA 75

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           +IVRL  +    + + ++ +++  G L D +  H+G L       +  Q+   + +    
Sbjct: 76  HIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
           G+ HR+L   N+LL S   ++V+DFG++  LP    +LL++   TP  ++A E +    Y
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194

Query: 187 DGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
               +DVWS GV ++ ++  G  P+    L  +   +
Sbjct: 195 T-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  102 bits (256), Expect = 6e-25
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 16/225 (7%)

Query: 9   AKYEV-------GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
            K+ +        + IG G F  V         + VA+K + +  + +    +    E  
Sbjct: 1   GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSE----EDFIEEAE 55

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLID 120
           +M  + HP +V+L+ V   +  + ++ EF+  G L D +   +G             + +
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
            +A+     V HRDL   N L+     +KVSDFG++           T    P  + +PE
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 175

Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKIN 223
           V S   Y  S +DVWS GV+++ V   G +P+       + + I+
Sbjct: 176 VFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  104 bits (262), Expect = 1e-24
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           ++ +TIG+G F  V     R  G  VA+K +                E S+M  +RH N+
Sbjct: 196 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNL 248

Query: 72  VRLHEV-LASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQQLIDAVA 123
           V+L  V +  +  +YI+ E++  G L D        ++    LL+     +   + +A+ 
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK-----FSLDVCEAME 303

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT--P-NYVAPEV 180
           +       HRDL   N+L+      KVSDFGL+       E   T      P  + APE 
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEA 357

Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
           L  + +  + +DVWS G++L+ +   G +P+    L  +  ++
Sbjct: 358 LREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  101 bits (253), Expect = 2e-24
 Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 11/215 (5%)

Query: 13  VGRTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + + +G G F  V+  +   +    VA+K++ + ++ +    D+  +E   M  + HP +
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKL 65

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           V+ + V +    +YI+ E+++ G L + +  H   L  +        + + +A   S   
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGS 189
            HRDL   N L+D    +KVSDFG++        +       P  + APEV     Y  S
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS-S 184

Query: 190 AADVWSCGVILF-VLMAGYLPFGETDLPTLYKKIN 223
            +DVW+ G++++ V   G +P+       +  K++
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  104 bits (261), Expect = 3e-24
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 11/215 (5%)

Query: 17  IGEGTFAKVRFAQNRETGES--VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  VR    R   +   VA+KVL + T       +++ RE  IM  + +P IVRL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 401

Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
             V      + +++E   GG L   +   +  +  ++      Q+   + +   K   HR
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNRGYDGSA 190
           +L   N+LL +    K+SDFGLS                   +   APE ++ R +  S 
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 519

Query: 191 ADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA 224
           +DVWS GV ++  L  G  P+ +   P +   I  
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  100 bits (252), Expect = 3e-24
 Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 14/207 (6%)

Query: 12  EVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           E+GR IGEG F  V        +N     +VA+K     T    R  ++  +E   M+  
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVR--EKFLQEALTMRQF 73

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 74  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192

Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 193 RFT-SASDVWMFGVCMWEILMHGVKPF 218

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =   99 bits (250), Expect = 5e-24
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 39/225 (17%)

Query: 10  KYEVGRT-------IGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
           +Y + R        +GEG F +V    +  ++    +VA+K   K   L ++  ++   E
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSE 63

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQL 118
             IMK + HP+IV+L  ++      +II+E    GEL   +  ++  L       Y  Q+
Sbjct: 64  AVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV-- 176
             A+A+  S    HRD+   N+L+ S   +K+ DFGLS   +             +Y   
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-----------DYYKA 171

Query: 177 ----------APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
                     +PE ++ R +  +A+DVW   V ++ +L  G  PF
Sbjct: 172 SVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPF 215

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 99.2 bits (248), Expect = 9e-24
 Identities = 52/215 (24%), Positives = 101/215 (46%), Gaps = 11/215 (5%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           ++   +G G F +V         + VA+K L + ++     +     E ++MK ++H  +
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFL----AEANLMKQLQHQRL 70

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           VRL+ V  ++  +YII E++  G L D +    G  L  +       Q+ + +A    + 
Sbjct: 71  VRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDG 188
             HRDL+  N+L+    + K++DFGL+ L +            P  + APE ++   +  
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT- 188

Query: 189 SAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             +DVWS G++L  ++  G +P+     P + + +
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  103 bits (257), Expect = 1e-23
 Identities = 68/205 (33%), Positives = 101/205 (49%), Gaps = 14/205 (6%)

Query: 14  GRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           GR IGEG F  V        +N     +VA+K     T    R  ++  +E   M+   H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAM--AVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 450

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHS 127
           P+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+  S
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
           K   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R +
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569

Query: 187 DGSAADVWSCGVILF-VLMAGYLPF 210
             SA+DVW  GV ++ +LM G  PF
Sbjct: 570 T-SASDVWMFGVCMWEILMHGVKPF 593

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 98.8 bits (247), Expect = 1e-23
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 9/215 (4%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
              + +G G F  V++ + R   + VA+K++ + ++ +    D+   E  +M  + H  +
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKL 81

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           V+L+ V   +  ++II E++  G L + +   + R          + + +A+ +  SK  
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGS 189
            HRDL   N L++  G +KVSDFGLS                P  +  PEVL    +  S
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-S 200

Query: 190 AADVWSCGVILF-VLMAGYLPFGETDLPTLYKKIN 223
            +D+W+ GV+++ +   G +P+         + I 
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 68/331 (20%), Positives = 112/331 (33%), Gaps = 81/331 (24%)

Query: 10  KYEVGRTIGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           +YE+   +GEGTF KV     +      VA+K++ ++     +  +  + EI+++K ++ 
Sbjct: 20  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RN---VGKYREAARLEINVLKKIKE 75

Query: 69  P------NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLID 120
                    V + +       + I  E + G   F+ +             R    QL  
Sbjct: 76  KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGN-------------------LKVSDFGLSALPQQ 161
           A+   H   + H DLKPEN+L  +                      ++V+DFG SA    
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFDH 193

Query: 162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTL-- 218
             E   T   T +Y  PEV+   G+     DVWS G ILF    G+  F    +   L  
Sbjct: 194 --EHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250

Query: 219 ---------YKKINAAEFSCPFW--------------------------------FSTGA 237
                       I+       F+                                     
Sbjct: 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQL 310

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY 268
             L+ ++L+ +P  RI +     HP+F    
Sbjct: 311 FDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 98.5 bits (246), Expect = 5e-23
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 37/229 (16%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETG-ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           +YE+  T+GEG F KV    + + G   VA+K++ K+     R  +  + EI +++ +  
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN---VDRYCEAARSEIQVLEHLNT 70

Query: 69  P------NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLID 120
                    V++ E       + I+ E + G   +D I   G      +  R+   Q+  
Sbjct: 71  TDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICK 129

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGN-------------------LKVSDFGLSALPQQ 161
           +V   HS  + H DLKPEN+L                         +KV DFG SA    
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SATYDD 188

Query: 162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
             E   T   T +Y APEV+   G+     DVWS G IL     G+  F
Sbjct: 189 --EHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVF 234

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.0 bits (242), Expect = 7e-23
 Identities = 47/223 (21%), Positives = 81/223 (36%), Gaps = 38/223 (17%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGES-------VAMKVLAKSTILKHRMVDQIKREISIMK 64
               ++G+GTF K+     RE G+        V +KVL K+        +      S+M 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMS 67

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVA 123
            + H ++V  + V     +  ++ EFV  G L   +  ++  +         +QL  A+ 
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNL--------KVSDFGLSALPQQGVELLHTTCGTPNY 175
                 + H ++  +N+LL    +         K+SD G+S                 + 
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-----------DI 176

Query: 176 -------VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
                  V PE + N      A D WS G  L+ +   G  P 
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 51/220 (23%), Positives = 104/220 (47%), Gaps = 21/220 (9%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           ++ + +G G F +V  A   +  + VA+K +   ++     +     E ++MK ++H  +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFL----AEANVMKTLQHDKL 245

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQQLIDAVAH 124
           V+LH V  ++  +YII EF+  G L D             +L++     +  Q+ + +A 
Sbjct: 246 VKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGMAF 299

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSN 183
              +   HRDL+  N+L+ +    K++DFGL+ + +            P  + APE ++ 
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 359

Query: 184 RGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             +    +DVWS G++L  ++  G +P+     P + + +
Sbjct: 360 GSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 17/230 (7%)

Query: 6   RRVAKYEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
                      IG G F  V       N       A+K L + T +      Q   E  I
Sbjct: 86  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGII 143

Query: 63  MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLID 120
           MK   HPN++ L  + L S     ++L ++  G+L + I          D   +  Q+  
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT--PNYV- 176
            +    SK   HRDL   N +LD    +KV+DFGL+  +  +  + +H   G   P  V 
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP--VK 261

Query: 177 --APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKIN 223
             A E L  + +  + +DVWS GV+L+ ++  G  P+ + +   +   + 
Sbjct: 262 WMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 17/229 (7%)

Query: 6   RRVAKYEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
                      IG G F  V       N       A+K L + T +      Q   E  I
Sbjct: 22  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGII 79

Query: 63  MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLID 120
           MK   HPN++ L  + L S     ++L ++  G+L + I          D   +  Q+  
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT--PNYV- 176
            + +  SK   HRDL   N +LD    +KV+DFGL+  +  +    +H   G   P  V 
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP--VK 197

Query: 177 --APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             A E L  + +  + +DVWS GV+L+ ++  G  P+ + +   +   +
Sbjct: 198 WMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 94.6 bits (236), Expect = 6e-22
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 29/229 (12%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
              R IG+G F  V   +  +  ++    A+K L++ T ++    +   RE  +M+ + H
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV--EAFLREGLLMRGLNH 81

Query: 69  PNIVRLHEV-LASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCH 126
           PN++ L  + L      +++L ++  G+L   I   Q      D   +  Q+   + +  
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS---------ALPQQGVELLHTTCGTPNYV- 176
            +   HRDL   N +LD    +KV+DFGL+         ++ Q     L      P  V 
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL------P--VK 193

Query: 177 --APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             A E L    +  + +DVWS GV+L+ +L  G  P+   D   L   +
Sbjct: 194 WTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 94.7 bits (236), Expect = 8e-22
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 44/241 (18%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
            +GR +G+G F  VR AQ ++   S   VA+K+L K+ I+    +++  RE + MK   H
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDH 84

Query: 69  PNIVRL------HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI--- 119
           P++ +L                 +IL F+  G+L   ++   R+ EN      Q L+   
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFNLPLQTLVRFM 143

Query: 120 ----DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
                 + +  S+   HRDL   N +L     + V+DFGLS         +++     +Y
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS-------RKIYSG----DY 192

Query: 176 -------------VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKK 221
                        +A E L++  Y    +DVW+ GV ++ ++  G  P+   +   +Y  
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251

Query: 222 I 222
           +
Sbjct: 252 L 252

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 33/218 (15%)

Query: 12  EVGRTIGEGTFAKVRFA-----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-I 65
             G+T+G G F KV  A        +   +VA+K+L  S  L  R  + +  E+ ++  +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLSYL 83

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGEL-----------FDKIVHQGRLLENDCRRY 114
             H NIV L           +I E+   G+L                    + +++    
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 115 FQQLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH 167
            + L+         +A   SK   HRDL   N+LL      K+ DFGL+   +     + 
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 168 TTCGT-PNYV---APEVLSNRGYDGSAADVWSCGVILF 201
                 P  V   APE + N  Y    +DVWS G+ L+
Sbjct: 204 KGNARLP--VKWMAPESIFNCVYT-FESDVWSYGIFLW 238

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 56/240 (23%), Positives = 100/240 (41%), Gaps = 43/240 (17%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
            +G+ +GEG F  V     ++   +   VA+K + K      R +++   E + MK   H
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95

Query: 69  PNIVRL-----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI---- 119
           PN++RL             K  +IL F+  G+L   +++  RL         Q L+    
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154

Query: 120 ---DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY- 175
                + +  ++   HRDL   N +L     + V+DFGLS       + +++     +Y 
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS-------KKIYSG----DYY 203

Query: 176 ------------VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
                       +A E L++R Y  S +DVW+ GV ++ +   G  P+       +Y  +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 52/220 (23%), Positives = 84/220 (38%), Gaps = 45/220 (20%)

Query: 14  GRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVR 67
           G+T+G G F KV  A        +    VA+K+L  +        + +  E+ IM  + +
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQ 108

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQQLID 120
           H NIV L         V +I E+   G+L +        +         +     + L+ 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 121 -------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
                   +A   SK   HRD+   N+LL +    K+ DFGL+                 
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA----------RDIMNDS 218

Query: 174 NYV------------APEVLSNRGYDGSAADVWSCGVILF 201
           NY+            APE + +  Y    +DVWS G++L+
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 55/219 (25%), Positives = 83/219 (37%), Gaps = 47/219 (21%)

Query: 14  GRTIGEGTFAKVRFAQNRETGES--VAMKVLAKSTILKHRMVDQIKREISIMK-IVRHPN 70
              IGEG F +V  A+ ++ G     A+K + +              E+ ++  +  HPN
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPN 87

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYF--QQLIDA 121
           I+ L      R  +Y+ +E+   G L D               + N        QQL+  
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 122 ---VA----HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN 174
              VA    +   K   HRDL   N+L+      K++DFGLS              G   
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------------GQEV 194

Query: 175 YV------------APEVLSNRGYDGSAADVWSCGVILF 201
           YV            A E L+   Y  + +DVWS GV+L+
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLW 232

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 50/233 (21%), Positives = 95/233 (40%), Gaps = 53/233 (22%)

Query: 12  EVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
            + R +G+G+F  V           E    VA+K + ++  ++ R+  +   E S+MK  
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEF 85

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI---- 119
              ++VRL  V++      +I+E +T G+L   +      + N+         ++I    
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 120 ---DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---------------ALPQQ 161
              D +A+ ++    HRDL   N ++     +K+ DFG++                LP  
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP-- 203

Query: 162 GVELLHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
                         V   +PE L +  +  + +DVWS GV+L+ +      P+
Sbjct: 204 --------------VRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPY 241

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 44/216 (20%), Positives = 74/216 (34%), Gaps = 34/216 (15%)

Query: 12  EVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
                +GE  F KV           E  ++VA+K L        R   + + E  +   +
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE--EFRHEAMLRARL 69

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFD---------KIVHQGRLLENDCRRYFQQ 117
           +HPN+V L  V+     + +I  + + G+L +          +                 
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 118 LIDAV-------AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC 170
            +  V        +  S  V H+DL   N+L+    N+K+SD GL               
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189

Query: 171 G------TPNYVAPEVLSNRGYDGSAADVWSCGVIL 200
                       APE +    +    +D+WS GV+L
Sbjct: 190 SLLPIRWM----APEAIMYGKFS-IDSDIWSYGVVL 220

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 48/214 (22%), Positives = 73/214 (34%), Gaps = 36/214 (16%)

Query: 12  EVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
            + R +G G F +V         N  +   VA+K L +    +  +      E  I+   
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 90

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI------- 119
            H NIVR   V       +I++E + GG+L   +                 L+       
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSAL-------PQQGVELLHTT 169
               +       HRD+   N LL   G     K+ DFG++          + G  +L   
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML--- 207

Query: 170 CGTPNYV---APEVLSNRGYDGSAADVWSCGVIL 200
              P  V    PE      +  S  D WS GV+L
Sbjct: 208 ---P--VKWMPPEAFMEGIFT-SKTDTWSFGVLL 235

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 49/214 (22%), Positives = 73/214 (34%), Gaps = 36/214 (16%)

Query: 12  EVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
            + R +G G F +V         N  +   VA+K L +    +  +      E  I+   
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 131

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI------- 119
            H NIVR   V       +I+LE + GG+L   +                 L+       
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSAL-------PQQGVELLHTT 169
               +       HRD+   N LL   G     K+ DFG++          + G  +L   
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML--- 248

Query: 170 CGTPNYV---APEVLSNRGYDGSAADVWSCGVIL 200
              P  V    PE      +  S  D WS GV+L
Sbjct: 249 ---P--VKWMPPEAFMEGIFT-SKTDTWSFGVLL 276

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 55/223 (24%), Positives = 85/223 (38%), Gaps = 38/223 (17%)

Query: 12  EVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-I 65
           E G+ +G G F KV  A             VA+K+L +      R    +  E+ +M  +
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE--ALMSELKMMTQL 105

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGEL----------------FDKIVHQGRLLEN 109
             H NIV L         +Y+I E+   G+L                  +   +    E+
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 110 DCRRYFQQLIDA---VA----HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQ 161
                F+ L+     VA        K   HRDL   N+L+     +K+ DFGL+  +   
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 162 GVELLHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVILF 201
              ++      P  V   APE L    Y    +DVWS G++L+
Sbjct: 226 SNYVVRGNARLP--VKWMAPESLFEGIYT-IKSDVWSYGILLW 265

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 53/230 (23%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
            + VG+ IG G F ++R  +N  T E VA+K+    +  +     Q+  E    K +   
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAP---QLHLEYRFYKQLGSG 64

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE---NDCRRYF---------Q 116
             I +++          ++LE              G  LE   + C R F          
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLEL------------LGPSLEDLFDLCDRTFSLKTVLMIAI 112

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVS-----DFGLS-----------ALPQ 160
           QLI  + + HSK + +RD+KPEN L+   GN         DF L+              +
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172

Query: 161 QGVELLHTTCGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLP 209
           +   L     GT  Y++  + ++ G + S   D+ + G +    + G LP
Sbjct: 173 EHKSL----TGTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 51/236 (21%), Positives = 91/236 (38%), Gaps = 46/236 (19%)

Query: 1   MKKQTRRVA-KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
           M  Q   V   Y+VGR IGEG+F  +    N    + VA+K   + +        Q++ E
Sbjct: 1   MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAP---QLRDE 55

Query: 60  ISIMKIVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE---NDCRRYF 115
               K++     I  ++          ++++              G  LE   + C R F
Sbjct: 56  YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL------------LGPSLEDLLDLCGRKF 103

Query: 116 ---------QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLK-----VSDFGLSAL--- 158
                    +Q++  V   H K + +RD+KP+N L+    +       V DFG+      
Sbjct: 104 SVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163

Query: 159 PQQGVELLHTT----CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLP 209
           P     + +       GT  Y++  + ++ G + S   D+ + G +    + G LP
Sbjct: 164 PVTKQHIPYREKKNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 50/228 (21%), Positives = 86/228 (37%), Gaps = 63/228 (27%)

Query: 14  GRTIGEGTFAKVR--FAQNRETGES---VAMKVLAKSTILKHRMVDQIK--REISIMKIV 66
            R +GEG F KV      N    +    VA+K L   T     +  +    RE  ++  +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-----LAARKDFQREAELLTNL 74

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFD---------KIVHQGRLLENDCRRYFQQ 117
           +H +IV+ + V      + ++ E++  G+L            I+  G+  +        Q
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 118 LI-------DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------------- 156
           ++         + +  S+   HRDL   N L+ +   +K+ DFG+S              
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194

Query: 157 -ALPQQGVELLHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVIL 200
             LP                +    PE +  R +  + +DVWS GVIL
Sbjct: 195 TMLP----------------IRWMPPESIMYRKFT-TESDVWSFGVIL 225

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 80.7 bits (200), Expect = 4e-17
 Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 54/229 (23%)

Query: 14  GRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           G+T+GEG F KV  A       R    +VA+K+L ++       +  +  E +++K V H
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNH 85

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGEL-----------------FDKIVHQGRLLENDC 111
           P++++L+   +    + +I+E+   G L                             ++ 
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 112 RRYFQQLI-------DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE 164
                 LI         + +     + HRDL   N+L+     +K+SDFGLS        
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS-------- 197

Query: 165 LLHTTCGTPNYV------------APEVLSNRGYDGSAADVWSCGVILF 201
                    +YV            A E L +  Y  + +DVWS GV+L+
Sbjct: 198 --RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 82.0 bits (202), Expect = 5e-17
 Identities = 59/228 (25%), Positives = 93/228 (40%), Gaps = 44/228 (19%)

Query: 7   RVA-KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           RV  K+ +GR IG G+F ++    N +T E VA+K+    T  KH    Q+  E  I +I
Sbjct: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHP---QLLYESKIYRI 58

Query: 66  VR-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE---NDCRRYF------ 115
           ++    I  +           ++++              G  LE   N C R        
Sbjct: 59  LQGGTGIPNVRWFGVEGDYNVLVMDL------------LGPSLEDLFNFCSRKLSLKTVL 106

Query: 116 ---QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSAL---PQQGVELL 166
               Q+I+ V   HSK   HRD+KP+N L+        + + DFGL+           + 
Sbjct: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166

Query: 167 HTT----CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLP 209
           +       GT  Y +  V ++ G + S   D+ S G +L   + G LP
Sbjct: 167 YRENKNLTGTARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 32/215 (14%)

Query: 14  GRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVR 67
           G+ +G G F +V  A         T  +VA+K+L +     H     +  E+ I+  I  
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGH 89

Query: 68  HPNIVRLHEV-LASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRY--FQQ 117
           H N+V L          + +I+EF   G L         + V      E+  + +   + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 118 LID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC 170
           LI         +    S+   HRDL   N+LL     +K+ DFGL+    +  + +    
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 171 GT-PNYV---APEVLSNRGYDGSAADVWSCGVILF 201
              P  +   APE + +R Y    +DVWS GV+L+
Sbjct: 210 ARLP--LKWMAPETIFDRVYT-IQSDVWSFGVLLW 241

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 81.3 bits (201), Expect = 6e-17
 Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 49/224 (21%)

Query: 14  GRTIGEGTFAKVRFA-------QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-I 65
           G+ +GEG F +V  A               VA+K+L        + +  +  E+ +MK I
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMI 131

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFD---------KIVHQGRLLENDCRRYFQ 116
            +H NI+ L         +Y+I+E+ + G L +                    + +   +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 117 QLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 169
            L+         + +  SK   HRDL   N+L+     +K++DFGL+         +H  
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA-------RDIHH- 243

Query: 170 CGTPNYV------------APEVLSNRGYDGSAADVWSCGVILF 201
                Y             APE L +R Y    +DVWS GV+L+
Sbjct: 244 --IDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 284

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 80.0 bits (198), Expect = 8e-17
 Identities = 47/213 (22%), Positives = 83/213 (38%), Gaps = 30/213 (14%)

Query: 12  EVGRTIGEGTFAKVR--FAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIV 66
            +   +GEG F KV      N    +    VA+K L +++          +RE  ++ ++
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTML 100

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGEL--------FDKIVHQGRLLENDCRRYFQQL 118
           +H +IVR   V      + ++ E++  G+L         D  +  G            QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 119 I-------DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC 170
           +         + +       HRDL   N L+     +K+ DFG+S  +       +    
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220

Query: 171 GTPNYV---APEVLSNRGYDGSAADVWSCGVIL 200
             P  +    PE +  R +  + +DVWS GV+L
Sbjct: 221 MLP--IRWMPPESILYRKFT-TESDVWSFGVVL 250

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 79.9 bits (198), Expect = 9e-17
 Identities = 67/263 (25%), Positives = 115/263 (43%), Gaps = 44/263 (16%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL-- 74
           IG G F KV +      G  VA+K     +        + + EI  +   RHP++V L  
Sbjct: 47  IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102

Query: 75  ------HEVLASRTKVYIILEFVTGGE----LFDKIVHQGRLLENDCRRYFQQLIDA--- 121
                   +L     +Y   +++  G     L+   +    +      +  +  I A   
Sbjct: 103 FCDERNEMIL-----IY---KYMENGNLKRHLYGSDLPTMSM---SWEQRLEICIGAARG 151

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAP 178
           + + H++ + HRD+K  N+LLD     K++DFG+S    +  +  H +    GT  Y+ P
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL-DQTHLSTVVKGTLGYIDP 210

Query: 179 E-VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGA 237
           E  +  R  + S  DV+S GV+LF ++          LP   + +N AE++     + G 
Sbjct: 211 EYFIKGRLTEKS--DVYSFGVVLFEVLCARSAI-VQSLPR--EMVNLAEWAVE-SHNNGQ 264

Query: 238 TSLIHKILDPNPKTRIRIEGIRK 260
              + +I+DPN   +IR E +RK
Sbjct: 265 ---LEQIVDPNLADKIRPESLRK 284

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 43/224 (19%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
           +Y +GR IG G+F  +    +   GE VA+K+    T  KH    Q+  E  I K+++  
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHP---QLHIESKIYKMMQGG 64

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE---NDCRRYF---------Q 116
             I  +    A      +++E              G  LE   N C R F          
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMEL------------LGPSLEDLFNFCSRKFSLKTVLLLAD 112

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTT---- 169
           Q+I  + + HSK   HRD+KP+N L+        + + DFGL+   +      H      
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172

Query: 170 ---CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLP 209
               GT  Y +  + ++ G + S   D+ S G +L     G LP
Sbjct: 173 KNLTGTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 71/377 (18%), Positives = 117/377 (31%), Gaps = 139/377 (36%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-- 67
           +Y V R +G G F+ V  + + +  + VAMKV+ KS        +    EI ++K VR  
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSA---EHYTETALDEIRLLKSVRNS 93

Query: 68  ---HPN---IVRL------------HEVLASRTKVYIILEFVTGGELFD--KIVHQGRLL 107
               PN   +V+L            H  +     V+ +L    G  L       +   L 
Sbjct: 94  DPNDPNREMVVQLLDDFKISGVNGTHICM-----VFEVL----GHHLLKWIIKSNYQGLP 144

Query: 108 ENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLL------------------------ 142
               ++  QQ++  + + H+K  + H D+KPEN+LL                        
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204

Query: 143 -------------------------DSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-YV 176
                                         +K++D G +    +      T       Y 
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYR 260

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK--------------- 221
           + EVL   GY+ + AD+WS   + F L  G   F         +                
Sbjct: 261 SLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP 319

Query: 222 ---INAAEFSCPFWFSTG------------------------------ATSLIHKILDPN 248
              I A ++S  F+   G                               T  +  +L+  
Sbjct: 320 RKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELI 379

Query: 249 PKTRIRIEGIRKHPWFR 265
           P+ R       +HPW  
Sbjct: 380 PEKRATAAECLRHPWLN 396

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 49/226 (21%)

Query: 12  EVGRTIGEGTFAKVRFA-------QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
            +G+ +GEG F +V  A          +   +VA+K+L      K    D +  E+ +MK
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV-SEMEMMK 95

Query: 65  -IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRY-- 114
            I +H NI+ L         +Y+I+E+ + G L +         +     +         
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 115 FQQLIDAV-------AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH 167
           F+ L+           +  S+   HRDL   N+L+     +K++DFGL+           
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA----------R 205

Query: 168 TTCGTPNYV------------APEVLSNRGYDGSAADVWSCGVILF 201
                  Y             APE L +R Y    +DVWS GV+++
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMW 250

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 52/236 (22%), Positives = 84/236 (35%), Gaps = 66/236 (27%)

Query: 12  EVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           E  R IGEG F +V  A+       E    VA+K+L +      +     +RE ++M   
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALMAEF 107

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGEL-----------------FDKIVHQGRLLEN 109
            +PNIV+L  V A    + ++ E++  G+L                  D           
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 110 DCRRYFQQLIDAV-------AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS------ 156
                  + +          A+   +   HRDL   N L+     +K++DFGLS      
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 157 ---------ALPQQGVELLHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVIL 200
                    A+P                +    PE +    Y  + +DVW+ GV+L
Sbjct: 228 DYYKADGNDAIP----------------IRWMPPESIFYNRYT-TESDVWAYGVVL 266

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 78.2 bits (193), Expect = 6e-16
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 33/218 (15%)

Query: 12  EVGRTIGEGTFAKVRFA-------QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
            +G+ +GEG F +V  A          +   +VA+K+L        + +  +  E+ +MK
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMK 141

Query: 65  -IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRY-- 114
            I +H NI+ L         +Y+I+E+ + G L +         +     +         
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 115 FQQLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH 167
           F+ L+         + +  S+   HRDL   N+L+     +K++DFGL+           
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261

Query: 168 TTCGT-PNYV---APEVLSNRGYDGSAADVWSCGVILF 201
           TT G  P  V   APE L +R Y    +DVWS GV+++
Sbjct: 262 TTNGRLP--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 74.1 bits (181), Expect = 9e-15
 Identities = 38/192 (19%), Positives = 63/192 (32%), Gaps = 48/192 (25%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLA-----KSTILKHRMVDQIKREISIMK 64
           K +    IGEG F +V F Q       VA+K++A            +  ++I  EI I K
Sbjct: 21  KLQRCEKIGEGVFGEV-F-QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 65  IV---------RHPNIVRLHEV------------------------------LASRTKVY 85
            +         R    + L+ V                                   +++
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 86  IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDS 144
           I+LEF  GG   +++  +        +    QL  ++A   +     HRDL   N+LL  
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197

Query: 145 YGNLKVSDFGLS 156
               K+      
Sbjct: 198 TSLKKLHYTLNG 209

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 26/205 (12%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G F KV +      G  VA+K L            Q + E+ ++ +  H N++RL  
Sbjct: 38  LGRGGFGKV-YKGRLADGTLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94

Query: 77  VLASRTKVYIILEFVTGG----ELFDKIVHQGRLLENDCRRYFQQLIDAVA--------H 124
              + T+  ++  ++  G     L ++   Q  L   D  +  +  + + A        H
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRERPESQPPL---DWPKRQRIALGS-ARGLAYLHDH 150

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVL 181
           C  K + HRD+K  N+LLD      V DFGL+ L        H T    GT  ++APE L
Sbjct: 151 CDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYL 207

Query: 182 SNRGYDGSAADVWSCGVILFVLMAG 206
           S  G      DV+  GV+L  L+ G
Sbjct: 208 S-TGKSSEKTDVFGYGVMLLELITG 231

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 57/227 (25%), Positives = 86/227 (37%), Gaps = 50/227 (22%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK----HRMVDQIKREIS 61
                   G  +GEG F  V   +      +VA+K LA    +      +   Q  +EI 
Sbjct: 28  DERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQ---QFDQEIK 82

Query: 62  IMKIVRHPNIVRL--------HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           +M   +H N+V L           L     VY    ++  G L    +         C  
Sbjct: 83  VMAKCQHENLVELLGFSSDGDDLCL-----VY---VYMPNGSL-LDRLS--------CLD 125

Query: 114 YFQQL---------IDA---VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ 161
               L           A   +   H     HRD+K  N+LLD     K+SDFGL+   ++
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185

Query: 162 GVELLHTT--CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
             + + T+   GT  Y+APE L       S  D++S GV+L  ++ G
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEALRGEITPKS--DIYSFGVVLLEIITG 230

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 31/167 (18%), Positives = 60/167 (35%), Gaps = 24/167 (14%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++ +G+ IG G F  +  A      E  A  V+     ++++    +  E+   + V   
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK----VEYQENGPLFSELKFYQRVAKK 93

Query: 70  NIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQ--GRLLEN--DCRRYF----- 115
           + ++                Y        G  +  +V +  G  L+        F     
Sbjct: 94  DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTV 153

Query: 116 ----QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV--SDFGLS 156
                +++D + + H     H D+K  NLLL      +V  +D+GLS
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 39/229 (17%), Positives = 77/229 (33%), Gaps = 33/229 (14%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            ++VG  IG+G F  +  A +  + ESV         +        +  E+   +    P
Sbjct: 36  AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSD-NGPLFTELKFYQRAAKP 93

Query: 70  NIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQ--GRLLE---NDCRRYF---- 115
             ++              K +        G+ +  ++    G  L+       + F    
Sbjct: 94  EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153

Query: 116 -----QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV--SDFGLS---ALPQQGVEL 165
                 +++D + + H     H D+K  NLLL+     +V   D+GL+            
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213

Query: 166 LHTT----CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLP 209
                    GT  + +  + ++ G   S   D+   G  +   + G+LP
Sbjct: 214 AADPKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 27/174 (15%), Positives = 59/174 (33%), Gaps = 35/174 (20%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETG--------ESVAMKVLAKSTILKHRMVDQIKREIS 61
           ++++           +  A    T         +  ++K+ AK   L +        E +
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFN--------EQN 94

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYI--ILEFVTGGELFDKIVHQ--GRLLE---NDC-RR 113
             +    P  V   + L S   + I   + F    + +  +V    GR L+   +   + 
Sbjct: 95  FFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKH 154

Query: 114 YF---------QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV--SDFGLS 156
                       +L+DA+   H     H ++  EN+ +D     +V  + +G +
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 4/116 (3%)

Query: 97  FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS 156
             + +++  L       Y  Q+   +    S+   HRDL   N+LL     +K+ DFGL+
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240

Query: 157 ALPQQGVELLHTTCGT-P-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLP 209
               +  + +       P  ++APE + +R Y    +DVWS GV+L+ + + G  P
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 37/183 (20%), Positives = 62/183 (33%), Gaps = 13/183 (7%)

Query: 12  EVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-I 65
           ++G+ +G G F +V  A         T  +VA+K+L +     H     +  E+ I+  I
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHI 82

Query: 66  VRHPNIVRLH-EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
             H N+V L          + +I+EF   G L   +    R   N+   Y  +       
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFRQG 138

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
               G    DLK     + S  +   S F          E         +++  E L   
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198

Query: 185 GYD 187
            + 
Sbjct: 199 SFQ 201

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 4e-07
 Identities = 56/326 (17%), Positives = 104/326 (31%), Gaps = 91/326 (27%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFA-QNRETGESVA---MK-----VLAKSTILKHRMVDQI 56
           +  AKY V R      + K+R A       ++V    +       +A    L +++  ++
Sbjct: 124 QVFAKYNVSR---LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKM 180

Query: 57  KREISIMKIVRHPNIVRLHEVLASRTKVYIILE--FVTGGELFDKIVHQGRLLENDCRRY 114
             +I  + +    N      VL    K+   ++  + +  +    I  +   ++ + RR 
Sbjct: 181 DFKIFWLNL---KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237

Query: 115 FQQ-------LI-DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
            +        L+   V   ++K     +L  + LL   +    V+DF LSA     + L 
Sbjct: 238 LKSKPYENCLLVLLNV--QNAKAWNAFNLSCKILLTTRFKQ--VTDF-LSAATTTHISLD 292

Query: 167 HTTCG-TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA 225
           H +   TP     EV S                    L+  YL     DLP      N  
Sbjct: 293 HHSMTLTP----DEVKS--------------------LLLKYLDCRPQDLPREVLTTN-- 326

Query: 226 EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV------ 279
               P        S+I + +     T           W   N+  V C +   +      
Sbjct: 327 ----PR-----RLSIIAESIRDGLAT-----------W--DNWKHVNCDKLTTIIESSLN 364

Query: 280 NLD--DVHAVFDDI----EDQYVAEQ 299
            L+  +   +FD +       ++   
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSAHIPTI 390

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 3e-05
 Identities = 55/437 (12%), Positives = 115/437 (26%), Gaps = 136/437 (31%)

Query: 35  ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV-------YII 87
             +  +    S + +   ++Q  R  +  ++    N+ RL   L  R  +        ++
Sbjct: 96  SPIKTEQRQPSMMTR-MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVL 154

Query: 88  LEFVTGGELFDKIVHQGRLLENDCRRY-FQQLID------AVAHCHSKGVYHRDLKP-EN 139
           ++ V G     K      +  + C  Y  Q  +D       + +C+S       L+  + 
Sbjct: 155 IDGVLG---SGKTW----VALDVCLSYKVQCKMDFKIFWLNLKNCNSP---ETVLEMLQK 204

Query: 140 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY-------DGSAAD 192
           LL     N        S +  +   +              +L ++ Y            +
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSI--------QAELRRLLKSKPYENCLLVLL----N 252

Query: 193 VWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTR 252
           V +                           NA   SC    +T    +    L     T 
Sbjct: 253 VQNAKA-----------------------WNAFNLSCKILLTTRFKQVT-DFLSAATTTH 288

Query: 253 IRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNA 312
           I ++             P    E + + L  +     D+         E     P  ++ 
Sbjct: 289 ISLDH------HSMTLTP---DEVKSLLLKYLDCRPQDL-------PREVLTTNPRRLS- 331

Query: 313 FEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSN-IEAVAESLSLKVHTRNYK 371
             +I        A      +D +     +  +      L+  IE+    L    + + + 
Sbjct: 332 --II--------AESI---RDGLATWDNW--KHVNCDKLTTIIESSLNVLEPAEYRKMFD 376

Query: 372 TRLEGVSANKTGQFAV----------VLEVF-----EVAPSLFMVDVRK---AAGD---- 409
                       + +V          +L +      +    + +  + K           
Sbjct: 377 ------------RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES 424

Query: 410 TLEYHKFYKNFCAKLEN 426
           T+     Y     KLEN
Sbjct: 425 TISIPSIYLELKVKLEN 441

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 24/178 (13%), Positives = 63/178 (35%), Gaps = 26/178 (14%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD-QIKRE 59
           + +  R      +G+ +GEG  + V    + +      +K          ++ + +   +
Sbjct: 82  LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGD 140

Query: 60  ISIMKIVR------HPNIVRLHEVLASRTKVY----IILEFVTGGELFDKIVHQGRLLEN 109
           +    +           + +L  +   +   +    +++E +   EL+        +   
Sbjct: 141 LHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYR-------VRVE 193

Query: 110 DCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH 167
           +       +++ VA  + +G+ H DL   N+L+     + + DF       Q VE+  
Sbjct: 194 NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP------QSVEVGE 244

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258

 Score = 43.1 bits (101), Expect = 7e-05
 Identities = 38/191 (19%), Positives = 66/191 (34%), Gaps = 32/191 (16%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNR--ETGESVAMKV-------LAKSTILKHR 51
           + K + +     +G  I  G  A V +A         ++A+K+         K     + 
Sbjct: 39  LYKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYG 98

Query: 52  MVDQIKREISIMKIVR------HPNIVRLHEVLASRTKVY------IILEFVTGGELFDK 99
                 R IS  + V         N+ R  E   S  + Y      +++EF+   EL   
Sbjct: 99  DERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAP 158

Query: 100 IVHQ--GRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLS 156
            + +    L E D    F  +++ V   + +  + H DL   N++      +   D G  
Sbjct: 159 TLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYI--DKVYFIDMG-- 214

Query: 157 ALPQQGVELLH 167
               Q V L H
Sbjct: 215 ----QAVTLRH 221

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	443
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
2ehb_D	143	CBL-interacting serine/threonine-protein kinase 2;	100.0
2zfd_B	123	Putative uncharacterized protein T20L15_90; calciu	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.45
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
3ose_A	120	Serine/threonine-protein kinase MARK1; kinase asso	99.22
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.89
1v5s_A	126	MAP/microtubule affinity-regulating kinase 3; Ka1	98.81
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.7
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.62
4eai_A	106	5'-AMP-activated protein kinase catalytic subunit	98.56
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.46
2v8q_A	157	5'-AMP-activated protein kinase catalytic subunit;	98.4
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.34
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.33
4eag_A	130	EG:132E8.2 protein; AMPK, transferase; HET: ATP TA	98.22
2y8l_A	173	5'-AMP-activated protein kinase catalytic subunit;	98.18
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.13
2qrd_A	137	SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind	98.11
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.09
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.85
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.83
3t4n_A	179	Carbon catabolite-derepressing protein kinase; CBS	97.74
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.73
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.63
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.45
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.41
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.32
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.26
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.19
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.13
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.98
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.76
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.75
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.64
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.7
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.57
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.44
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.9
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	81.65

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.2e-69  Score=514.17  Aligned_cols=262  Identities=44%  Similarity=0.862  Sum_probs=225.1

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +..+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus         9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   88 (275)
T 3hyh_A            9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI   88 (275)
T ss_dssp             -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            56789999999999999999999999999999999999987665555567899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+||||| +|+|++++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... .
T Consensus        89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~  166 (275)
T 3hyh_A           89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-N  166 (275)
T ss_dssp             EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-C
Confidence            9999999 7899999999999999999999999999999999999999999999999999999999999999865443 3


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHc
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (443)
                      ...+.+||+.|+|||++.+.+|++.++||||+||++|+|++|++||.+.+...+.+.+..+.+.+|.++|+++++||.+|
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  246 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM  246 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            45678999999999999998888899999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccccccC
Q 013421          245 LDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      |+.||++|||++|+++||||+...
T Consensus       247 L~~dP~~R~s~~eil~hpw~k~~~  270 (275)
T 3hyh_A          247 LIVNPLNRISIHEIMQDDWFKVDL  270 (275)
T ss_dssp             SCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred             ccCChhHCcCHHHHHcCcccccCC
Confidence            999999999999999999998643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-68  Score=521.19  Aligned_cols=260  Identities=31%  Similarity=0.563  Sum_probs=242.1

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            45678999999999999999999999999999999998876555555678999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc--cc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GV  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~--~~  163 (443)
                      +|||||+||+|++++.+.+.++|..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....  ..
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999987643  22


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ....+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||.+.+..+++.++....+.+|..+|+++++||.+
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  267 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK  267 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred             ccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence            345678999999999999988885 8999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCHHH------HhcCccccc
Q 013421          244 ILDPNPKTRIRIEG------IRKHPWFRK  266 (443)
Q Consensus       244 ~L~~dP~~R~t~~e------il~hp~f~~  266 (443)
                      ||++||++|||++|      |++||||+.
T Consensus       268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          268 LLVLDATKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             HSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence            99999999999988      689999964

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.6e-66  Score=513.77  Aligned_cols=261  Identities=28%  Similarity=0.568  Sum_probs=232.7

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++++..... ...+.+.+|+.+|++|+|||||++++++.+++.+|
T Consensus        21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y   99 (350)
T 4b9d_A           21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLY   99 (350)
T ss_dssp             SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            35789999999999999999999999999999999998876443 34678999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           86 IILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      ||||||+||+|+++|...+  .++|..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+......
T Consensus       100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999999997643  57899999999999999999999999999999999999999999999999998776554


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCCCCCHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIH  242 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~  242 (443)
                      ....+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+..+...++..+.+ +.+..+|+++.+||.
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~  258 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS  258 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence            455678999999999999988886 899999999999999999999999999888888877765 456679999999999


Q ss_pred             HccCCCCCCCCCHHHHhcCccccccC
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      +||+.||++|||++|+++||||++..
T Consensus       259 ~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          259 QLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHccCChhHCcCHHHHhcCHHhhcCC
Confidence            99999999999999999999998643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-65  Score=507.07  Aligned_cols=257  Identities=26%  Similarity=0.435  Sum_probs=233.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ...|++++.||+|+||+||+|+++.+|+.||||++++.....   .+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            356999999999999999999999999999999998754332   35688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      ||||+||+|.+++.+ +++++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+..........
T Consensus       150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            999999999998876 6899999999999999999999999999999999999999999999999999987765555667


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC---CCCCCCCHHHHHHHHHc
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGATSLIHKI  244 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~~  244 (443)
                      +.|||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+..+....+.....   ..+..+|+++++||.+|
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~  307 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL  307 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence            88999999999999888885 999999999999999999999999888888888766532   23345899999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccccccCC
Q 013421          245 LDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                      |+.||++|||++|+++||||++...
T Consensus       308 L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          308 LVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             cCCChhHCcCHHHHhcCHhhcCCCC
Confidence            9999999999999999999987643

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3e-66  Score=503.42  Aligned_cols=257  Identities=37%  Similarity=0.636  Sum_probs=229.1

Q ss_pred             ccCeEEeeeeeccCceEEEEEEEC---CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      .++|++++.||+|+||+||+|++.   .+++.||||++++....... ...+.+|+.+|++++|||||++++++.+++.+
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            367999999999999999999874   46889999999876543322 34578899999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+|||||+||+|++++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999987655545


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHc
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (443)
                      ...+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+..+...++....+.+|..+|+++.+||.+|
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  260 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRML  260 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHH
Confidence            66788999999999999988886 89999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCC-----HHHHhcCccccc
Q 013421          245 LDPNPKTRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       245 L~~dP~~R~t-----~~eil~hp~f~~  266 (443)
                      |+.||++|||     ++|+++||||+.
T Consensus       261 L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          261 FKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             TCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             cccCHHHCCCCCcCCHHHHHcCccccC
Confidence            9999999998     589999999964

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4e-64  Score=507.69  Aligned_cols=257  Identities=26%  Similarity=0.443  Sum_probs=233.3

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .+.|++++.||+|+||+||+|+++.+|+.||||++++.....   .+.+.+|+.+|+.++|||||++++++.+.+.+|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            357999999999999999999999999999999998754332   35688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      ||||+||+|.+++.. +++++.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+..........
T Consensus       227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            999999999998865 6799999999999999999999999999999999999999999999999999987665555667


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc---CCCCCCCCHHHHHHHHHc
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~~  244 (443)
                      +.|||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+..+....+....   +..+..+|+++++||.+|
T Consensus       306 ~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~  384 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL  384 (423)
T ss_dssp             CCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence            88999999999999888885 99999999999999999999999988888888776653   334456899999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccccccCC
Q 013421          245 LDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                      |+.||++|||++|+|+||||++...
T Consensus       385 L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          385 LVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             cCCChhHCcCHHHHhcCHHhcCCCC
Confidence            9999999999999999999987543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-63  Score=479.98  Aligned_cols=253  Identities=24%  Similarity=0.458  Sum_probs=222.2

Q ss_pred             cCe-EEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCE
Q 013421            9 AKY-EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS----RTK   83 (443)
Q Consensus         9 ~~y-~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~   83 (443)
                      ++| ++.+.||+|+||+||+|.++.++..||+|++.+..... ...+.+.+|+.+|++++|||||++++++.+    +..
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            465 78889999999999999999999999999998765433 346789999999999999999999999865    356


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CEeecCCCCcEEEcC-CCCeEEeeecCcCCCc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDS-YGNLKVSDFGLSALPQ  160 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~g--i~HrDlkp~NILl~~-~~~~kL~DFGls~~~~  160 (443)
                      +|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+||||+. +|.+||+|||+|+...
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            8999999999999999999999999999999999999999999998  999999999999984 7999999999997643


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC-ChHHHHHHhhhccC--CCCCCCCHHH
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET-DLPTLYKKINAAEF--SCPFWFSTGA  237 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~--~~~~~~s~~~  237 (443)
                      .  ....+.|||+.|||||++.+ .|+ .++|||||||++|+|++|++||.+. +...+...+..+..  ..+..+++++
T Consensus       184 ~--~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  259 (290)
T 3fpq_A          184 A--SFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  259 (290)
T ss_dssp             T--TSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             C--CccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence            3  34567899999999999865 564 9999999999999999999999764 44556666665543  3455689999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      .+||.+||+.||++|||++|+++||||++
T Consensus       260 ~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999999985

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.6e-62  Score=504.60  Aligned_cols=410  Identities=33%  Similarity=0.610  Sum_probs=314.7

Q ss_pred             cccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      .+...+++|.+++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~   89 (476)
T 2y94_A           10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS   89 (476)
T ss_dssp             CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            34567899999999999999999999999999999999998765433334577899999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++......
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999866443


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH  242 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~  242 (443)
                       ....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+......++..+.+..|..+++++.+||.
T Consensus       170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~  248 (476)
T 2y94_A          170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK  248 (476)
T ss_dssp             -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred             -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHH
Confidence             3456789999999999998887777899999999999999999999999988899999998888899999999999999


Q ss_pred             HccCCCCCCCCCHHHHhcCccccccCCCCCCccccccC-------------------cccccccc---------------
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVN-------------------LDDVHAVF---------------  288 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~~~~~~~~~~~~~~-------------------~~~~~~~~---------------  288 (443)
                      +||+.||.+|||++++++||||+...............                   .+++...+               
T Consensus       249 ~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~l  328 (476)
T 2y94_A          249 HMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHL  328 (476)
T ss_dssp             HHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC---------------------------
T ss_pred             HHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHHH
Confidence            99999999999999999999998754321111000000                   00000000               


Q ss_pred             --------cchhhhHHhhhcccc--cCCCcccchhhhhccCCCC------CCccc-----CccccccccceeeEEeCCCH
Q 013421          289 --------DDIEDQYVAEQSENK--VGGPLLMNAFEMITLSQGL------NLAAL-----FDRRQDYVKRQTRFVSRQPA  347 (443)
Q Consensus       289 --------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~------~~~~~-----~~~~~~~~~~~~rf~s~~~~  347 (443)
                              +...+.+...++...  ...............+...      .+..+     -...+...+++.++.|..+|
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~s~~~p  408 (476)
T 2y94_A          329 IIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRP  408 (476)
T ss_dssp             ----CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEEECSCH
T ss_pred             HHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecCccCCCH
Confidence                    000000000000000  0000000000000000000      00000     00112345788899999999


Q ss_pred             HHHHHHHHHHHHHcCcEEEee-cceEEEeeeccCCCccEEEEEEEEEEcCceEEEEEEecCCCchHH
Q 013421          348 QVILSNIEAVAESLSLKVHTR-NYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEY  413 (443)
Q Consensus       348 ~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le~  413 (443)
                      .+|+..|..|++.+|+.|+.. .+.|++....+.....+.|.+++|+++++.++|||++..|+.++|
T Consensus       409 ~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~  475 (476)
T 2y94_A          409 NDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV  475 (476)
T ss_dssp             HHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred             HHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence            999999999999999999875 477888654443345577999999999999999999999999987

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.6e-63  Score=484.53  Aligned_cols=254  Identities=25%  Similarity=0.347  Sum_probs=224.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ++.|++.++||+|+||+||+|+++.+|+.||||+++++...        .+|+.+|+.++|||||++++++.+++.+|||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            45799999999999999999999999999999999875432        3699999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC-CeEEeeecCcCCCccccc--
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQGVE--  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~~~--  164 (443)
                      ||||+||+|.+++.+.+++++..++.|+.||+.||+|||++||+||||||+||||+.+| ++||+|||+|+.......  
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            99999999999999999999999999999999999999999999999999999999988 699999999986543211  


Q ss_pred             ---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC---CCCCCCCHHHH
Q 013421          165 ---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGAT  238 (443)
Q Consensus       165 ---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~  238 (443)
                         ...+.|||+.|||||++.+.+|+ .++|||||||++|+|++|++||.+.+...+..++.....   ..|+.+|+++.
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             ceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence               22346899999999999988886 899999999999999999999998877777777766554   35678999999


Q ss_pred             HHHHHccCCCCCCCCCHHHH-------------hcCccccccCCC
Q 013421          239 SLIHKILDPNPKTRIRIEGI-------------RKHPWFRKNYNP  270 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~ei-------------l~hp~f~~~~~~  270 (443)
                      +||.+||+.||.+|||+.|+             ++|||++....|
T Consensus       288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            99999999999999999997             579999765443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-61  Score=484.69  Aligned_cols=259  Identities=28%  Similarity=0.390  Sum_probs=225.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------CC
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------RT   82 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~   82 (443)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            479999999999999999999999999999999976543 33345778899999999999999999999754      36


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc-
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ-  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~-  161 (443)
                      .+|||||||+ |+|++++...+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... 
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            7999999995 67999999989999999999999999999999999999999999999999999999999999976533 


Q ss_pred             ---ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCC---------
Q 013421          162 ---GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC---------  229 (443)
Q Consensus       162 ---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---------  229 (443)
                         ......+.|||+.|+|||++.+..+++.++||||+|||+|+|++|++||.+.+.......|.......         
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence               22345678999999999999887777799999999999999999999999988877776664322111         


Q ss_pred             ----------------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          230 ----------------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       230 ----------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                                            .+.+|+++.+||.+||+.||.+|||++|+|+||||++...
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                                  1236899999999999999999999999999999987543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-60  Score=502.77  Aligned_cols=260  Identities=30%  Similarity=0.462  Sum_probs=230.8

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHH---HHHHHHHhCCCCCcceEEEEEEeC
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK---REISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~---~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      ...+++|++++.||+|+||+||+|+++.+|+.||||++++......+....+.   .++.+++.++|||||+++++|.+.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            56789999999999999999999999999999999999876543332223333   446677788999999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      +.+|+|||||+||+|+++|.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|.....
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999986544


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC---ChHHHHHHhhhccCCCCCCCCHHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---DLPTLYKKINAAEFSCPFWFSTGAT  238 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~~  238 (443)
                        ....+.|||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.   +...+...+....+.+|..+|++++
T Consensus       345 --~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~  422 (689)
T 3v5w_A          345 --KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR  422 (689)
T ss_dssp             --CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             --CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHH
Confidence              34567899999999999975433459999999999999999999999763   3445677788888899999999999


Q ss_pred             HHHHHccCCCCCCCCC-----HHHHhcCccccc
Q 013421          239 SLIHKILDPNPKTRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t-----~~eil~hp~f~~  266 (443)
                      +||.+||+.||.+|++     ++||++||||+.
T Consensus       423 dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             HHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            9999999999999998     799999999975

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.7e-60  Score=460.38  Aligned_cols=255  Identities=26%  Similarity=0.414  Sum_probs=204.0

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT---   82 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---   82 (443)
                      +.+++|++++.||+|+||+||+|+++.+|+.||||++....  .....+.+.+|+.+|++++|||||++++++.+.+   
T Consensus         2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~   79 (299)
T 4g31_A            2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE   79 (299)
T ss_dssp             HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred             CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence            34678999999999999999999999999999999997654  3334578999999999999999999999986544   


Q ss_pred             ---------EEEEEEecCCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEE
Q 013421           83 ---------KVYIILEFVTGGELFDKIVHQGRL---LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV  150 (443)
Q Consensus        83 ---------~~~lv~Ey~~gg~L~~~i~~~~~l---~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL  150 (443)
                               .+|+|||||+||+|.+++...+.+   ++..++.++.||+.||+|||++||+||||||+|||++.+|.+||
T Consensus        80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence                     479999999999999999876654   44668899999999999999999999999999999999999999


Q ss_pred             eeecCcCCCccccc------------cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh-HH
Q 013421          151 SDFGLSALPQQGVE------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PT  217 (443)
Q Consensus       151 ~DFGls~~~~~~~~------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~  217 (443)
                      +|||+|+.......            ...+.|||+.|||||++.+..|+ .++|||||||++|+|++   ||..... ..
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            99999986543211            12456899999999999988875 99999999999999996   7864322 12


Q ss_pred             HHHHhhhccCC-CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          218 LYKKINAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       218 ~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      ....+....++ .+...++.+.+||.+||++||.+|||+.|+++||||+.
T Consensus       236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~  285 (299)
T 4g31_A          236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED  285 (299)
T ss_dssp             HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred             HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence            22333333221 11225778899999999999999999999999999975

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.1e-58  Score=462.44  Aligned_cols=253  Identities=28%  Similarity=0.465  Sum_probs=208.9

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEEC---CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~   81 (443)
                      ..-++|++++.||+|+||+||+|+++   .+++.||+|.+.+..     ....+.+|+.+|+.+ +||||+++++++.++
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            34467999999999999999999875   467899999986543     134678999999998 699999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC-CCeEEeeecCcCCCc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQ  160 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~-~~~kL~DFGls~~~~  160 (443)
                      +.+|+|||||+||+|.+++   +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        93 ~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            9999999999999999998   469999999999999999999999999999999999999876 899999999996433


Q ss_pred             cc----------------------------cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCC
Q 013421          161 QG----------------------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  212 (443)
Q Consensus       161 ~~----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  212 (443)
                      ..                            .....+.|||+.|+|||++.+..+++.++||||+|||+|+|++|+.||..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            21                            11234568999999999998776667999999999999999999999965


Q ss_pred             CC-hHHHHHHhhh--------------------------------------ccCC----------------CCCCCCHHH
Q 013421          213 TD-LPTLYKKINA--------------------------------------AEFS----------------CPFWFSTGA  237 (443)
Q Consensus       213 ~~-~~~~~~~i~~--------------------------------------~~~~----------------~~~~~s~~~  237 (443)
                      .+ ..+....|..                                      ....                ....+|+++
T Consensus       250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a  329 (361)
T 4f9c_A          250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA  329 (361)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred             CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence            43 2222222210                                      0000                112378999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      ++||++||+.||++|+|++|+|+||||++
T Consensus       330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          330 YDLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999999974

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.8e-58  Score=487.09  Aligned_cols=261  Identities=29%  Similarity=0.604  Sum_probs=236.4

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..+++|++++.||+|+||+||+|+++.+|+.||+|++.+..   ....+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            45789999999999999999999999999999999997654   223567889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC--CCeEEeeecCcCCCccc
Q 013421           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQG  162 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~--~~~kL~DFGls~~~~~~  162 (443)
                      +|||||+||+|++++.. .+.+++.+++.|+.||+.||+|||++||+||||||+|||++.+  |.+||+|||+++.....
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999999999999964 4689999999999999999999999999999999999999854  89999999999876543


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGAT  238 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~  238 (443)
                       ....+.|||+.|+|||++.+.+|. .++|||||||++|+|++|.+||.+.+..+...++....+.++    ..+|++++
T Consensus       311 -~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  388 (573)
T 3uto_A          311 -QSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  388 (573)
T ss_dssp             -SEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred             -CceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence             445678999999999999988885 899999999999999999999999999999999888776554    35899999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcCccccccCCCC
Q 013421          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV  271 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~~  271 (443)
                      +||.+||+.||.+|||++|+|+||||+....+.
T Consensus       389 dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence            999999999999999999999999999766543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.4e-59  Score=451.60  Aligned_cols=253  Identities=23%  Similarity=0.347  Sum_probs=221.1

Q ss_pred             ccCeEEeeeeeccCceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      .++|.+.+.||+|+||+||+|++.     .++..||||+++..   ..+..+.+.+|+.+|++++|||||++++++.+++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            467999999999999999999875     35789999999754   2345678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeE
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLK  149 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~k  149 (443)
                      .+|+|||||++|+|.+++...             ..+++.++..++.||+.||+|||+++|+||||||+|||++.++++|
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence            999999999999999999764             3689999999999999999999999999999999999999999999


Q ss_pred             EeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc
Q 013421          150 VSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE  226 (443)
Q Consensus       150 L~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~  226 (443)
                      |+|||+|+......  ......+||+.|+|||++.+..|+ .++|||||||++|||+| |+.||.+.+..+....+..+.
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~  247 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  247 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999997554322  223345799999999999888875 99999999999999998 999999998888888887664


Q ss_pred             -CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          227 -FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       227 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                       .+.|..+|+++.+|+.+||+.||++|||+++|  |+|++.
T Consensus       248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~  286 (299)
T 4asz_A          248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN  286 (299)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred             CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence             56788899999999999999999999999999  457653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-56  Score=441.92  Aligned_cols=264  Identities=41%  Similarity=0.759  Sum_probs=244.4

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ....+++|++++.||+|+||.||+|.+..+|+.||||++.+.... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT   88 (328)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence            345689999999999999999999999999999999999876543 3456778999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      .|+||||++||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++...... 
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  167 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-  167 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred             EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence            9999999999999999999899999999999999999999999999999999999999999999999999999765443 


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ......+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+.......+..+.+..|..+|+++.+||++
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  247 (328)
T 3fe3_A          168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKR  247 (328)
T ss_dssp             CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            34567899999999999998888778999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCHHHHhcCccccccCC
Q 013421          244 ILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                      ||+.||.+|||++|+++||||+....
T Consensus       248 ~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          248 FLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             HCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            99999999999999999999987543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.7e-57  Score=446.37  Aligned_cols=250  Identities=22%  Similarity=0.325  Sum_probs=214.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ..+|.+.+.||+|+||+||+|++.     .++..||||+++..   .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            457899999999999999999865     36889999999754   3445678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC
Q 013421           83 KVYIILEFVTGGELFDKIVHQ---------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN  147 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~---------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~  147 (443)
                      .+|||||||++|+|.+++...               +++++.++..++.||+.||.|||+++|+||||||+||||+.+++
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence            999999999999999999753               35899999999999999999999999999999999999999999


Q ss_pred             eEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhh
Q 013421          148 LKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA  224 (443)
Q Consensus       148 ~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~  224 (443)
                      +||+|||+++......  ......+||+.|+|||++.+..|+ .++|||||||+||||+| |+.||.+.+..+....+..
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  275 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ  275 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9999999998654322  233457899999999999888775 99999999999999998 9999999888888887766


Q ss_pred             c-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          225 A-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       225 ~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      + .++.|..+|+++.+|+.+||+.||++|||++||+++
T Consensus       276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            5 567788899999999999999999999999999874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.5e-57  Score=440.82  Aligned_cols=253  Identities=23%  Similarity=0.363  Sum_probs=221.8

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   80 (443)
                      ...+++++++.||+|+||+||+|...     .+++.||||+++...  .....+.+.+|+.+|++++|||||++++++.+
T Consensus        23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            34678999999999999999999863     467899999997543  22335789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS  144 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~  144 (443)
                      ++.+|+|||||++|+|.+++...                ..+++..+..++.||+.||+|||+++|+||||||+||||++
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            99999999999999999999653                35899999999999999999999999999999999999999


Q ss_pred             CCCeEEeeecCcCCCccc--cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 013421          145 YGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK  221 (443)
Q Consensus       145 ~~~~kL~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~  221 (443)
                      ++++||+|||+++.....  .......+||+.|+|||++.+..|+ .++|||||||+||||+| |..||.+.+..+....
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999865432  2234567899999999999887775 99999999999999998 8999999988888888


Q ss_pred             hhhcc-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          222 INAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       222 i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +..+. .+.|..+|+++.+|+.+||+.||++|||+.||+++
T Consensus       260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            76654 56778899999999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.9e-57  Score=438.43  Aligned_cols=249  Identities=20%  Similarity=0.332  Sum_probs=204.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .+++++.+.||+|+||+||+|++.   ..||||+++.... ..+..+.+.+|+.+|++++|||||++++++.+ +.+|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            457889999999999999999864   3599999975443 34456789999999999999999999998754 568999


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc--ccc
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVE  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~--~~~  164 (443)
                      ||||+||+|.+++... +++++.++..++.||+.||+|||++||+||||||+||||++++++||+|||+|+....  ...
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence            9999999999999764 5799999999999999999999999999999999999999999999999999986543  223


Q ss_pred             cccccCCCcccCCCcccccCC--CCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHH-HhhhccC-----CCCCCCCHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK-KINAAEF-----SCPFWFSTG  236 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~-~i~~~~~-----~~~~~~s~~  236 (443)
                      ...+.+||+.|||||++.+..  .++.++|||||||+||||+||+.||.+.+...... .+..+..     ..+..+|++
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  269 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA  269 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence            456779999999999986432  23489999999999999999999998866544333 3333221     234568999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +.+|+.+||+.||++|||+.||+++
T Consensus       270 l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          270 MKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999987543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.7e-56  Score=442.73  Aligned_cols=261  Identities=33%  Similarity=0.612  Sum_probs=233.9

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   83 (443)
                      ...+++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            34578999999999999999999999999999999999876544444567788999999988 79999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.......
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998655444


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ....+.|||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+.++......+|.++++++.+||++
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  257 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKS  257 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            556678999999999999877775 8999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCH------HHHhcCccccc
Q 013421          244 ILDPNPKTRIRI------EGIRKHPWFRK  266 (443)
Q Consensus       244 ~L~~dP~~R~t~------~eil~hp~f~~  266 (443)
                      ||+.||.+||++      ++|++||||+.
T Consensus       258 lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          258 FMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             HTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             HhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            999999999999      89999999975

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.7e-55  Score=436.02  Aligned_cols=259  Identities=32%  Similarity=0.584  Sum_probs=239.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      .+++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            57899999999999999999999999999999999987654333345678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      ||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..........
T Consensus        83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence            99999999999999998999999999999999999999999999999999999999999999999999998654443456


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccC
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD  246 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~  246 (443)
                      .+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+.......+......+|..+|+++.+||.+||+
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~  241 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK  241 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             cccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            678999999999999887774 8999999999999999999999999988888899888889999999999999999999


Q ss_pred             CCCCCCC-----CHHHHhcCccccc
Q 013421          247 PNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       247 ~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      .||.+||     +++++++||||+.
T Consensus       242 ~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          242 KDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             SSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             cCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            9999999     9999999999974

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.5e-56  Score=443.40  Aligned_cols=266  Identities=44%  Similarity=0.862  Sum_probs=240.5

Q ss_pred             CCcccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013421            1 MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (443)
Q Consensus         1 m~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   80 (443)
                      |.-....+++|++.+.||+|+||+||+|.+..+++.||+|++.+......+....+.+|+.+++.++||||+++++++.+
T Consensus         1 M~i~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~   80 (336)
T 3h4j_B            1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT   80 (336)
T ss_dssp             ---CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCcCccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            55667889999999999999999999999999999999999986544333334678999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      .+..|+||||+ +|+|++++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           81 PTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             SSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             CCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            99999999999 78999999998999999999999999999999999999999999999999999999999999998765


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHH
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL  240 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l  240 (443)
                      .. ....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+........++....+..|..+|+++.+|
T Consensus       160 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  238 (336)
T 3h4j_B          160 DG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSL  238 (336)
T ss_dssp             TS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHH
T ss_pred             CC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence            43 34567889999999999988887778999999999999999999999988777777777777788888999999999


Q ss_pred             HHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          241 IHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      |++||+.||.+|||++|+++||||+...
T Consensus       239 i~~~L~~dP~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          239 IRRMIVADPMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             HHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred             HHHHcCCChhHCcCHHHHHhChhhccCC
Confidence            9999999999999999999999998754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.7e-55  Score=435.92  Aligned_cols=261  Identities=30%  Similarity=0.583  Sum_probs=238.1

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   83 (443)
                      ...+++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+..|..+++.+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            45678999999999999999999999999999999999876543333456788899999877 99999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.......
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999998654444


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+.......+......+|.++|+++.+||.+
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  251 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK  251 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHH
Confidence            456678999999999999887775 9999999999999999999999999999999999988889999999999999999


Q ss_pred             ccCCCCCCCCCHH-HHhcCccccc
Q 013421          244 ILDPNPKTRIRIE-GIRKHPWFRK  266 (443)
Q Consensus       244 ~L~~dP~~R~t~~-eil~hp~f~~  266 (443)
                      ||+.||.+||++. +|++||||+.
T Consensus       252 lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          252 LFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             HSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HhcCCHhHcCCChHHHHcCccccC
Confidence            9999999999998 9999999975

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.9e-54  Score=428.52  Aligned_cols=261  Identities=32%  Similarity=0.587  Sum_probs=237.3

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   83 (443)
                      ...+++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus         5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            45678999999999999999999999999999999999987766666678899999999988 89999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.......
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999998644433


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCC---------CChHHHHHHhhhccCCCCCCCC
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE---------TDLPTLYKKINAAEFSCPFWFS  234 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~s  234 (443)
                      ....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||..         .+.....+.+......+|..+|
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s  243 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS  243 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSC
T ss_pred             CcccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCC
Confidence            456678999999999999887774 999999999999999999999975         2334566777788888899999


Q ss_pred             HHHHHHHHHccCCCCCCCCCH------HHHhcCccccc
Q 013421          235 TGATSLIHKILDPNPKTRIRI------EGIRKHPWFRK  266 (443)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~------~eil~hp~f~~  266 (443)
                      +++.+||.+||+.||.+||++      +++++||||+.
T Consensus       244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            999999999999999999995      89999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.2e-54  Score=438.52  Aligned_cols=260  Identities=32%  Similarity=0.588  Sum_probs=233.9

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~   84 (443)
                      ..+++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|..+++++ +||||+++++++.+.+.+
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            4567999999999999999999999999999999999987665555566788999999887 899999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++........
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence            99999999999999999989999999999999999999999999999999999999999999999999999986444445


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC---------ChHHHHHHhhhccCCCCCCCCH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---------DLPTLYKKINAAEFSCPFWFST  235 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~  235 (443)
                      ...+.|||+.|+|||++.+..|. .++|||||||++|+|++|.+||...         ......+.+......+|..+|+
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~  287 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV  287 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             ccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCH
Confidence            56788999999999999888775 9999999999999999999999642         2344677788888899999999


Q ss_pred             HHHHHHHHccCCCCCCCCCH------HHHhcCccccc
Q 013421          236 GATSLIHKILDPNPKTRIRI------EGIRKHPWFRK  266 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~------~eil~hp~f~~  266 (443)
                      ++.+||++||+.||.+||++      +||++||||+.
T Consensus       288 ~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          288 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            99999999999999999985      89999999975

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-54  Score=426.10  Aligned_cols=257  Identities=33%  Similarity=0.694  Sum_probs=237.6

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..+++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            46789999999999999999999999999999999998765433334567889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....   .
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~  159 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---V  159 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---C
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---c
Confidence            9999999999999999988999999999999999999999999999999999999999999999999999976543   2


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHcc
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  245 (443)
                      ..+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+.++......+|..+++++.+||.+||
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL  238 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI  238 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             cccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence            3567899999999999887775 899999999999999999999999998888999988889999999999999999999


Q ss_pred             CCCCCCCC-----CHHHHhcCccccc
Q 013421          246 DPNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       246 ~~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      ..||.+||     +++++++||||+.
T Consensus       239 ~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          239 TRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             ccCHHHcCCCcCCCHHHHhcCccccC
Confidence            99999999     9999999999975

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.1e-55  Score=436.61  Aligned_cols=251  Identities=22%  Similarity=0.362  Sum_probs=216.1

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCcceEEEEEEe-
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-PNIVRLHEVLAS-   80 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~-   80 (443)
                      .++|++++.||+|+||+||+|.+..+     ++.||||.+.....  ....+.+.+|+.+|++++| ||||++++++.+ 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            46899999999999999999997654     36899999976542  3345779999999999965 899999999865 


Q ss_pred             CCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS  144 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~  144 (443)
                      .+.+|+|||||++|+|.++|...                ..+++..+..++.||+.||+|||+++|+||||||+|||+++
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence            46799999999999999999753                34889999999999999999999999999999999999999


Q ss_pred             CCCeEEeeecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChH-HHHH
Q 013421          145 YGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP-TLYK  220 (443)
Q Consensus       145 ~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~  220 (443)
                      ++++||+|||+|+.......  ...+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+.. ....
T Consensus       221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~  299 (353)
T 4ase_A          221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  299 (353)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred             CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999986544322  23456899999999999888775 99999999999999998 99999886543 4445


Q ss_pred             Hhhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          221 KINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       221 ~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+..+ .+..|..+|+++.+||.+||+.||++|||++||++|
T Consensus       300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            55443 567788899999999999999999999999999987

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-54  Score=432.72  Aligned_cols=261  Identities=28%  Similarity=0.553  Sum_probs=238.1

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   83 (443)
                      ...+++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            45678999999999999999999999999999999999876543334456788999999988 89999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.......
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999998654443


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ....+.+||+.|+|||++.+.+|. .++|||||||++|+|++|..||.+.+....+.++....+.+|..+|+++.+||.+
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  254 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG  254 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            456678999999999999887774 9999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCC-----HHHHhcCccccc
Q 013421          244 ILDPNPKTRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       244 ~L~~dP~~R~t-----~~eil~hp~f~~  266 (443)
                      ||..||.+||+     +++|++||||+.
T Consensus       255 lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          255 LMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            99999999994     699999999974

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.9e-54  Score=428.38  Aligned_cols=258  Identities=32%  Similarity=0.647  Sum_probs=238.8

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ...+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            45688999999999999999999999999999999999876544334457788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......  
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            999999999999999999899999999999999999999999999999999999999999999999999999765432  


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHc
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (443)
                       ..+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+.++..+...+|..+++++.+||.+|
T Consensus       195 -~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l  272 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL  272 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHH
T ss_pred             -cccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence             3467899999999999887775 89999999999999999999999999889999999999999999999999999999


Q ss_pred             cCCCCCCCCC-----HHHHhcCccccc
Q 013421          245 LDPNPKTRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       245 L~~dP~~R~t-----~~eil~hp~f~~  266 (443)
                      |+.||.+||+     +++|++||||+.
T Consensus       273 L~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          273 LQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             SCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             hhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            9999999998     999999999974

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.9e-54  Score=427.18  Aligned_cols=260  Identities=34%  Similarity=0.591  Sum_probs=234.0

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---RMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      ...-++|++++.||+|+||.||+|++..+|+.||+|++.+......   ...+.+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            4456789999999999999999999999999999999987653221   1246789999999999999999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC----CeEEeeecCcC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSA  157 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~----~~kL~DFGls~  157 (443)
                      +.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++.
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            99999999999999999999888999999999999999999999999999999999999998877    79999999997


Q ss_pred             CCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCC
Q 013421          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWF  233 (443)
Q Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~  233 (443)
                      ..... ......+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+.......+....+.++    ..+
T Consensus       168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (361)
T 2yab_A          168 EIEDG-VEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT  245 (361)
T ss_dssp             ECCTT-CCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             EcCCC-CccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence            65543 334567899999999999877764 899999999999999999999999988888888888777665    458


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      |+++.+||.+||.+||.+|||++|+++||||+.
T Consensus       246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            999999999999999999999999999999974

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.8e-54  Score=429.35  Aligned_cols=261  Identities=32%  Similarity=0.563  Sum_probs=230.0

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ....++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            3467899999999999999999999999999999999998776555555667778877 577899999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.......
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999997644433


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+.+.++......+|..+++++.+||.+
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  272 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG  272 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHH
T ss_pred             CccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Confidence            456678999999999999887775 8999999999999999999999999999999999888888899999999999999


Q ss_pred             ccCCCCCCCCCH----HHHhcCccccc
Q 013421          244 ILDPNPKTRIRI----EGIRKHPWFRK  266 (443)
Q Consensus       244 ~L~~dP~~R~t~----~eil~hp~f~~  266 (443)
                      ||+.||.+||++    ++|++||||+.
T Consensus       273 lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          273 LLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HcccCHHhCCCCCCCHHHHhCCccccC
Confidence            999999999987    69999999974

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.3e-53  Score=434.51  Aligned_cols=261  Identities=38%  Similarity=0.701  Sum_probs=234.7

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +...++|++++.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence            344578999999999999999999999999999999998765433 3457789999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc---CCCCeEEeeecCcCCCcc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD---SYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~---~~~~~kL~DFGls~~~~~  161 (443)
                      |+||||++||+|++.+...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            99999999999999999999999999999999999999999999999999999999998   467899999999987665


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC----CCCHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGA  237 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~  237 (443)
                      ........+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+.......+..+.+.+|.    .+|+++
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          166 EQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             TCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            54555678899999999999877775 8999999999999999999999999988888888887665543    479999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .+||.+||+.||.+|||+.|+++||||+..
T Consensus       245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          245 KDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            999999999999999999999999999753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.6e-53  Score=426.21  Aligned_cols=261  Identities=28%  Similarity=0.548  Sum_probs=234.7

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ....+++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34567899999999999999999999999999999999987654444456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++...... 
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            9999999999999999999889999999999999999999999999999999999999999999999999999765443 


Q ss_pred             ccccccCCCcccCCCcccccC---CCCCCccchHHHHHHHHHHhhCCCCCCCC---ChHHHHHHhhhccCCCCCCCCHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNR---GYDGSAADVWSCGVILFVLMAGYLPFGET---DLPTLYKKINAAEFSCPFWFSTGA  237 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~  237 (443)
                      ....+.+||+.|+|||++.+.   +| +.++|||||||++|+|++|..||...   ........+......+|..+|+++
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~  247 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEM  247 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             CceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHH
Confidence            345678899999999999642   34 48999999999999999999999753   345566677777888899999999


Q ss_pred             HHHHHHccCCCCCCCCC-HHHHhcCccccc
Q 013421          238 TSLIHKILDPNPKTRIR-IEGIRKHPWFRK  266 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t-~~eil~hp~f~~  266 (443)
                      .+||.+||+.||.+||+ ++++++||||+.
T Consensus       248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             HHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             HHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            99999999999999998 899999999974

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5e-53  Score=422.32  Aligned_cols=260  Identities=39%  Similarity=0.720  Sum_probs=233.3

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            344456899999999999999999999999999999999876543 3346779999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC---CeEEeeecCcCCCc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQ  160 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~~~  160 (443)
                      .|+||||++||+|++++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++....
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999999999999888999999999999999999999999999999999999998654   59999999997665


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC----CCCHH
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTG  236 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~  236 (443)
                      .. ......+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+.......+..+.+.+|.    .++++
T Consensus       183 ~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (362)
T 2bdw_A          183 DS-EAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  260 (362)
T ss_dssp             TC-CSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred             CC-cccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            43 334567899999999999877765 8999999999999999999999998888888888877665553    37999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      +.+||.+||+.||.+|||++++++||||+.
T Consensus       261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          261 AKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            999999999999999999999999999975

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.3e-53  Score=408.70  Aligned_cols=258  Identities=25%  Similarity=0.422  Sum_probs=229.1

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +...++|++++.||+|+||+||+|.+..+|+.||+|++.......   .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            445678999999999999999999999999999999997654333   35688999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+||||++||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             EEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999999999876 5799999999999999999999999999999999999999999999999999876655444


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---cCCCCCCCCHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATSLI  241 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li  241 (443)
                      .....+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+...   ....|..+++.+.+||
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  250 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  250 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred             ccCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHH
Confidence            55677899999999999887775 8999999999999999999999887766555444332   3445667899999999


Q ss_pred             HHccCCCCCCCCCHHHHhcCcccccc
Q 013421          242 HKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .+||+.||.+|||++|+++||||+..
T Consensus       251 ~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          251 NRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHccCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999999754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.6e-53  Score=406.74  Aligned_cols=259  Identities=33%  Similarity=0.489  Sum_probs=220.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +++|++++.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            4789999999999999999999999999999999987653 333457788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||+++ +|.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence            999976 5555554 46789999999999999999999999999999999999999999999999999998765544555


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCC-CCCCChHHHHHHhhhcc-------------------
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLYKKINAAE-------------------  226 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P-f~~~~~~~~~~~i~~~~-------------------  226 (443)
                      ...+||+.|+|||++.+....+.++||||+||++|+|++|..| |.+.+.......+....                   
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T 3o0g_A          159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence            6778999999999998776556999999999999999988777 55555555544442210                   


Q ss_pred             ----------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          227 ----------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       227 ----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                                ....+.+++++.+||.+||+.||++|||++|+++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                      011224789999999999999999999999999999998643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.1e-53  Score=415.17  Aligned_cols=261  Identities=34%  Similarity=0.612  Sum_probs=225.0

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEEC---CCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   80 (443)
                      ....++|++++.||+|+||.||+|++.   .+|+.||+|++.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            455789999999999999999999985   689999999998764322 2234568899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      .+..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999987654


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHH
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL  240 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l  240 (443)
                      .........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|..+++++.+|
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  251 (327)
T 3a62_A          173 HDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDL  251 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred             cCCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            44344567789999999999987766 48999999999999999999999999888888888888888999999999999


Q ss_pred             HHHccCCCCCCCC-----CHHHHhcCccccc
Q 013421          241 IHKILDPNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       241 i~~~L~~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      |.+||..||.+||     +++++++||||+.
T Consensus       252 i~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            9999999999999     8899999999974

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.7e-53  Score=435.68  Aligned_cols=259  Identities=34%  Similarity=0.585  Sum_probs=227.8

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      .+++|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            46789999999999999999999999999999999987654444456678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      ||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||++.........
T Consensus       226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  305 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT  305 (446)
T ss_dssp             EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred             EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc
Confidence            99999999999999998999999999999999999999998 99999999999999999999999999999865544455


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHcc
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  245 (443)
                      ....+||+.|+|||++.+..|. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||
T Consensus       306 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L  384 (446)
T 4ejn_A          306 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL  384 (446)
T ss_dssp             -CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             cccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence            6678999999999999877774 999999999999999999999999999899999988889999999999999999999


Q ss_pred             CCCCCCCC-----CHHHHhcCccccc
Q 013421          246 DPNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       246 ~~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      +.||.+||     |++|+++||||+.
T Consensus       385 ~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          385 KKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             CSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             ccCHHHhCCCCCCCHHHHHhCccccC
Confidence            99999999     9999999999974

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.7e-53  Score=405.42  Aligned_cols=264  Identities=36%  Similarity=0.665  Sum_probs=236.4

Q ss_pred             CcccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013421            2 KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         2 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      ++....+++|++++.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++++.+.
T Consensus         2 k~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (279)
T 3fdn_A            2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   81 (279)
T ss_dssp             --CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CcceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence            45677899999999999999999999999999999999999775544333456789999999999999999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      +..|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999999999999889999999999999999999999999999999999999999999999999998865433


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI  241 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li  241 (443)
                      .  .....+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+.......|..+++++.+||
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (279)
T 3fdn_A          162 S--RRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI  238 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             c--cccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence            2  2345679999999999987665 489999999999999999999999999888888888888889999999999999


Q ss_pred             HHccCCCCCCCCCHHHHhcCccccccC
Q 013421          242 HKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .+||+.||.+|||++|+++||||+...
T Consensus       239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          239 SRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HHHhccChhhCCCHHHHhhCccccCCc
Confidence            999999999999999999999998754

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3e-53  Score=430.33  Aligned_cols=261  Identities=32%  Similarity=0.552  Sum_probs=229.4

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ...++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            34678999999999999999999999999999999998644322222345789999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-c
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-E  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~  164 (443)
                      +||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++....... .
T Consensus       146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence            99999999999998876 679999999999999999999999999999999999999999999999999997654432 2


Q ss_pred             cccccCCCcccCCCcccccCC---CCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cCCCC--CCCCHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCP--FWFSTGA  237 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~  237 (443)
                      ...+.+||+.|+|||++.+.+   +.+.++|||||||++|+|++|.+||.+.+....+.++...  .+.+|  ..+|+++
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  304 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  304 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence            345789999999999997654   2358999999999999999999999999988888887654  24444  4689999


Q ss_pred             HHHHHHccCCCCCC--CCCHHHHhcCcccccc
Q 013421          238 TSLIHKILDPNPKT--RIRIEGIRKHPWFRKN  267 (443)
Q Consensus       238 ~~li~~~L~~dP~~--R~t~~eil~hp~f~~~  267 (443)
                      ++||++||..+|.+  |++++||++||||+..
T Consensus       305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            99999999999998  9999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-53  Score=413.43  Aligned_cols=256  Identities=27%  Similarity=0.505  Sum_probs=230.5

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            4679999999999999999999999999999999987542    234678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC--CCCeEEeeecCcCCCcccc
Q 013421           87 ILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~--~~~~kL~DFGls~~~~~~~  163 (443)
                      ||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++...... 
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-  157 (321)
T 1tki_A           79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence            999999999999997654 7999999999999999999999999999999999999987  789999999999766543 


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGATS  239 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~  239 (443)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+.++    ..+|+++.+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence            33456779999999999987655 4899999999999999999999999988888888888777665    358999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ||.+||..||.+|||++|+++||||+...
T Consensus       237 li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          237 FVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            99999999999999999999999998653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-52  Score=410.72  Aligned_cols=261  Identities=33%  Similarity=0.588  Sum_probs=231.4

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---RMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++.+......   ...+.+.+|+.+++.++||||+++++++.+.
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            3445679999999999999999999999999999999987543221   1246788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC----CeEEeeecCcC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSA  157 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~----~~kL~DFGls~  157 (443)
                      ...|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++.
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            99999999999999999998888999999999999999999999999999999999999999887    89999999997


Q ss_pred             CCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCC
Q 013421          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWF  233 (443)
Q Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~  233 (443)
                      ..... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+....+..+    ..+
T Consensus       167 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (326)
T 2y0a_A          167 KIDFG-NEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  244 (326)
T ss_dssp             ECCTT-SCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             ECCCC-CccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC
Confidence            66443 234567899999999999876664 899999999999999999999998888777777766665554    457


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      |+.+.+||.+||+.||.+|||++++++||||+..
T Consensus       245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            9999999999999999999999999999999753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-52  Score=413.29  Aligned_cols=261  Identities=38%  Similarity=0.664  Sum_probs=225.1

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..+++|++++.||+|+||+||+|++..+++.||+|++.......  ..+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            35789999999999999999999999999999999997654322  3466889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc--c
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--V  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--~  163 (443)
                      +||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......  .
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            99999999999999988888999999999999999999999999999999999999999999999999999765432  2


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhhhccCCCC--CCCCHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSCP--FWFSTGATSL  240 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~l  240 (443)
                      ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+  ..+++++.+|
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence            33456789999999999988777668999999999999999999999876543 33333333333333  3489999999


Q ss_pred             HHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          241 IHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      |.+||+.||.+|||++|+++||||+...
T Consensus       242 i~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHccCChhhCcCHHHHhhChhhcccc
Confidence            9999999999999999999999998654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=407.34  Aligned_cols=260  Identities=35%  Similarity=0.635  Sum_probs=222.7

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch-----------------------HHHHHHHHHHH
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH-----------------------RMVDQIKREIS   61 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~-----------------------~~~~~~~~Ei~   61 (443)
                      ...+++|++.+.||+|+||.||+|.+..+++.||+|++.+......                       ...+.+.+|+.
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A            9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            3457899999999999999999999999999999999987543211                       12356889999


Q ss_pred             HHHhCCCCCcceEEEEEEe--CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCc
Q 013421           62 IMKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN  139 (443)
Q Consensus        62 il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~N  139 (443)
                      +++.++||||+++++++.+  ....|+||||+++++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            9999999999999999986  678999999999999987653 4679999999999999999999999999999999999


Q ss_pred             EEEcCCCCeEEeeecCcCCCccccccccccCCCcccCCCcccccCCC--CCCccchHHHHHHHHHHhhCCCCCCCCChHH
Q 013421          140 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY--DGSAADVWSCGVILFVLMAGYLPFGETDLPT  217 (443)
Q Consensus       140 ILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  217 (443)
                      ||++.++.+||+|||++.............+||+.|+|||++.+...  .+.++|||||||++|+|++|..||...+...
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            99999999999999999876554444566789999999999976542  3578999999999999999999999888777


Q ss_pred             HHHHhhhccCCCC--CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          218 LYKKINAAEFSCP--FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       218 ~~~~i~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      ....+.......|  ..+++++.+||.+||+.||.+|||++|+++||||+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            7777766655544  46899999999999999999999999999999996

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.4e-52  Score=417.14  Aligned_cols=258  Identities=40%  Similarity=0.728  Sum_probs=216.6

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ...++|++++.||+|+||.||+|++..+++.||+|++.......    +.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            34678999999999999999999999999999999998654332    45789999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC--eEEeeecCcCCCcccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGV  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~--~kL~DFGls~~~~~~~  163 (443)
                      +||||++||+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++...... 
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-  171 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  171 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence            99999999999999998899999999999999999999999999999999999999987765  999999998744332 


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh----HHHHHHhhhccCCCCC--CCCHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL----PTLYKKINAAEFSCPF--WFSTGA  237 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~--~~s~~~  237 (443)
                      ......+||+.|+|||++.+..+++.++|||||||++|+|++|..||...+.    ......+....+..|.  .+++++
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  251 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC  251 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence            2345668999999999998888876669999999999999999999987543    3444555555555555  479999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .+||.+||+.||.+|||++|+++||||.+..
T Consensus       252 ~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          252 CHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            9999999999999999999999999997654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.4e-52  Score=399.98  Aligned_cols=265  Identities=45%  Similarity=0.857  Sum_probs=230.9

Q ss_pred             cccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      .+....++|++++.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT   84 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            34567899999999999999999999999999999999997654333334567899999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      ..|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999998765443


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH  242 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~  242 (443)
                       ......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+.......|..+++++.++|.
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  243 (276)
T 2h6d_A          165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLM  243 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHH
Confidence             2344667999999999998777666899999999999999999999999888888888888888888889999999999


Q ss_pred             HccCCCCCCCCCHHHHhcCccccccC
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      +||+.||.+|||++++++||||+...
T Consensus       244 ~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          244 HMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHccCChhhCCCHHHHHhChhhccCc
Confidence            99999999999999999999998654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.2e-52  Score=401.21  Aligned_cols=265  Identities=34%  Similarity=0.685  Sum_probs=237.7

Q ss_pred             CCcccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013421            1 MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (443)
Q Consensus         1 m~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   80 (443)
                      |.+....+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (284)
T 2vgo_A            6 MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD   85 (284)
T ss_dssp             ----CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             CCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence            44566778999999999999999999999999999999999976543333334678999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      .+..|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999986543


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHH
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL  240 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l  240 (443)
                      ..  .....+|++.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.......|..+++++.++
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (284)
T 2vgo_A          166 SL--RRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL  242 (284)
T ss_dssp             SS--CBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred             cc--ccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHH
Confidence            32  23456799999999999877664 8999999999999999999999998888888888888888889999999999


Q ss_pred             HHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          241 IHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      |.+||..||.+|||++++++||||+...
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            9999999999999999999999998654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-52  Score=400.76  Aligned_cols=262  Identities=33%  Similarity=0.625  Sum_probs=209.3

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +..+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            45678999999999999999999999999999999999765433333457789999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999999875 578999999999999999999999999999999999999999999999999987665433


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (443)
                      ......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+....+..|..+++++.+||.+
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  245 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ  245 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHH
T ss_pred             CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHH
Confidence            34456789999999999987665 48999999999999999999999887766666666666777888899999999999


Q ss_pred             ccCCCCCCCCCHHHHhcCcccccc
Q 013421          244 ILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ||+.||.+|||++++++||||+..
T Consensus       246 ~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          246 LLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HcccCHhhCCCHHHHhcCccccCC
Confidence            999999999999999999999754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-52  Score=429.32  Aligned_cols=260  Identities=28%  Similarity=0.528  Sum_probs=227.8

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  151 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL  151 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence            35789999999999999999999999999999999986543332233458899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc-cc
Q 013421           87 ILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-VE  164 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~~  164 (443)
                      ||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++...... ..
T Consensus       152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~  231 (437)
T 4aw2_A          152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  231 (437)
T ss_dssp             EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred             EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence            9999999999999987 578999999999999999999999999999999999999999999999999999755432 22


Q ss_pred             cccccCCCcccCCCccccc----CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cCCCCCC---CCH
Q 013421          165 LLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW---FST  235 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~---~s~  235 (443)
                      .....+||+.|+|||++..    ....+.++|||||||++|+|++|+.||.+.+..+.+.++...  .+.+|..   +|+
T Consensus       232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~  311 (437)
T 4aw2_A          232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE  311 (437)
T ss_dssp             ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCH
T ss_pred             ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCH
Confidence            3445789999999999862    233358999999999999999999999999988888887543  3555543   899


Q ss_pred             HHHHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 013421          236 GATSLIHKILDPNPKT--RIRIEGIRKHPWFRK  266 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~--R~t~~eil~hp~f~~  266 (443)
                      ++.+||++||..+|++  |++++|+++||||+.
T Consensus       312 ~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          312 NAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             HHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             HHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            9999999999999888  999999999999975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.5e-51  Score=398.48  Aligned_cols=265  Identities=34%  Similarity=0.557  Sum_probs=242.4

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            34567899999999999999999999999999999999887655556678899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            99999999999999999888999999999999999999999999999999999999999999999999999976654334


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHc
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (443)
                      .....+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+..+....+.......|..+++.+.++|.+|
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  249 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM  249 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHH
Confidence            4456789999999999987666 489999999999999999999999988888888888888888889999999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccccccCCC
Q 013421          245 LDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                      |+.||.+|||++++++||||+....+
T Consensus       250 l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          250 LQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             TCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             cccChhhCcCHHHHhhChheecCCcC
Confidence            99999999999999999999876644

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.4e-52  Score=414.44  Aligned_cols=257  Identities=34%  Similarity=0.628  Sum_probs=223.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH--RMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      -++|++.+.||+|+||.||+|.++.+|+.||||++........  ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3579999999999999999999999999999999976432211  12467899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC---eEEeeecCcCC
Q 013421           86 IILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSAL  158 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~---~kL~DFGls~~  158 (443)
                      +||||++|++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999999888653    25899999999999999999999999999999999999987655   99999999977


Q ss_pred             CccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCC
Q 013421          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFS  234 (443)
Q Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s  234 (443)
                      ...........+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+ ......+..+.+..+    ..+|
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s  260 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS  260 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCC
Confidence            65543445677899999999999877774 99999999999999999999998753 455666666655544    3589


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      +++.+||.+||+.||.+|||+.++++||||+.
T Consensus       261 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            99999999999999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.5e-52  Score=448.74  Aligned_cols=260  Identities=28%  Similarity=0.557  Sum_probs=239.3

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~   84 (443)
                      ..+++|++++.||+|+||+||+|++..+++.||||++.+.........+.+..|..++..+ +||||+++++++.+.+.+
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            4578999999999999999999999999999999999876543344456788999999988 799999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||++........
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred             EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence            99999999999999999989999999999999999999999999999999999999999999999999999986444444


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHc
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (443)
                      ...+.+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+..+++..+....+.+|..+|+++.+||++|
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l  576 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL  576 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            56678999999999999888775 99999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCH-----HHHhcCccccc
Q 013421          245 LDPNPKTRIRI-----EGIRKHPWFRK  266 (443)
Q Consensus       245 L~~dP~~R~t~-----~eil~hp~f~~  266 (443)
                      |+.||.+||++     +||++||||+.
T Consensus       577 L~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          577 MTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             SCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             ccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            99999999998     99999999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.4e-52  Score=406.88  Aligned_cols=261  Identities=31%  Similarity=0.471  Sum_probs=209.5

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++.......  ..+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            4678999999999999999999999999999999997654222  23567899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           87 ILEFVTGGELFDKIVHQ------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      ||||++ |+|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            999997 5999988754      358999999999999999999999999999999999999999999999999998665


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------  226 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------------  226 (443)
                      .........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....              
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence            444445567899999999999765445699999999999999999999999887766555542210              


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          227 --------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       227 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                                          ...+..+++++.+||.+||+.||.+|||++|+++||||+..+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                01122478899999999999999999999999999999876643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.3e-52  Score=405.99  Aligned_cols=260  Identities=31%  Similarity=0.455  Sum_probs=217.0

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ....++|++++.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence            345789999999999999999999995 589999999976542 223456788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |+||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            999999975 788877664 459999999999999999999999999999999999999999999999999998765544


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--C--------------
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--F--------------  227 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~--------------  227 (443)
                      ......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+....  .              
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence            455667899999999998765555699999999999999999999998866655444432210  0              


Q ss_pred             --------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          228 --------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       228 --------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                    ...+.+++++.+||.+||+.||.+|||++|+++||||+.-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence                          0112368899999999999999999999999999999753

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-52  Score=423.56  Aligned_cols=259  Identities=29%  Similarity=0.526  Sum_probs=226.7

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ...++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            34678999999999999999999999999999999998754333333456889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           86 IILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      +||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++........
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            9999999999999998764 799999999999999999999999999999999999999999999999999976544322


Q ss_pred             -cccccCCCcccCCCccccc-------CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cCCCC---C
Q 013421          165 -LLHTTCGTPNYVAPEVLSN-------RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCP---F  231 (443)
Q Consensus       165 -~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~---~  231 (443)
                       .....+||+.|+|||++..       ..| +.++|||||||++|+|++|+.||.+.+..+.+.++...  ....|   .
T Consensus       218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  296 (412)
T 2vd5_A          218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE  296 (412)
T ss_dssp             EECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred             cccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence             2345789999999999873       334 58999999999999999999999998888888877653  23444   4


Q ss_pred             CCCHHHHHHHHHccCCCCCCC---CCHHHHhcCccccc
Q 013421          232 WFSTGATSLIHKILDPNPKTR---IRIEGIRKHPWFRK  266 (443)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R---~t~~eil~hp~f~~  266 (443)
                      .+|+++++||++||. +|.+|   ++++||++||||+.
T Consensus       297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence            699999999999999 99998   59999999999975

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.9e-51  Score=406.14  Aligned_cols=264  Identities=34%  Similarity=0.559  Sum_probs=242.3

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            34568999999999999999999999999999999998876656666788999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999766543344


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHcc
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  245 (443)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+....+..|..+++++.+||.+||
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  276 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML  276 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHc
Confidence            456789999999999987666 4899999999999999999999999888888888888888889999999999999999


Q ss_pred             CCCCCCCCCHHHHhcCccccccCCC
Q 013421          246 DPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                      +.||.+|||++++++||||+..+.+
T Consensus       277 ~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          277 QTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             CSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             cCChhHCcCHHHHhcCccccCCCcc
Confidence            9999999999999999999877654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5e-52  Score=434.27  Aligned_cols=262  Identities=29%  Similarity=0.465  Sum_probs=234.9

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      .....++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            44567899999999999999999999999999999999987654443345678899999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           84 VYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      +|+||||++||+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++...
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999999999764    36999999999999999999999999999999999999999999999999999866


Q ss_pred             ccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC----ChHHHHHHhhhccCCCCCCCCH
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET----DLPTLYKKINAAEFSCPFWFST  235 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~  235 (443)
                      ..........+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||...    +.....+.+......+|..+|+
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~  418 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP  418 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cCCCcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence            5543444566999999999999887775 9999999999999999999999875    3456777788888888999999


Q ss_pred             HHHHHHHHccCCCCCCCCC-----HHHHhcCccccc
Q 013421          236 GATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t-----~~eil~hp~f~~  266 (443)
                      ++.+||.+||+.||.+||+     +++|++||||+.
T Consensus       419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            9999999999999999996     589999999975

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.4e-52  Score=400.40  Aligned_cols=257  Identities=30%  Similarity=0.458  Sum_probs=214.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +++|++++.||+|+||.||+|.+ .+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            47899999999999999999999 67999999999765422 22236678999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..........
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            999975 898888764 679999999999999999999999999999999999999999999999999987654433344


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cC-----------------
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EF-----------------  227 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~-----------------  227 (443)
                      ...+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...  ..                 
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            56689999999999976554569999999999999999999999987766555443221  00                 


Q ss_pred             ----------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          228 ----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       228 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                .....+++++.+||.+||+.||++|||++|+++||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                      0113478999999999999999999999999999999753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.3e-52  Score=435.55  Aligned_cols=260  Identities=29%  Similarity=0.475  Sum_probs=232.7

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ....++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            45567899999999999999999999999999999999876544333456788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           85 YIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      |+||||++||+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++......
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999999998754  4999999999999999999999999999999999999999999999999999765443


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC----hHHHHHHhhhccCCCCCCCCHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFSCPFWFSTGAT  238 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~~  238 (443)
                       ......+||+.|+|||++.+..|. .++|||||||++|+|++|..||...+    .......+......+|..+|+++.
T Consensus       340 -~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~  417 (576)
T 2acx_A          340 -QTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR  417 (576)
T ss_dssp             -CCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             -ccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHH
Confidence             234567999999999999887775 99999999999999999999998753    355666777777788888999999


Q ss_pred             HHHHHccCCCCCCCC-----CHHHHhcCccccc
Q 013421          239 SLIHKILDPNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       239 ~li~~~L~~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      +||.+||+.||.+||     +++|+++||||+.
T Consensus       418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            999999999999999     7999999999985

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-51  Score=399.81  Aligned_cols=259  Identities=28%  Similarity=0.431  Sum_probs=217.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            679999999999999999999999999999999987654 2333457788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            99999999999988888899999999999999999999999999999999999999999999999999987655444556


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---------------------c
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------------------E  226 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------------~  226 (443)
                      ..+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+.......+...                     .
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            7789999999999976555569999999999999999999999987765544333211                     0


Q ss_pred             CCCC----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          227 FSCP----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       227 ~~~~----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .+.+          +.+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  291 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI  291 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence            1111          3478899999999999999999999999999999754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.2e-51  Score=392.29  Aligned_cols=261  Identities=39%  Similarity=0.713  Sum_probs=233.3

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +...++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence            34568999999999999999999999999999999999876543 33467789999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC---eEEeeecCcCCCcc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQ  161 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~---~kL~DFGls~~~~~  161 (443)
                      |+||||++|++|.+.+...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||++.....
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            999999999999999998899999999999999999999999999999999999999987665   99999999876544


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGA  237 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~  237 (443)
                      . .......||+.|+|||++.+..+. .++||||+|+++|+|++|..||...+.......+..+....|    ..+++++
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          161 S-EAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             S-CBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             C-ccccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            3 334557899999999999877764 899999999999999999999999888888888777665544    3579999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .+||.+||+.||.+|||++|+++||||+...
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             HHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            9999999999999999999999999997643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.9e-52  Score=413.60  Aligned_cols=253  Identities=34%  Similarity=0.620  Sum_probs=224.1

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~   84 (443)
                      ...++|++++.||+|+||+||+|.++.+|+.||+|++.+....       ..+|+.++.++ +||||+++++++.+.+..
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            4466899999999999999999999999999999999875422       34688888887 799999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC-C---CeEEeeecCcCCCc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-G---NLKVSDFGLSALPQ  160 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~-~---~~kL~DFGls~~~~  160 (443)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +   .+||+|||++....
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999999999998899999999999999999999999999999999999998543 3   59999999998765


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCC---CChHHHHHHhhhccCCCC----CCC
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCP----FWF  233 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~~----~~~  233 (443)
                      .......+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|..||..   .+..+....+..+.+..+    ..+
T Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          172 AENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             CTTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             CCCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence            544556678999999999999876665 899999999999999999999976   345567777777776654    358


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      |+++.+||++||..||.+|||++++++||||..
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            999999999999999999999999999999965

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.4e-51  Score=412.30  Aligned_cols=260  Identities=22%  Similarity=0.366  Sum_probs=219.9

Q ss_pred             cccCeEEeeeeecc--CceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            7 RVAKYEVGRTIGEG--TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         7 ~~~~y~i~~~LG~G--~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ..++|++++.||+|  +||.||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            46789999999999  9999999999999999999999876543 34567889999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           85 YIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      |+||||+++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            9999999999999999876  67999999999999999999999999999999999999999999999999987543221


Q ss_pred             -------cccccccCCCcccCCCccccc--CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC------
Q 013421          163 -------VELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF------  227 (443)
Q Consensus       163 -------~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------  227 (443)
                             .......+||+.|+|||++.+  ..| +.++|||||||++|+|++|..||.+.+.......+..+..      
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             cccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence                   122334589999999999976  345 5899999999999999999999987655444333222111      


Q ss_pred             ----------------------------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          228 ----------------------------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       228 ----------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                                              +.+..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence                                                    1334578999999999999999999999999999999764


Q ss_pred             C
Q 013421          268 Y  268 (443)
Q Consensus       268 ~  268 (443)
                      .
T Consensus       341 ~  341 (389)
T 3gni_B          341 K  341 (389)
T ss_dssp             -
T ss_pred             h
Confidence            3

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-51  Score=405.69  Aligned_cols=255  Identities=35%  Similarity=0.696  Sum_probs=206.1

Q ss_pred             cccCeEEe---eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 013421            7 RVAKYEVG---RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRT   82 (443)
Q Consensus         7 ~~~~y~i~---~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~   82 (443)
                      ...+|++.   +.||+|+||.||+|.+..+++.||+|++.+..      ...+.+|+.+++.+. ||||+++++++.+..
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            45678886   78999999999999999999999999997542      356778999999997 999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC---CeEEeeecCcCCC
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALP  159 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~~  159 (443)
                      ..|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            9999999999999999999988999999999999999999999999999999999999998766   7999999999866


Q ss_pred             ccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC-------hHHHHHHhhhccCCCCC-
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-------LPTLYKKINAAEFSCPF-  231 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~-  231 (443)
                      ..........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+       ..+....+..+.+..+. 
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          160 PPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             CC----------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             CCCCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence            5554556778899999999999887775 89999999999999999999997643       34566777777666553 


Q ss_pred             ---CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          232 ---WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       232 ---~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                         .+|+++.+||.+||+.||.+|||++++++||||+...
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence               4899999999999999999999999999999998653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.5e-52  Score=405.36  Aligned_cols=246  Identities=21%  Similarity=0.314  Sum_probs=193.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----KV   84 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~   84 (443)
                      .+|.+.+.||+|+||+||+|++  +|+.||||+++...    ........|+..+.+++|||||++++++.+++    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4689999999999999999987  58999999997543    11223345677778899999999999997653    68


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK--------GVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~--------gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                      |||||||++|+|.+++.. .+++++.+.+++.|++.||+|||++        ||+||||||+||||+.++++||+|||++
T Consensus        77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999999976 5799999999999999999999987        9999999999999999999999999999


Q ss_pred             CCCccccc----cccccCCCcccCCCcccccCCC-----CCCccchHHHHHHHHHHhhCCCCCCCC--------------
Q 013421          157 ALPQQGVE----LLHTTCGTPNYVAPEVLSNRGY-----DGSAADVWSCGVILFVLMAGYLPFGET--------------  213 (443)
Q Consensus       157 ~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DIwSlGvil~~ll~G~~Pf~~~--------------  213 (443)
                      +.......    ...+.+||+.|+|||++.+...     .+.++|||||||+||||++|.+||...              
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            76544222    2335689999999999975421     246899999999999999998776422              


Q ss_pred             -ChHHHHHHhhhcc--CCCCCC-----CCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          214 -DLPTLYKKINAAE--FSCPFW-----FSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       214 -~~~~~~~~i~~~~--~~~~~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                       ........+....  +..|..     .+..+.+|+.+||+.||++|||+.||++.
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence             1223333333322  233322     23467899999999999999999998863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-51  Score=411.48  Aligned_cols=259  Identities=27%  Similarity=0.555  Sum_probs=229.3

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +...++|++++.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.+|+.++||||+++++++.+....
T Consensus        47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            456678999999999999999999999999999999997653   22345788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC--CCCeEEeeecCcCCCcc
Q 013421           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~--~~~~kL~DFGls~~~~~  161 (443)
                      |+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++.....
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            99999999999999997654 7999999999999999999999999999999999999974  47899999999976544


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGA  237 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~  237 (443)
                      . ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+....+..+    ..+|+++
T Consensus       204 ~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  281 (387)
T 1kob_A          204 D-EIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  281 (387)
T ss_dssp             T-SCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             C-cceeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            3 334556899999999999877664 899999999999999999999999888777777776655443    3579999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .+||.+||+.||.+|||++++++||||+...
T Consensus       282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            9999999999999999999999999998754

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9e-52  Score=407.42  Aligned_cols=262  Identities=26%  Similarity=0.409  Sum_probs=213.2

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ....+++|++++.||+|+||+||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            45678899999999999999999999999999999999976543 22335667899999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc-----CCCCeEEeeecCcCC
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-----SYGNLKVSDFGLSAL  158 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~-----~~~~~kL~DFGls~~  158 (443)
                      .|+||||++| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||++..
T Consensus       108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            9999999975 9999999988999999999999999999999999999999999999994     445699999999976


Q ss_pred             CccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-cCC---------
Q 013421          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-EFS---------  228 (443)
Q Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~---------  228 (443)
                      ...........+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+... ..+         
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT  266 (329)
T ss_dssp             HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence            5544444566789999999999987665569999999999999999999999988776655554321 000         


Q ss_pred             -CC-------------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          229 -CP-------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       229 -~~-------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                       .+                   ..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence             00                   1168999999999999999999999999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.6e-51  Score=425.44  Aligned_cols=263  Identities=33%  Similarity=0.616  Sum_probs=231.3

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch----------HHHHHHHHHHHHHHhCCCCCcce
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH----------RMVDQIKREISIMKIVRHPNIVR   73 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~HpnIv~   73 (443)
                      .+...++|++++.||+|+||+||+|.+..+++.||+|++.+......          ...+.+.+|+.+++.++||||++
T Consensus        31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  110 (504)
T 3q5i_A           31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK  110 (504)
T ss_dssp             CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            34566789999999999999999999999999999999987553321          23467899999999999999999


Q ss_pred             EEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC---CeEE
Q 013421           74 LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKV  150 (443)
Q Consensus        74 l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~---~~kL  150 (443)
                      +++++.+....|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            9999999999999999999999999999989999999999999999999999999999999999999999776   6999


Q ss_pred             eeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC
Q 013421          151 SDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP  230 (443)
Q Consensus       151 ~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~  230 (443)
                      +|||++...... ......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.......+..+.+.++
T Consensus       191 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          191 VDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             CCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999999766543 34456789999999999864 45 5899999999999999999999999999888888888876655


Q ss_pred             ----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          231 ----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       231 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                          ..+|+++.+||++||++||.+|||++|+++||||+....
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence                458999999999999999999999999999999987543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.1e-51  Score=390.65  Aligned_cols=258  Identities=40%  Similarity=0.692  Sum_probs=232.4

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +...++|++.+.||+|+||.||+|.+..++..+|+|++.......   .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI   81 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence            445678999999999999999999999999999999998754332   46788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE---cCCCCeEEeeecCcCCCcc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls~~~~~  161 (443)
                      |+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            9999999999999999998999999999999999999999999999999999999999   7889999999999876544


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC----CCCHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGA  237 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~  237 (443)
                      . ......+||+.|+|||++.+. + +.++||||||+++|+|++|..||...+.......+..+....|.    .+++++
T Consensus       162 ~-~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T 3f3z_A          162 G-KMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA  238 (277)
T ss_dssp             T-SCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred             c-cchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence            3 344567899999999998653 4 58999999999999999999999998888888888887777664    589999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .+||.+||+.||.+|||+.++++||||++..
T Consensus       239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            9999999999999999999999999998654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-51  Score=412.49  Aligned_cols=261  Identities=30%  Similarity=0.420  Sum_probs=211.0

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC-
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRT-   82 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~-   82 (443)
                      ....++|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+++.+. ||||+++++++...+ 
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            456789999999999999999999999999999999997543 33345677889999999997 999999999997544 


Q ss_pred             -EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 -KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 -~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                       .+|+||||++ ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence             7999999997 589888876 6899999999999999999999999999999999999999999999999999875422


Q ss_pred             ---------------------ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHH
Q 013421          162 ---------------------GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  220 (443)
Q Consensus       162 ---------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  220 (443)
                                           ........+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  241 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE  241 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                                 11234557899999999999875555699999999999999999999999887766555


Q ss_pred             Hhhhc-cC----------------------------------------------CCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          221 KINAA-EF----------------------------------------------SCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       221 ~i~~~-~~----------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      .+... ..                                              ..+..+++++.+||.+||+.||.+||
T Consensus       242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~  321 (388)
T 3oz6_A          242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI  321 (388)
T ss_dssp             HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence            54311 00                                              01125789999999999999999999


Q ss_pred             CHHHHhcCccccccC
Q 013421          254 RIEGIRKHPWFRKNY  268 (443)
Q Consensus       254 t~~eil~hp~f~~~~  268 (443)
                      |++|+++||||+...
T Consensus       322 t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          322 SANDALKHPFVSIFH  336 (388)
T ss_dssp             CHHHHTTSTTTTTTC
T ss_pred             CHHHHhCCHHHHHhc
Confidence            999999999997644

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-51  Score=427.71  Aligned_cols=260  Identities=34%  Similarity=0.614  Sum_probs=233.1

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34568999999999999999999999999999999998765544444678999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE---cCCCCeEEeeecCcCCCccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls~~~~~~  162 (443)
                      +||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999999999998999999999999999999999999999999999999999   46789999999998765443


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC--C--CCCHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--F--WFSTGAT  238 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--~--~~s~~~~  238 (443)
                       ......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.......+..+.+.++  .  .+|+++.
T Consensus       183 -~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          183 -KKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             -CSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred             -cccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence             33456789999999999875 45 5899999999999999999999999998888888887765443  2  3899999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      +||.+||+.||.+|||++++++||||+...
T Consensus       260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             HHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            999999999999999999999999998654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.3e-51  Score=398.84  Aligned_cols=260  Identities=33%  Similarity=0.587  Sum_probs=231.2

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---RMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++........   ...+.+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            3455689999999999999999999999999999999987543221   1246789999999999999999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC----CeEEeeecCcC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSA  157 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~----~~kL~DFGls~  157 (443)
                      +..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            99999999999999999999888899999999999999999999999999999999999999888    79999999987


Q ss_pred             CCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCC
Q 013421          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWF  233 (443)
Q Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~  233 (443)
                      ..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+    ..+
T Consensus       168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (321)
T 2a2a_A          168 EIEDG-VEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT  245 (321)
T ss_dssp             ECCTT-CCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             ecCcc-ccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhccc
Confidence            65443 23456679999999999987666 4899999999999999999999999888888777777665554    458


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      ++.+.+||.+||..||.+|||++++++||||+.
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence            999999999999999999999999999999964

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.8e-51  Score=424.18  Aligned_cols=261  Identities=36%  Similarity=0.624  Sum_probs=230.7

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ++...++|++++.||+|+||+||+|.+..+++.||+|++.+...... ....+.+|+.+++.++||||+++++++.+...
T Consensus        17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (486)
T ss_dssp             CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence            45567899999999999999999999999999999999976543222 24678899999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc---CCCCeEEeeecCcCCCc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD---SYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~---~~~~~kL~DFGls~~~~  160 (443)
                      +|+||||++||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999999999999889999999999999999999999999999999999999995   45679999999998665


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC--C--CCCHH
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--F--WFSTG  236 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--~--~~s~~  236 (443)
                      .. ......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.......+..+.+..+  .  .+|++
T Consensus       176 ~~-~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  252 (486)
T 3mwu_A          176 QN-TKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (486)
T ss_dssp             CC-----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred             CC-CccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence            43 33456789999999999975 35 5899999999999999999999999988888888877765443  2  38999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      +.+||.+||+.||.+|||+.++++||||+...
T Consensus       253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            99999999999999999999999999998754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-50  Score=390.17  Aligned_cols=258  Identities=32%  Similarity=0.574  Sum_probs=221.0

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ++...++|++.+.||+|+||.||+|.+..++..+|+|++.......  ..+.+.+|+.+++.++||||+++++++.+...
T Consensus        17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            4556678999999999999999999999999999999998765322  24678999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE---cCCCCeEEeeecCc
Q 013421           84 VYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLS  156 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls  156 (443)
                      .|+||||+++|+|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            99999999999999988543    679999999999999999999999999999999999999   45678999999999


Q ss_pred             CCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC---CCC
Q 013421          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP---FWF  233 (443)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~  233 (443)
                      ...... ......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+.......+   ..+
T Consensus       175 ~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (285)
T 3is5_A          175 ELFKSD-EHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL  251 (285)
T ss_dssp             CC-----------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCC
T ss_pred             eecCCc-ccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcC
Confidence            765443 33456779999999999863 44 5899999999999999999999999888777776655544333   237


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      ++++.+||.+||+.||.+|||++|+++||||++
T Consensus       252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.4e-51  Score=422.85  Aligned_cols=259  Identities=33%  Similarity=0.638  Sum_probs=225.5

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +...++|++++.||+|+||.||+|++..++..||+|++.+...... ....+.+|+.+++.++||||+++++++.+....
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            3445679999999999999999999999999999999987653322 246788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC---CCeEEeeecCcCCCcc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQ  161 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~---~~~kL~DFGls~~~~~  161 (443)
                      |+|||||+||+|.+.+....++++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||++.....
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999999999999998999999999999999999999999999999999999999764   4599999999976654


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGA  237 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~  237 (443)
                      . ......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+..+....+..+.+.++    ..+|+++
T Consensus       192 ~-~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  268 (494)
T 3lij_A          192 Q-KKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA  268 (494)
T ss_dssp             T-BCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred             C-ccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence            3 34556789999999999864 45 4899999999999999999999999998888888887766544    2489999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .+||++||+.||.+|||++++++||||+..
T Consensus       269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          269 KDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            999999999999999999999999999753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.6e-50  Score=402.07  Aligned_cols=255  Identities=36%  Similarity=0.649  Sum_probs=208.8

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....     ..+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            3467999999999999999999999999999999997643     23567899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC---CCCeEEeeecCcCCCcccc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~---~~~~kL~DFGls~~~~~~~  163 (443)
                      ||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...... 
T Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-  204 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-  204 (349)
T ss_dssp             EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence            9999999999999998888999999999999999999999999999999999999975   889999999998765442 


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhhhccCCCC----CCCCHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSCP----FWFSTGAT  238 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~s~~~~  238 (443)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+.......+    ..+++++.
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  283 (349)
T 2w4o_A          205 VLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK  283 (349)
T ss_dssp             --------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             cccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence            33456789999999999987666 48999999999999999999999775544 35666665554332    34799999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      +||.+||+.||++|||+.++++||||+...
T Consensus       284 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          284 DLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            999999999999999999999999998653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.4e-51  Score=402.46  Aligned_cols=258  Identities=26%  Similarity=0.427  Sum_probs=211.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +++|++++.||+|+||.||+|.+..+++.||+|++......  .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            57899999999999999999999999999999999754321  1122455799999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||++ |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..........
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            99997 58988887754 58999999999999999999999999999999999999999999999999997665544455


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-------------------C
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-------------------F  227 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~  227 (443)
                      ...+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+....                   +
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            667899999999998775555699999999999999999999999888766555443210                   0


Q ss_pred             -----------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          228 -----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       228 -----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                                 ..++.+++++.+||.+||+.||.+|||++|+++||||....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence                       01124688999999999999999999999999999998654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-50  Score=387.17  Aligned_cols=260  Identities=38%  Similarity=0.662  Sum_probs=226.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      .+++|++++.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            567899999999999999999999999999999999765432  245778999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc--cc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VE  164 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--~~  164 (443)
                      ||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......  ..
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            9999999999999988788999999999999999999999999999999999999999999999999998765332  22


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhhhccCCC--CCCCCHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSC--PFWFSTGATSLI  241 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~--~~~~s~~~~~li  241 (443)
                      .....+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.. .....+.......  ...+++.+.+||
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence            3456789999999999987777668899999999999999999999876543 2333333332222  235899999999


Q ss_pred             HHccCCCCCCCCCHHHHhcCccccccC
Q 013421          242 HKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .+||+.||.+|||++++++||||+...
T Consensus       243 ~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          243 HKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHCCCCchhCCCHHHHhcCccccChh
Confidence            999999999999999999999998764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.7e-50  Score=393.44  Aligned_cols=254  Identities=26%  Similarity=0.450  Sum_probs=224.1

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      .|+..+.||+|+||.||+|++..+|+.||||++......   ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            488889999999999999999999999999999765422   24668899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccccc
Q 013421           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      |++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            9999999998765 679999999999999999999999999999999999999999999999999987665443444567


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC---CCCCCCCHHHHHHHHHccC
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGATSLIHKILD  246 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~~L~  246 (443)
                      +||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.....   ..+..+++++.+||.+||+
T Consensus       202 ~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  280 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV  280 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSC
T ss_pred             cCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHcc
Confidence            899999999999876664 899999999999999999999998887776666654432   2334579999999999999


Q ss_pred             CCCCCCCCHHHHhcCccccccC
Q 013421          247 PNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       247 ~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .||.+|||++++++||||+...
T Consensus       281 ~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          281 RDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             SSTTTSCCHHHHHTSGGGGGCC
T ss_pred             CChhhCcCHHHHhcChhhccCC
Confidence            9999999999999999997643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-50  Score=399.71  Aligned_cols=260  Identities=29%  Similarity=0.418  Sum_probs=219.5

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..+++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            467899999999999999999999999999999999976542 3334567889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus       101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            99999999999888887788999999999999999999999999999999999999999999999999999866554445


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-------------------c
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------E  226 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~  226 (443)
                      ....+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...                   .
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            567789999999999977655568999999999999999999999887765544333211                   0


Q ss_pred             CCC------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          227 FSC------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       227 ~~~------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      ...            .+.+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            011            1247899999999999999999999999999999975

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.6e-51  Score=420.49  Aligned_cols=257  Identities=28%  Similarity=0.452  Sum_probs=212.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----   81 (443)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++.+.. ......+.+.+|+.+|+.++||||+++++++...     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            4678999999999999999999999999999999998753 3344567889999999999999999999999654     


Q ss_pred             -CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        82 -~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                       ..+|+||||+++ +|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++....
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence             468999999976 4666664  359999999999999999999999999999999999999999999999999998664


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------  226 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------------  226 (443)
                      .. ......+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+......++....              
T Consensus       216 ~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~  293 (464)
T 3ttj_A          216 TS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  293 (464)
T ss_dssp             -C-CCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred             CC-cccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence            43 345667899999999999888775 89999999999999999999999988766655543210              


Q ss_pred             -------------CCC----CCC-----------CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          227 -------------FSC----PFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       227 -------------~~~----~~~-----------~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                                   ..+    |..           .++++.+||.+||+.||.+|||++|+++||||+..+.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence                         000    000           1567999999999999999999999999999986543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-50  Score=393.64  Aligned_cols=260  Identities=27%  Similarity=0.382  Sum_probs=213.8

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccc--hHHHHHHHHHHHHHHhC---CCCCcceEEEEEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK--HRMVDQIKREISIMKIV---RHPNIVRLHEVLA   79 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~   79 (443)
                      ....++|++++.||+|+||+||+|++..+++.||+|++.......  ......+.+|+.+++.+   +||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            345679999999999999999999999999999999997543211  11123566777777766   4999999999998


Q ss_pred             eCC-----EEEEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEee
Q 013421           80 SRT-----KVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (443)
Q Consensus        80 ~~~-----~~~lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (443)
                      ...     ..+++|||+. ++|.+++.....  +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            765     5899999996 599999987654  99999999999999999999999999999999999999999999999


Q ss_pred             ecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC--C--
Q 013421          153 FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF--S--  228 (443)
Q Consensus       153 FGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~--  228 (443)
                      ||++...... ......+||+.|+|||++.+..+. .++|||||||++|+|++|.+||.+.+......++.....  +  
T Consensus       164 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          164 FGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CccccccCCC-cccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9999866543 334567899999999999877764 899999999999999999999998887766665532110  0  


Q ss_pred             -----------------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          229 -----------------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       229 -----------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                             ..+.+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence                                   112478999999999999999999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.5e-51  Score=405.66  Aligned_cols=256  Identities=31%  Similarity=0.525  Sum_probs=224.8

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH-----RMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   80 (443)
                      ...++|++++.||+|+||.||+|++..+++.||+|++.+......     ...+.+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            345689999999999999999999999999999999987653221     123456789999999999999999999999


Q ss_pred             CCEEEEEEecCCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           81 RTKVYIILEFVTGG-ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      .+..|+||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            99999999998766 99999999889999999999999999999999999999999999999999999999999999765


Q ss_pred             ccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHH
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS  239 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~  239 (443)
                      ... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||....      .........|..+++++.+
T Consensus       181 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l~~  253 (335)
T 3dls_A          181 ERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELMS  253 (335)
T ss_dssp             CTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHHHH
T ss_pred             CCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHHHH
Confidence            443 334567899999999999888876789999999999999999999997632      1233445566778999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ||.+||++||.+|||++++++||||+...
T Consensus       254 li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          254 LVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             HHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            99999999999999999999999997643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.1e-50  Score=408.65  Aligned_cols=254  Identities=33%  Similarity=0.601  Sum_probs=211.1

Q ss_pred             cccccCeEEe-eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHH-HhCCCCCcceEEEEEEe--
Q 013421            5 TRRVAKYEVG-RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVRLHEVLAS--   80 (443)
Q Consensus         5 ~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~--   80 (443)
                      ...+++|.+. +.||+|+||+||+|.+..+|+.||||++...        ..+.+|+.++ +..+||||+++++++..  
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            4567889987 7899999999999999999999999998642        3456788887 45589999999999875  


Q ss_pred             --CCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC---CCCeEEeee
Q 013421           81 --RTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDF  153 (443)
Q Consensus        81 --~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~---~~~~kL~DF  153 (443)
                        ...+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              667999999999999999998754  5999999999999999999999999999999999999997   789999999


Q ss_pred             cCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH----HHHHHhhhccCCC
Q 013421          154 GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP----TLYKKINAAEFSC  229 (443)
Q Consensus       154 Gls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~  229 (443)
                      |++...... ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||...+..    .....+..+.+.+
T Consensus       209 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          209 GFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  286 (400)
T ss_dssp             TTCEECC------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred             ccccccCCC-CccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence            999765432 334678899999999999877775 8999999999999999999999765432    2445555555544


Q ss_pred             C----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          230 P----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       230 ~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      |    ..+|+++.+||++||+.||.+|||++++++||||....
T Consensus       287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            4    34899999999999999999999999999999998643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.1e-50  Score=400.74  Aligned_cols=264  Identities=26%  Similarity=0.369  Sum_probs=220.9

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS----   80 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----   80 (443)
                      ...+++|++++.||+|+||.||+|++..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+    
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   91 (351)
T 3mi9_A           13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASP   91 (351)
T ss_dssp             SCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred             cccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence            346789999999999999999999999999999999997654322 223567799999999999999999999976    


Q ss_pred             ----CCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecC
Q 013421           81 ----RTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (443)
Q Consensus        81 ----~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (443)
                          .+.+|+||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence                4579999999975 777777654 5799999999999999999999999999999999999999999999999999


Q ss_pred             cCCCcc----ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC
Q 013421          156 SALPQQ----GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF  231 (443)
Q Consensus       156 s~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~  231 (443)
                      +.....    ........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+.......+.
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            875542    1223456689999999999876555569999999999999999999999998877666655432221111


Q ss_pred             C--------------------------------CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          232 W--------------------------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       232 ~--------------------------------~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                      .                                .++++.+||.+||+.||.+|||++|+++||||+....+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            1                                26789999999999999999999999999999865543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.7e-50  Score=391.79  Aligned_cols=258  Identities=30%  Similarity=0.546  Sum_probs=216.8

Q ss_pred             ccccCeEEe-eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013421            6 RRVAKYEVG-RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (443)
Q Consensus         6 ~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   83 (443)
                      ...++|++. +.||+|+||.||+|.+..+++.||||++......   ..+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~   85 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR   85 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            345689995 7899999999999999999999999999765322   246788999999985 79999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC---eEEeeecCcCCCc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQ  160 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~---~kL~DFGls~~~~  160 (443)
                      .|+||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++....
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999999999999998889999999999999999999999999999999999999998776   9999999987543


Q ss_pred             cc-------cccccccCCCcccCCCccccc-----CCCCCCccchHHHHHHHHHHhhCCCCCCCCCh-------------
Q 013421          161 QG-------VELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDL-------------  215 (443)
Q Consensus       161 ~~-------~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-------------  215 (443)
                      ..       .......+||+.|+|||++.+     ..+ +.++|||||||++|+|++|..||...+.             
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            21       112345679999999999864     234 4899999999999999999999977542             


Q ss_pred             --HHHHHHhhhccCCCC----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          216 --PTLYKKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       216 --~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                        ......+..+.+..|    ..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence              335556666666665    3589999999999999999999999999999999854

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-50  Score=415.33  Aligned_cols=259  Identities=27%  Similarity=0.352  Sum_probs=199.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----eCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA-----SRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~   82 (443)
                      .++|++++.||+|+||.||+|++..+|+.||||++.+.. ......+.+.+|+.+|+.++||||+++++++.     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            468999999999999999999999999999999997643 33445678999999999999999999999984     336


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      .+|+||||+ +++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            799999998 5799999998889999999999999999999999999999999999999999999999999999765421


Q ss_pred             c---------------------------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh----------
Q 013421          163 V---------------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA----------  205 (443)
Q Consensus       163 ~---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~----------  205 (443)
                      .                           ......+||+.|+|||++......+.++||||||||+|+|++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            1                           134566899999999986544444599999999999999998          


Q ss_pred             -CCCCCCCCCh--------------------HHHHHHhhh--c--------------------c---------CCCCCCC
Q 013421          206 -GYLPFGETDL--------------------PTLYKKINA--A--------------------E---------FSCPFWF  233 (443)
Q Consensus       206 -G~~Pf~~~~~--------------------~~~~~~i~~--~--------------------~---------~~~~~~~  233 (443)
                       |.+||.+.+.                    ......+..  +                    .         ....+..
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             7777766431                    011111100  0                    0         0011346


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ++++.+||.+||..||.+|||++|+|+||||+...
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            99999999999999999999999999999998654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.3e-50  Score=389.74  Aligned_cols=258  Identities=37%  Similarity=0.680  Sum_probs=227.5

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++......   ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHY   81 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence            44567899999999999999999999999999999999865322   235688999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE---cCCCCeEEeeecCcCCCcc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls~~~~~  161 (443)
                      |+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9999999999999999988899999999999999999999999999999999999999   7789999999999876543


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGA  237 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~  237 (443)
                        ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+..+.+..+    ..+++++
T Consensus       162 --~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          162 --GIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             --BTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             --CccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence              233456799999999999876664 899999999999999999999999888888887777654433    4579999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .+||.+||..||.+|||++++++||||+...
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          239 KDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999997643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.8e-50  Score=399.16  Aligned_cols=258  Identities=33%  Similarity=0.607  Sum_probs=226.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~   81 (443)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++......     .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            35799999999999999999999999999999999765421     122346788999999999 899999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      +..|+||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            99999999999999999999888999999999999999999999999999999999999999999999999999876544


Q ss_pred             ccccccccCCCcccCCCcccccC-----CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CC
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNR-----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FW  232 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~  232 (443)
                      . ......+||+.|+|||++.+.     ...+.++|||||||++|+|++|..||...+.......+..+.+..+    ..
T Consensus       253 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  331 (365)
T 2y7j_A          253 G-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD  331 (365)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred             C-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            3 334567899999999998632     1235899999999999999999999998887777777776665543    35


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      +++++.+||.+||+.||.+|||++++++||||++
T Consensus       332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            7899999999999999999999999999999973

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.1e-51  Score=398.55  Aligned_cols=266  Identities=24%  Similarity=0.380  Sum_probs=225.1

Q ss_pred             CCcccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013421            1 MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (443)
Q Consensus         1 m~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   80 (443)
                      |.......++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   83 (311)
T 3ork_A            4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   83 (311)
T ss_dssp             CCCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred             CCCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence            45667778899999999999999999999999999999999988765566667789999999999999999999999875


Q ss_pred             CC----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           81 RT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        81 ~~----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                      ..    ..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           84 ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            43    35999999999999999998899999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccc---ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCC----
Q 013421          157 ALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC----  229 (443)
Q Consensus       157 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----  229 (443)
                      .......   ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.......    
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR  242 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence            7654321   123346799999999999877664 89999999999999999999999888766655554443322    


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       230 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +..+++++.++|.+||+.||.+||++.+++.|+|++..
T Consensus       243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            23489999999999999999999999999999999753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.3e-50  Score=384.10  Aligned_cols=258  Identities=34%  Similarity=0.627  Sum_probs=225.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---RMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++........   ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            3579999999999999999999999999999999987543321   1246789999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC----CeEEeeecCcCCCc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQ  160 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~----~~kL~DFGls~~~~  160 (443)
                      |+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999999888999999999999999999999999999999999999998877    89999999987654


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCHH
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTG  236 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~  236 (443)
                      .. .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......+    ..+++.
T Consensus       164 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T 3bhy_A          164 AG-NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL  241 (283)
T ss_dssp             ---------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred             CC-CcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence            43 23345679999999999987666 4899999999999999999999999888777777766655444    457999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +.+||.+||..||.+|||+.++++||||+..
T Consensus       242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            9999999999999999999999999999753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.3e-49  Score=381.93  Aligned_cols=258  Identities=21%  Similarity=0.274  Sum_probs=218.3

Q ss_pred             CcccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 013421            2 KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS   80 (443)
Q Consensus         2 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~   80 (443)
                      .-.....++|++++.||+|+||.||+|.+..+++.||+|++........ ....+.+|+..+..+ +||||+++++++.+
T Consensus         4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~   82 (289)
T 1x8b_A            4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAE   82 (289)
T ss_dssp             -CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred             cccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence            3345567899999999999999999999999999999999987543333 356788999999999 99999999999999


Q ss_pred             CCEEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC-----------
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-----------  145 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~-----------  145 (443)
                      .+..|+||||++|++|.+++...    +.+++..++.++.||+.||.|||++||+||||||+|||++.+           
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence            99999999999999999999765    679999999999999999999999999999999999999844           


Q ss_pred             --------CCeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHH
Q 013421          146 --------GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  217 (443)
Q Consensus       146 --------~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  217 (443)
                              ..+||+|||++......    ...+||+.|+|||++.+....+.++|||||||++|+|++|.+|+...+.  
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             cccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence                    47999999998765432    3456999999999997664555799999999999999999988754432  


Q ss_pred             HHHHhhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          218 LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       218 ~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                       ...+..+ ....|..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       237 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 -WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             -HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             -HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence             2333333 345667799999999999999999999999999999999764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-50  Score=399.35  Aligned_cols=265  Identities=26%  Similarity=0.347  Sum_probs=217.3

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH--RMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++........  ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            3567899999999999999999999999999999999976432221  12346789999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..|+||||+++ +|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  164 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence            99999999976 888888765 3689999999999999999999999999999999999999999999999999987655


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--CC---C-------
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FS---C-------  229 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~---~-------  229 (443)
                      ........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+....  ..   .       
T Consensus       165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (346)
T 1ua2_A          165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  244 (346)
T ss_dssp             CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence            44555677899999999999765545689999999999999999999999888766665543310  00   0       


Q ss_pred             ----------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          230 ----------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       230 ----------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                                      ...+++++.+||.+||+.||.+|||++|+++||||+....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence                            13457899999999999999999999999999999876443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.2e-50  Score=402.06  Aligned_cols=253  Identities=31%  Similarity=0.550  Sum_probs=218.2

Q ss_pred             cCeEE--eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            9 AKYEV--GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         9 ~~y~i--~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      +.|++  .+.||+|+||.||+|.+..+|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            34555  6789999999999999999999999999986542   345678999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE--cCCCCeEEeeecCcCCCcccc
Q 013421           87 ILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl--~~~~~~kL~DFGls~~~~~~~  163 (443)
                      ||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||++...... 
T Consensus       164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-  242 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-  242 (373)
T ss_dssp             EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-
T ss_pred             EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-
Confidence            99999999999988764 469999999999999999999999999999999999999  56788999999999866543 


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGATS  239 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~  239 (443)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+..+    ..+++++.+
T Consensus       243 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  321 (373)
T 2x4f_A          243 EKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKE  321 (373)
T ss_dssp             CBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHH
T ss_pred             cccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHH
Confidence            33456689999999999976655 4899999999999999999999999888888777776655444    358999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      ||.+||+.||.+|||++|+++||||+.
T Consensus       322 li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          322 FISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             HHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            999999999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-49  Score=406.67  Aligned_cols=261  Identities=26%  Similarity=0.390  Sum_probs=211.6

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR----   81 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----   81 (443)
                      ...++|++++.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+|+.++||||+++++++...    
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            34578999999999999999999999999999999997643 3344567899999999999999999999999766    


Q ss_pred             -CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        82 -~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                       ..+|+||||++ ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence             67999999996 5999999988889999999999999999999999999999999999999999999999999997654


Q ss_pred             ccc----------------------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhC-----------C
Q 013421          161 QGV----------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-----------Y  207 (443)
Q Consensus       161 ~~~----------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-----------~  207 (443)
                      ...                      ......+||+.|+|||++......+.++||||+||++|+|++|           .
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~  260 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF  260 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence            321                      1246788999999999875445456999999999999999984           4


Q ss_pred             CCCCCCCh-----------------HHHH------------------------HHhhhccCCCC-------CCCCHHHHH
Q 013421          208 LPFGETDL-----------------PTLY------------------------KKINAAEFSCP-------FWFSTGATS  239 (443)
Q Consensus       208 ~Pf~~~~~-----------------~~~~------------------------~~i~~~~~~~~-------~~~s~~~~~  239 (443)
                      ++|.+.+.                 ....                        ..+.......+       +.+++++.+
T Consensus       261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  340 (432)
T 3n9x_A          261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN  340 (432)
T ss_dssp             CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred             ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence            44444321                 0011                        11111111111       347999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ||.+||+.||.+|||++|+++||||+...
T Consensus       341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          341 LLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             HHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            99999999999999999999999998654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.2e-49  Score=396.51  Aligned_cols=254  Identities=26%  Similarity=0.403  Sum_probs=218.1

Q ss_pred             cccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----CCCcceEEEE
Q 013421            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-----HPNIVRLHEV   77 (443)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~~   77 (443)
                      ++...-++|++++.||+|+||.||+|++..+++.||+|++...    .........|+.+++.++     ||||++++++
T Consensus        29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~  104 (360)
T 3llt_A           29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK  104 (360)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred             cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence            3445567899999999999999999999999999999999743    223466788999999996     9999999999


Q ss_pred             EEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-----------
Q 013421           78 LASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-----------  144 (443)
Q Consensus        78 ~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-----------  144 (443)
                      +...+..|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.           
T Consensus       105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence            99999999999999 999999998754  5999999999999999999999999999999999999975           


Q ss_pred             --------------CCCeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCC
Q 013421          145 --------------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  210 (443)
Q Consensus       145 --------------~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf  210 (443)
                                    ++.+||+|||++.....   .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCC
Confidence                          78999999999975433   23466899999999999887765 9999999999999999999999


Q ss_pred             CCCChHHHHHHhhhccCCCCC----------------------------------------------CCCHHHHHHHHHc
Q 013421          211 GETDLPTLYKKINAAEFSCPF----------------------------------------------WFSTGATSLIHKI  244 (443)
Q Consensus       211 ~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~s~~~~~li~~~  244 (443)
                      ...+.......+.....+.|.                                              ..++.+.+||.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            987766655544332222111                                              1247788999999


Q ss_pred             cCCCCCCCCCHHHHhcCcccc
Q 013421          245 LDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~  265 (443)
                      |+.||.+|||++|+++||||+
T Consensus       340 L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          340 LQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCSSGGGSCCHHHHTTSGGGC
T ss_pred             hcCChhhCCCHHHHhcCcccC
Confidence            999999999999999999996

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.7e-49  Score=384.31  Aligned_cols=262  Identities=30%  Similarity=0.545  Sum_probs=228.4

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc------chHHHHHHHHHHHHHHhCC-CCCcceEEEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL------KHRMVDQIKREISIMKIVR-HPNIVRLHEV   77 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~   77 (443)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++......      .....+.+.+|+.+++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            45678999999999999999999999999999999999765311      1223467889999999995 9999999999


Q ss_pred             EEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421           78 LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus        78 ~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      +.+.+..|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence            99999999999999999999999988899999999999999999999999999999999999999999999999999987


Q ss_pred             CCccccccccccCCCcccCCCccccc-----CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC--
Q 013421          158 LPQQGVELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--  230 (443)
Q Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--  230 (443)
                      ..... ......+|++.|+|||++.+     ....+.++||||||+++|+|++|..||...+.......+....+..+  
T Consensus       173 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (298)
T 1phk_A          173 QLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  251 (298)
T ss_dssp             ECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             hcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence            65443 23456789999999999852     22235899999999999999999999998888777777766655443  


Q ss_pred             --CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          231 --FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       231 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                        ..+++.+.+||.+||+.||.+|||++++++||||++.
T Consensus       252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence              2479999999999999999999999999999999854

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-50  Score=400.71  Aligned_cols=257  Identities=28%  Similarity=0.403  Sum_probs=214.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----   81 (443)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            3568999999999999999999999999999999997643 3344567889999999999999999999999765     


Q ss_pred             -CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        82 -~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                       ..+|+||||+ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence             3569999999 8899998876 689999999999999999999999999999999999999999999999999997654


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-------------  227 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------------  227 (443)
                      .   .....+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+.....             
T Consensus       180 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  256 (367)
T 1cm8_A          180 S---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  256 (367)
T ss_dssp             S---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             c---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence            3   245678999999999987744446999999999999999999999998876655544422100             


Q ss_pred             ------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          228 ------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       228 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                                        .....+++++.+||.+||+.||.+|||++++++||||+....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                              122346999999999999999999999999999999986543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.9e-50  Score=388.87  Aligned_cols=264  Identities=31%  Similarity=0.603  Sum_probs=227.3

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhCCCCCcceEEEEE--EeCC
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIVRHPNIVRLHEVL--ASRT   82 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~   82 (443)
                      ..+++|++++.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+.+++.++||||+++++++  .+..
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            45789999999999999999999999999999999997654321 23457789999999999999999999998  4556


Q ss_pred             EEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           83 KVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      ..|+||||++++ |.+.+..  ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            899999999876 7777765  3579999999999999999999999999999999999999999999999999987654


Q ss_pred             c--ccccccccCCCcccCCCcccccCC-CCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHH
Q 013421          161 Q--GVELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGA  237 (443)
Q Consensus       161 ~--~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~  237 (443)
                      .  .........||+.|+|||++.+.. +.+.++||||||+++|+|++|..||...+.......+....+..|..+++.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l  240 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL  240 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence            2  223345667999999999987533 3357899999999999999999999998888888888888888888999999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                      .+||.+||+.||.+|||++++++||||+....+
T Consensus       241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence            999999999999999999999999999876543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.1e-49  Score=384.44  Aligned_cols=260  Identities=22%  Similarity=0.367  Sum_probs=221.1

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ...-++|++++.||+|+||.||+|++..++..||+|++...........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred             hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence            34457899999999999999999999999999999999876666666678899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (443)
                      |+||||++|++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            9999999999999999998999999999999999999999999999999999999999999999999999998654422 


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-----CCCCCCCHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-----SCPFWFSTGAT  238 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~s~~~~  238 (443)
                      ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+......+......     ..+..+++.+.
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS  245 (294)
T ss_dssp             --------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred             cccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence            22345679999999999988766 4899999999999999999999998877655444333322     23456899999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          239 SLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      ++|.+||..||.+||+..+.+.++|..
T Consensus       246 ~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          246 NVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            999999999999999766666667653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.5e-50  Score=407.40  Aligned_cols=257  Identities=38%  Similarity=0.679  Sum_probs=210.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccc-----hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK-----HRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+.....     ......+.+|+.+|++++||||+++++++.. +
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            568999999999999999999999999999999998754321     1122357899999999999999999999854 5


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC---CeEEeeecCcCCC
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALP  159 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~~  159 (443)
                      ..|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++...
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            6899999999999999999888999999999999999999999999999999999999997654   5999999999876


Q ss_pred             ccccccccccCCCcccCCCccccc--CCCCCCccchHHHHHHHHHHhhCCCCCCCCCh-HHHHHHhhhccCCCC----CC
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAEFSCP----FW  232 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~~----~~  232 (443)
                      ... ....+.+||+.|+|||++.+  ....+.++|||||||++|+|++|.+||..... ......+..+.+..+    ..
T Consensus       293 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  371 (419)
T 3i6u_A          293 GET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  371 (419)
T ss_dssp             C------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred             CCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence            543 34456789999999999864  22234799999999999999999999976543 344455555554443    34


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      +++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus       372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            7999999999999999999999999999999974

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.7e-50  Score=384.05  Aligned_cols=261  Identities=30%  Similarity=0.547  Sum_probs=227.7

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA--SRTK   83 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~   83 (443)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.  ....
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            4678999999999999999999999999999999999876543 334678999999999999999999999874  4678


Q ss_pred             EEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CEeecCCCCcEEEcCCCCeEEeeec
Q 013421           84 VYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFG  154 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~yLH~~g-----i~HrDlkp~NILl~~~~~~kL~DFG  154 (443)
                      .|+||||+++++|.+++...    ..+++..++.++.||+.||.|||++|     |+||||||+||+++.++.+||+|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999999764    34999999999999999999999999     9999999999999999999999999


Q ss_pred             CcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCCCC
Q 013421          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWF  233 (443)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~  233 (443)
                      ++.............+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..+.. ..|..+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  240 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY  240 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred             hheeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCccc
Confidence            987655433334456799999999999876664 899999999999999999999999888777777766654 566778


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ++++.++|.+||+.||.+|||++++++|||+....
T Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          241 SDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            99999999999999999999999999999997653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.7e-50  Score=397.32  Aligned_cols=261  Identities=31%  Similarity=0.511  Sum_probs=219.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL--KHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.+....  .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            35799999999999999999999999999999999865432  2234578999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 013421           86 IILEFVTGGELFDKIVH----------------------------------------QGRLLENDCRRYFQQLIDAVAHC  125 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~----------------------------------------~~~l~e~~~~~~~~qll~aL~yL  125 (443)
                      +||||++||+|.+++..                                        ...+++..++.++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999998852                                        11236778899999999999999


Q ss_pred             HhCCCEeecCCCCcEEEcCCC--CeEEeeecCcCCCcccc----ccccccCCCcccCCCcccccC-CCCCCccchHHHHH
Q 013421          126 HSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGV----ELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGV  198 (443)
Q Consensus       126 H~~gi~HrDlkp~NILl~~~~--~~kL~DFGls~~~~~~~----~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGv  198 (443)
                      |++||+||||||+|||++.++  .+||+|||++.......    ......+||+.|+|||++.+. ...+.++|||||||
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998776  89999999987543311    124567799999999998652 33458999999999


Q ss_pred             HHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          199 ILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       199 il~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ++|+|++|..||.+.+.......+.......+.    .+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            999999999999998887777777665543332    3799999999999999999999999999999997643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.4e-50  Score=393.56  Aligned_cols=257  Identities=25%  Similarity=0.400  Sum_probs=211.0

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT--   82 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--   82 (443)
                      ...+++|++++.||+|+||.||+|++..+|+.||||++....  .....+.+.+|+.+++.++||||+++++++.+..  
T Consensus         2 s~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   79 (332)
T 3qd2_B            2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE   79 (332)
T ss_dssp             CHHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred             chhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence            345789999999999999999999999999999999998654  2334578999999999999999999999985543  


Q ss_pred             -------------------------------------------------------EEEEEEecCCCCChHHHHHhcCC--
Q 013421           83 -------------------------------------------------------KVYIILEFVTGGELFDKIVHQGR--  105 (443)
Q Consensus        83 -------------------------------------------------------~~~lv~Ey~~gg~L~~~i~~~~~--  105 (443)
                                                                             ..|+||||++|++|.+++.....  
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~  159 (332)
T 3qd2_B           80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE  159 (332)
T ss_dssp             HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred             hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence                                                                   38999999999999999987654  


Q ss_pred             -CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc------------ccccccCCC
Q 013421          106 -LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV------------ELLHTTCGT  172 (443)
Q Consensus       106 -l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~------------~~~~~~~gt  172 (443)
                       .++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......            ......+||
T Consensus       160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence             4556789999999999999999999999999999999999999999999987654431            223456799


Q ss_pred             cccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCC-CCCCCHHHHHHHHHccCCCCCC
Q 013421          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-PFWFSTGATSLIHKILDPNPKT  251 (443)
Q Consensus       173 ~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~s~~~~~li~~~L~~dP~~  251 (443)
                      +.|+|||++.+..+. .++||||+||++|+|++|..|+..  .......+.....+. +...++++.+||.+||+.||.+
T Consensus       240 ~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  316 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE  316 (332)
T ss_dssp             GGGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred             cCccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCc
Confidence            999999999887764 899999999999999999877532  122222233322221 1235788999999999999999


Q ss_pred             CCCHHHHhcCccccc
Q 013421          252 RIRIEGIRKHPWFRK  266 (443)
Q Consensus       252 R~t~~eil~hp~f~~  266 (443)
                      |||++|+++||||++
T Consensus       317 Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          317 RPEATDIIENAIFEN  331 (332)
T ss_dssp             SCCHHHHHHSTTCCC
T ss_pred             CCCHHHHhhchhhhc
Confidence            999999999999974

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.1e-49  Score=379.47  Aligned_cols=252  Identities=23%  Similarity=0.432  Sum_probs=218.5

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS----RTKVY   85 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~   85 (443)
                      .|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++..    ...+|
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            489999999999999999999999999999999876543 3346788999999999999999999999865    46699


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CEeecCCCCcEEEc-CCCCeEEeeecCcCCCccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~g--i~HrDlkp~NILl~-~~~~~kL~DFGls~~~~~~  162 (443)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++..... 
T Consensus       106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~-  184 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-  184 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred             EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc-
Confidence            99999999999999998889999999999999999999999999  99999999999998 789999999999875443 


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh-HHHHHHhhhcc--CCCCCCCCHHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAE--FSCPFWFSTGATS  239 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~--~~~~~~~s~~~~~  239 (443)
                       ......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..... ......+..+.  ...+...++++.+
T Consensus       185 -~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  261 (290)
T 1t4h_A          185 -SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  261 (290)
T ss_dssp             -TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             -cccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHH
Confidence             23445679999999999864 34 5899999999999999999999987443 44444444432  2344557899999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      ||.+||+.||.+|||++++++||||+.
T Consensus       262 li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          262 IIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHccCChhhCCCHHHHhhCccccc
Confidence            999999999999999999999999975

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=388.09  Aligned_cols=250  Identities=26%  Similarity=0.396  Sum_probs=206.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ++|++++.||+|+||+||+|++..+|+.||||++......... ......|+..+..+ +||||+++++++.+.+..|+|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            6799999999999999999999999999999998765433333 33444555555544 999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++...... ...
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~~  213 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAG  213 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-CCC
Confidence            9999 678988887654 6999999999999999999999999999999999999999999999999998765432 334


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC--CCCCCCCHHHHHHHHHc
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF--SCPFWFSTGATSLIHKI  244 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~~~li~~~  244 (443)
                      ...+||+.|+|||++.+ .+ +.++||||+||++|+|++|..|+...+   ....+.....  ..+..+++++.+||.+|
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~  288 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLVMM  288 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred             cccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHHHH
Confidence            56679999999999875 45 589999999999999999976664432   2222332222  23456899999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccccc
Q 013421          245 LDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      |+.||.+|||++++++||||++
T Consensus       289 L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          289 LEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGSC
T ss_pred             cCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-49  Score=397.21  Aligned_cols=260  Identities=32%  Similarity=0.587  Sum_probs=224.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEEC---CCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~   81 (443)
                      .+++|++++.||+|+||.||+|++.   .+++.||||++.+.... .....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            4579999999999999999999984   58999999999765421 112234567899999999 699999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      +..|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            99999999999999999999888999999999999999999999999999999999999999999999999999875533


Q ss_pred             -ccccccccCCCcccCCCcccccC-CCCCCccchHHHHHHHHHHhhCCCCCCCC----ChHHHHHHhhhccCCCCCCCCH
Q 013421          162 -GVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGET----DLPTLYKKINAAEFSCPFWFST  235 (443)
Q Consensus       162 -~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~  235 (443)
                       ........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...    ........+.......|..+++
T Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (355)
T 1vzo_A          212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  291 (355)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCH
Confidence             22334456899999999999753 23358999999999999999999999753    3345555666677778888999


Q ss_pred             HHHHHHHHccCCCCCCCC-----CHHHHhcCccccc
Q 013421          236 GATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      .+.+||.+||..||.+||     |++++++||||+.
T Consensus       292 ~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            999999999999999999     9999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.5e-49  Score=394.24  Aligned_cols=257  Identities=27%  Similarity=0.423  Sum_probs=219.1

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----TK   83 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~   83 (443)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            58999999999999999999999999999999997533  333457789999999999999999999999654     47


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      .|+||||++ |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            999999997 589998876 679999999999999999999999999999999999999999999999999997654421


Q ss_pred             ---ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-------------
Q 013421          164 ---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-------------  227 (443)
Q Consensus       164 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------------  227 (443)
                         ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+.....             
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence               2235568999999999876655456999999999999999999999998776655554421100             


Q ss_pred             ------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          228 ------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       228 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                                        ...+.+++++.+||.+||+.||.+|||++|+++||||+..+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                              011347899999999999999999999999999999987654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.5e-49  Score=391.60  Aligned_cols=254  Identities=25%  Similarity=0.383  Sum_probs=221.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      .+|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45999999999999999999999999999999998765444555678999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        89 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      ||+. |+|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....    ..
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----~~  208 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----AN  208 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BC
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----CC
Confidence            9997 578887754 56799999999999999999999999999999999999999999999999999876543    23


Q ss_pred             ccCCCcccCCCcccc---cCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC--CCCCCCHHHHHHHH
Q 013421          168 TTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS--CPFWFSTGATSLIH  242 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~  242 (443)
                      ..+||+.|+|||++.   +..+ +.++|||||||++|+|++|..||...+.......+.....+  .+..+++.+.+||.
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  287 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD  287 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred             cccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            568999999999985   3344 48999999999999999999999887776655555444322  23457999999999


Q ss_pred             HccCCCCCCCCCHHHHhcCccccccC
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      +||+.||.+|||++++++||||....
T Consensus       288 ~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          288 SCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHcccChhhCcCHHHHhhChhhhccC
Confidence            99999999999999999999997653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-49  Score=397.97  Aligned_cols=251  Identities=29%  Similarity=0.409  Sum_probs=211.0

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------   80 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------   80 (443)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++......       ..+|+.+++.++||||+++++++..      
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            456899999999999999999999999999999998765322       2379999999999999999999843      


Q ss_pred             --------------------------------CCEEEEEEecCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 013421           81 --------------------------------RTKVYIILEFVTGGELFDKIV----HQGRLLENDCRRYFQQLIDAVAH  124 (443)
Q Consensus        81 --------------------------------~~~~~lv~Ey~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~aL~y  124 (443)
                                                      ...+++||||+++ +|.+.+.    ..+.+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3458999999985 6666554    45789999999999999999999


Q ss_pred             HHhCCCEeecCCCCcEEEc-CCCCeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHH
Q 013421          125 CHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL  203 (443)
Q Consensus       125 LH~~gi~HrDlkp~NILl~-~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~l  203 (443)
                      ||++||+||||||+|||++ .++.+||+|||++...... ......+||+.|+|||++.+....+.++||||+||++|+|
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            9999999999999999998 6889999999999765443 3345678999999999987766556999999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHhhhc-----------------cC------------CCCCCCCHHHHHHHHHccCCCCCCCCC
Q 013421          204 MAGYLPFGETDLPTLYKKINAA-----------------EF------------SCPFWFSTGATSLIHKILDPNPKTRIR  254 (443)
Q Consensus       204 l~G~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t  254 (443)
                      ++|.+||.+.+..+....+...                 ..            .+|..+++++.+||.+||+.||.+|||
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            9999999988766555444220                 00            134457999999999999999999999


Q ss_pred             HHHHhcCccccc
Q 013421          255 IEGIRKHPWFRK  266 (443)
Q Consensus       255 ~~eil~hp~f~~  266 (443)
                      +.|+++||||+.
T Consensus       316 ~~e~l~hp~f~~  327 (383)
T 3eb0_A          316 PYEAMAHPFFDH  327 (383)
T ss_dssp             HHHHHTSGGGHH
T ss_pred             HHHHhcCHHHHH
Confidence            999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.9e-50  Score=397.66  Aligned_cols=260  Identities=26%  Similarity=0.503  Sum_probs=227.8

Q ss_pred             cccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchH--------------HHHHHHHHHHHHHhCCC
Q 013421            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR--------------MVDQIKREISIMKIVRH   68 (443)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~H   68 (443)
                      ......++|++++.||+|+||.||+|.+  +|+.||+|++.........              ..+.+.+|+.+++.++|
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  102 (348)
T 2pml_X           25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN  102 (348)
T ss_dssp             SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred             hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence            3456678999999999999999999999  8999999999765432211              12678999999999999


Q ss_pred             CCcceEEEEEEeCCEEEEEEecCCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCc
Q 013421           69 PNIVRLHEVLASRTKVYIILEFVTGGELFDK------IVH--QGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPEN  139 (443)
Q Consensus        69 pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~------i~~--~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~N  139 (443)
                      |||+++++++.+.+..|+||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus       103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9999999999999999999999999999998      655  5689999999999999999999999 999999999999


Q ss_pred             EEEcCCCCeEEeeecCcCCCccccccccccCCCcccCCCcccccC-CCCCCccchHHHHHHHHHHhhCCCCCCCCCh-HH
Q 013421          140 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDL-PT  217 (443)
Q Consensus       140 ILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~  217 (443)
                      |+++.++.+||+|||++......  ......||+.|+|||++.+. .+.+.++||||+||++|+|++|..||...+. ..
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            99999999999999998765432  34567799999999999876 4443499999999999999999999988766 67


Q ss_pred             HHHHhhhccCCCC-------------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          218 LYKKINAAEFSCP-------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       218 ~~~~i~~~~~~~~-------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      ....+.......|                   ..+++++.+||.+||+.||.+|||++++++||||+.
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            7777777766666                   568999999999999999999999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.1e-49  Score=394.88  Aligned_cols=258  Identities=26%  Similarity=0.403  Sum_probs=221.0

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ....++|++++.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  106 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI  106 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence            345678999999999999999999999999999999998753  334567899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |+||||++|++|.+++...+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.....  
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--  184 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--  184 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred             EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence            99999999999999999988999999999999999999999996 999999999999999999999999999864432  


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHH----------------------
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----------------------  221 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~----------------------  221 (443)
                      ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......                      
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          185 SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             HC----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             ccccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence            233456899999999999877664 899999999999999999999987665433221                      


Q ss_pred             --------------------hhhcc-CCCC-CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          222 --------------------INAAE-FSCP-FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       222 --------------------i~~~~-~~~~-~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                          +.... ...+ ..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                                11111 1111 2378999999999999999999999999999999754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.3e-49  Score=396.81  Aligned_cols=256  Identities=29%  Similarity=0.443  Sum_probs=208.0

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----   82 (443)
                      ..++|++++.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.++||||+++++++....    
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            4679999999999999999999999999999999998654 23345677889999999999999999999997655    


Q ss_pred             --EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           83 --KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        83 --~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                        ..|+||||+++ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence              79999999975 7888875  468999999999999999999999999999999999999999999999999997654


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-------------  227 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------------  227 (443)
                      .. ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+.....             
T Consensus       179 ~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  256 (371)
T 2xrw_A          179 TS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  256 (371)
T ss_dssp             ------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred             cc-cccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            32 234567899999999999887765 899999999999999999999998877665555432110             


Q ss_pred             ---------C--------------CCC------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          228 ---------S--------------CPF------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       228 ---------~--------------~~~------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                               .              .|.      ..++++.+||.+||+.||.+|||++|+++||||+..+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                     0              000      0156789999999999999999999999999997644

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.7e-49  Score=388.42  Aligned_cols=258  Identities=31%  Similarity=0.531  Sum_probs=221.4

Q ss_pred             cccCeEEe-eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013421            7 RVAKYEVG-RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         7 ~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~   84 (443)
                      .-++|.+. +.||+|+||.||+|.+..+++.||+|++.+..... .....+.+|+.+++.+ +||||+++++++.+.+..
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            34568887 89999999999999999999999999998754332 2346788999999999 569999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC---CCCeEEeeecCcCCC
Q 013421           85 YIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALP  159 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~---~~~~kL~DFGls~~~  159 (443)
                      |+||||++||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~  184 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI  184 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence            9999999999999998653  67999999999999999999999999999999999999997   789999999999765


Q ss_pred             ccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCH
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFST  235 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~  235 (443)
                      ... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.......+    ..+++
T Consensus       185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  262 (327)
T 3lm5_A          185 GHA-CELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ  262 (327)
T ss_dssp             ----------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             CCc-cccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence            443 233456899999999999877664 899999999999999999999999888777777665544333    34799


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .+.+||.+||+.||.+|||++++++||||+..
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            99999999999999999999999999999754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-49  Score=389.93  Aligned_cols=259  Identities=25%  Similarity=0.424  Sum_probs=214.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH--PNIVRLHEVLASRTKVY   85 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~   85 (443)
                      -.+|++++.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.+++.++|  |||+++++++.+....|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            457999999999999999999984 689999999987653 33456789999999999976  99999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-  164 (443)
                      +|||+ .+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........ 
T Consensus        86 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           86 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             EEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             EEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            99994 5889999999989999999999999999999999999999999999999997 58899999999987654322 


Q ss_pred             -cccccCCCcccCCCccccc----------CCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhh--hccCCCC
Q 013421          165 -LLHTTCGTPNYVAPEVLSN----------RGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKIN--AAEFSCP  230 (443)
Q Consensus       165 -~~~~~~gt~~y~aPE~l~~----------~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~--~~~~~~~  230 (443)
                       .....+||+.|+|||++.+          ....+.++|||||||++|+|++|..||...... .....+.  .....+|
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP  243 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc
Confidence             2346689999999999864          133358999999999999999999999874332 2233332  2344567


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                      ...++++.+||.+||+.||.+|||+.++++||||+....+
T Consensus       244 ~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence            7788999999999999999999999999999999865543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.2e-48  Score=379.86  Aligned_cols=257  Identities=26%  Similarity=0.417  Sum_probs=227.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      -+.|++++.||+|+||.||+|.+..+++.||+|++.......  ..+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            457999999999999999999999999999999998765332  357789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |||+++++|.+++.. +++++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence            999999999998865 6799999999999999999999999999999999999999999999999999876554433445


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHHHHccC
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILD  246 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~  246 (443)
                      ..+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.... ...+..+++.+.+||.+||+
T Consensus       178 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  256 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN  256 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCC
T ss_pred             ccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcC
Confidence            67899999999999877665 89999999999999999999999887766665554433 34556789999999999999


Q ss_pred             CCCCCCCCHHHHhcCccccccC
Q 013421          247 PNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       247 ~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .||.+|||++++++||||....
T Consensus       257 ~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          257 KEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             SSGGGSCCHHHHTTCHHHHHHC
T ss_pred             CChhhCcCHHHHhhChhhhcCC
Confidence            9999999999999999997654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.3e-49  Score=382.24  Aligned_cols=259  Identities=29%  Similarity=0.461  Sum_probs=218.4

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ....++|++++.||+|+||.||+|.+..+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL   91 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence            3456789999999999999999999999999999999876432   2346788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |+||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999999999998876 4679999999999999999999999999999999999999999999999999875433222


Q ss_pred             ccccccCCCcccCCCcccc-----cCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC---CCCCCCCH
Q 013421          164 ELLHTTCGTPNYVAPEVLS-----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFST  235 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~  235 (443)
                      ......+||+.|+|||++.     +..+ +.++|||||||++|+|++|..||...+.......+.....   ..+..++.
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV  250 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred             cccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence            2334567999999999984     3344 5899999999999999999999998887766666554432   23456899


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ++.++|.+||..||.+|||++++++||||+..
T Consensus       251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  282 (302)
T 2j7t_A          251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSI  282 (302)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence            99999999999999999999999999999753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.1e-49  Score=395.59  Aligned_cols=257  Identities=26%  Similarity=0.379  Sum_probs=201.8

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----   81 (443)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...     
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            3478999999999999999999999999999999997643 2334467788999999999999999999998654     


Q ss_pred             -CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        82 -~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                       ...|+++||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence             5689999999 7899888876 689999999999999999999999999999999999999999999999999987654


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------  226 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------------  226 (443)
                      .   .....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+....              
T Consensus       184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          184 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             c---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            3   23456899999999998774445699999999999999999999999887665554432210              


Q ss_pred             ---------CCC--------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          227 ---------FSC--------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       227 ---------~~~--------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                               ...        ....++++.+||.+||+.||.+|||++++++||||+....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence                     000        1236889999999999999999999999999999987544

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.4e-49  Score=380.12  Aligned_cols=259  Identities=36%  Similarity=0.635  Sum_probs=227.9

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +...++|++++.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            455678999999999999999999999999999999997654332 2356788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC---CCeEEeeecCcCCCcc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQ  161 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~---~~~kL~DFGls~~~~~  161 (443)
                      |+||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++.....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            9999999999999999888899999999999999999999999999999999999999764   4699999999876544


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGA  237 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~  237 (443)
                      . .......||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+..+.+..+    ..+++++
T Consensus       177 ~-~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T 2wei_A          177 N-TKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (287)
T ss_dssp             C-SSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred             C-CccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence            3 223445689999999998653 4 5899999999999999999999999888887777777655433    3589999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      .++|.+||..||.+|||++++++||||++.
T Consensus       254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            999999999999999999999999999754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.2e-48  Score=384.22  Aligned_cols=251  Identities=25%  Similarity=0.446  Sum_probs=211.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CCE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLAS--RTK   83 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~   83 (443)
                      ..++|++++.||+|+||.||+|++..+++.||+|++....      .+.+.+|+.+++.++ ||||+++++++.+  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            3578999999999999999999999999999999987432      356889999999997 9999999999987  678


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC-CeEEeeecCcCCCccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQG  162 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~  162 (443)
                      .++||||+++++|.+++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus       108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999999988874   489999999999999999999999999999999999999777 8999999999765443


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC-hHHHHH-------------HhhhccCC
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYK-------------KINAAEFS  228 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~-------------~i~~~~~~  228 (443)
                       ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.... ......             .+......
T Consensus       185 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          185 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             -CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence             334567899999999999775555699999999999999999999995432 211111             11111111


Q ss_pred             ------------------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          229 ------------------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       229 ------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                              .+..+++++.+||.+||+.||.+|||++|+++||||+.-
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence                                    112279999999999999999999999999999999754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.1e-49  Score=382.93  Aligned_cols=257  Identities=28%  Similarity=0.449  Sum_probs=215.1

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ...++|++.+.||+|+||.||+|.+  +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            3467899999999999999999987  588999999976653 3344678899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--CEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           86 IILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~aL~yLH~~g--i~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      +||||+++|+|.+++...+.   +++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++....
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            99999999999999987553   999999999999999999999999  9999999999999999999999999997655


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHh--hhccCCCCCCCCHHHH
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFWFSTGAT  238 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~s~~~~  238 (443)
                      .........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+  .......|..+++++.
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  269 (309)
T 3p86_A          191 STFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA  269 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred             ccccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence            44344556789999999999987766 48999999999999999999999988877766655  3445667788999999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhc--Cccccc
Q 013421          239 SLIHKILDPNPKTRIRIEGIRK--HPWFRK  266 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~--hp~f~~  266 (443)
                      +||.+||+.||.+|||++++++  +++++.
T Consensus       270 ~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999988  455543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.2e-49  Score=395.64  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=216.3

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR--HPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~l   86 (443)
                      .+|++++.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+++.++  ||||+++++++...+.+|+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            359999999999999999999865 89999999987653 3445678999999999996  5999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc--c
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--E  164 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--~  164 (443)
                      ||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......  .
T Consensus       134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence            999 56889999999988999999999999999999999999999999999999996 5899999999998764422  1


Q ss_pred             cccccCCCcccCCCcccccC----------CCCCCccchHHHHHHHHHHhhCCCCCCCCCh-HHHHHHhhh--ccCCCCC
Q 013421          165 LLHTTCGTPNYVAPEVLSNR----------GYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINA--AEFSCPF  231 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~--~~~~~~~  231 (443)
                      .....+||+.|+|||++.+.          ...+.++|||||||++|+|++|..||..... ......+..  .....|.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  291 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD  291 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence            24567899999999998652          2345899999999999999999999987533 233344433  2345677


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                      +.++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus       292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            78999999999999999999999999999999986543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.8e-49  Score=382.09  Aligned_cols=255  Identities=27%  Similarity=0.476  Sum_probs=218.6

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++....     ..+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            3467999999999999999999999999999999997643     13567899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           87 ILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      ||||+++++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK  181 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence            999999999999997 4568999999999999999999999999999999999999999999999999999765544334


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---cCCCCCCCCHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~  242 (443)
                      .....||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+...   .+..+..+++.+.+||.
T Consensus       182 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  260 (314)
T 3com_A          182 RNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK  260 (314)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred             cCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence            4566899999999999877665 8999999999999999999999887765554444333   23345557999999999


Q ss_pred             HccCCCCCCCCCHHHHhcCcccccc
Q 013421          243 KILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +||..||.+|||++++++||||+..
T Consensus       261 ~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          261 QCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HHccCChhhCcCHHHHHhCHHHhcC
Confidence            9999999999999999999999754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.2e-49  Score=386.67  Aligned_cols=258  Identities=38%  Similarity=0.685  Sum_probs=214.8

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++......     .......+.+|+.+++.++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            446899999999999999999999999999999999765421     112234588999999999999999999999776


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC---eEEeeecCcCC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSAL  158 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~---~kL~DFGls~~  158 (443)
                      + .|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            5 8999999999999999998889999999999999999999999999999999999999987665   99999999876


Q ss_pred             CccccccccccCCCcccCCCccccc--CCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhhhccCCCC----C
Q 013421          159 PQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSCP----F  231 (443)
Q Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~----~  231 (443)
                      .... ......+||+.|+|||++.+  ....+.++|||||||++|+|++|..||...... .....+..+.....    .
T Consensus       167 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (322)
T 2ycf_A          167 LGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA  245 (322)
T ss_dssp             CCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred             cccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence            5432 23345679999999999742  223358999999999999999999999765432 34444554444332    3


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      .+++++.+||.+||+.||.+|||++++++||||+.
T Consensus       246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            57999999999999999999999999999999974

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-48  Score=399.26  Aligned_cols=254  Identities=26%  Similarity=0.421  Sum_probs=214.1

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC------CCCCcceEEEEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV------RHPNIVRLHEVLA   79 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~   79 (443)
                      ....+|++++.||+|+||.||+|.+..+++.||||++....    .....+.+|+.+++.+      +|+||+++++++.
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            34567999999999999999999999999999999997542    2346677888888877      5779999999999


Q ss_pred             eCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC--eEEeeecC
Q 013421           80 SRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN--LKVSDFGL  155 (443)
Q Consensus        80 ~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~--~kL~DFGl  155 (443)
                      ..+.+|+||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999999999995 68999998754  5899999999999999999999999999999999999999887  99999999


Q ss_pred             cCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc---------
Q 013421          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---------  226 (443)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------  226 (443)
                      +.....   ...+.+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+.......+....         
T Consensus       249 a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          249 SCYEHQ---RVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             CEETTC---CCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ceecCC---cccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            865432   34567899999999999887774 99999999999999999999999887665544332110         


Q ss_pred             -------------CC-------------------------------------CCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 013421          227 -------------FS-------------------------------------CPFWFSTGATSLIHKILDPNPKTRIRIE  256 (443)
Q Consensus       227 -------------~~-------------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~  256 (443)
                                   ++                                     .+...++++.+||.+||+.||++|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                         00                                     0112378899999999999999999999


Q ss_pred             HHhcCccccccC
Q 013421          257 GIRKHPWFRKNY  268 (443)
Q Consensus       257 eil~hp~f~~~~  268 (443)
                      |+++||||+...
T Consensus       405 e~L~Hpw~~~~~  416 (429)
T 3kvw_A          405 QALRHPWLRRRL  416 (429)
T ss_dssp             HHHTSTTTC---
T ss_pred             HHhCChhhccCC
Confidence            999999998754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6e-49  Score=378.79  Aligned_cols=259  Identities=23%  Similarity=0.336  Sum_probs=202.9

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.++...++.++||||+++++++.+.+..|
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            356789999999999999999999999999999999976542 2223344555666688899999999999999999999


Q ss_pred             EEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           86 IILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      +||||++| +|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999975 77776643    46899999999999999999999998 99999999999999999999999999987654


Q ss_pred             cccccccccCCCcccCCCcccc---cCCCCCCccchHHHHHHHHHHhhCCCCCCCCC-hHH-HHHHhhhccCCCC-CCCC
Q 013421          161 QGVELLHTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPT-LYKKINAAEFSCP-FWFS  234 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~-~~~~i~~~~~~~~-~~~s  234 (443)
                      .. ......+||+.|+|||++.   .....+.++||||+||++|+|++|..||.... ... ....+.......+ ..++
T Consensus       162 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          162 DD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS  240 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred             cc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence            43 2334557999999999962   22333589999999999999999999998633 223 3333333333333 3589


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +++.+||.+||+.||.+|||++++++||||+..
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            999999999999999999999999999999754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-49  Score=386.65  Aligned_cols=259  Identities=24%  Similarity=0.427  Sum_probs=215.1

Q ss_pred             CCcccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013421            1 MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (443)
Q Consensus         1 m~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   80 (443)
                      |.++...-++|++.+.||+|+||+||+|.+..+++.||||++.......  ..+.+.+|+.+++.++||||+++++++..
T Consensus         1 m~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (319)
T 4euu_A            1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (319)
T ss_dssp             -CEEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCcccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence            5566777889999999999999999999999999999999998654333  24667899999999999999999999986


Q ss_pred             CC--EEEEEEecCCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE----cCCCCeEEe
Q 013421           81 RT--KVYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVS  151 (443)
Q Consensus        81 ~~--~~~lv~Ey~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl----~~~~~~kL~  151 (443)
                      ..  ..|+||||+++++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (319)
T 4euu_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (319)
T ss_dssp             TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence            65  78999999999999999986543   9999999999999999999999999999999999999    778889999


Q ss_pred             eecCcCCCccccccccccCCCcccCCCcccc--------cCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh----HHHH
Q 013421          152 DFGLSALPQQGVELLHTTCGTPNYVAPEVLS--------NRGYDGSAADVWSCGVILFVLMAGYLPFGETDL----PTLY  219 (443)
Q Consensus       152 DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~  219 (443)
                      |||++...... ......+||+.|+|||++.        +..+ +.++|||||||++|+|++|..||.....    ....
T Consensus       159 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  236 (319)
T 4euu_A          159 DFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (319)
T ss_dssp             CCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred             cCCCceecCCC-CceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence            99999765543 3344667999999999985        2344 5899999999999999999999964332    2333


Q ss_pred             HHhhhccC---------------------CC----CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcc
Q 013421          220 KKINAAEF---------------------SC----PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  263 (443)
Q Consensus       220 ~~i~~~~~---------------------~~----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~  263 (443)
                      .++..+..                     +.    +..+++.+.+||++||+.||++|||++|+++||-
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            33333221                     11    1124567889999999999999999999999973

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.5e-50  Score=406.23  Aligned_cols=249  Identities=16%  Similarity=0.214  Sum_probs=207.1

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHH---HHHhCCCCCcceEE-------EE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS---IMKIVRHPNIVRLH-------EV   77 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~---il~~l~HpnIv~l~-------~~   77 (443)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++.+.........+.+.+|+.   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467999999999999999999999999999999998765555556788999995   55556899999998       77


Q ss_pred             EEeCCE-----------------EEEEEecCCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCEee
Q 013421           78 LASRTK-----------------VYIILEFVTGGELFDKIVHQGRLLE-------NDCRRYFQQLIDAVAHCHSKGVYHR  133 (443)
Q Consensus        78 ~~~~~~-----------------~~lv~Ey~~gg~L~~~i~~~~~l~e-------~~~~~~~~qll~aL~yLH~~gi~Hr  133 (443)
                      +.+.+.                 .|++|||+ +|+|.+++...+.+++       ..++.++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            776543                 89999999 6899999987666666       7788899999999999999999999


Q ss_pred             cCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcccCCCcccccC-----------CCCCCccchHHHHHHHHH
Q 013421          134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-----------GYDGSAADVWSCGVILFV  202 (443)
Q Consensus       134 Dlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~~~DIwSlGvil~~  202 (443)
                      ||||+|||++.+|.+||+|||++.....   .....+| +.|+|||++.+.           .+ +.++|||||||++|+
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il~e  305 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHHHH
Confidence            9999999999999999999999875332   3456678 999999999876           55 489999999999999


Q ss_pred             HhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          203 LMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       203 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      |++|..||.+.+.......+    ...+..+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus       306 lltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          306 IWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHSSCCC------CCSGGG----GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHCCCCCcccccccchhhh----hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            99999999876543332222    2334568999999999999999999999999999999964

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-48  Score=380.88  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=214.1

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS----   80 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----   80 (443)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++......    .+.+.+|+.+++.+ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            3467899999999999999999999999999999999765322    35688999999999 89999999999976    


Q ss_pred             --CCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           81 --RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        81 --~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                        .+..|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence              56899999999999999999864  57999999999999999999999999999999999999999999999999998


Q ss_pred             CCCccccccccccCCCcccCCCccccc----CCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC--CC
Q 013421          157 ALPQQGVELLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS--CP  230 (443)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~  230 (443)
                      .............+||+.|+|||++..    ....+.++|||||||++|+|++|..||...+.......+.....+  .+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  256 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc
Confidence            866543334456689999999999862    223358999999999999999999999887766555554443322  23


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus       257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            4579999999999999999999999999999999764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.1e-49  Score=396.57  Aligned_cols=254  Identities=30%  Similarity=0.424  Sum_probs=209.0

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT--   82 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--   82 (443)
                      .....+|++++.||+|+||.||+|.+..+++ +|+|.+......       ..+|+.+++.++||||+++++++....  
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            4456689999999999999999999987766 888887654322       236999999999999999999985433  


Q ss_pred             ----EEEEEEecCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc-CCCCeEEeee
Q 013421           83 ----KVYIILEFVTGGELFDKIV----HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF  153 (443)
Q Consensus        83 ----~~~lv~Ey~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~-~~~~~kL~DF  153 (443)
                          .+|+||||++++ +.+.+.    ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus       108 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             SSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence                388999999775 433332    356899999999999999999999999999999999999999 7899999999


Q ss_pred             cCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--------
Q 013421          154 GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--------  225 (443)
Q Consensus       154 Gls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------  225 (443)
                      |++...... ......+||+.|+|||++.+....+.++||||+||++|+|++|++||.+.+.......+...        
T Consensus       187 G~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          187 GSAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             TTCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CCcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999765443 23456789999999999977655569999999999999999999999988765554443221        


Q ss_pred             ---------cC------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          226 ---------EF------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       226 ---------~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                               ..            .++..+++++.+||.+||+.||.+|||+.|+++||||+.-.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence                     01            12334789999999999999999999999999999998643

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.4e-48  Score=383.62  Aligned_cols=261  Identities=30%  Similarity=0.435  Sum_probs=217.2

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR----   81 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----   81 (443)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++....  .......+.+|+.+++.++||||+++++++...    
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   85 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN   85 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence            45678999999999999999999999999999999996532  334456788999999999999999999988654    


Q ss_pred             -CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        82 -~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                       ...|++|||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence             67999999996 589888876 679999999999999999999999999999999999999999999999999987654


Q ss_pred             cccc----------cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-----
Q 013421          161 QGVE----------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-----  225 (443)
Q Consensus       161 ~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-----  225 (443)
                      ....          .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...     
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            3111          1234579999999999866455568999999999999999999999987765443332110     


Q ss_pred             -------------------c--C------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          226 -------------------E--F------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       226 -------------------~--~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                                         .  .      ..++.+++++.+||.+||+.||.+|||++++++||||+....+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  315 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP  315 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence                               0  0      0113579999999999999999999999999999999875443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.3e-48  Score=388.50  Aligned_cols=260  Identities=25%  Similarity=0.392  Sum_probs=205.0

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK-   83 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-   83 (443)
                      ...+++|++.+.||+|+||.||+|.+..+|+.||||++.......    ....+++..++.++||||+++++++..... 
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            356789999999999999999999999999999999987654322    345577888889999999999999865333 


Q ss_pred             ------EEEEEecCCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hCCCEeecCCCCcEEEcC-CCCeEE
Q 013421           84 ------VYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQQLIDAVAHCH--SKGVYHRDLKPENLLLDS-YGNLKV  150 (443)
Q Consensus        84 ------~~lv~Ey~~gg~L~~~i----~~~~~l~e~~~~~~~~qll~aL~yLH--~~gi~HrDlkp~NILl~~-~~~~kL  150 (443)
                            .|+||||++++ |.+.+    .....+++..++.++.|++.||.|||  ++||+||||||+|||++. ++.+||
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                  89999999864 44433    34567899999999999999999999  999999999999999996 899999


Q ss_pred             eeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc----
Q 013421          151 SDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE----  226 (443)
Q Consensus       151 ~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----  226 (443)
                      +|||++...... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....    
T Consensus       174 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          174 CDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             CCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            999999866543 334466799999999998766655699999999999999999999999887766555543210    


Q ss_pred             ----------------------------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          227 ----------------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       227 ----------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                                                  ...+...++++.+||.+||+.||.+|||+.|+++||||+....+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  324 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP  324 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence                                        01112256889999999999999999999999999999876544

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3e-48  Score=381.37  Aligned_cols=256  Identities=28%  Similarity=0.439  Sum_probs=215.8

Q ss_pred             CcccccccCeEEeeeeeccCceEEEEEEE-CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC------CcceE
Q 013421            2 KKQTRRVAKYEVGRTIGEGTFAKVRFAQN-RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP------NIVRL   74 (443)
Q Consensus         2 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l   74 (443)
                      +.+....++|++++.||+|+||.||+|.+ ..+++.||+|++...    ....+.+.+|+.+++.++|+      +|+++
T Consensus         7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~   82 (339)
T 1z57_A            7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM   82 (339)
T ss_dssp             STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred             ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence            34455668999999999999999999998 568899999999653    23456788999999988765      49999


Q ss_pred             EEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC--------
Q 013421           75 HEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS--------  144 (443)
Q Consensus        75 ~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~--------  144 (443)
                      ++++.+.+..|+||||+ +++|.+++...+  ++++..++.++.||+.||+|||++||+||||||+|||++.        
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence            99999999999999999 899999998765  6889999999999999999999999999999999999987        


Q ss_pred             -----------CCCeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC
Q 013421          145 -----------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET  213 (443)
Q Consensus       145 -----------~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  213 (443)
                                 ++.+||+|||++.....   .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CccccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCCC
Confidence                       67899999999875433   23456899999999999877765 8999999999999999999999987


Q ss_pred             ChHHHHHHhhhccCCC--------------------------------------------CCCCCHHHHHHHHHccCCCC
Q 013421          214 DLPTLYKKINAAEFSC--------------------------------------------PFWFSTGATSLIHKILDPNP  249 (443)
Q Consensus       214 ~~~~~~~~i~~~~~~~--------------------------------------------~~~~s~~~~~li~~~L~~dP  249 (443)
                      +..+....+.....+.                                            +...++++.+||.+||+.||
T Consensus       238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            7655444332211111                                            11135678899999999999


Q ss_pred             CCCCCHHHHhcCccccc
Q 013421          250 KTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       250 ~~R~t~~eil~hp~f~~  266 (443)
                      .+|||++|+++||||+.
T Consensus       318 ~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          318 AKRITLREALKHPFFDL  334 (339)
T ss_dssp             TTSCCHHHHTTSGGGGG
T ss_pred             ccccCHHHHhcCHHHHH
Confidence            99999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.5e-48  Score=394.78  Aligned_cols=252  Identities=29%  Similarity=0.391  Sum_probs=208.3

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------C
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------R   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~   81 (443)
                      ..+|++++.||+|+||.||+|++..+|+.||||++.....       ...+|+.+|+.++||||+++++++..      .
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            3469999999999999999999999999999999876432       23479999999999999999998843      2


Q ss_pred             CEEEEEEecCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC-CCeEEeeecCc
Q 013421           82 TKVYIILEFVTGGELFDKIV----HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLS  156 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~-~~~kL~DFGls  156 (443)
                      ..+++||||+++ +|.+.+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            247799999976 5655554    34679999999999999999999999999999999999999965 56899999999


Q ss_pred             CCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhh------------
Q 013421          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA------------  224 (443)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------  224 (443)
                      ...... ......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+.......+..            
T Consensus       205 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          205 KQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             EECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             hhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            765443 2334678999999999987654456999999999999999999999998776554443321            


Q ss_pred             -----ccCC------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          225 -----AEFS------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       225 -----~~~~------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                           ..+.            ++..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence                 0111            2234689999999999999999999999999999997644

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6e-49  Score=380.85  Aligned_cols=260  Identities=26%  Similarity=0.437  Sum_probs=197.6

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++...+..|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            4467899999999999999999999989999999998765422  23567889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421           86 IILEFVTGGELFDKIVH--------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~--------~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      +||||++|++|.+++..        .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999999974        4568999999999999999999999999999999999999999999999999886


Q ss_pred             CCcccc-----ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-----
Q 013421          158 LPQQGV-----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-----  227 (443)
Q Consensus       158 ~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-----  227 (443)
                      ......     ......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.............     
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  249 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET  249 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence            543321     1234567999999999986533345899999999999999999999988766554433322221     


Q ss_pred             -----CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          228 -----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       228 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                           .....+++++.++|.+||+.||.+|||++++++||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence                 1223478999999999999999999999999999999764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.6e-48  Score=377.27  Aligned_cols=259  Identities=27%  Similarity=0.380  Sum_probs=212.3

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE----
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA----   79 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----   79 (443)
                      +....++|++++.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.    
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            345567999999999999999999999999999999998754   2345678899999999999999999999873    


Q ss_pred             ----------eCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc-CCCCe
Q 013421           80 ----------SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNL  148 (443)
Q Consensus        80 ----------~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~-~~~~~  148 (443)
                                +....|+||||++ |+|.+++.. +++++..++.++.||+.||+|||++||+||||||+||+++ .++.+
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence                      4478999999997 599998865 6799999999999999999999999999999999999997 56799


Q ss_pred             EEeeecCcCCCccc---cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc
Q 013421          149 KVSDFGLSALPQQG---VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA  225 (443)
Q Consensus       149 kL~DFGls~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~  225 (443)
                      ||+|||++......   ........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999999865431   123345568999999999876444568999999999999999999999988766555544322


Q ss_pred             cC------------------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          226 EF------------------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       226 ~~------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ..                              ..+..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            10                              0123589999999999999999999999999999999854

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.4e-48  Score=386.85  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=213.5

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE--
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV--   84 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~--   84 (443)
                      .-++|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+..  
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            3468999999999999999999999999999999997654 2344567889999999999999999999999877654  


Q ss_pred             ----EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           85 ----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        85 ----~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                          |+||||+. ++|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence                99999997 57877763  459999999999999999999999999999999999999999999999999997554


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-C------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-F------------  227 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~------------  227 (443)
                      .   .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.... .            
T Consensus       196 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          196 A---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             c---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            3   23456899999999999774445699999999999999999999999887665554442210 0            


Q ss_pred             ------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          228 ------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       228 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                                        ..++.+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                              01234689999999999999999999999999999998543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.3e-48  Score=391.00  Aligned_cols=253  Identities=25%  Similarity=0.414  Sum_probs=209.2

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--------CCCcceEE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR--------HPNIVRLH   75 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~   75 (443)
                      +....++|++++.||+|+||+||+|++..+++.||+|++...    ....+.+.+|+.+++.++        ||||++++
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            344567899999999999999999999999999999999753    234567889999999985        78899999


Q ss_pred             EEEE----eCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCCC--
Q 013421           76 EVLA----SRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYG--  146 (443)
Q Consensus        76 ~~~~----~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~--  146 (443)
                      +++.    +....|+||||+ +++|.+.+...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++  
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred             cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence            9987    566899999999 66777777654  4699999999999999999999998 999999999999999775  


Q ss_pred             -----------------------------------------------CeEEeeecCcCCCccccccccccCCCcccCCCc
Q 013421          147 -----------------------------------------------NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE  179 (443)
Q Consensus       147 -----------------------------------------------~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE  179 (443)
                                                                     .+||+|||++.....   .....+||+.|+|||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~gt~~y~aPE  263 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---HFTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB---CSCSCCSCGGGCCHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc---cCccCCCCCcccCCh
Confidence                                                           799999999876543   234568999999999


Q ss_pred             ccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh------HHHHHHhhh------------c----------------
Q 013421          180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL------PTLYKKINA------------A----------------  225 (443)
Q Consensus       180 ~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~------~~~~~~i~~------------~----------------  225 (443)
                      ++.+..+. .++|||||||++|+|++|..||...+.      ......+..            +                
T Consensus       264 ~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          264 VLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            99887765 899999999999999999999976442      111111110            0                


Q ss_pred             --------------cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          226 --------------EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       226 --------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                                    .+..+...++++.+||.+||+.||.+|||++|+++||||+
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                          0111222356788999999999999999999999999996

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.9e-48  Score=375.83  Aligned_cols=254  Identities=24%  Similarity=0.378  Sum_probs=214.9

Q ss_pred             cccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ...-..++|++++.||+|+||+||+|.+..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus         4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   80 (310)
T 3s95_A            4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK   80 (310)
T ss_dssp             CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence            3445678999999999999999999999999999999988543   3445678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..|+||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            99999999999999999987 56799999999999999999999999999999999999999999999999999876543


Q ss_pred             ccc--------------cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHH---Hhhh
Q 013421          162 GVE--------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK---KINA  224 (443)
Q Consensus       162 ~~~--------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~---~i~~  224 (443)
                      ...              .....+||+.|+|||++.+..+. .++||||+||++|+|++|..||..........   ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~  239 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF  239 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence            211              11256899999999999887665 89999999999999999999987533211100   0001


Q ss_pred             ccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          225 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       225 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .....|..+++.+.++|.+||+.||.+|||++++++
T Consensus       240 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            112346678999999999999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.4e-49  Score=394.55  Aligned_cols=253  Identities=17%  Similarity=0.214  Sum_probs=196.2

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC--CCCCcceEE-------EEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV--RHPNIVRLH-------EVLA   79 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~-------~~~~   79 (443)
                      .+|++++.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            3599999999999999999999999999999999987654555667788886555555  699988865       5554


Q ss_pred             eC-----------------CEEEEEEecCCCCChHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHhCCCEeecC
Q 013421           80 SR-----------------TKVYIILEFVTGGELFDKIVHQG-RLLENDC------RRYFQQLIDAVAHCHSKGVYHRDL  135 (443)
Q Consensus        80 ~~-----------------~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~------~~~~~qll~aL~yLH~~gi~HrDl  135 (443)
                      ..                 ..+|+||||++ |+|.+++...+ .+++...      ..++.||+.||+|||++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            33                 34899999998 89999998743 3444444      566799999999999999999999


Q ss_pred             CCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcccCCCccccc--CCCCCCccchHHHHHHHHHHhhCCCCCCCC
Q 013421          136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGET  213 (443)
Q Consensus       136 kp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  213 (443)
                      ||+|||++.+|.+||+|||++......   .....||+.|+|||++.+  ..+ +.++|||||||++|+|++|..||...
T Consensus       221 kp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          221 TPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             SGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             CHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCCc
Confidence            999999999999999999999765432   224557799999999976  445 59999999999999999999999876


Q ss_pred             ChHHH--HHH-----hhhccCC--CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          214 DLPTL--YKK-----INAAEFS--CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       214 ~~~~~--~~~-----i~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      .....  +..     .....+.  .+..+++.+.+||.+||+.||++|||++++++||||+.
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            43211  111     1111222  23468999999999999999999999999999999974

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.3e-48  Score=386.32  Aligned_cols=262  Identities=24%  Similarity=0.377  Sum_probs=210.0

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccc--------cchHHHHHHHHHHHHHHhCCCCCcceEEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--------LKHRMVDQIKREISIMKIVRHPNIVRLHEV   77 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~   77 (443)
                      ...++|++++.||+|+||.||+|.+.. |..||||++.....        ......+.+.+|+.+++.++||||++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            345789999999999999999999865 99999999865432        123345789999999999999999999999


Q ss_pred             EEe-----CCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEe
Q 013421           78 LAS-----RTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVS  151 (443)
Q Consensus        78 ~~~-----~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~  151 (443)
                      +..     ...+|+||||++ |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence            843     347899999997 5888888754 378999999999999999999999999999999999999999999999


Q ss_pred             eecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc-----
Q 013421          152 DFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-----  226 (443)
Q Consensus       152 DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-----  226 (443)
                      |||++...... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....     
T Consensus       177 Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          177 DFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99999754432 334556799999999998774445699999999999999999999999887665555442210     


Q ss_pred             -------------------C--------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          227 -------------------F--------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       227 -------------------~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                                         .        ..++.+++.+.+||.+||+.||.+|||++|+++||||+..+.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                               0        1123468899999999999999999999999999999876544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.4e-48  Score=378.56  Aligned_cols=260  Identities=25%  Similarity=0.367  Sum_probs=202.4

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ...++|++++.||+|+||.||+|.+..++.   .||+|++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            345689999999999999999999887765   89999997654333 34678999999999999999999999998776


Q ss_pred             EE------EEEEecCCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEE
Q 013421           83 KV------YIILEFVTGGELFDKIVHQG------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV  150 (443)
Q Consensus        83 ~~------~lv~Ey~~gg~L~~~i~~~~------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL  150 (443)
                      ..      |++|||+++|+|.+++....      .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence            55      99999999999999996543      5899999999999999999999999999999999999999999999


Q ss_pred             eeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-c
Q 013421          151 SDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-E  226 (443)
Q Consensus       151 ~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~  226 (443)
                      +|||++.......  .......|++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... .
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  257 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR  257 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence            9999997654322  122344577899999999877664 89999999999999999 99999998887777766554 4


Q ss_pred             CCCCCCCCHHHHHHHHHccCCCCCCCCC-------HHHHhcCcccccc
Q 013421          227 FSCPFWFSTGATSLIHKILDPNPKTRIR-------IEGIRKHPWFRKN  267 (443)
Q Consensus       227 ~~~~~~~s~~~~~li~~~L~~dP~~R~t-------~~eil~hp~f~~~  267 (443)
                      ...+..+++++.+||.+||+.||.+|||       +++++.|||+...
T Consensus       258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            5667789999999999999999999999       7888999999754

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-47  Score=372.46  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=211.7

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      .+..+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence            45678999999999999999999999999999999999987665555566889999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      .|++|||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999987654421


Q ss_pred             -ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC---CCCCCCCHHHHH
Q 013421          164 -ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGATS  239 (443)
Q Consensus       164 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~  239 (443)
                       ......+|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.....   ..+..+|+++.+
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             cccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence             23345679999999999987666 4899999999999999999999998776655444443322   345668999999


Q ss_pred             HHHHccCCCCCCCC-CHHHHhc
Q 013421          240 LIHKILDPNPKTRI-RIEGIRK  260 (443)
Q Consensus       240 li~~~L~~dP~~R~-t~~eil~  260 (443)
                      +|.+||+.||.+|| |++++++
T Consensus       268 li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          268 VIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999 7888765

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-48  Score=393.70  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=195.4

Q ss_pred             ccCeEE-eeeeeccCceEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCC
Q 013421            8 VAKYEV-GRTIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA--SRT   82 (443)
Q Consensus         8 ~~~y~i-~~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~   82 (443)
                      -+.|++ +++||+|+||.||+|++.  .+++.||+|++.....     ...+.+|+.+|+.++||||+++++++.  ...
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            346887 568999999999999976  4688999999976542     235778999999999999999999995  477


Q ss_pred             EEEEEEecCCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE----cCCCCeE
Q 013421           83 KVYIILEFVTGGELFDKIVHQ---------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLK  149 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl----~~~~~~k  149 (443)
                      .+|+||||+. ++|.+.+...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+|
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            8999999996 5888887632         249999999999999999999999999999999999999    6778999


Q ss_pred             EeeecCcCCCcccc---ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH---------H
Q 013421          150 VSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---------T  217 (443)
Q Consensus       150 L~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------~  217 (443)
                      |+|||++.......   ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..         .
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            99999998664321   23456789999999999987665569999999999999999999999765431         1


Q ss_pred             HHHHhhh-ccCC-------------------------------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 013421          218 LYKKINA-AEFS-------------------------------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIR  259 (443)
Q Consensus       218 ~~~~i~~-~~~~-------------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil  259 (443)
                      ....+.. ...+                                     .....++.+.+||.+||+.||.+|||++|+|
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            1111111 0000                                     0011278899999999999999999999999


Q ss_pred             cCccccccCCC
Q 013421          260 KHPWFRKNYNP  270 (443)
Q Consensus       260 ~hp~f~~~~~~  270 (443)
                      +||||+....+
T Consensus       333 ~hp~f~~~~~~  343 (405)
T 3rgf_A          333 QDPYFLEDPLP  343 (405)
T ss_dssp             TSGGGTSSSCC
T ss_pred             cChhhccCCCC
Confidence            99999876543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.4e-48  Score=371.87  Aligned_cols=254  Identities=26%  Similarity=0.478  Sum_probs=208.6

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------   80 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------   80 (443)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++...    ....+.+.+|+.+++.++||||+++++++.+      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            457899999999999999999999999999999999643    3345778999999999999999999998865      


Q ss_pred             -------CCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEee
Q 013421           81 -------RTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (443)
Q Consensus        81 -------~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (443)
                             ....|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence                   457899999999999999998644 578899999999999999999999999999999999999999999999


Q ss_pred             ecCcCCCccc--------------cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC-ChHH
Q 013421          153 FGLSALPQQG--------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET-DLPT  217 (443)
Q Consensus       153 FGls~~~~~~--------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~  217 (443)
                      ||++......              .......+||+.|+|||++.+.+..+.++||||+||++|+|++   ||... +...
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998765421              1223456799999999999866555699999999999999998   55432 2334


Q ss_pred             HHHHhhhccCCCCC----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          218 LYKKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       218 ~~~~i~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ....+.......|.    ..++.+.++|.+||+.||.+|||++++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            44555544444443    456779999999999999999999999999999753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1e-47  Score=384.85  Aligned_cols=252  Identities=23%  Similarity=0.399  Sum_probs=219.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEEC-------CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNR-------ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVL   78 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~   78 (443)
                      ..++|++++.||+|+||.||+|.+.       .++..||+|++....  .....+.+.+|+.+++.+ +||||+++++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3578999999999999999999874       345689999997653  334567899999999999 899999999999


Q ss_pred             EeCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE
Q 013421           79 ASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL  142 (443)
Q Consensus        79 ~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl  142 (443)
                      .+.+.+|+||||+++|+|.+++....                .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence            99999999999999999999998753                47899999999999999999999999999999999999


Q ss_pred             cCCCCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHH
Q 013421          143 DSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  219 (443)
Q Consensus       143 ~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  219 (443)
                      +.+|.+||+|||++.......  .......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+..
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~~  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            999999999999997554322  123345678899999999877664 89999999999999999 99999998887777


Q ss_pred             HHhhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          220 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       220 ~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ..+..+ ....|..+++++.++|.+||+.||.+|||+.|++++
T Consensus       316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            776555 345677799999999999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.1e-47  Score=374.38  Aligned_cols=256  Identities=30%  Similarity=0.406  Sum_probs=215.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEEC-CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceEEEEEE----
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNR-ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVRLHEVLA----   79 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~----   79 (443)
                      .++|++++.||+|+||.||+|.+. .+|+.||+|++........ ....+.+|+.+++.+   +||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            478999999999999999999995 6789999999976542211 123456777777766   8999999999987    


Q ss_pred             -eCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           80 -SRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        80 -~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                       .....++||||++ |+|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             5678999999997 59999998753  4899999999999999999999999999999999999999999999999999


Q ss_pred             CCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-------c---
Q 013421          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------E---  226 (443)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------~---  226 (443)
                      ...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+...       .   
T Consensus       168 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (326)
T 1blx_A          168 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  245 (326)
T ss_dssp             CCCCGG-GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             ccccCC-CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence            766543 23456789999999999987666 48999999999999999999999988776655554321       0   


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          227 -----------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       227 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                       ...+..+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence                             01224578999999999999999999999999999999754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.4e-48  Score=383.03  Aligned_cols=256  Identities=32%  Similarity=0.528  Sum_probs=222.6

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCC--CCCcceEEEEEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---RMVDQIKREISIMKIVR--HPNIVRLHEVLA   79 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~   79 (443)
                      ....++|++++.||+|+||.||+|.+..+++.||+|++........   ...+.+.+|+.+++.++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            3456789999999999999999999999999999999987643321   11244678999999996  599999999999


Q ss_pred             eCCEEEEEEecCCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc-CCCCeEEeeecCcC
Q 013421           80 SRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSA  157 (443)
Q Consensus        80 ~~~~~~lv~Ey~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~-~~~~~kL~DFGls~  157 (443)
                      +.+..+++|||+.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            99999999999976 89999999889999999999999999999999999999999999999999 78999999999987


Q ss_pred             CCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHH
Q 013421          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGA  237 (443)
Q Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~  237 (443)
                      ....  ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+      .+.......+..+++++
T Consensus       199 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~  270 (320)
T 3a99_A          199 LLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC  270 (320)
T ss_dssp             ECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHH
T ss_pred             cccc--ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHHH
Confidence            6543  233456799999999999877776688999999999999999999997532      23344556677899999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .+||.+||+.||.+|||++++++||||+...
T Consensus       271 ~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          271 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            9999999999999999999999999998643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-47  Score=366.56  Aligned_cols=248  Identities=23%  Similarity=0.374  Sum_probs=218.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++++.||+|+||.||+|.+. +++.||+|++......    .+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence            468999999999999999999987 5778999999865432    25688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc-ccc
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-VEL  165 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~~~  165 (443)
                      |||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence            9999999999999764 46899999999999999999999999999999999999999999999999998765442 123


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~  243 (443)
                      .....||+.|+|||++.+..+. .++||||+|+++|+|++ |..||...+.......+... ....|..+++++.++|.+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  242 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH  242 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred             ccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHH
Confidence            3455678899999999877664 89999999999999999 99999998888887777665 455566789999999999


Q ss_pred             ccCCCCCCCCCHHHHhcC
Q 013421          244 ILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~h  261 (443)
                      ||+.||.+|||+.++++|
T Consensus       243 ~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          243 CWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HccCCcccCcCHHHHHHH
Confidence            999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=370.56  Aligned_cols=257  Identities=26%  Similarity=0.393  Sum_probs=213.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      .+|.....||+|+||.||+|.+..++..||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            34444559999999999999999999999999997653   233567899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-CCCeEEeeecCcCCCccccc
Q 013421           89 EFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~~~~  164 (443)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++........
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            9999999999998752   4678899999999999999999999999999999999987 89999999999876554333


Q ss_pred             cccccCCCcccCCCcccccCC-CCCCccchHHHHHHHHHHhhCCCCCCCCChHHH--HH-HhhhccCCCCCCCCHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPTL--YK-KINAAEFSCPFWFSTGATSL  240 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~--~~-~i~~~~~~~~~~~s~~~~~l  240 (443)
                      ......||+.|+|||++.+.. ..+.++||||||+++|+|++|..||...+....  .. .........|..+++++.+|
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  258 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF  258 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHH
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHH
Confidence            445678999999999986543 235899999999999999999999976433221  11 12233455677799999999


Q ss_pred             HHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          241 IHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      |.+||+.||.+|||++++++||||+...
T Consensus       259 i~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          259 ILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            9999999999999999999999997543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=381.05  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=212.7

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE----
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK----   83 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----   83 (443)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.....    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            478999999999999999999999999999999997654 334456778999999999999999999999987654    


Q ss_pred             --EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           84 --VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        84 --~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                        .|++|||+. ++|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence              599999997 58887764  3599999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc----------------
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----------------  225 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------  225 (443)
                      .   ....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...                
T Consensus       179 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  255 (353)
T 3coi_A          179 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  255 (353)
T ss_dssp             --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred             C---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence            2   345679999999999877444568999999999999999999999987765544433211                


Q ss_pred             ------------c---CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          226 ------------E---FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       226 ------------~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                                  .   ...+..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                        0   012235799999999999999999999999999999997543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=376.84  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=218.1

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ...++|++.+.||+|+||.||+|.+..+++   .||||++....  .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            345789999999999999999999986655   59999997643  3334577999999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            999999999999999999754 5799999999999999999999999999999999999999999999999999976544


Q ss_pred             ccc---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHH
Q 013421          162 GVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTG  236 (443)
Q Consensus       162 ~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~  236 (443)
                      ...   ......||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ..+.|..++++
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA  282 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHH
Confidence            222   22334567889999999877665 89999999999999999 99999998888777776554 45667779999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhc
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +.+||.+||..||.+|||+.++++
T Consensus       283 l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          283 LHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999999887

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=378.96  Aligned_cols=256  Identities=32%  Similarity=0.563  Sum_probs=213.6

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhC----CCCCcceEEEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---RMVDQIKREISIMKIV----RHPNIVRLHEV   77 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~HpnIv~l~~~   77 (443)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++........   .....+.+|+.+++.+    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            3445689999999999999999999999999999999976543221   1223466799999998    89999999999


Q ss_pred             EEeCCEEEEEEec-CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc-CCCCeEEeeecC
Q 013421           78 LASRTKVYIILEF-VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGL  155 (443)
Q Consensus        78 ~~~~~~~~lv~Ey-~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~-~~~~~kL~DFGl  155 (443)
                      +.+.+..++|||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            9999999999999 78999999999888999999999999999999999999999999999999999 889999999999


Q ss_pred             cCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCH
Q 013421          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFST  235 (443)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~  235 (443)
                      +......  ......||+.|+|||++.+..+.+.++|||||||++|+|++|..||....      .+.......+..+++
T Consensus       187 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~  258 (312)
T 2iwi_A          187 GALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHVSP  258 (312)
T ss_dssp             CEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTSCH
T ss_pred             hhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccCCH
Confidence            8765442  34566799999999999877776568999999999999999999997532      234456667788999


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      ++.+||.+||+.||.+|||++++++||||+...
T Consensus       259 ~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            999999999999999999999999999998654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.4e-47  Score=383.52  Aligned_cols=255  Identities=29%  Similarity=0.410  Sum_probs=213.3

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CC-----CcceEEEE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HP-----NIVRLHEV   77 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~   77 (443)
                      +....++|++.+.||+|+||+||+|.+..+++.||||++...    ......+.+|+.+++.++ |+     +|++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            445678999999999999999999999999999999999753    234567788999998885 55     49999999


Q ss_pred             EEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCCEeecCCCCcEEEc--CCCCeEEe
Q 013421           78 LASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCH--SKGVYHRDLKPENLLLD--SYGNLKVS  151 (443)
Q Consensus        78 ~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH--~~gi~HrDlkp~NILl~--~~~~~kL~  151 (443)
                      +...+..|+||||++ ++|.+++...  +.+++..++.++.||+.||.|||  +.||+||||||+|||++  .++.+||+
T Consensus       125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            999999999999996 5999999875  46899999999999999999999  57999999999999995  47889999


Q ss_pred             eecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCC--
Q 013421          152 DFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC--  229 (443)
Q Consensus       152 DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--  229 (443)
                      |||++.....   .....+||+.|+|||++.+..++ .++|||||||++|+|++|.+||.+.+.......+.......  
T Consensus       204 DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          204 DFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             CCTTCEETTC---CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             eccCceeccc---ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9999976543   23467899999999999887765 99999999999999999999999887766555443211000  


Q ss_pred             -----------------------------------CCC---------------------------CCHHHHHHHHHccCC
Q 013421          230 -----------------------------------PFW---------------------------FSTGATSLIHKILDP  247 (443)
Q Consensus       230 -----------------------------------~~~---------------------------~s~~~~~li~~~L~~  247 (443)
                                                         |..                           .++++.+||.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                                               000                           013789999999999


Q ss_pred             CCCCCCCHHHHhcCcccccc
Q 013421          248 NPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       248 dP~~R~t~~eil~hp~f~~~  267 (443)
                      ||++|||++|+|+||||+..
T Consensus       360 dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGCC-
T ss_pred             ChhhCCCHHHHhcCcccccC
Confidence            99999999999999999764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-48  Score=386.61  Aligned_cols=256  Identities=21%  Similarity=0.287  Sum_probs=220.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEE-----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      .++|++++.||+|+||.||+|.     +..++..||||++....  .......+.+|+.+++.++||||+++++++.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            4689999999999999999999     44577899999996543  3334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC---CeEEee
Q 013421           83 KVYIILEFVTGGELFDKIVHQG-------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSD  152 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~---~~kL~D  152 (443)
                      ..|+||||++||+|.+++...+       .+++..++.++.||+.||.|||++||+||||||+|||++.+|   .+||+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999999998753       489999999999999999999999999999999999999655   499999


Q ss_pred             ecCcCCCccc--cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CC
Q 013421          153 FGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FS  228 (443)
Q Consensus       153 FGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~  228 (443)
                      ||++......  ........||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+. ..
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~  306 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD  306 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9998643221  1223456689999999999877765 89999999999999998 999999988888877776553 55


Q ss_pred             CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      .+..+++.+.+||.+||+.||.+|||+++|++|.|+-.
T Consensus       307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            66779999999999999999999999999999988743

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.5e-47  Score=362.70  Aligned_cols=250  Identities=22%  Similarity=0.358  Sum_probs=218.4

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ...++|++++.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.+++.++||||+++++++.+....|
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            34578999999999999999999886 5778999999765432    256889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-
Q 013421           86 IILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (443)
                      +||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            9999999999999998764 59999999999999999999999999999999999999999999999999987554421 


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLI  241 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li  241 (443)
                      .......||+.|+|||++.+..+. .++||||+|+++|+|++ |..||...+.......+.... ...|...++.+.++|
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  238 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIM  238 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             hcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHH
Confidence            223345567889999999876665 89999999999999999 999999888877777665553 445666899999999


Q ss_pred             HHccCCCCCCCCCHHHHhcC
Q 013421          242 HKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+||+.||.+|||+.++++|
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          239 YSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3e-47  Score=376.85  Aligned_cols=254  Identities=25%  Similarity=0.420  Sum_probs=212.7

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCC-cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC------cceEEE
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETG-ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN------IVRLHE   76 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~   76 (443)
                      +....++|++++.||+|+||.||+|.+..++ ..||+|++...    ....+.+.+|+.+++.++|++      ++.+++
T Consensus        14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            3455679999999999999999999998776 68999999753    234567889999999997665      999999


Q ss_pred             EEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE------------
Q 013421           77 VLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL------------  142 (443)
Q Consensus        77 ~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl------------  142 (443)
                      ++...+..|+||||+ +++|.+.+....  .+++..++.++.||+.||.|||++||+||||||+|||+            
T Consensus        90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence            999999999999999 677888877654  69999999999999999999999999999999999999            


Q ss_pred             -------cCCCCeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh
Q 013421          143 -------DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  215 (443)
Q Consensus       143 -------~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  215 (443)
                             +.++.+||+|||++.....   .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                   5678999999999875433   23456899999999999877765 899999999999999999999998776


Q ss_pred             HHHHHHhhhccCCCC--------------------------------------------CCCCHHHHHHHHHccCCCCCC
Q 013421          216 PTLYKKINAAEFSCP--------------------------------------------FWFSTGATSLIHKILDPNPKT  251 (443)
Q Consensus       216 ~~~~~~i~~~~~~~~--------------------------------------------~~~s~~~~~li~~~L~~dP~~  251 (443)
                      ......+.....+.|                                            ...++++.+||.+||+.||.+
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            554433322111111                                            112457889999999999999


Q ss_pred             CCCHHHHhcCccccc
Q 013421          252 RIRIEGIRKHPWFRK  266 (443)
Q Consensus       252 R~t~~eil~hp~f~~  266 (443)
                      |||++|+++||||+.
T Consensus       325 Rpt~~e~l~hp~f~~  339 (355)
T 2eu9_A          325 RITLAEALLHPFFAG  339 (355)
T ss_dssp             SCCHHHHTTSGGGGG
T ss_pred             CcCHHHHhcChhhcC
Confidence            999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.5e-48  Score=379.98  Aligned_cols=254  Identities=33%  Similarity=0.580  Sum_probs=185.8

Q ss_pred             cccccCeEEee-eeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 013421            5 TRRVAKYEVGR-TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS---   80 (443)
Q Consensus         5 ~~~~~~y~i~~-~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---   80 (443)
                      ....++|++.+ .||+|+||.||+|.+..+|+.||+|++....       ....+....++.++||||+++++++..   
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            45668999965 6999999999999999999999999996532       112223334667799999999999976   


Q ss_pred             -CCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC---CCeEEeeec
Q 013421           81 -RTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFG  154 (443)
Q Consensus        81 -~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~---~~~kL~DFG  154 (443)
                       ....|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             556899999999999999998764  69999999999999999999999999999999999999864   559999999


Q ss_pred             CcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHH----HHHhhhccCCCC
Q 013421          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL----YKKINAAEFSCP  230 (443)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~~  230 (443)
                      ++.....  ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....    ...+.......+
T Consensus       177 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (336)
T 3fhr_A          177 FAKETTQ--NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP  253 (336)
T ss_dssp             TCEEC------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred             cceeccc--cccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence            9875543  234567899999999999776664 899999999999999999999977554332    222333333222


Q ss_pred             ----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          231 ----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       231 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                          ..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence                35899999999999999999999999999999998754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-47  Score=381.70  Aligned_cols=252  Identities=23%  Similarity=0.364  Sum_probs=214.6

Q ss_pred             cccCeEEeeeeeccCceEEEEEE-----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS   80 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~   80 (443)
                      ..++|++++.||+|+||.||+|.     +..+++.||||++....  .....+.+.+|+.+++++ +||||+++++++.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            35789999999999999999998     55677899999997653  233457799999999999 79999999999987


Q ss_pred             CC-EEEEEEecCCCCChHHHHHhcCC------------------------------------------------------
Q 013421           81 RT-KVYIILEFVTGGELFDKIVHQGR------------------------------------------------------  105 (443)
Q Consensus        81 ~~-~~~lv~Ey~~gg~L~~~i~~~~~------------------------------------------------------  105 (443)
                      .+ ..|+||||++||+|.+++.....                                                      
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            55 49999999999999999986543                                                      


Q ss_pred             ------------CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc--ccccccCC
Q 013421          106 ------------LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCG  171 (443)
Q Consensus       106 ------------l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--~~~~~~~g  171 (443)
                                  +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  .......|
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence                        8999999999999999999999999999999999999999999999999997653321  23345678


Q ss_pred             CcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHH-HHHhhh-ccCCCCCCCCHHHHHHHHHccCCC
Q 013421          172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL-YKKINA-AEFSCPFWFSTGATSLIHKILDPN  248 (443)
Q Consensus       172 t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~-~~~i~~-~~~~~~~~~s~~~~~li~~~L~~d  248 (443)
                      |+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.... ...+.. .....|..+++++.++|.+||+.|
T Consensus       258 t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  336 (359)
T 3vhe_A          258 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  336 (359)
T ss_dssp             CGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence            9999999999877665 89999999999999998 9999988664433 333333 345677789999999999999999


Q ss_pred             CCCCCCHHHHhcC
Q 013421          249 PKTRIRIEGIRKH  261 (443)
Q Consensus       249 P~~R~t~~eil~h  261 (443)
                      |.+|||++++++|
T Consensus       337 P~~Rps~~ell~~  349 (359)
T 3vhe_A          337 PSQRPTFSELVEH  349 (359)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhhCCCHHHHHHH
Confidence            9999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.3e-47  Score=371.82  Aligned_cols=252  Identities=24%  Similarity=0.343  Sum_probs=219.8

Q ss_pred             cccCeEEeeeeeccCceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      ...+|++.+.||+|+||.||+|.+.     .++..||+|++....  .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            3468999999999999999999983     456899999997643  334567899999999999999999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGR------------------------LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP  137 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~------------------------l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp  137 (443)
                      +..|+||||+++++|.+++.....                        +++..++.++.||+.||.|||++||+||||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp  178 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA  178 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence            999999999999999999987543                        88999999999999999999999999999999


Q ss_pred             CcEEEcCCCCeEEeeecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCC
Q 013421          138 ENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD  214 (443)
Q Consensus       138 ~NILl~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~  214 (443)
                      +||+++.++.+||+|||++........  ......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999875543222  23345678899999999876664 89999999999999999 999999888


Q ss_pred             hHHHHHHhhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          215 LPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       215 ~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .......+... ....|..+++++.++|.+||+.||.+|||+++++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          258 PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            77777766554 345667799999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.3e-47  Score=365.04  Aligned_cols=249  Identities=22%  Similarity=0.363  Sum_probs=216.1

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|++++.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence            3468999999999999999999886 6778999999865433    2568899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc-cc
Q 013421           87 ILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-VE  164 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~~  164 (443)
                      ||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence            9999999999999977 567999999999999999999999999999999999999999999999999998765442 12


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      ......||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+... ....|...++.+.++|.
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  255 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY  255 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHH
Confidence            2334557888999999987766 489999999999999998 99999998887777777655 44556678999999999


Q ss_pred             HccCCCCCCCCCHHHHhcC
Q 013421          243 KILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~h  261 (443)
                      +||+.||.+|||++++++|
T Consensus       256 ~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          256 SCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HTTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhHCcCHHHHHHH
Confidence            9999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-47  Score=376.81  Aligned_cols=252  Identities=24%  Similarity=0.331  Sum_probs=219.6

Q ss_pred             cccCeEEeeeeeccCceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      ..++|++++.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            4578999999999999999999987     355899999997654  334567899999999999999999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQ------------------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP  137 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp  137 (443)
                      +..|+||||+++|+|.+++...                        ..+++..++.++.||+.||.|||++||+||||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp  202 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  202 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence            9999999999999999999764                        5689999999999999999999999999999999


Q ss_pred             CcEEEcCCCCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCC
Q 013421          138 ENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD  214 (443)
Q Consensus       138 ~NILl~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~  214 (443)
                      +|||++.++.+||+|||++.......  .......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+
T Consensus       203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            99999999999999999986543321  223455689999999999877664 89999999999999999 999999988


Q ss_pred             hHHHHHHhhhcc-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          215 LPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       215 ~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .......+..+. ...|..+++++.++|.+||+.||.+|||+.+++++
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          282 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            877777766654 35677899999999999999999999999999873

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.6e-47  Score=364.87  Aligned_cols=251  Identities=28%  Similarity=0.398  Sum_probs=206.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ..++|++.+.||+|+||.||+|.+..+   +..||+|++....  .....+.+.+|+.+++.++||||+++++++. .+.
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            457899999999999999999998754   4579999987543  3345678999999999999999999999984 467


Q ss_pred             EEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           84 VYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      .|+||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            899999999999999998654 6899999999999999999999999999999999999999999999999999765442


Q ss_pred             c-ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHH
Q 013421          163 V-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATS  239 (443)
Q Consensus       163 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~  239 (443)
                      . .......+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ..+.+..+++++.+
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  248 (281)
T 1mp8_A          170 TYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  248 (281)
T ss_dssp             ---------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1 122344578899999999876664 89999999999999996 99999988877777766554 45667789999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcC
Q 013421          240 LIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +|.+||+.||.+|||+.+++++
T Consensus       249 li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          249 LMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=378.09  Aligned_cols=252  Identities=23%  Similarity=0.394  Sum_probs=221.0

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVL   78 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~   78 (443)
                      ..++|++++.||+|+||.||+|.+..       .+..||+|++....  .....+.+.+|+.+++.+ +||||+++++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            34689999999999999999999753       33579999997653  334567899999999999 999999999999


Q ss_pred             EeCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE
Q 013421           79 ASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL  142 (443)
Q Consensus        79 ~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl  142 (443)
                      .+.+..|+||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            99999999999999999999998754                48999999999999999999999999999999999999


Q ss_pred             cCCCCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHH
Q 013421          143 DSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  219 (443)
Q Consensus       143 ~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  219 (443)
                      +.++.+||+|||++.......  .......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+..
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999998654422  223445678899999999876664 89999999999999999 99999998888877


Q ss_pred             HHhhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          220 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       220 ~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ..+..+ ....|..+++++.+||.+||+.||.+|||+.+++++
T Consensus       304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            776655 455677799999999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.7e-46  Score=364.41  Aligned_cols=256  Identities=28%  Similarity=0.516  Sum_probs=207.5

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ...+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            34678999999999999999999999999999999999875555555677899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           85 YIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      |+||||+++++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999998864    4568999999999999999999999999999999999999999999999999987665


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC--hHHHHHHhhhccCCC--CCCCCHH
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINAAEFSC--PFWFSTG  236 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~~~--~~~~s~~  236 (443)
                      ..........|++.|+|||++.+..+. .++||||||+++|+|++|..||.+..  .......+....++.  +..++++
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence            543444566799999999999876664 89999999999999999999997643  334445554444332  2458999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +.+||.+||+.||.+|||+++++++
T Consensus       267 l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999873

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3e-47  Score=367.01  Aligned_cols=248  Identities=23%  Similarity=0.268  Sum_probs=212.2

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCC-------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETG-------ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVL   78 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~   78 (443)
                      ...++|++.+.||+|+||.||+|++..++       ..||+|++....   ....+.+.+|+.+++.++||||+++++++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            34678999999999999999999998877       479999997643   22356789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC--------eE
Q 013421           79 ASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN--------LK  149 (443)
Q Consensus        79 ~~~~~~~lv~Ey~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~--------~k  149 (443)
                      .+.+..|+||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999999987654 999999999999999999999999999999999999998887        99


Q ss_pred             EeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhC-CCCCCCCChHHHHHHhhhccCC
Q 013421          150 VSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAAEFS  228 (443)
Q Consensus       150 L~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~  228 (443)
                      |+|||++......    ....||+.|+|||++.+....+.++|||||||++|+|++| .+||...+... ..........
T Consensus       162 l~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~~  236 (289)
T 4fvq_A          162 LSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDRHQ  236 (289)
T ss_dssp             ECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTCC
T ss_pred             eccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhccCC
Confidence            9999998755332    2345789999999998744456899999999999999995 55555544433 3334445566


Q ss_pred             CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .|...++++.+||.+||+.||.+|||++++++|
T Consensus       237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            677789999999999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.2e-47  Score=382.13  Aligned_cols=250  Identities=27%  Similarity=0.410  Sum_probs=217.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            468999999999999999999999999999999987542  233456788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc-
Q 013421           88 LEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL-  165 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~-  165 (443)
                      |||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... 
T Consensus       191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~  270 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA  270 (377)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence            99999999999998754 6999999999999999999999999999999999999999999999999998754332111 


Q ss_pred             -ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          166 -LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       166 -~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                       .....+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+..+....+..+ ..+.|..+++++.+||.
T Consensus       271 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  349 (377)
T 3cbl_A          271 SGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME  349 (377)
T ss_dssp             CSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence             1122356789999999876664 89999999999999998 99999988877776665544 45677789999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||+.||.+|||++++++
T Consensus       350 ~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          350 QCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCCchhCcCHHHHHH
Confidence            999999999999999876

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.6e-47  Score=380.70  Aligned_cols=254  Identities=23%  Similarity=0.426  Sum_probs=208.5

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----------CCCcceE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-----------HPNIVRL   74 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l   74 (443)
                      ...++|++++.||+|+||.||+|.+..+++.||||++....    ...+.+.+|+.++++++           ||||+++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            34578999999999999999999999999999999997543    23466889999998886           8999999


Q ss_pred             EEEEEeCC----EEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcC---
Q 013421           75 HEVLASRT----KVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDS---  144 (443)
Q Consensus        75 ~~~~~~~~----~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~---  144 (443)
                      ++++...+    ..+++|||+ +++|.+++...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.   
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99987654    799999999 89999999863  4699999999999999999999998 9999999999999953   


Q ss_pred             ---CCCeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh------
Q 013421          145 ---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL------  215 (443)
Q Consensus       145 ---~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~------  215 (443)
                         .+.+||+|||++.....   .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.      
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcCcceEEEcccccccccCC---CCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence               34799999999876543   23456899999999999887764 999999999999999999999986542      


Q ss_pred             HHHHHHhh------------------------------------------hccCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 013421          216 PTLYKKIN------------------------------------------AAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       216 ~~~~~~i~------------------------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      ......+.                                          ...+.++..+++++.+||.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            11111111                                          111223334567889999999999999999


Q ss_pred             CHHHHhcCccccccC
Q 013421          254 RIEGIRKHPWFRKNY  268 (443)
Q Consensus       254 t~~eil~hp~f~~~~  268 (443)
                      |++|+++||||+...
T Consensus       327 t~~ell~hp~f~~~~  341 (373)
T 1q8y_A          327 DAGGLVNHPWLKDTL  341 (373)
T ss_dssp             CHHHHHTCGGGTTCT
T ss_pred             CHHHHhhChhhhccc
Confidence            999999999998754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=366.35  Aligned_cols=259  Identities=25%  Similarity=0.372  Sum_probs=198.8

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..+++|++++.||+|+||.||+|.+..+|+.||||++...... ....+.+.++..+++.++||||+++++++.+.+..|
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            3567899999999999999999999999999999999875432 223344555566788889999999999999999999


Q ss_pred             EEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +||||+ ++.+...... .+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++...... 
T Consensus       101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-  178 (318)
T ss_dssp             EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-
Confidence            999999 5555554443 46899999999999999999999995 9999999999999999999999999998765442 


Q ss_pred             ccccccCCCcccCCCccccc----CCCCCCccchHHHHHHHHHHhhCCCCCCCC-ChHHHHHHhhhccC-CCC--CCCCH
Q 013421          164 ELLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGET-DLPTLYKKINAAEF-SCP--FWFST  235 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~-~~~--~~~s~  235 (443)
                      ......+||+.|+|||++..    ....+.++|||||||++|+|++|..||... +.......+..... ..|  ..+++
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T 2dyl_A          179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG  258 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred             ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence            23345679999999999852    223358999999999999999999999873 34444444444332 223  34899


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ++.+||.+||+.||.+|||++++++||||+..
T Consensus       259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            99999999999999999999999999999753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.1e-46  Score=358.85  Aligned_cols=250  Identities=18%  Similarity=0.271  Sum_probs=217.6

Q ss_pred             cccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-
Q 013421            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-   81 (443)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-   81 (443)
                      .....+++|++.+.||+|+||.||+|.+.  ++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+. 
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP   80 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence            34567889999999999999999999985  889999999875433 33457799999999999999999999999877 


Q ss_pred             -CEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--CEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           82 -TKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        82 -~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~g--i~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                       ...++||||+++|+|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+||+++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence             78999999999999999998765  4899999999999999999999999  999999999999999999999999987


Q ss_pred             CCCccccccccccCCCcccCCCcccccCCCCC--CccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cCCCCCC
Q 013421          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW  232 (443)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~--~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~  232 (443)
                      .....     ...+||+.|+|||++.+..+..  .++|||||||++|+|++|..||...+.......+...  ....|..
T Consensus       161 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3kmu_A          161 FSFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG  235 (271)
T ss_dssp             CTTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred             eeecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCC
Confidence            54322     3457899999999998765542  2799999999999999999999988877665555433  4556777


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          233 FSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +++++.++|.+||+.||.+|||++++++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          236 ISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.7e-46  Score=366.45  Aligned_cols=259  Identities=25%  Similarity=0.419  Sum_probs=212.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR--HPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~   85 (443)
                      -.+|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++.++  ||||+++++++.+.+..|
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            457999999999999999999985 589999999976543 3345678999999999997  599999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc-
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-  164 (443)
                      ++|| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++........ 
T Consensus       105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred             EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence            9999 558899999999889999999999999999999999999999999999999965 8999999999986544221 


Q ss_pred             -cccccCCCcccCCCcccccC----------CCCCCccchHHHHHHHHHHhhCCCCCCCCCh-HHHHHHhhh--ccCCCC
Q 013421          165 -LLHTTCGTPNYVAPEVLSNR----------GYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINA--AEFSCP  230 (443)
Q Consensus       165 -~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~--~~~~~~  230 (443)
                       .....+||+.|+|||++.+.          ...+.++|||||||++|+|++|..||..... ......+..  .....|
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  262 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP  262 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence             23456799999999998651          2335799999999999999999999987543 222333322  234566


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                      ...++++.++|.+||+.||.+|||++++++||||+....+
T Consensus       263 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            6789999999999999999999999999999999876543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.4e-46  Score=358.92  Aligned_cols=249  Identities=25%  Similarity=0.431  Sum_probs=203.8

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..++|++.+.||+|+||.||+|.+.  ++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            4679999999999999999999974  8899999987654322 223467899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---CEeecCCCCcEEEcC--------CCCeEEeeec
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG---VYHRDLKPENLLLDS--------YGNLKVSDFG  154 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~g---i~HrDlkp~NILl~~--------~~~~kL~DFG  154 (443)
                      +||||+++++|.+++. .+++++..++.++.|++.||.|||++|   |+||||||+||+++.        ++.+||+|||
T Consensus        83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999988885 468999999999999999999999999   999999999999986        6789999999


Q ss_pred             CcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc--cCCCCCC
Q 013421          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW  232 (443)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~  232 (443)
                      ++......  ......||+.|+|||++.+..+. .++||||+|+++|+|++|..||...+.......+...  ..+.|..
T Consensus       162 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3dtc_A          162 LAREWHRT--TKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST  238 (271)
T ss_dssp             C---------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred             cccccccc--cccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence            99765432  22356799999999999876664 8999999999999999999999988776665555443  3456677


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          233 FSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +++.+.++|.+||+.||.+|||+.++++|
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            89999999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-46  Score=356.82  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=218.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++......    .+.+.+|+.+++.++||||+++++++.+.+..|++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence            468999999999999999999986 6788999999875432    25688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc-ccc
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-VEL  165 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~~~  165 (443)
                      |||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence            9999999999999875 46899999999999999999999999999999999999999999999999998765432 122


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~  243 (443)
                      .....|++.|+|||++.+..+. .++||||+|+++|+|++ |..||...+.......+..+ ....|..+++.+.++|.+
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  240 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH  240 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHH
Confidence            3445678899999999876664 89999999999999999 99999998887777777655 344566789999999999


Q ss_pred             ccCCCCCCCCCHHHHhcC
Q 013421          244 ILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~h  261 (443)
                      ||+.||.+|||+++++++
T Consensus       241 ~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          241 CWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HccCChhhCcCHHHHHHH
Confidence            999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.9e-47  Score=370.59  Aligned_cols=252  Identities=23%  Similarity=0.340  Sum_probs=216.3

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEE--EEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESV--AMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v--AiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~   82 (443)
                      ...++|++.+.||+|+||.||+|++..++..+  |+|.+....  .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            34679999999999999999999998888865  999887533  223456789999999999 8999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC
Q 013421           83 KVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG  146 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~  146 (443)
                      ..|+||||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            9999999999999999997654                689999999999999999999999999999999999999999


Q ss_pred             CeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc
Q 013421          147 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA  225 (443)
Q Consensus       147 ~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~  225 (443)
                      .+||+|||++...... .......+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+
T Consensus       180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  257 (327)
T ss_dssp             CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence            9999999998744322 222345578899999999776664 89999999999999998 99999998888877777654


Q ss_pred             -cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          226 -EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       226 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                       ....|..+++++.+||.+||..||.+|||+++++++
T Consensus       258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             455667789999999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-46  Score=370.15  Aligned_cols=256  Identities=22%  Similarity=0.376  Sum_probs=192.0

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-IMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++.....  ......+.+|+. +++.++||||+++++++.+.+..|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            45789999999999999999999999999999999976532  223445556666 677889999999999999999999


Q ss_pred             EEEecCCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           86 IILEFVTGGELFDKIVH-----QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~-----~~~l~e~~~~~~~~qll~aL~yLH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      +||||+++ +|.+++..     ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99999975 77777763     56799999999999999999999999 9999999999999999999999999999765


Q ss_pred             ccccccccccCCCcccCCCcccc----cCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhhhccC-CC----
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLS----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEF-SC----  229 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~-~~----  229 (443)
                      ... ......+||+.|+|||++.    +..+ +.++|||||||++|+|++|..||...+.. .....+..+.. ..    
T Consensus       177 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3aln_A          177 VDS-IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE  254 (327)
T ss_dssp             ------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred             ccc-cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence            443 2233457999999999983    3344 48999999999999999999999864422 22222222221 12    


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       230 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +..+++++.+||.+||+.||.+|||++++++||||...
T Consensus       255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            23489999999999999999999999999999999753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-46  Score=364.40  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=208.7

Q ss_pred             cccccCeEEeeeeeccCceEEEEEE----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   80 (443)
                      ....++|++++.||+|+||.||+|+    +..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3456789999999999999999998    5678999999998754   23445789999999999999999999999854


Q ss_pred             --CCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421           81 --RTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus        81 --~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                        ...+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence              456899999999999999998754 59999999999999999999999999999999999999999999999999998


Q ss_pred             CCcccc---ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH----------------HH
Q 013421          158 LPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP----------------TL  218 (443)
Q Consensus       158 ~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----------------~~  218 (443)
                      ......   .......|++.|+|||++.+..+. .++||||+||++|+|++|..||......                ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            664422   123344577889999999877764 8999999999999999999998653221                11


Q ss_pred             HHHh-hhccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          219 YKKI-NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       219 ~~~i-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ...+ .....+.|..+++++.++|.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            1122 23355667789999999999999999999999999876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.5e-46  Score=361.84  Aligned_cols=250  Identities=20%  Similarity=0.273  Sum_probs=212.0

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   83 (443)
                      ...-++|++++.||+|+||.||+|.+..+|+.||+|++.....     .+.+.+|+.+++.+ +|+|++++++++.+...
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            3445679999999999999999999999999999999875432     23577899999999 79999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC-----eEEeeecCcC
Q 013421           84 VYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN-----LKVSDFGLSA  157 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~-----~kL~DFGls~  157 (443)
                      .|+||||+ +++|.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||++.
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99999999 999999998754 5999999999999999999999999999999999999987776     9999999997


Q ss_pred             CCccccc-------cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC---hHHHHHHhhhccC
Q 013421          158 LPQQGVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---LPTLYKKINAAEF  227 (443)
Q Consensus       158 ~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~  227 (443)
                      .......       .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+   .......+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            6544211       2356679999999999987776 489999999999999999999998743   3344444433222


Q ss_pred             C-----CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          228 S-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       228 ~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .     .+..+++++.++|.+||+.||.+|||+++|++.
T Consensus       239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1     224689999999999999999999999998773

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-46  Score=362.55  Aligned_cols=250  Identities=26%  Similarity=0.376  Sum_probs=221.0

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ....+|++.+.||+|+||.||+|.+..++..||+|++....    ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            45678999999999999999999999999999999997543    23567889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           86 IILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            999999999999999874  358999999999999999999999999999999999999999999999999997665432


Q ss_pred             -ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHH
Q 013421          164 -ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL  240 (443)
Q Consensus       164 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l  240 (443)
                       .......||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... ....|..+++.+.+|
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  244 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL  244 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence             223345578899999999877664 89999999999999999 99999988877777666554 456677799999999


Q ss_pred             HHHccCCCCCCCCCHHHHhc
Q 013421          241 IHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~  260 (443)
                      |.+||..||.+|||++++++
T Consensus       245 i~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          245 MRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCChhhCcCHHHHHH
Confidence            99999999999999999977

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-46  Score=372.73  Aligned_cols=253  Identities=23%  Similarity=0.360  Sum_probs=213.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~   81 (443)
                      .++|++++.||+|+||.||+|.+     ..++..||+|++....  .....+.+.+|+.+++++ +||||+++++++...
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            46899999999999999999997     3456789999997543  222357789999999999 899999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQG-----------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE  138 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~  138 (443)
                      +..|+||||+++|+|.+++....                       .+++..++.++.||+.||.|||++||+||||||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            99999999999999999998653                       2789999999999999999999999999999999


Q ss_pred             cEEEcCCCCeEEeeecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCCh
Q 013421          139 NLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDL  215 (443)
Q Consensus       139 NILl~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~  215 (443)
                      |||++.++.+||+|||++........  ......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            99999999999999999976543221  23345678899999999876664 89999999999999998 9999988665


Q ss_pred             HHHHHH-hhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcc
Q 013421          216 PTLYKK-INAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  263 (443)
Q Consensus       216 ~~~~~~-i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~  263 (443)
                      ...... +... ....|..+++++.+||.+||+.||.+|||+.++++|..
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          281 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            444333 3322 44567778999999999999999999999999998753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5e-47  Score=373.38  Aligned_cols=246  Identities=22%  Similarity=0.284  Sum_probs=209.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l   86 (443)
                      -++|++.+.||+|+||+||+|.+..+|+.||||++.....     .+.+.+|+.+++.+ +||||+++++++.+.+..|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            3679999999999999999999999999999999876532     23578999999999 99999999999999999999


Q ss_pred             EEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC-----eEEeeecCcCCCc
Q 013421           87 ILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN-----LKVSDFGLSALPQ  160 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~-----~kL~DFGls~~~~  160 (443)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.     +||+|||++....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999 9999999987 368999999999999999999999999999999999999998887     9999999997654


Q ss_pred             cccc-------cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC---hHHHHHHhhhccCCCC
Q 013421          161 QGVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---LPTLYKKINAAEFSCP  230 (443)
Q Consensus       161 ~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~  230 (443)
                      ....       .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+   ..+.+..+.......+
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence            3211       13467899999999999887764 89999999999999999999998743   3344555544333332


Q ss_pred             C----CCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          231 F----WFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       231 ~----~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .    ...+++.++|.+||+.||.+||++++|++
T Consensus       241 ~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          241 IEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1    11339999999999999999999999876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.3e-46  Score=370.26  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=208.5

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEE----EEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ..++|++.+.||+|+||+||+|++..+++.+    |+|.+....  .....+.+.+|+.++++++||||+++++++.+..
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            3568999999999999999999998887755    777665432  2223467899999999999999999999998765


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                       .++++||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence             78999999999999999874 5799999999999999999999999999999999999999999999999999876543


Q ss_pred             ccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHH
Q 013421          162 GVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGA  237 (443)
Q Consensus       162 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~  237 (443)
                      ...  ......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ..+.|..++.++
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  248 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred             CcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence            222  22344578899999999887765 89999999999999999 99999988877776666554 456677799999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+++.+||+.||.+|||+.+++++
T Consensus       249 ~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          249 YMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999876

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-46  Score=365.83  Aligned_cols=251  Identities=25%  Similarity=0.364  Sum_probs=215.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~   81 (443)
                      .++|++++.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            46899999999999999999985     4578899999997654  233457899999999999 999999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQG------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD  143 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~------------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~  143 (443)
                      +..|+||||+++|+|.+++....                  .+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence            99999999999999999998754                  489999999999999999999999999999999999999


Q ss_pred             CCCCeEEeeecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHH
Q 013421          144 SYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK  220 (443)
Q Consensus       144 ~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~  220 (443)
                      .++.+||+|||++........  ......||+.|+|||++.+..+. .++|||||||++|+|++ |..||..........
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  258 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence            999999999999976654322  23345578899999999876664 89999999999999998 999998866544333


Q ss_pred             H-hhh-ccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          221 K-INA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       221 ~-i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      . +.. .....+..+++++.++|.+||+.||.+|||+++++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            3 322 2334566789999999999999999999999999874

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.1e-47  Score=372.09  Aligned_cols=251  Identities=21%  Similarity=0.327  Sum_probs=212.7

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcE----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ..++|++++.||+|+||+||+|.+..+++.    ||+|.+......  .....+.+|+.+++.++||||+++++++.+ +
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~   87 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-S   87 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEECB-S
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-C
Confidence            456899999999999999999999888876    677766543211  123456789999999999999999999864 5


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..++||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            689999999999999999874 5799999999999999999999999999999999999999999999999999986544


Q ss_pred             cc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHH
Q 013421          162 GV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGA  237 (443)
Q Consensus       162 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~  237 (443)
                      ..  .......|++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....|..+++++
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV  246 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTT
T ss_pred             ccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHH
Confidence            22  233456688899999999877664 89999999999999999 99999988877777766654 456677789999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .++|.+||..||.+|||+.++++|
T Consensus       247 ~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          247 YMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             THHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.4e-46  Score=356.37  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=210.9

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHH----HHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV----DQIKREISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...........    +.+.+|+.+++.++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            445789999999999999999999999999999999976543332221    6789999999999999999999999776


Q ss_pred             CEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--CEeecCCCCcEEEcCCCC-----eEEeee
Q 013421           82 TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGN-----LKVSDF  153 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~g--i~HrDlkp~NILl~~~~~-----~kL~DF  153 (443)
                      .  ++||||+++|+|.+.+... ..+++..++.++.|++.||.|||++|  |+||||||+|||++.++.     +||+||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            6  6999999999999988765 47999999999999999999999999  999999999999988776     999999


Q ss_pred             cCcCCCccccccccccCCCcccCCCcccccC-CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHH--HHHhhh--ccCC
Q 013421          154 GLSALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL--YKKINA--AEFS  228 (443)
Q Consensus       154 Gls~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~--~~~i~~--~~~~  228 (443)
                      |++.....   .....+||+.|+|||++... ...+.++||||+||++|+|++|..||...+....  ...+..  ....
T Consensus       174 g~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 4f0f_A          174 GLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT  250 (287)
T ss_dssp             TTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred             Cccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence            99875433   24457799999999998432 2235899999999999999999999987654333  333332  2345


Q ss_pred             CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .+..+++++.++|.+||+.||.+|||++++++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            66778999999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.2e-46  Score=367.36  Aligned_cols=251  Identities=23%  Similarity=0.403  Sum_probs=217.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEEC-------CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNR-------ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLA   79 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~   79 (443)
                      .++|++++.||+|+||.||+|.+.       .++..||+|++....  .....+.+.+|+.+++.+ +||||+++++++.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            478999999999999999999975       457789999997653  334567899999999999 8999999999999


Q ss_pred             eCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc
Q 013421           80 SRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD  143 (443)
Q Consensus        80 ~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~  143 (443)
                      +.+..|+||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence            9999999999999999999998654                389999999999999999999999999999999999999


Q ss_pred             CCCCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHH
Q 013421          144 SYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK  220 (443)
Q Consensus       144 ~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~  220 (443)
                      .++.+||+|||++.......  .......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+...
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  270 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  270 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence            99999999999987654321  123344578899999999876664 89999999999999999 999999988877777


Q ss_pred             Hhhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          221 KINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       221 ~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+..+ ....+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            66554 345667789999999999999999999999999885

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.2e-46  Score=365.58  Aligned_cols=251  Identities=21%  Similarity=0.276  Sum_probs=218.5

Q ss_pred             ccCeEEeeeeeccCceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.++||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            468999999999999999999876     357899999997653  2334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEee
Q 013421           83 KVYIILEFVTGGELFDKIVHQ----------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~----------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (443)
                      ..|+||||+++|+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~D  181 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  181 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECc
Confidence            999999999999999999753          4568999999999999999999999999999999999999999999999


Q ss_pred             ecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CC
Q 013421          153 FGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FS  228 (443)
Q Consensus       153 FGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~  228 (443)
                      ||++.......  .......||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+.... ..
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  260 (322)
T 1p4o_A          182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD  260 (322)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             CccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCC
Confidence            99987554321  223345678999999999876664 89999999999999999 899999988877777765544 45


Q ss_pred             CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          261 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            667799999999999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.6e-46  Score=359.71  Aligned_cols=250  Identities=20%  Similarity=0.315  Sum_probs=213.8

Q ss_pred             ccCeEEee-eeeccCceEEEEEE--ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGR-TIGEGTFAKVRFAQ--NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~-~LG~G~~g~V~~a~--~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      .++|++.+ .||+|+||.||+|.  +..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            45799998 99999999999995  456788999999976542 233467899999999999999999999999 56778


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999876543222


Q ss_pred             ---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHH
Q 013421          165 ---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATS  239 (443)
Q Consensus       165 ---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~  239 (443)
                         ......|++.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+..+ ....|..+++++.+
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  251 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD  251 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence               12334567899999999776664 89999999999999999 99999998887777766554 35567789999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhc
Q 013421          240 LIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~  260 (443)
                      +|.+||+.||.+|||+.++++
T Consensus       252 li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          252 LMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999886

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-46  Score=357.94  Aligned_cols=254  Identities=24%  Similarity=0.351  Sum_probs=218.1

Q ss_pred             ccccCeEEee-eeeccCceEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            6 RRVAKYEVGR-TIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         6 ~~~~~y~i~~-~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ...++|.+.+ .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            3456788887 9999999999999864  467889999997653  334567899999999999999999999999 456


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            699999999999999999654 5699999999999999999999999999999999999999999999999999876543


Q ss_pred             ccc---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHH
Q 013421          162 GVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTG  236 (443)
Q Consensus       162 ~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~  236 (443)
                      ...   ......||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+ ....|..++++
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  241 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence            211   22344578999999999776664 89999999999999998 99999988877777766554 35667789999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhcCcc
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRKHPW  263 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~  263 (443)
                      +.++|.+||+.||.+|||+.++++|.+
T Consensus       242 l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          242 LYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            999999999999999999999999754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.3e-46  Score=374.37  Aligned_cols=250  Identities=25%  Similarity=0.384  Sum_probs=206.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEEC---CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      .++|++.+.||+|+||.||+|++.   .++..||||++....  .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            457999999999999999999886   467789999997643  333457899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            99999999999999998754 69999999999999999999999999999999999999999999999999998664422


Q ss_pred             cc---ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHH
Q 013421          164 EL---LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGAT  238 (443)
Q Consensus       164 ~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  238 (443)
                      ..   .....+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+ ..+.+..++..+.
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  280 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY  280 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHH
T ss_pred             ccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence            21   1223457789999999877765 89999999999999998 99999988877777766554 4455667899999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhc
Q 013421          239 SLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ++|.+||+.||.+|||++++++
T Consensus       281 ~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          281 QLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhCcChhhCcCHHHHHH
Confidence            9999999999999999999887

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.3e-46  Score=356.27  Aligned_cols=252  Identities=24%  Similarity=0.307  Sum_probs=212.9

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRE---TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ...++|++.+.||+|+||.||+|.+..   ++..||+|++....  .....+.+.+|+.+++.++||||+++++++.++ 
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   85 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-   85 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence            456789999999999999999998654   34469999997653  233457899999999999999999999998754 


Q ss_pred             EEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..|+||||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            5689999999999999997754 599999999999999999999999999999999999999999999999999876544


Q ss_pred             cc-ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHH
Q 013421          162 GV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGAT  238 (443)
Q Consensus       162 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  238 (443)
                      .. .......|++.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... ..+.|..+++.+.
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  244 (281)
T 3cc6_A          166 EDYYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLY  244 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHH
T ss_pred             ccccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            22 123345678899999999776664 89999999999999998 99999887776666665544 4556677899999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcC
Q 013421          239 SLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ++|.+||..||.+|||+.+++++
T Consensus       245 ~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          245 TLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCchhCcCHHHHHHH
Confidence            99999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.5e-46  Score=367.78  Aligned_cols=257  Identities=20%  Similarity=0.275  Sum_probs=215.7

Q ss_pred             cccCeEEeeeeeccCceEEEEEE-----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   81 (443)
                      ..++|++++.||+|+||.||+|.     +..++..||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            45789999999999999999999     55678899999997543  333456788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC---CCeEEe
Q 013421           82 TKVYIILEFVTGGELFDKIVHQG-------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVS  151 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~---~~~kL~  151 (443)
                      ...|+||||++|++|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999999998753       48899999999999999999999999999999999999944   469999


Q ss_pred             eecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cC
Q 013421          152 DFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EF  227 (443)
Q Consensus       152 DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~  227 (443)
                      |||++.......  .......||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+ ..
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  264 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence            999986433211  223345689999999999876664 89999999999999998 99999988877777666554 44


Q ss_pred             CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          228 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       228 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      ..+..+++.+.++|.+||+.||.+|||++++++|.|+-.
T Consensus       265 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          265 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            566678999999999999999999999999999998743

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.1e-46  Score=364.18  Aligned_cols=251  Identities=23%  Similarity=0.378  Sum_probs=214.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~   81 (443)
                      .++|++++.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            46899999999999999999985     4577899999997654  233456789999999999 799999999998765


Q ss_pred             C-EEEEEEecCCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC
Q 013421           82 T-KVYIILEFVTGGELFDKIVHQGR----------------LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS  144 (443)
Q Consensus        82 ~-~~~lv~Ey~~gg~L~~~i~~~~~----------------l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~  144 (443)
                      + ..|+||||+++++|.+++.....                +++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~  183 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  183 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence            4 59999999999999999987554                889999999999999999999999999999999999999


Q ss_pred             CCCeEEeeecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChH-HHHH
Q 013421          145 YGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP-TLYK  220 (443)
Q Consensus       145 ~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~  220 (443)
                      ++.+||+|||++........  ......||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.. ....
T Consensus       184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~  262 (316)
T 2xir_A          184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  262 (316)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             CCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence            99999999999976543221  23345688999999999877664 89999999999999998 99999876543 3333


Q ss_pred             Hhhh-ccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          221 KINA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       221 ~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+.. .....|..+++++.++|.+||+.||.+|||++++++|
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          263 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3333 3456677799999999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.3e-46  Score=365.59  Aligned_cols=251  Identities=22%  Similarity=0.321  Sum_probs=209.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEE----EEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ..++|++++.||+|+||.||+|.+..+++.+    |+|.+.....  ....+.+.+|+.+++.++||||+++++++.+..
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            4578999999999999999999998888765    5565543322  223567889999999999999999999998765


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                       .++++||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence             78999999999999999874 5799999999999999999999999999999999999999999999999999986544


Q ss_pred             cc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHH
Q 013421          162 GV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGA  237 (443)
Q Consensus       162 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~  237 (443)
                      ..  .......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ..+.|..+++++
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  248 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred             ccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence            22  223344578899999999887765 89999999999999999 99999998877777766554 456677799999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .++|.+||..||.+|||+.++++.
T Consensus       249 ~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          249 YMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999999873

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.2e-46  Score=361.47  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=206.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRE---TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-   82 (443)
                      ..++|++.+.||+|+||.||+|.+..   ++..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+ 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34689999999999999999998765   456899999976543 3334677899999999999999999999997655 


Q ss_pred             ----EEEEEEecCCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEee
Q 013421           83 ----KVYIILEFVTGGELFDKIVH------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (443)
Q Consensus        83 ----~~~lv~Ey~~gg~L~~~i~~------~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (443)
                          ..|+||||+++++|.+++..      ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence                35999999999999999943      35699999999999999999999999999999999999999999999999


Q ss_pred             ecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCC
Q 013421          153 FGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFS  228 (443)
Q Consensus       153 FGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~  228 (443)
                      ||++.......  .......|++.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+ ...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  269 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK  269 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC
Confidence            99987654321  122345578899999999876664 89999999999999999 99999988877777766554 455


Q ss_pred             CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .|..+++++.++|.+||..||.+|||+++++++
T Consensus       270 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          270 QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            667799999999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8e-46  Score=359.25  Aligned_cols=250  Identities=25%  Similarity=0.386  Sum_probs=208.3

Q ss_pred             ccCeEEeeeeeccCceEEEEEE----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--   81 (443)
                      ..+|++++.||+|+||.||+|+    +..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.  
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            4569999999999999999999    5678999999999765422  2346789999999999999999999999876  


Q ss_pred             CEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           82 TKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      ..+|+||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            679999999999999999954 4579999999999999999999999999999999999999999999999999997655


Q ss_pred             ccc---ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC---------------hHHHHHHh
Q 013421          161 QGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKI  222 (443)
Q Consensus       161 ~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---------------~~~~~~~i  222 (443)
                      ...   .......||+.|+|||++.+..+. .++||||+||++|+|++|..|+....               .......+
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            432   233456788899999999877665 89999999999999999999864321               11122222


Q ss_pred             h-hccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          223 N-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       223 ~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      . ......|..+++++.+||.+||+.||.+|||++++++
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            2 2345567789999999999999999999999999886

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.9e-46  Score=365.63  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=214.3

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCc-----EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGE-----SVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~   81 (443)
                      .++|++.+.||+|+||.||+|.+..+++     .||+|++....  .....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            4689999999999999999999977664     79999997654  233457799999999999 899999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC
Q 013421           82 TKVYIILEFVTGGELFDKIVHQ--------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN  147 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~--------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~  147 (443)
                      +..|+||||+++|+|.+++...              ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~  202 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV  202 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence            9999999999999999999753              35799999999999999999999999999999999999999999


Q ss_pred             eEEeeecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhh
Q 013421          148 LKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA  224 (443)
Q Consensus       148 ~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~  224 (443)
                      +||+|||++........  ......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.........+..
T Consensus       203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  281 (333)
T 2i1m_A          203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK  281 (333)
T ss_dssp             EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred             EEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence            99999999976543221  23345578899999999876664 89999999999999998 9999988665444433322


Q ss_pred             c--cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          225 A--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       225 ~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .  ....|...++++.++|.+||+.||.+|||+++++++
T Consensus       282 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          282 DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            2  344566789999999999999999999999999873

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.5e-46  Score=355.76  Aligned_cols=247  Identities=25%  Similarity=0.368  Sum_probs=212.2

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------   80 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------   80 (443)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++....       +.+.+|+.+++.++||||+++++++..      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            3468999999999999999999999999999999997643       246689999999999999999998864      


Q ss_pred             ----------CCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCe
Q 013421           81 ----------RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL  148 (443)
Q Consensus        81 ----------~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~  148 (443)
                                ....|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence                      45689999999999999999754  579999999999999999999999999999999999999999999


Q ss_pred             EEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC
Q 013421          149 KVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS  228 (443)
Q Consensus       149 kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~  228 (443)
                      ||+|||++...... .......||+.|+|||++.+..+. .++||||||+++|+|++|..||...  ......+...  .
T Consensus       162 kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~  235 (284)
T 2a19_B          162 KIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--I  235 (284)
T ss_dssp             EECCCTTCEESSCC-SCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--C
T ss_pred             EECcchhheecccc-ccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--c
Confidence            99999998765443 233456799999999999877664 8999999999999999999887532  2233333332  3


Q ss_pred             CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      .+..+++.+.++|.+||+.||.+|||+.++++|+|.-.
T Consensus       236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            45668999999999999999999999999999988643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-45  Score=363.15  Aligned_cols=252  Identities=25%  Similarity=0.343  Sum_probs=211.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCC----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETG----ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ..++|++.+.||+|+||.||+|.+..++    ..||+|++....  .......+.+|+.+++.++||||+++++++.+.+
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            3467999999999999999999886553    359999997643  2334567899999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999999999765 5799999999999999999999999999999999999999999999999999976544


Q ss_pred             ccc---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHH
Q 013421          162 GVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTG  236 (443)
Q Consensus       162 ~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~  236 (443)
                      ...   ......||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+ ..+.+..+++.
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA  278 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred             ccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHH
Confidence            211   12233467889999999876664 89999999999999998 99999988877777776554 45566778999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +.++|.+||+.||.+||++.+++++
T Consensus       279 l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          279 IYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=379.47  Aligned_cols=257  Identities=25%  Similarity=0.436  Sum_probs=211.6

Q ss_pred             CCcccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013421            1 MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (443)
Q Consensus         1 m~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   80 (443)
                      |..+...-++|++.+.||+|+||.||+|.+..+|+.||||++.......  ..+.+.+|+.+++.++||||+++++++.+
T Consensus         1 m~~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   78 (396)
T 4eut_A            1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (396)
T ss_dssp             -CEEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCCCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence            5566777789999999999999999999999999999999998654333  24667899999999999999999999987


Q ss_pred             CC--EEEEEEecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE----cCCCCeEEe
Q 013421           81 RT--KVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVS  151 (443)
Q Consensus        81 ~~--~~~lv~Ey~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl----~~~~~~kL~  151 (443)
                      .+  ..|+||||++||+|.+++....   .+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence            55  7899999999999999997643   39999999999999999999999999999999999999    777889999


Q ss_pred             eecCcCCCccccccccccCCCcccCCCccccc--------CCCCCCccchHHHHHHHHHHhhCCCCCCCCC----hHHHH
Q 013421          152 DFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--------RGYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLY  219 (443)
Q Consensus       152 DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~  219 (443)
                      |||++...... ......+||+.|+|||++.+        ..+ +.++|||||||++|+|++|..||....    ..+..
T Consensus       159 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  236 (396)
T 4eut_A          159 DFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (396)
T ss_dssp             CGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred             cCCCceEccCC-CccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence            99999765443 33456789999999999864        233 478999999999999999999996422    23333


Q ss_pred             HHhhhccCC---------------------CC----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          220 KKINAAEFS---------------------CP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       220 ~~i~~~~~~---------------------~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .++..+...                     .+    ..+++.+.++|.+||+.||++|||+++++++
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            333333211                     11    1145678899999999999999999998653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.8e-45  Score=377.98  Aligned_cols=243  Identities=25%  Similarity=0.449  Sum_probs=211.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-KVY   85 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~   85 (443)
                      ..++|++.+.||+|+||.||+|.+.  |+.||||+++...     ..+.+.+|+.+|++++||||+++++++.+.. ..|
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence            3578999999999999999999885  7899999997653     2357889999999999999999999987655 799


Q ss_pred             EEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           86 IILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +||||+++|+|.+++...+.  +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            99999999999999987654  799999999999999999999999999999999999999999999999998744322 


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (443)
                        .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+..+ ....|..+++++.+||
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  419 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM  419 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             --ccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence              2234678899999999877765 89999999999999998 99999987777777666554 5667788999999999


Q ss_pred             HHccCCCCCCCCCHHHHhc
Q 013421          242 HKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (443)
                      .+||+.||.+|||+.++++
T Consensus       420 ~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          420 KNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHH
Confidence            9999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=360.70  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=205.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA----SRTKV   84 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~~~   84 (443)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++...   .....+.+.+|+.+++.++||||+++++++.    .....
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            5799999999999999999999999999999998653   2344677899999999999999999999986    34578


Q ss_pred             EEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           85 YIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      |+||||+++|+|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            999999999999999976    4679999999999999999999999999999999999999999999999999886543


Q ss_pred             cccc---------cccccCCCcccCCCcccccCCC--CCCccchHHHHHHHHHHhhCCCCCCCCC--hHHHHHHhh-hcc
Q 013421          161 QGVE---------LLHTTCGTPNYVAPEVLSNRGY--DGSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKIN-AAE  226 (443)
Q Consensus       161 ~~~~---------~~~~~~gt~~y~aPE~l~~~~~--~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~-~~~  226 (443)
                      ....         ......||+.|+|||++.+...  .+.++|||||||++|+|++|..||....  .......+. ...
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  265 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS  265 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC
Confidence            2111         1134468999999999875442  2589999999999999999999995411  111111121 223


Q ss_pred             CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          227 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       227 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+.+..+++++.++|.+||+.||.+|||+++++++
T Consensus       266 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            34445689999999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.8e-45  Score=355.51  Aligned_cols=247  Identities=21%  Similarity=0.285  Sum_probs=207.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEE-EEeCCEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEV-LASRTKVY   85 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-~~~~~~~~   85 (443)
                      .-++|++.+.||+|+||.||+|++..+|+.||+|++......     +.+.+|+.+++.++|++++..+.. .......|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            457899999999999999999999999999999998765422     357899999999998876665554 46788899


Q ss_pred             EEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE---cCCCCeEEeeecCcCCCcc
Q 013421           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls~~~~~  161 (443)
                      +||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999999 9999999974 4579999999999999999999999999999999999999   4889999999999876544


Q ss_pred             ccc-------cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC---hHHHHHHhhhccCCCC-
Q 013421          162 GVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---LPTLYKKINAAEFSCP-  230 (443)
Q Consensus       162 ~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~-  230 (443)
                      ...       .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+   .......+.......| 
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             cccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            221       2346679999999999987766 489999999999999999999998643   2233444433333333 


Q ss_pred             ----CCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          231 ----FWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       231 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                          ..+|+++.++|.+||+.||.+|||++++++
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                568999999999999999999999999887

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.2e-45  Score=352.28  Aligned_cols=246  Identities=23%  Similarity=0.393  Sum_probs=213.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++++.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.+++.++||||+++++++.+ +..|+|
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   85 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence            468999999999999999999975 5678999999765422    3578899999999999999999999864 558999


Q ss_pred             EecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-c
Q 013421           88 LEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-E  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~  164 (443)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            99999999999997543  79999999999999999999999999999999999999999999999999987654422 2


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      ......|++.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+..+....+..+ ....+..+++++.++|.
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  244 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR  244 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHH
Confidence            23345578899999999776664 89999999999999999 99999988877777766554 34556678999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||..||.+|||++++++
T Consensus       245 ~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          245 LCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHhccChhhCCCHHHHHH
Confidence            999999999999999886

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-45  Score=352.91  Aligned_cols=248  Identities=23%  Similarity=0.350  Sum_probs=211.3

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE-E
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV-Y   85 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~-~   85 (443)
                      .|++.+.||+|+||.||+|.+..++.   .||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            57788999999999999999765554   79999987533  334567889999999999999999999999866655 9


Q ss_pred             EEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc--
Q 013421           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--  162 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--  162 (443)
                      ++|||+.+|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......  
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            99999999999999987 356899999999999999999999999999999999999999999999999999755432  


Q ss_pred             --cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHH
Q 013421          163 --VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGAT  238 (443)
Q Consensus       163 --~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  238 (443)
                        ........|++.|+|||.+.+..+. .++|||||||++|+|++ |.+||...+.......+... ....+..+++.+.
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  258 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY  258 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence              1223455688999999999876664 89999999999999999 56667766666666665544 4556677899999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhc
Q 013421          239 SLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ++|.+||+.||.+|||++++++
T Consensus       259 ~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          259 QVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999887

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.7e-46  Score=384.82  Aligned_cols=248  Identities=26%  Similarity=0.383  Sum_probs=218.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ..+|++.+.||+|+||.||+|.+..++..||||++.....    ..+.+.+|+.+|++++||||+++++++.+...+|+|
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            4579999999999999999999998899999999976542    246788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-c
Q 013421           88 LEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-E  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~  164 (443)
                      |||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  374 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT  374 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence            9999999999999864  458999999999999999999999999999999999999999999999999998654321 1


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      ......+++.|+|||++....+. .++|||||||++|+|++ |..||.+.+.......+... ....|..+++++.+||.
T Consensus       375 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  453 (495)
T 1opk_A          375 AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR  453 (495)
T ss_dssp             CCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            22344567899999999877664 89999999999999999 99999998877777766544 45667789999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||+.||.+|||+.+|++
T Consensus       454 ~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          454 ACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCcChhHCcCHHHHHH
Confidence            999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.6e-45  Score=353.41  Aligned_cols=244  Identities=25%  Similarity=0.441  Sum_probs=205.7

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-RTKV   84 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~   84 (443)
                      ...++|++.+.||+|+||.||+|.+.  |+.||+|++....     ..+.+.+|+.+++.++||||+++++++.+ .+..
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence            34678999999999999999999874  8899999997543     34678899999999999999999999754 4578


Q ss_pred             EEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           85 YIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      |+||||+++++|.+++...+.  +++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999999999987543  899999999999999999999999999999999999999999999999998754432


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL  240 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l  240 (443)
                         .....+++.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+..+ ....+..+++.+.++
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  246 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV  246 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHH
T ss_pred             ---ccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHH
Confidence               2344678999999999876664 89999999999999998 99999988877777666554 455677799999999


Q ss_pred             HHHccCCCCCCCCCHHHHhc
Q 013421          241 IHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~  260 (443)
                      |.+||+.||.+|||+.++++
T Consensus       247 i~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          247 MKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999876

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=8.2e-46  Score=357.02  Aligned_cols=251  Identities=25%  Similarity=0.413  Sum_probs=205.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC-CCc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE-TGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      .++|++++.||+|+||.||+|.+.. +++  .||+|++...........+.+.+|+.+++.++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            4589999999999999999998643 333  68999998765545556788999999999999999999999998765 8


Q ss_pred             EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      ++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  175 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  175 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence            8999999999999999764 579999999999999999999999999999999999999999999999999987654322


Q ss_pred             c---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc--cCCCCCCCCHHH
Q 013421          164 E---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA--EFSCPFWFSTGA  237 (443)
Q Consensus       164 ~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~  237 (443)
                      .   ......||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+...  ..+.+..+++++
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (291)
T 1u46_A          176 DHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI  254 (291)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred             cchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHH
Confidence            1   23345678899999999876664 89999999999999999 99999998887777776554  344556789999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .++|.+||..||.+|||+.++++
T Consensus       255 ~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          255 YNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999997

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.9e-45  Score=354.93  Aligned_cols=234  Identities=31%  Similarity=0.575  Sum_probs=196.0

Q ss_pred             ccccccCeEEe-eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHH-HhCCCCCcceEEEEEEe-
Q 013421            4 QTRRVAKYEVG-RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVRLHEVLAS-   80 (443)
Q Consensus         4 ~~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~-   80 (443)
                      .+..+++|.+. +.||+|+||.||+|.+..+++.||+|++...        ....+|+.++ +.++||||+++++++.+ 
T Consensus        12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            45678899998 7899999999999999999999999998642        3456888887 66699999999999987 


Q ss_pred             ---CCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC---CCCeEEee
Q 013421           81 ---RTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSD  152 (443)
Q Consensus        81 ---~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~---~~~~kL~D  152 (443)
                         ....|+||||++||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               778999999999999999998764  6999999999999999999999999999999999999998   78999999


Q ss_pred             ecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHH----HhhhccCC
Q 013421          153 FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK----KINAAEFS  228 (443)
Q Consensus       153 FGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~----~i~~~~~~  228 (443)
                      ||++.....                      ..+ +.++||||+||++|+|++|..||...+......    .+......
T Consensus       164 fg~a~~~~~----------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  220 (299)
T 3m2w_A          164 FGFAKETTG----------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  220 (299)
T ss_dssp             CTTCEECTT----------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred             ccccccccc----------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence            998753321                      223 478999999999999999999997765433321    22233333


Q ss_pred             CC----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          229 CP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       229 ~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .|    ..+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            33    45899999999999999999999999999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.7e-45  Score=361.86  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=211.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEE----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA--SR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~   81 (443)
                      ..+|++++.||+|+||.||+|+    +..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.  +.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            4589999999999999999999    56789999999997643   334577899999999999999999999886  56


Q ss_pred             CEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           82 TKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      ...|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            779999999999999999987 3569999999999999999999999999999999999999999999999999997654


Q ss_pred             cccc---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH---------------HHHHHh
Q 013421          161 QGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---------------TLYKKI  222 (443)
Q Consensus       161 ~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------------~~~~~i  222 (443)
                      ....   ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......               .....+
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            3221   2334568889999999987666 48999999999999999999998654321               122222


Q ss_pred             h-hccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          223 N-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       223 ~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      . ....+.+..+++++.+||.+||+.||.+|||+++++++
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2 22455677799999999999999999999999999764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.2e-45  Score=377.76  Aligned_cols=246  Identities=22%  Similarity=0.422  Sum_probs=214.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|+||+||+|.+. ++..||||++.....    ..+.+.+|+.+|+.++||||+++++++. .+..|+|
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            457999999999999999999986 467899999976542    2467899999999999999999999986 5678999


Q ss_pred             EecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-c
Q 013421           88 LEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-E  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~  164 (443)
                      |||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~  340 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  340 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence            9999999999999754  368999999999999999999999999999999999999999999999999998654321 1


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      ......+++.|+|||++....+. .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++++.+||.
T Consensus       341 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  419 (454)
T 1qcf_A          341 AREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM  419 (454)
T ss_dssp             TTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             ccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            22344567889999999876664 89999999999999999 99999998887777776554 45667789999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||+.||.+|||+++|+.
T Consensus       420 ~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          420 RCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHccCChhHCcCHHHHHH
Confidence            999999999999999876

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4e-45  Score=353.85  Aligned_cols=251  Identities=24%  Similarity=0.292  Sum_probs=209.7

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVL-ASRT   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~   82 (443)
                      ...+|++.+.||+|+||.||+|.+..++   ..+|+|.+....  .....+.+.+|+.++++++||||+++++++ ..++
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            4457999999999999999999976433   368999887533  344567899999999999999999999985 5567


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..|++|||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            889999999999999999764 4689999999999999999999999999999999999999999999999999976543


Q ss_pred             cc----ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CCCCCCCCH
Q 013421          162 GV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFST  235 (443)
Q Consensus       162 ~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~  235 (443)
                      ..    .......||+.|+|||++.+..+. .++||||||+++|+|++ |.+||...+.......+.... ...|..+++
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD  259 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCH
Confidence            21    123445678899999999877664 89999999999999999 778888777666655554443 445667899


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          236 GATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .+.++|.+||+.||.+|||++++++
T Consensus       260 ~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          260 PLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999887

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.8e-45  Score=353.98  Aligned_cols=249  Identities=22%  Similarity=0.394  Sum_probs=197.3

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..-++|++.+.||+|+||.||+|.+.   ..||+|++..... .....+.+.+|+.+++.++||||++++++. .....+
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            34568999999999999999999864   3599999976543 344567899999999999999999999965 556789


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc--c
Q 013421           86 IILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--G  162 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~--~  162 (443)
                      +||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....  .
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            999999999999999643 5789999999999999999999999999999999999999999999999999875543  2


Q ss_pred             cccccccCCCcccCCCcccc---cCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhhhccCC-----CCCCC
Q 013421          163 VELLHTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFS-----CPFWF  233 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~-----~~~~~  233 (443)
                      .......+||+.|+|||++.   +..+ +.++|||||||++|+|++|..||...+.. .....+......     .+..+
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC  254 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred             cccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence            22344567999999999986   3333 47999999999999999999999875544 334444433322     22357


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ++++.+||.+||+.||.+|||++++++
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            899999999999999999999999886

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.7e-45  Score=354.04  Aligned_cols=247  Identities=21%  Similarity=0.286  Sum_probs=203.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEE-EEeCCEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEV-LASRTKVY   85 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-~~~~~~~~   85 (443)
                      .-++|++.+.||+|+||.||+|++..+++.||+|++.....     ...+.+|+.+++.++|++++..+.. +.+.+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence            34689999999999999999999999999999998765432     2347789999999988776666554 47888999


Q ss_pred             EEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE---cCCCCeEEeeecCcCCCcc
Q 013421           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls~~~~~  161 (443)
                      ++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999999 9999999985 4679999999999999999999999999999999999999   7889999999999976544


Q ss_pred             ccc-------cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh---HHHHHHhhhccCCCC-
Q 013421          162 GVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---PTLYKKINAAEFSCP-  230 (443)
Q Consensus       162 ~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~~-  230 (443)
                      ...       .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.   ......+.......| 
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            211       2345679999999999987776 4899999999999999999999976432   233333333333333 


Q ss_pred             ----CCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          231 ----FWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       231 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                          ..+|+++.+||.+||+.||.+|||++++++
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                557999999999999999999999999887

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=365.75  Aligned_cols=250  Identities=16%  Similarity=0.157  Sum_probs=200.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECC---CCcEEEEEEeecccccchHH--------HHHHHHHHHHHHhCCCCCcceEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRE---TGESVAMKVLAKSTILKHRM--------VDQIKREISIMKIVRHPNIVRLHEV   77 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~HpnIv~l~~~   77 (443)
                      ++|++++.||+|+||.||+|.+..   ++..+|+|++..........        ...+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            579999999999999999999987   78899999998653211111        1236678899999999999999999


Q ss_pred             EEe----CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC--CeEEe
Q 013421           78 LAS----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG--NLKVS  151 (443)
Q Consensus        78 ~~~----~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~--~~kL~  151 (443)
                      +.+    ....|+||||+ |++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~  195 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA  195 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence            987    78899999999 999999998878999999999999999999999999999999999999999877  99999


Q ss_pred             eecCcCCCcccc-------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC--ChHHHHHHh
Q 013421          152 DFGLSALPQQGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET--DLPTLYKKI  222 (443)
Q Consensus       152 DFGls~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~--~~~~~~~~i  222 (443)
                      |||++.......       ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...  +........
T Consensus       196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  274 (345)
T 2v62_A          196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK  274 (345)
T ss_dssp             CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred             eCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence            999997553321       12245689999999999987666 48999999999999999999999652  222222211


Q ss_pred             hhccCCCC---------CCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          223 NAAEFSCP---------FWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       223 ~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .......|         ..+++++.++|.+||..||.+|||+++|++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          275 TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            11111122         268899999999999999999999999887

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-45  Score=361.43  Aligned_cols=247  Identities=21%  Similarity=0.228  Sum_probs=199.5

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----   82 (443)
                      ..++|++++.||+|+||+||+|++.  ++.||||++....    .......+|+.+++.++||||+++++++.+..    
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            3468999999999999999999875  7999999996543    22345667999999999999999999997643    


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCEeecCCCCcEEEcCCCCeEEee
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK----------GVYHRDLKPENLLLDSYGNLKVSD  152 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~----------gi~HrDlkp~NILl~~~~~~kL~D  152 (443)
                      .+|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.          ||+||||||+|||++.++.+||+|
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             eEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            47999999999999999976 5699999999999999999999999          999999999999999999999999


Q ss_pred             ecCcCCCcccc--ccccccCCCcccCCCcccccCCC----CCCccchHHHHHHHHHHhhCCCCCCCCCh-----------
Q 013421          153 FGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGY----DGSAADVWSCGVILFVLMAGYLPFGETDL-----------  215 (443)
Q Consensus       153 FGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~----~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-----------  215 (443)
                      ||++.......  ......+||+.|+|||++.+...    .+.++|||||||++|+|++|..||.+...           
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            99997554322  22345689999999999876322    23578999999999999999999976421           


Q ss_pred             -----HHHHHHhhhccC--CCCCC-----CCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          216 -----PTLYKKINAAEF--SCPFW-----FSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       216 -----~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                           ......+.....  ..+..     .++++.+||.+||+.||.+|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                 122222211111  11111     2345999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.9e-46  Score=366.30  Aligned_cols=253  Identities=21%  Similarity=0.280  Sum_probs=208.5

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            34578999999999999999999974 68999999987643   224577899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           86 IILEFVTGGELFDKIVHQG----RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      +||||+++|+|.+++....    .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999999986543    589999999999999999999999999999999999999999999999999875432


Q ss_pred             c--cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHH---H----HHhhhccC-----
Q 013421          162 G--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL---Y----KKINAAEF-----  227 (443)
Q Consensus       162 ~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~---~----~~i~~~~~-----  227 (443)
                      .  .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||........   .    ........     
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD  270 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence            1  1223455689999999999876664 899999999999999999999976432211   1    11111111     


Q ss_pred             -----CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcc
Q 013421          228 -----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  263 (443)
Q Consensus       228 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~  263 (443)
                           ..+...+..+.+++.+||+.||.+|||+.++++|..
T Consensus       271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence                 111224567889999999999999999999998643

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=373.91  Aligned_cols=249  Identities=25%  Similarity=0.403  Sum_probs=197.0

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      +|++.+.||+|+||+|+.. ...+|+.||||++......      .+.+|+.+++.+ +||||+++++++.+....|+||
T Consensus        25 ~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            4999999999999997643 3467899999999765432      245799999999 7999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC---C--CCeEEeeecCcCCCccc
Q 013421           89 EFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---Y--GNLKVSDFGLSALPQQG  162 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~---~--~~~kL~DFGls~~~~~~  162 (443)
                      |||. |+|.+++.... ..++..+..++.||+.||.|||++||+||||||+|||++.   +  ..+||+|||++......
T Consensus        98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            9996 59999997654 4666678899999999999999999999999999999953   2  35889999999765432


Q ss_pred             c---ccccccCCCcccCCCcccccC--CCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhccCCC---CCCC
Q 013421          163 V---ELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSC---PFWF  233 (443)
Q Consensus       163 ~---~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~  233 (443)
                      .   ......+||+.|+|||++.+.  ...+.++|||||||++|+|++ |..||...........+.......   +...
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE  256 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence            1   234567899999999999742  223478999999999999999 999997665544433332222211   1224


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      +..+.+||.+||+.||.+|||++++++||||..
T Consensus       257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            667899999999999999999999999999964

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.4e-45  Score=366.45  Aligned_cols=250  Identities=14%  Similarity=0.170  Sum_probs=199.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCC-----CcEEEEEEeecccccchHHH--------HHHHHHHHHHHhCCCCCcceEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMV--------DQIKREISIMKIVRHPNIVRLH   75 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~--------~~~~~Ei~il~~l~HpnIv~l~   75 (443)
                      ++|++++.||+|+||.||+|.+..+     ++.||+|++...........        ..+.+|+..++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            3899999999999999999998765     58899999876542111111        1234566677888999999999


Q ss_pred             EEEEeC----CEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc--CCCCe
Q 013421           76 EVLASR----TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD--SYGNL  148 (443)
Q Consensus        76 ~~~~~~----~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~--~~~~~  148 (443)
                      +++...    ...|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++  .++.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~  193 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV  193 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence            998764    5689999999 99999999876 6799999999999999999999999999999999999999  88999


Q ss_pred             EEeeecCcCCCcccc-------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHH
Q 013421          149 KVSDFGLSALPQQGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  221 (443)
Q Consensus       149 kL~DFGls~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  221 (443)
                      ||+|||++.......       ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            999999997654321       11234569999999999987776 4999999999999999999999986332221111


Q ss_pred             -hhh---cc-------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          222 -INA---AE-------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       222 -i~~---~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                       ...   ..       .-.+..+++++.+++.+||..||.+||++++|++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          273 DSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence             100   00       0012457999999999999999999999999887

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.9e-45  Score=372.51  Aligned_cols=247  Identities=28%  Similarity=0.406  Sum_probs=192.7

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      .|.+.+.||+|+||+||.+. ..+|+.||||++....      .+.+.+|+.+++.+ +||||+++++++.+.+..|+||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            45667889999999998764 4579999999986542      34567899999876 8999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC-------------CCe
Q 013421           89 EFVTGGELFDKIVHQGRLL-------ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-------------GNL  148 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~-------e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~-------------~~~  148 (443)
                      |||+ |+|.+++.......       +..++.++.||+.||+|||++||+||||||+|||++.+             +.+
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            9995 69999998754332       23457899999999999999999999999999999754             489


Q ss_pred             EEeeecCcCCCccccc----cccccCCCcccCCCccccc------CCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHH
Q 013421          149 KVSDFGLSALPQQGVE----LLHTTCGTPNYVAPEVLSN------RGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  217 (443)
Q Consensus       149 kL~DFGls~~~~~~~~----~~~~~~gt~~y~aPE~l~~------~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  217 (443)
                      ||+|||++........    .....+||+.|+|||++.+      ....+.++|||||||++|+|++ |..||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            9999999986654321    2345689999999999865      1334589999999999999999 999997654433


Q ss_pred             HHHHhhhccCCCCC-------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          218 LYKKINAAEFSCPF-------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       218 ~~~~i~~~~~~~~~-------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                        ..+..+....+.       .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       248 --~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          248 --SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             --HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             --HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence              223333322221       24578999999999999999999999999999964

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.5e-45  Score=374.07  Aligned_cols=246  Identities=23%  Similarity=0.365  Sum_probs=209.1

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|+||.||+|.+.. +..||||++......    .+.+.+|+.+|+.++||||+++++++.+ +..|+|
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            4579999999999999999999864 467999999765422    3568899999999999999999999876 678999


Q ss_pred             EecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-c
Q 013421           88 LEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-E  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~  164 (443)
                      |||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  336 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  336 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence            9999999999999753  569999999999999999999999999999999999999999999999999998654321 1


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      ......+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++.+.+||.
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  415 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC  415 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             cccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            22344577899999999876664 89999999999999999 99999988877777776554 45667789999999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 013421          243 KILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (443)
                      +||+.||.+|||+++|++
T Consensus       416 ~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          416 QCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHccCChhhCcCHHHHHH
Confidence            999999999999999887

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-44  Score=350.26  Aligned_cols=247  Identities=24%  Similarity=0.383  Sum_probs=197.2

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCCcceEEEEEEe--
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI--VRHPNIVRLHEVLAS--   80 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~--   80 (443)
                      ....++|++++.||+|+||+||+|.+  +++.||||++....      ...+.+|.+++..  ++||||+++++++.+  
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            34567899999999999999999987  68999999986532      2445567777666  799999999998643  


Q ss_pred             --CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCEeecCCCCcEEEcCCCCeEE
Q 013421           81 --RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH--------SKGVYHRDLKPENLLLDSYGNLKV  150 (443)
Q Consensus        81 --~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH--------~~gi~HrDlkp~NILl~~~~~~kL  150 (443)
                        ....|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||        ++||+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence              3568999999999999999954 67999999999999999999999        999999999999999999999999


Q ss_pred             eeecCcCCCccccc----cccccCCCcccCCCcccccCCCC-----CCccchHHHHHHHHHHhhC----------CCCCC
Q 013421          151 SDFGLSALPQQGVE----LLHTTCGTPNYVAPEVLSNRGYD-----GSAADVWSCGVILFVLMAG----------YLPFG  211 (443)
Q Consensus       151 ~DFGls~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~-----~~~~DIwSlGvil~~ll~G----------~~Pf~  211 (443)
                      +|||++........    .....+||+.|+|||++.+....     +.++|||||||++|+|++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            99999865433211    12345899999999999765322     2589999999999999999          88885


Q ss_pred             CCC-----hHHHHHHhhh--ccCCCCC-----CCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          212 ETD-----LPTLYKKINA--AEFSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       212 ~~~-----~~~~~~~i~~--~~~~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ...     ..........  .....|.     ..++++.+||.+||+.||.+|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            532     1222222211  1222222     14577999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=355.99  Aligned_cols=248  Identities=29%  Similarity=0.420  Sum_probs=188.5

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEE--------
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLA--------   79 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~--------   79 (443)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.+. ||||+++++++.        
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            37999999999999999999999999999999986542   334567899999999995 999999999983        


Q ss_pred             eCCEEEEEEecCCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--CEeecCCCCcEEEcCCCCeEEeeec
Q 013421           80 SRTKVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFG  154 (443)
Q Consensus        80 ~~~~~~lv~Ey~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~aL~yLH~~g--i~HrDlkp~NILl~~~~~~kL~DFG  154 (443)
                      ....++++|||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence            4456899999995 689888865   467999999999999999999999999  9999999999999999999999999


Q ss_pred             CcCCCccccc------------cccccCCCcccCCCcccc---cCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHH
Q 013421          155 LSALPQQGVE------------LLHTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  219 (443)
Q Consensus       155 ls~~~~~~~~------------~~~~~~gt~~y~aPE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  219 (443)
                      ++........            .....+||+.|+|||++.   +..+ +.++|||||||++|+|++|..||.........
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~  262 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRIV  262 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence            9976543211            112556999999999983   3333 58999999999999999999999765543322


Q ss_pred             HHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcc
Q 013421          220 KKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  263 (443)
Q Consensus       220 ~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~  263 (443)
                      ..  ....+.+...++.+.+||.+||+.||.+|||++++++|-+
T Consensus       263 ~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          263 NG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             cC--cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            21  1123344557889999999999999999999999999854

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.3e-45  Score=355.82  Aligned_cols=249  Identities=25%  Similarity=0.354  Sum_probs=207.4

Q ss_pred             ccCe-EEeeeeeccCceEEEEEEE----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 013421            8 VAKY-EVGRTIGEGTFAKVRFAQN----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--   80 (443)
Q Consensus         8 ~~~y-~i~~~LG~G~~g~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--   80 (443)
                      -++| ++++.||+|+||+||++..    ..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+  
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            3455 9999999999999988753    4578999999998653  33456789999999999999999999999987  


Q ss_pred             CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      ...+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             CceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            4689999999999999999876 459999999999999999999999999999999999999999999999999997664


Q ss_pred             ccc---ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH---------------HHHHHh
Q 013421          161 QGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---------------TLYKKI  222 (443)
Q Consensus       161 ~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------------~~~~~i  222 (443)
                      ...   .......||+.|+|||++.+..+. .++|||||||++|+|++|..||......               .....+
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            432   223455688899999999877665 8999999999999999999999754321               111122


Q ss_pred             h-hccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          223 N-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       223 ~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      . ......+..+++++.+||.+||+.||.+|||++++++
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2 2244566779999999999999999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=352.17  Aligned_cols=242  Identities=29%  Similarity=0.441  Sum_probs=199.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|++.+.||+|+||.||+|.+.  ++.||+|++....     ..+.+.+|+.++++++||||+++++++.+  ..|+
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l   76 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL   76 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence            4578999999999999999999874  7889999986432     35678899999999999999999998764  4789


Q ss_pred             EEecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCCEeecCCCCcEEEcCCCC-eEEeeecCcCCC
Q 013421           87 ILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHS---KGVYHRDLKPENLLLDSYGN-LKVSDFGLSALP  159 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~yLH~---~gi~HrDlkp~NILl~~~~~-~kL~DFGls~~~  159 (443)
                      ||||++||+|.+++....   .+++..+..++.|++.||.|||+   +||+||||||+|||++.++. +||+|||++...
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            999999999999998755   36889999999999999999999   89999999999999998887 799999998754


Q ss_pred             ccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH--HHHHHh-hhccCCCCCCCCHH
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP--TLYKKI-NAAEFSCPFWFSTG  236 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--~~~~~i-~~~~~~~~~~~s~~  236 (443)
                      ...   .....||+.|+|||++.+..+. .++|||||||++|+|++|..||......  .....+ .......+..+++.
T Consensus       157 ~~~---~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (307)
T 2eva_A          157 QTH---MTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP  232 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHH
T ss_pred             ccc---cccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHH
Confidence            332   2345699999999999876664 8999999999999999999999864332  222222 22344555678999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +.++|.+||+.||.+|||+++++++
T Consensus       233 l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          233 IESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999999883

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=361.40  Aligned_cols=242  Identities=14%  Similarity=0.164  Sum_probs=202.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCC--------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcce-------
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRET--------GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR-------   73 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~-------   73 (443)
                      ++|++.+.||+|+||.||+|++..+        ++.||+|++...        +.+.+|+.+++.++||||++       
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            6899999999999999999999874        889999998754        35678999999999999887       


Q ss_pred             --------EEEEEEe-CCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE
Q 013421           74 --------LHEVLAS-RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL  142 (443)
Q Consensus        74 --------l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl  142 (443)
                              +++++.. ....|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence                    6777765 78899999999 99999999876  789999999999999999999999999999999999999


Q ss_pred             cCCC--CeEEeeecCcCCCccccc-------cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC
Q 013421          143 DSYG--NLKVSDFGLSALPQQGVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET  213 (443)
Q Consensus       143 ~~~~--~~kL~DFGls~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  213 (443)
                      +.++  .+||+|||++........       .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCcccC
Confidence            9988  999999999976543211       2234579999999999987666 48999999999999999999999875


Q ss_pred             C--hHHHHHHh---hhccCCCC------CCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          214 D--LPTLYKKI---NAAEFSCP------FWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       214 ~--~~~~~~~i---~~~~~~~~------~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .  ........   .......+      ..+++++.+||.+||+.||.+|||++++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            3  22222222   22222111      146999999999999999999999999887

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.9e-45  Score=359.63  Aligned_cols=253  Identities=22%  Similarity=0.272  Sum_probs=205.1

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++........  ...+.+|+.+++.++||||+++++++.+.+..++
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred             HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence            3468999999999999999999854 689999999976543221  2368899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           87 ILEFVTGGELFDKIVHQG----RLLENDCRRYFQQLIDAVAHCHSK---GVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~aL~yLH~~---gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      ||||+++|+|.+++....    .+++..++.++.|++.||.|||++   ||+||||||+|||++.++.+||+|||++...
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM  184 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence            999999999999997643    489999999999999999999999   9999999999999999999999999999765


Q ss_pred             ccc-cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCC-----ChHHHHHHhh---hc-cC--
Q 013421          160 QQG-VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET-----DLPTLYKKIN---AA-EF--  227 (443)
Q Consensus       160 ~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~---~~-~~--  227 (443)
                      ... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...     ........+.   .. ..  
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (326)
T 3uim_A          185 DYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA  263 (326)
T ss_dssp             CSSSSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred             CcccccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence            432 233445669999999999977666 48999999999999999999999521     1111111110   00 00  


Q ss_pred             --------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcc
Q 013421          228 --------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  263 (443)
Q Consensus       228 --------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~  263 (443)
                              ..+...++.+.+++.+||+.||.+|||+.++++|-+
T Consensus       264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                    111113467899999999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-45  Score=365.27  Aligned_cols=250  Identities=24%  Similarity=0.298  Sum_probs=202.5

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA-SRTKV   84 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~   84 (443)
                      ..|++.+.||+|+||.||+|.+..++   ..||+|.+....  .....+.+.+|+.+++.++||||+++++++. .++..
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            35889999999999999999875432   468999986533  3345678999999999999999999999864 45688


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            99999999999999997654 58899999999999999999999999999999999999999999999999997553321


Q ss_pred             ----ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHH
Q 013421          164 ----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGA  237 (443)
Q Consensus       164 ----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~  237 (443)
                          .......|++.|+|||++.+..+. .++|||||||++|+|++ |.+||...+..+....+..+ ....|..+++.+
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l  325 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL  325 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence                112344578899999999877664 89999999999999999 78899887666555555444 345567799999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .++|.+||+.||.+|||+++++++
T Consensus       326 ~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          326 YEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=361.56  Aligned_cols=242  Identities=15%  Similarity=0.216  Sum_probs=198.8

Q ss_pred             cCeEEeeeeeccCceEEEEE-----EECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceEEEEEEe
Q 013421            9 AKYEVGRTIGEGTFAKVRFA-----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR---HPNIVRLHEVLAS   80 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a-----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~   80 (443)
                      ++|++.+.||+|+||.||+|     .+..+++.||+|++....      ...+.+|+.+++.++   |+||+++++++..
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            56999999999999999999     467789999999997542      345778888888887   9999999999999


Q ss_pred             CCEEEEEEecCCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-----------
Q 013421           81 RTKVYIILEFVTGGELFDKIVH-----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-----------  144 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~-----~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-----------  144 (443)
                      .+..|+||||++||+|.+++..     ...+++..++.++.||+.||+|||++||+||||||+|||++.           
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence            9999999999999999999974     457999999999999999999999999999999999999998           


Q ss_pred             CCCeEEeeecCcCCCcc--ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHh
Q 013421          145 YGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  222 (443)
Q Consensus       145 ~~~~kL~DFGls~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  222 (443)
                      ++.+||+|||++.....  ........+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.......    .
T Consensus       219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~----~  293 (365)
T 3e7e_A          219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGE----C  293 (365)
T ss_dssp             CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTE----E
T ss_pred             cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCc----e
Confidence            89999999999965432  22345677899999999999887765 99999999999999999999996432210    0


Q ss_pred             hhccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       223 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .....-...+.++...+++.+||+.+|.+|++..+.+.+
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          294 KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            000111122457788999999999999999765554443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-44  Score=352.67  Aligned_cols=246  Identities=25%  Similarity=0.388  Sum_probs=196.2

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCCcceEEEEEEeC---
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI--VRHPNIVRLHEVLASR---   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~---   81 (443)
                      ..++|++++.||+|+||.||+|.+.  ++.||+|++....      .....+|.+++..  ++||||+++++++...   
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            4568999999999999999999885  8999999986432      2334455555554  4999999999999877   


Q ss_pred             -CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCEeecCCCCcEEEcCCCCeEEee
Q 013421           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK--------GVYHRDLKPENLLLDSYGNLKVSD  152 (443)
Q Consensus        82 -~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~--------gi~HrDlkp~NILl~~~~~~kL~D  152 (443)
                       ...|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++        ||+||||||+|||++.++.+||+|
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence             789999999999999999976 5799999999999999999999999        999999999999999999999999


Q ss_pred             ecCcCCCccccc----cccccCCCcccCCCcccccCCCCCC-----ccchHHHHHHHHHHhhC----------CCCCCCC
Q 013421          153 FGLSALPQQGVE----LLHTTCGTPNYVAPEVLSNRGYDGS-----AADVWSCGVILFVLMAG----------YLPFGET  213 (443)
Q Consensus       153 FGls~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~-----~~DIwSlGvil~~ll~G----------~~Pf~~~  213 (443)
                      ||++........    .....+||+.|+|||++.+..+...     ++|||||||++|+|++|          ..||...
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            999865543221    1235689999999999977655422     38999999999999999          7777542


Q ss_pred             C-----hHHHHHHhhh--ccCCCCC-----CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          214 D-----LPTLYKKINA--AEFSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       214 ~-----~~~~~~~i~~--~~~~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .     .......+..  .....|.     .+++++.+||.+||+.||.+|||+.++++|
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            2     1222222211  1222332     245679999999999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.5e-44  Score=383.01  Aligned_cols=243  Identities=20%  Similarity=0.336  Sum_probs=208.3

Q ss_pred             eeeeccCceEEEEEEE--CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCC
Q 013421           15 RTIGEGTFAKVRFAQN--RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~   92 (443)
                      +.||+|+||.||+|.+  ..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.+ +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            4799999999999954  45678999999976543 23345789999999999999999999999975 45889999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc---cccccc
Q 013421           93 GGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV---ELLHTT  169 (443)
Q Consensus        93 gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~---~~~~~~  169 (443)
                      +|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......   ......
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  532 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  532 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence            99999999988899999999999999999999999999999999999999999999999999987654322   122344


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHHccCC
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDP  247 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~  247 (443)
                      .||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++++.+||.+||+.
T Consensus       533 ~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~  611 (635)
T 4fl3_A          533 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY  611 (635)
T ss_dssp             --CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            578899999999877765 89999999999999998 99999998888877777655 4567778999999999999999


Q ss_pred             CCCCCCCHHHHhc
Q 013421          248 NPKTRIRIEGIRK  260 (443)
Q Consensus       248 dP~~R~t~~eil~  260 (443)
                      ||.+|||+++|++
T Consensus       612 dP~~RPs~~~l~~  624 (635)
T 4fl3_A          612 DVENRPGFAAVEL  624 (635)
T ss_dssp             STTTSCCHHHHHH
T ss_pred             CHhHCcCHHHHHH
Confidence            9999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.8e-45  Score=390.28  Aligned_cols=259  Identities=27%  Similarity=0.400  Sum_probs=208.5

Q ss_pred             ccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 013421            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS---   80 (443)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---   80 (443)
                      .+..+++|++.+.||+|+||.||+|.+..+|+.||||++....  .....+.+.+|+.+++.++||||+++++++..   
T Consensus         9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A            9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            3456799999999999999999999999999999999987643  33456779999999999999999999999765   


Q ss_pred             ---CCEEEEEEecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC---eEEe
Q 013421           81 ---RTKVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVS  151 (443)
Q Consensus        81 ---~~~~~lv~Ey~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~---~kL~  151 (443)
                         .+..|+||||++||+|.+++....   .+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence               677899999999999999998754   6899999999999999999999999999999999999997765   9999


Q ss_pred             eecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHH---------Hh
Q 013421          152 DFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK---------KI  222 (443)
Q Consensus       152 DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~---------~i  222 (443)
                      |||++...... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||........+.         .+
T Consensus       167 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          167 DLGYAKELDQG-ELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI  244 (676)
T ss_dssp             SCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred             ccccccccccc-cccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence            99999876543 334567899999999999877764 89999999999999999999997643322110         00


Q ss_pred             -----hhccC------CCC----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          223 -----NAAEF------SCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       223 -----~~~~~------~~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                           ..+..      +.|    ..+++.+.+||.+||..||.+|||++++++||||+.
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence                 01111      111    125688999999999999999999999999999964

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.3e-44  Score=349.96  Aligned_cols=247  Identities=24%  Similarity=0.348  Sum_probs=202.9

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      |..++.||+|+||.||+|.+  +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..|++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44558999999999999986  588999999976432 233456789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc--c
Q 013421           90 FVTGGELFDKIVH---QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--E  164 (443)
Q Consensus        90 y~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--~  164 (443)
                      |+++++|.+++..   ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  .
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            9999999999974   3468999999999999999999999999999999999999999999999999987554321  2


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHH----HHHHhhhccC-----------CC
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT----LYKKINAAEF-----------SC  229 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~-----------~~  229 (443)
                      .....+||+.|+|||++.+. + +.++||||||+++|+|++|..||.......    ....+.....           ..
T Consensus       191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA  268 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred             cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence            23456799999999998653 4 589999999999999999999998754322    2222211111           11


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       230 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +...+..+.+++.+||+.||.+|||+.+++++
T Consensus       269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            22245678999999999999999999999874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4e-44  Score=375.67  Aligned_cols=247  Identities=23%  Similarity=0.363  Sum_probs=214.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++.+.||+|+||.||+|.+.. +..||||++......    .+.+.+|+.+|+.++||||+++++++.+ +..|+|
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            4579999999999999999999864 467999999765422    3568899999999999999999999876 678999


Q ss_pred             EecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-c
Q 013421           88 LEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-E  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~  164 (443)
                      |||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  419 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  419 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence            9999999999999753  569999999999999999999999999999999999999999999999999998664321 1


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      ......++..|+|||++....+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++++.+||.
T Consensus       420 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  498 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC  498 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            22344577899999999876664 89999999999999999 99999998887777776554 45667789999999999


Q ss_pred             HccCCCCCCCCCHHHHhcC
Q 013421          243 KILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~h  261 (443)
                      +||+.||.+|||+++|++.
T Consensus       499 ~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          499 QCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHHH
Confidence            9999999999999998873

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.3e-44  Score=378.88  Aligned_cols=248  Identities=25%  Similarity=0.354  Sum_probs=208.6

Q ss_pred             cCeEEee-eeeccCceEEEEEEECC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            9 AKYEVGR-TIGEGTFAKVRFAQNRE--TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         9 ~~y~i~~-~LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      +++.+.+ .||+|+||.||+|.+..  ++..||||++.....  ....+.+.+|+.+|+.++||||+++++++.+ +.+|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            3456666 89999999999998753  566799999976532  2235789999999999999999999999976 5699


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           86 IILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      +||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus       412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            999999999999999754 4699999999999999999999999999999999999999999999999999986643221


Q ss_pred             ---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHH
Q 013421          165 ---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATS  239 (443)
Q Consensus       165 ---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~  239 (443)
                         ......+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++++.+
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  570 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA  570 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence               12233456899999999877765 89999999999999998 99999998888877777655 45677789999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhc
Q 013421          240 LIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~  260 (443)
                      ||.+||+.||.+|||++++++
T Consensus       571 li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          571 LMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-44  Score=351.18  Aligned_cols=250  Identities=25%  Similarity=0.379  Sum_probs=208.8

Q ss_pred             cccCeEEeeeeeccCceEEEEEE----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ..++|++++.||+|+||.||+|.    +..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            45679999999999999999998    46689999999997642   334678999999999999999999999986543


Q ss_pred             --EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           83 --KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        83 --~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                        ..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence              789999999999999999876 46999999999999999999999999999999999999999999999999999765


Q ss_pred             ccccc---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH----------------HHHH
Q 013421          160 QQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP----------------TLYK  220 (443)
Q Consensus       160 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----------------~~~~  220 (443)
                      .....   ......|++.|+|||++.+..+. .++|||||||++|+|++|..||......                ....
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            44322   12344578889999999876664 8999999999999999999998643110                1112


Q ss_pred             Hhh-hccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          221 KIN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       221 ~i~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .+. ....+.|..+++++.++|.+||+.||.+|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            222 2245567779999999999999999999999999886

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-43  Score=378.47  Aligned_cols=249  Identities=29%  Similarity=0.399  Sum_probs=212.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      .++|++++.||+|+||.||+|.+..+   +..||+|.+....  .....+.+.+|+.+++.++||||+++++++. ++..
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            46799999999999999999998654   4579999886543  3345578999999999999999999999985 4568


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~  545 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  545 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence            99999999999999998654 68999999999999999999999999999999999999999999999999998664422


Q ss_pred             -ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHH
Q 013421          164 -ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL  240 (443)
Q Consensus       164 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l  240 (443)
                       .......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++.+.+|
T Consensus       546 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  624 (656)
T 2j0j_A          546 YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL  624 (656)
T ss_dssp             --------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred             ceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHH
Confidence             122345578899999999877664 89999999999999997 99999998887777776554 456778899999999


Q ss_pred             HHHccCCCCCCCCCHHHHhc
Q 013421          241 IHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~  260 (443)
                      |.+||+.||.+|||+.++++
T Consensus       625 i~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          625 MTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999886

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=352.31  Aligned_cols=250  Identities=21%  Similarity=0.319  Sum_probs=208.2

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ...++|++.+.||+|+||.||+|.+..   .+|+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA  105 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence            346789999999999999999999853   49999997654222 12345778999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc---
Q 013421           86 IILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ---  161 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~---  161 (443)
                      ++|||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.....   
T Consensus       106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            9999999999999997754 689999999999999999999999999999999999998 68999999999875432   


Q ss_pred             --ccccccccCCCcccCCCcccccC--------CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCC--
Q 013421          162 --GVELLHTTCGTPNYVAPEVLSNR--------GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC--  229 (443)
Q Consensus       162 --~~~~~~~~~gt~~y~aPE~l~~~--------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--  229 (443)
                        .........||+.|+|||++.+.        ...+.++|||||||++|+|++|..||...+.......+..+..+.  
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS  264 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC
Confidence              11233455699999999998642        223579999999999999999999999888777776665554332  


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       230 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +..+++++.++|.+||..||.+|||++++++
T Consensus       265 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          265 QIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            2347899999999999999999999999987

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.4e-44  Score=350.86  Aligned_cols=256  Identities=20%  Similarity=0.249  Sum_probs=193.6

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA-----   79 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----   79 (443)
                      ...+++|++++.||+|+||.||+|.+  +++.||||++.....    .......|+..++.++||||+++++.+.     
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch----hhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            45678999999999999999999976  689999999975431    1112233444455689999999998653     


Q ss_pred             eCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCEeecCCCCcEEEcCCCCeEE
Q 013421           80 SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK---------GVYHRDLKPENLLLDSYGNLKV  150 (443)
Q Consensus        80 ~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~---------gi~HrDlkp~NILl~~~~~~kL  150 (443)
                      ....+|+||||+++|+|.+++.. ...++..++.++.||+.||.|||+.         ||+||||||+|||++.++.+||
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             CCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            23468999999999999999976 4568999999999999999999999         9999999999999999999999


Q ss_pred             eeecCcCCCccc--------cccccccCCCcccCCCcccccC------CCCCCccchHHHHHHHHHHhhCCCCCCCCCh-
Q 013421          151 SDFGLSALPQQG--------VELLHTTCGTPNYVAPEVLSNR------GYDGSAADVWSCGVILFVLMAGYLPFGETDL-  215 (443)
Q Consensus       151 ~DFGls~~~~~~--------~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-  215 (443)
                      +|||++......        .......+||+.|+|||++.+.      ...+.++|||||||++|+|++|..||..... 
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            999999754321        1223456799999999998752      1223689999999999999999776633211 


Q ss_pred             -----------------HHHHHHhh--hccCCCCCC------CCHHHHHHHHHccCCCCCCCCCHHHH------hcCccc
Q 013421          216 -----------------PTLYKKIN--AAEFSCPFW------FSTGATSLIHKILDPNPKTRIRIEGI------RKHPWF  264 (443)
Q Consensus       216 -----------------~~~~~~i~--~~~~~~~~~------~s~~~~~li~~~L~~dP~~R~t~~ei------l~hp~f  264 (443)
                                       ......+.  .....+|..      +++++.+||.+||+.||++|||+.|+      +.++|-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence                             11111111  112223322      34579999999999999999999999      446776


Q ss_pred             ccc
Q 013421          265 RKN  267 (443)
Q Consensus       265 ~~~  267 (443)
                      ++.
T Consensus       322 ~~~  324 (336)
T 3g2f_A          322 RNK  324 (336)
T ss_dssp             C--
T ss_pred             hcc
Confidence            654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9.8e-46  Score=365.02  Aligned_cols=243  Identities=20%  Similarity=0.254  Sum_probs=196.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCC---------CCCcce
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMKIVR---------HPNIVR   73 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------HpnIv~   73 (443)
                      .++|++++.||+|+||+||+|++  +|+.||||++......     .....+.+.+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46899999999999999999998  6899999999876421     1223467889999998885         888888


Q ss_pred             EEEEEE------------------------------eCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 013421           74 LHEVLA------------------------------SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA  123 (443)
Q Consensus        74 l~~~~~------------------------------~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~  123 (443)
                      +.+++.                              +.+..|+||||+++|++.+.+.. +.+++..++.++.||+.||.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            887753                              26889999999999988777754 67899999999999999999


Q ss_pred             HHH-hCCCEeecCCCCcEEEcCCC--------------------CeEEeeecCcCCCccccccccccCCCcccCCCcccc
Q 013421          124 HCH-SKGVYHRDLKPENLLLDSYG--------------------NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS  182 (443)
Q Consensus       124 yLH-~~gi~HrDlkp~NILl~~~~--------------------~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~  182 (443)
                      ||| ++||+||||||+|||++.+|                    .+||+|||+++....     ...+||+.|+|||++.
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSGGGC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccChhhhc
Confidence            999 99999999999999999887                    899999999986543     2458999999999998


Q ss_pred             cCCCCCCccchHHHHHH-HHHHhhCCCCCCCCCh-HHHHHHhh-hccCCC------CCCCCHHHHHHHHHccCCCCCCCC
Q 013421          183 NRGYDGSAADVWSCGVI-LFVLMAGYLPFGETDL-PTLYKKIN-AAEFSC------PFWFSTGATSLIHKILDPNPKTRI  253 (443)
Q Consensus       183 ~~~~~~~~~DIwSlGvi-l~~ll~G~~Pf~~~~~-~~~~~~i~-~~~~~~------~~~~s~~~~~li~~~L~~dP~~R~  253 (443)
                      +..  +.++||||+|++ .+++++|..||..... ......+. ......      +..+|+++.+||++||+.|     
T Consensus       251 g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----  323 (336)
T 2vuw_A          251 GDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----  323 (336)
T ss_dssp             CCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred             CCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence            655  589999998776 7788999999954321 11222222 111111      1236889999999999976     


Q ss_pred             CHHHHh-cCcccc
Q 013421          254 RIEGIR-KHPWFR  265 (443)
Q Consensus       254 t~~eil-~hp~f~  265 (443)
                      |++|++ +||||+
T Consensus       324 sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 SATDLLCQHSLFK  336 (336)
T ss_dssp             SHHHHHHHCGGGC
T ss_pred             CHHHHHhcCCCcC
Confidence            999999 999995

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2e-44  Score=366.20  Aligned_cols=248  Identities=18%  Similarity=0.205  Sum_probs=195.1

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCc---------ce-----
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-PNI---------VR-----   73 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnI---------v~-----   73 (443)
                      ..|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++| +|.         +.     
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            358899999999999999999999999999999985443333345779999999999987 221         11     


Q ss_pred             -------EEEEEEe-----CCEEEEEEecCCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeec
Q 013421           74 -------LHEVLAS-----RTKVYIILEFVTGGELFDKIVH-------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD  134 (443)
Q Consensus        74 -------l~~~~~~-----~~~~~lv~Ey~~gg~L~~~i~~-------~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrD  134 (443)
                             +..++..     ...++++|+++ +++|.+++..       ...+++..+..++.||+.||+|||++||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence                   1111111     23467788876 6799888842       23467788889999999999999999999999


Q ss_pred             CCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCCcccCCCccc----------ccCCCCCCccchHHHHHHHHHHh
Q 013421          135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL----------SNRGYDGSAADVWSCGVILFVLM  204 (443)
Q Consensus       135 lkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~~~~DIwSlGvil~~ll  204 (443)
                      |||+|||++.++.+||+|||++......   ....+| +.|+|||++          .+..+ +.++|||||||++|+|+
T Consensus       237 iKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHH
Confidence            9999999999999999999998754432   456788 999999998          33334 47999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          205 AGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       205 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      +|+.||...+.......+    +.....+|+++.+||.+||+.||.+|||+.++++||||+.
T Consensus       312 tg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGG----GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HCCCCCCCcchhhhHHHH----HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            999999876654433332    2223457899999999999999999999999999999964

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1e-42  Score=359.87  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=208.0

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-PNIVRLHEVLASRTKV   84 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~   84 (443)
                      ...++|++++.||+|+||.||+|.+..+++.||||++......     ..+.+|+.+++.++| ++|..+..+....+..
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            4457899999999999999999999999999999998765422     347789999999976 5666777777888999


Q ss_pred             EEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEE---cCCCCeEEeeecCcCCCc
Q 013421           85 YIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls~~~~  160 (443)
                      |+||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 9999999985 4679999999999999999999999999999999999999   688999999999997654


Q ss_pred             cccc-------cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh---HHHHHHhhhccC---
Q 013421          161 QGVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---PTLYKKINAAEF---  227 (443)
Q Consensus       161 ~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~---  227 (443)
                      ....       .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+...   ...+.++.....   
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            4221       12366899999999999887764 899999999999999999999987443   333333332222   


Q ss_pred             --CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          228 --SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       228 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                        ..+..+++++.+||.+||+.||.+||++++|++
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence              122457999999999999999999999998765

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.5e-43  Score=344.72  Aligned_cols=245  Identities=22%  Similarity=0.346  Sum_probs=202.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC---
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI--VRHPNIVRLHEVLASRT---   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~---   82 (443)
                      .++|++.+.||+|+||.||+|.+  +|+.||+|++....      ...+.+|+++++.  ++||||+++++++....   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            46899999999999999999998  48999999986532      3557788898887  79999999999998776   


Q ss_pred             -EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCEeecCCCCcEEEcCCCCeEEeee
Q 013421           83 -KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH--------SKGVYHRDLKPENLLLDSYGNLKVSDF  153 (443)
Q Consensus        83 -~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH--------~~gi~HrDlkp~NILl~~~~~~kL~DF  153 (443)
                       ..|+||||+++|+|.+++.. .++++..++.++.|++.||.|||        +.||+||||||+|||++.++.+||+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence             89999999999999999976 57999999999999999999999        899999999999999999999999999


Q ss_pred             cCcCCCccccc----cccccCCCcccCCCcccccCCCC-----CCccchHHHHHHHHHHhhC----------CCCCCCCC
Q 013421          154 GLSALPQQGVE----LLHTTCGTPNYVAPEVLSNRGYD-----GSAADVWSCGVILFVLMAG----------YLPFGETD  214 (443)
Q Consensus       154 Gls~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~-----~~~~DIwSlGvil~~ll~G----------~~Pf~~~~  214 (443)
                      |++........    .....+||+.|+|||++.+....     +.++|||||||++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            99875544221    23456799999999998765322     1579999999999999999          88986642


Q ss_pred             -----hHHHHHHhhhcc--CCCCC-----CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          215 -----LPTLYKKINAAE--FSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       215 -----~~~~~~~i~~~~--~~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                           .......+....  ...|.     ..+..+.+||.+||+.||.+|||++++++|
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                 233344333322  22222     123578899999999999999999999885

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.9e-42  Score=334.51  Aligned_cols=223  Identities=14%  Similarity=0.172  Sum_probs=190.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      .-++|++.+.||+|+||.||+|.+..+|+.||+|++........+..+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            34789999999999999999999999999999999988766555667889999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      ||||++|++|.+++.. + ....++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|            
T Consensus       109 v~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred             EEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence            9999999999999854 3 4666788999999999999999999999999999999999999998443            


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHH---HhhhccC----CCCCCCCHHHHH
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK---KINAAEF----SCPFWFSTGATS  239 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~---~i~~~~~----~~~~~~s~~~~~  239 (443)
                              |++|        .+.++|||||||++|+|++|..||.+.+......   +......    ..+..+++++.+
T Consensus       175 --------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  238 (286)
T 3uqc_A          175 --------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA  238 (286)
T ss_dssp             --------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred             --------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence                    3333        3589999999999999999999998765432110   1111111    123468999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhc
Q 013421          240 LIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~  260 (443)
                      +|.+||+.||.+| |++++++
T Consensus       239 li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          239 VAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHHHHCTTSSCC-CHHHHHH
T ss_pred             HHHHHcccCCccC-CHHHHHH
Confidence            9999999999999 9999988

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.2e-43  Score=376.86  Aligned_cols=243  Identities=24%  Similarity=0.340  Sum_probs=201.5

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECC-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRE-TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK-   83 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-   83 (443)
                      ...++|++.+.||+|+||.||+|.+.. +|+.||||++....  .....+.+.+|+.+++.++||||+++++++...+. 
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            344899999999999999999999976 78999999987543  33455678999999999999999999999987655 


Q ss_pred             ----EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421           84 ----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus        84 ----~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                          .|+||||++|++|.+++..  .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++...
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence                7999999999999987754  79999999999999999999999999999999999999984 9999999998765


Q ss_pred             ccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHH
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS  239 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~  239 (443)
                      ...    ...+||+.|+|||++.+. + +.++|||||||++|+|++|.+||.+......    .  ........++.+.+
T Consensus       232 ~~~----~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----~--~~~~~~~~~~~l~~  299 (681)
T 2pzi_A          232 NSF----GYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----P--EDDPVLKTYDSYGR  299 (681)
T ss_dssp             TCC----SCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----C--TTCHHHHHCHHHHH
T ss_pred             ccC----CccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccccc----c--ccccccccCHHHHH
Confidence            432    456799999999998754 3 5899999999999999999999875321100    0  00000114678999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      +|.+||++||.+||+..+.+.|+|+.
T Consensus       300 li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          300 LLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHhhhccCChhhCCCHHHHHHHHHHH
Confidence            99999999999999999999999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=8.3e-37  Score=321.79  Aligned_cols=234  Identities=13%  Similarity=0.101  Sum_probs=165.6

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeeccccc-------chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-------KHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~   85 (443)
                      ....+.|++|.+..++....|+.||+|++.+....       .+...+.+.+|+++|+++ .|+||+++++++++++..|
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y  318 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW  318 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence            34567888888888887788999999999875321       123346799999999999 7999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      |||||++|++|.++|.+.+++++.   .++.||+.||+|||++||+||||||+|||++.+|++||+|||+++........
T Consensus       319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred             EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence            999999999999999998888865   48899999999999999999999999999999999999999999877655455


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHcc
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  245 (443)
                      ..+.+||+.|+|||++.+. + ..++|+||+|++++.+.+|..|+.        ..+..    .|.. ...+..+...+.
T Consensus       396 ~~t~vGTp~YmAPE~l~g~-~-~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~----~~~~-~~~~~~l~~~l~  460 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAEN-K-SWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQ----EPVE-RWNFVLLLALFE  460 (569)
T ss_dssp             SHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHT----SCGG-GCSHHHHHHHHH
T ss_pred             ccCceechhhccHHHhCCC-C-CCcccccccccchhhhccccchhH--------HHhhc----CCCC-CCcHHHHHHHHh
Confidence            6778999999999999764 3 378999999999998877654431        11111    1110 112456677777


Q ss_pred             CCCCCCCCCHHHHhcCcccc
Q 013421          246 DPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~  265 (443)
                      ..+|..|+.......|+|..
T Consensus       461 ~~~~~~~~~~~~~~~~~~~~  480 (569)
T 4azs_A          461 KKAKLPSAEQQRGATEQWII  480 (569)
T ss_dssp             TGGGSCCGGGSSCCHHHHHH
T ss_pred             CCCCCCCCChhhhccchhHH
Confidence            88888888777777777754

>2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana}

Probab=100.00  E-value=1e-33  Score=240.94  Aligned_cols=136  Identities=76%  Similarity=1.188  Sum_probs=119.5

Q ss_pred             CCcccchhhhhccCCCCCCcccCccccccccceeeEEeCCCHHHHHHHHHHHHHHcCcEEEeecceEEEeeeccCCCccE
Q 013421          306 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQF  385 (443)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (443)
                      .|..+|||++|++|+++||++||+..+++++|+|||+|+.|++.|+++|+++|+.+|+.|++++++++++++.+|++|.|
T Consensus         3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l   82 (143)
T 2ehb_D            3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL   82 (143)
T ss_dssp             CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred             CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence            56779999999999999999999765555789999999999999999999999999999999888999999999999999


Q ss_pred             EEEEEEEEEcCceEEEEEEecCCCchHHHHHHHHHHHhcccceeccCCc---cchhhhc
Q 013421          386 AVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEG---SSLLRTM  441 (443)
Q Consensus       386 ~~~~~i~~~~~~~~~v~~~~~~Gd~le~~~~~~~~~~~l~~~v~~~~~~---~~~~~~~  441 (443)
                      ++.+|||||+|+++||||+|++||++||+++|++|++.|+||||+|++.   +.++|++
T Consensus        83 ~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~diV~~~~~~~~~~~~~~~~  141 (143)
T 2ehb_D           83 AVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWRATEGIPKSEILRTI  141 (143)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHSTTTBCC--------------
T ss_pred             EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhhcceecCCCCCchhhhhhhh
Confidence            9999999999999999999999999999999999999999999999885   6666665

>2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana}

Probab=99.96  E-value=2.3e-30  Score=215.09  Aligned_cols=121  Identities=26%  Similarity=0.410  Sum_probs=106.3

Q ss_pred             CCcccchhhhhccCCCCCCcccCccccccccceeeEEeCCCHHHHHHHHHHHHHHcCcEEEeecceEEEeeeccCCCccE
Q 013421          306 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQF  385 (443)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (443)
                      +|..+|||++|++|+++|||+||+.. ...+++|||+|+.||+.|+++||++|+++|+.|++++++   +++.++++|.|
T Consensus         2 ~~~~lNAFdiIs~S~g~dLSgLFe~~-~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l   77 (123)
T 2zfd_B            2 GARRMNAFDIISGSPGFNLSGLFGDA-RKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNF   77 (123)
T ss_dssp             --CCCCHHHHHHTSTTSSSGGGGGGG-CSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTE
T ss_pred             CcccccHHHHHHHCcCCCchHhcCcc-cccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccE
Confidence            56789999999999999999999753 234789999999999999999999999999999988876   66778999999


Q ss_pred             EEEEEEEEEcCceEEEEEEecCCCchHHHHHH-HHHHHhcccceec
Q 013421          386 AVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFY-KNFCAKLENIIWK  430 (443)
Q Consensus       386 ~~~~~i~~~~~~~~~v~~~~~~Gd~le~~~~~-~~~~~~l~~~v~~  430 (443)
                      ++.+|||||+|+++||||+|++||++||++|| ++|++.|+||||.
T Consensus        78 ~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~  123 (123)
T 2zfd_B           78 AMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE  123 (123)
T ss_dssp             EEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred             EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence            99999999999999999999999999999976 5899999999984

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.2e-29  Score=265.58  Aligned_cols=185  Identities=20%  Similarity=0.247  Sum_probs=145.1

Q ss_pred             EeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchH-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR-----MVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      ..+.||+|+||+||+|.  ..+..+|+|...........     ..+.+.+|+.++++++||||+++..+....+..|+|
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            35689999999999994  45788999987654332221     235689999999999999999555555566777999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc---
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~---  164 (443)
                      |||++|++|.+++..        +..++.|++.||+|||++||+||||||+|||++.  ++||+|||+++.......   
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            999999999999865        6689999999999999999999999999999999  999999999987655322   


Q ss_pred             ----cccccCCCcccCCCccccc--CCCCCCccchHHHHHHHHHHhhCCCCC
Q 013421          165 ----LLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPF  210 (443)
Q Consensus       165 ----~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf  210 (443)
                          ...+.+||+.|+|||++..  .+|. ..+|+||..+-..+..-++.+|
T Consensus       488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          488 DLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCC
T ss_pred             chhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhcccc
Confidence                1246789999999999976  5564 7789999988888777776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.2e-26  Score=221.61  Aligned_cols=146  Identities=18%  Similarity=0.241  Sum_probs=116.2

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch---------------HHHHHHHHHHHHHHhCCCCCcceEE
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---------------RMVDQIKREISIMKIVRHPNIVRLH   75 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~HpnIv~l~   75 (443)
                      |++++.||+|+||.||+|.+ .+|+.||+|++........               .....+.+|+.+|+.++|   +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence            33449999999999999999 8899999999965332110               134678999999999994   5555


Q ss_pred             EEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecC
Q 013421           76 EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (443)
Q Consensus        76 ~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (443)
                      +++.. +..|+||||++|++|.+ +.      ......++.|++.||.|||++||+||||||+|||++ +|.+||+|||+
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence            54444 45699999999999988 42      134567999999999999999999999999999999 99999999999


Q ss_pred             cCCCccccccccccCCCcccCCCcccc
Q 013421          156 SALPQQGVELLHTTCGTPNYVAPEVLS  182 (443)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~y~aPE~l~  182 (443)
                      +..             +..|.|||++.
T Consensus       239 a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          239 SVE-------------VGEEGWREILE  252 (282)
T ss_dssp             CEE-------------TTSTTHHHHHH
T ss_pred             CeE-------------CCCCCHHHHHH
Confidence            852             34578899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=3.3e-22  Score=189.76  Aligned_cols=140  Identities=19%  Similarity=0.240  Sum_probs=109.9

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcE--EEEEEeecccccc---------------------hHHHHHHHHHHHHHHhCC
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGES--VAMKVLAKSTILK---------------------HRMVDQIKREISIMKIVR   67 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~--vAiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~   67 (443)
                      |++.+.||+|+||.||+|.+..+|+.  ||||++.......                     ......+.+|+.+|+.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999998778988  9999975532110                     011246889999999998


Q ss_pred             CCCc--ceEEEEEEeCCEEEEEEecCCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCEeecCCCCc
Q 013421           68 HPNI--VRLHEVLASRTKVYIILEFVTG-G----ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPEN  139 (443)
Q Consensus        68 HpnI--v~l~~~~~~~~~~~lv~Ey~~g-g----~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH-~~gi~HrDlkp~N  139 (443)
                      |+++  +.+++.    +..++||||+.+ |    .|.+....   .++..+..++.|++.||.||| +.||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8754  445543    346899999942 3    66655432   345678899999999999999 9999999999999


Q ss_pred             EEEcCCCCeEEeeecCcCCC
Q 013421          140 LLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus       140 ILl~~~~~~kL~DFGls~~~  159 (443)
                      ||++.  .++|+|||+|...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99998  9999999998643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=5.8e-19  Score=175.48  Aligned_cols=138  Identities=18%  Similarity=0.237  Sum_probs=102.1

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc---------------chHH----HHHHHHHHHHHHhCCCCCc
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL---------------KHRM----VDQIKREISIMKIVRHPNI   71 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~---------------~~~~----~~~~~~Ei~il~~l~HpnI   71 (443)
                      |++++.||.|++|.||+|.+. +|+.||||++......               ....    .-...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999985 6999999997643211               0000    0123467888888865554


Q ss_pred             ceEEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC----
Q 013421           72 VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN----  147 (443)
Q Consensus        72 v~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~----  147 (443)
                      .-..-+....  .++||||++|++|....      ....+..++.||+.+|.|||+.||+||||||.|||++++|.    
T Consensus       176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            3222222222  27999999998886532      22345678999999999999999999999999999988773    


Q ss_pred             ------eEEeeecCcC
Q 013421          148 ------LKVSDFGLSA  157 (443)
Q Consensus       148 ------~kL~DFGls~  157 (443)
                            +.|+||+-+.
T Consensus       248 ~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMV  263 (397)
T ss_dssp             TSEEEEEEECCCTTCE
T ss_pred             cccccceEEEEeCCcc
Confidence                  8999998664

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.45  E-value=4e-13  Score=126.75  Aligned_cols=142  Identities=15%  Similarity=0.113  Sum_probs=114.7

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKV   84 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~   84 (443)
                      ..++.|++...+|.|+.+.||++...  +..+++|+........   ...+.+|+.+++.+. +.++.+++++..+.+..
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            45678999999999999999999753  6889999987532111   235889999999984 67888999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-------------------------------------  127 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-------------------------------------  127 (443)
                      |+||||++|.+|.+.+.     +......++.++..+|..||+                                     
T Consensus        86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999999876531     223345788999999999998                                     


Q ss_pred             ----------------------CCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421          128 ----------------------KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus       128 ----------------------~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                                            .+++|+|++|.||++++++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  458999999999999875556799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.29  E-value=1.2e-11  Score=115.92  Aligned_cols=136  Identities=15%  Similarity=0.164  Sum_probs=101.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN--IVRLHEVLASRTKV   84 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~   84 (443)
                      .+..|.+....+.|..+.||++.. .+|..+++|+.....      ...+.+|+.+++.+.+.+  +.+++.+..+.+..
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~   90 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   90 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence            355678765556777799999964 467789999976431      134678999999885444  56789988888889


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG-----------------------------------  129 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~g-----------------------------------  129 (443)
                      |+||||++|.+|.  .   ...+   ...++.++...|..||+..                                   
T Consensus        91 ~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            9999999998873  1   1111   2356677777788887643                                   


Q ss_pred             -----------------------CEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421          130 -----------------------VYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus       130 -----------------------i~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                                             ++|+|++|.||++++++.+.|+|||.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                   9999999999999876666799999764

>3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A

Probab=99.22  E-value=1.2e-10  Score=96.04  Aligned_cols=84  Identities=13%  Similarity=0.187  Sum_probs=75.4

Q ss_pred             EeCCCHHHHHHHHHHHHHHcCcEEEeec-ceEEEeeeccCCCccEEEEEEEEEEc-CceEEEEEEecCCCchHHHHHHHH
Q 013421          342 VSRQPAQVILSNIEAVAESLSLKVHTRN-YKTRLEGVSANKTGQFAVVLEVFEVA-PSLFMVDVRKAAGDTLEYHKFYKN  419 (443)
Q Consensus       342 ~s~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~~~~  419 (443)
                      +|..+|++|+..|++++.++|+.|+.++ |.+++........+.+.|.+||+++. +++++|+|+|.+||.+.|+++|.+
T Consensus        34 TS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc~~  113 (120)
T 3ose_A           34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK  113 (120)
T ss_dssp             EECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHHHH
Confidence            6899999999999999999999998876 78888765444567899999999996 899999999999999999999999


Q ss_pred             HHHhcc
Q 013421          420 FCAKLE  425 (443)
Q Consensus       420 ~~~~l~  425 (443)
                      |.+.|+
T Consensus       114 il~~L~  119 (120)
T 3ose_A          114 IANELK  119 (120)
T ss_dssp             HHHHCC
T ss_pred             HHHHhc
Confidence            998875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=6.1e-11  Score=117.19  Aligned_cols=142  Identities=20%  Similarity=0.332  Sum_probs=107.5

Q ss_pred             EEeeeeeccCceEEEEEEECCCCcEEEEEEee--cccccchHHHHHHHHHHHHHHhCC--CCCcceEEEEEEeC---CEE
Q 013421           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLA--KSTILKHRMVDQIKREISIMKIVR--HPNIVRLHEVLASR---TKV   84 (443)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~---~~~   84 (443)
                      .-++.|+.|.++.||++...  +..+++|+..  ......  ....+.+|+.+++.+.  +..+++++.++.+.   +..
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~--~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLP--SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCC--cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence            34678999999999998764  4678889775  322111  2356889999999997  45688899988776   458


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-------------------------------------  127 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-------------------------------------  127 (443)
                      |+||||++|..+.+..  ...++......++.++..+|..||+                                     
T Consensus       117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            9999999998775421  1346788888999999999999997                                     


Q ss_pred             ---------------------CCCEeecCCCCcEEEcCCCC--eEEeeecCcCCC
Q 013421          128 ---------------------KGVYHRDLKPENLLLDSYGN--LKVSDFGLSALP  159 (443)
Q Consensus       128 ---------------------~gi~HrDlkp~NILl~~~~~--~kL~DFGls~~~  159 (443)
                                           .+++|||++|.|||++.++.  +.|+||+.+..-
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                 36899999999999997764  689999987643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.08  E-value=1e-10  Score=112.85  Aligned_cols=184  Identities=17%  Similarity=0.222  Sum_probs=122.8

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCC--cceEEEEEEeCC---EEEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPN--IVRLHEVLASRT---KVYII   87 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn--Iv~l~~~~~~~~---~~~lv   87 (443)
                      ++.++.|..+.||++.     ..+++|+....     .....+.+|..+|+.+ .+..  +.+++......+   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4569999999999863     45889986432     2456789999999988 4433  445555443333   35899


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS----------------------------------------  127 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~----------------------------------------  127 (443)
                      ||+++|..|.+...  ..++.++...++.|+...+..||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999988865433  346777888888899888888886                                        


Q ss_pred             ------------------CCCEeecCCCCcEEEcC--CCCeEEeeecCcCCCccccccccccCCCcccCCCccccc--CC
Q 013421          128 ------------------KGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RG  185 (443)
Q Consensus       128 ------------------~gi~HrDlkp~NILl~~--~~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~  185 (443)
                                        ..++|+|++|.||+++.  .+.+.|+||+.+.......+........ .-..|+....  ..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHH
Confidence                              23799999999999998  4568899999876433211111110000 0012221100  01


Q ss_pred             CCC-----------CccchHHHHHHHHHHhhCCCCC
Q 013421          186 YDG-----------SAADVWSCGVILFVLMAGYLPF  210 (443)
Q Consensus       186 ~~~-----------~~~DIwSlGvil~~ll~G~~Pf  210 (443)
                      |..           ...+.|++|.++|.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            110           1268999999999999998776

>1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1

Probab=98.81  E-value=8.5e-09  Score=84.88  Aligned_cols=84  Identities=12%  Similarity=0.138  Sum_probs=73.1

Q ss_pred             EeCCCHHHHHHHHHHHHHHcCcEEEe-ecceEEEeeeccCCCccEEEEEEEEEEc-CceEEEEEEecCCCchHHHHHHHH
Q 013421          342 VSRQPAQVILSNIEAVAESLSLKVHT-RNYKTRLEGVSANKTGQFAVVLEVFEVA-PSLFMVDVRKAAGDTLEYHKFYKN  419 (443)
Q Consensus       342 ~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~~~~  419 (443)
                      +|..+|.+|+..|.++++++|+.|+. +.+.+++.......+..+.|.+||+++. .+++.|+|+|.+||.+.|+++|.+
T Consensus        34 TSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~~  113 (126)
T 1v5s_A           34 GSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK  113 (126)
T ss_dssp             CCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHHH
T ss_pred             ecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHHH
Confidence            57889999999999999999999987 4477777644333456799999999994 689999999999999999999999


Q ss_pred             HHHhcc
Q 013421          420 FCAKLE  425 (443)
Q Consensus       420 ~~~~l~  425 (443)
                      |...|+
T Consensus       114 IL~eLk  119 (126)
T 1v5s_A          114 IANELK  119 (126)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            999988

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.70  E-value=2e-07  Score=87.70  Aligned_cols=139  Identities=13%  Similarity=0.183  Sum_probs=101.5

Q ss_pred             ccCeEEeeeeeccCce-EEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 013421            8 VAKYEVGRTIGEGTFA-KVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g-~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~   85 (443)
                      +..|+.. .+..|..+ .||+......+..+.+|+-...      ....+.+|...|+.+. +-.+.+++.+..+.+..|
T Consensus        24 l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~   96 (272)
T 4gkh_A           24 LYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAW   96 (272)
T ss_dssp             HTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             ccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEE
Confidence            3445553 34445444 7998887777788999976432      3456889999999884 444788899999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS--------------------------------------  127 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~--------------------------------------  127 (443)
                      +|||+++|.++.+.....    ......+..++...|.-||+                                      
T Consensus        97 lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A           97 LLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             EEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             EEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            999999998887665431    22334556666667777764                                      


Q ss_pred             --------------------CCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421          128 --------------------KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus       128 --------------------~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                                          ..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                127999999999999987767799998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.62  E-value=4.9e-07  Score=87.13  Aligned_cols=134  Identities=19%  Similarity=0.245  Sum_probs=95.3

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC---CcceEEEEEE-eCCEEEEEEe
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP---NIVRLHEVLA-SRTKVYIILE   89 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lv~E   89 (443)
                      ++.++.|....||+.     |..+++|+...     ......+.+|..+|+.+.+.   .+.+.+.+.. ..+..|++||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            466899999999988     56788897422     23456789999999999652   3566676664 4556789999


Q ss_pred             cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 013421           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-----------------------------------------  128 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~-----------------------------------------  128 (443)
                      |++|..+.+...  ..++..+...+..|+...|..||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988765321  2345555555555555555555542                                         


Q ss_pred             -------------------CCEeecCCCCcEEEcC---CCCe-EEeeecCcCCC
Q 013421          129 -------------------GVYHRDLKPENLLLDS---YGNL-KVSDFGLSALP  159 (443)
Q Consensus       129 -------------------gi~HrDlkp~NILl~~---~~~~-kL~DFGls~~~  159 (443)
                                         .++|+|++|.||+++.   ++.+ .|+||+.+...
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                               3599999999999987   4564 89999977543

>4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A*

Probab=98.56  E-value=8.9e-07  Score=70.35  Aligned_cols=88  Identities=15%  Similarity=0.261  Sum_probs=74.0

Q ss_pred             eeeEEeCCCHHHHHHHHHHHHHHcCcEEEee-cceEEEeeeccCCCccEEEEEEEEEEcCceEEEEEEecCCC-------
Q 013421          338 QTRFVSRQPAQVILSNIEAVAESLSLKVHTR-NYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGD-------  409 (443)
Q Consensus       338 ~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd-------  409 (443)
                      .-...|...|.+|+..|..|++.+|+.|+.- .|.+++..........+.|.+++|++.++.+++||++..||       
T Consensus         9 ~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~~   88 (106)
T 4eai_A            9 HLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGGS   88 (106)
T ss_dssp             EESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSSC
T ss_pred             eEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCCc
Confidence            3345688889999999999999999999876 48888875543334568899999999999999999999995       


Q ss_pred             -chHHHHHHHHHHHhcc
Q 013421          410 -TLEYHKFYKNFCAKLE  425 (443)
Q Consensus       410 -~le~~~~~~~~~~~l~  425 (443)
                       .++|-++|.++...|.
T Consensus        89 ~~~~F~d~ca~li~~la  105 (106)
T 4eai_A           89 HTIEFFEMCANLIKILA  105 (106)
T ss_dssp             HHHHHHHHHHHHHHHCC
T ss_pred             CcEeHHHHHHHHHHHHh
Confidence             8999999998877764

>2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C*

Probab=98.40  E-value=4.1e-06  Score=70.51  Aligned_cols=76  Identities=14%  Similarity=0.238  Sum_probs=61.0

Q ss_pred             ceeeEEeCCCHHHHHHHHHHHHHHcCcEEEeec-ceEEEeeeccCCCccEEEEEEEEEEcCceEEEEEEecCCCchH
Q 013421          337 RQTRFVSRQPAQVILSNIEAVAESLSLKVHTRN-YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLE  412 (443)
Q Consensus       337 ~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le  412 (443)
                      ..-..-|..+|.+|+..|.+|++.+|+.|++.+ |.|++..........+.|.+++|++.++.+||||++..||+.|
T Consensus         5 WhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e   81 (157)
T 2v8q_A            5 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE   81 (157)
T ss_dssp             EEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred             ceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence            344456888999999999999999999999865 7888876543323457899999999999999999999999865

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.34  E-value=1e-06  Score=87.92  Aligned_cols=79  Identities=15%  Similarity=0.173  Sum_probs=50.2

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccc-cch---HHHHHHHHHHHHHHhCCC--C-CcceEEEEEEeCCEEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKH---RMVDQIKREISIMKIVRH--P-NIVRLHEVLASRTKVYI   86 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~H--p-nIv~l~~~~~~~~~~~l   86 (443)
                      .+.||.|..+.||++....++..+++|....... ...   ...+.+..|..+++.+..  | .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            5789999999999997666678899998653211 000   012456778888888742  3 34466654  3445689


Q ss_pred             EEecCCCC
Q 013421           87 ILEFVTGG   94 (443)
Q Consensus        87 v~Ey~~gg   94 (443)
                      ||||++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster}

Probab=98.22  E-value=1.5e-05  Score=64.92  Aligned_cols=74  Identities=16%  Similarity=0.275  Sum_probs=56.6

Q ss_pred             EEeCCCHHHHHHHHHHHHHHcCcEEEeec-ceEEEeeeccCCCccEEEEEEEEEEcCceEEEEEEecCCCchHHH
Q 013421          341 FVSRQPAQVILSNIEAVAESLSLKVHTRN-YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYH  414 (443)
Q Consensus       341 f~s~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le~~  414 (443)
                      .-|...|.+|+..|..|++.+|+.|+..+ |.+++..........+.+.+++|++.++.+++||+...||..|..
T Consensus        12 IrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~~   86 (130)
T 4eag_A           12 IRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQG   86 (130)
T ss_dssp             BCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-------
T ss_pred             eecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhcc
Confidence            34667899999999999999999998764 888887554443445789999999999999999999999965543

>2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A*

Probab=98.18  E-value=1.2e-05  Score=68.61  Aligned_cols=77  Identities=14%  Similarity=0.233  Sum_probs=62.3

Q ss_pred             cceeeEEeCCCHHHHHHHHHHHHHHcCcEEEeec-ceEEEeeeccCCCccEEEEEEEEEEcCceEEEEEEecCCCchH
Q 013421          336 KRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRN-YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLE  412 (443)
Q Consensus       336 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le  412 (443)
                      +..-...|..+|.+|+..|..|++.+|+.|++.+ |.|+++.........+.|.+++|++.++.+||||++..||+.|
T Consensus        18 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e   95 (173)
T 2y8l_A           18 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE   95 (173)
T ss_dssp             EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred             eeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence            5555677889999999999999999999999865 7888876533323357899999999999999999999999876

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.13  E-value=2e-06  Score=84.28  Aligned_cols=83  Identities=10%  Similarity=0.249  Sum_probs=56.7

Q ss_pred             EEeeee-eccCceEEEEEEEC---C---CCcEEEEEEeeccc---ccchHHHHHHHHHHHHHHhCC-C--CCcceEEEEE
Q 013421           12 EVGRTI-GEGTFAKVRFAQNR---E---TGESVAMKVLAKST---ILKHRMVDQIKREISIMKIVR-H--PNIVRLHEVL   78 (443)
Q Consensus        12 ~i~~~L-G~G~~g~V~~a~~~---~---~~~~vAiK~i~~~~---~~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~   78 (443)
                      ...+.| +.|..+.+|+....   .   ++..+++|+.....   ...   ...+.+|+.+++.+. +  -.+.+++.+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~   99 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE   99 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence            345778 89999999988653   1   15678999865432   101   134678888888884 3  3577888877


Q ss_pred             EeC---CEEEEEEecCCCCChH
Q 013421           79 ASR---TKVYIILEFVTGGELF   97 (443)
Q Consensus        79 ~~~---~~~~lv~Ey~~gg~L~   97 (443)
                      .+.   +..|+||||++|..+.
T Consensus       100 ~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          100 TTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             CSSTTTSSCEEEEECCCCBCCC
T ss_pred             cCCCccCCceEEEEecCCCChh
Confidence            655   3568999999886543

>2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A*

Probab=98.11  E-value=1e-05  Score=67.49  Aligned_cols=90  Identities=18%  Similarity=0.214  Sum_probs=72.8

Q ss_pred             cceeeEEeCCCHHHHHHHHHHHHHHcCcEEEee---------c-ceEEEeeeccCC-----CccEEEEEEEEEEcCceEE
Q 013421          336 KRQTRFVSRQPAQVILSNIEAVAESLSLKVHTR---------N-YKTRLEGVSANK-----TGQFAVVLEVFEVAPSLFM  400 (443)
Q Consensus       336 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~---------~-~~~~~~~~~~~~-----~~~l~~~~~i~~~~~~~~~  400 (443)
                      +..-..-|..+|.+|+..|..|++.+|+.|++.         + +.|++....+..     ...+.|.+++|++.++.+|
T Consensus        12 kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YL   91 (137)
T 2qrd_A           12 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM   91 (137)
T ss_dssp             CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred             ccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEE
Confidence            555556788899999999999999999999875         4 678776543321     2357899999999999999


Q ss_pred             EEEEecCCC---------------c----hHHHHHHHHHHHhcc
Q 013421          401 VDVRKAAGD---------------T----LEYHKFYKNFCAKLE  425 (443)
Q Consensus       401 v~~~~~~Gd---------------~----le~~~~~~~~~~~l~  425 (443)
                      |||+...|+               .    ++|-.+|.+|...|.
T Consensus        92 lDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa  135 (137)
T 2qrd_A           92 LDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF  135 (137)
T ss_dssp             EEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred             EEEEecCCccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence            999999999               5    889999988877664

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.09  E-value=4e-05  Score=74.13  Aligned_cols=135  Identities=13%  Similarity=0.133  Sum_probs=77.5

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----CCCcceEE-E--EEEeCCEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-----HPNIVRLH-E--VLASRTKVY   85 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~-~--~~~~~~~~~   85 (443)
                      ++.|+.|..+.||++...  +..+++|+.....       ..+..|..+++.|.     .|.++... +  +....+..+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~  107 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF  107 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence            355677889999998763  3358999887521       22334555555442     34444310 0  123467889


Q ss_pred             EEEecCCCCChH--------------HHHHh-cCCC--C-----------HH--------H-------------------
Q 013421           86 IILEFVTGGELF--------------DKIVH-QGRL--L-----------EN--------D-------------------  110 (443)
Q Consensus        86 lv~Ey~~gg~L~--------------~~i~~-~~~l--~-----------e~--------~-------------------  110 (443)
                      ++|||++|..+.              ..+.. ...+  +           ..        .                   
T Consensus       108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  187 (346)
T 2q83_A          108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL  187 (346)
T ss_dssp             EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred             EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence            999999986431              11111 0111  1           00        0                   


Q ss_pred             ----HHHHHHHHHHHHHHHH-------------hCCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421          111 ----CRRYFQQLIDAVAHCH-------------SKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus       111 ----~~~~~~qll~aL~yLH-------------~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                          ...+..++..++.+|+             ..+++|+|++|.|||++.++.+.|+||+.+.
T Consensus       188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                1111223344566665             2579999999999999888899999998653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.85  E-value=0.00011  Score=70.96  Aligned_cols=75  Identities=12%  Similarity=0.212  Sum_probs=60.3

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEec
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR---HPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      .+.|+.|....+|+...  ++..+++|+....      ....+..|...|+.|.   ...+++++.+....+..|+||||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            56799999999999875  4678889987643      1456788999998883   36688899888888899999999


Q ss_pred             CCCCCh
Q 013421           91 VTGGEL   96 (443)
Q Consensus        91 ~~gg~L   96 (443)
                      ++|..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.83  E-value=0.00016  Score=65.39  Aligned_cols=121  Identities=14%  Similarity=0.068  Sum_probs=80.9

Q ss_pred             ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH-hCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccCCC
Q 013421           95 ELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT  172 (443)
Q Consensus        95 ~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH-~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt  172 (443)
                      +|.+.+... .+++|+++|.++.|.+.+|.-+- ++.-..+=+.|..|++..+|++-+.+ +.+.            ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence            688888654 68999999999999999987762 22222344567999999999998764 1110            123


Q ss_pred             cccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccCC
Q 013421          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP  247 (443)
Q Consensus       173 ~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~  247 (443)
                      ..+.|||...  ...+.+.=|||||+++|.-+--..|=                 .-+..+|+.+.+||..|...
T Consensus       101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred             cCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence            3577898863  22347788999999999888533331                 12345899999999999866

>3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A

Probab=97.74  E-value=0.00025  Score=61.13  Aligned_cols=89  Identities=12%  Similarity=0.212  Sum_probs=70.4

Q ss_pred             cceeeEEeCCCHHHHHHHHHHHHHHcCcEEEee----cceEEEeeeccC---------CCccEEEEEEEEEEcCceEEEE
Q 013421          336 KRQTRFVSRQPAQVILSNIEAVAESLSLKVHTR----NYKTRLEGVSAN---------KTGQFAVVLEVFEVAPSLFMVD  402 (443)
Q Consensus       336 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~---------~~~~l~~~~~i~~~~~~~~~v~  402 (443)
                      ++.-...|...|.+|+..|..|++.+|+.|++.    .|.|+++...+.         ....+.|.+++|++.++.+|||
T Consensus        50 kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLD  129 (179)
T 3t4n_A           50 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD  129 (179)
T ss_dssp             CCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEE
T ss_pred             eeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEE
Confidence            444446788999999999999999999999874    467887743211         1134789999999999999999


Q ss_pred             EEecCC----------------------CchHHHHHHHHHHHhcc
Q 013421          403 VRKAAG----------------------DTLEYHKFYKNFCAKLE  425 (443)
Q Consensus       403 ~~~~~G----------------------d~le~~~~~~~~~~~l~  425 (443)
                      |+ ..|                      .++.|-.+|.+|.-.|.
T Consensus       130 fk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa  173 (179)
T 3t4n_A          130 FK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELA  173 (179)
T ss_dssp             EE-EEEEECC----------------CCCCHHHHHHHHHHHHHHH
T ss_pred             EE-eccccccccccccccccccccccccCCccHHHHHHHHHHHHH
Confidence            99 778                      67889999888877764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.73  E-value=0.00013  Score=73.32  Aligned_cols=33  Identities=18%  Similarity=0.261  Sum_probs=28.1

Q ss_pred             HhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCC
Q 013421          126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (443)
Q Consensus       126 H~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (443)
                      +...++|+|++|.|||++.++ +.++||+.+..-
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            356799999999999999876 999999987643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.63  E-value=0.00015  Score=69.30  Aligned_cols=74  Identities=11%  Similarity=0.057  Sum_probs=46.2

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEe
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYIILE   89 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~E   89 (443)
                      +.-++.|+.|....+|+.      ..+++|+.......    .-...+|+.+++.+...++ .+++.+  +.+.-++++|
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e   87 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR   87 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence            333788999999999998      45888987643211    1123467877777743222 456554  3334578999


Q ss_pred             cC-CCCCh
Q 013421           90 FV-TGGEL   96 (443)
Q Consensus        90 y~-~gg~L   96 (443)
                      |+ +|.++
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 66444

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.45  E-value=0.00091  Score=63.25  Aligned_cols=79  Identities=9%  Similarity=0.027  Sum_probs=55.4

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC---CCcceEEEEEEeCCEEEE
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH---PNIVRLHEVLASRTKVYI   86 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~~~~~l   86 (443)
                      +..-++.+|.|..+.||+.... +|+.|.+|+-.......   ...+..|...|+.|.-   -.+.+++.+  +.  -++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence            3556788999999999999864 68899999865433221   2357789999998842   234555554  22  368


Q ss_pred             EEecCCCCCh
Q 013421           87 ILEFVTGGEL   96 (443)
Q Consensus        87 v~Ey~~gg~L   96 (443)
                      +|||.+++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999987643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.41  E-value=0.0005  Score=66.47  Aligned_cols=136  Identities=15%  Similarity=0.168  Sum_probs=71.3

Q ss_pred             eeeeeccCceE-EEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEec
Q 013421           14 GRTIGEGTFAK-VRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH--PNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        14 ~~~LG~G~~g~-V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      .+.|+.|+... +|+... .+|..+++|.......      ..+..|+.+++.+..  -.+.+++.+..+.+  +++||+
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~   93 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED   93 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence            35576665555 556643 2366777776543210      234467777776632  23566776643333  789999


Q ss_pred             CCCCChHHHHHhc--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHH
Q 013421           91 VTGGELFDKIVHQ--------------------------GRLLENDCR-------R-YF------------QQLIDAVAH  124 (443)
Q Consensus        91 ~~gg~L~~~i~~~--------------------------~~l~e~~~~-------~-~~------------~qll~aL~y  124 (443)
                      +.+..+.+.+...                          ..++.....       . +.            ..+...+..
T Consensus        94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~  173 (333)
T 3csv_A           94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ  173 (333)
T ss_dssp             CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred             CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            9776665443211                          011111110       0 00            011122222


Q ss_pred             H------HhCCCEeecCCCCcEEEcCC----CCeEEeeecCcCC
Q 013421          125 C------HSKGVYHRDLKPENLLLDSY----GNLKVSDFGLSAL  158 (443)
Q Consensus       125 L------H~~gi~HrDlkp~NILl~~~----~~~kL~DFGls~~  158 (443)
                      +      +...++|||+.|.||+++.+    +.+.|+||+.+..
T Consensus       174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3      13469999999999999874    6799999997753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.32  E-value=0.0012  Score=63.24  Aligned_cols=138  Identities=12%  Similarity=0.105  Sum_probs=77.3

Q ss_pred             EeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEE
Q 013421           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN--IVRLHEV------LASRTKV   84 (443)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~   84 (443)
                      -++.|+.|....+|+.... +| .+++|+.....     ..+.+..|+.+++.+....  +.+++..      ....+..
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            3567888999999998764 33 68899886531     1134556777777663211  2333311      1234678


Q ss_pred             EEEEecCCCCChHH--------------HHHhc-CCC--------CHHHHHHHH---------------HHHHHHHHHHH
Q 013421           85 YIILEFVTGGELFD--------------KIVHQ-GRL--------LENDCRRYF---------------QQLIDAVAHCH  126 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~--------------~i~~~-~~l--------~e~~~~~~~---------------~qll~aL~yLH  126 (443)
                      +++++|++|..+..              .+... ..+        ........+               ..+...++.++
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            99999998864310              11110 011        101111100               11334455555


Q ss_pred             h-------CCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421          127 S-------KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus       127 ~-------~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      +       .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            2       369999999999999986656899998654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.26  E-value=0.0005  Score=68.05  Aligned_cols=136  Identities=18%  Similarity=0.185  Sum_probs=82.0

Q ss_pred             eeeeeccCceEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVY   85 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~   85 (443)
                      ++.|..|....+|++....       ++..+++|+.....  .  ....+.+|..+++.|. +.-..++++.+.+    .
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~--~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--Q--GVDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----C--CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--c--hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            3678888889999987642       35789999863311  1  1345668999998884 3334667766543    2


Q ss_pred             EEEecCCCCChHH----------HH----H---hc----C-CCC--HHHHHHHHHHHHH-------------------HH
Q 013421           86 IILEFVTGGELFD----------KI----V---HQ----G-RLL--ENDCRRYFQQLID-------------------AV  122 (443)
Q Consensus        86 lv~Ey~~gg~L~~----------~i----~---~~----~-~l~--e~~~~~~~~qll~-------------------aL  122 (443)
                      +||||++|..|..          .+    .   ..    + ...  ..++.+++.|+-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            8999998855421          11    1   10    1 111  3455666655432                   23


Q ss_pred             HHHH----h----CCCEeecCCCCcEEEcCC----CCeEEeeecCcC
Q 013421          123 AHCH----S----KGVYHRDLKPENLLLDSY----GNLKVSDFGLSA  157 (443)
Q Consensus       123 ~yLH----~----~gi~HrDlkp~NILl~~~----~~~kL~DFGls~  157 (443)
                      ..|.    .    ..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            3332    2    258999999999999876    789999998765

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.19  E-value=0.0015  Score=62.75  Aligned_cols=75  Identities=15%  Similarity=0.118  Sum_probs=47.3

Q ss_pred             eeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceEEEE-----EEeCCEEEEE
Q 013421           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLHEV-----LASRTKVYII   87 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~-----~~~~~~~~lv   87 (443)
                      ..|+ |....||++.. .+|+.+++|+.......    .+.+..|..+++.+...  .+++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 88889998754 34667999998643221    24566788887777321  23333332     2235677899


Q ss_pred             EecCCCCC
Q 013421           88 LEFVTGGE   95 (443)
Q Consensus        88 ~Ey~~gg~   95 (443)
                      |++++|..
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.13  E-value=0.0017  Score=65.26  Aligned_cols=73  Identities=12%  Similarity=0.145  Sum_probs=49.8

Q ss_pred             eeeeeccCceEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRTKVY   85 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~   85 (443)
                      ++.|+.|....+|++....       ++..+++|+.....  .   .+.+.+|..+++.+...+ ..++++.+.+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            4678999999999998653       25789999884321  1   133447899988884333 3667766542    3


Q ss_pred             EEEecCCCCC
Q 013421           86 IILEFVTGGE   95 (443)
Q Consensus        86 lv~Ey~~gg~   95 (443)
                      +|+||++|..
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            8999998643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.98  E-value=0.0017  Score=63.64  Aligned_cols=74  Identities=15%  Similarity=0.107  Sum_probs=44.8

Q ss_pred             eeeeeccCceEEEEEEECC--------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEE
Q 013421           14 GRTIGEGTFAKVRFAQNRE--------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRTKV   84 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~   84 (443)
                      .+.|+.|....+|++....        .+..+++|+.......    ......|..+++.+...+ ..+++...  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            4678889999999997643        1368899987543211    112357888888774333 45666554  22  


Q ss_pred             EEEEecCCCCC
Q 013421           85 YIILEFVTGGE   95 (443)
Q Consensus        85 ~lv~Ey~~gg~   95 (443)
                      ++||||++|..
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            68999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.76  E-value=0.0073  Score=58.54  Aligned_cols=31  Identities=19%  Similarity=0.328  Sum_probs=27.3

Q ss_pred             CCCEeecCCCCcEEEcCCCCeEEeeecCcCC
Q 013421          128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (443)
Q Consensus       128 ~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (443)
                      .+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888999999987654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.75  E-value=0.012  Score=59.67  Aligned_cols=75  Identities=19%  Similarity=0.175  Sum_probs=48.9

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEecCC
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYIILEFVT   92 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey~~   92 (443)
                      ++.|+.|....+|++.....+..+++|+.......   .. .-.+|..+++.|...++ .++++.+.  +  ..||||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---II-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence            47789999999999987654578899987542210   01 12578999998865444 56777663  2  25999998


Q ss_pred             CCCh
Q 013421           93 GGEL   96 (443)
Q Consensus        93 gg~L   96 (443)
                      |..|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.70  E-value=0.03  Score=56.00  Aligned_cols=75  Identities=13%  Similarity=0.104  Sum_probs=48.9

Q ss_pred             eeeeeccCceEEEEEEECCC-------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRET-------GESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVY   85 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~   85 (443)
                      ++.+..|....+|+......       +..+++|+.......    .-...+|..+++.+. +.-..++++.+  .+  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~----~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK----FYDSKVELDVFRYLSNINIAPNIIADF--PE--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C----CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch----hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence            46788899999999987531       578999986543211    112357888888874 33345666533  22  6


Q ss_pred             EEEecCCCCCh
Q 013421           86 IILEFVTGGEL   96 (443)
Q Consensus        86 lv~Ey~~gg~L   96 (443)
                      .||||++|..|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.57  E-value=0.21  Score=49.41  Aligned_cols=29  Identities=31%  Similarity=0.450  Sum_probs=24.8

Q ss_pred             CEeecCCCCcEEE------cCCCCeEEeeecCcCC
Q 013421          130 VYHRDLKPENLLL------DSYGNLKVSDFGLSAL  158 (443)
Q Consensus       130 i~HrDlkp~NILl------~~~~~~kL~DFGls~~  158 (443)
                      ++|+|+.+.|||+      ++++.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      4567899999988753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.44  E-value=1  Score=40.38  Aligned_cols=113  Identities=17%  Similarity=0.187  Sum_probs=80.2

Q ss_pred             CCCCcceEEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCCEeecCCCCcEEEcCC
Q 013421           67 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA-HCHSKGVYHRDLKPENLLLDSY  145 (443)
Q Consensus        67 ~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~-yLH~~gi~HrDlkp~NILl~~~  145 (443)
                      .||++  -..+-.+++.+.+.++.-+++.-+..+   ..++....++++.+|+.... ++  ..-+|--|+|+||++|.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            68888  555557788888888877666666666   34788889999988887665 44  345777899999999999


Q ss_pred             CCeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchH-HHHHHHHHHhhCCCCC
Q 013421          146 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW-SCGVILFVLMAGYLPF  210 (443)
Q Consensus       146 ~~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIw-SlGvil~~ll~G~~Pf  210 (443)
                      +.+++.-.|+-.                 -++|.-+       ...|.| +.=|++..++.++..|
T Consensus       121 ~~p~i~hRGi~~-----------------~lpP~e~-------~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          121 LEPFFLHVGVKE-----------------SLPPDEW-------DDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             CCEEESCCEETT-----------------TBSSCSC-------CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             CcEEEEEcCCcc-----------------cCCCCCC-------CHHHHHHHHHHHHHHHHcCCCCH
Confidence            999998777532                 2333221       334444 4667888888877665

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.90  E-value=0.7  Score=41.39  Aligned_cols=114  Identities=19%  Similarity=0.264  Sum_probs=80.2

Q ss_pred             CCCCcceEEEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC
Q 013421           67 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG  146 (443)
Q Consensus        67 ~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~  146 (443)
                      .||+++.. .+-.+.+.+.+.++.-+.+.-+..+   ..++....++++.+|+....++++  -+|=-|+|+||+++.++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~~~  116 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTRDG  116 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECTTS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcCCC
Confidence            68999877 5667777777777765544444444   347888899999999887755443  47778999999999999


Q ss_pred             CeEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchH-HHHHHHHHHhhCCCCC
Q 013421          147 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW-SCGVILFVLMAGYLPF  210 (443)
Q Consensus       147 ~~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIw-SlGvil~~ll~G~~Pf  210 (443)
                      .+++.--|+...                 ++|.       .....|.| ..=|++..+++++..|
T Consensus       117 ~p~i~~RGik~~-----------------l~P~-------~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          117 LPIAKTRGLQNV-----------------VDPL-------PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             CEEESCCEETTT-----------------BSCC-------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             CEEEEEccCccC-----------------CCCC-------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            999987775321                 2222       11333444 4668888899888777

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=81.65  E-value=0.086  Score=53.33  Aligned_cols=64  Identities=8%  Similarity=0.181  Sum_probs=18.4

Q ss_pred             EEeeeeeccCceEEEEEEECCCCcEEEE------EEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013421           12 EVGRTIGEGTFAKVRFAQNRETGESVAM------KVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA   79 (443)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vAi------K~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~   79 (443)
                      .+.+.||   ||.||.+.......+||+      |........ .+....+.+|..+++.++|||+++.+.+..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~-~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS-EKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCcccccccccc-ccccccccccccccccccccccCCCcceEE
Confidence            3456676   999999988765568888      655432222 223456778999999999999999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	443
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-89
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-85
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-83
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-81
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-80
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-79
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-79
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-79
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-78
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-77
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-77
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-76
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-75
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-75
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-74
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-74
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-72
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-72
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-72
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-71
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-70
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-69
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-66
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-65
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-65
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-65
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-64
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-64
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-62
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-62
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-61
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-60
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-60
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-59
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-58
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-58
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-57
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-56
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-56
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-55
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-55
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-53
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-50
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-45
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-39
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-22
d1ul7a_	102	d.129.6.1 (A:) Map/microtubule affinity-regulating	1e-13

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  269 bits (690), Expect = 4e-89
 Identities = 94/258 (36%), Positives = 148/258 (57%), Gaps = 3/258 (1%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHP
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK 
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R +D  
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTTLCGTLDYLPPEMIEGRMHD-E 183

Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 243

Query: 250 KTRIRIEGIRKHPWFRKN 267
             R  +  + +HPW   N
Sbjct: 244 SQRPMLREVLEHPWITAN 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  260 bits (666), Expect = 2e-85
 Identities = 100/265 (37%), Positives = 150/265 (56%), Gaps = 7/265 (2%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +++ +T+GEG + +V+ A NR T E+VA+K++     +     + IK+EI I K++ H 
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHE 63

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V + H  G
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYD 187
           + HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L  R + 
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW--FSTGATSLIHKI 244
               DVWSCG++L  ++AG LP+   +D    Y      +     W    +   +L+HKI
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 243

Query: 245 LDPNPKTRIRIEGIRKHPWFRKNYN 269
           L  NP  RI I  I+K  W+ K   
Sbjct: 244 LVENPSARITIPDIKKDRWYNKPLK 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  254 bits (650), Expect = 7e-83
 Identities = 81/270 (30%), Positives = 139/270 (51%), Gaps = 9/270 (3%)

Query: 4   QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           + +R   ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62

Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
             + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ 
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPEVL 181
           + H KG+ HRDLKPEN+LL+   +++++DFG + +     +        GT  YV+PE+L
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           + +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+
Sbjct: 183 TEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241

Query: 242 HKILDPNPKTRIRIE------GIRKHPWFR 265
            K+L  +   R+  E       ++ HP+F 
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  251 bits (641), Expect = 3e-81
 Identities = 67/280 (23%), Positives = 118/280 (42%), Gaps = 8/280 (2%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +   R IG G+F  V FA++    E VA+K ++ S    +     I +E+  ++ +RHP
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           N ++           ++++E+  G       VH+  L E +        +  +A+ HS  
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL--SNRGYD 187
           + HRD+K  N+LL   G +K+ DFG +++        ++  GTP ++APEV+   + G  
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQY 191

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW--FSTGATSLIHKIL 245
               DVWS G+    L     P    +  +    I   E        +S    + +   L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251

Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVH 285
              P+ R   E + KH +  +   P    +  +   D V 
Sbjct: 252 QKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVR 291

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (635), Expect = 1e-80
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 11/267 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   +G+G F KV  AQN+ET    A KV+          ++    EI I+    HPN
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPN 70

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCHSKG 129
           IV+L +       ++I++EF  GG +   ++   R L E+  +   +Q +DA+ + H   
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL----SNRG 185
           + HRDLK  N+L    G++K++DFG+SA   + ++   +  GTP ++APEV+    S   
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLIH 242
                ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+     + 
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYN 269
           K L+ N   R     + +HP+   + N
Sbjct: 251 KCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (628), Expect = 2e-79
 Identities = 69/261 (26%), Positives = 125/261 (47%), Gaps = 8/261 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      +    + I  EI +M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRENKNP 77

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRD+K +N+LL   G++K++DFG  A          T  GTP ++APEV++ + Y   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-P 195

Query: 190 AADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATSLIHKILD 246
             D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ LD
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 247 PNPKTRIRIEGIRKHPWFRKN 267
            + + R   + + +H + +  
Sbjct: 256 MDVEKRGSAKELLQHQFLKIA 276

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  246 bits (630), Expect = 5e-79
 Identities = 79/293 (26%), Positives = 137/293 (46%), Gaps = 12/293 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y++   +G G F  V     R TG + A K +           + +++EI  M ++RHP
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHP 83

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSK 128
            +V LH+      ++ +I EF++GGELF+K+  +  ++ E++   Y +Q+   + H H  
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 129 GVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
              H DLKPEN++  +     LK+ DFGL+A      + +  T GT  + APEV   +  
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTTGTAEFAAPEVAEGKPV 202

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGATSLIH 242
            G   D+WS GV+ ++L++G  PFG  +     + + + +++         S      I 
Sbjct: 203 -GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQY 295
           K+L  +P TR+ I    +HPW      P + S+        +        D +
Sbjct: 262 KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAW 314

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  246 bits (629), Expect = 8e-79
 Identities = 73/276 (26%), Positives = 132/276 (47%), Gaps = 12/276 (4%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           KQ      Y++   +G G F  V     + TG     K +     L       +K EISI
Sbjct: 23  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISI 79

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDA 121
           M  + HP ++ LH+    + ++ +ILEF++GGELFD+I  +  ++ E +   Y +Q  + 
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139

Query: 122 VAHCHSKGVYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           + H H   + H D+KPEN++ ++    ++K+ DFGL+       E++  T  T  + APE
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPE 198

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFST 235
           ++          D+W+ GV+ +VL++G  PF   D     + +   ++          S 
Sbjct: 199 IVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257

Query: 236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
            A   I  +L   P+ R+ +    +HPW + +++ +
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (620), Expect = 6e-78
 Identities = 78/258 (30%), Positives = 138/258 (53%), Gaps = 3/258 (1%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHP 69
           + + + +G+G+F KV  A+ ++T +  A+K L K  +L    V+    E  ++ +   HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
            +  +     ++  ++ ++E++ GG+L   I    +   +    Y  ++I  +   HSKG
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + +RDLK +N+LLD  G++K++DFG+      G    +T CGTP+Y+APE+L  + Y+  
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN-H 182

Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
           + D WS GV+L+ ++ G  PF   D   L+  I       P W    A  L+ K+    P
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREP 242

Query: 250 KTRIRIEG-IRKHPWFRK 266
           + R+ + G IR+HP FR+
Sbjct: 243 EKRLGVRGDIRQHPLFRE 260

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (611), Expect = 3e-77
 Identities = 79/269 (29%), Positives = 133/269 (49%), Gaps = 14/269 (5%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R   YEV  TIG G++ + +  + +  G+ +  K L   ++ +      +  E+++++ +
Sbjct: 2   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLREL 60

Query: 67  RHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLID 120
           +HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   QL  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 121 AVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +            GTP Y
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180

Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFS 234
           ++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P+ +S
Sbjct: 181 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 239

Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPW 263
                +I ++L+     R  +E I ++P 
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  239 bits (612), Expect = 8e-77
 Identities = 103/275 (37%), Positives = 157/275 (57%), Gaps = 11/275 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y+    +G G F++V  A+++ T + VA+K +AK  +        ++ EI+++  ++HP
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHP 67

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + H  G
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 130 VYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLL    D    + +SDFGLS +   G  +L T CGTP YVAPEVL+ + Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY 186

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
              A D WS GVI ++L+ GY PF + +   L+++I  AE  F  P+W   S  A   I 
Sbjct: 187 S-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
            +++ +P+ R   E   +HPW   +    K   + 
Sbjct: 246 HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  236 bits (604), Expect = 4e-76
 Identities = 82/273 (30%), Positives = 138/273 (50%), Gaps = 17/273 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH------RMVDQIKREISIM 63
            YE    +G G  + VR   ++ T +  A+K++  +            + +   +E+ I+
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 64  KIVR-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           + V  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
              H   + HRDLKPEN+LLD   N+K++DFG S     G E L   CGTP+Y+APE++ 
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIE 182

Query: 183 -----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
                N    G   D+WS GVI++ L+AG  PF       + + I +   +F  P W  +
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242

Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
           S     L+ + L   P+ R   E    HP+F++
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (601), Expect = 4e-75
 Identities = 72/270 (26%), Positives = 127/270 (47%), Gaps = 13/270 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY +   +G G F  V       + ++   K +      K      +K+EISI+ I RH 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSK 128
           NI+ LHE   S  ++ +I EF++G ++F++I      L E +   Y  Q+ +A+   HS 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 129 GVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            + H D++PEN++  +     +K+ +FG +   + G +        P Y APEV  +   
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVV 180

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGATSLIH 242
             +A D+WS G +++VL++G  PF       + + I  AE++         S  A   + 
Sbjct: 181 S-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
           ++L    K+R+      +HPW ++    V 
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVS 269

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  235 bits (601), Expect = 4e-75
 Identities = 84/261 (32%), Positives = 155/261 (59%), Gaps = 9/261 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +++ RT+G G+F +V   ++R  G   AMKVL K  +++ + V+    E  ++ IV HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+R+        ++++I++++ GGELF  +    R      + Y  ++  A+ + HSK +
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  G++K++DFG +   +   ++ +T CGTP+Y+APEV+S + Y+  +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAPEVVSTKPYN-KS 181

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D WS G++++ ++AGY PF +++    Y+KI  AE   P +F+     L+ +++  +  
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLS 241

Query: 251 TRIR-----IEGIRKHPWFRK 266
            R+       E ++ HPWF++
Sbjct: 242 QRLGNLQNGTEDVKNHPWFKE 262

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 4e-74
 Identities = 68/317 (21%), Positives = 121/317 (38%), Gaps = 57/317 (17%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK- 128
            IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            + HRD+KP N+L++S G +K+ DFG+S      +   ++  GT +Y++PE L    Y  
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYS- 181

Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW---------------- 232
             +D+WS G+ L  +  G  P    D   L                              
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 233 ----------------------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
                                       FS      ++K L  NP  R  ++ +  H + 
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 265 RKNYNPVKCSEEEEVNL 281
           ++       S+ EEV+ 
Sbjct: 302 KR-------SDAEEVDF 311

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 5e-74
 Identities = 84/261 (32%), Positives = 135/261 (51%), Gaps = 6/261 (2%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            ++  + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
            +  L     +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V +RD+K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y   
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG-R 184

Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
           A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +P
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244

Query: 250 KTRIR-----IEGIRKHPWFR 265
           K R+       + + +H +F 
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL 265

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 2e-72
 Identities = 85/279 (30%), Positives = 130/279 (46%), Gaps = 18/279 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKIV 66
           +Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K V
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 67  R--HPNIVRLHEVLASRTKVYIILEFVTGG-ELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
                 ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 124 HCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +    +     GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIR 182

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
              Y G +A VWS G++L+ ++ G +PF   +      +I   +       S+    LI 
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIR 236

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
             L   P  R   E I+ HPW +    P    E  E++L
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQDVLLP---QETAEIHL 272

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  228 bits (582), Expect = 9e-72
 Identities = 81/266 (30%), Positives = 128/266 (48%), Gaps = 13/266 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR--- 67
           + V R IG G F +V   +  +TG+  AMK L K  I   +       E  ++ +V    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H+
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + V +RDLKP N+LLD +G++++SD GL+    +     H + GT  Y+APEVL      
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAY 183

Query: 188 GSAADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
            S+AD +S G +LF L+ G+ PF      D   + +         P  FS    SL+  +
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 243

Query: 245 LDPNPKTRIRIEG-----IRKHPWFR 265
           L  +   R+   G     +++ P+FR
Sbjct: 244 LQRDVNRRLGCLGRGAQEVKESPFFR 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 9e-72
 Identities = 88/268 (32%), Positives = 140/268 (52%), Gaps = 13/268 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIV 66
            Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           +HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 127 SKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           S  + H DLKPEN++L         +K+ DFGL+     G        GTP +VAPE+++
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVN 189

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF----STGAT 238
                   AD+WS GVI ++L++G  PF           ++A  +     +    S  A 
Sbjct: 190 YEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRK 266
             I ++L  +PK R+ I+   +HPW + 
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 5e-71
 Identities = 61/265 (23%), Positives = 117/265 (44%), Gaps = 15/265 (5%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
            +    IG G+F  V    + ET   VA   L    + K     + K E  ++K ++HPN
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPN 69

Query: 71  IVRLHEVLASRTK----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           IVR ++   S  K    + ++ E +T G L   +     +     R + +Q++  +   H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 127 SKG--VYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           ++   + HRDLK +N+ +    G++K+ D GL+ L +          GTP ++APE+   
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE 187

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW--FSTGATSL 240
           + YD  + DV++ G+ +  +     P+    +   +Y+++ +      F          +
Sbjct: 188 K-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFR 265
           I   +  N   R  I+ +  H +F+
Sbjct: 246 IEGCIRQNKDERYSIKDLLNHAFFQ 270

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 2e-70
 Identities = 95/321 (29%), Positives = 152/321 (47%), Gaps = 29/321 (9%)

Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 5   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVE 56

Query: 62  IM-KIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG +         L T C 
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCY 175

Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD  + D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 176 TPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234

Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDD 283
           EF  P W   S     LI  +L   P  R+ I     HPW  ++    +        L +
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKE 294

Query: 284 VHAVFDDIEDQYVAEQSENKV 304
               ++D++++  +  +  +V
Sbjct: 295 DKERWEDVKEEMTSALATMRV 315

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  221 bits (563), Expect = 4e-69
 Identities = 90/315 (28%), Positives = 164/315 (52%), Gaps = 15/315 (4%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
            + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
             + HS  + +RDLKPENLL+D  G ++V+DFG +   ++      T CGTP  +APE++
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEII 210

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
            ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+
Sbjct: 211 LSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269

Query: 242 HKILDPNPKTRIR-----IEGIRKHPWFRK-NYNPVKCSEEE-----EVNLDDVHAVFDD 290
             +L  +   R       +  I+ H WF   ++  +   + E     +       + FDD
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

Query: 291 IEDQYVAEQSENKVG 305
            E++ +      K G
Sbjct: 330 YEEEEIRVSINEKCG 344

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  211 bits (538), Expect = 3e-66
 Identities = 64/267 (23%), Positives = 114/267 (42%), Gaps = 12/267 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 70  NIVRLHEVLASRTK----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV +++   + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL---PQQGVELLHTTCGTPNYVAPEVLS 182
           H  G+ HRD+KP N+++ +   +KV DFG++         V       GT  Y++PE   
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGAT 238
               D + +DV+S G +L+ ++ G  PF      ++  +    +   P       S    
Sbjct: 188 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFR 265
           +++ K L  NP+ R +     +    R
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLVR 273

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 3e-65
 Identities = 55/263 (20%), Positives = 109/263 (41%), Gaps = 16/263 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +  VG+ IG G+F  V   +       VA+K+L  +     + +   K E+ +++  RH 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHV 64

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           NI+      ++  ++ I+ ++  G  L+  + + + +          +Q    + + H+K
Sbjct: 65  NILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVL--SNR 184
            + HRDLK  N+ L     +K+ DFGL+ +     G        G+  ++APEV+   ++
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW------FSTGAT 238
                 +DV++ G++L+ LM G LP+   +       +    +  P              
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243

Query: 239 SLIHKILDPNPKTRIRIEGIRKH 261
            L+ + L      R     I   
Sbjct: 244 RLMAECLKKKRDERPLFPQILAS 266

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 5e-65
 Identities = 73/299 (24%), Positives = 121/299 (40%), Gaps = 41/299 (13%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y     IGEG +  V  A +      VA+K ++           +  REI I+   RH 
Sbjct: 9   RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 66

Query: 70  NIVRLHEVLASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           NI+ +++++ + T    K   ++  + G +L+  ++    L  +    +  Q++  + + 
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL---PQQGVELLHTTCGTPNYVAPEVLS 182
           HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y APE++ 
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-------------------- 222
           N      + D+WS G IL  +++    F           I                    
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 223 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
                S P               + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 5e-65
 Identities = 86/292 (29%), Positives = 137/292 (46%), Gaps = 31/292 (10%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            ++    IGEGT+  V  A+N+ TGE VA+K +   T     +     REIS++K + HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHP 61

Query: 70  NIVRLHEVLASRTKVYIILEFV-TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           NIV+L +V+ +  K+Y++ EF+    + F        +     + Y  QL+  +A CHS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 189 SAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-----------------EFSCP 230
           +A D+WS G I   ++     F G++++  L++                      + S P
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241

Query: 231 FW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
            W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 2e-64
 Identities = 70/294 (23%), Positives = 112/294 (38%), Gaps = 30/294 (10%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVRHP 69
           E    +GEG FA V  A+++ T + VA+K +        K  +     REI +++ + HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI+ L +    ++ + ++ +F+          +   L  +  + Y    +  + + H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRDLKP NLLLD  G LK++DFGL+               T  Y APE+L      G 
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 190 AADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-EFSCPFW--------------- 232
             D+W+ G IL  L+       G++DL  L +        +   W               
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240

Query: 233 -----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
                             LI  +   NP  RI      K  +F     P    +
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 7e-64
 Identities = 69/309 (22%), Positives = 117/309 (37%), Gaps = 45/309 (14%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
             V+KYE    IG+GTF +V  A++R+TG+ VA+K +      K        REI I+++
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQL 65

Query: 66  VRHPNIVRLHEVLASRT--------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ 117
           ++H N+V L E+  ++          +Y++ +F              +   ++ +R  Q 
Sbjct: 66  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL----PQQGVELLHTTCGTP 173
           L++ + + H   + HRD+K  N+L+   G LK++DFGL+                   T 
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--- 230
            Y  PE+L      G   D+W  G I+  +                  I+    S     
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245

Query: 231 -----------------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                                        +     A  LI K+L  +P  RI  +    H
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305

Query: 262 PWFRKNYNP 270
            +F  +  P
Sbjct: 306 DFFWSDPMP 314

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  202 bits (514), Expect = 1e-62
 Identities = 77/286 (26%), Positives = 125/286 (43%), Gaps = 31/286 (10%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IGEGT+  V  AQN   GE+ A+K +         +     REISI+K ++H 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV+L++V+ ++ ++ ++ E +         V +G L     + +  QL++ +A+CH + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+VL       +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--------------- 232
             D+WS G I   ++ G   F          +I       +   W               
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 233 ------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
                              L+ K+L  +P  RI  +   +H +F++
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (513), Expect = 2e-62
 Identities = 86/291 (29%), Positives = 123/291 (42%), Gaps = 31/291 (10%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KYE    IGEGT+  V  A+NRET E VA+K +         +     REI ++K ++H 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHK 61

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVRLH+VL S  K+ ++ EF             G L     + +  QL+  +  CHS+ 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRDLKP+NLL++  G LK+++FGL+      V        T  Y  P+VL       +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 190 AADVWSCGVILFVLMAGYLP-FGETDLPTLYKKINAAEFSCPF----------------- 231
           + D+WS G I   L     P F   D+    K+I     +                    
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 232 ------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
                         +     L+  +L  NP  RI  E   +HP+F     P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 7e-62
 Identities = 78/320 (24%), Positives = 134/320 (41%), Gaps = 48/320 (15%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y   + +G G +  V  A +  TG  VA+K L +          +  RE+ ++K +RH 
Sbjct: 19  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHE 77

Query: 70  NIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
           N++ L +V      L   T  Y+++ F+  G    K++   +L E+  +    Q++  + 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           + H+ G+ HRDLKP NL ++    LK+ DFGL+   +Q    +     T  Y APEV+ N
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRWYRAPEVILN 192

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF---------- 233
                   D+WS G I+  ++ G   F  +D     K+I     + P  F          
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 234 ---------------------STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
                                S  A +L+ K+L  + + R+       HP+F   ++   
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT-- 310

Query: 273 CSEEEEVNLDDVHAVFDDIE 292
              E+E  +      FDD++
Sbjct: 311 ---EDEPQVQKYDDSFDDVD 327

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 4e-61
 Identities = 60/257 (23%), Positives = 111/257 (43%), Gaps = 16/257 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + ++ +TIG+G F  V     R  G  VA+K +                E S+M  +RH 
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60

Query: 70  NIVRLHEVLA-SRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCH 126
           N+V+L  V+   +  +YI+ E++  G L D +  +GR  L  +   ++   + +A+ +  
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
                HRDL   N+L+      KVSDFGL+   ++      T      + APE L  + +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKF 177

Query: 187 DGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKI 244
             + +DVWS G++L+ + + G +P+    L  +  ++        P         ++   
Sbjct: 178 S-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNC 236

Query: 245 LDPNPKTRIRIEGIRKH 261
              +   R     +R+ 
Sbjct: 237 WHLDAAMRPSFLQLREQ 253

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 2e-60
 Identities = 86/284 (30%), Positives = 152/284 (53%), Gaps = 18/284 (6%)

Query: 1   MKKQTRRVA--KYEVGRTIGEGTFAKVRFAQ---NRETGESVAMKVLAKSTIL-KHRMVD 54
           +     +V    +E+ + +G G + KV   +     +TG+  AMKVL K+TI+ K +  +
Sbjct: 14  LTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE 73

Query: 55  QIKREISIMKIVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
             + E  +++ +R  P +V LH    + TK+++IL+++ GGELF  +  + R  E++ + 
Sbjct: 74  HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI 133

Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT 172
           Y  +++ A+ H H  G+ +RD+K EN+LLDS G++ ++DFGLS        E  +  CGT
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193

Query: 173 PNYVAPEVL-SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEF 227
             Y+AP+++         A D WS GV+++ L+ G  PF           + ++I  +E 
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253

Query: 228 SCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK 266
             P   S  A  LI ++L  +PK R+       + I++H +F+K
Sbjct: 254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 2e-60
 Identities = 52/260 (20%), Positives = 107/260 (41%), Gaps = 13/260 (5%)

Query: 15  RTIGEGTFAKVRFA--QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           + +G G F  V+    Q ++  ++VA+K+L K+      + D++  E ++M+ + +P IV
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           R+  +        +++E    G L   +     + + +      Q+   + +       H
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGS 189
           RDL   N+LL +    K+SDFGLS   +                 + APE ++   +  S
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 189

Query: 190 AADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDP 247
            +DVWS GV+++   + G  P+       +   +   E   CP         L++     
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249

Query: 248 NPKTRIRIEGIR---KHPWF 264
           + + R     +    ++ ++
Sbjct: 250 DVENRPGFAAVELRLRNYYY 269

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 3e-60
 Identities = 83/336 (24%), Positives = 132/336 (39%), Gaps = 51/336 (15%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K        RE+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDHCN 74

Query: 71  IVRLHEVLAS------RTKVYIILEFVTGG---ELFDKIVHQGRLLENDCRRYFQQLIDA 121
           IVRL     S         + ++L++V              +  L     + Y  QL  +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           +A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G E   +   +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPEL 193

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-----------------N 223
           +       S+ DVWS G +L  L+ G   F          +I                 N
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 224 AAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
             EF  P                  A +L  ++L+  P  R+       H +F +  +P 
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP- 312

Query: 272 KCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGP 307
                +  N  D  A+F+    +  +      +  P
Sbjct: 313 ---NVKLPNGRDTPALFNFTTQELSSNPPLATILIP 345

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 3e-60
 Identities = 67/296 (22%), Positives = 117/296 (39%), Gaps = 39/296 (13%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+    +G G +  V  A + +TG  VA+K L++          +  RE+ ++K ++H 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHE 77

Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           N++ L +V      +     + L     G   + IV   +L ++  +    Q++  + + 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HS  + HRDLKP NL ++    LK+ DFGL+      +        T  Y APE++ N  
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 194

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF------------ 233
           +     D+WS G I+  L+ G   F  TD     K I     +                 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254

Query: 234 -------------------STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
                              +  A  L+ K+L  +   RI       H +F + ++P
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 4e-60
 Identities = 54/255 (21%), Positives = 110/255 (43%), Gaps = 10/255 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
               + +G G F  V++ + R     VA+K++ + ++ +    D+   E  +M  + H  
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           +V+L+ V   +  ++II E++  G L + +   + R          + + +A+ +  SK 
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
             HRDL   N L++  G +KVSDFGLS  +          +     +  PEVL    +  
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS- 179

Query: 189 SAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIHKILD 246
           S +D+W+ GV+++ + + G +P+         + I        P   S    ++++    
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWH 239

Query: 247 PNPKTRIRIEGIRKH 261
                R   + +  +
Sbjct: 240 EKADERPTFKILLSN 254

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (491), Expect = 3e-59
 Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 12/277 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
              +   +G G + +V     ++   +VA+K L + T+     V++  +E ++MK ++HP
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 73

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHS 127
           N+V+L  V       YII EF+T G L D +    R  +          Q+  A+ +   
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT-TCGTPNYVAPEVLSNRGY 186
           K   HRDL   N L+     +KV+DFGLS L        H        + APE L+   +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193

Query: 187 DGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA-AEFSCPFWFSTGATSLIHKI 244
               +DVW+ GV+L+ +   G  P+   DL  +Y+ +        P         L+   
Sbjct: 194 S-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252

Query: 245 LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
              NP  R     I +   F   +     S+E E  L
Sbjct: 253 WQWNPSDRPSFAEIHQ--AFETMFQESSISDEVEKEL 287

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 3e-59
 Identities = 65/261 (24%), Positives = 110/261 (42%), Gaps = 12/261 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
             +   +G+G+F  VR  +         SVA+K L    + +   +D   RE++ M  + 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCH 126
           H N++RL+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  
Sbjct: 70  HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSN 183
           SK   HRDL   NLLL +   +K+ DFGL     Q  +             + APE L  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188

Query: 184 RGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSCPFW--FSTGATSL 240
           R +   A+D W  GV L+ +   G  P+   +   +  KI+      P          ++
Sbjct: 189 RTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247

Query: 241 IHKILDPNPKTRIRIEGIRKH 261
           + +     P+ R     +R  
Sbjct: 248 MVQCWAHKPEDRPTFVALRDF 268

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 4e-58
 Identities = 62/259 (23%), Positives = 107/259 (41%), Gaps = 15/259 (5%)

Query: 17  IGEGTFAKVRFAQNRETGES--VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  VR    R   +   VA+KVL + T  +    +++ RE  IM  + +P IVRL
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
             V      + +++E   GG L   +V  +  +  ++      Q+   + +   K   HR
Sbjct: 75  IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DL   N+LL +    K+SDFGLS                     + APE ++ R +  S 
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 192

Query: 191 ADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPN 248
           +DVWS GV ++  ++ G  P+ +   P +   I   +   CP        +L+       
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252

Query: 249 PKTRIRIEGIR---KHPWF 264
            + R     +    +  ++
Sbjct: 253 WEDRPDFLTVEQRMRACYY 271

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 9e-58
 Identities = 79/297 (26%), Positives = 123/297 (41%), Gaps = 40/297 (13%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           R   +YE    IGEG + KV  A++ +  G  VA+K +   T  +  M     RE+++++
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLR 62

Query: 65  I---VRHPNIVRLHEVLAS-----RTKVYIILEFVTGGEL-FDKIVHQGRLLENDCRRYF 115
                 HPN+VRL +V         TK+ ++ E V      +   V +  +     +   
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
            QL+  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    +  L +   T  Y
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWY 181

Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF--- 231
            APEVL    Y  +  D+WS G I   +      F G +D+  L K ++           
Sbjct: 182 RAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240

Query: 232 -----------------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
                                          L+ K L  NP  RI       HP+F+
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-57
 Identities = 59/262 (22%), Positives = 110/262 (41%), Gaps = 14/262 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
             ++   +G G F +V           VA+K L + ++      D    E ++MK ++H 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHS 127
            +VRL+ V+ ++  +YII E++  G L D +      +L  N       Q+ + +A    
Sbjct: 69  RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           +   HRDL+  N+L+    + K++DFGL+  +                + APE + N G 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGT 186

Query: 187 DGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIHKI 244
               +DVWS G++L  ++  G +P+     P + + +        P         L+   
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246

Query: 245 LDPNPKTRIRIEGIRK--HPWF 264
               P+ R   + +R     +F
Sbjct: 247 WKERPEDRPTFDYLRSVLEDFF 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 8e-57
 Identities = 57/255 (22%), Positives = 102/255 (40%), Gaps = 10/255 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
               + IG G F  V         + VA+K + +  + +    +    E  +M  + HP 
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCHSKG 129
           +V+L+ V   +  + ++ EF+  G L D +  Q  L            + + +A+     
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
           V HRDL   N L+     +KVSDFG+   +          T     + +PEV S   Y  
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS- 180

Query: 189 SAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIHKILD 246
           S +DVWS GV+++ + + G +P+       + + I        P   ST    +++    
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240

Query: 247 PNPKTRIRIEGIRKH 261
             P+ R     + + 
Sbjct: 241 ERPEDRPAFSRLLRQ 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 9e-57
 Identities = 58/265 (21%), Positives = 105/265 (39%), Gaps = 14/265 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
              +   +G+G F +V       T   VA+K L   T+      +   +E  +MK +RH 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHS 127
            +V+L+ V+ S   +YI+ E+++ G L D +  +    L          Q+   +A+   
Sbjct: 73  KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
               HRDL+  N+L+      KV+DFGL+  +                + APE      +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191

Query: 187 DGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIHKI 244
               +DVWS G++L  +   G +P+       +  ++       CP         L+ + 
Sbjct: 192 T-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250

Query: 245 LDPNPKTRIRIEGIRK--HPWFRKN 267
               P+ R   E ++     +F   
Sbjct: 251 WRKEPEERPTFEYLQAFLEDYFTST 275

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 9e-57
 Identities = 58/286 (20%), Positives = 107/286 (37%), Gaps = 37/286 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES-----VAMKVLAKSTILKHRMVDQIKREISIM- 63
             E G+ +G G F KV  A      ++     VA+K+L +      R  + +  E+ +M 
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EALMSELKMMT 95

Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-------------------- 103
           ++  H NIV L         +Y+I E+   G+L + +  +                    
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 104 ---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL-- 158
                L   D   +  Q+   +     K   HRDL   N+L+     +K+ DFGL+    
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT 217
                 +         ++APE L    Y    +DVWS G++L+ + + G  P+    +  
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 218 LYKKI--NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH 261
            + K+  N  +   PF+ +     ++      + + R     +   
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-56
 Identities = 74/259 (28%), Positives = 113/259 (43%), Gaps = 11/259 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V              VA+K     T     + ++  +E   M+  
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF 65

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFD-KIVHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL     V +  L       Y  QL  A+A+ 
Sbjct: 66  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +       ++APE ++ R
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIH 242
            +   A+DVW  GV ++ +LM G  PF       +  +I N      P        SL+ 
Sbjct: 185 RFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243

Query: 243 KILDPNPKTRIRIEGIRKH 261
           K    +P  R R   ++  
Sbjct: 244 KCWAYDPSRRPRFTELKAQ 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  187 bits (475), Expect = 1e-56
 Identities = 64/271 (23%), Positives = 106/271 (39%), Gaps = 21/271 (7%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
            ++ + IG G F +V     +  G+    VA+K L      K R       E SIM    
Sbjct: 28  VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFD 85

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFD-KIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           HPN++ L  V+   T V II EF+  G L      + G+          + +   + +  
Sbjct: 86  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-----CGTPNYVAPEVL 181
                HRDL   N+L++S    KVSDFGLS   +        T          + APE +
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205

Query: 182 SNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATS 239
             R +   A+DVWS G++++ +M+ G  P+ +     +   I        P    +    
Sbjct: 206 QYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264

Query: 240 LIHKILDPNPKTRI-------RIEGIRKHPW 263
           L+      +   R         ++ + ++P 
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  187 bits (476), Expect = 2e-56
 Identities = 68/298 (22%), Positives = 121/298 (40%), Gaps = 52/298 (17%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRH 68
            Y++ R +G G +++V  A N    E V +K      ILK     +IKREI I++ +   
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRGG 89

Query: 69  PNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           PNI+ L +++         ++ E V   +          L + D R Y  +++ A+ +CH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146

Query: 127 SKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           S G+ HRD+KP N+++D     L++ D+GL+     G +  +    +  +  PE+L +  
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQ 205

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETD--------------LPTLYKKINAAEFSCPF 231
               + D+WS G +L  ++    PF                     LY  I+        
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 232 WF------------------------STGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
            F                        S  A   + K+L  + ++R+      +HP+F 
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-56
 Identities = 57/270 (21%), Positives = 97/270 (35%), Gaps = 21/270 (7%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
            +    IGEG F +V  A+ ++ G  +   +                 E+ ++ K+  HP
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRR 113
           NI+ L      R  +Y+ +E+   G L D +                     L       
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
           +   +   + +   K   HRDL   N+L+      K++DFGLS   +  V+         
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLPV 190

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI-NAAEFSCPF 231
            ++A E L N     + +DVWS GV+L+ ++  G  P+       LY+K+        P 
Sbjct: 191 RWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 249

Query: 232 WFSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                   L+ +     P  R     I   
Sbjct: 250 NCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 1e-55
 Identities = 56/293 (19%), Positives = 109/293 (37%), Gaps = 11/293 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVRH 68
           ++  + +G G F  V        GE V + V  K        +   +I  E  +M  V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           P++ RL  +  + T   I      G  L     H+  +       +  Q+   + +   +
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC--GTPNYVAPEVLSNRGY 186
            + HRDL   N+L+ +  ++K++DFGL+ L     +  H         ++A E + +R Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190

Query: 187 DGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKI 244
               +DVWS GV ++ LM  G  P+       +   +   E    P   +     ++ K 
Sbjct: 191 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249

Query: 245 LDPNPKTRIRIEGIRKHPWF----RKNYNPVKCSEEEEVNLDDVHAVFDDIED 293
              +  +R +   +           + Y  ++  E   +        +  + D
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMD 302

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (462), Expect = 8e-55
 Identities = 53/283 (18%), Positives = 101/283 (35%), Gaps = 28/283 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +GR IG G+F  +    +   GE VA+K+    T        Q+  E  I K+++  
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGG 62

Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
             I  +    A      +++E +             +           Q+I  + + HSK
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122

Query: 129 GVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLH-------TTCGTPNYVAP 178
              HRD+KP+N L+        + + DFGL+   +      H          GT  Y + 
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFW--- 232
                        D+ S G +L     G LP+           Y++I+  + S P     
Sbjct: 183 NTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241

Query: 233 --FSTGATSLIHKILDPNPKTRIRIEGIR---KHPWFRKNYNP 270
             + +   + ++         +     +R   ++ + R+ ++ 
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 9e-53
 Identities = 67/269 (24%), Positives = 109/269 (40%), Gaps = 20/269 (7%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIV 66
               + IG G F +V     + +       VA+K L      K R+      E  IM   
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQF 66

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHC 125
            H NI+RL  V++    + II E++  G L   +    G           + +   + + 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC---GTPNYVAPEVLS 182
            +    HRDL   N+L++S    KVSDFGLS + +   E  +TT        + APE +S
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186

Query: 183 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL 240
            R +  SA+DVWS G++++ +M  G  P+ E     + K IN       P    +    L
Sbjct: 187 YRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245

Query: 241 IHKILDPNPKTRI-------RIEGIRKHP 262
           + +        R         ++ + + P
Sbjct: 246 MMQCWQQERARRPKFADIVSILDKLIRAP 274

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 3e-52
 Identities = 75/334 (22%), Positives = 126/334 (37%), Gaps = 54/334 (16%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V H 
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHK 76

Query: 70  NIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
           NI+ L  V      L     VY+++E +         V Q  L          Q++  + 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIK 133

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           H HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+  
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG 192

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF---------- 233
            GY     D+WS G I+  ++   + F   D    + K+     +    F          
Sbjct: 193 MGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 234 --------------------------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                                           ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311

Query: 262 PWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQY 295
           P+    Y+P +         D      +   +++
Sbjct: 312 PYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW 345

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-50
 Identities = 63/280 (22%), Positives = 102/280 (36%), Gaps = 32/280 (11%)

Query: 10  KYEVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIM- 63
           +   G+T+G G F KV  A        +   +VA+K+L  S  L  R  + +  E+ ++ 
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 81

Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI------------------VHQGR 105
            +  H NIV L           +I E+   G+L + +                    +  
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           L   D   +  Q+   +A   SK   HRDL   N+LL      K+ DFGL+   +     
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 166 LHTT--CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKK 221
           +          ++APE + N       +DVWS G+ L+ L +       G       YK 
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 222 INAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK 260
           I        P         ++    D +P  R   + I +
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (432), Expect = 2e-50
 Identities = 60/284 (21%), Positives = 106/284 (37%), Gaps = 36/284 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
             E  R IGEG F +V  A+       E    VA+K+L +       M    +RE ++M 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR------------------- 105
              +PNIV+L  V A    + ++ E++  G+L + +                        
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 106 -----LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL-- 158
                L   +     +Q+   +A+   +   HRDL   N L+     +K++DFGLS    
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL-PFGETDLPT 217
                +          ++ PE +    Y  + +DVW+ GV+L+ + +  L P+       
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 218 LYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK 260
           +   +      +CP        +L+       P  R     I +
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  169 bits (430), Expect = 4e-50
 Identities = 48/272 (17%), Positives = 94/272 (34%), Gaps = 27/272 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
            Y+VGR IGEG+F  +    N    + VA+K   + +        Q++ E    K++   
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGC 60

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
             I  ++          ++++ +         +   +          +Q++  V   H K
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 129 GVYHRDLKPENLLLDSY-----GNLKVSDFGLSALPQQGVE-------LLHTTCGTPNYV 176
            + +RD+KP+N L+          + V DFG+    +  V              GT  Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL---YKKINAAEFSCPFW- 232
           +      R       D+ + G +    + G LP+      T    Y++I   + S P   
Sbjct: 181 SINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239

Query: 233 ----FSTGATSLIHKILDPNPKTRIRIEGIRK 260
               F       +H   +         + ++ 
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 5e-49
 Identities = 64/278 (23%), Positives = 106/278 (38%), Gaps = 20/278 (7%)

Query: 14  GRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
              IG G F  V       N       A+K L + T      V Q   E  IMK   HPN
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPN 89

Query: 71  IVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCHSK 128
           ++ L  + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSAL----PQQGVELLHTTCGTPNYVAPEVLSNR 184
              HRDL   N +LD    +KV+DFGL+          V           ++A E L  +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209

Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIH 242
            +  + +DVWS GV+L+ LM  G  P+ + +   +   +        P +       ++ 
Sbjct: 210 KFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268

Query: 243 KILDPNPKTRIRIEGIRKH------PWFRKNYNPVKCS 274
           K   P  + R     +          +  ++Y  V  +
Sbjct: 269 KCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNAT 306

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-48
 Identities = 57/282 (20%), Positives = 109/282 (38%), Gaps = 28/282 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R   +   E S+MK
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMK 78

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN----------DCRRY 114
                ++VRL  V++      +I+E +T G+L   +      + N             + 
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGT 172
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++    +             
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAAE-FSCP 230
             +++PE L +  +    +DVWS GV+L+ +      P+       + + +        P
Sbjct: 199 VRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257

Query: 231 FWFSTGATSLIHKILDPNPKTRIRIEGIRK------HPWFRK 266
                    L+      NPK R     I         P FR+
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-48
 Identities = 61/280 (21%), Positives = 112/280 (40%), Gaps = 31/280 (11%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES-------VAMKVLAKSTILKHRMVDQIKREISI 62
           +  +G+ +GEG F +V  A+     +        VA+K+L        + +  +  E+ +
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71

Query: 63  MK-IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------R 105
           MK I +H NI+ L         +Y+I+E+ + G L + +  +                 +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           L   D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+         
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 166 LHT--TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             T        ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 223 NAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                   P   +     ++       P  R   + + + 
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 9e-46
 Identities = 57/294 (19%), Positives = 111/294 (37%), Gaps = 50/294 (17%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
              +  +IG+G F +V     +  GE VA+K+ +     +       + EI    ++RH 
Sbjct: 4   TIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHE 57

Query: 70  NIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           NI+           + T+++++ ++   G LFD + ++  +      +        +AH 
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHL 116

Query: 126 HS--------KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT----CGTP 173
           H           + HRDLK +N+L+   G   ++D GL+       + +        GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 174 NYVAPEVLSNR-----GYDGSAADVWSCGVILFVLMAGYLPFG---------------ET 213
            Y+APEVL +            AD+++ G++ + +       G               + 
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 214 DLPTLYKKINAAEFSCPF---WFSTGATSLIHKI----LDPNPKTRIRIEGIRK 260
            +  + K +   +        W S  A  ++ KI       N   R+    I+K
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-45
 Identities = 54/279 (19%), Positives = 103/279 (36%), Gaps = 29/279 (10%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           + ++G+ +G G F +V  A         T  +VA+K+L +           +     ++ 
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR-ALMSELKILIH 72

Query: 65  IVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKI----------------VHQGRLL 107
           I  H N+V L          + +I+EF   G L   +                +++  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 108 ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH 167
                 Y  Q+   +    S+   HRDL   N+LL     +K+ DFGL+    +  + + 
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 168 TT--CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY-LPFGETDLPTLYKKI-- 222
                    ++APE + +R Y    +DVWS GV+L+ + +    P+    +   + +   
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                  P + +      +       P  R     + +H
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  142 bits (358), Expect = 5e-39
 Identities = 54/328 (16%), Positives = 112/328 (34%), Gaps = 71/328 (21%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------REISI 62
           +Y + R +G G F+ V  A++      VAMK++    +      D+IK        + + 
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVT-----GGELFDKIVHQGRLLENDCRRYFQQ 117
              +   +I++L +    +    + +  V            K      +     ++  +Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 118 LIDAVAHCHSK-GVYHRDLKPENLLLDSYG------NLKVSDFGLSALPQQGVELLHTTC 170
           L+  + + H + G+ H D+KPEN+L++          +K++D G +    +       + 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TNSI 190

Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK---------- 220
            T  Y +PEVL    +    AD+WS   ++F L+ G   F   +  +  K          
Sbjct: 191 QTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 221 --------------------------------------KINAAEFSCPFWFSTGATSLIH 242
                                                  +   ++      +   +  + 
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNP 270
            +L  +P+ R    G+  HPW +     
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGM 337

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.6 bits (224), Expect = 7e-22
 Identities = 31/213 (14%), Positives = 71/213 (33%), Gaps = 44/213 (20%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI---------------LKHRMVDQ 55
             +G+ +GEG  + V    + E      +K                           +  
Sbjct: 2   DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 56  IKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF 115
            + E   ++ ++   + +++          +++E +             R+   +     
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAK-------ELYRVRVENPDEVL 109

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
             +++ VA  + +G+ H DL   N+L+   G + + DF  S      VE+          
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS------VEVGEEGW--REI 160

Query: 176 VAPEVLS-----NRGYDGSAADVWSCGVILFVL 203
           +  +V +     +R Y  +  D+ S   I  +L
Sbjct: 161 LERDVRNIITYFSRTY-RTEKDINS--AIDRIL 190

>d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Kinase associated domain 1, KA1
domain: Map/microtubule affinity-regulating kinase 3
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 64.4 bits (157), Expect = 1e-13
 Identities = 11/85 (12%), Positives = 28/85 (32%), Gaps = 2/85 (2%)

Query: 343 SRQPAQVILSNIEAVAESLSLKVHTR-NYKTRLEGVSANKTGQFAVVLEVFEVA-PSLFM 400
           S      ++  I  V  + +     R  +         +        +EV ++   SL  
Sbjct: 17  SSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNG 76

Query: 401 VDVRKAAGDTLEYHKFYKNFCAKLE 425
           V  ++ +G ++ +         +L+
Sbjct: 77  VRFKRISGTSIAFKNIASKIANELK 101

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	443
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1ul7a_	102	Map/microtubule affinity-regulating kinase 3 {Mous	99.42
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.64
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.19
d2v8qa1	153	5'-AMP-activated protein kinase catalytic subunit	98.17
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.09
d2qrda1	127	Snf1-like protein kinase ssp2 {Schizosaccharomyces	97.66
d2qlva1	171	Carbon catabolite-derepressing protein kinase SNF1	97.29
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.13
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.01
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.5

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-66  Score=489.90  Aligned_cols=259  Identities=36%  Similarity=0.679  Sum_probs=241.3

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..+++|++++.||+|+||+||+|+++.+|+.||+|++.+....+....+.+.+|+.+++.++|||||++++++.+++.+|
T Consensus         3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            46899999999999999999999999999999999998765544445677899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      +|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....  ..
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--~~  160 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SR  160 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--CC
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC--Cc
Confidence            9999999999999999989999999999999999999999999999999999999999999999999999976544  23


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHcc
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  245 (443)
                      ....+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+...++....+.+|..+|+++.+||.+||
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  239 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL  239 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence            4567899999999999988775 999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHHHHhcCcccccc
Q 013421          246 DPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ++||++|||++|+++||||+.+
T Consensus       240 ~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         240 KHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             CSSGGGSCCHHHHHTCHHHHHH
T ss_pred             cCCHhHCcCHHHHHcCcCcCCc
Confidence            9999999999999999999754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-64  Score=483.45  Aligned_cols=260  Identities=38%  Similarity=0.667  Sum_probs=226.1

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++++....  +..+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i   80 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   80 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence            367899999999999999999999999999999999876432  234678999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc--cc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VE  164 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--~~  164 (443)
                      |||||+||+|++++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|......  ..
T Consensus        81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            9999999999999988889999999999999999999999999999999999999999999999999999865432  23


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhhhccCCCC--CCCCHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSCP--FWFSTGATSLI  241 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~li  241 (443)
                      ...+.+||+.|+|||++.+..+++.++|||||||++|+|++|++||...+.. ..+..+.......+  ..+|+++.+||
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  240 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  240 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence            4567889999999999998888778899999999999999999999775543 33333333333222  34899999999


Q ss_pred             HHccCCCCCCCCCHHHHhcCccccccC
Q 013421          242 HKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      .+||+.||++|||++|+++||||++..
T Consensus       241 ~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         241 HKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            999999999999999999999998654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-64  Score=487.29  Aligned_cols=263  Identities=31%  Similarity=0.559  Sum_probs=238.1

Q ss_pred             cccccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      +...+.++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++||||+++++++.+++
T Consensus         2 P~~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   81 (288)
T d1uu3a_           2 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE   81 (288)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred             CCCCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence            45566789999999999999999999999999999999998765544445678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      .+|+|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999866432


Q ss_pred             --cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHH
Q 013421          163 --VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL  240 (443)
Q Consensus       163 --~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l  240 (443)
                        .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+....+.++....+.+|..+|+++++|
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  240 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL  240 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred             CcccccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence              2344567899999999999888775 8999999999999999999999999999999999999999999999999999


Q ss_pred             HHHccCCCCCCCCCHHH------HhcCccccc
Q 013421          241 IHKILDPNPKTRIRIEG------IRKHPWFRK  266 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~e------il~hp~f~~  266 (443)
                      |.+||+.||++|||++|      |++||||+.
T Consensus       241 i~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             HHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence            99999999999999988      588999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-64  Score=491.82  Aligned_cols=260  Identities=32%  Similarity=0.578  Sum_probs=243.8

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            35789999999999999999999999999999999998876544445678899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      +|||||+||+|++++...+.++|..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+........
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999876554456


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHcc
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  245 (443)
                      ..+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+..++.+++....+.+|..+|+++++||++||
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L  240 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL  240 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             cccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhc
Confidence            6788999999999999998885 899999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCC-----HHHHhcCccccc
Q 013421          246 DPNPKTRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       246 ~~dP~~R~t-----~~eil~hp~f~~  266 (443)
                      ++||.+|++     ++||++||||+.
T Consensus       241 ~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         241 KKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             CSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             cCCchhhcccccccHHHHHcCccccc
Confidence            999999994     899999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-63  Score=476.14  Aligned_cols=253  Identities=26%  Similarity=0.438  Sum_probs=227.7

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.......   .+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            47999999999999999999999999999999998754332   367899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccc
Q 013421           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (443)
                      |||+||+|.+++.+ +++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++............
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            99999999988765 67999999999999999999999999999999999999999999999999999876555455677


Q ss_pred             cCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc---cCCCCCCCCHHHHHHHHHcc
Q 013421          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATSLIHKIL  245 (443)
Q Consensus       169 ~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~~L  245 (443)
                      .+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+.......+...   .+..|..+|+++++||.+||
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  254 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHT
T ss_pred             cccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHc
Confidence            8899999999999887775 8999999999999999999999988776655544333   34456679999999999999


Q ss_pred             CCCCCCCCCHHHHhcCccccc
Q 013421          246 DPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~  266 (443)
                      ++||.+|||++|+++||||+.
T Consensus       255 ~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         255 DMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             CSSTTTSCCHHHHTTCGGGGG
T ss_pred             cCChhHCcCHHHHhcCHhhCC
Confidence            999999999999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.7e-62  Score=477.73  Aligned_cols=256  Identities=33%  Similarity=0.699  Sum_probs=239.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      ++++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            57899999999999999999999999999999999987655444456789999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||||+||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....   ..
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---~~  158 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VT  158 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---CB
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc---cc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999976543   24


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccC
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD  246 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~  246 (443)
                      .+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+..+...++..+...+|+.+|+++.++|.+||+
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  237 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT  237 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             ccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            567899999999999888886 8999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCC-----CHHHHhcCccccc
Q 013421          247 PNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       247 ~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      +||.+|+     |+++|++||||+.
T Consensus       238 ~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         238 RDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             SCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             hCHHhccccchhhHHHHHcCccccc
Confidence            9999996     9999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-62  Score=468.96  Aligned_cols=256  Identities=30%  Similarity=0.560  Sum_probs=218.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RTKV   84 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~   84 (443)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|++++.... ....+.+.+|+.+|++++|||||++++++.+  ++.+
T Consensus         2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            568999999999999999999999999999999999876543 3346779999999999999999999999864  5668


Q ss_pred             EEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----CEeecCCCCcEEEcCCCCeEEeeecC
Q 013421           85 YIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGL  155 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~yLH~~g-----i~HrDlkp~NILl~~~~~~kL~DFGl  155 (443)
                      |+|||||+||+|.+++..    .+.+++..++.++.||+.||+|||++|     |+||||||+|||++.+|.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            999999999999999864    457999999999999999999999976     99999999999999999999999999


Q ss_pred             cCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC-CCCCCCC
Q 013421          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFS  234 (443)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s  234 (443)
                      +...........+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+...++..+.+ ..|..+|
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s  239 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS  239 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence            98766554556678999999999999887775 899999999999999999999999988888888877765 4567799


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013421          235 TGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (443)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (443)
                      +++.+||.+||+.||.+|||++||++|||+
T Consensus       240 ~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         240 DELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            999999999999999999999999999995

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-62  Score=475.96  Aligned_cols=258  Identities=38%  Similarity=0.706  Sum_probs=215.6

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..-++|++++.||+|+||+||+|+++.+|+.||||++.+.....  ..+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   83 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY   83 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34567999999999999999999999999999999998765433  2366889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc---CCCCeEEeeecCcCCCccc
Q 013421           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD---SYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~---~~~~~kL~DFGls~~~~~~  162 (443)
                      +|||||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||+.   ++|.+||+|||++......
T Consensus        84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999999999999999989999999999999999999999999999999999999995   5789999999999866443


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGAT  238 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~  238 (443)
                       ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+....+.......+    ..+|+++.
T Consensus       164 -~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         164 -SVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             ----------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             -CeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence             345678899999999999888775 899999999999999999999999888888888877765443    45899999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +||.+||++||++|||++|+++||||+..
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-62  Score=471.47  Aligned_cols=255  Identities=30%  Similarity=0.482  Sum_probs=227.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      +.|++++.||+|+||+||+|+++.+|+.||+|++++...   ...+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            469999999999999999999999999999999986532   23467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        89 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |||+||+|.+++.+ .+++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|...........
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence            99999999999765 45799999999999999999999999999999999999999999999999999976554434456


Q ss_pred             ccCCCcccCCCcccc-----cCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC---CCCCCCCHHHHH
Q 013421          168 TTCGTPNYVAPEVLS-----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGATS  239 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~-----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~  239 (443)
                      +.+||+.|+|||++.     +.+| +.++|||||||++|+|++|.+||.+.+..+...++.....   ..|..+|+++.+
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~  247 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD  247 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             ccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence            788999999999984     3334 4899999999999999999999999888888777766643   345568999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ||.+||++||++|||++|+++||||+..
T Consensus       248 li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         248 FLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-61  Score=472.92  Aligned_cols=258  Identities=30%  Similarity=0.581  Sum_probs=237.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRHPNIVRLHEVLASRTKVYI   86 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~l   86 (443)
                      +++|++++.||+|+||+||+|+++.+|+.||||++++......+..+.+..|+.++. .++|||||++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            578999999999999999999999999999999998765444444556667777665 6899999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        87 v~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||||+||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..........
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998766555556


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHccC
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD  246 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~  246 (443)
                      ...+||+.|+|||++.+.+|+ .++||||+||++|+|++|+.||.+.+..++..++....+.+|..+|+++.+||++||+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~  239 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV  239 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSC
T ss_pred             cccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcc
Confidence            678999999999999988886 8999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCHH-HHhcCccccc
Q 013421          247 PNPKTRIRIE-GIRKHPWFRK  266 (443)
Q Consensus       247 ~dP~~R~t~~-eil~hp~f~~  266 (443)
                      +||.+|||+. ++++||||+.
T Consensus       240 ~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         240 REPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             SSGGGSBTTBSCGGGSGGGTT
T ss_pred             cCCCCCcCHHHHHHhCchhcc
Confidence            9999999995 8999999975

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-61  Score=477.75  Aligned_cols=258  Identities=32%  Similarity=0.646  Sum_probs=239.9

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ...+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||++++++.+...+
T Consensus        37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  116 (350)
T d1rdqe_          37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence            34578999999999999999999999999999999999876554444567889999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (443)
                      |+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....   
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---  193 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999986643   


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHHHHHc
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (443)
                      ...+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+......++....+..|..+|+++.+||++|
T Consensus       194 ~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  272 (350)
T d1rdqe_         194 RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL  272 (350)
T ss_dssp             CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHH
T ss_pred             ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence            23467899999999999988875 89999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCC-----CHHHHhcCccccc
Q 013421          245 LDPNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       245 L~~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      |++||.+|+     |+++|++||||+.
T Consensus       273 L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         273 LQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             SCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             hhhCHHhccccccccHHHHHcCccccC
Confidence            999999995     9999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-61  Score=463.34  Aligned_cols=259  Identities=34%  Similarity=0.600  Sum_probs=233.2

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---RMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      .-++|++++.||+|+||+||+|+++.+|+.||||++++......   ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            34679999999999999999999999999999999987654322   135778999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC----CeEEeeecCcCCC
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALP  159 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~----~~kL~DFGls~~~  159 (443)
                      +|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|    .+||+|||++...
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            999999999999999999989999999999999999999999999999999999999998776    5999999999766


Q ss_pred             ccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCH
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFST  235 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~  235 (443)
                      ... ....+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+....+.......+    ..+|+
T Consensus       168 ~~~-~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (293)
T d1jksa_         168 DFG-NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  245 (293)
T ss_dssp             TTS-CBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred             CCC-ccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence            543 34456789999999999987766 4999999999999999999999999998888888887766654    46899


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      ++.+||++||+.||++|||++|+++||||+..
T Consensus       246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-61  Score=468.35  Aligned_cols=255  Identities=25%  Similarity=0.369  Sum_probs=228.5

Q ss_pred             CeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E   89 (443)
                      .|++++.||+|+||+||+|++..+|+.||||++++......+..+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999988766666667789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccccc
Q 013421           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (443)
Q Consensus        90 y~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (443)
                      ||+||+|..++...+++++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....    ....
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~~~  171 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSF  171 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BCCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----CCcc
Confidence            999999988888888999999999999999999999999999999999999999999999999999986543    3467


Q ss_pred             CCCcccCCCcccccC--CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCC--CCCCCCHHHHHHHHHcc
Q 013421          170 CGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS--CPFWFSTGATSLIHKIL  245 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~~~L  245 (443)
                      +||+.|+|||++.+.  +.++.++|||||||++|+|++|..||.+.+..+...++.....+  .+..+|+++.+||.+||
T Consensus       172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L  251 (309)
T d1u5ra_         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL  251 (309)
T ss_dssp             CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred             ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence            899999999998642  22348999999999999999999999988877777666555443  23458999999999999


Q ss_pred             CCCCCCCCCHHHHhcCccccccC
Q 013421          246 DPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      +.||.+|||++|+++||||+...
T Consensus       252 ~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         252 QKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             CSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             cCChhHCcCHHHHHhCHHhcCCC
Confidence            99999999999999999998654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.6e-61  Score=474.59  Aligned_cols=261  Identities=29%  Similarity=0.606  Sum_probs=234.3

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ...+++|++++.||+|+||+||+|+++.+|+.||||++.+..   ....+.+.+|+.+|++++|||||++++++.+++.+
T Consensus        22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            456789999999999999999999999999999999997654   23356789999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc--CCCCeEEeeecCcCCCcc
Q 013421           85 YIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD--SYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~--~~~~~kL~DFGls~~~~~  161 (443)
                      |+|||||+||+|.+++.. .+++++..++.++.||+.||+|||++||+||||||+|||++  .+|.+||+|||++.....
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999999999999954 46799999999999999999999999999999999999996  468899999999986654


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGA  237 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~  237 (443)
                      . ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+....+....+..+    ..+|+++
T Consensus       179 ~-~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  256 (350)
T d1koaa2         179 K-QSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG  256 (350)
T ss_dssp             T-SCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred             c-cccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            3 345678899999999999888875 899999999999999999999999998888888887766554    3489999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                      ++||.+||+.||++|||++|+++||||+....+
T Consensus       257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            999999999999999999999999999876543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.8e-61  Score=473.91  Aligned_cols=260  Identities=27%  Similarity=0.550  Sum_probs=234.5

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      +..+++|++++.||+|+||+||+|+++.+|+.||||++++...   ...+.+.+|+.+|++++|||||++++++.+++.+
T Consensus        25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            4567789999999999999999999999999999999987542   2346788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc--CCCCeEEeeecCcCCCcc
Q 013421           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD--SYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~--~~~~~kL~DFGls~~~~~  161 (443)
                      |+|||||+||+|++++...+ ++++.+++.++.||+.||+|||++||+||||||+|||++  .+|.+||+|||+|.....
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            99999999999999887654 699999999999999999999999999999999999998  578999999999987654


Q ss_pred             ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCC----CCCCHHH
Q 013421          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGA  237 (443)
Q Consensus       162 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~  237 (443)
                      . ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+....+....+.+|    ..+|+++
T Consensus       182 ~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  259 (352)
T d1koba_         182 D-EIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  259 (352)
T ss_dssp             T-SCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             C-CceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            3 445678899999999999887775 899999999999999999999999998888888887766554    3589999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                      .+||.+||+.||.+|||++|+|+||||+....
T Consensus       260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~  291 (352)
T d1koba_         260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  291 (352)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence            99999999999999999999999999987543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-60  Score=454.98  Aligned_cols=253  Identities=23%  Similarity=0.441  Sum_probs=221.0

Q ss_pred             ccCe-EEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CC
Q 013421            8 VAKY-EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS----RT   82 (443)
Q Consensus         8 ~~~y-~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~   82 (443)
                      -++| ++.+.||+|+||+||+|++..++..||+|++...... ....+.+.+|+++|++++|||||++++++.+    +.
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence            3456 7888999999999999999999999999999876543 3346789999999999999999999999865    45


Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CEeecCCCCcEEEc-CCCCeEEeeecCcCCC
Q 013421           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLD-SYGNLKVSDFGLSALP  159 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~g--i~HrDlkp~NILl~-~~~~~kL~DFGls~~~  159 (443)
                      .+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++..
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            68999999999999999999899999999999999999999999998  99999999999996 5789999999999764


Q ss_pred             ccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCC-hHHHHHHhhhccC--CCCCCCCHH
Q 013421          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYKKINAAEF--SCPFWFSTG  236 (443)
Q Consensus       160 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~--~~~~~~s~~  236 (443)
                      ..  ....+.+||+.|+|||++.+ .| +.++||||+||++|+|++|+.||.+.+ .....+.+..+..  ..+...+++
T Consensus       166 ~~--~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (270)
T d1t4ha_         166 RA--SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  241 (270)
T ss_dssp             CT--TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             cC--CccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence            43  33457789999999999865 45 499999999999999999999997654 4556666665433  234558999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      +.+||.+||++||++|||++|+++||||+
T Consensus       242 ~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999999999996

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-61  Score=472.90  Aligned_cols=255  Identities=25%  Similarity=0.406  Sum_probs=218.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      -++|++++.||+|+||+||+|+++.+|+.||+|++++..  .....+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999999999999999998754  233457889999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (443)
                      |||++||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|.....  ...
T Consensus        83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~~~  160 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMA  160 (322)
T ss_dssp             EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--HTC
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--Ccc
Confidence            9999999999999998999999999999999999999997 4999999999999999999999999999975433  334


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHH-------------------------
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK-------------------------  221 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~-------------------------  221 (443)
                      .+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+.......                         
T Consensus       161 ~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             ccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            577999999999999987775 999999999999999999999977553221100                         


Q ss_pred             -----------------hhhc-cCCCCC-CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          222 -----------------INAA-EFSCPF-WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       222 -----------------i~~~-~~~~~~-~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                                       +... ....|. .+|+++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                             0000 011111 268999999999999999999999999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.4e-60  Score=453.05  Aligned_cols=258  Identities=30%  Similarity=0.564  Sum_probs=230.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccc------hHHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK------HRMVDQIKREISIMKIVR-HPNIVRLHEVLAS   80 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~   80 (443)
                      .++|++++.||+|+||+||+|++..+|+.||||++++.....      ....+.+.+|+.+|++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999999999999999998765332      223456889999999997 9999999999999


Q ss_pred             CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      ++.+|+|||||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998765


Q ss_pred             cccccccccCCCcccCCCcccccC-----CCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC----
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNR-----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----  231 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----  231 (443)
                      .. ......+||+.|+|||++.+.     ...+.++||||+||++|+|++|+.||.+.+.....+.+..+....+.    
T Consensus       162 ~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (277)
T d1phka_         162 PG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  240 (277)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            43 334567899999999998632     22358999999999999999999999999988888888777654432    


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                      .+|+++++||.+||++||++|||++|+++||||++
T Consensus       241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            58999999999999999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.8e-60  Score=472.11  Aligned_cols=258  Identities=30%  Similarity=0.465  Sum_probs=226.0

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHH---HHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK---REISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~---~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ++++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.   +|+.+++.++|||||++++++.+.+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            578999999999999999999999999999999999875543322223333   44677778889999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....  
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~--  159 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--  159 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999986544  


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH---HHHHHhhhccCCCCCCCCHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---TLYKKINAAEFSCPFWFSTGATSL  240 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~s~~~~~l  240 (443)
                      ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..   ...+.+.......|..+|+++.+|
T Consensus       160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (364)
T d1omwa3         160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL  239 (364)
T ss_dssp             SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHH
T ss_pred             CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHH
Confidence            23456789999999999975544469999999999999999999999875433   344555566677788899999999


Q ss_pred             HHHccCCCCCCCCC-----HHHHhcCccccc
Q 013421          241 IHKILDPNPKTRIR-----IEGIRKHPWFRK  266 (443)
Q Consensus       241 i~~~L~~dP~~R~t-----~~eil~hp~f~~  266 (443)
                      |.+||++||.+|||     ++|+++||||+.
T Consensus       240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            99999999999999     799999999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-60  Score=462.95  Aligned_cols=256  Identities=27%  Similarity=0.506  Sum_probs=232.1

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++++...    ....+.+|+.+|+.++|||||++++++.+++.+|
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   77 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            357899999999999999999999999999999999987542    2356889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCC--CCeEEeeecCcCCCccc
Q 013421           86 IILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQG  162 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~--~~~kL~DFGls~~~~~~  162 (443)
                      +|||||+||+|++++...+ ++++.+++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||++......
T Consensus        78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            9999999999999998765 79999999999999999999999999999999999999854  58999999999766443


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC----CCCHHHH
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGAT  238 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~  238 (443)
                       ....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+...++....+.++.    .+|+++.
T Consensus       158 -~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         158 -DNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             -CEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             -CcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence             345667899999999999887775 8999999999999999999999999999999999888777664    5899999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcCcccccc
Q 013421          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (443)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (443)
                      +||.+||+.||++|||++|+++||||+..
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999999999754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=455.17  Aligned_cols=258  Identities=25%  Similarity=0.311  Sum_probs=219.3

Q ss_pred             EeeeeeccCceEEEEEEECCCCcEEEEEEeecccccch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013421           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH--RMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (443)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey   90 (443)
                      .++.||+|+||+||+|+++.+|+.||||+++.......  ...+.+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            46899999999999999999999999999976543221  1235688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccccccccccC
Q 013421           91 VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC  170 (443)
Q Consensus        91 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~  170 (443)
                      +.|+++.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........+.+
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            99988877777677899999999999999999999999999999999999999999999999999987766555666789


Q ss_pred             CCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccC--------------------C--
Q 013421          171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF--------------------S--  228 (443)
Q Consensus       171 gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--------------------~--  228 (443)
                      ||+.|+|||++.+..+++.++||||+||++|+|++|.+||.+.+..+...++.....                    .  
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence            999999999987666556999999999999999999999998887776665532100                    0  


Q ss_pred             ------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          229 ------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       229 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                            ....+|+++.+||.+||+.||++|||++|+|+||||+....|
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence                  012368899999999999999999999999999999865433

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-59  Score=449.53  Aligned_cols=253  Identities=32%  Similarity=0.533  Sum_probs=223.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchH---HHHHHHHHHHHHHhCC--CCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR--HPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~   82 (443)
                      -++|++++.||+|+||+||+|++..+|+.||||++.+.......   ....+.+|+.+|++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            36899999999999999999999999999999999876543211   1234678999999996  899999999999999


Q ss_pred             EEEEEEecCCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-CCCeEEeeecCcCCCc
Q 013421           83 KVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQ  160 (443)
Q Consensus        83 ~~~lv~Ey~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~  160 (443)
                      ..|+||||+.+ +++.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            99999999976 688899988899999999999999999999999999999999999999985 4799999999997654


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCCCCCHHHHHH
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL  240 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l  240 (443)
                      .  ....+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.||...      ..+..+...++..+|+++.+|
T Consensus       163 ~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~~l  234 (273)
T d1xwsa_         163 D--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHL  234 (273)
T ss_dssp             S--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHHHH
T ss_pred             c--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHHHH
Confidence            3  34457789999999999988888778899999999999999999999753      235566778888999999999


Q ss_pred             HHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          241 IHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      |++||+.||++|||++|+++||||++..
T Consensus       235 i~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         235 IRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            9999999999999999999999998643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-58  Score=446.95  Aligned_cols=261  Identities=32%  Similarity=0.477  Sum_probs=220.9

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +++|++++.||+|+||+||+|++..+|+.||||+++.... .....+++.+|+.+|++++|||||++++++.+++.+|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            5789999999999999999999999999999999976542 222356788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccc
Q 013421           88 LEFVTGGELFDKIV-H-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~-~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (443)
                      |||+.++ +.+.+. . ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|.........
T Consensus        80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            9999765 444443 3 357999999999999999999999999999999999999999999999999999776555556


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc------------------C
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE------------------F  227 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------~  227 (443)
                      ....+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+......++....                  .
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence            6777899999999998888888899999999999999999999999877655544432110                  0


Q ss_pred             CCC-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          228 SCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       228 ~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                      ..+           ..+|+++.+||++||++||++|||++|+++||||++-..|
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            011           2368899999999999999999999999999999876544

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-58  Score=454.24  Aligned_cols=255  Identities=33%  Similarity=0.580  Sum_probs=218.1

Q ss_pred             ccccccCeEEee-eeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCCcceEEEEEEe-
Q 013421            4 QTRRVAKYEVGR-TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI-VRHPNIVRLHEVLAS-   80 (443)
Q Consensus         4 ~~~~~~~y~i~~-~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~-   80 (443)
                      +...+++|++++ .||+|+||+||+|++..+|+.||||++++.        ..+.+|+.++.+ ++|||||++++++.+ 
T Consensus         6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            445688999975 599999999999999999999999998642        346789998755 589999999999975 


Q ss_pred             ---CCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC---CCCeEEee
Q 013421           81 ---RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSD  152 (443)
Q Consensus        81 ---~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~---~~~~kL~D  152 (443)
                         +..+|+|||||+||+|++++...  .++++.+++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence               46799999999999999999875  36999999999999999999999999999999999999985   56799999


Q ss_pred             ecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHH----HHHHhhhccCC
Q 013421          153 FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT----LYKKINAAEFS  228 (443)
Q Consensus       153 FGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~~  228 (443)
                      ||+++..... ......+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+...    +...+....+.
T Consensus       158 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~  235 (335)
T d2ozaa1         158 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  235 (335)
T ss_dssp             CTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred             cceeeeccCC-CccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence            9999866543 345678899999999999888775 89999999999999999999997765433    33445555555


Q ss_pred             CCC----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          229 CPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       229 ~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                      +|.    .+|+++.+||++||+.||++|||++|+++||||+...
T Consensus       236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            553    3899999999999999999999999999999997654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.1e-57  Score=439.09  Aligned_cols=257  Identities=30%  Similarity=0.434  Sum_probs=219.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +++|++++.||+|+||+||+|+++ +|+.||||+++..... ....+.+.+|+.+|++++||||+++++++.+++..|++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            579999999999999999999996 7899999999776532 22357789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      |||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            99998888877777788999999999999999999999999999999999999999999999999999876655444455


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc---------------------
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---------------------  226 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------------  226 (443)
                      ..+|++.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+..+...++....                     
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            66799999999999877777899999999999999999999999887666555432110                     


Q ss_pred             --------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          227 --------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       227 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                              ...+..+|+++.+||++||++||++|||++|+++||||++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                    0112346899999999999999999999999999999974

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.4e-57  Score=430.69  Aligned_cols=259  Identities=24%  Similarity=0.391  Sum_probs=218.2

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT---   82 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---   82 (443)
                      ..-++|++.+.||+|+||+||+|++..+|+.||||++.+....+.+..+.+.+|+.+++.++||||+++++++...+   
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            34467999999999999999999999999999999998877666666788999999999999999999999987644   


Q ss_pred             -EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 -KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 -~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                       ..|+||||++|++|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++..+++|||.+.....
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence             4899999999999999999999999999999999999999999999999999999999999999999999998765433


Q ss_pred             c---cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCC----CCCCC
Q 013421          162 G---VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC----PFWFS  234 (443)
Q Consensus       162 ~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s  234 (443)
                      .   .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|++||.+.+..+...++.......    +..+|
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s  242 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS  242 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred             ccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence            2   2245567899999999999887775 89999999999999999999999988777766665554332    34589


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013421          235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (443)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (443)
                      +++.+||.+||++||.+||+..+.+.|+|.+
T Consensus       243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            9999999999999999999544445577764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=425.89  Aligned_cols=260  Identities=32%  Similarity=0.457  Sum_probs=227.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      +++|++++.||+|+||+||+|++..+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.+....+++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            4789999999999999999999999999999999977653 334578899999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccccccc
Q 013421           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (443)
                      +|++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||.+...........
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            99999999999998888999999999999999999999999999999999999999999999999999987765545556


Q ss_pred             ccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCC-CCCChHHHHHHhhhcc--------------------
Q 013421          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAE--------------------  226 (443)
Q Consensus       168 ~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~~--------------------  226 (443)
                      ...+++.|+|||++.+..+.+.++||||+||++|+|++|..|| .+.+..+...++....                    
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            6678899999999987777779999999999999999999886 4445455444432110                    


Q ss_pred             ---------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          227 ---------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       227 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                               ...+..+|+++.+||++||++||++|||++|+|+||||++..
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                     112234689999999999999999999999999999997643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=434.29  Aligned_cols=263  Identities=25%  Similarity=0.331  Sum_probs=217.9

Q ss_pred             cccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 013421            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS----   80 (443)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----   80 (443)
                      ...+++|+++++||+|+||+||+|++..+|+.||||++.+.... ....+.+.+|+.+|+.++||||+++++++..    
T Consensus         6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~   84 (318)
T d3blha1           6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASP   84 (318)
T ss_dssp             SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence            45689999999999999999999999999999999999776433 2234678899999999999999999998854    


Q ss_pred             ----CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           81 ----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        81 ----~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                          ++.+|++|||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             ------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeeccee
Confidence                4568999999988777666666678999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcc----ccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCCCC-
Q 013421          157 ALPQQ----GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF-  231 (443)
Q Consensus       157 ~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~-  231 (443)
                      .....    ......+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+.......+. 
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            65543    1233456789999999999877655569999999999999999999999987766655544332111110 


Q ss_pred             -------------------------------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          232 -------------------------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       232 -------------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                                                     ..++++.+||.+||+.||++|||++|+++||||+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p  312 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  312 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence                                           0377889999999999999999999999999998653

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-56  Score=431.35  Aligned_cols=257  Identities=29%  Similarity=0.379  Sum_probs=214.0

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCC-CcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceEEEEEEe--
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVRLHEVLAS--   80 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~--   80 (443)
                      .-++|++++.||+|+||+||+|++..+ ++.||||++........ ....+.+|+.+|+.|   +||||+++++++..  
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            457899999999999999999999765 67899999976543221 223456788877666   79999999999853  


Q ss_pred             ---CCEEEEEEecCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           81 ---RTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        81 ---~~~~~lv~Ey~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                         ...+|++|||++++.+..... ....+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence               357899999998887654443 3457899999999999999999999999999999999999999999999999998


Q ss_pred             CCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc----------
Q 013421          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE----------  226 (443)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------  226 (443)
                      ...... ......+||+.|+|||++.+..|+ .++||||+||++|+|++|++||.+.+..+...++....          
T Consensus       164 ~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         164 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             CCCCGG-GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhccc-ccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            765443 445678899999999999888875 89999999999999999999999888766655543210          


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          227 -----------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       227 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                                       ...+..+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~  298 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  298 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence                             0123347899999999999999999999999999999975

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8e-56  Score=426.25  Aligned_cols=247  Identities=26%  Similarity=0.376  Sum_probs=216.6

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.+...    .+++.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            4788999999999999999999999999999999765432    357889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-cc
Q 013421           89 EFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-EL  165 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~~  165 (443)
                      |||++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++...... ..
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~  172 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  172 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence            999999999999764  578999999999999999999999999999999999999999999999999998765432 22


Q ss_pred             ccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCC-CCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHH
Q 013421          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL-PFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHK  243 (443)
Q Consensus       166 ~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~-Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~  243 (443)
                      .....|++.|+|||++.+..|+ .++||||+||++|+|++|.. ||.+.+.....+.+..+ ..+.|..+|+++.+||.+
T Consensus       173 ~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  251 (287)
T d1opja_         173 HAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA  251 (287)
T ss_dssp             ETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             eccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHH
Confidence            3344589999999999887775 99999999999999999655 55666666666666544 466777899999999999


Q ss_pred             ccCCCCCCCCCHHHHhc
Q 013421          244 ILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       244 ~L~~dP~~R~t~~eil~  260 (443)
                      ||+.||++|||++|+++
T Consensus       252 cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         252 CWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HTCSSGGGSCCHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHH
Confidence            99999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-55  Score=433.27  Aligned_cols=256  Identities=27%  Similarity=0.398  Sum_probs=213.8

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----   82 (443)
                      .-++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++...+    
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            45789999999999999999999999999999999986543 4445678999999999999999999999997654    


Q ss_pred             --EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           83 --KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        83 --~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                        .+|+||||+ |++|...+ ..+++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++....
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence              579999999 66666655 45789999999999999999999999999999999999999999999999999997654


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------  226 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------------  226 (443)
                      .   .....+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+.......+....              
T Consensus       173 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         173 S---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             S---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             C---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            3   34567899999999999877777799999999999999999999998877554433322110              


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          227 -----------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       227 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                                       ......+|+++.+||.+||+.||++|||++|||+||||+.-.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                             012235799999999999999999999999999999998643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=418.72  Aligned_cols=247  Identities=23%  Similarity=0.378  Sum_probs=208.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++++.||+|+||+||+|++. +++.||||+++.....    .+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            58999999999999999999986 5778999999865432    256889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-ccc
Q 013421           89 EFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-ELL  166 (443)
Q Consensus        89 Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~~~  166 (443)
                      ||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++...... ...
T Consensus        80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  159 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence            999999999998765 568899999999999999999999999999999999999999999999999998665432 233


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHHc
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~  244 (443)
                      ....||+.|+|||++.+..|+ .++||||+||++|||+| |.+||...+..+....+..+ ....|..+++++.+||.+|
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  238 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC  238 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred             cceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHH
Confidence            456799999999999887775 89999999999999998 67888888877787777665 4556777899999999999


Q ss_pred             cCCCCCCCCCHHHHhcC
Q 013421          245 LDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       245 L~~dP~~R~t~~eil~h  261 (443)
                      |+.||++|||++||++|
T Consensus       239 l~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         239 WKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCCHhHCcCHHHHHHH
Confidence            99999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-56  Score=423.50  Aligned_cols=247  Identities=20%  Similarity=0.343  Sum_probs=211.6

Q ss_pred             eeeeccCceEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecCC
Q 013421           15 RTIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (443)
Q Consensus        15 ~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~   92 (443)
                      +.||+|+||+||+|.+.  .+++.||||++..... .....+.+.+|+.+|++++|||||++++++.++ ..|+|||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            46999999999999864  3567899999976543 334567899999999999999999999999754 5789999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc---cccccc
Q 013421           93 GGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV---ELLHTT  169 (443)
Q Consensus        93 gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~---~~~~~~  169 (443)
                      +|+|.+++....++++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......   ......
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            99999999998999999999999999999999999999999999999999999999999999997654321   223345


Q ss_pred             CCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHHccCC
Q 013421          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDP  247 (443)
Q Consensus       170 ~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~  247 (443)
                      .||+.|+|||++.+..|+ .++|||||||++|||++ |++||.+.+..+....+..+ .++.|..+|+++.+||.+||+.
T Consensus       171 ~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~  249 (277)
T d1xbba_         171 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY  249 (277)
T ss_dssp             CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence            799999999999877765 89999999999999997 99999998888887777665 4677888999999999999999


Q ss_pred             CCCCCCCHHHH---hcCccc
Q 013421          248 NPKTRIRIEGI---RKHPWF  264 (443)
Q Consensus       248 dP~~R~t~~ei---l~hp~f  264 (443)
                      ||.+|||+++|   |+|+|+
T Consensus       250 dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         250 DVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             STTTSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHhhCHHh
Confidence            99999999998   466665

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-55  Score=424.23  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=209.5

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   83 (443)
                      ..++|++.+.||+|+||+||+|.++.+++   .||||.+....  .....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            35789999999999999999999987765   58899886543  33345779999999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc
Q 013421           84 VYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (443)
                      +|+|||||++|+|.+++... +.+++.++..++.||+.||+|||++||+||||||+||||+.++++||+|||+++.....
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999999999988774 46899999999999999999999999999999999999999999999999999865442


Q ss_pred             cc-----cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCH
Q 013421          163 VE-----LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFST  235 (443)
Q Consensus       163 ~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~  235 (443)
                      ..     ......||+.|+|||++.+..|+ .++|||||||++|||+| |..||.+.+..+....+..+ ..+.|..+++
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS  260 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchH
Confidence            11     11234579999999999877775 89999999999999998 89999998888887777654 4567778999


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          236 GATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ++.+||.+||+.||++|||+.||+++
T Consensus       261 ~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         261 ALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999998874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=431.60  Aligned_cols=250  Identities=22%  Similarity=0.366  Sum_probs=213.1

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCc-----EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGE-----SVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~   82 (443)
                      ++|++++.||+|+||+||+|++..+++     .||+|.+.....  ......+.+|+.+|+++ +|||||++++++.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            689999999999999999999876544     699999876432  22346788999999998 8999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-----------------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN  139 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-----------------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~N  139 (443)
                      .+|+|||||+||+|.+++...                       +.+++..++.++.||+.||+|||++||+||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            999999999999999999754                       248899999999999999999999999999999999


Q ss_pred             EEEcCCCCeEEeeecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChH
Q 013421          140 LLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP  216 (443)
Q Consensus       140 ILl~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~  216 (443)
                      ||++.++++||+|||+|+.......  ...+.+||+.|+|||++.+..|+ .++|||||||++|||++ |.+||.+.+..
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999986554322  23456789999999999887775 89999999999999997 89999886655


Q ss_pred             HHHHHhhhc--cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          217 TLYKKINAA--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       217 ~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      ....++...  .++.|..+|+++.+||.+||+.||++|||++||++|
T Consensus       274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            544444333  456778899999999999999999999999999976

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=421.32  Aligned_cols=253  Identities=25%  Similarity=0.360  Sum_probs=218.9

Q ss_pred             cCeEEeee-eeccCceEEEEEEECCC--CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013421            9 AKYEVGRT-IGEGTFAKVRFAQNRET--GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (443)
Q Consensus         9 ~~y~i~~~-LG~G~~g~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   85 (443)
                      ++|.+.+. ||+|+||+||+|.++.+  +..||||+++...  .....+.+.+|+.+|++++|||||++++++.+ +.+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            56888885 99999999999987643  4579999997653  33456789999999999999999999999875 4589


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-
Q 013421           86 IILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (443)
                      +|||||++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            999999999999998654 579999999999999999999999999999999999999999999999999997654421 


Q ss_pred             --ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHH
Q 013421          164 --ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATS  239 (443)
Q Consensus       164 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~  239 (443)
                        ......+||+.|+|||++.+..++ .++|||||||++|||+| |..||.+.+..+....+..+ ..+.|..+|+++.+
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  243 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA  243 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence              223456789999999999877775 89999999999999998 99999998888887777665 46778889999999


Q ss_pred             HHHHccCCCCCCCCCHHHH---hcCcccc
Q 013421          240 LIHKILDPNPKTRIRIEGI---RKHPWFR  265 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~ei---l~hp~f~  265 (443)
                      ||.+||+.||++|||+.+|   |+|+|+.
T Consensus       244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999888   6778874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-55  Score=429.41  Aligned_cols=260  Identities=32%  Similarity=0.591  Sum_probs=225.6

Q ss_pred             cccCeEEeeeeeccCceEEEEEEE---CCCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhCCC-CCcceEEEEEEeC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQN---RETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIVRH-PNIVRLHEVLASR   81 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~---~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~   81 (443)
                      .+++|++++.||+|+||+||+|.+   ..+|+.||||++++..... ....+.+.+|+.+|++++| |||+++++++.+.
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            468999999999999999999987   4478999999998755322 2234568899999999976 8999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..+|++|||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999976543


Q ss_pred             -ccccccccCCCcccCCCcccccCC-CCCCccchHHHHHHHHHHhhCCCCCCCCChH----HHHHHhhhccCCCCCCCCH
Q 013421          162 -GVELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLP----TLYKKINAAEFSCPFWFST  235 (443)
Q Consensus       162 -~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~s~  235 (443)
                       ......+.+|++.|+|||.+.+.. +.+.++|||||||+||+|++|..||.+.+..    ...+.......++|..+|+
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  261 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  261 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCH
Confidence             333456778999999999987543 3468999999999999999999999775543    3344445566777888999


Q ss_pred             HHHHHHHHccCCCCCCCC-----CHHHHhcCccccc
Q 013421          236 GATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  266 (443)
Q Consensus       236 ~~~~li~~~L~~dP~~R~-----t~~eil~hp~f~~  266 (443)
                      ++.+||.+||++||.+||     |++|+++||||+.
T Consensus       262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            999999999999999999     5899999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=430.09  Aligned_cols=253  Identities=29%  Similarity=0.376  Sum_probs=211.3

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------CC
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------RT   82 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~   82 (443)
                      .+|+.++.||+|+||+||+|++..+|+.||||++.+....       ..+|+.+|++++||||+++++++..      ..
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            3699999999999999999999999999999999775422       2379999999999999999999843      34


Q ss_pred             EEEEEEecCCCCChHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC-CeEEeeecCcCC
Q 013421           83 KVYIILEFVTGGELFD---KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSAL  158 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~---~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~  158 (443)
                      ++|+|||||+++.+..   .......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            6899999997763322   233456799999999999999999999999999999999999999775 899999999876


Q ss_pred             CccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhc-------------
Q 013421          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------  225 (443)
Q Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------  225 (443)
                      .... ....+.+||+.|+|||++.+..+++.++||||+||++|+|++|..||...+.......+...             
T Consensus       173 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         173 LVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             ccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            6443 34566789999999999876665679999999999999999999999887765554443210             


Q ss_pred             ----cCC------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          226 ----EFS------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       226 ----~~~------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                          ...            ....+|+++.+||.+||+.||.+|||+.|+|+||||+.-..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence                001            12347899999999999999999999999999999986543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=429.14  Aligned_cols=259  Identities=27%  Similarity=0.431  Sum_probs=214.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----KV   84 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~   84 (443)
                      ++|++++.||+|+||+||+|++..+|+.||||++++..  .....+.+.+|+.+|+.++||||+++++++....    ..
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            57999999999999999999999999999999997644  3445678899999999999999999999997543    23


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc--
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--  162 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--  162 (443)
                      +++++|+.||+|++++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......  
T Consensus        86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            444556679999999976 57999999999999999999999999999999999999999999999999999765432  


Q ss_pred             -cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc---------------
Q 013421          163 -VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---------------  226 (443)
Q Consensus       163 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------  226 (443)
                       .......+||+.|+|||++.....++.++||||+||++|+|++|..||.+.+............               
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence             1234667899999999999766666799999999999999999999998876544433321100               


Q ss_pred             -------C---------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCCC
Q 013421          227 -------F---------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (443)
Q Consensus       227 -------~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (443)
                             .         ...+.+|+++.+||.+||+.||.+|||++|+|+||||+....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                   0         0123478899999999999999999999999999999876544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=420.97  Aligned_cols=249  Identities=21%  Similarity=0.338  Sum_probs=206.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++++.||+|+||+||+|+..   ..||||+++...... +..+.+.+|+.+|++++|||||++++++.+ +.+|+|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            478999999999999999999753   459999997665433 356789999999999999999999998754 568999


Q ss_pred             EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc--cc
Q 013421           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VE  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--~~  164 (443)
                      ||||+||+|.+++... +++++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|......  ..
T Consensus        82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence            9999999999999764 57999999999999999999999999999999999999999999999999999876442  23


Q ss_pred             cccccCCCcccCCCcccccCC--CCCCccchHHHHHHHHHHhhCCCCCCCCChHHH-HHHhhhccC-----CCCCCCCHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGETDLPTL-YKKINAAEF-----SCPFWFSTG  236 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~-~~~i~~~~~-----~~~~~~s~~  236 (443)
                      ...+.+||+.|+|||++.+..  ..+.++|||||||++|||++|+.||.+.+.... ...+..+..     ..+..+|++
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  241 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA  241 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence            445678999999999986432  235899999999999999999999988665433 333333321     234568999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      +.+||.+||+.||++|||++||+++
T Consensus       242 l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         242 MKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999987

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=420.02  Aligned_cols=251  Identities=23%  Similarity=0.393  Sum_probs=218.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++++.||+|+||+||+|+++ ++..||||+++.....    .+.+.+|+.+|++++|||||++++++.+ +..|+|
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            468999999999999999999985 5788999999765422    3568999999999999999999998755 567999


Q ss_pred             EecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCccc-cc
Q 013421           88 LEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-VE  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~~  164 (443)
                      |||+++|+|.+++...  .++++..+..++.||+.||+|||++||+||||||+||||++++.+||+|||+|+..... ..
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            9999999999977543  36999999999999999999999999999999999999999999999999999876543 23


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      ......||+.|+|||++.+..|+ .++||||+||++|||+| |.+||...+..+....+..+ ....|..+++++.+||.
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  244 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR  244 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHH
Confidence            34456799999999999877775 89999999999999999 56667777777777777654 45677889999999999


Q ss_pred             HccCCCCCCCCCHHHHhc--Ccccc
Q 013421          243 KILDPNPKTRIRIEGIRK--HPWFR  265 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~--hp~f~  265 (443)
                      +||+.||++|||++++++  |+||.
T Consensus       245 ~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         245 LCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            999999999999999998  88885

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-55  Score=413.85  Aligned_cols=247  Identities=22%  Similarity=0.368  Sum_probs=221.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~   88 (443)
                      ++|++++.||+|+||+||+|+++ ++..||||++++....    .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            58999999999999999999985 7889999999876543    256889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-ccc
Q 013421           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-ELL  166 (443)
Q Consensus        89 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~~~  166 (443)
                      ||+++|+|.+++.. ...+++..+.+++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  158 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  158 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence            99999999998765 4578999999999999999999999999999999999999999999999999997654432 233


Q ss_pred             cccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHHHc
Q 013421          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKI  244 (443)
Q Consensus       167 ~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~  244 (443)
                      ...+||+.|+|||++.+..|+ .++|||||||++|||+| |+.||.+.+..+...++..+ ....|...++++.+||.+|
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  237 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC  237 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred             cccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHH
Confidence            456799999999999888775 89999999999999998 89999999988888888765 4566778999999999999


Q ss_pred             cCCCCCCCCCHHHHhcC
Q 013421          245 LDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       245 L~~dP~~R~t~~eil~h  261 (443)
                      |+.||++|||+++|++|
T Consensus       238 l~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         238 WHEKADERPTFKILLSN  254 (258)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCCHhHCcCHHHHHHH
Confidence            99999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=426.79  Aligned_cols=256  Identities=25%  Similarity=0.354  Sum_probs=216.4

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----TK   83 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~   83 (443)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++...     ..
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            689999999999999999999999999999999987543 333457789999999999999999999998633     34


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      .+++|+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++.....  
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--  173 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--  173 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence            4666777889999998855 6899999999999999999999999999999999999999999999999999875543  


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhccCCC--------------
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC--------------  229 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--------------  229 (443)
                       ...+.+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+.......+.......              
T Consensus       174 -~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  252 (348)
T d2gfsa1         174 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  252 (348)
T ss_dssp             -GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred             -ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence             34567899999999998887777799999999999999999999999887666555543221110              


Q ss_pred             -----------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccCC
Q 013421          230 -----------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (443)
Q Consensus       230 -----------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (443)
                                       ...+|+++++||++||+.||.+|||++|+|+||||++...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                             1247899999999999999999999999999999987543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-53  Score=419.07  Aligned_cols=250  Identities=26%  Similarity=0.456  Sum_probs=209.9

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CCE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLAS--RTK   83 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~   83 (443)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++++..      .+.+.+|+.+|+.++ ||||+++++++..  ...
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            4578999999999999999999999999999999997542      356889999999995 9999999999974  456


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCC-CeEEeeecCcCCCccc
Q 013421           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQG  162 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~  162 (443)
                      +|+|||||++++|....   +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|......
T Consensus       107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999999997763   5799999999999999999999999999999999999998655 6999999999766543


Q ss_pred             cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-HHHHHhh-------------hccC-
Q 013421          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKIN-------------AAEF-  227 (443)
Q Consensus       163 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~-------------~~~~-  227 (443)
                       ......+||+.|+|||++.+....+.++||||+||++|+|++|..||...... .....+.             .... 
T Consensus       184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         184 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             -CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence             34567789999999999887665569999999999999999999999765432 1111110             0000 


Q ss_pred             -----------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013421          228 -----------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (443)
Q Consensus       228 -----------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (443)
                                             .....+|+++.+||++||+.||++|||++|+|+||||+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                                   011226899999999999999999999999999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-54  Score=412.20  Aligned_cols=250  Identities=29%  Similarity=0.396  Sum_probs=207.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      .++|++++.||+|+||+||+|++..++   ..||||.++...  .....+.+.+|+.+|++++|||||++++++. ++.+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            368999999999999999999987653   468888886543  3445678999999999999999999999986 4678


Q ss_pred             EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      |+||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            9999999999999987654 578999999999999999999999999999999999999999999999999998654422


Q ss_pred             -ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHHH
Q 013421          164 -ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSL  240 (443)
Q Consensus       164 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l  240 (443)
                       ......+||+.|+|||++.+..|+ .++|||||||++|||++ |.+||.+.+..+...++..+. .+.|..+|+++.+|
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l  241 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL  241 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence             233456789999999999887775 89999999999999997 899999988888888876654 56788899999999


Q ss_pred             HHHccCCCCCCCCCHHHHhcC
Q 013421          241 IHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~h  261 (443)
                      |.+||+.||.+|||++||++|
T Consensus       242 i~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         242 MTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999876

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=409.69  Aligned_cols=253  Identities=23%  Similarity=0.360  Sum_probs=213.0

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (443)
                      .++|++++.||+|+||+||+|+++.+ +.||||+++.....    .+.+.+|+.+|++++|||||++++++.+ +..|+|
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence            47899999999999999999999755 57999999765432    3568999999999999999999999855 567999


Q ss_pred             EecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc-c
Q 013421           88 LEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-E  164 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~  164 (443)
                      |||+++|+|.+++..  .+.+++.++..++.||+.||+|||++||+||||||+||||+.++++||+|||+++...... .
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            999999999988854  3579999999999999999999999999999999999999999999999999998654322 2


Q ss_pred             cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhC-CCCCCCCChHHHHHHhhhc-cCCCCCCCCHHHHHHHH
Q 013421          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (443)
Q Consensus       165 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (443)
                      .....+||+.|+|||++.+..++ .++||||+||++|+|++| .+|+...+..+....+..+ ..+.|..+|+++.+||.
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  248 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC  248 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             eeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHH
Confidence            33456799999999999887775 899999999999999995 5666667777777766544 55778889999999999


Q ss_pred             HccCCCCCCCCCHHHHhc--Ccccccc
Q 013421          243 KILDPNPKTRIRIEGIRK--HPWFRKN  267 (443)
Q Consensus       243 ~~L~~dP~~R~t~~eil~--hp~f~~~  267 (443)
                      +||+.||++|||+++|++  |+||...
T Consensus       249 ~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         249 QCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            999999999999999988  8898754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=423.21  Aligned_cols=256  Identities=29%  Similarity=0.444  Sum_probs=205.1

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE------e
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA------S   80 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~------~   80 (443)
                      .+.+|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.++++++||||+++++++.      +
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            34789999999999999999999999999999999987653 3445677899999999999999999999995      3


Q ss_pred             CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCc
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (443)
                      ...+|+|||||.++ +++.+  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++....
T Consensus        94 ~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          94 FQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             CCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence            47899999999765 44444  3579999999999999999999999999999999999999999999999999987665


Q ss_pred             cccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHHhhhcc--------------
Q 013421          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------  226 (443)
Q Consensus       161 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------------  226 (443)
                      .. ......+||+.|+|||++.+..++ .++||||+||++|+|++|++||.+.+......++....              
T Consensus       171 ~~-~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         171 TS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             -----------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             cc-cccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            43 344567899999999999887665 89999999999999999999998877655444332110              


Q ss_pred             --------CC--------------CC------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccccC
Q 013421          227 --------FS--------------CP------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (443)
Q Consensus       227 --------~~--------------~~------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (443)
                              ..              .+      ...|+++.+||++||..||++|||++|+|+||||+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                    00              00      01467899999999999999999999999999998754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-53  Score=405.12  Aligned_cols=251  Identities=25%  Similarity=0.332  Sum_probs=209.3

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCC----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETG----ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      ..+.|++.+.||+|+||+||+|.++.++    ..||||+++....  ......+.+|+.+|++++|||||++++++.+.+
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            3467999999999999999999987654    4799999976542  334567899999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcc
Q 013421           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (443)
                      ..++||||+.++++.+.+... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999999999988765 5799999999999999999999999999999999999999999999999999986544


Q ss_pred             ccc---cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhC-CCCCCCCChHHHHHHhhhc-cCCCCCCCCHH
Q 013421          162 GVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAA-EFSCPFWFSTG  236 (443)
Q Consensus       162 ~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~  236 (443)
                      ...   ......||+.|+|||++.+..|+ .++|||||||++|||++| .+||...+..+....+..+ ..+.|..++++
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA  241 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence            222   23345689999999999887775 899999999999999985 5666667777777776554 45677779999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhc
Q 013421          237 ATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      +.+||.+||+.||++|||+.||++
T Consensus       242 l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         242 IYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHCcCCHhHCcCHHHHHH
Confidence            999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-53  Score=413.08  Aligned_cols=250  Identities=22%  Similarity=0.322  Sum_probs=211.8

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      ++|++++.||+|+||+||+|.+..+|+    .||+|.+....  ..+..+.+.+|+.+|++++|||||++++++.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            679999999999999999999988876    57888776443  222357799999999999999999999999875 56


Q ss_pred             EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      ++++||+.+|+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||++.......
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            7888999999999988764 579999999999999999999999999999999999999999999999999998654422


Q ss_pred             c--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc-CCCCCCCCHHHHH
Q 013421          164 E--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATS  239 (443)
Q Consensus       164 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~  239 (443)
                      .  ......||+.|+|||++.+..|+ .++|||||||++|||+| |.+||.+.+..+....+..+. ++.|..+++++.+
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~  244 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM  244 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred             ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence            2  23345689999999999887775 89999999999999998 899999988888877776654 6677889999999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcCc
Q 013421          240 LIHKILDPNPKTRIRIEGIRKHP  262 (443)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp  262 (443)
                      ||.+||+.||.+|||+.||+.|.
T Consensus       245 li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         245 IMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhCCCChhhCcCHHHHHHHH
Confidence            99999999999999999999984

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=408.53  Aligned_cols=251  Identities=22%  Similarity=0.330  Sum_probs=216.2

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcE--EEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGES--VAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   83 (443)
                      .+++|++.+.||+|+||+||+|+++.+|..  ||||.++...  ..+..+.+.+|+.+|+++ +|||||++++++.+++.
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            456999999999999999999999888874  6677765433  233456789999999999 79999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCC
Q 013421           84 VYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN  147 (443)
Q Consensus        84 ~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~  147 (443)
                      +|+||||++||+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence            99999999999999999653                57899999999999999999999999999999999999999999


Q ss_pred             eEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhC-CCCCCCCChHHHHHHhhhc-
Q 013421          148 LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAA-  225 (443)
Q Consensus       148 ~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~-  225 (443)
                      +||+|||++...... ......+||+.|+|||.+.+..|+ .++|||||||++|+|++| .+||.+.+..++...+..+ 
T Consensus       166 ~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~  243 (309)
T d1fvra_         166 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  243 (309)
T ss_dssp             EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             eEEcccccccccccc-ccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence            999999999765442 223456799999999999887775 899999999999999996 5689888888888887664 


Q ss_pred             cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          226 EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       226 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+..|..+++++.+||.+||+.||++|||+++|++|
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            566777899999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=403.63  Aligned_cols=251  Identities=25%  Similarity=0.406  Sum_probs=205.8

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC-CCc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE-TGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   84 (443)
                      -++|++++.||+|+||+||+|+... +++  .||||++.+......+..+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            4679999999999999999998643 333  689999987766566667889999999999999999999999976 467


Q ss_pred             EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      ++||||+++|++.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            8999999999999887654 579999999999999999999999999999999999999999999999999998654421


Q ss_pred             ---ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhhcc--CCCCCCCCHHH
Q 013421          164 ---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE--FSCPFWFSTGA  237 (443)
Q Consensus       164 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~  237 (443)
                         .......|++.|+|||++.+..++ .++|||||||++|||++ |.+||.+.+..+...++....  ++.|..+|+++
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l  244 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI  244 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred             CcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence               123445688899999999887664 89999999999999998 899999999888888876554  45566799999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhc
Q 013421          238 TSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .+||.+||+.||++|||+++|++
T Consensus       245 ~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         245 YNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=398.94  Aligned_cols=244  Identities=24%  Similarity=0.432  Sum_probs=208.4

Q ss_pred             cccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEE
Q 013421            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA-SRTKVY   85 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~   85 (443)
                      .+++|++++.||+|+||.||+|+++  |..||||+++++.     ..+.+.+|+.++++++||||+++++++. +++.+|
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence            4678999999999999999999984  7889999997643     3467889999999999999999999885 456789


Q ss_pred             EEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc
Q 013421           86 IILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        86 lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (443)
                      +||||+++|+|.+++...+  .+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||++.....  
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--  155 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--  155 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC--
Confidence            9999999999999996643  589999999999999999999999999999999999999999999999999976433  


Q ss_pred             ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHHHhhh-ccCCCCCCCCHHHHHHH
Q 013421          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-AEFSCPFWFSTGATSLI  241 (443)
Q Consensus       164 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~s~~~~~li  241 (443)
                       .....++|+.|+|||++.+..++ .++|||||||++|||++ |.+||...+..+....+.. ..++.|..+++++.+||
T Consensus       156 -~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li  233 (262)
T d1byga_         156 -TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM  233 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred             -CCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence             23456789999999999887774 99999999999999998 7999999888888888765 45678888999999999


Q ss_pred             HHccCCCCCCCCCHHHHhcC
Q 013421          242 HKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+||+.||.+|||+.+++++
T Consensus       234 ~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         234 KNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcccCHhHCcCHHHHHHH
Confidence            99999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-52  Score=404.88  Aligned_cols=250  Identities=24%  Similarity=0.322  Sum_probs=217.4

Q ss_pred             ccCeEEeeeeeccCceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      .++|++++.||+|+||+||+|+++     .+++.||||+++...  ..+..+.+.+|+.+|++++||||+++++++.+.+
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            357999999999999999999875     356789999997654  3334678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCC
Q 013421           83 KVYIILEFVTGGELFDKIVHQG------------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE  138 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~~------------------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~  138 (443)
                      ..+++|||+++|+|.+++....                        .+++..+..++.||+.||+|||++||+||||||+
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~  169 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  169 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence            9999999999999999996532                        4788999999999999999999999999999999


Q ss_pred             cEEEcCCCCeEEeeecCcCCCccc--cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCC-CCCCCCCh
Q 013421          139 NLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY-LPFGETDL  215 (443)
Q Consensus       139 NILl~~~~~~kL~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~-~Pf~~~~~  215 (443)
                      |||++.++++||+|||+|......  .....+.+|++.|+|||++.+..|+ .++|||||||++|||++|. +||.+.+.
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            999999999999999998754332  2234467899999999999887776 8999999999999999985 78998888


Q ss_pred             HHHHHHhhhccC-CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          216 PTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       216 ~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .+....+..+.. +.|..+++++.+||.+||+.||++|||+.||++
T Consensus       249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            888888776654 467789999999999999999999999999865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=404.40  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=202.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS-   80 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-   80 (443)
                      .++|++++.||+|+||+||+|.+..     +++.||||+++....  ....+.+.+|..++.++ +||||+.+++++.+ 
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            3689999999999999999999754     456899999976442  33456677888888776 68999999998765 


Q ss_pred             CCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC
Q 013421           81 RTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS  144 (443)
Q Consensus        81 ~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~  144 (443)
                      +..+++|||||++|+|.+++...                ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence            45689999999999999999753                34889999999999999999999999999999999999999


Q ss_pred             CCCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhC-CCCCCCCChHHH-HH
Q 013421          145 YGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTL-YK  220 (443)
Q Consensus       145 ~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~-~~  220 (443)
                      ++++||+|||+|+......  ....+.+||+.|+|||++.+..|+ .++||||+||++|+|++| .+||.+.+.... ..
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~  248 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  248 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999997654422  234456899999999999887764 999999999999999986 578877654443 34


Q ss_pred             Hhhh-ccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          221 KINA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       221 ~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                      .+.. ..+..|..+++++.+||.+||+.||++|||++||++|
T Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4433 3566777899999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-52  Score=402.75  Aligned_cols=250  Identities=24%  Similarity=0.404  Sum_probs=215.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECCCC-------cEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRETG-------ESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLA   79 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~   79 (443)
                      .++|++++.||+|+||.||+|++..++       ..||||+++++.  .......+.+|...+.++ +|||||++++++.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            478999999999999999999976554       479999997754  233457788899998888 8999999999999


Q ss_pred             eCCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc
Q 013421           80 SRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD  143 (443)
Q Consensus        80 ~~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~  143 (443)
                      +++.+|+||||+++|+|.++|...                ..+++.++..++.||+.||+|||++||+||||||+|||++
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence            999999999999999999999754                3589999999999999999999999999999999999999


Q ss_pred             CCCCeEEeeecCcCCCccc--cccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHH
Q 013421          144 SYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK  220 (443)
Q Consensus       144 ~~~~~kL~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~  220 (443)
                      .++.+||+|||++......  .......+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+.....+
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~  248 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  248 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence            9999999999999866442  1234556799999999999887775 99999999999999998 799999988888888


Q ss_pred             Hhhhc-cCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          221 KINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       221 ~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      .+..+ .+..|.++|+++.+||.+||+.||++|||+.||++
T Consensus       249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            77654 56778889999999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-51  Score=397.59  Aligned_cols=255  Identities=22%  Similarity=0.274  Sum_probs=221.6

Q ss_pred             ccCeEEeeeeeccCceEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   82 (443)
                      .++|++++.||+|+||+||+|.+..     ++..||||++++..  ..+....+.+|+.++++++||||+++++++..++
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            3789999999999999999998752     35789999997654  3334567899999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEee
Q 013421           83 KVYIILEFVTGGELFDKIVHQ----------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (443)
Q Consensus        83 ~~~lv~Ey~~gg~L~~~i~~~----------~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (443)
                      ..++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++||+|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence            999999999999999988643          2468899999999999999999999999999999999999999999999


Q ss_pred             ecCcCCCccccc--cccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhC-CCCCCCCChHHHHHHhhhc-cCC
Q 013421          153 FGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAA-EFS  228 (443)
Q Consensus       153 FGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~-~~~  228 (443)
                      ||++........  .....+||+.|+|||.+.+..+. .++|||||||++|||++| .+||.+.+..+....+..+ ...
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~  255 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD  255 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            999986644322  23445789999999999887775 899999999999999998 6899998888888877664 455


Q ss_pred             CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc------Ccccc
Q 013421          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK------HPWFR  265 (443)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~------hp~f~  265 (443)
                      .|..+|+.+.++|.+||+.||++|||+++|++      +|+|+
T Consensus       256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~  298 (308)
T d1p4oa_         256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  298 (308)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence            67789999999999999999999999999998      56664

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=395.05  Aligned_cols=250  Identities=24%  Similarity=0.355  Sum_probs=214.2

Q ss_pred             ccCeEEeeeeeccCceEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013421            8 VAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (443)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~   81 (443)
                      .++|++++.||+|+||.||+|++.     .+++.||||+++....  ......+.+|+.+++.+ +|||||++++++.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            378999999999999999999863     4677999999986542  33456789999999999 799999999999999


Q ss_pred             CEEEEEEecCCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc
Q 013421           82 TKVYIILEFVTGGELFDKIVHQG------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD  143 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L~~~i~~~~------------------~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~  143 (443)
                      +..|++||||++|+|.+++....                  .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence            99999999999999999997543                  589999999999999999999999999999999999999


Q ss_pred             CCCCeEEeeecCcCCCcccc--ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhh-CCCCCCCCChHHHHH
Q 013421          144 SYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK  220 (443)
Q Consensus       144 ~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~  220 (443)
                      .++++|++|||++.......  ......+||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||...+......
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999998765432  23345679999999999987666 499999999999999998 677777766555444


Q ss_pred             Hh-hh-ccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          221 KI-NA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       221 ~i-~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                      ++ .. .....|..+|+++.+||.+||+.||++|||+++|++
T Consensus       259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            43 33 244556678999999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=385.34  Aligned_cols=247  Identities=23%  Similarity=0.271  Sum_probs=204.6

Q ss_pred             EEeeeeeccCceEEEEEEECCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEE
Q 013421           12 EVGRTIGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-RTKVYII   87 (443)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv   87 (443)
                      .+.+.||+|+||+||+|++..++   ..||||.+++..  .....+.+.+|+++|++++||||+++++++.+ +...++|
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            34678999999999999987653   368999987533  34456889999999999999999999999765 5689999


Q ss_pred             EecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecCcCCCcccc---
Q 013421           88 LEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV---  163 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~---  163 (443)
                      ||||++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++......   
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            99999999999887544 57788899999999999999999999999999999999999999999999998654321   


Q ss_pred             -ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCC-CChHHHHHHhhh-ccCCCCCCCCHHHHHH
Q 013421          164 -ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINA-AEFSCPFWFSTGATSL  240 (443)
Q Consensus       164 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~-~~~~~~~~~s~~~~~l  240 (443)
                       .......||+.|+|||++.+..+ +.++||||||+++|||++|..||.. .+..+....+.. ..+..|..+++++.+|
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l  266 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV  266 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence             12234568999999999987776 4999999999999999997776654 333344444443 3566778899999999


Q ss_pred             HHHccCCCCCCCCCHHHHhcC
Q 013421          241 IHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~h  261 (443)
                      |.+||+.||++|||+.||++|
T Consensus       267 i~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         267 MLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-49  Score=381.00  Aligned_cols=253  Identities=21%  Similarity=0.284  Sum_probs=202.9

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRTKVYII   87 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lv   87 (443)
                      ++|++++.||+|+||+||+|++..+|+.||||++......     +.+.+|+++++.++|+| |+.+..++.+.+..++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            4699999999999999999999999999999998765422     34778999999998766 55566777889999999


Q ss_pred             EecCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEc---CCCCeEEeeecCcCCCcccc
Q 013421           88 LEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD---SYGNLKVSDFGLSALPQQGV  163 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~---~~~~~kL~DFGls~~~~~~~  163 (443)
                      |||+ +++|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++   .+..+||+|||+|.......
T Consensus        82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9999 455655554 456899999999999999999999999999999999999986   34579999999998654321


Q ss_pred             -------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChHHHHHH---hhhccC-----C
Q 013421          164 -------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK---INAAEF-----S  228 (443)
Q Consensus       164 -------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~---i~~~~~-----~  228 (443)
                             ....+.+||+.|+|||++.+.+++ .++|||||||++|+|++|..||...........   ......     .
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  239 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence                   123456899999999999887775 999999999999999999999987554332221   111111     1


Q ss_pred             CCCCCCHHHHHHHHHccCCCCCCCCCHH---HHhcCccccccC
Q 013421          229 CPFWFSTGATSLIHKILDPNPKTRIRIE---GIRKHPWFRKNY  268 (443)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~---eil~hp~f~~~~  268 (443)
                      .+..+|+++.++|.+||+.||.+||+++   ++++|+|.+..+
T Consensus       240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~  282 (299)
T d1ckia_         240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  282 (299)
T ss_dssp             HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence            2346899999999999999999999987   457788776544

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.2e-48  Score=371.65  Aligned_cols=245  Identities=20%  Similarity=0.291  Sum_probs=206.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-PNIVRLHEVLASRTKVYII   87 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv   87 (443)
                      ++|++++.||+|+||+||+|++..+|+.||||++.....     ...+.+|+++++.++| +||+.+++++.+....|+|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            589999999999999999999999999999999876432     2346789999999965 8999999999999999999


Q ss_pred             EecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcC-----CCCeEEeeecCcCCCcc
Q 013421           88 LEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-----YGNLKVSDFGLSALPQQ  161 (443)
Q Consensus        88 ~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~-----~~~~kL~DFGls~~~~~  161 (443)
                      |||+ +++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+....
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999 789999887654 6999999999999999999999999999999999999974     57899999999976543


Q ss_pred             cc-------ccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCCh---HHHHHHhhhccCC---
Q 013421          162 GV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---PTLYKKINAAEFS---  228 (443)
Q Consensus       162 ~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~---  228 (443)
                      ..       ....+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.   .....++......   
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            21       123456899999999999887775 899999999999999999999976433   2333333322211   


Q ss_pred             --CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013421          229 --CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (443)
Q Consensus       229 --~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (443)
                        .+..+|+++.+++..|+..+|++||+.+.+.+
T Consensus       238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence              23458899999999999999999999887654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=371.34  Aligned_cols=246  Identities=21%  Similarity=0.322  Sum_probs=191.7

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----KV   84 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~   84 (443)
                      .+|.+.+.||+|+||.||+|++  +|+.||||+++...    ........|+..++.++||||+++++++.+++    .+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            4789999999999999999986  58999999986542    11122334566667889999999999997543    68


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCEeecCCCCcEEEcCCCCeEEeeecCc
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS--------KGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~--------~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (443)
                      |+||||+++|+|.+++.+ .++++.....++.|++.||.|||+        +||+||||||+||||+.+|++||+|||++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999999976 579999999999999999999996        59999999999999999999999999999


Q ss_pred             CCCccccc----cccccCCCcccCCCcccccCCC-----CCCccchHHHHHHHHHHhhCCCCCCCCC-------------
Q 013421          157 ALPQQGVE----LLHTTCGTPNYVAPEVLSNRGY-----DGSAADVWSCGVILFVLMAGYLPFGETD-------------  214 (443)
Q Consensus       157 ~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DIwSlGvil~~ll~G~~Pf~~~~-------------  214 (443)
                      ........    .....+||+.|+|||++.+...     .+.++|||||||+||||++|..||....             
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            76543221    2346789999999999865431     2368999999999999999998874321             


Q ss_pred             --hHHHHHHhhhccC--CCCCC-----CCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013421          215 --LPTLYKKINAAEF--SCPFW-----FSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (443)
Q Consensus       215 --~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (443)
                        .............  ..|..     ....+.+|+.+||+.||++|||+.||+++
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              1222222222222  22221     22358899999999999999999998773

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-46  Score=373.48  Aligned_cols=251  Identities=23%  Similarity=0.426  Sum_probs=197.0

Q ss_pred             cCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----------CCCcceEEEE
Q 013421            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-----------HPNIVRLHEV   77 (443)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~   77 (443)
                      ++|++++.||+|+||+||+|++..+|+.||||+++++..    ..+.+.+|+.+++.++           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            469999999999999999999999999999999986532    2356778998888775           5789999988


Q ss_pred             EE--eCCEEEEEEecCCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEeecCCCCcEEEcCCCC----
Q 013421           78 LA--SRTKVYIILEFVTGGELFDKI---VHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGN----  147 (443)
Q Consensus        78 ~~--~~~~~~lv~Ey~~gg~L~~~i---~~~~~l~e~~~~~~~~qll~aL~yLH~-~gi~HrDlkp~NILl~~~~~----  147 (443)
                      +.  .....+++++++..+......   .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.    
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            75  456777888877655433322   233578999999999999999999998 89999999999999987654    


Q ss_pred             --eEEeeecCcCCCccccccccccCCCcccCCCcccccCCCCCCccchHHHHHHHHHHhhCCCCCCCCChH-------HH
Q 013421          148 --LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-------TL  218 (443)
Q Consensus       148 --~kL~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-------~~  218 (443)
                        ++++|||.+.....   .....+||+.|+|||++.+..|+ .++||||+||++++|++|+.||...+..       ..
T Consensus       169 ~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             ceeeEeeccccccccc---ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence              99999999875443   33567899999999999888875 8999999999999999999999653311       00


Q ss_pred             HHHhh-----------h------------------------------ccCCCCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 013421          219 YKKIN-----------A------------------------------AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEG  257 (443)
Q Consensus       219 ~~~i~-----------~------------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e  257 (443)
                      ...+.           .                              .....+...++++.+||.+||+.||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            00000           0                              001111224678999999999999999999999


Q ss_pred             HhcCcccccc
Q 013421          258 IRKHPWFRKN  267 (443)
Q Consensus       258 il~hp~f~~~  267 (443)
                      +|+||||+..
T Consensus       325 ~L~Hp~f~~~  334 (362)
T d1q8ya_         325 LVNHPWLKDT  334 (362)
T ss_dssp             HHTCGGGTTC
T ss_pred             HhcCcccCCC
Confidence            9999999854

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=3.4e-26  Score=205.21  Aligned_cols=137  Identities=16%  Similarity=0.236  Sum_probs=109.7

Q ss_pred             eEEeeeeeccCceEEEEEEECCCCcEEEEEEeeccccc---------------chHHHHHHHHHHHHHHhCCCCCcceEE
Q 013421           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL---------------KHRMVDQIKREISIMKIVRHPNIVRLH   75 (443)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~HpnIv~l~   75 (443)
                      |.+++.||+|+||+||+|++. +|+.||||++......               .........+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568999999999999999985 6899999987542211               011123456789999999999999988


Q ss_pred             EEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEeecCCCCcEEEcCCCCeEEeeecC
Q 013421           76 EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (443)
Q Consensus        76 ~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (443)
                      ++..    .+++|||+++..+.       .+++..+..++.|++.||.|||++||+||||||+|||++++ .++|+|||+
T Consensus        81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            7632    27999999886553       35666778899999999999999999999999999999965 589999999


Q ss_pred             cCCCc
Q 013421          156 SALPQ  160 (443)
Q Consensus       156 s~~~~  160 (443)
                      |....
T Consensus       149 a~~~~  153 (191)
T d1zara2         149 SVEVG  153 (191)
T ss_dssp             CEETT
T ss_pred             cccCC
Confidence            86554

>d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Kinase associated domain 1, KA1
domain: Map/microtubule affinity-regulating kinase 3
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.42  E-value=4.2e-13  Score=105.27  Aligned_cols=84  Identities=13%  Similarity=0.165  Sum_probs=78.0

Q ss_pred             EeCCCHHHHHHHHHHHHHHcCcEEEee-cceEEEeeeccCCCccEEEEEEEEEEc-CceEEEEEEecCCCchHHHHHHHH
Q 013421          342 VSRQPAQVILSNIEAVAESLSLKVHTR-NYKTRLEGVSANKTGQFAVVLEVFEVA-PSLFMVDVRKAAGDTLEYHKFYKN  419 (443)
Q Consensus       342 ~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~~~~  419 (443)
                      +|..+|++|+..|+++++.+|+.|+.+ .|.++.+...+++++.+.|.+||+++. +++++|+|+|.+||+++|+++|.+
T Consensus        16 TS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l~~~   95 (102)
T d1ul7a_          16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK   95 (102)
T ss_dssp             CBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHHHHH
T ss_pred             CcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHHHHH
Confidence            689999999999999999999999876 488999988888899999999999995 799999999999999999999999


Q ss_pred             HHHhcc
Q 013421          420 FCAKLE  425 (443)
Q Consensus       420 ~~~~l~  425 (443)
                      |...|+
T Consensus        96 il~~l~  101 (102)
T d1ul7a_          96 IANELK  101 (102)
T ss_dssp             HHHHCC
T ss_pred             HHHhcc
Confidence            998875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.64  E-value=6e-08  Score=88.60  Aligned_cols=142  Identities=15%  Similarity=0.120  Sum_probs=99.4

Q ss_pred             ccccCeEEeeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 013421            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKV   84 (443)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~   84 (443)
                      ..++.|+..+..+.++.+.||+..  .++..+.+|+........   ...+.+|...++.+. +-.+.+++.+..+++..
T Consensus        11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_          11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            346789988887777778999875  356678888876543221   234678888888774 44467888888889999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 013421           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-------------------------------------  127 (443)
Q Consensus        85 ~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~yLH~-------------------------------------  127 (443)
                      |+||++++|..+.+....     ......+..++...+..||+                                     
T Consensus        86 ~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            999999999877554321     11122334444444444443                                     


Q ss_pred             ----------------------CCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421          128 ----------------------KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus       128 ----------------------~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                                            ..++|+|+.|.|||+++++..-|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  137999999999999976666799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.19  E-value=2.6e-06  Score=76.90  Aligned_cols=82  Identities=15%  Similarity=0.182  Sum_probs=56.8

Q ss_pred             cccCeEEeeeeeccC-ceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCE
Q 013421            7 RVAKYEVGRTIGEGT-FAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR--HPNIVRLHEVLASRTK   83 (443)
Q Consensus         7 ~~~~y~i~~~LG~G~-~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~   83 (443)
                      ++..+++.. +..|. .+.||+... .++..+.+|......      ...+..|...++.+.  .-.+.+++.+..+++.
T Consensus         9 ~l~g~~~~~-~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~   80 (255)
T d1nd4a_           9 RLFGYDWAQ-QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR   80 (255)
T ss_dssp             TTTTCEEEE-CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred             hccCCceEE-cCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccc
Confidence            345566644 44444 478998875 456778889765432      134677888888774  3346778888888889


Q ss_pred             EEEEEecCCCCCh
Q 013421           84 VYIILEFVTGGEL   96 (443)
Q Consensus        84 ~~lv~Ey~~gg~L   96 (443)
                      .+++|++++|.++
T Consensus        81 ~~~v~~~i~G~~~   93 (255)
T d1nd4a_          81 DWLLLGEVPGQDL   93 (255)
T ss_dssp             EEEEEECCSSEET
T ss_pred             eEEEEEeeecccc
Confidence            9999999988655

>d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.17  E-value=6.4e-06  Score=66.77  Aligned_cols=72  Identities=15%  Similarity=0.263  Sum_probs=60.4

Q ss_pred             EEeCCCHHHHHHHHHHHHHHcCcEEEeec-ceEEEeeeccCCCccEEEEEEEEEEcCceEEEEEEecCCCchH
Q 013421          341 FVSRQPAQVILSNIEAVAESLSLKVHTRN-YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLE  412 (443)
Q Consensus       341 f~s~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le  412 (443)
                      .-|...|.+|+..|..|++.||+.|++.+ |.|+++.........+.|.+++|++.++.+||||+...|+-.|
T Consensus         5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e   77 (153)
T d2v8qa1           5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE   77 (153)
T ss_dssp             EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred             cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence            45788999999999999999999998765 7888886655545667899999999999999999999998665

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.09  E-value=3.9e-06  Score=81.38  Aligned_cols=81  Identities=15%  Similarity=0.176  Sum_probs=50.2

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeeccccc--c--hHHHHHHHHHHHHHHhCC-C--CCcceEEEEEEeCCEEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL--K--HRMVDQIKREISIMKIVR-H--PNIVRLHEVLASRTKVYI   86 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~--~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~l   86 (443)
                      .+.||.|....||++.+..+++.+++|.-......  .  ....++...|...|+.+. +  ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            46799999999999998878889999964321100  0  001234557888887762 3  345666654  4445578


Q ss_pred             EEecCCCCCh
Q 013421           87 ILEFVTGGEL   96 (443)
Q Consensus        87 v~Ey~~gg~L   96 (443)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Snf1-like protein kinase ssp2
species: Schizosaccharomyces pombe [TaxId: 4896]

Probab=97.66  E-value=0.00014  Score=57.42  Aligned_cols=88  Identities=18%  Similarity=0.228  Sum_probs=64.8

Q ss_pred             eeeEEeCCCHHHHHHHHHHHHHHcCcEEEeec----------ceEEEeeec-----cCCCccEEEEEEEEEEcCceEEEE
Q 013421          338 QTRFVSRQPAQVILSNIEAVAESLSLKVHTRN----------YKTRLEGVS-----ANKTGQFAVVLEVFEVAPSLFMVD  402 (443)
Q Consensus       338 ~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~----------~~~~~~~~~-----~~~~~~l~~~~~i~~~~~~~~~v~  402 (443)
                      .-..-|...|.+|+-.|..|+++||+.|++-+          +.|+++...     .....-+.+.+++|++.++.+|||
T Consensus         4 hfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlD   83 (127)
T d2qrda1           4 HFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLD   83 (127)
T ss_dssp             EESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEE
T ss_pred             eeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEE
Confidence            33456889999999999999999999997643          567776331     122334678999999999999999


Q ss_pred             EE------ecCC-------------CchHHHHHHHHHHHhcc
Q 013421          403 VR------KAAG-------------DTLEYHKFYKNFCAKLE  425 (443)
Q Consensus       403 ~~------~~~G-------------d~le~~~~~~~~~~~l~  425 (443)
                      |+      ...+             .+.+|-.+|.+|...|.
T Consensus        84 FK~dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~  125 (127)
T d2qrda1          84 VKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF  125 (127)
T ss_dssp             EEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred             EccCCcccccCCccccccCccccccCCccHHHHHHHHHHHHh
Confidence            98      2222             24678888887776654

>d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Carbon catabolite-derepressing protein kinase SNF1
species: Saccharomyces cerevisiae [TaxId: 4932]

Probab=97.29  E-value=0.00061  Score=56.57  Aligned_cols=70  Identities=13%  Similarity=0.219  Sum_probs=51.6

Q ss_pred             cceeeEEeCCCHHHHHHHHHHHHHHcCcEEEeec----ceEEEeeecc---------CCCccEEEEEEEEEEcCceEEEE
Q 013421          336 KRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRN----YKTRLEGVSA---------NKTGQFAVVLEVFEVAPSLFMVD  402 (443)
Q Consensus       336 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~---------~~~~~l~~~~~i~~~~~~~~~v~  402 (443)
                      ++.-..-|..+|.+|+-.|.+|++.||+.|++.+    +.|++....+         .....+.|.+++|++.++.+|||
T Consensus        45 kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlD  124 (171)
T d2qlva1          45 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD  124 (171)
T ss_dssp             CCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEE
T ss_pred             eeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEE
Confidence            5666678999999999999999999999997643    6677764211         11123679999999999999999


Q ss_pred             EEe
Q 013421          403 VRK  405 (443)
Q Consensus       403 ~~~  405 (443)
                      |+-
T Consensus       125 FK~  127 (171)
T d2qlva1         125 FKF  127 (171)
T ss_dssp             EEE
T ss_pred             Eec
Confidence            974

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.13  E-value=0.00057  Score=63.71  Aligned_cols=69  Identities=16%  Similarity=0.136  Sum_probs=45.5

Q ss_pred             ceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc--ceEE-----EEEEeCCEEEEEEecCCCC
Q 013421           22 FAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI--VRLH-----EVLASRTKVYIILEFVTGG   94 (443)
Q Consensus        22 ~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~-----~~~~~~~~~~lv~Ey~~gg   94 (443)
                      --.||++.. ++|+.|++|+.......    .+++..|...+..|....+  +...     ..+......+.++++++|.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            468999876 46888999998765322    3567788888877742221  1111     2234567889999999764


Q ss_pred             C
Q 013421           95 E   95 (443)
Q Consensus        95 ~   95 (443)
                      .
T Consensus       110 ~  110 (325)
T d1zyla1         110 Q  110 (325)
T ss_dssp             E
T ss_pred             C
Confidence            3

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.01  E-value=0.0013  Score=63.02  Aligned_cols=77  Identities=13%  Similarity=0.173  Sum_probs=52.3

Q ss_pred             CeEEeeeeeccCceEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 013421           10 KYEVGRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASR   81 (443)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~   81 (443)
                      ..++ +.|+.|..-.+|++....       .++.|.+++.-...  .  . -...+|..+++.+. +.-..++++++.+ 
T Consensus        44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~--~-idr~~E~~i~~~ls~~gl~Pkll~~~~~-  116 (395)
T d1nw1a_          44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T--E-SHLVAESVIFTLLSERHLGPKLYGIFSG-  116 (395)
T ss_dssp             GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C--H-HHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred             ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--h--h-hHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence            3444 789999999999998653       34567888765321  1  1 23568999999884 4334577777643 


Q ss_pred             CEEEEEEecCCCCCh
Q 013421           82 TKVYIILEFVTGGEL   96 (443)
Q Consensus        82 ~~~~lv~Ey~~gg~L   96 (443)
                         ++|+||++|..+
T Consensus       117 ---g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ---GRLEEYIPSRPL  128 (395)
T ss_dssp             ---EEEECCCCEEEC
T ss_pred             ---ceEEEEeccccC
Confidence               689999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.50  E-value=0.0041  Score=57.05  Aligned_cols=137  Identities=16%  Similarity=0.152  Sum_probs=71.9

Q ss_pred             eeeeeccCceEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-----CCcceEE---EEEEeCCEEE
Q 013421           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-----PNIVRLH---EVLASRTKVY   85 (443)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-----pnIv~l~---~~~~~~~~~~   85 (443)
                      .+.|..|---+.|+.... +| .+++|++....     ..+.+..|+.+|..|..     |..+...   .+..-....+
T Consensus        23 ~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~   95 (316)
T d2ppqa1          23 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   95 (316)
T ss_dssp             EEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             eecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence            344567777889998764 34 48999986532     12345567777777642     2222210   1123345666


Q ss_pred             EEEecCCCCChHH--------------HHHh---c------CCCCHHH------------------HHHHHHHHHHHHHH
Q 013421           86 IILEFVTGGELFD--------------KIVH---Q------GRLLEND------------------CRRYFQQLIDAVAH  124 (443)
Q Consensus        86 lv~Ey~~gg~L~~--------------~i~~---~------~~l~e~~------------------~~~~~~qll~aL~y  124 (443)
                      .++.+..|.....              .+..   .      .......                  ....+..+...+.-
T Consensus        96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  175 (316)
T d2ppqa1          96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  175 (316)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence            7777766543210              0000   0      0001111                  11122222222222


Q ss_pred             HHh----CCCEeecCCCCcEEEcCCCCeEEeeecCcC
Q 013421          125 CHS----KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (443)
Q Consensus       125 LH~----~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (443)
                      .+.    .|++|+|+.++||+++.++..-+.||+.+.
T Consensus       176 ~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         176 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            222    479999999999999988777899999764